FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Smith, IO
   Baumann, MJ
   McCabe, LR
AF Smith, IO
   Baumann, MJ
   McCabe, LR
TI Electrostatic interactions as a predictor for osteoblast attachment to
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE zeta-potential; osteoblasts; Ti6A14V; CoCrMo; 316L stainless steel
ID INTERPARTICLE POTENTIALS; PARTICLE PACKING; SUSPENSION; BONE
AB The present study utilizes zeta (zeta)-potential analysis as an indicator of bonding of osteoblasts and whole bone to various biomaterials. Common metal alloys (316L stainless steel, CoCrMo, and Ti6Al4V) and bioceramics (hydroxyapatite and beta-tricalcium phosphate) used in orthopedic applications were suspended in particulate form in physiologic saline, both as-received and supplemented with bovine serum albumin (BSA). Metal alloys were also treated with NaOH washing to study the effect of such a surface treatment on the zeta-potential. The NaOH wash was found to increase the zeta-potential for CoCrMo and Ti6Al4V, but there was a decrease in the magnitude of the -potential for 316L stainless steel. When the metal alloy powders were suspended in BSA-supplemented physiologic saline, the -potential as a function of pH increased, thereby increasing the electronegativity gap and increasing the propensity for bonding between each of the metal alloys and bone. This increase is likely due to matrix proteins in the BSA, which adsorb onto the metal alloy surfaces, promoting bone growth. With the addition of BSA to each bioceramic system, a uniform decrease in zeta-potential was observed. However, the electronegativity gap remained large in each case, maintaining the anticipation of bonding. zeta-Potential analysis is an effective predictor of biomaterial attraction to osteoblasts and bone, providing a useful in vitro method for predicting such interactions. (C) 2004 Wiley Periodicals, Inc.
C1 Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
   Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.
RP Baumann, MJ (reprint author), Michigan State Univ, Dept Chem Engn & Mat Sci, 3509 Engn Bldg, E Lansing, MI 48824 USA.
EM mbaumann@msu.edu
OI McCabe, Laura/0000-0001-5407-162X
CR BOEHM HP, 1971, DISCUSS FARADAY SOC, P264
   CHANG JC, 1991, J AM CERAM SOC, V74, P2201, DOI 10.1111/j.1151-2916.1991.tb08284.x
   CRIMP MJ, 1995, J MAT SCI ENG A, V192, P633
   CRIMP MJ, 1995, P AM CER SOC SCI TEC, P91
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Gross KA, 2002, KEY ENG MAT, V218-2, P165, DOI 10.4028/www.scientific.net/KEM.218-220.165
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   KOWALCHUK RM, 1995, J BIOMED MATER RES, V29, P47, DOI 10.1002/jbm.820290108
   LANGE FF, 1989, J AM CERAM SOC, V72, P3, DOI 10.1111/j.1151-2916.1989.tb05945.x
   OBRIEN RW, 1990, J FLUID MECH, V212, P81, DOI 10.1017/S0022112090001872
   OBRIEN RW, 1988, J FLUID MECH, V190, P71, DOI 10.1017/S0022112088001211
   Oppermann DA, 1998, J BIOMED MATER RES, V42, P412, DOI 10.1002/(SICI)1097-4636(19981205)42:3<412::AID-JBM10>3.3.CO;2-V
   Park JB, 1992, BIOMATERIALS INTRO
   SACKS MD, 1986, SCI CERAMIC CHEM PRO, P522
   Smith W F., 1986, PRINCIPLES MAT SCI E
   VANDER A, 2001, HUMAN PHYSL MECH BOD
   VELAMAKANNI BV, 1991, J AM CERAM SOC, V74, P166, DOI 10.1111/j.1151-2916.1991.tb07313.x
   WANG CX, 2001, SOC BIOM 27 ANN M, P101
NR 18
TC 44
Z9 46
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2004
VL 70A
IS 3
BP 436
EP 441
DI 10.1002/jbm.a.30098
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 845YJ
UT WOS:000223281100009
PM 15293317
DA 2018-10-19
ER

PT J
AU Matsushita, N
   Terai, H
   Okada, T
   Nozaki, K
   Inoue, H
   Miyamoto, S
   Takaoka, K
AF Matsushita, N
   Terai, H
   Okada, T
   Nozaki, K
   Inoue, H
   Miyamoto, S
   Takaoka, K
TI A new bone-inducing biodegradable porous beta-tricalcium phosphate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE BMP; beta-TCP; synthetic delivery system; osteoinductive; biodegradable
ID GLYCOL BLOCK-COPOLYMERS; MORPHOGENETIC PROTEIN-2; SYNTHETIC-POLYMER;
   DELIVERY SYSTEM; DEFECTS; CARRIERS; RHBMP-2; REPAIR; GRAFT; DOGS
AB A new type of degradable biomaterial with bone-inducing capacity was made by combining porous beta-tricalcium phosphate (beta-TCP) with a delivery system for recombinant human bone morphogenetic protein-2 (rhBMP-2). The BMP delivery system consisted of a block copolymer composed of poly-D,L-lactic acid with random insertion of p-dioxanone and polyethylene glycol (PLA-DX-PEG), a known biocompatible and biodegradable material. The efficacy of this biomaterial in terms of its bone-inducing capacity was examined by ectopic bone formation in the dorsal muscles of the mouse. In the beta-TCP implants coated with the PLA-DX-PEG polymer containing more than 0.0025% (w/w) of rhBMP-2, new ectopic bone tissues with marrow were consistently found on the surface of implants. The radio-graphic density of beta-TCP was diminished in a time-dependent manner. On histological examination, numerous multinucleated osteoclasts with positive tartrate-resistant acid-phosphatase (TRAP) staining were noted on the surface of the beta-TCP. These experimental results indicate that beta-TCP implants coated with synthetic rhBMP-2 delivery system might provide effective artificial bone-graft substitutes with osteoinductive capacity and biodegradable properties. In addition, this type of biomaterial may require less rhBMP-2 to induce significant new bone mass. (C) 2004 Wiley Periodicals, Inc.
C1 Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka 5458585, Japan.
   Taki Chem Co Ltd, Res Dept, R&D Div, Kakogawa, Hyogo 6750125, Japan.
   Yamanouchi Pharmaceut Co Ltd, Appl Pharmacol Labs, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan.
   Olympus Co Ltd, Hachioji, Tokyo 1928512, Japan.
RP Terai, H (reprint author), Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.
EM hterai@med.osaka-cu.ac.jp
CR Alam MI, 2001, J BIOMED MATER RES, V54, P129, DOI 10.1002/1097-4636(200101)54:1<129::AID-JBM16>3.3.CO;2-4
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Jingushi Seiya, 2002, J Orthop Sci, V7, P490, DOI 10.1007/s007760200085
   Laffargue P, 1999, BONE, V25, p55S, DOI 10.1016/S8756-3282(99)00134-9
   Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3
   Murakami N, 2002, J BIOMED MATER RES, V62, P169, DOI 10.1002/jbm.10236
   Ogose A, 2002, J BIOMED MATER RES, V63, P601, DOI 10.1002/jbm.10380
   Saito M, 2000, J Orthop Sci, V5, P275, DOI 10.1007/s007760050163
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Saito N, 2001, J BONE JOINT SURG AM, V83A, pS92
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   Sandhu HS, 1996, SPINE, V21, P2115, DOI 10.1097/00007632-199609150-00012
   Sandhu HS, 2003, SPINE, V28, pS64, DOI 10.1097/00007632-200308011-00012
   URIST MR, 1987, CLIN ORTHOP RELAT R, P295
NR 17
TC 60
Z9 61
U1 0
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2004
VL 70A
IS 3
BP 450
EP 458
DI 10.1002/jbm.a.30102
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 845YJ
UT WOS:000223281100011
PM 15293319
DA 2018-10-19
ER

PT J
AU Polimeni, G
   Koo, KT
   Qahash, M
   Xiropaidis, AV
   Albandar, JM
   Wikesjo, UME
AF Polimeni, G
   Koo, KT
   Qahash, M
   Xiropaidis, AV
   Albandar, JM
   Wikesjo, UME
TI Prognostic factors for alveolar regeneration: effect of a
   space-providing biomaterial on guided tissue regeneration
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE alveolar bone; bone biomaterials; experimental studies; guided tissue
   regeneration
ID PERIODONTAL REPAIR; ATTACHMENT FORMATION; DOGS; BONE; MEMBRANES;
   DEFECTS; THERAPY
AB Objectives: There is a limited understanding of the effect of bone biomaterials on the healing potential when used in conjunction with guided tissue regeneration (GTR). The objective of this study was to evaluate the effect of a space-providing coral-derived biomaterial on alveolar bone regeneration in conjunction with GTR.
   Methods: Bilateral, critical-size, 6-mm, supra-alveolar, periodontal defects were created in four young adult Beagle dogs. In a split-mouth design, the animals received an ePTFE device to provide for GTR in contralateral defect sites with or without the coral biomaterial. The animals were euthanized at 4 weeks post surgery. A histometric analysis assessed vertical regeneration of alveolar bone relative to space-provision by the ePTFE device. Because of the correlation of within-dog measurements, a mixed model ANOVA was used to analyze the data.
   Results: There was significantly greater mean bone regeneration in sites receiving calcium carbonate coral implant GTR (cGTR) compared to GTR (p<0.0001). Sites providing larger wound areas exhibited greater bone regeneration compared to sites exhibiting smaller wound areas (p<0.0001). However, grouping the sites by wound area thresholds showed that bone regeneration was not significantly different in sites receiving cGTR compared to sites receiving GTR alone, irrespective of the size of the wound area (p>0.5).
   Conclusions: Space-provision has a significant effect on bone regeneration following GTR. The coral biomaterial effectively enhances space-provision, and this appears to be the principal mechanism by which this biomaterial supports bone regeneration rather than postulated osteoconductive properties.
C1 Temple Univ, Sch Dent, Lab Appl Periodontal & Craniofacial Regenerat, Dept Periodontol, Philadelphia, PA 19140 USA.
RP Polimeni, G (reprint author), Temple Univ, Sch Dent, Lab Appl Periodontal & Craniofacial Regenerat, Dept Periodontol, 3223 N Broad St, Philadelphia, PA 19140 USA.
EM gpolimeni@hotmail.com
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583; Albandar, Jasim M./0000-0001-7801-3811
CR CORTELLINI P, 1995, J PERIODONTOL, V66, P797, DOI 10.1902/jop.1995.66.9.797
   GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x
   GOTTLOW J, 1990, J PERIODONTOL, V61, P680, DOI 10.1902/jop.1990.61.11.680
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   ISIDOR F, 1986, J CLIN PERIODONTOL, V13, P145, DOI 10.1111/j.1600-051X.1986.tb01448.x
   KOO KT, 2003, J CLIN PERIODONTO S4, V30, P51
   KOO KT, 2003, J DENT RES, V82
   KOO KT, 2002, J PERIODONTOL, V73, P1399
   Mellonig JT, 1996, CLIN ORTHOP RELAT R, P116
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   POLIMENI G, 2002, J PERIODONTOL, V73, P1242
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   Stavropoulos A, 2001, Clin Implant Dent Relat Res, V3, P156, DOI 10.1111/j.1708-8208.2001.tb00136.x
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
NR 19
TC 43
Z9 45
U1 0
U2 7
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD SEP
PY 2004
VL 31
IS 9
BP 725
EP 729
DI 10.1111/j.1600-051X.2004.00542.x
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 845YX
UT WOS:000223282600004
PM 15312093
DA 2018-10-19
ER

PT J
AU Sorensen, RG
   Wikesjo, UME
   Kinoshita, A
   Wozney, JM
AF Sorensen, RG
   Wikesjo, UME
   Kinoshita, A
   Wozney, JM
TI Periodontal repair in dogs: evaluation of a bioresorbable calcium
   phosphate cement (Ceredex (TM)) as a carrier for rhBMP-2
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE bone induction; calcium phosphate; periodontal regeneration; tissue
   engineering
ID BONE MORPHOGENETIC PROTEIN-2; GUIDED TISSUE REGENERATION; HUMAN
   OSTEOGENIC PROTEIN-1; BABOON PAPIO-URSINUS; ALVEOLAR BONE; COLLAGEN
   SPONGE; ENHANCES BONE; DEFECTS; ATTACHMENT; SUBSTITUTE
AB Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to induce clinically relevant bone formation for orthopedic, craniofacial, and oral indications. It appears critical, in particular for onlay indications, that the associated carrier technology exhibits structural integrity to offset compressive forces in support of rhBMP-2-induced bone formation. The objective of this study was to evaluate a calcium phosphate (CP) cement, Ceredex(TM), as a candidate carrier for rhBMP-2 in a defect model with limited osteogenic potential.
   Materials: Bilateral, critical size, 6-mm, supra-alveolar, periodontal defects were created in six, adult, male, Hound Labrador mongrels. Three animals received rhBMP-2/Ceredex(TM) (rhBMP-2 at 0.20 and 0.40 mg/ml) in contralateral defect sites (implant volume/defect similar to1 ml). One defect site in each of the three remaining animals received Ceredex(TM) without rhBMP-2 (control). The animals were euthanized at 12 weeks postsurgery for histologic and histometric analysis.
   Results: Mean induced bone height exceeded 80% of the defect height for supra-alveolar periodontal defects receiving rhBMP-2/Ceredex(TM) without major differences between rhBMP-2 concentrations compared with approximately 40% for the control. The newly formed bone, a mixture of lamellar and woven bone in fibrovascular tissue, circumscribed relatively large portions of the residual Ceredex(TM) biomaterial. Inflammatory lesions were associated with limited bone formation in some sites. From a periodontal perspective, sites receiving rhBMP-2/Ceredex(TM) exhibited increased cementum formation compared with control, but without a functionally oriented periodontal ligament, and increased ankylosis and root resorption. Control sites exhibited early wound failure and exposure, loss of the Ceredex(TM) biomaterial, and limited bone formation.
   Conclusions: The Ceredex(TM) CP cement appears a potentially promising carrier technology for rhBMP-2 onlay indications. However, a slow resorption rate may prevent its wider use. This study does not support use of the rhBMP-2/Ceredex(TM) combination for periodontal indications.
C1 Temple Univ, Sch Dent, Lab Appl Periodontal & Craniofacial Regenerat, Dept Periodontol, Philadelphia, PA 19140 USA.
   Wyeth Res, Clin Res & Dev, Cambridge, MA USA.
   Tokyo Med & Dent Univ, Fac Dent, Dept Oral Hlth Care Promot, Sect Prevent Oral Hlth Care Promot, Tokyo, Japan.
   Wyeth Res, Musculoskeletal Sci, Cambridge, MA USA.
RP Wikesjo, UME (reprint author), Temple Univ, Sch Dent, Lab Appl Periodontal & Craniofacial Regenerat, Dept Periodontol, 3223 N Broad St, Philadelphia, PA 19140 USA.
EM wikesjo@comcast.net
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR Blumenthal NM, 2002, J PERIODONTOL, V73, P1494, DOI 10.1902/jop.2002.73.12.1494
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Ishikawa I, 1994, DENT JAPAN, V31, P141
   Ishikawa K, 1997, J BIOMED MATER RES, V36, P393, DOI 10.1002/(SICI)1097-4636(19970905)36:3<393::AID-JBM14>3.0.CO;2-F
   Kim CK, 1998, J PERIODONTOL, V69, P26, DOI 10.1902/jop.1998.69.1.26
   Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.3.CO;2-A
   KOO KT, IN PRESS J CLIN PERI
   Kuboki Y, 1998, EUR J ORAL SCI, V106, P197, DOI 10.1111/j.1600-0722.1998.tb02176.x
   Lee DD, 1999, CLIN ORTHOP RELAT R, pS396
   Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2
   LUNA LG, 1992, HISTOLOGIC METHODS C, P113
   Ripamonti U, 1996, ARCH ORAL BIOL, V41, P121, DOI 10.1016/0003-9969(95)00110-7
   Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x
   RIPAMONTI U, 1994, J PERIODONTAL RES, V29, P439, DOI 10.1111/j.1600-0765.1994.tb01246.x
   Schenk R, 1984, METHODS CALCIFIED TI, P1
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   SEEHERMAN H, 2001, T ANN M ORTH RES SOC
   Seeherman H, 2002, T 48 ANN M ORTH RES
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Tatakis DN, 2000, J CLIN PERIODONTOL, V27, P698, DOI 10.1034/j.1600-051x.2000.027009698.x
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110
   Wikesjo Ulf M E, 2003, Clin Implant Dent Relat Res, V5, P112, DOI 10.1111/j.1708-8208.2003.tb00192.x
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   Wikesjo UME, 1998, J CLIN PERIODONTOL, V25, P475, DOI 10.1111/j.1600-051X.1998.tb02476.x
   Wikesjo UME, 2004, J CLIN PERIODONTOL, V31, P662, DOI 10.1111/j.1600-051X.2004.00541.x
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P715, DOI 10.1034/j.1600-051X.2003.00364.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P705, DOI 10.1034/j.1600-051X.2003.00363.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
   Wikesjo UME, 2001, J BONE JOINT SURG AM, V83A, pS136
   WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P49, DOI 10.1111/j.1600-051X.1991.tb01119.x
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
   WIKESJO UME, 2003, J PERIODONTOL, V74, P955
   WIKESJO UME, 2002, CLIN IMPLANT DENT R, V4, P173
NR 42
TC 42
Z9 44
U1 0
U2 2
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD SEP
PY 2004
VL 31
IS 9
BP 796
EP 804
DI 10.1111/j.1600-051X.2004.00544.x
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 845YX
UT WOS:000223282600015
PM 15312104
DA 2018-10-19
ER

PT J
AU Menderes, A
   Baytekin, C
   Topcu, A
   Yilmaz, M
   Barutcu, A
AF Menderes, A
   Baytekin, C
   Topcu, A
   Yilmaz, M
   Barutcu, A
TI Craniofacial reconstruction with high-density porous polyethylene
   implants
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE high-density porous polyethylene implants; craniofacial reconstruction;
   facial augmentation
ID PROPLAST
AB Deformities of the facial skeleton may be reconstructed using autogenic or allogenic materials. Porous polyethylene is one of the few alloplastic materials currently in use having a well-documented history of reconstruction or augmentation in the maxillofacial region. High-density porous polyethylene, which is shown to be effective as a biomaterial, has additional advantages like tissue ingrowth, no capsule formation around it, and easy fixation. In this study, 83 implants in 71 patients were evaluated. Seven patients were in need of a second intervention. Three of the seven secondary interventions were for contour alignment, and four interventions were for extraction of the implants because of extrusion or infection. Placement of porous polyethylene implants directly under the skin without coverage of periosteum or another fascial envelope has an increased risk of early and especially late exposure. In cases like nasal dorsum or microtia reconstruction, we prefer autogenic grafts instead of allogenic materials.
C1 Dokuz Eylul Univ, Fac Med, Dept Plast & Reconstruct Surg, TR-35340 Izmir, Turkey.
RP Menderes, A (reprint author), Dokuz Eylul Univ, Tip Fak, Plast Rekonstruktif Estet Cerrahi Anabilim Dali, TR-35340 Izmir, Turkey.
EM amenderes@ipras.net
RI YILMAZ, Mustafa/A-4748-2012
CR BERGHAUS A, 1984, ARCH OTO-RHINO-LARYN, V240, P115
   BREITBART AS, 1997, GRABB SMITHS PLASTIC, P39
   Carboni A, 2002, EUR J PLAST SURG, V25, P310, DOI DOI 10.1007/S00238-002-0407-3
   Fialkov JA, 2001, J CRANIOFAC SURG, V12, P362, DOI 10.1097/00001665-200107000-00009
   Frodel JL, 1998, ARCH OTOLARYNGOL, V124, P1219, DOI 10.1001/archotol.124.11.1219
   Niechajev I, 1999, AESTHET PLAST SURG, V23, P395, DOI 10.1007/s002669900308
   Romano J J, 1993, J Craniofac Surg, V4, P142, DOI 10.1097/00001665-199307000-00007
   Romo T 3rd, 1998, Facial Plast Surg, V14, P151, DOI 10.1055/s-2008-1064339
   Romo T 3rd, 2000, Facial Plast Surg, V16, P15, DOI 10.1055/s-2000-7322
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   RUBIN PAD, 1994, OPHTHALMOLOGY, V101, P1697
   Sevin K, 2000, BRIT J ORAL MAX SURG, V38, P44, DOI 10.1054/bjom.1998.0038
   SPECTOR M, 1979, J BIOMED MATER RES, V13, P677, DOI 10.1002/jbm.820130502
   Villarreal PM, 2002, PLAST RECONSTR SURG, V109, P877, DOI 10.1097/00006534-200203000-00007
   YAREMCHUK MJ, 2000, PLAST RECONSTR SURG, V111, P1818
NR 15
TC 53
Z9 54
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD SEP
PY 2004
VL 15
IS 5
BP 719
EP 724
DI 10.1097/00001665-200409000-00004
PG 6
WC Surgery
SC Surgery
GA 854TR
UT WOS:000223926800004
PM 15346006
DA 2018-10-19
ER

PT J
AU Li, JP
   Van Blitterswijk, CA
   De Groot, K
AF Li, JP
   Van Blitterswijk, CA
   De Groot, K
TI Factors having influence on the rheological properties of Ti6A14V slurry
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POROUS HYDROXYAPATITE; CALCIUM-PHOSPHATE; BONE; METAL; IMPLANTS;
   CERAMICS; INGROWTH; OSTEOCONDUCTION; OSTEOINDUCTION; MANUFACTURE
AB A highly porous Ti6Al4V could be produced with a porous polymeric sponge and Ti6Al4V slurry. However, the rheological properties of Ti6Al4V slurry appeared to be the key issue in the preparation of porous Ti6Al4V. In this study, factors having influence on the rheological properties of Ti6Al4V slurry were addressed in detail. Ti6Al4V powders, organic thickening agents (binders), dispersants, concentration of powder and pH values were optimised with regard to the rheological properties of Ti6Al4V slurry. The results show that Ti6Al4V powder with a mean diameter of 45 Elm and spherical shape is beneficial for the preparation of Ti6Al4V slurry. Meanwhile binders with two ingredients, which decompose at different temperatures, have the advantage to keep the shape after debinding. The optimised procedure, based on the findings, made it possible to produce highly porous Ti6Al4V with reticulate porous structure. Porous Ti6Al4V produced by this way is expected to be a promising biomaterial for tissue engineering scaffolds and orthopaedic implant applications. (C) 2004 Kluwer Academic Publishers.
C1 Univ Twente, iBME, NL-7500 AE Enschede, Netherlands.
   Leiden Univ, Biomat Res Grp, NL-2300 RA Leiden, Netherlands.
RP Li, JP (reprint author), Univ Twente, iBME, POB 217, NL-7500 AE Enschede, Netherlands.
EM j.li@tnw.utwente.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR AMATO I, 1973, MATER SCI ENG, V12, P23, DOI 10.1016/0025-5416(73)90067-0
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BOBYN JD, 1987, J ORTHOP RES, V5, P393, DOI 10.1002/jor.1100050312
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   CONWAY BE, 2002, ENCY SURFACE COLLOID, P1658
   Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267
   Fukasawa T, 2001, J MATER SCI, V36, P2523, DOI 10.1023/A:1017946518955
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Jun YK, 2003, BIOMATERIALS, V24, P3731, DOI 10.1016/S0142-9612(03)00248-5
   Lelievre F, 1996, J MATER SCI-MATER M, V7, P489, DOI 10.1007/BF00705430
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   LI JP, 2001, KEY ENG MATER, V218, P52
   Li SH, 2003, J AM CERAM SOC, V86, P65, DOI 10.1111/j.1151-2916.2003.tb03279.x
   Li SH, 2002, J BIOMED MATER RES, V61, P109, DOI 10.1002/jbm.10163
   LIAO JC, 1978, POROUS MAT POWDER ME, P93
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   MADORSKY SL, 1964, THERMAL DEGRADATION, P1423
   MADORSKY SL, 1961, HIGH TEMPERATURE RES, P64
   PETZOLDT F, 1995, ADV POWDER METALLURG, P63
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   REJDA BV, 1977, J BIOENG, V1, P93
   ROY DM, 1974, MATER RES BULL, V9, P35, DOI 10.1016/0025-5408(74)90005-1
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   RYSHKEWITCH E, 1953, J AM CERAM SOC, V36, P65, DOI 10.1111/j.1151-2916.1953.tb12837.x
   Tian JT, 2001, J MATER SCI, V36, P3061, DOI 10.1023/A:1017935411108
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   VANKREVELEN DW, 1990, PROPERTIES POLYM, P641
   WOYANSKY JS, 1992, AM CERAM SOC B, V71, P1674
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhu XW, 2001, MATER LETT, V51, P363, DOI 10.1016/S0167-577X(01)00322-6
NR 37
TC 13
Z9 14
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2004
VL 15
IS 9
BP 951
EP 958
DI 10.1023/B:JMSM.0000042680.10087.15
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856RE
UT WOS:000224061500002
PM 15448402
DA 2018-10-19
ER

PT J
AU Rustichelli, F
   Romanzetti, S
   Dubini, B
   Girardin, E
   Raven, C
   Snigirev, A
   Rizzi, G
AF Rustichelli, F
   Romanzetti, S
   Dubini, B
   Girardin, E
   Raven, C
   Snigirev, A
   Rizzi, G
TI Phase-contrast microtomography of thin biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HARD X-RAYS; RADIOGRAPHY; TOMOGRAPHY
AB Phase-contrast microtomography, performed at the beamline ID 22 of the European Synchrotron Radiation Facility (ESRF, Grenoble, France), is demonstrated for high-resolution 3-D imaging of a hydroxyapatite sample. The technique, which relies on phase contrast imaging, gives the possibility to observe features inside samples with negligible absorption contrast. The positive results obtained suggest a possible future investigation of the influence of the distribution of pores and defects inside biomaterial coatings, on the growth of osteoblast cells. (C) 2004 Kluwer Academic Publishers.
C1 Univ Ancona, Ist Sci Fisiche, I-60131 Ancona, Italy.
   INFM, I-60131 Ancona, Italy.
   Univ Ancona, Fac Ingn, Dipartimento Fis & Ingn Mat & Terr, I-60131 Ancona, Italy.
   European Synchrotron Radiat Facil, F-38043 Grenoble, France.
   Biocoating, I-43040 Parma, Italy.
RP Rustichelli, F (reprint author), Univ Ancona, Ist Sci Fisiche, Via P Ranieri 65, I-60131 Ancona, Italy.
EM isf@alisf1.univpm.it
RI Snigirev, Anatoly/F-9831-2018; Romanzetti, Sandro/J-5663-2013
OI Romanzetti, Sandro/0000-0001-8519-1309
CR Baruchel J, 2001, BIOMATERIALS, V22, P1515, DOI 10.1016/S0142-9612(00)00307-0
   Beliaevskaya EA, 1998, PHYS MEDICA, V14, P19
   BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212
   Born M, 1980, PRINCIPLES OPTICS
   Cloetens P, 1997, J APPL PHYS, V81, P5878, DOI 10.1063/1.364374
   DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0
   GIRARDIN E, 1997, THESIS U REIMS
   Ingal V. N., 1997, Technical Physics, V42, P59, DOI 10.1134/1.1258639
   INGAL VN, 1995, J PHYS D APPL PHYS, V28, P2314, DOI 10.1088/0022-3727/28/11/012
   Ingal VN, 1996, PHYS MEDICA, V12, P75
   Koch A, 1998, J OPT SOC AM A, V15, P1940, DOI 10.1364/JOSAA.15.001940
   McLaughlin F, 2002, BONE, V30, P924, DOI 10.1016/S8756-3282(02)00737-8
   MORONI A, 1994, J MATER SCI-MATER M, V5, P411, DOI 10.1007/BF00058975
   Raven C, 1996, APPL PHYS LETT, V69, P1826, DOI 10.1063/1.117446
   Raven C, 1998, REV SCI INSTRUM, V69, P2978, DOI 10.1063/1.1149043
   Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073
   Spanne P, 1999, PHYS MED BIOL, V44, P741, DOI 10.1088/0031-9155/44/3/016
   WANG BC, 1994, MATER CHEM PHYS, V37, P55
   Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0
NR 19
TC 10
Z9 10
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2004
VL 15
IS 9
BP 1053
EP 1057
DI 10.1023/B:JMSM.0000042692.34537.8e
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856RE
UT WOS:000224061500014
PM 15448414
DA 2018-10-19
ER

PT J
AU Gray, JL
   Gorman, SP
   Jones, DS
   McCoy, CP
AF Gray, J. L.
   Gorman, S. P.
   Jones, D. S.
   McCoy, C. P.
TI Development of anti-infective polymeric biomaterial surfaces
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Gray, J. L.; Gorman, S. P.; Jones, D. S.; McCoy, C. P.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland.
EM l.gray@qub.ac.uk
CR Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/rccm.2105078
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   RUSSELL AD, 1999, PRINCIPLES PRACTICE, P32
NR 3
TC 0
Z9 0
U1 0
U2 2
PU PHARMACEUTICAL PRESS-ROYAL PHARMACEUTICAL SOC GREAT BRITIAN
PI LONDON
PA 1 LAMBETH HIGH ST, LONDON SE1 7JN, ENGLAND
SN 0022-3573
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD SEP
PY 2004
VL 56
SU S
MA 138
BP S50
EP S51
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA V50KV
UT WOS:000203408100138
DA 2018-10-19
ER

PT J
AU Lelu, S
   Tirelli, N
   Pluen, A
AF Lelu, S.
   Tirelli, N.
   Pluen, A.
TI Development of an extracellular components based biomaterial for the
   study of novel delivery to solid tumours
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Lelu, S.; Tirelli, N.; Pluen, A.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England.
EM sylvie.lelu@stud.man.ac.uk; alain.pluen@man.ac.uk
CR Clague DS, 1997, PHYS FLUIDS, V9, P1562, DOI 10.1063/1.869278
   JAIN RK, 1998, NAT MED, V4, P984
   OGSTON AG, 1961, J PHYSIOL-LONDON, V156, P67, DOI 10.1113/jphysiol.1961.sp006658
   Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-3573
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD SEP
PY 2004
VL 56
SU S
MA 137
BP S50
EP S50
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA V50KV
UT WOS:000203408100137
DA 2018-10-19
ER

PT J
AU Schiff, J
   Li, PS
   Goldstein, M
AF Schiff, J
   Li, PS
   Goldstein, M
TI Toward a sutureless vasovasostomy: Use of biomaterials and surgical
   sealants in a rodent vasovasostomy model
SO JOURNAL OF UROLOGY
LA English
DT Article
DE testis; vasovasostomy; rats; Wistar; biocompatible materials; hydrogel
ID MICROSURGICAL VASOVASOSTOMY; VASECTOMY REVERSAL; VASAL REANASTOMOSIS;
   EXPERIENCE; RAT; ANASTOMOSIS
AB Purpose: With 500,000 to 800,000 vasectomies performed annually and a reversal rate of 3% to 8% vasectomy reversal has become a commonly performed procedure. Two-layer microsurgical vasovasostomy remains the gold standard for surgical reconstruction of the vas. However, this procedure is technically demanding and time-consuming. We determined the ability of biomaterials and surgical sealants to decrease the number of sutures used, enhance anastomosis watertightness and decrease operative time.
   Materials and Methods: Adult male Wistar rats underwent vasectomy 2 weeks prior to vasovasostomy. Standard 2-layer microsurgical repair was performed in control animals. Experimental groups underwent 3-suture mucosal approximation and then completion of the anastomosis with a biomaterial membrane and/or synthetic sealant. The rats were sacrificed 9 weeks after vasovasostomy. Anastomotic patency was assessed functionally by the presence of motile sperm in the vas distal to the testes and anastomosis, and mechanically by methylene blue vasogram. The presence and size of sperm granulomas were also recorded.
   Results: Microsurgical vasovasostomy required significantly less time when biomaterial (42.7 minutes) or sealant (40 minutes) was used compared to the standard sutured group (102.5 minutes, each p <0.001). There was no difference in patency between the standard sutured and biomaterial groups (90% vs 92%). Patency was significantly lower in the sealant groups, that is 70% in the suture, biomaterial and sealant group, and 75% in the suture and sealant group. The biomaterial group had only 1 sperm granuloma in 12 procedures, which was significantly better than the 7 in the control group (p <0.001).
   Conclusions: Using a biomaterial wrap during vasovasostomy resulted in significantly decreased operative time and fewer sperm granulomas than in the control group. Sealants were not effective. Biomaterial wrap may support vasovasostomy and by decreasing leakage improve the outcome.
C1 Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Cornell Inst Reprod Med,Dept Urol, New York, NY 10021 USA.
   Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Cornell Inst Reprod Med,Ctr Male Reprod Med & Micr, New York, NY 10021 USA.
   Populat Council, Biomed Res Ctr, New York, NY 10021 USA.
RP Goldstein, M (reprint author), Box 580,525 E 68th St, New York, NY 10021 USA.
EM mgoldst@med.cornell.edu
CR ANTARIO JM, 1992, UROLOGY, V39, P478, DOI 10.1016/0090-4295(92)90253-S
   BELKER AM, 1991, J UROLOGY, V145, P505, DOI 10.1016/S0022-5347(17)38381-7
   COS LR, 1983, UROLOGY, V22, P567, DOI 10.1016/0090-4295(83)90297-2
   Glickman M, 2002, ARCH SURG-CHICAGO, V137, P326, DOI 10.1001/archsurg.137.3.326
   Goldstein M, 1998, J UROLOGY, V159, P188, DOI 10.1016/S0022-5347(01)64053-9
   JAROW JP, 1986, J UROLOGY, V136, P1132, DOI 10.1016/S0022-5347(17)45238-4
   LEE HY, 1986, J UROLOGY, V136, P413, DOI 10.1016/S0022-5347(17)44887-7
   MONTIE JE, 1974, J UROLOGY, V112, P111, DOI 10.1016/S0022-5347(17)59655-X
   NIEDERBERGER C, 1993, J UROLOGY, V149, P185
   OWEN ER, 1977, AUST NZ J SURG, V47, P305, DOI 10.1111/j.1445-2197.1977.tb04294.x
   ROSEMBERG SK, 1988, UROLOGY, V32, P225, DOI 10.1016/0090-4295(88)90389-5
   Seaman EK, 1997, J UROLOGY, V158, P642, DOI 10.1016/S0022-5347(01)64575-0
   SILBER SJ, 1977, FERTIL STERIL, V28, P1191
   SILBER SJ, 1989, HUM REPROD, V4, P318, DOI 10.1093/oxfordjournals.humrep.a136896
   SILVERSTEIN JI, 1991, J UROLOGY, V145, P1288, DOI 10.1016/S0022-5347(17)38616-0
   Vankemmel O, 1998, EUR UROL, V33, P318, DOI 10.1159/000019567
   Vankemmel O, 1996, BRIT J UROL, V78, P271, DOI 10.1046/j.1464-410X.1996.08823.x
NR 17
TC 8
Z9 9
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD SEP
PY 2004
VL 172
IS 3
BP 1192
EP 1195
DI 10.1097/01.ju.0000134976.03994.bb
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 847GE
UT WOS:000223379900104
PM 15311068
DA 2018-10-19
ER

PT J
AU Anderson, TD
   Sataloff, TT
AF Anderson, TD
   Sataloff, TT
TI Complications of collagen injection of the vocal fold: Report of several
   unusual cases and review of the literature
SO JOURNAL OF VOICE
LA English
DT Review
DE collagen injection; dysphonia; hoarseness; vocal fold paresis; vocal
   fold paralysis; vocal fold scar
ID INJECTABLE COLLAGEN; DERMATOMYOSITIS; AUGMENTATION; IMPLANTS
AB Injection laryngoplasty is one of the most frequently performed procedures in patients with voice complaints. Various biomaterials have been used to medialize vocal folds or to treat symptoms of vocal fold scar. The ideal biomaterial would be easily injected through a fine-gauge needle, well tolerated, and long lasting. Injectable collagen preparations fulfill at least two of these criteria, and collagen has been used widely for vocal fold injections. Materials and Methods: We present a retrospective review of two unusual complications of collagen injection and a review of the relevant literature on the complications of medical use of collagen compounds. Results: Two patients in whom collagen was injected formed firm submucosal deposits that interrupted the normal mucosal wave and produced significant dysphonia. Surgical removal of these deposits restored the mucosal wave and improved voice quality. Management of this unusual complication of human collagen injection in the vocal fold has not been reported previously. Other complications of collagen injection include hypersensitivity reactions to bovine collagen, local abscess formation at injection sites, and possibly induction of collagen vascular disease in some patients. Conclusions: Although collagen injections of the vocal fold rarely result in complications, physicians using collagen must be familiar with the types of complications that can occur. Proper diagnosis and prompt management of complications can result in good outcomes.
C1 Lahey Clin Fdn, Dept Otolaryngol Head & Neck Surg, Burlington, MA USA.
   Thomas Jefferson Univ, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA USA.
RP Sataloff, TT (reprint author), 1721 Pine St, Philadelphia, PA 19146 USA.
EM Sataloff@PhillyENT.com
CR CUKIER J, 1993, ANN INTERN MED, V118, P920, DOI 10.7326/0003-4819-118-12-199306150-00002
   Ford C. N., 1987, J VOICE, V1, P116
   FORD CN, 1986, LARYNGOSCOPE, V96, P863
   FORD CN, 1992, ANN OTO RHINOL LARYN, V101, P237, DOI 10.1177/000348949210100307
   HANKE CW, 1991, J AM ACAD DERMATOL, V25, P319, DOI 10.1016/0190-9622(91)70200-L
   Hanke CW, 1996, J AM ACAD DERMATOL, V34, P450, DOI 10.1016/S0190-9622(96)90438-7
   KNAPP TR, 1977, PLAST RECONSTR SURG, V60, P398
   Leonard MP, 1998, J UROLOGY, V160, P1012, DOI 10.1016/S0022-5347(01)62684-3
   REMACLE M, 1990, Annals of Otology Rhinology and Laryngology, V99, P438
   ROBINSON JK, 1985, J DERMATOL SURG ONC, V11, P124, DOI 10.1111/j.1524-4725.1985.tb02979.x
   Spiegel JR, 1987, J VOICE, V1, P119
   STEDMAN SJ, 1984, J DERMATOL SURG ONC, V6, P450
   Stothers L, 1998, J UROLOGY, V159, P1507, DOI 10.1097/00005392-199805000-00025
   VARVARES MA, 1995, ANN OTO RHINOL LARYN, V104, P511, DOI 10.1177/000348949510400702
NR 14
TC 25
Z9 26
U1 0
U2 1
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0892-1997
J9 J VOICE
JI J. Voice
PD SEP
PY 2004
VL 18
IS 3
BP 392
EP 397
DI 10.1016/j.jvoice.2002.002.04.001
PG 6
WC Audiology & Speech-Language Pathology; Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Otorhinolaryngology
GA 855QN
UT WOS:000223988900015
PM 15331113
DA 2018-10-19
ER

PT J
AU Neumann, A
   Kramps, M
   Ragoss, C
   Maier, HR
   Jahnke, K
AF Neumann, A
   Kramps, M
   Ragoss, C
   Maier, HR
   Jahnke, K
TI Histological and microradiographic appearances of Silicon Nitride and
   Aluminum Oxide in a rabbit femur implantation model
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article; Proceedings Paper
CT 107th Annual Meeting of the
   American-Academy-of-Otolaryngology-Head-and-Neck-Surgery
CY SEP 21-24, 2003
CL ORLANDO, FL
SP Amer Acad Otolaryngol Head & Neck Surg
DE silicon nitride; biocompatibility; femoral implantation; rabbit
ID TOXICITY; TISSUE; CELLS
AB Silicon nitride (Si3N4) is a ceramic known for its high performance characterized by fracture toughness, high wear resistance and low coefficient of friction. It has therefore been considered as a biomaterial especially for orthopaedic and dental indications. There is a controversy concerning the biocompatibility among the limited number of authors dealing with this material. Own investigations, applying the L929-fibroblast cell culture model revealed good biocompatibilty. The aim of this study is to verify these findings in the animal model. 36 cylinders of Si3N4 and the established biomaterial aluminum oxide (Al2O3) were implanted "press fit" into the lateral condyli of the femurs of 6 New Zealand white male rabbits (three implants per condylus, materials randomized). The right femur of each animal was prepared for microradiographs and grounded sections, the left for histological sections, respectively. Animals were divided into 2 groups with 3 rabbits each. One group was sacrificed after a period of 4 weeks and the other after 8 weeks. Morphometric assessment of bone-implant attachment was performed using a digital image analyzing system. Percentages of bone-implant attachment ranged from 44 to 82 %. There was no statistically different percentage of bone-implant attachment between Al2O3 and Si3N4 after 4 and 8 weeks, except in the histological section after 8 weeks of implantation. During the period of 4 to 8 weeks after implantation there was no significant decrease of bone-implant contact except for Al2O3 in the histological sections. No local or generalized immuno-inflammatory reactions were observed. The lamellar bone in direct contact to the materials showed no histological evidence of round cell infiltration or giant cell reactions. Our investigations suggest that Si3N4 shows good biocompatibility and presumably even better osseointegration than Al2O3.
C1 Univ Essen Gesamthsch, Dept Otorhinolaryngol, D-45122 Essen, Germany.
   Inst Ceram Components Mech Engn, D-52072 Aachen, Germany.
RP Neumann, A (reprint author), Univ Essen Gesamthsch, Dept Otorhinolaryngol, Hufelandstr 55, D-45122 Essen, Germany.
EM andreas.neumann@uni-essen.de
CR Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   BATHIS H, 2000, THESIS JL U GIESSEN
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Marti A, 2000, Injury, V31 Suppl 4, P33
   NEUMANN A, 2004, IN PRESS J MAT SCI M
   NORTHUP SJ, 1988, HDB BIOMATERIALS EVA, P209
   OWEN M, 1971, BIOCHEMISTRY PHYSIOL, V3, P271
   RICHERSON DW, 1989, MATER SCI FORUM, V47, P282
   ROSENBLUTH SA, 1965, J PHARM SCI-US, V54, P156, DOI 10.1002/jps.2600540139
   Ruan S, 1999, Zhonghua Kou Qiang Yi Xue Za Zhi, V34, P223
   SIEGELE D, 1989, International Journal of Oral and Maxillofacial Implants, V4, P333
   SOHRABI A, 1998, BIOCERAMICS, V2, P309
   Svensson I, 1997, AM J IND MED, V31, P335, DOI 10.1002/(SICI)1097-0274(199703)31:3<335::AID-AJIM10>3.0.CO;2-1
   Wilsnack R E, 1973, Biomater Med Devices Artif Organs, V1, P543
NR 17
TC 16
Z9 16
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD SEP
PY 2004
VL 35
IS 9
BP 569
EP 573
DI 10.1002/mawe.200400778
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 860BT
UT WOS:000224313500004
DA 2018-10-19
ER

PT J
AU Ohtake, S
   Schebor, C
   Palecek, SP
   de Pablo, JJ
AF Ohtake, S
   Schebor, C
   Palecek, SP
   de Pablo, JJ
TI Effect of pH, counter ion, and phosphate concentration on the glass
   transition temperature of freeze-dried sugar-phosphate mixtures
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE freeze-drying; glass transition; sucrose; phosphate; trehalose
ID LACTOBACILLUS-ACIDOPHILUS; BIOMATERIAL STABILIZATION; AQUEOUS-SOLUTIONS;
   TREHALOSE; STABILITY; SYSTEMS; CATIONS; BEHAVIOR; DIVALENT; VACUUM
AB Purpose. The aim of the present work is to study the interaction of phosphate salts with trehalose and sucrose in freeze-dried matrices, particularly the effect of the salts on the glass transition temperature (T-g) of the sugars.
   Methods. Freeze-dried trehalose and sucrose systems containing different amounts of sodium or potassium phosphate were analyzed by differential scanning calorimetry to determine the Tg and by Fourier-transform infrared spectroscopy ( FTIR) analysis to evaluate the strength of the interaction between sugars and phosphate ions.
   Results. Sucrose-phosphate mixtures show an increase in Tg up to 40 degreesC in a broad pH range ( 4 - 9) compared to that of pure sucrose. Sucrose-phosphate mixtures exhibit a higher T-g than pure sucrose while retaining higher water contents. Trehalose-phosphate mixtures (having a T-g of 135 degreesC at a pH of 8.8) are a better option than pure trehalose for preservation of labile materials. The - OH stretching of the sugars in the presence of phosphates decreases with increase in pH, indicating an increase in the sugar-phosphate interaction.
   Conclusions. Sugar-phosphate mixtures exhibit several interesting features that make them useful for lyophilization of labile molecules; T-g values much higher than those observed for the pure sugars can be obtained upon the addition of phosphate.
C1 Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.
   Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
RP Ohtake, S (reprint author), Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.
EM sohtake@students.wisc.edu
CR Buitink J, 2000, BIOPHYS J, V79, P1119, DOI 10.1016/S0006-3495(00)76365-X
   CARPENTER JF, 1986, ARCH BIOCHEM BIOPHYS, V250, P505, DOI 10.1016/0003-9861(86)90755-1
   CONRAD P, 2000, THESIS
   Conrad PB, 2000, CRYOBIOLOGY, V41, P17, DOI 10.1006/cryo.2000.2260
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9
   Duddu SP, 1997, PHARMACEUT RES, V14, P591, DOI 10.1023/A:1012144810067
   Ekdawi-Sever N, 2003, J FOOD SCI, V68, P2504, DOI 10.1111/j.1365-2621.2003.tb07052.x
   GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011
   KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   MacFarlane DR, 2002, CRYOBIOLOGY, V45, P188, DOI 10.1016/S0011-2240(02)00127-X
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   Miller DP, 1999, J PHYS CHEM B, V103, P10243, DOI 10.1021/jp984736i
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   MORELDESROSIERS N, 1991, J CHEM SOC FARADAY T, V87, P2173, DOI 10.1039/ft9918702173
   MURASE N, 1991, CRYOBIOLOGY, V28, P364, DOI 10.1016/0011-2240(91)90043-N
   Ohtake S, 2004, CRYOBIOLOGY, V48, P81, DOI 10.1016/j.cryobiol.2004.01.001
   Randolph TW, 1997, J PHARM SCI-US, V86, P1198, DOI 10.1021/js970135b
   RONGERE P, 1995, J CHEM SOC FARADAY T, V91, P2771, DOI 10.1039/ft9959102771
   Taylor LS, 1998, J PHARM SCI, V87, P1615, DOI 10.1021/js9800174
   Tzannis ST, 1999, J PHARM SCI-US, V88, P360, DOI 10.1021/js9800127
   URITANI M, 1995, J BIOCHEM-TOKYO, V117, P774, DOI 10.1093/oxfordjournals.jbchem.a124775
   VANDENBERG L, 1959, ARCH BIOCHEM BIOPHYS, V81, P319, DOI 10.1016/0003-9861(59)90209-7
   Wolkers WF, 1998, BBA-GEN SUBJECTS, V1379, P83, DOI 10.1016/S0304-4165(97)00085-8
NR 27
TC 41
Z9 41
U1 0
U2 18
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
J9 PHARM RES
JI Pharm. Res.
PD SEP
PY 2004
VL 21
IS 9
BP 1615
EP 1621
DI 10.1023/B:PHAM.0000041456.19377.87
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 854QS
UT WOS:000223919000014
PM 15497687
DA 2018-10-19
ER

PT J
AU Menassa, R
   Hong, Z
   Karatzas, CN
   Lazaris, A
   Richman, A
   Brandle, J
AF Menassa, R
   Hong, Z
   Karatzas, CN
   Lazaris, A
   Richman, A
   Brandle, J
TI Spider dragline silk proteins in transgenic tobacco leaves: accumulation
   and field production
SO PLANT BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE biofibres; molecular farming
ID GENE-EXPRESSION SYSTEM; RECOMBINANT PROTEINS; PLANTS; SEQUENCE;
   PROMOTER; FIBER; TCUP; DNA
AB Spider dragline silk is a unique biomaterial and represents nature's strongest known fibre. As it is almost as strong as many commercial synthetic fibres, it is suitable for use in many industrial and medical applications. The prerequisite for such a widespread use is the cost-effective production in sufficient quantities for commercial fibre manufacturing. Agricultural biotechnology and the production of recombinant dragline silk proteins in transgenic plants offer the potential for low-cost, large-scale production. The purpose of this work was to examine the feasibility of producing the two protein components of dragline silk (MaSp1 and MaSp2) from Nephila clavipes in transgenic tobacco. Two different promoters, the enhanced CaMV 35S promoter (Kay et al., 1987) and a new tobacco cryptic constitutive promoter, tCUP (Foster et al., 1999) were used, in conjunction with a plant secretory signal (PR1b), a translational enhancer (alfalfa mosaic virus, AMV) and an encloplasmic reticulum (ER) retention signal (KDEL), to express the MaSp1 and MaSp2 genes in the leaves of transgenic plants. Both genes expressed successfully and recombinant protein accumulated in transgenic plants grown in both greenhouse and field trials.
C1 Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON N5V 4T3, Canada.
   Nexia Biotechnol Inc, Vaudreuil Dorion, PQ J7V 8P5, Canada.
RP Brandle, J (reprint author), Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, 1391 Sandford St, London, ON N5V 4T3, Canada.
EM brandleje@agr.gc.ca
OI Menassa, Rima/0000-0003-3536-0332
CR ALPERT M, 2002, SCI AM, V287, P48
   *CFIA, 2003, INT AM DIR2000 07 CO
   CUTT JR, 1988, NUCLEIC ACIDS RES, V16, P9861, DOI 10.1093/nar/16.20.9861
   De Neve M, 1999, MOL GEN GENET, V260, P582
   Dyck MK, 2003, TRENDS BIOTECHNOL, V21, P394, DOI 10.1016/S0167-7799(03)00190-2
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Foster E, 1999, PLANT MOL BIOL, V41, P45, DOI 10.1023/A:1006229501860
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   JOBLING SA, 1987, NATURE, V325, P622, DOI 10.1038/325622a0
   Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4
   KARATZAS CN, 2003, BIOPOLYMERS, V8, P500
   KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299
   Kusnadi AR, 1997, BIOTECHNOL BIOENG, V56, P473, DOI 10.1002/(SICI)1097-0290(19971205)56:5<473::AID-BIT1>3.0.CO;2-F
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   LINTHORST HJM, 1993, PLANT MOL BIOL, V21, P685, DOI 10.1007/BF00014551
   Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177
   Macauley J, 2003, FOOD TECHNOL-CHICAGO, V57, P20
   Malik K, 2002, THEOR APPL GENET, V105, P505, DOI 10.1007/s00122-002-0926-0
   Menassa R, 2001, MOL BREEDING, V8, P177, DOI 10.1023/A:1013376407362
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   MIKI B, 1999, BIOTECHNOL AGR FOR, V45, P336
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Schouten A, 1996, PLANT MOL BIOL, V30, P781, DOI 10.1007/BF00019011
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x
NR 29
TC 51
Z9 54
U1 0
U2 12
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1467-7644
J9 PLANT BIOTECHNOL J
JI Plant Biotechnol. J.
PD SEP
PY 2004
VL 2
IS 5
BP 431
EP 438
DI 10.1111/j.1467-7652.2004.00087.x
PG 8
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA 853NM
UT WOS:000223834300006
PM 17168889
OA Bronze
DA 2018-10-19
ER

PT J
AU Bussieres, M
   Krohne, SG
   Stiles, J
   Townsend, WM
AF Bussieres, M
   Krohne, SG
   Stiles, J
   Townsend, WM
TI The use of porcine small intestinal submucosa for the repair of
   full-thickness corneal defects in dogs, cats and horses
SO VETERINARY OPHTHALMOLOGY
LA English
DT Article
DE cornea; corneal repair; small intestinal submucosa; xenograft
ID ULCERATIVE KERATITIS; GRAFT; BIOCOMPATIBILITY; ULCERS
AB Objective To evaluate the efficacy of using a porcine small intestinal submucosa (SIS) graft covered by a conjunctival flap for the surgical repair of full-thickness corneal wounds in dogs, cats and horses.
   Procedure All records dating from August 1999 to February 2003 from Purdue University Veterinary Teaching Hospital of patients that had undergone ophthalmic surgical procedures and received a SIS corneal graft for a full-thickness lesion were reviewed. Fifteen cases were identified including six dogs, two cats and seven horses. Requirements for inclusion in this study were that SIS was used as a corneal graft in a full-thickness corneal defect and that the graft was completely covered with a conjunctival flap.
   Results Of the 15 cases, one canine patient had received SIS following removal of an epibulbar melanocytoma. The remaining five canine patients had undergone this surgical procedure for the repair of corneal perforation. The two feline patients had been presented for corneal perforation following chronic ulceration. One equine patient had been presented for a deep melting ulcer, three for stromal corneal abscesses, and three for corneal perforations. Complications encountered postoperatively included aqueous leakage, conjunctival flap dehiscence, synechia, cataract and fibrin in the anterior chamber. Fourteen out of 15 patients were visual at the final re-evaluation.
   Conclusion SIS is an inexpensive, easy-to-handle biomaterial that appears to be suitable for the repair of full-thickness corneal wounds in dogs, cats and horses. Results of our study support the conclusion that this relatively new product is an effective alternative to traditional implantation materials utilized in veterinary ophthalmology.
C1 Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA.
RP Krohne, SG (reprint author), Purdue Univ, W Lafayette, IN 47907 USA.
EM sgk@vet.purdue.edu
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Andrade Alexandre L., 1999, Veterinary Ophthalmology, V2, P79
   AQUINO S, 2002, 33 ANN M AM COLL VET, P27
   BADYLAK S, 1994, J VASC SURG, V19, P467
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Barros Paulo S. M., 1998, Veterinary Ophthalmology, V1, P119, DOI 10.1046/j.1463-5224.1998.00026.x
   Featherstone H, 2000, VET REC, V146, P136, DOI 10.1136/vr.146.5.136
   Featherstone HJ, 2001, VET OPHTHALMOL, V4, P147, DOI 10.1046/j.1463-5224.2001.00192.x
   Gelatt KN, 2001, SMALL ANIMAL OPHTHAL
   GF P, 1995, ANN PLASTIC SURG, V35, P374
   Griguer F, 2001, REV MED VET-TOULOUSE, V152, P597
   HACKER DV, 1990, EQUINE VET J, V22, P88, DOI 10.1111/j.2042-3306.1990.tb04216.x
   HACKER DV, 1991, J AM ANIM HOSP ASSOC, V27, P387
   HAKANSON NE, 1987, J AM ANIM HOSP ASSOC, V23, P641
   Hansen P. A., 1999, Veterinary Ophthalmology, V2, P233, DOI 10.1046/j.1463-5224.1999.00084.x
   Herring IP, 2001, VET OPHTHALMOL, V4, P119, DOI 10.1046/j.1463-5224.2001.00187.x
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, WOUNDS, V13, P195
   IRVING AC, 1988, NEW ZEAL VET J, V36, P73, DOI 10.1080/00480169.1988.35486
   KIM JC, 1995, CORNEA, V14, P473
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LEGEAIS JM, 1991, OPHTHALMIC SURG LAS, V22, P213
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   NASISSE MP, 1985, COMP CONT EDUC PRACT, V7, P686
   PARSHALL C J JR, 1973, Journal of the American Animal Hospital Association, V9, P270
   PEIFFER RL, 1977, J AM ANIM HOSP ASSOC, V13, P387
   PEIFFER RL, 1987, COMPANION ANIMAL PRA, V7, P3
   Peiffer Robert L. Jr., 1999, P355
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Regnier A, 1999, VETERINARY OPHTHALMOLOGY, 3RD EDITION, P297
   SCAGLIOTTI RH, 1988, SEMIN VET MED SURG, V3, P69
   SCHOSTER J, 1989, VET MED, V3, P307
   SCHOSTER JV, 1992, VET MED-US, V87, P460
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Whittaker CJG, 1997, VET COMP OPHTHALMOL, V7, P19
   Wilkie DA, 1997, VET CLIN N AM-SMALL, V27, P1067, DOI 10.1016/S0195-5616(97)50104-5
NR 39
TC 39
Z9 42
U1 1
U2 6
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1463-5216
J9 VET OPHTHALMOL
JI Vet. Ophthalmol.
PD SEP-OCT
PY 2004
VL 7
IS 5
BP 352
EP 359
DI 10.1111/j.1463-5224.2004.04055.x
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA 845HC
UT WOS:000223231900011
PM 15310296
DA 2018-10-19
ER

PT J
AU Zeng, YJ
   Yang, J
   Zhao, JB
   Liao, DH
   Zhang, EP
   Gregersen, H
   Xu, XH
   Xu, H
   Xu, CQ
AF Zeng, Yan-Jun
   Yang, Jian
   Zhao, Jing-Bo
   Liao, Dong-Hua
   Zhang, En-Ping
   Gregersen, Hans
   Xu, Xiao-Hu
   Xu, Hong
   Xu, Chuan-Qing
TI Morphologic and biomechanical changes of rat oesophagus in experimental
   diabetes
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
AB AIM: To study morphologic and biomechanical changes of oesophagus in diabetes rats.
   METHODS: Diabetes was induced by a single injection of streptozotocin (STZ). The type of diabetes mellitus induced by parenteral STZ administration in rats was insulin-dependent (type I). The samples were excised and studied in vitro using a self-developed biomaterial test machine.
   RESULTS: The body mass was decreased after 4 d with STZ treatment. The length of esophagus shortened after 4, 7, 14 d. The opening angle increased after 14 d. The shear, longitudinal and circumferential stiffness were obviously raised after 28 d of STZ treatment.
   CONCLUSION: The changes of passive biomechanical properties reflect intra-structural alteration of tissue to a certain extent. This alteration will lead to some dysfunction of movement. For example, tension of esophageal wall will change due to some obstructive disease.
C1 [Zeng, Yan-Jun; Xu, Xiao-Hu; Xu, Hong; Xu, Chuan-Qing] Shantou Univ, Coll Med, Dept Forens Med, Shantou 515031, Guangdong, Peoples R China.
   [Yang, Jian; Zhang, En-Ping] Beijing Univ Technol, Beijing 100022, Peoples R China.
   [Zhao, Jing-Bo; Liao, Dong-Hua; Gregersen, Hans] Univ Aalborg, Dept Gastrointestinal Surg, Aalborg, Denmark.
RP Zeng, YJ (reprint author), Shantou Univ, Coll Med, Dept Forens Med, Shantou 515031, Guangdong, Peoples R China.
EM yjzeng@bjut.edu.cn
RI Gregersen, Hans/L-9506-2016
OI Gregersen, Hans/0000-0002-5792-2845
CR Assentoft JE, 2000, DIGEST DIS SCI, V45, P1260, DOI 10.1023/A:1005579214416
   Barlow JD, 2002, AM J PHYSIOL-GASTR L, V282, pG683, DOI 10.1152/ajpgi.00134.2001
   CLOUSE RE, 1986, GASTROENTEROLOGY, V90, P1146, DOI 10.1016/0016-5085(86)90379-3
   Dou Y, 2002, NEUROGASTROENT MOTIL, V14, P43, DOI 10.1046/j.1365-2982.2002.00301.x
   Dou YL, 2002, DIGEST DIS SCI, V47, P1158, DOI 10.1023/A:1015019030514
   Dou YL, 2001, MED ENG PHYS, V23, P557, DOI 10.1016/S1350-4533(01)00091-1
   Drewes AM, 2003, SCAND J GASTROENTERO, V38, P27, DOI 10.1080/00365520310000401
   Drewes AM, 2002, AM J PHYSIOL-GASTR L, V283, pG95, DOI 10.1152/ajpgi.00496.2001
   Gao CW, 2000, J BIOMECH, V33, P1089, DOI 10.1016/S0021-9290(00)00067-1
   Gao CW, 2000, DIGEST DIS SCI, V45, P1500, DOI 10.1023/A:1005592306587
   Gregersen H, 1999, J BIOMECH ENG-T ASME, V121, P442, DOI 10.1115/1.2835072
   Gregersen H, 1996, DIGESTION, V57, P174, DOI 10.1159/000201333
   Gregersen H, 1996, J BIOMECH, V29, P63, DOI 10.1016/0021-9290(95)00016-X
   Gregersen H, 2001, NEUROGASTROENT MOTIL, V13, P457, DOI 10.1046/j.1365-2982.2001.00279.x
   GREGERSEN H, 1992, GASTROENTEROLOGY, V103, P1547, DOI 10.1016/0016-5085(92)91176-5
   Grishaw EK, 1996, AM J ROENTGENOL, V167, P719, DOI 10.2214/ajr.167.3.8751689
   HEWSON EG, 1990, GASTROENTEROLOGY, V98, P626, DOI 10.1016/0016-5085(90)90281-5
   Holloway RH, 1999, AM J GASTROENTEROL, V94, P3150
   Jorgensen CS, 2001, DIGEST DIS SCI, V46, P960, DOI 10.1023/A:1010737323153
   JUHL CO, 1994, SCAND J GASTROENTERO, V29, P867, DOI 10.3109/00365529409094855
   Karayalcin B, 1992, Ann Nucl Med, V6, P89
   Kinekawa F, 2001, AM J GASTROENTEROL, V96, P2026, DOI 10.1016/S0002-9270(01)02425-X
   Liao D, 2003, MED ENG PHYS, V25, P413, DOI 10.1016/S1350-4533(03)00020-1
   Liao DH, 2003, MED ENG PHYS, V25, P731, DOI 10.1016/S1350-4533(03)00122-X
   LIU SQ, 1992, BIORHEOLOGY, V29, P443
   Lu X, 2001, J BIOMECH, V34, P225, DOI 10.1016/S0021-9290(00)00176-7
   MAYHEW TM, 1989, DIABETOLOGIA, V32, P649
   MITTAL RK, 1990, AM J PHYSIOL, V258, pG208
   Murtagh JE, 1999, CLIN EXP OPTOM, V82, P74
   Narawane N M, 1998, Indian J Gastroenterol, V17, P55
   Nicosia MA, 2001, AM J PHYSIOL-GASTR L, V281, pG1022
   Nicosia MA, 2002, J THEOR BIOL, V219, P235, DOI 10.1006/yjtbi.3118
   ORVAR KB, 1993, DIGEST DIS SCI, V38, P197, DOI 10.1007/BF01307535
   Patel RS, 1998, AM J PHYSIOL-GASTR L, V275, pG187, DOI 10.1152/ajpgi.1998.275.2.G187
   Pehlivanov N, 2001, AM J PHYSIOL-GASTR L, V280, pG1093
   Petersen JAK, 1998, DIGEST DIS SCI, V43, P521
   Pouderoux P, 1999, AM J GASTROENTEROL, V94, P1457
   RATHMANN W, 1991, DIABETES CARE, V14, P1086, DOI 10.2337/diacare.14.11.1086
   REN JL, 1993, AM J PHYSIOL, V264, pG407
   SMITH B, 1974, J NEUROL NEUROSUR PS, V37, P1151, DOI 10.1136/jnnp.37.10.1151
   SUNDKVIST G, 1989, ACTA RADIOL, V30, P17
   Takeda T, 2002, AM J PHYSIOL-GASTR L, V282, pG785, DOI 10.1152/ajpgi.00394.2001
   Verne GN, 1998, GASTROENTEROL CLIN N, V27, P861, DOI 10.1016/S0889-8553(05)70035-2
   Villadsen GE, 2001, NEUROGASTROENT MOTIL, V13, P199, DOI 10.1046/j.1365-2982.2001.00259.x
   VINTERJENSEN L, 1995, SCAND J GASTROENTERO, V30, P614, DOI 10.3109/00365529509096302
   WESTIN L, 1986, SCAND J GASTROENTERO, V21, P1200, DOI 10.3109/00365528608996443
   Yang J, 2003, WORLD J GASTROENTERO, V9, P2278
   Yang J, 2003, DIGEST DIS SCI, V48, P442, DOI 10.1023/A:1022516111538
   Zeng YJ, 2003, WORLD J GASTROENTERO, V9, P804, DOI 10.3748/wjg.v9.i4.804
   Zhao J, 2002, DIGEST LIVER DIS, V34, P707, DOI 10.1016/S1590-8658(02)80022-6
   Zhao JB, 2000, BIORHEOLOGY, V37, P385
   Zhao JB, 2003, ANN BIOMED ENG, V31, P700, DOI 10.1114/1.1575758
   Zhao JB, 2002, BIORHEOLOGY, V39, P719
   ZOUBI SA, 1995, VIRCHOWS ARCH, V427, P187
NR 54
TC 3
Z9 3
U1 0
U2 2
PU BAISHIDENG PUBL GRP CO LTD
PI BEIJING
PA RM 903, BLDG D, OCEAN INTERNATIONAL CTR, NO 62 DONGSIHUAN ZHONGLU,
   BEIJING, CHAOYANG DISTRICT 100025, PEOPLES R CHINA
SN 1007-9327
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD SEP 1
PY 2004
VL 10
IS 17
BP 2519
EP 2523
DI 10.3748/wjg.v10.i17.2519
PG 5
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA V19UI
UT WOS:000208096900012
PM 15300896
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Wang, MS
   Palmer, LB
   Schwartz, JD
   Razatos, A
AF Wang, MS
   Palmer, LB
   Schwartz, JD
   Razatos, A
TI Evaluating protein attraction and adhesion to biomaterials with the
   atomic force microscope
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ELECTROLYTE-SOLUTIONS; MICROBIAL ADHESION;
   HYDRATION FORCES; OXIDE SURFACES; MICA SURFACES; INFECTIONS; RESONANCE;
   BINDING; DLVO
AB Failure of implanted biomaterials is commonly due to nonspecific protein adsorption, which in turn causes adverse reactions such as the formation of fibrous capsules, blood clots, or bacterial biofilm infections.(1) Current research efforts have focused on modifying the biomaterial interface to control protein reactions. Designing biomaterial interfaces at the molecular level, however, requires an experimental technique that provides detailed, dynamic information on the forces involved in protein adhesion. The goal of this study was to develop an atomic force microscope (AFM)-based technique to evaluate protein adhesion on biomaterial surfaces. In this study, the AFM was used to evaluate (i) protein-protein, (ii) protein- substrate, and (iii) protein-dextran interactions. The AFM was first used to measure the pull-off forces'between bovine serum albumin (BSA) tips/BSA surfaces and BSA tips/anti-BSA surfaces. Results from these protein-protein studies were consistent with the literature. More importantly, the successful measurement of antibody-antigen binding interactions demonstrates that both the BSA and anti-BSA proteins retain their folded conformation and remain functional following our immobilization protocol. The AFM was also used to quantify the physiochemical interactions of proteins during adhesion to various self-assembled monolayers (SAMs) and dextran-coated substrates representative of potential biomaterial interface modifications. Dextran, which renders surfaces very hydrophilic, was the only surface coating that BSA protein did not adhere to. Hydrophobic interactions were not found to play a significant role in BSA adhesion. Therefore, the dextran molecules may resist protein adhesion by repulsive steric effects or hydration pressure. Moreover, the AFM-based methodology provides dynamic, quantitative information about protein adhesion at the nanoscale level.
C1 Arizona State Univ, Dept Chem & Mat Engn, Tempe, AZ 85287 USA.
RP Razatos, A (reprint author), Arizona State Univ, Dept Chem Engn, POB 876006, Tempe, AZ 85287 USA.
EM razatos@asu.edu
RI Wang, Min/C-6495-2009
OI Wang, Min/0000-0002-8978-4918
CR Basu S, 1996, J COLLOID INTERF SCI, V181, P443, DOI 10.1006/jcis.1996.0401
   BERTILSSON L, 1993, LANGMUIR, V9, P141, DOI 10.1021/la00025a032
   BrowningKelley ME, 1997, LANGMUIR, V13, P343, DOI 10.1021/la960918x
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CHEN GY, 1994, REV SCI INSTRUM, V65, P2532, DOI 10.1063/1.1144647
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   Hinterdorfer P., 2000, Single Molecules, V1, P99, DOI 10.1002/1438-5171(200006)1:2<99::AID-SIMO99>3.0.CO;2-K
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   KINGSHOTT P, 1999, CURR OPIN SOLID STAT, V4
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   MULHERN PJ, 1992, ULTRAMICROSCOPY, V42, P1214, DOI 10.1016/0304-3991(92)90426-K
   Ninham BW, 1999, ADV COLLOID INTERFAC, V83, P1, DOI 10.1016/S0001-8686(99)00008-1
   PASHLEY RM, 1981, J COLLOID INTERF SCI, V83, P531, DOI 10.1016/0021-9797(81)90348-9
   PASHLEY RM, 1981, J COLLOID INTERF SCI, V80, P153, DOI 10.1016/0021-9797(81)90171-5
   REID G, 1994, COLLOID SURFACE B, V2, P377
   Rixman MA, 2003, LANGMUIR, V19, P6202, DOI 10.1021/la026551f
   Ros R, 1998, P NATL ACAD SCI USA, V95, P7402, DOI 10.1073/pnas.95.13.7402
   Santin M, 1999, BIOMATERIALS, V20, P1245, DOI 10.1016/S0142-9612(99)00026-5
   SENDEN TJ, 1994, LANGMUIR, V10, P1003, DOI 10.1021/la00016a600
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   STICKLER DJ, 1995, CELL MATER, V5, P167
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   VROMAN L, 1980, BLOOD, V55, P156
   Yan L, 1997, LANGMUIR, V13, P6704, DOI 10.1021/la970762g
   YU JL, 1994, J MED MICROBIOL, V41, P133, DOI 10.1099/00222615-41-2-133
NR 36
TC 83
Z9 86
U1 2
U2 71
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 31
PY 2004
VL 20
IS 18
BP 7753
EP 7759
DI 10.1021/la049849+
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 849UZ
UT WOS:000223567900058
PM 15323528
DA 2018-10-19
ER

PT J
AU Inuzuka, M
   Nakamura, S
   Kishi, S
   Yoshida, K
   Hashimoto, K
   Toda, Y
   Yamashita, K
AF Inuzuka, M
   Nakamura, S
   Kishi, S
   Yoshida, K
   Hashimoto, K
   Toda, Y
   Yamashita, K
TI Hydroxyapatite-doped zirconia for preparation of biomedical composites
   ceramics
SO SOLID STATE IONICS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on the Reactivity of Solids
CY NOV 09-13, 2003
CL Kyoto, JAPAN
DE bioceramics; bioactivity; ion conductivity; zirconia composite;
   solid-state reaction
ID MECHANICAL-PROPERTIES
AB Yttria-stabilized zirconia (YSZ) ceramics doped with a small amount of hydroxyapatite (HA) were developed in order to produce a composite biomaterial with a high bioactivity as well as sufficient mechanical strength and fracture toughness for a heavy load. The maximum Vickers hardness of 964.1 Hv for HA-doped YSZ (HA-Z) composite was much greater than that of HA ceramics and almost the same as that of YSZ. The entire covering by bone-like apatite after a 5-day immersion in simulated body fluid (SBF) suggested that the HA-Z composite had bioactivities. The ion conductivity reduction of the HA-Z composite with an increasing amount of added HA was attributed to the diffusion of calcium ion from the HA to the YSZ grains caused by solid-state reactions. The HA-Z composite ceramics were recognized as osteoconductive and durable biomaterials and expected to be used in extended application fields. (C) 2004 Elsevier B.V All rights reserved.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   Chiba Inst Technol, Grad Sch Engn, Narashino, Chiba 2750016, Japan.
   Sci Univ Tokyo, Undergrad Sch Ind Sci & Technol, Noda, Chiba 2788510, Japan.
RP Yamashita, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM yama-k.bcr@tmd.ac.jp
RI Yoshida, Katsumi/H-9680-2014
OI Yoshida, Katsumi/0000-0002-2735-2263
CR Guo HB, 2003, BIOMATERIALS, V24, P667, DOI 10.1016/S0142-9612(02)00381-2
   IOKU K, 1991, J CERAM SOC JPN, V99, P191
   Kim HW, 2002, J AM CERAM SOC, V85, P1634, DOI 10.1111/j.1151-2916.2002.tb00328.x
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lee JS, 2001, J MATER RES, V16, P2739, DOI 10.1557/JMR.2001.0374
   Li W, 2003, BIOMATERIALS, V24, P937, DOI 10.1016/S0142-9612(02)00428-3
   PCONI C, 1999, BIOMATERIALS, V20, P1
   Rao RR, 2002, MAT SCI ENG C-BIO S, V20, P187
   Shen ZJ, 2001, ADV MATER, V13, P214, DOI 10.1002/1521-4095(200102)13:3<214::AID-ADMA214>3.0.CO;2-5
   YAMASHITA K, 1988, J CERAM SOC JPN, V96, P616
   YAMASHITA K, 1988, P 4 INT S SCI TECHN, V2, P1320
NR 11
TC 35
Z9 38
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-2738
J9 SOLID STATE IONICS
JI Solid State Ion.
PD AUG 31
PY 2004
VL 172
IS 1-4
SI SI
BP 509
EP 513
DI 10.1016/j.ssi.2004.01.054
PG 5
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 871MZ
UT WOS:000225139100103
DA 2018-10-19
ER

PT J
AU Garza, JM
   Schaaf, P
   Muller, S
   Ball, V
   Stoltz, JF
   Voegel, JC
   Lavalle, P
AF Garza, JM
   Schaaf, P
   Muller, S
   Ball, V
   Stoltz, JF
   Voegel, JC
   Lavalle, P
TI Multicompartment films made of alternate polyelectrolyte multilayers of
   exponential and linear growth
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; LIGHT-EMITTING-DIODES; WEAK POLYELECTROLYTES;
   POLYPEPTIDE FILMS; BUILDUP; COATINGS; REFLECTOMETRY; DEPOSITION;
   ADSORPTION; MECHANISM
AB The layer by layer deposition process of polyelectrolytes is used to construct films equipped with several compartments containing "free polyelectrolytes". Each compartment corresponds to a stratum of an exponentially growing polyelectrolyte multilayer film, and two consecutive compartments are separated by a stratum composed of a linearly growing multilayer that acts as a barrier preventing polyelectrolyte diffusion from one compartment to another. We use hyaluronic acid/poly(L-lysine) as the system to build the compartments and the poly(styrene sulfonate)/poly(allylamine) system for the barrier. Using confocal microscopy, it is shown that poly(L-lysine) diffuses only within the compartment in which it was initially introduced during the film construction and is thus unable to cross the barriers. Using fluorescein isothiocyanate as a pH indicator, it is also shown that although poly(styrene sulfonate)/poly(allylamine) multilayers act as a barrier for polyelectrolytes, they do not prevent proton diffusion through the film. Such films open the route for multiple fanctionalization of biomaterial coatings.
C1 Univ Strasbourg 1, Fac Chirurg Dent, INSERM Unite 595, F-67085 Strasbourg, France.
   Inst Charles Sadron, CNRS UPR 22, F-67083 Strasbourg, France.
   Fac Med Vandoeuvre Nancy, LEMTA, UMR CNRS 7563, F-54500 Vandoeuvre Les Nancy, France.
RP Voegel, JC (reprint author), Univ Strasbourg 1, Fac Chirurg Dent, INSERM Unite 595, 11 Rue Humann, F-67085 Strasbourg, France.
EM jean-claude.voegel@medecine.u-strasbg.fr
RI BALL, Vincent/E-8500-2016; Lavalle, Philippe/E-6328-2016; SCHAAF,
   Pierre/J-2751-2016
OI Lavalle, Philippe/0000-0001-8798-912X; SCHAAF,
   Pierre/0000-0001-7423-5492
CR Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Boulmedais F, 2003, LANGMUIR, V19, P440, DOI 10.1021/la0264522
   Boulmedais F, 2003, LANGMUIR, V19, P9873, DOI 10.1021/la0348259
   Caruso F, 1998, J PHYS CHEM B, V102, P2011, DOI 10.1021/jp980198y
   Caruso F, 1997, LANGMUIR, V13, P3422, DOI 10.1021/la960821a
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DeLongchamp DM, 2003, CHEM MATER, V15, P1575, DOI 10.1021/cm021045x
   Eckle M, 2001, NANO LETT, V1, P45, DOI 10.1021/nl005514a
   Grant GGS, 2001, BIOMED MICRODEVICES, V3, P301, DOI 10.1023/A:1012456714628
   Hammond PT, 1999, CURR OPIN COLLOID IN, V4, P430, DOI 10.1016/S1359-0294(00)00022-4
   HAMMOND PT, 2004, 227 ACS M AN CA
   Harris JJ, 2000, LANGMUIR, V16, P2006, DOI 10.1021/la990620h
   JESSEL N, 2003, J ADV MAT, V15, P692
   JONAS AT, 2004, 227 ACS M AN CA
   Kotov NA, 1998, CHEM MATER, V10, P886, DOI 10.1021/cm970649b
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lavalle P, 2004, MACROMOLECULES, V37, P1159, DOI 10.1021/ma035326h
   LAVALLE P, 2004, J PHYS CHEM B, V108, P636
   Liu XY, 2004, CHEM MATER, V16, P351, DOI 10.1021/cm034559k
   Losche M, 1998, MACROMOLECULES, V31, P8893, DOI 10.1021/ma980910p
   McAloney RA, 2001, LANGMUIR, V17, P6655, DOI 10.1021/la010136q
   Onitsuka O, 1996, J APPL PHYS, V80, P4067, DOI 10.1063/1.363369
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   RAMSDEN JJ, 1995, THIN SOLID FILMS, V254, P246, DOI 10.1016/0040-6090(94)06262-J
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Schoeler B, 2003, MACROMOLECULES, V36, P5258, DOI 10.1021/ma034018g
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
   2004, HDB FLUORESCENT PROB, pCH21
NR 37
TC 102
Z9 103
U1 3
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 17
PY 2004
VL 20
IS 17
BP 7298
EP 7302
DI 10.1021/la049106o
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 845WQ
UT WOS:000223276400048
PM 15301518
DA 2018-10-19
ER

PT J
AU Jenkins, J
   Prabhakarpandian, B
   Lenghaus, K
   Hickman, J
   Sundaram, S
AF Jenkins, J
   Prabhakarpandian, B
   Lenghaus, K
   Hickman, J
   Sundaram, S
TI Fluidics-resolved estimation of protein adsorption kinetics in a
   biomicrofluidic system
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE biomicrofluidics; protein/surface interaction; passive binding; least
   squares
ID MASS-TRANSPORT; RATE CONSTANTS; BIOSENSOR TECHNOLOGY; OPTICAL BIOSENSOR;
   SURFACE; BINDING; CONVECTION; DIFFUSION; BIACORE; DNA
AB Protein adsorption on surfaces is a complex phenomenon that is described by the balance of convective/diffusive transport of the protein species to the surface and its adsorption/desorption at the surface. The extent of binding depends on a variety of factors such as protein/surface interactions, availability of binding sites, localized concentrations of protein near biomaterial surfaces and flow characteristics of the protein in that region. Factors such as time-varying flows, complex device geometries, presence of multiple competitive species, or possible denaturing of proteins when they attach to the surface make it extremely difficult to quantitatively analyze protein interactions with surfaces. Adsorption/desorption rate constants are often inferred using simplistic models which neglect mass transport and have limited use across different microfluidic systems and flow protocols. In this work, we have developed and demonstrated a fluidics-resolved model that evaluates protein adsorption, accounting for both the fluidic transport and the biochemical kinetics in complex biomicrofluidic devices. The model is valid for both flow and static conditions. An automated procedure was also developed to extract the "intrinsic" mass-transport-independent adsorption kinetic rate constants from experimental data using a least squares optimization method. The automated data extraction methodology is applied to two proteins (alkaline phosphatase and glucose oxidase) that have been brought into contact with poly(etheretherketone) and Teflon capillaries. The applicability of the procedure in analyzing flow and adsorption in complex microfluidic structures is also demonstrated. (C) 2004 Elsevier Inc. All rights reserved.
C1 CFD Res Corp, Huntsville, AL 35805 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Sundaram, S (reprint author), CFD Res Corp, Huntsville, AL 35805 USA.
EM sxs@cfdrc.com
CR *CFD RES CORP, CFD ACE PLUS VERS 20
   Christensen LLH, 1997, ANAL BIOCHEM, V249, P153, DOI 10.1006/abio.1997.2182
   Edwards DA, 1999, IMA J APPL MATH, V63, P89, DOI 10.1093/imamat/63.1.89
   GILL PE, 1981, PRACTICAL OPTIMIZATI
   GLASER R, 1993, ANAL BIOCHEM, V312, P152
   GLASER RW, 1993, ANAL BIOCHEM, V213, P152, DOI 10.1006/abio.1993.1399
   Khalifa Myriam Ben, 2001, Analytical Biochemistry, V293, P194, DOI 10.1006/abio.2001.5119
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   LU C, 1995, J COLLOID INTERF SCI, V168, P152
   MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268
   Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6
   Nocedal J., 1999, NUMERICAL OPTIMIZATI
   Ricco AJ, 2002, BIOCHEM SOC T, V30, P73, DOI 10.1042/bst0300073
   Rossier J, 2002, ELECTROPHORESIS, V23, P858, DOI 10.1002/1522-2683(200203)23:6<858::AID-ELPS858>3.0.CO;2-3
   Sigmundsson K, 2002, BIOCHEMISTRY-US, V41, P8263, DOI 10.1021/bi020099h
   Sikavitsas V, 2002, BIOTECHNOL PROGR, V18, P885, DOI 10.1021/bp020045z
   Slomkowski S, 1998, PROG POLYM SCI, V23, P815, DOI 10.1016/S0079-6700(97)00053-1
   Sukhishvili SA, 1999, J CHEM PHYS, V110, P10153, DOI 10.1063/1.478888
   Topoglidis E, 1998, ANAL CHEM, V70, P5111, DOI 10.1021/ac980764l
   WATTS HJ, 1995, ANAL CHEM, V67, P4283, DOI 10.1021/ac00119a013
   Yarmush ML, 1996, MOL IMMUNOL, V33, P1203, DOI 10.1016/S0161-5890(96)00075-2
   Zhou AH, 2000, APPL SURF SCI, V158, P141, DOI 10.1016/S0169-4332(99)00596-6
NR 22
TC 18
Z9 18
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD AUG 15
PY 2004
VL 331
IS 2
BP 207
EP 215
DI 10.1016/j.ab.2004.03072
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 842LI
UT WOS:000223005200001
PM 15265724
DA 2018-10-19
ER

PT J
AU Jarman-Smith, M
   Bodamyali, T
   Stevens, C
   Howell, JA
   Horrocks, M
   Chaudhuri, JB
AF Jarman-Smith, M
   Bodamyali, T
   Stevens, C
   Howell, JA
   Horrocks, M
   Chaudhuri, JB
TI Human fibroblast culture on a crosslinked dermal porcine collagen matrix
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE biomedical; bioreactors; collagen; dermis; fibroblasts tissue cell
   culture
ID SKIN EQUIVALENT; KERATINOCYTES; BIOMATERIAL
AB The use of a novel porcine-derived collagen biomaterial as a dermal tissue engineering matrix was examined. The matrix is derived from porcine dermis, and is processed to retain the native collagen (Type 1) and elastin structure. Human primary fibroblasts were cultured on the matrix to examine its potential for creating a dermal replacement. Attachment of fibroblasts on the collagen was compared to tissue culture plastic and PET membranes. Cell proliferation was assessed using the MTT assay and DAPI staining. For seeding densities of 5x10(4) and 1x10(5) cells cm(-2), PET and plastic demonstrated >95% attachment of seeded numbers after 3 h. The collagen matrix reached levels >80% after 3-4 h with no influence of the seeding density. Matrix samples with perforating pores of 40 mum diameter were also studied. After 216 h culture in static culture, with media replacement every 3 days, the final cell numbers reached 2.1x10(5) (perforated) and 2.0x10(5) cells cm(-2) (unperforated). In comparison fibroblast culture in a perfusion bioreactor, with continuous media replacement, reached 2.3x10(5) (unperforated) and 2.5x10(5) cells cm(-2) (perforated) after 216 h. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Bath, Dept Chem Engn, Bath BA2 7AY, Avon, England.
   Univ Bath, Dept Med Sci, Bath BA2 7AY, Avon, England.
RP Chaudhuri, JB (reprint author), Univ Bath, Dept Chem Engn, Bath BA2 7AY, Avon, England.
EM cesjbc@bath.ac.uk
RI Chaudhuri, julian/F-5032-2012
CR Bellincampi LD, 1997, J APPL POLYM SCI, V63, P1493, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1493::AID-APP11>3.0.CO;2-3
   Butler CE, 1999, BRIT J PLAST SURG, V52, P127, DOI 10.1054/bjps.1997.3047
   CHEVALLAY B, 1999, J BIOMED MATER RES, V49, P449
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P139, DOI 10.1002/jbm.820290202
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GRIFFITHS RW, 1982, BRIT J PLAST SURG, V35, P519, DOI 10.1016/0007-1226(82)90056-X
   HardinYoung J, 1996, BIOTECHNOL BIOENG, V49, P675, DOI 10.1002/(SICI)1097-0290(19960320)49:6<675::AID-BIT9>3.0.CO;2-L
   HEENEN M, 1992, CELL PROLIFERAT, V25, P311, DOI 10.1111/j.1365-2184.1992.tb01442.x
   Kim BM, 1999, BRIT J PLAST SURG, V52, P573, DOI 10.1054/bjps.1999.3162
   Lee DY, 2000, J DERMATOL SCI, V23, P132, DOI 10.1016/S0923-1811(00)00068-2
   MEDALIE D, 1996, J INVEST DERMATOL, V106, P121
   Minuth WW, 2000, J BIOMAT SCI-POLYM E, V11, P495, DOI 10.1163/156856200743832
   OLDEDAMINK LHH, 1995, J MATER SCI-MATER M, V6, P429
   OLIVER RF, 1985, Patent No. 8505274
   Pomahac B, 1998, CRIT REV ORAL BIOL M, V9, P333, DOI 10.1177/10454411980090030601
   Smith M, 2000, FOOD BIOPROD PROCESS, V78, P19, DOI 10.1205/096030800532680
   VANLUYN M, 1992, BIOMATERIALS, V113, P1017
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WASSERMANN D, 1988, BURNS, V14, P326, DOI 10.1016/0305-4179(88)90076-9
NR 19
TC 9
Z9 10
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1369-703X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD AUG 15
PY 2004
VL 20
IS 2-3
BP 217
EP 222
DI 10.1016/j.bej.2003.09.016
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 838SD
UT WOS:000222732500018
DA 2018-10-19
ER

PT J
AU Fornasier, VL
   Goodman, SB
   Protzner, K
   Kamel, M
   Song, Y
   Shojaci, A
AF Fornasier, VL
   Goodman, SB
   Protzner, K
   Kamel, M
   Song, Y
   Shojaci, A
TI The role of implant alignment on stability and particles on
   periprosthetic osteolysis - A rabbit model of implant failure
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; POLYETHYLENE WEAR DEBRIS; BONE HARVEST CHAMBER;
   PARTICULATE POLYMETHYLMETHACRYLATE; TITANIUM-ALLOY; ACETABULAR
   COMPONENTS; IN-VITRO; TIBIA; TISSUE; BULK
AB The study objective was to determine the tissue response to polyethylene and/or titanium particles and the role that these play in peri-prosthetic osteolysis in a rabbit model of implant failure. Twenty-two mature rabbits were used. Unilateral tibial arthroplasty was performed on all of them. The test animals received implants that were intentionally rotationally unstable with reference to the host tibia in order to create a model of failure. The test rabbits were divided into three groups. Group 1 consisted of seven rabbits in which only the carrier was implanted. Group 2 consisted of seven rabbits that received only polyethylene particles suspended in the carrier. Group 3 consisted of eight rabbits that received a mixture of polyethylene and titanium alloy particles suspended in the carrier. The rabbits were sacrificed at 6 months post surgery. The entire knee, together with the immediately surrounding soft tissue, was retrieved. The position of the implant in each rabbit was assessed with reference to its alignment to the tibia. The number of inflammatory, foreign-body reactive cells, the presence of neovascularization, edema, and necrosis in the periprosthetic zones were recorded and assessed in a qualitative and semiquantitative manner. Quantitative histomorphometry was used to determine the proportion of implant surface that interfaced with osseous or fibrous tissue. Also assessed was the thickness and maturity of the fibrous tissue and the endosteal remodeling activity in the peri-implant bone counting both osteoclastic and osteoblastic activity. The results showed that implanted particles and misalignment of the implants combined to produce peri-prosthetic bone resorption. Bone resorption was found to be proportional to the degree of misalignment. The animals that received combined polyethylene/titanium particles had a greater degree of foreign-body and inflammatory response with osteolysis than the other groups. The combination of bio-material particles (polyethylene and titanium alloy) produced a greater degree of bone resorption than the single biomaterial particles (polyethylene). The amount of bone resorption surrounding the implant was directly proportional to the degree of misalignment of the implant. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Toronto, St Michaels Hosp, Dept Lab Med & Patholphysiol, Lab Bone & Joint Pathol, Toronto, ON M5B 1W8, Canada.
   Stanford Univ, Med Ctr, Div Orthopaed Surg, Stanford, CA 94305 USA.
RP Fornasier, VL (reprint author), Univ Toronto, St Michaels Hosp, Dept Lab Med & Patholphysiol, Lab Bone & Joint Pathol, 30 Bond St, Toronto, ON M5B 1W8, Canada.
EM vfornasi@smh.toronto.on.ca
CR Boynton EL, 1995, CAN J SURG, V38, P507
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   FORNASIER V, 1991, CLIN ORTHOP RELAT R, V271, P272
   FORNASIER VL, 1975, HUM PATHOL, V6, P623, DOI 10.1016/S0046-8177(75)80046-3
   GOLDNER RD, 1977, AM J PATHOL, V89, P335
   GOODMAN S, 1995, J APPL BIOMATER, V6, P27, DOI 10.1002/jab.770060105
   GOODMAN S, 1994, ACTA ORTHOP SCAND, V65, P157, DOI 10.3109/17453679408995425
   Goodman S, 1996, ACTA ORTHOP SCAND, V67, P599, DOI 10.3109/17453679608997764
   GOODMAN SB, 1990, J BIOMED MATER RES, V24, P1539, DOI 10.1002/jbm.820241109
   GOODMAN SB, 1991, ARCH ORTHOP TRAUM SU, V110, P123, DOI 10.1007/BF00395792
   GOODMAN SB, 1993, BIOMATERIALS, V14, P723, DOI 10.1016/0142-9612(93)90035-Z
   GOODMAN SB, 1991, CLIN ORTHOP RELAT R, V271, P300
   GOODMAN SB, 1998, CLIN ORTHOP RELAT R, V352, P25
   GOODMAN SB, 1990, CLIN ORTHOP RELAT R, V257, P305
   JASTY M, 1994, CLIN ORTHOP RELAT R, P111
   JASTY M, 1992, CLIN ORTHOP RELAT R, V85, P116
   La Budde J K, 1994, J Arthroplasty, V9, P291, DOI 10.1016/0883-5403(94)90084-1
   MANLEY MT, 1994, CLIN ORTHOPAEDICS, V298, P137
   Nizegorodcew T, 1997, INT ORTHOP, V21, P14, DOI 10.1007/s002640050110
   PAZZAGLIA UE, 1987, ARCH ORTHOP TRAUM SU, V106, P209, DOI 10.1007/BF00450457
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SCHMALZRIED TP, 1994, J BONE JOINT SURG AM, V76A, P677, DOI 10.2106/00004623-199405000-00008
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   Wooley PH, 1996, CLIN ORTHOP RELAT R, P63
   WRIGHT TM, 2000, AAOS B, P15
NR 26
TC 9
Z9 9
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG 15
PY 2004
VL 70B
IS 2
BP 179
EP 186
DI 10.1002/jbm.b.20038
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 841RS
UT WOS:000222949700002
PM 15264298
DA 2018-10-19
ER

PT J
AU Choubey, A
   Basu, B
   Balasubramaniam, R
AF Choubey, A
   Basu, B
   Balasubramaniam, R
TI Tribological behaviour of Ti-based alloys in simulated body fluid
   solution at fretting contacts
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE titanium; biomaterial; friction; wear
ID STAINLESS-STEEL; TITANIUM; CORROSION; SCREWS; WEAR
AB Friction and wear play an important role in determining the performance of biomaterials. To this end, the present research is carried out to understand the tribological behavior of some important biometallic alloys, CP titanium, Ti-6A1-4V, Ti-5Al-2.5Fe, Ti-13Nb-13Zr, and Co-28Cr-6Mo under fretting contacts. The fretting experiments were carried out on candidate biometallic alloys against bearing steel at ION normal load for 10,000 cycles with relative displacement stroke between the flat and ball set to 80 mum and the frequency at 10 Hz on a fretting (low amplitude reciprocatory tangential sliding) wear tester. The tests were performed in Hank's balanced salt solution to assess the performance of the materials in simulated body fluid (physiological) solution. The results revealed the lowest coefficient of friction (COF) of 0.3 for Ti-5Al-2.5Fe/steel couple while for other Ti-based alloys COF was in the range of 0.46-0.50. Tribomechanical wear, as evident from the observation of abrasion and cracking, is the predominant wear mechanism. (C) 2004 Elsevier B.V All rights reserved.
C1 Indian Inst Technol, Dept Mat & Met Engn, Kanpur 208016, Uttar Pradesh, India.
RP Basu, B (reprint author), Indian Inst Technol, Dept Mat & Met Engn, Kanpur 208016, Uttar Pradesh, India.
EM bikram@iitk.ac.in
RI BASU, BIKRAMJIT/A-9967-2013
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   Atkinson J.R., 1981, INTRO BIOMECHANICS J
   Black J, 1985, Hip, P199
   BROWN SA, 1981, J BIOMED MATER RES, V15, P867, DOI 10.1002/jbm.820150611
   BUNDINSKI KG, 1991, WEAR, V151, P203
   Collings E. W., 1994, MAT PROPERTIES HDB T, P1
   Donachie J., 2000, TITANIUM TECHNICAL G, P143
   MERCER AP, 1988, WEAR, V124, P165, DOI 10.1016/0043-1648(88)90242-6
   Park J.B., 1992, BIOMATERIALS INTRO, P75
   TORGERSEN S, 1994, J MATER SCI-MATER M, V5, P256, DOI 10.1007/BF00122394
   URBAN RM, 1994, J BONE JOINT SURG AM, V76A, P1345, DOI 10.2106/00004623-199409000-00009
   Williams D.F., 1973, DETERIORATION MAT US, P137
NR 12
TC 40
Z9 41
U1 0
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD AUG 15
PY 2004
VL 379
IS 1-2
BP 234
EP 239
DI 10.1016/j.msea.2004.02.027
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 846QG
UT WOS:000223330100028
DA 2018-10-19
ER

PT J
AU Madoff, RD
   Parker, SC
   Varma, MG
   Lowry, AC
AF Madoff, RD
   Parker, SC
   Varma, MG
   Lowry, AC
TI Faecal incontinence in adults
SO LANCET
LA English
DT Review
ID ANAL-SPHINCTER REPAIR; SACRAL NERVE-STIMULATION; QUALITY-OF-LIFE;
   INJECTABLE SILICONE BIOMATERIAL; RADIOFREQUENCY ENERGY DELIVERY;
   RANDOMIZED CONTROLLED-TRIAL; ARTIFICIAL BOWEL SPHINCTER; PUDENDAL
   NEUROPATHY; ANORECTAL INCONTINENCE; TOPICAL PHENYLEPHRINE
AB Faccal incontinence can affect individuals of all ages and in many cases greatly impairs quality of life, but incontinent patients should not accept their debility as either inevitable or untreatable. Education of the general public and of health-care providers alike is important, because most cases are readily treatable. Many cases of mild incontinence respond to simple medical therapy, whereas patients with more advanced incontinence are best cared for after complete physiological assessment. Recent advances in therapy have led to promising results, even for patients with refractory incontinence. Health-care providers must make every effort to communicate fully with incontinent patients and to help restore their self-esteem, eliminate their self-imposed isolation, and allow them to resume an active and productive lifestyle.
C1 Univ Minnesota, Dept Surg, Div Colon & Rectal Surg, Minneapolis, MN 55455 USA.
   Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.
RP Madoff, RD (reprint author), 393 Dunlap St N,Suite 500, St Paul, MN 55104 USA.
EM madof001@umn.edu
CR Altomare DF, 2001, BRIT J SURG, V88, P1481, DOI 10.1046/j.0007-1323.2001.01895.x
   BAETEN C, 1988, DIS COLON RECTUM, V31, P134, DOI 10.1007/BF02562646
   Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008
   Baxter NN, 2003, DIS COLON RECTUM, V46, P1591, DOI 10.1097/013DCR.0000098906.61097.1C
   BORRIE MJ, 1992, CAN MED ASSOC J, V147, P322
   Buie WD, 2001, DIS COLON RECTUM, V44, P1255
   BUSER WD, 1986, GASTROENTEROLOGY, V91, P1186, DOI 10.1016/S0016-5085(86)80015-4
   Carapeti EA, 1999, BRIT J SURG, V86, P267
   Carapeti EA, 2000, BRIT J SURG, V87, P38, DOI 10.1046/j.1365-2168.2000.01306.x
   Carapeti EA, 2000, DIS COLON RECTUM, V43, P1059, DOI 10.1007/BF02236550
   CARUANA BJ, 1991, GASTROENTEROLOGY, V100, P465, DOI 10.1016/0016-5085(91)90217-9
   Chassagne P, 1999, AM J MED, V106, P185, DOI 10.1016/S0002-9343(98)00407-0
   Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007
   CHRISTIANSEN J, 1987, LANCET, V2, P244
   CONSTANTINIDES CG, 1983, J PEDIATR SURG, V18, P276, DOI 10.1016/S0022-3468(83)80099-2
   DEVESA JM, 1992, DIS COLON RECTUM, V35, P339, DOI 10.1007/BF02048111
   Donnelly V, 1997, BRIT J OBSTET GYNAEC, V104, P311, DOI 10.1111/j.1471-0528.1997.tb11459.x
   Donnelly VS, 1998, DIS COLON RECTUM, V41, P586, DOI 10.1007/BF02235263
   DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162
   DUTHIE HL, 1960, BRIT J SURG, V47, P585, DOI 10.1002/bjs.18004720602
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   ENCK P, 1994, DIS COLON RECTUM, V37, P997, DOI 10.1007/BF02049311
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1994, BRIT J SURG, V81, P1231, DOI 10.1002/bjs.1800810853
   ENGEL BT, 1974, NEW ENGL J MED, V290, P646, DOI 10.1056/NEJM197403212901202
   EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229
   Faltin DL, 2001, BRIT J OBSTET GYNAEC, V108, P684, DOI 10.1016/S0306-5456(00)00185-6
   Faltin DL, 2001, INT UROGYNECOL J, V12, P117, DOI 10.1007/PL00004031
   Faltin DL, 2000, OBSTET GYNECOL, V95, P643, DOI 10.1016/S0029-7844(99)00631-6
   FELTBERSMA RJF, 1990, DIS COLON RECTUM, V33, P479, DOI 10.1007/BF02052142
   Feretis C, 2001, DIS COLON RECTUM, V44, P1605, DOI 10.1007/BF02234379
   Fynes MM, 1999, DIS COLON RECTUM, V42, P753, DOI 10.1007/BF02236930
   Ganio E, 2001, DIS COLON RECTUM, V44, P965, DOI 10.1007/BF02235484
   GarciaAguilar J, 1996, DIS COLON RECTUM, V39, P440, DOI 10.1007/BF02054061
   GIBBONS CP, 1986, LANCET, V1, P886
   Gilliland R, 1998, DIS COLON RECTUM, V41, P1516, DOI 10.1007/BF02237299
   Giordano P, 2002, DIS COLON RECTUM, V45, P635, DOI 10.1007/s10350-004-6260-7
   Gladman MA, 2003, DIS COLON RECTUM, V46, P238, DOI 10.1097/01.DCR.0000044711.76085.86
   GOLDENBERG DA, 1980, AM J GASTROENTEROL, V74, P342
   GUILLEMOT F, 1995, DIS COLON RECTUM, V38, P393, DOI 10.1007/BF02054228
   HALLGREN T, 1994, DIGEST DIS SCI, V39, P2612, DOI 10.1007/BF02087698
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Hasegawa H, 2000, DIS COLON RECTUM, V43, P961, DOI 10.1007/BF02237359
   Heymen S, 2001, DIS COLON RECTUM, V44, P728, DOI 10.1007/BF02234575
   Ho YH, 2000, DIS COLON RECTUM, V43, P169, DOI 10.1007/BF02236976
   Jensen LL, 1997, DIS COLON RECTUM, V40, P197, DOI 10.1007/BF02054988
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3
   JORGE JM, 1998, FUNDAMENTALS ANORECT, P1
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   KIFF ES, 1984, BRIT J SURG, V71, P614, DOI 10.1002/bjs.1800710817
   KIFF ES, 1984, GUT, V25, P1279, DOI 10.1136/gut.25.11.1279
   KONSTEN J, 1993, DIS COLON RECTUM, V36, P559, DOI 10.1007/BF02049862
   Kumar D, 1998, BRIT J SURG, V85, P978
   KUSUNOKI M, 1990, SURGERY, V107, P311
   LATIMER PR, 1984, BIOFEEDBACK SELF-REG, V9, P311, DOI 10.1007/BF00998975
   Lehur PA, 2000, DIS COLON RECTUM, V43, P1100, DOI 10.1007/BF02236557
   LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870
   LEWIS WG, 1995, DIS COLON RECTUM, V38, P259, DOI 10.1007/BF02055598
   Liberman H, 2001, DIS COLON RECTUM, V44, P1567, DOI 10.1007/BF02234373
   LOENINGBAUCKE V, 1990, GUT, V31, P1395, DOI 10.1136/gut.31.12.1395
   LONDONOSCHIMMER EE, 1994, INT J COLORECTAL DIS, V9, P110, DOI 10.1007/BF00699424
   MacArthur C, 2001, BRIT J OBSTET GYNAEC, V108, P678, DOI 10.1016/S0306-5456(00)00183-2
   MACINTYRE IM, 1972, LANCET, V1, P1094
   Madoff RD, 1999, GASTROENTEROLOGY, V116, P549, DOI 10.1016/S0016-5085(99)70176-9
   Malouf AJ, 2000, AM J ROENTGENOL, V175, P741, DOI 10.2214/ajr.175.3.1750741
   Malouf AJ, 2000, LANCET, V355, P2219, DOI 10.1016/S0140-6736(00)02409-0
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Malouf AJ, 2000, ANN SURG, V232, P143, DOI 10.1097/00000658-200007000-00020
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Matzel KE, 2004, LANCET, V363, P1270, DOI 10.1016/S0140-6736(04)15999-0
   MATZEL KE, 1990, DIS COLON RECTUM, V33, P666, DOI 10.1007/BF02150742
   Matzel KE, 2001, DIS COLON RECTUM, V44, P59, DOI 10.1007/BF02234822
   MCHUGH S, 1986, GASTROENTEROLOGY, V90, P154
   MCHUGH SM, 1987, DIGEST DIS SCI, V32, P726, DOI 10.1007/BF01296139
   Mellgren A, 1999, DIS COLON RECTUM, V42, P857, DOI 10.1007/BF02237089
   MINER PB, 1990, DIGEST DIS SCI, V35, P1291, DOI 10.1007/BF01536422
   Morren GL, 2001, BRIT J SURG, V88, P1506, DOI 10.1046/j.0007-1323.2001.01919.x
   Nakanishi N, 1999, AGE AGEING, V28, P301, DOI 10.1093/ageing/28.3.301
   NEILL ME, 1980, J NEUROL NEUROSUR PS, V43, P343, DOI 10.1136/jnnp.43.4.343
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Nelson R, 1998, DIS COLON RECTUM, V41, P1226, DOI 10.1007/BF02258218
   NIELSEN MB, 1992, BRIT J SURG, V79, P104, DOI 10.1002/bjs.1800790204
   Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x
   NORTON C, 2000, COCHRANE DB SYST REV, P2111
   Nyam DCNK, 1999, DIS COLON RECTUM, V42, P1306, DOI 10.1007/BF02234220
   O'Brien PE, 2000, DIS COLON RECTUM, V43, P1213, DOI 10.1007/BF02237423
   Oberwalder M, 2003, BRIT J SURG, V90, P1333, DOI 10.1002/bjs.4369
   Otto IC, 1996, DIS COLON RECTUM, V39, P1423, DOI 10.1007/BF02054533
   PARKS AG, 1975, P ROY SOC MED, V68, P681
   PARKS AG, 1977, GUT, V18, P656, DOI 10.1136/gut.18.8.656
   Pinedo G, 1999, BRIT J SURG, V86, P66
   Porell F, 1998, HEALTH SERV RES, V33, P835
   PRIOR A, 1990, GUT, V31, P458, DOI 10.1136/gut.31.4.458
   READ MG, 1982, BRIT J SURG, V69, P396, DOI 10.1002/bjs.1800690713
   Rieger NA, 1997, DIS COLON RECTUM, V40, P821, DOI 10.1007/BF02055440
   Rizk DEE, 2001, DIS COLON RECTUM, V44, P1850, DOI 10.1007/BF02234467
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199
   ROIG JV, 1995, DIS COLON RECTUM, V38, P952, DOI 10.1007/BF02049731
   Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120
   Rothbarth J, 2000, DIGEST SURG, V17, P390, DOI 10.1159/000018883
   Ryn AK, 2000, DIS COLON RECTUM, V43, P1262, DOI 10.1007/BF02237433
   Sailer M, 1998, BRIT J SURG, V85, P1716
   Sangwan YP, 1996, DIS COLON RECTUM, V39, P686, DOI 10.1007/BF02056951
   Santoro GA, 2000, DIS COLON RECTUM, V43, P1676, DOI 10.1007/BF02236848
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   SNOOKS SJ, 1985, GASTROENTEROLOGY, V89, P977, DOI 10.1016/0016-5085(85)90196-9
   SNOOKS SJ, 1984, LANCET, V2, P546
   SNOOKS SJ, 1986, ANN ROY COLL SURG, V68, P45
   Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1097/01.DCR.0000070034.58255.06
   SORENSEN M, 1993, BRIT J SURG, V80, P392, DOI 10.1002/bjs.1800800343
   SULTAN AH, 1993, NEW ENGL J MED, V329, P1905, DOI 10.1056/NEJM199312233292601
   SULTAN AH, 1994, BRIT J SURG, V81, P463, DOI 10.1002/bjs.1800810349
   SULTAN AH, 1994, BRIT MED J, V308, P887, DOI 10.1136/bmj.308.6933.887
   Takahashi T, 2003, DIS COLON RECTUM, V46, P711, DOI 10.1097/01.DCR.0000070342.56449.4A
   Thomas T M, 1984, Community Med, V6, P216
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   Vaizey CJ, 1999, GUT, V44, P407, DOI 10.1136/gut.44.3.407
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   vanTets WF, 1996, DIS COLON RECTUM, V39, P992, DOI 10.1007/BF02054687
   Varma A, 1999, DIS COLON RECTUM, V42, P1537, DOI 10.1007/BF02236202
   Varma A, 1999, DIS COLON RECTUM, V42, P1261, DOI 10.1007/BF02234210
   WALD A, 1984, NEW ENGL J MED, V310, P1282, DOI 10.1056/NEJM198405173102003
   WALD A, 1981, ANN INTERN MED, V95, P146, DOI 10.7326/0003-4819-95-2-146
   WARSHAW JS, 2001, SEM COLON RECTAL SUR, V12, P90
   Weiss KM, 2002, PERSPECT BIOL MED, V45, P46, DOI 10.1353/pbm.2002.0020
   WEXNER SD, 1991, DIS COLON RECTUM, V34, P22, DOI 10.1007/BF02050202
   WHITEHEAD WE, 1985, J AM GERIATR SOC, V33, P320, DOI 10.1111/j.1532-5415.1985.tb07130.x
   Wong WD, 1996, DIS COLON RECTUM, V39, P1345
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
   WRENN K, 1989, NEW ENGL J MED, V321, P658
   Yip B, 2002, DIS COLON RECTUM, V45, P184, DOI 10.1007/s10350-004-6142-z
   Young CJ, 1998, DIS COLON RECTUM, V41, P344, DOI 10.1007/BF02237489
   Zetterstrom J, 1999, DIS COLON RECTUM, V42, P1253, DOI 10.1007/BF02234209
NR 140
TC 140
Z9 145
U1 0
U2 8
PU LANCET LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0140-6736
J9 LANCET
JI Lancet
PD AUG 14
PY 2004
VL 364
IS 9434
BP 621
EP 632
DI 10.1016/S0140-6736(04)16856-6
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA 845WD
UT WOS:000223275100036
PM 15313364
DA 2018-10-19
ER

PT J
AU Salgado, AJ
   Coutinho, OP
   Reis, RL
AF Salgado, AJ
   Coutinho, OP
   Reis, RL
TI Bone tissue engineering: State of the art and future trends
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE bioengineering; biomaterials; bone; scaffolds; tissue engineering
ID MESENCHYMAL STEM-CELLS; BIODEGRADABLE POLYMER SCAFFOLDS; ENDOTHELIAL
   GROWTH-FACTOR; MARROW STROMAL CELLS; PEPTIDE-AMPHIPHILE NANOFIBERS;
   SOLID FREEFORM FABRICATION; ETHYLENE GLYCOL) HYDROGELS; DIFFERENTIATION
   IN-VITRO; STARCH-BASED SCAFFOLDS; DRUG-DELIVERY SYSTEMS
AB Although several major progresses have been introduced in the field of bone regenerative medicine during the years, current therapies, such as bone grafts, still have many limitations. Moreover, and in spite of the fact that material science technology has resulted in clear improvements in the field of bone substitution medicine, no adequate bone substitute has been developed and hence large bone defects/injuries still represent a major challenge for orthopaedic and reconstructive surgeons. It is in this context that TE has been emerging as a valid approach to the current therapies for bone regeneration/substitution. In contrast to classic biomaterial approach, TE is based on the understanding of tissue formation and regeneration, and aims to induce new functional tissues, rather than just to implant new spare parts. The present review pretends to give an exhaustive overview on all components needed for making bone tissue engineering a successful therapy. It begins by giving the reader a brief background on bone biology, followed by an exhaustive description of all the relevant components on bone TE, going-from materials to scaffolds and from cells to tissue engineering strategies that will lead to "engineered" bone.
C1 Univ Minho, Res Grp 3Bs, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Giumaraes, Portugal.
   Univ Minho, Dept Biol, P-4710057 Braga, Portugal.
RP Salgado, AJ (reprint author), Univ Minho, Res Grp 3Bs, Campus Gualtar, P-4710057 Braga, Portugal.
EM asalgado@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Salgado, Antonio/J-4129-2013; Group,
   3Bs/E-4374-2012; Xu, Qingguo/C-1962-2014; Coutinho, Olga/K-7155-2013
OI Reis, Rui L./0000-0002-4295-6129; Salgado, Antonio/0000-0003-3806-9823;
   Group, 3Bs/0000-0002-5195-3456; Xu, Qingguo/0000-0003-3191-0771;
   Coutinho, Olga/0000-0002-0647-080X
CR Abukawa H, 2003, J ORAL MAXIL SURG, V61, P94, DOI 10.1053/joms.2003.50015
   Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Agrawal CM, 2000, SYNTHETIC BIOABSORBA
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   ALLISON MR, 2002, J PATHOL, V197, P419
   ALMIN SF, 2003, BIOMATERIALS, V24, P1213
   AN YH, 1999, ANIMAL MODELS ORTHOP, P241
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   ASAHINA I, 1999, BONE ENG, P526
   Aubin Jane E., 1996, P51
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Baksh D, 1998, J MATER SCI-MATER M, V9, P743, DOI 10.1023/A:1008959103864
   Baksh D, 2003, EXP HEMATOL, V31, P723, DOI 10.1016/S0301-472X(03)00106-1
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Baran ET, 2004, J MATER SCI-MATER M, V15, P161, DOI 10.1023/B:JMSM.0000011818.85273.cd
   Baron Roland, 1993, P3
   Barry F, 2001, BIOCHEM BIOPH RES CO, V289, P519, DOI 10.1006/bbrc.2001.6013
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P374, DOI 10.1021/bm010158r
   BEHRAVESH E, 1999, CLIN ORTHOP S, V367, pS118
   Bishop AE, 2002, J PATHOL, V197, P424, DOI 10.1002/path.1154
   Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534
   Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3
   BODDEN SD, 1999, CLIN ORTHOP RELAT R, V367, pS84
   BOESEL LF, UNPUB J MAT SCI MATE
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Boskey A. L., 1999, DYNAMICS BONE CARTIL, P153
   BOSKEY AL, P 2 INT C CHEM BIOL, P335
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bruder SP, 1998, J BONE MINER RES, V13, P655, DOI 10.1359/jbmr.1998.13.4.655
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Bruder SP, 1997, BONE, V21, P225, DOI 10.1016/S8756-3282(97)00127-0
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323
   BUTTLER WT, 1996, PRINCIPLES BONE BIOL, P167
   Canalis E, 1996, CALCIFIED TISSUE INT, V58, P133, DOI 10.1007/s002239900023
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P1994
   Cassinelli C, 2003, INT J ORAL MAX IMPL, V18, P46
   Chang YL, 1999, INT J ORAL MAX IMPL, V14, P239
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   Choi DH, 2002, CELL TRANSPLANT, V11, P359
   Choi SH, 2002, J BIOMAT SCI-POLYM E, V13, P1163, DOI 10.1163/156856202320813864
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   CHRISTOFFERSEN J, 1991, ANAT RECORD, V230, P435, DOI 10.1002/ar.1092300402
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Cook SD, 1999, ORTHOPEDICS, V22, P669
   Dani C, 1997, J CELL SCI, V110, P1279
   Dani C, 1999, CELLS TISSUES ORGANS, V165, P173, DOI 10.1159/000016697
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Davies JE, 1996, ANAT REC, V245, P426
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   DEPORTER DA, 1988, CALCIFIED TISSUE INT, V42, P321, DOI 10.1007/BF02556367
   Devine Steven M, 2002, J Cell Biochem Suppl, V38, P73
   DIPPOLITO G, 1999, J BONE MINER RES, V14, P115
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   Droppert P M, 1990, J Br Interplanet Soc, V43, P19
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   EANES ED, 1980, PROG CRYST GROWTH CH, V3, P3, DOI 10.1016/0146-3535(80)90009-X
   El-Amin SF, 2002, J ORTHOPAED RES, V20, P20, DOI 10.1016/S0736-0266(01)00062-6
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   FEDCHENKO F, 1996, STEREOLITHOGRAPHY OT, P2
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Furumatsu T, 2003, J BIOCHEM, V133, P633, DOI 10.1093/jb/mvg081
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X
   Galli R, 2000, NAT NEUROSCI, V3, P986
   Gazit D, 1999, J GENE MED, V1, P121, DOI 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J
   Goldstein SA, 2002, ANN NY ACAD SCI, V961, P183, DOI 10.1111/j.1749-6632.2002.tb03079.x
   Gomes M., 2002, J APPL MED POLYM, V6, P75
   Gomes M. E., 2003, METHODS MOL BIOL SER, P65
   Gomes ME, 2002, NATO SCI SER II-MATH, V86, P221
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   GOMES ME, 2001, BIOMATERIALS, V22, P1991
   Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4
   GRAVES KH, 1993, MOL REPRODUCT DEV, V36, P1993
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416
   Haisch A, 2000, MED BIOL ENG COMPUT, V38, P686, DOI 10.1007/BF02344876
   Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1
   Hanada K, 2001, J CELL BIOCHEM, V81, P284, DOI 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   He W, 2003, BIOMED MICRODEVICES, V5, P101, DOI 10.1023/A:1024531010086
   Heath CA, 2000, TRENDS BIOTECHNOL, V18, P17, DOI 10.1016/S0167-7799(99)01396-7
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hill P A, 1998, Br J Orthod, V25, P101
   Hojo M, 2003, PLAST RECONSTR SURG, V111, P1638, DOI 10.1097/01.PRS.0000053842.90564.26
   Holly CE, 2000, J BIOMED MATER RES, V51, P376
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   HUTMACHER DW, 2000, BIOMATERIALS, V21, P2259
   Ibim SEM, 1998, J BIOMED MATER RES, V43, P374, DOI 10.1002/(SICI)1097-4636(199824)43:4<374::AID-JBM5>3.0.CO;2-5
   Ibim SEM, 1997, BIOMATERIALS, V18, P1565, DOI 10.1016/S0142-9612(97)00099-9
   Inoue K, 1997, J BONE MINER RES, V12, P989, DOI 10.1359/jbmr.1997.12.6.989
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jadlowiec JA, 2003, EXPERT OPIN BIOL TH, V3, P409, DOI 10.1517/14712598.3.3.409
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kadyala S, 1997, TISSUE ENG, P173
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   KHON J, 1986, BIOMATERIALS, V7, P176
   Kim BS, 1998, J BIOMED MATER RES, V41, P322, DOI 10.1002/(SICI)1097-4636(199808)41:2<322::AID-JBM18>3.0.CO;2-M
   Kneser U, 2002, MINIM INVASIV THER, V11, P107, DOI 10.1080/136457002320174177
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P75, DOI 10.1034/j.1600-0501.1994.050203.x
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   LABOSKY PA, 1994, DEVELOPMENT, V120, P3197
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   Landers R, 2000, MACROMOL MATER ENG, V282, P17, DOI 10.1002/1439-2054(20001001)282:1<17::AID-MAME17>3.0.CO;2-8
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee JY, 2001, J BONE JOINT SURG AM, V83A, P1032, DOI 10.2106/00004623-200107000-00008
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Leonor IB, 2003, J MATER SCI-MATER M, V14, P435, DOI 10.1023/A:1023214918592
   LI C, 1989, MACROMOLECULES, V22, P2029, DOI 10.1021/ma00195a001
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   LIND M, 1993, ACTA ORTHOP SCAND, V64, P553, DOI 10.3109/17453679308993691
   Lind M, 2001, EUR SPINE J, V10, pS102, DOI 10.1007/s005860100269
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lu LC, 1996, MRS BULL, V21, P28
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Mackie EJ, 2003, INT J BIOCHEM CELL B, V35, P1301, DOI 10.1016/S1357-2825(03)00107-9
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P297, DOI 10.1016/S1359-0286(02)00077-3
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P283, DOI 10.1016/S1359-0286(02)00075-X
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MALAFAYA PB, 2003, KEY ENG MATER, P240
   MALAFAYA PB, 2002, TISSUE ENG STEM CELL, P201
   Malekzadeh R, 1998, J PERIODONTOL, V69, P1256, DOI 10.1902/jop.1998.69.11.1256
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Marks Sandy C. Jr., 1996, P3
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Mendes SC, 2002, J MATER SCI-MATER M, V13, P575, DOI 10.1023/A:1015178827323
   Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010
   MENDES SC, 2001, BIOMATERIALS, V22, P2014
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417
   Nijweide P. J., 1996, P115
   Nilsson SK, 1999, J EXP MED, V189, P729, DOI 10.1084/jem.189.4.729
   Ochi K, 2003, J CELL PHYSIOL, V194, P45, DOI 10.1002/jcp.10185
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Oliveira AL, 2002, J MATER SCI-MATER M, V13, P1181, DOI 10.1023/A:1021106525097
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Partridge K, 2002, BIOCHEM BIOPH RES CO, V292, P144, DOI 10.1006/bbrc.2002.6623
   Peltoniemi H, 2002, ORAL SURG ORAL MED O, V94, P5, DOI 10.1067/moe.2002.122160
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   PETRAKOVA K. V., 1963, BYUL EKSPTL BIOL I MED, V56, P87
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PITTENGER MF, 2001, NATURE, V414, P132
   Platt JL, 1996, CRIT REV IMMUNOL, V16, P331
   Presnell SC, 2002, SEMIN CELL DEV BIOL, V13, P369, DOI 10.1016/S1084-9521(02)00093-9
   Preston SL, 2003, J CLIN PATHOL-MOL PA, V56, P86
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   Qiu QQ, 2001, IN VITRO CELL DEV-AN, V37, P157
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rabbany SY, 2003, TRENDS MOL MED, V9, P109, DOI 10.1016/S1471-4914(03)00021-2
   Rasubala L, 2003, BRIT J ORAL MAX SURG, V41, P173, DOI 10.1016/S0266-4356(03)00075-5
   REECE GP, 1998, FRONTIERS TISSUE ENG, P166
   Reis R., 2001, ENCY MAT SCI TECHNOL, P8810
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Robey Pamela Gehron, 1996, P155
   RODAN GA, 1992, BONE, V13, pS3, DOI 10.1016/S8756-3282(09)80003-3
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Rossert Jerome, 1996, P127
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   SALGADO AJ, IN PRESS J MAT SCI M
   Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337
   Schantz JT, 2002, CELL TRANSPLANT, V11, P125
   Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7
   SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353
   SHANTZ JT, 2002, INT J ORAL MAXILLOF, V17, P161
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen F, 2000, POLYM INT, V49, P1596, DOI 10.1002/1097-0126(200012)49:12<1596::AID-PI553>3.3.CO;2-J
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284
   SHMELZEISEN R, 2003, J CRANIOMAXILLOFAC S, V31, P34
   Shung AK, 2003, TISSUE ENG, V9, P243, DOI 10.1089/107632703764664710
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SIM H, 2003, BIOMACROMOLECULES, V4, P552
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   SIN H, 2000, BIOMATERIALS, V24, P3201
   Sinha Raj K, 2002, Spine J, V2, P239, DOI 10.1016/S1529-9430(02)00197-3
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   SODEK J, 1999, BONE ENG, P31
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283
   Sousa RA, 2000, J APPL POLYM SCI, V77, P1303, DOI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
   Spitzer RS, 2002, J BIOMED MATER RES, V59, P690, DOI 10.1002/jbm.1277
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tanahashi K, 2002, J BIOMED MATER RES, V62, P558, DOI 10.1002/jbm.10284
   TAYAPONGSAK P, 1994, J ORAL MAXIL SURG, V52, P161, DOI 10.1016/0278-2391(94)90401-4
   Temenoff J.S., 1999, BONE ENG, P454
   ter Brugge PJ, 2002, J BIOMED MATER RES, V60, P70, DOI 10.1002/jbm.10031
   Termine John D., 1993, P21
   THOMAS AE, 1999, CLIN ORTHOP S, V367, pS59
   THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Thordarson DB, 2002, FOOT ANKLE INT, V23, P1003, DOI 10.1177/107110070202301106
   Tolaimate A, 2003, POLYMER, V44, P7939, DOI 10.1016/j.polymer.2003.10.025
   Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778
   Triffitt James T., 1996, P39
   TUZLAGOKLU K, IN PRESS MACROMOL BI
   Uchida S, 2003, BONE, V32, P491, DOI 10.1016/S8756-3282(03)00053-X
   Ueda H, 2002, BIOMATERIALS, V23, P1003, DOI 10.1016/S0142-9612(01)00211-3
   Uhrich KE, 1998, BIOMATERIALS, V19, P2045, DOI 10.1016/S0142-9612(98)00110-0
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vaananen HK, 1996, PRINCIPLES BONE BIOL, P103
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Verfaillie CM, 2002, TRENDS CELL BIOL, V12, P502, DOI 10.1016/S0962-8924(02)02386-3
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   WANG R, 1992, DEVELOPMENT, V114, P303
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Washburn NR, 2002, J BIOMED MATER RES, V60, P20, DOI 10.1002/jbm.10049
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   WILES MV, 1991, DEVELOPMENT, V111, P259
   WILLIAMS DF, 1999, BONE ENG, P577
   Williams JT, 1999, AM SURGEON, V65, P22
   Wobus AM, 1998, TRENDS CARDIOVAS MED, V8, P64, DOI 10.1016/S1050-1738(97)00129-1
   Wobus Anna M., 2001, Molecular Aspects of Medicine, V22, P149, DOI 10.1016/S0098-2997(01)00006-1
   Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097
   Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47
   YASZEMSKI MJ, 1994, BONE ENG, P541
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Yoon ST, 2002, CLIN ORTHOP RELAT R, P33
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
   Zhang Y, 2001, J BIOMED MATER RES, V61, P1
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   ZULK PA, 2001, TISSUE ENG, V7, P211
NR 308
TC 877
Z9 906
U1 11
U2 419
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG 9
PY 2004
VL 4
IS 8
BP 743
EP 765
DI 10.1002/mabi.200400026
PG 23
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 849UR
UT WOS:000223567000007
PM 15468269
DA 2018-10-19
ER

PT J
AU Christman, KL
   Vardanian, AJ
   Fang, QZ
   Sievers, RE
   Fok, HH
   Lee, RJ
AF Christman, KL
   Vardanian, AJ
   Fang, QZ
   Sievers, RE
   Fok, HH
   Lee, RJ
TI Injectable fibrin scaffold improves cell transplant survival, reduces
   infarct expansion, and induces neovasculature formation in ischemic
   myocardium
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; DEGRADATION-PRODUCTS; SKELETAL MYOBLASTS;
   FRAGMENT-E; RAT; ANGIOGENESIS; REPERFUSION; MUSCLE; MODEL; HEART
AB OBJECTIVES In this study, we determined whether fibrin glue improves cell transplant retention and survival, reduces infarct expansion, and induces neovasculature formation.
   BACKGROUND Current efforts in restoring the myocardium after myocardial infarction (MI) include the delivery of viable cells to replace necrotic cardiomyocytes. Cellular transplantation techniques are, however, limited by transplanted cell retention and survival within the ischemic tissue.
   METHODS The left coronary artery of rats was occluded for 17 min followed by reperfusion. One week later, bovine serum albumin (BSA), fibrin glue, skeletal myoblasts in BSA, or skeletal myoblasts in fibrin glue were injected into the infarcted area of the left ventricle. The animals were euthanized five weeks after injection, and their hearts were excised, fresh frozen, and sectioned for histology and immunohistochemistry.
   RESULTS After five weeks, the mean area covered by skeletal myoblasts in fibrin glue was significantly greater than the area covered by myoblasts injected in BSA. Myoblasts within the infarct were often concentrated around arterioles. The infarct scar size and myoblasts in the fibrin group were significantly smaller than those in the control and BSA groups. Fibrin glue also significantly increased the arteriole density in the infarct scar as compared with the control group.
   CONCLUSIONS This study indicates that fibrin glue increases cell transplant survival, decreases infarct size, and increases blood flow to ischemic myocardium. Therefore, fibrin glue may have potential as a biomaterial scaffold to improve cellular cardiomyoplasty treat and MIs. (C) 2004 by the American College of Cardiology Foundation.
C1 Univ Calif Berkeley, Berkeley, CA 94720 USA.
   San Francisco Joint Bioengn Grad Grp, San Francisco, CA USA.
   Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.
RP Lee, RJ (reprint author), MU East Tower,Box 1354,500 Parnassus Ave, San Francisco, CA 94143 USA.
EM lee@medicine.ucsf.edu
CR Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844
   Benjamin LE, 1998, DEVELOPMENT, V125, P1591
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   DVORAK HF, 1987, LAB INVEST, V57, P673
   FISHBEIN MC, 1978, AM J PATHOL, V90, P57
   GHOSTINE S, 2002, CIRCULATION S1, V106, P131
   Gojo S, 1997, J THORAC CARDIOV SUR, V113, P10, DOI 10.1016/S0022-5223(97)70394-5
   HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X
   HAVENITH MG, 1990, HISTOCHEMISTRY, V93, P497, DOI 10.1007/BF00266407
   Jain M, 2001, CIRCULATION, V103, P1920
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Kloner RA, 2000, J THROMB THROMBOLYS, V10, P285, DOI 10.1023/A:1026507627097
   Leor J, 2000, CIRCULATION, V102, P56
   Li RK, 1996, ANN THORAC SURG, V62, P654
   Li W, 2003, AM J PHYSIOL-HEART C, V284, pH23, DOI 10.1152/ajpheart.00240.2002
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Naito M, 2000, THROMB RES, V98, P165, DOI 10.1016/S0049-3848(99)00202-9
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193
   Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494
   Reinecke H, 2000, CARDIOVASC PATHOL, V9, P337, DOI 10.1016/S1054-8807(00)00055-7
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Sakai T, 1999, J THORAC CARDIOV SUR, V118, P715, DOI 10.1016/S0022-5223(99)70018-8
   Scorsin M, 1997, CIRCULATION, V96, P188
   SEELICH T, 1982, J HEAD NECK PATHOL, P365
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   SIEVERS RE, 1989, MAGNET RESON MED, V10, P172, DOI 10.1002/mrm.1910100203
   Tambara K, 2003, CIRCULATION, V108, P259, DOI 10.1161/01.cir.0000087430.17543.b8
   Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763
   WOLFE CL, 1989, CIRCULATION, V80, P969, DOI 10.1161/01.CIR.80.4.969
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhu BQ, 2000, J AM COLL CARDIOL, V35, P787, DOI 10.1016/S0735-1097(99)00592-6
   Zhu BQ, 2001, J RENIN-ANGIO-ALDO S, V2, P129, DOI 10.3317/jraas.2001.014
NR 38
TC 328
Z9 338
U1 1
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD AUG 4
PY 2004
VL 44
IS 3
BP 654
EP 660
DI 10.1016/j.jacc.2004.04.040
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 843AV
UT WOS:000223047900027
PM 15358036
OA Bronze
DA 2018-10-19
ER

PT J
AU Tian, XB
   Yang, SQ
   Huang, YX
   Gong, CZ
   Xu, GC
   Fu, RKY
   Chu, PK
AF Tian, XB
   Yang, SQ
   Huang, YX
   Gong, CZ
   Xu, GC
   Fu, RKY
   Chu, PK
TI Two-dimensional numerical simulation of non-uniform plasma immersion ion
   implantation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE plasma immersion ion implantation; non-uniform plasma; dose uniformity
ID UNIFORMITY; DYNAMICS; SYSTEMS; PULSES
AB One of the biggest advantages of plasma immersion ion implantation (PIII) is the capability of treating objects with irregular geometries without complex manipulation of target holder or beam rastering. The effectiveness of this approach depends on the uniformity of the incident ion dose. However, it is known that the lateral dose variation (non-uniformity) is less than optimal in some applications. Ion dose non-uniformity may lead to large variations in the biocompatibility for biomaterial implants. Therefore, ion dose uniformity is an issue frequently investigated since the inception of PIII. Unfortunately, perfect dose uniformity is usually difficult to achieve when treating samples with a complex shape. The problem arises from the non-uniformity of the plasma density and self-consistent expansion of the plasma sheath. Concave surfaces frequently receive a smaller ion dose compared to convex surfaces since ions in a limited volume are competing for more surfaces and are depleted more readily. An effective solution is to produce non-uniform plasmas. For example, at the concave site, a higher plasma density may be helpful to weaken the ion competition and delay the depletion lime. Consequently, the ion dose uniformity can be improved. In the work described here, we conduct two-dimensional numerical simulation of PIII into a trench target with the novel notion of non-uniform plasma. (C) 2004 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Ion Engn Res Inst Corp, Hirakata, Osaka 5730128, Japan.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR CONRAD JR, 1989, J APPL PHYS, V65, P1707, DOI 10.1063/1.342942
   CONRAD JR, 1987, J APPL PHYS, V62, P4951
   Ensinger W, 1998, SURF COAT TECH, V104, P218, DOI 10.1016/S0257-8972(98)00396-X
   Mandl S, 2001, SURF COAT TECH, V139, P81, DOI 10.1016/S0257-8972(01)00986-0
   Miyagawa S, 2002, SURF COAT TECH, V156, P322, DOI 10.1016/S0257-8972(02)00101-9
   Nishimura Y, 2002, SURF COAT TECH, V156, P50, DOI 10.1016/S0257-8972(02)00111-1
   SHERIDAN TE, 1995, J PHYS D APPL PHYS, V28, P1094, DOI 10.1088/0022-3727/28/6/011
   Tian XB, 2001, J PHYS D APPL PHYS, V34, P354, DOI 10.1088/0022-3727/34/3/318
   YUKIMURA K, 7 INT WORKSH PLASM B
NR 9
TC 11
Z9 15
U1 0
U2 3
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 47
EP 52
DI 10.1016/j.surfcoat.2004.04.008
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200009
DA 2018-10-19
ER

PT J
AU Yang, P
   Chen, JY
   Leng, YX
   Sun, H
   Huang, N
   Chu, PK
AF Yang, P
   Chen, JY
   Leng, YX
   Sun, H
   Huang, N
   Chu, PK
TI Effect of annealing on structure and biomedical properties of amorphous
   hydrogenated carbon films
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE plasma immersion ion implantation-deposition; hydrogenated amorphous
   carbon (a-C : H) film; annealing; blood compatibility
ID DIAMOND-LIKE CARBON; IMMERSION ION-IMPLANTATION; BLOOD COMPATIBILITY;
   PROTEIN ADSORPTION; TITANIUM; PLASMA; DLC; COATINGS; HEMOCOMPATIBILITY;
   BIOCOMPATIBILITY
AB The usual failure of blood-contacting biomedical materials and devices arises from thrombogenesis. When a biomaterial comes in contact with a biological body, interface interaction will be concomitant between the biomaterial surface and biological substance, such as blood protein denaturation resulting from electrical charge transfer of proteins and platelet activation induced by interface thermodynamics. Diamond-like carbon (DLC) has been proposed for use in blood contacting devices. Further understanding of the intrinsic relationship between biomedical properties and structure of amorphous carbon films will promote improvement of their biocompatibility. In this study, hydrogenated amorphous carbon (a-C:H) films were fabricated at room temperature using plasma immersion ion implantation-deposition (PIII-D). A series of a-C:H films with different structures and chemical bonds were obtained by adjusting the DC bias voltage from - 75 to - 900 V, then their structure and physical properties were further modified by thermal anneal in vacuum at 600 degreesC. Raman, elastic recoil detection (ERD) and atomic force microscope (AFM) were used to characterize their structures and chemical bonds. The physical properties and surface characteristics of the films were also examined, including the carrier concentration and mobility, resistivity, and surface wettability. The anticoagulation of the films was evaluated employing in vitro platelet adhesion test. The adhesion, activation, and morphology of the platelets were investigated using scanning electron microscopy (SEM). The relationship between their structure and blood compatibility was elucidated. (C) 2004 Elsevier B.V. All rights reserved.
C1 SW Jiaotong Univ, Chinese Educ Minist, Sch Mat Sci & Engn, Key Lab Biomat Surface Modificat Sichuan, Chengdu 610031, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Chinese Educ Minist, Sch Mat Sci & Engn, Key Lab Biomat Surface Modificat Sichuan, Chengdu 610031, Peoples R China.
EM huangnan1956@163.com
RI Leng, Yongxiang/G-5488-2010; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR Alanazi A, 2000, ASAIO J, V46, P440, DOI 10.1097/00002480-200007000-00014
   Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   FENG L, 1994, J COLLOID INTERF SCI, V166, P419, DOI 10.1006/jcis.1994.1313
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   LYMAN DJ, 1972, T AM SOC ART INT ORG, V18, P19
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Ogwu AA, 1999, PHYSICA B, V269, P335, DOI 10.1016/S0921-4526(99)00138-6
   PINZARI F, 2000, DIAM RELAT MATER, V10, P781
   Robertson J, 1997, DIAM RELAT MATER, V6, P212, DOI 10.1016/S0925-9635(96)00627-9
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   TANG Z, 2001, J APPL PHYS, V89, P1956
   THOMSON A, 1991, BIOMATERIALS, V2, P37
   Tran HS, 1999, J INVEST SURG, V12, P133
   VANOSS CJ, 1988, J CHEM REV, V88, P92
   Young T, 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
NR 24
TC 22
Z9 22
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 125
EP 130
DI 10.1016/j.surfcoat.2004.04.039
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200024
DA 2018-10-19
ER

PT J
AU Reno, F
   Lombardi, F
   Cannas, M
AF Reno, F
   Lombardi, F
   Cannas, M
TI Surface-adsorbed alpha(1)-microglobulin modulation of human fibroblasts
   spreading and matrix metalloproteinases release
SO BIOMATERIALS
LA English
DT Article
DE alpha(1)-microglobulin; protein adsorption; cell adhesion; spreading;
   MMP-2; fibroblast
ID HUMAN PROTEIN HC; GROWTH-FACTOR; ALPHA-1-MICROGLOBULIN; PROLIFERATION;
   ADSORPTION; ADHESION; BIOMATERIALS; FIBRONECTIN; SUBSTRATUM; CHEMOTAXIS
AB The lipocalin alpha(1)-microglobulin (alpha(1)-m), an immunoregulatory protein produced by human hepatocytes and distributed in various organs and fluids, is physiologically adsorbed onto polymer surfaces from both serum and urine, and its adsorption correlated to the degree of surface hydrophobicity. Starting from the hypothesis that alpha(1)-m holds a modulatory role at the biomaterials-tissue interface, we have observed a dose-dependent reduction in adhesion of human fibroblasts (cell line MRC-5) seeded onto polystyrene (PS) in a serum-free medium in the presence of adsorbed alpha(1)-m (2.1 +/- 0.2 x 10(4) cells/cm(2) at 200 ng/ml alpha(1)-m) compared to cells seeded onto cell grade PS (2.9 +/- 0.05 x 10(4) cells/cm(2)) after 72 h. Moreover, in the presence of alpha(1)-m, adherent MRC-5 cells exhibit an altered shape due to inhibition of cell spreading, and release of matrix metalloproteinase -2 (gelatinase A, MMP-2) by fibroblasts was also increased by 1.6-1.9-fold after 72 h of incubation. These data extend the known spectrum of alpha(1)-m activities, suggesting a possible role of this protein in the complex series of events occurring at the tissue-biomaterial interface. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Eastern Piedmont, Dept Med Sci, Human Anat Lab, A Avogadro, I-28100 Novara, Italy.
RP Cannas, M (reprint author), Univ Eastern Piedmont, Dept Med Sci, Human Anat Lab, A Avogadro, Via Solaroli 17, I-28100 Novara, Italy.
EM cannas@med.unipmn.it
CR Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P172, DOI 10.1016/S0167-4838(00)00157-6
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Arumugam S, 1999, SURGERY, V125, P587, DOI 10.1067/msy.1999.98254
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   FERNANDEZLUNA JL, 1988, FEBS LETT, V236, P471, DOI 10.1016/0014-5793(88)80079-6
   ITO Y, 1993, J BIOMED MATER RES, V27, P901, DOI 10.1002/jbm.820270709
   Levi E, 1996, P NATL ACAD SCI USA, V93, P7069, DOI 10.1073/pnas.93.14.7069
   LOGDBERG L, 1981, SCAND J IMMUNOL, V13, P383, DOI 10.1111/j.1365-3083.1981.tb00148.x
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   MENDEZ E, 1986, P NATL ACAD SCI USA, V83, P1472, DOI 10.1073/pnas.83.5.1472
   MURPHY G, 1989, BIOCHEM J, V258, P463, DOI 10.1042/bj2580463
   ODUM L, 1994, HISTOCHEM J, V26, P799
   Ortega-Vinuesa JL, 1998, BIOMATERIALS, V19, P251, DOI 10.1016/S0142-9612(97)00206-8
   PEARLSTEIN E, 1977, J IMMUNOL, V119, P824
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   Santin M, 1998, J MATER SCI-MATER M, V9, P135, DOI 10.1023/A:1008863518572
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   Sasaki M, 2000, MEDIAT INFLAMM, V9, P155, DOI 10.1080/09629350020002895
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   TAKAGI K, 1980, J CLIN PATHOL, V33, P786, DOI 10.1136/jcp.33.8.786
   TEJLER L, 1976, BIOCHIM BIOPHYS ACTA, V439, P82, DOI 10.1016/0005-2795(76)90164-1
   WARKENTIN P, 1994, BIOMATERIALS, V15, P786, DOI 10.1016/0142-9612(94)90033-7
   Wassall MA, 1998, J BIOMED MATER RES, V40, P365, DOI 10.1002/(SICI)1097-4636(19980605)40:3<365::AID-JBM4>3.0.CO;2-D
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Wong WR, 2001, J FORMOS MED ASSOC, V100, P377
   Xu J, 2002, CLIN EXP ALLERGY, V32, P881, DOI 10.1046/j.1365-2745.2002.01386.x
NR 29
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3439
EP 3443
DI 10.1016/j.biomaterials.2003.10.047
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200012
PM 15020117
DA 2018-10-19
ER

PT J
AU Takemoto, S
   Yamamoto, T
   Tsuru, K
   Hayakawa, S
   Osaka, A
   Takashima, S
AF Takemoto, S
   Yamamoto, T
   Tsuru, K
   Hayakawa, S
   Osaka, A
   Takashima, S
TI Platelet adhesion on titanium oxide gels: effect of surface oxidation
SO BIOMATERIALS
LA English
DT Article
DE platelet adhesion; surface oxidation; titanium; peroxide gel; blood
   compatibility
ID HYDROGEN-PEROXIDE; METALLIC TITANIUM; BLOOD; PROTEIN; ACTIVATION;
   BIOMATERIAL; THICKNESS; CONTACT; ANATASE; PLASMA
AB The correlations between titanium oxide layers on oxidized titanium (Ti) substrates and platelet adhesion were examined. Ti substrates were prepared by three different oxidation methods: the first one was treated with hydrogen peroxide (H2O2) solution, the second one was heated in air at moderate temperatures, and the third one was processed with both H2O2 and heating. The titanium oxide layers formed on the Ti substrates were characterized by wettability, chemical composition, thickness, and crystal phase. The platelet adhesion on these oxide layers was examined and correlated to the characterizations of the surface layers. The number of adhesive platelets seemingly correlated with the contact angle towards distilled water, because the number increased close to 70-80degrees of the contact angle. The effect of surface oxidation on platelet adhesion was examined in detail and it was found that the composition and thickness of the oxide layer influenced platelet adhesion rather than wettability. Thick titanium oxide layers formed on Ti substrates by heating displayed less platelet adhesion than thin oxide layers on untreated Ti substrates. The largest number of adhesive platelets was found on H2O2-oxidized substrates; the substrates found on amorphous titanium oxide contained the Ti-peroxide radical species. The number of platelets, on the other hand, could hardly be observed on Ti substrates treated with H2O2 and subsequently heated above 300 degreesC. The titanium oxide layer on the substrate was thick and we found it to consist of only a few radical species. That is, the effect of heat treatment accelerates the growth of the oxide layer, and decomposes or decreases the number of radical species. Ti substrates with H2O2 and heat treatment above 300 degreesC held the least number of platelets, and were concluded to be the most inhibitory for platelet adhesion. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Okayama Univ, Fac Engn, Biomat Lab, Okayama 7008530, Japan.
   Okayama Univ, Cooperat Res Ctr, Okayama 7011221, Japan.
RP Osaka, A (reprint author), Okayama Univ, Fac Engn, Biomat Lab, Okayama 7008530, Japan.
EM osaka@cc.okayama-u.ac.jp
RI HAYAKAWA, Satoshi/B-2104-2011
OI HAYAKAWA, Satoshi/0000-0002-1097-8614
CR Broberg M, 2001, BIOMATERIALS, V22, P2403, DOI 10.1016/S0142-9612(00)00427-0
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Ichinose H, 1996, J CERAM SOC JPN, V104, P715, DOI 10.2109/jcersj.104.715
   Ikada Y., 1986, JPN J ARTIF ORGANS, V15, P12
   MATSUMOTO S, 1995, P 17 INT C GLASS, V3, P72
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   SAKKA S, 1988, ACS SYM SER, V360, P345
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   Takemoto S, 2001, J SOL-GEL SCI TECHN, V21, P97, DOI 10.1023/A:1011269802356
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   TAMADA Y, 1986, POLYM MED, V2, P101
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, J COLLOID INTERF SCI, V130, P405, DOI 10.1016/0021-9797(89)90117-3
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   TENGVALL P, 1990, J COLLOID INTERF SCI, V139, P575, DOI 10.1016/0021-9797(90)90131-7
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Walivaara Bengt, 1993, Clinical Materials, V12, P141, DOI 10.1016/0267-6605(93)90065-F
   Yanagisawa K, 1999, J PHYS CHEM B, V103, P7781, DOI 10.1021/jp990521c
NR 24
TC 77
Z9 81
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3485
EP 3492
DI 10.1016/j.biomaterials.2003.10.070
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200016
PM 15020122
DA 2018-10-19
ER

PT J
AU Barry, JJA
   Gidda, HS
   Scotchford, CA
   Howdle, SM
AF Barry, JJA
   Gidda, HS
   Scotchford, CA
   Howdle, SM
TI Porous methacrylate scaffolds: supercritical fluid fabrication and in
   vitro chondrocyte responses
SO BIOMATERIALS
LA English
DT Article
DE chondrocyte; scaffold; polymer; biomaterial; methacrylate; porosity
ID ARTICULAR CHONDROCYTES; CARBON-DIOXIDE; POLYMER SYSTEM; REPAIR TISSUE;
   CARTILAGE; CULTURE; BONE; REGENERATION; PHENOTYPE; DIFFUSION
AB This paper describes a method of foaming a polymer system comprising poly(ethyl methacrylate)/tetrahydrofurfuryl methacrylate (PEMA/THFMA), characterisation of the resulting porosity and use of the foam for chondrocyte culture. The potential for this polymer system to support cartilage repair, has been investigated previously, both in vivo and in vitro. PEMA/THFMA foamed created using supercritical carbon dioxide were characterised using scanning electron microscopy, mercury intrusion porosimetry and helium pycnometry. Foams were-found to be 82% porous with open porosities of 57%. The mean pore diameter was found to be 99+60mum. Bovine chondrocytes seeded directly onto the surface of the foamed and unfoamed PEMA/THFMA demonstrated lower proliferation on the foamed material, greater retention of the rounded cell morphology and increased glycosaminoglycan synthesis. In conclusion, this study has shown that a porous PEMA/THFMA system can further enhance the ability of the material to support chondrocytes in vitro. However, further modifications in processing are necessary to determine optimum conditions for cartilage tissue formation. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
   Univ Nottingham, Sch Mech Mat Mfg Engn & Management, Nottingham NG7 2RD, England.
   Univ Nottingham, Sch Med, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2UH, England.
RP Howdle, SM (reprint author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England.
EM steve.howdle@nottingham.ac.uk
RI Howdle, Steven/A-2954-2010
OI Howdle, Steven/0000-0001-5901-8342; Scotchford,
   Colin/0000-0003-1937-6692
CR ARCHER CW, 1990, J CELL SCI, V97, P361
   Argon AS, 1999, POLYMER, V40, P6991, DOI 10.1016/S0032-3861(99)00033-6
   Arora KA, 1998, MACROMOLECULES, V31, P4614, DOI 10.1021/ma971811z
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   COOPER AI, 1993, ANALYST, V118, P111
   COOPER AI, 2001, ADV MATER, V13, P1
   DOWNES S, 1994, J MATER SCI-MATER M, V5, P88, DOI 10.1007/BF00121696
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Fuss M, 2000, ANN ANAT, V182, P303
   Ghivizzani S C, 2000, Phys Med Rehabil Clin N Am, V11, P289
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   GOEL SK, 1994, POLYM ENG SCI, V34, P1148, DOI 10.1002/pen.760341408
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HOWDLE SM, 2001, CHEM COMMUN, V1, P109
   Hutcheon GA, 1998, J MATER SCI-MATER M, V9, P815, DOI 10.1023/A:1008940027063
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   INGBER DE, 1993, J CELL SCI, V104, P613
   Kazarian S. G., 2000, POLYM SCI SER C, V42, P78, DOI DOI 10.1080/03602549909351647
   Leon CALY, 1998, ADV COLLOID INTERFAC, V76, P341, DOI 10.1016/S0001-8686(98)00052-9
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   McFarland CD, 1999, J BIOMED MATER RES, V44, P1
   MCHUGH MA, 1994, SUPERCRITICAL FLUIDE
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   NEALEY PF, 1995, POLYMER, V36, P3687, DOI 10.1016/0032-3861(95)93771-D
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P402, DOI 10.1007/BF00058973
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P793, DOI 10.1007/BF00213137
   Sawtell RM, 1997, J MATER SCI-MATER M, V8, P667, DOI 10.1023/A:1018531722265
   Sawtell RM, 1995, J MATER SCI-MATER M, V6, P676, DOI 10.1007/BF00134299
   SAWTELL RM, 1995, CELL MATER, V5, P63
   SAWTELL RM, 1996, THESIS U NOTTINGHAM
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   WATT FM, 1988, J CELL SCI, V89, P373
   Wyre RM, 2000, BIOMATERIALS, V21, P335, DOI 10.1016/S0142-9612(99)00185-4
NR 40
TC 90
Z9 94
U1 2
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3559
EP 3568
DI 10.1016/j.biomaterials.2003.10.023
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200024
PM 15020130
DA 2018-10-19
ER

PT J
AU De Bartolo, L
   Morelli, S
   Rende, M
   Gordano, A
   Drioli, E
AF De Bartolo, L
   Morelli, S
   Rende, M
   Gordano, A
   Drioli, E
TI New modified polyetheretherketone membrane for liver cell culture in
   biohybrid systems: adhesion and specific functions of isolated
   hepatocytes
SO BIOMATERIALS
LA English
DT Article
DE PEEK-WC membrane; hepatocytes; surface free energy; adhesion; functions
ID POLYMER SURFACES; MORPHOLOGY; BIOCOMPATIBILITY; VIABILITY; ORGANS
AB There has been growing interest in innovative materials with physico-chemical properties that provide improved blood/cell compatibility. We propose new polymeric membranes made of modified polyetheretherketone (PEEK-WC) as materials with potential for use in biohybrid devices. PEEK-WC exhibits high chemical, thermal stability and mechanical resistance. Owing to its lack of crystallinity this polymer can be used for preparing membranes with cheap and flexible methods.
   We compared the properties of PEEK-WC membranes to polyurethane membranes prepared using the same phase inverse technique and commercial membranes. The physico-chemical properties of the membranes were characterised by contact angle measurements. The different parameters acid (gamma(+)), base (gamma(-)) and Lifshitz-van der Waals (gamma(LW)) of the surface free energy were calculated according to Good-van Oss's model.
   We evaluated the cytocompatibility of PEEK-WC membranes by culturing hepatocytes isolated from rat liver. Cell adhesion and metabolic behaviour in terms of ammonia elimination, urea synthesis and protein synthesis were evaluated during the first days of culture. Liver cells adhered and formed three-dimensional aggregates on the most tested membranes. PEEK-WC membranes promoted hepatocyte adhesion most effectively. Urea synthesis, ammonia elimination and protein synthesis improved significantly when cells adhered to PEEK-WC membrane. The considerable metabolic activities of cells cultured on this membrane confirmed the good structural and physico-chemical properties of the PEEK-WC membrane that could be a promising biomaterial for cell culture in biohybrid devices. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Calabria, CNR, ITM, Natl Res Council,Inst Membrane Technol, I-87036 Cosenza, Italy.
RP De Bartolo, L (reprint author), Univ Calabria, CNR, ITM, Natl Res Council,Inst Membrane Technol, Via P Bucci Cube 17-C, I-87036 Cosenza, Italy.
EM l.debartolo@itm.cnr.it
RI De Bartolo, Loredana/E-5074-2015
OI De Bartolo, Loredana/0000-0003-3774-9114; MORELLI,
   SABRINA/0000-0001-7551-8427; Drioli, Enrico/0000-0003-1092-5368
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Bader A, 2000, J BIOTECHNOL, V81, P95, DOI 10.1016/S0168-1656(00)00233-9
   BERRY MN, 1991, LAB TECHNIQUES BIOCH
   BERRY MN, 2000, NEPATOCYTE REV, P365
   Bismarck A, 1999, J COLLOID INTERF SCI, V217, P377, DOI 10.1006/jcis.1999.6345
   Catapano G, 1996, INT J ARTIF ORGANS, V19, P61
   Catapano G, 2001, BIOMATERIALS, V22, P659, DOI 10.1016/S0142-9612(00)00228-3
   De Bartolo L, 2003, MATER RES SOC SYMP P, V752, P291
   De Bartolo L, 1999, J BIOMAT SCI-POLYM E, V10, P641, DOI 10.1163/156856299X00856
   De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   de Bartolo L, 1998, BIOM HLTH R, V16, P167
   De Bartolo L, 2001, J MATER SCI-MATER M, V12, P959, DOI 10.1023/A:1012857031409
   Good R. J., 1992, MODERN APPROACHES WE
   Gugliuzza A, 2002, EUR POLYM J, V38, P235, DOI 10.1016/S0014-3057(01)00186-0
   Guillouzo A, 1997, J HEPATOL, V26, P73, DOI 10.1016/S0168-8278(97)80499-0
   KIMMERLE K, 1990, DESALINATION, V79, P283, DOI 10.1016/0011-9164(90)85012-Y
   KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392
   Krasteva N, 2002, BIOMATERIALS, V23, P2467, DOI 10.1016/S0142-9612(01)00381-7
   Kuo SM, 1997, ARTIF CELL BLOOD SUB, V25, P551, DOI 10.3109/10731199709117452
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Oss CJV, 1989, CELL BIOPHYS, V14, P1
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   VANOSS CJ, 1994, INTERFACIAL FORCES A
NR 26
TC 33
Z9 35
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3621
EP 3629
DI 10.1016/j.biomaterials.2003.10.042
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200030
PM 15020136
DA 2018-10-19
ER

PT J
AU Manwaring, ME
   Walsh, JF
   Tresco, PA
AF Manwaring, ME
   Walsh, JF
   Tresco, PA
TI Contact guidance induced organization of extracellular matrix
SO BIOMATERIALS
LA English
DT Article
DE wound healing; substrate topography; micropatterning
ID CENTRAL-NERVOUS-SYSTEM; MAGNETICALLY ALIGNED COLLAGEN; NEURITE
   OUTGROWTH; MICROGROOVED SURFACES; AXONAL REGENERATION; GROOVED
   SUBSTRATA; EPITHELIAL-CELLS; MAMMALIAN CNS; SCHWANN-CELLS; WHITE-MATTER
AB The scarring response following injury to the central nervous system disrupts the anatomical organization of nervous tissue posing a barrier to the regeneration of axons. In the present study, using materials with nanometer level surface features we examined whether matrix organization could be controlled by engineering meningeal cell asymmetry. Following 5 days in culture, the organization of meningeal cells along with their cytoskeletal elements and extracellular matrix proteins was evaluated. Meningeal cell morphology was markedly affected by nanometer level substrate topography. Cell alignment increased with increasing surface roughness. In addition, linear arrays of extracellular matrix were expressed that appeared related to cellular orientation. When cultured on substrates with topographical features of less than 10 nm neither cells nor their extracellular matrix showed organizational asymmetry. However, as oriented surface roughness increased, cellular and matrix asymmetrical organization became more pronounced reaching a threshold at 345 nm. These results suggest that biomaterial surface topography or other methods of altering the orientation of cells may be used to engineer orientation into the secreted extracellular matrix and as such may be a potential strategy for developing organized cell-derived matrix as a bridging material for nerve repair or other regenerative applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, 20 S 2030 E,Bldg 570,Room 108D, Salt Lake City, UT 84112 USA.
EM patrick.tresco@utah.edu
CR Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F
   Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31
   BIRAN R, IN PRESS EXP NEUROL
   BOVOLENTA P, 1992, PROG BRAIN RES, V94, P367
   Brandt J, 1999, EXP NEUROL, V160, P386, DOI 10.1006/exnr.1999.7210
   Brook GA, 2001, GLIA, V33, P118, DOI 10.1002/1098-1136(200102)33:2<118::AID-GLIA1011>3.0.CO;2-Y
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   CARBONETTO S, 1984, TRENDS NEUROSCI, V7, P382, DOI 10.1016/S0166-2236(84)80061-2
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Clemente CD, 1955, REGENERATION CENTRAL, P147
   DAVID S, 1988, J NEUROCYTOL, V17, P131, DOI 10.1007/BF01735385
   Davies SJA, 1997, NATURE, V390, P680
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   EBENDAL T, 1977, CELL TISSUE RES, V175, P439
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   Hall S, 1997, J ANAT, V190, P57, DOI 10.1046/j.1469-7580.1997.19010057.x
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1
   Manwaring ME, 2001, BIOMATERIALS, V22, P3155, DOI 10.1016/S0142-9612(01)00068-0
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   NOBLE M, 1984, J NEUROSCI, V4, P1892
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Oakley C, 1995, BIOCHEM CELL BIOL, V73, P473, DOI 10.1139/o95-053
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   PAINO CL, 1994, J NEUROCYTOL, V23, P433, DOI 10.1007/BF01207115
   Pettigrew DB, 1999, J NEUROSCI, V19, P8358
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Ramon, 1928, DEGENERATION REGENER
   Reier P J, 1988, Adv Neurol, V47, P87
   RISLING M, 1983, BRAIN RES, V280, P15, DOI 10.1016/0006-8993(83)91169-1
   RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5
   RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155
   SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5
   SUNG JH, 1981, J NEUROPATH EXP NEUR, V40, P645, DOI 10.1097/00005072-198111000-00006
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   VIDALSANZ M, 1987, J NEUROSCI, V7, P2894
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   WEISS P, 1959, REV MOD PHYS, V31, P11, DOI 10.1103/RevModPhys.31.11
   Yoshii S, 2001, J BIOMED MATER RES, V56, P400, DOI 10.1002/1097-4636(20010905)56:3<400::AID-JBM1109>3.0.CO;2-7
NR 48
TC 79
Z9 82
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3631
EP 3638
DI 10.1016/j.biomaterials.2003.10.043
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200031
PM 15020137
DA 2018-10-19
ER

PT J
AU Wang, XH
   Grogan, SP
   Rieser, F
   Winkelmann, V
   Maquet, V
   La Berge, M
   Mainil-Varlet, P
AF Wang, XH
   Grogan, SP
   Rieser, F
   Winkelmann, V
   Maquet, V
   La Berge, M
   Mainil-Varlet, P
TI Tissue engineering of biphasic cartilage constructs using various
   biodegradable scaffolds: an in vitro study
SO BIOMATERIALS
LA English
DT Article
DE chondrocyte; composite; bioreactor; biodegradation
ID OSTEOCHONDRAL DEFECTS; BIOREACTOR SYSTEM; REPAIR; BONE; HYDROXYAPATITE;
   IMPLANTS; TRANSPLANTATION; CHONDROGENESIS; CHONDROCYTES; GENERATION
AB Biological restoration of osteochondral defects requires suitable subchondral support material that also allows the induction of hyaline cartilage tissue. Biphasic implants consisting of pre-fabricated neocartilage and an underlying biodegradable osteoconductive base may meet these requirements. Here we explore various candidate biodegradable support materials onto which neo-cartilage was produced in vitro. Porcine chondrocytes were seeded in a closed and static bioreactor with a base of biomaterial consisting of either poly-L-lactide [P(L)LA], poly-D,L-lactide [P(D,L)LA] or Collagen-hydroxyapatite [Col-HA] and were cultured for 15 weeks. Viable neo-cartilage was produced on each biomaterial with differing amounts of cellular colonisation. P(D,L)LA breakdown was more rapid and uneven among the three biomaterials, leading to constructs of irregular shape. Little or no breakdown or chondrocyte colonisation was evident in P(L)LA. Col-HA constructs were superior in terms of viability, implant morphology and integration between neo-cartilage and biomaterial. These results indicate that our reported system has potential for producing biphasic implants that may be adequate for the repair of osteochondral defects. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Bern, Inst Pathol, Osteoarticular Res, CH-3010 Bern, Switzerland.
   Centerpulse, CH-8404 Winterthur, Switzerland.
   Univ Liege, Ctr Educ Res Macromol, B-4000 Cointe Ougree, Belgium.
   Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Mainil-Varlet, P (reprint author), Univ Bern, Inst Pathol, Osteoarticular Res, Murtenstr 31, CH-3010 Bern, Switzerland.
EM mainil@patho.unibe.ch
CR Adkisson HD, 2001, CLIN ORTHOP RELAT R, pS280
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   FREED LE, 1999, CLIN ORTHOP S, V367, P46
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   GIBSON DR, 1979, ANAL BIOCHEM, V96, P352, DOI 10.1016/0003-2697(79)90592-X
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Grogan SP, 2003, OSTEOARTHR CARTILAGE, V11, P403, DOI 10.1016/S1063-4584(03)00053-0
   Grogan SP, 2002, J PATHOL, V198, P5, DOI 10.1002/path.1169
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   Kreklau B, 1999, BIOMATERIALS, V20, P1743, DOI 10.1016/S0142-9612(99)00061-7
   Mainil-Varlet P, 2001, OSTEOARTHR CARTILAGE, V9, pS6, DOI 10.1053/joca.2001.0438
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   Martins VCA, 1998, ARTIF ORGANS, V22, P215, DOI 10.1046/j.1525-1594.1998.06004.x
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   REESE CA, 1981, BIOCHEMISTRY-US, V20, P5443, DOI 10.1021/bi00522a014
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Suominen E, 1996, J BIOMED MATER RES, V32, P543, DOI 10.1002/(SICI)1097-4636(199612)32:4<543::AID-JBM7>3.0.CO;2-R
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
NR 29
TC 83
Z9 89
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3681
EP 3688
DI 10.1016/j.biomaterials.2003.10.102
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200037
PM 15020143
DA 2018-10-19
ER

PT J
AU Roth, EA
   Xu, T
   Das, M
   Gregory, C
   Hickman, JJ
   Boland, T
AF Roth, EA
   Xu, T
   Das, M
   Gregory, C
   Hickman, JJ
   Boland, T
TI Inkjet printing for high-throughput cell patterning
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; micro patterning; collagen; hydrogel; inkjet
   printing; surface modification
ID SELF-ASSEMBLED MONOLAYERS; DIP-PEN NANOLITHOGRAPHY; JET METHOD;
   FABRICATION; PROTEIN; LITHOGRAPHY; GRADIENTS; NETWORKS; PLATFORM; ARRAYS
AB The adaptation of inkjet printing technology to the complex fields of tissue engineering and biomaterial development presents the potential to increase progress in these emerging technologies through the implementation of this high-throughput capability via automated processes to enable precise control and repeatability. In this paper, a method of applying high-throughput inkjet printing to control cellular attachment and proliferation by precise, automated deposition of collagen is presented. The results indicate that commercial inkjet printing. technology can be used to create viable cellular patterns with a resolution of 350 mum through the deposition of biologically active proteins. This method demonstrates a combination of off-the-shelf inkjet printing and biomaterials and has potential to be adapted to tissue engineering and colony patterning applications. Adapting this method into the three-dimensional construction of cellular structures for eventual high-throughput tissue engineering using a bottom-up approach is possible. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Clemson Univ, Dept Bioengn, Rhodes Res Ctr, Clemson, SC 29634 USA.
RP Boland, T (reprint author), Clemson Univ, Dept Bioengn, Rhodes Res Ctr, 502 Rhodes Hall, Clemson, SC 29634 USA.
EM tboland@clemson.edu
CR Allain LR, 2001, FRESEN J ANAL CHEM, V371, P146, DOI 10.1007/s002160100962
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   Blanchard JP, 1996, IEEE AERO EL SYS MAG, V11, P6, DOI 10.1109/62.484298
   Calvert P, 2001, CHEM MATER, V13, P3299, DOI 10.1021/cm0101632
   Chang PY, 2001, MUTAGENESIS, V16, P7, DOI 10.1093/mutage/16.1.7
   Fuierer RR, 2002, ADV MATER, V14, P154, DOI 10.1002/1521-4095(20020116)14:2<154::AID-ADMA154>3.0.CO;2-B
   Graham DJ, 2002, LANGMUIR, V18, P1518, DOI 10.1021/la010059z
   Herbert CB, 1997, CHEM BIOL, V4, P731, DOI 10.1016/S1074-5521(97)90311-2
   HICKMAN JJ, 1994, J VAC SCI TECHNOL A, V12, P607, DOI 10.1116/1.578844
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   LIEDBERG B, 1995, LANGMUIR, V11, P3821, DOI 10.1021/la00010a037
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   NEWMAN JD, 1992, ANAL CHIM ACTA, V262, P13, DOI 10.1016/0003-2670(92)80002-O
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   Pardo L, 2003, LANGMUIR, V19, P1462, DOI 10.1021/la026171u
   Pardo L, 2003, J COLLOID INTERF SCI, V257, P116, DOI 10.1016/S0021-9797(02)00022-X
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Xu T, 2004, BIOTECHNOL BIOENG, V85, P29, DOI 10.1002/bit.10768
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 29
TC 395
Z9 402
U1 7
U2 176
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3707
EP 3715
DI 10.1016/j.biomaterials.2003.10.052
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200040
PM 15020146
DA 2018-10-19
ER

PT J
AU VandeVord, PJ
   Gupta, N
   Wilson, RB
   Vinuya, RZ
   Schaefer, CJ
   Canady, AI
   Wooley, PH
AF VandeVord, PJ
   Gupta, N
   Wilson, RB
   Vinuya, RZ
   Schaefer, CJ
   Canady, AI
   Wooley, PH
TI Immune reactions associated with silicone-based ventriculo-peritoneal
   shunt malfunctions in children
SO BIOMATERIALS
LA English
DT Article
DE ventriculo-peritoneal shunt; silicone; immune response; antibodies
ID CEREBROSPINAL-FLUID EOSINOPHILIA; BREAST IMPLANTS; SILICATE ANTIBODIES;
   GEL; HYDROCEPHALUS; WOMEN; HYPERSENSITIVITY; ADJUVANCY; ASSAY; MICE
AB The implantation of ventriculo-peritoneal (VP) shunting systems is the most commonly performed neurological procedure in children with hydrocephalus. Although the overall complication risk is low, the cumulative risk of shunt failure is high and unfortunately results in a high prevalence of revision surgeries. In this study, we explored the concept that some pediatric patients may develop an immune response to either the proteins attached to the silicone implant surface or to the biomaterial itself, and that this reaction may contribute to VP shunt failure in some individuals. The data displays that the sterile shunt malfunction group had a higher rate of protein deposition and increased levels of autoantibodies to the extracted surface proteins as compared to individuals with functioning shunting systems. The precise nature of the shunt-bound proteins that serve as antigens in this experiment have not yet been determined. The data also indicated that some individuals develop antibodies to polymeric substances that cross-react with partially polymerized acrylamide. The detection of significant amounts of shunt-bound protein, antibody responses to these proteins and to polymeric substances suggest that an immunological response to these proteins may play a role in the mechanism behind sterile shunt malfunctions. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Wayne State Univ, Dept Biomed Engn, Bioengn Ctr 2102, Sch Med, Detroit, MI 48201 USA.
   Wayne State Univ, Sch Med, Dept Orthopaed Surg, Detroit, MI 48201 USA.
   Wayne State Univ, Sch Med, Dept Pediat Neurosurg, Detroit, MI 48201 USA.
   Autoimmune Technol LLC, New Orleans, LA 70112 USA.
RP VandeVord, PJ (reprint author), Wayne State Univ, Dept Biomed Engn, Bioengn Ctr 2102, Sch Med, 818 W Hancock, Detroit, MI 48201 USA.
EM pvord@wayne.edu
RI VandeVord, Pamela/B-4606-2012
CR Bondurant CP, 1995, PEDIATR NEUROSURG, V23, P254, DOI 10.1159/000120968
   Cinalli G, 1999, CHILD NERV SYST, V15, P718, DOI 10.1007/s003810050461
   Da Silva Marcia C., 1991, Pediatric Neurosurgery, V17, P304, DOI 10.1159/000120614
   DEJONG WH, 2002, CLIN EXP RHEUMATOL, V2, P151
   GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P
   GOWER DJ, 1984, J NEUROSURG, V61, P1079, DOI 10.3171/jns.1984.61.6.1079
   Jensen B, 2003, RHEUMATOLOGY, V42, P1032, DOI 10.1093/rheumatology/keg282
   JIMENEZ DF, 1994, CHILD NERV SYST, V10, P59, DOI 10.1007/BF00313586
   Kanev P M, 1993, Neurosurg Clin N Am, V4, P611
   LARSSON A, 1991, ACTA NEUROL SCAND, V84, P475, DOI 10.1111/j.1600-0404.1991.tb04998.x
   Lazareff JA, 1998, CHILD NERV SYST, V14, P271, DOI 10.1007/s003810050223
   LITTLE JR, 1972, MAYO CLIN PROC, V47, P396
   Naim JO, 1997, J BIOMED MATER RES, V37, P534, DOI 10.1002/(SICI)1097-4636(19971215)37:4<534::AID-JBM12>3.0.CO;2-8
   NAIM JO, 1993, IMMUNOL INVEST, V22, P151, DOI 10.3109/08820139309063397
   NAIM JO, 1995, IMMUNOL INVEST, V24, P537, DOI 10.3109/08820139509066849
   NAIM JO, 2000, CLIN DIAGN LAB IMMUN, V3, P366
   NARINI PP, 1995, PLAST RECONSTR SURG, V96, P371, DOI 10.1097/00006534-199508000-00016
   Oliver DW, 2000, BRIT J PLAST SURG, V53, P410, DOI 10.1054/bjps.2000.3344
   Pastor JC, 2001, OPHTHALMIC RES, V33, P87, DOI 10.1159/000055649
   Picha GJ, 1997, PLAST RECONSTR SURG, V100, P643, DOI 10.1097/00006534-199709000-00016
   SAINTEROSE C, 1993, PEDIATR NEUROSURG, V19, P156, DOI 10.1159/000120722
   SAINTEROSE C, 1987, J NEUROSURG, V66, P213, DOI 10.3171/jns.1987.66.2.0213
   Schaefer CJ, 1999, J RHEUMATOL, V26, P2215
   Schaefer CJ, 1997, ARTHRITIS RHEUM-US, V40, P1064, DOI 10.1002/art.1780400611
   SHAIKH S, 2002, J GLAUCOMA, V6, P508
   Shen GQ, 1996, CLIN DIAGN LAB IMMUN, V3, P162
   SNOW RB, 1989, SURG NEUROL, V31, P209, DOI 10.1016/0090-3019(89)90119-5
   Tangsinmankong N, 1999, ANN ALLERG ASTHMA IM, V83, P341, DOI 10.1016/S1081-1206(10)62675-0
   Tenenbaum SA, 1997, LANCET, V349, P449, DOI 10.1016/S0140-6736(96)07131-0
   TRAYNELIS VC, 1988, NEUROSURGERY, V23, P645, DOI 10.1227/00006123-198811000-00019
   VOJDANI A, 1994, IMMUNOPHARM IMMUNOT, V16, P497, DOI 10.3109/08923979409019737
   Wilson RB, 1999, J RHEUMATOL, V26, P402
NR 32
TC 19
Z9 21
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3853
EP 3860
DI 10.1016/j.biomaterials.2003.10.024
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200055
PM 15020161
DA 2018-10-19
ER

PT J
AU Schilling, AF
   Linhart, W
   Filke, S
   Gebauer, M
   Schinke, T
   Rueger, JM
   Amling, M
AF Schilling, AF
   Linhart, W
   Filke, S
   Gebauer, M
   Schinke, T
   Rueger, JM
   Amling, M
TI Resorbability of bone substitute biomaterials by human osteoclasts
SO BIOMATERIALS
LA English
DT Article
DE bioresorption; biomimetic material; calcium phosphate cement; cell
   culture; in vitro test; osteoclast
ID BETA-TRICALCIUM PHOSPHATE; IN-VITRO; MARROW; CELLS; OSTEOPROTEGERIN;
   DIFFERENTIATION; RESORPTION; CULTURES; HYDROXYAPATITE; OSTEOPETROSIS
AB Third generation biomaterials are being designed with the aim that once implanted they will help the body to heal itself. One desirable characteristic of these materials in bone is their ability to be remodeled, i.e. that osteoclasts resorb the material and it is subsequently replaced by newly formed bone through osteoblastic activity. So far the only way to test this biological property of bone substitutes are animal experiments with all their limitations like ethics, costs and limited transferability to man. The present study was designed, to develop a human in vitro assay, allowing to generate human osteoclasts directly on the biomaterial. The assay was validated using calcium phosphate cement and PMMA as biomaterials. Quantification was performed by raster electron microscopy and computer assisted image analysis. Dentin was used as internal standard. Our assay shows iso-bone resorbability of calcium phosphate cement in comparison to unresorbable PMMA cement. Both current clinical orthopedic practice and future skeletal engineering may profit from the availability and use of a test system for the assessment of resorption quality. The assay presented here allows to address this question of resorbability and to select the best materials for the use as bone substitutes in specific patients. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Hamburg, Sch Med, Ctr Biomech, Dept Trauma Hand & Reconstruct Surg, D-20246 Hamburg, Germany.
RP Amling, M (reprint author), Univ Hamburg, Sch Med, Ctr Biomech, Dept Trauma Hand & Reconstruct Surg, Martinistr 52, D-20246 Hamburg, Germany.
EM a.schilling@uke.uni-hamburg.de; amling@uke.uni-hamburg.de
CR AXHAUSEN G, 1908, MED KLIN, V2, P23
   Baron R, 1995, Acta Orthop Scand Suppl, V266, P66
   Baron Roland, 1993, P445
   BONATESTA G, 2000, MEDIZINGESCH ABH, V285, P1
   BUCAY N, 1998, GENE DEV, V12, P395
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Craelius W, 2002, SCIENCE, V295, P1018, DOI 10.1126/science.295.5557.1018
   DOROZHKIN SV, 2002, ANGEW CHEM INT EDIT, V41, P130
   Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   HATTERSLEY G, 1989, ENDOCRINOLOGY, V125, P1606, DOI 10.1210/endo-125-3-1606
   Hentunen TA, 1999, ENDOCRINOLOGY, V140, P2954, DOI 10.1210/en.140.7.2954
   HOLDEN C M, 1990, Journal of Oral Implantology, V16, P86
   JONES SJ, 1986, SCANNING ELECTRON MI, V4, P1571
   Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552
   Langston N, 2001, NURS HEALTH CARE PER, V22, P2
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   McMahon C, 2001, BLOOD, V97, P1947, DOI 10.1182/blood.V97.7.1947
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Nordstrom T, 1997, J BIOL CHEM, V272, P6354, DOI 10.1074/jbc.272.10.6354
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   Parfitt A, 1983, BONE HISTOMORPHOMETR, P143
   Rodan SB, 1997, J ENDOCRINOL, V154, pS47
   Rueger JM, 1998, ORTHOPADE, V27, P72
   SHIBUTANI T, 1993, J BONE MINER RES, V8, P331
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260
   WALKER DG, 1993, CLIN ORTHOP RELAT R, P4
   WILKE A, 1993, BIOMED TECH, V38, P126, DOI 10.1515/bmte.1993.38.6.126
   XIA ZD, 1994, CHINESE MED J-PEKING, V107, P845
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
   Zambonin Zallone A, 1982, Anat Embryol (Berl), V165, P405
NR 35
TC 111
Z9 114
U1 3
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 18
BP 3963
EP 3972
DI 10.1016/j.biomaterials.2003.10.079
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 813ZQ
UT WOS:000220945400004
PM 15046886
DA 2018-10-19
ER

PT J
AU Akay, G
   Birch, MA
   Bokhari, MA
AF Akay, G
   Birch, MA
   Bokhari, MA
TI Microcellular polyHIPE polymer supports osteoblast growth and bone
   formation in vitro
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; polyHIPE polymer (PHP); osteoblasts; hydroxyapatite;
   process miniaturization; micro-cellular polymers
ID OSTEOGENESIS; FILTRATION; MODULES
AB A novel micro-cellular polymer with a well-defined and uniform micro-architecture has been developed as a three-dimensional support matrix for in vitro tissue engineering applications. This material is manufactured through a high internal phase emulsion (HIPE) polymerization route and may be modified with hydroxyapatite. The generic form of the support is known as PolyHIPE Polymer (PHP). By changing the chemical composition of the emulsion and the processing conditions, the pore size can be altered from sub-micron range to a few hundred microns and the porosity varied from 70% to 97%. Our work has investigated the use of this micro-porous polymer as a biomaterial to support the growth of osteoblasts, the bone forming cells in vitro. Three groups of polymers were used that had pore sizes of 40, 60 and 100 mum. Results demonstrated in vitro cell-polymer compatibility, with osteoblasts forming multicellular layers on the polymer surface and also migrating to a maximum depth of 1.4 mm inside the scaffold after 35 days in culture. PHP was also able to support the differentiation of osteoblasts and the production of a bone-like matrix. The effect of modifying the polymer with hydroxyapatite was also studied and showed that there was a significant increase in osteoblast numbers penetrating into the polymer. There were few differences, between the pore sizes studied, on the overall penetration of osteoblasts into the polymer but the rate of movement into 100 mum PHP was significantly higher compared to the other sizes investigated. This study shows that osteoblasts seeded onto PHP demonstrate cellular attachment, proliferation and ingrowth leading to the support of an osteoblastic phenotype. Therefore this highly porous scaffold has a potential for bone tissue engineering. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Newcastle Upon Tyne, Inst Nanoscale Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   Univ Newcastle Upon Tyne, Proc Intensificat & Miniaturisat Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   Univ Newcastle Upon Tyne, Sch Med, Sch Surg & Reprod Sci Trauma & Orthopaed, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
RP Akay, G (reprint author), Univ Newcastle Upon Tyne, Inst Nanoscale Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM Galip.Akay@Newcastle.ac.uk
RI Birch, Mark/B-7051-2009
CR AKAY G, 1995, CHEM ENG RES DES, V73, P782
   Akay G, 1998, CHEM ENG SCI, V53, P203, DOI 10.1016/S0009-2509(97)00199-1
   AKAY G, 1994, J MEMBRANE SCI, V88, P177, DOI 10.1016/0376-7388(94)87005-5
   AKAY G, UNPUB PREPARATION PR
   AKAY G, 2002, Patent No. 1183328
   AKAY G, UNPUB BIOPROCESS INT
   AKAY G, 2003, Patent No. 1307402
   AKAY G, 1984, UNILEVER RES PORT SU
   Akay G, 1995, POLYM POWDER TECHNOL, P541
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Bokhari M, 2003, ADV EXP MED BIOL, V534, P247
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   BYRON VJ, 1999, THESIS U NEWCASTLE U
   ERHAN E, IN PRESS J CHEM TECH
   Hunziker EB, 1999, CLIN ORTHOP RELAT R, pS135
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Laurencin CT, 1996, BONE, V19, P93
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   Mooney DJ, 1999, SCI AM, V280, P38
   Ramires PA, 2002, BIOMATERIALS, V23, P397, DOI 10.1016/S0142-9612(01)00118-1
   SILKAVITSAS VI, 2002, J BIOMED MATER RES, V62, P136
   Wakeman RJ, 1998, CHEM ENG J, V70, P133, DOI 10.1016/S1385-8947(98)00088-6
NR 24
TC 213
Z9 222
U1 5
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 18
BP 3991
EP 4000
DI 10.1016/j.biomaterials.2003.10.086
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 813ZQ
UT WOS:000220945400007
PM 15046889
DA 2018-10-19
ER

PT J
AU Liu, HC
   Lee, IC
   Wang, JH
   Yang, SH
   Young, TH
AF Liu, HC
   Lee, IC
   Wang, JH
   Yang, SH
   Young, TH
TI Preparation of PLLA membranes with different morphologies for culture of
   MG-63 Cells
SO BIOMATERIALS
LA English
DT Article
DE PLLA; particulate membranes; MG-63 cells
ID EVAL MEMBRANES; IN-VITRO; PHASE-BEHAVIOR; POLYLACTIDE; POLYMERS; SYSTEM;
   GROWTH; WATER; ACID; BONE
AB In this work, Poly L-lactide (PLLA) membranes with different morphologies were prepared and the equilibrium phase diagram of membrane formation system of ethanol, methylene chloride, and PLLA was studied. Based on the phase diagram, particulate and porous membranes, dominated by crystallization and liquid-liquid demixing, respectively, could be prepared by changing the PLLA concentration of casting solution. In addition, in vitro interaction of MG-63 osteosarcoma cells and PLLA membranes with dense, porous and particulate morphologies was investigated. It was found that the particulate membrane not only could improve cell adhesion and growth, but also could upregulate the osteoblastic phenotype. Therefore, the PLLA membrane with particulate morphology satisfies the biomaterial requirement necessary for temporary scaffold to transplanted osteoblasts and provides a means for the architectural design of more complex tissue-engineered systems. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Taipei 100, Taiwan.
   Natl Taiwan Univ Hosp, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Taipei 100, Taiwan.
EM thyoung@ha.mc.ntu.edu.tw
OI Wang, Jyh- Horng/0000-0002-1531-5297; Yang, Shu-Hua/0000-0001-6565-0408;
   YANG, SHU-HUA/0000-0002-9879-0164
CR ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A
   Cheng LP, 1999, POLYMER, V40, P2395, DOI 10.1016/S0032-3861(98)00462-5
   Cheng LP, 1998, J MEMBRANE SCI, V145, P77, DOI 10.1016/S0376-7388(98)00063-5
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Kesting R.E., 1985, SYNTHETIC POLYM MEMB
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lin DT, 1998, J MEMBRANE SCI, V140, P185, DOI 10.1016/S0376-7388(97)00281-0
   LLOYD DR, 1990, J MEMBRANE SCI, V52, P239, DOI 10.1016/S0376-7388(00)85130-3
   MAJOLA A, 1989, CLIN ORTHOP RELAT R, V268, P260
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PIHLAJAMAKI H, 1994, ARCH ORTHOP TRAUM SU, V113, P101, DOI 10.1007/BF00572915
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   vandeWitte P, 1996, J MEMBRANE SCI, V113, P223, DOI 10.1016/0376-7388(95)00068-2
   vandeWitte P, 1996, J POLYM SCI POL PHYS, V34, P2569
   Wang JH, 2003, J BIOMED MATER RES A, V64A, P606, DOI 10.1002/jbm.a.10322
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 1998, MACROMOLECULES, V31, P1229, DOI 10.1021/ma9710388
   Young TH, 1997, J MEMBRANE SCI, V128, P55, DOI 10.1016/S0376-7388(96)00329-8
   Young TH, 2001, BIOMATERIALS, V22, P1771, DOI 10.1016/S0142-9612(00)00337-9
   Young TH, 2000, POLYMER, V41, P377, DOI 10.1016/S0032-3861(99)00149-4
   Young TH, 2000, J BIOMED MATER RES, V50, P490, DOI 10.1002/(SICI)1097-4636(20000615)50:4<490::AID-JBM4>3.0.CO;2-N
NR 28
TC 59
Z9 61
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 18
BP 4047
EP 4056
DI 10.1016/j.biomaterials.2003.10.098
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 813ZQ
UT WOS:000220945400013
PM 15046895
DA 2018-10-19
ER

PT J
AU Mitchell, SA
   Poulsson, AHC
   Davidson, MR
   Emmison, N
   Shard, AG
   Bradley, RH
AF Mitchell, SA
   Poulsson, AHC
   Davidson, MR
   Emmison, N
   Shard, AG
   Bradley, RH
TI Cellular attachment and spatial control of cells using micro-patterned
   ultra-violet/ozone treatment in serum enriched media
SO BIOMATERIALS
LA English
DT Article
DE UV/ozone; polystyrene (PS); surface modification; micropatterning; XPS;
   AFM; cell adhesion
ID ANTIBIOTIC-RELEASING POLYMERS; SELF-ASSEMBLED MONOLAYERS; BIOMATERIAL
   SURFACES; SELECTIVE ADHESION; PLASMA DEPOSITION; DRUG-DELIVERY;
   EXCIMER-LASER; POLYSTYRENE; BIOSENSORS; CHEMISTRY
AB Ultra-violet Ozone (UVO) modified polystyrene (PS) surfaces were analyzed by X-ray photoelectron spectroscopy (XPS), atomic force microscopy (AFM), contact angle (CA), optical microscopy (OM) and cell culture experiments. UV/Ozone treatment up to 900s was used to increase the surface oxygen concentration of PS surfaces from 0% to similar to35% (unwashed) and 0% to similar to27% (washed). The observed differences in oxygen concentration, between washed and unwashed surfaces, have been previously attributed to the removal of low molecular weight debris produced in this treatment process. Surface roughness (R,) is known to affect cellular attachment and proliferation. AFM studies of the UV/Ozone treated PS surfaces show the surface roughness is an order of magnitude less than that expected to cause an effect. UV/Ozone treatment of PS showed a marked change in CA which decreased to similar to60degrees after 900 s treatment. The increased attachment and proliferation of Chinese hamster ovarian (CHO) and mouse embryo 3T3-L1 (3T3) cells on the treated surfaces compared to untreated PS were found to correlate strongly with the increase in surface oxygen concentration. Surface chemical oxidation patterns on the PS were produced using a simple masking technique and a short UV/Ozone treatment time, typically 20-45 s. The chemical patterns on PS were visualized by water condensation and the spatially selective attachment of CHO and 3T3-L1 cells cultured with 10% (v/v) serum. This paper describes an easily reproducible, one step technique to produce a well-defined, chemically heterogeneous surface with a cellular resolution using UV/Ozone modification. By using a variety of cell types, that require different media conditions, we have been able to expand the potential applications of this procedure. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Robert Gordon Univ, Sch Engn, Adv Mat & Biomat Res Ctr, Aberdeen AB25 1HG, Scotland.
   Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England.
RP Bradley, RH (reprint author), Robert Gordon Univ, Sch Engn, Adv Mat & Biomat Res Ctr, St Andrew St, Aberdeen AB25 1HG, Scotland.
EM stephen.mitchell@rgu.ac.uk; r.bradley@rgu.ac.uk
RI Shard, Alexander/B-4530-2010
OI Shard, Alexander/0000-0002-8931-5740
CR Beamson G., 1992, HIGH RESOLUTION XPS
   Benoit D, 1999, J AM CHEM SOC, V121, P3904, DOI 10.1021/ja984013c
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Brewer NJ, 2001, J AM CHEM SOC, V123, P4089, DOI 10.1021/ja0155074
   Bullett NA, 2001, SURF INTERFACE ANAL, V31, P1074, DOI 10.1002/sia.1146
   CALLEN BW, 1995, J VAC SCI TECHNOL A, V13, P2023, DOI 10.1116/1.579647
   Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Fischbach C, 2001, SURF SCI, V491, P333, DOI 10.1016/S0039-6028(01)01297-3
   Fishman HA, 1998, ANNU REV BIOPH BIOM, V27, P165, DOI 10.1146/annurev.biophys.27.1.165
   Gopel W, 1998, BIOSENS BIOELECTRON, V13, P723, DOI 10.1016/S0956-5663(98)00032-3
   HIRONO T, 1988, BRAIN RES, V446, P189, DOI 10.1016/0006-8993(88)91314-5
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   HUBBELL JA, 1994, TRENDS POLYM SCI, V2, P20
   Ito Y, 1997, BIOMATERIALS, V18, P197, DOI 10.1016/S0142-9612(96)00119-6
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   KASEMO B, 1993, BIOMATERIALS INTERFA, P63
   Kwok CS, 1999, J CONTROL RELEASE, V62, P289, DOI 10.1016/S0168-3659(99)00106-6
   Kwok CS, 1999, J CONTROL RELEASE, V62, P301, DOI 10.1016/S0168-3659(99)00105-4
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   LEE JS, 1993, BIOMATERIALS, V14, P958, DOI 10.1016/0142-9612(93)90139-S
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, 1993, SCIENCE, V260, P647, DOI 10.1126/science.8480175
   Mathieson I, 1996, INT J ADHES ADHES, V16, P29, DOI 10.1016/0143-7496(96)88482-X
   MATHIESON I, 1995, KEY ENG MAT, V99-1, P185, DOI 10.4028/www.scientific.net/KEM.99-100.185
   MATSUSHIMA N, 1990, MOKUZAI GAKKAISHI, V36, P559
   Mitchell SA, 2002, SURF INTERFACE ANAL, V33, P742, DOI 10.1002/sia.1444
   MRKSICH M, 1995, TRENDS BIOTECHNOL, V13, P228, DOI 10.1016/S0167-7799(00)88950-7
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Naessens M, 1998, BIOSENS BIOELECTRON, V13, P341, DOI 10.1016/S0956-5663(97)00121-8
   NICOLINI C, 1995, BIOSENS BIOELECTRON, V10, P105, DOI 10.1016/0956-5663(95)96799-5
   NIINO H, 1993, APPL PHYS LETT, V63, P3527, DOI 10.1063/1.110091
   PHILLIPS HM, 1991, APPL PHYS LETT, V58, P2761, DOI 10.1063/1.104778
   PISKIN E, 1992, J BIOMAT SCI-POLYM E, V4, P45
   POULSSON AHC, 2002, EUR CELLS MAT S, V2, P104
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Sanders CA, 2001, BIOSENS BIOELECTRON, V16, P439, DOI 10.1016/S0956-5663(01)00158-0
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   StJohn PM, 1997, J NEUROSCI METH, V75, P171, DOI 10.1016/S0165-0270(97)00069-1
   SUZUKI Y, 1992, NUCL INSTRUM METH B, V65, P142, DOI 10.1016/0168-583X(92)95027-O
   Teare DOH, 2000, LANGMUIR, V16, P2818, DOI 10.1021/la9907533
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Welle A, 2002, BIOMED MICRODEVICES, V4, P33, DOI 10.1023/A:1014267712144
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 53
TC 37
Z9 37
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 18
BP 4079
EP 4086
DI 10.1016/j.biomaterials.2003.11.010
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 813ZQ
UT WOS:000220945400017
PM 15046899
DA 2018-10-19
ER

PT J
AU Arciola, CR
   Campoccia, D
   Gamberini, S
   Rizzi, S
   Donati, ME
   Baldassarri, L
   Montanaro, L
AF Arciola, CR
   Campoccia, D
   Gamberini, S
   Rizzi, S
   Donati, ME
   Baldassarri, L
   Montanaro, L
TI Search for the insertion element IS256 within the ica locus of
   Staphylococcus epidermidis clinical isolates collected from
   biomaterial-associated infections
SO BIOMATERIALS
LA English
DT Article
DE Staphylococcus epidermidis; biomaterial-associated infections; biofilm;
   ica locus; IS256; polysaccharide intercellular adhesin
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   CATHETER-ASSOCIATED INFECTIONS; SLIME PRODUCTION; IRON LIMITATION;
   BIOFILM FORMATION; MOLECULAR-BASIS; PHASE VARIATION; EXPRESSION; STRAINS
AB Staphylococcus epidermidis biofilm-forming strains produce a polysaccharide intercellular adhesin (PIA), which mediates bacterial cell aggregation and favours the colonisation on prosthetic implants. PIA synthesis is regulated by the icaADBC locus. In vitro, by repeated subcultures of a biofilm-producing strain, the loss of the ability to produce biofilm appears associated with the insertion of the IS256 element into the ica locus. This study was aimed (i) to investigate if the five genes of ica locus are always all present in different strains of S. epidermidis, and (ii) to search if IS256 insertion naturally occurs in ica locus without making recourse to the experimental procedure of repeated subcultures of strains. 120 S. epidermidis clinical isolates from peri-prosthesis infections were investigated both by an original multiplex PCR analysis of the ica genes and by PCR amplification of the IS256 element. Also two reference strains (the biofilm-negative S. epidermidis ATCC 12228 and the biofilm-forming ATCC 35984 [RP62A]) and two biofilm-negative RP62A-derived acriflavin mutants (139 and HAM892) were analysed. D9 e HAM892 were for the first time shown to contain in ica locus. at the base 3319, a 1300-bp insertion with a DNA sequence corresponding to IS256. Among the 120 clinical isolates, 51 (43%) turned out completely ica-positive, 69 completely ica-negative (57%).
   The genes of the ica locus appear, in all cases of the present collection, strictly linked each other, so they are either all present or all absent.
   In this collection, IS256 was present in eight out of the 69 ica-negative strains and in 34 out of the 51 ica-positive strains. IS256, also when present in bacterial genomic DNA, was never found inside the ica locus, thus suggesting that insertion/excision of this element is not a natural occurring mechanism for off/on switching of biofilm production. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Rizzoli Orthopaed Inst, Res Lab Biocompatibil Implant Mat, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   Ist Super Sanita, Ultrastrutture Lab, I-00161 Rome, Italy.
RP Montanaro, L (reprint author), Rizzoli Orthopaed Inst, Res Lab Biocompatibil Implant Mat, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it; lucio.montanaro@alma.unibo.it
RI Baldassarri, Lucilla/B-1042-2013; Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219; Donati, Maria
   Benedetta/0000-0003-1747-5443
CR Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   ARCIOLA CR, 2002, BIOMATERIALS, V23, P4223
   BADDOUR LM, 1987, REV INFECT DIS, V9, P1168
   BADDOUR LM, 1990, J CLIN MICROBIOL, V28, P676
   Baldassarri L, 2001, EUR J CLIN MICROBIOL, V20, P343, DOI 10.1007/s100960100495
   Baldassarri L, 1997, INFECT IMMUN, V65, P1522
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   DEIGHTON M, 1993, INFECT IMMUN, V61, P4473
   Deighton MA, 1996, EPIDEMIOL INFECT, V117, P267, DOI 10.1017/S0950268800001448
   Elci Saffet, 1995, Cytobios, V84, P141
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   FRERE JM, 1999, NAT BIOTECHNOL, V17, P7
   Gelosia A, 2001, CLIN MICROBIOL INFEC, V7, P193, DOI 10.1046/j.1469-0691.2001.00214.x
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2000, ADV EXP MED BIOL, V485, P103
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Huebner J, 1999, ANNU REV MED, V50, P223
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   Mason WJ, 2001, J CLIN MICROBIOL, V39, P3332, DOI 10.1128/JCM.39.9.3332-3338.2001
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   Rohde H, 2001, MED MICROBIOL IMMUN, V190, P105, DOI 10.1007/s00430-001-0099-5
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
   Ziebuhr W, 2000, ADV EXP MED BIOL, V485, P151
NR 29
TC 44
Z9 44
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 18
BP 4117
EP 4125
DI 10.1016/j.biomaterials.2003.11.027
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 813ZQ
UT WOS:000220945400020
PM 15046902
DA 2018-10-19
ER

PT J
AU Yuan, Y
   Zhang, PY
   Yang, YM
   Wang, X
   Gu, XS
AF Yuan, Y
   Zhang, PY
   Yang, YM
   Wang, X
   Gu, XS
TI The interaction of Schwann cells with chitosan membranes and fibers in
   vitro
SO BIOMATERIALS
LA English
DT Article
DE schwarm cell; biocompatibility; chitosan
ID BIOARTIFICIAL NERVE GRAFT; NUDE-MICE; REGENERATION; ATTACHMENT;
   BIOCOMPATIBILITY; TRANSPLANTATION; FIBRONECTIN; CONDUITS; GROWTH; CHITIN
AB The bridging of nerve gaps is still one of the major problems in peripheral nerve regeneration. A promising alternative for the repair of peripheral nerve injuries is the bioartificial nerve graft, comprised of a biomaterial pre-seeded with Schwann cells (SCs), which is an effective substrate for enhancing nerve regeneration. Interaction between cultured SCs and biomaterials is of importance. For the purposes of this study, culture systems of normal SCs were used. The biocompatibility of chitosan, including chitosan membranes and chitosan fibers, was evaluated in vitro. The growth of SCs was observed by light and scanning electron microscopy at regular intervals. SCs were identified by immunocytochemical staining and the viability of SCs was measured by MTT assay. The experimental results indicated that SCs could grow onto chitosan materials with two different shapes: spherical and long olivary. They contacted with the extensions. The long olivary cells inclined to encircle chitosan fibers up. It was also found that the cells on the chitosan fibers migrated faster than those on the chitosan membranes. There was a good biological compatibility between chitosan and SCs. Compared with the chitosan membranes, SCs migrated more easily onto the stereoframe of chitosan fibers. These studies contribute information necessary to enhancing our understanding of biocompatibility of chitosan. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Nantong Med Coll, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
RP Gu, XS (reprint author), Nantong Med Coll, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
EM neurongu@public.nt.js.cn
CR Ansselin AD, 1997, NEUROPATH APPL NEURO, V23, P387
   Berger A, 1994, Handchir Mikrochir Plast Chir, V26, P44
   Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7
   BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9
   BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   GILLEN C, 1995, J NEUROSCI RES, V42, P159, DOI 10.1002/jnr.490420203
   Gingras M, 2003, BIOMATERIALS, V24, P1653, DOI 10.1016/S0142-9612(02)00572-0
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   GU XS, 1995, J ANAT, V186, P153
   Gu XS, 2003, PROG NAT SCI, V13, P578
   Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6
   Huber M, 1998, J BIOMED MATER RES, V41, P278, DOI 10.1002/(SICI)1097-4636(199808)41:2<278::AID-JBM13>3.0.CO;2-H
   Kurita K, 1998, POLYM DEGRAD STABIL, V59, P117, DOI 10.1016/S0141-3910(97)00160-2
   LUNDBORG G, 1982, BRAIN RES, V232, P157, DOI 10.1016/0006-8993(82)90618-7
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   RATHKE TD, 1994, J MACROMOL SCI R M C, VC34, P375, DOI 10.1080/15321799408014163
   Rutkowski GE, 2002, BIOTECHNOL PROGR, V18, P362, DOI 10.1021/bp020300f
   Rutkowski GE, 2002, BIOTECHNOL PROGR, V18, P373, DOI 10.1021/bp020280h
   Sato H, 1998, ANAL CHEM, V70, P7, DOI 10.1021/ac9706685
   Shen ZL, 2001, MICROSURG, V21, P6, DOI 10.1002/1098-2752(2001)21:1<6::AID-MICR1001>3.0.CO;2-6
   Sunderland S, 1978, NERVES NERVE INJURIE, P69
   Suzuki T, 1997, J FERMENT BIOENG, V84, P128, DOI 10.1016/S0922-338X(97)82541-X
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   WILLIAMS LR, 1987, J COMP NEUROL, V264, P284, DOI 10.1002/cne.902640211
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhu AP, 2002, J BIOMAT SCI-POLYM E, V13, P501, DOI 10.1163/15685620260178364
NR 31
TC 166
Z9 196
U1 2
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 18
BP 4273
EP 4278
DI 10.1016/j.biomaterials.2003.11.029
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 813ZQ
UT WOS:000220945400035
PM 15046917
DA 2018-10-19
ER

PT J
AU Dong, J
   Sun, QS
   Wang, JY
AF Dong, J
   Sun, QS
   Wang, JY
TI Basic study of corn protein, zein, as a biomaterial in tissue
   engineering, surface morphology and biocompatibility
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; cell proliferation; MTT assay; protein; SEM; surface
   analysis
ID METHYL LINOLEATE; WATER ACTIVITY; MAIZE ZEIN; PROLIFERATION;
   OSTEOBLASTS; MACROPHAGES; POLYMERS
AB The zein films, were prepared for culturing human liver cells (HL-7702) and mice fibroblast cells (NIH3T3), while the Corning microplate and polylactic acid (PLA) were chosen as controls. The surface morphology of zein films prepared by two different methods was studied by scanning electron microscope (SEM), which revealed that the zein films were composed of particles of diameter 100-500 and 500-2500 nm, respectively. The biocompatibility of zein films was assessed by attachment, extensibility and proliferation of cells on them. Our study indicated that over 60% of both HL-7702 cells and NlH3T3 cells could attach to the Corning microplate, zein films and PLA at 3 h after seeding. The concentration and particle sizes for preparing zein films did not seem to affect the proliferation of the cells tested. There were no significant differences in the proliferation of both HL-7702 cells and NIH3T3 cells between the Corning microplate and two kinds of zein films, except that the zein film composed of smaller particles at the lowest concentration exhibited a very good ability for proliferation of both the cells, while PLA was a poor matrix in the latter period of the cell proliferation. This preliminary study demonstrates that zein is a promising biomaterial with good biocompatibility for the development of tissue engineering. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China.
   Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China.
RP Wang, JY (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, 354 Fenglin Rd, Shanghai 200032, Peoples R China.
EM ywang@mail.sioc.ac.cn
RI Wang, Jin-Ye/H-1450-2011
CR ARIYOSHI Y, 1993, TRENDS FOOD SCI TECH, V4, P139, DOI 10.1016/0924-2244(93)90033-7
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Coombes AGA, 2002, BIOMATERIALS, V23, P2113, DOI 10.1016/S0142-9612(01)00341-6
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P117
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   GREGORY SH, 1988, J LEUKOCYTE BIOL, V43, P67
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   Koller MR, 1998, BIOMATERIALS, V19, P1963, DOI 10.1016/S0142-9612(98)00101-X
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Mathiowitz E., 1991, WO Patent No, Patent No. [WO 91/06286, 9106286, 91/06286]
   RICH A, 1981, J CELL SCI, V50, P1
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Schoen F J, 1984, Cardiol Clin, V2, P717
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   WANG JY, 1991, J AGR FOOD CHEM, V39, P351, DOI 10.1021/jf00002a025
   WANG JY, 1991, AGR BIOL CHEM TOKYO, V55, P1531, DOI 10.1080/00021369.1991.10870822
NR 22
TC 145
Z9 154
U1 1
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 19
BP 4691
EP 4697
DI 10.1016/j.biomaterials.2003.10.084
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 817XY
UT WOS:000221211400020
PM 15120515
DA 2018-10-19
ER

PT J
AU Arciola, CR
   Campoccia, D
   Gamberini, S
   Donati, ME
   Montanaro, L
AF Arciola, CR
   Campoccia, D
   Gamberini, S
   Donati, ME
   Montanaro, L
TI Presence of fibrinogen-binding adhesin gene in Staphylococcus
   epidermidis isolates from central venous catheters-associated and
   orthopaedic implant-associated infections
SO BIOMATERIALS
LA English
DT Article
DE Staphylococcus epidermidis; adhesins; fibrinogen-binding protein;
   bacterial adhesion; biomaterial-associated infections
ID MOLECULAR CHARACTERIZATION; COLLAGEN-BINDING; CELL-WALL; AUREUS;
   PROTEIN; FIBRONECTIN; EXPRESSION; CLEAVAGE
AB Attention has recently been paid to identify and elucidate those pathogenetic mechanisms, which play a significant role in sustaining the early phases of Staphylococcus epidermidis colonisation and infection development. Several analogies with the physiology of Staphylococcus aureus, a more thoroughly investigated pathogen, have lead to carefully consider all bacterial surface components that mediate cell adhesion.
   This study aimed at investigating the presence of the fbe gene encoding for a fibrinogen-binding protein in a collection of 107 S. epidermidis strains isolated from orthopaedic infections and 67 from central venous catheter-associated infections. The strains isolated from orthopaedic infections were in large part associated to four different classes of orthopaedic devices, respectively: internal fixation devices. external fixation devices, knee arthroprostheses and hip arthroprostheses. The molecular epidemiology analysis performed by PCR enlightened a statistically significant difference in the prevalence of this adhesion mechanism between orthopaedic infections and catheter-related infections, respectively. of 78% and 91%. The prevalence of fbe ranged from 67% to 91%. suggesting that. even though this adhesin is not strictly necessary for the development of infection, nevertheless it represents a rather common characteristic of strains causing clinical infections, this independently on the presence or the absence of implant materials. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Rizzoli Orthoped Inst, Res Lab Biocompatibil Implant Mat, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
RP Montanaro, L (reprint author), Rizzoli Orthoped Inst, Res Lab Biocompatibil Implant Mat, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM lucio.montanaro@alma.unibo.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219; Donati, Maria
   Benedetta/0000-0003-1747-5443
CR Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200
   Cucarella C, 2002, INFECT IMMUN, V70, P3180, DOI 10.1128/IAI.70.6.3180-3186.2002
   HOLDERBAUM D, 1987, J CLIN MICROBIOL, V25, P2258
   Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198
   McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200
   McCrea KW, 2000, MICROBIOL-UK, V146, P1535, DOI 10.1099/00221287-146-7-1535
   MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x
   NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657
   Pei L, 1999, INFECT IMMUN, V67, P4525
   Pei L, 2001, J INFECT DIS, V184, P52, DOI 10.1086/321003
   Rice K, 2001, INFECT IMMUN, V69, P3791, DOI 10.1128/IAI.69.6.3791-3799.2001
   Thomas MG, 1999, J INFECT DIS, V179, P291, DOI 10.1086/314576
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 16
TC 24
Z9 24
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 19
BP 4825
EP 4829
DI 10.1016/j.biomaterials.2003.11.056
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 817XY
UT WOS:000221211400034
PM 15120529
DA 2018-10-19
ER

PT J
AU Simmons, CA
   Alsberg, E
   Hsiong, S
   Kim, WJ
   Mooney, DJ
AF Simmons, CA
   Alsberg, E
   Hsiong, S
   Kim, WJ
   Mooney, DJ
TI Dual growth factor delivery and controlled scaffold degradation enhance
   in vivo bone formation by transplanted bone marrow stromal cells
SO BONE
LA English
DT Article
DE alginate; mesenchymal stem cells; bone morphogenetic protein-2;
   transforming growth factor-beta 3; tissue engineering
ID MORPHOGENETIC PROTEIN-2; ALGINATE HYDROGELS; TGF-BETA; EXTRACELLULAR
   MATRICES; CALCIUM-SULFATE; DIFFERENTIATION; LOCALIZATION; REGENERATION;
   EXPRESSION; INJECTION
AB Supraphysiological concentrations of exogenous growth factors are typically required to obtain bone regeneration, and it is unclear why lower levels are not effective. We hypothesized that delivery of bone progenitor cells along with appropriate combinations of growth factors and scaffold characteristics would allow physiological doses of proteins to be used for therapeutic bone regeneration. We tested this hypothesis by measuring bone formation by rat bone marrow stromal cells (BMSCs) transplanted ectopically in SCID mice using alginate hydrogels. The alginate was gamma-irradiated to vary the degradation rate and then covalently modified with RGD-containing peptides to control cell behavior. In the same delivery vehicle, we incorporated bone morphogenetic protein-2 (BMP2) and transforming growth factor-beta (TGF-beta3), either individually or in combination. Individual delivery of BMP2 or TGF-beta3 resulted in negligible bone tissue formation up to 22 weeks, regardless of the implant degradation rate. In contrast, when growth factors were delivered together from readily degradable hydrogels, there was significant bone formation by the transplanted BMSCs as early as 6 weeks after implantation. Furthermore, bone formation, which appeared to occur by endochondral ossification, was achieved with the dual growth factor condition at protein concentrations that were more than an order of magnitude less than those reported previously to be necessary for bone formation. These data demonstrate that appropriate combinations of soluble and biomaterial-mediated regulatory signals in cell-based tissue engineering systems can result in both more efficient and more effective tissue regeneration. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biol & Mat Sci, Dent Bldg 5213,1011 N Univ Ave, Ann Arbor, MI 48109 USA.
EM mooneyd@umich.edu
RI Xu, Qingguo/C-1962-2014; Simmons, Craig/A-5880-2008
OI Xu, Qingguo/0000-0003-3191-0771; Simmons, Craig/0000-0001-7729-1772;
   Alsberg, Eben/0000-0002-3487-4625
FU NIDCR NIH HHS [T32-DE07057, R01-DE13033]
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Fried A, 1996, J CELL BIOCHEM, V61, P246
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P611, DOI 10.3109/17453679608997766
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Murashima Y, 2002, INT ENDOD J, V35, P768, DOI 10.1046/j.1365-2591.2002.00565.x
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   MURPHY WL, IN PRESS BIOMATERIAL
   NIELSEN HM, 1994, ACTA ORTHOP SCAND, V65, P37, DOI 10.3109/17453679408993715
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8
   Orsini G, 2004, J BIOMED MATER RES B, V68B, P199, DOI 10.1002/jbm.b.20012
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Raiche AT, 2004, BIOMATERIALS, V25, P677, DOI 10.1016/S0142-9612(03)00564-7
   Richardson TP, 2001, CRIT REV EUKAR GENE, V11, P47
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Sakou T, 1999, J BONE MINER RES, V14, P1145, DOI 10.1359/jbmr.1999.14.7.1145
   Schilephake H., 2002, INT J ORAL MAXILLOF, V31, P469, DOI DOI 10.1054/IJOM.2002.0244
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yu Y, 2002, J BIOMED MATER RES, V60, P392, DOI 10.1002/jbm.1289
NR 36
TC 290
Z9 300
U1 4
U2 48
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD AUG
PY 2004
VL 35
IS 2
BP 562
EP 569
DI 10.1016/j.bone.2004.02.027
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 842TO
UT WOS:000223027400028
PM 15268909
DA 2018-10-19
ER

PT J
AU Rizzi, G
   Scrivani, A
   Fini, M
   Giardino, R
AF Rizzi, G
   Scrivani, A
   Fini, M
   Giardino, R
TI Biomedical coatings to improve the tissue-biomaterial interface
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE biomaterial; surfaces; coatings; prostheses; tissue healing
ID IN-VITRO BEHAVIOR; EXTERNAL-FIXATION; SURFACE-ROUGHNESS; HYDROXYAPATITE
   PARTICLES; BIOACTIVE COATINGS; OSTEOPOROTIC BONE; TITANIUM; CELLS;
   OSTEOINTEGRATION; IMPLANTS
AB One of the most important factors determining the degree of tissue interaction of an implanted device is the property of its surface. Thus, great importance is given to chemical and morphological characteristics of biomaterial surfaces to improve biocompatibility, cell migration, proliferation and differentiation, mechanical stability and endogenous tissue ingrowth.
   In order to obtain new and healing stimulating properties, it is possible to apply a coating or more generally a surface treatment to the surface of a prosthetic device. One of the most versatile methods for coating is thermal spray technology. This paper considers the principle of thermal spray processes and their application in the biomedical field, namely the coatings used for orthopedic prostheses and dental implants. Among thermal spray processes, plasma spray as well as High Velocity Oxygen Fuel (HVOF) processes will be particularly considered and their most important aspects will be illustrated.
C1 Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, I-40136 Bologna, Italy.
   Natl Interuniv Assoc Sci & Technol Mat, INSTM, Florence, Italy.
   Biocoatings Srl, Rubbiano Solignano, Parma, Italy.
RP Giardino, R (reprint author), Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM roberto.giardino@ior.it
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570
CR BRACALI P, 1999, P 4 AITEM 1999 C BRE
   BRUNO MB, 2001, INT J ARTIF ORGANS, V24, P41
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2003, INT J ARTIF ORGANS, V26, P520
   Fini M, 2003, BIOMATERIALS, V24, P3183, DOI 10.1016/S0142-9612(03)00164-9
   Fischer EM, 2003, TISSUE ENG, V9, P1179, DOI 10.1089/10763270360728080
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Giavaresi G, 2003, INT J ARTIF ORGANS, V26, P774
   GROPPETTI R, 2004, 9 SEM M CER CELLS TI
   GROPPETTI R, 2004, IN PRESS GIB SIB NAT
   Heimann RB, 1996, PLASMA SPRAY COATING
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   *ISO, 13356 ISO
   IWASAKI Y, 2003, INT J ARTIF ORGANS, V6, P260
   Khor KA, 2004, BIOMATERIALS, V25, P1177, DOI 10.1016/j.biomaterials.2003.08.008
   Khor KA, 2003, BIOMATERIALS, V24, P2233, DOI 10.1016/S0142-9612(03)00027-9
   Khor KA, 2003, BIOMATERIALS, V24, P723, DOI 10.1016/S0142-9612(02)00404-0
   Khor KA, 2003, BIOMATERIALS, V24, P769, DOI 10.1016/S0142-9612(02)00413-1
   KI M, 1997, J CERAM SOC JPN, V105, P111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Martini D, 2003, BIOMATERIALS, V24, P1309, DOI 10.1016/S0142-9612(02)00508-2
   Massia SP, 2004, J BIOMED MATER RES A, V68A, P177, DOI 10.1002/jbm.a.20009
   Moroni A, 2001, J BONE JOINT SURG AM, V83A, P717, DOI 10.2106/00004623-200105000-00010
   Moroni A, 2002, J ORTHOP TRAUMA, V16, P189, DOI 10.1097/00005131-200203000-00009
   Nakashima A, 2003, INT J ARTIF ORGANS, V26, P200
   Pignatti G, 2003, Chir Organi Mov, V88, P369
   Reikeras A, 2003, ACTA ORTHOP SCAND, V74, P140, DOI 10.1080/00016470310013851
   Rickerby D. S., 1991, ADV SURFACE COATINGS
   RIZZI G, 2001, P BIOCERAMICS, V14
   RIZZI G, 2001, P INT SCH ADV MAT SC, P145
   RIZZI G, 2004, IN PRESS J APPL BIOM
   Ronold HJ, 2003, BIOMATERIALS, V24, P4559, DOI 10.1016/S0142-9612(03)00256-4
   Salernitano E, 2003, J Appl Biomater Biomech, V1, P3
   Sandrini E, 2003, J Appl Biomater Biomech, V1, P33
   Savarino L, 2003, J BIOMED MATER RES A, V66A, P652, DOI 10.1002/jbm.a.10018
   Scrivani A, 2003, J THERM SPRAY TECHN, V12, P504, DOI 10.1361/105996303772082242
   SCRIVANI A, 2001, P BIOCERAMICS, V14
   SCRIVANI A, 2000, P 2 COURS INT SUMM S, P124
   SIERRA RJ, 2004, CLIN ORTHOP RELAT R, V425, P200
   Stover MD, 2004, CLIN ORTHOP RELAT R, V418, P126
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Wen HB, 1997, J MATER SCI-MATER M, V8, P765, DOI 10.1023/A:1018512612695
   0904421
NR 50
TC 25
Z9 25
U1 1
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD AUG
PY 2004
VL 27
IS 8
BP 649
EP 657
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 857RI
UT WOS:000224135600002
PM 15478535
DA 2018-10-19
ER

PT J
AU Torricelli, P
   Fini, M
   Giavaresi, G
   Giardino, R
AF Torricelli, P
   Fini, M
   Giavaresi, G
   Giardino, R
TI In vitro models to test orthopedic biomaterials in view of their
   clinical application in osteoporotic bone
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE osteoporosis; biomaterial; cell cultures; osteoblasts
ID PRIMARY OSTEOBLAST CULTURES; OVARIECTOMIZED SHEEP; PROSTHETIC DEVICES;
   STAINLESS-STEEL; RAT MODEL; DONOR AGE; CELLS; HYDROXYAPATITE; IMPLANTS;
   SURFACE
AB The development of in vitro cell cultures, in association with in vivo experimentation, greatly improved the characterization of biomaterials for orthopedic devices before their clinical use. In recent years an increasing interest has arisen in the use of both pathological osteoblast cultures and animal models to perform in vitro and in vivo tests on biomaterial behavior. A growing number of prostheses, in fact, are implanted in osteoporotic patients, due to the increasing age of the population. Moreover, the presence of osteoporosis may affect bone-biomaterial osteointegration in these patients.
   The present paper is a literature review and, after a short description of in vitro studies for characterization of osteoblasts derived from osteoporotic bone, the results of in vitro studies on biomaterial biocompatibility and osteointegration rate in the presence of osteoporotic bone derived osteoblast cultures are reported. Pathological cell culture models are able to demonstrate the different behavior of osteoblasts in response to biomaterials, when comparing normal and pathological conditions.
C1 Ist Ortopedici Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, I-40136 Bologna, Italy.
   Univ Bologna, Chair Surg Pathophysiol, I-40126 Bologna, Italy.
RP Giardino, R (reprint author), Ist Ortopedici Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM roberto.giardino@ior.it
RI TORRICELLI, PAOLA/J-5298-2016; Fini, Milena/J-4808-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970; Fini, Milena/0000-0002-3732-3570;
   Giavaresi, Gianluca/0000-0001-7843-5969
CR An YH, 1999, ANIMAL MODELS ORTHOP, P39
   [Anonymous], 1994, 109936 ISO
   Bellino FL, 2000, MENOPAUSE, V7, P14, DOI 10.1097/00042192-200007010-00004
   Chan GK, 2002, GERONTOLOGY, V48, P62, DOI 10.1159/000048929
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   DAVIES JE, 1999, BONE ENG, P1
   Ding M, 2000, Acta Orthop Scand Suppl, V292, P1
   Fini M, 2000, INT J ARTIF ORGANS, V23, P275
   Fini M, 2004, J BIOMED MATER RES B, V71B, P30, DOI 10.1002/jbm.b.30068
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   Fini M, 2003, INT J ARTIF ORGANS, V26, P520
   Fini M, 2001, BIOMED PHARMACOTHER, V55, P213, DOI 10.1016/S0753-3322(01)00054-3
   Fini M, 2001, J BONE JOINT SURG BR, V83B, P139, DOI 10.1302/0301-620X.83B1.10162
   Fini M, 2000, J MATER SCI-MATER M, V11, P579, DOI 10.1023/A:1008932303913
   FINI M, 2000, J MATER SCI-MATER M, V11, P1
   Giavaresi G, 2001, J APPL ANIM RES, V20, P221, DOI 10.1080/09712119.2001.9706756
   Giavaresi G, 2001, INT J ARTIF ORGANS, V24, P814
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   Katzburg S, 1999, BONE, V25, P667, DOI 10.1016/S8756-3282(99)00225-2
   Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1
   Lill CA, 2000, J ORTHOP TRAUMA, V14, P559, DOI 10.1097/00005131-200011000-00007
   Lill CA, 2003, J ORTHOPAED RES, V21, P836, DOI 10.1016/S0736-0266(02)00266-8
   Marie PJ, 1999, HISTOL HISTOPATHOL, V14, P525, DOI 10.14670/HH-14.525
   MARIE PJ, 1993, J CLIN ENDOCR METAB, V77, P824, DOI 10.1210/jc.77.3.824
   MARIE PJ, 1989, J CLIN ENDOCR METAB, V69, P272, DOI 10.1210/jcem-69-2-272
   Martinez ME, 1999, BONE, V24, P203, DOI 10.1016/S8756-3282(98)00181-1
   Martinez P, 2001, BONE, V29, P35, DOI 10.1016/S8756-3282(01)00479-3
   MEUNIER PJ, 1979, OSTEOPOROSIS, V2, P27
   MODROWSKI D, 1992, J BONE MINER RES, V7, P961
   Motohashi M, 1999, ORAL SURG ORAL MED O, V87, P145, DOI 10.1016/S1079-2104(99)70264-7
   NEIDLINGERWILKE C, 1995, J BIOMECH, V28, P197
   NEWMAN E, 1995, BONE, V16, P277
   PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096
   Rocca M, 2001, INT J ARTIF ORGANS, V24, P649
   Torricelli P, 2000, J BIOMED MATER RES, V52, P177, DOI 10.1002/1097-4636(200010)52:1<177::AID-JBM23>3.0.CO;2-F
   Torricelli P, 2003, INT J ARTIF ORGANS, V26, P952
   Torricelli P, 2003, ARTIF CELL BLOOD SUB, V31, P263, DOI 10.1081/BIO-120023157
   Torricelli P, 2003, BIOMED PHARMACOTHER, V57, P57, DOI 10.1016/S0753-3322(02)00329-3
   Torricelli P, 2002, ARTIF CELL BLOOD SUB, V30, P219, DOI 10.1081/BIO-120004341
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
   Torricelli Paola, 2000, Artificial Cells Blood Substitutes and Immobilization Biotechnology, V28, P181, DOI 10.3109/10731190009118580
   WONG MM, 1994, OSTEOPOROSIS INT, V4, P21, DOI 10.1007/BF02352257
   Zhang H, 2004, J ORTHOPAED RES, V22, P30, DOI 10.1016/S0736-0266(03)00155-4
NR 46
TC 16
Z9 18
U1 0
U2 8
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD AUG
PY 2004
VL 27
IS 8
BP 658
EP 663
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 857RI
UT WOS:000224135600003
PM 15478536
DA 2018-10-19
ER

PT J
AU Fini, M
   Giavaresi, G
   Setti, S
   Martini, L
   Torricelli, P
   Giardino, R
AF Fini, M
   Giavaresi, G
   Setti, S
   Martini, L
   Torricelli, P
   Giardino, R
TI Current trends in the enhancement of biomaterial osteointegration:
   Biophysical stimulation
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE biomaterials; osteointegration; biophysical stimulation; pulsed
   electromagnetic fields; low intensity pulsed ultrasounds
ID PULSED ELECTROMAGNETIC-FIELDS; LOW-INTENSITY ULTRASOUND; OSTEOBLAST-LIKE
   CELLS; PLATELET-RICH PLASMA; POROUS-COATED IMPLANTS; TOTAL
   HIP-REPLACEMENT; IN-VITRO; BONE INGROWTH; TITANIUM IMPLANTS;
   STAINLESS-STEEL
AB To enhance bone implant osteointegration, many strategies for improving biomaterial properties have been developed which include optimization of implant material, implant design, surface morphology and osteogenetic coatings. Other methods that have been attempted to enhance endogenous bone healing around biomaterials are different forms of biophysical stimulations such as pulsed electromagnetic fields (PEMFs) and low intensity pulsed ultrasounds (LIPUS), which were initially developed to accelerate fracture healing. To aid in the use of adjuvant biophysical therapies in the management of bone-implant osteointegration, the present authors reviewed experimental and clinical studies published in the literature over the last 20 years on the combined use of biomaterials and PEMFs or LIPUS, and summarized the methodology, and the possible mechanism of action and effectiveness of the different biophysical stimulations for the enhancement of bone healing processes around bone implanted biomaterials.
C1 Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, I-40136 Bologna, Italy.
   IGEA Carpi, Modena, Italy.
   Univ Bologna, Fac Med, Chair Surg Pathophysiol, I-40126 Bologna, Italy.
RP Giardino, R (reprint author), Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM roberto.giardino@ior.it
RI TORRICELLI, PAOLA/J-5298-2016; Fini, Milena/J-4808-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970; Fini, Milena/0000-0002-3732-3570;
   Giavaresi, Gianluca/0000-0001-7843-5969
CR AARON RK, 2004, CLIN ORTHOP RELAT R, V419, P2
   ASCHERL R, 1985, BIOELECTROCH BIOENER, V14, P161, DOI 10.1016/0302-4598(85)85021-2
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243
   BRAGDON CR, 2003, CLIN ORTHOP RELAT R, V417, P50
   BRUNSKI JB, 1991, BONE-BIOMATERIAL INTERFACE, P391
   Buzza Edmur Pereira, 2003, Implant Dent, V12, P182
   CAPANNA R, 1994, CLIN ORTHOP RELAT R, P213
   Clarke SA, 2004, J BONE JOINT SURG BR, V86B, P126, DOI 10.1302/0301-620X.85B1.14175
   De Mattei M, 1999, BIOELECTROMAGNETICS, V20, P177, DOI 10.1002/(SICI)1521-186X(1999)20:3<177::AID-BEM4>3.0.CO;2-#
   Diniz P, 2002, BIOELECTROMAGNETICS, V23, P398, DOI 10.1002/bem.10032
   Doan N, 1999, J ORAL MAXIL SURG, V57, P409, DOI 10.1016/S0278-2391(99)90281-1
   Emami A, 1999, J ORTHOP TRAUMA, V13, P252, DOI 10.1097/00005131-199905000-00005
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   Fini M, 2002, J ORTHOP RES, V20, P756, DOI 10.1016/S0736-0266(01)00158-9
   Gebauer GP, 2002, J ORTHOPAED RES, V20, P587, DOI 10.1016/S0736-0266(01)00136-X
   Giavaresi G, 2002, INT J ARTIF ORGANS, V25, P806
   GLOWACKI J, 1991, BONE-BIOMATERIAL INTERFACE, P265
   GREENOUGH CG, 1992, J ORTHOPAED RES, V10, P256, DOI 10.1002/jor.1100100213
   Hadjiargyrou M, 1998, CLIN ORTHOP RELAT R, pS216, DOI 10.1097/00003086-199810001-00022
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   Hollinger JO, 1997, J HISTOTECHNOL, V20, P235, DOI 10.1179/his.1997.20.3.235
   Ijiri K, 1996, ANTICANCER RES, V16, P2853
   Jennissen HP, 2002, ANN NY ACAD SCI, V961, P139, DOI 10.1111/j.1749-6632.2002.tb03067.x
   Jensen TB, 2004, J ORTHOPAED RES, V22, P653, DOI 10.1016/j.orthres.2003.10.006
   KENNEDY WF, 1993, CLIN ORTHOP RELAT R, V286, P198
   Konrad K, 1996, CLIN RHEUMATOL, V15, P325, DOI 10.1007/BF02230352
   Korstjens CM, 2004, J ORTHOP RES, V22, P495, DOI 10.1016/j.orthres.2003.09.011
   Kronstrom M, 2001, INT J ORAL MAX IMPL, V16, P201
   Lavigne P, 2002, OSTEOARTHR CARTILAGE, V10, P898, DOI 10.1053/joca.2002.0846
   Li JK, 2003, BIOMATERIALS, V24, P2379, DOI 10.1016/S0142-9612(03)00033-4
   LIN FH, 1995, MED ENG PHYS, V17, P20, DOI 10.1016/1350-4533(95)90373-J
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P135, DOI 10.3109/17453678909149240
   Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417
   Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7
   Matsumoto H, 2000, CLIN ORAL IMPLAN RES, V11, P354, DOI 10.1034/j.1600-0501.2000.011004354.x
   Mayr E, 2001, J ORTHOP TRAUMA, V15, P407, DOI 10.1097/00005131-200108000-00005
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Nolte PA, 2001, J TRAUMA, V51, P693, DOI 10.1097/00005373-200110000-00012
   Ottani V, 2002, MICRON, V33, P121, DOI 10.1016/S0968-4328(01)00008-7
   Pazzaglia UE, 1998, ARCH ORTHOP TRAUM SU, V117, P279, DOI 10.1007/s004020050247
   Reher P, 2002, BONE, V31, P236, DOI 10.1016/S8756-3282(02)00789-5
   Reher P, 1999, CYTOKINE, V11, P416, DOI 10.1006/cyto.1998.0444
   RISPOLI FP, 1988, J BIOELECTRICITY, V7, P181, DOI 10.3109/15368378809027748
   Rocca M, 1998, INT J ARTIF ORGANS, V21, P553
   Rocca M, 2001, INT J ARTIF ORGANS, V24, P649
   Rubin C, 2001, J BONE JOINT SURG AM, V83A, P259, DOI 10.2106/00004623-200102000-00015
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   SHIMIZU T, 1988, J ORTHOPAED RES, V6, P248, DOI 10.1002/jor.1100060212
   Sollazzo V, 1997, BIOELECTROMAGNETICS, V18, P541, DOI 10.1002/(SICI)1521-186X(1997)18:8<541::AID-BEM2>3.3.CO;2-6
   SPADARO JA, 1990, J ORTHOPAED RES, V8, P685, DOI 10.1002/jor.1100080510
   STEINBERG GG, 1995, J ARTHROPLASTY, V10, P556, DOI 10.1016/S0883-5403(05)80163-9
   Tanzer M, 2001, J ORTHOPAED RES, V19, P195, DOI 10.1016/S0736-0266(00)00034-6
   Tanzer M, 1996, J ORTHOPAED RES, V14, P901, DOI 10.1002/jor.1100140609
   Tepper OM, 2004, FASEB J, V18, P1231, DOI 10.1096/fj.03-0847fje
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   Torricelli P, 2003, INT J ARTIF ORGANS, V26, P952
   Varani K, 2002, BRIT J PHARMACOL, V136, P57, DOI 10.1038/sj.bjp.0704695
   Wang FS, 2004, BONE, V35, P114, DOI 10.1016/j.bone.2004.02.012
   Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010
   Wilkinson JM, 2003, J BONE MINER RES, V18, P1995, DOI 10.1359/jbmr.2003.18.11.1995
   WILLMANN G, 2000, HIP INT, V10, P193
   Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202
   XIANG W, 1993, J ORAL MAXIL SURG, V51, P647, DOI 10.1016/S0278-2391(10)80264-2
NR 64
TC 15
Z9 19
U1 1
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD AUG
PY 2004
VL 27
IS 8
BP 681
EP 690
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 857RI
UT WOS:000224135600006
PM 15478539
DA 2018-10-19
ER

PT J
AU Longinotti, MP
   Corti, HR
AF Longinotti, MP
   Corti, HR
TI Electrical conductivity and complexation of sodium borate in trehalose
   and sucrose aqueous solutions
SO JOURNAL OF SOLUTION CHEMISTRY
LA English
DT Article
DE electrical conductivity; borate; sucrose; trehalose; speciation;
   friction mechanism
ID MOLECULAR-DYNAMICS; NMR-SPECTROSCOPY; BIOMATERIAL STABILIZATION;
   STABILITY-CONSTANTS; SUPERCOOLED LIQUIDS; GLASS-TRANSITION; SUGAR
   SYSTEMS; BORIC-ACID; ALPHA,ALPHA-TREHALOSE; MIXTURES
AB The formation equilibrium constants for the esterification reaction between sucrose or trehalose and borate ion have been determined by measuring the pH changes produced when the corresponding sugar is added to sodium borate solutions. The speciation of the ternary sugar - borate - water system was calculated from this equilibrium information and used to separate the contribution of each ionic species to the electrical conductivity of the system. From the analysis of the results it is concluded that, in the viscosity region studied, the complex borate - trehalose and borate - sucrose ions obey Walden's rule, while the behavior of the smaller borate ion is not clear. The dramatic difference of the infinite dilution molar conductivity, and consequently of the hydrodynamic radius, of the trehalose - and sucrose - borate ester ions is ascribed to the formation of an intramolecular diester in aqueous trehalose.
C1 Comis Nacl Energia Atom, Unidad Act Quim, RA-1650 Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, RA-1428 Buenos Aires, DF, Argentina.
RP Longinotti, MP (reprint author), Comis Nacl Energia Atom, Unidad Act Quim, Avda Gen Paz 1499, RA-1650 Buenos Aires, DF, Argentina.
CR BARTHEL J, 1980, J SOLUTION CHEM, V9, P209, DOI 10.1007/BF00648327
   BIRCH GG, 1985, CHEM SENSES, V10, P325, DOI 10.1093/chemse/10.3.325
   Bonanno G, 1998, J CHEM SOC FARADAY T, V94, P2755, DOI 10.1039/a804257h
   Conrad PB, 1999, J PHYS CHEM A, V103, P4049, DOI 10.1021/jp984102b
   CORTI H, 1980, J SOLUTION CHEM, V9, P617, DOI 10.1007/BF00649035
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9
   Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99
   EHLICH D, 1990, MACROMOLECULES, V23, P1600, DOI 10.1021/ma00208a008
   Engelsen SB, 2001, BIOPHYS CHEM, V93, P103, DOI 10.1016/S0301-4622(01)00215-0
   Goldfarb DL, 2001, J SOLUTION CHEM, V30, P307, DOI 10.1023/A:1010334021934
   Izutsu K, 2003, CHEM PHARM BULL, V51, P663, DOI 10.1248/cpb.51.663
   LAJUNEN K, 1986, FINN CHEM LETT, V13, P21
   Liu Q, 1997, J AM CHEM SOC, V119, P7851, DOI 10.1021/ja970798v
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   MESMER RE, 1972, INORG CHEM, V11, P537, DOI 10.1021/ic50109a023
   Miller DP, 1999, J PHYS CHEM B, V103, P10243, DOI 10.1021/jp984736i
   Miller DP, 2000, J PHYS CHEM B, V104, P10419, DOI 10.1021/jp000730t
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   Noel TR, 1996, J CHEM SOC FARADAY T, V92, P1921, DOI 10.1039/ft9969201921
   PAAL T, 1976, ACTA CHIM HUNG, V91, P393
   PANCOAST HM, 1980, HDB SUGARS
   RODRIGUEZRAPOSO R, 1994, 45 ANN M INT SOC EL
   ROSSLER E, 1990, PHYS REV LETT, V65, P1595, DOI 10.1103/PhysRevLett.65.1595
   SHENG SQ, 1995, BIOCHEM BIOPH RES CO, V215, P504, DOI 10.1006/bbrc.1995.2493
   Spiro M, 1984, PHYS METHODS CHEM
   STOKES RH, 1959, STRUCTURE ELECTROLYT
   Storey BT, 1998, CRYOBIOLOGY, V37, P46, DOI 10.1006/cryo.1998.2097
   Sweeton FH, 1974, J SOLUTION CHEM, V3, P191, DOI 10.1007/BF00645633
   VANDENBERG R, 1994, CARBOHYD RES, V253, P1, DOI 10.1016/0008-6215(94)80050-2
   VERCHERE JF, 1987, POLYHEDRON, V6, P1415, DOI 10.1016/S0277-5387(00)80903-1
NR 34
TC 20
Z9 20
U1 0
U2 16
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0095-9782
J9 J SOLUTION CHEM
JI J. Solut. Chem.
PD AUG
PY 2004
VL 33
IS 8
BP 1029
EP 1040
DI 10.1023/B:JOSL.0000048053.92048.7b
PG 12
WC Chemistry, Physical
SC Chemistry
GA 870NS
UT WOS:000225065300008
DA 2018-10-19
ER

PT J
AU Hodde, JP
   Suckow, MA
   Wolter, WR
   Hiles, MC
AF Hodde, JP
   Suckow, MA
   Wolter, WR
   Hiles, MC
TI Small intestinal submucosa does not promote PAIII tumor growth in
   Lobund-Wistar rats
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE metastasis; prostate cancer; graft; angiogenesis; biomaterial
ID EXTRACELLULAR-MATRIX; PROSTATE ADENOCARCINOMAS; REGENERATION; REPAIR;
   CANCER; CELLS
AB Background. Site-specific remodeling and angiogenesis are two observations associated with the use of small intestinal submucosa (SIS) as a tissue repair graft. Its angiogenic capacity has raised questions concerning its effect on tumor growth and metastasis in clinical tumor resection cases. The effect of SIS on the ability of neoplastic (prostate adenocarcinoma) cells to establish, grow, and metastasize was examined in Lobund-Wistar (L-W) rats.
   Materials and methods. In one study, SIS, expanded polytetrafluoroethylene (ePTFE), or human cadaveric dermis was placed in a subcutaneous pocket on the flank of L-W rats and immediately inoculated with PA-III cell suspension. Tumors were allowed to establish and metastasize for 5 weeks prior to sacrifice. Rate of tumor growth, tumor weight, and frequency of lung metastases were assessed. In a second study, SIS was placed in a resected tumor bed and tumors were allowed to recur. Rate of tumor growth, tumor weight, and frequency of lung metastases were assessed after 3 weeks.
   Results. ePTFE hastened the rate of formation of palpable tumors compared to controls and other materials; cadaveric dermis and SIS did not. No differences between materials were noted in final tumor weight nor in the frequency of metastasis to the lungs. Following surgical tumor resection, residual tumor cells led to recurrence of same-site tumors in all animals, but in the defects augmented with SIS, the tumors were significantly smaller than those which regrew in the resected, unaugmented group.
   Conclusions. This study demonstrates that SIS does not enhance tumor establishment, growth, or metastasis in de novo tumors. Furthermore, SIS appears to reduce the rate of tumor growth, but not metastasis, when applied in direct contact with a residual tumor bed in a rat model of prostate-related tumors. (C) 2004 Elsevier Inc. All rights reserved.
C1 Cook Biotech Inc, W Lafayette, IN USA.
   Univ Notre Dame, Lobund Inst, Notre Dame, IN 46556 USA.
RP Hodde, JP (reprint author), Cook Biotech Inc, 3055 Kent Ave, W Lafayette, IN USA.
EM hodde@cookbiotech.com
RI Suckow, Mark/C-2696-2014
OI Suckow, Mark/0000-0001-7317-697X
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Bello-DeOcampo D, 2003, CURR DRUG TARGETS, V4, P197, DOI 10.2174/1389450033491118
   Bellon JM, 1997, J BIOMATER APPL, V12, P121, DOI 10.1177/088532829701200203
   Brown-Etris M, 2002, WOUNDS, V14, P150
   Franklin M E Jr, 2002, Hernia, V6, P171
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hodde JP, 2001, WOUNDS, V13, P195
   Hurst RE, 2003, ANTICANCER RES, V23, P3119
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   Kropp BP, 2002, J UROLOGY, V168, P1742, DOI 10.1097/01.ju.0000028154.79247.ca
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Pollard M, 1992, J Cell Biochem Suppl, V16H, P84
   POLLARD M, 1979, J SURG ONCOL, V12, P371, DOI 10.1002/jso.2930120412
   POLLARD M, 1975, J NATL CANCER I, V54, P643
   Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   Zhang F, 2003, ANN PLAS SURG, V51, P488, DOI 10.1097/01.SAP.0000070648.65942.E6
NR 21
TC 9
Z9 9
U1 2
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD AUG
PY 2004
VL 120
IS 2
BP 189
EP 194
DI 10.1016/j.jss.2003.10.022
PG 6
WC Surgery
SC Surgery
GA 835RX
UT WOS:000222504300004
PM 15234212
DA 2018-10-19
ER

PT J
AU Goller, G
   Oktar, FN
   Ozyegin, LS
   Kayali, ES
   Demirkesen, E
AF Goller, G
   Oktar, FN
   Ozyegin, LS
   Kayali, ES
   Demirkesen, E
TI Plasma-sprayed human bone-derived hydroxyapatite coatings: effective and
   reliable
SO MATERIALS LETTERS
LA English
DT Article
DE human-derived hydroxyapatite; calcination; plasma spraying; bond
   coating; bone grafts; transmitting infectious diseases; economic
ID MECHANICAL-PROPERTIES; RECONSTRUCTION; COMPOSITES; DENTIN
AB Human bone-derived hydroxyapatite (HHA) was used as plasma-spraying powder in this study. The starting powder was derived with the calcination method as described in recent literature. There have been very few researchers who were seriously interested in calcined HHA as a grafting material. Instead, demineralized HHA (from other humans) was usually preferred among surgeons. This brings some possible danger of transmission of infectious diseases like hepatitis B and C, human immunodeficiency virus (HIV), and almost incurable prion diseases like Creutzfeldt-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE). Due to very high temperature application (850 degreesC), calcined HA seems to be safe and promising as an alternative product to other HA materials in the biomaterial market. As it is known, HA is very weak at load-bearing applications. To overcome this weakness, it is suggested to use it as a coating on metallic substrates. The HA plasma spraying process is a well-known process for such durable coatings. In addition, in order to gain higher strength, it is recommended to use a very thin bond-coating layer to prevent the mismatch of the thermal coefficients between metal and ceramic. Bond coatings are used very widely in industrial applications. Some biomedical bond-coating research has been conducted, but the reports are not yet commercialized. In this study, tensile strength, SEM and X-ray diffraction studies were performed. Bonding strength was found to be 6.91 MPa for nonbond-coated and 13.15 MPa for bond-coated HHA coatings. These results indicate that the application of bond coating with HHA had strengthened the structure of this material. The X-ray diffraction analysis showed a relatively high crystalline phase. SEM pictures indicate very good adhesion of the bond coating on the metal and on the main coating. The production of HHA with the calcination method is economic, and the resulting material (in combination with plasma spraying) can be used for bone grafting purposes. (C) 2004 Elsevier B.V. All rights reserved.
C1 Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
   Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Dept Dent Technol, Istanbul, Turkey.
RP Goller, G (reprint author), Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
EM goller@itu.edu.tr; foktar@gmx.net; ozyeginsevgi@yahoo.com;
   kayali@itu.edu.tr; demirkesen@itu.edu.tr
OI Goller, Gultekin/0000-0003-4680-3936
CR BERNECKER F, 1993, HNO, V41, P250
   BLAKESLEE S, 2000, NY TIMES        0523
   CANN AJ, 2001, PRINCIPLES MOL VIROL, P258
   Celik E, 1997, SURF COAT TECH, V97, P361, DOI 10.1016/S0257-8972(97)00383-6
   Clemens JAM, 1997, J BIOMED MATER RES, V36, P55, DOI 10.1002/(SICI)1097-4636(199707)36:1<55::AID-JBM7>3.0.CO;2-K
   Entezarian M, 1996, JOM-J MIN MET MAT S, V48, P53, DOI 10.1007/BF03222969
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Goller G, 2002, MATER LETT, V56, P142
   GREEN E, 2000, LA TIMES        0521
   HEDGES SJ, 2000, CHICAGO TRIBUNE 0522
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   HUTTENBRINK KB, 1993, HNO, V41, P440
   JOSHI SV, 1993, J MATER SCI-MATER M, V4, P251, DOI 10.1007/BF00122276
   LIN JHC, 1995, MATER CHEM PHYS, V41, P282
   Oktar FN, 2003, KEY ENG MAT, V240-2, P315, DOI 10.4028/www.scientific.net/KEM.240-242.315
   Oktar FN, 2002, CERAM INT, V28, P617, DOI 10.1016/S0272-8842(02)00017-2
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   OKTAR FN, 1999, THESIS BOGAZICI U IS, P26
   STEELMAN VM, 1999, AORN J, P1
   UZE M, 1992, P INT ENG DAYS BOG U, P239
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
NR 21
TC 48
Z9 49
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2004
VL 58
IS 21
BP 2599
EP 2604
DI 10.1016/j.matlet.2004.03.032
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 842PF
UT WOS:000223015700009
DA 2018-10-19
ER

PT J
AU Ozyegin, LS
   Oktar, FN
   Goller, G
   Kayali, ES
   Yazici, T
AF Ozyegin, LS
   Oktar, FN
   Goller, G
   Kayali, ES
   Yazici, T
TI Plasma-sprayed bovine hydroxyapatite coatings
SO MATERIALS LETTERS
LA English
DT Article
DE bovine derived hydroxyapatite; plasma spraying; bond-coating; economic
ID REINFORCED HYDROXYAPATITE; TITANIUM
AB With the increase in the life expectancy of humans, the maintenance of bone in our bodies has become crucial. Allografts extracted from different human and bovine sources bring the problem of potential disease transmittal, particularly the transmittal of disease that are difficult to detect. Autogen grafts bring another problem in surgery because the bone harvesting procedure creates cause for an additional surgery. In this study, the hydroxyapatite (HA) material was produced from bovine bones with the calcination method prohibits the transmission of various disease like mad cow disease (bovine spongiform encephalopathy (BSE)). In this study, the calcinated powder was used as plasma feeding powder for the plasma spraying process in biomedical applications. In industrial applications, the use of bond-coating prevents thermal coefficient mismatching and usually results in a stronger material. However, it was seen than bovine hydroxyapatite (BHA) was so strong that it does not need any bond-coating application. Nonetheless, bond-coating can be used to prevent the formation of micro-cracks. BHA material produced with the calcination method can be a very economic biomaterial for plasma spraying purposes when compared to other commercially available biomaterials. (C) 2004 Elsevier B.V. All rights reserved.
C1 Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Dept Dent Technol, Istanbul, Turkey.
   Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
EM ozyeginsevgi@yahoo.com; foktar@gmx.net; goller@itu.edu.tr;
   kayali@itu.edu.tr; tokayyazici@hotmail.com
OI Goller, Gultekin/0000-0003-4680-3936
CR Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Entezarian M, 1996, JOM-J MIN MET MAT S, V48, P53, DOI 10.1007/BF03222969
   Goldberg V M, 1993, Semin Arthroplasty, V4, P58
   Goller G, 2003, KEY ENG MAT, V240-2, P939
   Goller G, 2003, KEY ENG MAT, V240-2, P619
   Goller G, 2003, KEY ENG MAT, V240-2, P283
   HONG L, 1992, Journal of Biomedical Materials Research, V26, P7, DOI 10.1002/jbm.820260103
   Oktar FN, 2003, KEY ENG MAT, V240-2, P315, DOI 10.4028/www.scientific.net/KEM.240-242.315
   Oktar FN, 2003, KEY ENG MAT, V240-2, P327, DOI 10.4028/www.scientific.net/KEM.240-242.327
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   RITTER SK, CHEM ENG NEWS   0825
   TOMIN E, 2002, ARTHROPLAS ARTHROS S, V13, P114
   UZEL M, 1992, P INT ENG DAYS BOG U, P239
   Valerio P, 2004, KEY ENG MAT, V254-2, P837, DOI 10.4028/www.scientific.net/KEM.254-256.837
NR 14
TC 62
Z9 62
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2004
VL 58
IS 21
BP 2605
EP 2609
DI 10.1016/j.matlet.2004.03.033
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 842PF
UT WOS:000223015700010
DA 2018-10-19
ER

PT J
AU Shen, H
   Tan, J
   Saltzman, WM
AF Shen, H
   Tan, J
   Saltzman, WM
TI Surface-mediated gene transfer from nanocomposites of controlled texture
SO NATURE MATERIALS
LA English
DT Article
ID CHITOSAN-DNA NANOPARTICLES; DELIVERY; CELLS; EXPRESSION; COMPLEXES
AB Safe and efficient gene delivery would have great potential in gene therapy and tissue engineering, but synthetic biomaterial surfaces endowed with efficient gene-transferring functions do not yet exist. Inspired by naturally occurring biomineralization processes, we co-precipitated DNA with inorganic minerals onto cell-culture surfaces. The DNA/mineral nanocomposite surfaces obtained not only supported cell growth but also provided high concentrations of DNA in the immediate microenvironment of the cultured cells. Gene transfer from the engineered surfaces was as efficient as an optimized commercial lipid transfection reagent; in addition, the extent of gene transfer was adjustable by varying the mineral composition. DNA/mineral nanocomposite surfaces represent a promising system for enhancing gene transfer and controlling the extent of gene transfer for various biomedical applications, including tissue engineering or gene therapy of bone.
C1 Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
   Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
RP Saltzman, WM (reprint author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
EM mark.saltzman@yale.edu
FU NIDCR NIH HHS [DE14097]
CR BANYAY M, 2003, BIOPHYS CHEM, V404, P477
   Barralet JE, 2002, J BIOMED MATER RES, V60, P360, DOI 10.1002/jbm.10070
   Batard P, 2001, GENE, V270, P61, DOI 10.1016/S0378-1119(01)00467-X
   Bennett MJ, 1997, J MED CHEM, V40, P4069, DOI 10.1021/jm970155q
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   Lowenstam HA, 1989, BIOMINERALIZATION
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Matsumoto T, 2002, J BIOMED MATER RES, V60, P651, DOI 10.1002/jbm.10133
   Ngankam PA, 2000, J AM CHEM SOC, V122, P8998, DOI 10.1021/ja000783o
   Roy I, 2003, INT J PHARM, V250, P25, DOI 10.1016/S0378-5173(02)00452-0
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Shen H, 2003, J CONTROL RELEASE, V86, P339, DOI 10.1016/S0168-3659(02)00354-1
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647
   Uduehi AN, 1999, PHARMACEUT RES, V16, P1805, DOI 10.1023/A:1018986922710
NR 19
TC 156
Z9 160
U1 3
U2 46
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD AUG
PY 2004
VL 3
IS 8
BP 569
EP 574
DI 10.1038/nmat1179
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 842YL
UT WOS:000223040500024
PM 15258575
DA 2018-10-19
ER

PT J
AU Wang, YX
   Robertson, JL
   Spillman, WB
   Claus, RO
AF Wang, YX
   Robertson, JL
   Spillman, WB
   Claus, RO
TI Effects of the chemical structure and the surface properties of
   polymeric biomaterials on their biocompatibility
SO PHARMACEUTICAL RESEARCH
LA English
DT Review
DE biocompatibility; biomaterial; blood compatibility; cell adhesion;
   cytotoxicity; polymer; protein adsorption; surface property; tissue
   compatibility
ID SELF-ASSEMBLED MONOLAYERS; IMPROVED BLOOD COMPATIBILITY; PHOSPHOLIPID
   POLAR GROUPS; IN-VITRO CYTOTOXICITY; 4TH C4 COMPONENT; SEGMENTED
   POLYURETHANE; PROTEIN ADSORPTION; PLATELET-ADHESION; ENDOTHELIAL-CELLS;
   BIOMEDICAL APPLICATIONS
AB Polymeric biomaterials have extensively been used in medicinal applications. However, factors that determine their biocompatibility are still not very clear. This article reviews various effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility, including protein adsorption, cell adhesion, cytotoxicity, blood compatibility, and tissue compatibility. Understanding these aspects of biocompatibility is important to the improvement of the biocompatibility of existing polymers and the design of new biocompatible polymers.
C1 Virginia Tech, Fiber & Electroopt Res Ctr, Blacksburg, VA 24061 USA.
   Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
   Virginia Tech, Virginia Tech Appl Biosci Ctr, Blacksburg, VA 24061 USA.
RP Wang, YX (reprint author), Virginia Tech, Fiber & Electroopt Res Ctr, Blacksburg, VA 24061 USA.
EM youwang@vt.edu
CR Abraham GA, 2001, BIOMATERIALS, V22, P1971, DOI 10.1016/S0142-9612(00)00381-1
   ABSOLOM DR, 1983, T AM SOC ART INT ORG, V29, P146
   Akaike T., 1997, ADV POLYM BIOMATERIA
   Andrade J D, 1973, Med Instrum, V7, P110
   Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   Ashammakhi N, 1997, BIOMATERIALS, V18, P3, DOI 10.1016/S0142-9612(96)00107-X
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAKER PJ, 1975, J IMMUNOL, V114, P554
   Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K
   Benderly A.A, 1962, J APPL POLYM SCI, V6, P221
   Beverung CJ, 1998, BIOPHYS CHEM, V70, P121, DOI 10.1016/S0301-4622(97)00117-8
   Bowers R. W. J., 1994, US Patent, Patent No. [5,648,442, 5648442]
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   BROESTL JA, 1993, AM J PATHOL, V142, P529
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Brunette D.M., 1988, SURFACE CHARACTERIZA, P203
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   BURNHAM NL, 1994, AM J HOSP PHARM, V51, P210
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CAMPBELL EJ, 1994, ASAIO J, V40, P853
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   CHANG X, 1995, PHARM RES, V12, pS265
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   CHAPMAN D, 1993, BIOCHEM SOC T, V21, P259
   Chapman RG, 2000, LANGMUIR, V16, P6927, DOI 10.1021/la9915791
   CHENOWETH DE, 1987, BLOOD CONTACTS NATUR, P307
   CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U
   Cref R., 1994, SCIENCE, V263, P1600
   CREF R, 1995, ADV DRUG DEL REV, V16, P215
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dekie L, 2000, J CONTROL RELEASE, V65, P187, DOI 10.1016/S0168-3659(99)00235-7
   DEQUEIROZ AAA, 1997, THEOCHEM-J MOL STRUC, V394, P271
   DeRossi D, 1991, POLYM GELS FUNDAMENT
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   ESUMI K, 1983, J COLLOID INTERF SCI, V95, P102, DOI 10.1016/0021-9797(83)90077-2
   FerreiraGarcia E, 1997, POLIT EKON, V45, P46, DOI 10.18267/j.polek.266
   FERRUTI P, 1985, POLYMER, V26, P1336, DOI 10.1016/0032-3861(85)90309-X
   FERRUTI P, 1994, BIOMATERIALS, V15, P1235, DOI 10.1016/0142-9612(94)90275-5
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Fischer Dagmar, 1998, European Journal of Cell Biology, V75, P108
   GAO ZS, 1993, MACROMOLECULES, V26, P7353, DOI 10.1021/ma00078a035
   Gordon EJ, 1998, NATURE, V392, P30, DOI 10.1038/32073
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   HAMAD E, 1990, MACROMOLECULES, V23, P4185, DOI 10.1021/ma00221a001
   HAMAMOTO N, 1995, ARCH ORAL BIOL, V40, P97, DOI 10.1016/0003-9969(94)00153-3
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   Horbett TA, 1995, ACS S SERIES, V602
   HORROW JC, 1985, ANESTH ANALOG, V64, P221
   HSIUE GH, 1994, BIOMATERIALS, V15, P163
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Ishihara K, 1996, J BIOMED MATER RES, V32, P401, DOI 10.1002/(SICI)1097-4636(199611)32:3<401::AID-JBM13>3.0.CO;2-J
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   ISHIHARA K, 2001, J CONGESTIVE HEART C, V1, P265
   Iwasaki Y, 2000, J BIOMED MATER RES, V52, P701, DOI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   Jagur-Grodzinski J., 1997, HETEROGENEOUS MODIFI
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   KAELBLE DH, 1970, J ADHESION, V2, P50, DOI 10.1080/0021846708544579
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kim DT, 2002, LANGMUIR, V18, P5841, DOI 10.1021/la0256331
   Kim SY, 2003, BIOMATERIALS, V24, P55, DOI 10.1016/S0142-9612(02)00248-X
   KIM YH, 1990, MAKROMOL CHEM-M SYMP, V33, P319, DOI 10.1002/masy.19900330127
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   Koo LY, 2002, J CELL SCI, V115, P1423
   KORBELAR P, 1988, J BIOMED MATER RES, V22, P751, DOI 10.1002/jbm.820220902
   KRUKOWSKI M, 1990, J ORAL MAXIL SURG, V48, P468, DOI 10.1016/0278-2391(90)90233-R
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE JS, 1992, BIOMATERIALS, V13, P1025, DOI 10.1016/0142-9612(92)90154-G
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lewis AL, 2000, BIOMATERIALS, V21, P1847, DOI 10.1016/S0142-9612(00)00055-7
   Lin W, 1997, BIOMATERIALS, V18, P559, DOI 10.1016/S0142-9612(96)00176-7
   LOOS M, 1976, IMMUNOCHEMISTRY, V13, P789, DOI 10.1016/0019-2791(76)90202-0
   Lu D R, 1990, J Biomater Sci Polym Ed, V1, P243
   MAILLET F, 1990, TRANSFUS SCI, V11, P33, DOI 10.1016/0955-3886(90)90005-4
   MALMSTEN M, 1992, MACROMOLECULES, V25, P5440, DOI 10.1021/ma00046a049
   MATSUDA T, 1994, BIOMATERIALS, V15, P417, DOI 10.1016/0142-9612(94)90219-4
   MEUMER S, 1995, BLOOD, V86, P3452
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   MORGAN DML, 1989, J CELL SCI, V94, P553
   MORGAN DML, 1988, J CELL SCI, V91, P231
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Nagaoka S, 1992, KOBUNSHI RONBUNSHU, V39, P165
   Nagaoka S, 1990, J BIOACT COMPAT POLY, V5, P212
   NAIR PD, 1990, J POLYM SCI POL CHEM, V28, P3775, DOI 10.1002/pola.1990.080281320
   Noiset O, 1997, MACROMOLECULES, V30, P540, DOI 10.1021/ma960368+
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   Park H, 1996, PHARMACEUT RES, V13, P1770, DOI 10.1023/A:1016012520276
   Park JB, 1995, BIOMEDICAL ENG HDB, P530
   Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0
   Peppas NA, 1987, HYDROGELS MED PHARM
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Qin D, 1998, MICROSYST TECHNOL, P1
   RAEPPLE E, 1976, IMMUNOCHEMISTRY, V13, P251, DOI 10.1016/0019-2791(76)90223-8
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Ratner B. D., 1997, SURFACE MODIFICATION
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   RUCKENSTEIN E, 1986, BIOMATERIALS, V7, P403, DOI 10.1016/0142-9612(86)90028-1
   Ruiz L, 1998, BIOMATERIALS, V19, P987, DOI 10.1016/S0142-9612(97)00197-X
   RUIZ L, 1996, EC 95 P, P18
   Ryser H. J. P., 1967, NATURE, V215, P45
   SAWADA K, 1993, J BIOMED MATER RES, V27, P547, DOI 10.1002/jbm.820270416
   Sawada K, 1993, ASAIO J, V39, P910
   SCHAKENRAAD JM, 1989, BIOMATERIALS, V10, P43, DOI 10.1016/0142-9612(89)90008-2
   SCHAKENRAAD JM, 1986, ADV BIOMATER, V6, P263
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SCHOLZ C, 1995, MACROMOLECULES, V28, P7295, DOI 10.1021/ma00125a040
   SEIJO B, 1990, INT J PHARM, V62, P1, DOI 10.1016/0378-5173(90)90024-X
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   SINGH AK, 1992, BIOCHIM BIOPHYS ACTA, V1120, P337, DOI 10.1016/0167-4838(92)90257-E
   Smetana K, 1997, BIOMATERIALS, V18, P1009, DOI 10.1016/S0142-9612(97)00037-9
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   SMETANA K, 1993, J MATER SCI-MATER M, V4, P526, DOI 10.1007/BF00120134
   STRAUSBAUGH LJ, 1987, BRAIN RES, V409, P221, DOI 10.1016/0006-8993(87)90705-0
   Sugiyama K, 1996, KOBUNSHI RONBUNSHU, V53, P48, DOI 10.1295/koron.53.48
   TAKAKURA Y, 1994, INT J PHARM, V105, P19
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Teoh S.H., 1998, HDB BIOMATERIAL PROP, P270
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TSUTSUMI Y, 1995, J CONTROL RELEASE, V33, P447, DOI 10.1016/0168-3659(94)00121-A
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   VIENKEN J, 1995, ARTIF ORGANS, V19, P398, DOI 10.1111/j.1525-1594.1995.tb02349.x
   WEBSTER GF, 1981, INT ARCH ALLER A IMM, V66, P304, DOI 10.1159/000232834
   WESTERGREN I, 1993, ACTA PHYSIOL SCAND, V149, P99, DOI 10.1111/j.1748-1716.1993.tb09597.x
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, V2
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yeh EK, 1999, COLLOID SURFACE A, V156, P137, DOI 10.1016/S0927-7757(99)00065-5
   Yoneyama T, 1998, J BIOMED MATER RES, V43, P15, DOI 10.1002/(SICI)1097-4636(199821)43:1<15::AID-JBM2>3.0.CO;2-P
   Zhang SF, 1998, BIOMATERIALS, V19, P691, DOI 10.1016/S0142-9612(97)00174-9
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 151
TC 228
Z9 238
U1 6
U2 86
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
J9 PHARM RES
JI Pharm. Res.
PD AUG
PY 2004
VL 21
IS 8
BP 1362
EP 1373
DI 10.1023/B:PHAM.0000036909.41843.18
PG 12
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 843XG
UT WOS:000223119800005
PM 15359570
DA 2018-10-19
ER

PT J
AU Szarska, S
   Jungner, H
   Borsowska, A
AF Szarska, S
   Jungner, H
   Borsowska, A
TI Influence of ionizing radiation on biogel bone implants observed by
   luminescence measurements
SO RADIATION MEASUREMENTS
LA English
DT Article; Proceedings Paper
CT 5th European Conference on Luminescent Detectors and Transformers of
   Ionising Radiation (LUMDETR 2003)
CY SEP 01-05, 2003
CL Prague, CZECH REPUBLIC
SP Acad Sci Czech Republic, Inst Phys, Czech Tech Univ, Fac Nucl Sci & Phys Engn
DE biogel glass; luminescence; biomaterial
ID BIOACTIVE GLASSES
AB The preparation of sol-gel-derived bioactive glass thin films coated on glass is described. Biogel is one of the important modem materials, which are applied in medicine to reduce disability and thus to improve the level of human life. A patient with implanted biogel (i.e. bone, tooth) may be subjected to ionizing radiation during X-ray examination or treatment of cancer. Such an irradiation can generate electron and hole traps in the insulator surface layer. Changes in the microstructure of the biogel surface resulting from irradiation were observed using luminescence methods. Results from luminescence measurements after irradiation of a set of biogel samples are discussed in terms of point defects in the glass structure. (C) 2003 Published by Elsevier Ltd.
C1 Wroclaw Tech Univ, Inst Phys, PL-50370 Wroclaw, Poland.
   Univ Helsinki, Dating Lab, FIN-00014 Helsinki, Finland.
RP Szarska, S (reprint author), Wroclaw Tech Univ, Inst Phys, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM stanislawa.szarska@pwr.wroc.pl
CR Borsowska A, 2003, OPT APPL, V33, P107
   Botter-Jensen L, 2003, RADIAT MEAS, V37, P535, DOI 10.1016/S1350-4487(03)00020-9
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   Kawaguchi Y, 1996, PHYS REV B, V54, P9721, DOI 10.1103/PhysRevB.54.9721
   Kawazoe T, 1996, ANN I H POINCARE-PHY, V65, P1
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Padlyak B, 2000, OPT APPL, V30, P709
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   TRUKHIN AN, 1990, J NON-CRYST SOLIDS, V123, P250, DOI 10.1016/0022-3093(90)90791-J
NR 12
TC 1
Z9 1
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-4487
J9 RADIAT MEAS
JI Radiat. Meas.
PD AUG-DEC
PY 2004
VL 38
IS 4-6
SI SI
BP 497
EP 500
DI 10.1016/j.radmeas.2004.01.028
PG 4
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 853DV
UT WOS:000223807600037
DA 2018-10-19
ER

PT J
AU Wang, JW
   Hon, MH
AF Wang, JW
   Hon, MH
TI Synthesis and dynamic mechanical behavior of glucose-mediated
   poly(ethylene glycol/chitosan) membrane
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE chitosan; blending; glucose; glass transition; viscoelastic property
ID CHITOSAN; CULTURE
AB The pH-dependent chitosan/PEG membrane was prepared by a surface-mediated process with glucose as a source. Swelling study shows that the glucose-mediated membrane is more stable in a neutral environment than an acidic one and the stability in all soaking environments generally increases with increasing glucose concentration because of an increase in Schiff's reaction product as demonstrated by a mediated degree analysis. DMA analysis shows that as the glucose concentration increases, the rubber plateau of the glucose-mediated membrane is prolonged and keeps a higher storage modulus, and the tangent delta peak shifts to a high temperature as the temperature increases. In an isothermal mode, as the glucose concentration increases to 10 wt %, the storage modulus shows a small change in frequency dependence, indicating that the mediating effect is obviously affected by glucose addition. It can also be found that surface-mediated membrane has a higher complex viscosity than chitosan/PEG membrane at high frequencies. Thus, a new way was found to use glucose to produce stable biomaterial. (C) 2004 Wiley Periodicals, Inc.
C1 Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 70101, Taiwan.
   Chung Hwa Coll Med Technol, Dept Environm & Safety Engn, Tainan 717, Taiwan.
RP Wang, JW (reprint author), Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 70101, Taiwan.
EM jinwen.tw@yahoo.com.tw
CR AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   ARGUELLESMONAL W, 1998, POLYM GELS NETW, V6, P449
   DUMITRIU S, 1994, POLYM BIOMATERIALS
   Guan YL, 1996, J APPL POLYM SCI, V61, P2325, DOI 10.1002/(SICI)1097-4628(19960926)61:13<2325::AID-APP11>3.0.CO;2-3
   HOMMAN T, 1999, J FOOD TECHNOL, V209, P113
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   Kasapis S, 1995, INT J FOOD SCI TECH, V30, P693
   KLOKKEVOLD PR, 1992, J ORAL MAXIL SURG, V50, P41, DOI 10.1016/0278-2391(92)90194-5
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Ladizhansky V, 1998, J PHYS CHEM B, V102, P8505, DOI 10.1021/jp981711a
   Li Q, 1997, APPL PROPERTIES CHIT
   Martins S. I. F. S., 2001, Trends in Food Science & Technology, V11, P364, DOI 10.1016/S0924-2244(01)00022-X
   McCrum N. G., 1967, ANELASTIC DIELECTRIC
   Menard K. P., 1999, DYNAMIC MECH ANAL PR
   Muslim T, 2001, CARBOHYD POLYM, V46, P323, DOI 10.1016/S0144-8617(00)00331-3
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   Ross-Murphy S. B, 1994, PHYS TECHNIQUES STUD
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Sperling LH, 1993, INTRO PHYS POLYM SCI
   TRESSL R, 1998, J AGR FOOD CHEM, V43, P163
   VANKREVELIN, 1987, PROPERTIES POLYM
   Wang JW, 2003, J BIOMAT SCI-POLYM E, V14, P119, DOI 10.1163/156856203321142579
   YUKIO I, 1994, MAT SCI ENG C-BIO S, V1, P143
NR 24
TC 2
Z9 2
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 15
PY 2004
VL 93
IS 2
BP 809
EP 820
DI 10.1002/app.20525
PG 12
WC Polymer Science
SC Polymer Science
GA 820UL
UT WOS:000221414900046
DA 2018-10-19
ER

PT J
AU Zhu, BS
   Lu, QH
   Yin, J
   Hu, J
   Wang, ZG
AF Zhu, BS
   Lu, QH
   Yin, J
   Hu, J
   Wang, ZG
TI Effects of laser-modified polystyrene substrate on CHO cell growth and
   alignment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE laser; Chinese hamster ovary (CHO) cell; polystyrene; topography;
   hydrophilic; alignment
ID MULTIPLE GROOVED SUBSTRATA; TOPOGRAPHICAL CONTROL; POLYMER SURFACES;
   ADHESION; FIBROBLASTS; RADIATION; BEHAVIOR; GUIDANCE
AB Biomaterial surface chemistry and nanoscale topography of biomaterials can significantly influence cell behavior in vitro. Polystyrene (PS) Petri dishes were subjected to Nd:YAG laser irradiation at 266 nm, which resulted in well-defined three-dimensional (3D) periodic nanoscale surface topographies and surface oxidation. The surface changes were analyzed by X-ray photoelectron spectroscopy (XPS), atomic force microscopy (AFM), and a contact-angle goniometer. The samples were then used to investigate the cell behavior of Chinese hamster ovary (CHO) cells. The surface laser modification affected the CHO cell adhesion and alignment, and caused morphological changes in comparison with unmodified PS. The results obtained from the cell-behavior studies revealed that nanoscale hydrophilic surface topography cues affected the adhesion, extension, alignment, and morphology of cells. (C) 2004 Wiley Periodicals, Inc.
C1 Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
   Shanghai Jiao Tong Univ, BioX Life Sci Res Ctr, Shanghai 200030, Peoples R China.
RP Lu, QH (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
EM qhlu@sjtu.edu.cn
CR Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   BOLLE M, 1993, J APPL PHYS, V73, P3516, DOI 10.1063/1.352957
   BOLLE M, 1992, APPL PHYS LETT, V60, P674, DOI 10.1063/1.106588
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   HONG HL, 1987, J CELL SCI, V87, P259
   Kim KH, 2001, NUCL INSTRUM METH B, V175, P542, DOI 10.1016/S0168-583X(00)00650-9
   Klein CL, 1999, J MATER SCI-MATER M, V10, P721, DOI 10.1023/A:1008975105243
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Morra M, 2002, PLASMAS POLYM, V7, P89, DOI 10.1023/A:1016250718123
   MRKSICH M, 2000, CHEM SOC REV, V29, P276
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   ONYIRIUKA EC, 1994, J ADHES SCI TECHNOL, V8, P1, DOI 10.1163/156856194X00014
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Turner S, 1997, J VAC SCI TECHNOL B, V15, P2848, DOI 10.1116/1.589742
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   WEBB A, 1995, J CELL SCI, V108, P2747
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
NR 21
TC 36
Z9 39
U1 1
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL 15
PY 2004
VL 70B
IS 1
BP 43
EP 48
DI 10.1002/jbm.b.30011
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 834KJ
UT WOS:000222409700005
PM 15199582
DA 2018-10-19
ER

PT J
AU Tiainen, J
   Soini, Y
   Tormala, P
   Waris, T
   Ashammakhi, N
AF Tiainen, J
   Soini, Y
   Tormala, P
   Waris, T
   Ashammakhi, N
TI Self-reinforced polylactide/polyglycolide 80/20 screws take more than 1
   1/2 years to resorb in rabbit cranial bone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cranial bone; rabbit; SR-PLGA; tissue reaction; titanium
ID BIOABSORBABLE OSTEOFIXATION DEVICES; TISSUE-RESPONSE;
   CRANIOMAXILLOFACIAL SURGERY; FIXATION DEVICES; POLYGLYCOLIDE; POLYMER;
   ORTHOPEDICS; FRACTURES; IMPLANTS; PGA
AB The aim of this study was to assess tissue reactions to bioabsorbable self-reinforced polylactide/polyglycolide (SR-PLGA) 80/20 miniscrews in rabbit cranial bone. One PLGA screw was implanted on one side and one titanium screw on the other side of the sagittal suture (n = 21). Three animals were sacrificed after 2, 4, 8, 16, 24, 54, and 72 weeks. In histological examination the numbers of macrophages, giant cells, active osteoblasts, and fibrous tissue layers were assessed and degradation of the bioabsorbable screws was evaluated. After 2 weeks, macrophages were seen near the heads of both screws. After 4 and 8 weeks, the bioabsorbable screws were surrounded by fibrous tissue. Osteoblastic activity and groups of several giant cells were seen. After 24 weeks, a significant change in the morphology of the PLGA Screws had occurred. Osteoblastic activity and the amount of giant cells had decreased. After 1 year, some PLGA biomaterial was still present. PLGA screws had been replaced by adipose tissue, fibrous tissue, and "foamy macrophages" that had PLGA particles inside them. After 1 1/2 years, the amount of biomaterial remaining had decreased remarkably. The particles of biomaterial were inside foamy macrophages. SR-PLGA 80/20 screws are biocompatible and have no clinically manifested complications when used in the cranial bone of rabbits. No contraindications as regards their clinical use in craniofacial surgery was found when these screws were studied in the cranial bones of rabbits. (C) 2004 Wiley Periodicals, Inc.
C1 Oulu Univ Hosp, Dept Surg, Div Plast Surg, FIN-90014 Oulu, Finland.
   Oulu Univ, Dept Pathol, SF-90220 Oulu, Finland.
   Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland.
   Tampere Univ Hosp, Dept Surg, Tampere, Finland.
   Univ Tampere, FIN-33101 Tampere, Finland.
RP Tiainen, J (reprint author), Oulu Univ Hosp, Dept Surg, Div Plast Surg, POB 5000, FIN-90014 Oulu, Finland.
EM jtiainen@cc.oulu.fi
CR Ashammakhi N, 1997, BIOMATERIALS, V18, P3, DOI 10.1016/S0142-9612(96)00107-X
   Ashammakhi N, 2001, PLAST RECONSTR SURG, V108, P167, DOI 10.1097/00006534-200107000-00027
   Ashammakhi N, 1999, ANN CHIR GYNAECOL FE, V88, P313
   Ashammakhi NA, 1996, J BIOMED MATER RES, V33, P297, DOI 10.1002/(SICI)1097-4636(199624)33:4<297::AID-JBM10>3.0.CO;2-C
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   EPPLEY BL, 1995, PLAST RECONSTR SURG, V96, P316, DOI 10.1097/00006534-199508000-00009
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P116, DOI 10.1097/00001665-199703000-00010
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P103, DOI 10.1097/00001665-199703000-00008
   Habal MB, 1999, J CRANIOFAC SURG, V10, P491, DOI 10.1097/00001665-199911000-00008
   HOLLINGER JO, 1983, J BIOMED MATER RES, V17, P71, DOI 10.1002/jbm.820170107
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   KITCHELL JP, 1985, METHOD ENZYMOL, V112, P436
   LAM KH, 1993, J BIOMED MATER RES, V27, P1569, DOI 10.1002/jbm.820271214
   Nordstrom P, 1998, ARCH ORTHOP TRAUM SU, V117, P197, DOI 10.1007/s004020050229
   Peltoniemi H, 2002, ORAL SURG ORAL MED O, V94, P5, DOI 10.1067/moe.2002.122160
   PELTONIEMI H, 1997, J CRANIOFAC SURG, V6, P446
   Pietrzak WS, 1997, J CRANIOFAC SURG, V8, P87, DOI 10.1097/00001665-199703000-00004
   Rokkanen P, 1999, CURR ORTHOPAED, V13, P223, DOI 10.1016/S0268-0890(99)90007-5
   ROKKANEN P, 1990, ANN CHIR GYNAECOL FE, V79, P117
   Rokkanen PU, 1998, ANN CHIR GYNAECOL FE, V87, P13
   Serlo W, 2001, SCAND J PLAST RECONS, V35, P285
   Suuronen R, 2000, J Craniomaxillofac Trauma, V6, P19
   THERIN M, 1994, J BIOMED MATER RES, V28, P1267, DOI 10.1002/jbm.820281104
   Tormala P, 1998, P I MECH ENG H, V212, P101, DOI 10.1243/0954411981533872
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   VINCE D, 1991, BIOMATERIALS, P1
NR 26
TC 25
Z9 26
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL 15
PY 2004
VL 70B
IS 1
BP 49
EP 55
DI 10.1002/jbm.b.30013
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 834KJ
UT WOS:000222409700006
PM 15199583
DA 2018-10-19
ER

PT J
AU Yoo, WC
   Lee, JK
AF Yoo, WC
   Lee, JK
TI Field-dependent growth patterns of metals electroplated in nanoporous
   alumina membranes
SO ADVANCED MATERIALS
LA English
DT Article
ID GEL TEMPLATE SYNTHESIS; HIGH-ASPECT-RATIO; ANODIC ALUMINA; PULSED
   ELECTRODEPOSITION; NANOWIRE ARRAYS; FABRICATION; NANOSTRUCTURES;
   DEPOSITION; NANOTUBES; NANOPARTICLES
AB Over the past decade, the preparation and fabrication of nanostructured materials have attracted much interest for fundamental scientific research as well as industrial applications such as nanoelectric devices,([1]) high-density magnetic memories,([2]) high-performance catalysts,([3]) and biomaterial separation membranes.([4]) Among the various fabrication methods, the template method employing a nanoporous material as a reaction template is a very simple and facile approach because templates are well-defined and their lengths and diameters can be easily controlled.([5,6]) In particular, anodic aluminum oxide (AAO), which has nanometer-size channels (ca. 20-250 nm in diameter) with high pore density (up to 10(10) cm(-2)) and controllable channel length,([7,8]) has been used to prepare various nanoscaled materials such as nanorods, nanowires, and nanotubes of metals,([6.9]) semiconductors,([10]) ([11]) metal oxides, carbon nanotubes (CNTs)([12]), polymers,([13]) and some organic molecules.([14])
C1 Seoul Natl Univ, Sch Chem & Mol Engn, Seoul 151747, South Korea.
RP Lee, JK (reprint author), Seoul Natl Univ, Sch Chem & Mol Engn, Seoul 151747, South Korea.
EM jinklee@snu.ac.kr
CR ALMAWLAWI D, 1991, J APPL PHYS, V70, P4421, DOI 10.1063/1.349125
   Bao JC, 2001, ADV MATER, V13, P1631, DOI 10.1002/1521-4095(200111)13:21<1631::AID-ADMA1631>3.0.CO;2-R
   BRUMLIK CJ, 1991, J AM CHEM SOC, V113, P3174, DOI 10.1021/ja00008a057
   Cepak VM, 1999, CHEM MATER, V11, P1363, DOI 10.1021/cm9811500
   Choi J, 2003, CHEM MATER, V15, P776, DOI 10.1021/cm0208758
   Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a
   Hernandez BA, 2002, CHEM MATER, V14, P480, DOI 10.1021/cm010998c
   Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046
   Kim SW, 2002, J AM CHEM SOC, V124, P7642, DOI 10.1021/ja026032z
   Lakshmi BB, 1997, CHEM MATER, V9, P2544, DOI 10.1021/cm970268y
   Lee JK, 2002, CHEM COMMUN, P138, DOI 10.1039/b109881k
   Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396
   Lee W, 2002, ADV MATER, V14, P1187, DOI 10.1002/1521-4095(20020903)14:17<1187::AID-ADMA1187>3.0.CO;2-X
   Li J, 1998, CHEM MATER, V10, P1963, DOI 10.1021/cm980122e
   Martin BR, 1999, ADV MATER, V11, P1021, DOI 10.1002/(SICI)1521-4095(199908)11:12<1021::AID-ADMA1021>3.0.CO;2-S
   Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s
   Martin CR, 2001, ADV MATER, V13, P1351, DOI 10.1002/1521-4095(200109)13:18<1351::AID-ADMA1351>3.0.CO;2-W
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Masuda H., 1996, JPN J APPL PHYS, V35, P126
   MENON VP, 1995, ANAL CHEM, V67, P1920, DOI 10.1021/ac00109a003
   Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137
   Nielsch K, 2000, ADV MATER, V12, P582, DOI 10.1002/(SICI)1521-4095(200004)12:8<582::AID-ADMA582>3.3.CO;2-V
   PARTHASARATHY RV, 1995, ADV MATER, V7, P896, DOI 10.1002/adma.19950071103
   Sander MS, 2002, ADV MATER, V14, P665, DOI 10.1002/1521-4095(20020503)14:9<665::AID-ADMA665>3.0.CO;2-B
   Steinhart M, 2002, SCIENCE, V296, P1997, DOI 10.1126/science.1071210
   Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989
   Zhang Y, 2002, ADV MATER, V14, P1227, DOI 10.1002/1521-4095(20020903)14:17<1227::AID-ADMA1227>3.0.CO;2-2
NR 27
TC 104
Z9 109
U1 5
U2 103
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JUL 5
PY 2004
VL 16
IS 13
BP 1097
EP +
DI 10.1002/adma.200306595
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 842KO
UT WOS:000223003200009
DA 2018-10-19
ER

PT J
AU Fussell, GW
   Cooper, SL
AF Fussell, GW
   Cooper, SL
TI Synthesis and characterization of acrylic terpolymers with RGD peptides
   for biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE acrylic; RGD; vascular grafts; neutralization; chain transfer
ID ENDOTHELIAL-CELLS; VASCULAR GRAFTS; ATTACHMENT; ADHESION; BIOMATERIALS;
   FIBRONECTIN; RECEPTORS; POLYMERS; SURFACES
AB The goal of this research was to design a biomaterial, using acrylic terpolymers, which could support endothelial cells and function in small diameter vascular graft applications. Hexyl methacrylate (HMA) and octyl methacrylate (OMA) were used as comonomers to produce a material with a low glass transition temperature (T-g). Methacrylic acid (MAA) was used to provide ionic character. and methyl methacrylate (MMA) was selected because of its wide usage in biomedical applications. Cation neutralization was employed to modify the mechanical properties. RGD-based peptide sequences were attached to promote endothelial cell adhesion, because vascular grafts seeded with endothelial cells have fewer problems with thrombosis. The two methods used to incorporate peptide sequences were a chain transfer reaction during polymerization, and a coupling reaction attaching the peptides to carboxyl groups on the polymer after polymerization.
   The compositions that produced T(g)s of approximately 0degreesC were 75 mol% OMA and 92 mol% HMA. The Young's modulus of the HMA copolymer was approximately 0.37 MPa, well below the desired value of 0.9 MPa. Likewise, the Young's modulus of approximately 0.50 MPa for the OMA copolymer was also below the desired value. After partial neutralization with sodium cations, the Young's moduli increased to approximately 0.93 and 0.99 MPa, respectively. The chain transfer reaction lowered the molecular weights and mechanical properties of the copolymers, while the coupling reaction method had little effect on these properties. The chain transfer method appears to be a promising one-step method to produce polymers with a wide range of peptide concentrations. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
RP Fussell, GW (reprint author), Drexel Univ, 2710 Jacqueline Dr,Apt L-12, Wilmington, DE 19810 USA.
EM gwf25@drexel.edu; scooper@unity.ncsu.edu
FU NHLBI NIH HHS [HL57917]
CR Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Bos GW, 1999, J BIOMED MATER RES, V44, P330, DOI 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O
   Bowlin GL, 2001, J BIOMATER APPL, V16, P157, DOI 10.1106/NCQT-JFV9-2EQ1-EBGU
   BOYD KL, 1988, J BIOMED MATER RES, V22, P163, DOI 10.1002/jbm.820220302
   Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   BURKEL WE, 1987, ANN NY ACAD SCI, V516, P131, DOI 10.1111/j.1749-6632.1987.tb33036.x
   CARRUTHERS JDA, 1986, CAN J OPHTHALMOL, V21, P84
   Casazza E, 2002, POLYMER, V43, P1207, DOI 10.1016/S0032-3861(01)00722-4
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471
   COLEMAN MM, 1990, MACROMOLECULES, V23, P2339, DOI 10.1021/ma00210a033
   Coury Arthur J., 1996, P243
   DIDISHEIM P, 1996, BIOMATERIALS SCI INT, P283
   Fox T.G., 1956, B AM PHYS SOC, V1, P123
   FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Iayadene F, 1998, EUR POLYM J, V34, P219, DOI 10.1016/S0014-3057(97)00099-2
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Kerby RE, 2003, J ORAL REHABIL, V30, P780, DOI 10.1046/j.1365-2842.2003.01153.x
   KRALOVICH K, 2000, COMMUNICATION
   Krasia T, 2003, CHEM COMMUN, P538, DOI 10.1039/b212634f
   Lamba NMK, 1998, FRONTIERS TISSUE ENG, P121
   LAMBA NMK, 1999, TISSUE ENG VASCULAR, P553
   Ma YH, 2003, BIOMACROMOLECULES, V4, P864, DOI 10.1021/bm034118u
   MAZZUCOTELLI JP, 1994, INT J ARTIF ORGANS, V17, P112
   MILLERMJ, 1998, FRONTIERS TISSUE ENG, P213
   Murugesan G, 2000, J BIOMED MATER RES, V49, P396, DOI 10.1002/(SICI)1097-4636(20000305)49:3<396::AID-JBM13>3.0.CO;2-H
   NEMEC JW, 1985, ENCY POLYM SCI ENG, P201
   PAINTER PC, 1997, FUNDAMENTALS POLYM S, P478
   Parzuchowski PG, 2002, J AM CHEM SOC, V124, P12182, DOI 10.1021/ja020268l
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RAVVE A, 1995, PRINCIPLES POLYM CHE, P496
   Risbud MV, 2002, J BIOMAT SCI-POLYM E, V13, P1067, DOI 10.1163/156856202320813792
   ROBINS D, 1992, BR J THEATRE NURS, V12, P9
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   SAKARIASSEN KS, 1987, ANN NY ACAD SCI, V516, P52, DOI 10.1111/j.1749-6632.1987.tb33029.x
   Salacinski HJ, 2001, ARTIF ORGANS, V25, P974, DOI 10.1046/j.1525-1594.2001.06716.x
   SANK A, 1992, AM J SURG, V164, P199, DOI 10.1016/S0002-9610(05)81070-0
   SCHARF RE, 1987, BLUT, V55, P131, DOI 10.1007/BF00320567
   SZYMANSKI HA, 1968, NMR BAND HDB, P399
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   VANE JR, 1990, NEW ENGL J MED, V323, P27
   Williams DF, 1999, WILLIAMS DICT BIOMAT, P343
NR 45
TC 34
Z9 35
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2004
VL 25
IS 15
BP 2971
EP 2978
DI 10.1016/j.biomaterials.2003.09.062
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778CM
UT WOS:000189221600008
PM 14967529
DA 2018-10-19
ER

PT J
AU Murugan, R
   Ramakrishna, S
AF Murugan, R
   Ramakrishna, S
TI Coupling of therapeutic molecules onto surface modified coralline
   hydroxyapatite
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; polyglycidyl methacrylate; surface grafting; X-ray
   diffraction; drug delivery; in vitro test
ID GLYCIDYL METHACRYLATE; BONE REGENERATION; COMPOSITES;
   GLYCIDYLMETHACRYLATE; RELEASE; OSTEOMYELITIS; TETRACYCLINE; MEMBRANES;
   CERAMICS; DELIVERY
AB Surface modification and coupling of therapeutic molecules, tetracycline, onto coralline hydroxyapatite (CHA) and their in vitro evaluations were described in this study. Initially, CHA was graft polymerized with glycidylmethacrylate (GMA) using redox initiators and subsequently coupled to tetracycline through epoxy groups. The CHA grafted with polyGMA (CHA-g-PGMA) was characterized by Fourier transform infrared spectroscopy and powder X-ray diffraction (XRD) for proof of grafting. The absorption peaks pertaining to epoxy and ester carbonyl groups were observed for the graft polymer due to PGMA grafting. The XRD results signified that there was no secondary phase in the apatite lattice and crystallinity was also not affected by grafting, which suggested that the PGMA chains were grafted only on the surface of CHA. Drug loading and releasing was evaluated and found that CHA-g-PGMA exhibited higher loading efficiency than CHA. The in vitro release of tetracycline was performed in phosphate buffered saline under physiological condition and the release profiles showed that the tetracycline-containing graft polymer releases the drug for prolonged period as compared to CHA. Based on the experimental results, CHA-g-PGMA appears to be a promising biomaterial for drug delivery. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Natl Univ Singapore, Nanobioengn Lab, Div Bioengn, Dept Mech Engn, Singapore 117576, Singapore.
RP Murugan, R (reprint author), Natl Univ Singapore, Nanobioengn Lab, Div Bioengn, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
EM engmr@nus.edu.sg
RI Ramalingam, Murugan/C-9827-2010; Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR [Anonymous], 1980, 9432 JCPDS INT CTR D
   BAJPAI PK, 1992, BIOCERAMICS, P87
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DRURY G, 1980, J DENT RES, V59, P364
   Dupraz AMP, 1996, J BIOMED MATER RES, V30, P231, DOI 10.1002/(SICI)1097-4636(199602)30:2<231::AID-JBM13>3.0.CO;2-P
   Eckert AW, 2000, BIOMATERIALS, V21, P441
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   IPSEN T, 1991, ACTA ORTHOP SCAND, V62, P592, DOI 10.3109/17453679108994503
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   KIRKPATRICK DK, 1985, ORTHOPEDICS, V8, P1130
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   Merry JC, 1998, J MATER SCI-MATER M, V9, P779, DOI 10.1023/A:1008975507498
   Misra D. N., 1985, J DENT RES, V12, P1405
   Murugan R, 2003, KEY ENG MAT, V240-2, P51, DOI 10.4028/www.scientific.net/KEM.240-242.51
   Murugan R, 2003, MACROMOL RES, V11, P14, DOI 10.1007/BF03218272
   Murugan R, 2003, J BIOMAT SCI-POLYM E, V14, P457, DOI 10.1163/156856203766652066
   Murugan R, 2003, POLYM BULL, V49, P395, DOI 10.1007/s00289-002-0120-1
   Murugan R, 2002, MATER LETT, V57, P429, DOI 10.1016/S0167-577X(02)00805-4
   Murugan R, 2002, TRENDS BIOMATER ARTI, V16, P43
   ONO K, 1990, BIOMATERIALS, V11, P265
   Park YJ, 1997, J CONTROL RELEASE, V43, P151, DOI 10.1016/S0168-3659(96)01494-0
   Park YJ, 2000, J BIOMED MATER RES, V51, P391, DOI 10.1002/1097-4636(20000905)51:3<391::AID-JBM13>3.0.CO;2-9
   PAUL W, 2001, TRENDS BIOMATER ARTI, V14, P37
   PETTY W, 1978, J BONE JOINT SURG AM, V60, P752, DOI 10.2106/00004623-197860060-00004
   Ragel CV, 2000, J BIOMED MATER RES, V51, P424, DOI 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
   Rao K.P., 1969, LEATHER SCI, V16, P401
   SVEC F, 1981, ANGEW MAKROMOL CHEM, V99, P11, DOI 10.1002/apmc.1981.050990102
   WALSH WR, 1994, ANN BIOMED ENG, V22, P404, DOI 10.1007/BF02368247
   WANG M, 1994, BRIT CERAM T, V93, P91
   WEI GX, 1991, J BONE JOINT SURG BR, V73, P246
   WHALING H, 1978, J BONE JOINT SURG BR, V60, P270
   ZILCH H, 1986, ARCH ORTHOP TRAUM SU, V106, P36, DOI 10.1007/BF00435650
NR 33
TC 51
Z9 52
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2004
VL 25
IS 15
BP 3073
EP 3080
DI 10.1016/j.biomaterials.2003.09.089
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778CM
UT WOS:000189221600020
PM 14967541
DA 2018-10-19
ER

PT J
AU Drury, JL
   Dennis, RG
   Mooney, DJ
AF Drury, JL
   Dennis, RG
   Mooney, DJ
TI The tensile properties of alginate hydrogels
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; biomaterial design; mechanical tensile testing;
   polymer scaffold materials; Pronova MVG; Pronova MVM; FMC Protanal LF
   200S
ID POLY(ALDEHYDE GULURONATE) HYDROGELS; MECHANICAL-PROPERTIES;
   SKELETAL-MUSCLE; GEL BEADS; PART 1; TISSUE; CHONDROCYTES; CARTILAGE;
   SCAFFOLDS; DENSITY
AB Alginate hydrogels are currently being employed and explored for a broad range of medical applications including cell encapsulation, drug delivery.. and tissue engineering. In these capacities, knowledge of the mechanical and material properties of the hydrogels and the properties that govern and influence them is necessary to adequately design and effectively use these systems. Although much is known about the mechanical properties of alginate in compression and shear, little is known about the tensile characteristics. Thus, an extensive tensile assessment of alginate hydrogels was completed as a function of alginate type, formulation, gelling conditions, incubation, and strain rate. In general, the initial tensile behavior and properties of alginate hydrogels were highly dependent on the choice of the alginate polymer and how it was processed. Specifically, high guluronic acid containing alginate polymers yielded stronger, more ductile hydrogels than high mannuronic acid containing alginates. The ultimate stress, ultimate strain, and tensile modulus were decreased by increased phosphate concentrations, solution reconstitution with phosphate buffered saline instead of culture media, and peptide modification. Incubation of hydrogels for at least 7 days diminished many of the initial tensile property differences associated with formulation and gelling conditions. Overall, by controlling the specific alginate polymer and processing methods, a wide range of tensile properties are available from these hydrogels. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biol & Mat Sci, 1011 N Univ,Rm 5210 Dent, Ann Arbor, MI 48109 USA.
EM mooneyd@umich.edu
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Beer F.P., 1992, MECH MATER, P573
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   BLACK J, 1992, BIOL PERFORMANCE MAT, P73
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   de Chalain T, 1999, J BIOMED MATER RES, V44, P280, DOI 10.1002/(SICI)1097-4636(19990305)44:3<280::AID-JBM6>3.0.CO;2-H
   *DHHS, 2001 ANN REP US ORG
   Draget KI, 1996, CARBOHYD POLYM, V29, P209, DOI 10.1016/0144-8617(96)00029-X
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   Draget KI, 2000, INT J BIOL MACROMOL, V27, P117, DOI 10.1016/S0141-8130(00)00115-X
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Johnson FA, 1997, J PHARM PHARMACOL, V49, P639, DOI 10.1111/j.2042-7158.1997.tb06085.x
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2000, NATURE, V408, P998
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Lee KY, 2001, ADV MATER, V13, P837, DOI 10.1002/1521-4095(200106)13:11<837::AID-ADMA837>3.0.CO;2-D
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Okano T, 1998, CELL TRANSPLANT, V7, P71, DOI 10.1016/S0963-6897(97)00067-5
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   PARK JB, 2001, BIOMATERIALS INTRO, P185
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Rowley JA, 2002, ADV MATER, V14, P886, DOI 10.1002/1521-4095(20020618)14:12<886::AID-ADMA886>3.0.CO;2-I
   Serp D, 2002, BIOTECHNOL BIOENG, V79, P253, DOI 10.1002/bit.10287
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   VANDENBURGH HH, 1982, DEV BIOL, V93, P438, DOI 10.1016/0012-1606(82)90131-2
   VANDENBURGH HH, 1988, IN VITRO CELL DEV B, V24, P609
   West J, 1997, SYNTHETIC BIODEGRADA, P83
   Wong W.H., 1997, SYNTHETIC BIODEGRADA, P51
   Woo S.L, 1991, BASIC ORTHOPAEDIC BI, P199
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 44
TC 262
Z9 271
U1 13
U2 161
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2004
VL 25
IS 16
BP 3187
EP 3199
DI 10.1016/j.biomaterials.2003.10.002
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 800OV
UT WOS:000220038500008
PM 14980414
DA 2018-10-19
ER

PT J
AU Awad, HA
   Wickham, MQ
   Leddy, HA
   Gimble, JM
   Guilak, F
AF Awad, HA
   Wickham, MQ
   Leddy, HA
   Gimble, JM
   Guilak, F
TI Chondrogenic differentiation of adipose-derived adult stem cells in
   agarose, alginate, and gelatin scaffolds
SO BIOMATERIALS
LA English
DT Article
DE alginate; agarose; hydrogel; collagen; gelatin; cartilage tissue
   engineering; stem cell; differentiation
ID MESENCHYMAL PROGENITOR CELLS; ARTICULAR-CARTILAGE REPAIR; STROMAL CELLS;
   BONE-MARROW; IN-VITRO; EXTRACELLULAR-MATRIX; ALTERED MECHANICS;
   GENE-EXPRESSION; TISSUE; CHONDROCYTES
AB The differentiation and growth of adult stem cells within engineered tissue constructs are hypothesized to be influenced by cell-biomaterial interactions. In this study, we compared the chondrogenic differentiation of human adipose-derived adult stem (hADAS) cells seeded in alginate and agarose hydrogels, and porous gelatin scaffolds (Surgifoam), as well as the functional properties of tissue engineered cartilage constructs. Chondrogenic media containing transforming growth factor beta I significantly increased the rates of protein and proteoglycan synthesis as well as the content of DNA, sulfated glycosaminoglycans, and hydroxyproline of engineered constructs as compared to control conditions. Furthermore, chondrogenic culture conditions resulted in 86%. and 160% increases (p<0.05) in the equilibrium compressive and shear moduli of the gelatin scaffolds, although they did not affect the mechanical properties of the hydrogels over 28 days in culture. Cells encapsulated in the hydrogels exhibited a spherical cellular morphology, while cells in the gelatin scaffolds showed a more polygonal shape; however, this difference did not appear to hinder the chondrogenic differentiation of the cells. Furthermore, the equilibrium compressive and shear moduli of the gelatin scaffolds were comparable to agarose by day 28. Our results also indicated that increases in the shear moduli were significantly associated with increases in S-GAG content (R-2 = 0.36, p<0.05) and with the interaction between S-GAG and hydroxyproline (R-2 = 0.34 p<0.05). The findings of this study suggest that various biomaterials support the chondrogenic differentiation of hADAS cells, and that manipulating the composition of these tissue engineered constructs may have significant effects on their mechanical properties. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg, Durham, NC 27710 USA.
   Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Awad, Hani/G-6976-2014
OI Awad, Hani/0000-0003-2197-2610; Guilak, Farshid/0000-0001-7380-0330
FU NIAMS NIH HHS [AR49294]
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Awad HA, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P267
   Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1211, DOI 10.1177/002215540104901003
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   GUILAK F, 2001, CLIN ORTHOP S, V391, P295
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   LEDDY HA, 2003, SUM BIOENG C KEY BIS, P933
   Lee DA, 1998, J ORTHOP RES, V16, P726, DOI 10.1002/jor.1100160615
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   LeRoux MA, 2001, OSTEOARTHR CARTILAGE, V9, P633, DOI 10.1053/joca.2001.0432
   MACIEIRACOELHO A, 1990, J CELL PHYSIOL, V142, P610, DOI 10.1002/jcp.1041420322
   Majumdar MK, 2000, J CELL PHYSIOL, V185, P98
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Naughton G, 2001, NAT BIOTECHNOL, V19, P709, DOI 10.1038/90735
   Naughton GK, 2002, ANN NY ACAD SCI, V961, P372, DOI 10.1111/j.1749-6632.2002.tb03127.x
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Peng HR, 2003, CURR OPIN PHARMACOL, V3, P329, DOI 10.1016/S1471-4892(03)00051-1
   PESAKOVA V, 1990, FOLIA BIOL-PRAGUE, V36, P264
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2
   Setton LA, 1999, OSTEOARTHR CARTILAGE, V7, P2, DOI 10.1053/joca.1998.0170
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Wong M, 2001, J ORTHOPAED RES, V19, P493, DOI 10.1016/S0736-0266(00)90023-8
   Woolverton CJ, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P43
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 58
TC 497
Z9 526
U1 15
U2 258
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2004
VL 25
IS 16
BP 3211
EP 3222
DI 10.1016/j.biomaterials.2003.10.045
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 800OV
UT WOS:000220038500010
PM 14980416
DA 2018-10-19
ER

PT J
AU Holmes, RE
   Cohen, SR
   Cornwall, GB
   Thomas, KA
   Kleinhenz, KK
   Beckett, MZ
AF Holmes, RE
   Cohen, SR
   Cornwall, GB
   Thomas, KA
   Kleinhenz, KK
   Beckett, MZ
TI MacroPore resorbable devices in craniofacial surgery
SO CLINICS IN PLASTIC SURGERY
LA English
DT Article
ID POLY-L-LACTIDE; POLYLACTIC ACID MESH; IN-VIVO DEGRADATION;
   ILIAC-BONE-GRAFTS; TISSUE-RESPONSE; BIODEGRADABLE POLYMERS; INTERFERENCE
   SCREWS; POSTOPERATIVE PAIN; FRACTURE FIXATION; DURAL SUBSTITUTE
AB Resorbable polymer implants have become a compelling option in the treatment of acquired and congenital craniofacial deformities. The resorbable polylactide (PLa) and polyglycolide (PGa) polymers in particular have demonstrated excellent safety profiles in multiple in vitro, animal, and clinical studies and are currently being used in a wide variety of craniofacial applications. In this article, the authors discuss the biomaterial properties of PLa and PGa resorbable implants and provide an overview of the use of these polymers in craniofacial surgery. They conclude by relating their experience with an ongoing clinical series using MacroPore PLDLa and FRP implants for various applications, including Le Fort osteotomies, midface/monobloc internal distraction, and craniosynostosis reconstruction.
C1 Childrens Hosp San Diego, Craniofacial Surg Serv, San Diego, CA 92123 USA.
   MacroPore Biosurg Inc, San Diego, CA 92121 USA.
   Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.
RP Holmes, RE (reprint author), Childrens Hosp San Diego, Craniofacial Surg Serv, 8010 Frost St,412, San Diego, CA 92123 USA.
EM rholmes@sdfaces.com
CR Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bessho K, 1997, J ORAL MAXIL SURG, V55, P941, DOI 10.1016/S0278-2391(97)90065-3
   BESSHO K, 1997, J ORAL MAXILLOFAC SU, V55, P945
   BOS R, 1990, ORAL MAXILLOFACIAL C, V2, P745
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   BREKKE JH, 1983, ORAL SURG ORAL MED O, V56, P240, DOI 10.1016/0030-4220(83)90003-8
   Claes LE, 1996, BIOMATERIALS, V17, P1621, DOI 10.1016/0142-9612(95)00327-4
   Cohen SR, 2002, J CRANIOFAC SURG, V13, P578, DOI 10.1097/00001665-200207000-00021
   Cohen SR, 2001, J CRANIOFAC SURG, V12, P264, DOI 10.1097/00001665-200105000-00013
   Cohen SR, 2001, J CRANIOFAC SURG, V12, P596, DOI 10.1097/00001665-200111000-00019
   Coonts BA, 1998, J BIOMED MATER RES, V42, P303, DOI 10.1002/(SICI)1097-4636(199811)42:2<303::AID-JBM16>3.3.CO;2-Z
   CORDEWENER FW, 1995, J MATER SCI-MATER M, V6, P211, DOI 10.1007/BF00146858
   Cordewener FW, 1996, J ORAL MAXIL SURG, V54, P9, DOI 10.1016/S0278-2391(96)90292-X
   Cordewener FW, 1996, J ORAL MAXILLOFAC SU, V54, P13
   Cornier MA, 2002, OBES RES, V10, P1167, DOI 10.1038/oby.2002.158
   COWLEY SP, 1983, J BONE JOINT SURG AM, V65, P1023, DOI 10.2106/00004623-198365070-00022
   CUTRIGHT DE, 1971, ORAL SURG ORAL MED O, V31, P134, DOI 10.1016/0030-4220(71)90044-2
   CUTTING C, 1986, CLIN PLAST SURG, V13, P449
   DEMEDINACELI L, 1995, J RECONSTR MICROSURG, V11, P43, DOI 10.1055/s-2007-1006510
   Eppley BL, 1997, PLAST RECONSTR SURG, V100, P1, DOI 10.1097/00006534-199707000-00001
   Eppley BL, 2002, J CRANIOFAC SURG, V13, P650, DOI 10.1097/01.SCS.0000026428.32901.AD
   Eppley BL, 1997, PLAST RECONSTR SURG, V100, P8
   Epstein NE, 2003, J SPINAL DISORD TECH, V16, P20, DOI 10.1097/00024720-200302000-00004
   FINNEGAN MA, 1987, FRACTURE HEALING, P153
   FURNAS DW, 1991, P 2 INT C INT SOC CR, P77
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   GETTER L, 1972, J ORAL SURG, V30, P344
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   GUYURON B, 1989, J CRANIO MAXILL SURG, V17, P101, DOI 10.1016/S1010-5182(89)80079-4
   HAMAD MM, 1989, ARCH ORTHOP TRAUM SU, V108, P383, DOI 10.1007/BF00932452
   HARDY JH, 1977, CLIN ORTHOP RELAT R, P32
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   HOLMES RE, 2003, POLYLACTIDE FIXATION
   INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736
   KLEINSCHMIDT JC, 1993, PLAST RECONSTR SURG, V91, P581, DOI 10.1097/00006534-199304000-00002
   Koskikare K, 1997, ARCH ORTHOP TRAUM SU, V116, P352
   Kou JH, 1997, J CONTROL RELEASE, V43, P123, DOI 10.1016/S0168-3659(96)01477-0
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   KURZ LT, 1989, COMPLICATIONS SPINE, P323
   Leiggener C. S., 1998, J CRANIOMAXILLOFAC S, V26, P151
   LEVY FE, 1994, PLAST RECONSTR SURG, V93, P307, DOI 10.1097/00006534-199402000-00011
   LEVY FE, 1994, PLAST RECONSTR SURG, V93, P312
   LUNDGREN D, 1992, J CRANIO MAXILL SURG, V20, P257, DOI 10.1016/S1010-5182(05)80438-X
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   MAJOLA A, 1991, CLIN ORTHOP RELAT R, P260
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MAURER PK, 1985, J NEUROSURG, V63, P448, DOI 10.3171/jns.1985.63.3.0448
   MCMANUS AJ, 2003, T 29 ANN M SOC BIOM, P70
   Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MOSER RC, 2003, T 29 ANN M SOC BIOM
   NIEDERDELLMANN H, 1983, DTSCH Z MUND KIEFER, V7, P399
   NYILAS E, 1983, T AM SOC ART INT ORG, V29, P307
   OLSON RAJ, 1982, ORAL SURG ORAL MED O, V53, P441, DOI 10.1016/0030-4220(82)90453-4
   PARTIO EK, 1992, ACTA ORTHOP SCAND, V63, P170, DOI 10.3109/17453679209154816
   PARTIO EK, 1990, ACTA ORTHOP SCAND, V86
   Pihlajamaki H, 1997, BIOMATERIALS, V18, P1311, DOI 10.1016/S0142-9612(97)00068-9
   PISTNER H, 1993, BIOMATERIALS, V14, P671, DOI 10.1016/0142-9612(93)90066-B
   PREIN J, 1998, MANUAL INTERNAL FIXA
   Rokkanen P., 1996, J TRAUMA, V40, P123
   SECKEL BR, 1984, PLAST RECONSTR SURG, V74, P173, DOI 10.1097/00006534-198408000-00001
   Stahelin AC, 1997, ARTHROSCOPY, V13, P238, DOI 10.1016/S0749-8063(97)90162-6
   Stroman PW, 1999, MAGNET RESON MED, V42, P210, DOI 10.1002/(SICI)1522-2594(199907)42:1<210::AID-MRM29>3.0.CO;2-Q
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Suuronen R, 1998, J ORAL MAXIL SURG, V56, P604, DOI 10.1016/S0278-2391(98)90461-X
   SUURONEN R, 1992, J MATER SCI-MATER M, V3, P288, DOI 10.1007/BF00705295
   SUURONEN R, 1998, J ORAL MAXILLOFAC SU, V56, P614
   TORODE IP, 1994, J PEDIATR ORTHOPED, V14, P381, DOI 10.1097/01241398-199405000-00021
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   VANDERELST M, 1995, BIOMATERIALS, V16, P103, DOI 10.1016/0142-9612(95)98270-O
   VILJANEN J, 1995, BIOMATERIALS, V16, P1353, DOI 10.1016/0142-9612(95)91052-Z
   Wang MY, 2002, NEUROSURGERY, V51, P413, DOI 10.1227/01.NEU.0000019874.20153.AE
   Warden WH, 1999, ARTHROSCOPY, V15, P474, DOI 10.1053/ar.1999.v15.015047
   Yamada K, 1997, J NEUROSURG, V86, P1012, DOI 10.3171/jns.1997.86.6.1012
NR 79
TC 21
Z9 24
U1 1
U2 5
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0094-1298
J9 CLIN PLAST SURG
JI Clin. Plast. Surg.
PD JUL
PY 2004
VL 31
IS 3
BP 393
EP +
DI 10.1016/j.cps.2004.03.003
PG 15
WC Surgery
SC Surgery
GA 838XA
UT WOS:000222745500004
PM 15219746
DA 2018-10-19
ER

PT J
AU Jiang, Y
   Hou, QF
   Liu, BL
   Jian, S
   Lin, SC
AF Jiang, Y
   Hou, QF
   Liu, BL
   Jian, S
   Lin, SC
TI Platelet adhesive resistance of polyurethane surface grafted with
   zwitterions of sulfobetaine
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE polyurethane; sulfobetaine; zwitterions; blood compatibility; platelet
   adhesion; nonthrombogenic biomaterials
ID IMPROVING BLOOD COMPATIBILITY; POLY(ETHER URETHANE);
   CHEMICAL-MODIFICATION; VINYL MONOMER; COPOLYMERS; POLYMERS; FILM;
   HEMOCOMPATIBILITY
AB A possible approach to improve the blood compatibility of poly(etherurethane)s (PU) involves the covalent attachment of key molecular on its surface. Recently, polymer tailed with zwitterions was found having good blood compatibility. The purpose of present study was to design and synthesis a novel nonthrombogenic biomaterial by modifying the surface of poly(etherurethane) with zwitterions of sulfobetaine via HDI spacer.
   The films of polyurethane were grafted with sulfobetaine by a three-step procedure. In the first step, the film surfaces were treated with hexamethylene diisocyanate (HDI) in toluene at 50degreesC in the presence of di-n-butyl tin dilaurate(DBTDL) as a catalyst. The extent of the reaction was measured by ATR-IR spectra; a maximum number of free NCO group was obtained after a reaction time of 2.5 h. In the second step, the primary amine group of N,N-diethylethylenediamine (DEA) or N,N-dimethylethylenediamine (DMA) was allowed to react in toluene with isocyanate groups bound on surface. In the third step, two kinds of sulfobetaines were formed in the surface through the ring-opening reaction between tertiary amine of DMA or DEA and 1,3-propanesultone (PS).
   The reaction process was monitored with ATR-IR spectra and XPS spectra. The wettability of films was investigated by water contact angle measurement. A platelet adhesion experiment was conducted as a preliminary test to confirm the improved blood compatibility of PU. The number of platelets adhering to PU decreased greatly compared to original after I h and 3 h of contact with human plate-rich plasma. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanjing Univ, Coll Chem & Chem Engn, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Coll Chem & Chem Engn, Nanjing 210093, Peoples R China.
EM alchem@eyou.com
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Chen Z, 2000, J APPL POLYM SCI, V76, P382, DOI 10.1002/(SICI)1097-4628(20000418)76:3<382::AID-APP13>3.0.CO;2-A
   CHRISTINA FL, 1993, J APPL POLYM SCI, V50, P345
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   HUANG ZX, 1983, KEXUE TONGBAO, V28, P632
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   LELAH MD, 1996, POLYETHERURETHANE ME, P57
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Liaw DJ, 2000, POLYMER, V41, P6123, DOI 10.1016/S0032-3861(99)00824-1
   Lin JC, 2001, J MATER SCI-MATER M, V12, P827, DOI 10.1023/A:1017937304964
   Lin S. C., 1998, CHIN POLYM B, V1, P1
   Lowe AB, 2000, J BIOMED MATER RES, V52, P88, DOI 10.1002/1097-4636(200010)52:1<88::AID-JBM11>3.0.CO;2-#
   Lowe AB, 2002, CHEM REV, V102, P4177, DOI 10.1021/cr020371t
   MCCORMICK CL, 1992, POLYMER, V33, P4617, DOI 10.1016/0032-3861(92)90422-S
   Monroy V.M., 1984, POLYMER, V25, P121
   MONROYSOTO VM, 1984, POLYMER, V25, P254
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   SALAMONE JC, 1977, POLYMER, V18, P1058, DOI 10.1016/0032-3861(77)90013-1
   Wang DA, 2001, BIOMATERIALS, V22, P1549, DOI 10.1016/S0142-9612(00)00311-2
   Yuan J, 2003, J BIOMAT SCI-POLYM E, V14, P1339, DOI 10.1163/156856203322599680
   Yuan J, 2003, POLYM INT, V52, P1869, DOI 10.1002/pi.1277
   Yuan J, 2003, J BIOMATER APPL, V18, P123, DOI 10.1177/088532803038100
   Yuan J, 2003, CHINESE J POLYM SCI, V21, P419
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   Yuan J, 2003, COLLOID SURFACE B, V30, P147, DOI 10.1016/S0927-7765(03)00082-1
   YUAN J, 2004, IN PRESS POLYM INT
   YUAN J, 2004, IN PRESS COLLOIDS B
   [袁江 Yuan Jiang], 2003, [应用化学, Chinese Journal of Applied Chemistry], V20, P269
   Yuan YL, 2004, POLYM INT, V53, P121, DOI 10.1002/pi.1122
   Yuan YL, 2002, J BIOMAT SCI-POLYM E, V13, P1081, DOI 10.1163/156856202320813800
   YUAN YL, 2003, BIOINTERF, V29, P247
   Zhang J, 2003, COLLOID SURFACE B, V30, P249, DOI 10.1016/S0927-7765(03)00069-9
   Zhang J, 2003, BIOMATERIALS, V24, P4223, DOI 10.1016/S0142-9612(03)00365-X
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   Zhang J, 2003, EUR POLYM J, V39, P847, DOI 10.1016/S0014-3057(02)00286-0
   Zhou J, 2002, CHEM J CHINESE U, V23, P2393
NR 43
TC 8
Z9 10
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2004
VL 36
IS 1
BP 19
EP 26
DI 10.1016/j.colsurfb.2004.03.016
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 838XW
UT WOS:000222747800003
PM 15261019
DA 2018-10-19
ER

PT J
AU Mihara, E
   Shimizu, M
   Touge, C
   Inoue, Y
AF Mihara, E
   Shimizu, M
   Touge, C
   Inoue, Y
TI Case of a large, movable bacterial concretion with biofilm formation on
   the ocular surface
SO CORNEA
LA English
DT Article; Proceedings Paper
CT 39th Annual Meeting of the Japanese-Association-for-Ocular-Infection
CY 2002
CL JAPAN
SP Japanese Assoc Ocular Infection
DE biofilm; biomaterial; necrotizing scleritis; bacterial concretion;
   Corynebacterium
ID CRYSTALLINE KERATOPATHY; INFECTIOUS SCLERITIS; PTERYGIUM EXCISION
AB Objective: To report a case with a large movable bacterial concretion formed on the ocular surface without biomaterials.
   Methods: Interventional case report. A 74-year-old woman with left eye pain and injection was referred to us. She had a past history of scleral patch graft for necrotizing scleritis after pterygium removal and mitomycin C instillation on her left eye 7 years before. On present examination, a 2.5- to 3.0-mm yellowish-white calcification-like mass was present on the nasal sclera and cornea, and it moved slightly with blinking. The anterior chamber was shallow, and cornea was suspected to be perforated under this object.
   Results: This yellowish-white mass was surgically removed. Pathologic examination demonstrated that the specimen was not a calcification but a biofilm formation by many gram-positive bacilli with neutrophils. Corynebacterium was highly suspected as the causative agent of this unusual mass because of the earlier culture of the discharge before referral.
   Conclusion: The current case demonstrates that bacterial biofilms can be formed on the ocular surface without the involvement of biomaterials.
C1 Tottori Univ, Fac Med, Div Ophthalmol & Vis Sci, Yonago, Tottori 6838504, Japan.
   Shimizu Ophthalm Hosp, Matsue, Shimane, Japan.
RP Inoue, Y (reprint author), Tottori Univ, Fac Med, Div Ophthalmol & Vis Sci, 36-1 Nishimachi, Yonago, Tottori 6838504, Japan.
EM yoinoue@grape.med.tottori-u.ac.jp
CR ELDER MJ, 1995, EYE, V9, P102, DOI 10.1038/eye.1995.16
   Fulcher TP, 2001, OPHTHALMOLOGY, V108, P1088, DOI 10.1016/S0161-6420(01)00561-9
   Georgiou T, 2002, EYE, V16, P89, DOI 10.1038/sj/EYE/6700020
   HOLLAND SP, 1991, OPHTHALMOLOGY, V98, P933
   Hsiao CH, 1998, BRIT J OPHTHALMOL, V82, P29, DOI 10.1136/bjo.82.1.29
   Huang FC, 2000, CORNEA, V19, P34, DOI 10.1097/00003226-200001000-00008
   MAZA MSD, 1993, DOC OPHTHALMOL, V83, P33
   Sugita J, 2001, CORNEA, V20, P362, DOI 10.1097/00003226-200105000-00005
   WATSON PG, 1976, BRIT J OPHTHALMOL, V60, P163, DOI 10.1136/bjo.60.3.163
NR 9
TC 5
Z9 6
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0277-3740
J9 CORNEA
JI Cornea
PD JUL
PY 2004
VL 23
IS 5
BP 513
EP 515
DI 10.1097/01.ico.0000114838.91149.6d
PG 3
WC Ophthalmology
SC Ophthalmology
GA 833MJ
UT WOS:000222341200016
PM 15220738
DA 2018-10-19
ER

PT J
AU Magnani, A
   Barbucci, R
   Lamponi, S
   Chiumento, A
   Paffetti, A
   Trabalzini, L
   Martelli, P
   Santucci, A
AF Magnani, A
   Barbucci, R
   Lamponi, S
   Chiumento, A
   Paffetti, A
   Trabalzini, L
   Martelli, P
   Santucci, A
TI Two-step elution of human serum proteins from different glass-modified
   bioactive surfaces: A comparative proteomic analysis of adsorption
   patterns
SO ELECTROPHORESIS
LA English
DT Article
DE glass-modified bioactive surface; human plasma; hyaluronic acid;
   two-dimensional electrophoresis
ID SULFATED HYALURONIC-ACID; HIGH-DENSITY-LIPOPROTEINS; TYROSINE
   PHOSPHORYLATION; BIOLOGICAL CHARACTERIZATION; BIOMATERIAL SURFACES;
   POLYMER SURFACES; AQUEOUS-SOLUTION; PLASMA-PROTEINS; CELL BEHAVIOR;
   IN-VITRO
AB Plasma protein adsorption patterns on surfaces may give vital information to evaluate biocompatibility of biomaterials designed for direct blood-contacting applications or tissue integration. Adsorption of human serum proteins on four different types of biomaterials (glass, aminosilanized glass, hyaluronan and sulfated hyaluronan) was analyzed by two-dimensional electrophoresis. Desorption of proteins from the surfaces was first classically achieved by sodium dodecyl sulfate (SDS) elution. We introduced a second elution step (by use of isoelectric focusing (IEF) sample buffer consisting of urea, 3-[(3-cholamidopropyl)dimethylammonio]-1-propansulfonate, and dithioerythritol) which allows more stringent elution conditions and is a tool to evaluate the protein adsorption strength to biomaterials. Moreover, the two-step elution may discriminate between irreversible and reversible adsorption of plasma proteins for biomaterials, thus helping to elucidate the structure of protein multilayers which form a complex system at the surfaces. The IEF sample buffer proved not to alter the biomaterial structure and integrity. Hydrophobic bonds resulted to be the main strength driving protein adsorption onto our biomaterials. Apolipoproteins were the most important proteins interacting with the surfaces suggesting that high-density lipoprotein (HDL) particles could play a role in biocompatibility due to their beneficial effects on endothelial cells.
C1 Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy.
   Univ Siena, Dipartimento Sci & Tecnol Chim & Biosistemi, I-53100 Siena, Italy.
RP Santucci, A (reprint author), Univ Siena, Dipartimento Biol Mol, Via Fiorentina 1, I-53100 Siena, Italy.
EM santucci@unisi.it
RI Magnani, Agnese/E-7999-2017; Santucci, Annalisa/K-1932-2018
OI Santucci, Annalisa/0000-0001-6976-9086; Trabalzini,
   Lorenza/0000-0002-0850-7186; Magnani, Agnese/0000-0002-6960-9418
CR Abatangelo G, 1997, BIOMATERIALS, V18, P1411, DOI 10.1016/S0142-9612(97)00089-6
   Acton SL, 1999, MOL MED TODAY, V5, P518, DOI 10.1016/S1357-4310(99)01600-7
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   BARBUCCI R, 1994, J MATER SCI-MATER M, V5, P830, DOI 10.1007/BF00213143
   BARBUCCI R, 1995, GAZZ CHIM ITAL, V125, P169
   Barbucci R, 2002, BIOMOL ENG, V19, P161, DOI 10.1016/S1389-0344(02)00022-9
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BLUNK T, 1993, ELECTROPHORESIS, V14, P1382, DOI 10.1002/elps.11501401214
   BORNZIN GA, 1982, J COLLOID INTERF SCI, V86, P539, DOI 10.1016/0021-9797(82)90098-4
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   BURGHARDT TP, 1981, BIOPHYS J, V33, P455, DOI 10.1016/S0006-3495(81)84906-5
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   DAY A, IN PRESS JBC
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   EVANKO SP, INTRACELLULAR HYALUR
   Gallardo-Moreno AM, 2002, APPL ENVIRON MICROB, V68, P5784, DOI 10.1028/AEM.68.11.5784-5787.2002
   GENDREAU RM, 1986, SPECTROSC-BIOMED APP, P21
   Gessner A, 2002, EUR J PHARM BIOPHARM, V54, P165, DOI 10.1016/S0939-6411(02)00081-4
   Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371
   Greco RM, 1998, J CELL PHYSIOL, V177, P465, DOI 10.1002/(SICI)1097-4652(199812)177:3<465::AID-JCP9>3.0.CO;2-5
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   GUAN JL, 1991, CELL REGUL, V2, P951
   Hascall VC, 1997, HYALURONAN STRUCTURE
   HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORWITZ AF, 1997, SCIENZE, P347
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   JONSSON U, 1987, J COLLOID INTERF SCI, V117, P127, DOI 10.1016/0021-9797(87)90175-5
   KAESMO B, 1999, ADV DENT RES, V13, P8
   KNUDSON W, HYALURONAN RECEPTOR
   KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392
   LENK TJ, 1989, J BIOMED MATER RES, V23, P549, DOI 10.1002/jbm.820230603
   MACRITCHIE F, 1972, J COLLOID INTERF SCI, V38, P484, DOI 10.1016/0021-9797(72)90264-0
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   Magnani A, 1999, MACROMOL CHEM PHYSIC, V200, P2003, DOI 10.1002/(SICI)1521-3935(19990901)200:9<2003::AID-MACP2003>3.0.CO;2-W
   Magnani A, 2003, MAT SCI ENG C-BIO S, V23, P315, DOI 10.1016/S0928-4931(02)00284-9
   Magnani A, 1998, POLYM INT, V46, P225, DOI 10.1002/(SICI)1097-0126(199807)46:3<225::AID-PI45>3.0.CO;2-I
   Malmsten M, 2000, J COLLOID INTERF SCI, V224, P338, DOI 10.1006/jcis.1999.6689
   MCINTIRE LV, 1985, NIH PUBLICATION
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   O'Connell BJ, 2001, CIRCULATION, V104, P1978, DOI 10.1161/hc3901.096667
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   Slack SM, 1995, ACS SYM SER, V602, P112
   SPICER AP, EUKARYOTIC HYALURONA
   STEIN R, MAMMALIAN HYALURONID
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Toole B.P., HYALURONAN MORPHOGEN
   Torricelli C, 2004, BIOCHEM BIOPH RES CO, V315, P16, DOI 10.1016/j.bbrc.2004.01.017
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   Tsujita M, 2000, BBA-MOL CELL BIOL L, V1485, P199, DOI 10.1016/S1388-1981(00)00061-5
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   VADIVELOO PK, 1990, BIOCHIM BIOPHYS ACTA, V1045, P135, DOI 10.1016/0005-2760(90)90142-K
   VANDAMME HS, 1991, J BIOMAT SCI-POLYM E, V3, P69, DOI 10.1163/156856292X00088
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   Yu JL, 1997, BIOMATERIALS, V18, P421, DOI 10.1016/S0142-9612(96)00154-8
   Zuckerman SH, 2001, ATHEROSCLEROSIS, V155, P79, DOI 10.1016/S0021-9150(00)00540-2
NR 70
TC 17
Z9 18
U1 1
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD JUL
PY 2004
VL 25
IS 14
BP 2413
EP 2424
DI 10.1002/elps.200305826
PG 12
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 842VX
UT WOS:000223033600031
PM 15274024
DA 2018-10-19
ER

PT J
AU Li, HS
   Zou, XN
   Xue, QY
   Egund, N
   Lind, M
   Bunger, C
AF Li, HS
   Zou, XN
   Xue, QY
   Egund, N
   Lind, M
   Bunger, C
TI Anterior lumbar interbody fusion with carbon fiber cage loaded with
   bioceramics and platelet-rich plasma. An experimental study on pigs
SO EUROPEAN SPINE JOURNAL
LA English
DT Article
DE spinal fusion; bone substitute; platelet-rich plasma; tricalcium
   phosphate; pig
ID BETA-TRICALCIUM PHOSPHATE; BONE MORPHOGENETIC PROTEIN; DONOR SITE PAIN;
   GROWTH-FACTOR; SPINAL-FUSION; POROUS HYDROXYAPATITE; CANINE MODEL; ILIAC
   CREST; INGROWTH; RESORPTION
AB Platelet-rich plasma (PRP) is an autogenous source of growth factor and has been shown to enhance bone healing both in clinical and experimental studies. PRP in combination with porous hydroxyapatite has been shown to increase the bone ingrowth in a bone chamber rat model. The present study investigated whether the combination of beta tricalcium phosphate (beta-TCP) and PRP may enhance spinal fusion in a controlled animal study. Ten Danish Landrace pigs were used as a spinal fusion model. Immediately prior to the surgery, 55 ml blood was collected from each pig for processing PRP. Three-level anterior lumbar interbody fusion was performed with carbon fiber cages and staples on each pig. Autogenous bone graft, beta-TCP, and beta-TCP loaded with PRP were randomly assigned to each level. Pigs were killed at the end of the third month. Fusion was evaluated by radiographs, CT scanning, and histomorphometric analysis. All ten pigs survived the surgery. Platelet concentration increased 4.4-fold after processing. Radiograph examination showed 70% (7/10) fusion rate in the autograft level. All the levels with beta-TCP+PRP showed partial fusion, while beta-TCP alone levels had six partial fusions and four non-fusions (P=0.08). CT evaluation of fusion rate demonstrated fusion in 50% (5/10) of the autograft levels. Only partial fusion was seen at beta-TCP levels and beta-TCP+PRP levels. Histomorphometric evaluation found no difference between beta-TCP and beta-TCP+PRP levels on new bone volume, remaining beta-TCP particles, and bone marrow and fibrous tissue volume, while the same parameters differ significantly when compared with autogenous bone graft levels. We concluded from our results in pigs that the PRP of the concentration we used did not improve the bone-forming capacity of beta-TCP biomaterial in anterior spine fusion. Both beta-TCP and beta-TCP+PRP had poorer radiological and histological outcomes than that of autograft after 3 months.
C1 Aarhus Univ Hosp, Orthopaed Dept E, Orthopaed Res Lab, DK-8000 Aarhus C, Denmark.
   Univ Aarhus, Inst Expt Clin Res, Aarhus, Denmark.
   Aarhus Univ Hosp, Dept Radiol R, DK-8000 Aarhus, Denmark.
RP Li, HS (reprint author), Aarhus Univ Hosp, Orthopaed Dept E, Orthopaed Res Lab, Norrebrogade 44, DK-8000 Aarhus C, Denmark.
EM haisheng.li@iekf.au.dk
CR Arm DM, 1996, BIOMATERIALS, V17, P703, DOI 10.1016/0142-9612(96)86740-8
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Delecrin J, 1997, SPINE, V22, P1683, DOI 10.1097/00007632-199708010-00001
   Emery SE, 1996, SPINE, V21, P2713, DOI 10.1097/00007632-199612010-00003
   FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006
   Fuller DA, 1996, SPINE, V21, P2131, DOI 10.1097/00007632-199609150-00015
   GarciaBolao I, 1996, EUR J CLIN INVEST, V26, P929, DOI 10.1111/j.1365-2362.1996.tb02140.x
   GROGAARD B, 1990, ARCH ORTHOP TRAUM SU, V109, P268, DOI 10.1007/BF00419942
   Gunzburg R, 2002, ORTHOPEDICS, V25, pS591
   Lee YM, 2000, J PERIODONTOL, V71, P418, DOI 10.1902/jop.2000.71.3.418
   Li HS, 2002, EUR SPINE J, V11, P476, DOI 10.1007/s00586-002-0455-1
   LIND M, 1993, ACTA ORTHOP SCAND, V64, P553, DOI 10.3109/17453679308993691
   Linovitz RJ, 2002, ORTHOPEDICS, V25, pS585
   Lowery GL, 1999, BONE, V25, p47S, DOI 10.1016/S8756-3282(99)00132-5
   MARDEN LJ, 1993, J CLIN INVEST, V92, P2897, DOI 10.1172/JCI116912
   MARIE PJ, 1990, AM J PHYSIOL, V258, pE275
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Ohyama T, 2002, J NEUROSURG, V97, P350, DOI 10.3171/spi.2002.97.3.0350
   Olutoye OO, 1997, J PEDIATR SURG, V32, P827, DOI 10.1016/S0022-3468(97)90629-1
   Siebrecht MAN, 2002, ORTHOPEDICS, V25, P169
   SLATER M, 1995, J ORTHOP RES, V13, P655, DOI 10.1002/jor.1100130504
   SPENCER EM, 1991, BONE, V12, P21, DOI 10.1016/8756-3282(91)90050-S
   Steffen T, 2000, CLIN ORTHOP RELAT R, P28
   Steffen T, 2001, EUR SPINE J, V10, pS132, DOI 10.1007/s005860100325
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Voggenreiter G, 2000, J BONE MINER RES, V15, P1825, DOI 10.1359/jbmr.2000.15.9.1825
   Zou XN, 2003, ACTA ORTHOP SCAND, V74, P596, DOI 10.1080/00016470310018027
NR 29
TC 53
Z9 57
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD JUL
PY 2004
VL 13
IS 4
BP 354
EP 358
DI 10.1007/s00586-003-0647-3
PG 5
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 843EO
UT WOS:000223059200009
PM 14730438
OA Green Published
DA 2018-10-19
ER

PT J
AU Sonobe, J
   Okubo, Y
   Kaihara, S
   Miyatake, SI
   Bessho, K
AF Sonobe, J
   Okubo, Y
   Kaihara, S
   Miyatake, SI
   Bessho, K
TI Osteoinduction by bone morphogenetic protein 2-expressing adenoviral
   vector: Application of biomaterial to mask the host immune response
SO HUMAN GENE THERAPY
LA English
DT Article
ID IN-VIVO; RECOMBINANT ADENOVIRUS; OSTEOBLAST LINEAGE; C2C12 MYOBLASTS;
   GENE-EXPRESSION; MOUSE-LIVER; DELIVERY; DIFFERENTIATION; CELLS; LUNG
AB We constructed a human bone morphogenetic protein 2 (BMP-2)-expressing adenoviral vector, AxCABMP-2, which showed osteoinduction in immunosuppressed rats. In immunocompetent rats, new bone was not induced, because of the rapid elimination of transduced cells. Biomaterials such as collagen can be used as carriers for the delivery of DNA vectors, allowing prolonged expression of plasmid DNA in normal animals. We evaluated osteoinduction with AxCABMP-2 and atelopeptide type I collagen in immunocompetent rats. Collagen plus AxCABMP-2 (BMP group), collagen plus AxCALacZ (LacZ group), or collagen alone (CL group) was implanted into calf muscle pouches in immunocompetent rats, or AxCABMP-2 alone (injection group) was injected into the calf muscle. On days 3, 7, 14, and 21 after treatment, osteoinduction was evaluated. In the BMP group, bone formation was not observed on days 3 and 7. On day 14, radiographic formation was seen, but little bone formation was detected histologically. On day 21, new bone formation was observed both radiologically and histologically. In the other groups, osteoinduction was not found at any time. Immunohistochemical analysis on days 3 and 7 revealed decreased immunogenicity in the BMP group compared with the injection group. These findings suggested that collagen was an effective masking material for our vector.
C1 Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Osaka Med Coll, Dept Neurosurg, Osaka 5698686, Japan.
RP Bessho, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.
EM bes@kuhp.kyoto-u.ac.jp
CR Alden TD, 1999, HUM GENE THER, V10, P2245, DOI 10.1089/10430349950017220
   Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   BESSHO K, 1989, BIOCHEM BIOPH RES CO, V165, P595, DOI 10.1016/S0006-291X(89)80008-7
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   CONNERTY HV, 1966, AM J CLIN PATHOL, V45, P290
   Engstrand T, 2000, HUM GENE THER, V11, P205, DOI 10.1089/10430340050016274
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   Irvine KR, 1997, J NATL CANCER I, V89, P1595, DOI 10.1093/jnci/89.21.1595
   Jooss K, 1996, HUM GENE THER, V7, P1555, DOI 10.1089/hum.1996.7.13-1555
   Jooss K, 1998, GENE THER, V5, P309, DOI 10.1038/sj.gt.3300595
   KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816
   KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320
   Ochiya T, 1999, NAT MED, V5, P707
   Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887
   Okubo Y, 2000, BIOCHEM BIOPH RES CO, V267, P382, DOI 10.1006/bbrc.1999.1975
   Okubo Y, 2000, BIOCHEM BIOPH RES CO, V269, P317, DOI 10.1006/bbrc.2000.2294
   Okubo Y, 2001, LIFE SCI, V70, P325, DOI 10.1016/S0024-3205(01)01393-5
   Okubo Y, 2000, INT J ORAL MAX SURG, V29, P62, DOI 10.1016/S0901-5027(00)80127-7
   Okubo Y, 2000, CLIN ORTHOP RELAT R, P295
   Okubo Y, 1999, BIOCHEM BIOPH RES CO, V262, P739, DOI 10.1006/bbrc.1999.1281
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Siemens DR, 2000, J NATL CANCER I, V92, P403, DOI 10.1093/jnci/92.5.403
   Sonobe J., 2002, J MUSCULOSKELET RES, V6, P2329
   Sullivan DE, 1997, HUM GENE THER, V8, P1195, DOI 10.1089/hum.1997.8.10-1195
   WU DP, 1990, CLIN EXP IMMUNOL, V82, P33
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Zhang HG, 1998, HUM GENE THER, V9, P1875, DOI 10.1089/hum.1998.9.13-1875
NR 31
TC 22
Z9 22
U1 2
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1043-0342
J9 HUM GENE THER
JI Hum. Gene Ther.
PD JUL
PY 2004
VL 15
IS 7
BP 659
EP 668
DI 10.1089/1043034041361208
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 839LP
UT WOS:000222786900004
PM 15242526
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Cytometric viability assays of human corneal epithelial cells (HCE-T)
   grown ontissue culture plastic and a biomaterial.
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC IN VITRO BIOLOGY
PI LARGO
PA 9315 LARGO DR WEST, STE 25, LARGO, MD 20774 USA
SN 1071-2690
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD JUL-AUG
PY 2004
VL 40
IS 7
BP 250
EP 250
PG 1
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 889LE
UT WOS:000226443700029
DA 2018-10-19
ER

PT J
AU Martin, SM
   Schwartz, JL
   Giachelli, CM
   Ratner, BD
AF Martin, SM
   Schwartz, JL
   Giachelli, CM
   Ratner, BD
TI Enhancing the biological activity of immobilized osteopontin using a
   type-1 collagen affinity coating
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteopontin; poly(HEMA); type 1 collagen; affinity coating; cell
   adhesion
ID ADSORBED PROTEIN FILMS; CELL-SURVIVAL; IN-VITRO; INFLAMMATION;
   REGULATOR; MIGRATION; INTEGRIN; BONE; VIVO
AB The covalent attachment of biomolecules onto surfaces represents a step toward the improvement of biomaterial properties by providing relevant biological signals of interest to the cell culture or tissue environment. The chemistries involved, however, often attach proteins to the surface in a random fashion, rather than the conformation or orientation most easily recognized by cells and other proteins both in vitro and in vivo. An alternative approach is to take advantage of natural interactions to both bind and orient a biomolecule "naturally," thereby enhancing its biological activity. Type 1 collagen has been shown to bind to osteopontin (OPN), a protein implicated in processes such as wound healing, endothelial cell survival, and angiogenesis. This study seeks to characterize, quantify, and exploit this interaction in order to present a more naturally recognized form of OPN to the environment surrounding a biomaterial. Binding of OPN to type 1 collagen was confirmed using Surface Plasmon Resonance (SPR). Radio-iodination of OPN showed that binding to collagen was dose-dependent and maximal in basic conditions. Principal component analysis of Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) data identified differences in OPN immobilized via different techniques. Adhesion of bovine aortic endothelial cells on OPN immobilized using the affinity coating was also significantly enhanced compared to controls. Investigation into the in vivo relevance of this immobilization method is currently underway. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu
FU NCRR NIH HHS [RR01296]
CR Asou Y, 2001, ENDOCRINOLOGY, V142, P1325, DOI 10.1210/en.142.3.1325
   CHEN Y, 1992, J BIOL CHEM, V267, P24871
   Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980
   FARIS B, 1983, EXP CELL RES, V143, P15, DOI 10.1016/0014-4827(83)90104-0
   Giachelli CM, 1998, AM J PATHOL, V152, P353
   Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6
   Guo HT, 2001, J IMMUNOL, V166, P1079, DOI 10.4049/jimmunol.166.2.1079
   Kang JS, 2001, LANGMUIR, V17, P4352, DOI 10.1021/la001310y
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665
   LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214
   MADRI JA, 1988, AM J PATHOL, V132, P18
   Martin SM, 2003, J BIOMED MATER RES A, V67A, P334, DOI 10.1002/jbm.a.10060
   Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083
   Smetana K, 1997, ANN NY ACAD SCI, V831, P95
   Wagner MS, 2002, ANAL CHEM, V74, P1824, DOI 10.1021/ac0111311
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
NR 17
TC 23
Z9 23
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2004
VL 70A
IS 1
BP 10
EP 19
DI 10.1002/jbm.a.30052
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 833EA
UT WOS:000222318000002
PM 15174104
DA 2018-10-19
ER

PT J
AU Abraham, LC
   Vorrasi, J
   Kaplan, DL
AF Abraham, LC
   Vorrasi, J
   Kaplan, DL
TI Impact of collagen structure on matrix trafficking by human fibroblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; fibroblasts; tissue engineering; extracellular matrix; matrix
   metalloproteinases
ID HUMAN GINGIVAL FIBROBLASTS; GENE-EXPRESSION; EXTRACELLULAR-MATRIX;
   CELL-CYCLE; IN-VIVO; PHAGOCYTOSIS; METALLOPROTEINASES; SENESCENCE;
   ADHESION; GROWTH
AB Biodegradation of collagen biomaterial matrices and the deposition of new collagen extracellular matrix (ECM) are critical to the integration of in vitro bioengineered materials and tissues in vivo. In previous studies, we observed significant impact of collagen matrix structure on primary lung fibroblast behavior in vitro. In the present work, to begin to understand the mechanistic basis for our previous observation, the response of human fibroblasts (IMR-90) to the structural state of collagen matrices was studied with respect to cell proliferation, cell morphology, beta-galactosidase level, and transcript content for collagen (Col-1), matrix metalloproteinases (MMP-1, MMP-2), tissue inhibitors of matrix metalloproteinase (TIMP-1 and TIMP-2). Collagen digestion was assessed quantitatively by uptake of collagen-coated fluorescent beads incorporated in the preformed collagen matrix. Transcript levels related to the deposition of new ECM proteins varied as a function of the structure of the collagen matrix presented to the cells. Col-1 expression was 2-fold higher and expression for MMP-1, MMP-2, TIMP-1, and TIMP-2 increased for cells when grown on 156 mug/cm(2) denatured collagen compared with cells grown on tissue culture (TC) plastic. On 156 mug/cm(2) nondenatured (native) collagen, Col-1 expression was decreased by half and MMP-2 was increased by 2.5-fold compared with cells grown on TC plastic. On 78 mug/cm(2) denatured collagen, Col-1 expression was 80% whereas the MMPs and TIMPs were increased by 1.25- to 2-fold compared with cells grown on TC plastic. On 78 mug/cm(2) nondenatured collagen expression of all 5 transcripts was reduced 60-90% of the levels determined for the cells grown on TC plastic. Cell viability, based on cell morphology and beta-galactosidase activity, was improved on the denatured collagen. A higher level of collagen matrix incorporation was observed for cells grown on denatured collagen than on nondenatured collagen or TC plastic. These data suggest that tissue engineering matrices incorporating denatured collagen may promote more active remodeling toward new ECM in comparison to cells grown on nondenatured collagen or cells grown on TC plastic. (C) 2004 Wiley Periodicals, Inc.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Ctr Bioengn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIAMS NIH HHS [R01 AR46563]
CR Arora PD, 2003, EXP CELL RES, V286, P366, DOI 10.1016/S0014-4827(03)00096-X
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   Cate A R, 1974, J Anat, V117, P351
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543
   CHOI AMK, 1992, J CELL PHYSIOL, V151, P147, DOI 10.1002/jcp.1041510119
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Garfinkel S, 1996, BBA-MOL CELL RES, V1314, P109, DOI 10.1016/S0167-4889(96)00105-X
   Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W
   Grab B, 1996, J BIOL CHEM, V271, P12234, DOI 10.1074/jbc.271.21.12234
   Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X
   Huppertz B, 1998, CELL TISSUE RES, V291, P133
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   KIVIRIKKO KI, 1993, ANN MED, V25, P113, DOI 10.3109/07853899309164153
   KNOWLES GC, 1991, J CELL SCI, V98, P551
   Laliberte R, 2001, MATRIX BIOL, V19, P743, DOI 10.1016/S0945-053X(00)00120-7
   Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201
   Lee W, 1997, EXP CELL RES, V237, P383, DOI 10.1006/excr.1997.3802
   Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   MAUCH C, 1990, RHEUM DIS CLIN N AM, V16, P93
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   MCCULLOCH CAG, 1993, J CELL PHYSIOL, V155, P461, DOI 10.1002/jcp.1041550305
   MCKEOWN M, 1990, CELL TISSUE RES, V262, P523, DOI 10.1007/BF00305249
   MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324
   Patino Maria G, 2002, Implant Dent, V11, P280, DOI 10.1097/00008505-200207000-00014
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200
   Vogel WF, 2001, EUR J DERMATOL, V11, P506
   Volloch V, 2002, MATRIX BIOL, V21, P533, DOI 10.1016/S0945-053X(02)00038-0
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Williams FMK, 1998, CARDIOVASC SURG, V6, P10
   Winblade ND, 2002, J BIOMED MATER RES, V59, P618, DOI 10.1002/jbm.1273
   Wong TTL, 2002, SURV OPHTHALMOL, V47, P239, DOI 10.1016/S0039-6257(02)00287-4
   Wright NT, 2002, ANNU REV BIOMED ENG, V4, P109, DOI 10.1146/annurev.bioeng.4.101001.131546
NR 44
TC 14
Z9 14
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2004
VL 70A
IS 1
BP 39
EP 48
DI 10.1002/jbm.a.30057
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 833EA
UT WOS:000222318000005
PM 15174107
DA 2018-10-19
ER

PT J
AU Leach, JB
   Bivens, KA
   Collins, CN
   Schmidt, CE
AF Leach, JB
   Bivens, KA
   Collins, CN
   Schmidt, CE
TI Development of photocrosslinkable hyaluronic acid-polyethylene
   glycol-peptide composite hydrogels for soft tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyaluronic acid; polyethylene glycol; adhesive peptides; hydrogels;
   tissue engineering
ID CHEMICAL-MODIFICATION; ADHESION PEPTIDES; MATRIX; ATTACHMENT; SCAFFOLDS
AB Hyaluronic acid (HA; also called hyaluronan) is a naturally derived, nonimmunogenic, nonadhesive glycosaminoglycan that has important roles in several wound-healing processes. In previous work, we created photocrosslinkable glycidyl methacrylate-HA (GMHA) hydrogel biomaterials that were cytocompatible, biologically active, and had a decreased rate of hyaluronidase degradation compared with native HA. The goal of the studies presented herein was to explore peptide conjugation techniques to further adjust the material and biological properties of the GMHA hydrogels. We conjugated GMHA with acrylated forms of polyethylene glycol (PEG) and PEG-peptides to yield GMHA-PEG-peptide composite hydrogels. By varying the reactant concentrations, we created stable hydrogels with high peptide conjugation efficiencies (up to 80%), controllable peptide concentrations (in the range of 1-6 mumol peptide per milliliter of hydrogel), and defined physicochemical properties (e.g., swelling ratio, enzymatic degradation rate). These composite hydrogels may prove to be a promising scaffolding biomaterial for a variety of soft tissue engineering applications. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Texas Mat Inst, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Biomed Engn, 26th & Speedway,MC C0400, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
CR Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Gupta RK, 1997, VACCINE, V15, P672, DOI 10.1016/S0264-410X(96)00233-2
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   LEACH JB, 2004, ENCY BIOMATERIALS BI
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   OGAMO A, 1982, CARBOHYD RES, V105, P69, DOI 10.1016/S0008-6215(00)81855-8
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
NR 20
TC 97
Z9 102
U1 4
U2 52
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2004
VL 70A
IS 1
BP 74
EP 82
DI 10.1002/jbm.a.30063
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 833EA
UT WOS:000222318000009
PM 15174111
DA 2018-10-19
ER

PT J
AU Saito, A
   Suzuki, Y
   Ogata, S
   Ohtsuki, C
   Tanihara, M
AF Saito, A
   Suzuki, Y
   Ogata, S
   Ohtsuki, C
   Tanihara, M
TI Prolonged ectopic calcification induced by BMP-2-derived synthetic
   peptide
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE synthetic peptide; BMP-2; alginate; calcification; osteoclasts
ID BONE MORPHOGENETIC PROTEIN-2; DRIED ALGINATE GEL; IN-VIVO; BIOMATERIAL
   CARRIERS; REGENERATION; PHARMACOKINETICS; CYTOTOXICITY; COLLAGEN;
   CULTURE; MODEL
AB Bone morphogenetic protein-2 (BMP-2) promotes the formation and regeneration of bone and cartilage, and therefore constitutes the most promising candidate for a bone repair material. However, it also has a wide range of functions, such as in organogenesis and apoptosis. Therefore, we investigated a novel synthetic peptide corresponding to residues 73-92 of BMP-2. This peptide bound to a BMP-2-specific receptor and elevated both alkaline phosphatase activity and osteocalcin mRNA in the murine cell line, C3H10T1/2. The 73-92 peptide also induced ectopic calcification when conjugated to a covalently crosslinked alginate gel. Here we report that the 73-92 peptide-conjugated alginate gel showed prolonged ectopic calcification for up to 7 weeks in rat calf muscle. In contrast, rhBMP-2-impregnated collagen gel showed maximum ectopic calcification at 3 weeks, and the calcified products that had formed disappeared after 5 weeks. Histological examination showed that the 73-92 peptide-conjugated alginate gel induced many osteoblast-like cells and few osteoclasts. In contrast, rhBMP-2-impregnated collagen gel induced many osteoclasts. These results suggest that the 73-92 peptide on alginate gel remains active at the implanted site, continuously induces differentiation of osteoblast precursor cells into osteoblasts, and activates osteoblasts to promote ectopic calcification. (C) 2004 Wiley Periodicals, Inc.
C1 Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6309192, Japan.
   Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sect Surg Sensory & Motor Syst,Div Surg,Sakyo Ku, Kyoto 6068507, Japan.
RP Tanihara, M (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5 Takayama, Nara 6309192, Japan.
EM mtanihar@ms.naist.jp
RI Ohtsuki, Chikara/E-4973-2010
OI Ohtsuki, Chikara/0000-0002-6474-1540
CR Aubin J E, 1998, J Cell Biochem Suppl, V30-31, P73
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Butler D, 1998, NATURE, V391, P320
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Marks Sandy C. Jr., 1996, P3
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   ROSDY M, 1990, J BIOMED MATER RES, V24, P363, DOI 10.1002/jbm.820240308
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   SANK A, 1989, SURGERY, V106, P1141
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Suda Tatsuo, 1996, P87
   Suzuki K, 2000, J BIOMED MATER RES, V49, P528, DOI 10.1002/(SICI)1097-4636(20000315)49:4<528::AID-JBM11>3.0.CO;2-1
   Suzuki Y, 1999, J BIOMED MATER RES, V48, P522, DOI 10.1002/(SICI)1097-4636(1999)48:4<522::AID-JBM18>3.0.CO;2-O
   Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8
   Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
NR 23
TC 68
Z9 71
U1 0
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2004
VL 70A
IS 1
BP 115
EP 121
DI 10.1002/jbm.a.30071
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 833EA
UT WOS:000222318000013
PM 15174115
DA 2018-10-19
ER

PT J
AU Yunoki, S
   Nagai, N
   Suzuki, T
   Munekata, M
AF Yunoki, S
   Nagai, N
   Suzuki, T
   Munekata, M
TI Novel biomaterial from reinforced salmon collagen gel prepared by fibril
   formation and cross-linking
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE salmon; fish collagen; biomaterial; fibril formation; fibrillar gel;
   1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide
ID I COLLAGEN; ATELOCOLLAGEN GEL; MATRIX SYNTHESIS; PROPERTY; VITRO;
   PROLIFERATION; CHONDROCYTES; FIBROBLASTS; MEMBRANE; INVITRO
AB The improvement of the thermal stability of gel prepared from salmon atelocollagen (SC) was studied. The denaturation temperature (Td) of the SC solution was found to be 18.6degreesC. Neutral buffer including 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) was mixed with acidic SC solution at VC, resulting in the introduction of EDC cross-linking during fibril formation. The mechanical strength and thermal stability of the resultant cross-linked SC fibrillar gels reached maximum values at an EDC concentration of 50 mM (f-50 gel). In particular, the melting temperature of the f-50 gel was 47degreesC, much higher than that of the EDC cross-linked SC gel without fibril formation at the same EDC concentration. The proliferation rate of human periodontal ligament cells on the f-50 gel was higher than that of a porcine atelocollagen fibrillar gel. These results suggest that the gel employed for biomaterials can be fabricated from low Td fish collagen by EDC cross-linking during fibril formation.
C1 Hokkaido Univ, Div Mol Chem, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan.
   Ihara & Co Ltd, Otaru, Hokkaido 0470261, Japan.
RP Yunoki, S (reprint author), Hokkaido Univ, Div Mol Chem, Grad Sch Engn, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.
EM yunoki@dove-mc.eng.hokudai.ac.jp
CR Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DAMINK O, 1994, J MATER SCI, V6, P460
   GROSS J, 1958, J BIOL CHEM, V233, P355
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   HELSETH DL, 1981, J BIOL CHEM, V256, P7118
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KIMURA S, 1988, J FOOD SCI, V53, P1315, DOI 10.1111/j.1365-2621.1988.tb09266.x
   MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861
   MATSUI R, 1991, COMP BIOCHEM PHYS B, V99, P171, DOI 10.1016/0305-0491(91)90025-9
   MCCULLOCH CAG, 1991, J PERIODONTAL RES, V26, P144, DOI 10.1111/j.1600-0765.1991.tb01638.x
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Nohutcu RM, 1997, J PERIODONTOL, V68, P320, DOI 10.1902/jop.1997.68.4.320
   Nomura Y, 2000, J AGR FOOD CHEM, V48, P2028, DOI 10.1021/jf990773a
   Nomura Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1919, DOI 10.1271/bbb.61.1919
   Nomura Y, 1995, J FOOD SCI, V60, P1233, DOI 10.1111/j.1365-2621.1995.tb04563.x
   Nomura Y, 2000, J AGR FOOD CHEM, V48, P6332, DOI 10.1021/jf000584o
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Osborne CS, 1999, BIOMATERIALS, V20, P283, DOI 10.1016/S0142-9612(98)00179-3
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   PIEZ KA, 1982, CONNECT TISSUE RES, V10, P25, DOI 10.3109/03008208209034403
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Taguchi T, 2002, J BIOMED MATER RES, V61, P330, DOI 10.1002/jbm.10147
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   VEIS A, 1982, CONNECT TISSUE RES, V10, P11, DOI 10.3109/03008208209034402
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   YOSHIZATO K, 1984, ANN PLAS SURG, V13, P9, DOI 10.1097/00000637-198407000-00002
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
NR 32
TC 66
Z9 69
U1 1
U2 16
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUL
PY 2004
VL 98
IS 1
BP 40
EP 47
DI 10.1263/jbb.98.40
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 853ZN
UT WOS:000223869700007
PM 16233664
DA 2018-10-19
ER

PT J
AU Karuri, NW
   Liliensiek, S
   Teixeira, AI
   Abrams, G
   Campbell, S
   Nealey, PF
   Murphy, CJ
AF Karuri, NW
   Liliensiek, S
   Teixeira, AI
   Abrams, G
   Campbell, S
   Nealey, PF
   Murphy, CJ
TI Biological length scale topography enhances cell-substratum adhesion of
   human corneal epithelial cells
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE nanoscale topography; cell-substratum adhesion; epithelium
ID BASEMENT-MEMBRANE; NANOSCALE TOPOGRAPHY; ELECTRON-MICROSCOPY;
   SURFACE-TOPOGRAPHY; CONTACT GUIDANCE; IN-VITRO; GROOVES; TISSUE;
   DIFFERENTIATION; ORIENTATION
AB The basement membrane possesses a rich 3-dimensional nanoscale topography that provides a physical stimulus, which may modulate cell-substratum adhesion. We have investigated the strength of cell-substratum adhesion on nanoscale topographic features of a similar scale to that of the native basement membrane. SV40 human corneal epithelial cells were challenged by well-defined fluid shear, and cell detachment was monitored. We created silicon substrata with uniform grooves and ridges having pitch dimensions of 400-4000 nm using X-ray lithography. F-actin labeling of cells that had been incubated for 24 hours revealed that the percentage of aligned and elongated cells on the patterned surfaces was the same regardless of pitch dimension. In contrast, at the highest fluid shear, a biphasic trend in cell adhesion was observed with cells being most adherent to the smaller features. The 400 nm pitch had the highest percentage of adherent cells at the end of the adhesion assay. The effect of substratum topography was lost for the largest features evaluated, the 4000 nm pitch. Qualitative and quantitative analyses of the cells during and after flow indicated that the aligned and elongated cells on the 400 nm pitch were more tightly adhered compared to aligned cells on the larger patterns. Selected experiments with primary cultured human corneal epithelial cells produced similar results to the SV40 human corneal epithelial cells. These findings have relevance to interpretation of cell-biomaterial interactions in tissue engineering and prosthetic design.
C1 Univ Wisconsin, Sch Vet Med, Dept Chem Engn, Madison, WI 53706 USA.
   Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA.
RP Nealey, PF (reprint author), Univ Wisconsin, Sch Vet Med, Dept Chem Engn, Madison, WI 53706 USA.
EM nealey@engr.wisc.edu; murphyc@svm.vetmed.wisc.edu
OI Teixeira, Ana/0000-0001-8169-8815
FU NEI NIH HHS [R01 EY012253, R01 EY 012253-01]
CR Abrams GA, 2002, CELLS TISSUES ORGANS, V170, P251, DOI 10.1159/000047929
   Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004419900074
   Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   ABRAMS GA, 2002, BIOMIMETIC MAT DESIG, P91
   ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
   BIRD RB, 1960, TRANSPORT PHENOMENA, P62
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   DAVIES PF, 1994, J CLIN INVEST, V93, P2031, DOI 10.1172/JCI117197
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Evans DJR, 1999, DEV GENES EVOL, V209, P438, DOI 10.1007/s004270050275
   Evans MDM, 1999, J BIOMED MATER RES, V46, P485, DOI 10.1002/(SICI)1097-4636(19990915)46:4<485::AID-JBM6>3.0.CO;2-F
   Evans MDM, 2003, J BIOMED MATER RES A, V64A, P357, DOI 10.1002/jbm.a.10341
   FATT I, 1992, CLAO Journal, V18, P187
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Granick S, 2003, NAT MATER, V2, P221, DOI 10.1038/nmat854
   Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   King-Smith PE, 2000, INVEST OPHTH VIS SCI, V41, P3348
   MEIER S, 1975, J CELL BIOL, V66, P275
   Oakley C, 1995, BIOCHEM CELL BIOL, V73, P473, DOI 10.1139/o95-053
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383
   Stroock AD, 2002, ANAL CHEM, V74, P5306, DOI 10.1021/ac0257389
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5
   TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   WOJIAKSTODART B, 1995, CELL MOTIL CYTOSKEL, V31, P147
   WOODS A, 1988, COLLAGEN REL RES, V8, P155
NR 39
TC 210
Z9 216
U1 4
U2 49
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD JUL 1
PY 2004
VL 117
IS 15
BP 3153
EP 3164
DI 10.1242/jcs.01146
PG 12
WC Cell Biology
SC Cell Biology
GA 843VT
UT WOS:000223115600009
PM 15226393
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Blackwood, DJ
   Pereira, BP
AF Blackwood, DJ
   Pereira, BP
TI No corrosion of 304 stainless steel implant after 40 years of service
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID STAINLESS-STEELS; SURGICAL IMPLANTS; COMPLEXING AGENT; CASE-HISTORIES;
   BIOMATERIAL; TITANIUM
AB When exposed to 0.9% NaCl type 304 stainless steel undergoes severe pitting corrosion within a matter of days. However, a Sherman plate fabricated from type 304 stainless steel remained inside a patient's arm for almost 40 years without any visible indications of corrosion. Given the previous understanding of the pathological environments this was considered quite remarkable. It is proposed that the low dissolved oxygen levels found in human-body fluids makes the long-term in vivo environment much more benign than would be anticipated from in vitro experiments. Furthermore, it is proposed that previous cases of localized pitting corrosion on stainless steel implants most likely arose due to the development of short-term aggressive conditions due to pathological changes in the surrounding tissue as a result of the trauma of the implant procedure. In the present case the Sherman plate was sufficiently small that the surrounding tissue was not aggravated sufficiently to lead to the development of such an environment aggressive. The conclusion that surgical implants are at most risk during the first few weeks of service implies that short-term corrosion protection methods, such as coatings, may be more effective than previously thought. (C) 2004 Kluwer Academic Publishers.
C1 Natl Univ Singapore, Dept Orthopaed Surg, Dept Mat Sci, Singapore 119260, Singapore.
   Natl Univ Singapore, Dept Orthopaed Surg, Musculoskeletal Res Labs, Singapore 119260, Singapore.
RP Blackwood, DJ (reprint author), Natl Univ Singapore, Dept Orthopaed Surg, Dept Mat Sci, Kent Ridge, Singapore 119260, Singapore.
EM masdjb@anus.edu.sg
RI Blackwood, Daniel/F-4289-2011
OI Blackwood, Daniel/0000-0002-4897-3536
CR GREEN ND, 1985, ATSM STP, V859, P5
   Hadjiargyrou M, 2000, J BONE MINER RES, V15, P1014, DOI 10.1359/jbmr.2000.15.6.1014
   JACOBSON B, 1977, MED CLIN ENG, P525
   Jedwab J, 1974, Acta Orthop Belg, V40, P877
   Kocijan A, 2003, J MATER SCI-MATER M, V14, P69, DOI 10.1023/A:1021505621388
   Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6
   Leitao E, 1997, J MATER SCI-MATER M, V8, P365, DOI 10.1023/A:1018532900458
   Liang P. G., 1973, ORTHOP CLIN N AM, V4, P249
   Milosev I, 2000, J BIOMED MATER RES, V52, P404, DOI 10.1002/1097-4636(200011)52:2<404::AID-JBM22>3.0.CO;2-Z
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   Perren SM, 2002, J BONE JOINT SURG BR, V84B, P1093, DOI 10.1302/0301-620X.84B8.13752
   SCALES JT, 1959, J BONE JOINT SURG BR, V41, P810
   SIVAKUMAR M, 1995, J MATER SCI LETT, V14, P351, DOI 10.1007/BF00592147
   Souhami R. L., 1994, TXB MED, P444
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Walivaara Bengt, 1993, Clinical Materials, V12, P141, DOI 10.1016/0267-6605(93)90065-F
   WANG JH, 1988, CORROSION, V44, P732, DOI 10.5006/1.3584938
   Watt F, 1998, NUCL INSTRUM METH B, V136, P313, DOI 10.1016/S0168-583X(97)00710-6
   ZITTER H, 1991, WERKST KORROS, V42, P455
   ZITTER H, 1981, WERKST KORROS, V32, P324
NR 20
TC 8
Z9 8
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2004
VL 15
IS 7
BP 755
EP 758
DI 10.1023/B:JMSM.0000032814.20695.3c
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 831ZL
UT WOS:000222235600003
PM 15387410
DA 2018-10-19
ER

PT J
AU Puskas, JE
   Chen, YH
   Dahman, Y
   Padavan, D
AF Puskas, JE
   Chen, YH
   Dahman, Y
   Padavan, D
TI Polyisobutylene-based biomaterials
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE biomaterials; polyisobutylene; living carbocationic; polymerization;
   biocompatibility; surface modification; surfaces
ID LIVING CARBOCATIONIC POLYMERIZATION; TRANSFER AGENTS INIFERS;
   AMPHIPHILIC BLOCK-COPOLYMERS; SEQUENTIAL MONOMER ADDITION; ATOMIC-FORCE
   MICROSCOPY; THERMOPLASTIC ELASTOMERS; PHYSICAL-PROPERTIES; HYPERBRANCHED
   POLYISOBUTYLENES; TELECHELIC POLYMERS; ISOBUTYLENE POLYMERIZATIONS
AB This article highlights the biomaterial-related research of the Macromolecular Engineering Research Centre (MERC). The MERC group concentrated on polyisobutylene (PIB)-based biomaterials. In this article, first the unique properties of PIB are discussed, followed by a review of PIB-based potential biomaterials. MERC's systematic research program aimed to develop novel PIB-based biomaterials is then highlighted, including surface modification and biocompatibility studies. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Akron, Coll Polymer Sci & Polymer Engn, Dept Polymer Sci, Akron, OH 44325 USA.
   Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Puskas, JE (reprint author), Univ Akron, Coll Polymer Sci & Polymer Engn, Dept Polymer Sci, Akron, OH 44325 USA.
EM judit.puskas@uni-bayreuth.de
CR [Anonymous], 2001, U.S. Patent, Patent No. [6,197,240, 6197240]
   Antony P, 2003, EUR POLYM J, V40, P149
   AUTIAN J, 1961, Am J Hosp Pharm, V18, P329
   BATICH C, 1992, J LONG-TERM EFF MED, V1, P255
   CADIEUX P, 2002, COLLOID SURFACE B, V28, P95
   Cao XY, 1999, MACROMOLECULES, V32, P5487, DOI 10.1021/ma990370b
   CHATTOPADHYAY S, 2002, UNPUB EUR POLYM J
   CRAWFORD DM, 2000, THERMOCHIM ACTA, V125, P367
   Dahman Y, 2003, MACROMOLECULES, V36, P2198, DOI 10.1021/ma021608q
   Duffy J., 1998, ULLMANNS ENCY IND A, VA23, P51
   ERDODI G, 1998, POLYM MAT SCI ENG, V79, P481
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   FRECHET JMJ, 1995, SCIENCE, V269, P1080, DOI 10.1126/science.269.5227.1080
   GAUTHIER M, 1991, MACROMOLECULES, V24, P4548, DOI 10.1021/ma00016a011
   Gauthier M, 1999, NATO ADV SCI I E-APP, V359, P239
   GORIANOV V, 1873, LIEBIGS ANN CHEM, V169, P146
   Holden G., 1996, THERMOPLASTIC ELASTO
   Isayeva IS, 2003, BIOMATERIALS, V24, P3483, DOI 10.1016/S0142-9612(03)00172-8
   Isayeva IS, 2002, J POLYM SCI POL CHEM, V40, P2075, DOI 10.1002/pola.10303
   IVAN B, 1980, J POLYM SCI POL CHEM, V18, P3177, DOI 10.1002/pol.1980.170181104
   IVAN B, 1990, J POLYM SCI POL CHEM, V28, P89, DOI 10.1002/pola.1990.080280107
   KASZAS G, 1991, J POLYM SCI POL CHEM, V29, P427, DOI 10.1002/pola.1991.080290316
   KASZAS G, 1989, J MACROMOL SCI CHEM, VA26, P1099, DOI 10.1080/00222338908052037
   Kaszas G., 1992, U.S. Patent, Patent No. [5,169,914, 5169914]
   Kennedy J. P., 2001, MACROMOL S, V172, P56
   Kennedy J.P., 1990, U.S. Patent, Patent No. [4,946,899, 4946899]
   Kennedy J. P., 1992, DESIGNED POLYM CARBO
   Kennedy JP, 1999, J POLYM SCI POL CHEM, V37, P2285, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2285::AID-POLA1>3.0.CO;2-P
   KENNEDY JP, 1993, MACROMOLECULES, V26, P567, DOI 10.1021/ma00056a002
   Kennedy JP, 2001, MACROMOL SYMP, V175, P127, DOI 10.1002/1521-3900(200110)175:1<127::AID-MASY127>3.0.CO;2-X
   KENNEDY JP, 1993, TRENDS POLYM SCI, V1, P381
   KENNEDY JP, 1975, CATIONIC POLYM OLEFI, P11
   KILPADI DV, 2000, BIOMATERIALS ENG DEV, V1, P57
   Knoll A, 2001, MACROMOLECULES, V34, P4159, DOI 10.1021/ma001311x
   KRESGE E, 1993, KIRKOTHMER ENCY CHEM, V8, P934
   Kurian P, 2000, J POLYM SCI POL CHEM, V38, P3200, DOI 10.1002/1099-0518(20000901)38:17<3200::AID-POLA190>3.0.CO;2-R
   Kwon Y, 2002, MACROMOLECULES, V35, P3348, DOI 10.1021/ma011739b
   KWON Y, 2003, EUR POLYM J, V40, P119
   KYU T, 1993, MACROMOLECULES, V26, P5721
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Langstein G., 2000, U. S. Patent, Patent No. [6156859, 6,156,859]
   Li L, 1998, MACROMOLECULES, V31, P7248, DOI 10.1021/ma9718659
   MATYJASZEWSKI K, 1996, CATIONIC POLYM MECH, V35, P683
   Michel AJ, 2000, MACROMOLECULES, V33, P3518, DOI 10.1021/ma990983o
   Mishra M. K., 1997, DESK REFERENCE FUNCT, P57
   NOINVILLE S, 1988, J COLLOID INTERF SCI, V129, P484
   OTTO M, 1937, Patent No. 2084501
   PADAVAN D, 2003, P IUPAC INT S ION PO
   Paulo C, 2001, MACROMOLECULES, V34, P734, DOI 10.1021/ma001467x
   Percec V, 2003, J AM CHEM SOC, V125, P6503, DOI 10.1021/ja034746j
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Pinchuk L, 1998, US Patent, Patent No. [5,741,331, 5741331, no 5,741331]
   Pinchuk L, 2000, US Patent, Patent No. [6,102,939, 6102939]
   PINCHUK L, 2001, 6 WORLD BIOM C T, P1452
   Puskas J.E., 2003, ENCY POLYM SCI TECHN, P382
   Puskas J.E., 2002, [No title captured], Patent No. [6,495,647, 6495647]
   Puskas J.E., 2001, U.S. Patent, Patent No. [2,268,446, 2268446]
   PUSKAS JE, 1992, J POLYM SCI POL CHEM, V30, P41, DOI 10.1002/pola.1992.080300105
   Puskas JE, 1999, RUBBER CHEM TECHNOL, V72, P559, DOI 10.5254/1.3538818
   Puskas JE, 2000, J POLYM SCI POL CHEM, V38, P444, DOI 10.1002/(SICI)1099-0518(20000201)38:3<444::AID-POLA8>3.0.CO;2-B
   Puskas JE, 2003, EUR POLYM J, V39, P2147, DOI 10.1016/S0014-3057(03)00149-6
   Puskas JE, 2003, EUR POLYM J, V39, P2041, DOI 10.1016/S0014-3057(03)00130-7
   Puskas JE, 2002, RUBBER CHEM TECHNOL, V75, P853, DOI 10.5254/1.3547688
   Puskas JE, 2001, RUBBER CHEM TECHNOL, V74, P583, DOI 10.5254/1.3544959
   Puskas JE, 2002, MACROMOL SYMP, V183, P191, DOI 10.1002/1521-3900(200207)183:1<191::AID-MASY191>3.0.CO;2-N
   Puskas JE, 2000, MACROMOL SYMP, V161, P141, DOI 10.1002/1521-3900(200010)161:1<141::AID-MASY141>3.0.CO;2-K
   Puskas JE, 2001, MACROMOL MATER ENG, V286, P565, DOI 10.1002/1439-2054(20011001)286:10<565::AID-MAME565>3.0.CO;2-E
   Puskas JE, 1998, MACROMOL SYMP, V132, P117, DOI 10.1002/masy.19981320113
   Puskas JE, 1998, J POLYM SCI POL CHEM, V36, P85, DOI 10.1002/(SICI)1099-0518(19980115)36:1<85::AID-POLA12>3.0.CO;2-9
   Puskas JE, 1996, RUBBER CHEM TECHNOL, V69, P462, DOI 10.5254/1.3538381
   Puskas JE, 2000, PROG POLYM SCI, V25, P403, DOI 10.1016/S0079-6700(00)00010-1
   PUSKAS JE, 2003, POLYM ADVAN TECHNOL, V14, P1
   PUSKAS JE, 2004, BIOMACROMOLECULES
   PUSKAS JE, 2004, UNPUB BIOMACROMOLECU
   PUSKAS JE, 2003, 163 TECHN M SAN FRAN
   PUSKAS JE, 2003, Patent No. 200300665098
   RATTNER BD, 1996, BIOMATERIALS SCI INT
   Robertson CG, 2002, J RHEOL, V46, P307, DOI 10.1122/1.1428318
   Robertson CG, 2001, J RHEOL, V45, P759, DOI 10.1122/1.1357821
   Rodrigues UP, 1996, CHEM MATER, V8, P1375, DOI 10.1021/cm950528g
   RUNT J, 2001, POLYM PREPR, V42, P99
   Ruth WG, 1997, J POLYM SCI POL CHEM, V35, P163
   Santangelo PG, 1999, MACROMOLECULES, V32, P1972, DOI 10.1021/ma9815556
   Scherbakova N. V., 1977, Can. Pat., Patent No. 1019095
   Shamlou S, 1997, J BIOMED MATER RES, V35, P157, DOI 10.1002/(SICI)1097-4636(199705)35:2<157::AID-JBM3>3.0.CO;2-M
   Song J, 2002, J POLYM SCI POL CHEM, V40, P1005, DOI 10.1002/pola.10193
   St Lawrence S, 2001, RUBBER CHEM TECHNOL, V74, P601, DOI 10.5254/1.3544960
   Thomas R. M., 1944, U. S. Patent, Patent No. [2,356,128, 2356128]
   THOMAS RM, 1969, RUBBER CHEM TECHNOL, V42, pG90
   Tomalia DA, 1996, MACROMOL SYMP, V101, P243, DOI 10.1002/masy.19961010128
   Tse MF, 2000, POLYM ENG SCI, V40, P2182, DOI 10.1002/pen.11350
   *US PHARM CONV INC, 1965, USP PHARM US, P902
   vonRecum AF, 1999, HDB BIOMATERIALS EVA
   Weisberg DM, 2000, MACROMOLECULES, V33, P4380, DOI 10.1021/ma9919920
   WILCZEK L, 1987, J MACROMOL SCI CHEM, VA24, P1033, DOI 10.1080/00222338708078141
   WILLIAMS DF, 1986, DEFINITIONS BIOMATER, P49
   WONDRACZEK RH, 1981, POLYM BULL, V4, P445
   Yun JP, 2003, MACROMOLECULES, V36, P1717, DOI 10.1021/ma021618r
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
NR 99
TC 78
Z9 79
U1 0
U2 21
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JUL 1
PY 2004
VL 42
IS 13
BP 3091
EP 3109
DI 10.1002/pola.20114
PG 19
WC Polymer Science
SC Polymer Science
GA 830LW
UT WOS:000222124600001
OA Bronze
DA 2018-10-19
ER

PT J
AU Giacomelli, FC
   Giacomelli, C
   Spinelli, A
AF Giacomelli, FC
   Giacomelli, C
   Spinelli, A
TI Behavior of a Co-Cr-Mo biomaterial in simulated body fluid solutions
   studied by electrochemical and surface analysis techniques
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article; Proceedings Paper
CT 26th Latin American Congress of Chemistry/27th Annual Meeting of the
   Brazilian-Chemical-Society
CY MAY 30-JUN 02, 2004
CL Salvador, BRAZIL
SP Brazilian Chem Soc
DE biomaterial; Co-Cr-Mo alloy; electrochemical behavior; surface analysis
ID CORROSION-RESISTANCE; LOCALIZED CORROSION; AQUEOUS-SOLUTIONS; DIFFERENT
   PH; ALLOY; COBALT; FLUORIDE; NICKEL; MICROSTRUCTURE; CYTOTOXICITY
AB The behavior of a Co-Cr-Mo biomaterial used as dental prosthesis was studied by electrochemical (Open Circuit Potential (OCP) and potentiodynamic polarization) and surface analysis techniques (Scanning Electron Microscopy (SEM) and Energy Dispersive Spectroscopy (EDS)) in artificial saliva, artificial saliva with modified temperature (7degreesC-47degreesC) and pH (1.4-13.4), and containing fluoride (1500 ppm). The results revealed that the surface morphology after potentiodynamic polarization is highly heterogeneous exhibiting three regions of different composition. Soluble metal species such as CrO42- were released to the solution during the potentiodynamic polarization. The electrochemical processes were markedly influenced by solution temperature and pH, whereas the presence of fluoride did not produce changes in the system.
C1 Univ Fed Santa Catarina, Dept Quim, BR-88040900 Florianopolis, SC, Brazil.
RP Spinelli, A (reprint author), Univ Fed Santa Catarina, Dept Quim, BR-88040900 Florianopolis, SC, Brazil.
EM spin@qmc.ufsc.br
RI Spinelli, Almir/G-5771-2012; Giacomelli, Fernando/E-5791-2012;
   GIACOMELLI, CRISTIANO/H-7393-2014
OI Spinelli, Almir/0000-0001-5993-8851; Giacomelli,
   Fernando/0000-0002-6872-9354; GIACOMELLI, CRISTIANO/0000-0002-3283-7396
CR AlKharafi FM, 1997, ELECTROCHIM ACTA, V42, P579, DOI 10.1016/S0013-4686(96)00202-2
   ARVIDSON K, 1980, J DENT RES, V59, P651, DOI 10.1177/00220345800590031601
   Badawy WA, 1998, ELECTROCHIM ACTA, V44, P693, DOI 10.1016/S0013-4686(98)00180-7
   Black J., 1992, BIOL PERFORMANCE MAT
   Bouchard PR, 1996, J BIOMED MATER RES, V32, P37, DOI 10.1002/(SICI)1097-4636(199609)32:1<37::AID-JBM5>3.0.CO;2-Q
   Codaro EN, 2000, RUSS J ELECTROCHEM+, V36, P1117, DOI 10.1007/BF02757531
   Ermolli M, 2001, TOXICOLOGY, V159, P23, DOI 10.1016/S0300-483X(00)00373-5
   Escobedo J, 1996, MATER DESIGN, V17, P79, DOI 10.1016/S0261-3069(96)00036-2
   FISCHER T, 1985, CONTACT DERMATITIS, V12, P93, DOI 10.1111/j.1600-0536.1985.tb01060.x
   Florianovich GM, 1997, ELECTROCHIM ACTA, V42, P879, DOI 10.1016/S0013-4686(96)00327-1
   Fovet Y, 2001, TALANTA, V53, P1053, DOI 10.1016/S0039-9140(00)00592-0
   He DX, 2001, WEAR, V250, P180, DOI 10.1016/S0043-1648(01)00645-7
   Hsu HC, 1998, DENT MATER, V14, P339, DOI 10.1016/S0109-5641(99)00002-0
   Huang HH, 2003, BIOMATERIALS, V24, P275, DOI 10.1016/S0142-9612(02)00315-0
   KILNER T, 1987, J MATER SCI, V22, P565, DOI 10.1007/BF01160770
   Kolotyrkin Ya.M., 1978, DOKL AKAD NAUK SSSR, V243, P1483
   KOLOTYRKIN YM, 1980, ELECTROCHIM ACTA, V25, P89, DOI 10.1016/0013-4686(80)80055-7
   Lemons J., 1999, CORROSION BIODEGRADA, P155
   Messer RLW, 2000, DENT MATER, V16, P207, DOI 10.1016/S0109-5641(00)00010-5
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   Pourbaix M, 1996, ATLAS ELECTROCHEMICA
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Rondelli G, 2002, BIOMATERIALS, V23, P639, DOI 10.1016/S0142-9612(01)00142-9
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   SILVA AYV, 2002, 13 S BRAS EL EL AR B
   STENBERG T, 1982, SCAND J DENT RES, V90, P472
   VALERIA AA, 2002, CORROS SCI, V44, P1949
   VANJOOST T, 1982, ACTA DERM-VENEREOL, V62, P525
   VESTEY JP, 1986, CONTACT DERMATITIS, V15, P119, DOI 10.1111/j.1600-0536.1986.tb01310.x
   VETTER KJ, 1971, ELECTROCHIM ACTA, V16, P1923, DOI 10.1016/0013-4686(71)85147-2
   Yen SK, 2001, BIOMATERIALS, V22, P125, DOI 10.1016/S0142-9612(00)00133-2
NR 31
TC 20
Z9 20
U1 0
U2 7
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD JUL-AUG
PY 2004
VL 15
IS 4
BP 541
EP 547
DI 10.1590/S0103-50532004000400016
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 855HL
UT WOS:000223963900016
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zein: a potential biomaterial for tissue engineering TISSUE NGINEERING
SO MATERIALS TODAY
LA English
DT News Item
CR DONG, 2004, BIOMATERIALS, V25, P4691
NR 1
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD JUL-AUG
PY 2004
VL 7
IS 7-8
BP 24
EP 24
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA V32DL
UT WOS:000208931800020
OA Other Gold
DA 2018-10-19
ER

PT J
AU Kim, HY
   Satoru, H
   Kim, JI
   Hosoda, H
   Miyazaki, S
AF Kim, HY
   Satoru, H
   Kim, JI
   Hosoda, H
   Miyazaki, S
TI Mechanical properties and shape memory behavior of ti-nb alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterial; smart material;
   titanium based alloy
ID MARTENSITIC TRANSFORMATIONS; MO ALLOYS; SUPERELASTICITY
AB Mechanical properties and shape memory behavior of Ti-(20-29)at%Nb alloys were investigated in order to develop Ni-free biomedical shape memory alloys. The Ti-Nb alloys were fabricated by arc melting method. The ingots were cold-rolled with a reduction up to 95% in thickness and then solution treated at 1173 K for 1.8 ks. The martensitic transformation temperature decreased by 43 K per 1 at% increase of Nb content. The shape memory effect and superelastic behavior were observed at room temperature in the Ti-(22-25)at%Nb alloys and Ti-(25.5-27)at%Nb alloys, respectively. A small enthalpy of the martensitic transformation and a large difference between Ms and Mf were observed in the Ti-Nb alloys compared to Ti-Ni shape memory alloys. The maximum recovered strain of 3% was obtained at room temperature in solution treated Ti-(25-27)at%Nb alloys. The heat treatment at 573 K for 3.6 ks stabilized superelastic behavior of Ti-Nb alloys by increasing the critical stress for slip.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligent Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Baker C., 1971, Metal Science Journal, V5, P92
   DAVIS R, 1979, ACTA METALL MATER, V27, P1041, DOI 10.1016/0001-6160(79)90192-5
   DAVIS R, 1979, J MATER SCI, V14, P712
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H, 2001, T MRS J, V26, P243
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   TAKEI F, 1983, SCRIPTA METALL MATER, V17, P987, DOI 10.1016/0036-9748(83)90436-2
NR 17
TC 195
Z9 205
U1 4
U2 61
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2004
VL 45
IS 7
BP 2443
EP 2448
DI 10.2320/matertrans.45.2443
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 845LX
UT WOS:000223245300082
OA Bronze
DA 2018-10-19
ER

PT J
AU Hasebe, N
   Wang, X
   Okumura, M
AF Hasebe, N
   Wang, X
   Okumura, M
TI Conditions for cracking and debond development at partially bonded
   bimaterial half-planes
SO MECHANICS OF COMPOSITE MATERIALS
LA English
DT Article
DE biomaterial; half-plane; interface crack; debonding; stress intensity
   factor; energy release rate
AB Fracture phenomena at the debond tip of partially bonded bimaterial half-planes subjected to concentrated normal forces, couples, and uniform tension are considered. The crack initiation conditions are described by the stress distribution before the initiation and the energy release rate of the crack immediately after the initiation. The debond development conditions are described by the stress distribution and the energy release rate of the debond before its initiation. When both the crack and the debond have chances to occur, or when cracks can arise in both the materials, the fracture phenomena are predicted by comparing the ratio of energy release rates and the ratio of fracture toughnesses.
C1 Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Hasebe, N (reprint author), Nagoya Inst Technol, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
CR ENGLAND AH, 1965, J APPL MECH, V32, P400, DOI 10.1115/1.3625813
   HASEBE N, 1990, J ENG MECH-ASCE, V116, P2017, DOI 10.1061/(ASCE)0733-9399(1990)116:9(2017)
   Hasebe N., 1990, Journal of the Society of Materials Science, Japan, V39, P1405
   Okumura M., 1994, Journal of the Society of Materials Science, Japan, V43, P1564
NR 4
TC 0
Z9 0
U1 0
U2 2
PU CONSULTANTS BUREAU
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0191-5665
J9 MECH COMPOS MATER
JI Mech. Compos. Mater.
PD JUL-AUG
PY 2004
VL 40
IS 4
BP 287
EP 298
DI 10.1023/B:MOCM.0000039746.37812.77
PG 12
WC Mechanics; Materials Science, Composites; Polymer Science
SC Mechanics; Materials Science; Polymer Science
GA 871JD
UT WOS:000225126200003
DA 2018-10-19
ER

PT J
AU Plokhikh, NV
   Soin, AV
   Kuznetsov, AV
   Veresov, AG
   Putlayev, VI
   Tretyakov, YD
AF Plokhikh, NV
   Soin, AV
   Kuznetsov, AV
   Veresov, AG
   Putlayev, VI
   Tretyakov, YD
TI Synthesis of silicon-substituted hydroxylapatite
SO MENDELEEV COMMUNICATIONS
LA English
DT Article
ID HYDROXYAPATITE
AB Silicon-substituted hydroxylapatite was prepared to produce a biomaterial with improved bioactivity via aliovalent anion substitution, which leads to the instability of apatite Ca-5(PO4)(3)OH at T > 900 degreesC and to the formation of a Ca-3(PO4)(2) phase.
C1 Moscow MV Lomonosov State Univ, Dept Mat Sci, Moscow 119992, Russia.
   Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119992, Russia.
RP Veresov, AG (reprint author), Moscow MV Lomonosov State Univ, Dept Mat Sci, Moscow 119992, Russia.
EM veres@inorg.chem.msu.ru
CR Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   LAZORYAK B, 1988, CRYSTALLOGRAPHY USSR, V33, P659
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
NR 6
TC 3
Z9 4
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0959-9436
EI 1364-551X
J9 MENDELEEV COMMUN
JI Mendeleev Commun.
PD JUL-AUG
PY 2004
VL 14
IS 4
BP 178
EP 179
DI 10.1070/MC2004v014n04ABEH001975
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 859EV
UT WOS:000224247100027
DA 2018-10-19
ER

PT J
AU Li, LC
   Gao, JC
   Wang, Y
AF Li, LC
   Gao, JC
   Wang, Y
TI Evaluation of cyto-toxicity and corrosion behavior of
   alkali-heat-treated magnesium in simulated body fluid
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE magnesium; biomaterial; corrosion; cytotoxicity; chloride ion
ID BONE; ION
AB Compared to other popular metallic biomaterials, magnesium has many advantages, which include high specific strength-to-mass ratio, non-toxicity and similar elastic modulus to that of human bone. However, the knowledge gap in corrosion resistance in physiological environment has prevented it from being a substitute for human hard tissues. In this paper, preliminary corrosion tests on magnesium specimens in Simulated Body Fluid (SBF) with and without Cl- ions have been investigated. Cytotoxicity tests were then carried out for developing a new biomaterial. The corrosion results showed that alkali and heat-treated magnesium has relatively high corrosion resistance in SBF, compared to untreated samples. Calcium-phosphate apatites were detected on the treated samples after they had been soaked in SBF for 14 days. In cytotoxicity tests, no signs of morphological changes on cells or inhibitory effect on cell growth were detected. (C) 2004 Elsevier B.V. All rights reserved.
C1 Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.
RP Li, LC (reprint author), Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.
EM lilongchuan@yahoo.com.cn
RI Li, Longchuan/C-7619-2012
OI Li, Longchuan/0000-0002-0559-0754
CR Ambat R, 2000, J APPL ELECTROCHEM, V30, P865, DOI 10.1023/A:1004011916609
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   KIM SG, 1991, J MAT T, V9, P875
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Maker G.L., 1993, INT MATER REV, V3, P138
   MILLER PL, 1995, CORROSION, V51, P922, DOI 10.5006/1.3293568
   RASHMIRRAVEN AM, 1995, J APPL BIOMATER, V6, P237, DOI 10.1002/jab.770060404
   SALIMI MH, 1985, LANGMUIR, V1, P119, DOI 10.1021/la00061a019
NR 9
TC 267
Z9 305
U1 5
U2 57
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 1
PY 2004
VL 185
IS 1
BP 92
EP 98
DI 10.1016/j.surfcoat.2004.01.004
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 836NV
UT WOS:000222563500011
DA 2018-10-19
ER

PT J
AU Lam, JS
   Gupta, M
AF Lam, JS
   Gupta, M
TI Update on ureteral stents
SO UROLOGY
LA English
DT Review
ID DRAINAGE STENT; PORCINE MODEL; ENCRUSTATION; BIOCOMPATIBILITY;
   OBSTRUCTION; BIOMATERIAL; EXPERIENCE; CATHETERS; RETRIEVAL; UROLOGY
C1 Columbia Univ Coll Phys & Surg, Dept Urol, New York Presbyterian Hosp, New York, NY 10032 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA USA.
RP Gupta, M (reprint author), Columbia Univ Coll Phys & Surg, Dept Urol, 161 Ft Washington Ave,Irving Pavil,11th Floor, New York, NY 10032 USA.
CR Amiel GE, 2001, J UROLOGY, V165, P2091, DOI 10.1016/S0022-5347(05)66300-8
   Antimisiaris SG, 2000, J ENDOUROL, V14, P743, DOI 10.1089/end.2000.14.743
   Auge BK, 2002, J UROLOGY, V168, P808, DOI 10.1016/S0022-5347(05)64748-9
   Bitschay J., 1956, HIST UROLOGY EGYPT, P76
   Bloom DA, 1999, UROLOGY, V54, P767, DOI 10.1016/S0090-4295(99)00305-2
   Brauers A, 1998, Tech Urol, V4, P214
   Brewer AV, 1999, J ENDOUROL, V13, P269, DOI 10.1089/end.1999.13.269
   CORMIO L, 1995, J UROLOGY, V153, P494, DOI 10.1097/00005392-199502000-00069
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Denstedt JD, 2000, WORLD J UROL, V18, P237, DOI 10.1007/PL00007074
   Dunn MD, 2000, J ENDOUROL, V14, P195, DOI 10.1089/end.2000.14.195
   Esser JF, 1917, ANN SURG, V65, P297, DOI 10.1097/00000658-191703000-00004
   FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7
   GIBBONS RP, 1974, J UROLOGY, V111, P594, DOI 10.1016/S0022-5347(17)60023-5
   Goodwin WE, 1972, UROL DIG, V11, P13
   HEPPERLEN TW, 1978, J UROLOGY, V119, P731, DOI 10.1016/S0022-5347(17)57613-2
   HERDMAN JP, 1949, BRIT J SURG, V37, P105, DOI 10.1002/bjs.18003714520
   Herman J., 1973, UROLOGY VIEW RETROSP
   KAY A, 2002, J ENDOUROL S, V16, P8
   Kulkarni R, 2001, J UROLOGY, V166, P1750, DOI 10.1016/S0022-5347(05)65667-4
   Liatsikos EN, 2002, UROLOGY, V59, P15, DOI 10.1016/S0090-4295(01)01475-3
   Lingeman JE, 2003, J UROLOGY, V169, P1682, DOI 10.1097/01.ju.0000055600.18515.a1
   Lord JW, 1942, J UROLOGY, V48, P412, DOI 10.1016/S0022-5347(17)70729-X
   Lumiaho J, 1999, J ENDOUROL, V13, P107, DOI 10.1089/end.1999.13.107
   MACALUSO JN, 1989, J UROLOGY, V142, P701, DOI 10.1016/S0022-5347(17)38858-4
   MACK T, 1998, STENTING URINARY SYS, P102
   Mardis Hal K., 2001, Journal of Urology, V165, P362
   MARDIS HK, 1982, UROL CLIN N AM, V9, P95
   MARDIS HK, 1993, J ENDOUROL, V7, P105, DOI 10.1089/end.1993.7.105
   MARMAR JL, 1970, J UROLOGY, V104, P386, DOI 10.1016/S0022-5347(17)61744-0
   MONTIE JE, 1973, FERTIL STERIL, V24, P877
   Multanen M, 2002, UROL RES, V30, P227, DOI 10.1007/s00240-002-0252-7
   MYKULAK DJ, 1994, J UROLOGY, V152, P976, DOI 10.1016/S0022-5347(17)32634-4
   Olweny EO, 2000, UROLOGY, V56, P857, DOI 10.1016/S0090-4295(00)00734-2
   Olweny EO, 2002, J UROLOGY, V167, P2198, DOI 10.1016/S0022-5347(05)65128-2
   ORIKASA S, 1973, J UROLOGY, V110, P184, DOI 10.1016/S0022-5347(17)60154-X
   Pauer W, 1999, J UROLOGY, V162, P319, DOI 10.1016/S0022-5347(05)68549-7
   PHIPPS JH, 1992, BRIT J OBSTET GYNAEC, V99, P81, DOI 10.1111/j.1471-0528.1992.tb14400.x
   Riedl CR, 2002, INT J ANTIMICROB AG, V19, P507, DOI 10.1016/S0924-8579(02)00097-3
   SCHLICK RW, 1998, J ENDOUROL, V12, P151
   Slepian M J, 1996, Semin Interv Cardiol, V1, P103
   Stickler DJ, 2002, INT J ANTIMICROB AG, V19, P499, DOI 10.1016/S0924-8579(02)00091-2
   Stoller ML, 2000, BJU INT, V85, P628, DOI 10.1046/j.1464-410x.2000.00489.x
   Taylor WN, 2002, J UROLOGY, V168, P2020, DOI 10.1097/01.ju.0000033964.15384.e2
   TSCHADA RK, 1994, J ENDOUROL, V8, P119, DOI 10.1089/end.1994.8.119
   TULLOCH W S, 1952, Br J Urol, V24, P42
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Watterson JD, 2003, J ENDOUROL, V17, P269, DOI 10.1089/089277903322145431
   ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6
NR 49
TC 35
Z9 35
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-4295
J9 UROLOGY
JI Urology
PD JUL
PY 2004
VL 64
IS 1
BP 9
EP 15
DI 10.1016/j.urology.2004.03.005
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 837TL
UT WOS:000222663100003
PM 15245923
DA 2018-10-19
ER

PT J
AU Onur, R
   Rajpurkar, A
   Singla, A
AF Onur, R
   Rajpurkar, A
   Singla, A
TI New perineal bone-anchored male sling: Lessons learned
SO UROLOGY
LA English
DT Article
ID ARTIFICIAL URINARY SPHINCTER; POSTPROSTATECTOMY INCONTINENCE;
   PROSTATECTOMY; IMPLANTATION; RADIOTHERAPY; PATIENT; MEN
AB Objectives. To identify factors affecting outcome after the male sling procedure for stress urinary incontinence.
   Methods. A total of 46 incontinent men, with a mean age of 67 years, underwent perineal bone-anchored male sling placement. Three titanium bone screws with preattached pairs of No. 1 polypropylene sutures were placed directly into the medial aspect of each inferior ramus of the pubic bone. To compress the urethra, three different types of materials were used: absorbable biomaterial, silicone-coated polypropylene mesh, or a composite graft. Patient characteristics, incontinence etiology and severity before surgery, prior collagen injections, and type of material used were assessed, and the association with the outcome of the male sling procedure was determined.
   Results. The procedure was successful in 35 (76%) of 46 patients at a mean follow-up of 18 months (range 6 to 30). Nineteen patients were totally dry and 16 had improved 50% or more compared with before surgery. Failure occurred in 11 patients (24%). Patients who received a composite graft or mesh alone had a better outcome compared with the absorbable sling group (97% and 75% versus 0%, respectively, P = 0.001). The severity of pretreatment incontinence also had a negative impact on the outcome.
   Conclusions. Patients with mild-to-moderate incontinence and the use of a composite graft had the best outcomes after the perineal bone-anchored male sling. (C) 2004 Elsevier Inc.
C1 Wayne State Univ, Sch Med, Dept Urol, Detroit, MI 48201 USA.
RP Singla, A (reprint author), Wayne State Univ, Sch Med, Dept Urol, 4160 John R,Suite 1017, Detroit, MI 48201 USA.
OI Onur, Rahmi/0000-0001-6235-0389
CR Cespedes R D, 2001, Tech Urol, V7, P176
   Cespedes R. Duane, 2001, Journal of Urology, V165, P89
   Cespedes RD, 2000, UROLOGY, V55, P5, DOI 10.1016/S0090-4295(99)00418-5
   Clemens JQ, 2001, J UROLOGY, V166, P1372, DOI 10.1016/S0022-5347(05)65772-2
   Comiter CV, 2002, J UROLOGY, V167, P597, DOI 10.1016/S0022-5347(01)69092-X
   Gomha MA, 2002, J UROLOGY, V167, P591, DOI 10.1016/S0022-5347(01)69091-8
   JACOBY K, 2000, SOC URODYNAMICS FEMA
   Litwiller SE, 1996, J UROLOGY, V156, P1975, DOI 10.1016/S0022-5347(01)65408-9
   Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007
   Madjar S, 2001, J UROLOGY, V165, P72, DOI 10.1097/00005392-200101000-00018
   MARTINS FE, 1995, J UROLOGY, V153, P1188, DOI 10.1016/S0022-5347(01)67547-5
   Migliari R, 2003, EUR UROL, V43, P152, DOI 10.1016/S0302-2838(02)00542-0
   PEREZ LM, 1992, J UROLOGY, V148, P1166, DOI 10.1016/S0022-5347(17)36850-7
   Schaeffer AJ, 1998, J UROLOGY, V159, P1510, DOI 10.1097/00005392-199805000-00026
   WANG Y, 1992, J UROLOGY, V147, P612, DOI 10.1016/S0022-5347(17)37320-2
   Wilson TS, 2003, J UROLOGY, V169, P1662, DOI 10.1097/01.ju.0000058020.37744.aa
NR 16
TC 55
Z9 61
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-4295
J9 UROLOGY
JI Urology
PD JUL
PY 2004
VL 64
IS 1
BP 58
EP 61
DI 10.1016/j.urology.2004.03.003
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 837TL
UT WOS:000222663100016
PM 15245936
DA 2018-10-19
ER

PT J
AU Mao, C
   Qiu, YZ
   Sang, HB
   Mei, H
   Zhu, AP
   Shen, J
   Lin, SC
AF Mao, C
   Qiu, YZ
   Sang, HB
   Mei, H
   Zhu, AP
   Shen, J
   Lin, SC
TI Various approaches to modify biomaterial surfaces for improving
   hemocompatibility
SO ADVANCES IN COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE thrombus; surface modification; O-butyrylchitosan; cellulose; blood
   compatibility
ID MOLECULAR-WEIGHT PROTEINS; BLOOD COMPATIBILITY; PLATELET-ADHESION;
   2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE; CARDIOPULMONARY BYPASS;
   CHEMICAL-MODIFICATION; DIALYSIS MEMBRANES; GAMMA-IRRADIATION;
   ENDOTHELIAL-CELLS; VINYL MONOMER
AB In this paper, the mechanism of thrombus formation on the surface of polymeric materials and the various approaches of modifying biomaterial surfaces to improve their hemocompatibility are reviewed. Moreover, the blood compatibility of the cellulose membrane grafted with O-butyrylchitosan (OBCS) by using a radiation grafting technique was studied. Surface analysis of grafted cellulose membrane was verified by attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) and electron spectroscopy for chemical analysis (ESCA), which confirmed that OBCS was successfully grafted onto the cellulose membrane surfaces. Blood compatibility of the grafted cellulose membranes was evaluated by platelet rich plasma (PRP) contacting experiments and protein adsorption experiments using blank cellulose membranes as the control. The blood compatibility of OBCS grafted cellulose membranes is better than that of blank cellulose membranes. These results suggest that the photocrosslinkable chitosan developed here has the potential of serving in blood-contacting applications in medical use. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Shen, J (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Hankou Rd 22, Nanjing 210093, Peoples R China.
EM njusic2002@yahoo.com.cn
CR Aldenhoff YBJ, 1997, BIOMATERIALS, V18, P167, DOI 10.1016/S0142-9612(96)00095-6
   Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   ARTHEL M, 1997, GERINNUNGSANALYSEN
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   CJUANG WY, 1999, BIOMATERIALS, V20, P1479
   Davankov VA, 1997, J CHROMATOGR B, V689, P117, DOI 10.1016/S0378-4347(96)00307-6
   Defraigne JO, 2000, ANN THORAC SURG, V70, P2075, DOI 10.1016/S0003-4975(00)01838-5
   Edgar KJ, 2001, PROG POLYM SCI, V26, P1605, DOI 10.1016/S0079-6700(01)00027-2
   ENGBERS GHM, 1994, T SOC BIOMATER, V17, P109
   FOSTER A, 1998, P NOBCCHE, V25, P127
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Goodman SL, 1996, BIOMATERIALS, V17, P2087, DOI 10.1016/0142-9612(96)00016-6
   GRANT S, 1988, POLYM COMMUN, V29, P342
   Greisler HP, 1996, BIOMATERIALS, V17, P329, DOI 10.1016/0142-9612(96)85571-2
   Gu YJ, 1998, ANN THORAC SURG, V65, P1342, DOI 10.1016/S0003-4975(98)00223-9
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HAYASHI A, 1992, MACROMOLECULES, V25, P5094, DOI 10.1021/ma00045a041
   Heinze T, 2001, PROG POLYM SCI, V26, P1689, DOI 10.1016/S0079-6700(01)00022-3
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Ishihara K, 1999, BIOMATERIALS, V20, P1545, DOI 10.1016/S0142-9612(99)00052-6
   Ishihara K, 1995, ARTIF ORGANS, V19, P1215, DOI 10.1111/j.1525-1594.1995.tb02288.x
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   JAMES H, 1999, BIOMATERIALS, V20, P1533
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   KAMATH KR, 1994, J APPL BIOMATER, V5, P163, DOI 10.1002/jab.770050210
   KAMATH KR, 1994, COLLOID SURFACE B, V2, P471
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   KOREMATSU A, 1999, ACTA POLYM, V50, P636
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lee YL, 2003, APPL SURF SCI, V207, P51, DOI 10.1016/S0169-4332(02)01235-7
   LIN JC, 1995, BIOMATERIALS, V16, P1017
   Martens S, 2003, CARDIOVASC SURG, V11, P159, DOI 10.1016/S0967-2109(02)00111-4
   Moachon N, 2002, BIOMATERIALS, V23, P651, DOI 10.1016/S0142-9612(01)00151-X
   Nho YC, 2003, RADIAT PHYS CHEM, V66, P299, DOI 10.1016/S0969-806X(02)00387-0
   Nojiri C., 1993, ASAIO J, V39, P322
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   POPOWICZ P, 1985, BIOMED BIOCHIM ACTA, V44, P1329
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   Ranby B, 1999, INT J ADHES ADHES, V19, P337, DOI 10.1016/S0143-7496(98)00066-9
   Rhodes NP, 1996, BIOMATERIALS, V17, P1995, DOI 10.1016/0142-9612(96)00018-X
   SALACINSKI HJ, 2001, ARTIF ORGANS, V25, P947
   Suzuki Y, 2003, NUCL INSTRUM METH B, V206, P501, DOI 10.1016/S0168-583X(03)00808-5
   SUZUKI Y, 1991, NUCL INSTRUM METH B, V59, P698, DOI 10.1016/0168-583X(91)95306-X
   Valette P, 1999, BIOMATERIALS, V20, P1621, DOI 10.1016/S0142-9612(99)00070-8
   WACHTFOGEL YT, 1993, THROMB RES, V72, P1, DOI 10.1016/0049-3848(93)90168-N
   Wang DA, 2001, BIOMATERIALS, V22, P1549, DOI 10.1016/S0142-9612(00)00311-2
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Werner C, 1999, COLLOID SURFACE A, V159, P519, DOI 10.1016/S0927-7757(99)00290-3
   Xu JM, 2003, COLLOID SURFACE B, V30, P215, DOI 10.1016/S0927-7765(03)00084-5
   YANG MC, 2003, ADV TECHNOL, V14, P103
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   Zhang J, 2003, COLLOID SURFACE B, V30, P249, DOI 10.1016/S0927-7765(03)00069-9
   Zhao CS, 2003, BIOMATERIALS, V24, P3747, DOI 10.1016/S0142-9612(03)00250-3
NR 64
TC 124
Z9 132
U1 7
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-8686
J9 ADV COLLOID INTERFAC
JI Adv. Colloid Interface Sci.
PD JUN 30
PY 2004
VL 110
IS 1-2
BP 5
EP 17
DI 10.1016/j.cis.2004.02.001
PG 13
WC Chemistry, Physical
SC Chemistry
GA 827CT
UT WOS:000221876900002
PM 15142821
DA 2018-10-19
ER

PT J
AU Senel, S
   McClure, SJ
AF Senel, S
   McClure, SJ
TI Potential applications of chitosan in veterinary medicine
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE chitosan; veterinary; wound healing; tissue regeneration; drug delivery;
   mucosal immunization
ID NASAL DELIVERY SYSTEM; PEPTIDE DRUG-DELIVERY; IN-VIVO DEGRADATION;
   MUCOADHESIVE PROPERTIES; VACCINE DELIVERY; VITRO EVALUATION; DOSAGE
   FORMS; CHITIN; DOGS; RELEASE
AB (C)hitosan is a partially deacetylated polymer obtained from the alkaline deacetylation of chitin which is a glucose-based unbranched polysaccharide widely distributed in nature as the principal component of exoskeletons of crustaceans and insects as well as of cell walls of some bacteria and fungi.
   Chitosan exhibits a variety of physicochemical and biological properties resulting in numerous applications in fields such as waste and water treatment, agriculture, fabric and textiles, cosmetics, nutritional enhancement, and food processing. In addition to its lack of toxicity and allergenicity, and its biocompatibility, biodegradability and bioactivity make it a very attractive substance for diverse applications as a biomaterial in pharmaceutical and medical fields, where it has been used for systemic and local delivery of drugs and vaccines. It also has bioactive properties in its own right.
   This paper reviews current veterinary applications for chitosan including wound healing, bone regeneration, analgesic and antimicrobial effects. It also discusses the potential application of chitosan to drug and vaccine delivery in veterinary species. Given the restrictions imposed by financial and animal restraint considerations, especially in fanning applications, the veterinary drug delivery areas most likely to benefit from chitosan are the delivery of chemotherapeutics such as antibiotics, antiparasitics, anaesthetics, painkillers and growth promotants to mucosal epithelium for absorption for local or systemic activity, and the delivery of immunomodulatory agents to the mucosal associated lymphoid tissue for induction or modulation of local immune responses. The properties of chitosan expected to enhance these functions are discussed, and the future research directions in this field are indicated. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Hacettepe, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey.
   CSIRO Livestock Ind, FD McMaster Lab, Armidale, NSW 2350, Australia.
RP Senel, S (reprint author), Univ Hacettepe, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey.
EM sevda@tr.net
RI senel, sevda/A-4700-2012
CR Bacon A., 1998, Research in Immunology, V149, P98, DOI 10.1016/S0923-2494(98)80068-0
   Begin A, 1999, INT J BIOL MACROMOL, V26, P63, DOI 10.1016/S0141-8130(99)00064-1
   Bowersock TL, 1999, ADV DRUG DELIVER REV, V38, P167, DOI 10.1016/S0169-409X(99)00015-0
   BRYDEN DJ, 2001, MICROBES INFECT, V3, P867
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4
   Cleland WP, 2001, ADV DRUG DELIVER REV, V50, P261, DOI 10.1016/S0169-409X(01)00161-2
   Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7
   Duchene D, 1997, EUR J PHARM BIOPHARM, V44, P15, DOI 10.1016/S0939-6411(97)00097-0
   Dyer AM, 2002, PHARMACEUT RES, V19, P998, DOI 10.1023/A:1016418523014
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Genta I, 1998, CARBOHYD POLYM, V36, P81, DOI 10.1016/S0144-8617(98)00022-8
   Glerentes P, 2002, BIOMATERIALS, V23, P1295
   Gruet P, 2001, ADV DRUG DELIVER REV, V50, P245, DOI 10.1016/S0169-409X(01)00160-0
   Hannant D, 2002, VET IMMUNOL IMMUNOP, V87, P265, DOI 10.1016/S0165-2427(02)00051-X
   He P, 1998, INT J PHARMACEUT, V166, P75, DOI 10.1016/S0378-5173(98)00027-1
   Hillery AM, 1998, PHARM SCI TECHNOL TO, V1, P69, DOI 10.1016/S1461-5347(98)00024-8
   Hussain N, 2001, ADV DRUG DELIVER REV, V50, P107, DOI 10.1016/S0169-409X(01)00152-1
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   Khanal DR, 2001, CARBOHYD POLYM, V44, P99, DOI 10.1016/S0144-8617(00)00216-2
   Khanal DR, 2000, INDIAN VET J, V77, P1085
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   KOJIMA K, 2002, CARBOHYD POLYM, V46, P235
   KOPINGHOGGARD M, 1999, P INT S CONTR REL BI, V26, P795
   Kosaka T, 1996, J VET MED SCI, V58, P963, DOI 10.1292/jvms.58.10_963
   Kotze AF, 1997, INT J PHARM, V159, P243, DOI 10.1016/S0378-5173(97)00287-1
   KRISTL J, 1993, INT J PHARM, V99, P13, DOI 10.1016/0378-5173(93)90317-9
   LANDSVERK T, 1991, VET IMMUNOL IMMUNOP, V28, P1, DOI 10.1016/0165-2427(91)90038-E
   Le Buanec H, 2001, BIOMED PHARMACOTHER, V55, P316, DOI 10.1016/S0753-3322(01)00073-7
   Lim LY, 1999, J BIOMED MATER RES, V48, P111
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   McNeela EA, 2001, VACCINE, V19, P1198
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   Minami S, 1996, CARBOHYD POLYM, V29, P241, DOI 10.1016/0144-8617(95)00157-3
   Minami S., 1999, CHITIN CHITINASES, P265
   Morimoto M, 2001, BIOMACROMOLECULES, V2, P1133, DOI 10.1021/bm010063p
   Muzzarelli RAA, 1998, CARBOHYD POLYM, V36, P267, DOI 10.1016/S0144-8617(98)00008-3
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P925, DOI 10.1016/0142-9612(93)90134-N
   MUZZARELLI RAA, 1999, CHITIN CHITINASES, P251
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Okamoto Y, 2002, CARBOHYD POLYM, V49, P249, DOI 10.1016/S0144-8617(01)00316-2
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Okamoto Y, 2001, CARBOHYD POLYM, V44, P211, DOI 10.1016/S0144-8617(00)00229-0
   Okamoto Y, 1997, CARBOHYD POLYM, V33, P33, DOI 10.1016/S0144-8617(97)00040-4
   Ozmeric N, 2000, J BIOMED MATER RES, V51, P500, DOI 10.1002/1097-4636(20000905)51:3<500::AID-JBM26>3.0.CO;2-P
   Pastoret PP, 1998, HDB VERTEBRATE IMMUN
   Patel D, 2000, INT J PHARM, V200, P271, DOI 10.1016/S0378-5173(00)00396-3
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Rathbone MJ, 2001, ADV DRUG DELIVER REV, V50, P277, DOI 10.1016/S0169-409X(01)00156-9
   Roy K, 1999, NAT MED, V5, P387
   SANFORD PA, 1989, CHITIN CHITOSAN SOUR, P51
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   Seferia P.G., 2001, VACCINE, V19, P661
   Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4
   Senel S, 2000, CHITOSAN PER OS DIET, V5, P241
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Soane RJ, 2001, INT J PHARM, V217, P183, DOI 10.1016/S0378-5173(01)00602-0
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki Y, 2000, CARBOHYD POLYM, V42, P307, DOI 10.1016/S0144-8617(99)00161-7
   SWENSON MJ, 1970, DUKES PHYSL DOMESTIC
   Takeuchi H, 2001, ADV DRUG DELIVER REV, V47, P39, DOI 10.1016/S0169-409X(00)00120-4
   Tasker RAR, 1997, J VET PHARMACOL THER, V20, P362, DOI 10.1046/j.1365-2885.1997.00072.x
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Vachoud L, 2000, CARBOHYD RES, V326, P295, DOI 10.1016/S0008-6215(00)00038-0
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   van der Lubben IM, 2001, BIOMATERIALS, V22, P687, DOI 10.1016/S0142-9612(00)00231-3
   van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1
   Vikhoreva GA, 2001, FIBRE CHEM+, V33, P206, DOI 10.1023/A:1012321719255
   WANG W, 1994, INT J BIOL MACROMOL, V16, P149, DOI 10.1016/0141-8130(94)90042-6
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   WESTERINK MAJ, 2002, VACCINE, V20, P711
   Woodley J, 2001, CLIN PHARMACOKINET, V40, P77, DOI 10.2165/00003088-200140020-00001
   Xu YM, 2003, INT J PHARM, V250, P215, DOI 10.1016/S0378-5173(02)00548-3
   Yeh PY, 1998, ADV DRUG DELIVER REV, V34, P123, DOI 10.1016/S0169-409X(98)00036-2
   Zhang H, 2002, BIOMATERIALS, V23, P2761, DOI 10.1016/S0142-9612(02)00011-X
NR 87
TC 266
Z9 285
U1 7
U2 95
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JUN 23
PY 2004
VL 56
IS 10
BP 1467
EP 1480
DI 10.1016/j.addr.2004.02.007
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 832QB
UT WOS:000222280900009
PM 15191793
DA 2018-10-19
ER

PT J
AU Sen Gupta, A
   Lopina, ST
AF Sen Gupta, A
   Lopina, ST
TI Synthesis and characterization Of L-tyrosine based novel polyphosphates
   for potential biomaterial applications
SO POLYMER
LA English
DT Article
DE biodegradable; L-tyrosine; polyphosphates
ID STRUCTURE-PROPERTY RELATIONSHIPS; HYDROLYTIC DEGRADATION; MEDICAL
   APPLICATIONS; CONTROLLED-RELEASE; DRUG CARRIERS; POLYGLYCOLIDE;
   POLYLACTIDE; POLYANHYDRIDES; POLYMERS; POLY(EPSILON-CAPROLACTONE)
AB Starting from the natural amino-acid L-tyrosine, a diphenolic monomeric molecule was developed using carbodiimide mediated solid-phase synthesis techniques. This monomeric molecule was polymerized by reacting it in equimolar proportions with suitable dihalophosphates to yield novel biodegradable polyphosphates containing peptide linkages and phosphoester linkages alternating in the polymer backbone. The biodegradability of such a polymer is expected to arise from the hydrolytic degradability of the phosphoester linkages and the enzymatic degradability of the peptide linkages in the polymer backbone. Design of such a polymer is expected to make a significant contribution to biomaterials research, regarding drug delivery device and tissue engineering scaffold applications. The monomer was obtained by a novel solid phase carbodiimide-mediated amide coupling process. The subsequent polymers were obtained by solution-phase dehydrochlorination polycondensation reactions in the presence of a suitable acid acceptor. The synthesized polymers were characterized by C-13 NMR P-31 NMR and FTIR for their chemical structure, by GPC for their molecular weight distribution, and by DSC and TGA for their thermal transition characteristics. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Akron, Dept Chem Engn, Akron, OH 44325 USA.
RP Lopina, ST (reprint author), Univ Akron, Dept Chem Engn, 302A Whitby Hall, Akron, OH 44325 USA.
EM lopina@uakron.edu
CR Ashammakhi N, 1997, BIOMATERIALS, V18, P3, DOI 10.1016/S0142-9612(96)00107-X
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   Breitenbach A, 1998, POLYMER, V39, P3261, DOI 10.1016/S0032-3861(97)10077-5
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Coover H. W., 1954, US Pat, Patent No. [2,682,522, 2682522]
   DAHIYAT BI, 1995, J CONTROL RELEASE, V33, P13, DOI 10.1016/0168-3659(94)00039-W
   Domb AJ, 1999, PHARMACEUT RES, V16, P762, DOI 10.1023/A:1011995728760
   Domb AJ, 1998, ACTA POLYM, V49, P526, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<526::AID-APOL526>3.0.CO;2-C
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Epple M, 1998, J BIOMED MATER RES, V43, P83
   Epple M, 1997, J MATER CHEM, V7, P1037, DOI 10.1039/a700275k
   ERTEL SI, 1992, POLYM MAT SCI ENG, V66, P224
   Floudas G, 1998, MACROMOLECULES, V31, P7279, DOI 10.1021/ma9806716
   Gorenstein D. G., 1984, PHOSPHORUS 31 NMR PR
   Gugala Z, 2000, J BIOMED MATER RES, V49, P183, DOI 10.1002/(SICI)1097-4636(200002)49:2<183::AID-JBM5>3.0.CO;2-D
   HAWKINS JA, 1995, ANN THORAC SURG, V60, P55
   HELLER J, 1983, BIODEGRADABLE POLYM, P91
   Holder WD, 1998, J BIOMED MATER RES, V41, P412, DOI 10.1002/(SICI)1097-4636(19980905)41:3<412::AID-JBM11>3.0.CO;2-K
   Hooper KA, 1995, J BIOACT COMPAT POL, V10, P327, DOI 10.1177/088391159501000404
   Jaffe M, 2002, POLYM ADVAN TECHNOL, V13, P926, DOI 10.1002/pat.278
   James K, 1996, TRENDS POLYM SCI, V4, P394
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kissel T, 1996, J CONTROL RELEASE, V39, P315, DOI 10.1016/0168-3659(95)00163-8
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1990, POLYM PREPR, V31, P178
   Kosolapoff G. M., 1950, US Pat, Patent No. [2,495,108, 2495108]
   Lee SH, 2001, J POLYM SCI POL CHEM, V39, P973, DOI 10.1002/1099-0518(20010401)39:7<973::AID-POLA1073>3.0.CO;2-8
   LI NH, 1989, POLYM PREPR, V30, P454
   Li SM, 2003, BIOMACROMOLECULES, V4, P372, DOI 10.1021/bm025748j
   Liu L, 2001, J APPL POLYM SCI, V80, P1976, DOI 10.1002/app.1295
   Mall Julian W, 2002, J Orthop Sci, V7, P535, DOI 10.1007/s007760200095
   MAO H, 1999, Patent No. 5912225
   MOSBO JA, 1977, J ORG CHEM, V42, P1549, DOI 10.1021/jo00429a015
   Muggli DS, 1998, MACROMOLECULES, V31, P4120, DOI 10.1021/ma980108n
   Narendran N, 2002, J APPL POLYM SCI, V84, P701, DOI 10.1002/app.10008
   O'Hagan DT, 1998, ADV DRUG DELIVER REV, V32, P225, DOI 10.1016/S0169-409X(98)00012-X
   Ooi CP, 2002, J BIOMED MATER RES, V63, P280, DOI 10.1002/jbm.10180
   PENCZEK S, 1993, MACROMOLECULES, V26, P2228, DOI 10.1021/ma00061a014
   Perepelkin KE, 2002, FIBRE CHEM+, V34, P85, DOI 10.1023/A:1016359925976
   Porrata P, 2002, CHEM MATER, V14, P4378, DOI 10.1021/cm0205940
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   Renier ML, 1997, J BIOMED MATER RES, V34, P95, DOI 10.1002/(SICI)1097-4636(199701)34:1<95::AID-JBM13>3.0.CO;2-O
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   RICHARDS M, 1991, J POLYM SCI POL CHEM, V29, P1157, DOI 10.1002/pola.1991.080290809
   Schachter DM, 2002, J CONTROL RELEASE, V78, P143, DOI 10.1016/S0168-3659(01)00487-4
   Schwach-Abdellaoui K, 1999, J BIOMAT SCI-POLYM E, V10, P375, DOI 10.1163/156856299X00432
   Schwach-Abdellaoui K, 1999, MACROMOLECULES, V32, P301, DOI 10.1021/ma981517m
   Schwarz K, 1998, MACROMOL RAPID COMM, V19, P613, DOI 10.1002/(SICI)1521-3927(19981201)19:12<613::AID-MARC613>3.3.CO;2-D
   SENGUPTA A, 2004, UNPUB J POL SCI A
   Silver F H, 1992, J Long Term Eff Med Implants, V1, P329
   Sintzel MB, 1998, J CONTROL RELEASE, V55, P213, DOI 10.1016/S0168-3659(98)00051-0
   Sturesson C, 2000, J CONTROL RELEASE, V68, P441, DOI 10.1016/S0168-3659(00)00294-7
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2379, DOI 10.1016/S0142-9612(00)00105-8
   VENBERG EJ, 1999, MACROMOLECULES, V32, P3613
   Young JS, 2000, BIOMATERIALS, V21, P1181, DOI 10.1016/S0142-9612(00)00018-1
   Yuan ML, 2000, MACROMOLECULES, V33, P1613, DOI 10.1021/ma991388p
NR 56
TC 32
Z9 36
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD JUN 21
PY 2004
VL 45
IS 14
BP 4653
EP 4662
DI 10.1016/j.polymer.2004.04.052
PG 10
WC Polymer Science
SC Polymer Science
GA 832RC
UT WOS:000222283600005
DA 2018-10-19
ER

PT J
AU Bettencourt, A
   Calado, A
   Amaral, J
   Alfaia, A
   Vale, FM
   Monteiro, J
   Montemor, MF
   Ferreira, MGS
   Castro, M
AF Bettencourt, A
   Calado, A
   Amaral, J
   Alfaia, A
   Vale, FM
   Monteiro, J
   Montemor, MF
   Ferreira, MGS
   Castro, M
TI Surface studies on acrylic bone cement
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE poly(methyl methacrylate); methyl methacrylate; bone cement; aging;
   surface chemistry; surface energy
ID HYDROXYAPATITE; HYDROPHOBICITY; CARBONATE
AB Poly(methyl methacrylate) (PMMA) is used to fill the gap between the prosthesis and the surrounding bone in cemented arthroplasties. Biocompatibility problems related to bone cement application limit the clinical success of these cemented arthroplasties. Being the cement surface in close connection with the living bone, it is reasonable to assume that surface properties such as, surface composition and surface energy, will play a role in the biomaterial performance. X-ray photoelectron spectroscopy (XPS) analysis and surface energy studies were carried out during 4 months, in order to assess a possible correlation between aging time and surface changes. The aging of PMMA, in a biological model fluid, strongly influences the composition and wettability of the cement surface. These changes may be explained through the hydrolysis of PMMA ester groups and the subsequent hydrogen bonding. Although our study does not exactly reproduce the in vivo environment surrounding a prosthesis, it suggests that the changes in the composition and wettability of the surface may modulate the host response towards the implant, thus contributing to its loosening. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Lisbon, Fac Farm, P-1649003 Lisbon, Portugal.
   Univ Lisbon, Fac Ciencias, Ctr Electroquim & Cinet, P-1649003 Lisbon, Portugal.
   Univ Lisbon, Fac Med, P-1649003 Lisbon, Portugal.
   Hosp Santa Maria, Serv Ortopedia, Lisbon, Portugal.
   Univ Tecn Lisboa, Inst Super Tecn, Dept Eng Quim, P-1096 Lisbon, Portugal.
   Univ Lisbon, Fac Farm, Ctr Estudos Ciencias Farmaceut, P-1699 Lisbon, Portugal.
RP Bettencourt, A (reprint author), Univ Lisbon, Fac Farm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.
EM asimao@ff.ul.pt
RI Alfaia, Antonio/B-4887-2008; Bettencourt, Ana/M-4219-2013; iMed.ULisboa,
   CBT/B-4215-2014; iMed.ULisboa, iMed.ULisboa/C-6292-2014; Ferreira,
   Mario/D-5869-2014; Calado, Antonio/M-4647-2014; MONTEMOR,
   FATIMA/D-8976-2012; Castro, Matilde/A-9468-2014
OI Alfaia, Antonio/0000-0003-1130-300X; Bettencourt,
   Ana/0000-0002-8498-5892; Ferreira, Mario/0000-0002-2071-9851; Calado,
   Antonio/0000-0003-4110-0182; MONTEMOR, FATIMA/0000-0001-7835-6814;
   Castro, Matilde/0000-0002-6314-8251; Monteiro, Jacinto Manuel de Melo
   Oliveira/0000-0002-4067-200X
CR Bettencourt A, 2002, INT J PHARM, V241, P97, DOI 10.1016/S0378-5173(02)00136-9
   Briggs D., 1990, PRACTICAL SURFACE AN
   BRIGGS D, 1992, HIGH RESOLUTION XPS, P118
   COURY AJ, 1996, BIOMATER SCI, V11, P243
   EURANTO EK, 1969, CHEM CARBOXYLIC ACID, P529
   Hughes KF, 2003, J BIOMED MATER RES A, V65A, P126, DOI 10.1002/jbm.a.10373
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Wu S., 1971, J POLYM SCI C, V34, P19, DOI DOI 10.1002/POLC.5070340105
   Zanchetta P, 2001, COLLOID SURFACE B, V22, P301, DOI 10.1016/S0927-7765(01)00200-4
NR 12
TC 14
Z9 15
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD JUN 18
PY 2004
VL 278
IS 1
BP 181
EP 186
DI 10.1016/j.ijpharm.2004.03.011
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 829ZR
UT WOS:000222091900016
PM 15158960
DA 2018-10-19
ER

PT J
AU Malcolm, RK
   McCullagh, SD
   Woolfson, AD
   Gorman, SP
   Jones, DS
   Cuddy, J
AF Malcolm, RK
   McCullagh, SD
   Woolfson, AD
   Gorman, SP
   Jones, DS
   Cuddy, J
TI Controlled release of a model antibacterial drug from a novel
   self-lubricating silicone biomaterial
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE silicone; elastomer; cross-linker; oleyl alcohol; metronidazole
ID INTRAVAGINAL RING; URINARY CATHETERS; DELIVERY; DESIGN;
   17-BETA-ESTRADIOL; ENCRUSTATION
AB There is considerable interest in developing medical devices that provide controlled delivery of biologically active agents, for example, to reduce the incidence of device-related infection. Silicone elastomers are one of the commonest biomaterials used in medical device production. However, they have a relatively high coefficient of friction and the resulting lack of lubricity can cause pain and tissue damage on device insertion and removal. Novel silicone cross-linking agents have recently been reported that produce inherently 'self-lubricating' silicone elastomers with very low coefficients of friction. In this study, the model antibacterial drug metronidazole has been incorporated into these self-lubricating silicone elastomers to produce a novel bioactive biomaterial. The in vitro release characteristics of the bioactive component were evaluated as a function of crosslinker composition and drug loading. Although conventional matrix-type release kinetics were observed for metronidazole from the silicone systems, it was also observed that increasing the concentration of the cross-linking agent responsible for the lubricious character (tetra(oleyloxy)silane) relative to that of the standard non-lubricious cross-linking agent (tetrapropoxysilane) produced an increase in the metronidazole flux rate by up to 65% for a specified drug loading. The results highlight the potential for developing lubricious silicone medical devices with enhanced drug release characteristics. (C) 2004 Elsevier B.V. All rights reserved.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
RP Woolfson, AD (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM d.woolfson@qub.ac.uk
CR BIBBY JM, 1995, CELL MATER, V5, P183
   CHIEN YW, 1992, DRUG PHARM SCI, V50, P43
   COX AJ, 1989, J UROLOGY, V142, P1347, DOI 10.1016/S0022-5347(17)39095-X
   HIGUCHI WI, 1960, J AM PHARM ASSOC, V49, P598, DOI 10.1002/jps.3030490910
   Jones DS, 2001, J MATER SCI-MATER M, V12, P15, DOI 10.1023/A:1026744732504
   KHOURY AE, 1991, J UROLOGY, V145, P610, DOI 10.1016/S0022-5347(17)38405-7
   Malcolm R. K., 2003, J CONTROL RELEASE, V91, P355
   Malcolm R.K., 2003, MODIFIED RELEASE DRU, P775
   Malcolm RK, 2002, BIOMATERIALS, V23, P3589, DOI 10.1016/S0142-9612(02)00086-8
   Malcolm RK, 2003, J CONTROL RELEASE, V90, P217
   Marion-Ferey K, 2003, J HOSP INFECT, V53, P64, DOI 10.1053/jhin.2002.1320
   Mc Cullagh SD, 2004, J MATER CHEM, V14, P1093, DOI 10.1039/b313483k
   Russell JA, 2000, J CHROMATOGR B, V744, P157, DOI 10.1016/S0378-4347(00)00248-6
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   VANDERWEIJ FW, 1980, MAKROMOL CHEM, V181, P2541
   Woolfson AD, 2003, J MATER CHEM, V13, P2465, DOI 10.1039/b306578b
   Woolfson AD, 2000, CRIT REV THER DRUG, V17, P509
   Woolfson AD, 2003, J CONTROL RELEASE, V91, P465, DOI 10.1016/S0168-3659(03)00277-3
   Woolfson AD, 1999, J CONTROL RELEASE, V61, P319, DOI 10.1016/S0168-3659(99)00148-0
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
NR 20
TC 42
Z9 44
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUN 18
PY 2004
VL 97
IS 2
BP 313
EP 320
DI 10.1016/j.jconrel.2004.03.029
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 832VN
UT WOS:000222295600012
PM 15196758
DA 2018-10-19
ER

PT J
AU Quick, DJ
   Macdonald, KK
   Anseth, KS
AF Quick, DJ
   Macdonald, KK
   Anseth, KS
TI Delivering DNA from photocrosslinked, surface eroding polyanhydrides
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE controlled release; gene delivery; photopolymerization
ID PLASMID DNA; DRUG-DELIVERY; PLGA MICROSPHERES; DEGRADABLE NETWORKS;
   REACTION BEHAVIOR; POLYMER NETWORKS; GENE DELIVERY; IN-VITRO; RELEASE;
   ENCAPSULATION
AB Sustained delivery of DNA has the potential to enhance long-term gene therapy; however, precise control of a wide range of DNA release profiles may be needed. In this work, multifunctional anhydride monomers were photocrosslinked to produce hydrophobic, highly crosslinked polymer networks that degrade by surface erosion. Surface-eroding polymers can deliver molecules of a wide range of sizes at sustained, steady rates, which is advantageous for DNA delivery, where the high molecular weight may complicate control of the release profiles. When plasmid DNA was released from photocrosslinked polyanhydride matrices, DNA recovery was low ( similar to 25%). Electrophoresis indicated that the plasmid DNA was released primarily in the relaxed and supercoiled forms, yet the relative fraction of released DNA in the supercoiled form decreased over time. To improve DNA recovery and reduce the damaging effects of polymer degradation, DNA was pre-encapsulated in alginate microparticles, which served as a temporary coating that quickly dissolved upon microparticle release from the polyanhydride matrix. As photocrosslinked polyanhydrides have highly predictable drug release profiles that depend on the polymer erosion rate and implant geometry and not on the entrapped molecule size, they can serve dual purposes in many biomaterial applications where structural support and drug release would be beneficial. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, ECCH 111,UCB 424, Boulder, CO 80309 USA.
CR Abukawa H, 2003, J ORAL MAXIL SURG, V61, P94, DOI 10.1053/joms.2003.50015
   Adachi N, 2002, J RHEUMATOL, V29, P1920
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   ANSETH KS, 1994, POLYMER, V35, P3243, DOI 10.1016/0032-3861(94)90129-5
   Anseth KS, 2001, MACROMOL RAPID COMM, V22, P564, DOI 10.1002/1521-3927(20010501)22:8<564::AID-MARC564>3.0.CO;2-S
   Atuah KN, 2003, J MICROENCAPSUL, V20, P387, DOI 10.1080/0265204031000093041
   Benoit MA, 2001, J DRUG TARGET, V9, P253, DOI 10.3109/10611860108997934
   Berrada M, 2002, INT J RADIAT ONCOL, V54, P1550, DOI 10.1016/S0360-3016(02)03740-9
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Burkoth AK, 1999, MACROMOLECULES, V32, P1438, DOI 10.1021/ma9814651
   Burkoth AK, 2000, J BIOMED MATER RES, V51, P352
   Capan Y, 1999, PHARMACEUT RES, V16, P509, DOI 10.1023/A:1018862827426
   Cohen H, 2000, GENE THER, V7, P1896, DOI 10.1038/sj.gt.3301318
   Domb AJ, 1999, PHARMACEUT RES, V16, P762, DOI 10.1023/A:1011995728760
   Eliaz RE, 2002, GENE THER, V9, P1230, DOI 10.1038/sj.gt.3301786
   Gander B, 2001, CHIMIA, V55, P212
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Gopferich A, 2002, ADV DRUG DELIVER REV, V54, P911, DOI 10.1016/S0169-409X(02)00051-0
   Hao T, 2000, J CONTROL RELEASE, V69, P249, DOI 10.1016/S0168-3659(00)00304-7
   Hirosue S, 2001, J CONTROL RELEASE, V70, P231, DOI 10.1016/S0168-3659(00)00353-9
   Hsu YY, 1999, J DRUG TARGET, V7, P313, DOI 10.3109/10611869909085514
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   Li LC, 2002, ADV DRUG DELIVER REV, V54, P963
   LIN HH, 1987, CLIN RES, V35, pA820
   Lu SX, 2000, J PHARM SCI, V89, P45, DOI 10.1002/(SICI)1520-6017(200001)89:1<45::AID-JPS5>3.0.CO;2-8
   Lunsford L, 2000, J DRUG TARGET, V8, P39, DOI 10.3109/10611860009009208
   MASTERS DB, 1993, PHARMACEUT RES, V10, P1527, DOI 10.1023/A:1018995913972
   Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0
   Muggli DS, 1998, MACROMOLECULES, V31, P4120, DOI 10.1021/ma980108n
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   QUICK DJ, 2003, J PHARM SCI, V20, P1730
   Quong D, 1998, BIOTECHNOL BIOENG, V60, P124, DOI 10.1002/(SICI)1097-0290(19981005)60:1<124::AID-BIT14>3.0.CO;2-Q
   Richardson TP, 2001, CRIT REV EUKAR GENE, V11, P47
   Roy K, 2003, MOL THER, V7, P401, DOI 10.1016/1525-0016(03)00008-X
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Tarcha PJ, 2001, J POLYM SCI POL CHEM, V39, P4189, DOI 10.1002/pola.10073
   Walter E, 1999, J CONTROL RELEASE, V61, P361, DOI 10.1016/S0168-3659(99)00151-0
   Wang PP, 2002, ADV DRUG DELIVER REV, V54, P987, DOI 10.1016/S0169-409X(02)00054-6
NR 43
TC 66
Z9 69
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUN 18
PY 2004
VL 97
IS 2
BP 333
EP 343
DI 10.1016/j.jconrel.2004.03.001
PG 11
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 832VN
UT WOS:000222295600014
PM 15196760
DA 2018-10-19
ER

PT J
AU Zhou, Y
   Doerschuk, CM
   Anderson, JM
   Marchant, RE
AF Zhou, Y
   Doerschuk, CM
   Anderson, JM
   Marchant, RE
TI Biomaterial surface-dependent neutrophil mobility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE neutrophils; mobility; biomaterials; AFM; time lapse
ID CELL-MIGRATION; STAPHYLOCOCCUS-EPIDERMIDIS; MYOSIN-II; CHEMOTAXIS;
   DICTYOSTELIUM; INFECTIONS; MOTILITY; ADHESION; SHAPE
AB Compromised neutrophil function in the presence of an implanted biomaterial may represent an important mechanism that allows for the development of implant-associated infections. Here, human neutrophil mobility has been investigated on a polyurethane (ChronoFlex AR), a hydrophobic surface consisting of an octadecyltrichlorosilane (OTS) self-assembled monolayer, and a glass reference material. Neutrophil mobility was quantified, based on cell movement speed and persistence time obtained from time-lapse optical microscopy, while neutrophil cytoskeletal structures and morphology were visualized using confocal microscopy and atomic force microscopy. Our results show that material surface properties affect neutrophil-surface interactions, as reflected by morphological changes, and the mobility of neutrophils stimulated by N-formylmethionyl-leucyl-phenylalanine (fMLP). In the absence of adsorbed plasma proteins, the mobility of stimulated neutrophils increased with increasing material hydrophobicity from glass, to polyurethane, to OTS. The opposite trend was observed in the presence of adsorbed plasma proteins, such that neutrophil mobility increased with decreasing material hydrophobicity. Analysis of the results showed that the mobility of fMLP-stimulated neutrophils cells was inversely related to the extent of cell spreading on the materials. (C) 2004 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Marchant, RE (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Wickenden Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM rxm40@po.cwru.edu
FU NIBIB NIH HHS [EB 00279]
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Anderson JM, 2000, INFECT ASS INDWELLIN, P89, DOI 10.1128/9781555818067.ch5
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   DIMILLA PA, 1992, AICHE J, V38, P1092, DOI 10.1002/aic.690380712
   Dunn G A, 1983, Agents Actions Suppl, V12, P14
   Edwards SW, 1994, BIOCH PHYSL NEUTROPH
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Hallett MB, 1997, BIOESSAYS, V19, P615, DOI 10.1002/bies.950190712
   Henke PK, 1998, AM SURGEON, V64, P39
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Indorf AS, 1999, J INFECT DIS, V180, P1603, DOI 10.1086/315081
   JACKIE JM, 1983, AGENTS ACTIONS S, V12, P73
   KELLER HU, 1983, CELL MOTIL CYTOSKEL, V3, P47, DOI 10.1002/cm.970030105
   Koehl G, 2002, CELL BIOL INT, V26, P287, DOI 10.1006/cbir.2001.0855
   LAMBA NMK, 2001, HEMOSTASIS THROMBOSI, P661
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Shelden E, 1996, CELL MOTIL CYTOSKEL, V35, P59, DOI 10.1002/(SICI)1097-0169(1996)35:1<59::AID-CM5>3.3.CO;2-R
   SHIELDS JM, 1985, J CELL SCI, V74, P75
   SLACK SM, 1995, PROTEINS INTERFACES, V2, P112
   STICKLER DJ, 1995, CELL MATER, V5, P167
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233
   WESSELS D, 1994, CELL MOTIL CYTOSKEL, V27, P1, DOI 10.1002/cm.970270102
   WILKINSON PC, 1982, J IMMUNOL METHODS, V51, P133, DOI 10.1016/0022-1759(82)90253-8
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 29
TC 13
Z9 13
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2004
VL 69A
IS 4
BP 611
EP 620
DI 10.1002/jbm.a.30015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 827HR
UT WOS:000221890800003
PM 15162402
DA 2018-10-19
ER

PT J
AU Collier, TO
   Anderson, JM
   Brodbeck, WG
   Barber, T
   Healy, KE
AF Collier, TO
   Anderson, JM
   Brodbeck, WG
   Barber, T
   Healy, KE
TI Inhibition of macrophage development and foreign body giant cell
   formation by hydrophilic interpenetrating polymer network
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophage development; foreign body giant cells; hydrophilic
   interpenetrating polymer networks
ID PROTEIN SURFACE INTERACTIONS; PERIPHERAL-BLOOD MONOCYTES; POLYETHYLENE
   OXIDE; SEPRACELL-MN; ADHESION; ADSORPTION; FUSION; RHO; PURIFICATION;
   CYTOSKELETON
AB The ability of monocytes to adhere, differentiate into macrophages, and fuse to form foreign body giant cells (FBGCs) on an implanted material surface is a critical step toward biomaterial degradation. Novel homogenous surfaces were utilized to mediate adhesion. These surfaces consisted of N-(2 aminoethyl)-3-aminopropyltrimethoxysilane (EDS) and an interpenetrating polymer network (IPN) of polyacrylamide and poly(ethylene glycol). These surfaces were designed to control cell adhesion and morphology and mediate cell differentiation, activation, metabolic ability, and apoptosis, resulting in a reduced or controlled inflammatory response. The EDS surface promotes cell adhesion and the IPN minimizes protein adsorption and subsequent cell adhesion. Both surfaces had similar cellular adhesion rates at each respective time point. However, the adherent macrophage morphology was similar at 2 h and day 3, and at days 7 and 10 adherent macrophages on the EDS surface formed FBGCs (46% at day 7 and 40% at day 10). Adherent cells on the IPN surface did not form FBGCs but instead formed monocyte aggregates (73% of adherent cells formed aggregates at day 7 and 63% at day 10). It is indicated that the two surface chemistries differentially controlled monocyte differentiation into macrophages and subsequent macrophage fusion to form FBGCs. (C) 2004 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
EM jma6@po.cwru.edu
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j
   Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CHAIKOF EL, 1990, AICHE J, V36, P994, DOI 10.1002/aic.690360704
   COLLIER TO, 2000, 6 WORLD BIOM C T KAM, P75
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DENHOLM EM, 1991, J IMMUNOL METHODS, V144, P247, DOI 10.1016/0022-1759(91)90092-T
   GAD SC, 1986, STAT EXPT DESIGN TOX, P70
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459
   Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Ory S, 2000, J CELL SCI, V113, P1177
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Thomas CH, 1999, J BIOMECH ENG-T ASME, V121, P40, DOI 10.1115/1.2798041
   VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 29
TC 30
Z9 30
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2004
VL 69A
IS 4
BP 644
EP 650
DI 10.1002/jbm.a.30030
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 827HR
UT WOS:000221890800007
PM 15162406
DA 2018-10-19
ER

PT J
AU Wilson, K
   Stuart, SJ
   Garcia, A
   Latour, RA
AF Wilson, K
   Stuart, SJ
   Garcia, A
   Latour, RA
TI A molecular modeling study of the effect of surface chemistry on the
   adsorption of a fibronectin fragment spanning the 7-10th type-III
   repeats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE protein adsorption; fibronectin; molecular modeling; self-assembled
   monolayers; biomaterials
ID THEORETICAL-ANALYSIS; PROTEIN ADSORPTION; VARYING FUNCTIONALITY;
   DYNAMICS SIMULATIONS; INTEGRIN BINDING; POLYMER SURFACES; PEPTIDE
   RESIDUES; SOLID-SURFACES; SAM SURFACES; THERMODYNAMICS
AB Although it is well documented that proteins adsorb onto biomaterial surfaces, relatively little is quantitatively understood about the effects of adsorption on protein orientation and conformation. Because this is the primary determining factor of protein bioactivity, the ability to accurately predict a protein's orientation and conformation following adsorption will be essential for the rational design of biomaterial surfaces to control biological responses. Force field-based computational chemistry methods provide an excellent means to theoretically address this issue, with the nontrivial requirement that the force field must be tailored to appropriately represent protein adsorption behavior. Accordingly, we have modified an existing force field (CHARMm) based on semiempirical quantum-mechanical peptide adsorption data to enable it to simulate protein adsorption behavior in an implicit aqueous environment. This modified force field was then applied to predict the adsorption behavior of the 7-10 type III repeats of fibronectin on functionalized surfaces. Predicted changes in adsorption energy and adsorption-induced conformation as a function of surface chemistry were found to correlate well with experimentally observed trends for these same systems. This work represents a first attempt towards the development of a molecular mechanics force field that is specifically parameterized to accurately simulate protein adsorption to biomaterial surfaces. (C) 2004 Wiley Periodicals, Inc.
C1 Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   Clemson Univ, Dept Chem, Hunter Labs, Clemson, SC 29634 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, 501 Rhodes Engn Res Bldg, Clemson, SC 29634 USA.
EM LatourR@clemson.edu
RI Stuart, Steven/H-1111-2012
CR ALLINGER NL, 1998, ENCY COMPUTATIONAL C
   ANDRADE JK, 1992, PURE APPL CHEM, V62, P1777
   Basalyga DM, 2003, J BIOMED MATER RES A, V64A, P120, DOI 10.1002/jbm.a.10360
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Bujnowski AM, 1998, J COLLOID INTERF SCI, V203, P47, DOI 10.1006/jcis.1998.5477
   DUNCAN EHJ, 1995, J BIOL CHEM, V270, P21612
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351
   Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4
   Latour RA, 2002, BIOMATERIALS, V23, P4633, DOI 10.1016/S0142-9612(02)00213-2
   Latour RA, 2002, J BIOMED MATER RES, V60, P564, DOI 10.1002/jbm.10052
   LATOUR RA, 1999, CURR OPIN SOLID ST M, V3, P413
   Leach AR, 1996, MOL MODELING PRINCIP
   LU DR, 1993, J BIOMAT SCI-POLYM E, V4, P323, DOI 10.1163/156856293X00591
   MACHERELL AD, 1998, ENCY COMPUTATIONAL C
   Mantero S, 2002, J BIOMED MATER RES, V59, P329, DOI 10.1002/jbm.1249
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   NOINVILLE V, 1995, J PHYS CHEM-US, V99, P1516, DOI 10.1021/j100005a023
   Norde W, 1996, MACROMOL SYMP, V103, P5, DOI 10.1002/masy.19961030104
   Nordgren CE, 2002, BIOPHYS J, V83, P2906, DOI 10.1016/S0006-3495(02)75300-9
   Tobias DJ, 1996, BIOPHYS J, V71, P2933, DOI 10.1016/S0006-3495(96)79497-3
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Xu XHN, 1998, SCIENCE, V281, P1650, DOI 10.1126/science.281.5383.1650
NR 28
TC 37
Z9 38
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2004
VL 69A
IS 4
BP 686
EP 698
DI 10.1002/jbm.a.30042
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 827HR
UT WOS:000221890800012
PM 15162411
DA 2018-10-19
ER

PT J
AU Young, IM
   Crawford, JW
AF Young, IM
   Crawford, JW
TI Interactions and self-organization in the soil-microbe complex
SO SCIENCE
LA English
DT Review
ID SOLUTE TRANSPORT; STRUCTURED SOILS; SCIENCE; ECOLOGY; MODELS
AB Soil is the most complicated biomaterial on the planet. As with any material, the physical habitat is of prime importance in determining and regulating biological activity. However, until recently the opaque nature of soil has meant that any interrogation of its interior architecture has been relatively rudimentary, restricted to simple qualitative expressions of the physical heterogeneity that fail to relate to any specific function. However, new techniques and insights into the biophysical and biochemical processes of this inner space are leading to the developments of theoretical frameworks and experimental approaches that will allow us to sustainably manage Earth's most important resource. We introduce the concept that the soil-microbe system is self-organized and suggest new priorities for research based on an integrative approach that combines biochemistry and biophysics.
C1 Univ Abertay, SIMBIOS, Dundee DD1 1HG, Scotland.
RP Young, IM (reprint author), Univ Abertay, SIMBIOS, Bell St, Dundee DD1 1HG, Scotland.
EM imy@tay.ac.uk
RI Young, Iain/C-9210-2011
OI Young, Iain/0000-0002-7588-9006
CR Arah JRM, 1995, EUR J SOIL SCI, V46, P507, DOI 10.1111/j.1365-2389.1995.tb01347.x
   Baveye P, 1998, SOIL SCI SOC AM J, V62, P1469, DOI 10.2136/sssaj1998.03615995006200050046x
   Baveye P., 1998, FRACTALS SOIL SCI AD
   Bejat L, 2000, SOIL SCI SOC AM J, V64, P818, DOI 10.2136/sssaj2000.643818x
   Bunde A., 1991, FRACTALS DISORDERED
   Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0
   Crawford JW, 1997, EUR J SOIL SCI, V48, P643, DOI 10.1046/j.1365-2389.1997.00118.x
   CRAWFORD JW, 1996, INT UNION PURE APPL, V4
   CRESTANA S, 1986, SOIL SCI, V142, P56, DOI 10.1097/00010694-198607000-00008
   Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5
   Favis-Mortlock D, 1998, COMPUT GEOSCI, V24, P353, DOI 10.1016/S0098-3004(97)00116-7
   FOSTER RC, 1988, BIOL FERT SOILS, V6, P189
   Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6
   Hartmann A, 1998, SOIL TILL RES, V47, P67, DOI 10.1016/S0167-1987(98)00074-9
   Keil FJ, 1999, CATAL TODAY, V53, P245, DOI 10.1016/S0920-5861(99)00119-4
   LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425
   LETEY J, 1991, AUST J SOIL RES, V29, P699, DOI 10.1071/SR9910699
   Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088
   MEAKIN P, 1990, MATER RES SOC SYMP P, V180, P141, DOI 10.1557/PROC-180-141
   Nunan N, 2002, MICROBIAL ECOL, V44, P296, DOI 10.1007/s00248-002-2021-0
   Nunan N, 2003, FEMS MICROBIOL ECOL, V44, P203, DOI 10.1016/S0168-6496(03)00027-8
   OUSSAR M, 1993, SOIL TECHNOL, V6, P329
   Rappoldt C, 1999, GEODERMA, V88, P329, DOI 10.1016/S0016-7061(98)00112-8
   Stirzaker RJ, 1996, PLANT SOIL, V185, P151, DOI 10.1007/BF02257571
   TISDALL JM, 1982, J SOIL SCI, V23, P821
   Vogel HJ, 2000, EUR J SOIL SCI, V51, P99, DOI 10.1046/j.1365-2389.2000.00275.x
   Young IM, 2001, PROTIST, V152, P123, DOI 10.1078/1434-4610-00050
   Young IM, 2000, SOIL TILL RES, V53, P201, DOI 10.1016/S0167-1987(99)00106-3
   YOUNG IM, 2000, SOIL TILL RES, V61, P33
   Zhang XX, 2002, ADV WATER RESOUR, V25, P1, DOI 10.1016/S0309-1708(01)00047-1
NR 30
TC 332
Z9 379
U1 25
U2 275
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD JUN 11
PY 2004
VL 304
IS 5677
BP 1634
EP 1637
DI 10.1126/science.1097394
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 827WL
UT WOS:000221934300039
PM 15192219
DA 2018-10-19
ER

PT J
AU Paszti, Z
   Wang, J
   Clarke, ML
   Chen, Z
AF Paszti, Z
   Wang, J
   Clarke, ML
   Chen, Z
TI Sum frequency generation vibrational spectroscopy studies of protein
   adsorption on oxide-covered Ti surfaces
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID BOVINE SERUM-ALBUMIN; MOLECULAR CHEMICAL-STRUCTURE; INTERFACIAL
   WATER-STRUCTURE; DISCHARGE PLASMA TREATMENT; SCANNING FORCE MICROSCOPY;
   LIQUID-LIQUID INTERFACE; HYDROPHOBIC SURFACES; POLYMER SURFACES;
   METAL-SURFACES; TITANIUM
AB Sum frequency generation (SFG) vibrational spectroscopy has been applied to study protein adsorption on native oxide-covered polycrystalline Ti surfaces. We demonstrated that both H2O2 solution cleaning and plasma treating can effectively eliminate the unavoidable natural hydrocarbon contamination formed during storage of Ti samples in air. As the presence and potential biological role of this contamination has been a concern of recent studies of inorganic biomaterial interfaces, comparison of the protein adsorption behaviors on the contaminated and cleaned Ti samples has been performed using SFG. Various experiments indicate that hydrocarbon contamination does not greatly affect adsorption of soft proteins on native oxide-covered Ti surfaces. Additional SFG studies show that methyl groups of adsorbed bovine serum albumin have a relatively ordered structure on oxidized Ti, which is slightly affected by the cleaning method. Our data also reveal time-dependent changes of the protein structures during the adsorption process.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Chen, Z (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
EM zhanc@umich.edu
RI Chen, Zhan/G-8312-2016
OI Chen, Zhan/0000-0001-8687-8348; Clarke, Matthew/0000-0001-6776-5575
CR Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   BAIN CD, 1995, J CHEM SOC FARADAY T, V91, P1281, DOI 10.1039/ft9959101281
   BALAZS DJ, IN PRESS BIOMATERIAL
   BRANEMARK PI, 1985, TISSUE INTEGRATED PR
   Brash JL, 1987, ACS S SERIES, V343
   Briggman KA, 2001, J PHYS CHEM B, V105, P2785, DOI 10.1021/jp0037495
   Chen C, 2002, LANGMUIR, V18, P1302, DOI 10.1021/la0107805
   Chen Z, 2002, ANNU REV PHYS CHEM, V53, P437, DOI 10.1146/annurev.physchem.53.091801.115126
   Chen Z, 2000, J AM CHEM SOC, V122, P10615, DOI 10.1021/ja000808j
   Chen Z, 2002, J BIOMED MATER RES, V62, P254, DOI 10.1002/jbm.10075
   Cho JS, 2003, PROG ORG COAT, V48, P251, DOI 10.1016/S0300-9440(03)00098-5
   Conboy JC, 1996, J PHYS CHEM-US, V100, P7617, DOI 10.1021/jp953616x
   Eisenthal KB, 1996, CHEM REV, V96, P1343, DOI 10.1021/cr9502211
   FAUCHEUX N, IN PRESS BIOMATERIAL
   Gautam KS, 2000, PHYS REV LETT, V85, P3854, DOI 10.1103/PhysRevLett.85.3854
   Gautam KS, 2001, MACROMOLECULES, V34, P1137, DOI 10.1021/ma0015976
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V218, P404, DOI 10.1006/jcis.1999.6434
   Gracias DH, 1999, ACCOUNTS CHEM RES, V32, P930, DOI 10.1021/ar990034f
   Gragson DE, 1998, J PHYS CHEM B, V102, P3847, DOI 10.1021/jp9806011
   HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120
   HIROSE C, 1992, APPL SPECTROSC, V46, P1051, DOI 10.1366/0003702924124385
   HIROSE C, 1993, J PHYS CHEM-US, V97, P10064, DOI 10.1021/j100141a028
   Horbett TA, 1995, ACS S SERIES, V602
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P276
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Keller JC, 1995, J ADHESION, V54, P145, DOI 10.1080/00218469508014387
   Kim G, 2002, LANGMUIR, V18, P2807, DOI 10.1021/la0113365
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   Kim J, 2001, CHEMPHYSCHEM, V2, P543, DOI 10.1002/1439-7641(20010917)2:8/9<543::AID-CPHC543>3.0.CO;2-5
   Kim J, 2000, J AM CHEM SOC, V122, P12371, DOI 10.1021/ja003215h
   Koffas TS, 2003, LANGMUIR, V19, P3563, DOI 10.1021/la027041o
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   Lobau J, 1997, J OPT SOC AM B, V14, P2505, DOI 10.1364/JOSAB.14.002505
   Miranda PB, 1999, J PHYS CHEM B, V103, P3292, DOI 10.1021/jp9843757
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Nygren H, 1996, COLLOID SURFACE B, V6, P329, DOI 10.1016/0927-7765(96)01270-2
   Oh-e M, 2000, J CHEM PHYS, V113, P8827, DOI 10.1063/1.1318199
   Palik E. D., 1985, HDB OPTICAL CONSTANT
   Pizzolatto RL, 1999, ANAL CHIM ACTA, V397, P81, DOI 10.1016/S0003-2670(99)00394-3
   Scatena LF, 2001, SCIENCE, V292, P908, DOI 10.1126/science.1059514
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Shultz MJ, 2000, INT REV PHYS CHEM, V19, P123, DOI 10.1080/014423500229882
   van den Meerakker JEAM, 2002, J ELECTROCHEM SOC, V149, pC256, DOI 10.1149/1.1466859
   Walker RA, 1998, J AM CHEM SOC, V120, P6991, DOI 10.1021/ja980736k
   Wang CY, 2003, LANGMUIR, V19, P7330, DOI 10.1021/la0345542
   Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r
   Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d
   Wang J, 2004, J PHYS CHEM B, V108, P3625, DOI 10.1021/jp0370019
   Wang J, 2003, ANALYST, V128, P773, DOI 10.1039/b212551j
   Wang J, 2002, J PHYS CHEM B, V106, P11666, DOI 10.1021/jp021363j
   Wang J, 2002, J AM CHEM SOC, V124, P13302, DOI 10.1021/ja026881m
   Wang J, 2001, J AM CHEM SOC, V123, P9470, DOI 10.1021/ja0164071
   Wang R, 1999, J PHYS CHEM B, V103, P2188, DOI 10.1021/jp983386x
   Wassell DTH, 1996, BIOMATERIALS, V17, P859, DOI 10.1016/0142-9612(96)83280-7
   Williams CT, 2000, LANGMUIR, V16, P2343, DOI 10.1021/1a9910091
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, V1
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
   Zhuang X, 1999, PHYS REV B, V59, P12632, DOI 10.1103/PhysRevB.59.12632
NR 61
TC 31
Z9 31
U1 3
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JUN 10
PY 2004
VL 108
IS 23
BP 7779
EP 7787
DI 10.1021/jp0367474
PG 9
WC Chemistry, Physical
SC Chemistry
GA 826MO
UT WOS:000221833400037
DA 2018-10-19
ER

PT J
AU Park, PSH
   Ng, CC
   Buck, S
   Wells, JW
   Cheng, YL
   Pennefather, PS
AF Park, PSH
   Ng, CC
   Buck, S
   Wells, JW
   Cheng, YL
   Pennefather, PS
TI Characterization of radioligand binding to a transmembrane receptor
   reconstituted into Lipobeads
SO FEBS LETTERS
LA English
DT Article
DE assay system; biomaterial; biosensors and nanotechnology; muscarinic
   receptor; lipobead; transmembrane receptor
ID PROTEIN-COUPLED RECEPTORS; MUSCARINIC RECEPTORS; SF9 CELLS;
   COOPERATIVITY; MICROARRAYS; OLIGOMERS; MEMBRANES; AFFINITY
AB Lipobeads are hydrogel beads surrounded by a lipid bilayer membrane and have been developed to act as a cell analogue. The FLAG-tagged M-2 muscarinic receptor was incorporated onto the surface of the Lipobead by incubating pre-Lipobeads with proteoliposomes containing the receptor. Receptors reconstituted onto the surface of the Lipobeads were functional in that they bound the antagonists quinuclidinylbenzilate and scopolamine with characteristic muscarinic affinities. This demonstrates the feasibility of using Lipobeads to study the binding properties of the M-2 muscarinic receptor and offers a promising approach to the study of transmembrane protein biology in general. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
C1 Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 2S2, Canada.
   Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Pennefather, PS (reprint author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 2S2, Canada.
EM p.pennefather@utoronto.ca
CR Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t
   Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432
   DE MI, 2000, PHARM RES, V17, P817
   Fang Y, 2003, DRUG DISCOV TODAY, V8, P755, DOI 10.1016/S1359-6446(03)02779-X
   Fang Y, 2002, J AM CHEM SOC, V124, P2394, DOI 10.1021/ja017346+
   HAGA K, 1986, J BIOL CHEM, V261, P133
   HIRATA H, 1986, TECHNIQUES ANAL MEMB, P77
   Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299
   Karlsson OP, 2002, ANAL BIOCHEM, V300, P132, DOI 10.1006/abio.2001.5428
   Loidl-Stahlhofen A, 2001, ADV MATER, V13, P1829, DOI 10.1002/1521-4095(200112)13:23<1829::AID-ADMA1829>3.3.CO;2-V
   Naumann CA, 2002, BIOMACROMOLECULES, V3, P27, DOI 10.1021/bm0100211
   Ng CC, 2001, MACROMOLECULES, V34, P5759, DOI 10.1021/ma0100899
   NG CC, 2003, IN PRESS BIOPHYS J
   Park P, 2001, EUR J PHARMACOL, V421, P11, DOI 10.1016/S0014-2999(01)00998-0
   Park PSH, 2003, BIOCHEMISTRY-US, V42, P12960, DOI 10.1021/bi034491m
   Park PSH, 2002, BIOCHEMISTRY-US, V41, P5588, DOI 10.1021/bi011746s
   Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Wells J. W., 1992, RECEPTOR LIGAND INTE, P289
   Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6
   WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488
   YANAGITA Y, 1986, ANAL MEMBRANE PROTEI, P61
NR 22
TC 7
Z9 7
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUN 4
PY 2004
VL 567
IS 2-3
BP 344
EP 348
DI 10.1016/j.febslet.2004.03.124
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 827HJ
UT WOS:000221890000035
PM 15178349
OA Bronze
DA 2018-10-19
ER

PT J
AU Tcacencu, I
   Carlsoo, B
   Stierna, P
AF Tcacencu, I
   Carlsoo, B
   Stierna, P
TI Recombinant human bone morphogenetic protein-2 enhances experimental
   laryngotracheal reconstruction in rabbits
SO ACTA OTO-LARYNGOLOGICA
LA English
DT Article
DE airway; cartilage; epithelium; growth factor; wound healing
ID RAT ECTOPIC MODEL; GROWTH-FACTOR; BIOMATERIAL CARRIERS;
   ARTICULAR-CARTILAGE; WOUND REPAIR; RHBMP-2; DEFECTS; PHARMACOKINETICS;
   EPITHELIUM
AB Objective-Bone morphogenetic protein-2 offers potential benefits for cartilage regeneration. We investigated the effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the regeneration of laryngeal cartilage and respiratory epithelium in a rabbit model.
   Material and Methods-We used a cricoid defect rabbit model. Twenty-four rabbits were randomly divided into four equal groups. Two groups were treated with 5 mug of rhBMP-2 delivered on an absorbable collagen sponge and the other two groups were used as controls. One group of treated rabbits and one group of control rabbits were euthanized 1 week after surgery, while the others were euthanized 4 weeks after surgery. The healing pattern of the laryngeal wound was evaluated by means of histomorphometry.
   Results-Regeneration of both the epithelial layer and cartilage was significantly better in rabbits treated with rhBMP-2. Four weeks after surgery, the cricoid cartilage defect was completely repaired by new cartilage and new bone in rabbits treated with rhBMP-2. Furthermore, the lining respiratory epithelium healed more rapidly in treated rabbits.
   Conclusion -rhBMP-2, delivered via an absorbable collagen sponge, induces complete regeneration and repair of rabbit cricoid cartilage defects. It also induces faster relining and regeneration of airway epithelium than in control rabbits.
C1 Karolinska Inst, Huddinge Univ Hosp, Dept Otorhinolaryngol, SE-14186 Stockholm, Sweden.
RP Tcacencu, I (reprint author), Karolinska Inst, Huddinge Univ Hosp, Dept Otorhinolaryngol, SE-14186 Stockholm, Sweden.
EM tcacencu@yahoo.co.uk
RI Tcacencu, Ion/A-1791-2008
OI Tcacencu, Ion/0000-0002-1243-0433
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   Duprez DM, 1996, DEV BIOL, V174, P448, DOI 10.1006/dbio.1996.0087
   Hicks W, 1999, ARCH OTOLARYNGOL, V125, P1239, DOI 10.1001/archotol.125.11.1239
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Katic V, 2000, GROWTH FACTORS, V17, P221, DOI 10.3109/08977190009001071
   Loewen MS, 2001, WOUND REPAIR REGEN, V9, P44, DOI 10.1046/j.1524-475x.2001.00044.x
   MA S, 1990, ANN NY ACAD SCI, V580, P524, DOI 10.1111/j.1749-6632.1990.tb17979.x
   MCPHERSON J M, 1992, Clinical Materials, V9, P225, DOI 10.1016/0267-6605(92)90103-Z
   Reddi A. Hari, 1994, Current Opinion in Genetics and Development, V4, P737, DOI 10.1016/0959-437X(94)90141-O
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Samadi DS, 2002, ANN OTO RHINOL LARYN, V111, P295, DOI 10.1177/000348940211100403
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Sellers RS, 2000, J BONE JOINT SURG AM, V82A, P151, DOI 10.2106/00004623-200002000-00001
   Sung SW, 2001, EUR J CARDIO-THORAC, V19, P14, DOI 10.1016/S1010-7940(00)00624-2
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VANDENBERG WB, 2001, CLIN ORTHOP S, V391, pS244
   Verwoerd-Verhoef HL, 1998, INT J PEDIATR OTORHI, V43, P241, DOI 10.1016/S0165-5876(98)00003-2
   Walner DL, 1999, OTOLARYNG HEAD NECK, V120, P78, DOI 10.1016/S0194-5998(99)70373-6
   Zahm JM, 2000, J CELL PHYSIOL, V185, P447, DOI 10.1002/1097-4652(200012)185:3<447::AID-JCP16>3.0.CO;2-D
NR 20
TC 4
Z9 5
U1 0
U2 1
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0001-6489
J9 ACTA OTO-LARYNGOL
JI Acta Oto-Laryngol.
PD JUN
PY 2004
VL 124
IS 5
BP 612
EP 615
DI 10.1080/00016480310015696
PG 4
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 834WQ
UT WOS:000222442000012
PM 15267181
DA 2018-10-19
ER

PT J
AU Kim, JS
   Kang, JH
   Kang, SB
   Yoon, KS
   Kwon, YS
AF Kim, JS
   Kang, JH
   Kang, SB
   Yoon, KS
   Kwon, YS
TI Porous TiNi biomaterial by self-propagating high-temperature synthesis
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID SHAPE-MEMORY METAL; TITANIUM; NICKEL; BIOCOMPATIBILITY; IMPLANT; ALLOY;
   CORROSION
AB Porous TiNi shape-memory alloy (TiNi: SMA) bodies with controlled pore structure were produced from the (Ti+Ni) powder mixture by self-propagating high-temperature synthesis (SHS) method. The effect of processing variables such as the kind of starting powders; ignition temperature and preheating schedule on the behavior of combustion wave propagation, the formation of,phases and pore structure was investigated. The relationship between,pore structure and mechanical properties was also investigated: An in vivo test was performed to evaluate bone tissue response and histocompatibility of porous TiNi SMA using 15 New Zealand white rabbits. No apparent adverse reactions such as inflammation and foreign body reaction were noted on or around all implanted porous TiNi SMA,blocks. Bone ingrowth was found in the pore space of all implanted blocks.
C1 Univ Ulsan, Res Ctr Machine Parts & Mat Proc, Sch Mat Sci & Engn, Ulsan 680749, South Korea.
   Seoul Natl Univ, Med Univ, Dept Orthoped, Seoul 151, South Korea.
   Boramae Hosp, Dept Orthoped Surg, Seoul 156707, South Korea.
RP Kim, JS (reprint author), Univ Ulsan, Res Ctr Machine Parts & Mat Proc, Sch Mat Sci & Engn, Ulsan 680749, South Korea.
RI Kang, Seung Baik/J-5362-2012
CR ASSAD M, 1994, ANN CHIR, V48, P731
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   Buehler WJ, 1968, OCEAN ENGNG, V1, P105
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   DUERIG T, 1999, MAT SCI ENG A-STRUCT, V149, P273, DOI DOI 10.1016/S0921-5093(99)00294-4
   KIM JS, 2000, P SMST 2000 CAL US, P77
   MERZHANOV AG, 1997, EXPT HEAT TRANSFER F, P1869
   MOORE JJ, 1995, PROG MATER SCI, V39, P243, DOI 10.1016/0079-6425(94)00011-5
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
NR 13
TC 38
Z9 39
U1 1
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD JUN
PY 2004
VL 6
IS 6
BP 403
EP 406
DI 10.1002/adem.200405151
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 836RM
UT WOS:000222573300012
DA 2018-10-19
ER

PT J
AU Saha, AK
   Mazumdar, J
   Kohles, SS
AF Saha, AK
   Mazumdar, J
   Kohles, SS
TI Prediction of growth factor effects on engineered cartilage composition
   using deterministic and stochastic modeling
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE cartilage; extracellular matrix; growth factor; Gaussian white noise;
   Fokker-Planck equation; stochastic model; carrying capacity
ID FACTOR-BETA; EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; DECORIN;
   CULTURE; METABOLISM; CELL; CHONDROCYTES; PROTEOGLYCAN; EXPLANTS
AB In the design of engineered tissues, guided balance of biomaterial degeneration with tissue synthesis offers refined control of construct development. The objective of this study was to develop a mathematical model that describes the steady state metabolism of extracellular matrix molecules (ECM: glycosaminoglycan and collagen) in an engineered cartilage construct taking into account localized environmental changes that may arise because of the application of growth factors. The variable effects of growth factors were incorporated in the form of random noise rather than the difference in rates of synthesis and catabolism. Thus, the frequency of ECM accumulation for each matrix molecule in the steady state under the random influence of growth factor was produced relative to the matrix carrying capacity. Published synthesis-rate time constants and steady state ECM conditions from chondrocyte-polymer scaffold composites provided both input and validation for the model. Although the presence of growth factors in the presented system dynamics were considered randomized, the results described a positive feedback or promotional ECM synthesis at low levels of growth factors. While a negative feedback or inhibition of ECM synthesis was characterized at higher levels of growth factors. This transition phenomenon is based on a comparison with the results of a steady state condition in the form of a deterministic model and supports previous reports of guided accumulation in musculoskeletal, connective, and neuronal tissues.
C1 Swinburne Univ Technol, Sch Math Sci, Hawthorn, Vic 3122, Australia.
   Swinburne Univ Technol, Sch Engn Sci & Sci, Hawthorn, Vic 3122, Australia.
   Kohles Bioengn, Portland, OR 97214 USA.
RP Kohles, SS (reprint author), Kohles Bioengn, 1731 SE 37th Ave, Portland, OR 97214 USA.
EM ssk@kohlesbioengineering.com
OI Kohles, Sean/0000-0002-5869-7715
FU NIDCR NIH HHS [R03 DE014288, DE14288]
CR Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x
   Britt JC, 1998, ARCH OTOLARYNGOL, V124, P671, DOI 10.1001/archotol.124.6.671
   BUCHMANN MD, 1992, J ORTHOPAED RES, V10, P745
   Buschmann MD, 1996, J CELL SCI, V109, P499
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   GARDINER CW, 1997, SYNERGETICS, V13
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRAY ML, 1989, BIOCHIM BIOPHYS ACTA, V991, P415, DOI 10.1016/0304-4165(89)90067-6
   HANDLEY CJ, 1977, BIOCHIM BIOPHYS ACTA, V500, P132
   Hascall VC, 1999, BIOL SYNOVIAL JOINT, P101
   HASCALL VC, 1990, METHODS CARTILAGE RE, P108
   HASCALL VC, 1991, CELL BIOL EXTRACELLU, P149
   HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7
   HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527
   HORTON WE, 1989, J CELL PHYSIOL, V141, P8, DOI 10.1002/jcp.1041410103
   Klisch SM, 2003, J BIOMECH ENG-T ASME, V125, P169, DOI 10.1115/1.1560144
   Markmann A, 2000, MATRIX BIOL, V19, P631, DOI 10.1016/S0945-053X(00)00097-4
   MORALES TI, 1989, ARTHRITIS RHEUM-US, V32, P1197, DOI 10.1002/anr.1780321003
   Murray JD, 2001, MATH BIOL, VI
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Noble Nancy A., 1992, Progress in Growth Factor Research, V4, P369, DOI 10.1016/0955-2235(92)90017-C
   Obradovic B, 2000, AICHE J, V46, P1860, DOI 10.1002/aic.690460914
   Oksendal B., 1995, STOCHASTIC DIFFERENT
   Olsen B. R., 1991, CELL BIOL EXTRACELLU, P177
   Pazzano D, 2000, BIOTECHNOL PROGR, V16, P893, DOI 10.1021/bp000082v
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Ragan PM, 2000, ARCH BIOCHEM BIOPHYS, V383, P256, DOI 10.1006/abbi.2000.2060
   Roberts MG, 1999, APPL MATH LETT, V12, P37, DOI 10.1016/S0893-9659(98)00123-2
   RODRIGUEZ F, 1996, PRINCIPLES POLYM SYS, P732
   SAH RL, 1994, ARCH BIOCHEM BIOPHYS, V308, P137, DOI 10.1006/abbi.1994.1020
   Sah RL, 1996, J ORTHOPAED RES, V14, P44, DOI 10.1002/jor.1100140109
   TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634
   Weiser L, 1999, TISSUE ENG, V5, P533, DOI 10.1089/ten.1999.5.533
   Wilson CG, 2002, ARCH BIOCHEM BIOPHYS, V408, P246, DOI 10.1016/S0003-9861(02)00562-3
NR 36
TC 10
Z9 11
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2004
VL 32
IS 6
BP 871
EP 879
DI 10.1023/B:ABME.0000030262.82626.9c
PG 9
WC Engineering, Biomedical
SC Engineering
GA 833WC
UT WOS:000222370300010
PM 15255217
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Itoh, M
   Shimazu, A
   Hirata, I
   Yoshida, Y
   Shintani, H
   Okazaki, M
AF Itoh, M
   Shimazu, A
   Hirata, I
   Yoshida, Y
   Shintani, H
   Okazaki, M
TI Characterization of CO(3)Ap-collagen sponges using x-ray high-resolution
   microtomography
SO BIOMATERIALS
LA English
DT Article
DE bone repair; collagen; hydroxyapatite composite; scaffold
ID BONE-FORMATION; COMPOSITES; HYDROXYAPATITE; PHOSPHATE; HYDROXYLAPATITE;
   COATINGS; IMPLANTS; DEFECTS; SURFACE
AB For reconstruction and regeneration of hard tissues, scaffold biomaterials with large size pores and high porosity are important, in addition to their roles as supporting frames. To develop a new biodegradable scaffold biomaterial, CO(3)Ap, which has crystallinity and a chemical composition similar to bone, was synthesized at pH 7.4 and 60degreesC. Then, the CO(3)Ap was mixed with a neutralized collagen gel and the CO(3)Ap-collagen mixtures with different kinds Of CO(3)Ap contents and porosity were lyophilized into sponges. Scanning electron micrography (SEM) observation Of CO(3)Ap-collagen sponges showed favorable pores for cell invasion. Approximately 50-300 mum size pores appeared to continue through the bulk. Higher magnification of the sponge showed a better adhesion between CO(3)Ap crystals and collagen. X-ray high-resolution microtomography revealed a clear image of the 3D structure of the sponges. The porosity of 0, 70 and 90%(w/w) CO(3)Ap-collagen sponges was 79.2 +/- 2.8%, 72.6 +/- 2.4% and 48.9 +/- 6.1%, respectively. The 70%(w/w) CO(3)Ap-collagen sponge appeared to be the most favorable biomaterial from the viewpoint of natural bone properties. Mouse osteoblast MC3T3-E1 cells were cultured in alphaMEM with 10% FCS for 2 weeks. Hematoxylin-eosin staining confirmed osteoblast cells invaded well into the CO(3)Ap-collagen sponge. These sponges are expected to be used as hard tissue scaffold biornaterials for therapeutic uses. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Minami Ku, Hiroshima 7348553, Japan.
   Hiroshima Univ, Grad Sch Biomed Sci, Dept Operat Dent & Dent Mat, Minami Ku, Hiroshima 7348553, Japan.
   Hiroshima Univ, Grad Sch Biomed Sci, Dept Prevent Dent, Minami Ku, Hiroshima 7348553, Japan.
   Okayama Univ, Grad Sch Med & Dent, Dept Biomat, Okayama 7008525, Japan.
RP Okazaki, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
EM okazakix@hiroshima-u.ac.jp
RI YOSHIDA, Yasuhiro/B-2472-2011
CR Alberts B, 1994, MOL BIOL CELL, P949
   Brown W E, 1987, Adv Dent Res, V1, P306
   BROWN WE, 1965, J RES NBS A PHYS CH, VA 69, P547, DOI 10.6028/jres.069A.059
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   CONWAY EJ, 1950, MICRODIFFUSION ANAL
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   EASTOE JE, 1965, METHOD DETERMINATION
   GREGORY TM, 1974, J RES NBS A PHYS CH, VA 78, P667, DOI 10.6028/jres.078A.042
   HADDAD WS, 1994, SCIENCE, V266, P1213, DOI 10.1126/science.266.5188.1213
   Heikkila JT, 1996, BIOMATERIALS, V17, P1755, DOI 10.1016/0142-9612(95)00326-6
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Keller L, 2000, J BIOMED MATER RES, V49, P244, DOI 10.1002/(SICI)1097-4636(200002)49:2<244::AID-JBM13>3.3.CO;2-8
   KENNEY EB, 1986, J PERIODONTOL, V57, P76, DOI 10.1902/jop.1986.57.2.76
   Lehr J, 1997, OPTIK, V104, P166
   Linkow LI, 1970, THEORIES TECHNIQUES
   Miles A. E. W., 1967, STRUCTURAL CHEM ORG, VII
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   Noda M., 1993, CELLULAR MOL BIOL BO
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   OKAZAKI M, 1989, BIOMATERIALS, V10, P564, DOI 10.1016/0142-9612(89)90064-1
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   ROTHSTEIN SS, 1984, J ORAL MAXIL SURG, V42, P224, DOI 10.1016/0278-2391(84)90453-1
   Tanahashi M, 1996, BIOMATERIALS, V17, P47, DOI 10.1016/0142-9612(96)80754-X
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   TUNG MS, 1985, J DENT RES, V64, P2, DOI 10.1177/00220345850640010301
   VONLASZEWSKI G, REAL TIME ANAL VISUA
   WANG Y, 1998, THESIS U NEW YORK ST
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Zeng HT, 2000, J BIOMED MATER RES, V50, P239, DOI 10.1002/(SICI)1097-4636(200005)50:2<239::AID-JBM19>3.0.CO;2-V
NR 31
TC 34
Z9 36
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2004
VL 25
IS 13
BP 2577
EP 2583
DI 10.1016/j.biomaterials.2003.09.071
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 773DB
UT WOS:000188881500015
PM 14751743
DA 2018-10-19
ER

PT J
AU Botticelli, D
   Berglundh, T
   Lindhe, J
AF Botticelli, D
   Berglundh, T
   Lindhe, J
TI The influence of a biomaterial on the closure of a marginal hard tissue
   defect adjacent to implants - An experimental study in the dog
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; Bio-Gide; Bio-Oss; bone; defect; dental implant;
   histometry; membrane; morphometry; osseointegration; SLA surface;
   xenograft
ID ANORGANIC BOVINE BONE; IMMEDIATE PLACEMENT; EXTRACTION SITES; OSSEOUS
   RESPONSE; BEAGLE DOGS; REGENERATION; BIO-OSS(R); CHIMPANZEE
AB Objectives: The present experiment was performed to determine the influence of Bio-Oss(R) on hard tissue formation at sites that, following implant installation, presented a 1-1.25 mm wide marginal defect.
   Material and methods: Four Labrador dogs were used. The premolars and first molars on both sides of the mandible were extracted. After 3 months, mucoperiosteal flaps were elevated and three experimental sites were prepared for implant installation in each side of the mandible. A step drill was used to widen the marginal 5 mm of the canal. Thus, following the placement of the implant (3.3x10 mm, SLA surface, Straumann AG, Waldenburg, Switzerland) a circumferential gap, about 1-1.25 wide and 5 mm deep, remained lateral to the titanium rod. The test sites in the left side of the mandible were first filled with a deproteinized cancellous bone mineral (Bio-Oss(R)). The defect sites in the right side of the mandible (control sites) were left for spontaneous healing. A resorbable barrier membrane (Bio-Gide(R)) was placed to cover the implant and the bone tissue in two sites of each quadrant, while the third site was left without membrane placement. The flaps were repositioned to cover all defect sites and were sutured. After 4 months of healing, block biopsies of each implant site were dissected and processed for ground sectioning.
   Results: It was demonstrated that at 4 months, all types of defects were filled with newly formed bone and that the biomaterial placed in the marginal defect in conjunction with implant installation during healing became incorporated in the newly formed bone tissue. A high degree of contact was established between the Bio-Oss(R) particles and the newly formed bone.
   Conclusion: Bio-Oss became integrated with the newly formed bone. In the model used, Bio-Oss(R) did not enhance the process of bone formation and defect closure.
C1 Gothenburg Univ, Dept Periodontol, Inst Odontol, Sahlgrenska Acad, S-41124 Gothenburg, Sweden.
RP Botticelli, D (reprint author), Fac Odontol, Dept Periodontol, Box 450, SE-40530 Gothenburg, Sweden.
EM daniele.botticelli@odontologi.gu.se
OI Botticelli, Daniele/0000-0003-2804-1632
CR Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P35, DOI 10.1034/j.1600-0501.2003.140105.x
   Carmagnola D, 2002, J CLIN PERIODONTOL, V29, P377, DOI 10.1034/j.1600-051X.2002.290501.x
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donath K., 1988, PRAPARATOR, V34, P197
   Donath K, 1993, PREPARATION HISTOLOG
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hockers T, 1999, CLIN ORAL IMPLAN RES, V10, P487, DOI 10.1034/j.1600-0501.1999.100607.x
   HOFFMAN S, 1999, BIOMATERIALS, V20, P1155
   Hurzeler MB, 1998, INT J ORAL MAX SURG, V27, P315, DOI 10.1016/S0901-5027(05)80623-X
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Mayfield LJA, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P520
   McAllister BS, 1998, INT J PERIODONT REST, V18, P227
   McAllister BS, 1999, INT J ORAL MAX IMPL, V14, P361
   Misch C E, 1993, Dent Implantol Update, V4, P93
   PEETZ M, 1997, OSSEOUS RECONSTRUCTI, V1, P87
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   SchwartzArad D, 1997, J PERIODONTOL, V68, P915, DOI 10.1902/jop.1997.68.10.915
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   SPECTOR M, 1991, HEFTE UNFALLHEILKD, V216, P11
   Stephan EB, 1999, J PERIODONTOL, V70, P364, DOI 10.1902/jop.1999.70.4.364
   Thaller S R, 1993, J Craniofac Surg, V4, P79, DOI 10.1097/00001665-199304000-00005
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Young C, 1999, INT J ORAL MAX IMPL, V14, P72
   Zitzmann N U, 2001, Int J Periodontics Restorative Dent, V21, P288
NR 30
TC 59
Z9 63
U1 0
U2 4
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2004
VL 15
IS 3
BP 285
EP 292
DI 10.1046/j.1600-0501.2003.01008.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 819EZ
UT WOS:000221298600004
PM 15142090
DA 2018-10-19
ER

PT J
AU Peppas, NA
   Wood, KM
   Blanchette, JO
AF Peppas, NA
   Wood, KM
   Blanchette, JO
TI Hydrogels for oral delivery of therapeutic proteins
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE bioavailability; drug delivery; hydrogel; insulin; intelligent
   biomaterial; long-term stability; protein
ID ETHYLENE GLYCOL) NANOSPHERES; IN-VITRO EVALUATION; INTERPOLYMER
   COMPLEXATION; BIOMEDICAL APPLICATIONS; CHITOSAN HYDROGELS; INSULIN;
   ABSORPTION; SYSTEMS; MACROMOLECULES; CALCITONIN
AB In recent years there has been significant new interest in the development of transmucosal (mostly oral) pharmaceutical formulations for the delivery of therapeutic proteins. Emphasis has been given to the molecular design of new carriers for the delivery of insulin, calcitonin and various types of interferons for the treatment of diabetes, osteoporosis, multiple sclerosis and cancer. Most popular carriers include advanced designs of swollen hydrogels prepared from neutral or intelligent polymeric networks. In this review, the most successful of such systems are presented and their promise in the field described.
C1 Univ Texas, Dept Chem, Lab Biomat Drug Delivery Bionanotechnol & Mol Rec, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Lab Biomat Drug Delivery Bionanotechnol & Mol Rec, Austin, TX 78712 USA.
   Univ Texas, Div Pharmaceut, Austin, TX 78712 USA.
RP Peppas, NA (reprint author), Univ Texas, Dept Chem, Lab Biomat Drug Delivery Bionanotechnol & Mol Rec, Austin, TX 78712 USA.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Bernkop-Schnurch A, 1998, PHARMACEUT RES, V15, P263, DOI 10.1023/A:1011970703087
   BLANCHETTE J, 2002, BIOL BIOMIMETIC MAT, P218
   Donini C, 2002, INT J PHARM, V245, P83, DOI 10.1016/S0378-5173(02)00335-6
   Efremova NV, 2002, LANGMUIR, V18, P836, DOI 10.1021/la011303p
   Fasano A, 1997, J CLIN INVEST, V99, P1158, DOI 10.1172/JCI119271
   FOSS AC, 2001, POLYM PREPR, V42, P94
   GARCIA M, 2001, NEW TRENDS POLYM ORA, P386
   Goldberg M, 2003, NAT REV DRUG DISCOV, V2, P289, DOI 10.1038/nrd1067
   Ichikawa H, 2003, J BIOMED MATER RES A, V67A, P609, DOI 10.1002/jbm.a.10128
   ICHIKAWA H, 2001, NEW TRENDS POLYM ORA, P261
   Kapitza C, 2003, DIABETES, V52, pA37
   Kim B, 2003, BIOMED MICRODEVICES, V5, P333, DOI 10.1023/A:1027313931273
   Kipnes M, 2003, DIABETES CARE, V26, P421, DOI 10.2337/diacare.26.2.421
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lowman AM, 2000, POLYMER, V41, P73, DOI 10.1016/S0032-3861(99)00159-7
   Lowman AM, 2000, J POLYM SCI POL PHYS, V38, P2823, DOI 10.1002/1099-0488(20001101)38:21<2823::AID-POLB110>3.0.CO;2-5
   MESIHA M, 1994, INT J PHARM, V111, P213, DOI 10.1016/0378-5173(94)90343-3
   Morishita M, 2004, J CONTROL RELEASE, V97, P115, DOI 10.1016/j.jconrel.2004.03.008
   Morishita M, 2002, J CONTROL RELEASE, V81, P25, DOI 10.1016/S0168-3659(02)00019-6
   Nakamura K, 2004, J CONTROL RELEASE, V95, P589, DOI 10.1016/j.jconrel.2003.12.022
   Peppas N. A., 2001, ENCY MAT SCI TECHNOL, P3492
   Peppas N. A., 2001, ENCY MAT SCI TECHNOL, P2351
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Plate NA, 2002, BIOMATERIALS, V23, P1673, DOI 10.1016/S0142-9612(01)00294-0
   Robinson DN, 2002, MACROMOLECULES, V35, P3668, DOI 10.1021/ma011525u
   SCOTT R, 2000, HDB PHARM CONTROLLED, P47
   Sipahigil O, 2002, STP PHARMA SCI, V12, P345
   Still JG, 2002, DIABETES METAB RES, V18, pS29, DOI 10.1002/dmrr.207
   Torres-Lugo M, 2002, J NANOPART RES, V4, P73, DOI 10.1023/A:1020137616302
   Torres-Lugo M, 2002, BIOTECHNOL PROGR, V18, P612, DOI 10.1021/bp0101379
   Torres-Lugo M, 2002, J CONTROL RELEASE, V80, P197, DOI 10.1016/S0168-3659(02)00027-5
   Torres-Lugo M, 2000, BIOMATERIALS, V21, P1191, DOI 10.1016/S0142-9612(00)00011-9
   YAMAMOTO A, 1994, PHARMACEUT RES, V11, P1496, DOI 10.1023/A:1018968611962
NR 35
TC 83
Z9 86
U1 6
U2 35
PU ASHLEY PUBLICATIONS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1471-2598
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD JUN
PY 2004
VL 4
IS 6
BP 881
EP 887
DI 10.1517/14712598.4.6.881
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 831OO
UT WOS:000222204300012
PM 15174970
DA 2018-10-19
ER

PT J
AU Baugh, L
   Vogel, V
AF Baugh, L
   Vogel, V
TI Structural changes of fibronectin adsorbed to model surfaces probed by
   fluorescence resonance energy transfer
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fibronectin; fluorescence resonance energy transfer (FRET); protein
   adsorption; conformation; biomaterials
ID HUMAN-PLASMA FIBRONECTIN; CHEMICALLY DERIVATIZED SUBSTRATA;
   SELF-ASSEMBLED MONOLAYERS; EPITHELIAL-CELL OUTGROWTH; ATOMIC-FORCE
   MICROSCOPY; CONFORMATIONAL-CHANGES; IONIC-STRENGTH; DEPENDENT
   CONFORMATIONS; HYDROPHOBIC SURFACES; SPECTROSCOPIC RULER
AB Structural changes of proteins during adsorption to biomaterials affect the presentation of molecular binding sites and, ultimately, biomaterial performance. We have applied fluorescence resonance energy transfer (FRET) spectroscopy to study structural changes of the cell adhesion protein, fibronectin (Fn), following adsorption to model hydrophilic and hydrophobic surfaces. Fn was labeled with donor and acceptor fluorophores using two labeling schemes and intramolecular energy transfer was calibrated against measured structural changes of Fn in denaturing solutions. FRET was then applied to measure Fn's structure on surfaces. Based on FRET, Fn underwent greater extension of its dimer arms on hydrophilic glass than on hydrophobic fluoroalklysilane-derivatized glass (fluorosilane), and this extension was insensitive to molecular packing over a range of adsorption concentrations. Fn's conformation on glass better promoted cell attachment than on fluorosilane; the roles of both global structural changes (movements of modules) and local structural changes (disruption of secondary structure) on Fn's cell integrin binding activity are discussed. Based on previous FRET work, we compare Fn's conformations on these surfaces with its conformations in fibroblast culture. FRET is unique in allowing direct comparison of protein structure between biomaterial surfaces and cell culture. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Washington, Ctr Nanotechnol, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   ETH, Swiss Fed Inst Technol, Dept Mat, Zurich, Switzerland.
RP Vogel, V (reprint author), Univ Washington, Ctr Nanotechnol, Box 351721, Seattle, WA 98195 USA.
EM viola.vogel@mat.ethz.ch
RI Vogel, Viola/O-8025-2015
OI Vogel, Viola/0000-0003-2898-7671
FU NIBIB NIH HHS [8R01EB00249-09]
CR ALEXANDER SS, 1979, J BIOL CHEM, V254, P1501
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799
   Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998
   BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0
   BENECKY MJ, 1990, BIOCHEMISTRY-US, V29, P3082, DOI 10.1021/bi00464a027
   BENECKY MJ, 1991, BIOCHEMISTRY-US, V30, P4298, DOI 10.1021/bi00231a028
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   Conti M, 2002, J BIOMED MATER RES, V61, P370, DOI 10.1002/jbm.10168
   Creighton T, 1993, PROTEINS STRUCTURE M
   Culp LA, 1998, J BIOMAT SCI-POLYM E, V9, P1161, DOI 10.1163/156856298X00703
   ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0
   ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114
   ERICKSON HP, 1983, J BIOL CHEM, V258, P4539
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GROTH T, 1995, J BIOMAT SCI-POLYM E, V7, P297
   HOMANDBERG GA, 1985, ARCH BIOCHEM BIOPHYS, V238, P652, DOI 10.1016/0003-9861(85)90211-5
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   IWAMOTO GK, 1985, J COLLOID INTERF SCI, V106, P459, DOI 10.1016/S0021-9797(85)80020-5
   Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KHAN MY, 1990, BIOCHEM J, V270, P33, DOI 10.1042/bj2700033
   Kowalczynska HM, 2003, CELL BIOL INT, V27, P101, DOI 10.1016/S1065-6995(02)00290-1
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Maste MCL, 1997, J COLLOID INTERF SCI, V196, P224, DOI 10.1006/jcis.1997.5205
   Miller T, 2003, LANGMUIR, V19, P1723, DOI 10.1021/la0261500
   NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021
   Norde W, 1998, BIOTECHNOL APPL BIOC, V28, P133
   OSTERLUND E, 1988, BIOCHIM BIOPHYS ACTA, V955, P330, DOI 10.1016/0167-4838(88)90212-9
   PEARLSTEIN E, 1978, INT J CANCER, V22, P32, DOI 10.1002/ijc.2910220108
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   Pickford AR, 1997, STRUCTURE, V5, P359, DOI 10.1016/S0969-2126(97)00193-7
   PRICE TM, 1982, EUR J BIOCHEM, V129, P359, DOI 10.1111/j.1432-1033.1982.tb07058.x
   Raghavachari M, 2000, COLLOID SURFACE B, V19, P315, DOI 10.1016/S0927-7765(00)00140-5
   ROCCO M, 1983, J BIOL CHEM, V258, P4545
   ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x
   Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   SJOBERG B, 1989, EUR BIOPHYS J BIOPHY, V17, P5
   STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719
   STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131
   TOONEY NM, 1983, J CELL BIOL, V97, P1686, DOI 10.1083/jcb.97.6.1686
   UGAROVA T, 1995, THROMB HAEMOSTASIS, V74, P253
   van Kooten TG, 1999, TISSUE ENG, V5, P223
   WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973
NR 51
TC 111
Z9 111
U1 1
U2 27
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2004
VL 69A
IS 3
BP 525
EP 534
DI 10.1002/jbm.a.30026
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820VT
UT WOS:000221418400017
PM 15127399
DA 2018-10-19
ER

PT J
AU Otsuka, M
   Ohshita, Y
   Marunaka, S
   Matsuda, Y
   Ito, A
   Ichinose, N
   Otsuka, K
   Higuchi, WI
AF Otsuka, M
   Ohshita, Y
   Marunaka, S
   Matsuda, Y
   Ito, A
   Ichinose, N
   Otsuka, K
   Higuchi, WI
TI Effect of controlled zinc release on bone mineral density from
   injectable Zn-containing beta-tricalcium phosphate suspension in
   zinc-deficient diseased rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; zinc; drug delivery system; tricalcium phosphate; in vivo
   release; bone mineral density; therapeutical improvement; zinc-deficient
   osteoporosis
ID OVARIECTOMIZED RATS; CALCIUM LEVEL; DRUG-RELEASE; IN-VITRO; CEMENT
AB The purpose of this study was to evaluate the efficacy of zinc (Zn)-containing beta-tricalcium phosphate (Zn-TCP) in correcting the bone mineral deficiency noted in osteoporosis using ovariectomized rat model. Four rats were used for each of the four experimental groups: D0, D10, D20, and N10. The rats in D0, D10, and D20 groups were ovariectomized, and fed a vitamin D-, Ca-, and Zn-deficient diet, and induced Zn-deficient osteoporoses for 9 weeks. In contrast, the N10 group was the normal rats fed normal healthy diet for 9 weeks. D0 group was injected with pure beta-TCP suspension, D10 and D20 groups were injected with suspensions containing 10 mg of 10 mol % (6.17 wt % Zn) and 20 mol % (12.05 wt % Zn) Zn-TCP, respectively, and the healthy group, N10 were injected with 10 mol %. Zn-TCP suspensions. Injections were administered intramuscularly in the left thigh once a week in all rats, and fed a vitamin D- and Zn-deficient diet for 9 weeks. The plasma calcium (Ca) and Zn levels, plasma alkaline phosphatase activity (ALP) and bone mineral density (BMD) of the lumbar vertebra and femora were measured. The plasma Zn levels in all the rats were between 1.1 and 2.8 mug/mL. The areas under the curves for the Ca, Zn, and ALP (Ca-AUC, Zn-AUC, and ALP-AUC) levels between 0 and 63 days were calculated. Results for the AUCs were as follows: (1) the Zn-AUCs were in the order of N10 = D20 > D10 > D0; (2) the Ca-AUCs for D0, D10 groups were significantly lower than that for the N10 group; (3) the ALP-AUCs for the D10 and D20 groups were significantly higher than that for the N10 group, and that of the D0 group was in between those. The body weight of D10 and D20 groups significantly increased with time, that of the D0 group increased slightly, and that of the N10 group remained unchanged for the entire experimental period. The BMD of the lumbar vertebrae of the D10 and D20 groups (about 100 mg/cm(2)) was significantly higher than that of the D0 group but lower than that of the N10 group. The BMD of the left femur increased more than that of the right femur with the increase in the amount of Zn in the suspension. The results of this study suggest that the local effect on BMD was more pronounced than the effect on the whole body. (C) 2004 Wiley Periodicals, Inc.
C1 Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Higashinada, Osaka 6588558, Japan.
   Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan.
   Waseda Univ, Fac Sci & Engn, Shinjyuku Ku, Tokyo 1698555, Japan.
   Showa Univ, Sch Med, Shinagawa Ku, Tokyo 1428555, Japan.
   Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
RP Otsuka, M (reprint author), Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Higashinada, Osaka 6588558, Japan.
EM m-otsuka@kobepharma-u.ac.jp
RI Ito, Atsuo/M-6785-2018
OI Ito, Atsuo/0000-0003-3318-040X
CR Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KIND PRN, 1954, J CLIN PATHOL, V7, P322, DOI 10.1136/jcp.7.4.322
   KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0
   KITANO M, 1971, NIPPON KAGAKU ZASSHI, V92, P168, DOI 10.1246/nikkashi1948.92.168
   OKANO T, 1994, J BONE MINER MET, pS23
   Otsuka M, 1997, J CONTROL RELEASE, V43, P115, DOI 10.1016/S0168-3659(96)01493-9
   OTSUKA M, 1995, J PHARM SCI, V84, P733, DOI 10.1002/jps.2600840614
   Otsuka M, 1997, J PHARM PHARMACOL, V49, P1182, DOI 10.1111/j.2042-7158.1997.tb06067.x
   Otsuka M, 2000, J BIOMED MATER RES, V52, P819, DOI 10.1002/1097-4636(20001215)52:4<819::AID-JBM27>3.3.CO;2-F
   RELEA P, 1995, AGE AGEING, V24, P303, DOI 10.1093/ageing/24.4.303
   SUDA T, 1970, J NUTR, V100, P1049
   Szathmari Miklos, 1993, Orvosi Hetilap, V134, P911
   WILLIAMS RJP, 1984, ENDEAVOUR, V8, P65, DOI 10.1016/0160-9327(84)90040-1
   YAMAGUCHI M, 1993, JPN J PHARMACOL, V63, P203, DOI 10.1254/jjp.63.203
NR 15
TC 45
Z9 46
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2004
VL 69A
IS 3
BP 552
EP 560
DI 10.1002/jbm.a.30040
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820VT
UT WOS:000221418400020
PM 15127402
DA 2018-10-19
ER

PT J
AU Zou, JP
   Ruan, JM
   Huang, BY
   Liu, JB
   Zhou, XX
AF Zou, JP
   Ruan, JM
   Huang, BY
   Liu, JB
   Zhou, XX
TI Physico-chemical properties and microstructure of hydroxyapatite-316L
   stainless steel biomaterials
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
LA English
DT Article
DE hydroxyapatite-316L; stainless steel; biomaterial; sintering activity;
   mechanical property; microstructure; SEM; EDXA
ID COMPOSITES; BONE; DEPENDENCE; IMPLANTS
AB Sintering shrinkage, compressive strength, bending strength, metallurgical morphology, microstructure and chemical composition diffusion of hydroxyapatite-3161. stainless steet(HA-316L SS) composites were investigated. The results show that the sintering shrinkage of HA-316L SS composites decreases from 27.38% to 8.87% for cylinder sample or from 27.18% to 8.62% for cuboid sample with decreasing the volume ratio of HA to 316L SS, which leads to higher sintering activity of HA compared with that of 3161, SS. The compressive strength of HA-316L, SS composites changes just like parabolic curve (245.3-->126.3-->202.8 MPa) with reducing the volume ratio of HA to 316L SS, Bending strength increases from 86.3 MPa to 124.2 MPa with increasing the content of 316L SS. Furthermore, comprehensive mechanical properties of 1.0 : 3.0 (volume ratio of HA to 316L SS) composite are optimal with compressive strength and bending strength equal to 202.8 MPa and 124.2 MPa, respectively. The microstructure and metallurgical structure vary regularly with the volume ratio of HA to 316L SS. Some chemical reaction takes place at the interface of the composites during sintering.
C1 Cent S Univ, State Key Lab Power Met, Changsha 410083, Peoples R China.
   Jishou Univ, Dept Chem, Jishou 416000, Peoples R China.
RP Zou, JP (reprint author), Cent S Univ, State Key Lab Power Met, Changsha 410083, Peoples R China.
EM zjp8418@163.com
CR Aoki H, 2000, J Mater Sci Mater Med, V11, P67, DOI 10.1023/A:1008993814033
   GUO Y, 2001, RES DEV WORLDS SCI T, V23, P33
   Hoepfner TP, 2002, J BIOMED MATER RES, V60, P643, DOI 10.1002/jbm.10131
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P725, DOI 10.1023/A:1008979929632
   Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   Lavos-Valereto IC, 2001, J MATER SCI-MATER M, V12, P273, DOI 10.1023/A:1008975418453
   LI SP, 1989, BIOCERAMICS
   Lin FH, 2002, BIOMATERIALS, V23, P4029, DOI 10.1016/S0142-9612(02)00154-0
   Miao X, 2003, MATER LETT, V57, P1848, DOI 10.1016/S0167-577X(02)01080-7
   Miao X, 2001, J MATER SCI, V36, P3323, DOI 10.1023/A:1017915226015
   Mustafa K, 2002, J BIOMED MATER RES, V59, P655, DOI 10.1002/jbm.1275
   Ong JL, 2002, J BIOMED MATER RES, V59, P184, DOI 10.1002/jbm.1232
   RECLARU I, 2001, BIOMATERIALS, V22, P369
   Ruan Jian-ming, 2003, Chinese Journal of Nonferrous Metals, V13, P1361
   SONG XW, 2001, ORDNANCE MAT SCI ENG, V24, P20
   WANG PE, 1995, J MATER SCI-MATER M, V6, P94, DOI 10.1007/BF00120415
   Yasuda HY, 2001, MATER TRANS, V42, P2392, DOI 10.2320/matertrans.42.2392
   ZHOU DF, 2001, INTRO MAT
NR 18
TC 9
Z9 11
U1 0
U2 2
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 1005-9784
J9 J CENT SOUTH UNIV T
JI J. Cent. South Univ. Technol.
PD JUN
PY 2004
VL 11
IS 2
BP 113
EP 118
DI 10.1007/s11771-004-0024-3
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 848IF
UT WOS:000223460200001
DA 2018-10-19
ER

PT J
AU Koo, KT
   Polimeni, G
   Albandar, JM
   Wikesjo, UME
AF Koo, KT
   Polimeni, G
   Albandar, JM
   Wikesjo, UME
TI Periodontal repair in dogs: examiner reproducibility in the
   supraalveolar periodontal defect model
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE animal models; bone; histometrics; periodontal regeneration; tissue
   engineering; wound healing
ID PROBE
AB Background: Histometric assessments are routinely used to evaluate biologic events ascertained in histologic sections acquired from animal and human studies. The objective of this study was to evaluate the intra- and inter-examiner reproducibility of histometric assessments in the supraalveolar periodontal defect model.
   Methods: Histometric analysis using incandescent and polarized light microscopy, an attached digital camera system, and a PC-based image analysis system including a custom program for the supraalveolar periodontal defect model was performed on histologic sections acquired from one jaw quadrant in each of 12 dogs. The animals had received an experimental protocol including implantation of a coral biomaterial and guided tissue regeneration (GTR) barrier devices, and were evaluated following a 4-week healing interval. Histometric parameters were recorded and repeated within a 3-month interval by two examiners following brief training. Intra- and inter-examiner reproducibility was assessed using the intra-class correlation coefficient (ICC).
   Results: Most parameters showed high intra-examiner ICCs. Parameters including defect height, connective tissue repair, bone regeneration (height/area), formation of a junctional epithelium, positioning of the GTR device, ankylosis, root resorption, and defect area yielded an ICCgreater than or equal to0.9. The ICCs for bone density and biomaterial density were somewhat lower (0.8 and 0.7, respectively). The inter-examiner reproducibility was somewhat lower compared to the intra-examiner reproducibility. Nevertheless, the ICCs were generally high (ICC range: 0.6-0.9).
   Conclusions: Histometric evaluations in the supraalveolar periodontal defect model yield highly reproducible results, in particular when a single examiner performs the histometric measurements, even when the examiner was exposed to limited training.
C1 Temple Univ, Sch Dent, Lab Appl Peridontal & Craniofacial Regenerat, Philadelphia, PA 19122 USA.
   Temple Univ, Sch Dent, Dept Periodontol, Philadelphia, PA USA.
RP Koo, KT (reprint author), Temple Univ, Sch Dent, Lab Appl Peridontal & Craniofacial Regenerat, Philadelphia, PA 19122 USA.
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583; Albandar, Jasim M./0000-0001-7801-3811
CR ARMITAGE GC, 1977, J CLIN PERIODONTOL, V4, P173, DOI 10.1111/j.1600-051X.1977.tb02271.x
   Kingman A, 2002, PERIODONTOL 2000, V29, P11, DOI 10.1034/j.1600-0757.2002.290102.x
   KOO KT, IN PRESS J CLIN PERI
   LISTGARTEN MA, 1976, J PERIODONTOL, V47, P511, DOI 10.1902/jop.1976.47.9.511
   McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   VANDERVELDEN U, 1978, J CLIN PERIODONTOL, V5, P188
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   WIKESJO UME, 1990, J PERIODONTOL, V61, P559, DOI 10.1902/jop.1990.61.9.559
   WIKESJO UME, 1990, J PERIODONTOL, V61, P719, DOI 10.1902/jop.1990.61.12.719
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
NR 11
TC 12
Z9 11
U1 0
U2 2
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JUN
PY 2004
VL 31
IS 6
BP 439
EP 442
DI 10.1111/j.1600-051X.2004.00508.x
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 820FT
UT WOS:000221373500005
PM 15142212
DA 2018-10-19
ER

PT J
AU Schimming, R
   Schmelzeisen, R
AF Schimming, R
   Schmelzeisen, R
TI Tissue-engineered bone for maxillary sinus augmentation
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID IN-VITRO; FLOOR AUGMENTATION; SCAFFOLDS; CELLS; RECONSTRUCTION;
   COMBINATION; BIO-OSS(R); CARTILAGE; MARROW; REPAIR
AB Purpose: Autologous, allogenic, and alloplastic materials for bony reconstruction in the craniomaxillofacial region have specific drawbacks stimulating the ongoing search for new materials. Cultivated skin and mucosa grafts are in clinical routine use in head and neck reconstruction but so far, to the best of our knowledge, no successful clinical application has been described of periosteum-derived tissue-engineered bone for augmentation of the edentulous posterior maxilla.
   Patients and Methods: In a clinical study, augmentation of the posterior maxilla was carried out using a bone matrix derived from mandibular periosteum cells on an Ethisorb (Ethicon, Norderstedt, Germany) fleece. In this report, we show the fabrication of the matrix, clinical application, and results in 27 patients.
   Results: In 18 patients, an excellent clinical, radiologic, and histologic result could be proved 3 months after augmentation. Histologically, the bone biopsy samples from these patients revealed mineralized trabecular bone with remnants of the biomaterial. An unsuccessful result was found in 8 cases with a more extended augmentation procedure. The clinical inspection 3 months after augmentation showed almost no formation of new bone. In contrast, a replacement resorption with connective tissue was found. This may be the result of failure of the initial supply of the cells embedded within large cell-polymer constructs with sufficient oxygen and nutrients to sustain their survival and proliferation and allow for the integration of the developing tissue within the Surrounding tissue.
   Conclusion: our achieved results suggest that periosteum-derived osteoblasts on a suitable matrix can form lamellar bone within 3 months after transplantation and provide a reliable basis for simultaneous or secondary insertion of dental implants. (C) 2004 American Association of Oral and Maxillofacial Surgeons.
C1 Univ Hosp Freiburg, Dept Maxillofacial Surg, Freiberg, Germany.
RP Schimming, R (reprint author), St Leonhardstr 78, CH-9000 St Gallen, Switzerland.
EM praxis@kiefer-gesichtschirurgie.net
OI Schmelzeisen, Rainer/0000-0002-9686-6989
CR Abukawa H, 2003, J ORAL MAXIL SURG, V61, P94, DOI 10.1053/joms.2003.50015
   Bouhadir KH, 2001, J DRUG TARGET, V9, P397, DOI 10.3109/10611860108998775
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   ERGELETT C, 2003, ARTHROSCOPY, V19, P108
   Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010
   Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P513
   Karp JM, 2003, J CRANIOFAC SURG, V14, P317, DOI 10.1097/00001665-200305000-00009
   Lorenzetti M, 1998, INT J ORAL MAX IMPL, V13, P69
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   PUELACHER WC, 1994, J ORAL MAXIL SURG, V52, P1172, DOI 10.1016/0278-2391(94)90538-X
   RICH D, 1994, T ORTHOP RES SOC, V19, P241
   SITTINGER M, 1996, BIOMATERIALS, V17, P37
   Tamura S, 2001, BONE, V29, P169, DOI 10.1016/S8756-3282(01)00498-7
   Terheyden H, 1999, CLIN ORAL IMPLAN RES, V10, P510, DOI 10.1034/j.1600-0501.1999.100609.x
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   Yamagiwa H, 2001, J BONE MINER METAB, V19, P20, DOI 10.1007/s007740170056
   Yamanouchi K, 2001, J BONE MINER RES, V16, P857, DOI 10.1359/jbmr.2001.16.5.857
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Yoshikawa T, 1999, ANN CHIR GYNAECOL FE, V88, P186
NR 26
TC 126
Z9 134
U1 1
U2 22
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD JUN
PY 2004
VL 62
IS 6
BP 724
EP 729
DI 10.1016/j.joms.2004.01.009
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 825HC
UT WOS:000221745800016
PM 15170286
DA 2018-10-19
ER

PT J
AU Matsko, N
   Mueller, M
AF Matsko, N
   Mueller, M
TI AFM of biological material embedded in epoxy resin
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE atomic force microscopy; epoxy resin; freeze-substitution; high-pressure
   freezing; microtomy; transmission electron microscopy
ID ATOMIC-FORCE MICROSCOPE; ELECTRON-MICROSCOPY; FREEZE-SUBSTITUTION; AVOID
   COMPRESSION; SECTIONS; PRESERVATION; EPITHELIA; CONTRAST; FIXATION;
   SURFACE
AB We present a simple method to extract morphological details from the block face of epoxy embedded biopolymers by AFM. It is shown that topographical contrast and the identification of small structural details critically depend on the procedure of sample preparation before embedding (chemical fixation or high-pressure freezing and freeze-substitution) and on the hardness of the embedding epoxy resin. Ethanol treatment of the block face of the sample after microtomy elutes non-cross-linked polymer chains and makes the smallest details of the embedded biomaterial amenable to detection. AFM (height and phase contrast) examination of the block face of accordingly prepared cells of Caenorhabditis elegans provides data that are comparable to TEM. (C) 2004 Elsevier Inc. All rights reserved.
C1 ETH Honggerberg, Inst Angew Phys, CH-8093 Zurich, Switzerland.
RP Mueller, M (reprint author), ETH Honggerberg, Inst Angew Phys, CH-8093 Zurich, Switzerland.
EM mmueller@iap.phys.ethz.ch
CR ABRAHAM FF, 1988, PHYS REV LETT, V60, P1314, DOI 10.1103/PhysRevLett.60.1314
   AKAMINE S, 1990, APPL PHYS LETT, V57, P316, DOI 10.1063/1.103677
   Brydson JA, 1999, PLASTICS MAT
   Causton B.E., 1985, P209
   COLUCCIO LM, 1997, AM J PHYSIOL, V273, P347
   DAHL R, 1989, J ELECTRON MICR TECH, V13, P165, DOI 10.1002/jemt.1060130305
   Fasolka MJ, 2001, ULTRAMICROSCOPY, V90, P21, DOI 10.1016/S0304-3991(01)00129-2
   Haugstad G, 1999, ULTRAMICROSCOPY, V76, P77, DOI 10.1016/S0304-3991(98)00073-4
   Hayat M. A., 2000, PRINCIPLES TECHNIQUE
   HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x
   JESIOR JC, 1986, J ULTRA MOL STRUCT R, V95, P210, DOI 10.1016/0889-1605(86)90042-X
   JESIOR JC, 1985, J ULTRA MOL STRUCT R, V90, P135, DOI 10.1016/0889-1605(85)90104-1
   LANGE K, 2001, AM J PHYSIOL-CELL PH, V281, P369
   LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409
   Lutz J. T., 2001, POLYM MODIFIERS ADDI
   Magonov SN, 1997, ANNU REV MATER SCI, V27, P175, DOI 10.1146/annurev.matsci.27.1.175
   Melling M, 2001, NEUROIMAGE, V14, P1348, DOI 10.1006/nimg.2001.0924
   MENCO BPM, 1984, CELL TISSUE RES, V235, P225
   MENCO BPM, 1995, MICROSC RES TECHNIQ, V32, P337, DOI 10.1002/jemt.1070320408
   Mollenhauer HH, 1997, MICROSC RES TECHNIQ, V36, P417, DOI 10.1002/(SICI)1097-0029(19970301)36:5<417::AID-JEMT11>3.0.CO;2-V
   MOLLENHAUER HH, 1964, STAIN TECHNOL, V39, P111
   Moor H, 1987, CRYOTECHNIQUES BIOL
   MOOR H, 1968, P 4 EUR REG C EL MIC, P445
   Muelller M, 1984, SCI BIOL SPECIMEN PR, P131
   Nag K, 1999, J STRUCT BIOL, V126, P1, DOI 10.1006/jsbi.1999.4089
   Potter W. G., 1970, EPOXIDE RESINS
   STUDER D, 1992, PLANTA, V188, P155, DOI 10.1007/BF00216809
   VANHARREVELD A, 1964, ANAT REC, V149, P381, DOI 10.1002/ar.1091490307
   YAMAMOTO A, 1994, J HISTOCHEM CYTOCHEM, V42, P1463, DOI 10.1177/42.11.7930528
NR 29
TC 31
Z9 31
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUN
PY 2004
VL 146
IS 3
BP 334
EP 343
DI 10.1016/j.jsb.2004.01.010
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 817KP
UT WOS:000221176700008
PM 15099575
DA 2018-10-19
ER

PT J
AU Beiko, DT
   Knudsen, BE
   Watterson, JD
   Cadieux, PA
   Reid, G
   Denstedt, JD
AF Beiko, DT
   Knudsen, BE
   Watterson, JD
   Cadieux, PA
   Reid, G
   Denstedt, JD
TI Urinary tract biomaterials
SO JOURNAL OF UROLOGY
LA English
DT Review
DE urinary tract; biocompatible materials; urinary diversion; prostheses
   and implants
ID SMALL-INTESTINAL SUBMUCOSA; BACTERIUM OXALOBACTER-FORMIGENES; MALIGNANT
   URETERAL OBSTRUCTION; URETHRAL CATHETERS; METAL STENTS;
   SURFACE-PROPERTIES; PROTEUS-MIRABILIS; REDUCES ENCRUSTATION;
   CLINICAL-EXPERIENCE; RABBIT URETHRA
AB Purpose: As a result of endourological advances, biomaterials have become increasingly used within the urinary tract. This review article provides an update on the current status of urinary tract biomaterials, discussing issues of biocompatibility, biomaterials available for use, clinical applications and biomaterial related complications. Perspectives on future materials for use in the urinary tract are also provided.
   Materials and Methods: We performed a comprehensive search of the peer reviewed literature on all aspects of biomaterials in the urinary tract using PubMed and MEDLINE. All pertinent articles were reviewed in detail.
   Results: Any potential biomaterial must undergo rigorous physical and biocompatibility testing prior to its commercialization and use in humans. There are currently many different bulk materials and coatings available for the manufacturing of biomaterials, although the ideal material has yet to be discovered. For use in the urinary tract, biomaterials may be formed into devices, including ureteral and urethral stents, urethral catheters and percutaneous nephrostomy tubes. Despite significant advances in basic science research involving biocompatibility issues and biofilm formation, infection and encrustation remain associated with the use of biomaterials in the urinary tract and, therefore, limit their long-term indwelling time.
   Conclusions: Prosthetic devices formed from biomaterials will continue to be an essential tool in the practicing urologist's armamentarium. Ongoing research is essential to optimize biocompatibility and decrease biomaterial related complications such as infection and encrustation within the urinary tract. Future advances include biodegradables, novel coatings and tissue engineering.
C1 Queens Univ, Dept Urol, Kingston, ON, Canada.
   Univ Western Ontario, Dept Microbiol, London, ON, Canada.
   Univ Western Ontario, Dept Immunol, London, ON, Canada.
   Univ Ottawa, Div Urol, Ottawa, ON, Canada.
RP Denstedt, JD (reprint author), St Josephs Health Care London, 268 Grosvenor St, London, ON N6A 4V2, Canada.
EM John.Denstedt@sjhc.london.on.ca
RI Knudsen, Bodo/E-3411-2011
CR Adams F, 1846, 7 BOOKS PAULUS AEGIN
   Ahmed M, 1999, J ENDOUROL, V13, P221, DOI 10.1089/end.1999.13.221
   Amiel GE, 2001, J UROLOGY, V165, P2091, DOI 10.1016/S0022-5347(05)66300-8
   Antimisiaris SG, 2000, J ENDOUROL, V14, P743, DOI 10.1089/end.2000.14.743
   Auge BK, 2002, J UROLOGY, V168, P808, DOI 10.1016/S0022-5347(05)64748-9
   Barbalias GA, 1997, J UROLOGY, V158, P54, DOI 10.1097/00005392-199707000-00015
   Barbalias GA, 2002, EUR UROL, V42, P276, DOI 10.1016/S0302-2838(02)00281-6
   BITSCHAY J, 1956, HIST UROLOGY EGYPT, P56
   BLOOM DA, 1994, J UROLOGY, V151, P317, DOI 10.1016/S0022-5347(17)34937-6
   BORGOGNONI T, 1993, SURG THEODORIC, V7, P89
   Braf Z, 1996, J ENDOUROL, V10, P555, DOI 10.1089/end.1996.10.555
   CASTIGLIONI A, 1947, HIST MED, P202
   CASTIGLIONI A, 1947, HIST MED, P715
   CELSUS AC, 1989, MEDICINA, P569
   Choong S, 2001, INT J ANTIMICROB AG, V17, P305, DOI 10.1016/S0924-8579(00)00348-4
   Choong SKS, 2000, BJU INT, V86, P414, DOI 10.1046/j.1464-410X.2000.00861.x
   DAS S, 1983, SURG GYNECOL OBSTET, V157, P581
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   DENOS E, 1972, HIST UROLOGY, P70
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   FALKINHAM JO, 1984, J BACTERIOL, V158, P1037
   GALEN C, 1821, LIPSIAE, V14, P751
   GRAHAM DT, 1983, MED J AUSTRALIA, V1, P456
   Grossklaus DJ, 2001, J UROLOGY, V166, P636, DOI 10.1016/S0022-5347(05)66033-8
   Hekimoglu B, 1996, EUR RADIOL, V6, P675
   Hiatt BL, 2002, CATHETER CARDIO INTE, V55, P409, DOI 10.1002/ccd.10161
   JONES BD, 1987, INFECT IMMUN, V55, P2198
   Ko GY, 2002, RADIOLOGY, V223, P83, DOI 10.1148/radiol.2231010734
   Kulik E, 1996, J BIOMED MATER RES, V30, P295, DOI 10.1002/(SICI)1097-4636(199603)30:3<295::AID-JBM4>3.0.CO;2-L
   Kulkarni R, 2001, J UROLOGY, V166, P1750, DOI 10.1016/S0022-5347(05)65667-4
   Kulkarni RP, 1999, BJU INT, V83, P755
   Laaksovirta S, 2002, J ENDOUROL, V16, P311, DOI 10.1089/089277902760102811
   Laaksovirta S, 2002, J UROLOGY, V167, P1527, DOI 10.1016/S0022-5347(05)65357-8
   Lam J S, 2001, Curr Urol Rep, V2, P277, DOI 10.1007/s11934-001-0064-2
   Liatsikos EN, 2001, J UROLOGY, V165, P1719, DOI 10.1016/S0022-5347(05)66401-4
   Liedl B, 2001, Curr Opin Urol, V11, P75, DOI 10.1097/00042307-200101000-00011
   Lingeman JE, 2003, J UROLOGY, V169, P1682, DOI 10.1097/01.ju.0000055600.18515.a1
   LUNG HY, 1994, J BACTERIOL, V176, P2468
   MARDIS HK, 1988, UROL CLIN N AM, V15, P471
   MARDIS HK, 1993, J ENDOUROL, V7, P105, DOI 10.1089/end.1993.7.105
   MARINO RA, 1993, J ENDOUROL, V7, P89, DOI 10.1089/end.1993.7.89
   MARX M, 1988, J UROLOGY, V139, P180, DOI 10.1016/S0022-5347(17)42349-4
   MOBLEY HLT, 1987, J CLIN MICROBIOL, V25, P2216
   Multanen M, 2002, UROL RES, V30, P227, DOI 10.1007/s00240-002-0252-7
   MURPHY LJT, 1985, HIST UROLOGY, P70
   NACEY JN, 1986, J UROLOGY, V136, P706, DOI 10.1016/S0022-5347(17)45032-4
   O'Connor RC, 2002, UROLOGY, V60, P906, DOI 10.1016/S0090-4295(02)01965-9
   Olweny EO, 2002, J UROLOGY, V167, P2198, DOI 10.1016/S0022-5347(05)65128-2
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Pauer W, 1999, J UROLOGY, V162, P319, DOI 10.1016/S0022-5347(05)68549-7
   REID G, 1992, INT BIODETER BIODEGR, V30, P105, DOI 10.1016/0964-8305(92)90057-U
   REID G, 1995, SURF SCI REP, V21, P251, DOI 10.1016/0167-5729(94)00006-9
   REID G, 1995, COLLOID SURFACE B, V5, P171, DOI 10.1016/0927-7765(95)01208-Z
   Reid KA, 1995, ENVIRON CHEM, V1, P269
   Riedl CR, 2002, INT J ANTIMICROB AG, V19, P507, DOI 10.1016/S0924-8579(02)00097-3
   Roemer FD, 2000, J ENDOUROL, V14, P1, DOI 10.1089/end.2000.14.1
   Rotariu P, 2002, J ENDOUROL, V16, P617, DOI 10.1089/089277902320913332
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Sidhu H, 1997, J BACTERIOL, V179, P3378, DOI 10.1128/jb.179.10.3378-3381.1997
   Sidhu H, 1999, J CLIN MICROBIOL, V37, P1503
   Sofer M, 2002, J ENDOUROL, V16, P27, DOI 10.1089/089277902753483682
   Sofer M, 2000, Curr Opin Urol, V10, P563, DOI 10.1097/00042307-200011000-00005
   Stickler D, 1999, EUR J CLIN MICROBIOL, V18, P206, DOI 10.1007/s100960050260
   STICKLER D, 1993, UROL RES, V21, P407, DOI 10.1007/BF00300077
   Stickler DJ, 2002, INT J ANTIMICROB AG, V19, P499, DOI 10.1016/S0924-8579(02)00091-2
   THOMAS GJ, 1933, HIST UROLOGY, V2, P354
   THORNHILL JA, 1995, CONTROVERSIES ENDOUR, P287
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Verkoelen C F, 2000, Curr Opin Urol, V10, P539, DOI 10.1097/00042307-200011000-00001
   Watterson JD, 2003, J ENDOUROL, V17, P269, DOI 10.1089/089277903322145431
   WATTERSON JD, 2002, AUA UPDATE SERIES, V21, P122
   WERSHUB LP, 1970, UROLOGY ANTIQUITY 20, P253
   Zupkas P, 2000, J ENDOUROL, V14, P483, DOI 10.1089/end.2000.14.483
NR 75
TC 59
Z9 61
U1 1
U2 25
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD JUN
PY 2004
VL 171
IS 6
BP 2438
EP 2444
DI 10.1097/01.ju.0000125001.56045.6c
PN 1
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 822BV
UT WOS:000221510300105
PM 15126872
DA 2018-10-19
ER

PT J
AU Vartzouma, C
   Louloudi, M
   Prodromidis, M
   Hadjiliadis, N
AF Vartzouma, C
   Louloudi, M
   Prodromidis, M
   Hadjiliadis, N
TI Synthesis and characterization of NAD(+)-modified silica: a convenient
   immobilization of biomolecule via its phosphate group
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE NAD(+); immobilization; biocomposite material
ID POLYMERS; SURFACE
AB The development of a practical tethering of beta-nicotamide adenine dinucleotide (NAD(+)) molecule on a silica surface is presented, leading to a functional biomaterial. The covalent attachment of the biomolecule was achieved through its phosphate group. The NAD(+)-modified 14 silica was mainly characterized by diffuse reflectance FTIR and C-13, P-31 and Si-29 solid state NMR spectroscopy. The electrochemical behaviour of the biomaterial was also studied using cyclic voltammetry (CV). The present method is convenient and easily applicable. Its importance is discussed and possible applications are suggested. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Ioannina, Dept Chem, Lab Inorgan & Gen Chem, GR-45110 Ioannina, Greece.
RP Louloudi, M (reprint author), Univ Ioannina, Dept Chem, Lab Inorgan & Gen Chem, GR-45110 Ioannina, Greece.
EM mlouloud@cc.uoi.gr
OI Prodromidis, Mamas/0000-0002-1309-403X
CR AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   DUNCAN TM, 1984, CHEM PHYS, V87, P339, DOI 10.1016/0301-0104(84)85115-0
   Florou AB, 2000, ELECTROANAL, V12, P361, DOI 10.1002/(SICI)1521-4109(20000301)12:5<361::AID-ELAN361>3.0.CO;2-E
   GEROTHANASSIS IP, 1994, EUR J BIOCHEM, V226, P211, DOI 10.1111/j.1432-1033.1994.tb20043.x
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Gill I, 2001, CHEM MATER, V13, P3404, DOI 10.1021/cm0102483
   HERZFELD J, 1980, J CHEM PHYS, V73, P6021, DOI 10.1063/1.440136
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Jin W, 2002, ANAL CHIM ACTA, V461, P1, DOI 10.1016/S0003-2670(02)00229-5
   LUKES I, 1994, J AM CHEM SOC, V116, P1737, DOI 10.1021/ja00084a014
   Price PM, 2000, J CHEM SOC DALTON, P101, DOI 10.1039/a905457j
   Schmidt HL, 1996, BIOSENS BIOELECTRON, V11, P127, DOI 10.1016/0956-5663(96)83720-1
   Vartzouma C, 2002, CHEM COMMUN, P522, DOI 10.1039/b110808p
   Williams AK, 1998, J AM CHEM SOC, V120, P4366, DOI 10.1021/ja973772c
   YAMANAKA SA, 1995, J AM CHEM SOC, V117, P9095, DOI 10.1021/ja00140a038
NR 15
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JUN 1
PY 2004
VL 24
IS 4
BP 473
EP 477
DI 10.1016/j.msec.2003.09.167
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 828SG
UT WOS:000221992700003
DA 2018-10-19
ER

PT J
AU Mao, C
   Zhao, WB
   Zhu, AP
   Shen, J
   Lin, SC
AF Mao, C
   Zhao, WB
   Zhu, AP
   Shen, J
   Lin, SC
TI A photochemical method for the surface modification of poly(vinyl
   chloride) with O-butyrylchitosan to improve blood compatibility
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE surface modification; radiation grafting; O-butyrylchitosan; poly(vinyl
   chloride); blood compatibility; platelet adhesion
ID IN-VITRO; CHITOSAN; DERIVATIVES; MEMBRANES
AB In order to improve blood compatibility, the surfaces of poly(vinyl chloride) (PVC) were treated using irradiation with ultraviolet light, O-butyrylchitosan (OBCS) being coated on the film surface to photolyze azide groups, thus crosslinking OBCS and PVC together. Surface properties of PVC were investigated by attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR), electron spectroscopy for chemical analysis (ESCA) and the water contact angle measurements. The blood compatibility of PVC was evaluated by platelet rich plasma (PRP) contacting experiments and the results were observed by scanning electron microscopy (SEM). It demonstrated that fewer platelets adhered to the OBCS grafted surfaces than to the blank PVC. The modifications could be carried out to tailor PVC biomaterial to meet the specific needs of different biomedical applications. These results suggest that the photocrosslinkable chitosan developed here has the potential of serving as a new biomaterial in medical use. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
   Nanjing Univ, Inst Analyt Sci, Lab Mesoscop Mat Sci, Dept Chem, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Shen, J (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
EM shenjian@nju.edu.cn
CR Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   FOSTER A, 1998, P NOBCCHE, V25, P127
   GRANT S, 1988, POLYM COMMUN, V29, P342
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   JIE C, 1999, RADIAT PHYS CHEM, V55, P87
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kyrolainen M, 1997, ANAL CHIM ACTA, V353, P281, DOI 10.1016/S0003-2670(97)87787-2
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   POPOWICZ P, 1985, BIOMED BIOCHIM ACTA, V44, P1329
   Rhodes NP, 1996, BIOMATERIALS, V17, P1995, DOI 10.1016/0142-9612(96)00018-X
   ROLLASON G, 1986, THROMB RES, V44, P517, DOI 10.1016/0049-3848(86)90329-4
   vanderHeiden AP, 1997, J BIOMED MATER RES, V37, P282, DOI 10.1002/(SICI)1097-4636(199711)37:2<282::AID-JBM19>3.0.CO;2-G
   Yang MR, 1997, MATER CHEM PHYS, V48, P71, DOI 10.1016/S0254-0584(97)80081-8
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 19
TC 36
Z9 43
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
J9 PROCESS BIOCHEM
JI Process Biochem.
PD MAY 31
PY 2004
VL 39
IS 9
BP 1151
EP 1157
DI 10.1016/S0032-9592(03)00225-5
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA 820MP
UT WOS:000221393800016
DA 2018-10-19
ER

PT J
AU Elzein, T
   Nasser-Eddine, M
   Delaite, C
   Bistac, S
   Dumas, P
AF Elzein, T
   Nasser-Eddine, M
   Delaite, C
   Bistac, S
   Dumas, P
TI FTIR study of polycaprolactone chain organization at interfaces
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE polycaprolactone (PCL) thin films; orientation; infrared
ID QUANTITATIVE-ANALYSIS; ADSORBED POLYAMIDES; THIN-FILMS; ORIENTATION;
   SPECTROSCOPY; BLENDS; POLY(EPSILON-CAPROLACTONE)
AB Polycaprolactone (PCL), extensively known as a biomaterial, is the subject of this paper. Knowing well that some biomaterial applications exhibit specific chain organization, we focused our study on the orientation of PCL chains when this polymer is adsorbed (spin-coated) on inert substrates such as gold-coated glass slides. The main technique allowing adsorbed thin films analysis that we chose is polarization-modulation infrared reflection-absorption spectroscopy (PM-IRRAS), which permits qualitative and quantitative determination of chain anisotropy in the confined layers at the interface. Based on our spectroscopic results, we achieved an adsorption model of PCL chains and we calculated orientation angles with respect to the substrate normal. Calculated values show a quasi-perpendicular deposition of PCL chains on the gold substrate. Moreover. PCL thin films remain highly crystalline, a fact which could be the basis of the important anisotropy of PCL chains. (C) 2004 Elsevier Inc. All rights reserved.
C1 Inst Chim Surfaces & Interfaces, F-68057 Mulhouse, France.
RP Elzein, T (reprint author), Inst Chim Surfaces & Interfaces, 15 Rue Jean Starcky, F-68057 Mulhouse, France.
EM tamara_elzein@yahoo.fr
CR ALLARA DL, 1985, LANGMUIR, V1, P52, DOI 10.1021/la00061a008
   Bellamy L.J., 1958, INFRARED SPECTRA COM
   BUFFETEAU T, 1993, J CHIM PHYS PCB, V90, P1467, DOI 10.1051/jcp/1993901467
   BUFFETEAU T, 1991, APPL SPECTROSC, V45, P380, DOI 10.1366/0003702914337308
   BUFFETEAU T, 1993, J CHIM PHYS PCB, V90, P1871, DOI 10.1051/jcp/1993901871
   BUFFETEAU T, 1997, MIKROCHIM ACTA, V14, P627
   COLEMAN MM, 1979, J POLYM SCI POL PHYS, V17, P837, DOI 10.1002/pol.1979.180170509
   DUBOIS P, 1993, MACROMOLECULES, V26, P2730, DOI 10.1021/ma00063a015
   Elfick APD, 2002, BIOMATERIALS, V23, P4463, DOI 10.1016/S0142-9612(02)00163-1
   Elzein T, 2003, POLYMER, V44, P3649, DOI 10.1016/S0032-3861(03)00293-3
   Elzein T, 2002, J POLYM SCI POL PHYS, V40, P1464, DOI 10.1002/polb.10207
   ELZEIN T, 2002, POLYMER, V34, P4811
   ELZEIN T, 2003, J SURF INTERFACE ANA, V35, P231
   ELZEIN T, 2003, J SURF INTERFACE ANA, V35, P633
   Hummel D. O., 1966, INFRARED SPECTRA POL
   KEROACK D, 1998, POLYMER, V40, P243
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   PORTER MD, 1988, ANAL CHEM, V60, pA1143, DOI 10.1021/ac00171a001
   RABOLT JF, 1983, J CHEM PHYS, V78, P946, DOI 10.1063/1.444799
   Rutkowska M, 1998, REACT FUNCT POLYM, V38, P27, DOI 10.1016/S1381-5148(98)00029-7
   Schrader B, 1995, INFRARED RAMAN SPECT
   SOCRATES G, 1980, INFRARES CHARACTERIS
   Wang J, 2002, POLYMER, V43, P1357, DOI 10.1016/S0032-3861(01)00673-5
   Wunderlich B., 1973, MACROMOLECULAR PHYS, V3
NR 25
TC 263
Z9 270
U1 9
U2 74
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAY 15
PY 2004
VL 273
IS 2
BP 381
EP 387
DI 10.1016/j.jcis.2004.02.001
PG 7
WC Chemistry, Physical
SC Chemistry
GA 814UG
UT WOS:000220999000006
PM 15082371
DA 2018-10-19
ER

PT J
AU Tominaga, M
   Ohira, A
   Yamaguchi, Y
   Kunitake, M
AF Tominaga, M
   Ohira, A
   Yamaguchi, Y
   Kunitake, M
TI Electrochemical, AFM and QCM studies on ferritin immobilized onto a
   self-assembled monolayer-modified gold electrode
SO JOURNAL OF ELECTROANALYTICAL CHEMISTRY
LA English
DT Article
DE ferritin; modified electrode; AFM; monolayer; redox reaction
ID WALLED CARBON NANOTUBES; QUARTZ-CRYSTAL MICROBALANCE; INDIUM OXIDE
   ELECTRODES; MAMMALIAN FERRITIN; CATALYTIC NANOPARTICLES; PROTEIN CAGE;
   IRON UPTAKE; RELEASE; AU; SURFACES
AB A ferritin-immobilized electrode based on self-assembled monolayer (SAM)-modified gold electrodes was developed. Various alkane thiols containing functional groups as the terminal group were used for the SAMs. The ferritin-immobilized SAM-modified electrodes were characterized by electrochemical, atomic force microscopy (AFM) and quartz crystal microbalance (QCM) techniques. The results indicated that ferritin was selectively immobilized onto amino terminal alkane thiol-modified electrodes by the electrostatic interaction between ferritin and the terminal functional groups of the SAMs. The ferritin-immobilized modified electrode showed a direct electron transfer reaction between ferritin and the electrode. The electrochemically regulated uptake and release of iron ions for ferritin immobilized on the SAMs was demonstrated. The AFM and QCM results showed that ferritin molecules covered the whole electrode surface at almost a full monolayer level. The results obtained in this work indicate that ferritin has potential for a biomaterial in nanomaterial synthesis for potential magnetic, catalytic and biomedical sensing applications. (C) 2003 Elsevier B.V. All rights reserved.
C1 Kumamoto Univ, Coll Med Sci, Kumamoto 8620976, Japan.
   Kumamoto Univ, Fac Engn, Dept Appl Chem & Biochem, Kumamoto 8608555, Japan.
   Kumamoto Technol & Ind Fdn, Japan Sci & Technol Corp, Kumamoto 8612202, Japan.
RP Tominaga, M (reprint author), Kumamoto Univ, Coll Med Sci, 4-24-1 Kuhonji, Kumamoto 8620976, Japan.
EM masato@gpo.kumamotou.ac.jp
RI LUO, holly/G-7671-2012; Ohira, Akihiro/P-8914-2017
OI Ohira, Akihiro/0000-0002-5748-4830
CR Allen M, 2002, ADV MATER, V14, P1562, DOI 10.1002/1521-4095(20021104)14:21<1562::AID-ADMA1562>3.0.CO;2-D
   ANGERSTEINKOZLOWSKA H, 1987, J ELECTROANAL CHEM, V228, P429, DOI 10.1016/0022-0728(87)80122-5
   AROSIO P, 1978, J BIOL CHEM, V253, P4451
   BONARD JM, 2002, NANO LETT, V6, P665
   Cherry RJ, 1998, LANGMUIR, V14, P1971, DOI 10.1021/la970685p
   CLAVILIER J, 1980, J ELECTROANAL CHEM, V107, P205, DOI 10.1016/0368-1874(80)80076-1
   Douglas T, 2002, ADV MATER, V14, P415, DOI 10.1002/1521-4095(20020318)14:6<415::AID-ADMA415>3.0.CO;2-W
   Douglas T, 2000, INORG CHEM, V39, P1828, DOI 10.1021/ic991269q
   FENG ZQ, 1995, J ELECTROANAL CHEM, V394, P149, DOI 10.1016/0022-0728(95)04058-V
   FUNK F, 1985, EUR J BIOCHEM, V152, P167, DOI 10.1111/j.1432-1033.1985.tb09177.x
   Harrison P.M., 1989, IRON CARRIERS IRON P
   Heqing Huang, 1993, Biochemistry, V32, P1681
   KADIR FHA, 1991, BIOCHEM J, V278, P817, DOI 10.1042/bj2780817
   LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011
   Li YM, 2001, J PHYS CHEM B, V105, P11424, DOI 10.1021/jp012085b
   Marken F, 2002, NEW J CHEM, V26, P259, DOI 10.1039/b108500j
   Martin TD, 1997, J ELECTROANAL CHEM, V420, P279, DOI 10.1016/S0022-0728(96)04790-0
   Okahata Y, 1998, ANAL CHEM, V70, P1288, DOI 10.1021/ac970584w
   Okahata Y, 1998, BIOCHEMISTRY-US, V37, P5666, DOI 10.1021/bi980037k
   PROULXCURRY PM, 1995, COORDIN CHEM REV, V144, P347, DOI 10.1016/0010-8545(95)01148-I
   Pyon MS, 1999, LANGMUIR, V15, P7040, DOI 10.1021/la990403g
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   StPierre TG, 1996, COORDIN CHEM REV, V151, P125, DOI 10.1016/0010-8545(95)01220-6
   Su M, 2000, J PHYS CHEM B, V104, P6505, DOI 10.1021/jp0012404
   TARLOV MJ, 1991, J AM CHEM SOC, V113, P1847, DOI 10.1021/ja00005a068
   Tominaga M, 2001, CHEM LETT, P704, DOI 10.1246/cl.2001.704
   TOMINAGA M, 1993, CHEM LETT, V32, P954
   Tsang SC, 2000, CHEM PHYS LETT, V322, P553, DOI 10.1016/S0009-2614(00)00470-X
   Ulman A., 1991, NTRO ULTRATHIN ORGAN
   UOSAKI K, 1995, J PHYS CHEM-US, V99, P14117, DOI 10.1021/j100038a051
   VESENKA J, 1994, REV SCI INSTRUM, V65, P2249, DOI 10.1063/1.1144735
   WATT GD, 1988, P NATL ACAD SCI USA, V85, P7457, DOI 10.1073/pnas.85.20.7457
   WATT GD, 1985, P NATL ACAD SCI USA, V82, P3640, DOI 10.1073/pnas.82.11.3640
   WATT RK, 1992, BIOCHEMISTRY-US, V31, P9673, DOI 10.1021/bi00155a021
   WIDRIG CA, 1991, J ELECTROANAL CHEM, V310, P335, DOI 10.1016/0022-0728(91)85271-P
   Yamashita I, 2001, THIN SOLID FILMS, V393, P12, DOI 10.1016/S0040-6090(01)01083-5
   Zapien DC, 2000, J ELECTROANAL CHEM, V494, P114, DOI 10.1016/S0022-0728(00)00364-8
   Zhang Y, 2002, APPL PHYS A-MATER, V74, P325, DOI 10.1007/s003390201274
NR 39
TC 58
Z9 58
U1 0
U2 34
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0022-0728
J9 J ELECTROANAL CHEM
JI J. Electroanal. Chem.
PD MAY 15
PY 2004
VL 566
IS 2
BP 323
EP 329
DI 10.1016/j.jelechem.2003.11.056
PG 7
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 817XJ
UT WOS:000221209900010
DA 2018-10-19
ER

PT J
AU Soiderer, EE
   Lantz, GC
   Kazacos, EA
   Hodde, JP
   Wiegand, RE
AF Soiderer, EE
   Lantz, GC
   Kazacos, EA
   Hodde, JP
   Wiegand, RE
TI Morphologic study of three collagen materials for body wall repair
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE extracellular matrix; polypropylene mesh; small intestinal submucosa;
   body wall; collagen
ID SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL; POLYPROPYLENE-MESH;
   DOG-MODEL; RESORBABLE BIOSCAFFOLD; SHORT-TERM; GORE-TEX; DEFECTS;
   BIOMATERIAL; MATRIX
AB Background. The search for ideal prostheses for body wall repair continues. Synthetic materials such as polypropylene mesh (PPM) are associated with healing complications. A porcine-derived collagen-based material (CBM), small intestinal submucosa (SIS), has been studied for body wall repair. Renal capsule matrix (RCM) and urinary bladder submucosa (UBS) are CBMs not previously evaluated in this application. This is the first implant study using RCM.
   Materials and methods. Full-thickness muscle/fascia ventral abdominal wall defects were repaired with SIS, RCM, UBS, and PPM in rats with omentum and omentectomy. A random complete block design was used to allot implant type to each of 96 rats. Healing was evaluated at 4 and 8 weeks. Adhesion tenacity and surface area were scored. Implant site dimensions were measured at implantation and necropsy. Inflammation, vascularization, and fibrosis were histopathologically scored. Data were compared by analysis of variance (P < 0.05).
   Results. PPM produced a granulomatous foreign body response in contrast to the organized healing of CBM implants. CBM mean scores were lower than PPM scores for adhesion tenacity, surface area, and inflammation at each follow-up time for rats with omentums (P < 0.02). The CBMs had less tenacity and inflammation than PPM at each follow-up time in omentectomy groups (P < 0.008). Wound contraction was greater for PPM (P < 0.0001) for all rats.
   Conclusions. RCM and UBS were similar to SIS invoking reduced inflammation, adhesion, and contraction compared to PPM. The fibrotic response to PPM was unique and more intense compared to CBMs. These CBM implants appear morphologically acceptable and warrant continued investigation. (C) 2004 Elsevier Inc. All rights reserved.
C1 Purdue Univ, Dept Vet Clin Sci, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Vet Pathobiol, W Lafayette, IN 47907 USA.
   Cook Biotech Inc, W Lafayette, IN USA.
   Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA.
RP Lantz, GC (reprint author), Purdue Univ, Dept Vet Clin Sci, W Lafayette, IN 47907 USA.
OI Wiegand, Ryan/0000-0002-9486-1850
CR Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BAUER JJ, 1987, ANN SURG, V206, P765, DOI 10.1097/00000658-198712000-00013
   Bendavid R, 2001, ABDOMINAL WALL HERNI
   BLEICHRODT RP, 1993, SURG GYNECOL OBSTET, V176, P18
   BOYERS SP, 1988, FERTIL STERIL, V49, P1066
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   CUMBERLAND V H, 1952, Med J Aust, V1, P143
   Debodinance P, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P527
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, WOUNDS, V13, P195
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   JENKINS SD, 1983, SURGERY, V94, P392
   Klinge U, 1999, BIOMATERIALS, V20, P613, DOI 10.1016/S0142-9612(98)00211-7
   Klinge U, 2001, BIOMATERIALS, V22, P1415, DOI 10.1016/S0142-9612(00)00299-4
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kuhn MA, 2001, J SURG RES, V95, P54, DOI 10.1006/jsre.2000.6038
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MURPHY JL, 1989, CAN J SURG, V32, P244
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Rosen M, 2002, SURGERY, V132, P480, DOI 10.1067/msy.2002.126505
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SAS Institute, 2001, VERS 8 2
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   Stoll MR, 2002, VET SURG, V31, P379, DOI 10.1053/jvet.2002.33596
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WALDREP DJ, 1993, AM SURGEON, V59, P716
   Wallace DG, 1988, COLLAGEN BIOTECHNOLO, P118
   1995, VITAL HLTH STAT, V139, P9
NR 43
TC 57
Z9 58
U1 1
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD MAY 15
PY 2004
VL 118
IS 2
BP 161
EP 175
DI 10.1016/S0022-4804(03)00352-4
PG 15
WC Surgery
SC Surgery
GA 815KE
UT WOS:000221040400007
PM 15100005
DA 2018-10-19
ER

PT J
AU Senechal, A
   Carrigan, SD
   Tabrizian, M
AF Senechal, A
   Carrigan, SD
   Tabrizian, M
TI Probing surface adhesion forces of Enterococcus faecalis to
   medical-grade polymers using atomic force microscopy
SO LANGMUIR
LA English
DT Article
ID BIODEGRADABLE ANTIMICROBIAL POLYMER; BACTERIAL ADHESION; BIOMATERIAL
   SURFACES; ESCHERICHIA-COLI; IMAGE-ANALYSIS; BIOFILMS; ASSAY; DETACHMENT;
   SURVIVAL; AFM
AB The aim of this study was to compare the initial adhesion forces of the uropathogen Enterococcus faecalis with the medical-grade polymers polyurethane (PU), polyamide (PA), and poly(tetrafluoroethylene) (PTFE). To quantify the cell-substrate adhesion forces, a method was developed using atomic force microscopy (AFM) in liquid that allows for the detachment of individual live cells from a polymeric surface through the application of increasing force using unmodified cantilever tips. Results show that the lateral force required to detach E. faecalis cells from a substrate differed depending on the nature of the polymeric surface: a force of 19 +/- 4 nN was required to detach cells from PU, 6 +/- 4 nN from PA, and 0.7 +/- 0.3 nN from PTFE. Among the unfluorinated polymers (PU and PA), surface wettability was inversely proportional to the strength of adhesion. AFM images also demonstrated qualitative differences in bacterial adhesion; PU was covered by clusters of cells with few cell singlets present, whereas PA was predominantly covered by individual cells. Moreover, extracellular material could be observed on some clusters of PU-adhered cells as well as in the adjacent region surrounding cells adhered on PA. E. faecalis adhesion to the fluorinated polymer (PTFE) showed different characteristics; only a few individual cells were found, and bacteria were easily damaged, and thus detached, by the tip. This work demonstrates the utility of AFM for measurement of cell-substrate lateral adhesion forces and the contribution these forces make toward understanding the initial stages of bacterial adhesion. Further, it suggests that initial adhesion can be controlled, through appropriate biomaterial design, to prevent subsequent formation of aggregates and biofilms.
C1 McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
RP Tabrizian, M (reprint author), McGill Univ, Dept Biomed Engn, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.
EM annie.senechal@mail.mcgill.ca; shawn.carrigan@mail.mcgill.ca;
   maryam.tabrizian@mcgill.ca
CR An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550
   Andrews CS, 2001, BIOMATERIALS, V22, P3225, DOI 10.1016/S0142-9612(01)00160-0
   Beech IB, 2002, COLLOID SURFACE B, V23, P231, DOI 10.1016/S0927-7765(01)00233-8
   Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321
   Boyd RD, 2002, LANGMUIR, V18, P2343, DOI 10.1021/la011142p
   Busscher HJ, 1998, CURR MICROBIOL, V37, P319, DOI 10.1007/s002849900385
   CADIEUX P, 2003, COLLOID SURFACE B, V21, P361
   Camesano TA, 2000, LANGMUIR, V16, P4563, DOI 10.1021/la990805o
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Dexter SJ, 2003, BIOMATERIALS, V24, P27, DOI 10.1016/S0142-9612(02)00239-9
   *DIG INSTR, 1999, MULT SPM INSTR MAN
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P113, DOI 10.1016/0927-7765(96)01288-X
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Grapski JA, 2001, BIOMATERIALS, V22, P2239, DOI 10.1016/S0142-9612(00)00412-9
   KUHLMEIER D, 2002, BIOSENS BIOELECTRON, P1
   Lamba NMK, 2000, J BIOMAT SCI-POLYM E, V11, P1227, DOI 10.1163/156856200744174
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Otto K, 1999, J BACTERIOL, V181, P5210
   Park JH, 2002, BIOMATERIALS, V23, P3991, DOI 10.1016/S0142-9612(02)00144-8
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Rijnaarts HHM, 1999, COLLOID SURFACE B, V14, P179, DOI 10.1016/S0927-7765(99)00035-1
   Schachter B, 2003, NAT BIOTECHNOL, V21, P361, DOI 10.1038/nbt0403-361
   SENECHAL A, UNPUB
   Shiloh MU, 1997, INFECT IMMUN, V65, P3193
   SJOLLEMA J, 1989, J MICROBIOL METH, V9, P73, DOI 10.1016/0167-7012(89)90057-2
   Suci PA, 1998, BIOMATERIALS, V19, P327, DOI 10.1016/S0142-9612(97)00108-7
   Trafny EA, 1998, J BIOMED MATER RES, V41, P593, DOI 10.1002/(SICI)1097-4636(19980915)41:4<593::AID-JBM11>3.0.CO;2-G
   van der Aa BC, 2002, COLLOID SURFACE B, V23, P173, DOI 10.1016/S0927-7765(01)00229-6
   Woo GLY, 2002, J BIOMED MATER RES, V59, P35, DOI 10.1002/jbm.1214
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   Yao X, 2002, COLLOID SURFACE B, V23, P213, DOI 10.1016/S0927-7765(01)00249-1
NR 37
TC 29
Z9 29
U1 2
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 11
PY 2004
VL 20
IS 10
BP 4172
EP 4177
DI 10.1021/la035847y
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 819MQ
UT WOS:000221319400052
PM 15969413
DA 2018-10-19
ER

PT J
AU Jin, HJ
   Park, J
   Valluzzi, R
   Cebe, P
   Kaplan, DL
AF Jin, HJ
   Park, J
   Valluzzi, R
   Cebe, P
   Kaplan, DL
TI Biomaterial films of Bombyx mori silk fibroin with poly(ethylene oxide)
SO BIOMACROMOLECULES
LA English
DT Article
ID BLEND FILMS; PHYSICAL-PROPERTIES; POLYMERIC BIOMATERIALS; POLY(VINYL
   ALCOHOL); SEPARATION; MEMBRANES; SURFACES
AB Phase separation into controllable patterned microstructures was observed for Bombyx mori silkworm silk and poly(ethylene oxide) (PEO) (900 000 g/mol) blends cast from solution. The evolution of the microstructures with increasing PEO volume fraction is strikingly similar to the progression of phases and microstructures observed with surfactants. The chemically patterned materials obtained provide engineerable biomaterial Surfaces with predictable microscale features which can be used to create topographically patterned or chemically functionalized biomaterials. Solution blending was used to incorporate water-soluble PEO into silk to enhance elasticity and hydrophilicity. The sizes of the globule fibroin phase ranged from 2.1 +/- 0.5 to 18.2 +/- 2.1 mum depending on the ratio of silk/PEO. Optical microscopy and S EM analysis confirmed the micro-phase separation between PEO and silk. Surface properties were determined by XPS and contact angle. Methanol can be used to control the conformational transition of silk fibroin to the insoluble beta-sheet state. Subsequentially, the PEO can be easily extracted from the films with water to generate silk matrixes with definable porosity and enhanced surface roughness. These blend films formed from two biocompatible polymers provide potential new biomaterials for tissue engineering scaffolds.
C1 Tufts Univ, Dept Biomed Engn, Ctr Bioengn, Medford, MA 02155 USA.
   Tufts Univ, Dept Phys & Astron, Ctr Bioengn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biol & Chem Engn, Ctr Bioengn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Bioengn, 4 Colby St, Medford, MA 02155 USA.
OI Cebe, Peggy/0000-0002-8721-644X
FU NIDCR NIH HHS [R01 DE13405-01]
CR Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   BUNNING TJ, 1994, ACS SYM SER, V544, P353
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chen X, 1999, J APPL POLYM SCI, V73, P975, DOI 10.1002/(SICI)1097-4628(19990808)73:6<975::AID-APP15>3.0.CO;2-#
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Kesenci K, 2001, J BIOMAT SCI-POLYM E, V12, P337, DOI 10.1163/156856201750180852
   Kim KS, 2001, J APPL POLYM SCI, V82, P3618, DOI 10.1002/app.2224
   KIM SW, 1996, BIOMATERIALS SCI INT, P297
   Kweon HY, 2001, J APPL POLYM SCI, V80, P1848, DOI 10.1002/app.1281
   Lee K.Y., 2001, FIBER POLYM, V2, P71
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   Poza P, 2002, ENG FRACT MECH, V69, P1035, DOI 10.1016/S0013-7944(01)00120-5
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sun YY, 1997, J APPL POLYM SCI, V65, P959, DOI 10.1002/(SICI)1097-4628(19970801)65:5<959::AID-APP14>3.0.CO;2-N
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Tanaka T, 1997, POLYM INT, V42, P107, DOI 10.1002/(SICI)1097-0126(199701)42:1<107::AID-PI686>3.0.CO;2-9
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   YAMAURA K, 1990, J APPL POLYM SCI, V41, P2409, DOI 10.1002/app.1990.070410941
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
NR 30
TC 165
Z9 172
U1 4
U2 86
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2004
VL 5
IS 3
BP 711
EP 717
DI 10.1021/bm0343287
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 819LA
UT WOS:000221315200009
PM 15132651
DA 2018-10-19
ER

PT J
AU Nazarov, R
   Jin, HJ
   Kaplan, DL
AF Nazarov, R
   Jin, HJ
   Kaplan, DL
TI Porous 3-D scaffolds from regenerated silk fibroin
SO BIOMACROMOLECULES
LA English
DT Article
ID BIODEGRADABLE POLYMER SCAFFOLDS; IMPEDANCE SPECTROSCOPY; IMAGE-ANALYSIS;
   BONE-FORMATION; FABRICATION; BIOMATERIALS; MORPHOLOGY; CULTURE; FIBERS;
   MATRIX
AB Three fabrication techniques, freeze-drying, salt leaching and gas foaming, were used to form porous three-dimensional silk biomaterial matrixes. Matrixes were characterized for morphological and functional properties related to processing method and conditions. The porosity of the salt leached scaffolds varied between 84 and 98% with a compressive strength up to 175 +/- 3 KPa, and the gas foamed scaffolds had porosities of 87-97% and compressive strength up to 280 +/- 4 KPa. The freeze-dried scaffolds were prepared at different freezing temperatures (-80 and -20 degreesC) and subsequently treated with different concentrations (15 and 25%) and hydrophilicity alcohols. The porosity of these scaffolds was up to 99%, and the maximum compressive strength was 30 +/- 2 KPa. Changes in silk fibroin structure during processing to form the 3D matrixes were determined by FT-IR and XrD. The salt leached and gas foaming techniques produced scaffolds with a useful combination of high compressive strength, interconnected pores, and pore sizes greater than 100 microns in diameter. The results suggest that silk-based 3D matrixes can be formed for utility in biomaterial applications.
C1 Tufts Univ, Dept Biomed Engn, Ctr Bioengn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biol & Chem Engn, Ctr Bioengn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Bioengn, Medford, MA 02155 USA.
FU NIDCR NIH HHS [DE13405-04]
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   Blacher S, 2001, COLLOID SURFACE A, V187, P375, DOI 10.1016/S0927-7757(01)00652-5
   CALLISTER WD, 2000, MAT SCI ENG INTRO, P114
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   CUNNIFF PM, 1994, ACS SYM SER, V544, P234
   Ehrenstein G. W., 2001, POLYM MAT, P167
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kim E.S., 2001, FIBER POLYM, V2, P64, DOI DOI 10.1007/BF02875260
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   MAGOSHI J, 1974, KOBUNSHI RONBUNSHU, V31, P765
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 39
TC 559
Z9 578
U1 15
U2 210
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2004
VL 5
IS 3
BP 718
EP 726
DI 10.1021/bm034327e
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 819LA
UT WOS:000221315200010
PM 15132652
DA 2018-10-19
ER

PT J
AU Iwasaki, N
   Yamane, ST
   Majima, T
   Kasahara, Y
   Minami, A
   Harada, K
   Nonaka, S
   Maekawa, N
   Tamura, H
   Tokura, S
   Shiono, M
   Monde, K
   Nishimura, SI
AF Iwasaki, N
   Yamane, ST
   Majima, T
   Kasahara, Y
   Minami, A
   Harada, K
   Nonaka, S
   Maekawa, N
   Tamura, H
   Tokura, S
   Shiono, M
   Monde, K
   Nishimura, SI
TI Feasibility of polysaccharide hybrid materials for scaffolds in
   cartilage tissue engineering: Evaluation of chondrocyte adhesion to
   polyion complex fibers prepared from alginate and chitosan
SO BIOMACROMOLECULES
LA English
DT Article
ID ARTICULAR-CARTILAGE; II COLLAGEN; CULTURE; HYALURONAN; SURFACES; REPAIR;
   BEADS; JOINT; GEL
AB The ideal cell-carrier material for cartilage regeneration should be one that closely mimics the natural environment in a living articular cartilage matrix. In the current study, we considered that alginate-based chitosan hybrid biomaterials could provide excellent supports for chondrocyte adhesion. To test this hypothesis, we investigated the adhesion behavior of rabbit chondrocytes onto an alginate polymer versus the adhesion of the chondrocytes onto some alginate-based chitosan hybrid polymer fibers in vitro. We demonstrated that the alginate-based chitosan hybrid polymer fibers showed much improved adhesion capacity with chondrocytes in comparison with alginate polymer fiber. Additionally, morphologic studies revealed maintenance of the characteristic round morphology of the chondrocyte and the dense fiber of the type II collagen produced by the chondrocytes in the hybrid polymer. On the basis of these results, we conclude that an alginate-based chitosan hybrid polymer fiber has considerable potential as a desirable biomaterial for cartilage tissue scaffolds.
C1 Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido 0608638, Japan.
   Hokkaido Univ, Sch Med, Div Biol Sci, Lab Biomacromol Chem, Sapporo, Hokkaido 0600810, Japan.
   Kansai Univ, Fac Engn, Chem Branch, Suita, Osaka 5648680, Japan.
   Chem Biol Inst Co Ltd, Sapporo, Hokkaido 0040814, Japan.
RP Iwasaki, N (reprint author), Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido 0608638, Japan.
EM niwasaki@med.hokudai.ac.jp
RI Iwasaki, Norimasa/D-6448-2012; Monde, Kenji/F-5286-2011; Majima,
   Tokifumi/E-2412-2012; Nishimura, Shinichiro/F-5277-2011
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Budavari S, 1996, MERCK INDEX
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Degim Z, 2002, AMINO ACIDS, V22, P187, DOI 10.1007/s007260200007
   Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Huang JQ, 2002, J ORAL MAXIL SURG, V60, P1449, DOI 10.1053/joms.2002.36108
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KIVIRANTA I, 1988, J ORTHOPAED RES, V6, P188, DOI 10.1002/jor.1100060205
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   NISHIMURA S, 1985, INT J BIOL MACROMOL, V7, P100, DOI 10.1016/0141-8130(85)90038-8
   NISHIMURA SI, 2001, GLYCOSCIENCE CHEM CH, V1, pCH6
   SAAMANEN AM, 1987, CONNECT TISSUE RES, V16, P163, DOI 10.3109/03008208709002004
   Sakai S, 2000, J MICROENCAPSUL, V17, P691
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Silver FH, 2002, MATRIX BIOL, V21, P129, DOI 10.1016/S0945-053X(01)00195-0
   Steinmeyer J, 1997, BIOCHEM BIOPH RES CO, V240, P216, DOI 10.1006/bbrc.1997.7641
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tamura H, 2002, MAT SCI ENG C-BIO S, V20, P143, DOI 10.1016/S0928-4931(02)00024-3
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Wang LH, 2001, J PHARM SCI-US, V90, P1134, DOI 10.1002/jps.1067
NR 35
TC 122
Z9 130
U1 4
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2004
VL 5
IS 3
BP 828
EP 833
DI 10.1021/bm0400067
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 819LA
UT WOS:000221315200026
PM 15132668
DA 2018-10-19
ER

PT J
AU van Kooten, TG
   Spijker, HT
   Busscher, HJ
AF van Kooten, TG
   Spijker, HT
   Busscher, HJ
TI Plasma-treated polystyrene surfaces: model surfaces for studying
   cell-biomaterial interactions
SO BIOMATERIALS
LA English
DT Article
DE cell-material interaction; plasma treatment; fibronectin; focal
   adhesion; endothelial cell
ID FOCAL ADHESION KINASE; HUMAN-ENDOTHELIAL-CELLS; TYROSINE
   PHOSPHORYLATION; PROTEIN ADSORPTION; HUMAN-FIBROBLASTS; INTEGRIN
   FUNCTION; POLYMER SURFACES; WETTABILITY; FIBRONECTIN; PROLIFERATION
AB Biocompatibility of biomaterials relates, amongst others, to the absence of adverse cellular reactions and modulation of cell adhesion and subsequent responses. With respect to tissue-engineering applications, most materials need to evoke cell adhesion and spreading, while potentially displaying differential cell function. Adhesion has frequently been studied in a controlled fashion, using adhesion-supporting and -inhibiting substrata. The aim of this study is to create a panel of related materials with gradually changing surface characteristics in order to sustain similar individual cell adhesion and spreading, yet different cell population behaviour. A series of polystyrene materials was created with increasing oxygen surface incorporation and, concurrently, decreasing water-contact angles. Individual cells adhered and spread on all surfaces whilst showing well-developed focal adhesions and stress fibres. Cell populations demonstrated a decreased growth on surfaces with lower wettability. The biochemical activity of cell populations was not influenced by the surface treatment, but cell proliferation on surfaces increased with increasing oxygen incorporation. Furthermore, surface coverage with assembled fibronectin matrix was higher on the substrata with higher wettability. Finally, the expression of the adhesion-related proteins cadherin-5, focal adhesion kinase and RhoA was increased on surfaces with higher wettability. Further explorations of the cell biological basis of the observed differential behaviour will give more detailed answers on the rules governing cell-material interactions. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van Kooten, TG (reprint author), Univ Groningen, Dept Biomed Engn, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM t.q.van.kooten@med.rug.nl
CR Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   ALTANKOV G, 1997, J BIOMAT SCI-POLYM E, V8, P299
   Bacakova L, 2000, J BIOMED MATER RES, V49, P369, DOI 10.1002/(SICI)1097-4636(20000305)49:3<369::AID-JBM10>3.0.CO;2-W
   Bacakova L, 2000, BIOMATERIALS, V21, P1173, DOI 10.1016/S0142-9612(00)00009-0
   BARRY ST, 1994, J CELL SCI, V107, P2033
   Brown E, 1996, IMMUNOL LETT, V54, P189, DOI 10.1016/S0165-2478(96)02671-5
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   Dupont-Gillain CC, 1999, J COLLOID INTERF SCI, V220, P163, DOI 10.1006/jcis.1999.6524
   Dupont-Gillain CC, 2000, LANGMUIR, V16, P8194, DOI 10.1021/la000326l
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   GIRARD PR, 1995, J CELL PHYSIOL, V163, P179, DOI 10.1002/jcp.1041630121
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Groth T, 1999, J BIOMED MATER RES, V44, P341
   GROTH T, 1995, J BIOMAT SCI-POLYM E, V7, P297
   Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   HYNES RO, 1994, BIOESSAYS, V16, P663, DOI 10.1002/bies.950160912
   Ilic D, 1998, J CELL BIOL, V143, P547
   KOWALCZYK AP, 1992, J CELL PHYSIOL, V152, P126, DOI 10.1002/jcp.1041520117
   Lampugnani MG, 1997, J CELL SCI, V110, P2065
   LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323
   Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Murakami T, 1998, J COLLOID INTERF SCI, V202, P37, DOI 10.1006/jcis.1997.5386
   Nakaoka R, 2001, J BIOMED MATER RES, V57, P567, DOI 10.1002/1097-4636(20011215)57:4<567::AID-JBM1203>3.0.CO;2-D
   OPAS M, 1991, IN VITRO CELL DEV B, V27, P878
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347
   RUARDY TG, 1997, SURF SCI REP, V29, P1
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   Sanborn SL, 2002, BIOMATERIALS, V23, P1, DOI 10.1016/S0142-9612(01)00066-7
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V3, P203
   SCHWARTZ MA, 1994, MOL BIOL CELL, V5, P389
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   Tani T, 1996, HISTOCHEM CELL BIOL, V105, P17, DOI 10.1007/BF01450874
   van Kooten TG, 1999, TISSUE ENG, V5, P223
   van Kooten TG, 2000, J BIOMED MATER RES, V52, P199, DOI 10.1002/1097-4636(200010)52:1<199::AID-JBM26>3.0.CO;2-Z
   van Kooten TG, 1999, J BIOMED MATER RES, V46, P33, DOI 10.1002/(SICI)1097-4636(199907)46:1<33::AID-JBM4>3.0.CO;2-K
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Zar J. H., 1984, BIOSTATISTICAL ANAL
   ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161
NR 56
TC 135
Z9 136
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 10
BP 1735
EP 1747
DI 10.1016/j.biomaterials.2003.08.071
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770CQ
UT WOS:000188706000001
PM 14738836
DA 2018-10-19
ER

PT J
AU Kokubo, S
   Mochizuki, M
   Fukushima, S
   Ito, T
   Nozaki, K
   Iwai, T
   Takahashi, K
   Yokota, S
   Miyata, K
   Sasaki, N
AF Kokubo, S
   Mochizuki, M
   Fukushima, S
   Ito, T
   Nozaki, K
   Iwai, T
   Takahashi, K
   Yokota, S
   Miyata, K
   Sasaki, N
TI Long-term stability of bone tissues induced by an osteoinductive
   biomaterial, recombinant human bone morphogenetic protein-2 and a
   biodegradable carrier
SO BIOMATERIALS
LA English
DT Article
DE rhBMP-2; long-term stability; segmental defect; tibia; biomechanics
ID HUMAN OSTEOGENIC PROTEIN-1; SEGMENTAL DEFECT MODEL; DIFFERENTIATION
   IN-VITRO; OSTEOBLASTIC DIFFERENTIATION; INTERNAL-FIXATION; GRAFT
   SUBSTITUTE; REGENERATION; DOGS; IMPLANTS; BEARING
AB The long-term stability of bone tissues induced by recombinant human bone morphogenetic protein-2 (rhBMP-2) and poly[L-lactide-co-glycolide] copolymer-coated gelatin sponge (PGS) was examined. In 16 dogs, 2.5 cm unilateral bone defects were created in the left tibial diaphyses. Tibia was fixed with metal plate, and PGS impregnated with (0.4 mg/cm(3)) or without rhBMP-2 was implanted into 15 or one defects, respectively. The metal plates of rhBMP-2-treated limbs were removed 16 weeks after the implantation. The bilateral tibiae of five animals each of the rhBMP-2-treated group were harvested at 32, 52 or 104 weeks, and served for biomechanical testing and histology. Although the defect that received PGS alone resulted in nonunion at 16 weeks, all defects treated with rhBMP-2 achieved radiographic bony union by 8 weeks. Biomechanical properties of the regenerated bones restored to the levels of intact tibiae at 32 weeks, but torsional stiffness was significantly higher. No statistical significances were detected in all parameters between regenerated and intact tibiae at 104 weeks. No radiographic and histological findings suggesting enhanced resorption to the regenerated bones were observed. These results suggest the long-term stability of the bone tissues induced by rhBMP-2, and the usefulness of rhBMP-2-impregnated PGS as a biomaterial for long bone defect filling. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Tsukuba, Ibaraki 305, Japan.
   Yamanouchi Pharmaceut Co Ltd, Inst Drug Dev Res, Shizuoka, Japan.
   Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Surg & Obstet, Bunkyo Ku, Tokyo, Japan.
RP Kokubo, S (reprint author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 305, Japan.
EM kokubo@yamanouchi.co.jp
CR ASAHINA I, 1993, J CELL BIOL, V123, P921, DOI 10.1083/jcb.123.4.921
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   CLAES L, 1989, J ORTHOPAED RES, V7, P170, DOI 10.1002/jor.1100070203
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Cook SD, 1998, J ORTHOP TRAUMA, V12, P407, DOI 10.1097/00005131-199808000-00007
   GERHART TN, 1993, CLIN ORTHOP RELAT R, P317
   ITO S, 2002, J BIOMED MATER RES, V63, P507
   Itoh T, 1998, J VET MED SCI, V60, P451, DOI 10.1292/jvms.60.451
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kikuchi M, 2002, J BIOMED MATER RES, V62, P265, DOI 10.1002/jbm.10248
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   MEADOWS TH, 1990, J BONE JOINT SURG AM, V72A, P1074, DOI 10.2106/00004623-199072070-00018
   Nagao H, 2002, INT J ORAL MAX SURG, V31, P66, DOI 10.1054/ijom.2001.0133
   PERREN SM, 1988, CLIN ORTHOP RELAT R, P139
   Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803, DOI 10.2106/00004623-200106000-00001
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   Sciadini MF, 2000, J ORTHOPAED RES, V18, P289, DOI 10.1002/jor.1100180218
   Sciadini MF, 1997, J ORTHOP TRAUMA, V11, P496, DOI 10.1097/00005131-199710000-00007
   Seto I, 2002, CLIN ORAL IMPLAN RES, V13, P536, DOI 10.1034/j.1600-0501.2002.130514.x
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   UHTHOFF HK, 1993, J ORTHOPAED RES, V11, P78, DOI 10.1002/jor.1100110110
   UHTHOFF HK, 1971, CLIN ORTHOP RELAT R, P165
   Wang JS, 2000, CLIN ORTHOP RELAT R, P274
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411
   Yokota S, 2003, INT J PHARM, V251, P57, DOI 10.1016/S0378-5173(02)00581-1
   Yokota S, 2001, INT J PHARMACEUT, V223, P69, DOI 10.1016/S0378-5173(01)00728-1
NR 28
TC 40
Z9 42
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 10
BP 1795
EP 1803
DI 10.1016/j.biomaterials.2003.08.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770CQ
UT WOS:000188706000008
PM 14738843
DA 2018-10-19
ER

PT J
AU Meyer, U
   Joos, U
   Mythili, J
   Stamm, T
   Hohoff, A
   Fillies, T
   Stratmann, U
   Wiesmann, HP
AF Meyer, U
   Joos, U
   Mythili, J
   Stamm, T
   Hohoff, A
   Fillies, T
   Stratmann, U
   Wiesmann, HP
TI Ultrastructural characterization of the implant/bone interface of
   immediately loaded dental implants
SO BIOMATERIALS
LA English
DT Article
DE implants; immediate loading; interface; osseointegration
ID BONE-TITANIUM INTERFACE; HEALING RESPONSE; BEAGLE DOGS; ALLOY;
   OSSEOINTEGRATION; ADJACENT; TISSUES; MAXILLA; STRAIN; MODEL
AB Primary stability and an optimized load transfer are assumed to account for an undisturbed osseointegration process of implants. Immediate loaded newly designed titanium dental implants inserted in the mandible of minipigs were used for the characterization of the interfacial area between the implant surface and the surrounding bone tissue during the early healing phase. Histological and electron microscopical studies were performed from implant containing bone specimens. Two different load regimens were applied to investigate the load related tissue reaction. Histological and electron microscopical analysis revealed a direct bone apposition oil the implant surfaces, as well as the attachment of cells and matrix proteins in the early loading phase. A striking finding of the ultrastructural immunocytochemical investigations was the synthesis and deposition of bone related proteins (osteonectin, fibronectin, fibronectin receptor) by osteoblasts from day one of bone/biomaterial interaction. Calcium-phosphate needle-like crystallites were newly synthesized in a time-related manner directly at the titanium surface. No difference in the ultrastructural appearance of the interface was found between the two loading groups. Our experimental data suggest that loading of specially designed implants can be performed immediately after insertion without disturbing the biological osseointegration process. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Munster, Dept Craniomaxillofacial Surg, D-48149 Munster, Germany.
   Univ Munster, Dept Orthodont, D-48149 Munster, Germany.
   Univ Munster, Dept Anat, D-48149 Munster, Germany.
RP Meyer, U (reprint author), Univ Munster, Dept Craniomaxillofacial Surg, Waldeyerstr 30, D-48149 Munster, Germany.
EM ulmeyer@uni-muenster.de
CR AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   Akin-Nergiz N, 1998, AM J ORTHOD DENTOFAC, V114, P292, DOI 10.1016/S0889-5406(98)70211-2
   Bolind P, 1999, CLIN IMPLANT DENT R, V1, P33
   Buser D, 1998, INT J ORAL MAX IMPL, V13, P611
   CARTER DR, 1991, BONE-BIOMATERIAL INTERFACE, P367
   CHEAL EJ, 1991, J ORTHOPAED RES, V9, P131, DOI 10.1002/jor.1100090116
   Corso M, 1999, J PROSTHET DENT, V82, P428, DOI 10.1016/S0022-3913(99)70029-6
   DEPORTER DA, 1986, J DENT RES, V65, P1064, DOI 10.1177/00220345860650080501
   FROST H, ALVEOLAR DISTRACTION
   Futami T, 2000, J PERIODONTOL, V71, P287, DOI 10.1902/jop.2000.71.2.287
   HASHIMOTO M, 1988, J ORAL REHABIL, V15, P65, DOI 10.1111/j.1365-2842.1988.tb00147.x
   HOHLING HJ, 1990, ULTRASTRUCTURE SKELE, P41
   Joos U, 2000, Mund Kiefer Gesichtschir, V4, P143, DOI 10.1007/s100060050186
   Landis W J, 1996, Connect Tissue Res, V34, P239, DOI 10.3109/03008209609005267
   Lavos-Valereto IC, 2001, J BIOMED MATER RES, V58, P727, DOI 10.1002/jbm.1072
   Lum L B, 1991, Int J Oral Maxillofac Implants, V6, P456
   MEYER U, 1993, BIOMATERIALS, V14, P917, DOI 10.1016/0142-9612(93)90133-M
   Meyer U, 1999, PLAST RECONSTR SURG, V103, P800, DOI 10.1097/00006534-199903000-00005
   MEYER U, 2001, COMPUT METHOD BIOMEC, V3, P553
   Misch CE, 2001, J PERIODONTOL, V72, P1276, DOI 10.1902/jop.2000.72.9.1276
   Murai K, 1996, J BIOMED MATER RES, V30, P523, DOI 10.1002/(SICI)1097-4636(199604)30:4<523::AID-JBM11>3.3.CO;2-6
   Piattelli A, 1993, J Oral Implantol, V19, P314
   Piattelli A, 1997, J PERIODONTOL, V68, P591, DOI 10.1902/jop.1997.68.6.591
   PILLIAR RM, 1991, BONE-BIOMATERIAL INTERFACE, P380
   ROACH HI, 1994, CELL BIOL INT, V18, P617, DOI 10.1006/cbir.1994.1088
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   Roser K, 2000, J BIOMED MATER RES, V51, P280
   SAGARA M, 1993, J PROSTHET DENT, V69, P281, DOI 10.1016/0022-3913(93)90107-Y
   Simmons CA, 2001, J BIOMED MATER RES, V55, P63, DOI 10.1002/1097-4636(200104)55:1<63::AID-JBM90>3.3.CO;2-M
   Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C
   Simmons CA, 2001, J ORTHOPAED RES, V19, P187, DOI 10.1016/S0736-0266(00)90006-8
   Sowden D, 2002, J ORAL MAXIL SURG, V60, P294, DOI 10.1053/joms.2002.30585
   SZMUKLERMONCLER S, 1998, J BIOMED MATER RES, V43, P193
NR 33
TC 92
Z9 95
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 10
BP 1959
EP 1967
DI 10.1016/j.biomaterials.2003.08.070
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770CQ
UT WOS:000188706000025
PM 14738860
DA 2018-10-19
ER

PT J
AU Cheng, ZY
   Teoh, SH
AF Cheng, ZY
   Teoh, SH
TI Surface modification of ultra thin poly (epsilon-caprolactone) films
   using acrylic acid and collagen
SO BIOMATERIALS
LA English
DT Article
DE poly (epsilon-caprolactone); surface modification; human dermal
   fibroblasts; myoblasts; collagen immobilization
ID GRAFT-POLYMERIZATION; BLOOD COMPATIBILITY; PLATELET-ADHESION;
   GLOW-DISCHARGE; CELL AFFINITY; TISSUE; POLYCAPROLACTONE; ACRYLAMIDE;
   IMMOBILIZATION; DEPOSITION
AB Poly (e-caprolactone) (PCL) has been used as a bioresorbable polymer in numerous medical devices as well as for tissue engineering applications. Its main advantage is its biocompatibility and slow degradation rate. PCL surface, however, is hydrophobic and cell-biomaterial interaction is not the best. We attempt for the first time to modify an ultra thin PCL surface with collagen. The PCL film was prepared using solvent casting and biaxial stretching technique developed in our laboratory. This biaxial stretching produced an ultra thin PCL 3-7 mum thick, ideal for membrane tissue engineering applications. The PCL film was pretreated using Argon plasma, and then UV polymerized with acrylic acid (AAc). Collagen immobilization was then carried out. The modified film surface was characterized by Fourier Transform Infrared (FT-IR) and X-ray Photoelectron Spectroscopy (XPS). Water contact angles were also measured to evaluate the hydrophilicity of the modified surface. Results showed that the hydrophilicity of the surface has improved significantly after surface modification. The water contact angle dropped from 66degrees to 32degrees. Atomic Force Microscopy (AFM) showed an increase in roughness of the film. A change from 46 to 60 nm in the surface morphology was also observed. The effect of cells attachment on the PCL film was studied. Human dermal fibroblasts and myoblasts attachment and proliferation were improved remarkably on the modified surface. The films showed excellent cell attachment and proliferation rate. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Natl Univ Singapore, Ctr Biomed Mat Appl & Technol, Dept Mech Engn, Div Bioengn, Singapore 119260, Singapore.
RP Teoh, SH (reprint author), Biomed Engn Lab, Div Bioengn, 9 Engn Dr 1, Singapore 117576, Singapore.
EM bietsh@nus.edu.sg
CR Ayhan H, 2000, J BIOACT COMPAT POL, V15, P27, DOI 10.1106/1DMH-AFLF-1DXF-1831
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Boyce ST, 1998, MED BIOL ENG COMPUT, V36, P791, DOI 10.1007/BF02518886
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Haddow DB, 1999, J BIOMED MATER RES, V47, P379, DOI 10.1002/(SICI)1097-4636(19991205)47:3<379::AID-JBM13>3.0.CO;2-#
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kang ET, 1997, J PHYS CHEM B, V101, P10744, DOI 10.1021/jp9727052
   Kang IK, 2001, INT J BIOL MACROMOL, V28, P205, DOI 10.1016/S0141-8130(00)00165-3
   Khor HL, 2002, MAT SCI ENG C-BIO S, V20, P71, DOI 10.1016/S0928-4931(02)00015-2
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   LIN JC, 1995, BIOMATERIALS, V16, P1017
   LIN JC, 1994, J COLLOID INTERF SCI, V164, P99, DOI 10.1006/jcis.1994.1147
   Lindberg T, 2000, POLYMER, V41, P4099, DOI 10.1016/S0032-3861(99)00559-5
   Matsumura K, 2000, J BIOMED MATER RES, V50, P512, DOI 10.1002/(SICI)1097-4636(20000615)50:4<512::AID-JBM6>3.3.CO;2-7
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   NARKIS M, 1985, POLYMER, V26, P50, DOI 10.1016/0032-3861(85)90056-4
   Ng CS, 2000, POLYMER, V41, P5855, DOI 10.1016/S0032-3861(99)00760-0
   Ng Kee Woei, 2001, Tissue Engineering, V7, P441, DOI 10.1089/10763270152436490
   Schantz JT, 2002, INT J ORAL MAX IMPL, V17, P161
   Sodergard A, 1998, J POLYM SCI POL CHEM, V36, P1805, DOI 10.1002/(SICI)1099-0518(199808)36:11<1805::AID-POLA14>3.0.CO;2-I
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   Sun YH, 1999, J APPL POLYM SCI, V74, P2826, DOI 10.1002/1097-4628(19991213)74:12<2826::AID-APP6>3.0.CO;2-I
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   Teng MY, 2000, EUR POLYM J, V36, P663, DOI 10.1016/S0014-3057(99)00130-5
   TEOH SH, 2002, CARD TISS ENG S WORL
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
   YING L, 2001, MACROMOLECULES, V35, P673
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
NR 31
TC 260
Z9 268
U1 5
U2 116
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 11
BP 1991
EP 2001
DI 10.1016/j.biomaterials.2003.08.038
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771QB
UT WOS:000188796600003
PM 14741613
DA 2018-10-19
ER

PT J
AU Speranza, G
   Gottardi, G
   Pederzolli, C
   Lunelli, L
   Canteri, R
   Pasquardini, L
   Carli, E
   Lui, A
   Maniglio, D
   Brugnara, M
   Anderle, M
AF Speranza, G
   Gottardi, G
   Pederzolli, C
   Lunelli, L
   Canteri, R
   Pasquardini, L
   Carli, E
   Lui, A
   Maniglio, D
   Brugnara, M
   Anderle, M
TI Role of chemical interactions in bacterial adhesion to polymer surfaces
SO BIOMATERIALS
LA English
DT Article
DE bacterial adhesion; acid-base interactions; XPS; Tof-SIMS; SEM; contact
   angle
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; BIOMEDICAL POLYMERS;
   MICROBIAL ADHESION; IONIC-STRENGTH; HYDROPHOBICITY; PREVENTION;
   INFECTIONS; CATHETERS; GROWTH
AB Development of biomaterial-related infections is attracting an increasing interest due to the significant percentage of implant failure in the hospital care. Recent literature puts in evidence the dependence of the infection risk on the different biomaterials used, because of the different interactions between material surface and micro-organisms. Despite this, the mechanisms underlying the adhesion of bacteria to the biomaterial surface are still unclear. Aim of this work is to study the initial events of the processes responsible for the bacterial adhesion on polymers in order to prevent the development of bacterial infections and the consequent failure and replacement of biomedical devices. Electrostatic and Lifshitz-van der Waals forces are usually considered responsible for the interactions at the biomaterial interface. A new term that involves Lewis acid-base interactions is here introduced to better describe the bacterial adhesion to the polymer surface. Two requirements are needed to test this hypothesis: the development of an ideal polymeric surface in terms of chemical and morphological properties and the choice of a specific bacterial strain to be utilized as "probe". Experiments were worked out using an Escherichia coli (Gram-) strain that represent one of the principal isolates from infected biomaterial implants and its adhesion was investigated on polymers having different acid/basic character. The findings indicate that the bacterial adhesion is influenced by the chemical properties of the polymeric surface. These results may be interpreted taking into account a mechanism in which the acid/base (Lewis) interaction plays an important role. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Ist Ric Sci & Tecnol, ITC, I-38050 Trent, Italy.
   Univ Trent, Dept Mat Engn & Ind Technol, Trent, Italy.
RP Speranza, G (reprint author), Ist Ric Sci & Tecnol, ITC, Sommarive Str 18, I-38050 Trent, Italy.
EM speranza@itc.it
RI Gottardi, Gloria/E-5334-2010; Speranza, Giorgio/G-6275-2011; Maniglio,
   Devid/C-4187-2014
OI Gottardi, Gloria/0000-0002-3472-8572; Speranza,
   Giorgio/0000-0003-1478-0995; Maniglio, Devid/0000-0002-1653-861X;
   Canteri, Roberto/0000-0002-0895-8884
CR An YH, 2000, HDB BACTERIAL ADHESI
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Beamson G., 1992, HIGH RESOLUTION XPS
   Boonaert CJP, 2001, COLLOID SURFACE B, V22, P171, DOI 10.1016/S0927-7765(01)00196-5
   Boonaert CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000
   Briandet R, 1999, APPL ENVIRON MICROB, V65, P5328
   BRUNISMA GM, 2002, BIOMATERIALS, V22, P3217
   BUNT CR, 1993, INT J PHARMACEUT, V99, P93, DOI 10.1016/0378-5173(93)90350-O
   CARLEN A, 2000, BIOMATERIALS, V22, P481
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P235, DOI 10.1163/156856100742546
   Della Volpe C., 2002, COLLOID SURF A, V206, P46
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P239
   DELLAVOLLPE C, IN PRESS J ADHES SCI
   DELLAVOLPE C, 2002, ENCY SURFACE COLLOID, V1
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GARBASSI F, 2000, POLYM SURFACES
   GOOD RJ, 1991, FUNDAMENTALS ADHESIO, pCH3
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   JARVIS NL, 1964, CONTACT ANGLE WETTAB
   Jones DS, 1996, INT J PHARM, V131, P83, DOI 10.1016/0378-5173(95)04368-3
   Kiaie D., 1995, J BIOMED MATER RES, V29, P729
   Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q
   Maruyama N, 1998, THIN SOLID FILMS, V327, P854, DOI 10.1016/S0040-6090(98)00777-9
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   Otto K, 1999, J BACTERIOL, V181, P5210
   PAGE B, 1993, INT J ONCOL, V3, P473
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   REID G, 1994, COLLOID SURFACE B, V2, P377
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Yousefi Rad A, 1998, J Biomater Sci Polym Ed, V9, P915, DOI 10.1163/156856298X00244
NR 42
TC 126
Z9 132
U1 2
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 11
BP 2029
EP 2037
DI 10.1016/j.biomaterials.2003.08.061
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771QB
UT WOS:000188796600007
PM 14741617
DA 2018-10-19
ER

PT J
AU Ruhe, PQ
   Kroese-Deutman, HC
   Wolke, JGC
   Spauwen, PHM
   Jansen, JA
AF Ruhe, PQ
   Kroese-Deutman, HC
   Wolke, JGC
   Spauwen, PHM
   Jansen, JA
TI Bone inductive properties of rhBMP-2 loaded porous calcium phosphate
   cement implants in cranial defects in rabbits
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate cement; BMP (bone morphogenetic protein); growth
   factors; bone tissue engineering
ID GROWTH-FACTOR-BETA; MORPHOGENETIC PROTEIN-2; CRYSTAL-STRUCTURE; COLLAGEN
   SPONGE; MODEL; HYDROXYAPATITE; RECONSTRUCTION; OSTEOINDUCTION;
   OSTEOGENESIS; BIOMATERIAL
AB In this study, the osteoinductive properties of porous calcium phosphate (Ca-P) cement loaded with bone morphogenetic protein 2 (rhBMP-2) were evaluated and compared with rhBMP-2 loaded absorbable collagen sponge (ACS). Discs with a diameter of 8 turn were loaded with a buffer solution with or without 10 mug rhBMP-2 and inserted in 8 turn full thickness cranial defects in rabbits for 2 and 10 weeks of implantation. Histological analysis revealed excellent osteoconductive properties of the Ca-P material. It maintained its shape and stability during the implantation time better than the ACS but showed no degradation like the ACS. Quantification of the Ca-P cement implants showed that bone formation was increased significantly by administration of rhBMP-2 (10 weeks pore fill: 53.0 +/- 5.4%), and also reached a reasonable amount without rhBMP-2 (43.1 +/- 10.4%). Remarkably, callus-like bone formation outside the implant was observed frequently in the 2 weeks rhBMP-2 loaded Ca-P cement implants, suggesting a correlation with the presence of growth factor in the surrounding tissue. However, an additional in vitro assay revealed an accumulative release of no more than 9.7+/-0.9% after 4 weeks. We conclude that: (1) Porous Ca-P cement is an appropriate candidate scaffold material for bone engineering. (2) Bone formation can be enhanced by lyophilization of rhBMP-2 on the cement. (3) Degradation of porous Ca-P cement is species-, implantation site- and implant dimension-specific. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Nijmegen, Med Ctr, Dept Plast & Reconstruct Surg, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Dept Biomat, POB 9101,THK 117, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Jansen, John/H-8055-2014; Wolke, J.G.C./L-4768-2015
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Blom EJ, 2002, BIOMATERIALS, V23, P1261, DOI 10.1016/S0142-9612(01)00246-0
   Blom EJ, 2001, CLIN ORAL IMPLAN RES, V12, P609, DOI 10.1034/j.1600-0501.2001.120609.x
   Blumenthal NM, 2002, J PERIODONTOL, V73, P1494, DOI 10.1902/jop.2002.73.12.1494
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   Comuzzi L, 2002, CLIN ORAL IMPLAN RES, V13, P304, DOI 10.1034/j.1600-0501.2002.130311.x
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   DELREAL RP, 2003, J BIOMED MATER RES A, V5, P30
   Dodde R, 2000, J CRANIOFAC SURG, V11, P346, DOI 10.1097/00001665-200011040-00013
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   FRAME JW, 1980, J ORAL SURG, V38, P176
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   GERHART TN, 1993, CLIN ORTHOP RELAT R, P317
   GOMBOTZ WR, 1994, J APPL BIOMATER, V5, P141, DOI 10.1002/jab.770050207
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105
   Kusumoto K, 1996, J CRANIO MAXILL SURG, V24, P360, DOI 10.1016/S1010-5182(96)80037-0
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Lee D D, 1999, Clin Orthop Relat Res, pS396, DOI 10.1097/00003086-199910001-00038
   Li G, 2002, J ORTHOP RES, V20, P779, DOI 10.1016/S0736-0266(01)00166-8
   LI RH, 2001, 28 INT S CONTR REL B
   Lind M, 1996, J ORTHOPAED RES, V14, P343, DOI 10.1002/jor.1100140303
   Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Ono I, 1996, J CRANIOFAC SURG, V7, P418, DOI 10.1097/00001665-199611000-00006
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Pluhar GE, 2001, J ORTHOP RES, V19, P308, DOI 10.1016/S0736-0266(00)90002-0
   Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1, DOI 10.2106/00004623-200100001-00001
   REDDI AH, 1993, J BONE MINER RES, V8, P499
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   RUHE PQ, 2003, J BONE JT SURG A S3, V85, pS75
   Sandhu HS, 1996, SPINE, V21, P2115, DOI 10.1097/00007632-199609150-00012
   Si XH, 1998, INT J ORAL MAX SURG, V27, P310, DOI 10.1016/S0901-5027(05)80622-8
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wozney JM, 1998, EUR J ORAL SCI, V106, P160, DOI 10.1111/j.1600-0722.1998.tb02170.x
   Yoshida K, 1999, J DENT RES, V78, P1505, DOI 10.1177/00220345990780090401
NR 49
TC 119
Z9 132
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 11
BP 2123
EP 2132
DI 10.1016/j.biomaterials.2003.09.007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771QB
UT WOS:000188796600017
PM 14741627
DA 2018-10-19
ER

PT J
AU Tengvall, P
   Skoglund, B
   Askendal, A
   Aspenberg, P
AF Tengvall, P
   Skoglund, B
   Askendal, A
   Aspenberg, P
TI Surface immobilized bisphosphonate improves stainless-steel screw
   fixation in rats
SO BIOMATERIALS
LA English
DT Article
DE bisphosphonate; immobilize; bone; pullout; implant; biomaterial
ID COATED TITANIUM IMPLANTS; FORMATION IN-VIVO; BONE-RESORPTION; PORE-SIZE;
   HYDROXYAPATITE; ALENDRONATE; REGENERATION; DEGRADATION; PROSTHESES;
   INGROWTH
AB An increase in the mechanical fixation in bone of metallic biomaterials is considered advantageous in joint replacement and fracture surgery. Different approaches to improve fixation may be e.g. surface roughening, Ca-mineral coating or surface immobilization of growth factors or drugs. In the present work, bisphosphonate, a class of drugs that inhibit bone resorption, was immobilized onto stainless-steel screws.
   The screws were first roughened and coated with immobilized and cross-linked fibrinogen. Subsequently, an N-bisphosphonate, pamidronate, was immobilized onto fibrinogen, and another N-bisphosphonate, ibandronate, adsorbed on top of this. The so coated screws were inserted into the tibiae of eight male Sprague-Dawley rats. Another eight rats received screws prepared in the same way, but without the bisphosphonate coating. Pullout strength tests were performed after 2 weeks of implantation.
   The results showed a 28% (p = 0.0009) higher pullout force and 90% increased pullout energy for the bisphosphonate coated screws, and support the idea that surface immobilized bisphosphonates can be used to improve biomaterials fixation in bone. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Linkoping Univ, Appl Phys Lab, Dept Phys & Measurement Technol Biol & Chem, SE-58183 Linkoping, Sweden.
   Fac Hlth Sci, Dept Neurosci & Locomot, Div Orthopaed & Sports Med, Linkoping, Sweden.
RP Tengvall, P (reprint author), Linkoping Univ, Appl Phys Lab, Dept Phys & Measurement Technol Biol & Chem, SE-58183 Linkoping, Sweden.
EM pet@ifm.liu.se
CR Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   Benesch J, 2000, COLLOID SURFACE B, V18, P71, DOI 10.1016/S0927-7765(99)00136-8
   Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Christensen FB, 2000, EUR SPINE J, V9, P97, DOI 10.1007/s005860050218
   Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133
   Frith JC, 2001, ARTHRITIS RHEUM, V44, P2201, DOI 10.1002/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E
   Gross KA, 2002, J BIOMED MATER RES, V63, P106, DOI 10.1002/jbm.10090
   Hermanson G. T., 1992, IMMOBILIZED AFFINITY
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   KARRHOLM J, 1994, J BONE JOINT SURG BR, V76B, P912
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   LARSSON C, 2001, TITANIUM BONE INTERF
   McCrackin F. L., 1969, 479 NBS
   Meraw SJ, 1999, J PERIODONTOL, V70, P1228, DOI 10.1902/jop.1999.70.10.1228
   Meraw SJ, 1999, J PERIODONTOL, V70, P151, DOI 10.1902/jop.1999.70.2.151
   Mjoberg B, 1997, ORTHOPEDICS, V20, P1169
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   PASCHALIS EP, 1995, J BIOMED MATER RES, V29, P1499, DOI 10.1002/jbm.820291206
   PIOTROWSKI G, 1975, J BIOMED MATER RES, V9, P47, DOI 10.1002/jbm.820090408
   Qui SJ, 1997, OSTEOCYTE APOPTOSIS
   Rejda B V, 1978, Ned Tijdschr Geneeskd, V122, P625
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   SKOGLUND B, UNPUB SYSTEMIC LOCAL
   Skripitz R, 2001, J BONE JOINT SURG BR, V83B, P437, DOI 10.1302/0301-620X.83B3.10256
   Stenberg M, 1983, J PHYS C S12, VC10, P83
   Tengvall P, 2003, COLLOID SURFACE B, V28, P261, DOI 10.1016/S0927-7765(02)00151-0
   Tong WD, 1996, BIOMATERIALS, V17, P1507, DOI 10.1016/0142-9612(96)89775-4
   Voggenreiter G, 2003, BIOMATERIALS, V24, P247, DOI 10.1016/S0142-9612(02)00312-5
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
NR 36
TC 104
Z9 112
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 11
BP 2133
EP 2138
DI 10.1016/j.biomaterials.2003.08.049
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771QB
UT WOS:000188796600018
PM 14741628
DA 2018-10-19
ER

PT J
AU Balazs, DJ
   Triandafillu, K
   Wood, P
   Chevolot, Y
   van Delden, C
   Harms, H
   Hollenstein, C
   Mathieu, HJ
AF Balazs, DJ
   Triandafillu, K
   Wood, P
   Chevolot, Y
   van Delden, C
   Harms, H
   Hollenstein, C
   Mathieu, HJ
TI Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen
   glow discharge, sodium hydroxide and silver nitrate treatments
SO BIOMATERIALS
LA English
DT Article
DE surface modification; silver; bacterial adhesion; oxygen plasma; X-ray
   photoelectron spectroscopy (XPS)
ID PSEUDOMONAS-AERUGINOSA; SURFACE MODIFICATION; BIOFILM FORMATION; PLASMA;
   INFECTION; EFFICACY
AB Medical-grade poly(vinyl chloride) (PVC) was chemically modified to study how the incorporation of monovalent silver influences Pseudomonas aeruginosa adhesion and colonization. The modification investigated consisted of a radio frequency-oxygen (RF-O-2) glow discharge pre-functionalization, followed by a two-step wet-treatment in sodium hydroxide and silver nitrate solutions. X-ray photoelectron spectroscopy (XPS) analysis and contact angle measurements were used to investigate the chemical nature and surface wettability of the films following each step of the modification. XPS analysis proved that the RF-O-2 plasma pre-functionalization of native PVC reproducibly increased the amount of functional groups representative of PVC additives, including ether/alcohol, esters and carboxyl groups. More specifically, we demonstrated that the O-C-O groups representative of the phthalic ester and zinc carboxylate additives identified for native PVC increased by two-fold following the RF-O-2 plasma pre-functionalization step. Although RF-O-2 pre-functionalization did not have an effect on the silver content of the NaOH/AgNO3 treated substrates, such a modification was necessary for biomaterial products that did not have reproducible surfaces amongst production lots. XPS analysis also demonstrated that saponification with sodium hydroxide (NaOH) of esters, like those of the phthalic ester additives of PVC is a simple, irreversible method of hydrolysis, which produced sodium carboxylate and sodium phthalate salts. Exposure of native PVC to NaOH resulted in an increased surface hydrophilicity (from ca 90degrees to ca 60degrees) due to dechlorination. XPS analysis following further incubation in silver nitrate demonstrated that silver ions can be trapped when the sodium of sodium carboxylate is replaced by silver after performing a second treatment with a monovalent silver-containing solution. The creation of silver salt on native PVC resulted in an ultra-hydrophobic (> 120degrees) surface. The chemical modifications using NaOH and AgNO3 wet treatments completely inhibited bacterial adhesion of four strains of P. aeruginosa to both native and oxygen-pre-functionalized PVC, and efficiently prevented colonization over longer periods (72 h). Our results suggest that surface modifications that incorporate silver ions would be extremely effective at reducing bacterial colonization to medical devices. (C) 2003 Elsevier Ltd. All rights reserved.
C1 EPFL, Swiss Fed Inst Technol, Inst Mat Sci, CH-1005 Lausanne, Switzerland.
   EPFL, Swiss Fed Inst Technol, Inst Environm Sci & Technol, CH-1015 Lausanne, Switzerland.
   Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva, Switzerland.
   EPFL, Swiss Fed Inst Technol, Plasma Phys Res Ctr, CH-1015 Lausanne, Switzerland.
RP Balazs, DJ (reprint author), EPFL, Swiss Fed Inst Technol, Inst Mat Sci, CH-1005 Lausanne, Switzerland.
EM dawn.balazs@epfl.ch
RI Harms, Hauke/I-4406-2012
OI Harms, Hauke/0000-0002-7316-7341; Chevolot, Yann/0000-0003-3479-3371
CR ASFARDJANI K, 1991, J APPL POLYM SCI, V43, P271, DOI 10.1002/app.1991.070430206
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   BARTH G, 1988, SURF INTERFACE ANAL, V11, P307, DOI 10.1002/sia.740110607
   Darouiche RO, 1999, CLIN INFECT DIS, V29, P1371, DOI 10.1086/313561
   Davies RL, 1997, CATAL TODAY, V36, P107, DOI 10.1016/S0920-5861(96)00203-9
   EGINTON PJ, 1995, J IND MICROBIOL, V15, P305, DOI 10.1007/BF01569984
   Favia P, 2001, SURF COAT TECH, V142, P1, DOI 10.1016/S0257-8972(01)01191-4
   Favia P., 2000, PLASMAS POLYM, DOI [10.1023/A:1009517408368, DOI 10.1023/A:1009517408368]
   FOX CL, 1969, SURG GYNECOL OBSTETR, V128, P1021
   GOODE R, 1993, COMMERCIAL AND CONSUMER LAW, P3
   Gupta B, 2000, J APPL POLYM SCI, V78, P1083, DOI 10.1002/1097-4628(20001031)78:5<1083::AID-APP170>3.0.CO;2-5
   Hart H., 1998, ORGANIC CHEM SHORT C
   HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572
   HUDIS M, 1974, PLASMA TREATMENT SOL, P113
   INAGAKI N, 1996, HYDROPHILIC SURFACES
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q
   LIGHTFOOT J, 1991, J BACTERIOL, V173, P5624, DOI 10.1128/jb.173.18.5624-5630.1991
   Olson ME, 2002, CHEST, V121, P863, DOI 10.1378/chest.121.3.863
   RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shin SM, 2002, POLYM DEGRAD STABIL, V78, P511, DOI 10.1016/S0141-3910(02)00198-2
   SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001
   Stickler DJ, 2000, CURR OPIN INFECT DIS, V13, P389, DOI 10.1097/00001432-200008000-00011
   Takeoka K, 1998, CHEMOTHERAPY, V44, P190, DOI 10.1159/000007114
   TERRY JM, 1992, INFECT IMMUN, V60, P1329
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639
   WYSOR MS, 1983, SILVER SULFADIAZINE
NR 29
TC 136
Z9 143
U1 2
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 11
BP 2139
EP 2151
DI 10.1016/j.biomaterials.2003.08.053
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771QB
UT WOS:000188796600019
PM 14741629
DA 2018-10-19
ER

PT J
AU Kim, YT
   Hitchcock, RW
   Bridge, MJ
   Tresco, PA
AF Kim, YT
   Hitchcock, RW
   Bridge, MJ
   Tresco, PA
TI Chronic response of adult rat brain tissue to implants anchored to the
   skull
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; fluorescence; immunochemistry; membrane
ID NERVOUS-SYSTEM REPAIR; DIFFUSION-CHAMBERS; CEREBRAL-CORTEX; SHUNT
   REVISION; STAB WOUNDS; INTERFACE; STIMULATION; ASTROCYTES; INJURY; CELLS
AB Using quantitative immunohistological methods, we examined the brain tissue response to hollow fiber membranes (HFMs) that were either implanted intraparenchymally, as in a cell encapsulation application, or were attached to the skull as in a biosensor application (transcranially). We found that the reaction surrounding transcranially implanted HFMs was significantly greater than that observed with intraparenchymally implanted materials including increases in immunoreactivity against GFAP, vimentin, ED-1 labeled macrophages and microglia, and several extracellular matrix proteins including collagen, fibronectin, and laminin. In general, these markers were elevated along the entire length of transcranially implanted HFMs extending into the adjacent parenchyma up to 0.5 min from the implant interface. Intraparenchymal implants did not appear to have significant involvement of a fibroblastic component as suggested by a decreased expression of vimentin, fibronectin and collagen-type I at the implant tissue interface. The increase in tissue reactivity observed with transcranially implanted HFMs may be influenced by several mechanisms including chronic contact with the meninges and possibly motion of the device within brain tissue. Broadly speaking, our results suggest that any biomaterial, biosensor or device that is anchored to the skull and in chronic contact with meningeal tissue will have a higher level of tissue reactivity than the same material completely implanted within brain tissue. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Utah, Keck Ctr Tissue Engn, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Keck Ctr Tissue Engn, Dept Bioengn, 20 S 2030 E Bldg 570,Room 108D, Salt Lake City, UT 84112 USA.
EM patrick.tresco@utah.edu
CR ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5
   Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31
   Brauker J, 1996, TRANSPLANTATION, V61, P1671, DOI 10.1097/00007890-199606270-00002
   Bridge MJ, 2002, J MEMBRANE SCI, V195, P51, DOI 10.1016/S0376-7388(01)00523-3
   BROWN WJ, 1977, J NEUROSURG, V47, P366, DOI 10.3171/jns.1977.47.3.0366
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   EGAN RA, 1991, BRAIN RES, V568, P330, DOI 10.1016/0006-8993(91)91421-V
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095
   GELLER HM, 1988, PROG BRAIN RES, V78, P643
   Gratton DG, 2001, J PROSTHET DENT, V85, P47, DOI 10.1067/mpr.2001.112796
   HAINES DE, 1997, FUNDAMENTAL NEUROSCI, P99
   HITCHCOCK RW, 2001, T SOC BIOMATER, V21, P14
   Hudgins RJ, 1998, PEDIATR NEUROSURG, V29, P57, DOI 10.1159/000028689
   ICARD P, 1990, TRANSPLANT P, V22, P724
   Johnson D, 1996, Biomed Sci Instrum, V32, P127
   Jones LC, 2001, J BONE JOINT SURG BR, V83B, P448, DOI 10.1302/0301-620X.83B3.10734
   KRAINICK JU, 1980, J NEUROSURG, V52, P346, DOI 10.3171/jns.1980.52.3.0346
   Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V
   LIESI P, 1984, EMBO J, V3, P683, DOI 10.1002/j.1460-2075.1984.tb01867.x
   LOGAN A, 1993, TRENDS PHARMACOL SCI, V14, P337, DOI 10.1016/0165-6147(93)90007-7
   Manwaring ME, 2001, BIOMATERIALS, V22, P3155, DOI 10.1016/S0142-9612(01)00068-0
   MAXWELL WL, 1984, HISTOCHEM J, V16, P1219, DOI 10.1007/BF01003445
   MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121
   Ness R, 1997, GLIA, V19, P47, DOI 10.1002/(SICI)1098-1136(199701)19:1<47::AID-GLIA5>3.0.CO;2-7
   PUCA A, 1991, NEUROSURGERY, V29, P822, DOI 10.1227/00006123-199112000-00003
   REYNOLDS AF, 1983, NEUROSURGERY, V13, P63, DOI 10.1227/00006123-198307000-00013
   ROBERTSON LT, 1979, J NEUROSURG, V51, P510, DOI 10.3171/jns.1979.51.4.0510
   RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5
   Sajanti J, 1999, BBA-MOL BASIS DIS, V1454, P209, DOI 10.1016/S0925-4439(99)00016-2
   Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151
   STICHEL CC, 1994, J NEUROCYTOL, V23, P615, DOI 10.1007/BF01191556
   THEODOROU NA, 1980, DIABETOLOGIA, V18, P313
   Tresco PA, 2000, PROG BRAIN RES, V128, P349
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   WINN SR, 1989, J BIOMED MATER RES, V23, P31, DOI 10.1002/jbm.820230104
NR 38
TC 115
Z9 117
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 12
BP 2229
EP 2237
DI 10.1016/j.biomaterials.2003.09.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 772GJ
UT WOS:000188833300002
PM 14741588
DA 2018-10-19
ER

PT J
AU Freytes, DO
   Badylak, SF
   Webster, TJ
   Geddes, LA
   Rundell, AE
AF Freytes, DO
   Badylak, SF
   Webster, TJ
   Geddes, LA
   Rundell, AE
TI Biaxial strength of multilaminated extracellular matrix scaffolds
SO BIOMATERIALS
LA English
DT Article
DE ECM (extracellular matrix); ball-burst strength; mechanical properties;
   SEM (scanning electron microscopy); SIS (small intestinal submucosa);
   disinfection
ID SMALL-INTESTINAL SUBMUCOSA; MECHANICAL-PROPERTIES; GAMMA-IRRADIATION;
   ELASTIC-MODULUS; VASCULAR GRAFT; DOG-MODEL; REPAIR; BIOMATERIAL;
   BEHAVIOR; COLLAGEN
AB Xenogeneic extracellular matrix (ECM) can be harvested and configured to function as a bioscaffold for tissue and organ reconstruction. The mechanical properties of the ECM vary depending upon the tissue from which it is harvested. Likewise, the manufacturing steps required to develop ECMs into medical grade devices will affect the surface morphology and the mechanical properties of the bioscaffold; important properties for constructive tissue remodeling. The present study compared the ball-burst strength of five different ECM scaffolds before and after treatment with peracetic acid (PAA): porcine small intestinal submucosa (SIS), porcine urinary bladder submucosa (UBS), porcine urinary bladder matrix (UBM), a composite of UBS + UBM, and canine stomach submucosa (SS). This study also compared the mechanical properties of 2- and 4-layer ECM scaffolds. Results showed 2-layer SS devices had the highest ball-burst value of all 2-layer ECM devices. Moreover, all 4-layer ECM devices had similar ball-burst strength except for 4-layer UBM devices which was the weakest. PAA-treatment decreased the ball-burst strength of SS and increased the ball-burst strength of UBS 2-layer devices. This study showed the material properties of the ECM scaffolds could be engineered to mimic those of native soft tissues (i.e. vascular, musculotendinous, etc) by varying the number of layers and modifying the disinfection/sterilization treatments used for manufacturing. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15219 USA.
RP Rundell, AE (reprint author), Purdue Univ, Dept Biomed Engn, 500 Cent Dr, W Lafayette, IN 47907 USA.
EM rundell@ecn.purdue.edu
RI Rundell, Ann/P-1822-2014
OI Badylak, Stephen/0000-0003-3555-0689
FU NIBIB NIH HHS [8 R01 EB00261]
CR Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BLEYER M, COMMUNICATION
   Brown LR, 2002, FUTURIST, V36, P23
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Crow S, 1993, Todays OR Nurse, V15, P43
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   EWALT DH, 1992, J UROLOGY, V148, P544, DOI 10.1016/S0022-5347(17)36650-8
   FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   HERBERT ST, 1993, ANN BIOMED ENG, V21, P727, DOI 10.1007/BF02368651
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Monboisse J C, 1992, EXS, V62, P323
   MONTGOMERY DC, 2001, DESIGN ANAL EXPT, P100
   Naik NK, 2003, J COMPOS MATER, V37, P21, DOI 10.1106/002199803028677
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   RASMUSSEN TJ, 1994, ARTHROSCOPY, V10, P188, DOI 10.1016/S0749-8063(05)80092-1
   ROE S C, 1992, Clinical Materials, V9, P149, DOI 10.1016/0267-6605(92)90094-A
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   WAYKOLE P, 1976, CONNECT TISSUE RES, V4, P219, DOI 10.3109/03008207609152224
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
NR 34
TC 129
Z9 138
U1 0
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 12
BP 2353
EP 2361
DI 10.1016/j.biomaterials.2003.09.015
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 772GJ
UT WOS:000188833300014
PM 14741600
DA 2018-10-19
ER

PT J
AU Stolz, M
   Raiteri, R
   Daniels, AU
   VanLandingham, MR
   Baschong, W
   Aebi, U
AF Stolz, M
   Raiteri, R
   Daniels, AU
   VanLandingham, MR
   Baschong, W
   Aebi, U
TI Dynamic elastic modulus of porcine articular cartilage determined at two
   different levels of tissue organization by indentation-type atomic force
   microscopy
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID HUMAN FEMORAL HEAD; SCANNING FORCE; MECHANICAL-PROPERTIES;
   ELECTRON-MICROSCOPY; SPRING CONSTANT; THIN-FILMS; STIFFNESS;
   NANOINDENTATION; SAMPLES; AFM
AB Cartilage stiffness was measured ex vivo at the micrometer and nanometer scales to explore structure-mechanical property relationships at smaller scales than has been done previously. A method was developed to measure the dynamic elastic modulus, \E*\, in compression by indentation-type atomic force microscopy (IT AFM). Spherical indenter tips (radius=similar to2.5 mum) and sharp pyramidal tips (radius=similar to20 nm) were employed to probe micrometer-scale and nanometer-scale response, respectively. \E*\ values were obtained at 3 Hz from 1024 unloading response curves recorded at a given location on subsurface cartilage from porcine femoral condyles. With the microsphere tips, the average modulus was similar to2.6 MPa, in agreement with available millimeter-scale data, whereas with the sharp pyramidal tips, it was typically 100-fold lower. In contrast to cartilage, measurements made on agarose gels, a much more molecularly amorphous biomaterial, resulted in the same average modulus for both indentation tips. From results of AFM imaging of cartilage, the micrometer-scale spherical tips resolved no. ne structure except some chondrocytes, whereas the nanometer-scale pyramidal tips resolved individual collagen fibers and their 67-nm axial repeat distance. These results suggest that the spherical AFM tip is large enough to measure the aggregate dynamic elastic modulus of cartilage, whereas the sharp AFM tip depicts the elastic properties of its. ne structure. Additional measurements of cartilage stiffness following enzyme action revealed that elastase digestion of the collagen moiety lowered the modulus at the micrometer scale. In contrast, digestion of the proteoglycans moiety by cathepsin D had little effect on \E*\ at the micrometer scale, but yielded a clear stiffening at the nanometer scale. Thus, cartilage compressive stiffness is different at the nanometer scale compared to the overall structural stiffness measured at the micrometer and larger scales because of the fine nanometer-scale structure, and enzyme-induced structural changes can affect this scale-dependent stiffness differently.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Genoa, Dept Biophys & Elect Engn, Genoa, Italy.
   Univ Basel, Felix Platter Hosp, Lab Orthoped Biomech, CH-4003 Basel, Switzerland.
   Army Res Lab, Aberdeen Proving Ground, MD USA.
   Univ Basel, Dept Oral Surg, CH-4003 Basel, Switzerland.
RP Aebi, U (reprint author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelberstr 70, CH-4056 Basel, Switzerland.
EM ueli.aebi@unibas.ch
CR A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3
   Appleyard RC, 2001, PHYS MED BIOL, V46, P541, DOI 10.1088/0031-9155/46/2/319
   ASPDEN RM, 1991, J BIOMED ENG, V13, P521, DOI 10.1016/0141-5425(91)90102-D
   BADER DL, 1994, BIO-MED MATER ENG, V4, P245
   Bueckle H, 1973, SCI HARDNESS TESTING
   Cappella B, 1997, IEEE Eng Med Biol Mag, V16, P58, DOI 10.1109/51.582177
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203
   Gibson CT, 1996, NANOTECHNOLOGY, V7, P259, DOI 10.1088/0957-4484/7/3/014
   Hay J., 2000, ASM HDB, V8, P232
   Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156
   HOH JH, 1994, J CELL SCI, V107, P1105
   HORI RY, 1976, J BIOMECH, V9, P259, DOI 10.1016/0021-9290(76)90012-9
   HUES SM, 1993, MRS BULL, V18, P41
   Hunziker PR, 2002, CHIMIA, V56, P520, DOI 10.2533/000942902777680234
   Jurvelin JS, 1996, J STRUCT BIOL, V117, P45, DOI 10.1006/jsbi.1996.0068
   KEMPSON GE, 1971, J BIOMECH, V4, P239, DOI 10.1016/0021-9290(71)90030-3
   KEMPSON GE, 1970, BIOCHIM BIOPHYS ACTA, V215, P70, DOI 10.1016/0304-4165(70)90388-0
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   LINN FC, 1967, J BONE JOINT SURG AM, VA 49, P1079, DOI 10.2106/00004623-196749060-00005
   LUEKE HD, 1991, SPRINGER LEHRBUCH, V5, P200
   LYYRA T, 1995, MED ENG PHYS, V17, P395, DOI 10.1016/1350-4533(95)97322-G
   MAK AF, 1987, J BIOMECH, V20, P703, DOI 10.1016/0021-9290(87)90036-4
   MANKIN H, 1994, ORTHOPEDIC BASIC SCI
   MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0
   Matzelle TR, 2002, J PHYS CHEM B, V106, P2861, DOI 10.1021/jp0128426
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PERSCH G, 1994, MICROELECTRON ENG, V24, P113, DOI 10.1016/0167-9317(94)90061-2
   PHARR GM, 1992, MRS BULL, V17, P28, DOI 10.1557/S0883769400041634
   PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613
   POPKO J, 1986, Beitraege zur Orthopaedie und Traumatologie, V33, P506
   RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6
   Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176
   Raiteri R., 1998, COLLOID INTERF A, V136, P195
   Randall NX, 1998, SURF COAT TECH, V108, P489, DOI 10.1016/S0257-8972(98)00573-8
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921
   Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8
   Shepherd DET, 1997, P I MECH ENG H, V211, P155, DOI 10.1243/0954411971534278
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Stolz M, 1999, MOL BIOL CELL, V10, p145A
   STOLZ M, 2003, BIOWORLD, V3, P2
   Swanepoel M. W., 1994, Proceedings of the Institution of Mechanical Engineers, Part H (Journal of Engineering in Medicine), V208, P33
   TKACZUK H, 1982, J MED ENG TECHNOL, V6, P104, DOI 10.3109/03091908209040998
   TKACZUK H, 1986, CLIN ORTHOP RELAT R, P301
   Torii A, 1996, MEAS SCI TECHNOL, V7, P179, DOI 10.1088/0957-0233/7/2/010
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   Van Leeuwen T., 1999, DISCOURSE STUDIES, V1, P83, DOI DOI 10.1177/1461445699001001005
   Vanlandingham MR, 1997, J MATER SCI LETT, V16, P117, DOI 10.1023/A:1018533708655
   VANLANDINGHAM MR, 1997, S MAT RES SOC PITTSB
   VAWTER DL, 1983, J BIOMECH ENG-T ASME, V105, P194, DOI 10.1115/1.3138405
   Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4
   Walch M, 2000, ULTRAMICROSCOPY, V82, P259, DOI 10.1016/S0304-3991(99)00135-7
   Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006
   WEISENHORN AL, 1993, P SOC PHOTO-OPT INS, V1855, P26, DOI 10.1117/12.146382
   WEISENHORN AL, 1992, PHYS REV B, V45, P11226, DOI 10.1103/PhysRevB.45.11226
NR 58
TC 280
Z9 287
U1 6
U2 103
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD MAY
PY 2004
VL 86
IS 5
BP 3269
EP 3283
DI 10.1016/S0006-3495(04)74375-1
PG 15
WC Biophysics
SC Biophysics
GA 816HW
UT WOS:000221102000057
PM 15111440
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Mauney, JR
   Sjostorm, S
   Blumberg, J
   Horan, R
   O'Leary, JP
   Vunjak-Novakovic, G
   Volloch, V
   Kaplan, DL
AF Mauney, JR
   Sjostorm, S
   Blumberg, J
   Horan, R
   O'Leary, JP
   Vunjak-Novakovic, G
   Volloch, V
   Kaplan, DL
TI Mechanical stimulation promotes osteogenic differentiation of human bone
   marrow stromal cells on 3-D partially demineralized bone scaffolds in
   vitro
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Article
DE bioreactor; tissue engineering; biomaterial
ID ALKALINE-PHOSPHATASE ACTIVITY; OSTEOBLAST-LIKE CELLS; FLUID-FLOW;
   MESSENGER-RNA; RAT TIBIA; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION;
   ARTICULAR-CARTILAGE; HORMONAL-REGULATION; GENE-EXPRESSION
AB Bone is a dynamic tissue that is able to sense and adapt to mechanical stimuli by modulating its mass, geometry, and structure. Bone marrow stromal cells (BMSCs) are known to play an integral part in bone formation by providing an osteoprogenitor cell source capable of differentiating into mature osteoblasts in response to mechanical stresses. Characteristics of the in vivo bone environment including the three dimensional (3-D) lacunocanalicular structure and extracellular matrix composition have previously been shown to play major roles in influencing mechanotransduction processes within bone cells. To more accurately model this phenomenon in vitro, we cultured human BMSCs on 3-D, partially demineralized bone scaffolds in the presence of four-point bending loads within a novel bioreactor. The effect of mechanical loading and dexamethasone concentration on BMSC osteogenic differentiation and mineralized matrix production was studied for 8 and 16 days of culture. Mechanical stimulation after 16 days with 10 nM dexamethasone promoted osteogenic differentiation of BMSCs by significantly elevating alkaline phosphatase activity as well as alkaline phosphatase and osteopontin transcript levels over static controls. Mineralized matrix production also increased under these culture conditions. Dexamethasone concentration had a dramatic effect on the ability of mechanical stimulation to modulate these phenotypic and genotypic responses. These results provide increased insight into the role of mechanical stimulation on osteogenic differentiation of human BMSCs in vitro and may lead to improved strategies in bone tissue engineering.
C1 Tufts Univ, Dept Biomed Engn, Ctr Biotechnol, Medford, MA 02155 USA.
   Tufts Univ, Dept Biol & Chem Engn, Ctr Biotechnol, Medford, MA 02155 USA.
   Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
   MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Biotechnol, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574
CR AKHTER MP, 1992, J BIOMECH, V25, P1241, DOI 10.1016/0021-9290(92)90082-C
   ALTMAN GH, 2001, FASEB J, V16, P270
   Aubin JE, 1995, BONE, V17, P77
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Becerra J, 1996, J BONE MINER RES, V11, P1703
   Beck BR, 2002, CALCIFIED TISSUE INT, V71, P335, DOI 10.1007/s002230020050
   BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9
   BERESFORD JN, 1992, J CELL SCI, V102, P341
   Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413
   Bodine PVN, 1996, ENDOCRINOLOGY, V137, P4592, DOI 10.1210/en.137.11.4592
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   BRIGHTON CT, 1991, J BONE JOINT SURG AM, V73A, P320, DOI 10.2106/00004623-199173030-00002
   Burger EH, 1999, FASEB J, V13, P101
   Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2
   CAPLAN AI, MESENCHYMAL STEM CEL
   Carvalho RS, 2002, J CELL BIOCHEM, V84, P497
   Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J
   CHEN JK, 1993, MATRIX, V13, P113, DOI 10.1016/S0934-8832(11)80070-3
   Cooper LF, 2001, J DENT RES, V80, P314, DOI 10.1177/00220345010800010401
   Cullen DM, 2001, J APPL PHYSIOL, V91, P1971
   Davisson T, 2002, J ORTHOPAED RES, V20, P842, DOI 10.1016/S0736-0266(01)00160-7
   Forwood MR, 1998, BONE, V23, P307, DOI 10.1016/S8756-3282(98)00090-8
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Gere J. M., 1990, MECH MAT
   Glantschnig H, 1996, EUR J CLIN INVEST, V26, P544, DOI 10.1046/j.1365-2362.1996.165312.x
   HARAKAS NK, 1984, CLIN ORTHOP RELAT R, P239
   HARTER LV, 1995, ENDOCRINOLOGY, V136, P528, DOI 10.1210/en.136.2.528
   Hartig M, 2000, EUR BIOPHYS J BIOPHY, V29, P499, DOI 10.1007/s002490000100
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Heinonen A, 2001, BONE, V29, P279, DOI 10.1016/S8756-3282(01)00574-9
   Hsieh YF, 1999, BONE, V25, P379, DOI 10.1016/S8756-3282(99)00181-7
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2
   KEILA S, 1994, J BONE MINER RES, V9, P321
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   KleinNulend J, 1996, J CELL PHYSIOL, V168, P1, DOI 10.1002/(SICI)1097-4652(199607)168:1<1::AID-JCP1>3.0.CO;2-T
   KleinNulend J, 1997, J CELL PHYSIOL, V170, P174, DOI 10.1002/(SICI)1097-4652(199702)170:2<174::AID-JCP9>3.0.CO;2-L
   Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   MacGinitie LA, 1997, J BIOMECH, V30, P1133, DOI 10.1016/S0021-9290(97)85605-9
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   MAUNEY JR, 2003, IN PRESS TISSUE ENG
   Miles RR, 1998, J CELL BIOCHEM, V68, P355, DOI 10.1002/(SICI)1097-4644(19980301)68:3<355::AID-JCB6>3.0.CO;2-T
   MURRAY DW, 1990, CALCIFIED TISSUE INT, V47, P35, DOI 10.1007/BF02555863
   NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109
   Owan I, 1997, AM J PHYSIOL, V273, P810
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Pri-Chen S, 1998, BONE, V23, P111, DOI 10.1016/S8756-3282(98)00087-8
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0
   RAABCULLEN DM, 1994, J BONE MINER RES, V9, P1143
   Robling AG, 2001, J EXP BIOL, V204, P3389
   Rosenthal RK, 1999, CLIN ORTHOP RELAT R, P61
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   Sakai K, 1998, CALCIFIED TISSUE INT, V63, P515, DOI 10.1007/s002239900567
   SATO N, 1994, BLOOD, V83, P1093
   Seshi B, 2000, BLOOD CELL MOL DIS, V26, P234, DOI 10.1006/bcmd.2000.0301
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Smalt R., 1997, AM J PHYSIOL, V273, P751
   Solheim E, 1998, INT ORTHOP, V22, P335, DOI 10.1007/s002640050273
   Tanck E, 2001, BONE, V28, P650, DOI 10.1016/S8756-3282(01)00464-1
   Tang Kai, 2002, Zhonghua Yi Xue Za Zhi, V82, P665
   Tate MLK, 2000, J EXP BIOL, V203, P2737
   Thomas GP, 1996, CALCIFIED TISSUE INT, V58, P101, DOI 10.1007/BF02529731
   Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626
   Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064
   TURNER CH, 1994, FASEB J, V8, P875
   TURNER CH, 1991, BONE, V12, P73, DOI 10.1016/8756-3282(91)90003-2
   Turner R, 2001, TOURISM MANAGE, V22, P463, DOI 10.1016/S0261-5177(01)00015-2
   Umemura Y, 1997, J BONE MINER RES, V12, P1480, DOI 10.1359/jbmr.1997.12.9.1480
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wang LY, 1999, J BIOMECH, V32, P663, DOI 10.1016/S0021-9290(99)00059-7
   Wang Q, 1998, CLIN ORTHOP RELAT R, P259
   Westbroek I, 2000, BIOCHEM BIOPH RES CO, V268, P414, DOI 10.1006/bbrc.2000.2154
   Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731
   Yang Y, 2002, BIOMATERIALS, V23, P2119, DOI 10.1016/S0142-9612(01)00342-8
   Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P369
   ZHANG RW, 1995, J BONE MINER RES, V10, P415
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 84
TC 144
Z9 164
U1 3
U2 37
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0171-967X
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PD MAY
PY 2004
VL 74
IS 5
BP 458
EP 468
DI 10.1007/s00223-003-0104-7
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 820AP
UT WOS:000221359100008
PM 14961210
DA 2018-10-19
ER

PT J
AU Simon, A
   Cohen-Bouhacina, T
   Aime, JP
   Porte, MC
   Amedee, J
   Baquey, C
AF Simon, A
   Cohen-Bouhacina, T
   Aime, JP
   Porte, MC
   Amedee, J
   Baquey, C
TI Heterogeneous cell mechanical properties: An atomic force microscopy
   study
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE cell mechanical properties; atomic force microscopy; cell elasticity;
   cytoskeleton organization; osteoblast; living cell
ID ADHESION; FRICTION; RGD; INTEGRIN; SURFACE; MODULATION; ELASTICITY;
   DYNAMICS; BINDING; FILMS
AB Atomic force microscopy (AFM) is a non-invasive microscopy to explore living biological systems like cells in liquid environment. Thus AFM is an appropriate tool to investigate surface chemical modification and its influence on biological systems. In particular, control over biomaterial surface chemistry can result in a regulated cell response. This report investigates the influence of adhesive and non-adhesive surfaces on the cell morphology and the influence of the cytoskeleton structure on the local mechanical proper-ties. In this study, the main work concerns a thorough investigation of the height images obtained with an AFM as the recorded images provide the evolution of the mechanical properties of the cell as function of its local structure. Information on the cell elasticity due to the cytoskeleton organization is deduced when comparing the AFM tip indentation depth versus the distance between the cytoskeleton bundles for the different samples.
C1 Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France.
   Univ Bordeaux 2, U443, INSERM, F-33076 Bordeaux, France.
RP Cohen-Bouhacina, T (reprint author), Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, 351 Cours Liberat, F-33405 Talence, France.
EM t.bouhacina@cpmoh.u-bourdeaux1.fr
RI DURRIEU, Marie-Christine/I-4358-2016; VILAMITJANA AMEDEE,
   Joelle/F-3369-2013
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; 
CR AIME JP, 1995, SURF SCI, V329, P149, DOI 10.1016/0039-6028(95)00122-0
   AIME JP, 1994, J APPL PHYS, V76, P754, DOI 10.1063/1.357777
   BASSON CT, 1992, J CELL PHYSIOL, V153, P118, DOI 10.1002/jcp.1041530116
   Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267
   BUTT HJ, 1990, J STRUCT BIOL, V105, P54, DOI 10.1016/1047-8477(90)90098-W
   Carpick RW, 1996, J VAC SCI TECHNOL B, V14, P1289, DOI 10.1116/1.589083
   Domke J, 2000, COLLOID SURFACE B, V19, P367, DOI 10.1016/S0927-7765(00)00145-4
   Haydon PG, 1996, J MICROSC-OXFORD, V182, P114, DOI 10.1046/j.1365-2818.1996.141423.x
   HENDERSON E, 1992, SCIENCE, V257, P1944, DOI 10.1126/science.1411511
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kasas S, 1997, INT J IMAG SYST TECH, V8, P151, DOI 10.1002/(SICI)1098-1098(1997)8:2<151::AID-IMA2>3.0.CO;2-9
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MEYER E, 1992, PHYS REV LETT, V69, P1777, DOI 10.1103/PhysRevLett.69.1777
   Overney RM, 1996, J VAC SCI TECHNOL B, V14, P1276, DOI 10.1116/1.589080
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RADMACHER M, 1994, BIOPHYS J, V66, P2159, DOI 10.1016/S0006-3495(94)81011-2
   Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schaus SS, 1997, BIOPHYS J, V73, P1205, DOI 10.1016/S0006-3495(97)78153-0
   Schmidt RH, 1999, LANGMUIR, V15, P317, DOI 10.1021/la980739a
   Simon A, 2002, J COLLOID INTERF SCI, V251, P278, DOI 10.1006/jcis.2002.8385
   Simon A, 2003, CYTOM PART A, V54A, P36, DOI 10.1002/cyto.a.10052
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   VANWACHEM PB, 1989, BIOMATERIALS, V10, P532, DOI 10.1016/0142-9612(89)90058-6
   Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4
   YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3
   Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347
NR 32
TC 19
Z9 19
U1 0
U2 5
PU CELLULAR & MOLECULAR BIOLOGY
PI NOISY-LE-GRAND
PA PROF R WEGMANN RESIDENCE HAUSSMANN 1 AVENUE DU PAVE NEUF, 93160
   NOISY-LE-GRAND, FRANCE
SN 0145-5680
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PD MAY
PY 2004
VL 50
IS 3
BP 255
EP 266
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 827CE
UT WOS:000221875200006
PM 15209346
DA 2018-10-19
ER

PT J
AU Luo, YF
   Wang, YL
   Niu, XF
   Pan, J
   Shi, LP
AF Luo, YF
   Wang, YL
   Niu, XF
   Pan, J
   Shi, LP
TI Synthesis and characterization of a novel biomaterial: Maleic
   anhydride-modified poly(dl-lactic acid)
SO CHINESE CHEMICAL LETTERS
LA English
DT Article
DE poly(dl-lactic acid); maleic anhydride; modification; characterization
ID POLY(LACTIC ACID-CO-LYSINE); POLY(ETHYLENE GLYCOL); SCAFFOLDS; LACTIDE
AB A novel modified poly(dl-lactic acid) (PDLLA) was obtained by covalently grafting of maleic anhydride onto the backbone of PDLLA, attempting to improve PDLLA's hydrophilicity and cell affinity and to provide reactive groups for further chemical modification. FTIR, C-13 NMR and DSC were used to characterize the maleic anhydride-modified PDLLA.
C1 Chongqing Univ, Bioengn Coll, State Minist Educ China, Key Lab Biomech & Tissue Engn, Chongqing 400044, Peoples R China.
RP Luo, YF (reprint author), Chongqing Univ, Bioengn Coll, State Minist Educ China, Key Lab Biomech & Tissue Engn, Chongqing 400044, Peoples R China.
EM wyl@cqu.edu.cn
CR BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Han DK, 1996, MACROMOLECULES, V29, P5233, DOI 10.1021/ma9601070
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Wang NL, 1997, J CIRCUIT SYST COMP, V7, P1, DOI 10.1142/S0218126697000024
   Yu Yen, 2000, SHENGWU YIYONG CAILI, P54
   Zheng J, 1998, IN VITRO CELL DEV-AN, V34, P679
NR 7
TC 19
Z9 25
U1 1
U2 8
PU CHINESE CHEMICAL SOCIETY
PI BEIJING
PA C/O DEPT INT AFFAIRS, SECRETARY OF CHEM SOC, PO BOX 2709, BEIJING
   100080, PEOPLES R CHINA
SN 1001-8417
J9 CHINESE CHEM LETT
JI Chin. Chem. Lett.
PD MAY
PY 2004
VL 15
IS 5
BP 521
EP 524
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 829SS
UT WOS:000222070600006
DA 2018-10-19
ER

PT J
AU Lu, Q
   Cao, CB
   Zhai, HZ
   Zhu, HS
AF Lu, Q
   Cao, CB
   Zhai, HZ
   Zhu, HS
TI Preparation of insoluble fibroin films and its tensile property
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE fibroin; insoluble; mechanical properties; concentration
ID SILK FIBROIN; METHANOL
AB Silk fibroin is becoming a promising biomaterial because of its excellent biocompatibility. However, the regenerated fibroin is usually soluble in water and its mechanical properties should be improved. Although many methods, such as adding other polymers or treating with methanol, can ameliorate the mechanical properties and insolubility, the biocompatibility of fibroin is usually damaged in these processes. In this article, it is first reported that the insoluble fibroin films are directly prepared without methanol treatment. According to the results of Fourier transform infrared spectroscope (FTIR) and the X-ray diffraction (XRD), the amount of beta-sheet conformation increased with the increasing of concentration. When fibroin films are dried from 15 wt% at 60degreesC, the films become insoluble in water. More importantly, The tensile strength and elongation of the insoluble fibroin films dried from 15% solution at 60degreesC reached 15.9 MPa and 49.4% respectively in the wet state, which is distinctly superior to the fibroin films treated with methanol.
C1 Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Cao, CB (reprint author), Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
EM cbcao@bit.edu.cn
RI Cao, Chuanbao/J-5396-2013
OI Cao, Chuanbao/0000-0003-2830-4383
CR ANSHU BM, 1997, BIOPOLY, V42, P61
   GREGORY HA, 2002, BIOMATERIALS, V23, P4131
   Haeyong K., 2001, J APPL POLYM SCI, V80, P928
   HIROAKI Y, 1990, J APP POLY SCI, V40, P1745
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jin N., 2001, J APPL POLYM SCI, V81, P3008
   KWEON H, 2001, J APPL POLYM SCI, V81, P1467
   Kweon HY, 2001, J APPL POLYM SCI, V80, P1848, DOI 10.1002/app.1281
   Li MZ, 2002, POLYM ADVAN TECHNOL, V13, P605, DOI 10.1002/pat.159
   MAKOTO D, 1991, J MEMBRANE SCI, V59, P39
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   OLEG NT, 2001, LANGMUIR, V17, P7406
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Sun YY, 1997, J APPL POLYM SCI, V65, P959, DOI 10.1002/(SICI)1097-4628(19970801)65:5<959::AID-APP14>3.0.CO;2-N
   SUSAN S, 2001, J BIOMEDICAL MAT RES, V54, P139
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Yasutomo N., 2002, J APPL POLYM SCI, V86, P3425
NR 18
TC 0
Z9 0
U1 1
U2 11
PU SCIENCE CHINA PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD MAY
PY 2004
VL 49
IS 10
BP 1009
EP 1011
DI 10.1360/03wb0195
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 844GT
UT WOS:000223146800006
DA 2018-10-19
ER

PT J
AU Yuan, YL
   Ai, F
   Zang, XP
   Zhuang, W
   Shen, J
   Lin, SC
AF Yuan, YL
   Ai, F
   Zang, XP
   Zhuang, W
   Shen, J
   Lin, SC
TI Polyurethane vascular catheter surface grafted with zwitterionic
   sulfobetaine monomer activated by ozone
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE ozonization; graft copolymerization; PUVC-g-PDMMSA; platelet adhesion
ID BLOOD COMPATIBILITY; POLY(ETHER URETHANE); PLATELET-ADHESION
AB Polyurethane (PU) is a conventional biomedical material with favorable biocompatibility and excellent mechanical properties and widely used in making vascular catheter, but its anti thrombogenic property is not good enough to make it as a more demanding applicable biomaterial. Surface modification is an effective way to improve the hemocompatibility for biomaterials. The purpose of present study was to use ozonization method to modify the surface of PU vascular catheter slice to improve its antithrombogenicity by grafting N,N-dimethyl-N-methacrytoxyethyl-N-(3-sulfopropyl) ammonium (DMMSA), a zwitterionic sulfobetaine monomer. PU vascular catheter (PUVC) grafted with DMMSA (PUVC-g-PDMMSA) was characterized by ATR-FTIR and XPS. ATR-FTIR and XPS investigation confirmed the graft polymerization. The blood compatibility of the grafted films was evaluated by platelet rich plasma (PRP) platelet adhesion study and scanning electron microscopy (SEM) was used to observe the morphology of platelet using PU vascular catheter (PUVC) as the reference. No platelet adhesion was observed for the grafted PUVC slice incubated with PRP at 37degreesC for 120 min. It is significant that this new zwitterionic sulfobetaine grafted PUVC have improved antithrobogenicity. It is effective that the inner surface of vascular catheter with inner diameter in only 3 mm can be grafted with PDMMSA by using ozonization method. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Techol, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Techol, Nanjing 210093, Peoples R China.
EM sicong_lin@yahoo.com
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   FOUGNOT C, 1984, MACROMOLECULAR BIOMA
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HORNING EC, 1955, ORGANIC SYNTHESES CO, V3, pP415
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Lin SC, 1998, POLYM B, V1, P1
   NEILL TO, 1972, J POLYM SCI POL CHEM, V10, P569
   PENN LS, 1994, POLYM ADVAN TECHNOL, V5, P809
   THOMPSON AR, 1983, MANUAL HEMOSTASIS TH
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   WANG CH, 1997, ACTA POLYM SIN, V1, P114
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   Yuan YL, 2003, COLLOID SURFACE B, V29, P247, DOI 10.1016/S0927-7765(02)00210-2
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   ZHANG J, 2003, BIOINTERFACES, V30, P249
NR 22
TC 74
Z9 81
U1 6
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2004
VL 35
IS 1
BP 1
EP 5
DI 10.1016/j.colsurfb.2004.01.005
PG 5
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 823RA
UT WOS:000221629500001
PM 15261048
DA 2018-10-19
ER

PT J
AU Jansson, E
   Tengvall, P
AF Jansson, E
   Tengvall, P
TI Adsorption of albumin and IgG to porous and smooth titanium
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE albumin; IgG; porous surfaces; radio labeled proteins; titanium
ID HUMAN SERUM-ALBUMIN; PROTEIN ADSORPTION; METAL-SURFACES; FIBRINOGEN;
   PLASMA; NEUTROPHILS; PLATELETS; SILICON; POWDER
AB The possibility to load submicrometer porous titanium surfaces with relatively small proteins, albumin and immunoglobulin G (IgG) was investigated. The loading ability is of interest due to the possibility of slow release of molecules from biomaterial surfaces, and may be important for the manipulation of wound healing around prostheses. Iodine-125 (I-125) labeled albumin and IgG were adsorbed onto smooth and to porous titanium with a pore diameter of 200-300 mn. The smooth and porous surfaces were divided into three groups: hydrophilic, hydrophobic, or to amine-terminated silane (3-aminopropyltriethoxysilane) that bound proteins via glutaraldehyde. The protein solution pH and protein concentrations were varied, and the adsorption experiments made without or in the presence of calcium and magnesium ions. The adsorbed amounts were quantified with a gamma counter. Two to eleven times more proteins adsorbed onto porous than smooth surfaces and the adsorbed amounts increased with increasing protein concentration (0.1 - 10 mg/ml) during a constant incubation time. The elutability by sodium dodecyl sulphate (SDS) was incomplete on porous surfaces. (C) 2004 Elsevier B.V. All rights reserved.
C1 Linkoping Univ, Dept Phys & Measurement Technol, Appl Phys Lab, SE-58183 Linkoping, Sweden.
RP Tengvall, P (reprint author), Linkoping Univ, Dept Phys & Measurement Technol, Appl Phys Lab, SE-58183 Linkoping, Sweden.
EM pet@ifm.liu.se
CR Benesch J, 2000, COLLOID SURFACE B, V18, P71, DOI 10.1016/S0927-7765(99)00136-8
   Endo K, 1995, Dent Mater J, V14, P199
   Fasman G. D, 1976, HDB BIOCH MOL BIOL P, V2
   IVARSSON B A, 1985, Colloids and Surfaces, V13, P169, DOI 10.1016/0166-6622(85)80015-9
   JONSSON U, 1985, THIN SOLID FILMS, V124, P117, DOI 10.1016/0040-6090(85)90253-6
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   LAW SK, 1995, COMPLEMENT
   Liu FY, 1998, APPL RADIAT ISOTOPES, V49, P67
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   Sheardown H, 1997, COLLOID SURFACE B, V10, P29, DOI 10.1016/S0927-7765(97)00045-3
   STEINBERG D, 1995, BIOMATERIALS, V16, P1339, DOI 10.1016/0142-9612(95)91050-9
   Tengvall P, 2003, COLLOID SURFACE B, V28, P261, DOI 10.1016/S0927-7765(02)00151-0
   TENGVALL P, 2001, TITANIUM MED, P457
   ULMAN A, 1991, INTRO ULTRATHIN ORGA, P245
   Wassell DTH, 1996, BIOMATERIALS, V17, P859, DOI 10.1016/0142-9612(96)83280-7
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   Wettero J, 2003, BIOMATERIALS, V24, P1559, DOI 10.1016/S0142-9612(02)00543-4
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
   Zangooie S, 1998, THIN SOLID FILMS, V313, P825, DOI 10.1016/S0040-6090(97)01003-1
NR 24
TC 28
Z9 34
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2004
VL 35
IS 1
BP 45
EP 51
DI 10.1016/j.colsurfb.2004.02.007
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 823RA
UT WOS:000221629500008
PM 15261055
DA 2018-10-19
ER

PT J
AU Bartouilh de Taillac, L
   Porte-Durrieu, MC
   Labrugere, C
   Bareille, R
   Amedee, J
   Baquey, C
AF Bartouilh de Taillac, L
   Porte-Durrieu, MC
   Labrugere, C
   Bareille, R
   Amedee, J
   Baquey, C
TI Grafting of RGD peptides to cellulose to enhance human osteoprogenitor
   cells adhesion and proliferation
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE bioactive material
ID HUMAN BONE; COVALENT ATTACHMENT; TITANIUM SURFACES; GROWTH; SILICA
AB Despite the controversy about the ideal properties of bone replacement materials, it seems that the concept of tissue engineered constructs, materials pre-colonized with autologous bone cells before implantation gathers most of favorable opinions. Cellulosic materials possess osteoconductive properties but have no intrinsic osteoinductive capacity. Then, one solution to develop bone substitutes with osteogenic properties would be to associate biomaterials with osteoprogenitors cells and the biomaterial should support cellular adhesion and induce tissue ingrowth. In a first part of this paper, we describe a new method to immobilize bioactive molecules onto cellulose. Second part of this paper is dedicated to the characterization by X-ray photoelectron spectroscopy (XPS) and static contact angle measurements of cellulose surfaces functionalized with RGD peptides. Finally, the influence of these RGD-containing peptides on osteoprogenitor cells adhesion and proliferation is discussed. These data suggest that, by controlling the preparation of the raw material, bone substitutes with intrinsic osteoinductive property can be developed from cellulose. (C) 2003 Elsevier Ltd. All rights reserved.
C1 INSERM, U443, Biomat & Reparat Tissulaire, F-33076 Bordeaux, France.
   CNRS, ICMCB, Ctr Caracterisat Mat Avances, F-33608 Pessac, France.
RP Bartouilh de Taillac, L (reprint author), INSERM, U443, Biomat & Reparat Tissulaire, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
EM laure.detaillac@bordeaux.inserm.fr
RI DURRIEU, Marie-Christine/I-4358-2016; VILAMITJANA AMEDEE,
   Joelle/F-3369-2013
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; 
CR ALBREKTSSON T, 1998, HARD TISSUE RESPONSE
   BAQUEY C, 1992, SCI TECHNIQUES TECHN, V20, P28
   BAQUEY C, 1989, ORGANES ARTIFICIELSH
   BARBIE C, 1990, Clinical Materials, V5, P251, DOI 10.1016/0267-6605(90)90023-O
   BARBIE C, 1987, BIOMAT 87 C BORD FRA, P319
   Black J., 1988, ORTHOPAEDIC BIOMATER
   Briggs D, 1992, HIGH RESOLUTION XPS
   Briggs D., 1998, SURFACE ANAL POLYM X
   FREED LE, 1995, TISSUE ENG CARTILAGE
   Fricain JC, 2002, BIOMATERIALS, V23, P673, DOI 10.1016/S0142-9612(01)00155-7
   GALGUT PN, 1990, BIOMATERIALS, V11, P561, DOI 10.1016/0142-9612(90)90078-5
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GROSS U, 1992, 4 WORLD BIOM C BERL, P192
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   HOLLINGER J, 1995, BONE ITS REPAIR
   IKADA Y, 1989, BIOMEDICAL APPL CELL
   KAHN FJ, 1973, APPL PHYS LETT, V22, P386, DOI 10.1063/1.1654684
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Lenzi F, 2003, POLYMER, V44, P1577, DOI 10.1016/S0032-3861(02)00939-4
   LI PJ, 1995, J BIOMED MATER RES, V29, P325, DOI 10.1002/jbm.820290307
   MAJESKA RJ, 1993, J BONE MINER RES, V8, P3
   Martson M, 1998, EUR SURG RES, V30, P426, DOI 10.1159/000008609
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McFarland CD, 1999, J BIOMED MATER RES, V44, P1
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Pollok J M, 1996, Semin Pediatr Surg, V5, P191
   POMMIER JC, 1987, BIOCOMPATIBLE HYDROP
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   PORTEDURRIEU MC, 2002, J BIOMED MAT RES
   PORTEDURRIEU MC, 2002, BIOMATERIALS
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Skoog T, 1967, Scand J Plast Reconstr Surg, V1, P113
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 43
TC 27
Z9 27
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD MAY
PY 2004
VL 64
IS 6
BP 827
EP 837
DI 10.1016/j.compscitech.2003.09.011
PG 11
WC Materials Science, Composites
SC Materials Science
GA 815GR
UT WOS:000221031300004
DA 2018-10-19
ER

PT J
AU Pawlowski, KJ
   Rittgers, SE
   Schmidt, SP
   Bowlin, GL
AF Pawlowski, KJ
   Rittgers, SE
   Schmidt, SP
   Bowlin, GL
TI Endothelial cell seeding of polymeric vascular grafts
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE vessel; endothelial cell; endothelium; seeding; graft; tissue
   engineering; review
ID EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS; POROUS ARTERIAL PROSTHESES;
   MICROVASCULAR ENDOTHELIUM; INTRAVASCULAR THROMBOSIS;
   EXTRACELLULAR-MATRIX; FIBRONECTIN; CULTURE; PTFE; KINETICS; SURFACE
AB Pioneers in the field of small diameter graft development sought to promote graft endothelialization and, thereby, increase patency by transplanting a varying degree of autologous endothelial cells onto vascular grafts prior to implantation. This process has become known as endothelial cell seeding. The underlying hypothesis is quite simple; that is, by promoting the establishment of the patient's own endothelial cells on the blood contacting surface of a vascular prosthesis, a "normal" endothelial cell lining and associated basement membrane, together known as the neointima, will form on the graft and counteract the rheologic, physiologic, and biomaterial forces working synergistically to promote graft failure. After 30 years of research in this area, this simple hypothesis has proven to be deceptively naive. The purpose of this review is to summarize the historic context and current base of knowledge regarding many of the technical issues relevant to the endothelial cell seeding process. Special attention is given to electrostatic endothelial cell seeding, the latest research methodology designed specifically to accelerate endothelial cell adhesion and morphological maturation onto expanded poly(tetrafluoroethylene) (e-PTFE) small diameter vascular grafts.
C1 Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23298 USA.
   Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   Akron City Hosp, Summa Hlth Syst, Falor Div Surg Res, Akron, OH 44309 USA.
RP Bowlin, GL (reprint author), Virginia Commonwealth Univ, Dept Biomed Engn, POB 980694, Richmond, VA 23298 USA.
EM glbowlin@vcu.edu
RI Bowlin, Gary/E-8617-2010
CR Abramson HA, 1928, J EXP MED, V47, P677, DOI 10.1084/jem.47.5.677
   ANDERSON JS, 1987, SURGERY, V101, P577
   ANDO T, 1993, ADV EXP MED BIOL, V332, P361
   Bellon J M, 1993, Ann Vasc Surg, V7, P549, DOI 10.1007/BF02000149
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BLAKEMORE AH, 1954, ANN SURG, V140, P324, DOI 10.1097/00000658-195409000-00008
   BOURKE BM, 1986, J VASC SURG, V4, P257, DOI 10.1067/mva.1986.avs0040257
   Bowlin GL, 1997, CELL TRANSPLANT, V6, P631, DOI 10.1016/S0963-6897(97)00095-X
   Bowlin GL, 2000, CELL TRANSPLANT, V9, P337, DOI 10.1177/096368970000900305
   Bowlin GL, 1998, J VASC SURG, V27, P504, DOI 10.1016/S0741-5214(98)70325-8
   Bowlin GL, 1997, CELL TRANSPLANT, V6, P623, DOI 10.1016/S0963-6897(97)00096-1
   Bowlin GL, 2000, BIOMATERIALS ENGINEERING AND DEVICES: HUMAN APPLICATIONS, VOL 1, P85
   Bowlin GL, 2001, J BIOMATER APPL, V16, P157, DOI 10.1106/NCQT-JFV9-2EQ1-EBGU
   Budd J S, 1991, Eur J Vasc Surg, V5, P397, DOI 10.1016/S0950-821X(05)80171-9
   CLAGETT GP, 1984, CIRCULATION, V69, P632, DOI 10.1161/01.CIR.69.3.632
   CLOWES AW, 1987, ANN NY ACAD SCI, V516, P673, DOI 10.1111/j.1749-6632.1987.tb33084.x
   CLOWES AW, 1986, J VASC SURG, V3, P877, DOI 10.1067/mva.1986.avs0030877
   CLOWES AW, 1985, AM J PATHOL, V118, P43
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Conte MS, 1998, FASEB J, V12, P43
   DIDISHEIM P, 1996, BIOMATERIALS SCI INT, P283
   Fields C, 2002, J BIOMATER APPL, V17, P135, DOI 10.1106/088532802030556
   FINK DG, 1989, ELECT ENG HDB, P29
   FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1
   GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673
   Gosselin C, 1996, J SURG RES, V60, P327, DOI 10.1006/jsre.1996.0052
   GOTTLIEB AI, 1991, LAB INVEST, V65, P123
   GRAHAM LM, 1980, ARCH SURG-CHICAGO, V115, P929
   GRAHAM LM, 1982, SURGERY, V91, P550
   GUYTON AC, 1991, TXB MED PHYSL, P269
   HALLIDAY D, 1981, FUNDAMENTALS PHYSICS, P484
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1984, J VASC SURG, V1, P279, DOI 10.1067/mva.1984.avs0010279
   HOWARD BV, 1976, P NATL ACAD SCI USA, V73, P2361, DOI 10.1073/pnas.73.7.2361
   JACKSON CJ, 1990, J CELL SCI, V96, P257
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JAFFE EA, 1978, J EXP MED, V147, P1779, DOI 10.1084/jem.147.6.1779
   JAFFE EA, 1976, J EXP MED, V144, P209, DOI 10.1084/jem.144.1.209
   JARRELL BE, 1986, SURGERY, V100, P392
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   KEMPCZINSKI RF, 1987, SURGERY, V101, P439
   KEMPCZINSKI RF, 1985, J VASC SURG, V2, P424, DOI 10.1067/mva.1985.avs0020424
   KERN PA, 1983, J CLIN INVEST, V71, P1822, DOI 10.1172/JCI110937
   KESLER KA, 1986, J VASC SURG, V3, P58
   Lee Y S, 1993, ASAIO J, V39, pM740
   LINDBLAD B, 1986, ACTA CHIR SCAND, V152, P653
   LONGNECKER DE, 1992, INTRO ANESTHESIA, P419
   LOWELL J, 1976, J PHYS D APPL PHYS, V9, P1571, DOI 10.1088/0022-3727/9/11/006
   MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112
   MARMUR A, 1976, B MATH BIOL, V38, P713, DOI 10.1016/S0092-8240(76)80011-0
   MAZZUCOTELLI JP, 1993, ARTIF ORGANS, V17, P787
   Niu S, 1990, ASAIO Trans, V36, pM164
   PRATT KJ, 1988, J VASC SURG, V7, P591, DOI 10.1067/mva.1988.avs0070591
   Prendiville E J, 1991, Eur J Vasc Surg, V5, P311, DOI 10.1016/S0950-821X(05)80515-8
   RAMALANJAONA G, 1986, J VASC SURG, V3, P264, DOI 10.1067/mva.1986.avs0030264
   RAMALANJAONA GR, 1986, J SURG RES, V41, P479, DOI 10.1016/0022-4804(86)90165-4
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   RUCKENSTEIN E, 1975, J THEOR BIOL, V51, P429, DOI 10.1016/0022-5193(75)90072-7
   RUCKENSTEIN E, 1976, THROMB HAEMOSTASIS, V36, P334
   RUPNICK MA, 1989, J VASC SURG, V9, P788, DOI 10.1067/mva.1989.vs0090788
   SAUVAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   SAWYER PN, 1966, BIOPHYS J, V6, P653, DOI 10.1016/S0006-3495(66)86684-5
   SAWYER PN, 1967, AM J SURG, V114, P42, DOI 10.1016/0002-9610(67)90038-4
   SCHAKENRAAD JM, 1989, BIOMATERIALS, V10, P43, DOI 10.1016/0142-9612(89)90008-2
   Schmidt S P, 1988, J Invest Surg, V1, P35, DOI 10.3109/08941938809141074
   SCHMIDT SP, 1995, ENCY HDB BIOMATERI B, V2, P1089
   SCHMIDT SP, 1991, HIGH PERFORMANCE BIO, P483
   SCHNEIDER A, 1992, J VASC SURG, V15, P649, DOI 10.1016/0741-5214(92)90010-6
   SEEGER JM, 1988, J VASC SURG, V8, P476
   SENTISSI JM, 1986, SURGERY, V99, P337
   SHAREFKIN JB, 1986, J VASC SURG, V4, P567
   Sharp W V, 1989, Ann Vasc Surg, V3, P104, DOI 10.1016/S0890-5096(06)62001-3
   SHINDO S, 1987, J VASC SURG, V6, P325, DOI 10.1067/mva.1987.avs0060325
   SRINIVASAN S, 1970, J COLLOID INTERF SCI, V32, P456, DOI 10.1016/0021-9797(70)90131-1
   Stanley J. C., 1986, VASCULAR GRAFT UPDAT, P33
   SUGIMOTO Y, 1981, EXP CELL RES, V135, P39, DOI 10.1016/0014-4827(81)90297-4
   TURGEON ML, 1988, CLIN HEMATOLOGY THEO, P279
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1990, BIOMATERIALS, V11, P602, DOI 10.1016/0142-9612(90)90086-6
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   VANWACHEM PB, 1989, BIOMATERIALS, V10, P532, DOI 10.1016/0142-9612(89)90058-6
   VANWACHEM PB, 1988, BIOMATERIALS, V9, P121, DOI 10.1016/0142-9612(88)90083-X
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   WILLIAMS SK, 1985, J SURG RES, V38, P618, DOI 10.1016/0022-4804(85)90084-8
   WILLIAMS SK, 1994, J VASC SURG, V19, P916, DOI 10.1016/S0741-5214(94)70019-2
   YATES SG, 1978, ANN SURG, V188, P611, DOI 10.1097/00000658-197811000-00005
   YU ZZ, 1989, J PHYS D APPL PHYS, V22, P798, DOI 10.1088/0022-3727/22/6/014
   YU ZZ, 1990, J PHYS D APPL PHYS, V23, P1207, DOI 10.1088/0022-3727/23/9/011
NR 88
TC 59
Z9 61
U1 0
U2 20
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD MAY
PY 2004
VL 9
BP 1412
EP 1421
DI 10.2741/1302
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 779ZA
UT WOS:000189333700032
PM 14977556
DA 2018-10-19
ER

PT J
AU Artzi, Z
   Weinreb, M
   Givol, N
   Rohrer, MD
   Nemcovsky, CE
   Prasad, HS
   Tal, H
AF Artzi, Z
   Weinreb, M
   Givol, N
   Rohrer, MD
   Nemcovsky, CE
   Prasad, HS
   Tal, H
TI Biomaterial resorption rate and healing site morphology of inorganic
   bovine bone and beta-tricalcium phosphate in the canine: A 24-month
   longitudinal histologic study and morphometric analysis
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE alloplast; beta-tricalcium phosphate; biomaterial resorption; bovine
   bone mineral; osteoconduction; xenograft
ID SINUS AUGMENTATION PROCEDURES; DIFFERENT GRAFTING MATERIALS; HUMAN
   EXTRACTION SOCKETS; 10 CONSECUTIVE PATIENTS; AUTOGENOUS BONE; DENTAL
   IMPLANTS; FLOOR AUGMENTATION; GRINDING TECHNIQUE; BIO-OSS;
   HISTOMORPHOMETRIC EVALUATIONS
AB Purpose: An inorganic xenograft (inorganic bovine bone [IBB]) and a porous alloplast (beta-tricalcium phosphate [beta-TCP]) material were compared at different healing periods in experimental bone defects in dogs. Materials and Methods: Six round defects, 5 x 4 mm, were made on the lateral bony mandibular angle in 8 dogs at different times. Two defects were randomly filled with IBB, 2 with beta-TCP, and 2 were left to blood clot. A bi-layer collagen membrane covered 1 defect of each type. Four specimens per treatment group were obtained for each treatment group at 3, 6, 12, and 24 months postoperatively. Morphometric analysis of decalcified (Donath technique) histologic slides was conducted using the measured areas of regenerated bone, grafted particles, and remaining concavity. Results: In IBB sites, complete bone healing was evident at 12 and 24 months, but grafted particles dominated the sites. In beta-TCP sites, only particle remnants remained at 12 months. At 24 months, particles had completely resorbed in both membrane-protected (MP) and uncovered (UC) defects. Data were combined for final analysis since there were no statistically significant differences within each graft material group (MP or UC). Mean bone area fraction increased from 3 to 24 months at all sites. In bone area fraction a statistically significant difference was found between 3 and 6 months in the IBB and beta-TCP groups. IBB sites also showed such significance between 6 and 12 months. A statistically significant difference was found between MP ungrafted sites (42.9%) vs IBB (24.7%) and vs the control (24.8%) at 3 months. At 6 months, beta-TCP bone area fraction (68.8%) was significantly greater than IBB (47.9%) and control (37.5%) sites. At 12 months, beta-TCP bone area fraction (79.0%) was significantly greater than the control (42.5%). At 24 months, beta-TCP bone area fraction (86.5%) was significantly greater than IBB (55.6%) sites. Mean particle area fraction of beta-TCP sites decreased gradually until complete resorption at 24 months. IBB sites showed a significant decrease only between 3 (38.7%) and 6 (29.4%) months. Discussion and Conclusion: Complete bone healing was established in all grafted defects. IBB and beta-TCP are both excellent biocompatible materials. However, at 24 months beta-TCP particles were completely resorbed, whereas IBB particles still occupied a remarkable area fraction without significant resorption beyond 6 months.
C1 Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Periodontol, Tel Aviv, Israel.
   Univ Minnesota, Sch Dent, Hard Tissue Res Lab, Minneapolis, MN 55455 USA.
   Univ Minnesota, Sch Dent, Div Oral & Maxillofacial Pathol, Minneapolis, MN 55455 USA.
   Chaim Sheba Med Ctr, Dept Oral & Maxillofacial Surg, IL-52621 Tel Hashomer, Israel.
   Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, Tel Aviv, Israel.
RP Artzi, Z (reprint author), Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Periodontol, Tel Aviv, Israel.
EM zviartzi@post.tau.ac.il
CR Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Artzi Z, 1998, J PERIODONTOL, V69, P1062, DOI 10.1902/jop.1998.69.9.1062
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Artzi Z, 2001, J PERIODONTOL, V72, P911, DOI 10.1902/jop.2001.72.7.911
   Artzi Z, 2001, INT J PERIODONT REST, V21, P395
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Artzi Z, 2001, J PERIODONTOL, V72, P152, DOI 10.1902/jop.2001.72.2.152
   BELLHOUSE DR, 1981, BIOMETRICS, V37, P303, DOI 10.2307/2530419
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BREITBART AS, 1995, PLAST RECONSTR SURG, V96, P699, DOI 10.1097/00006534-199509000-00024
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Chalkley HW, 1943, J NATL CANCER I, V4, P47
   Chanavaz M, 2000, Implant Dent, V9, P197
   Clergeau LP, 1996, J PERIODONTOL, V67, P140, DOI 10.1902/jop.1996.67.2.140
   Cong Z, 2000, J Biomed Mater Res, V52, P354, DOI 10.1002/1097-4636(200011)52:2<354::AID-JBM15>3.0.CO;2-D
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DONATH K, 1985, PATHOL RES PRACT, V179, P631, DOI 10.1016/S0344-0338(85)80209-0
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   Fukuta K, 1992, J Craniofac Surg, V3, P25, DOI 10.1097/00001665-199207000-00010
   Gao TJ, 1997, ARCH ORTHOP TRAUM SU, V116, P290, DOI 10.1007/BF00390056
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hallman M, 2002, J ORAL MAXIL SURG, V60, P277, DOI 10.1053/joms.2002.30576
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hanisch O, 1999, INT J ORAL MAX IMPL, V14, P329
   HISLOP WS, 1993, BRIT J ORAL MAX SURG, V31, P149, DOI 10.1016/0266-4356(93)90113-B
   Hossain MZ, 1996, CLEFT PALATE-CRAN J, V33, P277, DOI 10.1597/1545-1569(1996)033<0277:BROABA>2.3.CO;2
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Isaksson S, 1992, Swed Dent J Suppl, V84, P1
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P513
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   KARNOVSKY MJ, 1965, J CELL BIOL, V3, P112
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   Le Huec J C, 1997, Acta Orthop Belg, V63, P202
   Lundgren S, 1999, INT J ORAL MAX SURG, V28, P31, DOI 10.1034/j.1399-0020.1999.280108.x
   McAllister BS, 1999, INT J ORAL MAX IMPL, V14, P361
   Merten HA, 2001, J CRANIOFAC SURG, V12, P59, DOI 10.1097/00001665-200101000-00010
   Muschik M, 2001, EUR SPINE J, V10, pS178, DOI 10.1007/s005860100271
   OHNISHI H, 2000, J PERIODONTOL, V7, P341
   Ohsawa K, 2000, J BIOMED MATER RES, V52, P460, DOI 10.1002/1097-4636(20001205)52:3<460::AID-JBM3>3.3.CO;2-L
   Palti Ady, 2002, Implant Dent, V11, P73
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Porter BD, 2000, J BIOMECH ENG-T ASME, V122, P286, DOI 10.1115/1.429659
   Rasmusson L, 1999, INT J ORAL MAX SURG, V28, P224, DOI 10.1034/j.1399-0020.1999.283280315.x
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   Rosa A L, 1995, Braz Dent J, V6, P103
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Saito M, 2000, J Orthop Sci, V5, P275, DOI 10.1007/s007760050163
   Scheuhammer AM, 1999, ECOTOXICOLOGY, V8, P49, DOI 10.1023/A:1008936910823
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   SCHLEGEL AK, 2003, INT J ORAL MAXILLOF, V18, P53
   Schmitt JM, 1997, J PERIODONTOL, V68, P1043, DOI 10.1902/jop.1997.68.11.1043
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   SMILER D G, 1992, Dental Clinics of North America, V36, P151
   SPECTOR M, 1994, CLIN PLAST SURG, V21, P437
   Spector M, 1999, TISSUE ENGINEERING, P3
   Steffen T, 2001, EUR SPINE J, V10, pS132, DOI 10.1007/s005860100325
   Szabo G, 2001, INT J ORAL MAX IMPL, V16, P681
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   Tarnow DP, 2000, INT J PERIODONT REST, V20, P116
   Terheyden H, 1999, CLIN ORAL IMPLAN RES, V10, P510, DOI 10.1034/j.1600-0501.1999.100609.x
   Thaller S R, 1993, J Craniofac Surg, V4, P79, DOI 10.1097/00001665-199304000-00005
   Trisi P, 2003, INT J PERIODONT REST, V23, P69
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   YILDIRIM M, 2000, CLIN ORAL IMPLAN RES, V11, P214
   Young C, 1999, INT J ORAL MAX IMPL, V14, P72
NR 72
TC 131
Z9 141
U1 1
U2 10
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAY-JUN
PY 2004
VL 19
IS 3
BP 357
EP 368
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 828BG
UT WOS:000221946900004
PM 15214219
DA 2018-10-19
ER

PT J
AU Bayston, R
   Ashraf, W
   Bhundia, C
AF Bayston, R
   Ashraf, W
   Bhundia, C
TI Mode of action of an antimicrobial biomaterial for use in hydrocephalus
   shunts
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE hydrocephalus shunt infections; prevention; catheters
ID CEREBROSPINAL-FLUID SHUNTS; INFECTION; CATHETER; PREVENTION;
   COLONIZATION; ANTIBIOTICS; BIOFILMS; ADHESION; AGENTS
AB Objectives: Infection remains a major complication of shunting for hydrocephalus. The causative bacteria, mainly staphylococci, gain access to the shunt at operation and colonize the shunt tubing. This leads to biofilm development requiring shunt removal. As there is no clear evidence to support antibiotic prophylaxis, we have developed an impregnated antimicrobial shunt material. This study aimed to elucidate its mode of action in terms of bacterial adherence and killing kinetics.
   Methods: Plain and impregnated material, with and without plasma protein conditioning film, were exposed to Staphylococcus epidermidis. Bacterial adherence was determined by scanning electron microscopy, chemiluminescence and culture. Time taken to kill 100% of bacteria (tK(100)) was determined by serial chemiluminescence, culture and the use of differential viability microscopy.
   Results: The antimicrobial material did not reduce bacterial adherence. However, 100% of attached bacteria were killed in 48-52 h, even in the presence of a conditioning film.
   Conclusions: Impregnated antimicrobial material is likely to reduce shunt infection rates significantly without the risks and side effects of systemic antibiotics.
C1 Univ Hosp, Div Orthopaed & Accid Surg, Biomat Related Infect Grp, Nottingham NG7 2UH, England.
RP Bayston, R (reprint author), Univ Hosp, Div Orthopaed & Accid Surg, Biomat Related Infect Grp, C Floor W Block, Nottingham NG7 2UH, England.
EM roger.bayston@nottingham.ac.uk
CR ABED WT, 1994, BRIT J NEUROSURG, V8, P725, DOI 10.3109/02688699409101187
   ARCHER GL, 1983, REV INFECT DIS S3, V5, P538
   ASHBY MJ, 1994, J ANTIMICROB CHEMOTH, V33, P443, DOI 10.1093/jac/33.3.443
   BAYSTON E, 1980, Z KINDERCHIR, V31, P353
   BAYSTON R, 1989, J NEUROL NEUROSUR PS, V52, P605, DOI 10.1136/jnnp.52.5.605
   BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25
   BAYSTON R, 1974, DEV MED CHILD NEUROL, V16, P16
   Bayston R, 1997, J NEUROSURG, V87, P247, DOI 10.3171/jns.1997.87.2.0247
   BROWN EM, 1994, LANCET, V344, P1547
   Brydon HL, 1998, J NEUROL NEUROSUR PS, V64, P643, DOI 10.1136/jnnp.64.5.643
   Camboulives J, 2002, ANN FR ANESTH, V21, P84, DOI 10.1016/S0750-7658(01)00500-7
   *CODM SHURTL INC, 890227 IDE CODM SHUR
   GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865
   Govender ST, 2003, J NEUROSURG, V99, P831, DOI 10.3171/jns.2003.99.5.0831
   GUEVARA JA, 1987, J NEUROSURG, V67, P438, DOI 10.3171/jns.1987.67.3.0438
   HAMPL J, 1995, ACTA NEUROCHIR, V133, P147, DOI 10.1007/BF01420065
   Lundberg F, 1997, J MED MICROBIOL, V46, P285, DOI 10.1099/00222615-46-4-285
   MCCLONE DG, 1982, PEDIATRICS, V70, P338
   NERNST W, 1904, Z PHYS CHEM, V47, P52
   O'Kane MC, 1997, EUR J PEDIATR SURG, V7, P56
   POPLE IK, 1992, J NEUROSURG, V77, P29, DOI 10.3171/jns.1992.77.1.0029
   RAAHAVE D, 1976, ACTA CHIRURG SCANDIN, V140, P585
   RENIER D, 1988, CHILD NERV SYST, V4, P213, DOI 10.1007/BF00270917
   Schierholz JM, 1998, ZBL BAKT-INT J MED M, V288, P527
   Svensson E, 1997, J ANTIMICROB CHEMOTH, V39, P817, DOI 10.1093/jac/39.6.817
NR 25
TC 54
Z9 55
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD MAY
PY 2004
VL 53
IS 5
BP 778
EP 782
DI 10.1093/jac/dkh183
PG 5
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 816XY
UT WOS:000221143800015
PM 15056650
OA Bronze
DA 2018-10-19
ER

PT J
AU Lin, CY
   Kikuchi, N
   Hollister, SJ
AF Lin, CY
   Kikuchi, N
   Hollister, SJ
TI A novel method for biomaterial scaffold internal architecture design to
   match bone elastic properties with desired porosity
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE scaffold design; topology optimizatiom; material microstructure;
   homogenization theory; tissue engineering
ID TRABECULAR BONE; TOPOLOGY OPTIMIZATION; FABRICATION
AB An often-proposed tissue engineering design hypothesis is that the scaffold should provide a biomimetic mechanical environment for initial function and appropriate remodeling of regenerating tissue while concurrently providing sufficient porosity for cell migration and cell/gene delivery. To provide a systematic study of this hypothesis, the ability to precisely design and manufacture biomaterial scaffolds is needed. Traditional methods for scaffold design and fabrication cannot provide the control over scaffold architecture design to achieve specified properties within fixed limits on porosity. The purpose of this paper was to develop a general design optimization scheme for 3D internal scaffold architecture to match desired elastic properties and porosity simultaneously, by introducing the homogenization-based topology optimization algorithm (also known as general layout optimization). With an initial target for bone tissue engineering, we demonstrate that the method can produce highly porous structures that match human trabecular bone anisotropic stiffness using accepted biomaterials. In addition, we show that anisotropic bone stiffness may be matched with scaffolds of widely different porosity. Finally. we also demonstrate that prototypes of the designed structures can be fabricated using solid free-form fabrication (SFF) techniques. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Michigan, Dept Biomed Engn Surg & Mech Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Biomed Engn Surg & Mech Engn, Rm 3414,GG Brown Bldg,2520 Hayward St, Ann Arbor, MI 48109 USA.
EM scottho@umich.edu
FU NIDCR NIH HHS [DE 13608]
CR BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2
   Bendsoe MP, 1989, STRUCTURAL OPTIMIZAT, V1, P193, DOI [10.1007/bf01650949, DOI 10.1007/BF01650949]
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Bruder S. P., 1998, T 44 ANN M ORTH RES, P147
   Chen B.C., 2000, THESIS U MICHIGAN
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0
   HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7
   HOLLISTER SJ, 1994, J BIOMECH, V27, P433, DOI 10.1016/0021-9290(94)90019-1
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   HUTMACHER DW, 2000, BIOMATERIALS, V21, P2925
   LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038
   LIN CY, 2003, P 29 ANN M BIOM REN
   LIN CY, 2003, P 5 WORLD C STRUCT M
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MILTON GW, 1988, J MECH PHYS SOLIDS, V36, P597, DOI 10.1016/0022-5096(88)90001-4
   Neves MM, 2002, INT J NUMER METH ENG, V54, P809, DOI 10.1002/nme.449
   NISHIWAKI S, 1998, THESIS U MICHIGAN AN
   Rozvany GIN, 2001, STRUCT MULTIDISCIP O, V21, P90, DOI 10.1007/s001580050174
   Sanchez-Palencia E, 1987, HOMOGENIZATION TECHN
   SIGMUND O, 1994, INT J SOLIDS STRUCT, V31, P2313, DOI 10.1016/0020-7683(94)90154-6
   SIGMUND O, 1995, MECH MATER, V20, P351, DOI 10.1016/0167-6636(94)00069-7
   Sigmund O, 2000, PHILOS T ROY SOC A, V358, P211, DOI 10.1098/rsta.2000.0528
   SVANBERG K, 1987, INT J NUMER METH ENG, V24, P359, DOI 10.1002/nme.1620240207
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   TURNER CH, 1990, J BIOMECH, V23, P549, DOI 10.1016/0021-9290(90)90048-8
   Van Cleynenbreugel T, 2002, J MATER SCI-MATER M, V13, P1245, DOI 10.1023/A:1021183230549
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zysset PK, 1998, J BIOMECH ENG-T ASME, V120, P640, DOI 10.1115/1.2834756
NR 31
TC 206
Z9 217
U1 4
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
J9 J BIOMECH
JI J. Biomech.
PD MAY
PY 2004
VL 37
IS 5
BP 623
EP 636
DI 10.1016/j.jbiomech.2003.09.029
PG 14
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 811OQ
UT WOS:000220781600004
PM 15046991
DA 2018-10-19
ER

PT J
AU Moore, DC
   Pedrozo, HA
   Crisco, JJ
   Ehrlich, MG
AF Moore, DC
   Pedrozo, HA
   Crisco, JJ
   Ehrlich, MG
TI Preformed grafts of porcine small intestine submucosa (SIS) for bridging
   segmental bone defects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE intestinal submucosa; bone healing; rat; tissue engineering;
   extracellular matrix; segmental defect
ID LONG BONES; REGENERATION; INDUCTION; MODEL; BIOMATERIAL; MARROW; RABBIT;
   MATRIX; REPAIR; DOGS
AB Previous studies suggest that fresh, morselized porcine small intestine submucosa (SIS) may have promise in the treatment of large bone defects. This study evaluated the bone regenerative potential of preformed tubular SIS grafts, designed to provide a scaffold for regeneration of diaphyseal bone. Critical length segmental defects in the femurs of male rats were either left unfilled (n = 11) or filled with morselized cancellous bone (n = 12), or spanned with intramedullary tubes (n = 12) or periosteal sleeves (n = 12) fabricated from SIS. All of the animals were euthanized 12 weeks postoperatively. Healing was assessed with biweekly radiographs, routine histology, and mechanical testing. Copious new bone formed in the defects of all of the animals treated with cancellous bone; 10 of the 12 animals in that group had healed their defects. In contrast, no new bone was formed in the defects left unfilled or treated with SIS; only fibrous tissue was found. In both of the SIS-treated groups, the SIS persisted at twelve weeks. The cellular response to the SIS involved a mild mononuclear infiltrate in the loose or delaminated superficial layers of the tubes and sleeves, with few cells in the deeper layers. The results of this study cast doubt on the ability of SIS to support or stimulate growth of bone across a critical length segmental bone defect. Additional work will be required to determine whether our results reflect the protocols used to prepare and fabricate the SIS grafts used in the study or the inherent inability of SIS to support new bone growth. (C) 2004 Wiley Periodicals, Inc.
C1 Rhode Isl Hosp, Brown Med Sch, Dept Orthopaed, Orthopaed Res Labs, Providence, RI 02903 USA.
RP Moore, DC (reprint author), Rhode Isl Hosp, Brown Med Sch, Dept Orthopaed, Orthopaed Res Labs, CORO W,Suite 404,1 Hoppin St, Providence, RI 02903 USA.
EM douglas-moore@brown.edu
CR Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Baltoyannis G, 2000, INT ANGIOL, V19, P280
   BLUHM AE, 1995, J ORAL MAXIL SURG, V53, P163, DOI 10.1016/0278-2391(95)90395-X
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   Feighan JE, 1995, J ORTHOP RES, V13, P881, DOI 10.1002/jor.1100130612
   GEBHART M, 1991, Acta Orthopaedica Belgica, V57, P130
   GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   JAFFE KA, 1991, SOUTHERN MED J, V84, P975, DOI 10.1097/00007611-199108000-00010
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   KROPP BP, 1995, ADV EXP MED BIOL, V385, P229
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Marshall SE, 2000, J INVEST SURG, V13, P333
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   NIELSEN FF, 1992, ACTA ORTHOP SCAND, V63, P66, DOI 10.3109/17453679209154853
   NYMAN R, 1995, ACTA ORTHOP SCAND, V66, P169, DOI 10.3109/17453679508995515
   Owen TJ, 1997, J SURG RES, V71, P179, DOI 10.1006/jsre.1997.5148
   PANJABI MM, 1979, ACTA ORTHOP SCAND, V50, P653, DOI 10.3109/17453677908991288
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   SARMIENTO A, 1977, J BONE JOINT SURG AM, V59, P369, DOI 10.2106/00004623-197759030-00014
   STEVENSON S, 1994, J BONE JOINT SURG AM, V76A, P1676, DOI 10.2106/00004623-199411000-00011
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   VOYTIKHARBIN SL, 1996, T 1 SIS S, P31
   WANG CC, 1992, PROTEIN SCI, V1, P1206, DOI 10.1002/pro.5560010913
   Wang H L, 1998, Dent Clin North Am, V42, P505
   Wang XG, 1998, J VISUAL COMP ANIMAT, V9, P33, DOI 10.1002/(SICI)1099-1778(199801/03)9:1<33::AID-VIS174>3.0.CO;2-Q
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zellin G, 1997, SCAND J PLAST RECONS, V31, P97, DOI 10.3109/02844319709085475
   Zellin G, 1998, Swed Dent J Suppl, V129, P7
NR 37
TC 24
Z9 27
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY 1
PY 2004
VL 69A
IS 2
BP 259
EP 266
DI 10.1002/jbm.a.20123
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 812ST
UT WOS:000220859900007
PM 15057998
DA 2018-10-19
ER

PT J
AU Jansen, K
   Meek, MF
   van der Werff, JFA
   van Wachem, PB
   van Luyn, MJA
AF Jansen, K
   Meek, MF
   van der Werff, JFA
   van Wachem, PB
   van Luyn, MJA
TI Long-term regeneration of the rat sciatic nerve through a biodegradable
   poly(DL-lactide-epsilon-caprolactone) nerve guide: Tissue reactions with
   focus on collagen III/IV reformation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(DL-lactide-epsilon-caprolactone) [poly(DLLA-epsilon-CL)] nerve
   guide; long-term nerve regeneration; collagen Ill/IV distribution;
   foreign body reaction
ID EXTRACELLULAR-MATRIX; PERIPHERAL-NERVE; RECONSTRUCTION; COMPONENTS
AB Long-term studies on nerve-guide regeneration are scarce. Therefore, in rats, long-term (16 months) sciatic nerve regeneration through poly(DL-lactide-epsilon-caprolactone) [poly(DLLA-epsilon-CL)] nerve guides was studied and compared with the nonoperated control side. Poly(DLLA-epsilon-CL) degradation and possible long-term foreign body reaction against poly(DLLA-epsilon-CL) nerve guides, as well as the distribution of both collagen type III and IV were studied. In vivo poly(DLLA-epsilon-CL) studies have been performed before but not for such long time points; also, a detailed analysis of collagen III/IV has not been presented before. The results demonstrate that biodegradable poly(DLLA-epsilon-CL) nerve guides yield good nerve regeneration and collagen III/IV deposition relative to the anatomy of the control side. Regenerated nerve showed almost similar collagen type III/IV distribution patterns as compared with the nonoperated control side, although the delineation of matrix was clearer in the control side. The relative amount of collagen III and IV immunostaining in nerve cross-sections did not, however, differ between the control nerve tissue and the operated side after 16 months. After 16 months of implantation, however, some very small fragments of biomaterial could still be found on the edge of the epineurium of the regenerated nerve, indicating remnants of a secondary foreign body reaction. The biomaterial fragments and foreign body reaction did not influence the nerve regeneration process after 16 months. Biodegradable poly(DLLA-epsilon-CL) nerve guides are useful for long-term bridging of short peripheral nerve gaps. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Groningen Hosp, Dept Plast Surg, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, NL-9713 GZ Groningen, Netherlands.
RP Jansen, K (reprint author), Univ Groningen Hosp, Dept Plast Surg, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM k.jansen@med.rug.nl
CR BANNERMAN PGC, 1986, J NEUROCYTOL, V15, P733, DOI 10.1007/BF01625191
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   DUCKER TB, 1968, J NEUROSURG, V28, P582, DOI 10.3171/jns.1968.28.6.0582
   Gorgulu A, 1998, ACTA NEUROCHIR, V140, P1303, DOI 10.1007/s007010050254
   GRIJPMA DW, 1991, POLYM BULL, V25, P327, DOI 10.1007/BF00316902
   LONGO FM, 1984, BRAIN RES, V309, P105, DOI 10.1016/0006-8993(84)91014-X
   LORIMIER P, 1992, J HISTOCHEM CYTOCHEM, V40, P859, DOI 10.1177/40.6.1588030
   LOW SQ, 1992, J DERMATOL SURG ONC, V18, P981, DOI 10.1111/j.1524-4725.1992.tb02770.x
   LUNDBORG G, 1994, J RECONSTR MICROSURG, V10, P345, DOI 10.1055/s-2007-1006604
   MACKINNON SE, 1988, SURG PERIPHERAL NERV
   MARAGH H, 1990, J RECONSTR MICROSURG, V6, P331, DOI 10.1055/s-2007-1006838
   Meek MF, 1999, MICROSURG, V19, P381, DOI 10.1002/(SICI)1098-2752(1999)19:8<381::AID-MICR6>3.0.CO;2-7
   MEEK MF, 2001, THESIS U GRONINGEN N
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Nath RK, 1997, J NEUROSURG, V86, P866, DOI 10.3171/jns.1997.86.5.0866
   Nicoli Aldini N., 1996, Biomaterials, V17, P959
   PEREGO G, 1994, BIOMATERIALS, V15, P189, DOI 10.1016/0142-9612(94)90066-3
   Petersen J, 1996, NEUROSURGERY, V38, P976, DOI 10.1097/00006123-199605000-00025
   RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155
   Siironen J, 1996, J Peripher Nerv Syst, V1, P209
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
NR 22
TC 26
Z9 27
U1 1
U2 6
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY 1
PY 2004
VL 69A
IS 2
BP 334
EP 341
DI 10.1002/jbm.a.30004
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 812ST
UT WOS:000220859900015
PM 15058006
DA 2018-10-19
ER

PT J
AU Rosso, F
   Giordano, A
   Barbarisi, M
   Barbarisi, A
AF Rosso, F
   Giordano, A
   Barbarisi, M
   Barbarisi, A
TI From cell-ECM interactions to tissue engineering
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Review
ID CAPILLARY ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; GROWTH-FACTOR;
   IN-VITRO; EGF RECEPTOR; INTEGRIN; ADHESION; BINDING; KINASE; FIBRONECTIN
AB The extracellular matrix (ECM) consists of a complex mixture of structural and functional macromolecules and serves an important role in tissue and organ morphogenesis and in the maintenance of cell and tissue structure and function. The great diversity observed in the morphology and composition of the ECM contributes enormously to the properties and function of each organ and tissue. The ECM is also important during growth, development, and wound repair: its own dynamic composition acts as a reservoir for soluble signaling molecules and mediates signals from other sources to migrating, proliferating, and differentiating cells. Approaches to tissue engineering center on the need to provide signals to cell populations to promote cell proliferation and differentiation. These "external signals" are generated from growth factors, cell-ECM, and cell-cell interactions, as well as from physical-chemical and mechanical stimuli. This review considers recent advances in knowledge about cell-ECM interactions. A description of the main ECM molecules and cellular receptors with particular care to integrins and their role in stimulation of specific types of signal transduction pathways is also explained. The general principles of biomaterial design for tissue engineering are considered, with same examples. J. Cell. Physiol. 199: 174-180, 2004. (C) 2003 Wiley-Liss, Inc.
C1 Univ Naples 2, Dept Anaesthesiol Surg & Emergency Sci, Div Gen Surg & Appl Biotechnol 9, I-80138 Naples, Italy.
RP Rosso, F (reprint author), Univ Naples 2, Dept Anaesthesiol Surg & Emergency Sci, Div Gen Surg & Appl Biotechnol 9, Piazza Miraglia 1, I-80138 Naples, Italy.
EM francesco.rosso@unina2.it
OI Barbarisi, Alfonso/0000-0003-2357-1132
CR Abatangelo GBP, 2001, INTEGRATED BIOMATERI, P885
   ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Aplin AE, 2002, J CELL SCI, V115, P2781
   Aplin AE, 1999, J CELL SCI, V112, P695
   Bagutti C, 2001, DEV BIOL, V231, P321, DOI 10.1006/dbio.2000.0149
   BARRY ELR, 1988, J BIOL CHEM, V263, P10464
   Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9
   Bouhadir KH, 1998, ANN NY ACAD SCI, V842, P188, DOI 10.1111/j.1749-6632.1998.tb09647.x
   CARSONS S, 1988, ANN RHEUM DIS, V47, P797, DOI 10.1136/ard.47.10.797
   Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4
   Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098
   Couchman JR, 2001, INT REV CYTOL, V207, P113
   DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539
   DEUEL TF, 1997, PRINCIPLES TISSUE EN
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911
   Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498
   Giancotti FG, 2003, DEV CELL, V4, P149, DOI 10.1016/S1534-5807(03)00034-0
   GIUSTI P, 1994, 9401468 NWO
   GORDON MY, 1988, BRIT J HAEMATOL, V70, P1, DOI 10.1111/j.1365-2141.1988.tb02425.x
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X
   Huhtala MT, 1999, STRUCT FOLD DES, V7, P699, DOI 10.1016/S0969-2126(99)80091-4
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   KEELY PJ, 1995, J CELL SCI, V108, P595
   Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106
   Kim BS, 1998, J BIOMED MATER RES, V41, P322, DOI 10.1002/(SICI)1097-4636(199808)41:2<322::AID-JBM18>3.0.CO;2-M
   Kosher RA, 1998, MICROSC RES TECHNIQ, V43, P123, DOI 10.1002/(SICI)1097-0029(19981015)43:2<123::AID-JEMT5>3.0.CO;2-G
   Lee YJ, 1999, J BIOL CHEM, V274, P22401, DOI 10.1074/jbc.274.32.22401
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   MOSCATELLI D, 1988, J CELL BIOL, V107, P753, DOI 10.1083/jcb.107.2.753
   Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176
   Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609
   Orgill DP, 1998, J BIOMED MATER RES, V39, P531, DOI 10.1002/(SICI)1097-4636(19980315)39:4<531::AID-JBM4>3.3.CO;2-P
   ORTIZ A, 1995, CLIN EXP IMMUNOL, V101, P334
   Park KH, 2002, BIOSCI BIOTECH BIOCH, V66, P1473, DOI 10.1271/bbb.66.1473
   PAULSSON M, 1988, EUR J BIOCHEM, V177, P477, DOI 10.1111/j.1432-1033.1988.tb14397.x
   Prasad N, 2002, J CELL SCI, V115, P3807, DOI 10.1242/jcs.00070
   PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3
   RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369
   SAGE EH, 1991, J BIOL CHEM, V266, P14831
   Schaffert CS, 2001, ALCOHOL CLIN EXP RES, V25, P1749, DOI 10.1097/00000374-200112000-00010
   Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145
   SCHLAEPFER DD, 1994, NATURE, V372, P786
   Schmugge M, 2003, TRANSFUS APHER SCI, V28, P269, DOI 10.1016/S1473-0502(03)00046-6
   SCHWARTZ MA, 1992, P NATL ACAD SCI USA, V89, P6138, DOI 10.1073/pnas.89.13.6138
   Schwartz MA, 1999, CURR OPIN CELL BIOL, V11, P197, DOI 10.1016/S0955-0674(99)80026-X
   STROKER AW, 1990, CURR OPIN CELL BIOL, V2, P864
   Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103
   Taipale J, 1997, FASEB J, V11, P51
   Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200
   Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X
   TURKER RW, 1990, CELL CALCIUM, V11, P201
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Vainio S, 1997, CELL, V90, P975, DOI 10.1016/S0092-8674(00)80363-3
   VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156
   WATT FM, 1993, J CELL SCI, V106, P175
   WOOD SA, 1986, J BIOMED MATER RES, V20, P315, DOI 10.1002/jbm.820200305
   Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
   Zhang H, 2003, OSTEOARTHR CARTILAGE, V11, P309, DOI 10.1016/S1063-4584(03)00032-3
NR 67
TC 322
Z9 332
U1 1
U2 57
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD MAY
PY 2004
VL 199
IS 2
BP 174
EP 180
DI 10.1002/jcp.10471
PG 7
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 808OC
UT WOS:000220577400002
PM 15039999
DA 2018-10-19
ER

PT J
AU Scabbia, A
   Trombelli, L
AF Scabbia, A
   Trombelli, L
TI A comparative study on the use of a HA/collagen/chondroitin sulphate
   biomaterial (Biostite (R)) and a bovine-derived HA xenograft (Bio-Oss
   (R)) in the treatment of deep intra-osseous defects
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE bone substitutes; collagen Type I; grafts; hydroxyapatites;
   intra-osseous defects; periodontal diseases; periodontal regeneration;
   periodontal therapy; proteochondroitin sulfates; surgery; therapy
ID PERIODONTAL OSSEOUS DEFECTS; PAPILLA PRESERVATION TECHNIQUE; COLLAGEN
   COMPLEX IMPLANTS; ENAMEL MATRIX PROTEINS; BIO-OSS; INTRABONY DEFECTS;
   BONE REGENERATION; HISTOLOGIC EVALUATION; CHONDROITIN-SULFATE; SURGICAL
   APPROACH
AB Objectives: This parallel-group, randomized, clinical trial was designed to evaluate the clinical outcome of deep intra-osseous defects following reconstructive surgery with the use of a synthetic hydroxyapatite/equine Type I collagen/chondroitin sulphate biomaterial (Biostite(R)), as compared to a bovine-derived hydroxyapatite xenograft (Bio-Oss(R)).
   Material and methods: Twenty-four systemically healthy subjects with moderate to advanced periodontitis, 11 females and 13 males, aged 30-64 years, seven smokers, were selected. Patients presented with one interproximal deep intra-osseous defect (intra-osseous componentgreater than or equal to4 mm) as clinically and radiographically evaluated. Immediately before surgery and 12 months after surgery, pocket probing depth (PPD), clinical attachment level (CAL) and radiographic depth of the defect (DEPTH) were evaluated.
   Results: Thirteen defects were treated with Biostite(R) (test) and 11 defects with Bio-Oss(R) (control). In the test group, PPD amounted to 7.8+/-1.3 mm before surgery, and decreased significantly to 3.6+/-1.6 mm 12 months following surgery, while in the control group PPD significantly decreased from 7.5+/-2.0 mm pre-surgery to 3.1+/-1.0 mm post-surgery. At 1 year, CAL gain and DEPTH gain were 2.9+/-1.9 and 2.5+/-1.4 mm, respectively, in the test group, and 4.0+/-2.4 mm and 3.1+/-1.8 mm, respectively, in the control group. No statistically significant differences for PPD reduction, CAL gain and DEPTH gain were detected between the groups.
   Conclusions: The results of the present study indicate that both Biostite(R) and Bio-Oss(R) grafting biomaterials have determined a clinically and statistically significant improvement in terms of CAL gain, PPD reduction and radiographic DEPTH gain when used for the treatment of deep intra-osseous defects.
C1 Univ Ferrara, Dipartimento Discipline Medicochirurg Comunicaz &, Res Ctr Study Periodontal Dis, I-44100 Ferrara, Italy.
RP Scabbia, A (reprint author), Univ Ferrara, Dipartimento Discipline Medicochirurg Comunicaz &, Res Ctr Study Periodontal Dis, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM l.trombelli@unife.it
RI Trombelli, Leonardo/I-4671-2015
OI Trombelli, Leonardo/0000-0002-1147-2199
CR Arrocha R, 1968, J PERIODONTOL, V39, P40
   Artzi Z, 1998, J PERIODONTOL, V69, P1062, DOI 10.1902/jop.1998.69.9.1062
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9
   Benque E, 1997, J CLIN PERIODONTOL, V24, P550, DOI 10.1111/j.1600-051X.1997.tb00228.x
   BENQUE EP, 1985, J BIOL BUCCALE, V13, P271
   BENQUE EP, 1992, J PARODONTOL, V11, P67
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BLUMENTHAL N, 1986, J PERIODONTOL, V57, P84, DOI 10.1902/jop.1986.57.2.84
   BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   BRUNEL G, 1992, J PARODONTOL, V11, P419
   CALLAN DP, 1993, J PERIODONTOL, V64, P575, DOI 10.1902/jop.1993.64.6.575
   Camargo PM, 2000, J CLIN PERIODONTOL, V27, P889, DOI 10.1034/j.1600-051x.2000.027012889.x
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   Clergeau LP, 1996, J PERIODONTOL, V67, P140, DOI 10.1902/jop.1996.67.2.140
   Cortellini P, 1999, INT J PERIODONT REST, V19, P589
   CORTELLINI P, 1995, J PERIODONTOL, V66, P261, DOI 10.1902/jop.1995.66.4.261
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P99
   DEPUTTER C, 1983, J PROSTHET DENT, V49, P87, DOI 10.1016/0022-3913(83)90246-9
   DOCHERTY R, 1989, J CELL SCI, V92, P263
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hutchens L H Jr, 1999, Compend Contin Educ Dent, V20, P365
   JARCHO M, 1977, J BIOENG, V1, P79
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Kurioka Kazuhito, 1999, Kobe Journal of Medical Sciences, V45, P149
   Lekovic V, 2000, J PERIODONTOL, V71, P1110, DOI 10.1902/jop.2000.71.7.1110
   Mellonig JT, 2000, INT J PERIODONT REST, V20, P19
   MINABE M, 1988, J PERIODONTOL, V59, P671, DOI 10.1902/jop.1988.59.10.671
   NIELSEN IM, 1981, J PERIODONTOL, V52, P723, DOI 10.1902/jop.1981.52.12.723
   NIELSEN IM, 1980, J PERIODONTAL RES, V15, P328, DOI 10.1111/j.1600-0765.1980.tb00288.x
   Ogiso M, 1998, J LONG-TERM EFF MED, V8, P193
   OLDER LB, 1967, J PERIODONTOL, V38, P539, DOI 10.1902/jop.1967.38.6_part1.539
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   Paolantonio M, 2001, INT J PERIODONT REST, V21, P505
   PAPAPANOU PN, 1991, J CLIN PERIODONTOL, V18, P317, DOI 10.1111/j.1600-051X.1991.tb00435.x
   Parodi R, 1996, INT J PERIODONT REST, V16, P175
   PEETZ M, 1997, OSSEOUS RECONSTRUCTI, P87
   PENAUD J, 1992, J PARADONTOL, V11, P45
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Pietruska MD, 2001, EUR J ORAL SCI, V109, P178, DOI 10.1034/j.1600-0722.2001.00007.x
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
   Santarelli G, 1996, INT J PERIODONT REST, V16, P69
   SCABBIA A, 2003, IMPLANTOLOGIA ORALE, V6, P9
   Scheyer ET, 2002, J PERIODONTOL, V73, P423, DOI 10.1902/jop.2002.73.4.423
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   SCOPP IW, 1966, J PERIODONTOL, V37, P400, DOI 10.1902/jop.1966.37.5.400
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   SPECTOR M, 1994, CLIN PLAST SURG, V21, P437
   SUGAYA A, 1989, J PERIODONTAL RES, V24, P284, DOI 10.1111/j.1600-0765.1989.tb01795.x
   TAKEI HH, 1985, J PERIODONTOL, V56, P204, DOI 10.1902/jop.1985.56.4.204
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P433, DOI 10.1034/j.1600-051X.2002.290508.x
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Velasquez-Plata D, 2002, J PERIODONTOL, V73, P433, DOI 10.1902/jop.2002.73.4.433
   YAFFE A, 1984, J PERIODONTOL, V55, P623, DOI 10.1902/jop.1984.55.11.623
   Zitzmann NU, 2001, INT J PERIODONT REST, V21, P289
   ZITZMANN NU, 1997, INT J ORAL MAXILLOF, V12, P100
NR 64
TC 49
Z9 51
U1 0
U2 12
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD MAY
PY 2004
VL 31
IS 5
BP 348
EP 355
DI 10.1111/j.1600-051X.2004.00483.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 812KX
UT WOS:000220839500004
PM 15086616
DA 2018-10-19
ER

PT J
AU DiMasi, E
   Sarikaya, M
AF DiMasi, E
   Sarikaya, M
TI Synchrotron x-ray microbeam diffraction from abalone shell
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID FLAT PEARLS; NACRE; BIOFABRICATION; ORIENTATION; GROWTH
AB Microstructured biomaterials such as mollusk shells receive much attention at present, due to the promise that advanced materials can be designed and synthesized with biomimetic techniques that take advantage of self-assembly and aqueous, ambient processing conditions. A satisfactory understanding of this process requires characterization of the microstructure not only in the mature biomaterial, but at the growth fronts where the control over crystal morphology and orientation is enacted. In this paper, we present synchrotron microbeam x-ray diffraction (XRD) and electron microscopy observations near the nacre-prismatic interface of red abalone shell. The relative orientations of calcite and aragonite grains exhibit some differences from the idealizations reported previously. Long calcite grains impinge the nacre-prismatic boundary at 45degrees angles, suggestive of nucleation on (104) planes followed by growth along the c axis. In the region within 100 mum of the boundary, calcite and aragonite crystals lose their bulk orientational order, but we found no evidence for qualitative changes in long-range order such as ideal powder texture or an amorphous structure factor. XRD rocking curves determined the mosaic of calcite crystals in the prismatic region to be no broader than the 0.3degrees resolution limit of the beamline's capillary optics, comparable to what can be measured on geological calcite single crystals.
C1 Brookhaven Natl Lab, Dept Phys, Upton, NY 11975 USA.
   Univ Washington, Seattle, WA 98195 USA.
RP DiMasi, E (reprint author), Brookhaven Natl Lab, Dept Phys, Upton, NY 11975 USA.
EM dimasi@bnl.gov
CR Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Feng QL, 2000, MAT SCI ENG C-BIO S, V11, P19, DOI 10.1016/S0928-4931(00)00138-7
   FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0
   Graham T, 2000, MAT SCI ENG C-BIO S, V11, P145, DOI 10.1016/S0928-4931(00)00202-2
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   MANNE S, 1994, P ROY SOC B-BIOL SCI, V256, P17, DOI 10.1098/rspb.1994.0043
   Noyan IC, 1999, REV SCI INSTRUM, V70, P1300, DOI 10.1063/1.1149588
   SARIKAYA M, 1992, BIOMIMETICS, P34
   SARIKAYA M, 1992, NACRE ABALONE SHELL, P1
   Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i
   Zaremba CM, 1996, CHEM MATER, V8, P679, DOI 10.1021/cm9503285
   Zolotoyabko E, 2002, J APPL CRYSTALLOGR, V35, P594, DOI 10.1107/S0021889802011160
NR 12
TC 44
Z9 48
U1 0
U2 12
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD MAY
PY 2004
VL 19
IS 5
BP 1471
EP 1476
DI 10.1557/JMR.2004.0196
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 833DL
UT WOS:000222316500026
DA 2018-10-19
ER

PT J
AU Flores, MS
   Ciapetti, G
   Gonzalez-Carrasco, JL
   Montealegre, MA
   Multigner, M
   Pagani, S
   Rivero, G
AF Flores, MS
   Ciapetti, G
   Gonzalez-Carrasco, JL
   Montealegre, MA
   Multigner, M
   Pagani, S
   Rivero, G
TI Evaluation of magnetic behaviour and in vitro biocompatibility of
   ferritic PM2000 alloy
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CORROSION BEHAVIOR; OVERDENTURES; SUPERALLOY; RETENTION; IMPLANTS;
   MA-956
AB PM2000 is a ferritic alloy obtained by powder metallurgy and is being investigated for potential applications as a biomaterial. This work aimed to assess the biological compatibility and to determine the influence of the processing route and further recrystallisation treatment on the magnetic behaviour. The magnetic behaviour has been analysed as a function of the hysteresis loop obtained by using an inductive method. The biocompatibility has been tested using human osteoblast-like cells seeded onto discs of PM2000. The ability of cells, on its surface, to attach, grow, and produce alkaline phosphatase (ALP) was determined. It is shown that PM2000 is a soft magnetic material irrespective of its material condition, its remanent magnetisation being very low (up to about 3% for the recrystallised swaged material). Fields close to 200 Oe are required to saturate the material. The saturation magnetisation is about 135 emu g(-1). In vitro tests indicate that cells are able to attach and grow onto its surface, and produce ALP, a specific marker of cells with bone-forming activity. In this respect, PM2000 holds promise as a suitable substrate for bone integration. These properties could make PM2000 a useful candidate for the preparation of medical devices where biocompatible and soft magnetic materials are sought. Applications for dental magnetic attachments could be envisaged. (C) 2004 Kluwer Academic Publishers.
C1 CSIC, Ctr Nacl Invest Met, CENIM, Madrid, Spain.
   UCM, CSIC, RENFE, Inst Magnetismo Aplicado,Lab Salvador Velayos, Madrid, Spain.
   Ist Ortoped Rizzoli, Lab Fisiopatol Impianti Ortoped, Bologna, Italy.
RP Gonzalez-Carrasco, JL (reprint author), CSIC, Ctr Nacl Invest Met, CENIM, Madrid, Spain.
EM jlg@cenim.csic.es
RI Gonzalez Carrasco, Jose Luis/A-7971-2008; Multigner, Marta/H-5210-2015
OI Multigner, Marta/0000-0002-1584-0163; Ciapetti,
   Gabriela/0000-0001-6740-0357; Gonzalez-Carrasco, Jose
   Luis/0000-0003-2004-4505
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   CHAO J, 1998, MAT ADV POWER ENG 2, V5, P827
   CIAPETTI G, UNPUB
   CIAPETTI G, 2002, P P44 17 EUR C BIOM
   CULLITY BD, 1972, INTRO MAGNETIC MAT, P319
   ESCUDERO ML, 1994, BIOMATERIALS, V15, P1175, DOI 10.1016/0142-9612(94)90239-9
   Garcia-Alonso MC, 2001, J MATER SCI-MATER M, V12, P589, DOI 10.1023/A:1011281425321
   GILLINGS BRD, 1981, J PROSTHET DENT, V45, P484, DOI 10.1016/0022-3913(81)90032-9
   GILLINGS BRD, 1983, J PROSTHET DENT, V49, P607, DOI 10.1016/0022-3913(83)90382-7
   Gonzalez-Carrasco JL, 2001, OXID MET, V55, P209, DOI 10.1023/A:1010351909187
   GONZALEZCARRASC.JL, 1997, J BIOMED MATER RES, P453
   GONZALEZCARRASC.JL, 2002, P T39 17 EUR C BIOM
   *GRD, GRD1199910659
   Hendrich C, 2002, CLIN ORTHOP RELAT R, P278
   KULIK T, 1993, J APPL PHYS, V73, P6855, DOI 10.1063/1.352461
   LAAKMAN RW, 1985, RADIOLOGY, V157, P711, DOI 10.1148/radiology.157.3.4059558
   OKUNO O, 1997, 3 INT C DENT MAT SHE, P53
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   TAKADA Y, 1994, J J MAG DENT, V3, P14
   Watanabe I, 2001, DENT MATER, V17, P217, DOI 10.1016/S0109-5641(00)00072-5
NR 20
TC 10
Z9 10
U1 3
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2004
VL 15
IS 5
BP 559
EP 565
DI 10.1023/B:JMSM.0000026100.73945.85
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 817LF
UT WOS:000221178300002
PM 15386963
DA 2018-10-19
ER

PT J
AU Girija, EK
   Yokogawa, Y
   Nagata, F
AF Girija, EK
   Yokogawa, Y
   Nagata, F
TI Apatite formation on collagen fibrils in the presence of polyacrylic
   acid
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE FORMATION; HYDROXYAPATITE; BONE; INTERFACE; PROTEINS;
   MINERALIZATION; BIOMATERIAL; IMPLANTS; MODEL
AB Recently, we reported the formation of bone-like apatite on collagen fibrils by biomimetic method. Compounds containing carboxyl moieties are believed to be effective in the formation of apatite. Polyacrylic acid [-CH2CH(COOH)-](n) (PAAc) is widely used in dentistry. In the present study, the effect of PAAc in the formation of apatite from revised simulated body fluid (R-SBF) on collagen fibrils was studied. Two different experimental approaches were tried to study the effect of PAAc present in the collagen and in the R-SBF solution. In the first, collagen gel was soaked with 1 mg/ml PAAc (molecular weights 25000 and 100000) for the time intervals of 30 min and 6 h. The gels were then dried in air and incubated in R-SBF. Characterization of the precipitates formed on the collagen fibrils in gel showed that the formation of apatite was inhibited when soaked in PAAc for 6 h. In the second experiment, when PAAc (0.1 and 1.0 mg/ml) was mixed with R-SBF the microstructure of the precipitates formed on collagen fibrils was affected partially. Hence, it is confirmed that the presence of PAAc in the biomimetic environment of collagen affects the mineralization of apatite. (C) 2004 Kluwer Academic Publishers.
C1 Natl Inst Adv Ind Sci & Technol, Ceram Res Inst, Biofunct Ceram Res Grp, Moriyama Ku, Nagoya, Aichi 4638560, Japan.
RP Yokogawa, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Ceram Res Inst, Biofunct Ceram Res Grp, Moriyama Ku, 2266-98 Aza Anaga Hora, Nagoya, Aichi 4638560, Japan.
RI nagata, fukue/M-8449-2018; Easwaradas, Girija/H-3398-2012
OI nagata, fukue/0000-0002-5284-9626; 
CR BOSKEY AL, 1989, BONE MINER, V6, P111, DOI 10.1016/0169-6009(89)90044-5
   DEGROOT K, 1991, J CERAM SOC JPN, V99, P945
   DIMUZIO MT, 1978, CALC TISS RES, V25, P169, DOI 10.1007/BF02010765
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   Endo A, 1989, Connect Tissue Res, V21, P179, DOI 10.3109/03008208909050008
   Girija EK, 2002, CHEM LETT, P702, DOI 10.1246/cl.2002.702
   GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205
   GRANJA PL, 2001, J MATER SCI-MATER M, V12, P658
   Greish YE, 1999, J MATER RES, V14, P4637, DOI 10.1557/JMR.1999.0627
   HEMMERLE J, 1995, J MATER SCI-MATER M, V6, P360, DOI 10.1007/BF00120305
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   *JCPDS, 411475 JCPDS
   *JCPDS, 9432 JCPDS
   JOHNSSON M, 1991, CALCIFIED TISSUE INT, V49, P134, DOI 10.1007/BF02565136
   Kamitakahara M, 2001, BIOMATERIALS, V22, P3191, DOI 10.1016/S0142-9612(01)00071-0
   KIM HM, 2000, BIOCERAMICS, V13, P47
   MORENO EC, 1979, CALCIFIED TISSUE INT, V28, P7, DOI 10.1007/BF02441212
   MULLERMAI CM, 1995, J BIOMED MATER RES, V29, P9, DOI 10.1002/jbm.820290103
   Rhee SH, 2000, J AM CERAM SOC, V83, P2890
   SASAKI N, 1989, BIOMATERIALS, V10, P129, DOI 10.1016/0142-9612(89)90046-X
   Spanos N, 2001, J COLLOID INTERF SCI, V236, P260, DOI 10.1006/jcis.2000.7396
   SUGAYA A, 1989, J PERIODONTAL RES, V24, P284, DOI 10.1111/j.1600-0765.1989.tb01795.x
   TAGUCHI T, 1999, BIOCERAMICS, V12, P133
   TANAHASHI M, 1997, J BIOMED MATER RES, V34, P7
   Tas AC, 2001, J AM CERAM SOC, V84, P295
   VIGNOLES M, 1988, CALCIFIED TISSUE INT, V43, P33, DOI 10.1007/BF02555165
   Wilson AD, 1974, BR POLYM J, V6, P165
   Yokogawa Y, 1999, J MATER SCI LETT, V18, P367, DOI 10.1023/A:1006620431320
   Yokogawa Y, 1999, CHEM LETT, P527
NR 30
TC 33
Z9 33
U1 1
U2 17
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2004
VL 15
IS 5
BP 593
EP 599
DI 10.1023/B:JMSM.0000026101.53272.86
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 817LF
UT WOS:000221178300006
PM 15386967
DA 2018-10-19
ER

PT J
AU Barboza, EP
   Caula, AL
   Caula, FD
   de Souza, RO
   Neto, LG
   Sorensen, RG
   Li, XJ
   Wikesjo, UME
AF Barboza, EP
   Caula, AL
   Caula, FD
   de Souza, RO
   Neto, LG
   Sorensen, RG
   Li, XJ
   Wikesjo, UME
TI Effect of recombinant human bone morphogenetic protein-2 in an
   absorbable collagen sponge with space-providing biomaterials on the
   augmentation of chronic alveolar ridge defects
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE alveolar ridge augmentation; animal studies; bone matrix; bone
   regeneration; glass, biologically active; proteins, bone morphogenetic;
   proteins, recombinant
ID PERIODONTAL REGENERATION; RHBMP-2; DOGS; OSSEOINTEGRATION;
   RECONSTRUCTION; IMPLANTATION; REPAIR
AB Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) in an absorbable collagen sponge (ACS) carrier has been shown to support significant bone formation in the craniofacial skeleton. When used as an onlay, however, rhBMP-2/ACS may become compressed with limited resulting bone formation. The objective of this study was to evaluate the effect of two space-providing biomaterials, bioactive glass (BG) and demineralized/mineralized bone matrix (DMB), on rhBMP-2/ACS induced alveolar ridge augmentation.
   Methods: Bilateral alveolar ridge defects were produced in the mandible in six mongrel dogs. rhBMP-2/ACS with biomaterials was surgically implanted into contralateral defects in four animals. Treatments were alternated between jaw quadrants in consecutive animals. Two animals received rhBMP-2/ACS or sham-surgery in contralateral defects. The animals were injected with fluorescent bone labels to monitor bone formation. Clinical evaluations were made at ridge augmentation and 12 weeks post-implantation when the animals were euthanized and block biopsies collected for histopathologic evaluation.
   Results: Sham-surgery produced limited horizontal alveolar augmentation (0.1 +/- 0.6 mm). Implantation of rhBMP-2/ACS resulted in alveolar augmentation amounting to 2.2 +/- 1.8 mm. Alveolar augmentation in sites receiving rhBMP-2/ACS with DMB or BG was 2-fold greater compared to rhBMP-2/ACS alone averaging 4.4 +/- 1.3 and 4.6 +/- 1.5 mm, respectively. The DMB biomaterial appeared substituted by newly formed bone. The BG particles were observed imbedded in bone or encapsulated in dense connective tissue without associated bone metabolic activity. Fluorescent light microscopy suggested that the new bone was formed within 4 weeks.
   Conclusion: The bioglass and demineralized/mineralized bone matrix biomaterials utilized in this study in combination with rhBMP-2/ACS supported clinical and histological ridge augmentation.
C1 Univ Fed Fluminense, Rio De Janeiro, Brazil.
   Rio Janeiro State Fire Dept, Rio De Janeiro, Brazil.
   Wyeth Res, Cambridge, MA USA.
   Temple Univ, Philadelphia, PA 19122 USA.
RP Barboza, EP (reprint author), Av Pres Wilson,165,Sala 810,Ctr, BR-20030020 Rio De Janeiro, Brazil.
EM barbozae@uol.com.br
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR Barboza EP, 2000, J PERIODONTOL, V71, P488, DOI 10.1902/jop.2000.71.3.488
   BARBOZA EP, 1993, THESIS BOSTON U BOST
   Boyne PJ, 1998, BRIT J ORAL MAX SURG, V36, P84, DOI 10.1016/S0266-4356(98)90173-5
   Boyne PJ, 1996, BONE, V19, P83
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P604
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P785
   Ishibashi K, 2002, SUPERLATTICE MICROST, V31, P141, DOI 10.1006/spmi.2002.1035
   Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103
   Nevins M, 1996, Int J Periodontics Restorative Dent, V16, P8
   Niederwanger M, 1996, J Oral Implantol, V22, P210
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Sigurdsson TJ, 1997, CLIN ORAL IMPLAN RES, V8, P367, DOI 10.1034/j.1600-0501.1997.080503.x
   Sigurdsson TJ, 2001, INT J PERIODONT REST, V21, P461
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
NR 18
TC 34
Z9 35
U1 0
U2 6
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAY
PY 2004
VL 75
IS 5
BP 702
EP 708
DI 10.1902/jop.2004.75.5.702
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 822SJ
UT WOS:000221560100011
PM 15212353
DA 2018-10-19
ER

PT J
AU Lloyd-Evans, M
AF Lloyd-Evans, Meredith
TI Regulating tissue engineering
SO MATERIALS TODAY
LA English
DT Article
AB Tissue engineering is a radical new approach to the repair and replacement of damaged or diseased body tissues. Cells, often seeded into or shaped around a biomaterial matrix, are used to replace damaged or diseased tissue or stimulate repair by the body. Because it is an area of tremendous focus and achievement, there is a risk that technical developments will outstrip the capacity of existing regulatory frameworks to cope with these novel products. Australia, the USA, and Canada are somewhat ahead of Japan in establishing a feasible regulatory approach. All four are currently ahead of the European Union (EU), but individual European countries and the EU as a whole are catching up. However, for the foreseeable future, it may still be possible in certain European countries to use autologous cell therapies in hospitals and market allogeneic tissue- engineered products, especially skin replacements, without regulatory control.
C1 BioBridge Ltd, Cambridge CB1 2BX, England.
RP Lloyd-Evans, M (reprint author), BioBridge Ltd, 45 St Barnabas Rd, Cambridge CB1 2BX, England.
EM mlloydevans@biobridge.co.uk
CR [Anonymous], 2002, COM, P319
   [Anonymous], 2000, INF SEC QUAL SAF DRU
   [Anonymous], 2001, FED REGISTER, V66, P5447
   [Anonymous], 2000, COD PRACT HUM TISS B
   [Anonymous], 1999, NOT GUID SAF QA CELL
   [Anonymous], 2003, S505 MEDMARKET INT L
   [Anonymous], 2001, FED REG, V66, P1508
   LANG J, COMMUNICATION
   Lloyd-Evans L. P. M., 2003, JAPANESE APPROACH TI, P12
   Ministry of Education Culture Sports Science and Technology (Japan) (MEXT), 2001, GUID DER UT HUM EMBR
   Moore R., 2003, MED DEVICE TECHNOL, P34
   Patrick C. W., 1998, FRONTIERS TISSUE ENG
   US Food and Drug Administration, 1993, FED REGISTER, V58
   Williams D. F., 2003, JAPANESE APPROACH TI, P7
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT, P318
   Wilson A., 2003, REGULATORY REV, V6, P4
NR 16
TC 9
Z9 11
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD MAY
PY 2004
VL 7
IS 5
BP 48
EP 55
DI 10.1016/S1369-7021(04)00235-4
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA V32DJ
UT WOS:000208931600023
OA Other Gold
DA 2018-10-19
ER

PT J
AU Kobayashi, S
   Matsuzaki, A
   Nakai, K
   Okazaki, Y
AF Kobayashi, S
   Matsuzaki, A
   Nakai, K
   Okazaki, Y
TI Decomposition processes of beta phase in a Ti-15Zr-4Nb-4Ta alloy
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 10th World Titanium Conference
CY JUL, 2003
CL Hamburg, GERMANY
DE phase decomposition; titanium alloy; biomaterial; athermal omega phase;
   transmission electron microscopy
ID TI-NB ALLOYS; PERCENT-MO ALLOY; OMEGA-PHASE; TITANIUM-ALLOYS;
   CORROSION-RESISTANCE; MEDICAL IMPLANTS; MECHANICAL-PROPERTIES;
   ELECTRON-MICROSCOPY; TRANSITION-METALS; TRANSFORMATION
AB Decomposition processes of beta phase in a Ti-15Zr-4Nb-4Ta alloy during isothermal holding have been examined mainly by transmission electron microscopy. Specimens solution-treated at 1000degreesC in beta phase field were held at temperatures between 400 and 600degreesC. alpha phase lath formed in beta phase during isothermal holding at 600degreesC. After holding at 600degreesC for a short duration, remaining beta phase, untransformed beta phase into a phase at 600degreesC, was transformed into alpha' martensite during quenching into ice-brine. As increasing holding time at 600 C, remaining,B phase was transformed into alpha" or athermal omega phases during quenching. After prolonged holding at 600degreesC, remaining beta phase was not transformed during quenching. Enrichment of Nb, Ta and Zr into remaining phase occurred with increasing holding time at 600degreesC, resulting in the variation of transformation of remaining beta phase during quenching. Microstructures evolved at 400 and 500degreesC were almost same as those at 600degreesC.
C1 Ehime Univ, Dept Mat Sci & Engn, Matsuyama, Ehime 7908577, Japan.
   Natl Inst AIST, Inst Mech Syst Engn, AIST Tsukuba E, Tsukuba, Ibaraki 3058564, Japan.
RP Kobayashi, S (reprint author), Ehime Univ, Dept Mat Sci & Engn, Matsuyama, Ehime 7908577, Japan.
CR Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Aurelio G, 1999, J ALLOY COMPD, V292, P31, DOI 10.1016/S0925-8388(99)00295-9
   Aurelio G, 2000, Z METALLKD, V91, P35
   CLIFF G, 1975, J MICROSC-OXFORD, V103, P203, DOI 10.1111/j.1365-2818.1975.tb03895.x
   COOK HE, 1974, ACTA METALL MATER, V22, P239, DOI 10.1016/0001-6160(74)90014-5
   COOK HE, 1973, ACTA METALL MATER, V21, P1445, DOI 10.1016/0001-6160(73)90093-X
   Cuello GJ, 1998, Z METALLKD, V89, P823
   DEFONTAI.D, 1970, ACTA METALL MATER, V18, P275, DOI 10.1016/0001-6160(70)90035-0
   DEFONTAINE D, 1988, METALL TRANS A, V19, P169
   DEFONTAINE D, 1979, ACTA METALL, V27, P1139
   IKEDA M, 1989, J JPN I MET, V53, P664, DOI 10.2320/jinstmet1952.53.7_664
   IKEDA M, 1988, J JPN I MET, V52, P1206, DOI 10.2320/jinstmet1952.52.12_1206
   Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   Kobayashi S, 2002, MATER TRANS, V43, P2956, DOI 10.2320/matertrans.43.2956
   MASSALSKI TB, 1990, BINARY ALLOY PHASE D, P3502
   Matsumoto H, 2001, J JPN I MET, V65, P374, DOI 10.2320/jinstmet1952.65.5_374
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   MOFFAT DL, 1988, METALL TRANS A, V19, P1687, DOI 10.1007/BF02645136
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   OKAZAKI Y, 1995, J JPN I MET, V59, P1078, DOI 10.2320/jinstmet1952.59.10_1078
   OKAZAKI Y, 1995, J JPN I MET, V59, P1070, DOI 10.2320/jinstmet1952.59.10_1070
   OKAZAKI Y, 1995, J JPN I MET, V59, P108, DOI 10.2320/jinstmet1952.59.1_108
   OKAZAKI Y, 1995, J JPN I MET, V59, P1061, DOI 10.2320/jinstmet1952.59.10_1061
   OKAZAKI Y, 1995, J JPN I MET, V59, P229, DOI 10.2320/jinstmet1952.59.2_229
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   SASS SL, 1969, ACTA METALL MATER, V17, P813, DOI 10.1016/0001-6160(69)90100-X
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   SILCOCK JM, 1958, ACTA METALL MATER, V6, P481, DOI 10.1016/0001-6160(58)90111-1
   SUKEDAI E, 1992, J JPN I MET, V56, P1392, DOI 10.2320/jinstmet1952.56.12_1392
   TAKEMOTO Y, 1993, J JPN I MET, V57, P261, DOI 10.2320/jinstmet1952.57.3_261
   WILLIAMS JC, 1973, METALL TRANS, V4, P2701, DOI 10.1007/BF02644570
NR 32
TC 1
Z9 2
U1 0
U2 5
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAY
PY 2004
VL 45
IS 5
BP 1624
EP 1628
DI 10.2320/matertrans.45.1624
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 826XX
UT WOS:000221863900041
OA Bronze
DA 2018-10-19
ER

PT J
AU Ohtsu, N
   Sato, K
   Saito, K
   Hanawa, T
   Asami, K
AF Ohtsu, N
   Sato, K
   Saito, K
   Hanawa, T
   Asami, K
TI Evaluation of degradability of CaTiO3 thin films in simulated body
   fluids
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 10th World Titanium Conference
CY JUL, 2003
CL Hamburg, GERMANY
DE calcium titanate thin film; ion beam assisted deposition; degradability;
   biomaterial
ID BEAM-ASSISTED DEPOSITION; HYDROXYAPATITE COATINGS; TITANIUM
AB In vitro dissolution behaviors of CaTiO3 thin films deposited with ion beam assisted deposition (IBAD) and sputter-deposition techniques were investigated using Rutherford backscattering spectrometry (RBS) and Auger electron spectroscopy (AES). In vitro test was carried out by immersion in a simulated body fluid at 37degreesC for 5, 24, and 888 h. The dissolution of titanium ions from CaTiO3 film was almost independent of deposition techniques while that of calcium ions was dependent on those. In the specimens deposited by sputter-deposition, the dissolution rate of the calcium ions increased proportionally with time, and in the case of IBAD, it increased proportionally with the logarithm of time. Furthermore, in IBAD, the dissolution rate of the calcium ions was also intimately related with the total kinetic energy of the titanium ions when implanted. The results reveal that IBAD CaTiO3 coating film makes it possible to control dissolution rate of calcium ions from the film.
C1 Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
   Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
   Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan.
RP Ohtsu, N (reprint author), Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RI Ohtsu, Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR Asami K, 2003, SURF INTERFACE ANAL, V35, P483, DOI 10.1002/sia.1554
   Choi JM, 2000, BIOMATERIALS, V21, P469, DOI 10.1016/S0142-9612(99)00186-6
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   Cui FZ, 1997, J MATER SCI-MATER M, V8, P403, DOI 10.1023/A:1018597320022
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Luo ZS, 2000, SURF COAT TECH, V131, P192, DOI 10.1016/S0257-8972(00)00824-0
   OHTSUKA Y, 1994, SURF COAT TECH, V65, P224, DOI 10.1016/S0257-8972(94)80037-5
   Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Uchida M, 2001, J AM CERAM SOC, V84, P2041
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
NR 15
TC 14
Z9 14
U1 0
U2 3
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAY
PY 2004
VL 45
IS 5
BP 1778
EP 1781
DI 10.2320/matertrans.45.1778
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 826XX
UT WOS:000221863900066
OA Bronze
DA 2018-10-19
ER

PT J
AU Yanagisawa, N
   Li, DQ
   Ljungh, A
AF Yanagisawa, N
   Li, DQ
   Ljungh, A
TI Protein adsorption on ex vivo catheters and polymers exposed to
   peritoneal dialysis effluent
SO PERITONEAL DIALYSIS INTERNATIONAL
LA English
DT Article
DE biomaterial; protein adsorption; medical grade silicone; polyethylene;
   polyvinyl chloride; Staphylococcus epidermidis; vitronectin; von
   Willebrand factor
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; VON-WILLEBRAND-FACTOR;
   BINDING-PROTEIN; PLASMA-PROTEINS; AFFINITY-CHROMATOGRAPHY;
   PLATELET-AGGREGATION; AUREUS; SURFACE; FIBRONECTIN; ADHESION
AB Background: Deposition of proteins on surfaces of medical devices has been recognized to putatively relate to the process of regulation of biomaterial-associated complications by attachment of fibrin clots, eukaryotic cells, and microbes. The molecules adsorb to a varying extent, depending not only on the physicochemical properties of the biomaterial, but also on the composition of the host fluid.
   Objective: Adsorption of proteins on catheters exposed both ex vivo and in vitro to dialysate of patients on peritoneal dialysis (PD) was studied.
   Methods: Peritoneal dialysis effluent was collected from 5 patients with end-stage renal disease on continuous ambulatory PD. Tenckhoff catheters were obtained from 16 patients. Deposition of proteins on excised Tenckhoff catheters and tubing of different materials exposed to PD effluent in vitro was studied using (125)iodine-labeled antibodies. Adhesion of Staphylococcus aureus and Staphylococcus epidermidis strains was quantified on tubing exposed to PD effluent in vitro.
   Results: The presence of album in, transferrin, immunoglobulin G, fibrinogen, fibronectin, von Willebrand factor, vitronectin, and thrombospondin was determined at various concentrations in PD effluent. All proteins analyzed were detected on PD catheters removed from patients. The extent of protein deposition on Tenckhoff catheters exposed to PD effluent, in vitro, rapidly reached a plateau and remained constant, as it did on polyvinyl chloride and polyethylene tubing. Adhesion of staphylococci was enhanced on Tenckhoff catheters exposed to PD effluent compared to unused PD solution.
   Conclusions: The data identify surface exposed proteins that may serve as adhesion sites for microbes on peritoneal catheters indwelled in patients undergoing PD.
C1 Lund Univ, Dept Med Microbiol Dermatol & Infect, S-22362 Lund, Sweden.
RP Ljungh, A (reprint author), Lund Univ, Dept Med Microbiol Dermatol & Infect, Solvegatan 23, S-22362 Lund, Sweden.
EM asa.ljungh@mmb.lu.se
CR BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   DASGUPTA MK, 1994, AM J KIDNEY DIS, V23, P709, DOI 10.1016/S0272-6386(12)70281-0
   DULANEY JT, 1984, KIDNEY INT, V26, P253, DOI 10.1038/ki.1984.167
   Falkenback D, 2000, EUR J VASC ENDOVASC, V19, P468, DOI 10.1053/ejvs.1999.1075
   Faull RJ, 1996, NEPHROL DIAL TRANSPL, V11, P2037, DOI 10.1093/oxfordjournals.ndt.a027093
   Flessner MF, 2001, AM J PHYSIOL-GASTR L, V281, pG424
   Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7
   Giangrande A, 1993, Perit Dial Int, V13 Suppl 2, pS133
   GOLDSTEIN CS, 1986, J LEUKOCYTE BIOL, V39, P457
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Guiserix J, 1996, PERITON DIALYSIS INT, V16, P93
   Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003
   Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Kies S, 2001, INFECT IMMUN, V69, P7933, DOI 10.1128/IAI.69.12.7933-7936.2001
   Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505
   Li DQ, 2000, J MED MICROBIOL, V49, P217, DOI 10.1099/0022-1317-49-3-217
   Lundberg F, 1997, ACTA NEUROCHIR, V139, P734, DOI 10.1007/BF01420046
   Lundberg F, 1997, J MED MICROBIOL, V46, P285, DOI 10.1099/00222615-46-4-285
   Lundberg F, 1997, INFECT IMMUN, V65, P897
   Marosok R, 1996, J BIOMED MATER RES, V30, P245
   Modun B, 1999, INFECT IMMUN, V67, P1086
   Morganti M, 1996, BIOMED PHARMACOTHER, V50, P369, DOI 10.1016/S0753-3322(96)89670-3
   NIELSEN H, 1992, AM J KIDNEY DIS, V20, P372, DOI 10.1016/S0272-6386(12)70301-3
   OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x
   Ortega-Vinuesa JL, 1998, BIOMATERIALS, V19, P251, DOI 10.1016/S0142-9612(97)00206-8
   Palma M, 2001, J BIOL CHEM, V276, P31691, DOI 10.1074/jbc.M104554200
   Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpt.2002.0533
   PAULSSON M, 1993, J MED MICROBIOL, V38, P96, DOI 10.1099/00222615-38-2-96
   Pei L, 2001, J INFECT DIS, V184, P52, DOI 10.1086/321003
   POOLEWARREN LA, 1991, CLIN NEPHROL, V35, P198
   READ RR, 1989, KIDNEY INT, V35, P614, DOI 10.1038/ki.1989.30
   Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   Wolz C, 2000, MOL MICROBIOL, V36, P230, DOI 10.1046/j.1365-2958.2000.01853.x
   Yanagisawa N, 2001, J MED MICROBIOL, V50, P712, DOI 10.1099/0022-1317-50-8-712
   YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281
   YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3
   ZARDI L, 1980, J IMMUNOL METHODS, V34, P155, DOI 10.1016/0022-1759(80)90169-6
   Zelenitsky S, 2000, AM J KIDNEY DIS, V36, P1009, DOI 10.1053/ajkd.2000.19103
NR 42
TC 7
Z9 7
U1 1
U2 5
PU MULTIMED INC
PI TORONTO
PA 66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA
SN 0896-8608
J9 PERITON DIALYSIS INT
JI Perit. Dial. Int.
PD MAY-JUN
PY 2004
VL 24
IS 3
BP 264
EP 273
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA 825KS
UT WOS:000221756700008
PM 15185775
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Rodriguez, M
   Serrano, N
   San-Martin, AC
   Bujan, J
AF Bellon, JM
   Rodriguez, M
   Serrano, N
   San-Martin, AC
   Bujan, J
TI Improved biomechanical resistance using an expanded
   polytetrafluoroethylene composite-structure prosthesis
SO WORLD JOURNAL OF SURGERY
LA English
DT Article
ID ABDOMINAL-WALL DEFECTS; INCISIONAL HERNIA; MESH REPAIR; IMPLANTATION
AB We designed a composite-structure (laminar-reticular) prosthesis using expanded polytetrafluoroethylene (ePTFE) as the biomaterial in an attempt to improve the biomechanical resistance of the same biomaterial in the form of a single lamina. Defects (7 X 5 cm) were created in the abdominal wall of male white New Zealand rabbits (n = 24). The defects, which comprised all the wall layers except the skin, were then repaired with one of two types of ePTFE prosthesis. One was a latest generation laminar prosthesis (DualMesb, or Gore-Tex) and the other was a composite of in-house design (CV-4 mesh composite) made by suturing a mesh woven out of ePTFE thread to an ePTFE lamina. After sacrificing the animals at 14 or 90 days after surgery, implant specimens were subjected to morphologic analysis (light microscopy and scanning electron microscopy); and adhesion formation, neoperitoneal thickness, and biomechanical strength were evaluated. No significant differences were recorded between the two prosthesis regarding the consistency of adhesions or the area occupied by adhesions (DM 0.17 +/- 0.06; CV-4 mesh composite 0.18 +/- 0.08 cm(2)) (p > 0.05). Notably, improved tissue integration was achieved using the composite prosthesis; its reticular side became infiltrated by dense connective tissue that enveloped the mesh filaments. In contrast, the DM prosthesis became encapsulated by host tissue. The neoperitoneum induced by both prostheses was homogeneous and orderly, with a layer of typical mesothelial cells lining its inner surface. The thickness of the neoperitoneum was similar (P > 0.05) for the two implants (385.0 +/- 3.4 vs. 390 +/- 3.1 mum), although significantly higher (p < 0.05) mechanical resistance values were recorded for the composite prosthesis (26.75 &PLUSMN; 3.71 vs. 14.11 &PLUSMN; 3.71 N). Our findings suggest that the use of a reticular and a laminar ePTFE layer in the same prosthesis leads to better repair and biomechanical behavior compared to the use of a single-structure laminar implant.
C1 Univ Alcala de Henares, Fac Med, Dept Surg, Madrid 28871, Spain.
   Univ Alcala de Henares, Fac Med, Dept Med Specialties, Madrid 28871, Spain.
   ESTII, Dept Struct Mech, Madrid 28006, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Surg, Ctra N II,Km 33 600, Madrid 28871, Spain.
EM juanm.bellon@uah.es
RI Serrano Amarilla, Natalia/P-6803-2015
OI Serrano Amarilla, Natalia/0000-0002-8337-7211; BELLON, JUAN
   M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476
CR Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 2003, J MATER SCI-MATER M, V14, P359, DOI 10.1023/A:1022936016618
   Bellon JM, 2002, WORLD J SURG, V26, P661, DOI 10.1007/s00268-001-0286-y
   Bellon JM, 2002, J BIOMED MATER RES, V63, P182, DOI 10.1002/jbm.10123
   Bellon JM, 1996, BIOMATERIALS, V17, P1369, DOI 10.1016/0142-9612(96)87276-0
   Bellon JM, 1997, J BIOMED MATER RES, V38, P197
   Bellon JM, 1999, EUR J SURG, V165, P145
   Chew DKW, 2000, SURGERY, V127, P352, DOI 10.1067/msy.2000.100886
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   DEGUZMAN LJ, 1995, ENDOSCOPY, V27, P459, DOI 10.1055/s-2007-1005743
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Macintyre IMC, 2003, BRIT J SURG, V90, P131, DOI 10.1002/bjs.4064
   SCHEIN M, 1995, J AM COLL SURGEONS, V180, P745
NR 14
TC 6
Z9 6
U1 2
U2 4
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0364-2313
J9 WORLD J SURG
JI World J.Surg.
PD MAY
PY 2004
VL 28
IS 5
BP 461
EP 465
DI 10.1007/s00268-004-7299-2
PG 5
WC Surgery
SC Surgery
GA 822AH
UT WOS:000221505200005
PM 15085391
DA 2018-10-19
ER

PT J
AU Mao, C
   Zhang, C
   Qiu, YZ
   Zhu, AP
   Shen, J
   Lin, SC
AF Mao, C
   Zhang, C
   Qiu, YZ
   Zhu, AP
   Shen, J
   Lin, SC
TI Introduction of anticoagulation group to polypropylene film by radiation
   grafting and its blood compatibility
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE surface modification; radiation grafting; O-butyrylchitosan;
   polypropylene; blood compatibility
ID IN-VITRO; PLATELET-ADHESION; CHITOSAN; SURFACE; DERIVATIVES; MEMBRANES;
   POLYMERS
AB Based on in vitro tests for an improvement of the blood compatibility of polypropylene (PP) films by grafting O-butyrylchitosan (OBCS), we prepared a novel biocompatible film. The immobilization was accomplished by irradiating with ultraviolet light. OBCS being coated on the film surface to photolyze azide groups, thus cross-linking OBCS and PP together. The grafted sample films were verified by attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR), electron spectroscopy for chemical analysis (ESCA) and the water contact angle measurements. The blood compatibility of the OBCS-grafted PP films was evaluated by platelet rich plasma (PRP) contacting experiments and protein adsorption experiments using blank PP film as the control. It demonstrated that blood compatibility of the OBCS-grafted surfaces is better than that of the blank PP. The Suitable modifications could be carried out to tailor PP biomaterial to meet the specific needs of different biomedical applications. These results suggest that the photocrosslinkable chitosan developed here has the potential of serving as a new biomaterial in medical use. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
   China Pharmaceut Univ, Coll Pharm, Nanjing 210009, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Shen, J (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Hankou Rd 22, Nanjing 210093, Peoples R China.
EM njusic2002@yahoo.com.cn
CR Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   Delpeux S, 1998, EUR POLYM J, V34, P905, DOI 10.1016/S0014-3057(97)00225-5
   FOSTER A, 1998, P NOBCCHE, V25, P127
   GRANT S, 1988, POLYM COMMUN, V29, P342
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HAYASHI A, 1992, MACROMOLECULES, V25, P5094, DOI 10.1021/ma00045a041
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   JIE C, 1999, RADIAT PHYS CHEM, V55, P87
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kyrolainen M, 1997, ANAL CHIM ACTA, V353, P281, DOI 10.1016/S0003-2670(97)87787-2
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Nho YC, 2002, RADIAT PHYS CHEM, V64, P67, DOI 10.1016/S0969-806X(01)00281-X
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   POPOWICZ P, 1985, BIOMED BIOCHIM ACTA, V44, P1329
   Rhodes NP, 1996, BIOMATERIALS, V17, P1995, DOI 10.1016/0142-9612(96)00018-X
   Risbud M, 2001, BIOMATERIALS, V22, P1591, DOI 10.1016/S0142-9612(00)00325-2
   Sklenak S, 1997, J MOL STRUC-THEOCHEM, V397, P249
   Yang MR, 1997, MATER CHEM PHYS, V48, P71, DOI 10.1016/S0254-0584(97)80081-8
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 23
TC 26
Z9 32
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 30
PY 2004
VL 228
IS 1-4
BP 26
EP 33
DI 10.1016/j.apsusc.2003.12.021
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 820DL
UT WOS:000221367000005
DA 2018-10-19
ER

PT J
AU Sekhar, KC
   Kamala, CT
   Chary, NS
   Sastry, ARK
   Rao, TN
   Vairamani, M
AF Sekhar, KC
   Kamala, CT
   Chary, NS
   Sastry, ARK
   Rao, TN
   Vairamani, M
TI Removal of lead from aqueous solutions using an immobilized biomaterial
   derived from a plant biomass
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE lead; immobilization; biomass; beads; phytofiltration; regeneration
ID HEAVY-METALS; ENVIRONMENTAL-CONTROL; IONS; BIOSORPTION; WATER; CADMIUM;
   COPPER; RECOVERY; ABILITY; HAZARD
AB Because of the severity of heavy metal contamination and potential adverse health impact on the public, a tremendous effort has taken place to purify waters containing toxic metal ions. Traditional methods which have been employed prove to be costly and prohibitive for low level waste remediation. Biosorption is presented as an alternative to traditional physicochemical means for removing toxic metals from ground and wastewaters. Most recently, plant based biomaterials have been of interest.
   The bark of Hemidesinus indicus, an extensively available plant biomass commonly called as Indian sarsaparilla was used as biomaterial for removal of lead from aqueous streams. Batch experiments were carried out with immobilized biomass of H. indicus (IPBFIX) to optimize the experimental parameters like effect of contact time, initial metal concentration, initial IPBFIX concentration and co-metal ion effect on biosorption of lead from contaminated waters. Column experiments were performed under flow conditions for regeneration and recycle efficiency of IPBFIX and was found to be effective for three cycles. Elution experiments were carried out to remove lead ions from loaded IPBFIX and 100%, elution was achieved with a 0.1 M HNO3 solution. The effectiveness of the IPBFIX for biosorption of lead ions was demonstrated using the wastewater samples emanating from a non-ferrous metal industry and the results are presented in this paper. The results from these studies will be useful for a novel phytofiltration technology to remove and recover lead from wastewaters and this can also be well adapted for secondary treatment or polishing of wastewaters. An attempt has been made to remove lead from the lead polluted waters (both ground and surface) from an industrially contaminated sites. (C) 2004 Elsevier B.V. All rights reserved.
C1 Indian Inst Chem Technol, Discovery Lab D 120, Analyt Chem & Environm Sci Div, Hyderabad 500007, Andhra Pradesh, India.
   Indian Inst Chem Technol, Organ Coatings & Polymers Div, Hyderabad 500007, Andhra Pradesh, India.
RP Sekhar, KC (reprint author), Indian Inst Chem Technol, Discovery Lab D 120, Analyt Chem & Environm Sci Div, Hyderabad 500007, Andhra Pradesh, India.
EM kavi223@yahoo.com
OI Vairamani, Mariappanadar/0000-0002-8356-6258
CR [Anonymous], 2001, GUID DRINK WAT
   BERGERS M, 1995, P 10 ANN C HAZ WAST, P324
   Brierley J. A., 1987, US Patent, Patent No. 4690894
   BRUCE R, 1993, IN SITU BIOREMEDIATO
   COUNTRYMAN C, 1995, TEXAS OBSERVER  0206
   DARNALL DW, 1986, ENVIRON SCI TECHNOL, V20, P206, DOI 10.1021/es00144a018
   Forest E., 1992, APPL MICROBIOL BIOT, V37, P399
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P181, DOI 10.1016/0304-3894(95)00155-7
   GOYER RA, 1972, METALLIC CONTAMINANT, P57
   *IS, 1995, 10500 IS BIS
   Jalali R, 2002, J HAZARD MATER, V92, P253, DOI 10.1016/S0304-3894(02)00021-3
   JEFFERS TH, 1992, 9340 US DEP INT BUR
   JENETTE JC, 1982, FACTORS INFFLUENCING, P124
   KANSANEN PH, 1991, WATER AIR SOIL POLL, V60, P337, DOI 10.1007/BF00282631
   KHOVRYCHEV MP, 1994, MICROBIOLOGY+, V63, P83
   KIMBROUGH DE, 1995, ENVIRON SCI TECHNOL, V29, P2217, DOI 10.1021/es00009a010
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   KUMAR P, 1980, Indian Journal of Environmental Health, V22, P196
   KUMAR PBAN, 1995, ENVIRON SCI TECHNOL, V29, P1232, DOI 10.1021/es00005a014
   Manahan S., 1984, ENV CHEM
   MARCUS Y, 1969, ION EXCHANGE SOLVENT
   MATTUSCHKA B, 1993, J CHEM TECHNOL BIOT, V58, P57
   MICERA G, 1988, J INORG BIOCHEM, V34, P157, DOI 10.1016/0162-0134(88)85026-8
   Muralikrishna K.V.S.G, 1997, CHEM ANAL WATER SOIL
   Osman MS, 1996, BIOPROCESS ENG, V14, P249, DOI 10.1007/s004490050212
   Perkin Elmer Instruments Manual, 2002, PERKIN ELMER INSTRUM, P96
   PIP E, 1991, B ENVIRON CONTAM TOX, V46, P790, DOI 10.1007/BF01689969
   Reddy BR, 1997, RESOUR CONSERV RECY, V21, P227, DOI 10.1016/S0921-3449(97)00036-0
   RUNNELLS DD, 1992, ENVIRON SCI TECHNOL, V26, P2316, DOI 10.1021/es00036a001
   Schiewer S, 1996, ENVIRON SCI TECHNOL, V30, P2921, DOI 10.1021/es950800n
   SCOTT CD, 1992, BIOTECHNOL BIOENG, V39, P1064, DOI 10.1002/bit.260391011
   Sekhar KC, 2003, INT J MINER PROCESS, V68, P37
   Sekhar KC, 1998, INT J MINER PROCESS, V53, P107, DOI 10.1016/S0301-7516(97)00061-6
   Shan L., 2002, ADV ENVIRON RES, V6, P523
   SUBRAMANIAN KS, 1991, J ENVIRON HEALTH, V54, P29
   Sun G, 1998, IND ENG CHEM RES, V37, P1324, DOI 10.1021/ie970468j
   TAN H, 1994, ENVIRON SCI TECHNOL, V28, P2402, DOI 10.1021/es00062a027
   Texier AC, 2002, CHEMOSPHERE, V47, P333, DOI 10.1016/S0045-6535(01)00244-2
   Villaescusa I, 2000, J CHEM TECHNOL BIOT, V75, P812, DOI 10.1002/1097-4660(200009)75:9<812::AID-JCTB284>3.3.CO;2-2
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   ZHANG WX, 1994, ENVIRON SCI TECHNOL, V28, P1577, DOI 10.1021/es00058a007
NR 41
TC 60
Z9 64
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD APR 30
PY 2004
VL 108
IS 1-2
BP 111
EP 117
DI 10.1016/j.jhazmat.2004.01.013
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 815TQ
UT WOS:000221065000011
DA 2018-10-19
ER

PT J
AU Fujihara, T
   Tsukamoto, M
   Abe, N
   Miyake, S
   Ohji, T
   Akedo, J
AF Fujihara, T
   Tsukamoto, M
   Abe, N
   Miyake, S
   Ohji, T
   Akedo, J
TI Hydroxyapatite film formed by particle beam irradiation
SO VACUUM
LA English
DT Article; Proceedings Paper
CT 4th International Symposium on Applied Plasma Science (ISAPS 2003)
CY SEP 01-05, 2003
CL Kyoto, JAPAN
DE hydroxyapatite; biomaterial; coating technology; aerosol deposition
   method
ID COATINGS; SUBSTRATE
AB A hydroxyapatite (HA) film was fabricated on the titanium (Ti) plate by an aerosol deposition method using HA submicron-size particle beam. Technology of HA film formation on the Ti is important for biomaterial production. In this process, neither substrate nor HA particles were heated during deposition. Effect of varying the beam incident angle on the HA film formation was investigated. The incidence angle of the beam was varied from 0degrees to 60degrees with a period of 20degrees by rotation of substrate. Adhesion strength between the HA film and the Ti plate was increased as the incident angle increased although its thickness was decreased. In the films formed at incident angle of 60degrees, the adhesion strength was found to be higher than 30 MPa. Possible formation mechanisms of the HA film dependent on the incident angle was discussed. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan.
   Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan.
   Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan.
RP Fujihara, T (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
EM fujiwara@jwri.osaka-u.ac.jp
RI AKEDO, JUN/M-5992-2018
OI AKEDO, JUN/0000-0002-2956-9802
CR AKEDO J, 1998, SENSOR ACTUAT A-PHYS, V69, P107
   Choi JM, 2000, BIOMATERIALS, V21, P469, DOI 10.1016/S0142-9612(99)00186-6
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   KASYU S, 1984, JPN J APPL PHYS, V23, pL910
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
NR 8
TC 15
Z9 16
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD APR 19
PY 2004
VL 73
IS 3-4
BP 629
EP 633
DI 10.1016/j.vacuum.2003.12.082
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 813TH
UT WOS:000220928900048
DA 2018-10-19
ER

PT J
AU Yang, C
   Hillas, P
   Tang, J
   Balan, J
   Notbohm, H
   Polarek, J
AF Yang, C
   Hillas, P
   Tang, J
   Balan, J
   Notbohm, H
   Polarek, J
TI Development of a recombinant human collagen-type III based hemostat
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE hemostat; recombinant human collagen; biomaterial; platelet; wound
ID YEAST PICHIA-PASTORIS; LACTIC-ACID OLIGOMERS; I COLLAGEN; STEREOCOMPLEX
   FORMATION; PLATELET INTERACTION; HYDROGELS; RECEPTOR; SEQUENCE;
   IDENTIFICATION; EXPRESSION
AB Animal-tissue-derived collagen, containing mostly type I collagen with a minor amount of type III collagen, has been widely used in the production of hemostats for many decades, although it has been known for a long time that type III collagen is more likely to induce platelet aggregation in vitro. Because it is hard to purify type III from animal tissue, it has not been possible to correlate this finding with in vivo data. In this report, it is demonstrated that recombinant human collagen III fibrils are more capable of inducing platelet aggregation in vitro than those comprised of bovine collagen I, in agreement with previously published data on tissue-derived type III collagen. When formed into three-dimensional matrices, the use of type III collagen results in formulations with better mechanical integrity, larger surface area, and higher hemostatic activity in a rabbit spleen injury model as compared with commercially available hemostats formed from bovine type I collagen. (C) 2003 Wiley Periodicals, Inc.
C1 FibroGen Inc, San Francisco, CA 94080 USA.
   Med Univ Lubeck, Inst Med Mol Biol, D-23538 Lubeck, Germany.
RP Polarek, J (reprint author), FibroGen Inc, 225 Gateway Blvd, San Francisco, CA 94080 USA.
FU NIAMS NIH HHS [AR45879]
CR Areida SK, 2001, J BIOL CHEM, V276, P1594, DOI 10.1074/jbc.M008709200
   BALLESIEN L, 1975, KLIN WASCHR, V52, P903
   BATEMAN JF, 1996, EXTRACELLULAR MATRIX, V2, P22
   BOURELA A, 1997, EMBO J, V16, P6702
   BROWDER IW, 1986, AM SURGEON, V52, P492
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2001, BIOMATERIALS, V22, P619, DOI 10.1016/S0142-9612(00)00225-8
   Bulleid NJ, 2000, BIOCHEM SOC T, V28, P350, DOI 10.1042/0300-5127:0280350
   Chiang TM, 1997, J CLIN INVEST, V100, P2079, DOI 10.1172/JCI119741
   Chiang TM, 1997, J CLIN INVEST, V100, P514, DOI 10.1172/JCI119560
   Chiang TM, 1999, HISTOL HISTOPATHOL, V14, P579, DOI 10.14670/HH-14.579
   CHIANG TM, 1993, THROMB RES, V71, P443, DOI 10.1016/0049-3848(93)90118-8
   de Jong SJ, 2001, J CONTROL RELEASE, V72, P47, DOI 10.1016/S0168-3659(01)00261-9
   de Jong SJ, 2001, J CONTROL RELEASE, V71, P261, DOI 10.1016/S0168-3659(01)00228-0
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Grinnell F., 1992, WOUND HEALING BIOCH, P209
   Kielty Cay M., 1993, P103
   KIVIRIKKO KI, 1993, ANN MED, V25, P113, DOI 10.3109/07853899309164153
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   Mast B.A., 1992, WOUND HEALING BIOCH, V13, P344
   Monnet E, 2000, J BIOL CHEM, V275, P10912, DOI 10.1074/jbc.275.15.10912
   Moroi M, 1997, THROMB HAEMOSTASIS, V78, P439
   Morton LF, 1997, J BIOL CHEM, V272, P11044
   MORTON LF, 1994, BIOCHEM J, V299, P791, DOI 10.1042/bj2990791
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   ROMANIC AM, 1991, J BIOL CHEM, V266, P12706
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   SWEAT F, 1964, ARCH PATHOL, V78, P69
   YANG C, 1994, MATRIX BIOL, V14, P643
NR 30
TC 6
Z9 7
U1 0
U2 5
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR 15
PY 2004
VL 69B
IS 1
BP 18
EP 24
DI 10.1002/jbm.b.20030
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 807PZ
UT WOS:000220514700003
PM 15015205
DA 2018-10-19
ER

PT J
AU Huang, XA
   Jiang, DL
   Tan, SH
AF Huang, XA
   Jiang, DL
   Tan, SH
TI Apatite formation on the surface of wollastonite/tricalcium phosphate
   composite immersed in simulated body fluid
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE wollastonite-tricalcium phosphate; composites; simulated body fluid; in
   situ porous structure
AB Wollastonite/tricalcium phosphate composites were prepared and immersed in SBF for various periods to investigate the apatite-formation mechanism on their surfaces. Surface morphologies and composition before and after immersion were analyzed by SEM and EDS technologies. The concentration changes of calcium, silicon, and phosphorus in SBF due to the immersion of the samples were measured with inductively coupled plasma atomic emission spectroscopy, and the corresponding pH values in SBF were recorded. XRD and IR were used to examine the changes in crystalline phases and functional groups. It was found that, after immersion for 1 day, the samples were covered by pom-pom-like apatite granules, resulting from the dissolution of wollastonite and the simultaneous transformation of TCP. This quickly led to the subsequent precipitation of another apatite layer, which covered the earlier-formed surface completely. These results indicate that the wollastonite/tricalcium phosphate composite is a potential biomaterial candidate because of its high bioactivity and in situ porous structure. (C) 2004 Wiley Periodicals, Inc.
C1 Ocean Univ China, Inst Mat Sci & Engn, Qingdao 266003, Peoples R China.
   Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Huang, XA (reprint author), Ocean Univ China, Inst Mat Sci & Engn, Qingdao 266003, Peoples R China.
EM hx929@hotmail.com
CR DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Siriphannon P, 1999, J MATER RES, V14, P529, DOI 10.1557/JMR.1999.0076
NR 5
TC 15
Z9 16
U1 0
U2 9
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR 15
PY 2004
VL 69B
IS 1
BP 70
EP 72
DI 10.1002/jbm.b.20025
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 807PZ
UT WOS:000220514700010
PM 15015212
DA 2018-10-19
ER

PT J
AU Hopkins, TE
   Wagener, KB
AF Hopkins, TE
   Wagener, KB
TI Bio-olefins via condensation metathesis chemistry
SO JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Olefin Metathesis and Related Chemistry
   (ISOM 15)
CY AUG   02, 2003
CL Kyoto, JAPAN
DE ADMET; metathesis; amino acids; peptides; polyolefins; biologically
   functionalized surfaces
ID POLYMETHACRYLIC ACID-DERIVATIVES; RADICAL POLYMERIZATION; AMINO-ACIDS;
   SIDE-CHAIN; ADMET POLYMERIZATION; METHYL-METHACRYLATE; CHIRAL
   POLYOLEFINS; POLYMERS; COPOLYMERS; ESTER
AB Amino acid based polymers are of interest for a variety of biomaterial applications including drug delivery, proteomics, and tissue engineering. A new class of polymers bearing amino acids and dipeptides has been prepared using acyclic diene metathesis (ADMET) to create copolymers of polyethylene with linear amino alcohol, branched amino acid, or branched peptide substituents termed bio-olefins. Monomers with the amino acid/dipeptide functionality attached through both the N and C-terminus have been prepared, and a discussion on the synthesis of the monomers and a comparison of the thermal properties of the resulting polymers are discussed. The resulting highly functionalized polymers are strong, film-forming materials with moduli in the range of LDPE with molecular weights typical of polycondensation polymers, i.e. Nylon and PET. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Florida, Dept Chem, Gainesville, FL 32611 USA.
RP Hopkins, TE (reprint author), Univ Florida, Dept Chem, POB 117200, Gainesville, FL 32611 USA.
EM wagener@chem.ufl.edu
CR Ayres L, 2003, MACROMOLECULES, V36, P5967, DOI 10.1021/ma025727h
   Biagini SCG, 2001, POLYMER, V42, P6669, DOI 10.1016/S0032-3861(01)00146-X
   Birchall AC, 2001, POLYMER, V42, P375, DOI 10.1016/S0032-3861(00)00383-9
   Brzezinska KR, 2002, MACROMOLECULES, V35, P2970, DOI 10.1021/ma011951f
   Brzezinska KR, 2001, MACROMOLECULES, V34, P4348, DOI 10.1021/ma010097p
   Bush SM, 1998, POLYMER, V39, P933, DOI 10.1016/S0032-3861(97)00294-2
   Bush SM, 1998, POLYMER, V39, P2991, DOI 10.1016/S0032-3861(97)10004-0
   Bush SM, 1996, POLYMER, V37, P4649, DOI 10.1016/0032-3861(96)00346-1
   Church A. C., 2003, SYNTHETIC METHODS ST, P431
   Church AC, 2003, MACROMOL CHEM PHYSIC, V204, P32, DOI 10.1002/macp.200290053
   Courchay FC, 2003, MACROMOLECULES, V36, P8231, DOI 10.1021/ma0302964
   Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g
   Hopkins TE, 2003, MACROMOLECULES, V36, P2206, DOI 10.1021/ma021668w
   Hopkins TE, 2002, ADV MATER, V14, P1703, DOI 10.1002/1521-4095(20021203)14:23<1703::AID-ADMA1703>3.0.CO;2-5
   Hopkins TE, 2001, MACROMOLECULES, V34, P7920, DOI 10.1021/ma010930i
   HOPKINS TE, 2002, POLYM PREPR, V43, P281
   HOPKINS TE, 2000, POLYM PREPR, V41, P1533
   HOPKINS TE, 2003, IN PRESS MACROMOLECU
   HOPKINS TE, 2002, POLYM PREP-ACS, V14, P1703
   KATAKAI R, 1977, J CHEM SOC CHEM COMM, P805, DOI 10.1039/c39770000805
   Kudo H, 1999, MACROMOL CHEM PHYSIC, V200, P1232, DOI 10.1002/(SICI)1521-3935(19990501)200:5<1232::AID-MACP1232>3.0.CO;2-U
   LINDMARKHAMBERG M, 1987, MACROMOLECULES, V20, P2949, DOI 10.1021/ma00177a053
   Maynard HD, 1999, MACROMOLECULES, V32, P6917, DOI 10.1021/ma990749y
   Maynard HD, 2000, MACROMOLECULES, V33, P6239, DOI 10.1021/ma000460c
   Maynard HD, 2001, J AM CHEM SOC, V123, P1275, DOI 10.1021/ja003305m
   METHENITIS C, 1994, MACROMOLECULES, V27, P1455, DOI 10.1021/ma00084a027
   METHENITIS C, 1984, POLYM BULL, V12, P133, DOI 10.1007/BF00263336
   METHENITIS C, 1984, POLYM BULL, V12, P141, DOI 10.1007/BF00263337
   MORCELLETSAUVAGE J, 1982, MAKROMOL CHEM, V183, P831
   MORCELLETSAUVAGE J, 1982, MAKROMOL CHEM, V183, P821
   MORCELLETSAUVAGE J, 1981, MAKROMOL CHEM, V182, P949
   Murata H, 1996, MACROMOLECULES, V29, P5535, DOI 10.1021/ma9601981
   Murata H, 1998, J POLYM SCI POL CHEM, V36, P1679, DOI 10.1002/(SICI)1099-0518(19980730)36:10<1679::AID-POLA21>3.3.CO;2-G
   Murata H, 1997, MACROMOLECULES, V30, P2902, DOI 10.1021/ma970131t
   Sanda F, 1999, MACROMOLECULES, V32, P2490, DOI 10.1021/ma9814090
   Sanda F, 1999, MACROMOL CHEM PHYSIC, V200, P2651, DOI 10.1002/(SICI)1521-3935(19991201)200:12<2651::AID-MACP2651>3.0.CO;2-P
   Sanda F, 1998, POLYMER, V39, P5543, DOI 10.1016/S0032-3861(97)10201-4
   Smith JA, 2000, MACROMOLECULES, V33, P3781, DOI 10.1021/ma9920792
   Sworen JC, 2003, J AM CHEM SOC, V125, P2228, DOI 10.1021/ja020862v
   WAGENER KB, 1990, MACROMOLECULES, V23, P5155, DOI 10.1021/ma00226a022
NR 40
TC 6
Z9 6
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-1169
J9 J MOL CATAL A-CHEM
JI J. Mol. Catal. A-Chem.
PD APR 13
PY 2004
VL 213
IS 1
BP 93
EP 99
DI 10.1016/j.molcata.2003.11.024
PG 7
WC Chemistry, Physical
SC Chemistry
GA 806XU
UT WOS:000220467400012
DA 2018-10-19
ER

PT J
AU Gekas, J
   Hindie, M
   Faucheux, N
   Lanvin, O
   Maziere, C
   Fuentes, V
   Gouilleux-Gruart, V
   David, B
   Maziere, JC
   Lassoued, K
   Nagel, MD
AF Gekas, J
   Hindie, M
   Faucheux, N
   Lanvin, O
   Maziere, C
   Fuentes, V
   Gouilleux-Gruart, V
   David, B
   Maziere, JC
   Lassoued, K
   Nagel, MD
TI The inhibition of cell spreading on a cellulose substrate (cuprophan)
   induces an apoptotic process via a mitochondria-dependent pathway
SO FEBS LETTERS
LA English
DT Article
DE apoptosis; caspase; cell aggregation; biomaterial; fibroblast
ID SWISS 3T3 CELLS; CYCLIC-AMP; HEMODIALYSIS MEMBRANES; GEOMETRIC CONTROL;
   RHO FAMILY; INTEGRINS; PHOSPHATIDYLSERINE; GTPASES; GROWTH; SIGNAL
AB Cell shape was found to be a strong indicator of whether individual cells grow or die, and may play an important role in controlling apoptosis as well as cell growth. We compared here the behaviour of rounded Swiss 3T3 cells aggregated on a cellulose cuprophan membrane to those cultured on dish polystyrene. We demonstrated that cells aggregated on cellulose substrates for up to 48 h underwent programmed cell death that was associated with phosphatidylserine flipping and caspase 9 and caspase 3 activation, suggesting a mitochondria-dependent apoptotic process. In addition, we found that this phenomenon cannot be entirely explained by disengagement of alpha5beta1 integrin ligation. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
C1 Univ Technol Compiegne, CNRS, UMR 6600, F-60205 Compiegne, France.
   INSERM, E0351, Fac Med, Immunol Lab, F-80036 Amiens, France.
RP Nagel, MD (reprint author), Univ Technol Compiegne, CNRS, UMR 6600, Domaine Biomat Biocompatibilite,POB 20529, F-60205 Compiegne, France.
EM marie-danielle.nagel@utc.fr
CR Barry S T, 1997, Cell Adhes Commun, V4, P387, DOI 10.3109/15419069709004456
   Boutonnat J, 1998, ANTICANCER RES, V18, P4243
   Carracedo J, 1998, J AM SOC NEPHROL, V9, P46
   Carracedo J, 1995, J AM SOC NEPHROL, V6, P1586
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383
   Embade N, 2000, MOL BIOL CELL, V11, P4347, DOI 10.1091/mbc.11.12.4347
   FADOK VA, 1992, J IMMUNOL, V148, P2207
   Faucheux N, 2002, BIOMATERIALS, V23, P2295, DOI 10.1016/S0142-9612(01)00363-5
   Faucheux N, 2001, BIOMATERIALS, V22, P2993, DOI 10.1016/S0142-9612(01)00045-X
   Faucheux N, 2002, BIOMATERIALS, V23, P413, DOI 10.1016/S0142-9612(01)00120-X
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   Hotchin NA, 1996, CANCER SURV, V27, P311
   Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   McGill G, 1997, J CELL BIOL, V138, P901, DOI 10.1083/jcb.138.4.901
   Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691
   RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7
   Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675
   Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4
   Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200
   Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404
   VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028
   Werner E, 2001, J CELL SCI, V114, P3333
   Yin XM, 1999, NATURE, V400, P886
NR 34
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD APR 9
PY 2004
VL 563
IS 1-3
BP 103
EP 107
DI 10.1016/S0014-5793(04)00276-5
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 811LK
UT WOS:000220773200020
PM 15063731
OA Bronze
DA 2018-10-19
ER

PT J
AU Shieh, SJ
   Terada, S
   Vacanti, JP
AF Shieh, SJ
   Terada, S
   Vacanti, JP
TI Tissue engineering auricular reconstruction: in vitro and in vivo
   studies
SO BIOMATERIALS
LA English
DT Article
DE auricular tissue engineering; chondrogenesis; animal model
ID SYNTHETIC BIODEGRADABLE POLYMERS; MESENCHYMAL STEM-CELLS; RIB CARTILAGE
   GRAFTS; PERSONAL-EXPERIENCE; EAR RECONSTRUCTION; CHONDROCYTES; COLLAGEN;
   MICROTIA; INVITRO; RABBIT
AB Although investigators have demonstrated that neocartilage can be constituted in a predetermined shape and in complex three-dimensional Structures, Such as a human ear, by using cell transplantation on polymer constructs, many unsolved problems still remain. The crucial issues for auricular tissue engineering consisted of optimal cell Culture environment, choice of polymers, behavior of chondrocytes, study of cell-polymer constructs in an acceptable animal model, and long-term structural integrity. Here we describe Our tissue engineering approaches for auricular reconstruction including auricular scaffold fabrication, in vitro chondrogenesis, in vivo immunocompromized xenograft and immunocompetent autologous animal models, and long-term follow-up. Though many current obstacles regarding auricular tissue engineering still exist, we demonstrate techniques of auricular scaffold fabrication with promising in vitro and in vivo neocartilage formation, optimal selection and application of animal models, and, to the best of our knowledge, the first report of different biodegradable biomaterial trials and the longest in vivo results (10 months) for auricular tissue engineering. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Massachusetts Gen Hosp, Dept Surg, Lab Tissue Engn & Organ Fabricat, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Boston, MA 02114 USA.
   Natl Cheng Kung Univ, Coll Med, Dept Surg, Div Plast & Reconstruct Surg, Tainan 70101, Taiwan.
   Tokyo Womens Med Univ, Dept Plast & Reconstruct Surg, Tokyo 1628666, Japan.
RP Vacanti, JP (reprint author), Massachusetts Gen Hosp, Dept Surg, Lab Tissue Engn & Organ Fabricat, 1157 Warren,55 Fruit St, Boston, MA 02114 USA.
EM sjshieh@mail.ncku.edu.tw; sterada@big.jp; jvacanti@partners.org
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BERRY L, 1992, J CELL SCI, V101, P333
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Brent B, 2002, CLIN PLAST SURG, V29, P257, DOI 10.1016/S0094-1298(01)00013-X
   Brent B, 1999, PLAST RECONSTR SURG, V104, P319, DOI 10.1097/00006534-199908000-00001
   Britt JC, 1998, ARCH OTOLARYNGOL, V124, P671, DOI 10.1001/archotol.124.6.671
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Cronin T D, 1978, Clin Plast Surg, V5, P367
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   FREED LE, 1999, CLIN ORTHOP S, V367, P46
   HADLOCK TA, 1997, FACIAL PLAST SURG CL, V5, P311
   Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Klagsbrun M, 1979, Methods Enzymol, V58, P560
   MADSEN K, 1984, BIOCHEM J, V221, P189, DOI 10.1042/bj2210189
   MARTIN DP, 2002, METHODS TISSUE ENG, P275
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Ohmori S, 1978, Clin Plast Surg, V5, P379
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023
   SKOOG T, 1972, SCAND J PLAST RECONS, V6, P123, DOI 10.3109/02844317209036711
   TANZER RC, 1975, PLAST RECONSTR SURG, V55, P406
   TANZER RC, 1978, PLAST RECONSTR SURG, V61, P161, DOI 10.1097/00006534-197802000-00001
   TANZER RC, 1967, PLAST RECONSTR SURG, V40, P547, DOI 10.1097/00006534-196740060-00006
   Thorne CH, 2001, PLAST RECONSTR SURG, V107, P1241, DOI 10.1097/00006534-200104150-00024
   Ushida T, 2002, CELL TRANSPLANT, V11, P489
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VACANTI CA, 1992, MATER RES SOC SYMP P, V252, P367
   Vacanti JP, 1999, LANCET, V354, pSI32
   van Osch GJVM, 2001, PLAST RECONSTR SURG, V107, P433, DOI 10.1097/00006534-200102000-00020
   van Osch GJVM, 2000, TISSUE ENG, V6, P321, DOI 10.1089/107632700418047
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Walton RL, 2002, PLAST RECONSTR SURG, V110, P234, DOI 10.1097/00006534-200207000-00041
   WELLISZ T, 1993, PLAST RECONSTR SURG, V91, P811, DOI 10.1097/00006534-199304001-00009
   WILKES GH, 1994, PLAST RECONSTR SURG, V93, P967, DOI 10.1097/00006534-199404001-00011
   Williams JD, 1997, ARCH OTOLARYNGOL, V123, P578
   Wong W.H., 1997, SYNTHETIC BIODEGRADA, P51
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
   Yotsuyanagi T, 1999, PLAST RECONSTR SURG, V103, P1120, DOI 10.1097/00006534-199904040-00002
NR 51
TC 100
Z9 107
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2004
VL 25
IS 9
BP 1545
EP 1557
DI 10.1016/S0142-9612(03)00501-5
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761PA
UT WOS:000187916100010
PM 14697857
DA 2018-10-19
ER

PT J
AU Kamelger, FS
   Marksteiner, R
   Margreiter, E
   Klima, G
   Wechselberger, G
   Hering, S
   Piza, H
AF Kamelger, FS
   Marksteiner, R
   Margreiter, E
   Klima, G
   Wechselberger, G
   Hering, S
   Piza, H
TI A comparative study of three different biomaterials in the engineering
   of skeletal muscle using a rat animal model
SO BIOMATERIALS
LA English
DT Article
DE animal model; muscle; tissue engineering; polyglycolic acid; alginate;
   hyaluronic acid
ID SYNTHETIC BIODEGRADABLE POLYMERS; FIBRIN GLUE; DELIVERY VEHICLE; TISSUE;
   TRANSPLANTATION; ALGINATE; CELLS; CHONDROCYTES; MYOBLASTS; INJECTION
AB Defects caused by traumatic or postsurgical loss of muscle mass may result in severe impairments of the functionality of skeletal muscle. Tissue engineering represents a possible approach to replace the lost or defective muscle. The aim of this study was to compare the suitability of three different biomaterials as scaffolds for rat myoblasts, using a new animal model. PKH26-fluorescent-stained Cultured rat myoblasts were either seeded onto polyglycolic acid meshes or, alternatively, suspended in alginate or in hyaluronic acid-hydrogels. In each of the eight Fisher CDF-344 rats, four capsule pouches were induced by subcutaneous implantation of four silicone sheets. After two weeks the silicone sheets were removed and myoblast-biomaterial-constructs were implanted in the preformed capsules. Specimens were harvested after four weeks and examined histologically by H&E-staining and fluorescence microscopy. All capsules were well-vascularized. Implanted myoblasts fused by forming multinucleated myotubes. This study demonstrates that myoblasts seeded onto different biomaterials can be Successfully transplanted into preformed highly vascularized capsule pouches. Our animal model has paved the way for studies of myoblast-biomaterial transplantations into an ectopic non-muscular environment. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Innsbruck Hosp, Dept Plast & Reconstruct Surg, A-6020 Innsbruck, Austria.
   Ludwig Boltzmann Inst Qual Control Plast & Recons, A-6020 Innsbruck, Austria.
   Univ Innsbruck, Inst Biochem Pharmacol, A-6020 Innsbruck, Austria.
   Univ Innsbruck, Inst Anat Histol & Embryol, A-6020 Innsbruck, Austria.
   Univ Vienna, Inst Pharmacol & Toxicol, Vienna, Austria.
RP Kamelger, FS (reprint author), Univ Innsbruck Hosp, Dept Plast & Reconstruct Surg, Anichstr 35, A-6020 Innsbruck, Austria.
EM florian.kamelger@uibk.ac.at
CR ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4
   Cao Yilin, 2002, Zhonghua Wai Ke Za Zhi, V40, P24
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Dalla Paola Luca, 2002, Ostomy Wound Manage, V48, P46
   DHAWAN J, 1991, SCIENCE, V254, P1509, DOI 10.1126/science.1962213
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   JIAO SS, 1993, NATURE, V362, P450, DOI 10.1038/362450a0
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   LAW PK, 1990, LANCET, V336, P114, DOI 10.1016/0140-6736(90)91628-N
   MESSINA LM, 1992, P NATL ACAD SCI USA, V89, P12018, DOI 10.1073/pnas.89.24.12018
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Rahman MS, 2001, TISSUE ENG, V7, P781, DOI 10.1089/107632701753337726
   Rainer C, 2001, J THORAC CARDIOV SUR, V121, P1187, DOI 10.1067/mtc.2001.113936
   SAMLOWSKI WE, 1991, J IMMUNOL METHODS, V144, P101, DOI 10.1016/0022-1759(91)90236-9
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   Saxena AK, 2001, BIO-MED MATER ENG, V11, P275
   Schoeller T, 2001, AESTHET PLAST SURG, V25, P57, DOI 10.1007/s002660010096
   Schoeller T, 2001, J UROLOGY, V165, P980, DOI 10.1016/S0022-5347(05)66588-3
   SLEZAK SE, 1989, BLOOD, V74, P2172
   Wechselberger G, 1998, J UROLOGY, V160, P583, DOI 10.1016/S0022-5347(01)62962-8
   Wechselberger G, 2001, TISSUE ENG, V7, P153, DOI 10.1089/107632701300062750
   Wernig A, 2000, J PHYSIOL-LONDON, V522, P333, DOI 10.1111/j.1469-7793.2000.t01-2-00333.x
   YAO SN, 1992, P NATL ACAD SCI USA, V89, P3357, DOI 10.1073/pnas.89.8.3357
NR 29
TC 46
Z9 51
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2004
VL 25
IS 9
BP 1649
EP 1655
DI 10.1016/S0142-9612(03)00520-9
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761PA
UT WOS:000187916100019
PM 14697866
DA 2018-10-19
ER

PT J
AU Le Ricousse-Roussanne, S
   Barateau, V
   Contreres, JO
   Boval, B
   Kraus-Berthier, L
   Tobelem, G
AF Le Ricousse-Roussanne, S
   Barateau, V
   Contreres, JO
   Boval, B
   Kraus-Berthier, L
   Tobelem, G
TI Ex vivo differentiated endothelial and smooth muscle cells from human
   cord blood progenitors home to the angiogenic tumor vasculature
SO CARDIOVASCULAR RESEARCH
LA English
DT Article
DE progenitors; vasculogenesis; cord blood
ID BONE-MARROW CELLS; VESSEL FORMATION; IN-VITRO; GROWTH-FACTORS;
   EXPRESSION; NEOVASCULARIZATION; HETEROGENEITY; RECRUITMENT; CONTRIBUTE;
   PRECURSOR
AB Objectives: Recent studies have provided increasing evidence that postnatal neovascularization does not rely exclusively on sprouting of preexisting vessels, but also involves bone marrow-derived circulating endothelial precursors (BM-EPCs). Animal studies revealed that neovascularization of ischemic tissue can be enhanced by BM-EPCs transplantation. But a possible limitation to the use of vascular precursors for therapeutic angiogenesis is the relatively low number of these cells. In this study, we demonstrate that ex vivo expanded differentiated endothelial cells (ECs) and smooth muscle cells (SMCs), may home to the tumor vasculature allowing targeting of transgene expression to the neoangiogenic site. Methods: Mononuclear cells (MNCs) or CD34(+)-enriched cells were purified from cord blood. We have defined culture conditions in which we observed two types of clones easily differentiated according to their morphology: cobblestone or spindle-shaped. Phenotypic characterization was assessed by immunocytochemistry, flow cytometry analysis and polymerase reaction with reverse transcription. Formation of capillary-like network in vitro was studied in three-dimensional collagen culture. And recruitment of these cells to a tumoral neoangiogenic site was assessed into tumor-bearing Severe Combined Immunodeficient (SCID) mouse model. Results: The cobblestone cells uniformly positive for CD31, VE-cadherin, vWF, VEGF R1 and R2, ecNOS and incorporating acetylated LDL were ECs. Spindle-shaped cells expressed alpha-smooth muscle actin (alpha-SMA), Smooth Muscle Heavy Chain (SMHC), SM22 and calponin. They also displayed a carbachol-induced contractility in a medium containing IGF1. So we concluded that spindle-shaped cells were SMCs. ECs and SMCs interacted with each other to form a capillary like network in three-dimensional type 1 collagen culture. Moreover, these ex vivo differentiated cells are able to home to the tumor vasculature. Conclusion: We provide evidence that progenitors for ECs and SMCs circulate in human cord blood and differentiate into functional ECs and SMCs. These differentiated cells could provide a biomaterial for vascular cell therapy, because of their homing capacity to the neovascularization site. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
C1 Hop Lariboisiere, Ctr Rech Assoc Claude Bernard, Inst Vaisseaux & Sang, F-75475 Paris 10, France.
   Hop Lariboisiere, Hematol Lab, F-75475 Paris, France.
   Inst Rech Servier, Div Expt Cancerol, F-92150 Suresnes, France.
RP Le Ricousse-Roussanne, S (reprint author), Hop Lariboisiere, Ctr Rech Assoc Claude Bernard, Inst Vaisseaux & Sang, 8 Rue Guy Patin, F-75475 Paris 10, France.
EM sophie.lericousse@lrb.ap-hop-paris.fr
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   BERANEK JT, 1995, LAB INVEST, V72, P771
   Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Choi K, 1998, DEVELOPMENT, V125, P725
   Davidoff AM, 2001, CLIN CANCER RES, V7, P2870
   de Bont ESJM, 2001, CANCER RES, V61, P7654
   DeRuiter MC, 1997, CIRC RES, V80, P444, DOI 10.1161/01.RES.80.4.444
   DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28
   Gehling UM, 2000, BLOOD, V95, P3106
   Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589
   Han CL, 2001, J VASC RES, V38, P113, DOI 10.1159/000051038
   Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48
   Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860
   Hellstrom M, 1999, DEVELOPMENT, V126, P3047
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kawamoto A, 2001, CIRCULATION, V103, P634
   Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071
   Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194
   MUROHARA T, 2000, J CLIN INVEST, V105, P1257
   Peichev M, 2000, BLOOD, V95, P952
   PESCE M, 2003, CIRC RES, P93
   Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403
   Shi Q, 1998, BLOOD, V92, P362
   Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121
   Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957
   Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8
   TUDER RM, 1994, AM J PATHOL, V144, P275
   VAJKOCZY P, 2003, J EXP MED, V12, P1755
   Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1
   WUNSCH AM, 1994, DEV BIOL, V165, P585, DOI 10.1006/dbio.1994.1278
   Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   YURUGIKOBAYASHI T, 2002, BLOOD
   Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599
NR 37
TC 58
Z9 60
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0008-6363
J9 CARDIOVASC RES
JI Cardiovasc. Res.
PD APR 1
PY 2004
VL 62
IS 1
BP 176
EP 184
DI 10.1016/j.cardiores.2004.01.017
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 808RT
UT WOS:000220586900019
PM 15023564
OA Bronze
DA 2018-10-19
ER

PT J
AU Tjandra, JJ
   Han, WR
   Rajendra, P
AF Tjandra, JJ
   Han, WR
   Rajendra, P
TI Injectable silicone biomaterial for faecal incontinence due to internal
   sphincter dysfunction is effective
SO DISEASES OF THE COLON & RECTUM
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY MAY 08-13, 2004
CL Dallas, TX
SP Amer Soc Colon & Rectal Surg
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD APR
PY 2004
VL 47
IS 4
BP 596
EP 596
PG 1
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 808MZ
UT WOS:000220574500094
DA 2018-10-19
ER

PT J
AU Jorge, JM
   Yusuf, S
   Alvarenga, C
   Habr-Gama, A
   Kiss, DR
   Gama-Rodrigues, JJ
AF Jorge, JM
   Yusuf, S
   Alvarenga, C
   Habr-Gama, A
   Kiss, DR
   Gama-Rodrigues, JJ
TI Trans-sphincteric injection of silicone biomaterial in the treatment of
   fecal incontinence due to internal anal sphincter defects
SO DISEASES OF THE COLON & RECTUM
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY MAY 08-13, 2004
CL Dallas, TX
SP Amer Soc Colon & Rectal Surg
NR 0
TC 1
Z9 1
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD APR
PY 2004
VL 47
IS 4
BP 612
EP 612
PG 1
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 808MZ
UT WOS:000220574500132
DA 2018-10-19
ER

PT J
AU Verey, F
   Munikrishnan, V
   Kenefick, NJ
   DeFriend, DJ
   Pullan, RD
AF Verey, F
   Munikrishnan, V
   Kenefick, NJ
   DeFriend, DJ
   Pullan, RD
TI A novel biomaterial (Permacol (R)) for use in complex abdominal wall
   reconstructions: Early results
SO DISEASES OF THE COLON & RECTUM
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY MAY 08-13, 2004
CL Dallas, TX
SP Amer Soc Colon & Rectal Surg
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD APR
PY 2004
VL 47
IS 4
BP 636
EP 636
PG 1
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 808MZ
UT WOS:000220574500186
DA 2018-10-19
ER

PT J
AU Danner, OK
   Eid, GM
   Mattar, SG
   Ramanathan, RC
   Hamad, GG
   Cottam, DR
   Schauer, PR
AF Danner, OK
   Eid, GM
   Mattar, SG
   Ramanathan, RC
   Hamad, GG
   Cottam, DR
   Schauer, PR
TI Laparoscopic paraesophageal hernia repair (LPEHR) with biomaterial mesh:
   Favorable short term results
SO GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT Digestive Disease Week/105th Annual Meeting of the
   American-Gastroenterological-Association
CY MAY 16-19, 2004
CL New Orleans, LA
SP Amer Gastroenterol Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD APR
PY 2004
VL 126
IS 4
SU 2
BP A800
EP A800
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 813EK
UT WOS:000220890203994
DA 2018-10-19
ER

PT J
AU Feng, D
   Aldrich, C
AF Feng, D
   Aldrich, C
TI Adsorption of heavy metals by biomaterials derived from the marine alga
   Ecklonia maxima
SO HYDROMETALLURGY
LA English
DT Article
DE biosorption; Ecklonia maxima; heavy metal; removal; particle size;
   regeneration
ID RHIZOPUS-ARRHIZUS BIOMASS; SACCHAROMYCES-CEREVISIAE; AQUEOUS-SOLUTIONS;
   SIMULTANEOUS BIOSORPTION; CADMIUM BIOSORPTION; ACCUMULATION LEAD;
   ION-EXCHANGE; EQUILIBRIUM; ALGINATE; REMOVAL
AB The adsorption of heavy metals onto biomaterial derived from the marine alga Ecklonia maxima was investigated via batch experiments. The adsorption equilibria of Cu, Ph and Cd could be represented by Langmuir isotherms and the capacity of fresh alga for Cu, Ph and Cd was approximately 85-94, 227-243 and 83.5 mg/g dry alga, respectively. The rate of adsorption onto the marine alga was high. The alga particle size played an important role in the adsorption behaviour. The coarse alga particles had a higher adsorption capacity and slower adsorption kinetics and could be regenerated without significant loss of capacity. In contrast, the fine alga particles had a lower adsorption capacity and faster adsorption kinetics and could not be regenerated without significant loss of capacity. Comparison with a commercial resin indicated that the activated biomass derived from E. maxima could be used as an efficient biosorbent for the treatment of waste waters containing heavy metals. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Stellenbosch, Dept Chem Engn, ZA-7602 Matieland, South Africa.
   Univ Melbourne, Dept Chem & Biomol Engn, Melbourne, Vic 3010, Australia.
RP Aldrich, C (reprint author), Univ Stellenbosch, Dept Chem Engn, Private Bag XI, ZA-7602 Matieland, South Africa.
EM cheming@ing.sun.ac.za
CR Barba D, 2001, HYDROMETALLURGY, V59, P89, DOI 10.1016/S0304-386X(00)00144-4
   BRADY JM, 1995, ENZYME MICROB TECH, V17, P791, DOI 10.1016/0141-0229(95)00142-R
   BREUER K, 1990, OECOLOGIA, V82, P461, DOI 10.1007/BF00319786
   BREUER K, 1990, OECOLOGIA, V82, P468, DOI 10.1007/BF00319787
   CHONG KH, 1995, BIOTECHNOL BIOENG, V47, P451, DOI 10.1002/bit.260470406
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   de Carvalho RP, 2001, HYDROMETALLURGY, V59, P407, DOI 10.1016/S0304-386X(00)00170-5
   DECARVALHO RP, 1994, BIOTECHNOL LETT, V16, P875, DOI 10.1007/BF00133971
   DESHKAR AM, 1990, WATER RES, V24, P1011, DOI 10.1016/0043-1354(90)90123-N
   Esposito A, 2001, HYDROMETALLURGY, V60, P129, DOI 10.1016/S0304-386X(00)00195-X
   Ferguson CR, 1989, BIOTECHNOLOGY MINERA, P193
   Fourest E, 1997, APPL BIOCHEM BIOTECH, V67, P215, DOI 10.1007/BF02788799
   FOUREST E, 1994, FEMS MICROBIOL REV, V14, P325
   FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   FREER J, 1989, J CHEM TECHNOL BIOT, V46, P41
   HOLAN ZR, 1993, BIOTECHNOL BIOENG, V41, P819, DOI 10.1002/bit.260410808
   HUANG CP, 1990, WATER RES, V24, P433, DOI 10.1016/0043-1354(90)90225-U
   Huang J. P., 1991, Heavy metals in the environment., P329
   JEFFERS TH, 1989, INT S BIOHYDR JACKS
   KUYUCAK N, 1989, BIOTECHNOL BIOENG, V33, P809, DOI 10.1002/bit.260330703
   Matheickal JT, 1997, ENVIRON TECHNOL, V18, P25, DOI 10.1080/09593331808616509
   Matheickal JT, 1996, WATER SCI TECHNOL, V34, P1, DOI 10.1016/S0273-1223(96)00780-9
   Matheickal JT, 1997, MINER ENG, V10, P947, DOI 10.1016/S0892-6875(97)00076-9
   OZER D, 1994, ENVIRON TECHNOL, V15, P439
   Puranik PR, 1999, HYDROMETALLURGY, V52, P189, DOI 10.1016/S0304-386X(99)00017-1
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   Sag Y, 1995, CHEM ENG J BIOCH ENG, V60, P181, DOI 10.1016/0923-0467(95)03014-X
   Sag Y, 2000, HYDROMETALLURGY, V55, P165, DOI 10.1016/S0304-386X(99)00081-X
   Sag Y, 2001, HYDROMETALLURGY, V59, P77, DOI 10.1016/S0304-386X(00)00143-2
   SCHNEIDER IAH, 1995, MINER ENG, V8, P979, DOI 10.1016/0892-6875(95)00061-T
   SCOTT JA, 1992, BIOTECHNOL LETT, V14, P737, DOI 10.1007/BF01021653
   STRANDBERG GW, 1981, APPL ENVIRON MICROB, V41, P237
   TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821
   TSEZOS M, 1990, J CHEM TECHNOL BIOT, V48, P29
   Tsezos M, 2001, HYDROMETALLURGY, V59, P241, DOI 10.1016/S0304-386X(99)00056-0
   Veglio F, 1997, HYDROMETALLURGY, V44, P317, DOI 10.1016/S0304-386X(96)00058-8
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1111/j.1574-6976.1994.tb00102.x
   VOLESKY B, 1993, BIOTECHNOL BIOENG, V41, P826, DOI 10.1002/bit.260410809
   Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2
   Volesky Bohumil, 1990, BIOSORPTION HEAVY ME
   WHITE C, 1990, J CHEM TECHNOL BIOT, V49, P331
   YU Q, 1997, P AWWA 17 FED CONV, V2, P258
NR 45
TC 118
Z9 126
U1 3
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-386X
J9 HYDROMETALLURGY
JI Hydrometallurgy
PD APR
PY 2004
VL 73
IS 1-2
BP 1
EP 10
DI 10.1016/S0304-386X(03)00138-5
PG 10
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 805FJ
UT WOS:000220351900001
DA 2018-10-19
ER

PT J
AU Carmen, JC
   Roeder, BL
   Nelson, JL
   Beckstead, BL
   Runyan, CM
   Schaalje, GB
   Robison, RA
   Pitt, WG
AF Carmen, JC
   Roeder, BL
   Nelson, JL
   Beckstead, BL
   Runyan, CM
   Schaalje, GB
   Robison, RA
   Pitt, WG
TI Ultrasonically enhanced vancomycin activity against Staphylococcus
   epidermidis biofilms in vivo
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE ultrasound; vancomycin; Staphylococcus epidermidis; biofilm; implant
   infection
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; ESCHERICHIA-COLI BIOFILMS; BACTERIAL
   BIOFILMS; ANTIBIOTIC ACTION; ANTIMICROBIAL RESISTANCE; ULTRASOUND;
   INFECTIONS; PERMEABILITY; FREQUENCY; MECHANISM
AB Infection of implanted medical devices by Gram-positive organisms such as Staphylococcus ssp. is a serious concern in the biomaterial community. In this research the application of low frequency ultrasound to enhance the activity of vancomycin against implanted Staphylococcus epidermidis biofilms was examined. Polyethylene disks covered with a biofilm of S. epidermidis were implanted subcutaneously in rabbits on both sides of their spine. The rabbits received systemic vancomycin for the duration of the experiment. Following 24 h of recovery, one disk was insonated for 24 or 48 h while the other was a control. Disks were removed and viable bacteria counted. At 24 h of insonation, there was no difference in viable counts between control and insonated biofilms, while at 48 h of insonation there were statistically fewer viable bacteria in the insonated. biofilm. The S. epidermidis biofilms responded favorably to combinations of ultrasound and vancomycin, but longer treatment times are required for this Gram-positive organism than was observed previously for a Gram-negative species.
C1 Brigham Young Univ, Dept Chem Engn, Provo, UT 84602 USA.
   Brigham Young Univ, Dept Stat, Provo, UT 84602 USA.
   Brigham Young Univ, Dept Integrat Biol, Provo, UT 84602 USA.
   Brigham Young Univ, Dept Micro & Mol Biol, Provo, UT 84602 USA.
RP Pitt, WG (reprint author), Brigham Young Univ, Dept Chem Engn, Provo, UT 84602 USA.
EM pitt@byu.edu
RI Pitt, William/M-6647-2014
OI Runyan, Christopher/0000-0002-3985-7250
FU NHLBI NIH HHS [HL59923, R01 HL059923]
CR BADDOUR LM, 1984, J INFECT DIS, V150, P721, DOI 10.1093/infdis/150.5.721
   CARMEN JC, 2003, UNPUB J INFECT CHEMO
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2001, SCI AM, V285, P74, DOI 10.1038/scientificamerican0701-74
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Donlan RM, 2000, ASAIO J, V46, pS47, DOI 10.1097/00002480-200011000-00037
   NIKAIDO H, 1985, MICROBIOL REV, V49, P1
   NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831
   Peterson RV, 2000, COLLOID SURFACE B, V17, P219, DOI 10.1016/S0927-7765(99)00117-4
   Pitt WG, 2003, BIOTECHNOL PROGR, V19, P1038, DOI 10.1021/bp0340685
   PITT WG, 1994, ANTIMICROB AGENTS CH, V38, P2577, DOI 10.1128/AAC.38.11.2577
   Qian Z, 1997, COLLOID SURFACE B, V9, P239, DOI 10.1016/S0927-7765(97)00029-5
   Qian Z, 1997, ANN BIOMED ENG, V25, P69, DOI 10.1007/BF02738539
   Qian Z, 1999, J BIOMED MATER RES, V44, P198, DOI 10.1002/(SICI)1097-4636(199902)44:2<198::AID-JBM10>3.0.CO;2-P
   Rapoport N, 1997, ARCH BIOCHEM BIOPHYS, V344, P114, DOI 10.1006/abbi.1997.0176
   RAPOPORT N, 1998, ARCH BIOCHEM BIOPHYS, V362, P233
   Rediske AM, 1999, ANTIMICROB AGENTS CH, V43, P1211, DOI 10.1128/AAC.43.5.1211
   Rediske AM, 2000, ANTIMICROB AGENTS CH, V44, P771, DOI 10.1128/AAC.44.3.771-772.2000
   Rediske AM, 1999, LETT APPL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2672.1999.00461.x
   Rediske AM, 1998, J GEN APPL MICROBIOL, V44, P283, DOI 10.2323/jgam.44.283
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P367, DOI 10.1016/0195-6701(91)90043-8
   Sieradzki K, 1999, J CLIN MICROBIOL, V37, P39
   Sotozono C, 2002, CORNEA, V21, pS94, DOI 10.1097/01.ICO.0000032125.18742.26
   Steckelberg James M., 1994, P259
   Strahilevitz Jacob, 2002, Int J Infect Dis, V6 Suppl 1, pS38, DOI 10.1016/S1201-9712(02)90153-0
   Williams RG, 1997, J BIOMATER APPL, V12, P20, DOI 10.1177/088532829701200102
   Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9
NR 29
TC 61
Z9 72
U1 1
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD APR
PY 2004
VL 18
IS 4
BP 237
EP 245
DI 10.1177/0885328204040540
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 817AL
UT WOS:000221150300001
PM 15070512
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Han, B
   Bischof, JC
AF Han, B
   Bischof, JC
TI Thermodynamic nonequilibrium phase change behavior and thermal
   properties of biological solutions for cryobiology applications
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
ID AQUEOUS SALT-SOLUTIONS; UNIDIRECTIONAL SOLIDIFICATION; ANTIFREEZE
   PROTEINS; BINARY-SOLUTIONS; MASS-TRANSPORT; COUPLED HEAT;
   CRYSTALLIZATION; GLYCEROL; ICE; SYSTEMS
AB Understanding the phase change behavior of biomaterials during freezing/thawing including their thermal properties at low temperatures is essential to design and improve cryobiology applications such as cryopreservation and cryosurgery. However, knowledge of phase change behavior and thermal properties of various biomaterials is still incomplete, especially at cryogenic temperatures (less than or equal to -40degreesC). Moreover, in these applications, chemicals are often added to improve their outcome, which can result in significant variation in the phase change behavior and thermal properties from those of the original biomaterials. These chemical additives include cryoprotective agents (CPAs), antifreeze protein (AFP), or cryosurgical adjuvants like sodium chloride (NaCl). In the present study, phase change behavior and thermal properties of saline solutions-either water-NaCl or phosphate buffered saline (PBS)-with various chemical additives were investigated. The chemical additives studied are glycerol and raffinose as CPAs, an AFP (Type III, molecular weight = 6500), and NaCl as a cryosurgical adjuvant. The phase change behavior was investigated using a differential scanning calorimeter (DSC) and a cryomicroscope. The specific and latent heat of these solutions were also measured with the DSC The saline solutions have two distinct phase changes-water/ice and eutectic phase changes. During freezing, eutectic solidification a both water-NaCl and PBS are significantly supercooled below their thermodynamic equilibrium eutectic temperatures. However, their melting temperatures are close to thermodynamic equilibrium during thawing. These eutectic phase changes disappear when even a small amount (0.1 M glycerol) of CPA was added, but they are still observed after the addition of an AFP. The specific heats of these solutions are close to that of ice at very low temperatures (less than or equal to -100degreesC) regardless of the additives, but they increase between -100degreesC and -30degreesC with the addition of CPAs. The amount of latent heat, which is evaluated with sample weight, generally decreases with the addition of the additives, but can be normalized to approximately 300 J/g based on the weight of water which participates in the phase change. This illustrates that thermal properties, especially latent heat, of a biomaterial should be evaluated based on the understanding of its phase change behavior The results of the present study art, discussed in the context of the implications for cryobiology applications.
C1 Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA.
   Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
   Univ Minnesota, Dept Urol Surg, Minneapolis, MN 55455 USA.
RP Bischof, JC (reprint author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA.
EM bischof@umn.edu
FU NCI NIH HHS [5R29CA75284-05]
CR BALD WB, 1982, REP PROG PHYS, V45, P1381, DOI 10.1088/0034-4885/45/12/001
   BERRADA MS, 2000, ADV HEAT MASS TRANSF, V47, P41
   BICKFORD HR, 1979, CRYOBIOLOGY, V16, P569, DOI 10.1016/0011-2240(79)90075-0
   BOUTRON P, 1984, CRYOBIOLOGY, V21, P183, DOI 10.1016/0011-2240(84)90210-4
   BOUTRON P, 1986, CRYOBIOLOGY, V23, P88, DOI 10.1016/0011-2240(86)90022-2
   BOWMAN HF, 1975, ANNU REV BIOPHYS BIO, V4, P43, DOI 10.1146/annurev.bb.04.060175.000355
   Chato JC, 1985, HEAT TRANSFER MED BI, P167
   COOKE R, 1974, ANNU REV BIOPHYS BIO, V3, P95, DOI 10.1146/annurev.bb.03.060174.000523
   Devireddy RV, 2002, INT J HEAT MASS TRAN, V45, P1915, DOI 10.1016/S0017-9310(01)00290-3
   DILLER KR, 1999, BIOHEAT TRANSFER CRC, P4114
   DUMAN RS, 1993, RECEPTORS DEV NERVOU, V2, P1
   ECHLIN P, 1992, LOW TEMPERATURE MICR
   FAHY GM, 1980, BIOPHYS J, V32, P837, DOI 10.1016/S0006-3495(80)85019-3
   FAHY GM, 1988, LOW TEMPERATURE BIOT, V10, P113
   Fennema O. R., 1973, LOW TEMPERATURE PRES
   GREAVES RIN, 1965, P CRYOB C SPONS AM C, V24, pS253
   Han B, 2003, P SOC PHOTO-OPT INS, V4954, P106, DOI 10.1117/12.476533
   HAN B, 2002, ASME 2002 INT MECH E
   HAN B, 2002, CRYOBIOLOGY, V45, P217
   Hey JM, 1998, CRYOBIOLOGY, V37, P119, DOI 10.1006/cryo.1998.2108
   Hey JM, 1997, J THERM ANAL, V49, P991, DOI 10.1007/BF01996785
   Hobbs P. V., 1974, ICE PHYS
   IZUTSU K, 1995, CHEM PHARM BULL, V43, P1804
   KORBER C, 1983, INT J HEAT MASS TRAN, V26, P1241
   KORBER C, 1983, J CRYST GROWTH, V61, P307, DOI 10.1016/0022-0248(83)90367-6
   KOUROSH S, 1990, INT J HEAT MASS TRAN, V33, P39, DOI 10.1016/0017-9310(90)90139-L
   KOUROSH S, 1990, INT J HEAT MASS TRAN, V33, P29, DOI 10.1016/0017-9310(90)90138-K
   Koushafar H, 1997, J SURG ONCOL, V66, P114, DOI 10.1002/(SICI)1096-9098(199710)66:2<114::AID-JSO8>3.0.CO;2-G
   Macfarlane Douglas R., 1992, V1, P221
   MACFARLANE DR, 1987, CRYOBIOLOGY, V24, P181, DOI 10.1016/0011-2240(87)90022-8
   MACKENZIE AP, 1977, PHILOS T ROY SOC B, V278, P167, DOI 10.1098/rstb.1977.0036
   Mehl PL, 1996, ADV LOW TEM, V3, P185
   MULDREW K, 2001, CRYOBIOLOGY, V43, P388
   REY LR, 1960, ANN NY ACAD SCI, V85, P510, DOI 10.1111/j.1749-6632.1960.tb49979.x
   ROBARDS AW, 1985, LOW TEMPERATURE METH
   RUBINSKY B, 1991, BIOCHEM BIOPH RES CO, V180, P566, DOI 10.1016/S0006-291X(05)81102-7
   RUBINSKY B, 1985, CRYOBIOLOGY, V22, P55, DOI 10.1016/0011-2240(85)90008-2
   SHEPARD ML, 1976, CRYOBIOLOGY, V13, P9, DOI 10.1016/0011-2240(76)90154-1
   TONER M, 1993, J BIOMECH ENG-T ASME, V115, P169, DOI 10.1115/1.2894117
   Zhang H., 2002, CELL PRESERV TECHNOL, V1, P141
NR 40
TC 19
Z9 20
U1 1
U2 26
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD APR
PY 2004
VL 126
IS 2
BP 196
EP 203
DI 10.1115/1.1688778
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 819XN
UT WOS:000221349700008
PM 15179849
DA 2018-10-19
ER

PT J
AU Hinds, MT
   Courtman, DW
   Goodell, T
   Kwong, M
   Brant-Zawadzki, H
   Burke, A
   Fox, BA
   Gregory, KW
AF Hinds, MT
   Courtman, DW
   Goodell, T
   Kwong, M
   Brant-Zawadzki, H
   Burke, A
   Fox, BA
   Gregory, KW
TI Biocompatibility of a xenogenic elastin-based biomaterial in a murine
   implantation model: The role of aluminum chloride pretreatment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE elastin; biomaterial; calcification; inflammation; subdermal
ID RAT SUBDERMAL MODEL; CALCIFICATION; INHIBITION; MICE; MINERALIZATION;
   PREINCUBATIONS; TISSUES; ALCL3; LEADS; FECL3
AB We have investigated the long-term effect of aluminum chloride (AlCl3) treatment on the calcification and inflammatory reaction of a porcine elastin-derived biomaterial (PEB) in a novel subdermal adult mouse model. Untreated PEB disks and PEB treated with AlCl3 were implanted subdermally in BALB/c mice for 30, 60, and 180 days. The calcification of the elastin disks was examined with histological analysis and atomic absorption analysis of calcium content. The inflammatory reaction was evaluated both with histological analysis of explants and by an enzyme-linked immunosorbent assay of the serum in each mouse to determine the production of antielastin antibodies. Robust calcification was evident in all untreated PEBs with calcium levels of 107.1 +/- 11.8, 151.4 +/- 14.4, and 227.2 +/- 23.8 mug/mg for 30, 60, and 180 days, respectively. AlCl3 treatment only temporarily prevented the calcification of the elastin disks for 30 days. By 60 and 180 days, the AlCl3 treated materials had significant calcification with 88.7 +/- 17.4 and 105.3 +/- 27.0 mug/mg calcium, respectively. The inflammatory reaction was moderate for both types of implants. The A103-treated implants displayed significantly more macrophage and lymphocyte infiltration at 180 days after implantation, and a trend to higher humoral responses at 30 and 60 days when compared with untreated PEBs. We conclude that PEBs extensively calcify in the adult mice model. AlCl3, treatment of elastin enhances the long-term immunological response to xenogenic elastin implants and merely delays the onset of calcification. (C) 2004 Wiley Periodicals, Inc.
C1 Oregon Hlth & Sci Univ, Dept Biomed Engn, Beaverton, OR 97006 USA.
   Providence St Vincent Med Ctr, Oregon Med Laser Ctr, Portland, OR 97225 USA.
   Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada.
   Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada.
   Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA.
   Earle A Chiles Res Inst, Lab Mol & Tumor Immunol, Portland, OR 97213 USA.
RP Hinds, MT (reprint author), Oregon Hlth & Sci Univ, Dept Biomed Engn, 20000 NW Walker Rd, Beaverton, OR 97006 USA.
EM monica.hinds@bme.ogi.edu
CR Bailey M, 2001, AM J PATHOL, V159, P1981, DOI 10.1016/S0002-9440(10)63048-9
   BORGSTROMLINDBERG P, 1993, SWED DENT J, V17, P95
   Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260
   CRISSMAN RS, 1984, STAIN TECHNOL, V59, P171, DOI 10.3109/10520298409113851
   FINLAY JB, 1973, J MICROSC-OXFORD, V99, P57, DOI 10.1111/j.1365-2818.1973.tb03852.x
   Giachelli C M, 2001, Z Kardiol, V90 Suppl 3, P31
   Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6
   HEIM RA, 1991, MATRIX, V11, P359, DOI 10.1016/S0934-8832(11)80207-6
   HINDS MT, 2000, SOC BIOM WORLD C HAW
   Howe AM, 2000, INT J EXP PATHOL, V81, P51, DOI 10.1046/j.1365-2613.2000.00140.x
   Janzen J, 2001, Z Kardiol, V90 Suppl 3, P6
   Kaiitani M, 2001, ASAIO J, V47, P342, DOI 10.1097/00002480-200107000-00009
   Kajitani M, 2000, ASAIO J, V46, P409, DOI 10.1097/00002480-200007000-00007
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LEVY RJ, 1995, J BIOMED MATER RES, V23, P589
   Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0
   Meuris B, 2001, Semin Thorac Cardiovasc Surg, V13, P99
   Parhami F, 2001, Z Kardiol, V90 Suppl 3, P27
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011
   PAULE WJ, 1992, J BIOMED MATER RES, V26, P1169, DOI 10.1002/jbm.820260907
   Vyavahare N, 1999, AM J PATHOL, V155, P973, DOI 10.1016/S0002-9440(10)65197-8
   Vyavahare N, 2000, AM J PATHOL, V157, P885, DOI 10.1016/S0002-9440(10)64602-0
   Webb C L, 1990, ASAIO Trans, V36, pM408
   WEBB CL, 1992, AM J PATHOL, V141, P487
   WEBB CL, 1991, AM J PATHOL, V138, P971
NR 29
TC 14
Z9 17
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2004
VL 69A
IS 1
BP 55
EP 64
DI 10.1002/jbm.a.20109
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 803IK
UT WOS:000220224600007
PM 14999751
DA 2018-10-19
ER

PT J
AU Knabe, C
   Berger, G
   Gildenhaar, R
   Meyer, J
   Howlett, CR
   Markovic, B
   Zreiqat, H
AF Knabe, C
   Berger, G
   Gildenhaar, R
   Meyer, J
   Howlett, CR
   Markovic, B
   Zreiqat, H
TI Effect of rapidly resorbable calcium phosphates and a calcium phosphate
   bone cement on the expression of bone-related genes and proteins in
   vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium phosphate ceramics; human bone-derived cells; cell-biomaterial
   interactions; calcium phosphate cements; in situ hybridization
ID MESSENGER-RNA EXPRESSION; OSTEOBLAST-LIKE CELLS; BIOACTIVE GLASS;
   TRICALCIUM PHOSPHATE; POROUS HYDROXYAPATITE; OSTEOGENIC CULTURES;
   INTEGRIN EXPRESSION; SITU HYBRIDIZATION; IMPLANT MATERIALS; AUTOGENOUS
   BONE
AB The use of biodegradable bone substitutes is advantageous for alveolar ridge augmentation because it avoids second-site surgery for autograft harvesting. This study examines the effect of novel, rapidly resorbable calcium phosphates and a calcium phosphate bone cement on the expression of bone-related genes and proteins by human bone-derived cells (HBDCs) and compares this behavior to that of tricalciumphosphate (TCP). Test materials were alpha-TCP, two materials with a crystalline phase Ca2KNa(PO4)(2) and with a small amorphous portion containing either magnesium potassium phosphate (material denominated GB14) or silica phosphate (material denominated GB9), and a calcium phosphate bone cement (material denominated Biocement D). HBDCs were grown on the substrata for 3, 7, 14, and 21 days, counted, and probed for various rnRNAs and proteins (type I collagen, osteocalcin, osteopontin, osteonectin, alkaline phosphatase, and bone sialoprotein). All substrates supported continuous cellular growth for 21 days. In the presence of GB14 and Biocement D specimens cell proliferation was reduced and cell differentiation increased. At day 21, the greatest number of cells was found on GB9 expressing significantly higher levels of bone-related proteins than cells grown on all other surfaces. Because all novel materials facilitated the expression of the osteoblastic phenotype at least as much as TCP and the polystyrene control, these biomaterials can be regarded as excellent candidate bone substitute materials. GB9 induced the highest proliferation and cellular differentiation after 21 days of incubation, suggesting that this material may possess a higher potency for enhancing osteogenesis than TCP. (C) 2004 Wiley Periodicals, Inc.
C1 Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Expt Dent, D-14197 Berlin, Germany.
   UNSW, Fac Med, Sch Med Sci, Dept Pathol,Bone Biomat Unit, Sydney, NSW 2052, Australia.
   Fed Inst Mat Res & Testing, Lab Biomat, D-12200 Berlin, Germany.
   Merck Biomat GMBH, R&D, D-64271 Darmstadt, Germany.
   Univ New S Wales, Sch Safety Sci, Sydney, NSW 2052, Australia.
RP Knabe, C (reprint author), Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Expt Dent, Assmannshuser Str 4-6, D-14197 Berlin, Germany.
EM Christine.Knabe@medizin.fu-berlin.de
CR Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Aubin JE, 2000, BONE ENG, P19
   BATES RC, 1995, CANCER METAST REV, V14, P191, DOI 10.1007/BF00690291
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   BERGER G, 1995, BIOMATERIALS, V16, P1241, DOI 10.1016/0142-9612(95)98131-W
   BERGER G, 1995, BIOCERAMICS, V8, P453
   Bolind P, 1999, CLIN IMPLANT DENT R, V1, P33
   BUSER D, 1994, GUIDED BONE REGENERA, P189
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   Davies JE, 1996, ANAT REC, V245, P426
   DEBRUIJN JD, 1994, BIOMATERIALS, V15, P543, DOI 10.1016/0142-9612(94)90021-3
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUCHEYNE P, 1994, J CELL BIOCHEM, V56, P162, DOI 10.1002/jcb.240560207
   Ducheyne P, 1998, HIP SURG NEW MAT DEV, P179
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   FISHER LW, 1985, CLIN ORTHOP RELAT R, P362
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   GROSS UM, 1991, BONE-BIOMATERIAL INTERFACE, P308
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HOWLETT CR, 2000, BONE ENG, P240
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   KAHARI VM, 1987, MED SCI RES-BIOCHEM, V15, P417
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)00096-3
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   KHAIROUN I, 2002, J BIOMED MATER RES, V6, P633
   Knabe C, 1998, J MATER SCI-MATER M, V9, P337, DOI 10.1023/A:1008854930676
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Malaval L., 1999, J CELL BIOCHEM, V74, P16
   Merten HA, 2001, J CRANIOFAC SURG, V12, P59, DOI 10.1097/00001665-200101000-00010
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MULLERMAI C, 1997, BIOCERAMICS, V10, P53
   MULLERMAI CM, 2000, THESIS FREE U BERLIN
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Neo M, 1996, J BIOMED MATER RES, V30, P485, DOI 10.1002/(SICI)1097-4636(199604)30:4<485::AID-JBM6>3.0.CO;2-L
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Ohsawa K, 2000, J BIOMED MATER RES, V52, P460, DOI 10.1002/1097-4636(20001205)52:3<460::AID-JBM3>3.3.CO;2-L
   OLDBERG A, 1988, J BIOL CHEM, V263, P19430
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   Oreffo ROC, 1998, TISSUE ENG, V4, P293, DOI 10.1089/ten.1998.4.293
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Reis SA, 1996, CLIN ORAL IMPLAN RES, V7, P253, DOI 10.1034/j.1600-0501.1996.070307.x
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   RODAN GA, 1984, BONE MINERAL RES ANN, V2, P244
   Roeser Kerstin, 2000, Journal of Biomedical Materials Research, V51, P280
   SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   SCHNEIDER M, 1994, CRYST RES TECH, V26, P671
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615
   SODEK J, 1991, BONE-BIOMATERIAL INTERFACE, P97
   SODEK J, 2000, BONE ENG, P31
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 76
TC 50
Z9 53
U1 2
U2 16
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2004
VL 69A
IS 1
BP 145
EP 154
DI 10.1002/jbm.a.20131
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 803IK
UT WOS:000220224600018
PM 14999762
DA 2018-10-19
ER

PT J
AU Lee, YK
   Song, J
   Lee, SB
   Kim, KM
   Choi, SH
   Kim, CK
   LeGeros, RZ
   Kim, KN
AF Lee, YK
   Song, J
   Lee, SB
   Kim, KM
   Choi, SH
   Kim, CK
   LeGeros, RZ
   Kim, KN
TI Proliferation, differentiation, and calcification of preosteoblast-like
   MC3T3-E1 cells cultured onto noncrystalline calcium phosphate glass
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bond graft; calcium phosphate; MC3T3-E1 cell; proliferation;
   differentiation; calcification
ID IMPLANT MATERIALS; INVITRO; EXPRESSION; OSTEOBLASTS; TISSUE
AB The purpose of this study was to investigate calcium phosphate glass as a potential biomaterial for hard tissue repair. We prepared calcium phosphate glass using the system CaO-CaF2-P2O5-MgO-ZnO and cultured MC3T3-E1 cells onto the glass in alpha-MEM with beta-glycerophosphatase and ascorbic acid. Proliferation of the cells was determined to evaluate the biocompatibility of the prepared calcium phosphate glass. The alkaline phosphatase activity was measured to examine the osteoblast differentiation. Mineralization was evaluated by staining the calcium precipitates with Alizarin red. Culture onto the calcium phosphate glass exhibited no significant influence on cell proliferation compared to the polystyrene chosen as a control in this experiment (p > 0.05). The alkaline phosphatase activity in the experimental group, however, was enhanced by the calcium phosphate glass significantly at 10-18 days after incubation than that of the control group (p < 0.05). The promotion of bone-like tissue formation by the calcium phosphate glass was observed after 7 days and thereafter. The results of the present study indicate that the prepared calcium phosphate glass affects osteogenesis by increasing calcification of the extracellular matrix. (C) 2004 Wiley Periodicals, Inc.
C1 Yonsei Univ, Coll Dent, Med Sci & Engn Res Ctr, Seoul 120752, South Korea.
   Yonsei Univ, Brain Korea 21 Project Med Sci, Seoul 120752, South Korea.
   Yonsei Univ, Coll Dent, Dept Dent Biomat & Bioengn, Seoul 120752, South Korea.
   Yonsei Univ, Coll Dent, Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
   Yonsei Univ, Coll Dent, Dept Periodont, Seoul 120752, South Korea.
   NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
RP Kim, KN (reprint author), Yonsei Univ, Coll Dent, Med Sci & Engn Res Ctr, Seoul 120752, South Korea.
EM kimkn@yumc.yonsei.ac.kr
CR ABE Y, 1988, BIOCERAMICS, V1, P181
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DUCHEYNE P, 1985, J BIOMED MATER RES, V19, P273, DOI 10.1002/jbm.820190309
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   ITAKURA Y, 1988, J BIOMED MATER RES, V22, P613, DOI 10.1002/jbm.820220703
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   MCGEERUSSELL SM, 1958, J HISTOCHEM CYTOCHEM, V6, P22, DOI 10.1177/6.1.22
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   SIFFERT RS, 1951, J EXP MED, V93, P415, DOI 10.1084/jem.93.5.415
   STEIN GS, 1990, FASEB J, V4, P3111
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 18
TC 26
Z9 27
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2004
VL 69A
IS 1
BP 188
EP 195
DI 10.1002/jbm.a.20137
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 803IK
UT WOS:000220224600023
PM 14999767
DA 2018-10-19
ER

PT J
AU Tomlinson, DJ
   Mulling, CH
   Fakler, TM
AF Tomlinson, DJ
   Mulling, CH
   Fakler, TM
TI Invited review: Formation of keratins in the bovine claw: Roles of
   hormones, minerals, and vitamins in functional claw integrity
SO JOURNAL OF DAIRY SCIENCE
LA English
DT Review
DE keratin protein; laminitis; bovine hoof; nutrition
ID EQUINE HOOF WALL; EPIDERMAL GROWTH-FACTOR; DAIRY-COWS; WHITE LINE;
   PREDISPOSING FACTORS; STRATUM MEDIUM; ZINC-SULFATE; LAMINITIS; LAMENESS;
   CATTLE
AB Keratins are the characteristic structural proteins of the highly cornified epidermis of the skin, feathers, and hoof. Keratin proteins provide the structural basis for the unique properties of the biomaterial horn and its protective function against a wide range of environmental factors. Hoof horn is produced through a complex process of differentiation (keratinization) of epidermal cells. Formation and biochemical binding of keratin proteins and synthesis and exocytosis of intercellular cementing substance (ICS) are the hallmarks of keratinization. It is finalized by the programmed death of the living epidermal cells, i.e., cornification, that turns the living epidermal cells into dead horn cells. The latter. become connected by the intercellular cementing substance. The functional integrity of hoof horn essentially depends on a proper differentiation, i.e., keratinization of hoof epidermal cells. Keratinization of hoof epidermis is controlled and modulated by a variety of bioactive molecules and hormones. This process is dependent on an appropriate supply of nutrients, including vitamins, minerals, and trace elements. Regulation and control of differentiation and nutrient flow to the epidermal cells play a central role in determining the quality and, consequently, the functional integrity of hoof horn. Decreasing nutrient supply to keratinizing epidermal cells leads to horn production of inferior quality and increased susceptibility to chemical, physical, or microbial damage from the environment. A growing body of evidence suggests that hormones, vitamins, minerals, and trace elements play critical roles in the normal development of claw horn and correct keratin formation.
C1 Zinpro Corp, Eden Prairie, MN 55344 USA.
   Free Univ Berlin, Inst Vet Anat, D-14195 Berlin, Germany.
RP Tomlinson, DJ (reprint author), Zinpro Corp, Eden Prairie, MN 55344 USA.
EM dtomlinson@zinpro.com
CR BAGGOTT DG, 1988, BRIT VET J, V144, P534
   BALLANTINE HT, 2002, PROF ANIM SCI, V18, P211, DOI DOI 10.15232/S1080-7446(15)31524-2
   BRAZLE FK, 1993, J ANIM SCI S1, V71, P40
   Budras KD, 1996, AM J VET RES, V57, P444
   BUDRAS KD, 1989, AM J VET RES, V50, P1150
   CALHOUN ML, 1981, TXB VET HISTOLOGY, P404
   COMBS GF, 2000, P 2000 CORN NUTR C F, P40
   Cousins RJ, 1996, PRESENT KNOWLEDGE NU, P293
   CROSS RF, 1981, J AM VET MED ASSOC, V178, P704
   CURTIS CR, 1984, J DAIRY SCI, V67, P817, DOI 10.3168/jds.S0022-0302(84)81372-7
   Da Costa-Gomez C., 1998, P SOC NUTR PHYS, V7, P30
   Dale Beverly A., 1993, P79
   DEMERTZIS PN, 1973, VET REC, V93, P219, DOI 10.1136/vr.93.8.219
   EKFALCK A, 1990, J VET MED B, V37, P1, DOI 10.1111/j.1439-0450.1990.tb01019.x
   EKFALCK A, 1990, J VET MED A, V37, P481, DOI 10.1111/j.1439-0442.1990.tb00934.x
   ELIAS PM, 1981, ARCH DERMATOL RES, V270, P95, DOI 10.1007/BF00417155
   Fitzgerald T, 2000, J DAIRY SCI, V83, P338, DOI 10.3168/jds.S0022-0302(00)74884-3
   Fraser R. D. B., 1972, KERATIN THEIR COMPOS
   Fraser R. D. B., 1980, MECH PROPERTIES BIOL, P211
   GEYER H, 1998, 10 INT S LAM RUM, P192
   GIROUD A, 1951, ANN NY ACAD SCI, V53, P613, DOI 10.1111/j.1749-6632.1951.tb31963.x
   Goff JP, 1997, J DAIRY SCI, V80, P1260, DOI 10.3168/jds.S0022-0302(97)76055-7
   Green LE, 2002, J DAIRY SCI, V85, P2250, DOI 10.3168/jds.S0022-0302(02)74304-X
   GREENOUGH PR, 1991, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, P371
   GROSENBAUGH DA, 1991, EQUINE VET J, V23, P201, DOI 10.1111/j.2042-3306.1991.tb02755.x
   GROSENBAUGH DA, 1992, AM J VET RES, V53, P1859
   GROSENBAUGH DA, 1993, EQUINE PRACT, V15, P8
   Hart I. C., 1980, MONOGRAPHS ENDOCRINO, V15
   HART IC, 1978, J ENDOCRINOL, V77, P333, DOI 10.1677/joe.0.0770333
   Hedges J, 2001, J DAIRY SCI, V84, P1969, DOI 10.3168/jds.S0022-0302(01)74639-5
   Hendry KAK, 1999, J DAIRY RES, V66, P23, DOI 10.1017/S0022029998003288
   Hendry KAK, 1997, J DAIRY RES, V64, P475, DOI 10.1017/S002202999700229X
   HORST RL, 1986, J DAIRY SCI, V69, P604, DOI 10.3168/jds.S0022-0302(86)80445-3
   JOHNSON H D, 1976, Journal of Dairy Science, V59, P1603, DOI 10.3168/jds.S0022-0302(76)84413-X
   KEEN CL, 1996, PRESENT KNOWLEDGE NU, P334
   KEMPSON SA, 1993, VET REC, V132, P499, DOI 10.1136/vr.132.20.499
   KRANKE WW, 1993, GUIDEBOOK CYTOSKELET, P145
   LARSON L L, 1980, Journal of Animal Science, V51, P296
   LARSSON B., 1956, Nordisk Veterinaermedicin, V8, P761
   LEACH DH, 1993, ACTA ANAT, V147, P45
   Linder M., 1996, PRESENT KNOWLEDGE NU, P307
   MARQUARDT JP, 1977, J DAIRY SCI, V60, P929, DOI 10.3168/jds.S0022-0302(77)83965-9
   Maynard LA, 1979, ANIMAL NUTR
   MERCER EH, 1961, KERATIN KERATINIZATI
   MEYER K, 1998, P 10 INT S LAM RUM, P210
   Miller J. K., 1988, THE RUMINANT ANIMAL, P342
   MILNE F, 1985, EQUINE PRACT, V7, P32
   Mock DM, 1996, PRESENT KNOWLEDGE NU, P220
   MOORE C L, 1989, Transactions of the Illinois State Academy of Science, V82, P99
   Mulling C, 1998, WIEN TIERARZTL MONAT, V85, P216
   MULLING C, 1997, P 9 INT C PROD DIS F, P396
   Mulling C, 2002, RECENT ADV BOVINE ME, P2
   Mulling C., 2000, 11 INT S DIS RUM DIG, P78
   MULLING C, 1998, P 10 INT S LAM RUM L, P176
   Mulling C K, 2000, Folia Morphol (Warsz), V59, P239
   Mulling CKW, 1999, ANAT HISTOL EMBRYOL, V28, P103
   National Research Council, 2001, NUTR REQ DAIR CATTL
   Nocek JE, 2000, J DAIRY SCI, V83, P1553, DOI 10.3168/jds.S0022-0302(00)75028-4
   Nocek JE, 1997, J DAIRY SCI, V80, P1005, DOI 10.3168/jds.S0022-0302(97)76026-0
   Norman AW, 1996, PRESENT KNOWLEDGE NU, P120
   O'Dell B. L, 1990, PRESENT KNOWLEDGE NU, P261
   OLSON JA, 1996, PRESENT KNOWLEDGE NU, P109
   PARRY DAD, 1995, INTERMEDIATE FILAMEN, P9
   PLAUT K, 1993, J DAIRY SCI, V76, P1526, DOI 10.3168/jds.S0022-0302(93)77485-8
   Potzsch CJ, 2003, J DAIRY SCI, V86, P2577, DOI 10.3168/jds.S0022-0302(03)73852-1
   Puls R., 1984, MINERAL LEVELS ANIMA
   Smart M, 1997, LAMENESS CATTLE
   Sokol RJ., 1996, PRESENT KNOWLEDGE NU, P130
   Steinert P.M., 1984, J CELL BIOL, V99, P22
   STEINERT PM, 1975, BIOCHEM J, V151, P603, DOI 10.1042/bj1510603
   VERMUNT JJ, 1994, BRIT VET J, V150, P151
   VERMUNT JJ, 1994, P 8 INT S DIS RUM DI, P236
   Vernon R. G., 1988, Nutrition and lactation in the dairy cow. Proceedings of the 46th University of Nottingham Easter School in Agricultural Science., P32
   WARD WH, 1954, ADV PROTEIN CHEM, V9, P243, DOI 10.1016/S0065-3233(08)60208-9
   Warnick LD, 2001, J DAIRY SCI, V84, P1988, DOI 10.3168/jds.S0022-0302(01)74642-5
   WEDEKIND KJ, 1992, J ANIM SCI, V70, P178
   Weiss W. P., 2000, P CORN NUTR C CORN U, P22
NR 77
TC 85
Z9 87
U1 1
U2 29
PU AMER DAIRY SCIENCE ASSOC
PI SAVOY
PA 1111 N DUNLAP AVE, SAVOY, IL 61874 USA
SN 0022-0302
J9 J DAIRY SCI
JI J. Dairy Sci.
PD APR
PY 2004
VL 87
IS 4
BP 797
EP 809
DI 10.3168/jds.S0022-0302(04)73223-3
PG 13
WC Agriculture, Dairy & Animal Science; Food Science & Technology
SC Agriculture; Food Science & Technology
GA 811QL
UT WOS:000220786300003
PM 15259213
DA 2018-10-19
ER

PT J
AU Harris, LG
   Richards, RG
AF Harris, LG
   Richards, RG
TI Staphylococcus aureus adhesion to different treated titanium surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 18th European Conference on Biomaterials
CY OCT 01-04, 2003
CL Stuttgart, GERMANY
ID BACTERIAL ADHESION; BIOFILM FORMATION; INFECTIONS; BIOMATERIALS;
   EPIDERMIDIS; MICROSCOPY; ROUGHNESS; POLYMER; ENERGY
AB Staphylococcus aureus is a major pathogen, associated with medical-device related infections. Converting biomaterial surfaces into non-interactive surfaces requires a specific surface/interface design. One approach is to polish the surface, and a second is to coat the surface with an antimicrobial or protein resistant coating. This study showed that polishing a titanium surface or coating titanium with various treatments that decreased the surface's coefficient of friction, had no significant effect on minimising S. aureus adhesion to these surfaces under static conditions in comparison to standard medical grade titanium. The cell promoting coating, TAST, was found to increase the S. aureus density on its surface as expected. The only coating that significantly decreased the density of adhering S. aureus was the titanium surface coated with sodium hyaluronate. Thus such a coating could have potential use as a coating for ostoesynthesis, orthopaedic or dental implants. (C) 2004 Kluwer Academic Publishers.
C1 AO Res Inst, CH-7270 Davos, Switzerland.
RP Richards, RG (reprint author), AO Res Inst, Clavadelerstr, CH-7270 Davos, Switzerland.
EM geoff.richards@aofoundation.org
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480; Harris, Llinos/0000-0002-0295-3038
CR An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   ANSELME K, 2000, J BIOMED MATER RES, V49, P1556
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Cassinelli C, 2000, J BIOMAT SCI-POLYM E, V11, P961, DOI 10.1163/156856200744138
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Francois P, 1996, INFECT CONT HOSP EP, V17, P514
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   HARRIS LG, 2004, IN PRESS BIOMATERIAL
   HOYLE BD, 1991, PROG DRUG RES, V37, P41
   Koerner RJ, 2002, BIOMATERIALS, V23, P2835, DOI 10.1016/S0142-9612(01)00404-5
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   NAGAOKA S, 1995, ASAIO J, V41, pM365, DOI 10.1097/00002480-199507000-00032
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Pavesio A, 1997, Med Device Technol, V8, P20
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43, DOI 10.1111/j.1365-2818.1995.tb03532.x
   STICKLER DJ, 1995, CELL MATER, V5, P167
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   VERHEYEN CCPM, 1993, BIOMATERIALS, V14, P383, DOI 10.1016/0142-9612(93)90059-B
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   XIAO SJ, 2001, TITANIUM MED, P649
NR 26
TC 71
Z9 74
U1 2
U2 15
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2004
VL 15
IS 4
BP 311
EP 314
DI 10.1023/B:JMSM.0000021093.84680.bb
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 805XN
UT WOS:000220399100003
PM 15332591
DA 2018-10-19
ER

PT J
AU Renner, L
   Jorgensen, B
   Markowski, M
   Salchert, K
   Werner, C
   Pompe, T
AF Renner, L
   Jorgensen, B
   Markowski, M
   Salchert, K
   Werner, C
   Pompe, T
TI Control of fibronectin displacement on polymer substrates to influence
   endothelial cell behaviour
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 18th European Conference on Biomaterials
CY OCT 01-04, 2003
CL Stuttgart, GERMANY
ID EXTRACELLULAR-MATRIX; ADSORPTION; PROTEINS; DIFFERENTIATION; DESORPTION;
   KINETICS; SURFACE; SYSTEM
AB Thin layered biomaterial surfaces of maleic anhydride copolymers are provided as a versatile platform for biomaterial applications. The provided comonomers define the character of the surface and its behaviour towards biomolecules and biosystems, such as proteins and cells. The kinetics of adsorption, desorption, and exchange of fibronectin and human serum albumin were investigated on different copolymer surfaces. Two different species of adsorbed proteins were found, a fast and a slow desorbing one. Furthermore, the exchange process depends on the kind of pre-adsorbed protein and the kind of exchange protein, as well as of the hydrophobicity of the copolymer surface. In this context adhesion, proliferation, and differentiation of endothelial cells from the umbilical cord vein onto fibronectin pre-coated surfaces were studied. Strong correlation between fibronectin exchange characteristics and the formation of focal adhesions, reorganisation of fibronectin, and generation of vascular-like structures by the cells was observed. (C) 2004 Kluwer Academic Publishers.
C1 Inst Polymer Res Dresden, D-01069 Dresden, Germany.
   Max Bergmann Ctr Biomat Dresden, D-01069 Dresden, Germany.
RP Pompe, T (reprint author), Inst Polymer Res Dresden, Hohe Str 6, D-01069 Dresden, Germany.
EM pompe-tilo@ipfdd.de
RI Umlauf, Ursula/D-3356-2014; Renner, Lars/D-6291-2012; Werner,
   Carsten/F-8127-2010
OI Renner, Lars/0000-0003-0178-1788; Werner, Carsten/0000-0003-0189-3448;
   Pompe, Tilo/0000-0003-1508-4959
CR Ball V, 1996, LANGMUIR, V12, P1614, DOI 10.1021/la950735v
   EVANS JW, 1993, REV MOD PHYS, V65, P1281, DOI 10.1103/RevModPhys.65.1281
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Giacomelli CE, 2001, J COLLOID INTERF SCI, V233, P234, DOI 10.1006/jcis.2000.7219
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Hibbert DB, 2002, LANGMUIR, V18, P1770, DOI 10.1021/la015567n
   HUETZ P, 1995, LANGMUIR, V11, P3145, DOI 10.1021/la00008a046
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   INGBER DE, 2002, CIRC RES, V15, P877
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Krasteva N, 2001, J BIOMAT SCI-POLYM E, V12, P613, DOI 10.1163/156856201316883449
   Pompe T, 2003, BIOMACROMOLECULES, V4, P1072, DOI 10.1021/bm034071c
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   POMPE T, 2003, IN PRESS TISSUE ENG, V10
   Salchert K, 2003, J CHROMATOGR A, V1005, P113, DOI 10.1016/S0021-9673(03)00932-4
NR 15
TC 14
Z9 14
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2004
VL 15
IS 4
BP 387
EP 390
DI 10.1023/B:JMSM.0000021107.12809.8d
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 805XN
UT WOS:000220399100016
PM 15332604
DA 2018-10-19
ER

PT J
AU Ball, MD
   Sherlock, R
   Glynn, T
AF Ball, MD
   Sherlock, R
   Glynn, T
TI Cell interactions with laser-modified polymer surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 18th European Conference on Biomaterials
CY OCT 01-04, 2003
CL Stuttgart, GERMANY
ID HUMAN ENDOTHELIAL-CELLS; IN-VITRO; ADHESION
AB The performance of a polymeric biomaterial depends on the bulk and surface properties. Often, however, the suitability of the surface properties is compromised in favour of the bulk properties. Altering the surface properties of these materials will have a profound effect on how cells and proteins interact with them. Here, we have used an excimer laser to modify the surface wettability of nylon 12. The surface treatment is rapid, cost-effective and can cause reproducible changes in the surface structure of the polymers. Polymers were treated with short wavelength ( < 200 nm) UV light. These wavelengths have sufficient photon energy (6.4 eV) to cause bond scission at the material surface. This results in a surface reorganisation with incorporation of oxygen. Surface wettability changes were confirmed using contact angle measurements. Cell interactions with the surfaces were examined using 3T3 fibroblast and HUVEC cells. Cells morphology was examined using a confocal laser scanning microscope (CLSM). Cell activity and cell number on the treated nylon were assessed using biochemical assays for up to seven days. Both fibroblasts and endothelial cells initially proliferated better on treated compared with untreated samples. However, over seven days activity decreased for both cell types on the control samples and endothelial cell activity and cell number also decreased on the treated polymer. (C) 2004 Kluwer Academic Publishers.
C1 Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
   Natl Univ Ireland Univ Coll Galway, Natl Ctr Laser Applicat, Galway, Ireland.
RP Ball, MD (reprint author), Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
EM michael.ball@nuigalway.ie
CR Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Dadbin S, 2002, EUR POLYM J, V38, P2489, DOI 10.1016/S0014-3057(02)00134-9
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P813, DOI 10.1007/BF00134323
   Ozdemir M, 1998, TRENDS FOOD SCI TECH, V9, P159, DOI 10.1016/S0924-2244(98)00035-1
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Pu FR, 2002, BIOMATERIALS, V23, P4705, DOI 10.1016/S0142-9612(02)00219-3
   Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969
   SHWARTZ MA, 2002, NATURE CELL BIOL, V4, pE65
NR 10
TC 15
Z9 16
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2004
VL 15
IS 4
BP 447
EP 449
DI 10.1023/B:JMSM.0000021118.85955.4a
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 805XN
UT WOS:000220399100027
PM 15332615
DA 2018-10-19
ER

PT J
AU Schiff, JD
   Li, PS
   Goldstein, M
AF Schiff, JD
   Li, PS
   Goldstein, M
TI A randomized, prospective study of biomaterial membranes and sealants
   for microsurgical vasovasostomy (VV) and vasoepididymostomy (VE) in rats
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the American-Urological-Association
CY MAY 08-13, 2004
CL San Francisco, CA
SP Amer Urol Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2004
VL 171
IS 4
SU S
BP 510
EP 511
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA 807IP
UT WOS:000220495501928
DA 2018-10-19
ER

PT J
AU Sotome, S
   Uemura, T
   Kikuchi, M
   Chen, J
   Itoh, S
   Tanaka, J
   Tateishi, T
   Shinomiya, K
AF Sotome, S
   Uemura, T
   Kikuchi, M
   Chen, J
   Itoh, S
   Tanaka, J
   Tateishi, T
   Shinomiya, K
TI Synthesis and in vivo evaluation of a novel
   hydroxyapatite/collagen-alginate as a bone filler and a drug delivery
   carrier of bone morphogenetic protein
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT International Symposium on Cell Biomechanics and Tissue Engineering
CY SEP   28, 2002
CL Univ Tokyo, Tokyo, JAPAN
HO Univ Tokyo
DE hydroxyapatite/collagen composite; alginate; bone filler; carrier; bone
   morphogenetic protein
ID MESENCHYMAL STEM-CELLS; POROUS HYDROXYAPATITE; RHBMP-2; OSTEOGENESIS;
   OSTEOINDUCTION; IMPLANTATION; BIOMATERIAL; ENDOSTATIN; COMPOSITE;
   POLYMER
AB Recently, hydroxyapatite/collagen (HAp/Col) nanocomposites incorporated into bone remodeling processes have been developed. Because bone tissue reaction to the composites is obviously suitable for bone tissue engineering, a novel HAp/Col-alginate hybrid, material, as one variety of the HAp/Col implants, was prepared to expand the limited applications of the composite. The ability of HAp/Col-alginate as a bone filler was investigated in the rat femur and as a carrier of BMP using an ectopic bone formation model. Active bone formation around the material and tissue invasion into the material were observed throughout the experiment in bone, compared to those observed for simple alginate and porous HA. Furthermore, HAp/Col-alginate was investigated as a carrier of recombinant human bone morphogenetic protein 2 (rh-BMP2). The HAp/Col-alginate (20 mul) with the rh-BMP2 (100 mug/ml, 15 mul) showed bone formation throughout the implant 5 weeks after implantation without obvious deformation of the material, whereas bone formation was observed only in a part of a squashed collagen sponge. (C) 2004 Elsevier B.V. All rights reserved.
C1 Tokyo Med & Dent Univ, Dept Orthopaed & Spinal Surg, Grad Sch, Bunkyo Ku, Tokyo 1138519, Japan.
   Natl Inst Adv Ind Sci & Technol, Tsuuba Res Ctr, Tsukuba, Ibaraki 3058562, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   Univ Tokyo, Grad Sch Engn, Biomed Engn Lab, Bunkyo Ku, Tokyo 1138656, Japan.
RP Shinomiya, K (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed & Spinal Surg, Grad Sch, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
EM shinomiya.orth@tmd.ac.jp
RI Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   Alam MI, 2001, J BIOMED MATER RES, V54, P129, DOI 10.1002/1097-4636(200101)54:1<129::AID-JBM16>3.3.CO;2-4
   Becker TA, 2001, J BIOMED MATER RES, V54, P76, DOI 10.1002/1097-4636(200101)54:1<76::AID-JBM9>3.0.CO;2-V
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Dong J, 2002, BIO-MED MATER ENG, V12, P203
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.3.CO;2-T
   Joki T, 2001, NAT BIOTECHNOL, V19, P35
   Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.0.CO;2-Q
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Mahmood J, 2001, J BIOCHEM-TOKYO, V129, P163, DOI 10.1093/oxfordjournals.jbchem.a002828
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471
   Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1, DOI 10.2106/00004623-200100001-00001
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Santa-Comba A, 2001, J BIOMED MATER RES, V55, P396
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Tamura S, 2001, BONE, V29, P169, DOI 10.1016/S8756-3282(01)00498-7
   Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Yokota S, 2001, INT J PHARMACEUT, V223, P69, DOI 10.1016/S0378-5173(01)00728-1
NR 26
TC 62
Z9 66
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 1
PY 2004
VL 24
IS 3
BP 341
EP 347
DI 10.1016/j.msec.2003.12.003
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 814JS
UT WOS:000220971600005
DA 2018-10-19
ER

PT J
AU Tanabe, T
   Okitsu, N
   Yamauchi, K
AF Tanabe, T
   Okitsu, N
   Yamauchi, K
TI Fabrication and characterization of chemically crosslinked keratin films
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT International Symposium on Cell Biomechanics and Tissue Engineering
CY SEP   28, 2002
CL Univ Tokyo, Tokyo, JAPAN
HO Univ Tokyo
DE keratin; biomaterial; diepoxy crosslinker; biocompatibility
AB A film was prepared by casting the reduced keratin solution after mixing with chemical crosslinkers such as ethylene glycol diglycidyl ether (EGDE) and glycerol diglycidyl ether (GDE). Although the keratin without an addition of a plasticizer gave rise to a fragile film, the keratin treated with those crosslinkers gave a tenacious and flexible film similarly to the mixing with chitosan, which we previously reported [Biomaterials 23 (2002) 817]. Chemically crosslinked keratin films stretched longer than keratin-chitosan composite film and showed much improved waterproof characteristics, that is, no swelling was observed under acidic and neutral aqueous conditions and they swelled to a lesser extent under basic condition, although keratin-chitosan composite film significantly swelled in acidic and neutral solution. Chemically crosslinked keratin film as well as keratin-chitosan composite film maintained their mechanical properties upon re-drying after swelling. When mouse fibroblast cells are cultured on crosslinked keratin-coated surface, the attachment of cells is a little delayed compared with the cells on keratin, keratin-chitosan composite and chitosan films. However, the cells once attached to the crosslinked keratin surface well proliferated, suggesting the biocompatibility of chemically crosslinked keratin film. (C) 2004 Elsevier B.V. All rights reserved.
C1 Osaka City Univ, Sch Engn, Dept Bioappl Chem, Osaka 5588585, Japan.
RP Yamauchi, K (reprint author), Osaka City Univ, Sch Engn, Dept Bioappl Chem, 3-3-13 Sugimoto, Osaka 5588585, Japan.
EM yamauchi@bioa.eng.osaka-cu.ac.jp
CR DOWLING LM, 1986, BIOCHEM J, V236, P705, DOI 10.1042/bj2360705
   RATNER BD, 1975, J BIOMED MATER RES, V9, P407, DOI 10.1002/jbm.820090505
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Yamauchi K, 1997, COLLOID SURFACE B, V9, P117, DOI 10.1016/S0927-7765(96)01322-7
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
NR 7
TC 85
Z9 92
U1 3
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 1
PY 2004
VL 24
IS 3
BP 441
EP 446
DI 10.1016/j.msec.2003.11.004
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 814JS
UT WOS:000220971600022
DA 2018-10-19
ER

PT J
AU Watanabe, Y
   Iwamoto, T
   Teramoto, A
   Abe, K
   Ohkoshi, Y
AF Watanabe, Y
   Iwamoto, T
   Teramoto, A
   Abe, K
   Ohkoshi, Y
TI Biodegradability of poly (L-lactic acid) functionally graded materials
   with hardness gradient
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; poly(L-lactic acid) (PLLA); functionally graded material
   (FGM); hardness; extrusion; biodegradability
ID POLY(L-LACTIC ACID)
AB The aim of this study is to develop a functionally graded material (FGM) of biodegradable poly (L-lactic acid) (PLLA) with a hardness gradient. For this purpose, the PLLA was extruded at elevated temperatures to introduce molecular orientation. Two types of extrusion, direct extrusion and equal channel angular (ECA) extrusion, were carried out. Heat treatment without extrusion was also carried out at 50degreesC, 60degreesC and 70degreesC. For the mechanical property characterization, the hardness distributions were investigated using a Vickers microhardness tester. Biodegradability of PLLA FGM was measured by evaluating the mass decreasing ratio after incubation in a physiological saline solution at 37degreesC. It was found that the PLLA FGMs with symmetric and asymmetric hardness gadients could be fabricated by direct extrusion and ECA extrusion at elevated temperature, respectively. Although in the initial state the mass of PLLA gradually increased with the softening of the FGM. it started to decrease after two weeks.
C1 Shinshu Univ, Dept Funct Machinery & Mech, Ueda, Nagano 3868567, Japan.
   Shinshu Univ, Dept Funct Polymer Sci, Ueda, Nagano 3868567, Japan.
   Shinshu Univ, Dept Text Syst Engn, Ueda, Nagano 3868567, Japan.
RP Iwamoto, T (reprint author), Shinshu Univ, Dept Funct Machinery & Mech, Ueda, Nagano 3868567, Japan.
CR CALLISTER WD, 1997, MAT SCI ENG INTRO, P437
   DIETER GE, 1988, MECH METALLURGY, P616
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   Hirakawa K, 1997, J BIOMED MATER RES, V36, P529, DOI 10.1002/(SICI)1097-4636(19970915)36:4<529::AID-JBM11>3.0.CO;2-5
   Karduna AR, 1997, J BONE JOINT SURG AM, V79A, P1166, DOI 10.2106/00004623-199708000-00008
   Liu LJ, 2000, BIOMACROMOLECULES, V1, P350, DOI 10.1021/bm000046k
   Miyamoto Y., 1999, FUNCTIONALLY GRADED, P1
   Nakashima K, 1998, ACTA MATER, V46, P1589, DOI 10.1016/S1359-6454(97)00355-8
   Ohkoshi Y, 1999, SEN-I GAKKAISHI, V55, P21, DOI 10.2115/fiber.55.21
   Park A, 1996, J BIOMED MATER RES, V31, P117
   SCHILLER C, 2001, CERAMIC T, V114, P675
   SEGAL VM, 1995, MAT SCI ENG A-STRUCT, V197, P157, DOI 10.1016/0921-5093(95)09705-8
   Semiatin SL, 2000, ACTA MATER, V48, P1841, DOI 10.1016/S1359-6454(00)00019-7
   TSUJI H, 1995, POLYMER, V36, P2675
   Watanabe Y, 2000, RRD MET MAT SCI, V4, P51
   Yamamoto A, 2002, J BIOMED MATER RES, V59, P176, DOI 10.1002/jbm.1231
NR 16
TC 6
Z9 8
U1 0
U2 4
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1005
EP 1009
DI 10.2320/matertrans.45.1005
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900007
OA Bronze
DA 2018-10-19
ER

PT J
AU Okuyama, M
   Kobayashi, J
   Take, S
   Itoi, Y
AF Okuyama, M
   Kobayashi, J
   Take, S
   Itoi, Y
TI Effect of plasma spray and surface sealing treatment of Ni-Ti shape
   memory alloy applying to biomaterials
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 15th International Corrosion Congress
CY SEP 22-27, 2002
CL GRANADA, SPAIN
DE biomaterial; nickel-titanium shape memory alloy; plasma-spray; sealing
   method; physical evaporation deposition (PVD)
ID IMPLANTATION; CORROSION; BEHAVIOR; TITANIUM
AB Sealing treatment for the porous titanium layers was performed in attempt to prevent cytotoxic nickel ions releasing, from porous titanium plasma-sprayed Ni-Ti alloys due to the existence of-chloride ions in the body liquid. Two types of sealants were used for this purpose, one was a group of biocompatible polymer resins and the other was metallic titanium. As polymer sealants, 4 kinds of resins (silicone. cyanoacryl resin, epoxy resin and polyamide resin) were used. The first three sealants were soaked into the porous coating layers after dilution by organic solvents, while the thermoplastic polyamide resin was melted and then penetrated into them. On the other hand, physical evaporation deposition (PVD) technique was employed for scaling with titanium metal. The effect of combination of the thickness of the plasma-sprayed layers and the amount of titanium deposited by PVD was investigated. The effectiveness of the sealants was evaluated by electrochemical polarization measurement. The adhesion test of the coating layer to the alloy substrate was also carried out. Among the polymer sealants, the polyamide resin showed excellent performance. As for the titanium PVD sealing, optimum combinations of the thickness of the coating layers and the amount of titanium PVD existed for both corrosion resistance and adhesion strength.
C1 Oyama Natl Coll Technol, Oyama 3230806, Japan.
RP Okuyama, M (reprint author), Oyama Natl Coll Technol, Oyama 3230806, Japan.
CR COVINGTON JS, 1985, J PROSTHET DENT, V54, P127, DOI 10.1016/S0022-3913(85)80087-1
   DAI KR, 1993, INJURY, V24, P427
   GREEN SM, 1993, J MATER SCI LETT, V12, P618, DOI 10.1007/BF00465570
   HAYASHI T, 2003, ADHESIVE ADHESION TE, V5, P157
   IMANISHI Y, 1986, MED POLYM MAT, P8
   IMURA H, 1988, DENT METERIALS APPRA, V7, P106
   KAKIUCHI H, 1988, NEW EPOXY RESIN, P736
   KIMURA S, 1987, DENT MAT APPARATUS, V6, P73
   Knabe C, 2002, BIOMATERIALS, V23, P3235, DOI 10.1016/S0142-9612(02)00078-9
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   NAKAYAMA Y, 1989, BIOMATERIALS, V10, P420, DOI 10.1016/0142-9612(89)90134-8
   OKUYAMA M, 1999, J TECHNOLOGY ED, V8, P9
   OKUYAMA M, 2001, P 12 AS PAS CORR CON, V1, P143
   OKUYAMA M, 1995, J TECH ED ELECTROCHE, V4, P139
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   PESSALL N, 1971, ELECTROCHIM ACTA, V16, P1987, DOI 10.1016/0013-4686(71)85152-6
   RONDELI G, 1990, CORROS SCI, V50, P805
   SINH CC, 2000, J BIOMED MATER RES, V52, P395
   Solar RJ, 1979, ASTM STP, P259
   SUZUKI K, 1981, J DENT ENG, V57, P28
   Tan L, 2003, BIOMATERIALS, V24, P3931, DOI 10.1016/S0142-9612(03)00271-0
   THIERRY B, 2000, J BIOMED MATER RES, V51, P687
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   YAHIA LH, 1994, 94 INT S SHAP MEM MA, P616
   G1686 ASTM
NR 25
TC 2
Z9 2
U1 0
U2 11
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1045
EP 1053
DI 10.2320/matertrans.45.1045
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900014
OA Bronze
DA 2018-10-19
ER

PT J
AU Ogata, Y
   Takatugu, M
   Kunimasa, T
   Uenishi, K
   Kobayashi, KF
AF Ogata, Y
   Takatugu, M
   Kunimasa, T
   Uenishi, K
   Kobayashi, KF
TI Tensile strength and pseudo-elasticity oT YAG laser spot melted Ti-Ni
   shape memory alloy wires
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-nickel shape memory alloy; YAG laser; laser welding; tensile
   strength; pseudo-elasticity; biomaterial
ID STAINLESS-STEEL
AB In order to investigate the applicability of laser micro welding to the fabrication of medical devices, Ti-Ni shape memory alloy wires with pseudo-elasticity were micro spot melted by using YAG laser. By changing the melting parameters, such as laser power or pulse duration, the evolution in microstructure, tensile strength and pseudo-elasticity was investigated. Melted metal width decreased with decreasing the input energy and Pulse duration. The microstructure of melted areas was Cellular dendrite structures and that of heat affected areas was brown cell structure with a cell size of about 3similar to10mum. Tensile strength of spot melted wires was 30% lower than that of base metal. and the fracture occurred in melted areas with a brittle fracture surface. Although melted areas and heat affected areas did not show a pseudo-elasticity due to the larger grain size, minimizing the width of melted metal improved the overall pseudo-elasticity of spot melted samples. For the sample wires that were prepared by spot melting of cold rolled wires and by the subsequent heat treatment for shape memorizing, the pseudo-elasticity was improved because heat affected zone recrystallized to form fine grains.
C1 Osaka Univ, Grad Sch Engn, Dept Mfg Sci, Suita, Osaka 5650871, Japan.
RP Ogata, Y (reprint author), Osaka Univ, Grad Sch Engn, Dept Mfg Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
CR HAMANAKA H, 1997, FERRUM, V27, P30
   HIROSE A, 1990, J JPN I MET, V54, P262, DOI 10.2320/jinstmet1952.54.3_262
   MIYAZAKI S, 1996, MAT JAPAN, V35, P179
   TUBOI T, 2000, REV LASER ENG, V28, P413
   Uenishi K, 2003, P SOC PHOTO-OPT INS, V4830, P57, DOI 10.1117/12.499698
   Uenishi K, 2002, MATER TRANS, V43, P3083, DOI 10.2320/matertrans.43.3083
   YONEYAMA T, J JSNDI, V49, P420
NR 7
TC 29
Z9 30
U1 0
U2 23
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1070
EP 1076
DI 10.2320/matertrans.45.1070
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900018
OA Bronze
DA 2018-10-19
ER

PT J
AU Kim, HY
   Ohmatsu, Y
   Kim, JI
   Hosoda, H
   Miyazaki, S
AF Kim, HY
   Ohmatsu, Y
   Kim, JI
   Hosoda, H
   Miyazaki, S
TI Mechanical properties and shape memory behavior of Ti-Mo-Ga alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterial; smart material;
   titanium based alloy
ID MARTENSITIC TRANSFORMATIONS
AB Mechanical properties and shape memory behavior of Ti-Mo-Ga alloys were investigated in order to develop Ni-free biomedical shape memory alloys. The Ti-Mo-Ga alloys were fabricated by arc melting method. The ingots were cold-rolled tip to 95% reduction in thickness. The cold-rolled specimens were heat treated in the temperature range 673-1273K for 60s-3.6ks. The martensitic transformation temperature decreased with increase in Mo and Ga content. The maximum shape recovery strain was obtained in a solution treated Ti-6 at%Mo-3 at%Ga alloy. Mechanical properties and shape memory behavior strongly depend on heat treatment condition in the Ti-6 at%Mo-3 at%Ga. Premature failure was observed in specimens heat treated in the temperature range 673-773 K. Ultimate tensile strength decreased and fracture strain increased with increasing heat treatment temperature. Shape memory effect was obtained in specimens heat treated in the temperature range 1073-1273 K. The shape memory effect was due to the stress induced martensitic transformation yielding tensile deformation and the reverse transformation upon heating after unloading. The martensitic transformation start temperature increased and the yield stress decreased with increasing heat treatment temperature and time. Stable superclastic behavior was obtained in a Ti-7 at%Mo-4 at%Ga alloy at room temperature by cyclic tensile tests. The recovery strain exceeding 4% was achieved in the pre-strained Ti-7 at%Mo-4 at%Ga alloy.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Baker C., 1971, Metal Science Journal, V5, P92
   DAVIS R, 1979, ACTA METALL MATER, V27, P1041, DOI 10.1016/0001-6160(79)90192-5
   DAVIS R, 1979, J MATER SCI, V14, P712
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   MIYAZAKI S, 1990, ENG ASPECTS SHAPE ME, P452
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Ohmatsu Y, 2001, 4 PAC RIM INT C ADV, P1627
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
NR 16
TC 99
Z9 103
U1 0
U2 25
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1090
EP 1095
DI 10.2320/matertrans.45.1090
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900021
OA Bronze
DA 2018-10-19
ER

PT J
AU Maeshima, T
   Nishida, M
AF Maeshima, T
   Nishida, M
TI Shape memory properties of biomedical Ti-Mo-Ag and Ti-Mo-Sn alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; biomaterial; titanium-molybdenum-silver alloy;
   titanium-molybdenum-tin alloy; martensitic transformation
AB Shape memory properties of Ti-Mo-Ag and Ti-Mo-Sn alloys consisting of biocompatible elements were investigated. The alloys with appropriate combination of Mo and Ag or Sn showed nearly perfect shape memory effect in convenient bending and heating tests. Recoverable tensile strain is more than 3% in some of Ti-Mo-Ag and Ti-Mo-Sn alloys. Microstructure observations and X-ray diffraction measurements before and after tensile test revealed that stress induced beta to alpha" martensitic transformation was origin of the shape memory effect.
C1 Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.
   Kumamoto Univ, Dept Mat Sci & Engn, Kumamoto 8608555, Japan.
RP Maeshima, T (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.
RI nishida, minoru/E-4027-2012
CR *ASM INT, 1994, MAT PROP HDB TIT ALL, P7
   Furuhara T, 1998, MATER T JIM, V39, P31, DOI 10.2320/matertrans1989.39.31
   HAMADA T, 1988, P 6 WORLD C TIT, P877
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   Ikeda M., 2000, Journal of Japan Institute of Light Metals, V50, P435, DOI 10.2464/jilm.50.435
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LEI CY, 1992, P INT C MART TRANSF, P539
   *MAR CO LTD, 1993, MET DAT BOOK, P31
   OHYAMA H, 1995, P 8 WORLD C TIT, P2273
   SASANO H, 1984, P 5 INT C TIT, P1667
   Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745
   SUGIMOTO T, 1988, P 6 WORLD C TIT, P1069
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
NR 14
TC 114
Z9 117
U1 3
U2 42
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1096
EP 1100
DI 10.2320/matertrans.45.1096
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900022
OA Bronze
DA 2018-10-19
ER

PT J
AU Maeshima, T
   Nishida, M
AF Maeshima, T
   Nishida, M
TI Shape memory and mechanical properties of biomedical Ti-Sc-Mo alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; shape memory alloy; shape memory effect;
   titanium-scandium-molybdenum alloy; martensitic transformation
AB Ni-free Ti-Sc-Mo shape memory alloys are designed as a substitute for Ti-Ni alloys in the biomedical field. From results of bending and recovery test with heating, Ti-Sc-Mo alloys were found to have superior shape memory effect. The optimum composition for the shape memory effect was Ti-4.0 to 6.0Sc-6.0Mo alloys. The maximum shape recovery strain in the Ti-5.0Sc-6.0Mo alloy was 5.3% measured through cyclic tensile deformation. Vickers hardness and 0.2% proof stress were remarkably decreased and elongation was increased with Sc content. The marked grain refining was also achieved. The relationship between microstructure and mechanical properties was briefly discussed. Microstructure observations and XRD measurements before and after tensile deformation showed that the shape memory effect was associated with the stress induced beta to alpha" transformation.
C1 Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.
   Kumamoto Univ, Dept Mat Sci & Engn, Kumamoto 8608555, Japan.
RP Maeshima, T (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.
RI nishida, minoru/E-4027-2012
CR *ASM INT, 1994, MAT PROP HDB TIT ALL, P7
   Furuhara T, 1998, MATER T JIM, V39, P31, DOI 10.2320/matertrans1989.39.31
   HAMADA T, 1988, P 6 WORLD C TIT, P877
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   Ikeda M., 2000, Journal of Japan Institute of Light Metals, V50, P435, DOI 10.2464/jilm.50.435
   Ikeda M., 1992, Journal of Japan Institute of Light Metals, V42, P622
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LEI CY, 1992, P INT C MART TRANSF, P539
   *MAR CO LTD, 1993, MET DAT BOOK, P31
   OHYAMA H, 1995, P 8 WORLD C TIT, P2273
   SASANO H, 1984, P 5 INT C TIT, P1667
   Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745
   SUGIMOTO T, 1988, P 6 WORLD C TIT, P1069
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
NR 15
TC 53
Z9 54
U1 1
U2 19
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1101
EP 1105
DI 10.2320/matertrans.45.1101
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900023
OA Bronze
DA 2018-10-19
ER

PT J
AU Sakaguch, N
   Niinomi, M
   Akahori, T
AF Sakaguch, N
   Niinomi, M
   Akahori, T
TI Tensile deformation behavior of Ti-Nb-Ta-Zr biomedical alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the Japan-Institute-of-Metals
CY MAR 28, 2003
CL CHIBA, JAPAN
SP Japan Inst Metals
DE titanium alloy; super elastic deformation; shape memory biomaterial;
   powder metallurgy
ID MECHANICAL-PROPERTIES; INDUCED MARTENSITE; MICROSTRUCTURE; MO
AB The composition of Ti-30Nb-10Ta-5Zr, which is simplified that of the Ti-29Nb-13Ta-4.6Zr alloy developed for biomedical applications, was selected, and then Nb content in the basic composition was varied from 20 to 35%. The deformation mechanisms of such Ti-Nb-Ta-Zr system alloys were investigated by loading-unloading tensile tests and characterizing deformed microstructures. The behavior of unloading and reloading of the stress-strain curves up to strain about 2% of Ti-20Nb-10Ta-5Zr and Ti-25Nb-10Ta-5Zr alloys is similar to that obtained in metastable beta type titanium alloys where the stress induced martensite transformation occurs. This indicates that the stress and strain induced martensite transformation occurred in these alloys. Furthermore, the elastic deformation of Ti-30Nb-10Ta-5Zr alloy disobeys Hooke's law. However, the behavior of stress or strain-induced martensite transformation does not recognized in the stress-strain curve up to strain about 2% of this alloy. The main deformation mechanism up to fracture of Ti-20Nb-10Ta-5Zr alloy, Ti-25Nb-10Ta-5Zr alloy and Ti-35Nb-10Ta-5Zr alloy is identified as the deformation - induced martensite transformation of phase beta to alpha" phase, deformation-induced martensite transformation of beta phase to alpha" phase and deformation twin, and slip, respectively. The deformation mechanisms for Ti-30Nb-10Ta-5Zr alloy are not explained by slip, deformation twining and deformation-induced martensite transformation. However, the super elastic behavior observed in this alloy is expected to occur without deformation-induced martensite transformation.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Sakaguch, N (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Ahmed T., 1996, P 8 WORLD C TIT, P1760
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Grosdidier T, 2000, METALL MATER TRANS A, V31, P1095, DOI 10.1007/s11661-000-0105-3
   HANADA S, 1985, METALL TRANS A, V16, P789, DOI 10.1007/BF02814829
   HIDA M, 1980, J JPN I MET, V44, P436, DOI 10.2320/jinstmet1952.44.4_436
   IKEDA K, 2003, 104 SPRING M JAP I L, P409
   Kuroda D, 2000, TETSU TO HAGANE, V86, P610, DOI 10.2355/tetsutohagane1955.86.9_610
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Li SJ, 2002, MATER TRANS, V43, P2964, DOI 10.2320/matertrans.43.2964
   MAEJIMA T, 2003, 2003 SPRING M JAP I, P134
   MAEJIMA T, 2003, 2003 SPRING M JAP I, P135
   OHMORI Y, 2001, MAT SCI ENG A-STRUCT, V321, P182
   OKA M, 1978, J JPN I MET, V42, P814, DOI 10.2320/jinstmet1952.42.8_814
   Sakaguchi N, 2003, J JPN I MET, V67, P681, DOI 10.2320/jinstmet1952.67.11_681
   SAKAGUCHI N, 2003, P INT C ADV TECHN EX
   SAKAGUCHI N, 2003, 104 SPRING M JAP I L, P75
   TAKAHASHI E, 2003, 2003 SPRING M JAP I, P135
   YOSHITANI S, 2000, P 2000 POWD MET WORL, P1085
NR 19
TC 52
Z9 55
U1 2
U2 39
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1113
EP 1119
DI 10.2320/matertrans.45.1113
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900025
OA Bronze
DA 2018-10-19
ER

PT J
AU Peters, F
   Reif, D
AF Peters, F
   Reif, D
TI Functional materials for bone regeneration from beta-tricalcium
   phosphate
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE beta-tricalcium phosphate; porous; biomaterial; granules; block forms
ID BIODEGRADATION; HYDROXYAPATITE; DEGRADATION; CERAMICS
AB Biodegradable ceramics of beta-tricalcium phosphate (beta-TCP, Ca-3(PO4)(2)) are widely used as bone regeneration materials. The goal is a complete regeneration of the bony defect (restitutio ad integrum = full recovery). Different bioceramics made of beta-TCP show fundamental differences in terms of phase purity, primary particle size, stability, porosity, solubility and therefore biodegradation of the material.
   Cerasorb(R) is a bioceramic consisting of phase pure beta-TCP. The primary particle size in connection with a stable sinter structure forms a porous biomaterial which is optimised in the functional surface, porosity and resorption/degradation behaviour. Different forms of Cerasorb(R) are available: granular materials with high and low porosity optimised for specific indications as well as block forms shapeable by the surgeon for various bony defects.
C1 Cursan AG, Kleinostheim, Germany.
RP Peters, F (reprint author), Cursan AG, Lindigstr 4, Kleinostheim, Germany.
EM fabian.peters@curasan.de
CR *AM SOC TEST MAT, 1992, STAND SPEC BET TRIC
   BAUER G, 1989, CFI-CERAM FORUM INT, V66, P23
   BERGER G, 1998, BIOCERAMICS, V11, P121
   De Groot K., 1990, HDB BIOACTIVE CERAMI, V2
   DEGROOT K, 1988, ANN NY ACAD SCI, P227
   DENHOLLANDER W, 1991, BIOMATERIALS, V12, P569, DOI 10.1016/0142-9612(91)90053-D
   Eggli PS, 1987, BIOMATERIALS CLIN AP, P53
   FISCHERBRANDIES E, 1987, Z ZAHNARZTL IMPLANTO, V111, P39
   GREENWALD AS, 2003, BONE GRAFT SUBSTITUT
   HEIDE H, 1975, CHEM-ING-TECH, V47, P327, DOI 10.1002/cite.330470803
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   ROESGEN M, 1997, TRAUMATOLOGIE AKTUEL, V4
   SHIMIZU S, 1988, BIOMED RES-TOKYO, V9, P95
   TADIC D, 2004, BIOMATERIALS, V24, P987
   TenHuisen KS, 1998, BIOMATERIALS, V19, P2209, DOI 10.1016/S0142-9612(98)00131-8
   VANDERMEULEN J, 1994, J BIOMED MATER RES, V28, P1455, DOI 10.1002/jbm.820281211
   WIBRICH G, 2000, MUNDKIEFERGESICHTSCH, V4, P148
NR 20
TC 48
Z9 48
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD APR
PY 2004
VL 35
IS 4
BP 203
EP 207
DI 10.1022/mawe.200400735
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 815AQ
UT WOS:000221015600006
DA 2018-10-19
ER

PT J
AU Karlsson, M
   Johansson, A
   Tang, L
   Boman, M
AF Karlsson, M
   Johansson, A
   Tang, L
   Boman, M
TI Nanoporous aluminum oxide affects neutrophil behaviour
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE polymorphonuclear leukocytes (PMN); activation; morphology; biomaterial;
   surface topography
ID TOPOGRAPHICAL CONTROL; INFLAMMATORY RESPONSES; SURFACE-TOPOGRAPHY;
   LEUKOCYTE ADHESION; CELL BEHAVIOR; IN-VITRO; BIOMATERIALS; CHEMISTRY;
   MOTILITY
AB This study evaluates neutrophil responses on aluminum oxide membranes. Using an in vitro cell culture system, we have found that the pore size (20 and 200 nm in diameter) of alumina membranes have a significant effect on leukocyte morphology and activation. Specifically, our results show that 20-nm pore-size membranes were more potent in triggering PMN spreading and extending of pseudopodia than 200-nm pore-size membranes. The morphological changes are also associated with cell activation. In fact, adherent neutrophils on 20-nm pore-size membranes elicit much stronger initial oxygen free radical production. Overall, our results point out that membrane pore size significantly affects the extent of cellular responses of adherent neutrophils. (C) 2004 Wiley-Liss, Inc.
C1 BMC, Dept Surface Biotechnol, S-75123 Uppsala, Sweden.
   Angstrom Lab, Dept Chem Mat, Uppsala, Sweden.
   Univ Texas, Biomed Engn Program, Arlington, TX 76019 USA.
RP Karlsson, M (reprint author), BMC, Dept Surface Biotechnol, Husarg 3,D7-3, S-75123 Uppsala, Sweden.
EM Marjam.Karlsson@ytbioteknik.uu.se
CR Andersen PJ, 1999, MATER RES INNOV, V3, P2, DOI 10.1007/s100190050118
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Chang S, 2003, J VASC SURG, V37, P1082, DOI 10.1067/mva.2003.160
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   DAHLGREN C, 1991, TRENDS PHOTOCHEM PHO, V2, P427
   DUNN GA, 1982, CELL BEHAVIOUR, P247
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FURNEAUX RC, 1989, NATURE, V337, P147, DOI 10.1038/337147a0
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   LANZEROTTI LJ, 1978, NATURE, V272, P433
   Nygren H, 2001, COLLOID SURFACE B, V22, P87, DOI 10.1016/S0927-7765(00)00216-2
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tan J, 2000, J BIOMED MATER RES, V51, P694, DOI 10.1002/1097-4636(20000915)51:4<694::AID-JBM18>3.3.CO;2-E
   TANG L, 2000, BIOMATERIAL ENG DEVI, V1, P3
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
NR 24
TC 35
Z9 36
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD APR 1
PY 2004
VL 63
IS 5
BP 259
EP 265
DI 10.1002/jemt.20040
PG 7
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 825FE
UT WOS:000221740600002
PM 15170755
DA 2018-10-19
ER

PT J
AU Saraydin, D
   Unver-Saraydin, S
   Karadag, E
   Koptagel, E
   Guven, O
AF Saraydin, D
   Unver-Saraydin, S
   Karadag, E
   Koptagel, E
   Guven, O
TI In vivo biocompatibility of radiation crosslinked acrylamide copolymers
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article
DE radiation; acrylamide; biocompatibility; biomaterial; hydrogel
ID SWELLING BEHAVIOR; ACID COPOLYMERS; HYDROGELS; WATER; COMPOSITES;
   MEDICINE
AB In vitro swelling and in vivo biocompatibility of radiation crosslinked acrylamide copolymers such as acrylamide/crotonic acid (AAm/CA) and acrylamide/itaconic acid (AAm/IA) were studied. The swelling kinetics of acrylamide copolymers were performed in distilled water, human serum and some simulated physiological fluids such as phosphate buffer, pH 7.4, glycine-HCl buffer, pH 1.1, physiological saline solution, and some swelling and diffusion parameters have been calculated. AAm/CA and AAm/IA hydrogels were subcutaneously implanted in rats for up to 10 weeks and the immediate short- and long-term tissue response to these implants were investigated. Histological analysis indicated that tissue reaction at the implant site progressed from an initial acute inflammatory response. No necrosis, tumorigenesis or infection was observed at the implant site up to 10 weeks. The radiation crosslinked AAm/CA and AAm/IA copolymers were found well tolerated, non-toxic and highly biocompatible. However, AAm/IA copolymer was not found to be compatible biomaterials, because one of the AAm/IA samples was disintegrated into small pieces in the rat. (C) 2003 Elsevier B.V. All rights reserved.
C1 Cumhuriyet Univ, Dept Chem, Hydrogel Res Lab, TR-58140 Sivas, Turkey.
   Cumhuriyet Univ, Fac Med, Dept Histol & Embryol, TR-58140 Sivas, Turkey.
   Adnan Menderes Univ, Dept Chem, TR-09010 Aydin, Turkey.
   Hacettepe Univ, Dept Chem, TR-06532 Ankara, Turkey.
RP Saraydin, D (reprint author), Cumhuriyet Univ, Dept Chem, Hydrogel Res Lab, TR-58140 Sivas, Turkey.
EM saraydin@cumhuriyet.edu.tr
RI Karadag, Engin/D-8713-2014
OI Saraydin, Dursun/0000-0001-7191-510X
CR Bell CL, 1996, BIOMATERIALS, V17, P1203, DOI 10.1016/0142-9612(96)84941-6
   BENSON RS, 1999, NUCL INSTRUM METH B, V191, P752
   Dengre R, 2000, J APPL POLYM SCI, V76, P1706, DOI 10.1002/(SICI)1097-4628(20000613)76:11<1706::AID-APP12>3.0.CO;2-W
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   GREENE WB, 1995, EUR MICROS ANAL  MAY, P31
   Guven O, 1999, RADIAT PHYS CHEM, V56, P381, DOI 10.1016/S0969-806X(99)00326-6
   Hron P, 1997, BIOMATERIALS, V18, P1069, DOI 10.1016/S0142-9612(97)00039-2
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Karadag E, 1996, BIOMATERIALS, V17, P67, DOI 10.1016/0142-9612(96)80757-5
   Karadag E, 2001, MACROMOL MATER ENG, V286, P34, DOI 10.1002/1439-2054(20010101)286:1<34::AID-MAME34>3.0.CO;2-J
   Khalid MN, 2002, EUR J PHARM SCI, V15, P425, DOI 10.1016/S0928-0987(02)00029-5
   Nakabayashi N, 2000, MACROMOL SYMP, V159, P27, DOI 10.1002/1521-3900(200010)159:1<27::AID-MASY27>3.0.CO;2-H
   Pascual B, 1996, POLYMER, V37, P1005, DOI 10.1016/0032-3861(96)87284-3
   Pena J, 1997, J BIOMED MATER RES, V35, P129, DOI 10.1002/(SICI)1097-4636(199704)35:1<129::AID-JBM13>3.0.CO;2-E
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   ROSIAK J, 1983, RADIAT PHYS CHEM, V22, P917, DOI 10.1016/0146-5724(83)90112-7
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   SARAYDIN D, 1995, RADIAT PHYS CHEM, V46, P1049, DOI 10.1016/0969-806X(95)00318-R
   SARAYDIN D, 1995, TURK J CHEM, V19, P179
   Saraydin D, 2001, J MATER SCI, V36, P2473, DOI 10.1023/A:1017934116229
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   Smith EL, 1987, PRINCIPLES BIOCH MAM
   Yoshida M, 1999, RADIAT PHYS CHEM, V55, P677, DOI 10.1016/S0969-806X(99)00210-8
NR 24
TC 27
Z9 29
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 2004
VL 217
IS 2
BP 281
EP 292
DI 10.1016/j.nimb.2003.09.035
PG 12
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 802DA
UT WOS:000220143000009
DA 2018-10-19
ER

PT J
AU Blouin, S
   Moreau, MF
   Weiss, P
   Daculsi, G
   Basle, MF
   Chappard, D
AF Blouin, S
   Moreau, MF
   Weiss, P
   Daculsi, G
   Basle, MF
   Chappard, D
TI Does injectable biomaterial restore bone mass and architecture in a rat
   model of osteoporosis (orchidectomy and disuse)?
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Meeting Abstract
CT IOF World Congress on Osteoporosis
CY MAY 14-18, 2004
CL Rio de Janeiro, BRAZIL
SP Int Ostoeporosis Fdn
C1 INSERM EMI335 LHEA, Angers, France.
   Fac Chirurg Dentaire, INSERM EMI9903, Nantes, France.
RI Daculsi, Guy/P-1320-2014; Weiss, Pierre/P-1372-2014
OI Daculsi, Guy/0000-0003-1030-3446; Weiss, Pierre/0000-0002-6159-8590
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0937-941X
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD APR
PY 2004
VL 15
SU 1
BP S112
EP S112
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 821IM
UT WOS:000221453600360
DA 2018-10-19
ER

PT J
AU Kavanagh, CA
   Rochev, YA
   Gallagher, WA
   Dawson, KA
   Keenan, AK
AF Kavanagh, CA
   Rochev, YA
   Gallagher, WA
   Dawson, KA
   Keenan, AK
TI Local drug delivery in restenosis injury: thermoresponsive co-polymers
   as potential drug delivery systems
SO PHARMACOLOGY & THERAPEUTICS
LA English
DT Review
DE restenosis; local drug delivery; thermoresponsive polymers; stent
   coatings; vascular smooth muscle cells; endothelial cells
ID MUSCLE CELL-PROLIFERATION; MOLECULAR-WEIGHT HEPARIN; CORONARY BALLOON
   ANGIOPLASTY; SIROLIMUS-ELUTING STENTS; PLATELET-DEPENDENT THROMBOSIS;
   HYDROGEL-COATED BALLOONS; PLACEBO-CONTROLLED TRIAL; ARTERIAL
   GENE-TRANSFER; RAT CAROTID-ARTERY; 6-MONTH FOLLOW-UP
AB The success of percutaneous transluminal coronary angioplasty in treatment of acute coronary syndromes has been compromised by the incidence of restenosis. The physical insult of balloon insertion can damage or remove the endothelial monolayer, thereby generating a prothrombotic surface. The resulting inappropriate response to injury can also lead to penetration of inflammatory cells, conversion of the underlying media to a synthetic phenotype, deposition of extracellular matrix, constrictive remodeling, and neointimal hyperplasia. While stent implantation at the time of balloon insertion has offset some of these events, inflammatory responses to the implanted biomaterial (stent) and intimal hyperplasia are still prominent features of the procedure, leading in 20-30% of cases to in-stent restenosis within a year. Systemic delivery of drugs designed to offset in-stent restenosis injury has been largely unsuccessful, which has led to the development of strategies for coating stents with drugs for local delivery. Drug-eluting stents constitute an innovative means of further reducing the incidence of restenosis injury and clinical trials have shown encouraging results. This review focuses on properties of a class of environment-sensitive hydrogels, the N-isopropylacrylamide-based thermoresponsive co-polymers, on their potential roles as stent coatings, on their demonstrated ability to incorporate and release drugs that modify vascular endothelial and smooth muscle cell functions, and on issues that still await clarification, prior to their adoption in a clinical setting. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dept Pharmacol, Dublin 4, Ireland.
   Natl Univ Ireland Univ Coll Galway, Natl Ctr Bioengn Sci, Galway, Ireland.
   Univ Coll Dublin, Dept Chem, Dublin 4, Ireland.
RP Keenan, AK (reprint author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dept Pharmacol, Dublin 4, Ireland.
EM Alan.Keenan@ucd.ie
RI Dawson, Kenneth A./L-2540-2016; Rochev, Yury/M-9077-2014
OI Dawson, Kenneth A./0000-0002-0568-6588; Rochev,
   Yury/0000-0003-4213-9476; Gallagher, William/0000-0002-4307-5999
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   ANTONSEN KP, 1993, BIOMAT ARTIF CELL IM, V21, P1
   ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   AZRIN MA, 1994, CIRCULATION, V90, P433, DOI 10.1161/01.CIR.90.1.433
   Baron JH, 2000, CARDIOVASC RES, V46, P585, DOI 10.1016/S0008-6363(00)00042-0
   Bennett MR, 2001, PHARMACOL THERAPEUT, V91, P149, DOI 10.1016/S0163-7258(01)00153-X
   BRACK MJ, 1995, J AM COLL CARDIOL, V26, P947, DOI 10.1016/0735-1097(95)00277-4
   Brazel CS, 1996, J CONTROL RELEASE, V39, P57, DOI 10.1016/0168-3659(95)00134-4
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Bult H, 2000, TRENDS PHARMACOL SCI, V21, P274, DOI 10.1016/S0165-6147(00)01505-4
   Cairns JA, 1996, CIRCULATION, V94, P1553, DOI 10.1161/01.CIR.94.7.1553
   CAMENZIND E, 1995, CIRCULATION, V92, P2463, DOI 10.1161/01.CIR.92.9.2463
   CHAN JK, 2000, ARTERIOSCLER THROMB, V20, P2573
   CHERVU A, 1989, J VASC SURG, V10, P1116
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   CHIN JT, 1994, BIOTECHNOL BIOENG, V44, P140, DOI 10.1002/bit.260440120
   CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0
   CLOWES AW, 1983, LAB INVEST, V49, P208
   CLOWES AW, 1986, LAB INVEST, V54, P295
   COLLIER TO, 2001, J BIOMED MATER RES, V59, P136
   Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6
   Costa MA, 2000, J INVASIVE CARDIOL, V12, P113
   COTTIN Y, 2001, ARCH MAL COEUR VAISS, V91, P218
   CUMBERLAND DC, 1994, J AM COLL CARDIOL, V23, pA186
   CURCIO A, 2003, UNPUB AM J PHYSL HEA
   CURRIER JW, 1991, J AM COLL CARDIOL, V17, pB118
   Degertekin M, 2002, J AM COLL CARDIOL, V39, p38A
   deScheerder I, 1996, CORONARY ARTERY DIS, V7, P161, DOI 10.1097/00019501-199602000-00011
   DOMB AJ, 1995, MOL MED TODAY, V3, P134
   DONG L C, 1986, Journal of Controlled Release, V4, P223, DOI 10.1016/0168-3659(86)90006-4
   Doorty KB, 2003, CARDIOVASC PATHOL, V12, P105, DOI 10.1016/S1054-8807(02)00165-5
   DRACHMAN DE, 2002, REV CARDIOVASC MED, V3, P31
   Eccleston DS, 1997, ADV DRUG DELIVER REV, V24, P31, DOI 10.1016/S0169-409X(96)00480-2
   Edelman ER, 1998, AM J CARDIOL, V81, p4E, DOI 10.1016/S0002-9149(98)00189-1
   EDELMAN ER, 1994, CIRCULATION, V89, P770, DOI 10.1161/01.CIR.89.2.770
   EDELMAN ER, 1990, P NATL ACAD SCI USA, V87, P3773, DOI 10.1073/pnas.87.10.3773
   Eeckman F, 2002, INT J PHARMACEUT, V241, P113, DOI 10.1016/S0378-5173(02)00198-9
   ELIASSAF J, 1978, J APPL POLYM SCI, V22, P873, DOI 10.1002/app.1978.070220328
   Ellis SG, 1999, CIRCULATION, V100, P799
   Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44
   Farb A, 2002, CIRCULATION, V105, P2974, DOI 10.1161/01.CIR.0000019071.72887.BD
   FAXON DP, 1994, CIRCULATION, V90, P908, DOI 10.1161/01.CIR.90.2.908
   Faxon DP, 1997, PROG CARDIOVASC DIS, V40, P129, DOI 10.1016/S0033-0620(97)80005-9
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Foo RSY, 2000, THROMB HAEMOSTASIS, V83, P496
   FRAM DB, 1994, J AM COLL CARDIOL, V23, P1570, DOI 10.1016/0735-1097(94)90658-0
   GEHRKE SH, 1990, MANUFACTURING PRODUC, P333
   GELLMAN J, 1991, J AM COLL CARDIOL, V17, P251, DOI 10.1016/0735-1097(91)90735-R
   Gershlick AH, 2002, ATHEROSCLEROSIS, V160, P259, DOI 10.1016/S0021-9150(01)00618-9
   Gibson CM, 1998, J AM COLL CARDIOL, V32, P28, DOI 10.1016/S0735-1097(98)00192-2
   Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1
   Gurbel PA, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00317-X
   Gurbel PA, 2003, AM HEART J, V145, P239, DOI 10.1067/mhj.2003.109
   Gutowska A, 1997, J CONTROL RELEASE, V48, P141, DOI 10.1016/S0168-3659(97)00041-2
   GUTOWSKA A, 1992, J CONTROL RELEASE, V22, P95, DOI 10.1016/0168-3659(92)90194-V
   GUYTON JR, 1980, CIRC RES, V46, P625, DOI 10.1161/01.RES.46.5.625
   Heldman AW, 2001, CIRCULATION, V103, P2289
   HERRMAN JPR, 1993, DRUGS, V46, P18, DOI 10.2165/00003495-199346010-00003
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Hong MK, 2003, CIRCULATION, V107, P517, DOI 10.1161/01.CIR.0000054163.42072.D4
   HONG MK, 1994, CATHETER CARDIOVASC, V33, P181
   HUANG Y, 2002, J INVASIVE CARDIOL, V14, P503
   Janicki C, 2003, MED PHYS, V30, P2622, DOI 10.1118/1.1607506
   Janssens S, 1998, CIRCULATION, V97, P1274, DOI 10.1161/01.CIR.97.13.1274
   Javed Q, 2002, EXP MOL PATHOL, V73, P104, DOI 10.1006/exmp.2002.2450
   KARAS SP, 1992, J AM COLL CARDIOL, V20, P467, DOI 10.1016/0735-1097(92)90119-8
   Kavanagh CA, 2003, BRIT J CLIN PHARMACO, V56, P240
   Kay IP, 2000, HEART, V83, P332, DOI 10.1136/heart.83.3.332
   Kiesz RS, 2001, CIRCULATION, V103, P26
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6
   Labhasetwar V, 1997, ADV DRUG DELIVER REV, V24, P63, DOI 10.1016/S0169-409X(96)00483-8
   Lablanche JM, 1997, CIRCULATION, V96, P3396
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Le Tourneau T, 1999, J AM COLL CARDIOL, V33, P876, DOI 10.1016/S0735-1097(98)00621-4
   Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   LIBBY P, 1992, CIRCULATION, V86, P47
   LINCOFF AM, 1994, CIRCULATION, V90, P2070, DOI 10.1161/01.CIR.90.4.2070
   Liu XS, 2003, CATHETER CARDIO INTE, V60, P172, DOI 10.1002/ccd.10636
   MCKAY RG, 1994, CATHETER CARDIOVASC, V32, P193
   McKenna CJ, 1997, TRENDS CARDIOVAS MED, V7, P245, DOI 10.1016/S1050-1738(97)00066-2
   Meneveau N, 2000, EUR HEART J, V21, P1767, DOI 10.1053/euhj.1999.2041
   MITCHEL JF, 1995, CIRCULATION, V91, P785, DOI 10.1161/01.CIR.91.3.785
   MITCHEL JF, 1994, CIRCULATION, V90, P1979, DOI 10.1161/01.CIR.90.4.1979
   MITCHEL JF, 1995, CATHETER CARDIO DIAG, V34, P149, DOI 10.1002/ccd.1810340416
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   MURRAY JB, 1983, IN VITRO CELL DEV B, V19, P743
   Nakayama Yasuhide, 2003, Cardiovasc Radiat Med, V4, P77, DOI 10.1016/S1522-1865(03)00143-4
   NUNES GL, 1995, CIRCULATION, V92, P1697, DOI 10.1161/01.CIR.92.7.1697
   NUNES GL, 1994, J AM COLL CARDIOL, V23, P1578, DOI 10.1016/0735-1097(94)90659-9
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   Parikh SA, 2000, ADV DRUG DELIVER REV, V42, P139, DOI 10.1016/S0169-409X(00)00058-2
   POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370
   Rochev Y, 2001, PROG COLL POL SCI S, V118, P153
   RODGERS C, 1995, CIRCULATION, V91, P2995
   ROLLASON G, 1993, BIOMATERIALS, V14, P153, DOI 10.1016/0142-9612(93)90230-Y
   Sabate M, 2000, CIRCULATION, V101, P2467, DOI 10.1161/01.CIR.101.21.2467
   SAREMBOCK IJ, 1991, CIRCULATION, V84, P232, DOI 10.1161/01.CIR.84.1.232
   SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   SCHILD HG, 1990, J PHYS CHEM-US, V94, P4352, DOI 10.1021/j100373a088
   Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5
   SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603
   Schwartz RS, 1998, AM J CARDIOL, V81, p14E, DOI 10.1016/S0002-9149(98)00191-X
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5
   SERRUYS PW, 1991, CIRCULATION, V84, P1568, DOI 10.1161/01.CIR.84.4.1568
   Serruys PW, 1999, EUR HEART J, V20, P58, DOI 10.1053/euhj.1998.1150
   SERRUYS PW, 1995, NEW ENGL J MED, V333, P757, DOI 10.1056/NEJM199509213331203
   Serruys PW, 2002, CIRCULATION, V106, P798, DOI 10.1161/01.CIR.0000025585.63486.59
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   SHEARS LL, 1998, J AM COLL SURGEONS, V187, P298
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   SIMONS M, 1994, J CLIN INVEST, V93, P2351, DOI 10.1172/JCI117240
   SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0
   Simonsen EB, 1997, SCAND J MED SCI SPOR, V7, P1
   Sousa JE, 2003, CIRCULATION, V107, P381, DOI 10.1161/01.CIR.0000051720.59095.6D
   SUZUKI T, 2001, CIRCULATION, V104, P1118
   Tahlil O, 1997, CARDIOVASC RES, V33, P181, DOI 10.1016/S0008-6363(96)00188-5
   Tardiff BE, 1999, J AM COLL CARDIOL, V33, P88, DOI 10.1016/S0735-1097(98)00551-8
   Teirstein PS, 2000, CIRCULATION, V101, P360, DOI 10.1161/01.CIR.101.4.360
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Uludag H, 2001, BIOTECHNOL BIOENG, V73, P510, DOI 10.1002/bit.1086
   VanBelle E, 1997, J AM COLL CARDIOL, V29, P1371, DOI 10.1016/S0735-1097(97)00049-1
   VanBelle E, 1997, CIRCULATION, V95, P438
   Verin V, 2001, NEW ENGL J MED, V344, P243, DOI 10.1056/NEJM200101253440401
   Versaci F, 2002, J AM COLL CARDIOL, V40, P1935, DOI 10.1016/S0735-1097(02)02562-7
   VILLA AE, 1994, J CLIN INVEST, V93, P1243, DOI 10.1172/JCI117078
   VIRAMANI R, 1998, SEMIN INTERV CARDIOL, V3, P163
   von Recum H, 1998, J CONTROL RELEASE, V55, P121, DOI 10.1016/S0168-3659(98)00042-X
   WAKSMAN R, 1995, CIRCULATION, V91, P1533, DOI 10.1161/01.CIR.91.5.1533
   WIEDERMANN JG, 1995, J AM COLL CARDIOL, V25, P1451, DOI 10.1016/0735-1097(95)00010-2
   WIENEKE H, 2003, EXPERT OPIN INV DRUG, V12, P1
   Wilcox JN, 1996, INT J RADIAT ONCOL, V36, P789, DOI 10.1016/S0360-3016(96)00299-4
   Wilson SJ, 2003, J BIOMED MATER RES A, V67A, P667, DOI 10.1002/jbm.a.10137
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 142
TC 76
Z9 77
U1 2
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0163-7258
J9 PHARMACOL THERAPEUT
JI Pharmacol. Ther.
PD APR
PY 2004
VL 102
IS 1
BP 1
EP 15
DI 10.1016/j.pharmthera.2003.01.001
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 813OO
UT WOS:000220916600001
PM 15056495
DA 2018-10-19
ER

PT J
AU Gardea-Torresdey, JL
   de la Rosa, G
   Peralta-Videa, JR
AF Gardea-Torresdey, JL
   de la Rosa, G
   Peralta-Videa, JR
TI Use of phytofiltration technologies in the removal of heavy metals: A
   review
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT Inaugural Conference for the
   Southern-and-Eastern-Africa-Network-of-Analytical-Chermists (SEANAC)
CY JUL 07-10, 2004
CL Gaborone, BOTSWANA
SP SO & Eastern Africa Network Analyt Chem
ID X-RAY-ABSORPTION; MEDICAGO-SATIVA ALFALFA; AGRICULTURAL BY-PRODUCTS;
   SPHAGNUM MOSS PEAT; AQUEOUS-SOLUTION; HUMIC SUBSTANCES; COPPER
   ADSORPTION; BINDING-SITES; IMMOBILIZED BIOMASS; AU(III) BINDING
AB Biosorption is a relatively new process that has proven very promising in the removal of contaminants from aqueous effluents. Microorganisms as well as plant- and animal-derived materials have been used as biosorbents by many researchers. Biomaterial immobilization and chemical modification improves the adsorption capacity and stability of biosorbents. Biosorption experiments over Cu(II), Cd(II), Pb(II), Cr(III), and Ni(II) demonstrated that biomass Cu(II) adsorption ranged from 8.09 to 45.9 mg g(-1) while Cd(II) and Cr(VI) adsorption ranged from 0.4 to 10. 8 mg g(-1) and from 1.47 to 119 mg g(-1) respectively. Mechanisms involved in the biosorption process include chemisorption, complexation, surface and pore adsorption-complexation, ion exchange, microprecipitation, hydroxide condensation onto the biosurface, and surface adsorption. Chemical modification and spectroscopic studies have shown that cellular components including carboxyl, hydroxyl, sulfate, sulfhydryl, phosphate, amino, amide, imine, and imidazol moieties have metal binding properties and are therefore the functional groups in the biomass. Column studies using support matrices for biomass immobilization such as silica, agar, polyacrilamide, polysulfone, alginates, cellulase, and different cross-linking agents have been performed to improve the biomass adsorption capacity and reusability. In this review, the salient features of plant-derived materials are highlighted as potential phytofiltration sources in the recovery of toxic heavy and precious metals.
C1 Univ Texas, Dept Chem, El Paso, TX 79968 USA.
   Univ Texas, Environm Sci & Engn Ph D Program, El Paso, TX 79968 USA.
RP Gardea-Torresdey, JL (reprint author), Univ Texas, Dept Chem, El Paso, TX 79968 USA.
EM jgardea@utep.edu
CR Aderhold D, 1996, BIORESOURCE TECHNOL, V58, P1, DOI 10.1016/S0960-8524(96)00072-7
   Ajmal M, 2000, J HAZARD MATER, V79, P117, DOI 10.1016/S0304-3894(00)00234-X
   Akhtar N, 2003, BIORESOURCE TECHNOL, V88, P163, DOI 10.1016/S0960-8524(02)00289-4
   AlAsheh S, 1997, J HAZARD MATER, V56, P35, DOI 10.1016/S0304-3894(97)00040-X
   Arica MY, 2003, CARBOHYD POLYM, V52, P167
   Bai RS, 2003, BIORESOURCE TECHNOL, V87, P17
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Bayramoglu G, 2002, MICROCHEM J, V72, P63, DOI 10.1016/S0026-265X(01)00151-5
   Brown PA, 2000, WATER RES, V34, P3907, DOI 10.1016/S0043-1354(00)00152-4
   Brown TL, 1981, CHEM CENTRAL SCI
   CANORODRIGUEZ I, 2002, REV MEX ING QUIM, V1, P97
   CORDERY J, 1994, MINER ENG, V7, P1003, DOI 10.1016/0892-6875(94)90029-9
   CRIST DR, 1994, FEMS MICROBIOL REV, V14, P309, DOI 10.1111/j.1574-6976.1994.tb00104.x
   Davila-Jimenez MM, 2003, COLLOID SURFACE A, V219, P243, DOI 10.1016/S0927-7757(03)00052-9
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   de la Rosa G, 2003, BIORESOURCE TECHNOL, V90, P11, DOI 10.1016/S0960-8524(03)00099-3
   de la Rosa G, 2003, J HAZARD MATER, V97, P207, DOI 10.1016/S0304-3894(02)00262-5
   DECARVALHO RP, 2001, HYDROMETALLURGY, V59, P3407
   Donmez GC, 1999, PROCESS BIOCHEM, V34, P885
   Drake LR, 1996, ANAL CHEM, V68, pA22, DOI 10.1021/ac9618029
   Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2
   FERGUSON J.E, 1990, HEAVY METALS CHEM EN
   Fu YZ, 2001, BIORESOURCE TECHNOL, V79, P251, DOI 10.1016/S0960-8524(01)00028-1
   Gard PR, 2001, PHARMACOL BIOCHEM BE, V69, P35, DOI 10.1016/S0091-3057(01)00491-9
   Gardea-Torresday JL, 2000, J HAZARD MATER, V80, P175, DOI 10.1016/S0304-3894(00)00301-0
   Gardea-Torresdey J, 2002, J HAZARD MATER, V91, P95, DOI 10.1016/S0304-3894(01)00363-6
   Gardea-Torresdey JL, 2000, ENVIRON SCI TECHNOL, V34, P4392, DOI 10.1021/es991325m
   Gardea-Torresdey JL, 1998, J HAZARD MATER, V57, P29, DOI 10.1016/S0304-3894(97)00072-1
   Gardea-Torresdey JL, 2002, MICROCHEM J, V71, P157, DOI 10.1016/S0026-265X(02)00007-3
   Gardea-Torresdey JL, 2002, ADV ENVIRON RES, V6, P313, DOI 10.1016/S1093-0191(01)00064-8
   Gardea-Torresdey JL, 1999, J HAZARD MATER, V69, P41, DOI 10.1016/S0304-3894(99)00057-6
   Gardea-Torresdey JL, 2002, MICROCHEM J, V71, P193, DOI 10.1016/S0026-265X(02)00011-5
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P181, DOI 10.1016/0304-3894(95)00155-7
   GardeaTorresdey JL, 1996, J HAZARD MATER, V49, P205, DOI 10.1016/0304-3894(96)01757-8
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P171, DOI 10.1016/0304-3894(95)00148-4
   GardeaTorresdey JL, 1997, J HAZARD MATER, V56, P169, DOI 10.1016/S0304-3894(97)00053-8
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P191, DOI 10.1016/0304-3894(95)00156-5
   Gin KYH, 2002, WATER RES, V36, P1313, DOI 10.1016/S0043-1354(01)00332-3
   GOODWIN TW, 1975, INTRO PLANT BIOCH
   Hashim MA, 2000, SEP PURIF TECHNOL, V19, P39, DOI 10.1016/S1383-5866(99)00076-3
   Herrera I, 2003, J HAZARD SUBST RES, V4, P1
   HINCHEE RE, 1995, BIOREMEDIATION INORG
   HO YS, 1995, WATER RES, V29, P1327, DOI 10.1016/0043-1354(94)00236-Z
   Iqbal M, 2002, BIORESOURCE TECHNOL, V81, P151, DOI 10.1016/S0960-8524(01)00126-2
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kim DS, 2003, BIORESOURCE TECHNOL, V87, P355, DOI 10.1016/S0960-8524(02)00259-6
   KLEIN J, 1990, J BIOTECHNOL, V16, P1, DOI 10.1016/0168-1656(90)90061-F
   Korshin GV, 1998, ENVIRON SCI TECHNOL, V32, P2699, DOI 10.1021/es980016d
   Langmuir D., 1997, AQUEOUS ENV GEOCHEMI
   Lister SK, 2001, BIORESOURCE TECHNOL, V79, P35, DOI 10.1016/S0960-8524(01)00035-9
   Meunier N, 2002, HYDROMETALLURGY, V67, P19, DOI 10.1016/S0304-386X(02)00132-9
   Mittal AK, 1996, WATER SCI TECHNOL, V34, P81, DOI 10.1016/S0273-1223(96)00700-7
   Nobel P. S., 1991, PHYSICOCHEMICAL ENV
   Nuhoglu Y, 2003, PROCESS BIOCHEM, V38, P1627, DOI 10.1016/S0032-9592(03)00055-4
   ORHAN Y, 1993, WATER SCI TECHNOL, V28, P247
   Pagnanelli F, 2001, PROCESS BIOCHEM, V37, P115, DOI 10.1016/S0032-9592(01)00180-7
   Parsons JG, 2003, ANAL CHIM ACTA, V478, P139, DOI 10.1016/S0003-2670(02)01506-4
   Parsons JG, 2002, MICROCHEM J, V71, P175, DOI 10.1016/S0026-265X(02)00009-7
   Parsons JG, 2002, MICROCHEM J, V71, P211, DOI 10.1016/S0026-265X(02)00013-9
   Parsons JG, 2002, APPL SPECTROSC REV, V37, P187, DOI 10.1081/ASR-120006044
   Pethkar AV, 2001, BIORESOURCE TECHNOL, V80, P211, DOI 10.1016/S0960-8524(01)00080-3
   Petruzzelli D, 1997, REACT FUNCT POLYM, V35, P89, DOI 10.1016/S1381-5148(97)00050-3
   Polman JK, 1996, TEXT CHEM COLOR, V28, P31
   SAEED A, 2003, WATER RES, V37, P3742
   Schneider IAH, 2001, INT J MINER PROCESS, V62, P111, DOI 10.1016/S0301-7516(00)00047-8
   SHARMA DC, 1993, WATER RES, V27, P1201, DOI 10.1016/0043-1354(93)90012-7
   SHARMA DC, 1995, PROCESS BIOCHEM, V30, P293, DOI 10.1016/0032-9592(94)00024-C
   SIENKIEWICZ J, 1986, SCI TOTAL ENVIRON, V55, P339, DOI 10.1016/0048-9697(86)90191-9
   Spinti M, 1995, WATER ENVIRON RES, V67, P943, DOI 10.2175/106143095X133176
   Srinath T, 2002, CHEMOSPHERE, V48, P427, DOI 10.1016/S0045-6535(02)00089-9
   Steenkamp JB, 2001, J CONSUM PSYCHOL, V10, P27
   Teo B., 1981, EXAFS SPECTROSCOPY T
   Texier AC, 2002, CHEMOSPHERE, V47, P333, DOI 10.1016/S0045-6535(01)00244-2
   Tiemann KJ, 2000, ENVIRON SCI TECHNOL, V34, P693, DOI 10.1021/es9909071
   Tiemann KJ, 1999, ENVIRON SCI TECHNOL, V33, P150, DOI 10.1021/es9804722
   Tiemann KJ, 2002, MICROCHEM J, V71, P287, DOI 10.1016/S0026-265X(02)00021-8
   Tiemann KJ, 2002, MICROCHEM J, V71, P133, DOI 10.1016/S0026-265X(02)00005-X
   TOBIN JH, 1990, ENZYME MICROB TECHNO, P591
   TSEZOS M, 1989, WATER RES, V23, P561, DOI 10.1016/0043-1354(89)90022-5
   Villaescusa I, 2002, POLYHEDRON, V21, P1363, DOI 10.1016/S0277-5387(02)00957-9
   Volesky B, 2003, WATER RES, V37, P297, DOI 10.1016/S0043-1354(02)00282-8
   Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2
   Woolhouse H. W., 1983, ENCY PLANT PHYSL C, V12C, P246
   Xia HY, 2002, ADV ENVIRON RES, V7, P157, DOI 10.1016/S1093-0191(01)00121-6
   Xia K, 1997, GEOCHIM COSMOCHIM AC, V61, P2211, DOI 10.1016/S0016-7037(97)00079-3
   Xia K, 1997, GEOCHIM COSMOCHIM AC, V61, P2223, DOI 10.1016/S0016-7037(97)00080-X
NR 86
TC 80
Z9 83
U1 0
U2 21
PU INT UNION PURE APPLIED CHEMISTRY
PI RES TRIANGLE PK
PA 104 TW ALEXANDER DR, PO BOX 13757, RES TRIANGLE PK, NC 27709-3757 USA
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD APR
PY 2004
VL 76
IS 4
BP 801
EP 813
DI 10.1351/pac200476040801
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA 829BE
UT WOS:000222017100009
DA 2018-10-19
ER

PT J
AU Kamm, B
   Kamm, M
AF Kamm, B
   Kamm, M
TI Polycarnitine - A new biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 227th ACS National Meeting
CY MAR 28-APR 01, 2004
CL Anaheim, CA
SP Amer Chem Soc
C1 Univ Potsdam, Res Inst Bioact Polymer Syst eV, D-14513 Teltow, Germany.
   Biorefinery de GmbH, D-14471 Potsdam, Germany.
EM kamm@biopos.de; kamm@biorefinery.de
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 28
PY 2004
VL 227
MA 290-PMSE
BP U533
EP U534
PN 2
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 851AK
UT WOS:000223655702742
DA 2018-10-19
ER

PT J
AU Klemm, DO
   Udhardt, URE
   Schumann, DA
   Marsch, SE
AF Klemm, DO
   Udhardt, URE
   Schumann, DA
   Marsch, SE
TI Moulded biomaterial BASYC (bacterial synthesized cellulose) - A
   promising artificial blood vessel for microsurgical use.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 227th National Meeting of the American-Chemical Society
CY MAR 28-APR 01, 2004
CL Anaheim, CA
SP Amer Chem Soc
C1 Univ Jena, Inst Organ Chem & Macromol Chem, D-07743 Jena, Germany.
   Univ Jena, Clin Maxillofacial & Plast Surg, D-07743 Jena, Germany.
EM c9kldi@rz.uni-jena.de; dieter.schumann@med.uni-jena.de
NR 0
TC 1
Z9 1
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 28
PY 2004
VL 227
MA 156-CELL
BP U303
EP U303
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 851AJ
UT WOS:000223655601204
DA 2018-10-19
ER

PT J
AU Kim, JH
   Sim, SJ
   Lee, DH
   Kim, D
   Lee, YK
   Kim, JH
AF Kim, JH
   Sim, SJ
   Lee, DH
   Kim, D
   Lee, YK
   Kim, JH
TI Preparation and properties of biodegradable hydrogels based on
   glutaraldehyde-crosslinked poly(2-hydroxyethyl aspartamide)
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE polu(succinimide); PHEA; crosslinking; biodegradable hydrogel; scaffold;
   swelling behavior
ID COPOLYMERS; ACID
AB alpha, beta-Poly(N-2-hydroxyethyl-DL-aspartamide), PHEA, one of the poly(amino acid)s having pendent hydroxyl groups, is biodegradable and biocompatible, and has been studied as a useful biomaterial, especially for drug delivery, by appropriate structural modification. In this work, PHEA, which we derived from polysuccinimide, was crosslinked by glutaraldehyde units in the presence of an acid catalyst to provide hydrogels with relatively good gel strength. The dry gels were formed into pressed discs, and their swelling behavior was investigated in different media under various conditions (pH, temperature, etc). In addition, we examined the hydrolytic degradation in aqueous solution. A porous scaffold was fabricated by freeze-drying the water-swollen gel; its morphology was observed by scanning electron microscopy. The PHEA-based hydrogels are potentially useful in biomedical applications; for example, as biodegradable matrices for DDS and tissue engineering.
C1 Sungkyunkwan Univ, Dept Chem Engn, Suwon 440746, South Korea.
RP Kim, JH (reprint author), Sungkyunkwan Univ, Dept Chem Engn, Suwon 440746, South Korea.
EM kimjh@skku.edu
RI Sim, Sang Jun/F-6697-2013
OI Sim, Sang Jun/0000-0003-1045-0286; Kim, Dukjoon/0000-0001-6187-0737
CR Andrade J. D., 1996, ACS S SER, V631
   Caldwell G, 1997, J APPL POLYM SCI, V66, P911, DOI 10.1002/(SICI)1097-4628(19971031)66:5<911::AID-APP11>3.0.CO;2-Q
   Caliceti P, 2001, BBA-GEN SUBJECTS, V1528, P177, DOI 10.1016/S0304-4165(01)00191-X
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   DUMITRIU S, 1994, POLYM BIOMATERIALS
   Giammona G, 2000, POLYM INT, V49, P93, DOI 10.1002/(SICI)1097-0126(200001)49:1<93::AID-PI299>3.0.CO;2-6
   Giammona G., 1994, COLLOID POLYM SCI, V272, P12
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kim JH, 2002, J IND ENG CHEM, V8, P138
   Kwon OH, 2003, J IND ENG CHEM, V9, P138
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Nakato T, 1998, MACROMOLECULES, V31, P2107, DOI 10.1021/ma971629y
   NERI P, 1973, J MED CHEM, V16, P893, DOI 10.1021/jm00266a006
   Pitarresi G, 2001, COLLOID POLYM SCI, V279, P579, DOI 10.1007/s003960000457
   Pitarresi G, 1996, J BIOACT COMPAT POL, V11, P328, DOI 10.1177/088391159601100405
   WOLK SK, 1994, MACROMOLECULES, V27, P7613, DOI 10.1021/ma00104a016
NR 17
TC 8
Z9 8
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD MAR 25
PY 2004
VL 10
IS 2
BP 278
EP 282
PG 5
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 807OF
UT WOS:000220510100015
DA 2018-10-19
ER

PT J
AU Hao, L
   Lawrence, J
AF Hao, L
   Lawrence, J
TI The adsorption of human serum albumin (HSA) on CO2 laser modified
   magnesia partially stabilised zirconia (MgO-PSZ)
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE CO2 laser; magnesia partially stabilised zirconia (MgO-PSZ); human serum
   albumin (HSA); surface energy; protein adsorption
ID WETTABILITY CHARACTERISTICS; CELL RESPONSE; TITANIUM; CERAMICS; EXCIMER;
   SURFACES; PROTEIN
AB Magnesia partially stabilised zirconia (MgO-PSZ), a bioinert ceramic, exhibits high mechanical strength, excellent corrosion resistance and good biocompatibility, but it does not naturally form a direct bond with bone resulting in a lack of osteointegration. The surface properties and structure of a biomaterial play an essential role in protein adsorption. As such, changes in the surface properties and structure of biomaterials may in turn alter their bioactivity. So, the fundamental reactions at the interface of biomaterials and tissue should influence their integration and bone-bonding properties. To this end, CO2 laser radiation was used to modify the surface roughness, crystal size, phase and surface energy of the MgO-PSZ. The basic mechanisms active in improving the surface energy were analysed and found to be the phase change and augmented surface area. The adsorption of human serum albumin (HSA), which is a non-cell adhesive protein, was compared on the untreated and CO2 laser modified MgO-PSZ. It was observed that the thickness of the adsorbed HSA decreased as the polar surface energy of the MgO-PSZ increased, indicating that HSA adsorbed more effectively on the hydrophobic MgO-PSZ surface than the hydrophilic surface. The current study provided important information regarding protein-biomaterial interactions and possible mechanisms behind the cell interaction and in vivo behaviour. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Mfg Engn Div, Mat Lab N3 1B2 02 A, Singapore 639798, Singapore.
RP Hao, L (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Mfg Engn Div, Mat Lab N3 1B2 02 A, Nanyang Ave, Singapore 639798, Singapore.
EM haoliang@pmail.ntu.edu.sg
OI Hao, Liang/0000-0003-2071-7044; Lawrence, Jonathan/0000-0002-1649-9948
CR ADAM NK, 1958, J CHEM SOC, V18, P2206
   AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anzai J, 1996, BIOELECTROCH BIOENER, V40, P35, DOI 10.1016/0302-4598(95)05047-7
   AZAROFF LV, 1968, ELEMENTS XRAY CRYSTA, P552
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Christensen A, 1998, PHYS REV B, V58, P8050, DOI 10.1103/PhysRevB.58.8050
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Feng B, 2002, MATER CHARACT, V49, P129, DOI 10.1016/S1044-5803(02)00341-8
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   GRAIN CF, 1967, J AM CERAM SOC, V50, P288, DOI 10.1111/j.1151-2916.1967.tb15111.x
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   HAO L, 2004, IN PRESS J LASER APP
   HAO L, 2004, IN PRESS OPT LASERS
   HAO L, 2003, IN PRESS BIOMATERIAL
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Horbett T. A., 1996, INTERFACIAL PHENOMEN, P351
   Janocha B, 2001, SURF COAT TECH, V142, P1051, DOI 10.1016/S0257-8972(01)01279-8
   Kappel H., 1998, OPTO LASER EUROPE, V50, P34
   KINLOCH AJ, 1987, ADHESION ADHESIVES S, P30
   Lawrence J, 1999, APPL SURF SCI, V138, P388, DOI 10.1016/S0169-4332(98)00431-0
   Lawrence J, 1999, J PHYS D APPL PHYS, V32, P1075, DOI 10.1088/0022-3727/32/10/301
   LI J., 1998, HDB BIOMATERIAL PROP, P340
   Liu QG, 1999, SOLID STATE IONICS, V121, P61, DOI 10.1016/S0167-2738(98)00529-3
   Man HC, 1997, J MATER PROCESS TECH, V66, P123, DOI 10.1016/S0924-0136(96)02505-8
   Pei YT, 1996, SURF COAT TECH, V81, P131, DOI 10.1016/0257-8972(95)02483-2
   Putman B, 1997, COLLOID SURFACE A, V121, P81, DOI 10.1016/S0927-7757(96)03978-7
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   TABORELLI M, 1995, J BIOMED MATER RES, V29, P707, DOI 10.1002/jbm.820290606
   WALTON AG, 1982, BIOMATERIALS INTERFA, P245
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Zhang XM, 1997, MATER LETT, V30, P327, DOI 10.1016/S0167-577X(96)00229-7
NR 35
TC 35
Z9 35
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 15
PY 2004
VL 34
IS 2
BP 87
EP 94
DI 10.1016/j.colsurfb.2003.12.008
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 804AO
UT WOS:000220271800003
PM 15261078
DA 2018-10-19
ER

PT J
AU Dziubla, TD
   Lowman, AM
AF Dziubla, TD
   Lowman, AM
TI Vascularization of PEG-grafted macroporous hydrogel sponges: A
   three-dimensional in vitro angiogenesis model using human microvascular
   endothelial cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydrogel sponges; poly(ethylene glycol); human microvascular endothelial
   cells (HMVEC); angiogenesis
ID POLY(2-HYDROXYETHYL METHACRYLATE); MEMBRANES; INVITRO; GROWTH; MATRIX;
   PUMP
AB Vascular tissue can penetrate implants that have an interconnected porous structure. The extent of vascularization is heavily dependent on a number of factors, including the nature of the material as well as the size and porosity of the implant's pore morphology. Currently, it is still not clear what mechanisms are controlling this response. In this work, in vitro human microvascular endothelial cell (HMVEC) experiments employed in angiogenesis research have been adapted as a screening technique for biomaterial vascularization. Hydrogels composed of poly(2-hydroxy ethyl methacrylate) (PHEMA) containing poly(ethylene glycol) (PEG) grafts were capable of supporting in vitro tubule formation. The sizes and lengths of tubules were dependent upon the porosity of the polymer network and pore sizes. When compared to the pure PHEMA sponges, PEG-grafted networks possessed a more lattice-type structure, with greater pore interconnection. As a result, these polymers were better suited to supporting tubule formation. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Penn, Dept Chem Engn, Biomat & Drug Delivery Lab, Philadelphia, PA 19104 USA.
RP Lowman, AM (reprint author), Univ Penn, Dept Chem Engn, Biomat & Drug Delivery Lab, 32nd & Chestnut St, Philadelphia, PA 19104 USA.
EM alowman@drexel.edu
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Bachetti T, 2000, PHARMACOL RES, V42, P9, DOI 10.1006/phrs.1999.0655
   Bertolini F, 2000, EXP HEMATOL, V28, P993, DOI 10.1016/S0301-472X(00)00508-7
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036
   Dziubla TD, 2001, BIOMATERIALS, V22, P2893, DOI 10.1016/S0142-9612(01)00035-7
   DZIUBLA TD, 2002, BIOMETRIC MAT DESIGN, P507
   Fujiwara M, 2001, MICROVASC RES, V61, P215, DOI 10.1006/mvre.2001.2305
   Gerwins P, 2000, CRIT REV ONCOL HEMAT, V34, P185, DOI 10.1016/S1040-8428(00)00062-7
   Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG
   MATSUDA T, 1990, AM SOC ARTIF INTERN, V36
   Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3
   OH SH, 1989, J POLYM SCI POL CHEM, V27, P1731, DOI 10.1002/pola.1989.080270524
   Ohmi K, 1998, BIOCHEM BIOPH RES CO, V251, P137, DOI 10.1006/bbrc.1998.9417
   Peppas N. A., 1986, HYDROGELS MED PHARM, V180, P171
   RONEL SH, 1983, J BIOMED MATER RES, V17, P855, DOI 10.1002/jbm.820170512
   Scavini M, 1997, DIABETES CARE, V20, P610, DOI 10.2337/diacare.20.4.610
   SELAM JL, 1992, DIABETES CARE, V15, P877, DOI 10.2337/diacare.15.7.877
   SHWARKAWY AA, 1997, J BIOMED MATER RES, V37, P401
   SHWARKAWY AA, 1998, J BIOMED MATER RES, V40, P598
   SHWARKAWY AA, 1998, J BIOMED MATER RES, V40, P586
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   SPRINCL L, 1981, J BIOMED MATER RES, V15, P437, DOI 10.1002/jbm.820150314
   THURSTON G, 2000, ANN BIOMED ENG, V28, pS72
NR 30
TC 25
Z9 26
U1 0
U2 12
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2004
VL 68A
IS 4
BP 603
EP 614
DI 10.1002/jbm.a.20023
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 779CG
UT WOS:000189277600002
PM 14986316
DA 2018-10-19
ER

PT J
AU Yang, HH
   Zhang, SQ
   Chen, XL
   Zhuang, ZX
   Xu, JG
   Wang, XR
AF Yang, HH
   Zhang, SQ
   Chen, XL
   Zhuang, ZX
   Xu, JG
   Wang, XR
TI Magnetite-containing spherical silica nanoparticles for biocatalysis and
   bioseparations
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; SOFT MATERIALS; IMMUNOASSAY; PROTEINS;
   ENCAPSULATION; PARTICLES; BEADS; SIZE
AB The simultaneous entrapment of biological macromolecules and nanostructured silica-coated magnetite in solgel materials using a reverse-micelle technique leads to a bioactive, mechanically stable, nanometer-sized, and magnetically separable particles. These spherical particles have a typical diameter of 53 +/- 4 nm, a large surface area of 330 m(2)/g, an average pore diameter of 1.5 nm, a total pore volume of 1.427 cm(3)/g and a saturated magnetizaton (M-S) of 3.2 emu/g. Peroxidase entrapped in these particles shows Michaelis-Mentan kinetics and high activity. The catalytic reaction will take place immediately after adding these particles to the reaction solution. These enzyme entrapping particles catalysts can be easily separated from the reaction mixture by simply using an external magnetic field. Experiments have proved that these catalysts have a long-term stability toward temperature and pH change, as compared to free enzyme molecules. To further prove the application of this novel magnetic biomaterial in analytical chemistry, a magnetic-separation immunoassay system was also developed for the quantitative determination of gentamicin. The calibration for gentamicin has a working range of 200-4000 ng/mL, with a detection limit of 160 ng/mL, which is close to that of the fluorescent polarization immunoassay (FPIA) using the same reactants.
C1 SOA, Inst Oceanog 1, Mat Transport & Transformat Environm & Life Proc, Qingdao 266061, Peoples R China.
   Xiamen Univ, Dept Chem, Key Lab Analyt Sci MOE, Xiamen 361005, Peoples R China.
RP Yang, HH (reprint author), SOA, Inst Oceanog 1, Mat Transport & Transformat Environm & Life Proc, Qingdao 266061, Peoples R China.
EM hhyang@xmu.edu.cn
RI Zhuang, ZX/G-4127-2010; Chen, XL/G-3951-2010
CR Aoyama Y, 2003, J AM CHEM SOC, V125, P3455, DOI 10.1021/ja029608t
   ARRIAGADA FJ, 1995, J COLLOID INTERF SCI, V170, P8, DOI 10.1006/jcis.1995.1064
   Cannas C, 2002, J MATER CHEM, V12, P3141, DOI 10.1039/b204292d
   Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Collinson MM, 2002, TRAC-TREND ANAL CHEM, V21, P30
   Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Gill I, 2001, CHEM MATER, V13, P3404, DOI 10.1021/cm0102483
   Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/ange.200200546
   HAUKANES BI, 1993, BIO-TECHNOL, V11, P60, DOI 10.1038/nbt0193-60
   Jain TK, 1998, J AM CHEM SOC, V120, P11092, DOI 10.1021/ja973849x
   JOLLEY ME, 1981, CLIN CHEM, V27, P1190
   KI CD, 2002, AM CHEM SOC, V124
   Kiselev MV, 1999, ANAL BIOCHEM, V269, P393, DOI 10.1006/abio.1999.4015
   Klabunde K.J., 2001, NANOSCALE MAT CHEM
   Lu Y, 2002, NANO LETT, V2, P183, DOI 10.1021/nl015681q
   Martin CR, 1998, ANAL CHEM, V70, p322A, DOI 10.1021/ac9818430
   Matsunaga T, 1996, ANAL CHEM, V68, P3551, DOI 10.1021/ac9603690
   MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086
   Murthy N, 2002, J AM CHEM SOC, V124, P12398, DOI 10.1021/ja026925r
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Safarik I, 1999, J CHROMATOGR B, V722, P33, DOI 10.1016/S0378-4347(98)00338-7
   Santra S, 2001, LANGMUIR, V17, P2900, DOI 10.1021/la0008636
   Spitzer B, 2000, J CHROMATOGR A, V880, P113, DOI 10.1016/S0021-9673(99)01311-4
   Tanaka T, 2000, ANAL CHEM, V72, P3518, DOI 10.1021/ac9912505
   Wang BQ, 1999, ANAL CHEM, V71, P1935, DOI 10.1021/ac980940q
   Wang J, 1998, ANAL CHEM, V70, P1171, DOI 10.1021/ac971093e
   WANG R, 1993, ANAL CHEM, V65, P2671, DOI 10.1021/ac00067a020
   Yang HH, 2002, ANAL BIOCHEM, V308, P71, DOI 10.1016/S0003-2697(02)00222-1
   ZHAN W, 2002, ANAL CHEM, V74, P1233
NR 33
TC 422
Z9 443
U1 9
U2 200
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD MAR 1
PY 2004
VL 76
IS 5
BP 1316
EP 1321
DI 10.1021/ac034920m
PG 6
WC Chemistry, Analytical
SC Chemistry
GA 779BE
UT WOS:000189275100019
PM 14987087
DA 2018-10-19
ER

PT J
AU Wagner, MS
   Pasche, S
   Castner, DG
   Textor, M
AF Wagner, MS
   Pasche, S
   Castner, DG
   Textor, M
TI Characterization of poly(L-lysine)-graft-poly(ethylene glycol) assembled
   monolayers on niobium pentoxide substrates using time-of-flight
   secondary ion mass spectrometry and multivariate analysis
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID PARTIAL LEAST-SQUARES; PRINCIPAL COMPONENT ANALYSIS; RAY
   PHOTOELECTRON-SPECTROSCOPY; ADSORBED PROTEIN FILMS; PLASMA-DEPOSITED
   FILMS; METAL-OXIDE SURFACES; RESOLUTION TOF-SIMS; POLYMER SURFACES;
   FIBRINOGEN ADSORPTION; BIOMATERIAL SURFACES
AB Control of protein adsorption onto solid surfaces is a critical area of biomaterials and biosensors research. Application of high performance surface analysis techniques to these problems can improve the rational design and understanding of coatings that control protein adsorption. We have used static time-of-flight secondary ion mass spectrometry (TOF-SIMS) to investigate several poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) adlayers adsorbed electrostatically onto negatively charged niobium pentoxide (Nb2O5) substrates. By varying the PEG graft ratio (i.e., the number of lysine monomers per grafted PEG chain) and the molecular weights of the PLL and PEG polymers, the amount of protein adsorption can be tailored between 1 and 300 ng/cm(2). Detailed multivariate analysis using principal component analysis (PCA) of the positive and negative ion TOF-SIMS spectra showed changes in the outermost surface of the polymer films that were related to the density and molecular weight of the PEG chains on the surface. However, no significant differences were noted due to PLL molecular weight, despite observed differences in the serum adsorption characteristics for adlayers of PLL-g-PEG polymers with different PLL molecular weights. From the PCA results, multivariate peak intensity ratios were developed that correlated with the thickness of the adlayer and the enrichment of the PEG chains and the methoxy terminus of the PEG chains at the outermost surface of the adlayer. Furthermore, partial least squares regression was used to correlate the TOF-SIMS spectra with the amount of protein adsorption, resulting in a predictive model for determining the amount of protein adsorption on the basis of the TOF-SIMS spectra. The accuracy of the prediction of the amount of serum adsorption depended on the molecular weight of the PLL and PEG polymers and the PEG graft ratio. The combination of multivariate analysis and static TOF-SIMS provides detailed information on the surface chemistry and insight into the mechanism for protein resistance of the coatings.
C1 Swiss Fed Inst Technol ETH, Dept Mat, Lab Surface Sci & Technol, BioInterfaceGrp, CH-8952 Schlieren, Switzerland.
   NIST, Surface & Microanal Sci Div, Gaithersburg, MD 20899 USA.
   Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem Engn, Seattle, WA 98195 USA.
RP Textor, M (reprint author), Swiss Fed Inst Technol ETH, Dept Mat, Lab Surface Sci & Technol, BioInterfaceGrp, CH-8952 Schlieren, Switzerland.
EM marcus.textor@mat.ethz.ch
RI Textor, Marcus/A-6200-2012
OI Textor, Marcus/0000-0002-0178-1801
FU NIBIB NIH HHS [EB-002027]
CR Adriaens A, 1999, MASS SPECTROM REV, V18, P48, DOI 10.1002/(SICI)1098-2787(1999)18:1<48::AID-MAS2>3.3.CO;2-9
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   BENNINGHOVEN A, 1994, SURF SCI, V299, P246, DOI 10.1016/0039-6028(94)90658-0
   Bertrand P., 1996, MIKROCHIM ACTA S, V13, P167
   BRIGGS D, 1985, INT J MASS SPECTROM, V67, P47, DOI 10.1016/0168-1176(85)83036-6
   BRIGGS D, 1989, BRIT POLYM J, V21, P3, DOI 10.1002/pi.4980210103
   Briggs D, 1996, SURF INTERFACE ANAL, V24, P419, DOI 10.1002/(SICI)1096-9918(199606)24:6<419::AID-SIA132>3.3.CO;2-P
   Briggs D, 1997, SURF INTERFACE ANAL, V25, P167, DOI 10.1002/(SICI)1096-9918(199703)25:3<167::AID-SIA220>3.0.CO;2-J
   BRIGGS D, 1986, SURF INTERFACE ANAL, V9, P391
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chan CM, 2000, REV CHEM ENG, V16, P341
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   Coullerez G, 2000, SURF INTERFACE ANAL, V29, P431, DOI 10.1002/1096-9918(200007)29:7<431::AID-SIA886>3.3.CO;2-T
   DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X
   Delcorte A, 2001, J PHYS CHEM B, V105, P9474, DOI 10.1021/jp011099e
   Delcorte A, 1996, SURF SCI, V366, P149, DOI 10.1016/0039-6028(96)00779-0
   Elbert DL, 1998, CHEM BIOL, V5, P177, DOI 10.1016/S1074-5521(98)90062-X
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Favia P., 1996, PLASMAS POLYM, V1, P299
   Ferrari S, 2000, SURF INTERFACE ANAL, V29, P837, DOI 10.1002/1096-9918(200012)29:12<837::AID-SIA937>3.0.CO;2-O
   Franzreb K, 1998, SURF INTERFACE ANAL, V26, P597, DOI 10.1002/(SICI)1096-9918(199807)26:8<597::AID-SIA399>3.0.CO;2-I
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   Gilmore IS, 1996, SURF INTERFACE ANAL, V24, P746, DOI 10.1002/(SICI)1096-9918(199610)24:11<746::AID-SIA177>3.0.CO;2-A
   GONZALEZ G, 1994, J DISPER SCI TECHNOL, V15, P123
   Graham DJ, 2002, LANGMUIR, V18, P5861, DOI 10.1021/la0113062
   Graham DJ, 2002, LANGMUIR, V18, P1518, DOI 10.1021/la010059z
   Gresham GL, 2000, J FORENSIC SCI, V45, P310
   Hagenhoff B, 2000, MIKROCHIM ACTA, V132, P259
   Hanley L, 1999, J MASS SPECTROM, V34, P705, DOI 10.1002/(SICI)1096-9888(199907)34:7<705::AID-JMS845>3.0.CO;2-B
   Hanton SD, 2001, CHEM REV, V101, P527, DOI 10.1021/cr9901081
   Horbett Thomas A., 1996, P133
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   JACKSON JE, 1991, USERS GUIDE PRINCIPL
   John CM, 1997, INT J MASS SPECTROM, V161, P47, DOI 10.1016/S0168-1176(96)04505-3
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Karpuzov DS, 2002, NUCL INSTRUM METH B, V187, P311, DOI 10.1016/S0168-583X(01)00933-8
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   LEGGETT GJ, 1992, INT J MASS SPECTROM, V122, P281, DOI 10.1016/0168-1176(92)87021-6
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   McArthur SL, 2002, SURF INTERFACE ANAL, V33, P924, DOI 10.1002/sia.1446
   McArthur SL, 2000, COLLOID SURFACE B, V17, P37, DOI 10.1016/S0927-7765(99)00086-7
   McLean KM, 2000, COLLOID SURFACE B, V18, P221, DOI 10.1016/S0927-7765(99)00149-6
   Medard N, 2002, SURF INTERFACE ANAL, V34, P565, DOI 10.1002/sia.1361
   MICHAUD D, 1993, J AIR WASTE MANAGE, V43, P729
   Michel R, 2002, LANGMUIR, V18, P3281, DOI 10.1021/la011715y
   Morra M., 1993, Clinical Materials, V14, P255, DOI 10.1016/0267-6605(93)90010-5
   Norrman K, 2002, J MASS SPECTROM, V37, P699, DOI 10.1002/jms.330
   Ohrlund A, 1997, SURF INTERFACE ANAL, V25, P105, DOI 10.1002/(SICI)1096-9918(199702)25:2<105::AID-SIA213>3.0.CO;2-R
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Pacholski ML, 1999, CHEM REV, V99, P2977, DOI 10.1021/cr980137w
   Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   Phatak A, 1997, J CHEMOMETR, V11, P311, DOI 10.1002/(SICI)1099-128X(199707)11:4<311::AID-CEM478>3.3.CO;2-W
   REICHLMAIER S, 1994, SURF INTERFACE ANAL, V21, P739, DOI 10.1002/sia.740211102
   Ruiz-Taylor LA, 2001, P NATL ACAD SCI USA, V98, P852, DOI 10.1073/pnas.98.3.852
   Sanni OD, 2002, SURF INTERFACE ANAL, V33, P715, DOI 10.1002/sia.1438
   Shard AG, 1996, SURF INTERFACE ANAL, V24, P787, DOI 10.1002/(SICI)1096-9918(199611)24:12<787::AID-SIA181>3.3.CO;2-5
   SHARD AG, 1995, MACROMOLECULES, V28, P7855, DOI 10.1021/ma00127a036
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   SHORT RD, 1993, VACUUM, V44, P1143, DOI 10.1016/0042-207X(93)90340-G
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Van Vaeck L, 1999, MASS SPECTROM REV, V18, P1
   VANDEGINSTE BGM, 1998, HDB CHEMOMETRICS QUA
   Vanden Eynde X, 1999, APPL SURF SCI, V141, P1, DOI 10.1016/S0169-4332(98)00626-6
   Vanden Eynde X, 1998, SURF INTERFACE ANAL, V26, P579, DOI 10.1002/(SICI)1096-9918(199807)26:8<579::AID-SIA404>3.0.CO;2-Z
   Vanden-Eynde X, 1997, SURF INTERFACE ANAL, V25, P878
   Voros J, 2002, BIOMATERIALS, V23, P3699, DOI 10.1016/S0142-9612(02)00103-5
   Voros J., 2003, BIOWORLD, V2, P16
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   Wagner MS, 2002, J BIOMAT SCI-POLYM E, V13, P407, DOI 10.1163/156856202320253938
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Xia N, 2002, LANGMUIR, V18, P3255, DOI 10.1021/la011423x
   ZEHNPFENNING J, 1994, SURF INTERFACE ANAL, V21, P566, DOI 10.1002/sia.740210809
   Ziegler JF, STOPPING RANGE IONS
NR 85
TC 50
Z9 50
U1 1
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD MAR 1
PY 2004
VL 76
IS 5
BP 1483
EP 1492
DI 10.1021/ac034873y
PG 10
WC Chemistry, Analytical
SC Chemistry
GA 779BE
UT WOS:000189275100039
PM 14987107
DA 2018-10-19
ER

PT J
AU Amsden, B
   Hatefi, A
   Knight, D
   Bravo-Grimaldo, E
AF Amsden, B
   Hatefi, A
   Knight, D
   Bravo-Grimaldo, E
TI Development of biodegradable injectable thermoplastic oligomers
SO BIOMACROMOLECULES
LA English
DT Article
ID EPSILON-CAPROLACTONE; MOLECULAR-WEIGHT
AB Injectable thermoplastic oligomers represent a promising biomaterial for drug delivery provided they possess a melting point at or very near physiologic temperature, as well as a low melt viscosity. One approach would be to prepare an oligolactone. In this paper, we examine the role of different alcohol initiators used in the ring-opening polymerization of epsilon-caprolactone oligomers on the melting point and melt viscosity of the resultant thermoplastics. We found that the initiator used plays a significant role in the final properties of the final oligomer. For primary alcohols, the longer the chain length of the oligomer the lower its melt viscosity, until a chain length of 8 carbons, after which there was no noticeable effect. There was no significant effect observed of primary initiators on the melting point. The use of secondary alcohols produced oligomers with higher viscosities but with reduced overall crystallinity. The use of an unsaturated alcohol, oleyl alcohol, not only reduced the melting point and overall crystallinity but also reduced the melt viscosity of the oligomer. The oleyl alcohol initiated oligomer appears to be a promising vehicle for localized, sustained drug delivery applications.
C1 Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.
RP Amsden, B (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RI Knight, Darryl/A-7949-2013
CR Bezwada RS, 1997, United States Patent US, Patent No. [5653992, 5,653,992]
   BEZWADA RS, 1995, Patent No. 5442033
   Boyer R. F., 1963, RUBBER CHEM TECHNOL, V36, P1303, DOI DOI 10.5254/1.3539649
   BRODE GL, 1972, J MACROMOL SCI CHEM, VA  6, P1109, DOI 10.1080/10601327208056888
   Carreau P. J., 1997, RHEOLOGY POLYM SYSTE
   Chiao CS, 1995, REMINGTON SCI PRACTI, VII, P1660
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   Grosvenor MP, 1996, INT J PHARM, V135, P103, DOI 10.1016/0378-5173(95)04404-3
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Ho RM, 2002, MACROMOLECULES, V35, P1299, DOI 10.1021/ma011381j
   In't Veld PJA, 1997, J POLYM SCI POL CHEM, V35, P219, DOI 10.1002/(SICI)1099-0518(19970130)35:2<219::AID-POLA3>3.0.CO;2-N
   SCHINDLER A, 1982, J POLYM SCI POL CHEM, V20, P319, DOI 10.1002/pol.1982.170200206
   SCOPELIANOS AG, 1998, Patent No. 5728752
   SCOPELIANOS AG, 1998, Patent No. 5824333
   SENIOR J, 2000, SUSTAINED RELEASE IN
   Stevens MP, 1999, POLYM CHEM
   WEAST RC, 1982, CRC HDB CHEM PHYSICS
   WUNDERLICH B, 1997, THERMAL CHARACTERIZA, V1, P206
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 19
TC 18
Z9 18
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2004
VL 5
IS 2
BP 637
EP 642
DI 10.1021/bm034457n
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 801QA
UT WOS:000220109200051
PM 15003031
DA 2018-10-19
ER

PT J
AU Sanguanchaipaiwong, V
   Gabelish, CL
   Hook, J
   Scholz, C
   Foster, LJR
AF Sanguanchaipaiwong, V
   Gabelish, CL
   Hook, J
   Scholz, C
   Foster, LJR
TI Biosynthesis of natural-synthetic hybrid copolymers:
   Polyhydroxyoctanoate-diethylene glycol
SO BIOMACROMOLECULES
LA English
DT Article
ID END GROUP-STRUCTURE; POLY(ETHYLENE GLYCOL); PSEUDOMONAS-OLEOVORANS;
   MOLECULAR-WEIGHT; DEGRADATION; POLYESTER; VESICLES; FUSION
AB A new natural-synthetic hybrid biomaterial has been isolated from the growth of Pseudomonas oleovorans in the presence of diethylene glycol (DEG). DEG was consumed by P. oleovorans with 20 mM sodium octanoate in modified E* medium, but its presence in the fermentation medium retarded cell growth and viability, influencing production and composition of polyhydroxyalkanoates with medium chain length substituents (mc/PHAs) and consequently attenuating PHA yield. DEG affected the composition of the mc/PHA with an increase in the C8 component: polyhydroxyoctanoate (PHO). Gas chromatography- mass spectrometry (GC-MS) was used to quantitatively monitor DEG in the system and reveal its cellular adsorption and penetration. Intracellularly, the DEG significantly reduced the molar mass of the mc/PHA; PHO with a bimodal distribution of high and low molecular weight fractions was observed. H-1 NMR, 2-D COSY, and heteronuclear single quantum coherence spectra confirmed that the high molecular weight fraction consisted of PHO chains terminated by DEG. Thus, the synthesis of this natural-synthetic hybrid copolymer, PHO-DEG, opens the way for microbial synthesis of a wide variety of PHA-DEG copolymers with a range of bioactive properties.
C1 Univ New S Wales, Biopolymer Res Grp, CAMD, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   Univ New S Wales, Nucl Magnet Resonance Facil, Sydney, NSW 2052, Australia.
   Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
RP Foster, LJR (reprint author), Univ New S Wales, Biopolymer Res Grp, CAMD, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
EM J.Foster@unsw.edu.au
RI Hook, James/D-6805-2011
OI Hook, James/0000-0002-1185-7320
CR Albertsson P. A., 1986, PARTITION CELL PARTI
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Ashby RD, 2002, APPL MICROBIOL BIOT, V60, P154, DOI 10.1007/s00253-002-1110-9
   Ashby RD, 1997, TETRAHEDRON, V53, P15209, DOI 10.1016/S0040-4020(97)00958-7
   Ashby RD, 1999, BIOTECHNOL BIOENG, V62, P106, DOI 10.1002/(SICI)1097-0290(19990105)62:1<106::AID-BIT12>3.0.CO;2-X
   AZUMA Y, 1992, POLYMER, V33, P4763, DOI 10.1016/0032-3861(92)90690-X
   BONI LT, 1984, BIOCHIM BIOPHYS ACTA, V775, P409, DOI 10.1016/0005-2736(84)90198-6
   Brandl H, 1990, Adv Biochem Eng Biotechnol, V41, P77
   BUDWILL K, 1992, APPL ENVIRON MICROB, V58, P1398
   Byrom D., 1994, PLASTICS MICROBES MI, P5
   Curley JM, 1997, POLYMER, V38, P5313, DOI 10.1016/S0032-3861(97)00088-8
   Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0
   DOI Y, 2001, BIOPOLYMERS, V1
   Doi Y., 1990, MICROBIAL POLYESTERS
   Foster LJR, 1996, INT J BIOL MACROMOL, V19, P177, DOI 10.1016/0141-8130(96)01125-7
   FRITZSCHE K, 1990, MAKROMOL CHEM, V191, P1957
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   HOWELLS ER, 1982, CHEM IND-LONDON, P508
   Inada Y, 1990, J BIOACT COMPAT POL, V5, P343, DOI 10.1177/088391159000500309
   INGRAM LO, 1984, ADV MICROBIOLOGY PHY, P25
   Kawai F, 1995, APPL MICROBIOL BIOT, V44, P532
   Kim O, 2000, J POLYM RES, V7, P91, DOI 10.1007/s10965-006-0108-x
   Lemogne M., 1925, ANN I PASTEUR PARIS, V39, P144
   Mergaert Joris, 1994, Journal of Environmental Polymer Degradation, V2, P177, DOI 10.1007/BF02067443
   Satoh H, 1999, INT J BIOL MACROMOL, V25, P105, DOI 10.1016/S0141-8130(99)00021-5
   Shi FY, 1996, MACROMOLECULES, V29, P10, DOI 10.1021/ma950707j
   Shi FY, 1996, MACROMOLECULES, V29, P7753, DOI 10.1021/ma960805k
   STEINBUCHEL, 1996, BIOTECHNOLOGY, P405
   YAMAZAKI M, 1990, BIOCHEMISTRY-US, V29, P1309, DOI 10.1021/bi00457a029
   YASIN M, 1993, PLAST RUB COMPOS PRO, V19, P15
NR 31
TC 22
Z9 23
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2004
VL 5
IS 2
BP 643
EP 649
DI 10.1021/bm0344708
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 801QA
UT WOS:000220109200052
PM 15003032
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Hanawa, T
   Asami, K
AF Hiromoto, S
   Hanawa, T
   Asami, K
TI Composition of surface oxide film of titanium with culturing murine
   fibroblasts L929
SO BIOMATERIALS
LA English
DT Article
DE titanium; surface analysis; amino acid; protein; cell culture;
   biomaterial
ID QUASI-BIOLOGICAL ENVIRONMENTS; PHYSIOLOGICAL SOLUTION; STAINLESS-STEEL;
   XPS; ALLOYS; ADSORPTION; IMPLANTS; INTERFACE; CHROMIUM; IRON
AB Changes in the composition of surface oxide film on titanium specimens in the presence of amino acids, serum proteins, and cells were characterized using X-ray photoelectron spectroscopy. The surface oxide film on titanium formed in the air is so protective that the further oxidation of titanium is prevented in various circumstances. During immersion of the specimen in Hanks' solution, Eagle's minimum essential medium (MEM), and MEM with the addition of fetal bovine serum (MEM + FBS), calcium phosphate precipitated, causing the increase in thickness of the surface oxide film. Calcium phosphate was also precipitated with culturing murine fibroblast L929, but the amount of the calcium phosphate was smaller than those in Hanks' solution, MEM, and MEM + FBS. The relative concentration ratio of calcium to phosphorous, [Ca]/[P], increased with proteins charging negatively, while the ratio decreased with the cells whose extracellular matrix charging positively. In addition, sulfur precipitated as S-0 and/or S2- only with culturing the cells. Sulfate ions in the MEM + FBS are reduced at the interface between titanium and the solution with the existence of cells. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050047, Japan.
   Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Hiromoto, S (reprint author), Natl Inst Mat Sci, Ctr Biomat, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011
CR ALBERTS B, 1990, MOL BIOL CELL, P808
   ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1990, CORROS SCI, V31, P727, DOI 10.1016/0010-938X(90)90188-B
   ASAMI K, 1993, CORROS SCI, V35, P43, DOI 10.1016/0010-938X(93)90131-Y
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Asami K., 1985, P 6 EUR S CORR BEH A, P769
   ASAMI K, 1979, JPN I MET, V20, P119
   EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432
   Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
   Frauchiger L, 1999, APPL SURF SCI, V143, P67, DOI 10.1016/S0169-4332(98)00932-5
   HAMAGUCHI K, 1985, PROTEIN MOL, P32
   Hanawa T, 2002, MATER TRANS, V43, P3088, DOI 10.2320/matertrans.43.3088
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   HASHIMOTO K, 1979, CORROS SCI, V19, P3, DOI 10.1016/0010-938X(79)90003-9
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Hiromoto S, 2002, ELECTROCHIM ACTA, V48, P387, DOI 10.1016/S0013-4686(02)00684-9
   Kelly E. J., 1982, MOD ASPECT ELECTROC, P319
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   RAIKAR GN, 1995, J VAC SCI TECHNOL A, V13, P2633, DOI 10.1116/1.579462
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   TAKEMOTO S, 2002, P 24 ANN M JAP SOC B, P124
   TERADA Y, 1977, TAISHA, V14, P241
   TERAMOTO K, 1978, BOSHOKU GIJUTSU, V27, P57
NR 32
TC 65
Z9 69
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2004
VL 25
IS 6
BP 979
EP 986
DI 10.1016/S0142-9612(03)00620-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GF
UT WOS:000186853600005
PM 14615162
DA 2018-10-19
ER

PT J
AU Jin, HJ
   Chen, JS
   Karageorgiou, V
   Altman, GH
   Kaplan, DL
AF Jin, HJ
   Chen, JS
   Karageorgiou, V
   Altman, GH
   Kaplan, DL
TI Human bone marrow stromal cell responses on electrospun silk fibroin
   mats
SO BIOMATERIALS
LA English
DT Article
DE electrospinning; nano-fiber; silkworm silk; scaffolds; human bone marrow
   stem cells (BMSCs)
ID POLYMER THIN-FILMS; POLY(ETHYLENE OXIDE); COLLAGEN NANOFIBERS; FIBERS;
   BIOCOMPATIBILITY; BIOMATERIALS; SCAFFOLD
AB Fibers with nanoscale diameters provide benefits due to high surface area for biomaterial scaffolds. In this study electrospun silk fibroin-based fibers with average diameter 700 +/- 50 nm were prepared from aqueous regenerated silkworm silk solutions. Adhesion, spreading and proliferation of human bone marrow stromal cells (BMSCs) on these silk matrices was studied. Scanning electron microscopy (SEM) and MTT analyses demonstrated that the electrospun silk matrices supported BMSC attachment and proliferation over 14 days in culture similar to native silk fibroin (similar to15 mum fiber diameter) matrices. The ability of electrospun silk matrices to support BMSC attachment, spreading and growth in vitro, combined with a biocompatibility and biodegradable properties of the silk protein matrix, suggest potential use of these biomaterial matrices as scaffolds for tissue engineering. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biomed Engn, Ctr Bioengn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biol & Chem Engn, 4 Colby St, Medford, MA 02155 USA.
OI Karageorgiou, Vassilis/0000-0002-0892-510X
FU NIDCR NIH HHS [R01 DE13405-01]
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ANDERSON JP, 1994, BIOACTIVE SILK LIKE, V330, P71
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Buchko CJ, 2001, BIOMATERIALS, V22, P1289, DOI 10.1016/S0142-9612(00)00281-7
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   BUNNING TJ, 1993, ACS SYM SER, V544, P351
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang L, 2001, SCANNING, V23, P372
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kadler K. E., 1996, BIOCHEM J, V316, P71
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park H, 1996, PHARMACEUT RES, V13, P1770, DOI 10.1023/A:1016012520276
   Putthanarat S, 2000, POLYMER, V41, P7735, DOI 10.1016/S0032-3861(00)00036-7
   Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stitzel JD, 2001, J BIOMATER APPL, V16, P22, DOI 10.1106/U2UU-M9QH-Y0BB-5GYL
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Tsou L, 2000, J POLYM SCI POL PHYS, V38, P1369, DOI 10.1002/(SICI)1099-0488(20000515)38:10<1369::AID-POLB140>3.0.CO;2-9
   YAMAURA K, 1990, J APPL POLYM SCI, V41, P2409, DOI 10.1002/app.1990.070410941
   Zarkoob S, 1998, POLYM PREPR, V39, P244
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 33
TC 442
Z9 468
U1 6
U2 163
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2004
VL 25
IS 6
BP 1039
EP 1047
DI 10.1016/S0142-9612(03)00609-4
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GF
UT WOS:000186853600012
PM 14615169
DA 2018-10-19
ER

PT J
AU Unger, RE
   Wolf, M
   Peters, K
   Motta, A
   Migliaresi, C
   Kirkpatrick, CJ
AF Unger, RE
   Wolf, M
   Peters, K
   Motta, A
   Migliaresi, C
   Kirkpatrick, CJ
TI Growth of human cells on a non-woven silk fibroin net: a potential for
   use in tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE fibroin; human cells; growth; biomaterial; biocompatibility; silk
ID OSTEOBLAST IN-VITRO; POLY(D,L-LACTIC ACID); BIOMATERIALS; MEMBRANE;
   CULTURE; LINES
AB We have examined a novel biomaterial consisting of a non-woven fibroin net produced from silk (Bombyx mori) cocoons for its ability to support the growth of human cells. Various human cells of different tissue and cell types (endothelial, epithelial, fibroblast, glial, keratinocyte, osteoblast) were examined for adherence and growth on the nets by confocal laser microscopy after staining of the cells with calcein-AM and by electron microscopy. All the cells readily adhered and spread over the individual fibers of the nets. Most of the cells were able to grow and survive on the nets for at least 7 weeks and growth not only covered the individual fibers of the net but generally bridged the gaps between individual fibers forming tissue-like structures. Scanning electron microscopic examination of the nets demonstrated a tight association of individual cells with the fibers and nets examined after removal of cells showed no evidence that the growth of cells in any way changed the structure of the fibers. Thus, silk fibroin nets are highly human cell-compatible and should be a useful new scaffolding biomaterial applicable for a wide range of target tissues in addition to supporting endothelial cells required for the vascularization of the newly formed tissue. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   Univ Trent, Dept Mat Engn, I-38100 Trent, Italy.
RP Unger, RE (reprint author), Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
RI Peters, Kirsten/S-3484-2016
OI Motta, Antonella/0000-0003-4893-6863
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARMATO U, Patent No. 0100501
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Rossitch E Jr, 1987, N C Med J, V48, P669
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2002, IN VITRO CELL DEV-AN, V38, P273
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
NR 20
TC 182
Z9 209
U1 1
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2004
VL 25
IS 6
BP 1069
EP 1075
DI 10.1016/S0142-9612(03)00619-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GF
UT WOS:000186853600015
PM 14615172
DA 2018-10-19
ER

PT J
AU McKenzie, JL
   Waid, MC
   Shi, RY
   Webster, TJ
AF McKenzie, JL
   Waid, MC
   Shi, RY
   Webster, TJ
TI Decreased functions of astrocytes on carbon nanofiber materials
SO BIOMATERIALS
LA English
DT Article
DE carbon nanofibers; neural biomaterial; astrocytes; nanotechnology;
   nanophase
ID NANOPHASE CERAMICS; OSTEOBLAST ADHESION; ENHANCED FUNCTIONS; CELL
   ATTACHMENT; SPINAL-CORD; INJURY; GROWTH; COMPOSITE; SILICON;
   BIOMATERIALS
AB Carbon nanofibers possess excellent conductivity properties, which may be beneficial in the design of more effective neural prostheses; however, limited evidence on their cytocompatibility properties currently exists. The objective of the present in vitro study was to determine cytocompatibility properties of formulations containing carbon nanofibers pertinent to neural implant applications. Substrates were prepared from four different types of carbon fibers, two with nanoscale diameters (nanophase, or less than or equal to 100 nm) and two with conventional diameters (or greater than 100 nm). Within these two categories, both a high and a low surface energy fiber were investigated and tested. Carbon fibers were compacted in a manual hydraulic press via a uniaxial loading cycle. Astrocytes (glial scar tissue-forming cells) were seeded onto the substrates for adhesion, proliferation, and long-term function studies (such as total intracellular protein and alkaline phosphatase activity). Results provided the first evidence that astrocytes preferentially adhered and proliferated on carbon fibers that had the largest diameter and the lowest surface energy. Based on these results, composite substrates were also formed using different weight percentages (0-25 wt%) of the nanophase, high surface energy fibers in a polycarbonate urethane matrix. Results provided the first evidence of decreased adhesion of astrocytes with increasing weight percents of the high surface energy carbon nanofibers in the polymer composite; this further demonstrates that formulations containing carbon fibers in the nanometer regime may limit astrocyte functions leading to decreased glial scar tissue formation. Positive interactions with neurons, and, at the same time, limited astrocyte functions leading to decreased gliotic scar tissue formation are essential for increased neuronal implant efficacy. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, W Lafayette, IN 47907 USA.
RP Webster, TJ (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
EM twebster@ecn.purdue.edu
CR Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5
   Allaoui A, 2002, COMPOS SCI TECHNOL, V62, P1993, DOI 10.1016/S0266-3538(02)00129-X
   Andrews R, 1999, APPL PHYS LETT, V75, P1329, DOI 10.1063/1.124683
   *APPL SCI INC PYR, 2001, PYR 3
   Bayliss SC, 1999, SENSOR ACTUAT A-PHYS, V74, P139, DOI 10.1016/S0924-4247(98)00346-X
   Chauhan NB, 1999, INT J DEV NEUROSCI, V17, P255, DOI 10.1016/S0736-5748(99)00003-9
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Di Prospero NA, 1998, J NEUROCYTOL, V27, P491, DOI 10.1023/A:1006995624754
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Geisert EE, 1996, INT J DEV NEUROSCI, V14, P257, DOI 10.1016/0736-5748(96)00012-3
   Heiduschka P, 1998, PROG NEUROBIOL, V55, P433, DOI 10.1016/S0301-0082(98)00013-6
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#
   Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   KHAN T, 1991, BRAIN RES, V541, P139, DOI 10.1016/0006-8993(91)91087-H
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222
   Kuriger RJ, 2002, COMPOS PART A-APPL S, V33, P53, DOI 10.1016/S1359-835X(01)00070-7
   Little AR, 2001, NEUROTOXICOLOGY, V22, P607, DOI 10.1016/S0161-813X(01)00032-8
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Lozano K, 2000, JOM-J MIN MET MAT S, V52, pA34
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Park KW, 2001, NEUROSCI RES, V40, P315, DOI 10.1016/S0168-0102(01)00242-5
   Peduzzi JD, 1999, EXP NEUROL, V160, P460, DOI 10.1006/exnr.1999.7234
   Pesakova V, 2000, J MATER SCI-MATER M, V11, P793, DOI 10.1023/A:1008953529111
   *POL TECHN GROUP I, 2002, BION POL UR
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SPENCE A, 2002, NNUN BIOL CHEM, V13
   StJohn PM, 1997, J NEUROSCI METH, V75, P171, DOI 10.1016/S0165-0270(97)00069-1
   Tanzi MC, 2000, J BIOMATER APPL, V14, P325, DOI 10.1106/7TJU-H1YA-4NYT-XL84
   TORIMITSU K, 2002, ICCE C P SAN DIEG CA, P795
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   WALSH JF, 2002, SOC BIOM C P TAMP FL, P49
   Webb K, 2001, BIOMATERIALS, V22, P1017, DOI 10.1016/S0142-9612(00)00353-7
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
NR 41
TC 177
Z9 192
U1 0
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR-APR
PY 2004
VL 25
IS 7-8
BP 1309
EP 1317
DI 10.1016/j.biomaterials.2003.08.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 753PJ
UT WOS:000187239500019
PM 14643605
DA 2018-10-19
ER

PT J
AU Jones, DS
   Garvin, CP
   Gorman, SP
AF Jones, DS
   Garvin, CP
   Gorman, SP
TI Relationship between biomedical catheter surface properties and
   lubricity as determined using textural analysis and multiple regression
   analysis
SO BIOMATERIALS
LA English
DT Article
DE lubricity; catheters; dynamic contact angle analysis; microrugosity;
   textural analysis; agar; multiple regression
ID IN-VITRO; FRICTION; ADHESION; DEVICES; ENERGY
AB In this study, the surface properties of and work required to remove 12 commercially available and developmental catheters from a model biological medium (agar), a measure of catheter lubricity, were characterised and the relationships between these properties were examined using multiple regression and correlation analysis. The work required for removal of catheter sections (7 cm) from a model biological medium (1% w/w agar) were examined using tensile analysis. The water wettability of the catheters were characterised using dynamic contact angle analysis, whereas surface roughness was determined using atomic force microscopy. Significant differences in the ease of removal were observed between the various catheters, with the silicone-based materials generally exhibiting the greatest ease of removal. Similarly, the catheters exhibited a range of advancing and receding contact angles that were dependent on the chemical nature of each catheter. Finally, whilst the microrugosities of the various catheters differed, no specific relationship to the chemical nature of the biomaterial was apparent. Using multiple regression analysis, the relationship between ease of removal, receding contact angle and surface roughness was defined as: Work done (N mm) 17.18 + 0.055 Rugosity (nm)-0.52 Receding contact angle (degrees) (r = 0.49). Interestingly, whilst the relationship between ease of removal and surface roughness was significant (r = 0.48, p = 0.0005), in which catheter lubricity increased as the surface roughness decreased, this was not the case with the relationship between ease of removal and receding contact angle (r = -0.18, p > 0.05). This study has therefore uniquely defined the contributions of each of these surface properties to catheter lubricity. Accordingly, in the design of urethral catheters. it is recommended that due consideration should be directed towards biomaterial surface roughness to ensure maximal ease of catheter removal. Furthermore, using the method described in this study, differences in the lubricity of the various catheters were observed that may be apparent in their clinical use. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Unit, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Unit, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
CR AKADA Y, 1993, LUBRICATING POLYM SU
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   COX AJ, 1987, BIOMATERIALS, V8, P500, DOI 10.1016/0142-9612(87)90089-5
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V60, P89, DOI 10.1016/0378-1097(89)90083-9
   GOLD P, 1985, Patent No. 4534363
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   Gorman SP, 2003, MED IMPLICATIONS BIO, P136
   GROSCH KA, 1963, PROC R SOC LON SER-A, V274, P21, DOI 10.1098/rspa.1963.0112
   HEILMAN MS, 1978, Patent No. 4080706
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 1997, PHARMACEUT RES, V14, P450, DOI 10.1023/A:1012091231023
   Jones DS, 2001, J MATER SCI-MATER M, V12, P15, DOI 10.1023/A:1026744732504
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   LAPORTE RJ, 1997, HYDROPHILLIC POLYM C
   Marmieri G, 1996, J BIOMED MATER RES, V33, P29, DOI 10.1002/(SICI)1097-4636(199621)33:1<29::AID-JBM5>3.3.CO;2-M
   McGovern JG, 1997, INT J PHARM, V149, P251, DOI 10.1016/S0378-5173(97)04883-7
   NAGAOKA S, 1990, BIOMATERIALS, V11, P419, DOI 10.1016/0142-9612(90)90098-B
   Polderman KH, 2002, INTENS CARE MED, V28, P1, DOI 10.1007/s00134-001-1154-9
   Pomfret I J, 1996, Br J Nurs, V5, P245
   RAMSAY JWA, 1986, BRIT J UROL, V58, P70, DOI 10.1111/j.1464-410X.1986.tb05431.x
   Rosen M, 1992, HDB PERCUTANEOUS CEN
   Tunney MM, 1999, METHOD ENZYMOL, V310, P558
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
NR 25
TC 24
Z9 26
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR-APR
PY 2004
VL 25
IS 7-8
BP 1421
EP 1428
DI 10.1016/j.biomaterials.2003.08.01
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 753PJ
UT WOS:000187239500031
PM 14643617
DA 2018-10-19
ER

PT J
AU Diener, A
   Nebe, B
   Luthen, F
   Becker, P
   Neumann, HG
   Rychly, J
AF Diener, A
   Nebe, B
   Luthen, F
   Becker, P
   Neumann, HG
   Rychly, J
TI Dynamics of focal adhesions in osteoblastic cells are controlled by
   characteristics of biomaterial surfaces
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Deutschen-Gesellschaft-fur-Zellbiologie
CY MAR 24-27, 2004
CL Berlin, Germany
SP Deutsch Gesell Zellbiol
C1 Univ Rostock, Dept Internal Med, D-2500 Rostock, Germany.
   DOT GmbH, Rostock, Germany.
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
NR 0
TC 0
Z9 0
U1 0
U2 2
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2004
VL 83
SU 54
BP 34
EP 34
PG 1
WC Cell Biology
SC Cell Biology
GA 812EX
UT WOS:000220823900050
DA 2018-10-19
ER

PT J
AU Piotrowski, A
   Kahlenberg, V
   Fischer, RX
AF Piotrowski, A
   Kahlenberg, V
   Fischer, RX
TI Mixed phosphate-sulfate fluor apatites as possible materials in dental
   fillers
SO EUROPEAN JOURNAL OF MINERALOGY
LA English
DT Article
DE phosphate-sulfate apatite; solid solution; Rietveld study; dental
   filler; biomaterial
ID CRYSTAL-STRUCTURE; X-RAY; FLUOROAPATITES; FLUORAPATITE; CESANITE
AB A series of sulfate-phosphate apatite samples of formal composition Na(x)Ca(10-x)(SO(4)),(PO(4))(6-x)F(2) (x = 1,2,...,6) were prepared by solid state reactions and hydrothermal techniques. Rietveld analyses based on X-ray diffraction data clearly indicate that the samples synthesized by solid state reaction of the reactants Na(2)SO(4), CaSO(4), CaF(2), and Ca(3)(PO(4))(2) consist of a mixture of two apatite end-members Na(6)Ca(4)(SO(4))(6)F(2) and Ca(10)(PO(4))(6)F(2) which contradicts previous work assuming a solid solution series between the end-members. The X-ray diffraction powder patterns of the samples synthesized by hydrothermal methods show a splitting of reflections which can be interpreted as a monoclinic reduction of the hexagonal symmetry, thus representing an apatite-like phase of the solid solution series with sulfate and phosphate groups. The hydrothermally synthesized compounds exhibit physical properties that are required for dental applications where apatite-like phases are used as fillers in composite materials.
C1 Univ Bremen, Fachbereich Geowissensch Kristallog, D-28359 Bremen, Germany.
   Univ Innsbruck, Inst Mineral & Petrog, A-6020 Innsbruck, Austria.
   Heraeus Kulzer GmbH, Res & Dev, D-61273 Wehrheim, Germany.
RP Kahlenberg, V (reprint author), Univ Bremen, Fachbereich Geowissensch Kristallog, D-28359 Bremen, Germany.
EM Volker.Kahlenberg@uibk.ac.at
CR APELLA MC, 1981, Z NATURFORSCH B, V36, P644
   APELLA MC, 1979, Z NATURFORSCH B, V34, P1124
   BIRKENSTOCK J, 1993, THESIS U MAINZ GERMA
   CHEETHAM AK, 1971, J PHYS PART C SOLID, V4, P3107, DOI 10.1088/0022-3719/4/18/016
   DIHN P, 1942, Z ELEKTROCHEM, V48, P331
   Fischer R. X., 1993, MATERIALS SCI FORUM, V133-136, P287
   GOULTIF A, 1991, J APPL CRYSTALLOGR, V24, P987
   HAWTHORNE FC, 1975, CANADIAN MINERALOGIS, V0013
   Klement R, 1939, NATURWISSENSCHAFTEN, V27, P568
   LAGHZIZIL A, 1993, SOLID STATE IONICS, V67, P137, DOI 10.1016/0167-2738(93)90319-X
   LE BAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0
   PERRET R, 1975, B SOC FR MINERAL CR, V98, P254
   Piotrowski A, 2002, J SOLID STATE CHEM, V163, P398, DOI 10.1006/jssc.2001.9408
   Piotrowski A, 2002, AM MINERAL, V87, P715
   PRIMAK W, 1948, J AM CHEM SOC, V70, P2043, DOI 10.1021/ja01186a018
   RENTSCH H, 1999, Patent No. 5952399
   RODRIGUEZCARVAJ.J, FULLPROF 25 VERSION
   SCHNEIDER W, 1967, NEUES JB MINER MONAT, P284
   SCHNEIDER W, 1969, NEUES JB MINER MONAT, P58
   SHIGA Y, 1987, CAN MINERAL, V25, P673
   SUDARSAN.K, 1972, MATER RES BULL, V7, P1331, DOI 10.1016/0025-5408(72)90113-4
   SUDARSANAN K, 1980, ACTA CRYSTALLOGR B, V36, P1636, DOI 10.1107/S0567740880006759
   TAZZOLI V, 1983, MINERAL MAG, V47, P59, DOI 10.1180/minmag.1983.047.342.10
   Wilson RM, 1999, AM MINERAL, V84, P1406
NR 24
TC 3
Z9 3
U1 1
U2 4
PU E SCHWEIZERBARTSCHE VERLAGS
PI STUTTGART
PA NAEGELE U OBERMILLER, SCIENCE PUBLISHERS, JOHANNESSTRASSE 3A, D 70176
   STUTTGART, GERMANY
SN 0935-1221
J9 EUR J MINERAL
JI Eur. J. Mineral.
PD MAR-APR
PY 2004
VL 16
IS 2
BP 279
EP 284
DI 10.1127/0935-1221/2004/0016-0279
PG 6
WC Mineralogy
SC Mineralogy
GA 808NT
UT WOS:000220576500010
DA 2018-10-19
ER

PT J
AU Yang, SY
   Wu, B
   Mayton, L
   Mukherjee, P
   Robbins, PD
   Evans, CH
   Wooley, PH
AF Yang, SY
   Wu, B
   Mayton, L
   Mukherjee, P
   Robbins, PD
   Evans, CH
   Wooley, PH
TI Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model
   of wear debris-induced osteolysis
SO GENE THERAPY
LA English
DT Article
DE gene transfer; wear debris; inflammation; bone resorption
ID COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; FACTOR M-CSF;
   INTERLEUKIN-1 RECEPTOR ANTAGONIST; BONE-RESORBING CELLS; AIR POUCH
   MODEL; OSTEOCLAST DIFFERENTIATION; MACROPHAGES DIFFERENTIATE;
   PERIPROSTHETIC OSTEOLYSIS; OSTEOPROTEGERIN LIGAND
AB The current study evaluated the protective effects of anti-inflammatory cytokine gene transfer on osteolysis provoked by orthopedic biomaterial particles using a murine model of inflammatory bone loss. A section of bone was surgically implanted into an air pouch established on a syngeneic recipient mouse. Inflammation was provoked by introduction of ultra-high-molecular-weight polyethylene (UHMWPE) particles into the pouch, and retroviruses encoding for interleukin-1 receptor antagonist (HIL-1Ra), viral interleukin-10 (vIL-10), or LacZ genes were injected. Pouch fluid and tissue were harvested 7 days later for histological and molecular analyses. The results indicated that IL-1Ra or vIL-10 gene transfer significantly inhibited IL-1beta and tumor necrosis factor (TNF) expression at both mRNA and protein levels. There were significantly lower mRNA expressions of calcitonin receptor and cathepsin K in RNA isolated from hIL-1Ra- or vIL-10-transduced pouches than LacZ-transduced and virus-free controls. Both anti-inflammatory cytokine gene transfers significantly reduced the mRNA expression of M-CSF (70-90%) and RANK (> 65%) in comparison with LacZ- and virus-free controls. Histological examination showed that hIL-1Ra or vIL-10 gene transfer dramatically abolished UHMWPE-induced inflammatory cellular infiltration and bone pit erosion compared to LacZ-transduced and virus-free controls. Histochemical staining revealed significantly fewer osteoclast-like cells in samples treated with IL-1Ra or vIL-10 gene transfer. In addition, bone collagen content was markedly preserved in the groups with anti-inflammatory cytokine gene transfers compared with the other two groups. Overall, retrovirus-mediated hIL-1Ra or vIL-10 gene transfer effectively protected against UHMWPE-particle-induced bone resorption, probably due to the inhibition of IL-1/TNF-induced M-CSF production and the consequent osteoclast recruitment and maturation.
C1 Wayne State Univ, Hutzel Hosp, Dept Orthopaed Surg, Detroit, MI 48201 USA.
   Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA USA.
   Harvard Univ, Sch Med, Ctr Mol Orthopaed, Boston, MA USA.
RP Yang, SY (reprint author), Wayne State Univ, Hutzel Hosp, Dept Orthopaed Surg, 1 South,4707 St Antoine Blvd, Detroit, MI 48201 USA.
OI Yang, Shang-You/0000-0002-8835-5302
CR Algan SM, 1996, J ORTHOPAED RES, V14, P30, DOI 10.1002/jor.1100140107
   Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P138, DOI 10.1097/01.blo.00000038467.05771.90
   BOTTOMLEY KMK, 1988, BRIT J PHARMACOL, V93, P627, DOI 10.1111/j.1476-5381.1988.tb10320.x
   CAMPBELL IK, 1993, BIOCHIM BIOPHYS ACTA, V1182, P57, DOI 10.1016/0925-4439(93)90153-R
   Carmody EE, 2002, ARTHRITIS RHEUM, V46, P1298, DOI 10.1002/art.10227
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
   Evans CH, 2000, J CLIN IMMUNOL, V20, P334, DOI 10.1023/A:1006616029205
   Evans CH, 1999, ARTHRITIS RHEUM, V42, P1, DOI 10.1002/1529-0131(199901)42:1<1::AID-ANR1>3.0.CO;2-4
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Goater JJ, 2002, J ORTHOPAED RES, V20, P169, DOI 10.1016/S0736-0266(01)00083-3
   GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0
   Greenfield EM, 2002, J ORTHOPAED RES, V20, P1, DOI 10.1016/S0736-0266(01)00070-5
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   HAMILTON JA, 1993, GROWTH FACTORS, V9, P157
   Harris WH, 2001, CLIN ORTHOP RELAT R, P66
   HENDERSON B, 1995, ANN RHEUM DIS, V54, P519, DOI 10.1136/ard.54.6.519
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Jones LC, 1999, J BIOMED MATER RES, V48, P889
   Joosten LAB, 1999, ARTHRITIS RES, V1, P81, DOI 10.1186/ar14
   Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552
   Lubberts E, 2000, J CLIN INVEST, V105, P1697, DOI 10.1172/JCI7739
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Neale SD, 1999, J ORTHOPAED RES, V17, P686, DOI 10.1002/jor.1100170510
   Nita I, 1996, ARTHRITIS RHEUM, V39, P820, DOI 10.1002/art.1780390515
   Pandey R, 1996, ANN RHEUM DIS, V55, P388, DOI 10.1136/ard.55.6.388
   *PE APPL BIOS, 1998, PROTOCOL, P37, DOI UNSP P/N 4304671
   Qin LH, 1996, J IMMUNOL, V156, P2316
   REN W, 2003, IN PRESS J ORTHOP RE
   Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308
   Sabokbar A, 1997, ANN RHEUM DIS, V56, P414, DOI 10.1136/ard.56.7.414
   Schwarz EM, 2000, J ORTHOPAED RES, V18, P472, DOI 10.1002/jor.1100180321
   Stea S, 2000, CYTOKINE, V12, P1575, DOI 10.1006/cyto.2000.0753
   Sud S, 2001, INFLAMMATION, V25, P361, DOI 10.1023/A:1012898513512
   Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252
   Toumbis CA, 1997, SEMIN ARTHRITIS RHEU, V27, P44, DOI 10.1016/S0049-0172(97)80036-4
   Trindade MCD, 2001, BIOMATERIALS, V22, P2067, DOI 10.1016/S0142-9612(00)00376-8
   van de Loo FAJ, 2002, RHEUM DIS CLIN N AM, V28, P127, DOI 10.1016/S0889-857X(03)00073-5
   Wang W, 1997, J BONE JOINT SURG BR, V79B, P849, DOI 10.1302/0301-620X.79B5.7780
   Wooley PH, 1997, J ORTHOP RES, V15, P874, DOI 10.1002/jor.1100150613
   WOOLEY PH, 1993, ARTHRITIS RHEUM, V36, P1305, DOI 10.1002/art.1780360915
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Xu JW, 1997, CLIN RHEUMATOL, V16, P243, DOI 10.1007/BF02238958
   Yang S, 2002, INFLAMM RES, V51, P342, DOI 10.1007/PL00000313
   Yang SY, 2002, ARTHRITIS RHEUM, V46, P2514, DOI 10.1002/art.10527
   YANG SY, 2000, ARTHRITIS RHEUM, V43, pS884
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
   YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0
NR 49
TC 51
Z9 57
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
J9 GENE THER
JI Gene Ther.
PD MAR
PY 2004
VL 11
IS 5
BP 483
EP 491
DI 10.1038/sj.gt.3302192
PG 9
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 774WE
UT WOS:000189008600008
PM 14724688
OA Bronze
DA 2018-10-19
ER

PT J
AU Esudero, ML
   Munoz-Morris, MA
   Garcia-Alonso, MC
   Fernandez-Escalante, E
AF Esudero, ML
   Munoz-Morris, MA
   Garcia-Alonso, MC
   Fernandez-Escalante, E
TI In vitro evaluation of a gamma-TiAl intermetallic for potential
   endoprothesic applications
SO INTERMETALLICS
LA English
DT Article
DE titanium aluminides; based on TiAl; corrosion; trace element analysis;
   electron microscopy, scanning; biomedical applications
ID CATHODIC STRIPPING VOLTAMMETRY; TITANIUM ALUMINIDES; ALLOYS; CORROSION;
   WATER; PROTECTION; RESISTANCE; OXIDATION; BEHAVIOR; METAL
AB In vitro properties of a new gamma-based TiAl intermetallic have been evaluated in the as-received state and after carrying out surface modifications by oxidation under two different heat treatments, namely 700 degreesC, 24 It and 1000 degreesC, I h. Cathodic stripping voltammetry was used to determine the concentration of Ti and Al elements released into a solution simulating the body fluids (Ringer's solution) after six months immersion. Electrochemical techniques were used to measure the corrosion resistance and the susceptibility to pitting corrosion. The results confirmed that the best material is the TiAl intermetallic pre-oxidised at 700 degreesC, since it produces a much lower concentration of Al and Ti ions and also exhibits the lowest passive current densities. The latter are one order of magnitude lower than those of the as-received intermetallic alloy and after pre-oxidation at 1000 degreesC and two orders of magnitude lower than that obtained from a conventional Ti6Al4V currently used as biomaterial. (C) 2004 Elsevier Ltd. All rights reserved.
C1 CSIC, CENIM, Dept Met Phys, E-28040 Madrid, Spain.
   CSIC, CENIM, Dept Mat Engn Degradat & Durabil, E-28040 Madrid, Spain.
RP Munoz-Morris, MA (reprint author), CSIC, CENIM, Dept Met Phys, Avenida Gregorio Amo 8, E-28040 Madrid, Spain.
EM mmunoz@cenim.csic.es
RI Garcia-Alonso, Maria Cristina/K-3779-2014
OI Garcia-Alonso, Maria Cristina/0000-0003-0275-4626; Munoz, Maria
   Antonia/0000-0002-9410-098X
CR Bloyce A, 1998, SURF COAT TECH, V107, P125, DOI 10.1016/S0257-8972(98)00580-5
   Brady MP, 1996, JOM-J MIN MET MAT S, V48, P46, DOI 10.1007/BF03223244
   Dimiduk DM, 1999, MAT SCI ENG A-STRUCT, V263, P281, DOI 10.1016/S0921-5093(98)01158-7
   Doorn PF, 1998, J BIOMED MATER RES, V42, P103, DOI 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M
   Escudero ML, 2003, SCRIPTA MATER, V48, P1549, DOI 10.1016/S1359-6462(03)00090-3
   Gil I, 2001, INTERMETALLICS, V9, P373, DOI 10.1016/S0966-9795(01)00014-0
   Gurappa I, 2003, INTERMETALLICS, V11, P867, DOI 10.1016/S0966-9795(03)00094-3
   Hallab NJ, 2000, J BIOMED MATER RES, V49, P353, DOI 10.1002/(SICI)1097-4636(20000305)49:3<353::AID-JBM8>3.0.CO;2-T
   KIM YW, 1994, JOM-J MIN MET MAT S, V46, P30
   KIM YW, 1992, ACTA METALL MATER, V40, P1121, DOI 10.1016/0956-7151(92)90411-7
   Lang FQ, 2003, INTERMETALLICS, V11, P129, DOI 10.1016/S0966-9795(02)00192-9
   LI H, 1989, ANAL CHIM ACTA, V221, P269, DOI 10.1016/S0003-2670(00)81963-7
   MORRIS MA, 1994, SCRIPTA METALL MATER, V31, P449, DOI 10.1016/0956-716X(94)90017-5
   MUNOZMORRIS MA, 1997, MATER SCI ENG, V124, P1
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Schmitz-Niederau M, 1999, OXID MET, V52, P225, DOI 10.1023/A:1018839511102
   VAN DEN BERG CMG, 1986, ANAL CHIM ACTA, V188, P177, DOI 10.1016/S0003-2670(00)86041-9
   YOKOI K, 1991, ANAL CHIM ACTA, V245, P167, DOI 10.1016/S0003-2670(00)80217-2
NR 18
TC 20
Z9 20
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-9795
J9 INTERMETALLICS
JI Intermetallics
PD MAR
PY 2004
VL 12
IS 3
BP 253
EP 260
DI 10.1016/j.intermet.2003.10.004
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 778FR
UT WOS:000189229300002
DA 2018-10-19
ER

PT J
AU Meng, B
   Wang, XH
   Cui, FZ
   Dong, HY
   Yu, F
AF Meng, B
   Wang, XH
   Cui, FZ
   Dong, HY
   Yu, F
TI A new method of heparinizing PLLA film by surface entrapment
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE heparin; biocompatibility; PLLA; blood compatibility; biomaterials
ID POLY(LACTIC ACID); LOCAL-DELIVERY; FOLLOW-UP; STENT; POLY(L-LACTIDE);
   BIODEGRADATION; BIOMATERIAL; POLYLACTIDE; POLYMERS; MODEL
AB A new method of surface heparinizing biodegradable polymers was designed. A heparin-modified poly(L-lactic acid) (PLLA) system was developed by physically entrapping the heparin on the PLLA surface. The surface characterization and biological performance of these materials were carried out by SEM, attenuated-total-reflection spectroscopy, contact angle measurements, and platelet adhesion evaluations. The modification strategy was performed by reversible swelling of the PLLA surface following exposure to a solvent-nonsolvent mixture. This process resulted in the localized physical entrapment of the diffused heparin. X-ray photoelectron spectroscopy was used to confirm that control over the heparin surface density can be achieved by using set polymer treatment times. Platelet adhesion tests showed significant improvement in blood compatibility by the PLLA surfaces after modification.
C1 Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   Dalian Univ Technol, Inst Biomed Engn, Dalian, Peoples R China.
   Peking Univ, Hlth Sci Ctr, Dept Lab Anim Sci, Beijing 100871, Peoples R China.
RP Cui, FZ (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@mail.tsinghua.edu.cn
CR Farb A, 2001, CIRCULATION, V104, P473, DOI 10.1161/hc3001.092037
   HERRMANN K, 1994, J MATER SCI-MATER M, V5, P728, DOI 10.1007/BF00120365
   Hietala EM, 2001, J VASC RES, V38, P361, DOI 10.1159/000051067
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   Hyon SH, 2003, MACROMOL SYMP, V197, P355, DOI 10.1002/masy.200350731
   KIM SW, 1985, CRC CRITICAL REV B 6, V13, P229
   LI CH, 2001, PERFUSION, V16, P417
   Lincoff AM, 1997, J AM COLL CARDIOL, V29, P808, DOI 10.1016/S0735-1097(96)00584-0
   Michanetzis GPA, 2003, BIOMATERIALS, V24, P677, DOI 10.1016/S0142-9612(02)00382-4
   Multanen M, 2002, UROL RES, V30, P227, DOI 10.1007/s00240-002-0252-7
   Nijenhuis AJ, 1996, POLYMER, V37, P2783, DOI 10.1016/0032-3861(96)87642-7
   Paoletti L, 2003, ATMOS ENVIRON, V37, P4869, DOI 10.1016/j.atmosenv.2003.08.031
   PUSINERI C, 1986, BLOOD SURFACE INTERA, P209
   Quirk RA, 2001, LANGMUIR, V17, P2817, DOI 10.1021/la001509a
   Quirk RA, 2001, SURF INTERFACE ANAL, V31, P46, DOI 10.1002/sia.951
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Ratner BD, 1997, NATO ADV SCI I E-APP, V346, P453
   Ratner BD, 1997, SURFACE MODIFICATION OF POLYMERIC BIOMATERIALS, P1
   RATNER BD, 1997, SURFACE MODIFICATION, P206
   Sailynoja E, 2001, J BIOACT COMPAT POL, V16, P58
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Tsuji T, 2001, J AM COLL CARDIOL, V37, p47A
   vanDelden CJ, 1997, BIOMATERIALS, V18, P845, DOI 10.1016/S0142-9612(96)00209-8
   VINCENT CB, 2000, HDB MONOCHROMATIC XP
NR 24
TC 13
Z9 13
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2004
VL 19
IS 2
BP 131
EP 143
DI 10.1177/0883911504042644
PG 13
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 823VZ
UT WOS:000221643200005
DA 2018-10-19
ER

PT J
AU Wang, XD
   Gu, XS
   Yuan, CW
   Chen, SJ
   Zhang, PY
   Zhang, TY
   Yao, J
   Chen, F
   Chen, G
AF Wang, XD
   Gu, XS
   Yuan, CW
   Chen, SJ
   Zhang, PY
   Zhang, TY
   Yao, J
   Chen, F
   Chen, G
TI Evaluation of biocompatibility of polypyrrole in vitro and in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE conducting polymer; polypyrrole; biomaterial; biocompatibility; nerve
   regeneration
ID PERIPHERAL-NERVE REGENERATION; COATED POLYESTER FABRICS; GROWTH CONE
   GUIDANCE; CONDUCTING POLYMERS; BIOMATERIALS; TISSUE; CELLS
AB In this study, the biocompatibility of the electrically conductive polymer polypyrrole (PPy) with nerve tissue was evaluated in vitro and in vivo. The extraction solution of PPy powder, which was synthesized chemically, was tested for acute toxicity, subacute toxicity, pyretogen, quantitative measure of cell viability, hemolysis, allergen, and micronuclei. The PPy membrane was synthesized electrochemically on the indium tin oxide conductive borosilicate glass. The dorsal root ganglia from 1-3-day-old SpragueDawley rats were cultured above PPy membrane and observed by light or scanning electron microscopy. The PPy-silicone tube (PPy membrane on the inner surface of the silicone tube) also synthesized electrochemically was used to bridge across 10-mm sciatic nerve gap in rats. Twenty-four weeks after the operation to rats, the regenerated tissues were observed by electrophysiological and histological techniques. PPy extraction solution showed no evidence of acute and subacute toxicity, pyretogen, hemolysis, allergen, and mutagenesis, and the Schwann cells from the PPy extraction solution group showed better survival rate and proliferation rate as compared with the saline solution control group. The migration of the Schwann cells and the neurite extension from dorsal root ganglia on the surface of PPy membrane-coated glass was better than those of bare glass. There was only lightly inflammation during 6 months of the postoperation, when the PPy-silicone tube bridged across the gap of the transected sciatic nerve. The regeneration of nerve tissue in the PPy-silicone tube was slightly better than that in the plain silicone tube by means of electrophysiological and histological examination. The results of this study indicate that PPy has a good biocompatibility with rat peripheral nerve tissue and that PPy might be a candidate material for bridging the peripheral nerve gap. (C) 2003 Wiley Periodicals, Inc.
C1 Nantong Med Coll, Jiangsu Key Lab Neuron Regenerat, Nantong 226001, Peoples R China.
   SE Univ, Nan Lab Mol & Biomol Elect, Nanjing 210018, Peoples R China.
RP Wang, XD (reprint author), Nantong Med Coll, Jiangsu Key Lab Neuron Regenerat, Nantong 226001, Peoples R China.
EM wxdzw@hotmail.com
CR ASTM, 1983, ANN BOOK ASTM STAND
   BATZ P, 1991, PHYS REV B, V43, P9178, DOI 10.1103/PhysRevB.43.9178
   BORGENS RB, 1986, J COMP NEUROL, V250, P168, DOI 10.1002/cne.902500204
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DEPOOTER M, 1991, J APPL POLYM SCI, V42, P399, DOI 10.1002/app.1991.070420212
   DICKS JM, 1989, ANN BIOL CLIN-PARIS, V47, P607
   Diefenbach TJ, 2000, J NEUROSCI, V20, P1484
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   GENOUD F, 1985, PHYS REV LETT, V55, P118, DOI 10.1103/PhysRevLett.55.118
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   *INT ORG STAND, 1997, INT STAND ISO 10993
   Jiang XP, 2002, J BIOMED MATER RES, V62, P507, DOI 10.1002/jbm.10240
   Jiang XP, 2002, TISSUE ENG, V8, P635, DOI 10.1089/107632702760240553
   KEELEY R, 1993, J RECONSTR MICROSURG, V9, P349, DOI 10.1055/s-2007-1006742
   KHOR E, 1995, BIOMATERIALS, V16, P657, DOI 10.1016/0142-9612(95)93864-A
   Kimura K, 1998, MED BIOL ENG COMPUT, V36, P493, DOI 10.1007/BF02523221
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Livache T, 1998, CLIN CHIM ACTA, V278, P171, DOI 10.1016/S0009-8981(98)00143-0
   McCaig CD, 2002, TRENDS NEUROSCI, V25, P354, DOI 10.1016/S0166-2236(02)02174-4
   MEYER R, 1995, MICROSURG, V16, P129, DOI 10.1002/micr.1920160302
   Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3
   Rosen J M, 1981, Ann Plast Surg, V7, P165, DOI 10.1097/00000637-198108000-00016
   SCHMIDT CE, 1997, P NATL ACAD SCI USA, V94, P8949
   Street GB, 1986, HDB CONDUCTING POLYM, VI, P265
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Zhang Z, 2001, J BIOMED MATER RES, V57, P63, DOI 10.1002/1097-4636(200110)57:1<63::AID-JBM1142>3.0.CO;2-L
NR 29
TC 223
Z9 231
U1 10
U2 95
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2004
VL 68A
IS 3
BP 411
EP 422
DI 10.1002/jbm.a.20065
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 774XN
UT WOS:000189011800002
PM 14762920
DA 2018-10-19
ER

PT J
AU Fisher, JP
   Lalani, Z
   Bossano, CM
   Brey, EM
   Demian, N
   Johnston, CM
   Dean, D
   Jansen, JA
   Wong, MEK
   Mikos, AG
AF Fisher, JP
   Lalani, Z
   Bossano, CM
   Brey, EM
   Demian, N
   Johnston, CM
   Dean, D
   Jansen, JA
   Wong, MEK
   Mikos, AG
TI Effect of biomaterial properties on bone healing in a rabbit tooth
   extraction socket model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone formation; bone healing; immunohistochemistry; tissue engineering
ID FIBROBLAST-GROWTH-FACTOR; POLY(ETHYLENE OXIDE); PROTEIN ADSORPTION;
   IN-VITRO; TISSUE; DIFFERENTIATION; QUANTIFICATION; ANGIOGENESIS;
   IMMUNOASSAY; MECHANISMS
AB In this work we sought to understand the effect of biomaterial properties upon healing bone tissue. We hypothesized that a hydrophilic polymer gel implanted into a bone tissue defect would impede the healing process owing to the biomaterial's prevention of protein adsorption and thus cell adhesion. To test this hypothesis, healing bone was investigated within a rabbit incisor extraction socket, a subcritical size bone defect that resists significant soft tissue invasion by virtue of its conformity. After removal of the incisor teeth, one tooth socket was left as an empty control, one was filled with crosslinked polymer networks formed from the hydrophobic polymer poly(propylene fumarate) (PPF), and one was filled with a hydrogel formed from the hydrophilic oligomer oligo(poly(ethylene glycol) fumarate) (OPF). At five different times (4 days as well as 1, 2, 4, and 8 weeks), jaw bone specimens containing the tooth sockets were removed. We analyzed bone healing by histomorphometrical analysis of hematoxylin and eosin stained sections as well as immunohistochemically stained sections. The proposed hypothesis, that a hydrophilic material would hinder bone healing, was supported by the histomorphometrical results. In addition, the immunohistochemical results reflect molecular signaling indicative of the early invasion of platelets, the vascularization. of wound-healing tissue, the differentiation of migrating progenitor cells, and the formation and remodeling of bone tissue. Finally, the results emphasize the need to consider biomaterial properties and their differing effects upon endogenous growth factors, and thus bone healing, during the development of tissue engineering devices. (C) 2003 Wiley Periodicals, Inc.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Univ Texas, Hlth Sci Ctr, Dent Branch, Dept Oral & Maxillofacial Surg, Houston, TX 77030 USA.
   Univ Texas, MD Anderson Canc Ctr, Lab Reparat Biol & Bioengn, Dept Plast Surg, Houston, TX 77030 USA.
   Case Western Reserve Univ, Univ Hosp Cleveland, Dept Neurol Surg, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA.
   Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, POB 1892,MS 142, Houston, TX 77251 USA.
EM mikos@rice.edu
RI Jansen, John/H-8055-2014; Fisher, John/F-8078-2012
OI Lalani, Zahid/0000-0002-8626-0078
FU NIDCR NIH HHS [R01-DE13740, R01-DE13031]
CR AASMUNDSTAD TA, 1992, J CLIN PATHOL, V45, P125, DOI 10.1136/jcp.45.2.125
   Bhatnagar J, 1999, ANTICANCER RES, V19, P2181
   Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503
   CANALIS E, 1988, J CLIN INVEST, V81, P277, DOI 10.1172/JCI113318
   CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   CENTRELLA M, 1989, CONNECT TISSUE RES, V20, P267, DOI 10.3109/03008208909023896
   Dias P, 2000, AM J PATHOL, V156, P399, DOI 10.1016/S0002-9440(10)64743-8
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   FRIESEL RE, 1995, FASEB J, V9, P919
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Hogg R. V., 1992, APPL STAT ENG PHYS S
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   LALANI Z, IN PRESS J ORAL MAXI
   Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   Neter J., 1996, APPL LINEAR STAT MOD
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   Podhajsky RJ, 1997, EXP NEUROL, V143, P153, DOI 10.1006/exnr.1996.6354
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Simone NL, 2000, AM J PATHOL, V156, P445, DOI 10.1016/S0002-9440(10)64749-9
   Toi M, 2001, LANCET ONCOL, V2, P667, DOI 10.1016/S1470-2045(01)00556-3
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   VENTER DJ, 1987, LANCET, V2, P69
   Wang JS, 1996, ACTA ORTHOP SCAND, V67, P1
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
NR 29
TC 35
Z9 38
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2004
VL 68A
IS 3
BP 428
EP 438
DI 10.1002/jbm.a.20073
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 774XN
UT WOS:000189011800004
PM 14762922
DA 2018-10-19
ER

PT J
AU Larsson, J
   Persson, C
   Tengvall, P
   Lundqvist-Gustafsson, H
AF Larsson, J
   Persson, C
   Tengvall, P
   Lundqvist-Gustafsson, H
TI Anti-inflammatory effects of a titanium-peroxy gel: Role of oxygen
   metabolites and apoptosis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium; polymorphonuclear neutrophil; apoptosis; necrosis; oxidative
ID BIOMATERIAL-INDUCED ALTERATIONS; NEUTROPHIL RESPIRATORY BURST;
   HYDROGEN-PEROXIDE; IN-VITRO; POLYMORPHONUCLEAR GRANULOCYTES; METALLIC
   TITANIUM; ACTIVATION; SURFACES; ADHESION; BLOOD
AB Polymorphonuclear neutrophils (PMN) are among the first inflammatory cells to arrive at an implant interface, where they encounter with the foreign material and may produce reactive oxygen species (ROS). During the interaction between titanium and ROS, titanium-peroxy (Ti-peroxy) compounds may be formed. We used a Ti-peroxy gel, made from titanium and hydrogen peroxide, to study the effects of Ti-peroxy compounds on PMN. In the absence of serum, the Ti-peroxy gel decreased the oxidative response of PMN to yeast and PMA and reduced PMN apoptosis without inducing necrosis. These effects could not be ascribed to the release of hydrogen peroxide from the Ti-peroxy gel, because a steady-state hydrogen peroxide producing system failed to mimic the effects of the gel. The effects were similarly unaffected when PMN were preincubated with beta(2)-integrin antibodies, questioning the involvement of adhesion molecules. Nevertheless, when a filter was used to separate the Ti-peroxy gel from the cells, the gel effect on PMN life span was abolished, pointing to a contact-dependent mechanism. In the presence of serum, the Ti-peroxy gel had no effect on the PMN oxidative response and life span, but appeared rather inert. In summary, this study demonstrates that the Ti-peroxy gel has potentially anti-inflammatory properties through a combined peroxide and physical contact effect, supporting the notion that interactions between titanium and inflammatory cells are responsible for the good performance of titanium in vivo. (C) 2003 Wiley Periodicals, Inc.
C1 Linkoping Univ, Div Pathol 2, S-58185 Linkoping, Sweden.
   Linkoping Univ, Appl Phys Lab, S-58185 Linkoping, Sweden.
RP Larsson, J (reprint author), Linkoping Univ, Div Pathol 2, S-58185 Linkoping, Sweden.
EM jenny.larsson@inr.liu.se
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Andonegui G, 1997, J IMMUNOL, V158, P3372
   Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Ciapetti G, 2000, J BIOMED MATER RES, V52, P338, DOI 10.1002/1097-4636(200011)52:2<338::AID-JBM13>3.3.CO;2-C
   Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2
   EREAUX L P, 1955, Can Med Assoc J, V73, P47
   Eriksson C, 2001, J LAB CLIN MED, V137, P56, DOI 10.1067/mlc.2001.111470
   Fabre T, 1999, J BIOMED MATER RES, V44, P429, DOI 10.1002/(SICI)1097-4636(19990315)44:4<429::AID-JBM9>3.0.CO;2-C
   Ginis I, 1997, AM J PHYSIOL, V272, P295
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Gretzer C, 2002, BIOMATERIALS, V23, P1639, DOI 10.1016/S0142-9612(01)00290-3
   HASLETT C, 1992, CLIN SCI, V83, P639, DOI 10.1042/cs0830639
   HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3
   INDIK ZK, 1995, BLOOD, V86, P4389
   JANDL RC, 1978, J CLIN INVEST, V61, P1176, DOI 10.1172/JCI109033
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   Karlsson C, 1996, J LAB CLIN MED, V128, P496, DOI 10.1016/S0022-2143(96)90047-5
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Larsson J, 2000, INFLAMM RES, V49, P452, DOI 10.1007/s000110050616
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lundqvist-Gustafsson H, 1999, J LEUKOCYTE BIOL, V65, P196
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   Moore MA, 2001, J BIOMED MATER RES, V55, P257, DOI 10.1002/1097-4636(20010605)55:3<257::AID-JBM1013>3.0.CO;2-H
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Steinemann S. G., 1996, Injury, V27, pSC16
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TENGVALL P, 1989, J COLLOID INTERF SCI, V130, P405, DOI 10.1016/0021-9797(89)90117-3
   TENGVALL P, 1990, J BIOMED MATER RES, V24, P319, DOI 10.1002/jbm.820240305
   Tomczok J, 1996, BIOMATERIALS, V17, P1359, DOI 10.1016/0142-9612(96)87275-9
   Walzog B, 1997, FASEB J, V11, P1177
   Watson RWG, 1997, J IMMUNOL, V158, P945
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   Whitlock BB, 2000, J CELL BIOL, V151, P1305, DOI 10.1083/jcb.151.6.1305
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, V2, P45
   WINN JS, 1991, BIOCHEM PHARMACOL, V41, P31, DOI 10.1016/0006-2952(91)90007-R
   ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407
NR 41
TC 11
Z9 12
U1 1
U2 10
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2004
VL 68A
IS 3
BP 448
EP 457
DI 10.1002/jbm.a.20078
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 774XN
UT WOS:000189011800006
PM 14762924
DA 2018-10-19
ER

PT J
AU Zhang, HL
   Bremmell, K
   Kumar, S
   Smart, RSC
AF Zhang, HL
   Bremmell, K
   Kumar, S
   Smart, RSC
TI Vitronectin adsorption on surfaces visualized by tapping mode atomic
   force microscopy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial surfaces; vitronectin; protein adsorption; atomic force
   microscopy (AFM); oxidized titanium
ID SERUM SPREADING FACTOR; HUMAN-PLASMA; MULTIMERIC VITRONECTIN;
   CONFORMATIONAL-CHANGES; FIBRINOGEN ADSORPTION; APATITE FORMATION;
   SELF-ASSOCIATION; CELL ATTACHMENT; BOVINE SERUM; IN-VITRO
AB Vitronectin (Vn) is an abundant glycoprotein present in plasma and the extracellular matrix of most tissue and is an important medium required for bone cells to attach and spread on biomaterial surfaces. Hence, Vn adsorption is an initial and key step in implantation. In this study, adsorption of Vn molecules on mica and oxidized titanium substrates in Milli-Q water (pH 5.6) and in simulated body fluid (SBF, pH 7.4) has been investigated using tapping mode atomic force microscopy. Conformation of the adsorbed proteins was determined from the images. The effect of adsorption time was investigated on mica surfaces. The protein first attaches to the surface, then immediately spreads out with different lateral dimensions of adsorbed protein and becomes aggregated. After 15 min of adsorption, globular Vn molecules form clusters of aggregates in extended chains on the mica surface. Globular Vn molecules appear flatter (i.e., oblate ellipsoids) and coalesce on the ridges of the uneven oxidized titanium surface. From crosssectional analyses of the Vn images, it was found that the contact areas of Vn molecules associated with Ti surfaces are larger than those with mica surfaces. This suggests that the different surface properties of substrates contribute to this different conformation of adsorbed Vn molecules. The larger contact areas of Vn associated with Ti substrates indicates higher affinity for the biomaterial oxidized titanium surface than for mica. In SBF, Vn interacted weakly with the mica surfaces and Vn molecules were easily desorbed during the imaging process. On oxidized titanium substrates, after 3 h of incubation time in Vn-SBF solution, images can be obtained showing adsorbed Vn aggregates on the oxidized titanium surface. In this case, the protein colloids are strongly adherent, with increased lateral dimensions compared with the adsorption on mica. (C) 2003 Wiley Periodicals, Inc.
C1 Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
RP Bremmell, K (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM kristen.bremmell@unisa.edu.au
RI Smart, Roger/D-1786-2009; Bremmell, Kristen/B-7725-2011
OI Bremmell, Kristen/0000-0002-7633-0562
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Ahariz M, 2000, J BIOMED MATER RES, V52, P567, DOI 10.1002/1097-4636(20001205)52:3<567::AID-JBM16>3.0.CO;2-K
   Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   BARNES DW, 1983, J BIOL CHEM, V258, P2548
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   CHAN BMC, 1981, J COLLOID INTERF SCI, V84, P263, DOI 10.1016/0021-9797(81)90283-6
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V218, P404, DOI 10.1006/jcis.1999.6434
   Gibson A, 1997, J BIOL CHEM, V272, P5112, DOI 10.1074/jbc.272.8.5112
   Gibson AD, 1999, J BIOL CHEM, V274, P6432, DOI 10.1074/jbc.274.10.6432
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HOLMES R, 1967, J CELL BIOL, V32, P297, DOI 10.1083/jcb.32.2.297
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   IZUMI M, 1989, BIOCHIM BIOPHYS ACTA, V990, P101, DOI 10.1016/S0304-4165(89)80019-4
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   JENNE D, 1985, EMBO J, V4, P3153, DOI 10.1002/j.1460-2075.1985.tb04058.x
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Luthi PO, 1997, PHYS REV E, V55, P3111, DOI 10.1103/PhysRevE.55.3111
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   Malmsten M., 2000, PROTEIN ARCHITECTURE
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423
   PREISSNER KT, 1989, BLUT, V59, P419, DOI 10.1007/BF00349063
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ramsden J. J., 1998, BIOPOLYMERS INTERFAC, P321
   Roddick-Lanzilotta AD, 1998, LANGMUIR, V14, P6479, DOI 10.1021/la980425n
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   STOCKMANN A, 1993, J BIOL CHEM, V268, P22874
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WILSON DH, 1982, METALS HDB, V5, P650
   ZHANG H, UNPUB
   Zhuang P, 1997, J BIOL CHEM, V272, P6858, DOI 10.1074/jbc.272.11.6858
NR 47
TC 21
Z9 21
U1 1
U2 7
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2004
VL 68A
IS 3
BP 479
EP 488
DI 10.1002/jbm.a.20083
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 774XN
UT WOS:000189011800009
PM 14762927
DA 2018-10-19
ER

PT J
AU Weber, N
   Bolikal, D
   Bourke, SL
   Kohn, J
AF Weber, N
   Bolikal, D
   Bourke, SL
   Kohn, J
TI Small changes in the polymer structure influence the adsorption behavior
   of fibrinogen on polymer surfaces: Validation of a new rapid screening
   technique
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fibrinogen; protein adsorption; polyarylates; polymer library; rapid
   screening; poly(lactic acid); biomaterial; immunofluorescence assay
ID DEGRADABLE BIOMATERIALS; PROTEIN; PLASMA; IDENTIFICATION; VITRONECTIN;
   CHEMISTRY; MEMBRANES; STATE; BLOOD
AB Numerous studies conclude that the selective adsorption of plasma proteins on materials contacting blood or tissue affects all subsequent interactions related to the biocompatibility of artificial surfaces. However, there are only a few studies available, which clearly demonstrate that there is a correlation between surface chemistry and selective protein adsorption. Detailed knowledge of such correlations would facilitate the design of biocompatible materials. In this study, a rapid, fluorescence-based, screening technique using a 384-well format for polymer-protein interactions was developed. The screening assay was used to measure the adsorption of human fibrinogen on 46 test polymers (44 polyarylates selected from a combinatorial library of tyrosine-derived polyarylates, and two lactide-based polymers). In this library of polyarylates, structural changes are generated by variations in either the polymer backbone or the polymer pendent chain. Although no overall trend between polymer hydrophobicity and fibrinogen adsorption could be identified using the entire set of test polymers (R-2 = 0.43), fibrinogen adsorption was clearly correlated with variations in the pendent chain structure. Thus, when the test polymers were grouped by backbone composition, increased hydrophobicity of the pendent chain was significantly correlated with reduced fibrinogen adsorption. The following R-2 coefficients within the polymer backbone groups were determined: 0.87 (diglycolates); 0.98 (glutarates); 0.73 (adipates); 0.87 (suberates); 0.67 (3-methyl-adipates). Our results demonstrate that it is possible to screen for protein-material interactions in a cost-effective fashion using a miniaturized immunofluorescence technique. Further, we demonstrate that small changes in chemical composition can significantly influence the adsorption of human fibrinogen on polymer surfaces. The lactide-based polymers were among those polymers exhibiting the highest tendency to adsorb fibrinogen. This information may be useful when polymers have to be selected for specific biomaterial applications. (C) 2004 Wiley Periodicals, Inc.
C1 Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem & Biol Chem, 610 Taylor Rd, Piscataway, NJ 08854 USA.
EM kohn@rutchem.rutgers.edu
RI Weber, Norbert/E-8701-2011
FU NHLBI NIH HHS [HL60416]
CR BALE MD, 1989, BLOOD, V74, P2698
   BOSTMAN OM, 1992, CLIN ORTHOP RELAT R, P193
   BRASH JL, 1989, J BIOMED MATER RES, V23, P157, DOI 10.1002/jbm.820230203
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   BROCCHINI S, 1997, ANN M SOC BIOM NEW O, V20, P143
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Hamman BD, 2002, J BIOMOL SCREEN, V7, P45, DOI 10.1089/108705702753520332
   KOHN J, 1999, P MAT RES SOC SPRING
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   MULZER S R, 1990, Journal of Biomaterials Science Polymer Edition, V1, P173
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P1003, DOI 10.1002/jbm.820260804
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
NR 23
TC 52
Z9 52
U1 0
U2 9
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2004
VL 68A
IS 3
BP 496
EP 503
DI 10.1002/jbm.a.20086
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 774XN
UT WOS:000189011800011
PM 14762929
DA 2018-10-19
ER

PT J
AU Wollensak, G
   Spoerl, E
AF Wollensak, G
   Spoerl, E
TI Collagen crosslinking of human and porcine sclera
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID PHYSICAL-PROPERTIES; PROGRESSIVE MYOPIA; SURFACE-AREA; TREE SHREW;
   REINFORCEMENT; ELONGATION; REFRACTION; THICKNESS; GLYCATION; PROTEINS
AB Purpose: To develop methods of collagen crosslinking the sclera to increase its biomechanical strength for the treatment of progressive myopia.
   Setting: Department of Ophthalmology, Technical University of Dresden, Dresden, Germany.
   Methods: Sagitally oriented scleral strips of 4.0 mm x 8.0 mm were prepared from 5 human postmortem eyes and 50 porcine cadaver eyes and treated with various crosslinking methods including physical crosslinking by combined riboflavin-ultraviolet A (UVA) or rose bengal/white-light irradiation and chemical crosslinking by incubation with glucose, ribose, glyceraldehyde, and glutaraldehyde solutions. Parallel scleral strips from the same eye were used as untreated controls. After crosslinking, stress-strain measurements of the treated and control scleras were performed using a microcomputer-controlled biomaterial tester.
   Results: A statistically significant increase in scleral rigidity was found after crosslinking with riboflavin-UVA, with a rise in stress in treated porcine (157%) and human (29%) sclera, and after treatment with glyceraldehyde, with a rise in stress in treated porcine (487%) and human (34%) sclera, and with glutaraldehyde, with a rise in stress in treated porcine (817%) and human sclera. (122%) at 8% strain. The other crosslinking methods proved ineffective. The untreated human sclera had a 4-fold higher stiffness than porcine sclera.
   Conclusions: Collagen crosslinking induced by riboflavin-UVA, glyceraldehyde, and glutaraldehyde led to a significant increase in biomechanical strength in human and porcine sclera. Using these methods, collagen crosslinking might become a treatment possibility for progressive myopia. Future animal and clinical studies must determine the best application methods and the long-term effects of increased crosslinking on scleral rigidity and prevent potential toxicity or serious side effects. (C) 2004 ASCRS and ESCRS.
C1 Tech Univ Dresden, Dept Ophthalmol, Dresden, Germany.
RP Wollensak, G (reprint author), Univ Eye Clin Dresden, Fetscherstr 74, D-01307 Dresden, Germany.
EM gwollens@hotmail.com
CR Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
   Avetisov E., 1984, METAB PEDIATR SYST O, V7, P183
   Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   AWETISSOW ES, 1980, KLIN MONATSBL AUGENH, V176, P777, DOI 10.1055/s-2008-1057552
   BAILEY AJ, 1987, EYE-T OPHTH SOC UK, V1, P175, DOI 10.1038/eye.1987.34
   Bell G R, 1993, J Am Optom Assoc, V64, P332
   Bullimore MA, 2002, INVEST OPHTH VIS SCI, V43, P2110
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Curtin B J, 1969, Trans Am Ophthalmol Soc, V67, P417
   FEENSTRA RPG, 1992, OPHTHALMOLOGY, V99, P605
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674
   Jacob JT, 1997, J BIOMED MATER RES, V37, P525, DOI 10.1002/(SICI)1097-4636(19971215)37:4<525::AID-JBM11>3.0.CO;2-7
   JACOBLABARRE JT, 1993, ARCH OPHTHALMOL-CHIC, V111, P979, DOI 10.1001/archopht.1993.01090070099027
   Kosmala JD, 2000, BIOMATERIALS, V21, P2019, DOI 10.1016/S0142-9612(00)00057-0
   Lee KW, 1999, BBA-MOL BASIS DIS, V1453, P141, DOI 10.1016/S0925-4439(98)00097-0
   Liu K.R., 1986, J FORMOS MED ASSOC, V85, P1032
   Logstrup N, 1997, BRIT J OPHTHALMOL, V81, P343, DOI 10.1136/bjo.81.5.343
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   MECHANIC G, 1972, BIOCHEM BIOPH RES CO, V47, P267, DOI 10.1016/S0006-291X(72)80038-X
   Ohan MP, 2002, J BIOMED MATER RES, V60, P384, DOI 10.1002/jbm.10111
   Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8
   Olsen TW, 2002, INVEST OPHTH VIS SCI, V43, P2529
   Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028
   Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005
   Pitts JD, 2002, PHOTOCHEM PHOTOBIOL, V76, P135, DOI 10.1562/0031-8655(2002)076<0135:NPFMET>2.0.CO;2
   Saw SM, 2002, OPHTHALMOLOGY, V109, P415, DOI 10.1016/S0161-6420(01)00972-1
   Spoerl E, 1999, J REFRACT SURG, V15, P711
   Tano Y, 2002, AM J OPHTHALMOL, V134, P645, DOI 10.1016/S0002-9394(02)01883-4
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
NR 32
TC 112
Z9 128
U1 1
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD MAR
PY 2004
VL 30
IS 3
BP 689
EP 695
DI 10.1016/j.jcrs.2003.11.032
PG 7
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 846DK
UT WOS:000223295100030
PM 15050269
DA 2018-10-19
ER

PT J
AU Isenhath, SN
   Usui, ML
   Underwood, RA
   Miyashita, Y
   Irvin, CA
   Ciridon, WA
   Hauch, KD
   Fleckman, P
   Ratner, BD
   Olerud, JE
AF Isenhath, SN
   Usui, ML
   Underwood, RA
   Miyashita, Y
   Irvin, CA
   Ciridon, WA
   Hauch, KD
   Fleckman, P
   Ratner, BD
   Olerud, JE
TI Skin cell attachment to an implanted transcutaneous biomaterial: a mouse
   model
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the Society-for-Investigative-Dermatology
CY APR 28-MAY 01, 2004
CL Providence, RI
SP Soc Investigat Dermatol
C1 Univ Washington, Div Dermatol, Seattle, WA 98195 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD MAR
PY 2004
VL 122
IS 3
MA 218
BP A37
EP A37
PG 1
WC Dermatology
SC Dermatology
GA 809UB
UT WOS:000220660500270
DA 2018-10-19
ER

PT J
AU Lamari, FN
   Anastassiou, ED
   Kolonitsiou, F
   Dimitracopoulos, G
   Karamanos, NK
AF Lamari, FN
   Anastassiou, ED
   Kolonitsiou, F
   Dimitracopoulos, G
   Karamanos, NK
TI Potential use of solid phase immunoassays in the diagnosis of
   coagulase-negative staphylococcal infections
SO JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
LA English
DT Article
DE enzyme immunoassay; Staphylococcus epidermidis; coagulase-negative
   staphylococci; diagnosis; typing
ID BACTERIAL SURFACE-ANTIGENS; HUMAN-IMMUNOGLOBULIN PREPARATIONS;
   EXTRACELLULAR SLIME LAYER; ENZYME-IMMUNOASSAY; TEICHOIC-ACID;
   BLOOD-SERUM; EPIDERMIDIS; ANTIBODIES; ELISA; PEPTIDOGLYCAN
AB Staphylococcus epidermidis is a major nosocomial pathogen, even though it is a member of the normal bacterial flora of skin and the mucous membranes. A major complication is the development of biofilms on implanted medical devices. Diagnosis of coagulase-negative staphylococcal infections relies on the presense of clinical manifestation of infections and on microbiologic evidence, usually obtained after the removal of the biomaterial. Solid-phase immunoassays have not yet been used for routine diagnosis of coagulase-negative staphylococcal infections and distinction between pathogenic and normal cocci. The enzyme immunoassays developed in the last decade are presented in this review article. Serodiagnosis has been attempted by determining antibodies against bacterial cells, mixtures of S. epidermidis slime antigens and discrete slime antigens. Detection or typing of staphylococcal cells has been performed by specific antibodies and lectins. There is still a long way until the application of such assays in the routine clinical laboratory and large clinical studies are necessary. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Patras, Biochem Lab, Sect Organ Chem Biochem & Nat Prod, Dept Chem, GR-26500 Patras, Greece.
   Univ Patras, Sch Med, Dept Microbiol, GR-26500 Patras, Greece.
RP Karamanos, NK (reprint author), Univ Patras, Biochem Lab, Sect Organ Chem Biochem & Nat Prod, Dept Chem, GR-26500 Patras, Greece.
EM n.k.karamanos@upatras.gr
RI Lamari, Fotini/G-1008-2010; Karamanos, Nikos/A-3616-2008
OI Lamari, Fotini/0000-0002-6938-3500; Karamanos, Nikos/0000-0003-3618-0288
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   ARVANITI A, 1994, ARCH BIOCHEM BIOPHYS, V308, P432, DOI 10.1006/abbi.1994.1061
   Bouza E, 2002, CLIN MICROBIOL INFEC, V8, P265, DOI 10.1046/j.1469-0691.2002.00385.x
   BRAKSTAD OG, 1989, SERODIAG IMMUN INF D, V3, P201, DOI 10.1016/0888-0786(89)90034-6
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSSON B, 1985, SCAND J INFECT DIS, V17, P47, DOI 10.3109/00365548509070419
   CONNAUGHTON M, 2001, J INFECTION, V422, P140
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Deighton MA, 1996, EPIDEMIOL INFECT, V117, P267, DOI 10.1017/S0950268800001448
   Elliott TSJ, 2000, J INFECTION, V40, P262, DOI 10.1053/jinf.2000.0656
   Georgakopoulos CD, 2002, J PHARMACEUT BIOMED, V29, P255, DOI 10.1016/S0731-7085(02)00056-0
   Huebner J, 1999, ANNU REV MED, V50, P223
   Itoh S, 2002, BIOL PHARM BULL, V25, P986, DOI 10.1248/bpb.25.986
   JARLOV JO, 1992, J MED MICROBIOL, V37, P195, DOI 10.1099/00222615-37-3-195
   KARAMANOS NK, 1995, BIOCHIMIE, V77, P217, DOI 10.1016/0300-9084(96)88127-2
   Karamanos NK, 1997, ARCH BIOCHEM BIOPHYS, V342, P389, DOI 10.1006/abbi.1997.0107
   KJERULF A, 1994, APMIS, V102, P736, DOI 10.1111/j.1699-0463.1994.tb05228.x
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   Kolonitsiou F, 2001, J PHARMACEUT BIOMED, V24, P429, DOI 10.1016/S0731-7085(00)00449-0
   Lamari F, 2000, J PHARMACEUT BIOMED, V23, P363, DOI 10.1016/S0731-7085(00)00299-5
   Lamari F, 1999, J PHARMACEUT BIOMED, V20, P913, DOI 10.1016/S0731-7085(99)00087-4
   Lamari F, 2000, J PHARMACEUT BIOMED, V22, P1029, DOI 10.1016/S0731-7085(00)00297-1
   Lambert PA, 1996, J MED MICROBIOL, V44, P355, DOI 10.1099/00222615-44-5-355
   Lambert PA, 2000, FEMS IMMUNOL MED MIC, V29, P195, DOI 10.1016/S0928-8244(00)00205-4
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Mempel M, 1996, MICROBIOL IMMUNOL, V40, P115, DOI 10.1111/j.1348-0421.1996.tb03325.x
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Perdreau-Remington F, 1998, INFECT IMMUN, V66, P2778
   Rafiq M, 2000, J BONE JOINT SURG BR, V82B, P1156, DOI 10.1302/0301-620X.82B8.10366
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Ryding U, 2002, DIAGN MICR INFEC DIS, V42, P9, DOI 10.1016/S0732-8893(01)00311-X
   SCHULIN T, 2001, CLIN MICROBIOL INFEC, V4, P1
   Selan L, 2002, LANCET, V359, P2166, DOI 10.1016/S0140-6736(02)09086-4
   Srinivasan A, 2002, CLIN MICROBIOL REV, V15, P430, DOI 10.1128/CMR.15.3.430-438.2002
   Thomas VL, 1997, CURR MICROBIOL, V35, P249, DOI 10.1007/s002849900248
   Thylefors JD, 1998, INFECT CONT HOSP EP, V19, P581
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320
   WERGELAND HI, 1989, J CLIN MICROBIOL, V27, P1286
   Worthington T, 2002, J CLIN PATHOL, V55, P41, DOI 10.1136/jcp.55.1.41
   Yazdankhah SP, 1998, VET MICROBIOL, V62, P17
NR 41
TC 5
Z9 6
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0731-7085
J9 J PHARMACEUT BIOMED
JI J. Pharm. Biomed. Anal.
PD MAR 1
PY 2004
VL 34
IS 4
BP 803
EP 810
DI 10.1016/S0731-7085(03)00564-8
PG 8
WC Chemistry, Analytical; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 803NK
UT WOS:000220237600009
PM 15019058
DA 2018-10-19
ER

PT J
AU Suciu, AN
   Iwatsubo, T
   Matsuda, M
   Nishino, T
AF Suciu, AN
   Iwatsubo, T
   Matsuda, M
   Nishino, T
TI A study upon durability of the artificial knee joint with PVA hydrogel
   cartilage
SO JSME INTERNATIONAL JOURNAL SERIES C-MECHANICAL SYSTEMS MACHINE ELEMENTS
   AND MANUFACTURING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Leading Edge Manufacturing in the 21st
   Century (LEM21)
CY NOV 03-06, 2003
CL Niigata, JAPAN
SP Japan Soc Mech Engineers, Mfg & Machine Tool Div, Mfg Syst Div
DE biomechanics; artificial knee joint; wear; artificial cartilage;
   biomaterial; polyvinyl alcohol (PVA) hydrogel
ID ARTICULAR-CARTILAGE; SURFACE FRICTION; LUBRICATION; REPLACEMENTS;
   BEARINGS
AB An experimental investigation upon the durability of the artificial knee joints with PVA hydrogel articular cartilage is presented. PVA hydrogel is manufactured by the cyclic freezing/thawing and annealing methods; femoral component is a disc made in stainless steel. This work is original in the meaning that: a weighting method to differentiate the worn mass from the mass of exuded water for PVA hydrogel is suggested; an original wear test rig, which simulates the anterior-posterior displacement of the knee motion during walking is proposed; wear factor variation against the number of walking cycles (durability curve) for PVA hydrogel is reported. The lowest wear factor obtained is on order of 10(-6) 10(-5)mm(3)/Nm. PVA hydrogel with reduced water content (45 - 50%) produces the smallest wear factor, for the same polymerization degree. Reduction of the wear factor is on order of 10(4) when the PVA polymerization degree increases from 1800 to 12 300. PVA hydrogel manufactured on a hydrophobic substrate (PTFE) presents a 16 - 27% lower wear factor than that prepared on a hydrophilic substrate (glass). When layer thickness increases from 2 to 3.6 mm, the wear factor reduction is 18%. Influence of the standing interval in start-up conditions on the wear factor is also investigated.
C1 Kobe Univ, Fac Engn, Dept Mech Engn, Kobe, Hyogo 6578501, Japan.
   Kobe Univ, Fac Engn, Dept Sci & Chem Engn, Kobe, Hyogo 6578501, Japan.
RP Suciu, AN (reprint author), Kobe Univ, Fac Engn, Dept Mech Engn, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.
EM uicuscv@yahoo.co.jp
RI Kobe Univ, Engineering/D-2028-2017; Nishino, Takashi/H-5232-2016
OI Nishino, Takashi/0000-0002-5095-9944
CR Auger D D, 1995, Proc Inst Mech Eng H, V209, P73, DOI 10.1243/PIME_PROC_1995_209_323_02
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   CARAVIA L, 1995, WEAR, V181, P236, DOI 10.1016/0043-1648(95)90029-2
   COVERT RJ, 2001, P 2001 BIOENG C ASME, V50, P355
   Fisher J., 1991, J ENG MED H, V205, P73
   Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02
   Gong JP, 2001, J AM CHEM SOC, V123, P5582, DOI 10.1021/ja003794q
   IWATSUBO T, 2001, ASME, V50, P447
   Ku DN, 2001, [US Patent, Poly (vinyl alcohol) hydrogel], Patent No. 6231605
   MOW CV, 1987, HDB BIOENGINEERING
   Murakami T, 1998, P I MECH ENG H, V212, P23, DOI 10.1243/0954411981533791
   Nickel JC, 2001, ARCH ORAL BIOL, V46, P155, DOI 10.1016/S0003-9969(00)00101-1
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   OKA M, 1995, J JPN SOC LIN BIOMEC, V16, P351
   PEPPAS NA, 1977, HYDROGELS SYNTHETIC, P62
   SASADA T, 1985, J JPN SOC BIOMATERIA, V3, P151
   Schmalzried TP, 1999, J BONE JOINT SURG AM, V81A, P115, DOI 10.2106/00004623-199901000-00016
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Stewart T, 1997, P I MECH ENG H, V211, P451, DOI 10.1243/0954411981534574
   Suciu AN, 2003, J BIOMECH ENG-T ASME, V125, P425, DOI 10.1115/1.1589505
   1999, 14243000 ISOWD, P1
NR 21
TC 50
Z9 52
U1 2
U2 18
PU JAPAN SOC MECHANICAL ENGINEERS
PI TOKYO
PA SHINANOMACHI-RENGAKAN BLDG., SHINANOMACHI 35, SHINJUKU-KU, TOKYO,
   160-0016, JAPAN
SN 1344-7653
J9 JSME INT J C-MECH SY
JI JSME Int. J. Ser. C-Mech. Syst. Mach. Elem. Manuf.
PD MAR
PY 2004
VL 47
IS 1
BP 199
EP 208
DI 10.1299/jsmec.47.199
PG 10
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 816XX
UT WOS:000221143700030
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Suciu, AN
   Iwatsubo, T
   Matsuda, M
   Nishino, T
AF Suciu, AN
   Iwatsubo, T
   Matsuda, M
   Nishino, T
TI Wear characteristics of a novel bearing system for artificial knee joint
   - (Micro-pocket-covered femoral component and tibial
   poro-elastic-hydrated cartilage)
SO JSME INTERNATIONAL JOURNAL SERIES C-MECHANICAL SYSTEMS MACHINE ELEMENTS
   AND MANUFACTURING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Leading Edge Manufacturing in the 21st
   Century (LEM21)
CY NOV 03-06, 2003
CL Niigata, JAPAN
SP Japan Soc Mech Engineers, Mfg & Machine Tool Div, Mfg Syst Div
DE biomechanics; artificial knee joint; wear; micro-pocket-covered
   component; artificial cartilage; biomaterial; polyvinyl alcohol (PVA)
   hydrogel
AB This paper presents an experimental investigation upon the wear characteristics of a novel bearing system proposed for the artificial knee joints. Such bearing system is original in the meaning that micro-pockets are machined on surface of the rigid femoral component; a poro-elastic-hydrated layer, called artificial cartilage, covers the rigid tibial substrate. Under compression, the fluid exudes from the artificial cartilage, fills and pressurizes the micro-pockets. In this way, a poro-elasto-hydrodynamic regime of lubrication is developed. Wear tests are performed with different types of artificial cartilages made in PVA hydrogel, articulating against smooth and micro-pocket-covered femoral components. Influence of the number of walking cycles, femoral porosity, depth of the micro-pockets, water content and polymerization degree of the PVA hydrogel upon its wear factor is illustrated. For wear tests performed until 10(6) walking cycles, in the case of PVA hydrogel with 12 300 polymerization degree and 77% water content versus smooth component, the wear factor is on order of 10(-6) - 10(-5) mm(3)/Nm; for the same artificial cartilage against a femoral component uniformly covered by identical micro-pockets of 50 mum depth, on 15% of its surface, the wear factor drops in the range 10(-7) - 10(-6) mm(3)/Nm, i.e., the wear factor reduces with 80%. The highest wear reduction due to the micro-pockets presence is obtained in the case of PVA hydrogel with 77% water content, i.e., for a fluid amount similar to that of the natural cartilage.
C1 Kobe Univ, Fac Engn, Dept Mech Engn, Kobe, Hyogo 6578501, Japan.
   Kobe Univ, Fac Engn, Dept Sci & Chem Engn, Kobe, Hyogo 6578501, Japan.
RP Suciu, AN (reprint author), Kobe Univ, Fac Engn, Dept Mech Engn, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.
EM uicuscv@yahoo.co.jp
CR COVERT RJ, 2001, P 2001 BIOENG C ASME, V50, P355
   Etsion I, 1999, TRIBOL T, V42, P511, DOI 10.1080/10402009908982248
   Fisher J., 1991, J ENG MED H, V205, P73
   IWATSUBO T, 2000, P BIOTR SAT FOR INT, P35
   IWATSUBO T, 2001, P 2001 BIOENG C KAMM, V50, P447
   Ku DN, 2001, [US Patent, Poly (vinyl alcohol) hydrogel], Patent No. 6231605
   MCCUTCHEN CW, 1962, WEAR, V5, P1, DOI DOI 10.1016/0043-1648(62)90176-X
   MOW CV, 1987, HDB BIOENGINEERING
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   OKA M, 1995, J JPN SOC LIN BIOMEC, V16, P351
   PINKUS O, 1961, THEORY HYDRODYNAMIC, P1
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   Schmalzried TP, 1999, J BONE JOINT SURG AM, V81A, P115, DOI 10.2106/00004623-199901000-00016
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Suciu AN, 2003, J BIOMECH ENG-T ASME, V125, P425, DOI 10.1115/1.1589505
   SUCIU AN, 2002, P MECH ENG C TOK JAP, P43
   Walker Peter S., 1997, P461
   14243000 ISOWD
NR 19
TC 12
Z9 17
U1 0
U2 1
PU JAPAN SOC MECHANICAL ENGINEERS
PI TOKYO
PA SHINANOMACHI-RENGAKAN BLDG., SHINANOMACHI 35, SHINJUKU-KU, TOKYO,
   160-0016, JAPAN
SN 1344-7653
J9 JSME INT J C-MECH SY
JI JSME Int. J. Ser. C-Mech. Syst. Mach. Elem. Manuf.
PD MAR
PY 2004
VL 47
IS 1
BP 209
EP 217
DI 10.1299/jsmec.47.209
PG 9
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 816XX
UT WOS:000221143700031
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Belkas, JS
   Shoichett, MS
   Midha, R
AF Belkas, JS
   Shoichett, MS
   Midha, R
TI Peripheral nerve regeneration through guidance tubes
SO NEUROLOGICAL RESEARCH
LA English
DT Review
DE peripheral nerve injury; peripheral nerve repair; tissue engineering;
   synthetic nerve conduits; biomaterial considerations; clinical trials
ID RAT SCIATIC-NERVE; SCHWANN-CELL GRAFTS; MAGNETICALLY ALIGNED COLLAGEN;
   LAMININ-CONTAINING GEL; MONKEY MEDIAN NERVE; SPINAL-CORD INJURY;
   SILICONE CHAMBER; WALLERIAN DEGENERATION; EXTRACELLULAR-MATRIX; MUSCLE
   REINNERVATION
AB Biological nerve grafts have been extensively utilized in the past to repair peripheral nerve injuries. More recently, the use of synthetic guidance tubes in repairing these injuries has gained in popularity. This review focuses on artificial conduits, nerve regeneration through them, and an account of various synthetic materials that comprise these tubes in experimental animal and clinical trials. It also lists and describes several biomaterial considerations one should regard when designing, developing, and manufacturing potential guidance channel candidates. In the future, it it likely that the most successful synthetic nerve conduit will be one that has been fabricated with some of these strategies in mind.
C1 Univ Toronto, Div Neurosurg, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.
   Univ Toronto, Neurosci Res Program, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem, Toronto, ON, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
RP Midha, R (reprint author), Univ Toronto, Div Neurosurg, Sunnybrook & Womens Coll Hlth Sci Ctr, 2075 Bayview Ave,Suite A131, Toronto, ON M4N 3M5, Canada.
EM Rajiv.Midha@sw.ca
CR AEBISCHER P, 1989, J NEUROSCI, V9, P3590
   AEBISCHER P, 1988, BRAIN RES, V454, P179, DOI 10.1016/0006-8993(88)90817-7
   AEBISCHER P, 1990, BRAIN RES, V531, P211, DOI 10.1016/0006-8993(90)90776-8
   AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   Aldini NN, 2000, INT ORTHOP, V24, P121
   Arai T, 2000, SCAND J PLAST RECONS, V34, P101
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   BAFFOUR R, 1995, J NEUROSURG, V83, P105, DOI 10.3171/jns.1995.83.1.0105
   BELKAS JS, 2003, J PERIPHERAL NERV S1, V8, P5
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705
   BRUSHART TM, 1983, J HAND SURG-AM, V8, P248, DOI 10.1016/S0363-5023(83)80152-X
   Bryan DJ, 2003, J RECONSTR MICROSURG, V19, P125, DOI 10.1055/s-2003-37820
   CAJAL SRY, 1928, DEGENERATION REGENER, V1
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   CHAUDHRY V, 1992, NEUROL CLIN, V10, P613
   Cheng B, 2002, MICROSURG, V22, P133, DOI 10.1002/micr.21740
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   Dahlin LB, 2001, NEUROSURG CLIN N AM, V12, P341, DOI 10.1016/S1042-3680(18)30059-7
   DANIELSEN N, 1995, J RECONSTR MICROSURG, V11, P231, DOI 10.1055/s-2007-1006537
   DELAGENIERE H, 1924, SURG GYNECOL OBSTET, V39, P543
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   DEMEDINACELI L, 1987, BIOSYSTEMS, V20, P243, DOI 10.1016/0303-2647(87)90032-3
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0
   DUCKER TB, 1968, J NEUROSURG, V28, P582, DOI 10.3171/jns.1968.28.6.0582
   Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   FERRARA G, 1608, NUOVA SELVA CIRURGIA
   FINE EG, 1991, BIOMATERIALS, V12, P775, DOI 10.1016/0142-9612(91)90029-A
   GLASBY MA, 1986, J HAND SURG-BRIT EUR, V11B, P347, DOI 10.1016/0266-7681(86)90155-5
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   GUENTHER J, 1985, EMBO J, V4, P1963, DOI 10.1002/j.1460-2075.1985.tb03878.x
   Guest JD, 1997, J NEUROSCI RES, V50, P888, DOI 10.1002/(SICI)1097-4547(19971201)50:5<888::AID-JNR24>3.3.CO;2-6
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hall S, 1997, J ANAT, V190, P57, DOI 10.1046/j.1469-7580.1997.19010057.x
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   Huber GC, 1920, SURG GYNECOL OBSTET, V30, P464
   HUBER GC, 1895, J MORPHOL, V11, P629
   HUDSON AR, 1972, J SURG RES, V12, P267, DOI 10.1016/0022-4804(72)90021-2
   Hudson TW, 1999, CLIN PLAST SURG, V26, P617
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1
   JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407
   KELSEY J, 1997, EXTREMITY DISORDERS, P26
   KEYNES RJ, 1982, BRAIN RES, V253, P13, DOI 10.1016/0006-8993(82)90668-0
   KILMER SL, 1984, NATURE, V307, P455, DOI 10.1038/307455a0
   Krarup C, 2002, ANN NEUROL, V51, P69, DOI 10.1002/ana.10054
   Labrador RO, 1998, EXP NEUROL, V149, P243, DOI 10.1006/exnr.1997.6650
   Logan Ann, 1994, Progress in Growth Factor Research, V5, P379, DOI 10.1016/0955-2235(94)00008-9
   LUNDBORG G, 1991, SCAND J PLAST RECONS, V25, P79, DOI 10.3109/02844319109034927
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   LUNDBORG G, 1994, J HAND SURG-BRIT EUR, V19B, P273, DOI 10.1016/0266-7681(94)90068-X
   Lundborg G., 1988, NERVE INJURY REPAIR, P149
   LUNDBORG G, 1980, J HAND SURG, V5, P35
   Luo Y, 2001, CHEM MATER, V13, P4087, DOI 10.1021/cm010323+
   Mackinnon S, 1988, SURG PERIPHERAL NERV, P89
   MACKINNON SE, 1984, ANN PLAS SURG, V13, P112, DOI 10.1097/00000637-198408000-00004
   MACKINNON SE, 1985, PLAST RECONSTR SURG, V76, P345, DOI 10.1097/00006534-198509000-00001
   MACKINNON SE, 1992, PLAST RECONSTR SURG, V90, P695, DOI 10.1097/00006534-199210000-00024
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MADISON R, 1985, EXP NEUROL, V88, P767, DOI 10.1016/0014-4886(85)90087-1
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   MAEDA T, 1993, BRAIN RES, V618, P196, DOI 10.1016/0006-8993(93)91266-U
   MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Midha R, 2001, TRANSPLANT P, V33, P612, DOI 10.1016/S0041-1345(00)02167-9
   MILLESI H, 1981, SURG CLIN N AM, V61, P321
   MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004
   MILLESI H, 1984, CLIN PLAST SURG, V11, P105
   MIYAMOTO Y, 1979, PLAST RECONSTR SURG, V64, P540, DOI 10.1097/00006534-197910000-00017
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   MORRIS JH, 1972, Z ZELLFORSCH MIK ANA, V124, P76
   MULLER H, 1987, BRAIN RES, V413, P320, DOI 10.1016/0006-8993(87)91023-7
   Nakahara Y, 1996, CELL TRANSPLANT, V5, P191, DOI 10.1016/0963-6897(95)02028-4
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   NORRIS RW, 1988, J BONE JOINT SURG BR, V70, P530
   ORTIGUELA ME, 1987, J HAND SURG-AM, V12A, P1119, DOI 10.1016/S0363-5023(87)80129-6
   Philipeaux J, 1870, ARCH PHYSL NORM PATH, V3, P618
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   POLITIS MJ, 1982, BRAIN RES, V253, P1, DOI 10.1016/0006-8993(82)90667-9
   RAIVICH G, 1993, INT J DEV NEUROSCI, V11, P311, DOI 10.1016/0736-5748(93)90003-V
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Richardson P M, 1991, Curr Opin Neurobiol, V1, P401, DOI 10.1016/0959-4388(91)90061-B
   Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1
   ROSEN JM, 1990, ANN PLAS SURG, V25, P375, DOI 10.1097/00000637-199011000-00006
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Rutkowski GE, 2002, BIOTECHNOL PROGR, V18, P373, DOI 10.1021/bp020280h
   Sanders FK, 1942, BRAIN, V65, P281, DOI 10.1093/brain/65.3.281
   Saneinejad S, 2000, J BIOMED MATER RES, V50, P465, DOI 10.1002/(SICI)1097-4636(20000615)50:4<465::AID-JBM1>3.3.CO;2-B
   SATOU T, 1986, ACTA PATHOL JAPON, V36, P199
   Scherman P, 2001, J NEUROSURG, V95, P316, DOI 10.3171/jns.2001.95.2.0316
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SECKEL BR, 1986, PLAST RECONSTR SURG, V78, P793, DOI 10.1097/00006534-198678060-00014
   SECKEL BR, 1990, MUSCLE NERVE, V13, P785, DOI 10.1002/mus.880130904
   SECKEL BR, 1984, PLAST RECONSTR SURG, V74, P173, DOI 10.1097/00006534-198408000-00001
   SEDDON HJ, 1947, BRIT J SURG, V35, P151, DOI 10.1002/bjs.18003513808
   Stanec S, 1998, J RECONSTR MICROSURG, V14, P227, DOI 10.1055/s-2007-1000173
   STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086
   STRAND FL, 1980, PEPTIDES, V1, P135, DOI 10.1016/0196-9781(80)90077-7
   Sundback C, 2003, BIOMATERIALS, V24, P819, DOI 10.1016/S0142-9612(02)00409-X
   TANG JB, 1995, J RECONSTR MICROSURG, V11, P21, DOI 10.1055/s-2007-1006506
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Tong YW, 1998, J BIOMAT SCI-POLYM E, V9, P713, DOI 10.1163/156856298X00109
   Utley DS, 1996, ARCH OTOLARYNGOL, V122, P407
   UZMAN BG, 1983, J NEUROSCI RES, V9, P325, DOI 10.1002/jnr.490090309
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Valero-Cabre A, 2001, J NEUROSCI RES, V63, P214, DOI 10.1002/1097-4547(20010115)63:2<214::AID-JNR1014>3.0.CO;2-D
   Verdu E, 2002, RESTOR NEUROL NEUROS, V20, P169
   WALLER AV, 1852, CR HEBD ACAD SCI, V35, P301
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P944, DOI 10.1097/00006534-198912000-00013
   Wang KK, 1998, MICROSURG, V18, P270, DOI 10.1002/(SICI)1098-2752(1998)18:4<270::AID-MICR11>3.0.CO;2-V
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   WEISS PAUL, 1941, SCIENCE, V93, P67, DOI 10.1126/science.93.2403.67
   Weiss P, 1944, J NEUROSURG, V1, P400, DOI 10.3171/jns.1944.1.6.0400
   WILLIAMS LR, 1985, J COMP NEUROL, V231, P209, DOI 10.1002/cne.902310208
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   WILLIAMS LR, 1987, J COMP NEUROL, V264, P284, DOI 10.1002/cne.902640211
   XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   ZHAO Q, 1993, RESTOR NEUROL NEUROS, V5, P197, DOI 10.3233/RNN-1993-5304
   Zheng M, 2000, J NEUROBIOL, V42, P212, DOI 10.1002/(SICI)1097-4695(20000205)42:2<212::AID-NEU5>3.0.CO;2-C
NR 136
TC 229
Z9 243
U1 3
U2 76
PU FOREFRONT PUBL GROUP
PI WILTON
PA C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA
SN 0161-6412
J9 NEUROL RES
JI Neurol. Res.
PD MAR
PY 2004
VL 26
IS 2
BP 151
EP 160
DI 10.1179/016164104225013798
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 809BS
UT WOS:000220612800005
PM 15072634
DA 2018-10-19
ER

PT J
AU Brockman, JB
   Patterson, NW
   Richardson, WS
AF Brockman, JB
   Patterson, NW
   Richardson, WS
TI Burst strength of laparoscopic and open hernia repair
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE laparoscopic; incisional hernia; burst strength; ventral hernia; open
   hernia; mesh hernia repair
ID INTRA-ABDOMINAL PRESSURE; INCISIONAL HERNIA; INTRAABDOMINAL PRESSURE;
   MESH FIXATION; SUTURES
AB Background: There are few reports of overall strength of laparoscopic and open incisional hernia repair.
   Methods: After anesthesia, a 2-inch circular defect was made in the abdominal wall of 28 female swine. Gore-Tex DualMesh Biomaterial (W. L. Gore & Associates, Flagstaff, AZ) was used for all repairs. Sixteen animals underwent open repair and 12 underwent laparoscopic repair. Burst strength was detected within 2 weeks and at 6 weeks by euthanizing the animals and insufflating the abdominal cavity with water while measuring the intraabdominal pressure until it could no longer be pressurized.
   Results: Three events occurred after insufflation: rupture around patch (R), dissection from insufflation or pressure monitoring sites (D), or rectal prolapse (P). Failure after open early repair occurred at 289 (range 219-388) mmHg with 7-R, 1-P and late 289 (196-343) mmHg with 1-R, 6-P. Failure after laparoscopic early repair occurred at 259 (191-388) mmHg with 4-R, 1-P, 1-D and late 291 (140-330) mmHg with 2-R, 1-P, 3-D. Late groups were less likely to rupture.
   Conclusion: Both hernia repairs are durable at early and late periods. Tissue ingrowth adds to repair strength. We could not show that one repair was stronger than the other. Nonetheless, laparoscopic repair tended to degrade by dissection, which was our highest pressure event.
C1 Ochsner Clin Fdn, Dept Surg, New Orleans, LA 70121 USA.
RP Richardson, WS (reprint author), Ochsner Clin Fdn, Dept Surg, 1514 Jefferson Highway, New Orleans, LA 70121 USA.
RI Richardson, William/D-3569-2011
CR Bageacu S, 2002, SURG ENDOSC, V16, P345, DOI 10.1007/s00464-001-0018-2
   BAUER JJ, 1987, ANN SURG, V206, P765, DOI 10.1097/00000658-198712000-00013
   CRESSWELL AG, 1994, EUR J APPL PHYSIOL O, V68, P315, DOI 10.1007/BF00571450
   CRESSWELL AG, 1992, ACTA PHYSIOL SCAND, V144, P409, DOI 10.1111/j.1748-1716.1992.tb09314.x
   CRESSWELL AG, 1989, ERGONOMICS, V32, P1237, DOI 10.1080/00140138908966893
   DION YM, 1994, SURG ENDOSC-ULTRAS, V8, P1324
   FITZGIBBONS RJ, 2002, NYHUS CONDONS HERNIA, P368
   GRILLNER S, 1978, ACTA PHYSIOL SCAND, V103, P275, DOI 10.1111/j.1748-1716.1978.tb06215.x
   Heniford BT, 2000, J AM COLL SURGEONS, V190, P645, DOI 10.1016/S1072-7515(00)00280-5
   Hollinsky C, 1999, SURG ENDOSC-ULTRAS, V13, P958, DOI 10.1007/s004649901146
   LeBlanc KA, 2002, SURG ENDOSC, V16, P1542, DOI 10.1007/s00464-001-8271-y
   LOBATO RF, 2001, HERNIA, V5, P107
   Losanoff J E, 2002, Hernia, V6, P144
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   MALT RA, 1977, NEW ENGL J MED, V297, P722, DOI 10.1056/NEJM197709292971312
   Papadimitriou D, 2002, VASA-J VASCULAR DIS, V31, P111, DOI 10.1024/0301-1526.31.2.111
   SANTORA TA, 1993, SURG CLIN N AM, V73, P57
   TERA H, 1976, ACTA CHIR SCAND, V142, P349
   Treska V, 2000, INT ANGIOL, V19, P64
   van't Riet M, 2002, SURG ENDOSC, V16, P1713, DOI 10.1007/s00464-001-9202-7
NR 20
TC 6
Z9 6
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD MAR
PY 2004
VL 18
IS 3
BP 536
EP 539
DI 10.1007/s00464-003-8159-0
PG 4
WC Surgery
SC Surgery
GA 839ZJ
UT WOS:000222826500035
PM 14716545
DA 2018-10-19
ER

PT J
AU Christman, KL
   Fok, HH
   Sievers, RE
   Fang, QH
   Lee, RJ
AF Christman, KL
   Fok, HH
   Sievers, RE
   Fang, QH
   Lee, RJ
TI Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve
   cardiac function after myocardial infarction
SO TISSUE ENGINEERING
LA English
DT Article
ID LEFT-VENTRICULAR GEOMETRY; ENDOTHELIAL GROWTH-FACTOR; CARDIOMYOCYTE
   TRANSPLANTATION; RAT; ANGIOGENESIS; PERFORMANCE; REPERFUSION; ISCHEMIA;
   IMPROVES; MODEL
AB Current efforts in cardiac tissue engineering center around the use of scaffolds that deliver cells to the epicardial surface. In this study, we examined the effects of fibrin glue as an injectable scaffold and wall support in ischemic myocardium. The left coronary artery of rats was occluded for 17 min, followed by reperfusion. Echocardiography was performed 8 days after infarction. One to 2 days later, either 0.5% bovine serum albumin (BSA) in phosphate-buffered saline, fibrin glue alone, skeletal myoblasts alone, or skeletal myoblasts in fibrin glue were injected into the ischemic left ventricle. Echocardiography was again performed 5 weeks after injection. The animals were then sacrificed and the hearts were fresh frozen and sectioned for histology and immunohistochemistry. Both the fractional shortening (FS) and infarct wall thickness of the BSA group decreased significantly after 5 weeks (p = 0.0005 and 0.02, respectively). In contrast, both measurements for the fibrin glue group, cells group, and cells in fibrin glue group did not change significantly (FS: p = 0.18, 0.89, and 0.19, respectively; wall thickness: p = 0.40, 0.44, 0.43, respectively). Fibrin glue is capable of preserving infarct wall thickness and cardiac function after a myocardial infarction in rats and may be useful as a biomaterial scaffold for myocardial cell transplantation.
C1 Univ Calif Berkeley, Berkeley, CA 94720 USA.
   Univ Calif San Francisco, San Francisco Joint Bioengn Grad Grp, San Francisco, CA USA.
   Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA.
RP Lee, RJ (reprint author), UCSF Cardiac Electrophysiol, MU E Tower,Box 1354,500 Parnassus Ave, San Francisco, CA 94143 USA.
EM lee@medicine.ucsf.edu
CR Andree C, 2001, TISSUE ENG, V7, P757, DOI 10.1089/107632701753337708
   Chawla PS, 1999, INT ANGIOL, V18, P185
   CHRISTMAN KL, 2003, 7 ANN HILT HEAD WORK
   CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9
   Doursout MF, 2001, ULTRASOUND MED BIOL, V27, P195, DOI 10.1016/S0301-5629(00)00330-6
   ERLEBACHER JA, 1984, J AM COLL CARDIOL, V4, P201, DOI 10.1016/S0735-1097(84)80203-X
   FISHBEIN MC, 1978, AM J PATHOL, V90, P57
   GHOSTINE S, 2002, CIRCULATION S1, V106, P131
   Gojo S, 1997, J THORAC CARDIOV SUR, V113, P10, DOI 10.1016/S0022-5223(97)70394-5
   HAVENITH MG, 1990, HISTOCHEMISTRY, V93, P497, DOI 10.1007/BF00266407
   Jain M, 2001, CIRCULATION, V103, P1920
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kipshidze N, 2000, TEX HEART I J, V27, P196
   Leor J, 2000, CIRCULATION, V102, P56
   Li RK, 1996, ANN THORAC SURG, V62, P654
   LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Nakamura A, 2001, AM J PHYSIOL-HEART C, V281, pH1104
   OLIVETTI G, 1990, CIRC RES, V67, P23, DOI 10.1161/01.RES.67.1.23
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Pandit AS, 1998, GROWTH FACTORS, V15, P113, DOI 10.3109/08977199809117187
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193
   Sakai T, 1999, J THORAC CARDIOV SUR, V118, P715, DOI 10.1016/S0022-5223(99)70018-8
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Scorsin M, 1997, CIRCULATION, V96, P188
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   SIEVERS RE, 1989, MAGNET RESON MED, V10, P172, DOI 10.1002/mrm.1910100203
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   WARREN SE, 1988, J AM COLL CARDIOL, V11, P12, DOI 10.1016/0735-1097(88)90159-3
   Watanabe E, 1998, CELL TRANSPLANT, V7, P239, DOI 10.1016/S0963-6897(98)00011-6
   WOLFE CL, 1989, CIRCULATION, V80, P969, DOI 10.1161/01.CIR.80.4.969
   Youn HJ, 1999, J AM SOC ECHOCARDIOG, V12, P70, DOI 10.1016/S0894-7317(99)70175-6
   Zhu BQ, 2000, J AM COLL CARDIOL, V35, P787, DOI 10.1016/S0735-1097(99)00592-6
   Zhu BQ, 2001, J RENIN-ANGIO-ALDO S, V2, P129, DOI 10.3317/jraas.2001.014
NR 37
TC 256
Z9 275
U1 3
U2 33
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAR-APR
PY 2004
VL 10
IS 3-4
BP 403
EP 409
DI 10.1089/107632704323061762
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA 816JA
UT WOS:000221105000010
PM 15165457
DA 2018-10-19
ER

PT J
AU Tessmar, J
   Kellner, K
   Schulz, MB
   Blunk, T
   Gopferich, A
AF Tessmar, J
   Kellner, K
   Schulz, MB
   Blunk, T
   Gopferich, A
TI Toward the development of biomimetic polymers by protein immobilization:
   PEGylation of insulin as a model reaction
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT 1st Biennial Meeting of the European-Tissue-Engineering-Society
CY NOV 06-10, 2001
CL FREIBURG, GERMANY
SP European Tissue Engn Soc
ID GROWTH-FACTOR; BIOMATERIALS; COPOLYMERS; RELEASE; ACID)
AB Many current tissue-engineering investigations aim at the rational control of cell adhesion and tailored composition of biomaterial surfaces by immobilizing various protein and peptide components, such as growth factors. As a step on the way to develop polymers that allow for such surface modifications, water-soluble polymers were used as model substances to examine reactions with proteins containing amine groups. Consequently, the uncommon PEGylation of insulin in aqueous buffers was used to characterize reaction products and simulate the intended immobilization step for surface modification. Amine reactive poly(ethylene glycol)s were synthesized and characterized by H-1 nuclear magnetic resonance and gel-permeation chromatography. Furthermore, the model protein insulin was characterized concerning its accessible amino groups, using a fluorescent dye (TAMRA-SE). The resulting reaction products were identified by reversed-phase high-performance liquid chromatography and electrospray mass spectrometry. After PEGylation with hydrolytically stable poly(ethylene glycol) succinimidyl ester, the obtained PEGylated insulin was investigated by gel filtration chromatography, indicating successful attachment of the hydrophilic polymer chains. Application of an aqueous PEGylation scheme opens the door to the immediate investigation of various growth factors in cell culture, allowing for direct assessment of biological activity after forming the polymer-protein constructs with regard to later immobilization on surfaces.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
EM achim.goepferich@chemie.uni-regensburg.de
RI Tessmar, Joerg/H-3606-2012; Goepferich, Achim/G-1151-2016
OI Tessmar, Joerg/0000-0001-7057-5369; Goepferich,
   Achim/0000-0002-7646-0252
CR ABUCHOWSKI A, 1984, CANCER BIOCHEM BIOPH, V7, P175
   ANDERSON GW, 1964, J AM CHEM SOC, V86, P1839, DOI 10.1021/ja01063a037
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Bailon P, 1998, PHARM SCI TECHNOL TO, V1, P352, DOI 10.1016/S1461-5347(98)00086-8
   Brange J, 1993, STABILITY CHARACTERI, P315
   HARRIS JM, 1985, J MACROMOL SCI R M C, VC25, P325, DOI 10.1080/07366578508081960
   Hinds KD, 2002, ADV DRUG DELIVER REV, V54, P505, DOI 10.1016/S0169-409X(02)00025-X
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   INADA Y, 1995, TRENDS BIOTECHNOL, V13, P86, DOI 10.1016/S0167-7799(00)88912-X
   Kellner K, 2004, TISSUE ENG, V10, P429, DOI 10.1089/107632704323061799
   Kellner K, 2001, J DRUG TARGET, V9, P439, DOI 10.3109/10611860108998778
   Klee D, 1999, ADV POLYM SCI, V149, P1
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   Liu F, 1997, BIOCONJUGATE CHEM, V8, P664, DOI 10.1021/bc970128e
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   NUCCI ML, 1991, ADV DRUG DELIVER REV, V6, P133, DOI 10.1016/0169-409X(91)90037-D
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Tessmar J, 2003, BIOMATERIALS, V24, P4475, DOI 10.1016/S0142-9612(03)00345-4
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   YOKOYAMA M, 1992, BIOCONJUGATE CHEM, V3, P275, DOI 10.1021/bc00016a003
NR 24
TC 9
Z9 9
U1 0
U2 5
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAR-APR
PY 2004
VL 10
IS 3-4
BP 441
EP 453
DI 10.1089/107632704323061807
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 816JA
UT WOS:000221105000014
PM 15165461
DA 2018-10-19
ER

PT J
AU van der Borden, AJ
   van der Mei, HC
   Busscher, HJ
AF van der Borden, AJ
   van der Mei, HC
   Busscher, HJ
TI Electric-current-induced detachment of Staphylococcus epidermidis
   strains from surgical stainless steel
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE electric current; detachment; stainless steel; Staphylococcus
   epidermidis; Staphylococcus aureus; percutaneous devices; biofilms
ID MICROBIAL ADHESION; TISSUE INTEGRATION; BACTERIAL ADHESION;
   CHARGE-TRANSFER; BIOFILMS; FIXATION; SURFACE
AB Infection of percutaneous biomaterials implants, such as fixation frames used for the repair of complicated fractures in orthopedics, is a major complication that almost inevitably leads to replacement of the implant. As antibiotic therapy usually has little impact on biomaterial-associated infections, it is the aim of this article to examine whether implact-associated Staphylococcus epidermidis and Staphylococcus aureus strains could be stimulated to detach from a surgical stainless steel anode during application of an electric current. First, bacteria were allowed to adhere from a flowing suspension of physiological ionic strength in a parallel plate flow chamber to a stainless-steel surface, after which the suspension was replaced by a bacterium- free solution with a specified ionic strength (0.5-150-mM potassium phosphate). DC currents ranging from 15 to 125 muA were applied to induce bacterial detachment. Initial detachment decreased with increasing ionic strength at 100 muA. The percentage detachment achieved by application of an electric current after 2.5 h was highest (95%) in 1-mM potassium phosphate and decreased to 15% when the ionic strength exceeded 40 mM. The electric current did not significantly affect the percentage detachment, but initial detachment rates increased with increasing current from 1000 cm(-2) s(-1) at 15 muA to 7000 cm(-2) s(-1) at 125 muA. Although different isolates of S. epidermidis and S. aureus showed different patterns of current-induced detachment, all strains could be stimulated to detach. The results of this study define ionic-strength conditions and electric currents yielding staphylococcal detachment from surgical stainless steel and therewith point to a pathway for the treatment and prevention of percutaneous metal-implant infection. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM H.J.Busscher@med.rug.nl
CR ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   BOLTON L, 1980, ANTIMICROB AGENTS CH, V18, P137, DOI 10.1128/AAC.18.1.137
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   GREEN SA, 1983, CLIN ORTHOP RELAT R, P109
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687
   Mostafavi HR, 1997, CLIN ORTHOP RELAT R, P187
   Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1
   Poortinga AT, 2001, BIOPHYS CHEM, V91, P273, DOI 10.1016/S0301-4622(01)00177-6
   Poortinga AT, 2001, BIOTECHNOL BIOENG, V76, P395, DOI 10.1002/bit.10129
   Poortinga AT, 2000, BIOTECHNOL BIOENG, V67, P117, DOI 10.1002/(SICI)1097-0290(20000105)67:1<117::AID-BIT14>3.0.CO;2-6
   SJOLLEMA J, 1989, J MICROBIOL METH, V9, P73, DOI 10.1016/0167-7012(89)90057-2
   Ueshima M, 2002, J BIOMED MATER RES, V60, P578, DOI 10.1002/jbm.10113
NR 18
TC 34
Z9 34
U1 1
U2 11
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2004
VL 68B
IS 2
BP 160
EP 164
DI 10.1002/jbm.b.20015
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 769AE
UT WOS:000188603300006
PM 14737763
DA 2018-10-19
ER

PT J
AU Benkirane-Jessel, N
   Schwinte, P
   Falvey, P
   Darcy, R
   Haikel, Y
   Schaaf, P
   Voegel, JC
   Ogier, J
AF Benkirane-Jessel, N
   Schwinte, P
   Falvey, P
   Darcy, R
   Haikel, Y
   Schaaf, P
   Voegel, JC
   Ogier, J
TI Build-up of polypeptide multilayer coatings with anti-inflammatory
   properties based on the embedding of piroxicam-cyclodextrin complexes
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BETA-CYCLODEXTRIN; INCLUSION COMPOUND; GROWTH-FACTOR; FILMS;
   POLYELECTROLYTES; ENVIRONMENT; ADSORPTION; DELIVERY; POLYMER; WATER
AB We describe the build-up of biomaterial coatings based on polypeptide multilayers possessing anti-inflammatory properties. Poly(L-lysine) (PLL) and poly(L-glutamic acid) (PGA) are used as polypeptides, and piroxicam (Px) is used as the anti-inflammatory agent. In order to embed high enough amounts of Px, the drug is incorporated in the films in the form of complexes with a charged 6(A)-carboxymethylthio-beta-cyclodextrin (cCD). It is shown that this cyclodextrin can solubilize higher amounts of Px than the cyclodextrins used commercially. The anti-inflammatory properties are evaluated by determining the inhibition of TNFalpha production by human monocytic THP-1 cells stimulated with lipopolysaccharide (LPS) bacterial endotoxin. Using Fourier-transform (FT) Raman spectroscopy, we show that Px is mainly in the neutral form in cCD-Px complexes in solution, and that it remains biologically active under this form, whereas up to now only the zwitterionic form was reported to possess anti-inflammatory properties. When incorporated in PLL/PGA multilayers, Px in the cCD-Px complexes changes from the neutral to the zwitterionic form. It is shown that these films present anti-inflammatory properties, which can be delayed, and whose duration can be tuned by changing the film architecture.
C1 Univ Strasbourg, INSERM, Unite 595, F-67085 Strasbourg, France.
   Inst Charles Sadron, CNRS, ULP, F-67083 Strasbourg, France.
   Natl Univ Ireland Univ Coll Dublin, Dept Chem, Conway Inst, Ctr Synth & Chem Biol, Dublin 4, Ireland.
RP Benkirane-Jessel, N (reprint author), Univ Strasbourg, INSERM, Unite 595, 11 Rue Humann, F-67085 Strasbourg, France.
EM joelle.ogier@medecine.u-strasbg.fr
RI SCHAAF, Pierre/J-2751-2016; Benkirane-Jessel, Nadia/H-6438-2016
OI SCHAAF, Pierre/0000-0001-7423-5492; Benkirane-Jessel,
   Nadia/0000-0003-3059-3559
CR Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7
   Banerjee R, 2002, J LUMIN, V99, P255, DOI 10.1016/S0022-2313(02)00344-7
   Bertoluzza A, 1999, J MOL STRUCT, V481, P535, DOI 10.1016/S0022-2860(98)00734-0
   BRADY B, 2000, ORG SYNTH, V7, P220
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   CONNORS KA, 1987, BINDING CONSTANTS
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DEFAYE J, 1989, CARBOHYD RES, V192, P251, DOI 10.1016/0008-6215(89)85184-5
   Doliwa A, 2001, SKIN PHARMACOL APPL, V14, P97, DOI 10.1159/000056339
   Escandar GM, 1999, ANALYST, V124, P587, DOI 10.1039/a809180c
   HIROTSU K, 1982, J ORG CHEM, V47, P1143, DOI 10.1021/jo00345a054
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Jinno J, 2000, J PHARM SCI, V89, P268, DOI 10.1002/(SICI)1520-6017(200002)89:2<268::AID-JPS14>3.0.CO;2-F
   KONG W, 1994, J AM CHEM SOC, V116, P1297
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1994, LANGMUIR, V10, P4232, DOI 10.1021/la00023a052
   McEwen J, 2000, CLIN DRUG INVEST, V19, P27, DOI 10.2165/00044011-200019002-00004
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Redenti E, 1999, BIOSPECTROSCOPY, V5, P243, DOI 10.1002/(SICI)1520-6343(1999)5:4<243::AID-BSPY5>3.0.CO;2-C
   Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031
   Schwinte P, 1998, J CHEM SOC PERK T 2, P805, DOI 10.1039/a708602d
   Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1
   Taddei P, 2001, BIOPOLYMERS, V62, P68, DOI 10.1002/1097-0282(2001)62:1<68::AID-BIP80>3.0.CO;2-X
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   YOON K, 1998, B KOR CHEM SOC, V9, P171
NR 33
TC 98
Z9 98
U1 1
U2 25
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD FEB
PY 2004
VL 14
IS 2
BP 174
EP 182
DI 10.1002/adfm.200304413
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 776ZL
UT WOS:000189149200011
DA 2018-10-19
ER

PT J
AU Nilsdotter-Augustinsson, A
   Wilsson, A
   Larsson, J
   Stendahl, O
   Ohman, L
   Lundqvist-Gustafsson, H
AF Nilsdotter-Augustinsson, A
   Wilsson, A
   Larsson, J
   Stendahl, O
   Ohman, L
   Lundqvist-Gustafsson, H
TI Staphylococcus aureus, but not Staphylococcus epidermidis, modulates the
   oxidative response and induces apoptosis in human neutrophils
SO APMIS
LA English
DT Article
DE chemiluminescence; annexin V; p38-mitogen-activated-protein-kinase;
   inflammation; biomaterial infections
ID P38-MITOGEN-ACTIVATED PROTEIN-KINASE; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   INFLUENZA-A-VIRUS; SIGNAL-TRANSDUCTION; RESPIRATORY BURST; NADPH
   OXIDASE; IN-VITRO; ACTIVATION; RECOGNITION; INFECTIONS
AB S. epidermidis is the most common isolate in foreign body infections. The aim of this study was to understand why S. epidermidis causes silent biomaterial infections. In view of the divergent inflammatory responses S. epidermidis and S. aureus cause in patients, we analyzed how they differ when interacting with human neutrophils. Neutrophils interacting with S. epidermidis strains isolated either from granulation tissue covering infected hip prostheses or from normal skin flora were tested by measuring the oxidative response as chemiluminescence and apoptosis as annexin V binding. Different S. aureus strains were tested in parallel. All S. epidermidis tested were unable to modulate the oxidative reaction in response to formyl-methionyl-leucyl-phenylalanine (fMLP) and did not provoke, but rather inhibited, apoptosis. In contrast, some S. aureus strains enhanced the oxidative reaction, and this priming capacity was linked to p38-mitogen-activated-protein-kinase (p38-MAPK) activation and induction of apoptosis. Our results may explain why S. epidermidis is a weak inducer of inflammation compared to S. aureus, and therefore responsible for the indolent and chronic course of S. epidermidis biomaterial infections.
C1 Linkoping Univ, Div Infect Dis, Linkoping, Sweden.
   Linkoping Univ, Div Med Microbiol, Dept Mol & Clin Med, Linkoping, Sweden.
   Linkoping Univ, Div Pathol 2, Dept Neurosci & Locomot, Linkoping, Sweden.
RP Nilsdotter-Augustinsson, A (reprint author), Linkoping Univ, Div Infect Dis, Linkoping, Sweden.
EM asa.nilsdotter@lio.se
CR Akgul C, 2001, FEBS LETT, V487, P318, DOI 10.1016/S0014-5793(00)02324-3
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Aoshiba K, 1999, J IMMUNOL, V162, P1692
   ARCHER GL, 2000, PRINCIPLES PRACTICE, P2092
   Augustinsson A, 2001, SCAND J INFECT DIS, V33, P408, DOI 10.1080/00365540152029855
   Babior BM, 1999, BLOOD, V93, P1464
   BASS DA, 1986, J IMMUNOL, V136, P860
   BISAILLON JG, 1985, EXP BIOL, V43, P225
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Chilvers ER, 2000, J ROY COLL PHYS LOND, V34, P68
   Colamussi ML, 1999, BLOOD, V93, P2395
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Engelich G, 2002, J MED MICROBIOL, V51, P484, DOI 10.1099/0022-1317-51-6-484
   Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI200114122
   FELTHAM RKA, 1978, J APPL BACTERIOL, V44, P313, DOI 10.1111/j.1365-2672.1978.tb00804.x
   Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93
   Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389
   GHERNA R, 1992, CATALOGUE BACTERIA B, P301
   Grassme H, 2001, APOPTOSIS, V6, P441, DOI 10.1023/A:1012485506972
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Hampton MB, 1998, BLOOD, V92, P3007
   Hampton MB, 1998, TOXICOL LETT, V103, P355, DOI 10.1016/S0378-4274(98)00333-6
   HED J, 1977, FEMS MICROBIOL LETT, V1, P357, DOI 10.1016/0378-1097(77)90092-1
   Heilmann C, 2000, GRAM-POSITIVE PATHOGENS, P442
   Homburg C H, 1996, Curr Opin Hematol, V3, P94
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#
   Larsson J, 2000, INFLAMM RES, V49, P452, DOI 10.1007/s000110050616
   Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3
   Leuenroth SJ, 2000, SURGERY, V128, P171, DOI 10.1067/msy.2000.107609
   Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230
   Lundqvist-Gustafsson H, 1999, J LEUKOCYTE BIOL, V65, P196
   Lundqvist-Gustafsson H, 2001, J LEUKOCYTE BIOL, V70, P642
   Moulding DA, 1998, BLOOD, V92, P2495
   Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783
   Pei L, 2001, MICROB PATHOGENESIS, V31, P185, DOI 10.1006/mpat.2001.0462
   Perskvist N, 2002, J IMMUNOL, V168, P6358, DOI 10.4049/jimmunol.168.12.6358
   Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a
   RIBER U, 1995, APMIS, V103, P439, DOI 10.1111/j.1699-0463.1995.tb01130.x
   Rupp M E, 1997, Curr Clin Top Infect Dis, V17, P51
   Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722
   Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304
   Squier MKT, 2000, METH MOL B, V144, P327
   STOUT RD, 1994, INFECT IMMUN, V62, P4160
   van Eeden SF, 1999, J IMMUNOL METHODS, V232, P23, DOI 10.1016/S0022-1759(99)00148-9
   Vaudaux P., 2000, INFECT ASS INDWELLIN, P1
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309
   WHYTE MKB, 1993, J IMMUNOL, V150, P5124
   Whyte MKB, 1997, J LEUKOCYTE BIOL, V62, P195
   Wilsson A, 1996, J LEUKOCYTE BIOL, V59, P902
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 53
TC 14
Z9 15
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0903-4641
EI 1600-0463
J9 APMIS
JI APMIS
PD FEB
PY 2004
VL 112
IS 2
BP 109
EP 118
DI 10.1111/j.1600-0463.2004.apm1120205.x
PG 10
WC Immunology; Microbiology; Pathology
SC Immunology; Microbiology; Pathology
GA 807LR
UT WOS:000220503500005
PM 15056227
DA 2018-10-19
ER

PT J
AU Jansen, K
   van der Werff, JFA
   van Wachem, PB
   Nicolai, JPA
   de Leij, LFMH
   van Luyn, MJA
AF Jansen, K
   van der Werff, JFA
   van Wachem, PB
   Nicolai, JPA
   de Leij, LFMH
   van Luyn, MJA
TI A hyaluronan-based nerve guide: in vitro cytotoxicity, subcutaneous
   tissue reactions, and degradation in the rat
SO BIOMATERIALS
LA English
DT Article
DE nerve guided; biocompatibility; biodegradation; cytotoxicity; hyaluronan
ID ACID; BIOCOMPATIBILITY; DELIVERY; BIODEGRADATION; REGENERATION;
   DERIVATIVES; COLLAGEN; RELEASE; RABBITS; ESTERS
AB We investigated possible cytotoxic effects, biocompatibility, and degradation of a hyaluronan-based conduit for peripheral nerve repair. We subjected the conduits to an in vitro fibroblast cytotoxicity test and concluded that the conduits were not cytotoxic. Subsequently, we implanted the conduits subcutaneously in rats, in order to investigate tissue reactions and biodegradation. Initially, a fibrin matrix was formed around the material, while the surroundings were relatively quiet. Macrophages (MO) migrated to the conduits and formed giant cells next to the material after 5 days. The maximum presence of MO was found after 3/6 weeks. The appearance of MHC class II cells showed a similar pattern. Highest numbers of giants reached a maximum after 6-12 weeks. Angiogenesis was started in the surroundings of the hyaluronan-based conduit within a few days. Massive ingrowth of bloodvessels into the biomaterial was found after 6 weeks as well as cellular ingrowth into the lumen of the tube. At that time the tubular structure of the conduit was lost and loose biomaterial fibers were observed. The results show that a hyaluronan-based conduit is not cytotoxic and shows good biocompatibility. Such a conduit may be suitable as a guide in peripheral nerve repair. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Groningen Hosp, Dept Plast & Reconstruct Surg, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Dept Plast & Reconstruct Surg, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Dept Pathol & Lab Med, Med Biol Sect, Fac Med Sci, NL-9713 GZ Groningen, Netherlands.
RP Jansen, K (reprint author), Univ Groningen Hosp, Dept Plast & Reconstruct Surg, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
CR Andreassi L, 1995, CLIN DERMATOL, V13, P369, DOI 10.1016/0738-081X(95)00069-R
   Avitabile T, 2001, BIOMATERIALS, V22, P195, DOI 10.1016/S0142-9612(00)00169-1
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Berger A, 1994, Handchir Mikrochir Plast Chir, V26, P44
   Campoccia D, 1996, BIOMATERIALS, V17, P963, DOI 10.1016/0142-9612(96)84670-9
   DAVIDSON J M, 1991, Clinical Materials, V8, P171, DOI 10.1016/0267-6605(91)90027-D
   DENDUNNEN WFA, 1996, THESIS U GRONINGEN N
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   JOSHI HN, 1992, J CONTROL RELEASE, V20, P109, DOI 10.1016/0168-3659(92)90157-M
   KYYRONEN K, 1992, INT J PHARM, V80, P161, DOI 10.1016/0378-5173(92)90274-6
   MEEK MF, 1996, THESIS U GRONINGEN N
   Mohammad JA, 2000, ANN PLAS SURG, V44, P59, DOI 10.1097/00000637-200044010-00010
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   SECKEL BR, 1995, J NEUROSCI RES, V40, P318, DOI 10.1002/jnr.490400305
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P267, DOI 10.1016/0142-9612(92)90049-T
   VANLUYN MJA, 1995, J MATER SCI-MATER M, V6, P288, DOI 10.1007/BF00120273
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   WANG KK, 1995, J NEUROSCI RES, V15, P318
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 22
TC 42
Z9 42
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 3
BP 483
EP 489
DI 10.1016/s0142-9612(03)00544-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 746CA
UT WOS:000186727900013
PM 14585697
DA 2018-10-19
ER

PT J
AU Woods, AM
   Rodenberg, EJ
   Hiles, MC
   Pavalko, FM
AF Woods, AM
   Rodenberg, EJ
   Hiles, MC
   Pavalko, FM
TI Improved biocompatibility of small intestinal submucosa (SIS) following
   conditioning by human endothelial cells
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; cell culture; endothelial cell; platelet adhesion;
   inflammation
ID MICROVASCULAR GRAFT MATERIAL; EXTRACELLULAR-MATRIX; CAROTID-ARTERY;
   REPAIR; GROWTH; BIOSCAFFOLD; ADHERENCE; DOGS
AB Small intestinal submucosa (SIS) is a naturally occurring tissue matrix composed of extracellular matrix proteins and various growth factors. SIS is derived from the porcine jejunum and functions as a remodeling scaffold for tissue repair. While SIS has proven to be a useful biomaterial for implants in vivo, problems associated with endothelialization and thrombogenicity of SIS implants may limit its vascular utility. The goal of this study was to determine if the biological properties of SIS could be improved by growing human umbilical vein endothelial cells (HUVEC) on SIS and allowing these cells to deposit human basement membrane proteins on the porcine substrate to create what we have called "conditioned" SIS (c-SIS). Using an approach in which HUVEC were grown for 2 weeks on SIS and then removed via a technique that leaves behind an intact basement membrane, we hypothesized that the surface properties of SIS might be improved. We found that when re-seeded on c-SIS, HUVEC exhibited enhanced organization of cell junctions and had increased metabolic activity compared to cells on native SIS (n-SIS). Furthermore, HUVEC grown on c-SIS released lower amounts of the pro-inflammatory prostaglandin PGI(2) into the media compared to cells grown on n-SIS. Additionally, we found that adhesion of resting or activated human platelets to c-SIS was significantly decreased compared to n-SIS suggesting that, in addition to improved cell growth characteristics, conditioning SIS with human basement membrane proteins might decrease its thrombogenic potential. In summary, conditioning of porcine SIS by human endothelial cells improves key biological properties of the material that may improve its usefulness as remodeling scaffold for tissue repair. Identification of critical modifications of SIS by human endothelial cells should help guide future efforts to develop more biocompatible vascular grafts. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.
   Cook Biotech Inc, W Lafayette, IN 47906 USA.
RP Pavalko, FM (reprint author), Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,Med Sci Bldg,Rm 2069, Indianapolis, IN 46202 USA.
FU NIAMS NIH HHS [AR45831, AR45218]
CR Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   COOLEY BC, 1994, MICROSURG, V15, P592, DOI 10.1002/micr.1920150813
   FUNG YC, 1990, BIOMECHANICS MOTION, P196
   Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85
   GOSPODAROWICZ D, 1984, METHODS PREPARATION, P275
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Lindberg K, 2001, BURNS, V27, P254, DOI 10.1016/S0305-4179(00)00113-3
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   PREVEL CD, 1994, MICROSURG, V15, P586, DOI 10.1002/micr.1920150812
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 23
TC 29
Z9 32
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 3
BP 515
EP 525
DI 10.1016/S0142-9612(03)00552-0
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 746CA
UT WOS:000186727900017
PM 14585701
DA 2018-10-19
ER

PT J
AU Sun, JS
   Chang, WHS
   Chen, LT
   Huang, YC
   Juang, LW
   Lin, FH
AF Sun, JS
   Chang, WHS
   Chen, LT
   Huang, YC
   Juang, LW
   Lin, FH
TI The influence on gene-expression profiling of osteoblasts behavior
   following treatment with the ionic products of sintered beta-dicalcium
   pyrophosphate dissolution
SO BIOMATERIALS
LA English
DT Article
DE gene expression; sintered dicalcium pyrophosphate; biocompatability;
   osteoblastic cells
ID BONE-MATRIX PROTEINS; MESSENGER-RNA; ALKALINE-PHOSPHATASE; INSITU
   HYBRIDIZATION; COLLAGEN-SYNTHESIS; CELL-GROWTH; I COLLAGEN; OSTEOPONTIN;
   DIFFERENTIATION; OSTEOCLASTS
AB Sintered dicalcium pyrophosphate (SDCP) is biocompatible to bone tissue both in the in vivo and in vitro model. However, the molecular mechanisms that mediated these processes have yet to be identified. In this study, we investigated the influence of SDCP ions on in vitro osteoblasts behavior. The powder of sintered beta-dicalcium pyrophosphate (SDCP) was dissolved by HCl and then diluted into different concentration of solutions by culture medium used in the osteoblast cell culture. The effects of various concentration of SDCP on bone cell activities were evaluated by using MTT assay. For the differentiation of osteoblasts, alkaline phosphatase (AP) staining, von Kossa stain for mineralized nodules and bone markers messenger ribonucleic acid (mRNA) isolation and identification were performed at 3 h, days 1, 3 7 and 14.
   In the presence of 10(-8) M SDCP for 14 days, the osteoblasts population was still significantly higher than that of control. In the qualitative analysis for the formation of AP staining colonies and mineralization nodules formation were not affected by SDCP ions. When osteoblasts cultured in the presence of 10(-8) M SDCP ions, the osteocalcin mRNA expression was up-regulated; while the collagen, osteonectin and osteopontin mRNA expression were down-regulated.
   In this study, we demonstrated that the elevated concentration of calcium and pyrophosphate ions can activate genes of the bone cells. This study will contribute to a better understanding of cell/biomaterial interactions and mechanisms that SDCP affect the bone cells. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan.
   Natl Taiwan Univ Hosp, Dept Biomed Engn, Taipei, Taiwan.
   Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan.
   Chung Yuan Christian Univ, Dept Biomed Engn, Tao Yuan, Taiwan.
RP Lin, FH (reprint author), Natl Taiwan Univ, Inst Biomed Engn, 1 Jen Ai Rd, Taipei, Taiwan.
RI Lin, Feng-Huei/E-3970-2010
OI SUN, JUI-SHENG/0000-0001-5142-8777
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   BECKER Y, 2001, XENOTRANSPLANTATION, V8, P165
   BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   BOS GD, 1983, J BONE JOINT SURG AM, V65, P239, DOI 10.2106/00004623-198365020-00015
   BURNSTONE M, 1960, ANN NY ACAD SCI, V85, P431
   Caplan AI, 1987, BONE MINERAL RES, P117
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Davies JE, 1996, ANAT REC, V245, P426
   DODDS RA, 1993, J BONE MINER RES, V8, P261
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   FRESHNEY RI, 2000, CULTURE ANIMAL CELLS, P309
   GENOVESE C, 1984, BIOCHEMISTRY-US, V23, P6210, DOI 10.1021/bi00320a049
   GOLDRING SR, 1991, BONE-BIOMATERIAL INTERFACE, P241
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   GUNBERG CM, 1999, DYNAMICS BONE CARTIL, P45
   GUNDLE R, 1995, CALCIFIED TISSUE INT, V56, P8
   HALL AK, 1985, ACTA ENDOCRINOL-COP, V108, P217, DOI 10.1530/acta.0.1080217
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   HARRIS ST, 1993, J CLIN ENDOCR METAB, V76, P1399, DOI 10.1210/jc.76.6.1399
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HIRAKAWA K, 1994, J BONE MINER RES, V9, P1551
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   IKEDA T, 1992, J HISTOCHEM CYTOCHEM, V40, P1079, DOI 10.1177/40.8.1619274
   IOANNIS D, 2001, J BIOMED MATER RES, V55, P151
   Kawai N, 1997, J BIOMED MATER RES, V37, P1
   Kishida A, 1996, BIOMATERIALS, V17, P1301, DOI 10.1016/0142-9612(96)88675-3
   LANE TF, 1994, FASEB J, V8, P163
   LEE MJ, 1995, UNPUB REGIONAL DIFFE
   LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143
   Lin CC, 1996, BIOMATERIALS, V17, P1133, DOI 10.1016/0142-9612(96)85916-3
   LIN FH, 1995, BIOMATERIALS, V16, P793, DOI 10.1016/0142-9612(95)99642-Y
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   MANKIN HJ, 1987, ORTHOP CLIN N AM, V18, P275
   MERRY K, 1993, J CELL SCI, V104, P1013
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NAKAJIMA T, 1993, J CLIN INVEST, V92, P186, DOI 10.1172/JCI116548
   O'Brien EA, 2001, BONE, V28, P208, DOI 10.1016/S8756-3282(00)00431-2
   OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819
   RAIF EM, 1993, BIOMATERIALS, V14, P978, DOI 10.1016/0142-9612(93)90189-9
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   STEIN GS, 1990, FASEB J, V4, P3111
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Stein GS, 1996, PHYSIOL REV, V76, P593
   Sun JS, 2003, J BIOMED MATER RES A, V64A, P616, DOI 10.1002/jbm.a.10439
   Sun JS, 2002, J BIOMED MATER RES, V59, P246, DOI 10.1002/jbm.1238
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   TEZUKA K, 1992, BIOCHEM BIOPH RES CO, V186, P911, DOI 10.1016/0006-291X(92)90832-6
   URIST MR, 1981, CLIN ORTHOP RELAT R, P97
   Von Der Mark K, 1999, DYNAMICS BONE CARTIL, P3
   WEINREB M, 1990, J BONE MINER RES, V5, P831
   WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   Zambonin G, 2000, J BIOMED MATER RES, V49, P120, DOI 10.1002/(SICI)1097-4636(200001)49:1<120::AID-JBM15>3.0.CO;2-Q
NR 55
TC 36
Z9 36
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 4
BP 607
EP 616
DI 10.1016/S0142-9612(03)00567-2
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GB
UT WOS:000186853200005
PM 14607498
DA 2018-10-19
ER

PT J
AU Wang, YW
   Wu, QO
   Chen, GQ
AF Wang, YW
   Wu, QO
   Chen, GQ
TI Attachment, proliferation and differentiation of osteoblasts on random
   biopolyester poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds
SO BIOMATERIALS
LA English
DT Article
DE PHB; poly(3-hydroxybutyrate-co-3-hydroxyhexanoate); PHBHHx; PLA;
   osteoblast; bone marrow cells
ID BONE CELL-CULTURES; IN-VITRO; SURFACE-ROUGHNESS; MICROBIAL
   POLYHYDROXYALKANOATES; OSTEOGENIC DIFFERENTIATION; BIODEGRADABLE
   IMPLANT; STEM-CELLS; MARROW; BIOCOMPATIBILITY; HYDROXYAPATITE
AB Rabbit bone marrow cells were inoculated on 3D scaffolds of poly(lactic acid) (PLA), poly(3-hydroxybutyrate) (PHB) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) to evaluate their in vitro biocompatibilities. It was found that PHBHHx had the best performance on attachment, proliferation of bone marrow cells. The cells on PHBHHx scaffolds presented typical osteoblast phenotypes: round cell shape, high alkaline phosphotase (ALP) activity, strong calcium deposition, and fibrillar collagen synthesis. After incubation for 10 days, cells grown on PHBHHx scaffolds were approximately 2 x 10(5) ml(-1), 40% more than that on PHB scaffolds and 60% more than that on PLA scaffolds. ALP activity of the cells grown on PHBHHx scaffolds was up to about 65 U/g scaffolds, 50% higher than that of PHB and PLA, respectively. The scanning electronic microscopy (SEM) results showed that PHBHHx scaffolds had the appropriate roughness for osteoblast attachment and proliferation comparing with PHB and PLA. All these indicated that PHBHHx was a suitable biomaterial for osteoblast attachment, proliferation and differentiation from bone marrow cells. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
RP Wu, QO (reprint author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
EM wuqiong@mail.tsinghua.edu.cn
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Chen G., 2001, TSINGHUA J SCI TECHN, V6, P193
   Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   Chen XY, 2003, POLYM J, V35, P148, DOI 10.1295/polymj.35.148
   Coelho MJ, 2000, BIOMATERIALS, V21, P1087, DOI 10.1016/S0142-9612(99)00284-7
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Holmes P. A., 1988, DEV CRYSTALLINE POLY, P1
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   JIAN Y, 2002, BIOMATERIALS, V23, P2607
   Keller JC, 1997, DENT MATER, V13, P62, DOI 10.1016/S0109-5641(97)80010-3
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   Kramp B, 2002, LARYNGO RHINO OTOL, V81, P351, DOI 10.1055/s-2002-28343
   Kunze C, 2002, J MATER SCI-MATER M, V13, P1051, DOI 10.1023/A:1020392606225
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Ong J.L., 1998, J BIOMED MATER RES, V29, P389
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Yang T, 2002, BIOMOL ENG, V19, P1, DOI 10.1016/S1389-0344(02)00002-3
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   YANG XS, 2001, TSINGHUA J SCI TECHN, V6, P216
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Zanchetta P, 2001, COLLOID SURFACE B, V22, P301, DOI 10.1016/S0927-7765(01)00200-4
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 42
TC 147
Z9 158
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 4
BP 669
EP 675
DI 10.1016/S0142-9612(03)00561-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GB
UT WOS:000186853200012
PM 14607505
DA 2018-10-19
ER

PT J
AU Freyria, AM
   Cortial, D
   Ronziere, MC
   Guerret, S
   Herbage, D
AF Freyria, AM
   Cortial, D
   Ronziere, MC
   Guerret, S
   Herbage, D
TI Influence of medium composition, static and stirred conditions on the
   proliferation of and matrix protein expression of bovine articular
   chondrocytes cultured in a 3-D collagen scaffold
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; collagen-based biomaterial; cartilage repair;
   serum-free medium; ITS
ID GROWTH-FACTOR-I; SERUM-FREE CULTURE; CARTILAGE REPAIR; MECHANICAL
   COMPRESSION; EXTRACELLULAR-MATRIX; HYDROSTATIC-PRESSURE; ENGINEERED
   CARTILAGE; GENE-EXPRESSION; ALGINATE BEADS; IGF-I
AB Interest in chemical and physical modifications of culture conditions and composition, as a way to improve engineered cartilage, has grown over the last decade. To address some of these aspects, articular bovine chondrocytes seeded in collagen sponges (2.3 x 10(6) cells/cm(3), whose growth and metabolism have been previously reported) were grown under static or stirred conditions (orbital shaker at 30 rpm), in either 10% FCS-supplemented or serum-free media (1% ITS + 1 mm cysteine). Under stirred conditions, we observed a 2-fold increase in both cell proliferation and sulphated glycosaminoglycan deposition after 1 month of culture, compared to static conditions, and after 3 months, a more homogeneous distribution of both cells and neomatrix in the constructs. During the first month of culture, the substitution of FCS by ITS led to low cell proliferation and poor neomatrix deposition but, after 2 months a steep increase was observed with ITS for these two parameters that reached, after 3 months the levels observed with FCS. Aggrecan was the more abundant component at both gene and protein levels, whereas the collagenous network formed was looser than with FCS. In conclusion, the use of these simple Culture conditions should improve, in long-term culture, the quality of the cartilage construct. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon 7, France.
   IFR, F-69367 Lyon, France.
   Univ Lyon 1, Lab Biomat, EA 3090, F-69373 Lyon 08, France.
RP Freyria, AM (reprint author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, 128 Biosci Lyon Gerland,7 Passage Vercors, F-69367 Lyon 7, France.
CR Alini M, 1996, J BONE MINER RES, V11, P105
   An YH, 2001, ANAT REC, V263, P336, DOI 10.1002/ar.1114
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   Blain EJ, 2001, ARCH BIOCHEM BIOPHYS, V396, P49, DOI 10.1006/abbi.2001.2575
   BOHME K, 1992, J CELL BIOL, V116, P1035, DOI 10.1083/jcb.116.4.1035
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Boyan BD, 1999, CLIN PLAST SURG, V26, P629
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   BRUCKNER P, 1989, J CELL BIOL, V109, P2537, DOI 10.1083/jcb.109.5.2537
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Carver SE, 1999, TISSUE ENG, V5, P1, DOI 10.1089/ten.1999.5.1
   Chaipinyo K, 2002, J ORTHOPAED RES, V20, P1070, DOI 10.1016/S0736-0266(02)00025-6
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   DEHAART M, 1999, ACTA ORTHOP SCAND, V70, P5561
   Dell'Accio F, 2001, ARTHRITIS RHEUM, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T
   DEMARQUAY D, 1992, EXP CELL RES, V202, P412, DOI 10.1016/0014-4827(92)90094-O
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   DUKE PJ, 1993, J CELL BIOCHEM, V51, P274, DOI 10.1002/jcb.240510306
   DUNKELMAN NS, 1995, BIOTECHNOL BIOENG, V46, P299, DOI 10.1002/bit.260460402
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1999, CLIN ORTHOP S, V367, P46
   FRENKEL SR, 1999, FRONT BIOSCI, V4, P671
   Freyria Anne-Marie, 1999, Journal of Cellular Biochemistry, V76, P84
   Gooch KJ, 2001, BIOCHEM BIOPH RES CO, V286, P909, DOI 10.1006/bbrc.2001.5486
   Grande DA, 1999, CLIN ORTHOP RELAT R, pS176
   Guerret S, 2003, WOUND REPAIR REGEN, V11, P35, DOI 10.1046/j.1524-475X.2003.11107.x
   Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6
   Hardingham Tim, 2002, Arthritis Res, V4 Suppl 3, pS63, DOI 10.1186/ar561
   Heath CA, 1996, BIOTECHNOL BIOENG, V50, P430, DOI 10.1002/(SICI)1097-0290(19960520)50:4<430::AID-BIT10>3.0.CO;2-N
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ikenoue T, 2003, J ORTHOPAED RES, V21, P110, DOI 10.1016/S0736-0266(02)00091-8
   JIN G, 2000, J ORTHOPAED RES, V18, P889
   JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
   Kaps C, 2002, ARTHRITIS RHEUM, V46, P149, DOI 10.1002/1529-0131(200201)46:1<149::AID-ART10058>3.0.CO;2-W
   Kellner K, 2001, J DRUG TARGET, V9, P439, DOI 10.3109/10611860108998778
   KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Lee RB, 2002, BIORHEOLOGY, V39, P133
   Liu HX, 1998, BBA-GEN SUBJECTS, V1425, P505, DOI 10.1016/S0304-4165(98)00105-6
   Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988
   Loeser RF, 2000, ARTHRITIS RHEUM-US, V43, P1552, DOI 10.1002/1529-0131(200007)43:7<1552::AID-ANR20>3.0.CO;2-W
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Mizuno S, 2002, J CELL PHYSIOL, V193, P319, DOI 10.1002/jcp.10180
   Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V
   Nixon AJ, 2001, J ORTHOPAED RES, V19, P26, DOI 10.1016/S0736-0266(00)00013-9
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   PARKKINEN JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P458, DOI 10.1006/abbi.1993.1062
   Pazzano D, 2000, BIOTECHNOL PROGR, V16, P893, DOI 10.1021/bp000082v
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Quarto R, 1997, ENDOCRINOLOGY, V138, P4966, DOI 10.1210/en.138.11.4966
   Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343
   Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3
   Ronziere MC, 1997, OSTEOARTHR CARTILAGE, V5, P205, DOI 10.1016/S1063-4584(97)80015-5
   Ronziere MC, 2003, BIOMATERIALS, V24, P851, DOI 10.1016/S0142-9612(02)00418-0
   ROSSELOT G, 1992, IN VITRO CELL DEV-AN, V28A, P235
   SEYEDIN SM, 1991, CARTILAGE MOL ASPECT, P131
   Stewart MC, 2000, J BONE MINER RES, V15, P166, DOI 10.1359/jbmr.2000.15.1.166
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Toolan BC, 1996, J BIOMED MATER RES, V31, P273, DOI 10.1002/(SICI)1097-4636(199606)31:2<273::AID-JBM15>3.0.CO;2-M
   Trippel ST, 1992, BIOL REGULATION CHON, P161
   TSCHAN T, 1990, J CELL BIOL, V111, P257, DOI 10.1083/jcb.111.1.257
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   van Osch GJVM, 2001, PLAST RECONSTR SURG, V107, P433, DOI 10.1097/00006534-200102000-00020
   van Susante JLC, 2000, J ORTHOP RES, V18, P68, DOI 10.1002/jor.1100180111
   Venezian R, 1998, J CELL PHYSIOL, V174, P331
   Verbruggen G, 1995, OSTEOARTHR CARTILAGE, V3, P249, DOI 10.1016/S1063-4584(05)80016-0
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Wang CCB, 2002, BIORHEOLOGY, V39, P11
   Weisser J, 2001, OSTEOARTHR CARTILAGE, V9, pS48, DOI 10.1053/joca.2001.0444
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   Wright M, 1996, CLIN SCI, V90, P61, DOI 10.1042/cs0900061
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
NR 80
TC 46
Z9 46
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 4
BP 687
EP 697
DI 10.1016/S0142-9612(03)00568-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GB
UT WOS:000186853200014
PM 14607507
DA 2018-10-19
ER

PT J
AU Vrijhof, EJ
   de Bruine, A
   Nijeholt, AABLA
   Koole, LH
AF Vrijhof, EJ
   de Bruine, A
   Nijeholt, AABLA
   Koole, LH
TI A polymeric mini-stent designed to facilitate the vasectomy reversal
   operation. A rabbit model study
SO BIOMATERIALS
LA English
DT Article
DE vasectomy reversal; vasovasostomy; stent; hydrogel; NVP
ID INTRACYTOPLASMIC SPERM INJECTION; COST-BENEFIT-ANALYSIS; MICROSURGICAL
   VASOVASOSTOMY; WIRES
AB Vasectomy has become popular since it is the safest surgical method for contraception. It is known that approximately 6% of the men that undergo vasectomy will seek reversal (vasovasostomy). This operation is, however, technically demanding and relatively time-consuming. This study was based on the hypothesis that a polymeric mini-stent can facilitate and accelerate vasovasostomies. A mini-stent was manufactured out of a crosslinked hydrogel biomaterial, which was synthesized from N-vinyl-pyrrolidinone (NVP), n-butylmethacrylate, and (triethyleneglycol) dimethacrylate. The device was tested with 28 rabbits, which were divided over two equal groups. In one group, the vasa deferentia were dissected and reanastomosed via microsurgical one-layer technique (end-to-end group). In the other group, the vasa deferentia were dissected and reattached through implantation of the mini-stent. Sperm counts revealed 100% patency in both groups, i.e. all vasovasostomies were successful. It was experienced that the operation was easier and faster in the case of the mini-stent, probably since the mini-stent keeps the lumens of both vas ends exactly in line during suturing. This study demonstrates the feasibility of the mini-stent. Further work is necessary to evaluate the utility of this approach for clinical vasovasostomies. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   Catharina Hosp, Dept Urol, Eindhoven, Netherlands.
   Acad Hosp Maastricht, Dept Pathol, Maastricht, Netherlands.
   Leiden Univ, Med Ctr, Dept Urol, Leiden, Netherlands.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
CR Cox B, 2002, JAMA-J AM MED ASSOC, V287, P3110, DOI 10.1001/jama.287.23.3110
   Fischer MA, 2000, BJU INT, V85, P1085, DOI 10.1046/j.1464-410x.2000.00668.x
   Hanssen HHL, 1999, J BIOMED MATER RES, V48, P820, DOI 10.1002/(SICI)1097-4636(1999)48:6<820::AID-JBM9>3.0.CO;2-K
   Heidenreich A, 2000, UROLOGE A, V39, P240, DOI 10.1007/s001200050348
   Heidenreich A, 2000, EUR UROL, V37, P609, DOI 10.1159/000020201
   Hendrix N W, 1999, Obstet Gynecol Surv, V54, P766, DOI 10.1097/00006254-199912000-00005
   Holman CDJ, 2000, BJU INT, V86, P1043, DOI 10.1046/j.1464-410x.2000.00977.x
   HUANG JC, 2002, CHANG GUNG MED J, V25, P453
   Jokelainen OS, 2001, SCAND J UROL NEPHROL, V35, P132
   KAO F, 1997, J BIOMED MATER RES B, V34, P191
   Kolettis PN, 1997, J UROLOGY, V158, P467, DOI 10.1016/S0022-5347(01)64504-X
   Pavlovich CP, 1997, FERTIL STERIL, V67, P133, DOI 10.1016/S0015-0282(97)81870-5
   Peerlings CCL, 2002, J BIOMED MATER RES, V63, P692, DOI 10.1002/jbm.10381
   Rothman I, 1997, J UROLOGY, V157, P1697, DOI 10.1016/S0022-5347(01)64837-7
   Seaman EK, 1998, J CLIN LASER MED SUR, V16, P45, DOI 10.1089/clm.1998.16.45
   SILBER SJ, 1977, NEW ENGL J MED, V296, P886
   SILBER SJ, 1977, FERTIL STERIL, V28, P72
   SWINGL P, 2000, FERTIL STERIL, V73, P923
NR 18
TC 4
Z9 4
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 4
BP 729
EP 734
DI 10.1016/S0142-9612(03)00569-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GB
UT WOS:000186853200019
PM 14607512
DA 2018-10-19
ER

PT J
AU Declercq, H
   Van den Vreken, N
   De Maeyer, E
   Verbeeck, R
   Schacht, E
   De Ridder, L
   Cornelissen, M
AF Declercq, H
   Van den Vreken, N
   De Maeyer, E
   Verbeeck, R
   Schacht, E
   De Ridder, L
   Cornelissen, M
TI Isolation, proliferation and differentiation of osteoblastic cells to
   study cell/biomaterial interactions: comparison of different isolation
   techniques and source
SO BIOMATERIALS
LA English
DT Article
DE cell culture; cell proliferation; osteogenesis; osteoblast; alkaline
   phosphatase; calcification
ID RAT CALVARIA CELLS; IN-VITRO BIOCOMPATIBILITY; NODULES FORMED INVITRO;
   BONE-DERIVED CELLS; PHYSIOLOGICAL CONCENTRATIONS; ALKALINE-PHOSPHATASE;
   MINERALIZATION; PHENOTYPE; POLYMERS; HYDROXYAPATITE
AB A sufficient amount of easily obtained and well-characterized ostcoblastic cells is a useful tool to study biomaterial/cell interactions essential for bone tissue engineering. Osteoblastic cells were derived from adult and fetal rat via different isolation techniques. The isolation and in vitro proliferation of primary cultures were compared. The osteogenic potential of subcultures was studied by culturing them in osteogenic medium and compared with respect to alkaline phosphatase activity, nodule formation and mineralization potential. Calvaria cells were easier to obtain and the amount of cells released by enzymatic isolation was higher than for the long bone cells. The expansion of the cells in primary culture was highest for fetal calvaria cells compared to fetal and adult long bone cells. All cultures expressed high alkaline phosphatase activity except for calvaria cells obtained by spontaneous outgrowth. Enzymatic isolation of fetal calvaria and long bone cells favoured the osteogenic differentiation. Enzymatically isolated calvaria cells formed well-defined three-dimensional nodules which mineralized restricted to this area. On the contrary, cultures derived from fetal as well as adult long bones mineralized in ill-defined deposits throughout the culture and only formed occasionally nodular-like structures. The mineral phase of all osteoblastic cultures was identified as a carbonate-containing apatite. The present study demonstrates that considering the isolation method, proliferation capacity and the osteogenic potential, the enzymatically released fetal calvaria cells are most satisfactory to study cell/biomaterial interactions. (C) 2003 Elsevier Ltd. All rights reserved.
C1 State Univ Ghent, Dept Anat Embryol Histol & Med Phys, B-9000 Ghent, Belgium.
   State Univ Ghent, Dept Dent Mat Sci, B-9000 Ghent, Belgium.
   FSR, Flanders, Belgium.
   State Univ Ghent, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
RP Cornelissen, M (reprint author), State Univ Ghent, Dept Anat Embryol Histol & Med Phys, Louis Pasteurlaan 2, B-9000 Ghent, Belgium.
OI Van den Vreken, Natasja/0000-0003-4656-6037
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   AUBIN JE, 1998, MARROW STROMAL CELL
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K
   BELLOWS CG, 1991, BONE MINER, V14, P27, DOI 10.1016/0169-6009(91)90100-E
   BELLOWS CG, 1987, ENDOCRINOLOGY, V121, P1985, DOI 10.1210/endo-121-6-1985
   BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205
   BOCK P, 1984, SEMIDUNNSCHNITT, P98
   Coelho MJ, 2000, BIOMATERIALS, V21, P1087, DOI 10.1016/S0142-9612(99)00284-7
   Driessens FCM, 1990, BIOMINERALS
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FRESHNEY RI, CULTURE ANIMAL CELLS, P273
   Furuya K, 1999, J CELL BIOCHEM, V72, P177, DOI 10.1002/(SICI)1097-4644(19990201)72:2<177::AID-JCB2>3.0.CO;2-#
   GUNDLE G, 1998, MARROW STROMAL CELL
   HALSTEAD LR, 1992, CALCIFIED TISSUE INT, V50, P93, DOI 10.1007/BF00297304
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   ISHIDA H, 1993, ENDOCRINOLOGY, V132, P61, DOI 10.1210/en.132.1.61
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   Malaval L, 1999, J CELL BIOCHEM, V74, P616
   Manduca P, 1997, BONE, V21, P31, DOI 10.1016/S8756-3282(97)00037-9
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   MILLHORN DE, 1988, NEWS PHYSIOL SCI, V3, P1
   Moreau MF, 1998, J BIOMED MATER RES, V40, P124, DOI 10.1002/(SICI)1097-4636(199804)40:1<124::AID-JBM14>3.0.CO;2-O
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   Pieters IY, 1998, INORG CHEM, V37, P6392, DOI 10.1021/ic9802810
   RIFAS L, 1989, J BONE MINER RES, V4, pS409
   Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.3.CO;2-Y
   STRINGA E, 1995, BONE, V16, P663, DOI 10.1016/8756-3282(95)00100-R
   Voegele TJ, 2000, ANTICANCER RES, V20, P3575
   WONG MM, 1990, J BONE MINER RES, V5, P803
NR 31
TC 127
Z9 142
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 5
BP 757
EP 768
DI 10.1016/S0142-9612(03)00580-5
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GD
UT WOS:000186853400001
PM 14609664
DA 2018-10-19
ER

PT J
AU Bujan, J
   Garcia-Honduvilla, N
   Bellon, JM
AF Bujan, J
   Garcia-Honduvilla, N
   Bellon, JM
TI Engineering conduits to resemble natural vascular tissue
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Review
DE endothelial-cell seeding; expanded polytetrafluoroethylene (ePTFE);
   scaffold; tissue engineering; vascular prostheses
ID IN-VITRO ENDOTHELIALIZATION; DACRON ARTERIAL GRAFTS; MARROW STROMAL
   CELLS; EXPANDED POLYTETRAFLUOROETHYLENE; INTIMAL HYPERPLASIA; PROSTHETIC
   GRAFTS; PULMONARY-ARTERY; EPTFE GRAFTS; PLATELET-AGGREGATION;
   CLINICAL-EXPERIENCE
AB Research on the use of biomaterials as vascular substitutes has been dominated in the past by studies focusing on the properties of the materials used. These need to be resistant to protein absorption and should allow cell colonization and integration of the biomaterial within recipient tissue. Despite promising perspectives related both to the appearance of new synthetic materials with biomedical applications and to developments in arterial replacement techniques, there are still many unresolved problems. These include the appearance of occlusive phenomena when using medium- or small-calibre arterial substitutes, and the lack of growth and adaptability of the biomaterial to changes in the host. Notwithstanding, the tissue-engineering techniques developed in recent decades have vastly improved prosthetic behaviour at the blood/ biomaterial interface. There is also no doubt that developments in engineered arterial grafts made of natural biomaterials colonized with cells harvested from the recipient patient are drawing us closer and closer to achieving the living graft.
C1 Univ Alcala de Henares, Fac Med, Dept Med Specialties, Madrid, Spain.
   Univ Alcala de Henares, Fac Med, Dept Surg, Madrid, Spain.
RP Bujan, J (reprint author), Univ Alcala de Henares, Fac Med, Dept Med Specialties, Madrid, Spain.
EM mjulia.bujan@uah.es
OI BELLON, JUAN M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476;
   Garcia Honduvilla, Natalio/0000-0003-0904-6198
CR AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   ALLEN BT, 1984, J VASC SURG, V1, P224, DOI 10.1067/mva.1984.avs0010224
   Almeida JI, 1998, J VASC SURG, V27, P896, DOI 10.1016/S0741-5214(98)70270-8
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Arts CHP, 2002, EUR J VASC ENDOVASC, V23, P29, DOI 10.1053/ejvs.2001.1532
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Bader A, 2000, TRANSPLANTATION, V70, P7
   BADYLAK SF, 1998, BIOMATER SCI POLYM E, V8, P863
   BARRENA EG, 2000, BIOMATERIALS AQUI AH, P31
   Bellon J M, 1993, Ann Vasc Surg, V7, P549, DOI 10.1007/BF02000149
   Bellon JM, 1997, EUR J VASC ENDOVASC, V13, P142, DOI 10.1016/S1078-5884(97)80010-X
   BELLON JM, 1992, CIR ESPAN, V51, P25
   BENGTSSON LA, 1995, ANN THORAC SURG, V60, pS365, DOI 10.1016/0003-4975(95)00316-D
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Bos GW, 1999, THROMB HAEMOSTASIS, V82, P1757
   Brockbank KGM, 2000, TRANSPLANT P, V32, P3, DOI 10.1016/S0041-1345(99)00851-9
   Bujan J, 1998, J BIOMED MATER RES, V39, P32, DOI 10.1002/(SICI)1097-4636(199801)39:1<32::AID-JBM5>3.0.CO;2-J
   BUJAN J, 1999, PATOL VASC, V5, P9
   BUJAN J, 1997, ANGIOLOGIA, V3, P111
   CAMPBELL LB, 1988, EUR J VASCULAR SURG, V2, P365
   Chakfe N, 2003, EUR J VASC ENDOVASC, V25, P360, DOI 10.1053/ejvs.2002.1790
   CIMA LG, 1993, CHEM ENG PROG    JUN, P46
   Clarke DR, 2001, ANN THORAC SURG, V71, pS433, DOI 10.1016/S0003-4975(01)02556-5
   Coito A J, 1996, Ann Transplant, V1, P14
   Coito A J, 2000, Dev Immunol, V7, P239, DOI 10.1155/2000/98187
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   COURTMAN DW, 1999, P SOC BIOM 25 ANN M
   Curtil A, 1997, J HEART VALVE DIS, V6, P296
   CURTIS ASG, 1984, J CELLS CI, V86, P9
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   Dardik H, 1999, Semin Vasc Surg, V12, P1
   DEBAKEY ME, 1964, ARCH SURG-CHICAGO, V89, P757
   Falkenback D, 2000, EUR J VASC ENDOVASC, V19, P468, DOI 10.1053/ejvs.1999.1075
   Fauza DO, 2001, J PEDIATR SURG, V36, P146, DOI 10.1053/jpsu.2001.20034
   FLETCHER JP, 1990, AUST NZ J SURG, V60, P801, DOI 10.1111/j.1445-2197.1990.tb07477.x
   GALLARDO A, 2000, BIOMATERIALS AQUI AH, P45
   GARCIAHONDUVILL.N, 2002, ANGIOLOGIA, V54, P270
   GARCIAHONDUVILL.N, 1995, ARTIF ORGANS, V19, P144
   GARCIAHONDUVILL.N, 2000, PATOL VASC, V6, P203
   GIMBRONE MA, 1976, PROG HEMOST THROMB, V31, P1
   Goissis G, 2000, ARTIF ORGANS, V24, P217, DOI 10.1046/j.1525-1594.2000.06537.x
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   GRAHAM L, 1987, ENDOTHELIALISATION V, P57
   GRAHAM LM, 1991, J BIOMED MATER RES, V25, P525, DOI 10.1002/jbm.820250409
   GRAHAM LM, 1982, SURGERY, V91, P550
   GREISLER HP, 1990, ARCH SURG-CHICAGO, V125, P1622
   HARRISON JH, 1958, AM J SURG, V95, P3, DOI 10.1016/0002-9610(58)90735-9
   Hazama K, 1999, J SURG RES, V81, P174, DOI 10.1006/jsre.1998.5497
   Hernandez D.J., 1994, SOCIAL POLICY REPORT, V8, P1
   HERNANDO A, 1995, EUR J VASC ENDOVASC, V10, P387, DOI 10.1016/S1078-5884(05)80077-2
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1994, J VASC SURG, V20, P650, DOI 10.1016/0741-5214(94)90291-7
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUBBELL JA, 1995, CHEM ENG NEWS   0313, P42
   HUSSAIN S, 1989, J VASC SURG, V9, P656, DOI 10.1067/mva.1989.vs0090656
   IMANISHI Y, 1988, J MACROMOL SCI CHEM, VA25, P555, DOI 10.1080/00222338808053384
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kadner A, 2002, EUR J CARDIO-THORAC, V21, P1055, DOI 10.1016/S1010-7940(02)00079-9
   Kao WYJ, 2000, BIOMATERIALS, V21, P2295, DOI 10.1016/S0142-9612(00)00156-3
   KATZ MH, 1991, J AM ACAD DERMATOL, V25, P1054, DOI 10.1016/0190-9622(91)70306-M
   Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945
   Kaviani A, 2002, J PEDIATR SURG, V37, P995, DOI 10.1053/jpsu.2002.33828
   KEMPCZINSKI RF, 1985, J VASC SURG, V2, P424, DOI 10.1067/mva.1985.avs0020424
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KIRKPATRICK CJ, 1990, PATHOBIOLOGY, V58, P221
   KRIJGSMAN B, 1995, EUR J VASC ENDOVASC, V10, P387, DOI 10.1016/S1078-5884(05)80076-0
   LALKA SG, 1989, ANN VASC SURG, V3, P187
   Lamm P, 1999, J THORAC CARDIOV SUR, V117, P1217, DOI 10.1016/S0022-5223(99)70264-3
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040
   Liechty KW, 2000, NAT MED, V6, P1282
   LIVESEY S, 1999, MAT RES SOC S P SER, V530
   LOGERFO FW, 1983, ANN SURG, V197, P479, DOI 10.1097/00000658-198304000-00018
   MACKENZIE DC, 1960, BRIT J SURG, V48, P212, DOI 10.1002/bjs.18004820827
   Madden R, 2002, AM J KIDNEY DIS, V40, P1240, DOI 10.1053/ajkd.2002.36892
   MALONE JM, 1984, J VASC SURG, V1, P181, DOI 10.1067/mva.1984.avs0010181
   MANSFIELD P B, 1970, Review of Surgery, V27, P291
   Marois Y, 1999, ASAIO J, V45, P272, DOI 10.1097/00002480-199907000-00005
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mikucki S A, 1999, Semin Vasc Surg, V12, P18
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niu S, 1991, ASAIO Trans, V37, pM441
   Noishiki Y, 1989, ASAIO Trans, V35, P267, DOI 10.1097/00002480-198907000-00030
   NUWAYSER ES, 1973, ASAIO T, V19, P168
   OBLATH RW, 1978, SURGERY, V84, P37
   PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0
   Park JC, 2001, YONSEI MED J, V42, P304, DOI 10.3349/ymj.2001.42.3.304
   PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242
   Pascual G, 2002, EUR J VASC ENDOVASC, V24, P23, DOI 10.1053/ejvs.2002.1663
   Patterson R B, 1989, Ann Vasc Surg, V3, P160, DOI 10.1016/S0890-5096(06)62010-4
   Phaneuf MD, 2001, BIOMATERIALS, V22, P463, DOI 10.1016/S0142-9612(00)00202-7
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PREVEL CD, 1994, MICROSURG, V15, P586, DOI 10.1002/micr.1920150812
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   RAMALANJAONA GR, 1986, J SURG RES, V41, P479, DOI 10.1016/0022-4804(86)90165-4
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SanRoman J, 1996, J BIOMED MATER RES, V32, P19, DOI 10.1002/(SICI)1097-4636(199609)32:1<19::AID-JBM3>3.0.CO;2-S
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHMITZRIXEN T, 1988, J VASC SURG, V7, P82, DOI 10.1067/mva.1988.avs0070082
   SCHNEIDER PA, 1989, J VASC SURG, V23, P183
   SEEGER JM, 1988, J VASC SURG, V8, P476
   SHAREFKIN JB, 1982, SURGERY, V92, P385
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Siegel G, 2001, BIOSENS BIOELECTRON, V16, P895, DOI 10.1016/S0956-5663(01)00235-4
   SOYER T, 1972, SURGERY, V72, P864
   Sparks SR, 2002, ANN VASC SURG, V16, P73, DOI 10.1007/s10016-001-0133-5
   STANSBY G, 1994, CARDIOVASC SURG, V2, P254
   STERPETTI AV, 1988, J VASC SURG, V7, P677, DOI 10.1067/mva.1988.avs0070677
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   SZILAGYI DE, 1982, J CARDIOVASC SURG, V23, P183
   Takasaki K., 1989, REV MATH PHYS, V1, P1
   Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Thomson JJ, 1900, PHYS Z, V1, P20
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Tsukagoshi T, 1999, J RECONSTR MICROSURG, V15, P127, DOI 10.1055/s-2007-1000083
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   VANDERLEI B, 1991, INT ANGIOL, V10, P202
   VANHINSBERGH VWM, 1990, BLOOD, V75, P1490
   Vinard E, 1999, ANN VASC SURG, V13, P141, DOI 10.1007/s100169900232
   Vohra R K, 1990, Eur J Vasc Surg, V4, P33, DOI 10.1016/S0950-821X(05)80036-2
   VOHRA RK, 1990, ARTIF ORGANS, V14, P41
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   Walles T, 2003, INT J ARTIF ORGANS, V26, P225
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
   Wilson G J, 1993, ASAIO J, V39, pM526
   WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Zdrahala RJ, 1996, J BIOMATER APPL, V10, P309, DOI 10.1177/088532829601000402
NR 143
TC 25
Z9 26
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD FEB
PY 2004
VL 39
BP 17
EP 27
DI 10.1042/BA20030111
PN 1
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 773MH
UT WOS:000188927200003
PM 14535843
DA 2018-10-19
ER

PT J
AU Choi, SB
   Yun, YS
AF Choi, SB
   Yun, YS
TI Lead biosorption by waste biomass of Corynebacterium glutamicum
   generated from lysine fermentation process
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE biosorption; Corynebacterium glutamicum; fermentation wastes; lead;
   lysine
ID MARINE-ALGAE; HEAVY-METALS; AQUEOUS-SOLUTIONS; CADMIUM; COPPER
AB Biomass waste, mainly Corynebacterium glutamicum, is generated from large-scale lysine fermentation process. In this study, protonated C. glutamicum biomass was evaluated as a biosorbent for the removal of lead from synthetic wastewater. As Pb2+ were bound to the biomass, the solution pH deceased, indicating that protons in the biomass were exchanged with lead ions. The Corynebacterium biomass bound Pb2+ at up to 2.74 mmol g(-1) at pH 5, where lead does not precipitate. Compared with other biosorbents and conventional sorbents, such as natural zeolite, activated carbon and synthetic ion exchange resin, the protonated C. glutamicum biomass was considered to be a useful biomaterial for lead biosorption.
C1 Chonbuk Natl Univ, Div Environm & Chem Engn, Chonju 561756, Chonbuk, South Korea.
   Chonbuk Natl Univ, Res Inst Ind Technol, Chonju 561756, Chonbuk, South Korea.
RP Yun, YS (reprint author), Chonbuk Natl Univ, Div Environm & Chem Engn, Chonju 561756, Chonbuk, South Korea.
EM ysyun@chonbuk.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278
CR Ariff A.B., 1999, WORLD J MICROB BIOT, V15, P292
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Berner EK, 1987, GLOBAL WATER CYCLE G
   Chang JS, 1997, WATER RES, V31, P1651, DOI 10.1016/S0043-1354(97)00008-0
   EVANGELOU VP, 1998, ENV SOIL WATER CHEM, P476
   Jalali R, 2002, J HAZARD MATER, V92, P253, DOI 10.1016/S0304-3894(02)00021-3
   JEON C, 2002, THESIS SEOUL NATL U
   Kapoor A, 1998, BIORESOURCE TECHNOL, V63, P109, DOI 10.1016/S0960-8524(97)00118-1
   Kuyucak N., 1990, BIOSORPTION HEAVY ME, P371
   Lo WH, 1999, CHEMOSPHERE, V39, P2723, DOI 10.1016/S0045-6535(99)00206-4
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   Matheickal JT, 1996, WATER SCI TECHNOL, V34, P1, DOI 10.1016/S0273-1223(96)00780-9
   MATHEICKAL JT, 1996, P 10 NATL CONV ROYAL
   MATTUSCHKA B, 1993, J CHEM TECHNOL BIOT, V58, P57
   MURALEEDHARAN TR, 1995, APPL ENVIRON MICROB, V61, P3507
   Pagnanelli F, 2003, WATER RES, V37, P627, DOI 10.1016/S0043-1354(02)00358-5
   SCHECHER WD, 1991, MINEQL CHEM EQUILIBR
   Veglio F, 1997, PROCESS BIOCHEM, V32, P99, DOI 10.1016/S0032-9592(96)00047-7
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1111/j.1574-6976.1994.tb00102.x
   Volesky B, 1990, BIOSORPTION HEAVY ME, P7
   Yun YS, 2003, ENVIRON SCI TECHNOL, V37, P3601, DOI 10.1021/es011454e
   Yun YS, 2001, ENVIRON SCI TECHNOL, V35, P4353, DOI 10.1021/es010866k
   YUN YS, 2001, BIOHYDROMETALLURGY B, P181
NR 24
TC 29
Z9 36
U1 1
U2 7
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD FEB
PY 2004
VL 26
IS 4
BP 331
EP 336
DI 10.1023/B:BILE.0000015453.20708.fc
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 772QM
UT WOS:000188852800013
PM 15055771
DA 2018-10-19
ER

PT J
AU Ewers, R
   Goriwoda, W
   Schopper, C
   Moser, D
   Spassova, E
AF Ewers, R
   Goriwoda, W
   Schopper, C
   Moser, D
   Spassova, E
TI Histologic findings at augmented bone areas supplied with two different
   bone substitute materials combined with sinus floor lifting - Report of
   one case
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE hydroxyapatite; resorption; Bio-Oss (R); Algipore (R); sinus
   augmentation; bioceramic
ID ANORGANIC BOVINE BONE; MAXILLARY SINUS; AUTOGENOUS BONE; IMPLANTS;
   HUMANS; DOGS
AB This case report is focused on the histologic findings of bone tissue supplied with two different hydroxyapatites (HAs) used for maxillary sinus floor grafting in the same patient after various healing intervals. An insufficient unilateral sinus floor grafting with Bio-Oss(R) biomaterial was followed by an additional grafting procedure with Algipore(R) biomaterial performed 4 years later. Bone samples obtained during second-stage dental implantation contained the interesting combination of Bio-Oss(R), a bovine anorganic bone substitute, and Algipore(R), a porous algae-derived HA, in close vicinity, yet after different healing periods. Light microscopy exhibited satisfactory osseointegration of both grafting materials. However, Bio-Oss(R) biomaterial showed no evidence of substantial remodeling after a healing period of 4.5 years. On the other hand, Algipore(R) particles demonstrated signs of remodeling by being locally resorbed and partially replaced with newly formed bone already within 6 months.
C1 Univ Vienna, Sch Med, Univ Hosp Craniomaxillofacial & Oral Surg, A-1090 Vienna, Austria.
   CMF Inst Craniomaxillofacial & Oral Rehabil, Vienna, Austria.
RP Ewers, R (reprint author), Univ Vienna, Sch Med, Univ Hosp Craniomaxillofacial & Oral Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
EM rolf.ewers@akh-wien.ac.at
CR BOYNE PJ, 1980, J ORAL SURG, V38, P613
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ewers R, 1987, Zahnarztl Prax, V38, P318
   Ewers R, 1992, BIOMATERIALS HARD TI, P67
   EWERS R, 1998, J CRANIO MAXILLOF S1, V2, P46
   Groeneveld EHJ, 1999, CLIN ORAL IMPLAN RES, V10, P499, DOI 10.1034/j.1600-0501.1999.100608.x
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P117, DOI 10.1034/j.1600-0501.1998.090207.x
   HAUPTNER R, 1990, STOMATOLOGIE, V87, P535
   Honig JF, 1999, PLAST RECONSTR SURG, V103, P1324
   HONIG JF, 2000, PLASTIC RECONSTRUCTI, V105, P2273
   Hurzeler M B, 1996, Int J Oral Maxillofac Implants, V11, P466
   HURZELER MB, 1994, J ORAL REHABIL, V21, P373, DOI 10.1111/j.1365-2842.1994.tb01152.x
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Kasperk C, 1986, Z ZAHNARZTL IMPLANTO, V2, P242
   Kubler N R, 1997, Mund Kiefer Gesichtschir, V1, P2
   LEONARDIS D, 1999, INT J ORAL MAXILLOF, V14, P869
   McAllister BS, 1999, INT J ORAL MAX IMPL, V14, P361
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Schlegel A K, 1996, Schweiz Monatsschr Zahnmed, V106, P141
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   SCHOPPER C, 1998, J CRANIO MAXILLOF S1, V26, P172
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Terheyden H, 1997, Mund Kiefer Gesichtschir, V1, P272
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Young C, 1999, INT J ORAL MAX IMPL, V14, P72
NR 29
TC 59
Z9 60
U1 0
U2 5
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2004
VL 15
IS 1
BP 96
EP 100
DI 10.1111/j.1600-0501.2004.00987.x
PG 5
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 765VV
UT WOS:000188305800012
PM 14731182
DA 2018-10-19
ER

PT J
AU Ohtake, S
   Schebor, C
   Palecek, SP
   de Pablo, JJ
AF Ohtake, S
   Schebor, C
   Palecek, SP
   de Pablo, JJ
TI Effect of sugar-phosphate mixtures on the stability of DPPC membranes in
   dehydrated systems
SO CRYOBIOLOGY
LA English
DT Article
DE glass transition; glasses; vacuum-drying; lipids; trehalose; sucrose
ID POLYMER-ION SOLUTIONS; LACTOBACILLUS-ACIDOPHILUS; BIOMATERIAL
   STABILIZATION; PHOSPHOLIPID-BILAYERS; AMORPHOUS MATRICES;
   THERMAL-STABILITY; COMPLEX-FORMATION; GLASS-TRANSITION; TREHALOSE;
   SUCROSE
AB The stabilizing role of sugars on dehydrated membranes is well established. The formation of a glassy matrix and the direct interaction between the sugars and the lipids are some of the mechanisms proposed to be involved in this stabilizing effect. Phospholipidic systems have been studied extensively as models for biological membranes and also due to the practical applications of liposomes as vehicles for drug delivery. In this work, we evaluate the effect of sugar-phosphate mixtures on the transition temperature of dehydrated 1,2-dipalmitoylphosphatidylcholine, and also examine some physical characteristics of these mixtures, such as the glass transition temperature and water sorption properties. The addition of phosphate salts to sugar systems has several interesting features that merit its consideration in formulations to protect dehydrated labile biomaterials. In particular, sucrose-phosphate mixtures provide an interesting alternative to pure saccharide formulations due to their high glass transition temperatures and their increased ability to maintain a low melting transition temperature in the presence of small amounts of water. (C) 2004 Published by Elsevier Inc.
C1 Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.
   Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
RP de Pablo, JJ (reprint author), Univ Wisconsin, Dept Biol & Chem Engn, 1415 Engn Dr, Madison, WI 53706 USA.
EM depablo@engr.wisc.edu
CR CAFFREY M, 1988, PLANT PHYSIOL, V86, P754, DOI 10.1104/pp.86.3.754
   Cardona S, 1997, J FOOD SCI, V62, P105, DOI 10.1111/j.1365-2621.1997.tb04378.x
   CARPENTER JF, 1987, BIOCHIM BIOPHYS ACTA, V923, P109, DOI 10.1016/0304-4165(87)90133-4
   Conrad PB, 2000, CRYOBIOLOGY, V41, P17, DOI 10.1006/cryo.2000.2260
   CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701
   CROWE JH, 1987, BIOCHEM J, V242, P1
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   CROWE JH, 1992, LIPOSOME TECHNOLOGY
   Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9
   CROWE LM, 1986, BIOCHIM BIOPHYS ACTA, V861, P131, DOI 10.1016/0005-2736(86)90411-6
   CROWE LM, 1988, BIOCHIM BIOPHYS ACTA, V946, P193, DOI 10.1016/0005-2736(88)90392-6
   Ekdawi-Sever N, 2003, J FOOD SCI, V68, P2504, DOI 10.1111/j.1365-2621.2003.tb07052.x
   ENGELSEN SB, 1995, J PHYS CHEM-US, V99, P13334, DOI 10.1021/j100036a005
   GENNIS RB, 1989, BIOMEMBRANES MOL STR
   GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011
   Hancock BC, 1997, J PHARM SCI, V86, P1, DOI 10.1021/js9601896
   Koster KL, 2000, BIOPHYS J, V78, P1932, DOI 10.1016/S0006-3495(00)76741-5
   Kostka K., 1994, European Journal of Pharmaceutical Sciences, V2, P143, DOI 10.1016/0928-0987(94)90271-2
   LEE JC, 1981, J BIOL CHEM, V256, P7193
   LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   MacFarlane DR, 2002, CRYOBIOLOGY, V45, P188, DOI 10.1016/S0011-2240(02)00127-X
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   Mazzobre MF, 1997, BIOTECHNOL PROGR, V13, P195, DOI 10.1021/bp9700014
   Miller DP, 1999, J PHYS CHEM B, V103, P10243, DOI 10.1021/jp984736i
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   Moreira T, 1998, CRYO-LETT, V19, P115
   MURAKAMI R, 1992, POLYMER, V33, P1108, DOI 10.1016/0032-3861(92)90032-R
   Nagase H, 1997, BBA-BIOMEMBRANES, V1328, P197, DOI 10.1016/S0005-2736(97)00088-6
   PEZRON E, 1989, MACROMOLECULES, V22, P2656, DOI 10.1021/ma00196a021
   PEZRON E, 1989, MACROMOLECULES, V22, P1169, DOI 10.1021/ma00193a030
   Rossi S, 1997, BIOTECHNOL PROGR, V13, P609, DOI 10.1021/bp970061+
   RUMSEY SC, 1992, J LIPID RES, V33, P1551
   Schebor C, 1997, BIOTECHNOL PROGR, V13, P857, DOI 10.1021/bp970093x
   STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551
   Sum AK, 2003, BIOPHYS J, V85, P2830, DOI 10.1016/S0006-3495(03)74706-7
   Sun WQ, 1996, BIOPHYS J, V70, P1769, DOI 10.1016/S0006-3495(96)79740-0
   Zhang J., 1996, CRYOBIOLOGY, V33, p21A
NR 39
TC 31
Z9 31
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD FEB
PY 2004
VL 48
IS 1
BP 81
EP 89
DI 10.1016/j.cryobiol.2004.01.001
PG 9
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 812HR
UT WOS:000220831100009
PM 14969685
DA 2018-10-19
ER

PT J
AU Richmond, R
   Macfarlane, TV
   McCord, JF
AF Richmond, R
   Macfarlane, TV
   McCord, JF
TI An evalution of the surface changes in PMMA biomaterial formulations as
   a result of toothbrush/dentifrice abrasion
SO DENTAL MATERIALS
LA English
DT Article
DE poly(methylmethacrylate); abrasion; injection-molded; surface roughness
ID DENTURE BASE MATERIALS; ACRYLIC RESIN; CLEANERS
AB Objectives. The objective of this study was to evaluate the abrasion resistance and surface roughness of two injection-molded poly(methylmethacrylate) denture base materials (SR-Ivocap 'Plus', Ipsyl 60 RV), and also one compression- molded material (Trevalon). A fourth group of specimens (prepared from Trevalon using the injection-molding procedure) was compared to the compression-molded specimens.
   Methods. Ten specimens were prepared according to manufacturers' instructions. An experiment involving toothbrush and dentifrice abrasion was performed on all specimens from each of the materials and the cumulative percentage weight-loss was calculated after 100,000 brushstrokes. A series of surface roughness profile measurements were also obtained from each specimen within the groups. The data were analysed by using the Kolmogorov-Smirnov test. A level of significance of 0.017 was set in order to adjust for multiple comparisons between the three sets of materials.
   Results. There was found to be no statistically significant difference between the three groups of materials in terms of percentage weight-loss, and no statistically significant difference between the Trevalon specimens when injection-molded or compression-molded. In terms of surface roughness, however, SR-Ivocap 'Plus' recorded the Lowest surface roughness profile of the three groups. It was found that there was a statistically significant difference (P < 0.017) between this material and Ipsyl RV 60 (producing the highest roughness), and compression-molded Trevalon. Furthermore, there was found to be no statistically significant difference between injection-molded and compression-molded specimens of Trevalon with regard to surface texture.
   Significance. From a clinical standpoint, the surface roughness results suggest SR-Ivocap 'Plus' to be the material most likely to produce the least suitable substrate for the accumulation of denture plaque. (C) 2003 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 Univ Dent Hosp Manchester, Manchester M15 6FH, Lancs, England.
RP Richmond, R (reprint author), Univ Dent Hosp Manchester, Higher Cambridge St, Manchester M15 6FH, Lancs, England.
EM mdtmszrr@den.scg.man.ac.uk
OI Macfarlane, Tatiana/0000-0002-9392-0812
CR Anusavice KJ, 1996, PHILLIPS SCI DENT MA
   BLACOW NW, 1972, MARTINDALE EXTRA PHA, P180
   BUDTZJORGENSEN E, 1979, J PROSTHET DENT, V42, P619, DOI 10.1016/0022-3913(79)90190-2
   DILLS SS, 1988, J PROSTHET DENT, V60, P467, DOI 10.1016/0022-3913(88)90250-8
   Dixon DL, 1999, J PROSTHET DENT, V81, P207, DOI 10.1016/S0022-3913(99)70250-7
   Grant A. A., 1994, COMPLETE PROSTHODONT
   GUVARA PA, 1977, J DENT RES, V56, pB237
   Harrison A, 1997, Prim Dent Care, V4, P21
   HARRISON A, 1984, DENT ADVER, V39, P8
   HEATH JR, 1983, J ORAL REHABIL, V10, P159, DOI 10.1111/j.1365-2842.1983.tb00110.x
   Hutchings I. M., 1992, TRIBOLOGY FRICTION W
   Keng S B, 1996, Quintessence Int, V27, P341
   MURPHY WM, 1982, J ORAL REHABIL, V9, P401, DOI 10.1111/j.1365-2842.1982.tb01029.x
   MURPHY WM, 1982, BRIT DENT J, V152, P273, DOI 10.1038/sj.bdj.4804796
   Nikawa H, 1995, Int J Prosthodont, V8, P527
   Radford DR, 1997, J PROSTHET DENT, V78, P200, DOI 10.1016/S0022-3913(97)70126-4
   RICHMOND R, 1999, THESIS U MANCHESTER
   Sander M., 1991, PRACTICAL GUIDE ASSE
   SEXTON JC, 1951, J PROSTHET DENT, V1, P454
   SIEGEL S, 1988, JOH NONPARAMETRIC ST
   Unlu A, 1996, INT J PROSTHODONT, V9, P266
NR 21
TC 21
Z9 25
U1 3
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD FEB
PY 2004
VL 20
IS 2
BP 124
EP 132
DI 10.1016/S0109-5641(03)00083-6
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 779CN
UT WOS:000189278200003
PM 14706795
DA 2018-10-19
ER

PT J
AU Kim, BS
   Yoo, JJ
   Atala, A
AF Kim, BS
   Yoo, JJ
   Atala, A
TI Peripheral nerve regeneration using acellular nerve grafts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE peripheral nerve; nerve regeneration; acellular collagen matrix; growth
   factors; neural function
ID SMALL-INTESTINAL SUBMUCOSA; ENDOTHELIAL GROWTH-FACTOR; RAT
   SCIATIC-NERVE; VEIN GRAFT; IN-VITRO; NEUROTROPHIC FACTOR; BASAL LAMINA;
   TISSUE; REPAIR; CELLS
AB Long gap peripheral nerve injuries usually require a graft to facilitate axonal regeneration into the distal nerve stump. The use of autografts is often limited because of graft availability and donor-site morbidity. We investigated whether acellular nerve allografts would provide an appropriate channel for the promotion and induction of sciatic nerve regeneration in rats. Axons sprouted from the proximal portion and reached the distal portion in the 1 cm-long grafts by 1 month. The number of axons in the regenerated nerves was similar to that of normal nerves at 1 month. Loading the grafts with betaNGF and VEGF increased the number and mean diameter of axons and neovascularization in the regenerated nerves at I month. The motor conduction velocity increased over time and reached 63 +/- 10% of that of normal nerves at 6 months. The nerve injuries treated with the acellular grafts had a significant improvement in motor, nociception, and proprioception function compared to untreated nerves. The results from this study suggest that acellular nerve allografts may be a useful biomaterial for functional peripheral nerve regeneration. (C) 2003 Wiley Periodicals, Inc.
C1 Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
RP Atala, A (reprint author), Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, 300 Longwood Ave, Boston, MA 02115 USA.
EM a.atala@tch.harvard.edu
RI Kim, Byung-Soo/O-2352-2013
OI Atala, Anthony/0000-0001-8186-2160
CR Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Bryan DJ, 2000, TISSUE ENG, V6, P129, DOI 10.1089/107632700320757
   Chamberlain LJ, 1998, BIOMATERIALS, V19, P1393, DOI 10.1016/S0142-9612(98)00018-0
   CHIU DTW, 1982, SURGERY, V91, P226
   CORDEIRO PG, 1989, PLAST RECONSTR SURG, V83, P1013, DOI 10.1097/00006534-198906000-00014
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   DERBY A, 1993, EXP NEUROL, V119, P176, DOI 10.1006/exnr.1993.1019
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   EVANS PJ, 1994, PROG NEUROBIOL, V43, P187, DOI 10.1016/0301-0082(94)90001-9
   FAWCETT JW, 1986, J NEUROSURG, V65, P354, DOI 10.3171/jns.1986.65.3.0354
   FIELDS RD, 1986, EXP NEUROL, V92, P48, DOI 10.1016/0014-4886(86)90124-X
   Fujimoto E, 1997, J NEUROCYTOL, V26, P511, DOI 10.1023/A:1015410023132
   GLASBY MA, 1986, J NEUROCYTOL, V15, P497, DOI 10.1007/BF01611732
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   Hadlock TA, 1999, J PERIPHER NERV SYST, V4, P258
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Ho PR, 1998, ARCH OTOLARYNGOL, V124, P761, DOI 10.1001/archotol.124.7.761
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kohane DS, 1998, ANESTHESIOLOGY, V89, P119, DOI 10.1097/00000542-199807000-00019
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Pu LLQ, 1999, PLAST RECONSTR SURG, V104, P1379, DOI 10.1097/00006534-199910000-00021
   RICH KM, 1989, EXP NEUROL, V105, P162, DOI 10.1016/0014-4886(89)90115-5
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   SENIUK NA, 1992, J RECONSTR MICROSURG, V8, P399, DOI 10.1055/s-2007-1006725
   Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9
   Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x
   THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   WANG KK, 1993, MICROSURG, V14, P608, DOI 10.1002/micr.1920140914
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Welch JA, 1997, AM J VET RES, V58, P1033
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Wilson G J, 1990, ASAIO Trans, V36, pM340
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 39
TC 63
Z9 75
U1 2
U2 12
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2004
VL 68A
IS 2
BP 201
EP 209
DI 10.1002/jbm.a.10045
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770EJ
UT WOS:000188710000001
PM 14704961
DA 2018-10-19
ER

PT J
AU Burugapalli, K
   Koul, V
   Dinda, AK
AF Burugapalli, K
   Koul, V
   Dinda, AK
TI Effect of composition of interpenetrating polymer network hydrogels
   based on poly(acrylic acid) and gelatin on tissue response: A
   quantitative in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE interpenetrating polymer network; hydrogels; biomaterial;
   biocompatibility; poly(acrylic acid); gelatin
ID GENTAMICIN SULFATE; RELEASE; GLUTARALDEHYDE; VITRO
AB The local tissue response of the biomaterial is the most important criteria for determination of its biocompatibility. In the present study, full and semi-interpenetrating polymer networks (IPN) based on polyacrylic acid (AAc) and gelatin (Ge) crosslinked with 0.5 mol % N,N'-methylene bisacrylamide (BAm) and 4% glutaraldehyde (GA), respectively, were evaluated for tissue response in rats. IPNs with varying ratios of AAc and Ge were implanted subcutaneously in rats. Gentamicin sulfate (GS)-loaded IPN samples were also studied to evaluate the possible therapeutic use of these polymers. The site of implantation was biopsied and processed for light microscopy (LM) with image analysis for assessment of tissue reaction at 2-, 6-, and 12-week intervals. The tissue reaction was evaluated as a function of composition and time. The degree of neutrophil, lymphocyte and macrophage infiltration, fibrosis, granuloma formation, integration with extracellular matrix, vascular proliferation, and damage of adjacent structures were assessed. Polymers with >66% crosslinked Ge (Gx) showed persistence of acute inflammatory reaction till 3 months, with marked tissue injury and fibrosis. On the other hand, high crosslinked AAc (Ax) content showed chronic inflammatory reaction with high macrophage infiltration. Macrophages took active part in phagocytosis, degradation, and removal of polymers without granuloma formation or significant giant cell reaction. The IPNs with acrylic acid and gelatin in the ratio of 1:1 showed least tissue reaction and thus appeared to be most biocompatible. The majority of the polymers showed integration with extracellular matrix and growth of capillaries in and around the polymer. The heamogram, liver and renal function tests, and histology of vital organs were all normal. GS loading showed no additional local or systemic reaction suggesting the potential usefulness of the hydrogels as carrier for drugs such as GS. (C) 2003 Wiley Periodicals, Inc.
C1 All India Inst Med Sci, Dept Pathol, New Delhi 110029, India.
   Indian Inst Technol, Ctr Biomed Engn, New Delhi, India.
RP Dinda, AK (reprint author), All India Inst Med Sci, Dept Pathol, New Delhi 110029, India.
EM akdinda@hotmail.com
RI Burugapalli, Krishna/A-7673-2008
OI Burugapalli, Krishna/0000-0002-9898-0902
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Bancroft J, 1996, THEORY PRACTICE HIST
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   BRAYBROOK JH, 1990, PROG POLYM SCI, V15, P715, DOI 10.1016/0079-6700(90)90009-P
   Burugapalli K, 2001, J APPL POLYM SCI, V82, P217, DOI 10.1002/app.1841
   Changez M, 2004, BIOMATERIALS, V25, P139, DOI 10.1016/S0142-9612(03)00466-6
   Changez M, 2003, BIOMATERIALS, V24, P527, DOI 10.1016/S0142-9612(02)00364-2
   CHATTERJI PR, 1990, J APPL POLYM SCI, V40, P404
   Iyer VK, 1999, ANAL QUANT CYTOL, V21, P505
   Kim KM, 1999, AM J PATHOL, V154, P843, DOI 10.1016/S0002-9440(10)65331-X
   KLEMPMNER D, 1994, SERIES AM CHEM SOC, V239, pCH1
   Murphy George F., 1997, P5
   PARK JB, 1984, BIOMATERIALS SCI ENG, pCH1
   PARK K, 1993, BIODEGRADABLE HYDROG, pCH1
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   SPERLING LH, 1982, INTERPENETRATING POL, P1
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TORCHILIN VP, 1977, J BIOMED MATER RES, V11, P223, DOI 10.1002/jbm.820110208
NR 19
TC 40
Z9 40
U1 2
U2 21
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2004
VL 68A
IS 2
BP 210
EP 218
DI 10.1002/jbm.a.10117
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770EJ
UT WOS:000188710000002
PM 14704962
DA 2018-10-19
ER

PT J
AU Wang, HM
   Springer, ING
   Schildberg, H
   Acil, Y
   Ludwig, K
   Rueger, DR
   Terheyden, H
AF Wang, HM
   Springer, ING
   Schildberg, H
   Acil, Y
   Ludwig, K
   Rueger, DR
   Terheyden, H
TI Carboxymethylcellulose-stabilized collagenous rhOP-1 device - a novel
   carrier biomaterial for the repair of mandibular continuity defects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carrier biomaterials; osteogenic protein; carboxymethylcellulose;
   collagenous matrix; biomechanical testing
ID HUMAN OSTEOGENIC PROTEIN-1; BONE MORPHOGENETIC PROTEIN-7; MINIATURE
   PIGS; RECONSTRUCTION; RHBMP-2; REGENERATION; IMPLANT; MODEL; HOP-1
AB Human recombinant osteogenic protein-1 (rhOP-1) is osteoinductive. Efforts are made to develop carrier biomaterials with improved space-keeping properties. Bovine collagen type I matrix charged with rhOP-1 was suggested to be an advantageous device of relative liquid quality. We hypothesized that the addition of carboxymethylcellulose (CMC) may stabilize the device and facilitate the regeneration of mandibular continuity defects without further addition of mineralized carrier materials. To test this hypothesis, the anatomical shape, functional remodeling, and mechanical stability of such bony regenerates were evaluated in the course of an animal experiment. Mandibular continuity defects of 5 cm in size were created in five Gottingen minipigs on one side (contralateral hemimandible: control) and bridged with titanium plates. Four animals were treated with the rhOP-I device (3000 mug rhOP-1, 2 g collagen, 1 g CMQ, and one animal was treated with a placebo device omitting rhOP-1. After 12 weeks of experimental period, bony continuity was reestablished in rhOP-1-treated hemimandibles. The bony regenerates were of good anatomical shape, volume, and functional remodeling. Placebo treatment led to insufficient bony regenerates of significant lower bone volume (volume in 3D-CT scan 29.81 cm(3) vs 8.85 cm(3)). To produce 1 mm of bending, 1972 N were needed for rhOP-1-treated hemimandibles, 2617 N for control hemimandibles, and 642 N for the placebo treated hemimandible. CMC stabilization of collagen carrier biomaterials for rhOP-1 provides good plasticity as well as excellent space-keeping properties and may not interfere with osteoinduction. The results of this preliminary study suggest that the applied rhOP-1 device offers a potential option for further studies on the reconstruction of mandibular defects. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Kiel, Dept Oral & Maxillofacial Surg, Kiel, Germany.
   Univ Kiel, Dept Prosthodont Propaedeut & Dent Mat, Kiel, Germany.
   Stryker Biotech, Hopkinton, MA USA.
RP Wang, HM (reprint author), Univ Kiel, Dept Oral & Maxillofacial Surg, Kiel, Germany.
EM terheyden@mkg.uni-kiel.de
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Acil Y, 2002, J CELL BIOCHEM, V86, P90, DOI 10.1002/jcb.10197
   Axhausen G., 1909, LANGENBECKS ARCH KLI, V88, P23
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Boyne PJ, 1999, BRIT J ORAL MAX SURG, V37, P344, DOI 10.1054/bjom.1999.0205
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS160
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x
   Ripamonti U, 1996, GROWTH FACTORS, V13, P273, DOI 10.3109/08977199609003228
   Ripamonti U, 1998, PLAST RECONSTR SURG, V101, P227, DOI 10.1097/00006534-199801000-00040
   Rodgers JB, 1998, J CRANIOFAC SURG, V9, P147, DOI 10.1097/00001665-199803000-00012
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   Santa-Comba A, 2001, J BIOMED MATER RES, V55, P396
   SPRINGER ING, 2002, BONE, V31, P1190
   Terato K, 1996, CLIN IMMUNOL IMMUNOP, V79, P142, DOI 10.1006/clin.1996.0061
   Terheyden H, 1997, Mund Kiefer Gesichtschir, V1, P272
   Terheyden H, 2001, LARYNGO RHINO OTOL, V80, P47, DOI 10.1055/s-2001-11032
   Terheyden H, 1999, INT J ORAL MAX SURG, V28, P461, DOI 10.1016/S0901-5027(99)80063-0
   Terheyden H, 1999, CLIN ORAL IMPLAN RES, V10, P510, DOI 10.1034/j.1600-0501.1999.100609.x
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   Toriumi DM, 1999, LARYNGOSCOPE, V109, P1481, DOI 10.1097/00005537-199909000-00023
   TRAUTINGER F, 1991, ARCH DERMATOL RES, V283, P395, DOI 10.1007/BF00371822
   Ullmark G, 2000, ARCH ORTHOP TRAUM SU, V120, P445, DOI 10.1007/s004029900122
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Young MPJ, 2002, CLIN ORAL IMPLAN RES, V13, P298, DOI 10.1034/j.1600-0501.2002.130310.x
NR 27
TC 27
Z9 27
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2004
VL 68A
IS 2
BP 219
EP 226
DI 10.1002/jbm.a.10129
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770EJ
UT WOS:000188710000003
PM 14704963
DA 2018-10-19
ER

PT J
AU Matsuzaka, K
   Yoshinari, M
   Shimono, M
   Inoue, T
AF Matsuzaka, K
   Yoshinari, M
   Shimono, M
   Inoue, T
TI Effects of multigrooved surf aces on osteoblast-like cells in vitro:
   Scanning electron microscopic observation and mRNA expression of
   osteopontin and osteocalcin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE combination groove; multigrooves; osteoblast-like cells; mineralized
   extracellular matrix; quantitative RT-PCR
ID IMPLANT MATERIALS; MICROGROOVED POLYSTYRENE; MICROMACHINED SUBSTRATA;
   SUBCUTANEOUS IMPLANTS; QUANTITATIVE-ANALYSIS; BIOMATERIAL SURFACES;
   DIFFERENT DIMENSIONS; MORPHOLOGIC ASPECTS; CELLULAR-RESPONSES; TITANIUM
   SUBSTRATA
AB This study evaluated the behavior of osteoblast-like cells on multigrooved surfaces consisting of a combination of microgrooves and macrogrooves. A polystyrene substrate was fabricated with multigrooves with 90-degree, V-shaped microgrooves with a 2-mum pitch cut on trapezoidal macrogrooves, which had a 50-mum ridge width, a 50-mum wall width, a 50-mum bottom width, and 25-mum depth. Smooth polystyrene substrates were also prepared as controls. Rat bone marrow cells were cultured as osteoblast-like cells on the substrates for morphological evaluation using a scanning electron microscope, and for biochemical evaluation using the quantitative reverse transcriptase-polymerase chain reaction technique for osteopontin and osteocalcin mRNA expression. After 8 days of incubation, the osteoblast-like cells were aligned parallel to the surface grooves on the multigrooved substrates. After 16 days of incubation, a dense mineralized extracellular matrix (ECM) was produced along the multigrooves. The ECM on the multigrooved surface appeared oriented more in the direction of the grooves than on the smooth surface, and trapezoid-shaped macrogrooves of the ECM were cast upside down. Although there were not significant differences, the osteopontin and osteocalcin mRNA expressions of the osteoblast-like cells on the multigrooved surfaces tended to be higher than on smooth surfaces. These results suggest that multigrooves could be used to control the orientation of mineralized ECM as well as of cells, and also to enhance the production of mineralized ECM. (C) 2003 Wiley Periodicals, Inc.
C1 Tokyo Dent Coll, Dept Clin Pathophysiol, Mihama Ku, Chiba 2618502, Japan.
   Tokyo Dent Coll, Oral Hlth Sci Ctr, Mihama Ku, Chiba 2618502, Japan.
   Tokyo Dent Coll, Dept Dent Mat Sci, Mihama Ku, Chiba 2618502, Japan.
   Tokyo Dent Coll, Dept Pathol, Mihama Ku, Chiba 2618502, Japan.
RP Matsuzaka, K (reprint author), Tokyo Dent Coll, Dept Clin Pathophysiol, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.
EM matsuzak@tdc.ac.jp
CR Boyan B D, 1993, J Oral Implantol, V19, P116
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Brunette D.M., 2001, TITANIUM MED, P485
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Davies JE, 1996, ANAT REC, V245, P426
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   DOLEY TG, 1991, J PERIODONTOL, V62, P153
   GOMI K, 1993, J BIOMED MATER RES, V27, P429, DOI 10.1002/jbm.820270403
   GRAY S, 1996, PRINCIPLES BONE BIOL, P69
   Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961
   Inoue Takashi, 1997, Bulletin of Tokyo Dental College, V38, P187
   ITAKURA Y, 1988, J BIOMED MATER RES, V22, P613, DOI 10.1002/jbm.820220703
   Jansen J A, 1999, Adv Dent Res, V13, P57
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   JANSEN JA, 1989, BIOMATERIALS, V10, P604, DOI 10.1016/0142-9612(89)90114-2
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   OAKLEY C, 1995, CELL MOTIL CYTOSKEL, V31, P45, DOI 10.1002/cm.970310106
   Pearson R G, 2002, J Long Term Eff Med Implants, V12, P1
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Qu J, 1996, Oral Dis, V2, P102
   ROBEY PG, 1972, DISORDERS BONE MINER, P241
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   VERMEULEN AHM, 1989, J HISTOCHEM CYTOCHEM, V37, P1503, DOI 10.1177/37.10.2789247
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Walboomers XF, 1998, J BIOMED MATER RES, V42, P634, DOI 10.1002/(SICI)1097-4636(19981215)42:4<634::AID-JBM21>3.3.CO;2-F
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Yoshinari M, 2003, J BIOMED MATER RES A, V65A, P359, DOI 10.1002/jbm.a.10521
   Yoshinari M, 2002, METALL MATER TRANS A, V33, P511, DOI 10.1007/s11661-002-0113-6
NR 46
TC 51
Z9 55
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2004
VL 68A
IS 2
BP 227
EP 234
DI 10.1002/jbm.a.10158
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770EJ
UT WOS:000188710000004
PM 14704964
DA 2018-10-19
ER

PT J
AU Aldini, NN
   Fini, M
   Giavaresi, G
   Martini, L
   Dubini, B
   Bossi, MGP
   Rustichelli, F
   Krajewski, A
   Ravaglioli, A
   Mazzocchi, M
   Giardino, R
AF Aldini, NN
   Fini, M
   Giavaresi, G
   Martini, L
   Dubini, B
   Bossi, MGP
   Rustichelli, F
   Krajewski, A
   Ravaglioli, A
   Mazzocchi, M
   Giardino, R
TI Osteointegration of bioactive glass-coated and uncoated zirconia in
   osteopenic bone: An in vivo experimental study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteoporosis; zirconia; bioactive glass; osteointegration; animal model
ID TERM OVARIECTOMIZED SHEEP; OSTEOPOROTIC BONE; ESTROGEN DEFICIENCY;
   TITANIUM IMPLANTS; RAT BONE; HYDROXYAPATITE; OSSEOINTEGRATION;
   BIOMATERIALS; INTERFACE; FIXATION
AB In elderly and osteoporotic patients an age-related loss of osteoinductivity could be the biological cause of implant failure regardless of the high quality of the implanted device. yttria stabilized tetragonal zirconia (YSTZ), either coated with the bioactive glass named RKKP bioglaze(R) (RKKP) or uncoated, was implanted in the distal femurs of sham-operated and ovariectomized female rats. Animals were sacrificed at 30 and 60 days. Histomorphometry and microhardness tests were performed to assess osteointegration rate as well as bone quality around the implants. Significant decreases (p < 0.0005) in trabecular bone volume, BV/TV (41%), trabecular bone surface BS/TV (33%), trabecular thickness Tb.Th (20%), and trabecular number Tb.N (32%), together with a significant increase in trabecular separation Tb.Sp (184%), were found for the osteopenic rats compared with the sham-operated rats. At both experimental times the RKKP coating ensured a better osteointegration rate with higher AI values than the uncoated YSTZ, even when osteopenic rats were used (48% at 30 days and 12% at 60 days). No differences were observed at the bone-biomaterial interfaces for either material when comparing sham-operated with osteopenic rats. The present results demonstrate that the RKKP bioactive glass used as a coating ensures a high osteointegration rate even in osteoporotic bone, which is already visible from postoperative day 30 and is still apparent on day 60. (C) 2003 Wiley Periodicals, Inc.
C1 Rizzoli Orthopaed Inst, Res Inst Codivilla, Expt Surg Dept, I-40136 Bologna, Italy.
   Univ Bologna, Sch Med, Chair Surg Patophysiol, Bologna, Italy.
   Univ Politecn Marche, Inst Phys Sci, Ancona, Italy.
   INFM, Unit Ancona, Ancona, Italy.
   CNR, Inst Technol Res Ceram Irtec, Faenza, Italy.
RP Giardino, R (reprint author), Rizzoli Orthopaed Inst, Res Inst Codivilla, Expt Surg Dept, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM roberto.giardino@ior.it
RI Fini, Milena/J-4808-2016; Mazzocchi, Mauro/D-9631-2016
OI Fini, Milena/0000-0002-3732-3570; Mazzocchi, Mauro/0000-0002-0243-6890;
   Giavaresi, Gianluca/0000-0001-7843-5969
CR Aldini NN, 2002, J ORTHOPAED RES, V20, P1217
   Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   Avioli LV, 1998, METABOLIC BONE DIS C
   Binkley Neil, 2002, WMJ, V101, P28
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2003, J BIOMED MATER RES A, V66A, P176, DOI 10.1002/jbm.a.10605
   Fini M, 2002, INT J ORAL MAX IMPL, V17, P28
   Fini M, 2002, J ORTHOP RES, V20, P756, DOI 10.1016/S0736-0266(01)00158-9
   Fini M, 2001, J BONE JOINT SURG BR, V83B, P139, DOI 10.1302/0301-620X.83B1.10162
   Fini M, 2000, J MATER SCI-MATER M, V11, P579, DOI 10.1023/A:1008932303913
   Fujimoto T, 1998, INT J ORAL MAX IMPL, V13, P183
   Giavaresi G, 2002, CLIN EXP RHEUMATOL, V20, P171
   Goseki MS, 1996, J NUTR SCI VITAMINOL, V42, P55
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   JOHNELL O, 1992, OSTEOPOROSIS INT, V2, P298, DOI 10.1007/BF01623186
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   KLEINSCHMIDT, 1992, BONE GRAFTS BONE SUB, P133
   Lohmann CH, 2001, ARCH ORTHOP TRAUM SU, V121, P583, DOI 10.1007/s004020100291
   LU XJ, 1998, J BIOMED MATER RES, V42, P357
   Lugero G G, 2000, Implant Dent, V9, P303, DOI 10.1097/00008505-200009040-00005
   MARTIN RB, 1988, J BONE JOINT SURG AM, V70A, P540, DOI 10.2106/00004623-198870040-00010
   MELTON LJ, 1995, J BONE MINER RES, V10, P175
   Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5
   Moroni A, 2001, J BONE JOINT SURG AM, V83A, P717, DOI 10.2106/00004623-200105000-00010
   MOSEKILDE L, 1995, BONE, V17, pS343, DOI 10.1016/8756-3282(95)00312-2
   Motohashi M, 1999, ORAL SURG ORAL MED O, V87, P145, DOI 10.1016/S1079-2104(99)70264-7
   OSAWA S, 2002, BONE, V30, P137
   Pan JL, 2000, J ORAL MAXIL SURG, V58, P877, DOI 10.1053/joms.2000.8212
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Rocca M, 2002, BIOMATERIALS, V23, P1017, DOI 10.1016/S0142-9612(01)00213-7
   Rocca M, 2001, INT J ARTIF ORGANS, V24, P649
   Stanic V, 2002, BIOMATERIALS, V23, P3833, DOI 10.1016/S0142-9612(02)00119-9
   STEA S, 1995, J BIOMED MATER RES, V29, P695, DOI 10.1002/jbm.820290604
   Thomas John G., 1995, Clinical Microbiology Newsletter, V17, P125, DOI 10.1016/S0196-4399(00)80022-7
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
   Tuck SP, 2002, OSTEOPOROSIS INT, V13, P630, DOI 10.1007/s001980200085
   Yamazaki M, 1999, ORAL SURG ORAL MED O, V87, P411, DOI 10.1016/S1079-2104(99)70239-8
NR 44
TC 32
Z9 33
U1 1
U2 7
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2004
VL 68A
IS 2
BP 264
EP 272
DI 10.1002/jbm.a.20057
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770EJ
UT WOS:000188710000008
PM 14704968
DA 2018-10-19
ER

PT J
AU Shu, XZ
   Ghosh, K
   Liu, YC
   Palumbo, FS
   Luo, Y
   Clark, RA
   Prestwich, GD
AF Shu, XZ
   Ghosh, K
   Liu, YC
   Palumbo, FS
   Luo, Y
   Clark, RA
   Prestwich, GD
TI Attachment and spreading of fibroblasts on an RGD peptide-modified
   injectable hyaluronan hydrogel
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE glycosaminoglycan; fibronectin; Arg-Gly-Asp; in vitro cell growth; in
   vivo fibrous tissue engineering; crosslinked biomaterial; engineered
   extracellular matrix
ID CELL-ADHESION; EXTRACELLULAR-MATRIX; FUNCTIONALIZED DERIVATIVES;
   POLY(ETHYLENE GLYCOL); CHEMICAL-MODIFICATION; DRUG-DELIVERY; ACID;
   BIOMATERIALS; FILMS; PROLIFERATION
AB Hyaluronan (HA) hydrogels resist attachment and spreading of fibroblasts and most other mammalian cell types. A thiol-modified HA (3,3'-dithiobis(propanoic dihydrazide) [HA-DTPH]) was modified with pepticles containing the Arg-Gly-Asp (RGD) sequence and then crosslinked with polyethylene glycol (PEG) diacrylate (PEGDA) to create a biomaterial that supported cell attachment, spreading, and proliferation. The hydrogels were evaluated in vitro and in vivo in three assay systems. First, the behavior of human and murine fibroblasts on the surface of the hydrogels was evaluated. The concentration and structure of the RGD pep-. tides and the length of the PEG spacer influenced cell attachment and spreading. Second, murine fibroblasts were seeded into HA-DTPH solutions and encapsulated via in situ crosslinking with or without bound RGD pepticles. Cells remained viable and proliferated within the hydrogel for 15 days in vitro. Although the RGD peptides significantly enhanced cell proliferation on the hydrogel surface, the cell proliferation inside the hydrogel in vitro was increased only modestly. Third, HA-DTPH/PEGDA/peptide hydrogels were evaluated as injectable tissue engineering materials in vivo. A suspension of murine fibroblasts in HA-DTPH was crosslinked using PEGDA plus PEGDA peptide, and the viscous, gelling mixture was injected subcutaneously into the flanks of nude mice; gels formed in vivo following injection. After 4 weeks, growth of new fibrous tissue had been accelerated by the sense RGD peptides. Thus, attachment, spreading, and proliferation of cells is dramatically enhanced on RGD-modified surfaces but only modestly accelerated in vivo tissue formation. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA.
   SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
   Univ Palermo, Dipartimento CHim & Tecnol Farmaceut, I-90123 Palermo, Italy.
   SUNY Stony Brook, Dept Dermatol, Stony Brook, NY 11794 USA.
RP Prestwich, GD (reprint author), Univ Utah, Dept Med Chem, 419 Wakara Way,Suite 205, Salt Lake City, UT 84108 USA.
EM gprestwich@pharm.utah.edu
FU NIDCD NIH HHS [DC04663]; NIAMS NIH HHS [AR45883]
CR Band PA, 1998, WENN GR INT, V72, P33
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Cheung WF, 1999, BIOCHEM SOC T, V27, P135, DOI 10.1042/bst0270135
   COELHO AM, 1974, J CELL PHYSL, V83, P379
   Dowthwaite GP, 1998, J HISTOCHEM CYTOCHEM, V46, P641, DOI 10.1177/002215549804600509
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Faucheux N, 2000, BIOMATERIALS, V21, P1031, DOI 10.1016/S0142-9612(99)00277-X
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Hu M, 2000, TISSUE ENG, V6, P585, DOI 10.1089/10763270050199532
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jackson JK, 2002, PHARM RES-DORDR, V19, P411, DOI 10.1023/A:1015175108183
   JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243
   Leach RE, 1998, FERTIL STERIL, V69, P415, DOI 10.1016/S0015-0282(97)00573-6
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   LIU Y, IN PRESS J BIOMED MA
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Miller JA, 1997, J BIOMED MATER RES, V38, P25, DOI 10.1002/(SICI)1097-4636(199721)38:1<25::AID-JBM4>3.0.CO;2-J
   Moriyama K, 1999, J CONTROL RELEASE, V59, P77, DOI 10.1016/S0168-3659(98)00183-7
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Ohya S, 2001, BIOMACROMOLECULES, V2, P856, DOI 10.1021/bm010040a
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 1987, HYDROGELS MED PHARM
   Piacquadio D, 1997, J AM ACAD DERMATOL, V36, P544, DOI 10.1016/S0190-9622(97)70241-X
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   Prestwich GD, 2000, INT CONGR SER, V1196, P181
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Preswich GD, 1998, PHARM SCI TECHNOL TO, V1, P42
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Ramamurthi A, 2002, J BIOMED MATER RES, V60, P196
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sawada T, 1999, HUM REPROD, V14, P1470, DOI 10.1093/humrep/14.6.1470
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   SHU XZ, 2004, BIOMATERIALS, V25, P1139
   THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Yoldemir T, 2002, FERTIL STERIL, V78, P335, DOI 10.1016/S0015-0282(02)03224-7
NR 51
TC 185
Z9 187
U1 6
U2 84
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2004
VL 68A
IS 2
BP 365
EP 375
DI 10.1002/jbm.a.20002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770EJ
UT WOS:000188710000019
PM 14704979
DA 2018-10-19
ER

PT J
AU Hao, L
   Lawrence, J
AF Hao, L
   Lawrence, J
TI Laser surface treatment of magnesia partially stabilized zirconia for
   enhanced human skin fibroblast cell response
SO JOURNAL OF LASER APPLICATIONS
LA English
DT Article
DE laser treatment; magnesia partially stabilized zirconia (MgO-PSZ);
   microstructure; human skin fibroblast cell; cell adhesion
ID OSTEOBLAST-LIKE CELLS; CORROSION-RESISTANCE; TITANIUM; BIOMATERIALS;
   GROWTH; ROUGHNESS; ADHESION; HYDROXYAPATITE; DEPOSITION; COATINGS
AB Promoting or inhibiting cell adhesion to biomaterials is often crucial to the proper function of a biomaterial. In order to induce a surface with better bioactivity for promoting the bonding between the tissue and this bioinert ceramic interface, an industrial CO2 laser was used to alter the surface properties of magnesia (MgO)-partially stabilized zirconia (PSZ) with various laser power densities. The general effects Of CO2 laser radiation on the MgO-PSZ were analyzed to investigate the modifications of surface microstructure, surface oxygen content, and surface roughness of the material. In in vitro evaluation, human skin fibroblast cells were seen to attach onto the MgO-PSZ following CO2 laser treatment, whereas, no cell attachment was found on the untreated MgO-PSZ after 7 day cell culture. Moreover, some cells on the CO2 laser treated MgO-PSZ could be considered as flattened and spread, implying the final stage of the cell attachment. A relationship was observed between the extent of cell attachment and surface properties of the MgO-PSZ with various laser power densities, exhibiting the ability of laser surface process for controlling the cell attachment. (C) 2004 Laser Institute of America.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Manufacture Engn Div, Singapore 639798, Singapore.
RP Hao, L (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Manufacture Engn Div, 50 Nanyang Ave, Singapore 639798, Singapore.
EM haoliang@pmail.ntu.edu.sg
OI Hao, Liang/0000-0003-2071-7044; Lawrence, Jonathan/0000-0002-1649-9948
CR Alessio L.D., 1999, APPL SURF SCI, V138-139, P527
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   BRASH JL, 1996, INTERFACIAL PHENOMEN
   Cheang P, 1996, BIOMATERIALS, V17, P1901, DOI 10.1016/0142-9612(95)00146-8
   Chwa SO, 2001, SURF COAT TECH, V148, P88
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   D'Alessio L, 2001, APPL SURF SCI, V183, P10, DOI 10.1016/S0169-4332(01)00466-4
   Dadsetan M, 2001, J BIOMED MATER RES, V57, P183, DOI 10.1002/1097-4636(200111)57:2<183::AID-JBM1157>3.0.CO;2-M
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Gaggl A, 2000, BIOMATERIALS, V21, P1067, DOI 10.1016/S0142-9612(00)00002-8
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   HAO L, IN PRESS OPT LASERS
   HAYASHI H, 1992, ARCH ORTHOP TRAUM SU, V112, P1, DOI 10.1007/BF00431035
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   JANSEN JA, 1999, DENT RES, V13, P57
   Kasemo B, 1999, Adv Dent Res, V13, P8
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LI J., 1998, HDB BIOMATERIAL PROP, P340
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Liu QG, 1999, SOLID STATE IONICS, V121, P61, DOI 10.1016/S0167-2738(98)00529-3
   MAN HC, 1997, J MAT PROCES TECH, V1, P123
   Miller R. A., 1982, ADV CERAM, V3, P241, DOI DOI 10.1098/RSPA.2007.1829
   MIRZADEH H, 1995, RADIAT PHYS CHEM, V46, P859, DOI 10.1016/0969-806X(95)00278-6
   MIRZADEHA H, 1995, BIOMATERIALS, V168, P641
   Northup S. J., 1999, HDB BIOMATERIALS EVA, P325
   Pei YT, 1996, SURF COAT TECH, V81, P131, DOI 10.1016/0257-8972(95)02483-2
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Sivakumar R., 1988, Surface Engineering, V4, P127
   SPALDING IJ, 1987, J MANAG ENG MANUF, V201, P165
   Villermaux F, 1997, APPL SURF SCI, V109, P62, DOI 10.1016/S0169-4332(96)00619-8
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Yue TM, 2002, MATER LETT, V52, P206, DOI 10.1016/S0167-577X(01)00395-0
   Yue TM, 2001, SURF COAT TECH, V137, P65, DOI 10.1016/S0257-8972(00)01104-X
   ZHANG XM, 1997, MATER LETT, V5, P327
NR 40
TC 3
Z9 4
U1 0
U2 3
PU LASER INST AMER
PI ORLANDO
PA 13501 INGENUITY DR, SUITE 128, ORLANDO, FL 32826 USA
SN 1042-346X
J9 J LASER APPL
JI J. Laser Appl.
PD FEB
PY 2004
VL 16
IS 1
BP 55
EP 64
DI 10.2351/1.1642634
PG 10
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 775FX
UT WOS:000189031000011
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Herrero, EJ
   Rocha, A
   Maestro, M
   Castillo-Olivares, JL
AF Paez, JMG
   Herrero, EJ
   Rocha, A
   Maestro, M
   Castillo-Olivares, JL
TI Comparative study of the mechanical behaviour of a cyanoacrylate and a
   bioadhesive
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOPROSTHETIC VALVES; BOVINE PERICARDIUM; PATHOLOGY; STRENGTH
AB We compared the mechanical resistance of 18 samples of calf pericardium bonded with a 100 mm(2) overlap, by two types of glues: a cyanoacrylate (Loctite 4011) and a bioadhesive (BioGlue). Comparative tensile testing was also carried out in 40 paired samples, 20 bonded with the cyanoacrylate and 20 unbonded controls. The findings at rupture showed a greater resistance of the calf pericardium glued with cyanoacrylate, with a mean tensile strength of 0.15 MPa vs. 0.04 MPa for the biological glue (p=0.000). They also demonstrated a loss of resistance of the samples bonded with cyanoacrylate when compared with that of the unbonded other halves of the pairs: 0.20 MPa and 0.27 MPa vs. 19.47 MPa and 24.44 MPa (p<0.001). The method of selection by means of paired samples made it possible to establish the equations that relate the stress and strain, or deformation, with excellent coefficients of determination (R-2).
   These equations demonstrate the marked elastic behaviour of the bonded samples. Moreover, these findings show the cyanoacrylate to be superior to the biological glue, leading to the examination of the compatibility, inalterability over time and mechanical behaviour of the cyanoacrylate in sutured samples, as well as the study of the anisotropy of the biomaterial when bonded with a bioadhesive. (C) 2004 Kluwer Academic Publishers.
C1 Clin Puerto Hierro, Serv Cirugia Expt, Madrid 28035, Spain.
   Clin Puerto Hierro, Serv Bioestadist, Madrid 28035, Spain.
   Escuela Tecn Super Ingn Ind, Dept Mecan Estructural & Resistencia Mat, Madrid, Spain.
RP Paez, JMG (reprint author), Clin Puerto Hierro, Serv Cirugia Expt, San Martin Porres 4, Madrid 28035, Spain.
EM josempaez@telefonica.net
CR Bingley JA, 2000, ANN THORAC SURG, V69, P1764, DOI 10.1016/S0003-4975(00)01250-9
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Carrera San Martin A., 1993, Biomaterials, V14, P76, DOI 10.1016/0142-9612(93)90079-H
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   Duncan AC, 1997, J THORAC CARDIOV SUR, V113, P302, DOI 10.1016/S0022-5223(97)70327-1
   EDWARDS TJ, 1995, ANN THORAC SURG, V60, pS211, DOI 10.1016/0003-4975(95)00220-F
   GONSALBEZ J, 1996, SCAND J THORAC CAR S, V44
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   Greene D, 1999, Arch Facial Plast Surg, V1, P292, DOI 10.1001/archfaci.1.4.292
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   KUNZELMAN KS, 1993, J LONG-TERM EFF MED, V3, P161
   OHO K, 1995, ENDOSCOPY, V27, P349, DOI 10.1055/s-2007-1005712
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 1996, J BIOMED MATER RES, V30, P47
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   Quintanar-Guerrero D, 2001, BIOMATERIALS, V22, P957, DOI 10.1016/S0142-9612(00)00260-X
   San Martin AC, 1998, J MATER SCI-MATER M, V9, P77
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 23
TC 9
Z9 9
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2004
VL 15
IS 2
BP 109
EP 115
DI 10.1023/B:JMSM.0000011810.12031.c6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 762XA
UT WOS:000188006700002
PM 15330043
DA 2018-10-19
ER

PT J
AU Seifert, M
   Hesse, S
   Kabrelian, V
   Klemm, D
AF Seifert, M
   Hesse, S
   Kabrelian, V
   Klemm, D
TI Controlling the water content of never dried and reswollen bacterial
   cellulose by the addition of water-soluble polymers to the culture
   medium
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article; Proceedings Paper
CT International Symposium Macromolecules in the 21st Century
CY OCT 07-09, 2002
CL VIENNA, AUSTRIA
DE bacterial cellulose; Acetobacter xylinum; composites; water-soluble
   polymers; biomaterials; carboxymethylcellulose; methylcellulose;
   poly(vinyl alcohol); NMR; scanning electron microscopy (SEM)
ID IN-SITU CRYSTALLIZATION; ACETOBACTER-XYLINUM; ALPHA; BETA
AB For the modification of medically useful biomaterials from bacterially synthesized cellulose, fleeces of Acetobacter xylinum have been produced in the presence of 0.5, 1.0, and 2.0% (m/v) carboxymethylcellulose (CMC), methylcellulose (MC), and poly(vinyl alcohol) (PVA), respectively, in the Hestrin-Schramm culture medium. The incorporation of the water-soluble polymers into cellulose and their influence on the structure, crystal modifications, and material properties are described. With IR and solid-state (13)C NMR spectroscopy of the fleeces, the presence of the cellulose ethers and an increase in the amorphous parts of the cellulose modifications (NMR results) have been detected. The incorporation is represented by a higher product yield, too. As demonstrated by scanning electron microscopy, a porelike cellulose network structure forms in the presence of CMC and MC. This modified structure increases the water retention ability (expressed as the water content), the ion absorption capacity, and the remaining nitrogen-containing residues from the culture medium or bacteria cells. The water content of bacterial cellulose (BC) in the never dried state and the freeze-dried, reswollen state can be controlled by the CMC concentration in the culture solution. The freeze-dried, reswollen BC-CMC (2.0%) contains 96% water after centrifugation, whereas standard BC has only 73%. About 98% water is included in a BC-MC composite in the wet state, and about 93% is included in the reswollen state synthesized in the presence of 0.5, 1.0, or 2.0% MC. These biomaterial composites can be stored in the dried state and reswollen before use, reaching a higher water absorption than pure, never dried 13C. The copper ion capacity of BC-CMC composites increases proportionally with the added amount of CMC. BC-CMC (0.5%) can absorb 3 times more copper ions than original 13C. In the case of 0.5 and 1.0% PVA additions to the culture solution, this polymer cannot be detected in the cellulose fleeces after they are washed. Nevertheless the presence of PVA in the culture medium effects a decreased product yield, a retention of nitrogen-containing residues in the material during purification, a reduced water absorption ability, and a slightly higher copper ion capacity in comparison with original BC. The water content of freeze-dried, reswollen BC-PVA (0.5%) is only 62%. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Jena, Inst Opt & Quantenelektron, D-07743 Jena, Germany.
   Teshrien Univ, Fac Sci, Sect Chem, Latakia, Syria.
RP Klemm, D (reprint author), Univ Jena, Inst Organ Chem & Makromol Chem, Lessingstr 8, D-07743 Jena, Germany.
EM dieter.klemm@uni-jena.de
RI Hesse-Ertelt, Stephanie/A-6254-2008
OI Hesse-Ertelt, Stephanie/0000-0003-2016-7724
CR Brown Jr R., 1990, US Patent, Patent No. [4942128, 4,942,128]
   BROWN RM, 1992, CONF P ACS, P76
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   GEYER U, 1994, ACTA BIOTECHNOL, V14, P261, DOI 10.1002/abio.370140308
   HAIGLER CH, 1991, BIOSYNTHESIS BIODEGR, P99
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Jayme G, 1948, PAPIER DARMSTADT, V2, P7
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 1999, POLYM NEWS, V24, P377
   KUGA S, 1991, BIOSYNTHESIS BIODEGR, P125
   ROSS P, 1991, BIOSYNTHESIS BIODEGR, P219
   Sakairi N, 1998, CARBOHYD POLYM, V37, P409, DOI 10.1016/S0144-8617(97)00226-9
   TAJIMA K, 1995, MACROMOL SYMP, V99, P149, DOI 10.1002/masy.19950990116
   TAJIMA K, 1995, MOKUZAI GAKKAISHI, V41, P749
   TAKAI M, 1991, J SENI GAKKAISHI, V47, P1198
   Tokura S, 1998, MACROMOL SYMP, V127, P23, DOI 10.1002/masy.19981270106
   VANDAMME EJ, 1998, POLYM DEGRAD STABIL, V56, P932
   White DG, 1989, CELLULOSE WOOD CHEM, P573
   Yamamoto H, 1996, CELLULOSE, V3, P229, DOI 10.1007/BF02228804
   YAMAMOTO H, 1994, CELLULOSE, V1, P57, DOI 10.1007/BF00818798
NR 20
TC 72
Z9 75
U1 2
U2 43
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD FEB 1
PY 2004
VL 42
IS 3
BP 463
EP 470
DI 10.1002/pola.10862
PG 8
WC Polymer Science
SC Polymer Science
GA 764FR
UT WOS:000188197200009
DA 2018-10-19
ER

PT J
AU Nussbaum, DA
   Gailloud, P
   Murphy, K
AF Nussbaum, DA
   Gailloud, P
   Murphy, K
TI The chemistry of acrylic bone cements and implications for clinical use
   in image-guided therapy
SO JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
LA English
DT Review
ID CALCIUM-PHOSPHATE CEMENTS; FATIGUE-STRENGTH; HIGH-VISCOSITY; PMMA;
   RATIO; VERTEBROPLASTY; HYDROXYAPATITE; PROPAGATION; INITIATION; POROSITY
AB Advances in image-guided therapy for vertebral fractures and other bone-related disorders have made acrylic bone cement an integral part of the interventional armamentarium. Unfortunately, information on the properties and chemistry of these compounds is mostly published in the biomaterial sciences literature, a source with which the interventional community is generally unfamiliar. This review focuses on the chemistry of bone cement polymerization and the properties of components in polymethylmethacrylate (PMMA)-based polymers, the most commonly used bone cements in interventional procedures such as percutaneous vertebroplasty. The effects of altering the concentration of components such as methylmethacrylate monomers, PMMA beads, benzoyl peroxide activator, N,N-dimethyl-p-toluidine (DMPT) initiator, and radiopacifiers on the setting time, polymerization temperature, and compressive strength of the cement are also considered. This information will allow interventional radiologists to manipulate bone cement characteristics for specific applications and maximize the clinical potential of image-guided interventions.
C1 Johns Hopkins Univ Hosp, Div Intervent Neuroradiol, Baltimore, MD 21287 USA.
RP Murphy, K (reprint author), Johns Hopkins Univ Hosp, Div Intervent Neuroradiol, 600 N Wolfe St, Baltimore, MD 21287 USA.
EM kmurphy@jhmi.edu
CR Baleani M, 2003, P I MECH ENG H, V217, P9, DOI 10.1243/095441103762597683
   Belkoff SM, 2002, J BIOMED MATER RES, V63, P396, DOI 10.1002/jbm.10258
   Belkoff SM, 2002, AM J NEURORADIOL, V23, P1647
   BHAMBRI SK, 1995, J BIOMED MATER RES, V29, P233, DOI 10.1002/jbm.820290214
   Deb S, 2001, BIOMATERIALS, V22, P2177, DOI 10.1016/S0142-9612(00)00409-9
   Dehdashti AR, 2000, CARDIOVASC INTER RAD, V23, P235, DOI 10.1007/s002700010052
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Harper EJ, 2000, J BIOMED MATER RES, V53, P605, DOI 10.1002/1097-4636(200009)53:5<605::AID-JBM22>3.0.CO;2-5
   Hasenwinkel JM, 1999, J BIOMED MATER RES, V47, P36, DOI 10.1002/(SICI)1097-4636(199910)47:1<36::AID-JBM5>3.0.CO;2-R
   Hasenwinkel JM, 2002, J BIOMED MATER RES, V59, P411, DOI 10.1002/jbm.1257
   Ishikawa K, 1999, J BIOMED MATER RES, V46, P504, DOI 10.1002/(SICI)1097-4636(19990915)46:4<504::AID-JBM8>3.0.CO;2-H
   JAMES SP, 1992, J BIOMED MATER RES, V26, P651, DOI 10.1002/jbm.820260507
   JASPER LE, 1999, BONE S, V25, P27
   Kim HY, 1999, J BIOMED MATER RES, V48, P135, DOI 10.1002/(SICI)1097-4636(1999)48:2<135::AID-JBM7>3.0.CO;2-6
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2002, J BIOMED MATER RES, V63, P191, DOI 10.1002/jbm.10127
   Lim TH, 2002, SPINE, V27, P1297, DOI 10.1097/00007632-200206150-00010
   Liu CS, 1997, J BIOMED MATER RES, V35, P75, DOI 10.1002/(SICI)1097-4636(199704)35:1<75::AID-JBM7>3.0.CO;2-J
   Molino LN, 1996, J BIOMED MATER RES, V31, P131, DOI 10.1002/(SICI)1097-4636(199605)31:1<131::AID-JBM14>3.0.CO;2-Q
   OWEN AB, 1978, J BIOMED ENG, V1, P277
   Pascual B, 1996, BIOMATERIALS, V17, P509, DOI 10.1016/0142-9612(96)82725-6
   Pascual B, 1999, BIOMATERIALS, V20, P465, DOI 10.1016/S0142-9612(98)00192-6
   RUDIGIER J, 1977, AKTUEL TRAUMATOL, V7, P35
   SOLTESZ U, 1984, METAL CERAMIC BIOMAT, V2, pCH2
   TOPOLESKI LDT, 1990, J BIOMED MATER RES, V24, P135, DOI 10.1002/jbm.820240202
   TREHARNE RW, 1975, J BIOMED MATER RES, V6, P81
   TURNER RC, 1981, J BIOMED MATER RES, V15, P425, DOI 10.1002/jbm.820150312
   WADE LG, 1995, ORGANIC CHEM, P1231
   Xu HHK, 2001, J BIOMED MATER RES, V57, P457, DOI 10.1002/1097-4636(20011205)57:3<457::AID-JBM1189>3.0.CO;2-X
NR 29
TC 32
Z9 33
U1 0
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1051-0443
J9 J VASC INTERV RADIOL
JI J. Vasc. Interv. Radiol.
PD FEB
PY 2004
VL 15
IS 2
BP 121
EP 126
DI 10.1097/01.RVI.0000109394.74740.56
PN 1
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular
   Disease
SC Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System &
   Cardiology
GA 919EF
UT WOS:000228600400003
PM 14963178
DA 2018-10-19
ER

PT J
AU Ohtsu, N
   Ashino, T
   Asami, K
AF Ohtsu, N
   Ashino, T
   Asami, K
TI Silicon contamination adsorbed on pure titanium plate during soaking
   test in Hanks' balanced saline solution
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE silicon contamination; biomaterial; Hanks' balanced saline solution;
   inductively coupled plasma atomic emission spectrometry (ICP-AES); X-ray
   photoelectron spectroscopy (XPS)
ID ALLOYS; SURFACES; CHROMIUM; OXIDES; IRON; XPS
AB Silicon contamination adsorbed on pure Titanium plate during soaking test in Hanks' balanced saline solution (HBSS) and distilled water was investigated. Amounts of silicon eluted from various materials of vessels were determined by inductively coupled plasma atomic emission spectrometry (ICP-AES). The amounts of silicon deposited on the surface of pure titanium plates after soaking were evaluated by XPS. The amounts of eluted silicon in the solutions were dependent on the materials of vessels and pH value of solutions. The surface concentration of silicon on titanium plates reflected the amounts of eluted silicon in solutions. It is possible to reduce the silicon contamination by choosing suitable vessels as containers for solutions. However, in spite of using a vessel with no silicon elution. surface concentration of silicon on titanium plates was detected because of the silicon impurity of solution itself.
C1 Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RP Ohtsu, N (reprint author), Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
EM nohtsu@imr.edu
RI Ashino, Tetsuya/B-9979-2011; Ohtsu, Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   Asami K, 2003, SURF INTERFACE ANAL, V35, P483, DOI 10.1002/sia.1554
   ASAMI K, 1990, CORROS SCI, V31, P727, DOI 10.1016/0010-938X(90)90188-B
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Chern LJH, 1994, J BIOMED MAT, V28, P723
   HASHIMOTO K, 1984, P 9 INT C MET CORR T, V1, P208
   HASHIMOTO K, 1978, BOSHOKU GIJUTSU, V27, P279
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   *JAP SOC PROM SCI, 1963, TEKK KAG BUNS ZENSH, V1, P30
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Prewett W, 1997, ANAL CHIM ACTA, V339, P297, DOI 10.1016/S0003-2670(96)00480-1
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
NR 15
TC 7
Z9 7
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2004
VL 45
IS 2
BP 550
EP 553
DI 10.2320/matertrans.45.550
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 804BY
UT WOS:000220275400079
OA Bronze
DA 2018-10-19
ER

PT J
AU Eid, GM
   Mattar, SG
   Hamad, G
   Cottam, DR
   Lord, IL
   Watson, A
   Dallal, RM
   Schauer, PR
AF Eid, GM
   Mattar, SG
   Hamad, G
   Cottam, DR
   Lord, IL
   Watson, A
   Dallal, RM
   Schauer, PR
TI Repair of ventral hernias-in morbidly obese patients undergoing
   laparoscopic gastric bypass should not be deferred
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   Society-of-American-Gastrointestinal-Endoscopic-Surgeons
CY MAR 13-15, 2003
CL LOS ANGELES, CA
SP Soc Amer Gastrointestinal Endoscop Surg
DE ventral hernias; morbid obesity; small intestine submucosa; laparoscopic
   gastric bypass
ID INCISIONAL HERNIORRHAPHY; INTESTINE SUBMUCOSA; POLYPROPYLENE MESH;
   RECURRENCE
AB Background: There is no consensus regarding the optimal treatment of ventral hernias in patients who present for weight loss surgery.
   Methods: Medical records of consecutive morbidly obese patients who underwent laparoscopic Roux-en-Y (LRYGB) gastric bypass with a secondary diagnosis of ventral hernia were reviewed. Only patients who were beyond 6 months of follow-up were included.
   Results: The study population was 85 patients. There were three groups of patients according to the method of repair: primary repair (59), small intestine submucosa (SIS) (12), and deferred treatment (14). Average follow-up was 26 months. There was a 22% recurrence in the primary repair group. There were no recurrences in the SIS group. Five of the patients in the deferred treatment group (37.5%) presented with small bowel obstruction due to incarceration.
   Conclusion: Biomaterial mesh (SIS) repair of ventral hernias concomitant with LRYGB resulted in the most favorable outcome albeit having short follow-up. Concomitant primary repair is associated with a high rate of recurrence. All incarcerated ventral hernias should be repaired concomitant with LRYGB, as deferment may result in small bowel obstruction.
C1 Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Dept Surg,Minimally Invas Ctr, Pittsburgh, PA 15213 USA.
   Vet Adm Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA.
RP Eid, GM (reprint author), Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Dept Surg,Minimally Invas Ctr, Suite 5500,300 Halket St, Pittsburgh, PA 15213 USA.
CR Anthony T, 2000, WORLD J SURG, V24, P95, DOI 10.1007/s002689910018
   Birgisson G, 2001, SURG ENDOSC-ULTRAS, V15, P1419, DOI 10.1007/s004640080077
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   CLEVELAND RD, 1986, AM SURGEON, V55, P1
   Costanza MJ, 1998, AM SURGEON, V64, P1121
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   DAYTON MT, 1986, ARCH SURG-CHICAGO, V121, P954
   Israelsson LA, 1997, EUR J SURG, V163, P175
   LIAKAKOS T, 1994, BRIT J SURG, V81, P284
   Raftopoulos I, 2002, J LAPAROENDOSC ADV A, V12, P425, DOI 10.1089/109264202762252695
   Ramshaw BJ, 1999, AM SURGEON, V65, P827
   Rios A, 2001, EUR J SURG, V167, P855
   Sugerman HJ, 1996, AM J SURG, V171, P80, DOI 10.1016/S0002-9610(99)80078-6
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 14
TC 57
Z9 58
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD FEB
PY 2004
VL 18
IS 2
BP 207
EP 210
DI 10.1007/s00464-003-8915-1
PG 4
WC Surgery
SC Surgery
GA 839ZI
UT WOS:000222826400007
PM 14691700
DA 2018-10-19
ER

PT J
AU Chu, CL
   Lin, PH
   Dong, YS
   Zhu, JC
   Yin, ZD
AF Chu, CL
   Lin, PH
   Dong, YS
   Zhu, JC
   Yin, ZD
TI Microstructure of titanium component in hydroxyapatite-Ti asymmetrical
   functionally graded biomaterial
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE functionally graded biomaterial; microstructure; hydroxyapatite;
   titanium
ID STABILITY
AB The microstructure of the titanium component in hydroxyapatite (HA)-Ti asymmetrical functionally graded biomaterial (FGM) fabricated by powder metallurgical process was investigated. It is found that the main substructure of the Ti component in the FGM consists of screw dislocations whose Burgers vectors are 1/3<1120> and there are not deformation twins. Screw dislocations are straight and regularly distributed, and cross slip can be observed. The density of the dislocations in the Ti component increases with the rise of the content of the HA component in the FGM. The subgrain boundaries of the Ti component consist of dislocation network walls. Some microbands with bamboo-leaf-shape distribute regularly in Ti grains, which exhibit a specific orientation relationship with alpha-Ti parent phase.
C1 Southeast Univ, Dept Mech Engn, Nanjing 210096, Peoples R China.
   Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Chu, CL (reprint author), Southeast Univ, Dept Mech Engn, Nanjing 210096, Peoples R China.
EM clchu@scu.edu.cn
OI Zhu, Jingchuan/0000-0002-6075-2373
CR BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   Chu CL, 2003, MAT SCI ENG A-STRUCT, V348, P244, DOI 10.1016/S0921-5093(02)00738-4
   Chu CL, 2001, MAT SCI ENG A-STRUCT, V316, P205, DOI 10.1016/S0921-5093(01)01239-4
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Chu CL, 2000, T NONFERR METAL SOC, V10, P505
   CHU CL, 2000, FABRICATION MICROSTR
   CHU CL, 1999, J INORGANIC MAT, V14, P75
   FENG D, 1975, PHYSICS METAL, P627
   KEHAGIAS T, 1994, SCRIPTA METALL MATER, V30, P1311, DOI 10.1016/0956-716X(94)90264-X
   LU XG, 1985, COURSE METALLOGRAPHY, P177
   Moskalenko VA, 1998, MAT SCI ENG A-STRUCT, V246, P282, DOI 10.1016/S0921-5093(97)00713-2
   SMIRNOV AR, 1994, ACTA METALL MATER, V42, P2603, DOI 10.1016/0956-7151(94)90201-1
   SMIRNOV AR, 1988, PHYS MET METALLOGR, V66, P162
   Yang D.Z., 1991, DISLOCATIONS STRENGT, P107
   YOO MH, 1991, PHILOS MAG A, V63, P987, DOI 10.1080/01418619108213931
NR 15
TC 0
Z9 1
U1 0
U2 2
PU ALLERTON PRESS INC
PI NEW YORK
PA 18 WEST 27TH ST, NEW YORK, NY 10001 USA
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD FEB
PY 2004
VL 14
IS 1
BP 25
EP 28
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 800NI
UT WOS:000220034600005
DA 2018-10-19
ER

PT J
AU Shchipunov, YA
   Karpenko, TY
   Bakunina, LY
   Burtseva, YV
   Zvyagintseva, TN
AF Shchipunov, YA
   Karpenko, TY
   Bakunina, LY
   Burtseva, YV
   Zvyagintseva, TN
TI A new precursor for the immobilization of enzymes inside sol-gel-derived
   hybrid silica nanocomposites containing polysaccharides
SO JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
LA English
DT Article
DE O-glycoside hydrolyse; immobilization; sol-gel; hybrid nanocomposite;
   biomaterial; biocatalyst
ID ENCAPSULATION; BIOLOGICALS; POLYMERS
AB Tetrakis(2-hydroxyethyl) orthosilicate (THEOS) introduced by Hoffmann et a]. (J. Phys. Chem. B. 106 (2002) 1528) was first used to prepare hybrid nanocomposites containing various polysaccharides and immobilize enzymes in these materials. Two different types of 0-glycoside hydrolyses (EC3.2.1), 1 --> 3-beta-D-glucanase L-IV from marine mollusk Spisula sacchalinensis and (alpha-D-galactosidase from marine bacterium Pseudoalteromonas sp. KMM 701, were taken for the immobilization. To reveal whether the polysaccharide inside the hybrid material. influences the enzyme entrapment and functioning, negatively charged xanthan, cationic derivative of hydroxyethylcellulose and uncharged locust bean gum were examined. The mechanical properties of these nanocomposites were characterized by a dynamic rheology and their structure by a scanning electron microscopy. It was found that 1-->3+beta-D-glucanase was usually immobilized without the loss of its activity, while the alpha-D-galactosidase activity in the immobilized state depended on the polysaccharide type of material. An important point is that the amount of immobilized enzymes was small, comparable to their content in the living cells. It was shown by the scanning electron microscopy that the hybrid nanocomposites are sufficiently porous that allows the enzymatic substrates and products to diffuse from an external aqueous solution to the enzymes, whereas protein molecules were immobilized firmly and not easily washed out of the silica matfix. A sharp increase of the enzyme lifetime (more than a hundred times) was observed after the immobilization. As established, the efficient entrapment of enzymes is caused by few advantages of new precursor over the currently used TEOS and TMOS: (i) organic solvents and catalysts are not needed owing to the complete solubility of THEOS in water and the catalytic effect of polysaccharides on the sol-gel processes; (ii) the entrapment of enzymes can be performed at any pH which is suitable for their structural integrity and functionality; (iii) a gel can be prepared at reduced concentrations of THEOS (1-2%) in the initial solution that excludes a notable heat release in the course of its hydrolysis. (C) 2003 Elsevier B.V All rights reserved.
C1 Russian Acad Sci, Inst Chem, Far East Dept, Vladivostok 690022, Russia.
   Russian Acad Sci, Inst Bioorgan Chem, Far East Dept, Vladivostok 690022, Russia.
RP Shchipunov, YA (reprint author), Russian Acad Sci, Inst Chem, Far East Dept, Vladivostok 690022, Russia.
EM YAS@ich.dvo.ru
RI Dubrovskaya, Yuliya/M-7325-2013; Zvyagintseva, Tatyana/I-3110-2013;
   Bkunina, Irina/F-9469-2013
CR ANDREEVA AI, 2002, ACTA PHYTOPATHOL ENT, V37, P335
   Bakunina IY, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1209
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Bulgakov VP, 2002, FITOTERAPIA, V73, P638, DOI 10.1016/S0367-326X(02)00231-9
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   Fraasto da Silva J. J.R, 2001, INORGANIC CHEM LIFE
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Goodwin J. W., 2000, RHEOLOGY CHEM INTRO
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Lu ZL, 2002, CHEM REV, V102, P3543, DOI 10.1021/cr010358t
   MEHROTRA RC, 1967, INDIAN J CHEM, V5, P444
   Meyer M, 2002, J PHYS CHEM B, V106, P1528, DOI 10.1021/jp013371q
   Nelson N, 1944, J BIOL CHEM, V153, P375
   Pierre A. C., 1998, INTRO SOL GEL PROCES
   SHCHIPUNOV YA, 2002, 2 INT RHOD C PHYS CH, P72
   SHEVCHENKO NM, 2000, BIOTECHNOLOGIYA, V6, P3
   Shumilina EV, 2002, COLLOID J+, V64, P372, DOI 10.1023/A:1015985229667
   SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006
   Soloveva TF, 1996, MAR TECHNOL SOC J, V30, P35
   SOVA VV, 1972, BIOCHIM BIOPHYS ACTA, V258, P219, DOI 10.1016/0005-2744(72)90980-1
   Yermakova SP, 2002, CARBOHYD RES, V337, P229, DOI 10.1016/S0008-6215(01)00304-4
   Zvyagintseva T. N., 1997, Acta Phytopathologica et Entomologica Hungarica, V32, P59
   Zvyagintseva TN, 1999, CARBOHYD RES, V322, P32, DOI 10.1016/S0008-6215(99)00206-2
   ZVYAGINTSEVA TN, 1998, RUSS J BIOORGAN CHEM, V24, P195
NR 26
TC 75
Z9 77
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-022X
J9 J BIOCHEM BIOPH METH
JI J. Biochem. Biophys. Methods
PD JAN 30
PY 2004
VL 58
IS 1
BP 25
EP 38
DI 10.1016/S0165-022X(03)00108-8
PG 14
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 761ZZ
UT WOS:000187946500003
PM 14597186
DA 2018-10-19
ER

PT J
AU Yang, P
   Kwok, SCH
   Fu, RKY
   Leng, YX
   Wang, J
   Wan, GJ
   Huang, N
   Leng, Y
   Chu, PK
AF Yang, P
   Kwok, SCH
   Fu, RKY
   Leng, YX
   Wang, J
   Wan, GJ
   Huang, N
   Leng, Y
   Chu, PK
TI Structure and properties of annealed amorphous hydrogenated carbon (a-C
   : H) films for biomedical applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 30th International Conference on Metallurgical Coatings and Thin Films
CY APR 28-MAY 02, 2003
CL SAN DIEGO, CALIFORNIA
DE plasma immersion ion implantation-deposition; hydrogenated amorphous
   carbon (a-C : H) film; annealing; blood compatibility
ID DIAMOND-LIKE CARBON; TEMPERATURE ISOTROPIC CARBON; PROTEIN ADSORPTION;
   DLC COATINGS; IN-VITRO; HEMOCOMPATIBILITY; TITANIUM; PLASMA;
   BIOCOMPATIBILITY; ACTIVATION
AB When a biomaterial comes in contact with a biological body, biological substance denaturation will be concomitant with the physical interaction between the biomaterial surface and biological substance, such as blood protein denaturation resulting from electrical charge transfer. In this study, we investigated the relationship between the physical properties of amorphous hydrogenated carbon (a-C:H) and its blood compatibility. The films were fabricated using plasma immersion ion implantation-deposition (PIII-D), followed by annealing in vacuum between 200 and 600 degreesC. A series of a-C:H films with different structures and chemical bonds were characterized by Raman, elastic recoil detection (ERD) and atomic force microscopy (AFM). The results indicate that hydrogen effusion and film. graphitization are promoted at high annealing temperature. The physical properties and surface characteristics of the films including the carrier concentration and mobility, resistivity, band gap and surface wettability were also examined. Their changes with anneal temperature are due to the increase of sp(2) bonding cluster caused by graphitization. The thrombogenesis of the films was evaluated employing in vitro platelet adhesion tests. The adhesion, activation, and morphology of the platelets were investigated using scanning electron microscopy (SEM). The results were correlated with the biological data to elucidate the blood compatibility mechanism of a-C:H films. The platelet adhesion and activation of a-C:H is affected by annealing. It is believed that the possible factors affecting blood compatibility are the adhesion energy of blood plasma, band gap, carrier type and concentration. Improving the electronic structure of a-C:H films is critical to the abatement of platelet activation. (C) 2003 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Leng, Yongxiang/G-5488-2010; Chu, Paul/B-5923-2013; Leng,
   Yang/B-3187-2010; Wan, Guojiang/A-6651-2013; Leng, Y.X./C-2278-2012
OI Chu, Paul/0000-0002-5581-4883; Wan, Guojiang/0000-0002-1636-5405; Leng,
   Y.X./0000-0001-6823-1233
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   FENG L, 1994, J COLLOID INTERF SCI, V166, P419, DOI 10.1006/jcis.1994.1313
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Gutmann F, 1986, MODERN BIOELECTROCHE
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kimura K, 2001, APPL PHYS LETT, V78, P1679, DOI 10.1063/1.1356452
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Ogwu AA, 1999, PHYSICA B, V269, P335, DOI 10.1016/S0921-4526(99)00138-6
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Robertson J, 1997, DIAM RELAT MATER, V6, P212, DOI 10.1016/S0925-9635(96)00627-9
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   SCHALDACH RNS, 1996, J ELECT SPECTROSC PH, V81, P269
   TANG Z, 2001, J APPL PHYS, V89, P1956
   THOMSON A, 1991, BIOMATERIALS, V2, P37
   Tran HS, 1999, J INVEST SURG, V12, P133
   Yu LJ, 2000, SURF COAT TECH, V128, P484, DOI 10.1016/S0257-8972(00)00626-5
NR 26
TC 30
Z9 32
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JAN 30
PY 2004
VL 177
BP 747
EP 751
DI 10.1016/j.surfcoat.2003.08.016
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 775JZ
UT WOS:000189038100113
DA 2018-10-19
ER

PT S
AU Zhang, MJ
   Tarn, TJ
   Xi, N
AF Zhang, MJ
   Tarn, TJ
   Xi, N
GP IEEE
TI A nano-liter bio-material spotting system for bio-chip microarray
   fabrication
SO 2004 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-
   5, PROCEEDINGS
SE IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION
LA English
DT Proceedings Paper
CT IEEE International Conference on Robotics and Automation
CY APR 26-MAY 01, 2004
CL New Orleans, LA
SP IEEE Robot & Automat Soc, IEEE
ID PIN
AB This paper proposes an integrated nano-liter biomaterial spotting system. The system can be used for DNA gene-chip microarray, protein microarray and other chemical microarray fabrication. The system features a fixed print head, which significantly reduces spotting position and spot size uniformity variations. The system also features a unique spotting pin and print head alignment system design.
C1 Agilent Technol, Palo Alto, CA 94304 USA.
RP Zhang, MJ (reprint author), Agilent Technol, Palo Alto, CA 94304 USA.
CR Moore SK, 2001, IEEE SPECTRUM, V38, P54, DOI 10.1109/6.908856
   Smith JT, 2002, P ANN INT IEEE EMBS, P1630, DOI 10.1109/IEMBS.2002.1106573
   Tsai J, 2002, P ANN INT IEEE EMBS, P1632, DOI 10.1109/IEMBS.2002.1106574
   Wu RZ, 2002, TRENDS CELL BIOL, V12, P485, DOI 10.1016/S0962-8924(02)02354-1
   ZHANG MJ, 2002, P 2002 IEEE INT C RO, P1683
   ZHANG MJ, 2003, P 2003 IEEE INT C RO, P2895
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1050-4729
BN 0-7803-8232-3
J9 IEEE INT CONF ROBOT
PY 2004
BP 1456
EP 1461
PG 6
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Robotics
SC Automation & Control Systems; Computer Science; Robotics
GA BAE24
UT WOS:000221794800235
DA 2018-10-19
ER

PT B
AU Aldea, E
   Meghea, A
   Demetrescu, I
AF Aldea, E
   Meghea, A
   Demetrescu, I
GP IEEE
TI Experiment and prognosis of titanium implant behaviour in oral cavity
   environment
SO 2004 International Semiconductor Conference, Vols 1and 2, Proceedings
LA English
DT Proceedings Paper
CT 27th International Semiconductor Conference (CAS)
CY OCT 04-06, 2004
CL Sinaia, ROMANIA
SP Natl Inst Res & Dev Microtechnol, Romanian Acad, Electrochem Soc Inc, IEEE, IEEE Elect Devices Soc, Minist Educ & Res, IEEE Romania Sect, Elect Devices Chapter
AB The paper aims at detecting the corrosion susceptibility of titanium exposed in various simulated artificial saliva. Complementary method such as infrared analysis (IR) and atomic absorption spectroscopy have been used in order to put in evidence the products formed on the surface of metallic biomaterials and the ion release indentification respesctively.
   A Medcalc Programme devoted to medical applications was the instrument for the statistical treatment and the chance to do a prognosis of the biomaterial behaviour for long term.
C1 Politehn Univ Bucharest, Fac Chim Ind, Bucharest, Romania.
RP Aldea, E (reprint author), Politehn Univ Bucharest, Fac Chim Ind, Bucharest, Romania.
RI Meghea, Aurelia/C-2573-2011
CR ALDEA E, 2003, P ROM INT C CHEM CHE, V2, P76
   DEMETRESCU I, 2003, EUROPEAN CELL MAT S, V5, P7
   DEMETRESCU I, IN PRESS MOL CRYSTAL
   HANAVA T, 1998, J BIOMED MAT, V32, P530
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   Popa MV, 2004, ELECTROCHIM ACTA, V49, P2113, DOI 10.1016/j.electacta.2003.12.036
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8499-7
PY 2004
BP 437
EP 440
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BBV33
UT WOS:000228010700090
DA 2018-10-19
ER

PT S
AU Fernando, AL
   Godovikova, V
   Oliveira, JFS
AF Fernando, AL
   Godovikova, V
   Oliveira, JFS
BE Martins, R
   Fortunato, E
   Ferreira, I
   Dias, C
TI Miscanthus X giganteus: Contribution to a sustainable agriculture of a
   future/present - Oriented biomaterial
SO ADVANCED MATERIALS FORUM II
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 2nd International Materials Symposium
CY APR 14-16, 2003
CL New Univ Lisbon, Fac Sci & Technol, Caparica, PORTUGAL
SP Portuguese Mat Soc, Portuguese Sci Fdn, Calouste Gulbenkian Fdn, Luso Amer Fdn
HO New Univ Lisbon, Fac Sci & Technol
DE phytoremediation; heavy metals; Miscanthus; polluted soil; sludge;
   biomaterials
AB The main purpose of this work was to study the phytoremediation capacity of Miscanthus x giganteus to soils contaminated with heavy metals and also to evaluate the environmental risks due to its utilisation as a biomaterial. Indeed, the concentration of metals in the aerial part of the plant might represent a question of its future use. Four levels of contamination were studied: P-0 = 0 t; P-50 = 50 t; P-100 = 100 t; P-200 = 200 t domestic sludge.ha(-1). The results obtained permit to conclude that in terms of the productivity there are significant differences among the plants obtained with different levels of contamination. P50 and P100 presented significantly higher values. In relation to the ash, nitrogen and phosphorous contents, the results showed an increase in mineral matter and an accumulation in nitrogen and phosphorous, in the plants, with the increase of the level of contaminants. But this increase was not significant. No significant differences were observed in the plants among the different levels of sludge, for most of the metals studied. This fact leads to the conclusion that the utilisation of the biomass, obtained in those contaminated fields, is possible, as a biomaterial. Thus, contributing not only to increase its economical value but also to a sustainable agriculture.
C1 Univ Nova Lisboa, Fac Ciencias & Tecnol, Grp Disciplinas Ecol Hidrosfera, P-2829516 Quinta De Torre, Caparica, Portugal.
   Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia.
RP Oliveira, JFS (reprint author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Grp Disciplinas Ecol Hidrosfera, P-2829516 Quinta De Torre, Caparica, Portugal.
EM jfso@fct.unl.pt
RI Fernando, Ana Luisa/I-2796-2012
OI Fernando, Ana Luisa/0000-0001-9270-3982
CR Baird C., 1998, ENV CHEM
   DUARTE P, 1996, FIN M EUR MISC NETW
   ElBassam N, 1998, ENERGY PLANT SPECIES
   FERNANDO A, 2000, 9 ENC NAC SAN BAS LO, P623
   Jones MB, 2001, MISCANTHUS ENERGY FI
   WILKINS C, 1995, P 8 EUR C BIOM EN EN, V3, P2269
NR 6
TC 7
Z9 8
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-941-5
J9 MATER SCI FORUM
PY 2004
VL 455-456
BP 437
EP 441
DI 10.4028/www.scientific.net/MSF.455-456.437
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BAF50
UT WOS:000222018500095
DA 2018-10-19
ER

PT J
AU Mizutani, M
   Komotori, J
   Katahira, K
   Watanabe, Y
   Ohmori, H
AF Mizutani, M
   Komotori, J
   Katahira, K
   Watanabe, Y
   Ohmori, H
TI Improvement of corrosion resistance and mechanical properties of the
   biomaterial Ti-6Al-4V alloy by ELID grinding
SO ADVANCES IN ABRASIVE TECHNOLOGY VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article
DE biornaterial; Ti-6Al-4V alloy; ELID grinding; surface modification;
   corrosion response; surface hardness
AB To clarify the effects of the ELID (Electrolytic In-process Dressing) grinding on surface characteristics of the biomaterial Ti-6Al-4V alloy, electrochemical corrosion tests were carried out using a three-electrode electrochemical cell connected to a computer driven potentiostat. The processed surfaces were analyzed by the X-ray Photoelectron Spectroscopy (XPS). The surface hardness of the samples was measured by a Nano Hardness Tester (NHT). The surface finished by the ELID grinding method showed higher corrosion resistance, compared to the surface finished by polishing. This is due to the influence of the oxidized layer on the surface and also due to the diffusion of oxygen. The diffused oxygen accelerates the regeneration of the oxide layer broken by the raised potential and prevents the dissolution of metal ions. Surface hardness was increased by the ELID grinding. This is because of the existence of the carbon diffused layer beneath the surface.
C1 Keio Univ, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
   Inst Phys & Chem Res, Wako 3580198, Japan.
RP Mizutani, M (reprint author), Keio Univ, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
RI Komotori, Jun/G-9232-2014; Ohmori, Hitoshi/A-7562-2015
CR KATAHIRA K, 2002, 3 EUSP INT C EINDH N, P217
   OHMORI H, 2002, ANN CIRP, V51, P491
   Ohmori H, 1995, ANN CIRP, V44, P287
   OHMORI H, 1997, ANN CIRP, V46, P261
   WINTER GD, 1980, EVALUATION BIOMATERI
   WISBEY A, 1991, BIOMATERIALS, V12, P470, DOI 10.1016/0142-9612(91)90144-Y
   1972, STANDARD REFERENCE T
   1974, CONVENTIONS APPL ELE
NR 8
TC 1
Z9 1
U1 2
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2004
VL 257-258
BP 473
EP 476
DI 10.4028/www.scientific.net/KEM.257-258.473
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BBY24
UT WOS:000228297900079
DA 2018-10-19
ER

PT S
AU Park, SD
   Todo, M
   Arakawa, K
AF Park, SD
   Todo, M
   Arakawa, K
BE Kishimoto, K
   Kikuchi, M
   Shoji, T
   Saka, M
TI Effect of annealing on fracture mechanism of biodegradable poly(lactic
   acid)
SO ADVANCES IN FRACTURE AND FAILURE PREVENTION, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Fracture and Strength of Solids/2nd
   International Conference on Physics and Chemistry of Fracture and
   Failure Prevention
CY OCT 20-22, 2003
CL Tohoku Univ, Sendai, JAPAN
SP Far E & Ocean Fracture Soc, Thohku Univ, Ctr Phys & Chem Fracture & Failure Prevent, Minist Educ, Culture, Sports, Sci & Technol
HO Tohoku Univ
DE biomaterial; annealing; fracture toughness; crack growth behavior;
   crazing; crystallization; dynamic loading
ID SOLUTION-GROWN CRYSTALS; POLY(L-LACTIDE)
AB Effect of annealing on the fracture behavior of poly(lactic acid) (PLA) was investigated. Fracture toughness of PLA samples prepared under different annealing conditions was measured under static and dynamic loadings. Microstructure and crack growth behavior were characterized by polarizing microscopy (POM). Crystallinity was determined by DSC analysis. Fracture surface morphology was also studied by scanning electron microscopy. It was shown that the static fracture toughness increased with increase of crystallinity, while the dynamic toughness increased as crystallinity increased. POM exhibited that craze formation played an important role in the fracture mechanism of amorphous samples. Macroscopic fracture toughness and microscopic crack growth mechanism were correlated on the basis of these experimental results, and effect of annealing on the toughness and mechanism were discussed.
C1 Kyushu Univ, Res Inst Appl Mech, Kasuga, Fukuoka 8168580, Japan.
RP Park, SD (reprint author), Kyushu Univ, Res Inst Appl Mech, Kasuga, Fukuoka 8168580, Japan.
RI Kyushu, RIAM/F-4018-2015; U-ID, Kyushu/C-5291-2016
OI Kyushu, RIAM/0000-0002-3518-444X; 
CR *ASTM, D504591A ASTM
   BOTSIS J, 1987, INT J FRACTURE, V33, P263, DOI 10.1007/BF00044415
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   Huda MS, 2002, MAT SCI ENG A-STRUCT, V333, P98, DOI 10.1016/S0921-5093(01)01834-2
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Miyata T, 1997, POLYMER, V38, P4003, DOI 10.1016/S0032-3861(96)00987-1
   Todo M, 2002, J MATER SCI LETT, V21, P1203, DOI 10.1023/A:1016520518959
   TSUJI H, 1995, POLYMER, V36, P2709, DOI 10.1016/0032-3861(95)93647-5
NR 8
TC 13
Z9 13
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-938-5
J9 KEY ENG MAT
PY 2004
VL 261-263
BP 105
EP 110
DI 10.4028/www.scientific.net/KEM.261-263.105
PN 1&2
PG 6
WC Materials Science, Ceramics; Mechanics; Materials Science, Composites
SC Materials Science; Mechanics
GA BAC70
UT WOS:000221573900016
DA 2018-10-19
ER

PT J
AU Patrick, CW
AF Patrick, CW
TI Breast tissue engineering
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE adipogenesis; adipose tissue engineering; biomaterial; breast
   reconstruction; fat tissue
ID FIBROBLAST-GROWTH-FACTOR; EXTRACELLULAR-MATRIX COMPONENTS;
   ABDOMINAL-WALL FUNCTION; DE-NOVO ADIPOGENESIS; HUMAN ADIPOSE-TISSUE;
   LONG-TERM; ADIPOCYTE DIFFERENTIATION; CAPSULAR CONTRACTURE;
   ENDOTHELIAL-CELLS; IN-VITRO
AB Tissue engineering has the potential to redefine rehabilitation for the breast cancer patient by providing a translatable strategy that restores the postmastectomy breast mound while concomitantly obviating limitations realized with contemporary reconstructive surgery procedures. The engineering design goal is to provide a sufficient volume of viable fat tissue based on a patient's own cells such that deficits in breast volume can be abrogated. To be sure, adipose tissue engineering is in its infancy, but tremendous strides have been made. Numerous studies attest to the feasibility of adipose tissue engineering. The field is now poised to challenge barriers to clinical translation that are germane to most tissue engineering applications, namely scale-up, large animal model development, and vascularization. The innovative and rapid progress of adipose engineering to date, as well as opportunities for its future growth, is presented.
C1 Univ Texas, MD Anderson Canc Ctr, Lab Reparat Biol & Bioengn, Dept Plast Surg, Houston, TX 77030 USA.
   Univ Texas, Ctr Biomed Engn, Houston, TX 77030 USA.
RP Patrick, CW (reprint author), Univ Texas, MD Anderson Canc Ctr, Lab Reparat Biol & Bioengn, Dept Plast Surg, 1515 Holcombe Blvd, Houston, TX 77030 USA.
EM cpatrick@mdanderson.org
CR *AM CANC SOC, 2002, BREAST CANC STAT 200
   *AM SOC PLAST SURG, 2002, 2001 NAT CLEAR PLAST
   ATALA A, 2001, METHODS TISSUE ENG
   Baran CN, 2001, AESTHET PLAST SURG, V25, P427, DOI 10.1007/s00266-001-0003-0
   BEAHM E, 2000, AM SOC REC MICR SAN
   Beahm EK, 2003, CLIN PLAST SURG, V30, P547, DOI 10.1016/S0094-1298(03)00072-5
   Bosetti M, 1998, J BIOMED MATER RES, V40, P307, DOI 10.1002/(SICI)1097-4636(199805)40:2<307::AID-JBM16>3.0.CO;2-I
   Bostwick III J., 2000, PLASTIC RECONSTRUCTI
   Bouloumie A, 2002, ANN ENDOCRINOL-PARIS, V63, P91
   Bronz G, 1999, AESTHET PLAST SURG, V23, P424, DOI 10.1007/s002669900313
   Brown MH, 2002, PLAST RECONSTR SURG, V109, P2242, DOI 10.1097/00006534-200206000-00011
   CASTELLOT JJ, 1982, P NATL ACAD SCI-BIOL, V79, P5597, DOI 10.1073/pnas.79.18.5597
   CASTELLOT JJ, 1980, P NATL ACAD SCI-BIOL, V77, P6007, DOI 10.1073/pnas.77.10.6007
   CHAJCHIR A, 1986, AESTHET PLAST SURG, V10, P115, DOI 10.1007/BF01575279
   Chen DT, 2000, LECT NOTES COMPUT SC, V1935, P1040
   Cinti S, 2002, J ENDOCRINOL INVEST, V25, P823, DOI 10.1007/BF03344046
   CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317
   Clough KB, 2001, PLAST RECONSTR SURG, V107, P1702, DOI 10.1097/00006534-200106000-00010
   COLEMAN DJ, 1991, BRIT J PLAST SURG, V44, P444, DOI 10.1016/0007-1226(91)90204-W
   Coleman SR, 1997, CLIN PLAST SURG, V24, P347
   COLEMAN SR, 1995, AESTHET PLAST SURG, V19, P421, DOI 10.1007/BF00453875
   Coleman WP, 1999, DERMATOL CLIN, V17, P891, DOI 10.1016/S0733-8635(05)70136-4
   CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531
   Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786
   DELAFUENTE A, 1988, AESTHET PLAST SURG, V12, P39, DOI 10.1007/BF01570384
   DUNNINGTON GL, 2000, ESSENTIALS GEN SURG, P368
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   ELLENBOGEN R, 1990, AESTHET PLAST SURG, V24, P197
   EROL OO, 1990, PLAST RECONSTR SURG, V86, P510, DOI 10.1097/00006534-199009000-00022
   Ersek RA, 1998, PLAST RECONSTR SURG, V101, P820, DOI 10.1097/00006534-199803000-00038
   FELLER AM, 1994, CLIN PLAST SURG, V21, P223
   Flassbeck D, 2003, ANAL BIOANAL CHEM, V375, P356, DOI 10.1007/s00216-002-1694-z
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130
   Gerszten PC, 1999, BIOMATERIALS, V20, P1063, DOI 10.1016/S0142-9612(99)00008-3
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Halberstadt C, 2002, TISSUE ENG, V8, P309, DOI 10.1089/107632702753725067
   HALBERSTADT CR, 2000, 6 WORLD BIOM C KAM H
   Harp JB, 2001, BIOCHEM BIOPH RES CO, V281, P907, DOI 10.1006/bbrc.2001.4460
   HARTRAMPF CR, 1984, ANN PLAS SURG, V12, P139, DOI 10.1097/00000637-198402000-00008
   Hausman GJ, 1998, J ANIM SCI, V76, P48
   Holst D, 2002, CURR OPIN LIPIDOL, V13, P241, DOI 10.1097/00041433-200206000-00002
   Huss FRM, 2001, CELLS TISSUES ORGANS, V169, P361, DOI 10.1159/000047903
   Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037
   Jacobson N, 1998, AM J PUBLIC HEALTH, V88, P1254, DOI 10.2105/AJPH.88.8.1254
   JUNQUEIRA LC, 1989, BASIC HISTOLOGY, P461
   Kakadiaris I., 2000, Tissue Engineering, V6, P662
   Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062
   Kimura Y, 2002, TISSUE ENG, V8, P603, DOI 10.1089/107632702760240526
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Knutson VP, 2000, ENDOCRINOLOGY, V141, P693, DOI 10.1210/en.141.2.693
   Kral JG, 1999, PLAST RECONSTR SURG, V104, P1732, DOI 10.1097/00006534-199911000-00018
   LAU DC, 1990, INT J OBESITY, V20, P16
   LAVKER RM, 1991, AM J PATHOL, V138, P687
   LEJOUR M, 1991, PLAST RECONSTR SURG, V87, P1054, DOI 10.1097/00006534-199106000-00007
   Loftus TM, 1997, CURR OPIN GENET DEV, V7, P603, DOI 10.1016/S0959-437X(97)80006-8
   Lucarelli E, 1999, INT J MOL MED, V4, P593
   Maas CS, 1998, PLAST RECONSTR SURG, V101, P1307, DOI 10.1097/00006534-199804050-00023
   MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021
   MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3
   Maeda K, 1997, GENE, V190, P227, DOI 10.1016/S0378-1119(96)00730-5
   Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   MATSUDO PKR, 1988, AESTHET PLAST SURG, V12, P35, DOI 10.1007/BF01570383
   Mick GJ, 2002, ENDOCRINOLOGY, V143, P948, DOI 10.1210/en.143.3.948
   MOORE KL, 1992, CLIN ORIENTED ANATOM, P45
   MORRISON W, 2001, ASS REC MICR SAN DIE
   MUZAFFER AR, 2001, PLAST RECONSTR SURG, V109, P742
   Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1046/j.1432-0436.1998.6340193.x
   NIECHAJEV I, 1994, PLAST RECONSTR SURG, V94, P496, DOI 10.1097/00006534-199409000-00012
   Ntambi JM, 2000, J NUTR, V130, p3122S
   Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473
   Pandya AN, 2002, BRIT J PLAST SURG, V55, P455, DOI 10.1054/bjps.2002.3864
   PANEPINTO LM, 1986, LAB ANIM SCI, V36, P344
   Patel P., 2003, SEMIN PLAST SURG, V17, P99
   PATEL PN, 2004, SCAFFOLDING TISSUE E
   PATEL PN, 2002, 2 JOINT EMBS BMES C
   Patrick C.W.J., 1998, FRONTIERS TISSUE ENG, P369
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2003, ANN BIOMED ENG, V31, P505, DOI 10.1114/1.1566446
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   PATRICK CW, 2001, METHODS TISSUE ENG, P143
   PEER LA, 1977, RECONSTRUCTIVE PLAST, P251
   Peters W, 1998, ANN PLAS SURG, V41, P348, DOI 10.1097/00000637-199810000-00002
   POLLOCK H, 1993, PLAST RECONSTR SURG, V91, P404, DOI 10.1097/00006534-199303000-00002
   RENNEKER R, 1952, JAMA-J AM MED ASSOC, V148, P834
   ROBB G, 2001, METHODS TISSUE ENG, P881
   ROBB GL, 2001, BREAST CANC, P223
   Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950
   ROWETON S, 2000, JOHNS JOHNS EXC SCI
   SARH K, 2001, AM SOC MECH ENG NEW
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   Siggelkow W, 2003, BIOMATERIALS, V24, P1101, DOI 10.1016/S0142-9612(02)00429-5
   SILVERMAN KJ, 1988, BIOCHEM BIOPH RES CO, V153, P347, DOI 10.1016/S0006-291X(88)81229-4
   SMAHEL J, 1985, CHIR PLAST, V8, P109
   SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697
   Sorisky A, 1999, CRIT REV CL LAB SCI, V36, P1, DOI 10.1080/10408369991239169
   SPEAR S, 1999, PLAST RECONSTR SURG, V105, P15
   Sul HS, 1998, PROG NUCLEIC ACID RE, V60, P317, DOI 10.1016/S0079-6603(08)60896-X
   Tabata Y, 2000, TISSUE ENG, V6, P279, DOI 10.1089/10763270050044452
   Tebbetts JB, 2002, PLAST RECONSTR SURG, V109, P1396, DOI 10.1097/00006534-200204010-00030
   VARZANEH FE, 1994, METABOLISM, V43, P906, DOI 10.1016/0026-0495(94)90275-5
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   von Heimburg D, 2001, PLAST RECONSTR SURG, V108, P411, DOI 10.1097/00006534-200108000-00020
   VONHEIMBURG D, 1994, BRIT J PLAST SURG, V47, P470, DOI 10.1016/0007-1226(94)90029-9
   WALTON RL, 1993, ANN PLAS SURG, V30, P105, DOI 10.1097/00000637-199302000-00002
   WALTON RL, 2004, IN PRESS MICROSURGER
   Wechselberger G, 2002, PLAST RECONSTR SURG, V110, P123, DOI 10.1097/00006534-200207000-00022
   Xaymardan M, 2002, ANAT REC, V267, P28, DOI 10.1002/ar.10072
   Young VL, 1997, PLAST RECONSTR SURG, V100, P182, DOI 10.1097/00006534-199707000-00029
   Yu ZK, 1998, OBES RES, V6, P299, DOI 10.1002/j.1550-8528.1998.tb00353.x
   Yuksel E, 2000, PLAST RECONSTR SURG, V105, P1712, DOI 10.1097/00006534-200004050-00017
   Yuksel E, 2000, PLAST RECONSTR SURG, V105, P1721, DOI 10.1097/00006534-200004050-00018
   Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983
   Zuckerman Diana, 2002, Plast Surg Nurs, V22, P66
NR 119
TC 88
Z9 94
U1 1
U2 13
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1523-9829
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2004
VL 6
BP 109
EP 130
DI 10.1146/annurev.bioeng.6.040803.140032
PG 24
WC Engineering, Biomedical
SC Engineering
GA 852ZM
UT WOS:000223795500005
PM 15255764
DA 2018-10-19
ER

PT B
AU Major, R
   Kustosz, R
   Pawlowski, A
AF Major, R
   Kustosz, R
   Pawlowski, A
BE Morawiec, H
   Stroz, D
TI Thin layers of TiN fabricated on metallic titanium and polyurethane by
   pulsed laser deposition
SO APPLIED CRYSTALLIGRAPHY
LA English
DT Proceedings Paper
CT 19th Conference on Applied Crystallography
CY SEP 01-04, 2003
CL Cracow, POLAND
SP Polish Minist Educ, Polish Acad Sci, State Comm Sci Res, Int Union Crystallog
ID NITRIDE FILMS; ROOM-TEMPERATURE; ABLATION; GROWTH
AB Blood-contacting devices are routinely used in modem medicine. All surfaces other than the undamaged vascular wall endothelium induce a sequence of processes that results in thrombus formation. Titanium nitride (TiN) is regarded as a potential biomaterial for blood-contact applications. Titanium nitride thin layers were fabricated by pulsed laser deposition (PLD) using a Nd:YAG laser on two types of biomaterials like: metallic titanium and polyurethane. Formation of the uniform smooth surface was stated in both cases. Application of scanning electron microscopy (SEM) for examination of the cross-section of the materials revealed the form of diffusion layers with continuous variation of the titanium content between the deposited film and the substrate. Transmission electron microscopy (TEM) examinations performed on the thin foils prepared from the cross-section of the metallic titanium covered with the TiN confirmed the diffusion character of the deposited layer, presenting moreover a fine grained microstructure of the deposited TiN phase. Texture examinations were carried out for the deposited TiN as well as for the titanium substrate. Application of the position sensitive detector in texture examination allow to draw simultaneously the pole figures of crystallographic texture and the residual stresses, while using the X-ray diffraction method for residual stress measurement (sin2Psi) made possible to measure their values which were for the TiN phase in the range -8 to -10 GPa for films fabricated on the metallic titanium substrate and of the order of 4 to -5 GPa for the polyurethane substrate. Morphology of the surface of the deposited layers was examined by application of atomic force microscopy (AFM). The results revealed influence of the deposition parameters as well as the thickness of the layer on the crystallite sizes and vertical diameter.
C1 Polish Acad Sci, Inst Met & Mat Sci, PL-30059 Krakow, Poland.
RP Major, R (reprint author), Polish Acad Sci, Inst Met & Mat Sci, 25 Reymonta St, PL-30059 Krakow, Poland.
CR AUCIELLO O, 1989, THIN SOLID FILMS, V181, P65, DOI 10.1016/0040-6090(89)90473-2
   BIUNNO N, 1989, APPL PHYS LETT, V54, P1519, DOI 10.1063/1.101338
   BORDIJ K, 1996, BIOMATERIALS, V17, P92
   BULL, 1990, SURF COAT TECHNOL, P41
   Chowdhury R, 1996, J MATER RES, V11, P1458, DOI 10.1557/JMR.1996.0182
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Czarnowska E, 2000, J Mater Sci Mater Med, V11, P73, DOI 10.1023/A:1008980631780
   DION I, 1992, BIOCERAMICS AND THE HUMAN BODY, P345
   DION I, 1993, BIOMATERIALS, V14, P107, DOI 10.1016/0142-9612(93)90218-Q
   DION I, 1992, INT J ARTIF ORGANS, V15, P457
   DION I, 1993, BIOMATERIALS, V14, P9
   DION I, 1992, EMBS IEEE, V1, P5
   DION I, 1993, INT J ARTIF ORGANS
   DUCHATEAU D, 1991, CETIM INFORMATIONS, V122, P42
   Gu HD, 1998, SURF COAT TECH, V110, P153, DOI 10.1016/S0257-8972(98)00690-2
   HOLMBERG K, 1994, COATINGS TRIBOLOGY
   Huaxia J., 1993, BIOMATERIALS, V<bold>14</bold>, P64, DOI 10.1016/0142-9612(93)90077-F
   LACKNER JM, 2003, IN PRESS ANGEWANDTE
   MELTIS EI, 1996, SURFACE COATING TECH, V149
   Phani AR, 2001, APPL SURF SCI, V174, P132, DOI 10.1016/S0169-4332(01)00153-2
   SCHULZ HA, 1991, MED DEVICES TECHNOL, V2
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 22
TC 0
Z9 0
U1 1
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 981-238-761-7
PY 2004
BP 307
EP 315
DI 10.1142/9789812702913_0060
PG 9
WC Crystallography; Materials Science, Ceramics; Materials Science,
   Multidisciplinary; Polymer Science
SC Crystallography; Materials Science; Polymer Science
GA BCM10
UT WOS:000229966600060
DA 2018-10-19
ER

PT S
AU Geer, DJ
   Swartz, DD
   Andreadis, ST
AF Geer, DJ
   Swartz, DD
   Andreadis, ST
BE Wong, JY
   Plant, AL
   Schmidt, CE
   Shea, L
   Coury, AJ
   Chen, CS
   Barron, AE
   Klok, HA
   Saltzman, WM
   Chilkoti,A
   Luo, D
   Uhrich, K
TI Cell-controlled delivery of keratinocyte growth factor for accelerated
   healing of skin wounds in vivo
SO ARCHITECTURE AND APPLICATION OF BIOMATERIALS AND BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Architecture and Application of Biomaterials and
   Biomolecular Materials held at the 2003 MRS Fall Meeting
CY DEC 01-04, 2003
CL Boston, MA
ID CONTROLLED-RELEASE; CROSS-LINKING; FIBRIN; GELS
AB Controlled delivery of growth factors using fibrin gels has been recently demonstrated by incorporating peptides that effectively link heparin-binding proteins into the fibrin matrix during polymerization. In this study, we developed a novel method to conjugate keratinocyte growth factor (KGF) to fibrin gels by covalently attaching fluorescent matrix-binding peptides to the protein surface. The release profile of the modified KGF (pKGF) was studied in vitro to determine the best gel formulations for Sustained delivery by degrading fibrin gels with plasmin to mimic cell-mediated degradation. Total fluorescence measurements revealed that approximately 95% of modified KGF Could be incorporated into the fibrin matrix as compared to only < 2% using unmodified growth factor. Incorporation was dose dependent on Factor XIII with 10 PEU/ml yielding the best results. Western analysis revealed that peptides could be effectively attached to KGF at various molar ratios. Surprisingly, plasmin-mediated degradation recovered the KGF protein without substantial changes in molecular weight. The pKGF and plasmin-derived pKGF was found to be functional as determined by an ELISA, cell cycle and BrdU incorporation assays with keratinocytes in culture. To demonstrate & effectiveness of the KGF delivery system, we developed an in vivo model of wound healing using human skin equivalents transplanted onto athymic mice. The transplanted tissues were punch Wounded and treated with fibrin loaded with pKGF. We found that the gel localized to the area of the Wound and was Subsequently degraded by migrating cells. Our results suggest that fibrin May be a suitable biomaterial for controlled release of growth factors to increase cellular migration and growth, ultimately promoting faster healing of the skin.
C1 SUNY Buffalo, Dept Chem Engn, Buffalo, NY 14260 USA.
RP Geer, DJ (reprint author), SUNY Buffalo, Dept Chem Engn, Buffalo, NY 14260 USA.
CR Coulombe PA, 1997, BIOCHEM BIOPH RES CO, V236, P231, DOI 10.1006/bbrc.1997.6945
   DVORAK HF, 1987, LAB INVEST, V57, P673
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   ICHINOSE A, 1983, FEBS LETT, V153, P369, DOI 10.1016/0014-5793(83)80645-0
   Medalie DA, 1996, J INVEST DERMATOL, V107, P121, DOI 10.1111/1523-1747.ep12298363
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
NR 9
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-745-8
J9 MATER RES SOC SYMP P
PY 2004
VL 1
BP 17
EP 21
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAB22
UT WOS:000221434200004
DA 2018-10-19
ER

PT S
AU Leach, JB
   Schmidt, CE
AF Leach, JB
   Schmidt, CE
BE Wong, JY
   Plant, AL
   Schmidt, CE
   Shea, L
   Coury, AJ
   Chen, CS
   Barron, AE
   Klok, HA
   Saltzman, WM
   Chilkoti,A
   Luo, D
   Uhrich, K
TI Photocrosslinkable hyaluronic acid hydrogels for tissue engineering
SO ARCHITECTURE AND APPLICATION OF BIOMATERIALS AND BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Architecture and Application of Biomaterials and
   Biomolecular Materials held at the 2003 MRS Fall Meeting
CY DEC 01-04, 2003
CL Boston, MA
AB Comprehensive tissue engineering therapies Should lie bioactive, provide a degradable scaffold for cell growth, and promote natural healing. Our goal was to design a hydrogel biomaterial based on hyaluronic acid (HA; also called hyaluronan). HA is a natural, non-immunogenic polynier that has a unique combination of advantages: an case of production and modification. a hydrophilic and non-adhesive character, and an enzymatically-mediated degradation. We created glycidyl methacrylate-HA (GMHA) conjugates, which were then photocrosslinked to form hydrogels. We demonstrated the feasibility of GMHA hydrogels and composites with poly(lactic-co-glycolic acid) (PLGA) microspheres to controllably release a model protein, bovine serum albumin (BSA). We conclude that GMHA hydrogels are promising scaffolding biomaterials for a variety of soft tissue engineering applications.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RP Leach, JB (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
CR Cleland JL, 2001, CURR OPIN BIOTECH, V12, P212, DOI 10.1016/S0958-1669(00)00202-0
   Crank J, 1975, MATH DIFFUSION
   DAVIS BK, 1974, P NATL ACAD SCI USA, V71, P3120, DOI 10.1073/pnas.71.8.3120
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   LEACH JB, IN PRESS ENCY BIOMAT
   LEACH JB, UNPUB J BIOMED MAT R
   LEACH JB, UNPUB BIOMATERIALS
   LEACH WT, UNPUB
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG, P397
   Narasimhan B., 1999, ENCY CONTROLLED DRUG, P921
   YI Z, 2002, EUR J PHARM BIOPHARM, V54, P221
NR 11
TC 1
Z9 1
U1 2
U2 10
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-745-8
J9 MATER RES SOC SYMP P
PY 2004
VL 1
BP 33
EP 35
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAB22
UT WOS:000221434200007
DA 2018-10-19
ER

PT S
AU Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
AF Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
BE Wong, JY
   Plant, AL
   Schmidt, CE
   Shea, L
   Coury, AJ
   Chen, CS
   Barron, AE
   Klok, HA
   Saltzman, WM
   Chilkoti,A
   Luo, D
   Uhrich, K
TI Development of a novel method for surface modification of synthetic
   polymer using combinatorial peptide screening technologies
SO ARCHITECTURE AND APPLICATION OF BIOMATERIALS AND BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Architecture and Application of Biomaterials and
   Biomolecular Materials held at the 2003 MRS Fall Meeting
CY DEC 01-04, 2003
CL Boston, MA
AB The goal in biomaterial surface modification is to retain the bulk properties while modifying only the surface to possess desired functional groups. In this investigation a novel method for surface modification of synthetic polymers was developed where polymer-specific peptide were used for surface functionalization. Phage display technology, a combinatorial method of screening peptide sequence library, was used to select peptides that have binding specificity to chlorine-doped polypyrrole, an electrically conductive polymer. Once specific-peptides are identified, any biomolecule, including cells. can potentially be immobilized and spatially controlled for functionalizing biomaterials. This approach presents several advantages such as the ability to control orientation of the biomolecule immobilized using the selected peptide eliminates changes to the bulk property of the material, and can be potentially applied to various biomaterials.
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Dept Bioengn, Cambridge, MA 02139 USA.
RP Sanghvi, AB (reprint author), Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
CR Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   MAO C, 2003, P NATL ACAD SCI USA, V12, P6946
   MILLER KPH, 2002, THESIS U TEXAS AUSTI
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Whaley SR, 2000, NATURE, V405, P665
NR 5
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-745-8
J9 MATER RES SOC SYMP P
PY 2004
VL 1
BP 281
EP 283
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAB22
UT WOS:000221434200057
DA 2018-10-19
ER

PT S
AU Yu, SM
   Wang, YL
   Yun, CS
AF Yu, SM
   Wang, YL
   Yun, CS
BE Wong, JY
   Plant, AL
   Schmidt, CE
   Shea, L
   Coury, AJ
   Chen, CS
   Barron, AE
   Klok, HA
   Saltzman, WM
   Chilkoti,A
   Luo, D
   Uhrich, K
TI Exploitation of collagen mimetic peptide as a collagen adhesive
   biopolymer for novel biomaterials development
SO ARCHITECTURE AND APPLICATION OF BIOMATERIALS AND BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Architecture and Application of Biomaterials and
   Biomolecular Materials held at the 2003 MRS Fall Meeting
CY DEC 01-04, 2003
CL Boston, MA
AB Collagen, either alone or in combination with other component, is in important biomaterial that is used in a variety of medical applications ranging from hemostatic materials and biocompatible coatings to drug delivery and tissue engineering. Currently, there are manifest biomedical interests in modifying the structure of natural collagen to improve its biochemical and mechanical properties. As an alternative to the prevalent "chemical" modification method, we have developed a novel "physical" collagen modification technique that is based on collagen's native ability to fold into triple-helix molecular architecture. Here we present that synthetic collagen mimetic peptides exhibit specific affinity to natural collagen under controlled thermal conditions (heat or laser treatment). Such affinity can be explored as a new targeting method to attach therapeutic drugs to collagens in the living tissues and to biomaterials that incorporate natural collagens.
C1 Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA.
RP Yu, SM (reprint author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
RI Yu, Michael/A-3332-2010
CR Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
NR 4
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-745-8
J9 MATER RES SOC SYMP P
PY 2004
VL 1
BP 295
EP 299
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAB22
UT WOS:000221434200059
DA 2018-10-19
ER

PT J
AU Matsuda, T
AF Matsuda, T
TI Recent progress of vascular graft engineering in Japan
SO ARTIFICIAL ORGANS
LA English
DT Article
DE scaffold; artificial extracellular matrix; antithrombogenic coating;
   vascular cell type; vascular tissue engineering
ID SURFACE MICROARCHITECTURAL DESIGN; BONE-MARROW-TRANSPLANTATION;
   AUTOLOGOUS ADIPOSE-TISSUE; LASER ABLATION TECHNIQUE; SMOOTH-MUSCLE
   CELLS; IN-VITRO; EXCIMER-LASER; BIOMEDICAL APPLICATIONS; REGENERATION
   PROCESS; ARTERIAL PROSTHESES
AB The development of a small-diameter vascular graft has long been awaited. This review covers research activities, achievements and progress on vascular engineering in Japan, which was conducted over the last decade. The article includes recently developed experimental scaffolds, biologically active artificial extracellular matrices (ECMs) or non-fouling synthetic coatings, cell sourcing including the autologous vascular cell type, endothelial progenitor cells and genetically-engineered, temporary endothelial-like cells. The discussions were presented from biomechanical, biomaterial, cellular and tissue aspects. Once the mechano-biological and biologically active extracellular milieus are established in a designed vascular graft, the functional, structural and mechanical tissue morphogenesis and adaptation of implanted vascular grafts may proceed with implantation duration, and the spatio-temporal tissue modulations at cytokine, cellular, ECM levels under physiological stress proceed to regenerate vascular tissue architecture. The ultimate solution to a small-diameter vascular graft should be realized by optimal combinations of these factors.
C1 Kyushu Univ, Grad Sch Med Sci, Div Biomed Engn, Higashi Ku, Fukuoka 8128582, Japan.
RP Matsuda, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Div Biomed Engn, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.
EM matsuda@med.kyushu-u.AC.JP
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Doi K, 1997, J BIOMED MATER RES, V34, P361, DOI 10.1002/(SICI)1097-4636(19970305)34:3<361::AID-JBM11>3.0.CO;2-J
   Doi K, 1997, J BIOMED MATER RES, V37, P573, DOI 10.1002/(SICI)1097-4636(19971215)37:4<573::AID-JBM17>3.0.CO;2-9
   Doi K, 1996, J BIOMED MATER RES, V31, P27, DOI 10.1002/(SICI)1097-4636(199605)31:1<27::AID-JBM4>3.0.CO;2-S
   FRY WJ, 1964, ARCH SURG-CHICAGO, V88, P836
   HAYASHI K, 1985, Journal of Biomedical Materials Research, V19, P133, DOI 10.1002/jbm.820190204
   HE H, IN PRESS GENETICALLY
   He HB, 2002, TISSUE ENG, V8, P213, DOI 10.1089/107632702753724987
   He HB, 2003, J THORAC CARDIOV SUR, V126, P455, DOI 10.1016/S0022-5223(02)73264-9
   He Hongbing, 2002, Cell Transplantation, V11, P75
   HIRABAYASHI K, 1992, J BIOMED MATER RES, V26, P1433, DOI 10.1002/jbm.820261104
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   HIRAI J, 1995, CELL TRANSPLANT, V4, P597, DOI 10.1016/0963-6897(95)00029-1
   Ishibashi K, 1994, ASAIO J, V40, pM284, DOI 10.1097/00002480-199407000-00009
   KANDA K, 1993, CELL TRANSPLANT, V2, P475, DOI 10.1177/096368979300200606
   KANDA K, 1994, CELL TRANSPLANT, V3, P537, DOI 10.1177/096368979400300611
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   KANDA K, 1995, CELL TRANSPLANT, V4, P587, DOI 10.1016/0963-6897(95)00028-3
   Kito H, 1996, J BIOMED MATER RES, V30, P321
   Kobashi T, 1999, CELL TRANSPLANT, V8, P477, DOI 10.1177/096368979900800503
   Kobashi T, 2000, CELL TRANSPLANT, V9, P93, DOI 10.1177/096368970000900112
   Lian X., 2003, J VASC SURG, V37, P472
   Masuda S, 1997, ASAIO J, V43, pM530
   MATSUDA T, 1995, LANGMUIR, V11, P2272
   MATSUDA T, 1995, J BIOMED MATER RES, V29, P749, DOI 10.1002/jbm.820290611
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   MATSUDA T, 1995, J THORAC CARDIOV SUR, V110, P988, DOI 10.1016/S0022-5223(05)80166-7
   MATSUMOTO A, 1995, ARTIF ORGANS, V19, P51, DOI 10.1111/j.1525-1594.1995.tb02244.x
   MIWA H, 1994, J VASC SURG, V19, P658, DOI 10.1016/S0741-5214(94)70039-7
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   NOISHIKI Y, 1993, J THORAC CARDIOV SUR, V105, P796
   Noishiki Y, 1996, NAT MED, V2, P90, DOI 10.1038/nm0196-90
   Noishiki Y, 1998, MAT SCI ENG C-BIO S, V6, P227, DOI 10.1016/S0928-4931(98)00055-1
   NOISHIKI Y, 1994, J VASC SURG, V20, P279, DOI 10.1016/0741-5214(94)90017-5
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   Nojiri C., 1993, ASAIO J, V39, P322
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shinoka T, 1998, J THORAC CARDIOVASC, V115, P545
   Shirota T, 2003, TISSUE ENG, V9, P473, DOI 10.1089/107632703322066651
   Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Sonoda H, 2002, J BIOMED MATER RES, V60, P191, DOI 10.1002/jbm.10055
   Sonoda H, 2003, J BIOMED MATER RES A, V65A, P170, DOI 10.1002/jbm.a.10462
   Sugawara T, 1996, J BIOMED MATER RES, V32, P157
   WANG C, 2000, J BIOMED MATER RES, V62, P315
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WHITE RA, 1988, T AM SOC ART INT ORG, V34, P95
   Yoneyama T, 2000, ARTIF ORGANS, V24, P23, DOI 10.1046/j.1525-1594.2000.06433.x
   YONEYAMA T, 2002, BIOMATERIALS, V23, P145
NR 51
TC 39
Z9 40
U1 0
U2 4
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2004
VL 28
IS 1
BP 64
EP 71
DI 10.1111/j.1525-1594.2004.07324.x
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 762EE
UT WOS:000187957500013
PM 14720291
DA 2018-10-19
ER

PT J
AU Najman, S
   Savic, V
   Djordjevic, L
   Ignjatovic, N
   Uskokovic, D
AF Najman, S
   Savic, V
   Djordjevic, L
   Ignjatovic, N
   Uskokovic, D
TI Biological evaluation of hydroxyapatite/poly-L-lactide (HAp/PLLA)
   composite biomaterials with poly-L-lactide of different molecular
   weights intraperitoneally implanted into mice
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE hydroxyapatite/poly-L-lactide composite biomaterial; bone implants; in
   vivo; intraperitoneal implantation
ID INTERNAL-FIXATION; BONE-FRACTURES; IN-VIVO; DEGRADATION;
   POLY(L-LACTIDE); OSTEOGENESIS; POLYLACTIDES; PARTICLES; BEHAVIOR; RODS
AB Histopathologic analysis of the tissue with HAp/PLLA implants was made and the leukocyte formula and chemiluminescence response of peritoneal phagocytes 2, 7 and 12 weeks after intraperitoneal implantation studied. Implants were made of HAp/PLLA biocomposites with PLLA molecular weights of 50,000 (HAp/PLLA(50)) and 430,000 g/mol (HAp/PLLA(430)) and of crushed devitalized femur bone of a young Wistar rat. Leukocyte formula and chemiluminescence of peritoneal phagocytes showed no systemic inflammatory response. The studied implants caused locally weak inflammatory reaction. The resorption of implants ranges in intensity (polymer resorption, i.e. disappearance rate), from the highest with the bone implants, low with HAp/PLLA(50), to the lowest with the HAp/PLLA(430) implants. Good resorption of the biocomposites and its mutual ingrowth with connective tissue prove their good biocompatibility.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, YU-11000 Belgrade, Yugoslavia.
   Univ Nish, Fac Med, YU-18000 Nish, Yugoslavia.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, K Mihailova 35-4, YU-11000 Belgrade, Yugoslavia.
EM uskok@itn.sanu.ac.yu
RI Uskokovic, Dragan/B-4129-2008; Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X; Najman, Stevo/0000-0002-2411-9802
CR AGRAWAL M, 1998, JOM              JAN, P31
   [Anonymous], 1993, [No title captured], Patent No. [0289562 B1, 0289562]
   BAB I, 1988, BONE MINER, V4, P373
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   Furukawa T, 2000, CLIN ORTHOP RELAT R, P247
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hooper KA, 2000, J BIOMED MATER RES, V50, P365, DOI 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2000, ADV ENG MATER, V2, P511, DOI 10.1002/1527-2648(200008)2:8<511::AID-ADEM511>3.0.CO;2-B
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   IGNJATOVIC N, 2000, 5 INT C FUND APPL AS, P489
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   KURASHINA K, 1995, BIOMATERIALS, V16, P119, DOI 10.1016/0142-9612(95)98273-H
   Lewandrowski KU, 2002, BIO-MED MATER ENG, V12, P259
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   NAJMAN S, 1999, ACTA FM  NAISS, V15, P177
   Pohjonen T, 1997, J MATER SCI-MATER M, V8, P311, DOI 10.1023/A:1018516529591
   Sarasua JR, 1998, MACROMOLECULES, V31, P3895, DOI 10.1021/ma971545p
   SCHUMACHER HR, 1987, AM J MED, V83, P1, DOI 10.1016/0002-9343(87)90843-6
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   VANSLIEDREGT A, 1992, BIOMATERIALS, V12, P819
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
NR 26
TC 17
Z9 19
U1 0
U2 2
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2004
VL 14
IS 1
BP 61
EP 70
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 768LR
UT WOS:000188544900008
PM 14757954
DA 2018-10-19
ER

PT J
AU Hedia, HS
   Mahmoud, NA
AF Hedia, HS
   Mahmoud, NA
TI Design optimization of functionally graded dental implant
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE von Mises stress; dental implant; functionally graded material (FGM);
   finite element; optimization
ID NONHOMOGENEOUS MATERIALS; CRACK PROBLEM; STRESS; BIOCERAMICS; FIELDS;
   BONE
AB The continuous increase of man's life span, and the growing confidence in using artificial materials inside the human body necessities introducing more effective prosthesis and implant materials. However, no artificial implant has biomechanical properties equivalent to the original tissue. Recently, titanium and bioceramic materials, such as hydroxyapatite are extensively used as fabrication materials for dental implant due to their high compatibility with hard tissue and living bone. Titanium has reasonable stiffness and strength while hydroxyapatite has low stiffness, low strength and high ability to reach full integration with living bone. In order to obtain good dental implantation of the biomaterial; full integration of the implant with living bone should be satisfied. Minimum stresses in the implant and the bone must be achieved to increase the life of the implant and prevent bone resorption. Therefore, the aim of the current investigation is to design an implant made from functionally graded material (FGM) to achieve the above advantages. The finite element method and optimization technique are used to reach the required implant design. The optimal materials of the FGM dental implant are found to be hydroxyapatite/titanium. The investigations have shown that the maximum stress in the bone for the hydroxyapatite/titanium FGM implant has been reduced by about 22% and 28% compared to currently used titanium and stainless steel dental implants, respectively.
C1 Mansoura Univ, Fac Engn, Prod Eng & MC Design Dept, Mansoura, Egypt.
   Assiut Univ, Fac Engn, Dept Mech Engn, Assiut, Egypt.
RP Hedia, HS (reprint author), Mansoura Univ, Fac Engn, Prod Eng & MC Design Dept, Mansoura, Egypt.
EM hedia@mans.eun.eg
CR *ANSYS, 1992, ANSYS US MAN VERS 5
   Choi HJ, 1996, J APPL MECH-T ASME, V63, P479, DOI 10.1115/1.2788893
   Clift S E, 1992, Proc Inst Mech Eng H, V206, P233, DOI 10.1243/PIME_PROC_1992_206_295_02
   Erdogan F, 1997, J APPL MECH-T ASME, V64, P449, DOI 10.1115/1.2788914
   ERDOGAN F, 1991, J APPL MECH-T ASME, V58, P410, DOI 10.1115/1.2897201
   FUCHIYAMA T, 1993, CERAMIC T FUNCTIONAL, V34, P425
   FUJIMOTO T, 2001, P 4 INT C THERM STRE, P121
   Hedia HS, 2002, BIO-MED MATER ENG, V12, P111
   Hench L. L., 1993, INTRO BIOCERAMICS, V1
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1995, CHEM IND, P17
   HUISKES R, 1984, CALCIF TISS INT S, V3361, P110
   HUISKES R, 1986, FRONTIERS BIOMECHANI, P245
   ISAAC DH, 1994, CLIN MAT, P15
   JIN ZH, 1994, J APPL MECH-T ASME, V61, P738, DOI 10.1115/1.2901529
   KERNER EH, 1956, P PHYS SOC LOND B, V69, P808, DOI 10.1088/0370-1301/69/8/305
   KIM GY, 2002, 3864 FUNCTIONALLY GR
   Kingery WD, 1976, INTRO CERAMICS
   Miyao R, 2001, J DENT MAT, V20, P344
   NEMATALLA M, 2002, 3 ASS U INT C MECH E
   NODA N, 1993, J THERM STRESSES, V16, P181, DOI 10.1080/01495739308946224
   NODA N, 1995, JSME INT J A-MECH M, V38, P364, DOI 10.1299/jsmea1993.38.3_364
   REVELL PA, 1986, PATHOLOGY BONE
   Shackelford JF, 1999, MATER SCI FORUM, V293, P99, DOI 10.4028/www.scientific.net/MSF.293.99
   SIMON SR, 1994, ORTHOPEDIC BASIC SCI
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Wang BL, 2000, J APPL MECH-T ASME, V67, P87, DOI 10.1115/1.321153
   ZIENKIEWICZ OC, 1977, FINITE ELEMENT METHO
NR 28
TC 52
Z9 57
U1 1
U2 16
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2004
VL 14
IS 2
BP 133
EP 143
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 830GW
UT WOS:000222111100002
PM 15156104
DA 2018-10-19
ER

PT J
AU Kodjikian, L
   Burillon, C
   Roques, C
   Pellon, G
   Renaud, FNR
   Hartmann, D
   Freney, J
AF Kodjikian, L
   Burillon, C
   Roques, C
   Pellon, G
   Renaud, FNR
   Hartmann, D
   Freney, J
TI Intraocular lenses, bacterial adhesion and endophthalmitis prevention: A
   review
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE bacterial adhesion; biofilm; Staphylococcus epidermidis; intraocular
   lenses; endophthalmitis; in vitro & in vivo studies
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYSACCHARIDE INTERCELLULAR ADHESIN;
   EXTRACAPSULAR CATARACT-EXTRACTION; POLYMER-ASSOCIATED INFECTIONS;
   IN-VITRO ADHERENCE; ANTERIOR-CHAMBER; POSTOPERATIVE ENDOPHTHALMITIS;
   PSEUDOMONAS-AERUGINOSA; GROWTH-RATE; NATIONAL OUTCOMES
AB Postoperative endophthalmitis following intraocular lens (IOL) implantation is still one of the most feared complications of cataract surgery. Bacterial adhesion to IOLs during their insertion is a prominent etiological factor. Polypropylene was the first biomaterial that allowed this relation of cause and effect to be proven. Following adhesion, bacteria replicate, congregate and form multiple layers of microcolonies which actually represent the basic structural unit of the biofilm. The bacteria are embedded in a slime layer. Personal photographs illustrate the different steps of biofilm formation. This slime matrix is not only an adhesive medium; it also affects virulence. Adhesion to IOLs has been studied by several in vitro studies and discrepancies can be found between them which are due to variations of experimental conditions. The strains, the incubation times and the methods all varied. Adhesion is affected by the nature of the IOLs, the isolates and the surrounding medium. Since this medium is very difficult to model because of its complexity, in vivo studies seemed essential. We have recently determined in vivo evolution of the amount of attached bacteria to five types of IOLs. Crystalline lenses from 90 domestic pigs were removed aseptically and replaced with previously infected IOLs. There have been few epidemiological studies published to determine the relationship between endophthalmitis and the IOL type. However, the perfect biomaterial that could prevent postoperative endophthalmitis does not yet exist. Globally, hydrophilic materials and hydrophobic acrylic seem to be less sticky than silicone or PMMA, but this remains to be proven clinically.
C1 Croix Rousse Hosp, Dept Ophthalmol, F-69004 Lyon, France.
   Hop Edouard Herriot, Dept Ophthalmol, Lyon, France.
   Univ Lyon 1, EA 3090, Lab Biomat & Matrix Remodeling, F-69365 Lyon, France.
   Univ Toulouse 3, Fac Pharm, EA 819, Dept Microbiol, F-31062 Toulouse, France.
   Univ Lyon 1, Dept Biochem, F-69622 Villeurbanne, France.
   Inst Sci Pharmaceut & Biol, Dept Microbiol, Lyon, France.
RP Kodjikian, L (reprint author), Croix Rousse Hosp, Dept Ophthalmol, 103 Grande Rue Croix Rousse, F-69004 Lyon, France.
EM kodjikian.laurent@wanadoo.fr
RI roques, christine/D-9889-2014
CR Aaberg TM, 1998, OPHTHALMOLOGY, V105, P1004, DOI 10.1016/S0161-6420(98)96000-6
   AbuElAsrar AM, 1997, INT OPHTHALMOL, V21, P71, DOI 10.1023/A:1005835013581
   ALFONSO EC, 1995, ARCH OPHTHALMOL-CHIC, V113, P1369, DOI 10.1001/archopht.1995.01100110029018
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   Bainbridge JWB, 1998, BRIT J OPHTHALMOL, V82, P1312, DOI 10.1136/bjo.82.11.1312
   Bannerman TL, 1997, ARCH OPHTHALMOL-CHIC, V115, P357, DOI 10.1001/archopht.1997.01100150359008
   BRIGHT J, 1983, APPL ENVIRON MICROB, V43, P1166
   Bron A, 1996, J FR OPHTALMOL, V19, P225
   Burillon C, 2002, DRUG DEV IND PHARM, V28, P95, DOI 10.1081/DDC-120001490
   CARPENTIER B, 1993, J APPL BACTERIOL, V75, P499, DOI 10.1111/j.1365-2672.1993.tb01587.x
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   CUSUMANO A, 1994, ARCH OPHTHALMOL-CHIC, V112, P1015, DOI 10.1001/archopht.1994.01090200017002
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DICKEY JB, 1991, AM J OPHTHALMOL, V112, P278, DOI 10.1016/S0002-9394(14)76728-5
   DILLY PN, 1989, J CATARACT REFR SURG, V15, P317, DOI 10.1016/S0886-3350(89)80092-6
   DOYLE A, 1995, BRIT J OPHTHALMOL, V79, P347, DOI 10.1136/bjo.79.4.347
   DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P791, DOI 10.1093/jac/30.6.791
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   EGGER SF, 1994, OPHTHALMOLOGICA, V208, P77, DOI 10.1159/000310457
   ELDER MJ, 1995, EYE, V9, P102, DOI 10.1038/eye.1995.16
   EVANS DJ, 1991, J ANTIMICROB CHEMOTH, V27, P177, DOI 10.1093/jac/27.2.177
   EVANS DJ, 1990, J ANTIMICROB CHEMOTH, V25, P585, DOI 10.1093/jac/25.4.585
   Gabriel MM, 1998, J CATARACT REFR SURG, V24, P124, DOI 10.1016/S0886-3350(98)80085-0
   Garcia-Saenz MC, 2000, J CATARACT REFR SURG, V26, P1673, DOI 10.1016/S0886-3350(00)00483-1
   GRIFFITHS PG, 1989, BRIT J OPHTHALMOL, V73, P402, DOI 10.1136/bjo.73.6.402
   Herde J, 1996, KLIN MONATSBL AUGENH, V209, P13, DOI 10.1055/s-2008-1035270
   Heukelekian H, 1940, J BACTERIOL, V40, P547
   Jansen B, 1988, J Biomater Appl, V2, P520
   JANSEN B, 1991, J HOSP INFECT, V19, P83, DOI 10.1016/0195-6701(91)90100-M
   JAVITT JC, 1994, OPHTHALMOLOGY, V101, P100
   JAVITT JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P1085, DOI 10.1001/archopht.1991.01080080045025
   Kadry AA, 1999, CHEMOTHERAPY, V45, P56, DOI 10.1159/000007165
   KATTAN HM, 1991, OPHTHALMOLOGY, V98, P227
   Kodjikian L, 2002, INVEST OPHTH VIS SCI, V43, P3717
   Kresloff MS, 1998, SURV OPHTHALMOL, V43, P193, DOI 10.1016/S0039-6257(98)00036-8
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   LEMAGREX E, 1994, COLLOID SURFACE B, V2, P89, DOI 10.1016/0927-7765(94)80022-7
   Leong JK, 2002, J CATARACT REFR SURG, V28, P826, DOI 10.1016/S0886-3350(01)01160-9
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Mack D, 1999, INFECT IMMUN, V67, P1004
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   MAGNUSSON KE, 1982, SCAND J INFECT DIS, P32
   Masket S, 1997, J CATARACT REFR SURG, V23, P814, DOI 10.1016/S0886-3350(97)80225-8
   MAZZOCCO TR, 1985, T OPHTHAL SOC UK, V104, P578
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   MENIKOFF JA, 1991, OPHTHALMOLOGY, V98, P1761
   Merritt K, 1991, J Biomater Appl, V5, P185, DOI 10.1177/088532829100500304
   Mistlberger A, 1997, J CATARACT REFR SURG, V23, P1064, DOI 10.1016/S0886-3350(97)80081-8
   Montan P, 2002, ACTA OPHTHALMOL SCAN, V80, P258, DOI 10.1034/j.1600-0420.2002.800305.x
   Montan PG, 1998, OPHTHALMOLOGY, V105, P2171, DOI 10.1016/S0161-6420(98)91211-8
   Ng EWM, 1996, J CATARACT REFR SURG, V22, P1331, DOI 10.1016/S0886-3350(96)80093-9
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PAULSSON M, 1994, J BIOMED MATER RES, V28, P311, DOI 10.1002/jbm.820280305
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   Pinna A, 2000, OPHTHALMOLOGY, V107, P2162, DOI 10.1016/S0161-6420(00)00408-5
   PORTOLES M, 1993, J CATARACT REFR SURG, V19, P755, DOI 10.1016/S0886-3350(13)80345-8
   Prosdocimo G, 1997, Eur J Ophthalmol, V7, P241
   RASKIN EM, 1993, ARCH OPHTHALMOL-CHIC, V111, P250, DOI 10.1001/archopht.1993.01090020104032
   Rostand KS, 1997, INFECT IMMUN, V65, P1
   RUPP ME, 1992, INFECT IMMUN, V60, P4322
   Ruther P., 1980, MICROBIAL ADHESION S, P79
   Salvanet-Bouccara A, 1992, Rev Prat, V42, P960
   SALVANETBOUCCARA A, 1992, J FR OPHTALMOL, V15, P669
   SCHIOTZ PO, 1983, ACTA PAEDIATR SCAND, V72, P283, DOI 10.1111/j.1651-2227.1983.tb09712.x
   Schloricke E, 1997, OPHTHALMOLOGE, V94, P785, DOI 10.1007/s003470050204
   Schmidt D, 1998, COMBUST THEOR MODEL, V2, P135, DOI 10.1088/1364-7830/2/2/002
   SHERWOOD DR, 1989, EYE, V3, P308
   SPEAKER MG, 1991, OPHTHALMOLOGY, V98, P639
   Srinivasan R, 2002, J CATARACT REFR SURG, V28, P2173, DOI 10.1016/S0886-3350(02)01493-1
   Srinivasan Renuka, 1999, Indian Journal of Ophthalmology, V47, P185
   Stamm WE, 1999, INT J ANTIMICROB AG, V11, P237
   SUTHERLAND IW, 1983, CRC CR REV MICROBIOL, V10, P173
   TETZ MR, 1996, ASCRS S CAT IOL REFR
   VAFIDIS GC, 1984, BRIT J OPHTHALMOL, V68, P520, DOI 10.1136/bjo.68.8.520
   Vidal O, 1998, J BACTERIOL, V180, P2442
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 81
TC 23
Z9 24
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2004
VL 14
IS 4
BP 395
EP 409
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HX
UT WOS:000226003300006
PM 15472388
DA 2018-10-19
ER

PT J
AU Zambito, Y
   Baggiani, A
   Carelli, V
   Serafini, MF
   Di Colo, G
AF Zambito, Y
   Baggiani, A
   Carelli, V
   Serafini, MF
   Di Colo, G
TI Methyl-DEAE-dextran: A candidate biomaterial
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE DEAE-dextran; methyl-DEAE-dextran; cationic polymer; biomaterial;
   N-acetylcysteine; dry eye
ID MEDIATED GENE-TRANSFER; CHARGED-PARTICLES; ENHANCEMENT
AB The full quaternisation of DEAE-dextran was successfully attempted and an application of the quaternised product was suggested. Commercial DEAE-dextran was reacted with iodomethane at 60degreesC in the presence of NaOH. The raw product was purified by dialysis, during which the iodide ion was replaced by chloride. N-methylation and O-methylation resulted from the reaction. A second methylation step produced no further changes in the molecule. Alkalimetry indicated the absence of amino groups in the methylated polymer molecule, thus testifying to a complete quaternisation. N-acetylcysteine (AcCy) was neutralised with the polymer in the hydroxide form, thus obtaining the methyl DEAE-dextran salt of AcCy (Me-DEAE-dextran/AcCy), whereby an ophthalmic formulation for the treatment of the dry eye syndrome was prepared. For comparison, the neutral AcCy salt of commercial DEAE-dextran (DEAE-dextran/AcCy) was prepared. The AcCy content in Me-DEAE-dextran/AcCy was higher than in DEAE-dextran/AcCy (23 vs 13%), while the viscosity of a solution containing the salt concentration corresponding to the therapeutic AcCy concentration (4%w/v) was lower with the former compared to the latter salt (20.5 vs 23.9 mPa s). Both solutions were ipotonic (245 mOsm/kg), whereas the commercial Tirocular(R) is strongly hypertonic (900 mOsm/kg) and irritant.
C1 Univ Pisa, Dept Bioorgan Chem & Biopharmaceut, I-56126 Pisa, Italy.
RP Zambito, Y (reprint author), Univ Pisa, Dept Bioorgan Chem & Biopharmaceut, Via Bonanno 36, I-56126 Pisa, Italy.
EM zambito@farm.unipi.it
OI ZAMBITO, YLENIA/0000-0003-0064-233X
CR Gregory LG, 2003, MOL THER, V7, P19, DOI 10.1016/S1525-0016(02)00021-7
   Guler M, 2002, ARCH SURG-CHICAGO, V137, P813, DOI 10.1001/archsurg.137.7.813
   HOLLY FJ, 1981, INVEST OPHTH VIS SCI, V20, P236
   Mack KD, 1998, J IMMUNOL METHODS, V211, P79, DOI 10.1016/S0022-1759(97)00194-4
   Sieval AB, 1998, CARBOHYD POLYM, V36, P157, DOI 10.1016/S0144-8617(98)00009-5
   Wu LC, 1999, J SURG RES, V85, P43, DOI 10.1006/jsre.1999.5354
   Yang YW, 1997, BIOTECHNOL APPL BIOC, V25, P47, DOI 10.1111/j.1470-8744.1997.tb00413.x
NR 7
TC 3
Z9 3
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2004
VL 14
IS 4
BP 411
EP 417
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HX
UT WOS:000226003300007
PM 15472389
DA 2018-10-19
ER

PT J
AU Anselme, K
   Bigerelle, M
   Loison, I
   Noel, B
   Hardouin, P
AF Anselme, K
   Bigerelle, M
   Loison, I
   Noel, B
   Hardouin, P
TI Kinetic study of the expression of beta-catenin, actin and vinculin
   during osteoblastic adhesion on grooved titanium substrates
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE adhesion; beta-catenin; vinculin; osteoblast; titanium; actin; human
ID CELL-ADHESION; IMPLANT MATERIALS; FOCAL CONTACTS; N-CADHERIN; IN-VITRO;
   BIOMATERIALS; ATTACHMENT; PROLIFERATION; ORGANIZATION; FIBROBLASTS
AB Intercellular adhesions are known to play an important role in differentiation of osteoblasts and in the development of bone tissue architecture. However, to our knowledge, they have never been studied during the formation of bone tissue in contact with a biomaterial surface. In an in vitro kinetic study, we followed the expression of proteins involved in cell-cell interactions (beta-catenin), in cell-material interactions (vinculin) and in cytoskeleton (actin) of human osteoblastic cells cultured on grooved titanium-based substrates during 1, 2, 4, 6, 24, 48, and 72 hours. The human osteoblasts aligned themselves in the 150 mum wide grooves only after 24 hours. The distribution of vinculin-positive focal contacts, actin cytoskeleton and beta-catenin positive-adherens junctions was not significantly influenced by the cell alignment. beta-catenin-positive adherens junctions were expressed by human osteoblasts as soon as 1 hour after inoculation. At this time, they showed a patch-like aspect along cytoplasmic processes in contact with an underlying or an adjacent cell. After 2 hours, the patches were more and more numerous underlining the connections between cells. After 4 hours and more, the patches were organised in a parallel arrangement perpendicular to the two connected cells forming a "zip-like" aspect. Additionally, using double immuno-staining, we demonstrated that sometimes beta-catenin and vinculin appeared co-localised and sometimes not. The linkage of catenin/cadherin complex and vinculin-positive focal contacts with actin filaments may explain this apparent co-localisation.
C1 Univ Littoral Cote Opale, Lab Rech Biomat & Biotechnol, F-62608 Berck Sur Mer, France.
   ENSAM, Equipe Mat, Met Phys Lab, CNRS,URA234, Lille, France.
RP Anselme, K (reprint author), Univ Littoral Cote Opale, Lab Rech Biomat & Biotechnol, 52 Rue Dr Calot, F-62608 Berck Sur Mer, France.
EM k.anselme@uha.fr
OI Maxence, Bigerelle/0000-0002-4144-245X; Anselme,
   Karine/0000-0002-6669-205X
CR Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899
   Ahmad M, 1999, J BIOMED MATER RES, V46, P121, DOI 10.1002/(SICI)1097-4636(199907)46:1<121::AID-JBM14>3.0.CO;2-P
   Anselme K, 2000, SPINAL CORD, V38, P622, DOI 10.1038/sj.sc.3101065
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Babich Michael, 1994, Life Sciences, V54, P201
   BRUNETTE DM, 1991, BONE-BIOMATERIAL INTERFACE, P170
   BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403
   Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Goomer RS, 1998, CALCIFIED TISSUE INT, V62, P532, DOI 10.1007/s002239900474
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   GUMBINER BM, 1995, CURR OPIN CELL BIOL, V7, P634, DOI 10.1016/0955-0674(95)80104-9
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Hunter I, 2001, J BONE MINER RES, V16, P466, DOI 10.1359/jbmr.2001.16.3.466
   LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203
   Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073
   Meyer U, 1998, J MATER SCI-MATER M, V9, P301, DOI 10.1023/A:1008894612021
   OKASAKI M, 1994, J BIOL CHEM, V269, P12092
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   Sandig M, 1997, CELL MOTIL CYTOSKEL, V36, P149, DOI 10.1002/(SICI)1097-0169(1997)36:2<149::AID-CM5>3.3.CO;2-#
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
NR 27
TC 12
Z9 12
U1 1
U2 2
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2004
VL 14
IS 4
BP 545
EP 556
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HX
UT WOS:000226003300019
PM 15472401
DA 2018-10-19
ER

PT S
AU Saravanapavan, P
   Gough, JE
   Jones, JR
   Hench, LL
AF Saravanapavan, P
   Gough, JE
   Jones, JR
   Hench, LL
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Antimicrobial macroporous gel-glasses: Dissolution and cytotoxicity
SO BIOCERAMICS 16
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Oporto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE antimicrobial; macroporous; silver; bioactive glass
ID BIOACTIVE GLASS
AB The incidence of biomaterial-centred infections underlies the need to improve the properties of existing biomaterials. Combining the bioactive properties of calcia-silicate gel-glasses with that of the silver would prevent infections without the use of antibiotic drugs. Inclusion of silver into bioactive gel-glass foam scaffolds is explored using in vitro characterization techniques. The amount of silver released from Ag-doped S70C30 foams is well above the minimum bactericidal concentration (0.1 ppm) but below the cytotoxic concentration (1.6 ppm) for human cells. Primary human osteoblasts proliferate on the silver-doped gel-glasses.
C1 UCL, Tissue Engn Ctr, Dept Mat, London WC1E 6BT, England.
   Univ Manchester, Inst Sci & Technol, Manchester Mat Sci Ctr, Manchester M60 1QD, Lancs, England.
RP Saravanapavan, P (reprint author), UCL, Tissue Engn Ctr, Dept Mat, London WC1E 6BT, England.
EM p.pavan@imperial.ac.uk; j.gough@umist.ac.uk
OI Jones, Julian/0000-0002-2647-8024
CR Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   Saravanapavan P, 2003, KEY ENG MAT, V240-2, P233, DOI 10.4028/www.scientific.net/KEM.240-242.233
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
NR 4
TC 21
Z9 22
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MATER
PY 2004
VL 254-2
BP 1087
EP 1090
DI 10.4028/www.scientific.net/KEM.254-256.1087
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000268
DA 2018-10-19
ER

PT S
AU Weiss, P
   Vinatier, C
   Guicheux, J
   Grimandi, G
   Daculsi, G
AF Weiss, P
   Vinatier, C
   Guicheux, J
   Grimandi, G
   Daculsi, G
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Self setting hydrogel as an extracellular synthetic matrix for tissue
   engineering
SO BIOCERAMICS 16
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Oporto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE biomaterial; hydrogel; rheology; polymer network; tissue engineering
ID GENERAL-PROPERTIES; BONE
AB The use of hydrogel for biomaterials or as 3D synthetic matrix for tissue engineering lead to determine the viscoelastic properties of the hydrogels and the moment when the viscous liquid is transformed in a reticulated polymer network. This can be performed by oscillatory rheological study. We developed a new self-reticulating polymer wich is silated hydroxyl propylmethylcellulosc (Si-BPMC). This study shows that the parameters (pH, swelling, amount of silane grafting) can be controlled and adjusted using oscillatory rheological measurements. The polymer network can be adapted to provide the best environment for specific cell functions and use it as a scaffold for tissue engineering and as injectable biomaterial for bone repair.
RP Weiss, P (reprint author), EMI 99-03,1 Pl A Ricordeau,BP 84215, F-44042 Nantes 1, France.
EM pweiss@sante.univ-nantes.fr
RI guicheux, Jerome/F-7767-2013; Weiss, Pierre/P-1372-2014; Vinatier,
   Claire/P-1686-2014; Daculsi, Guy/P-1320-2014
OI guicheux, Jerome/0000-0003-2754-3024; Weiss, Pierre/0000-0002-6159-8590;
   Vinatier, Claire/0000-0002-6063-9901; Daculsi, Guy/0000-0003-1030-3446
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   LAPKOWSKI M, 1995, Patent No. 9705911
   SAU AC, 1992, ACS SYM SER, V476, P265
   Turczyn R, 2000, J BIOMAT SCI-POLYM E, V11, P217, DOI 10.1163/156856200743661
   WEISS P, IN PRESS BIOMATERIAL
NR 9
TC 13
Z9 13
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MATER
PY 2004
VL 254-2
BP 1107
EP 1110
DI 10.4028/www.scientific.net/KEM.254-256.1107
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000273
DA 2018-10-19
ER

PT S
AU Loof, J
   Engqvist, H
   Hermansson, L
   Ahnfelt, NO
AF Loof, J
   Engqvist, H
   Hermansson, L
   Ahnfelt, NO
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Mechanical testing of chemically bonded bioactive ceramic materials
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE chemically bonded ceramics; bioceramics; calcium aluminates; mechanical
   properties; test methods
AB Most chemically bonded ceramics that are used as biomaterial are resorbable. Therefore their mechanical properties often change over time. Calcium aluminate has proven to be bioactive but non-resorbable. This opens up new application areas compared to the conventional chemically bonded ceramics, especially for load bearing applications where the long-term mechanical properties are important, e.g. in dentistry. So far no consensus has been reached upon how to test the material to obtain reliable results. This paper describes how to test hardness, expansion pressure, flexural strength and compressive strength
   The delicate chemistry of the material makes mechanical testing difficult. The final microstructure develops through water uptake both from the initially added water and from the storage medium. Thus some of the materials properties will be dependent on how the material has been handled, e.g. the expansion pressure. It is therefore of outermost importance to store the material in a medium that resembles the real application as close as possible. It is also important to be very careful when preparing and polishing the samples so that no flaws or defects are introduced, especially when measuring strength and hardness.
C1 Doxa AB, S-75451 Uppsala, Sweden.
RP Loof, J (reprint author), Doxa AB, Axel Johanssonsgata 4-6, S-75451 Uppsala, Sweden.
EM jesper.loof@doxa.se; hakan.engqvist@doxa.se
OI Engqvist, Hakan/0000-0001-9529-650X
CR ENGQVIST H, IN PRESS BIOMATERIAL
   ENGQVIST H, IN PRESS J ADV MAT
   Ernst CP, 2000, AM J DENT, V13, P69
   KRAFT L, 2002, THESIS UPPSALA U SWE
   LEA FM, 1970, LEAS CHEM CEMENT CON
   Lewis JA, 2000, J AM CERAM SOC, V83, P1905
   LOOF J, 2003, P BIOC PORT, V16
   LOOF J, IN PRESS J MAT SCI M
   Scrivener KL, 1999, CEMENT CONCRETE RES, V29, P1215, DOI 10.1016/S0008-8846(99)00103-9
NR 9
TC 4
Z9 4
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 51
EP 54
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000013
DA 2018-10-19
ER

PT S
AU LeGeros, RZ
   Gatti, AM
   Kijkowska, R
   Mijares, DQ
   LeGeros, JP
AF LeGeros, RZ
   Gatti, AM
   Kijkowska, R
   Mijares, DQ
   LeGeros, JP
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Mg-substituted tricalcium phosphates: Formation and properties
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE tricalcium phosphate; magnesium; dissolution; bone formation
ID WHITLOCKITE
AB This study aimed to investigate the formation and properties of magnesium (Mg)-substituted tricalcium phosphate, beta-TCMP, its properties and potential as biomaterial for bone repair. beta-TCMPs were prepared and characterized using x-ray diffraction, FT-IR and SEM. Dissolution properties were determined in acidic buffer. beta-TCMP discs were implanted in surgically created holes in femoral and tibial diaphyses of rabbits.
   Results demonstrated that the formation of beta-TCMP and Mg incorporation in beta-TCMP were dependent on reaction pH, temperature and solution Mg/Ca ratios. Sintered beta-TCMP was significantly less soluble than beta-TCP. Implanted unsintered beta-TCMP showed osteoconductive properties associated with new bone formation. This study suggests that beta-TCMP (sintered or unsintered), alone or in combination with other calcium phosphates, may be useful as biomaterials for bone repair and maybe useful in cases where slower biodegradation than that of beta-TCP is desired.
C1 NYU, Coll Dent, New York, NY 10010 USA.
   Univ Modena, Coll Med, I-41100 Modena, Italy.
   Inst Chem & Technol, Krakow, Poland.
RP LeGeros, RZ (reprint author), NYU, Coll Dent, 345 E 24th St, New York, NY 10010 USA.
EM rzl1@nyu.edu; gatti@unimo.it; kij@chemia.pk.edu.pl; dqm1@nyu.edu;
   jpl4@nyu.edu
CR DACULSI G, 1987, J DENT RES, V66, P1356, DOI 10.1177/00220345870660081401
   Gatti AM, 1998, BIOCERAMICS, V11, P399
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   LEGEROS RZ, 1989, MAGNESIUM HLTH DIS, P11
   METZGER SD, 1982, J AM DENT ASSOC, V105, P1035
   Ryan LM, 1999, CALCIFIED TISSUE INT, V65, P374, DOI 10.1007/s002239900716
   Schwartz C, 1999, J MATER SCI-MATER M, V10, P821, DOI 10.1023/A:1008944227417
   SCOTCHFORD CA, 1995, ANN RHEUM DIS, V54, P339, DOI 10.1136/ard.54.5.339
NR 10
TC 15
Z9 16
U1 0
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 127
EP 130
DI 10.4028/www.scientific.net/KEM.254-256.127
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000032
DA 2018-10-19
ER

PT S
AU Mukaida, M
   Ohsawa, K
   Neo, M
   Nakamura, T
AF Mukaida, M
   Ohsawa, K
   Neo, M
   Nakamura, T
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI The expression of bone matrix protein mRNAs around calcium phosphate
   cement particles implanted into bone
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE in situ hybridization; calcium phosphate cement; bone formation;
   biocompatibility
ID IN-SITU HYBRIDIZATION; BETA-TCP PARTICLES
AB Tissue response around calcium phosphate cement(CPC) particles (150-300/mum in diameter) implanted into rat tibiae was analyzed by in situ hybridization with digoxigenin-labeled procollagen alpha1(I) (COL), osteopontin (OPN), and osteocalcin (OC) mRNA probes. Specimens were collected at 3,5,7, and 10 days after the operation. New bone was formed centripetally and all three kinds of mRNA were expressed in activated osteoblasts. A COL signal was expressed most strongly and widely, and was detected at the peripheral region of the hole at day 3. The other two mRNAs were also expressed in bone forming osteoblasts by day 7. In the earlier cell reaction stage, OPN mRNA was seen exclusively in the cells on the particles, and an OPN signal was detected not only in COL-positive cells, but also in COL-negative cells.
   In the previous studies, we have shown tissue response around beta-tricalciumphosphate (beta-TCP) particles using in situ hybridization with COL, OPN, ON, and OC mRNA probes. In the present study, the temporal and spatial patterns of cellular response on calcium phosphate cement surface were similar to that on beta-TCP. The COL- and OPN-positive cells were speculated to be osteoblasts and to reflect active bone formation on the surface of the biomaterial, whereas the COL-negative OPN-positive cells were thought be macrophages and to reflect foreign body reaction. Expression of these OPN mRNAs induced by implantation of these bioactive materials may play a role in bone formation on the materials and in determining their biocompatibility.
C1 Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Shiga Med Ctr Adults, Moroyama, Shiga 5248524, Japan.
   Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068507, Japan.
RP Mukaida, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.
EM mmasashi@kuhp.kyoto-u.ac.jp; Kunitaka5@aol.com
CR Neo M, 1996, J BIOMED MATER RES, V30, P485, DOI 10.1002/(SICI)1097-4636(199604)30:4<485::AID-JBM6>3.0.CO;2-L
   Neo M, 1998, J BIOMED MATER RES, V39, P1, DOI 10.1002/(SICI)1097-4636(199801)39:1<1::AID-JBM1>3.0.CO;2-U
   Neo M, 1998, J BIOMED MATER RES, V39, P71, DOI 10.1002/(SICI)1097-4636(199801)39:1<71::AID-JBM9>3.0.CO;2-F
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Ohsawa K, 2001, J BIOMED MATER RES, V54, P501, DOI 10.1002/1097-4636(20010315)54:4<501::AID-JBM50>3.3.CO;2-3
   Ohsawa K, 2000, J BIOMED MATER RES, V52, P460, DOI 10.1002/1097-4636(20001205)52:3<460::AID-JBM3>3.3.CO;2-L
   SUGIMOTO T, 1999, BIOCERAMICS, V12, P533
NR 7
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 241
EP 244
DI 10.4028/www.scientific.net/KEM.254-256.241
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000060
DA 2018-10-19
ER

PT S
AU Gildenhaar, R
   Bernstein, A
   Berger, G
   Hein, W
AF Gildenhaar, R
   Bernstein, A
   Berger, G
   Hein, W
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI In-vitro surface reactions of bioceramic materials
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE ceramics; coating; biomaterial; bone; biocompatibility; surface reaction
AB Bioceramics used as coatings show different biocompatibility and bioactive behaviour in relation to their chemical and morphological composition. Hydroxyapatite of low crystallinity can be detected by XRD on the surface of different plasma sprayed bioceramic materials after treatment in SBF solution. Solubility and cell adhesion tests as well as test of toxicity on discs, however, did not show similar effects. Especially the crystallographic composition and also surface morphology of the material determined the release of ions into the solutions which could be responsible for cytotoxic reactions as well as for the ability of the hydroxyapatite formation. However, the reaction mechanisms which lead to a formation of apatite layers seems to be of different nature. Moreover, there is also the question if such an apatite formation in vitro can indicate the material's ability to favour osteogeneses.
C1 Univ Halle Wittenberg, Dept Orthopaed, D-06097 Halle Saale, Germany.
   Fed Inst Mat Res & Testing, D-12205 Berlin, Germany.
RP Gildenhaar, R (reprint author), Univ Halle Wittenberg, Dept Orthopaed, Magdeburger Str 22, D-06097 Halle Saale, Germany.
EM renate.gildenhaar@bam.de
CR Ignatius AA, 2001, J BIOMED MATER RES, V55, P285, DOI 10.1002/1097-4636(20010605)55:3<285::AID-JBM1016>3.3.CO;2-T
   Knabe C, 1998, J MATER SCI-MATER M, V9, P337, DOI 10.1023/A:1008854930676
   OSBORN JF, 1989, NEUERE ERGEBNISSE OS, P358
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Willmann G, 1999, MATERIALWISS WERKST, V30, P317
NR 5
TC 3
Z9 3
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 407
EP 410
DI 10.4028/www.scientific.net/KEM.254-256.407
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000101
DA 2018-10-19
ER

PT S
AU Kikuchi, M
   Ikoma, T
   Syoji, D
   Matsumoto, HN
   Koyama, Y
   Itoh, S
   Takakuda, K
   Shinomiya, K
   Tanaka, J
AF Kikuchi, M
   Ikoma, T
   Syoji, D
   Matsumoto, HN
   Koyama, Y
   Itoh, S
   Takakuda, K
   Shinomiya, K
   Tanaka, J
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Porous body preparation of hydroxyapatite/coliagen nanocomposites for
   bone tissue regeneration
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE porous body; hydroxyapatite/collagen nanocomposite; bone tissue
   regeneration; elastic property
ID IN-VITRO; COMPOSITE; BIOMATERIAL; COLLAGEN; DOGS; VIVO
AB Elastic porous bodies were fabricated from the self-organized hydroxyapatite/collagen nanocomposite fibers by lyophilization with the use of collagen as a binder. The porous bodies obtained rapidly absorbed water droplet on them and composed of interconnected pores. The pore size was depending on freezing temperatures. The porous bodies demonstrated sponge-like elastic property when wetted and 70 kPa in tensile strength. The cell attachment and resorption with osteoclastic cells for the porous bodies examined by animal tests were the same as those for the compact bodies of hydroxyapatite/collagen nanocomposite. These mechanical and biological properties provide easier handling to operator and better cell invasiveness in both in vitro and in vivo than those of "hard" porous ceramics and "soft" collagen sponges.
C1 Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan.
   PENTAX Corp, Itabashi Ku, Tokyo 1748639, Japan.
   Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138510, Japan.
RP Kikuchi, M (reprint author), Natl Inst Mat Sci, Ctr Biomat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM KIKUCHI.Masanori@nims.go.jp; IKOMA.Toshiyuki@nims.go.jp;
   daisuke.shoji@aoc.pentax.co.jp; hnm.mech@tmd.ac.jp;
   koyama.mech@tmd.ac.jp; itoso.gene@tmd.ac.jp; takakuda.mech@tmd.ac.jp;
   shinomiya.orth@tmd.ac.jp; TANAKA.Junzo@nims.go.jp
RI Kikuchi, Masanori/B-5993-2008; Matsumoto, Hiroko/B-8335-2011; Ikoma,
   Toshiyuki/E-4288-2012
OI Kikuchi, Masanori/0000-0002-9451-8147; Ikoma,
   Toshiyuki/0000-0003-3154-1777
CR Aoki H, 1994, MED APPL HYDROXYAPAT
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   Fuller DA, 1996, SPINE, V21, P2131, DOI 10.1097/00007632-199609150-00015
   Hasegawa Y, 2002, J BIOMED MATER RES, V63, P679, DOI 10.1002/jbm.10388
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2003, KEY ENG MAT, V240-2, P567, DOI 10.4028/www.scientific.net/KEM.240-242.567
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   KIKUCHI M, IN PRESS
   Kim CK, 1998, J PERIODONTOL, V69, P1317, DOI 10.1902/jop.1998.69.12.1317
   Mizuno S, 1996, BIOMATERIALS, V17, P1819, DOI 10.1016/0142-9612(96)00041-5
   Sikinami Y, 1999, BIOMATERIALS, V20, P859
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
NR 15
TC 28
Z9 28
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 561
EP 564
DI 10.4028/www.scientific.net/KEM.254-256.561
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000139
DA 2018-10-19
ER

PT S
AU Silva, JVL
   Gouveia, MF
   Barbara, AS
   Meurer, E
   Zavaglia, CAC
AF Silva, JVL
   Gouveia, MF
   Barbara, AS
   Meurer, E
   Zavaglia, CAC
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Rapid prototyping applications in the treatment of craniomaxillofacial
   deformities - Utilization of bioceramics
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE rapid prototyping; customized implants; biomaterials
AB The aim of this article is to develop a methodology for the selection of suitable biomaterials for the treatment of craniofacial deformities using rapid prototyping as a support tool. This research is carried out by a multidisciplinary team of electronic, chemical and computer engineers, and surgeons. The main motivation for the team is to put available, disseminate and integrate computer systems, methodologies, and rapid prototyping usage in order to reduce postoperative costs and risks from the insufficiency of information. It is also useful for the effective surgical planning and for the selection of the suitable biomaterial to create a customized implant for the patient. The present work dealt with bioceramics for the production of customized implants considering small injuries.
C1 Renato Archer Res Ctr, Div Prod Dev, BR-13083970 Campinas, SP, Brazil.
   PUCRS, Post Grad Program Oral & Maxillofacial Surg, Porto Alegre, RS, Brazil.
   Univ Estadual Campinas, Fac Mech Engn, Dept Mat Engn, BR-13083970 Campinas, SP, Brazil.
RP Silva, JVL (reprint author), Renato Archer Res Ctr, Div Prod Dev, POB 6162, BR-13083970 Campinas, SP, Brazil.
EM jorge.silva@cenpra.gov.br; emeurer@matrix.com.br; czavaglia@uol.com.br
CR LUTZ M, 2001, SOLUTIONS PYTHON PRO
   MEURER E, 2002, RAPID PROTOTYPING BI
   Perry M, 1998, BRIT J ORAL MAX SURG, V36, P275, DOI 10.1016/S0266-4356(98)90711-2
   Santagostino E, 2000, HAEMOPHILIA, V6, P1
   SCHROEDER, 1998, VISUALIZATION TOOLKI
   Silva JVL, 1999, 15 INT C CAD CAM ROB
NR 6
TC 4
Z9 5
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 687
EP 690
DI 10.4028/www.scientific.net/KEM.254-256.687
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000170
DA 2018-10-19
ER

PT S
AU Lopez, E
   Milet, C
   Lamghari, M
   Mouries, LP
   Borzeix, S
   Berland, S
AF Lopez, E
   Milet, C
   Lamghari, M
   Mouries, LP
   Borzeix, S
   Berland, S
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI The dualism of nacre
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE biomaterial; nacre; bone cells; osteogenesis; organic matrix; signal
   molecules
ID BONE; SHEEP
AB The nacreous part of the shell of Pinctada maxima, bivalve mollusk, was used in these studies. In vivo studies, carried out on adult sheep, showed that implanted pieces of nacre pass bone acceptance. Nacre implants were not subjected to intolerance reaction and the recipient bone provided with nacre underwent a sequence of bone regeneration within an osteoprogenitor rich cell layer. Newly formed bone and nacre welded into a dual biomineralized unit. For in vitro studies, the water soluble organic matrix was extracted from powdered nacre by a gentle non-decalcifying process. Three mammalian cell types, fibroblasts (human), bone marrow stromal cells (rat) and pre-osteoblasts (mouse) were used to characterize the effect of nacre water soluble matrix (WSM) on mammal cell recruitment and differentiation in the osteogenic pathway. Alkaline phosphatase activity and osteocalcine expression, markers of cell stimulation and osteoblastic differentiation, were analysed in the culture models. In vitro studies provided evidence for the presence, in nacre organic matrix, of signal molecules responsible for the recruitment of mammal cells in the osteogenic pathway and bone cell activation undergoing a complete sequence of mineralization.
C1 Museum Natl Hist Nat, UMR CNRS 5178, Dept Milieux & Peuplements Aquat, F-75231 Paris 05, France.
RP Lopez, E (reprint author), Museum Natl Hist Nat, UMR CNRS 5178, Dept Milieux & Peuplements Aquat, USM 0401,7 Rue Cuvier, F-75231 Paris 05, France.
EM lopez@mnhn.fr; milet@mnhn.fr; berland@mnhn.fr
RI Lamghari, Meriem/K-2159-2013
OI Lamghari, Meriem/0000-0002-2500-4548
CR Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1
   Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x
   PEREIRAMOURIES L, 2002, COMP BIOCH PHYSL, V132, P217
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
NR 7
TC 6
Z9 6
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 733
EP 736
DI 10.4028/www.scientific.net/KEM.254-256.733
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000181
DA 2018-10-19
ER

PT S
AU Hattar, S
   Asselin, A
   Greenspan, D
   Oboeuf, M
   Berdal, A
   Sautier, JM
AF Hattar, S
   Asselin, A
   Greenspan, D
   Oboeuf, M
   Berdal, A
   Sautier, JM
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Effect of enamel matrix protein-coated bioactive glasses on the
   proliferation and differentiation of the osteogenic MC3T3.E1 cell line
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE bioactive glass; enamel matrix protein; osteoblast; in vitro
ID IN-VITRO; PERIODONTAL-LIGAMENT; BONE; EXPRESSION; TEMPLATE
AB Bioactive glasses, osteoproductive materials, have received considerable attention as a bone graft substitute in the treatment of periodontal loss. More recent strategies for achieving a predictable periodontal regeneration include the use of enamel matrix proteins (EMP). However, the osteoblastic response to these materials has not yet been clearly understood. The aim of our study is to examine the effects of these two materials on the behaviour of osteoblastic cells in vitro. For this purpose, cells of the murine ostcoblastic cell line MC3T3.E1, were seeded in contact with 45S5(R) bioactive glass granules coated or not with Emwdogain(R) and a less reactive glass with 60wt% silica content (60S). Phase contrast microscopy was used to evaluate the evolution of the cultures. The bone/biomaterial interface as well as tissue ultra-structural features were visualized using transmission electron microscopy. Our results have shown that the granules supported the growth and maturation of osteoblastic cells. Zones of early differentiation and mineralization were observed in all three cultures, while occurring at an earlier stage in cultures with the bioactive glasses, compared to 60S cultures. Transmission electron microscopic (TEM) observations have shown metabolically active cells in contact with granules. Furthermore, The tissue/biomaterial interface was established via an electron dense layer located at the periphery of bioactive granules. In conclusion, these findings indicate that bioactive glasses alone or combined to enamel matrix proteins have the ability to support the growth and enhance the differentiation of osteoblast-like cells in vitro. Our findings would have potential clinical applications in cases of severe bone loss, when both osteoconductive and osteoproductive properties are required to assure an optimal periodontal regeneration.
C1 Univ Paris 07, INSERM, Lab Biol Orofaciale & Pathol, U0110,UFR Odontol,Inst Biomed Cordeliers, F-75270 Paris 06, France.
   US Biomat Corp, Novamin Technol Inc, Alachua, FL USA.
RP Hattar, S (reprint author), Univ Paris 07, INSERM, Lab Biol Orofaciale & Pathol, U0110,UFR Odontol,Inst Biomed Cordeliers, 15-21 Rue Ecole Med, F-75270 Paris 06, France.
EM sautier@ccr.jussieu.fr
OI Berdal, Ariane/0000-0001-5833-5813
CR Boyan BD, 2000, J PERIODONTOL, V71, P1278, DOI 10.1902/jop.2000.71.8.1278
   Camargo PM, 2001, J CLIN PERIODONTOL, V28, P1016, DOI 10.1034/j.1600-051X.2001.281105.x
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x
   Hattar S., 2002, European Cells & Materials, V4, P61
   Kaufmann EABE, 2000, TISSUE ENG, V6, P19, DOI 10.1089/107632700320856
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   van der Pauw MTM, 2002, J PERIODONTAL RES, V37, P317, DOI 10.1034/j.1600-0765.2002.00349.x
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
NR 11
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 749
EP 752
DI 10.4028/www.scientific.net/KEM.254-256.749
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000185
DA 2018-10-19
ER

PT S
AU Pryce, RS
   Hench, LL
AF Pryce, RS
   Hench, LL
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Surface modification of 58S bioactive gel-glass with an aminosilane
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE bioactive glasses; surface modification; aminosilane; APTS; sol-gel;
   dissolution kinetics; in-vitro bioactivity
AB 58S bioactive gel-glasses containing amino-functional (-NH2) moieties have been prepared by means of a surface modification process using an organosilane (3-aminopropyltriethoxysilane, APTS) dissolved in an organic solvent (toluene). Textural characterisation. using nitrogen sorption revealed that the surface modified gel-glasses retain the mesoporous structure, but with a reduced surface area, pore diameter and pore volume as APTS concentration increases. However, the initial loading concentration of the aminosilane onto the surface of the 58S gel-glass does not seem to strongly influence the final coverage; rather it is the availability of surface silanols that provide active sites for chemical bonding with the aminosilane. Dissolution of the modified bioactive gel-glasses was assessed using inductively coupled plasma-optical emission spectroscopy, whilst bioactivity was examined using Fourier transform infrared spectroscopy. The in-vitro studies indicate that the surface modified NH58S gel-glasses retain the bioactivity of the unmodified 58S powder, exhibiting similar dissolution profiles and HCA formation. It has been shown that surface modification of bioactive glasses with an aminosilane can produce an amino-functionalised biomaterial, which could be used as reaction handles for further modification.
C1 Univ London Imperial Coll Sci & Technol, Dept Mat, Tissue Engn Ctr, London SW7 2AZ, England.
RP Pryce, RS (reprint author), Univ London Imperial Coll Sci & Technol, Dept Mat, Tissue Engn Ctr, London SW7 2AZ, England.
EM russell.pryce@imperial.ac.uk
CR Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Lenza RFS, 2002, J MATER SCI-MATER M, V13, P837, DOI 10.1023/A:1016592127407
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Plueddemann E., 1991, SILANE COUPLING AGEN
   STOCH A, 1999, J MOL STRUCT, V511, P735
   Vansant E.E., 1995, CHARACTERIZATION CHE
NR 7
TC 1
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 765
EP 768
DI 10.4028/www.scientific.net/KEM.254-256.765
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000189
DA 2018-10-19
ER

PT S
AU Damien, E
   Revell, PA
AF Damien, E
   Revell, PA
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Changes in distant organs in response to local osteogenic growth factors
   delivered by intraosseous implants: a histological evaluation
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE bioactive; biomaterial; bone ingrowth; drug delivery; hydroxyapatite
   implant; insulin like growth factor; inflammation; osteogenesis
ID MESSENGER-RIBONUCLEIC-ACID; FACTOR-II; POROUS HYDROXYAPATITE; IN-VIVO;
   IGF-II; BONE; MICE
AB Osteogenic growth factors are added to enhance osteointegration and osteogenesis of synthetic bone substitutes to improve clinical outcome. Reactions to particles of wear debris from implanted material could lead to bone resorption similar to resorption around a total joint prosthesis and also to inflammatory responses in distant organs. Porous hydroxyapatite (HA) scaffolds pretreated. with insulin like growth factor (IGF)-I (0.5 (LD) or 3.0 (HD) mug/implant) and IGF-II (0.5 mug/implant) were implanted in vivo in rabbit femur to enhance their bioactivity and bone bonding properties. Heart, kidney, liver, lung, lymph nodes and spleen were collected during systematic postmortem examination at 1, 3 and 5 weeks postimplantation for quantitative and qualitative analysis. Local wound healing of the periprosthetic bone and the responses in the distant internal organs were characterised using light microscopy and electron microscopy. All tissues from implanted groups except heart and kidneys exhibited an increase in the cellularity at week I and 3. In the lung, there was also evidence of lympho-proliferation and aggregation in the IGF groups and presence of exudates in the IGF-1 HD group. The hypertropby and hyperplasia appeared to be growth factor, dose and time dependent with IGF-1 LD <IGF-II <IGF-1 HD. At 5 weeks the tissues appeared as regenerated to the normal level with regression of the lymphocytic infiltration. We report for the first time, that local delivery of IGF-I and -II by intraosseous HA implant to enhance osteointegration produced no adverse persistent effects in important internal organs.
C1 Univ London, Osteoart Res, Dept Histopathol, London NW3 2PF, England.
RP Damien, E (reprint author), Univ London, Osteoart Res, Dept Histopathol, Royal Free Campus, London NW3 2PF, England.
EM edamien@rfc.ucl.ac.uk
CR Bell L, 2001, Biomed Sci Instrum, V37, P161
   BIKLE DD, 1994, AM J PHYSIOL, V276, pE278
   Damien E, 2001, BONE, V28, pS140
   Damien E, 2001, J PATHOL, V193, p6A
   Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169
   DAMIEN E, 2001, P EUR SOC BIOM, pT140
   DAMIEN E, 2003, IN PRESS J BIOMED MA
   DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68
   DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Rosen CJ, 1998, P SOC EXP BIOL MED, V219, P1
   SAEED S, 2002, P EUR SOC BIOM, pP109
   SHINAR DM, 1993, ENDOCRINOLOGY, V132, P1158, DOI 10.1210/en.132.3.1158
   WARD A, 1994, P NATL ACAD SCI USA, V91, P10365, DOI 10.1073/pnas.91.22.10365
   Yamamoto T, 2000, J BONE JOINT SURG BR, V82B, P1117, DOI 10.1302/0301-620X.82B8.11194
NR 15
TC 4
Z9 4
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 797
EP 800
DI 10.4028/www.scientific.net/KEM.254-256.797
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000197
DA 2018-10-19
ER

PT S
AU Shirosaki, Y
   Tsuru, K
   Hayakawa, S
   Osaka, A
   Lopes, MA
   Santos, JD
   Fernandes, MH
AF Shirosaki, Y
   Tsuru, K
   Hayakawa, S
   Osaka, A
   Lopes, MA
   Santos, JD
   Fernandes, MH
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI In vitro cytocompatibility of osteoblastic cells cultured on
   chitosan-organosiloxane hybrid membrane
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE chitosan; chitosan-inorganic hybrid;
   gamma-glycidoxypropyltrimethoxysilane (GPSM); osteoblastic cell (MG63);
   cytocompatibility
ID BIOMATERIAL
AB Chitosan-silicate hybrids were synthesized using gamma-glycidoxypropyltrimethoxysilane (GPSM) as the agent to cross-link the chitosan chains. Fourier-transform infrared (FT-IR) spectroscopy was used to analyze the structures of the hybrids. The swelling ability and the cytocompatibility of the hybrids were investigated as a function of the GPSM concentration. The swelling of the hybrids was suppressed by addition of GPSM. MG63 human osteoblastic cells were cultured on the hybrids. The adhesion and proliferation of the MG63 cells cultured on the chitosan-GPSM hybrid surface were improved comparing to that on chitosan membrane, regardless the GPSM concentration.
C1 Okayama Univ, Fac Engn, Biomat Lab, Okayama 7008530, Japan.
   Univ Porto, Fac Engn, FEUP, DEMM, P-4200465 Oporto, Portugal.
   INEB, Inst Engn Biomed, Lab Biomat, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Med Dent, FMDUP, P-4200393 Oporto, Portugal.
RP Shirosaki, Y (reprint author), Okayama Univ, Fac Engn, Biomat Lab, Okayama 7008530, Japan.
EM osaka@cc.okayama-u.ac.jp
RI HAYAKAWA, Satoshi/B-2104-2011; Fernandes, Maria Helena/K-6917-2014;
   Lopes, Maria A./P-4442-2014; SHIROSAKI, Yuki/B-2601-2011; Lopes,
   Cristina/A-4241-2010
OI HAYAKAWA, Satoshi/0000-0002-1097-8614; Lopes, Maria
   A./0000-0003-4105-8148; Santos, Jose Domingos/0000-0002-6871-9850;
   Fernandes, Maria Helena/0000-0001-9391-9574
CR CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
NR 4
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 857
EP 860
DI 10.4028/www.scientific.net/KEM.254-256.857
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000212
DA 2018-10-19
ER

PT S
AU Braccini, S
   Leonelli, C
   Lusvardi, G
   Malavasi, G
   Menabue, L
AF Braccini, S
   Leonelli, C
   Lusvardi, G
   Malavasi, G
   Menabue, L
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI In vitro evaluation of zirconia nanopowders
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE zirconia; nanopowders; in vitro behaviour; microwave; bioactivity
ID REFINEMENT
AB ZrO2 is used for a long time as biomaterial. Nanopowders of ZrO2 are prepared via a microwave assisted hydrothermal synthesis and morphological studies carried out by TEM. The powders are tested in vitro and this test does not alter the dimension of the particles.
C1 Univ Modena, Dept Mat & Environm Engn, I-41100 Modena, Italy.
   Univ Modena, Dept Chem, I-41100 Modena, Italy.
RP Braccini, S (reprint author), Univ Modena, Dept Mat & Environm Engn, Via Vignolese 905, I-41100 Modena, Italy.
EM lusvardi.gigliola@unimore.it
RI Leonelli, Cristina/O-2324-2015; Malavasi, Gianluca/H-4658-2013; Menabue,
   Ledi/L-7324-2015; Lusvardi, Gigliola/L-6941-2015
OI Leonelli, Cristina/0000-0001-8524-8715; Malavasi,
   Gianluca/0000-0002-4557-8135; Menabue, Ledi/0000-0002-7984-3208;
   Lusvardi, Gigliola/0000-0002-0772-6037
CR BELLOTTO M, 1996, MATER SCI FORUM, V79, P745
   Bondioli F, 2001, J AM CERAM SOC, V84, P2728, DOI 10.1111/j.1151-2916.2001.tb01084.x
   BONDIOLI F, 2002, 8 INT S MICR HIGH FR
   GILMAN LB, 1989, SPECTROSCOPY, V4, P14
   GUALTIERI AF, 1996, POWDER DIFFR, V11, P1
   KAPLAN FS, 1994, ORTHOPAEDIC BASIC SC, V127
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LARSON AC, 1997, 86748 LAUR LANL
   LAUTENSCHLAEGER W, 1990, LABOR PRAXIS, V14, P376
   MATUSIEWICZ H, 1994, ANAL CHEM, V66, P751, DOI 10.1021/ac00077a027
   MATUSIEWICZ H, 1997, HIGH PRESSURE CLOSED
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   RIETVELD HM, 1967, ACTA CRYSTALLOGR, V22, P151, DOI 10.1107/S0365110X67000234
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Siegel RW, 1996, SCI AM, V275, P42
   SNYDER RL, 1992, POWDER DIFFR, V7, P186, DOI DOI 10.1017/S0885715600018686
NR 16
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 899
EP 902
DI 10.4028/www.scientific.net/KEM.254-256.899
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000222
DA 2018-10-19
ER

PT S
AU Tamura, K
   Takashi, N
   Akasaka, T
   Roska, ID
   Uo, M
   Totsuka, Y
   Watari, F
AF Tamura, K
   Takashi, N
   Akasaka, T
   Roska, ID
   Uo, M
   Totsuka, Y
   Watari, F
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Effects of micro/nano particle size on cell function and morphology
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE particle; biomaterial; titanium; titanium dioxide; carbon nanotube;
   biocompatibility
ID TITANIUM
AB The cytotoxicity of micro/nano particles in Ti, TiO and carbon nanotube was investigated by in vitro biochemical analyses using human neutrophils. The particles smaller and larger than the neutrophils were used to determine the relationship between cell and particle size with respect to cytotoxicity. As the particle size decreased, the cell survival rate was decreased and, with the good corresponding relation to this, the value of lactate dehydrogenase (LDH), which is the indication of cell disruption, was increased. The release of superoxide anion showed the increasing tendency. Proinflammatory cytokines were detected distinctly for 3 mum or smaller particles and very little in more than 10 mum, which is closely related to the phagocytosis by neutrophils. ICP elemental analysis showed that the dissolution from Ti particles was below detection limit. Micro and nano particles stimulated the cell reactions according to the results of the human neutrophil functional tests. As the particle size was smaller, the inflammation was pronounced. The fine particles less than 3 mum caused distinctly the inflammation in the surrounding tissue. All these results indicated that the cytotoxicity was induced due to the physical size effect of particles, which is different from the ionic dissolution effect. The clinical phenomenon confirmed the result obtained in vitro cell tests. The neutrophils stimulated by fine particles may cause the inflammatory cascade and harm the surrounding tissue.
C1 Hokkaido Univ, Grad Sch Dent Med, Dept Oral & Maxillofacial Surg, Kita Ku, Sapporo, Hokkaido 0608586, Japan.
RP Tamura, K (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral & Maxillofacial Surg, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608586, Japan.
EM tam@den.hokudai.ac.jp
CR ROSENBERG A, 1993, INT J ORAL MAX SURG, V22, P185, DOI 10.1016/S0901-5027(05)80249-8
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Takeshita F, 1997, BIOMATERIALS, V18, P21, DOI 10.1016/S0142-9612(96)00051-8
   Tamura K, 2002, MATER TRANS, V43, P3052, DOI 10.2320/matertrans.43.3052
   TANIMURA Y, 2000, J ORAL MAXILLOFACIAL, V46, P750
   UO M, 1999, BIOMATERIALS, V20, P47
   YEO YK, 1997, J ORAL MAXILLOFAC SU, V55, P322
NR 7
TC 28
Z9 35
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 919
EP 922
DI 10.4028/www.scientific.net/KEM.254-256.919
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000227
DA 2018-10-19
ER

PT S
AU Kim, SR
   Lee, JH
   Kim, YT
   Jung, SJ
   Lee, YJ
   Song, H
   Kim, YH
AF Kim, SR
   Lee, JH
   Kim, YT
   Jung, SJ
   Lee, YJ
   Song, H
   Kim, YH
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Bioactive behaviors of porous Si-substituted hydroxyapatite derived from
   coral
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE hydroxyapatite; silicon substitution; coral; bioactive behavior; porous
AB A porous silicon-substituted hydroxyapatite has been prepared using natural coral as a calcium source to obtain a biomaterial having an improved biocompatibility. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon dioxide or other calcium phosphate species. Silicon content was 0.369% by weight. EDS investigation confirmed the presence of silicon in the framework. of hydroxyapatite structure, Based on in-vivo test, Si-substituted porous hydroxyapatite can be considered a useful material for bone implants.
C1 Korea Inst Ceram Engn & Technol, Seoul, South Korea.
   Univ Ulsan, Coll Med, ASAN Med Ctr, Dept Orthoped Surg, Ulsan, South Korea.
RP Kim, SR (reprint author), Korea Inst Ceram Engn & Technol, Seoul, South Korea.
EM yhkokim@kicet.re.kr
CR Bertoni E, 1998, J INORG BIOCHEM, V72, P29, DOI 10.1016/S0162-0134(98)10058-2
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   LOPEZ JG, 2001, J RAMAN SPECTROSC, V32, P255
   Mayer I, 2000, J CRYST GROWTH, V219, P98, DOI 10.1016/S0022-0248(00)00608-4
   OKAZAKI M, 1995, BIOMATERIALS, V16, P703, DOI 10.1016/0142-9612(95)99698-L
   Skrtic D, 2002, J BIOMED MATER RES, V59, P597, DOI 10.1002/jbm.10017
NR 7
TC 4
Z9 5
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 969
EP 972
DI 10.4028/www.scientific.net/KEM.254-256.969
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000239
DA 2018-10-19
ER

PT S
AU Rousseau, M
   Lopez, E
   Coute, A
   Mascarel, G
   Smith, DC
   Naslain, R
   Bourrat, X
AF Rousseau, M
   Lopez, E
   Coute, A
   Mascarel, G
   Smith, DC
   Naslain, R
   Bourrat, X
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Multi-scale structure and growth of nacre: a new model for bioceramics
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE biomaterial; nacre; structure; crystal growth; organic matrix; biofilm
ID MOLLUSK SHELLS; MACROMOLECULES; ORIENTATION
AB Nacre is the internal lustrous 'mother of pearl' layer of many molluscan shells. The structure is a brick and mortar arrangement: the bricks are flat polygonal crystals of aragonite and the mortar consists of organic compounds. The biological mineralization of composites such as the molluscan shell has generally been thought to be directed by preformed organic arrays of proteins or others biopolymers. The possibility that the organic matrix behaves as a template for crystal formation by heteroepitaxial growth, is examined. The structure and growth of nacre of Pinctada margaritifera and Pinctada maxima are studied at different scales. We propose a new model in nacre growth and maturation. Understanding the molecular mechanisms that regulate biomineralization may thus provide practical routes to the synthesis of new high-performance composite materials.
   Nacreous shell growth was studied by electron microscopy after fixation of immature nacre. It shows that the first step in crystal formation takes place in a biofilm, as evidenced by Laser Raman Spectroscopy. This biofilm is composed of organic matrix and calcium carbonate in the aragonite crystal form. Crystalin nuclei grow in the biofilm as an aligned sequence, starting with a row of intitial nucleation centres, gradually increasing concentrically in size and fusing together to form polygons in the next highest nacreous level.
   In Pinctada biomineralization takes place in a biopolymer that has the ability to initiate nucleation and to control orientation in the aragonite crystal form and growth. Also is stressed the existence of several levels or steps of mineralization, simultaneously, as a key mechanism for the thickening of the shell. This natural bioceramic is studied with the aim of using it as a biomaterial in bone repair.
C1 Museum Natl Hist Nat, Dept Milieux & Peuplements Aquat, UMR 5178 CNRS MNHN, F-75231 Paris 05, France.
   Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, USM 505 Ecosyst & Interact Tox, F-75231 Paris, France.
   Natl Museum Nat Hist, Dept Hist Terre, F-75231 Paris 05, France.
   Univ Bordeaux, Lab Composites Thermo Struct, UMR 5801 CNRS, SNECMA CEA UB1, F-33600 Pessac, France.
RP Rousseau, M (reprint author), Museum Natl Hist Nat, Dept Milieux & Peuplements Aquat, UMR 5178 CNRS MNHN, 7 Rue Cuvier, F-75231 Paris 05, France.
EM rousseam@gmx.net; lopez@mnhn.fr; acoute@mnhn.fr; mascarel@mnhn.fr;
   smith@mnhn.fr; naslain@lctcs.u-bordeaux.fr; bourrat@lcts.u-bordeaux.fr
CR Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   Feng QL, 1999, J MATER SCI LETT, V18, P1547, DOI 10.1023/A:1006687627323
   Naslain R., 1998, P ECCM 8 C, V4, P191
   WATABE N, 1965, J ULTRA MOL STRUCT R, V12, P351, DOI 10.1016/S0022-5320(65)80104-6
   WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036
NR 6
TC 9
Z9 9
U1 1
U2 14
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 1009
EP 1012
DI 10.4028/www.scientific.net/KEM.254-256.1009
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000249
DA 2018-10-19
ER

PT S
AU Zreiqat, H
   Berger, G
   Gildenhaar, R
   Knabe, C
AF Zreiqat, H
   Berger, G
   Gildenhaar, R
   Knabe, C
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI The functional expression of human bone-derived cells grown on rapidly
   resorbable calcium phosphate ceramics
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE calcium phosphate ceramics; human bone-derived cells; cell-biomaterial
   interactions; bone-substitutes; in situ hybridization
AB The use of biodegradable bone substitutes is advantageous for alveolar ridge augmentation, since it avoids second-site surgery for autograft harvesting. This study examines the effect of novel, rapidly resorbable calcium phosphates on the expression of bone-related genes and proteins by human bone derived cells (HBDC) and compares this behavior to that of tricalciumphosphate (TCP). Test materials were alpha-TCP, and four materials created from beta-Rhenanite and its derivatives: R1-beta-Rhenanite (CaNaPO4); R1/M2 - composed of CaNaPO4 and MgNaPO4; R1+SiO2 composed of CaNaPO4 and 9% SiO2 (wt%); and R17 - Ca2KNa(PO4)(2). HBDC were grown on the substrata for 3, 5, 7, 14 and 21 days and probed for Type I collagen, osteocalcin, osteopontin, osteonectin, alkaline phosphatase and bone sialoprotein mRNA and proteins. All substrata supported continuous cellular growth for 21 days when R1+SiO2 and R17 had the highest number of HBDC. At 14 and 21d, cells on R1 and on R1+SiO2 displayed significantly enhanced expression of all osteogenic proteins. Since all novel calcium phosphates supported cellular proliferation together with expression of bone-related proteins at least as much as TCP, these ceramics can be regarded as potential bone substitutes. R1 and R1+SiO2 had the most effect on osteoblastic differentiation, thus suggesting that these materials may possess a higher potency to enhance osteogenesis than TCP.
C1 Univ New S Wales, Sch Med Sci, Dept Pathol, Sydney, NSW 2052, Australia.
   Fed Res Inst Mat Res & Testing, Lab Biomat, D-12200 Berlin, Germany.
   Univ Hosp Benjamin Franklin, Dept Expt Dent, Berlin, Germany.
RP Zreiqat, H (reprint author), Univ New S Wales, Sch Med Sci, Dept Pathol, Sydney, NSW 2052, Australia.
EM H.Zreiqat@unsw.edu.au; georg.berger@bam.de; renate.gildenhaar@bam.de;
   Christine.knabe@medizin.fu-berlin.de
CR BERGER G, 1995, BIOCERAMICS, V8
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   KNABE C, 1997, BIOMATERIALS, V18, P1347
   Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   ZERBO IR, 2001, CLIN ORAL IMPLAN RES, V12, P384
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
NR 7
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 1059
EP 1062
DI 10.4028/www.scientific.net/KEM.254-256.1059
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000261
DA 2018-10-19
ER

PT S
AU Mesquita, P
   Branco, R
   Afonso, A
   Vasconcelos, M
   Cavalheiro, J
AF Mesquita, P
   Branco, R
   Afonso, A
   Vasconcelos, M
   Cavalheiro, J
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Mineralised membranes for bone regeneration
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE biomaterial; membrane; bone regeneration; natural material
AB Guided bone regeneration can be achieved using filling biomaterials and protective membranes. The aim of this work is to study a new membrane prepared from shrimp shells, without modification of the natural concave shape. The "in vitro" bioactivity was evaluated using a simulated body fluid prepared with substitution of calcium by strontium (SBR-Sr). The bioactivity behaviour was increased using a surface treatment with sodium silicate.
   The "in vitro" and "in vivo" tests allow to conclude that these membranes are bioactive and can induce bone growth on their surfaces.
C1 Inst Biomed Engn, INEB, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, Oporto, Portugal.
   Univ Porto, Fac Med Dent, P-4200393 Oporto, Portugal.
RP Mesquita, P (reprint author), Inst Biomed Engn, INEB, R do Campo Alegre 823, P-4150180 Oporto, Portugal.
EM jcavalheiro@fe.up.pt
RI Vasconcelos, Mario/G-5472-2013
CR Baron M, 2000, INT J ORAL MAX IMPL, V15, P533
   Brunel G, 2001, J PERIODONTOL, V72, P257, DOI 10.1902/jop.2001.72.2.257
   Hammerle CHF, 2002, J CLIN PERIODONTOL, V29, P226, DOI 10.1034/j.1600-051X.29.s3.14.x
   Karapataki S, 2000, J CLIN PERIODONTOL, V27, P325, DOI 10.1034/j.1600-051x.2000.027005325.x
   SIMOES F, 2002, 17 ESB BARC SPAIN SE
NR 5
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 1091
EP 1094
DI 10.4028/www.scientific.net/KEM.254-256.1091
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000269
DA 2018-10-19
ER

PT J
AU Miller, DC
   Thapa, A
   Haberstroh, KM
   Webster, TJ
AF Miller, DC
   Thapa, A
   Haberstroh, KM
   Webster, TJ
TI Endothelial and vascular smooth muscle cell function on
   poly(lactic-co-glycolic acid) with nano-structured surface features
SO BIOMATERIALS
LA English
DT Article
DE nano-structured; vascular; poly(lactic-co-glycolic acid); endothelial
   cells; smooth muscle cells; tissue-engineering
ID OSTEOBLAST ADHESION; NANOPHASE CERAMICS; BEHAVIOR
AB Biomaterials that successfully integrate into surrounding tissue should match not only the tissue's mechanical properties, but also its topography. The cellular response to a biomaterial may be enhanced in synthetic polymer formulations by mimicking the surface roughness created by the associated nano-structured extra-cellular matrix components of natural tissue. As a first step towards this endeavor, the goal of the present in vitro study was to use these design parameters to develop a synthetic, nano-structured, polymeric biomaterial that promotes cell adhesion and growth for vascular applications. In a novel manner, poly(lactic-co-glycolic acid) (PLGA) (50/50wt% mix) was synthesized to possess a range (from micron to nanometer) of surface features. Reduction of surface features was accomplished by treating conventional PLGA with various concentrations of NaOH for select periods of time. Results from cell experiments indicated that, compared to conventional PLGA, NaOH treated PLGA enhanced vascular smooth muscle cell adhesion and proliferation. However, PLGA prepared by soaking in NaOH decreased endothelial cell adhesion and proliferation compared to conventional PLGA. After further investigation, this finding was determined to be a result of chemical (and not topographical) changes during polymer synthesis. Surface chemistry effects were removed while retaining nano-structured topography by using polymer/elastomer casting methods. Results demonstrated that endothelial and smooth muscle cell densities increased on nano-structured cast PLGA. For these reasons, the present in vitro study provided the first evidence that nano-structured surface features can significantly improve vascular cell densities; such design criteria can be used in the synthesis of the next-generation of more successful tissue-engineered vascular grafts. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Webster, TJ (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
CR ABBOTT WM, 1993, J VASC SURG, V17, P746, DOI 10.1016/0741-5214(93)90120-B
   CHU CFL, 1999, BIOCHIM BIOPHYS ACTA, V3, P479
   CLARK P, 1987, DEVELOPMENT, V99, P439
   CLAYSON KR, 1976, ARCH SURG-CHICAGO, V111, P1276
   DARLING RC, 1972, AM J SURG, V123, P472, DOI 10.1016/0002-9610(72)90202-4
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GAO J, 1998, J BIOMED MATER RES, V3, P417
   GOODMAN SL, 1997, J BIOMED MATER RES, V4, P539
   HOCH HC, 1987, SCIENCE, V235, P1659, DOI 10.1126/science.235.4796.1659
   Mikos AG, 2000, J BIOTECHNOL, V3, P1
   *NAT HIGHW TRAFF S, 1981, AIR AMB GUID, P2
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   Solan A, 2001, TRANSPLANT P, V33, P66, DOI 10.1016/S0041-1345(00)01909-6
   THAPA A, 2003, BIOMATERIALS, V17, P2915
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
NR 19
TC 314
Z9 326
U1 8
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2004
VL 25
IS 1
BP 53
EP 61
DI 10.1016/S0142-9612(03)00471-X
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 745DR
UT WOS:000186674300006
PM 14580908
DA 2018-10-19
ER

PT J
AU Kikuchi, M
   Matsumoto, HN
   Yamada, T
   Koyama, Y
   Takakuda, K
   Tanaka, J
AF Kikuchi, M
   Matsumoto, HN
   Yamada, T
   Koyama, Y
   Takakuda, K
   Tanaka, J
TI Glutaraldehyde cross-linked hydroxyapatite/collagen self-organized
   nanocomposites
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; collagen; self-organized composite; glutaraldehyde;
   cross-link; bone tissue reaction
ID COLLAGEN COMPOSITE; HISTOLOGIC EVALUATION; BONE-GRAFT; BIOMATERIAL;
   DIFFRACTION; FRACTURE; IMPLANTS; RELEASE; PHASES; MODEL
AB To control the mechanical properties and biodegradability of self-organized hydroxyapatite/collagen (HAp/Col) nanocomposites, cross-linkage was introduced into the composites with glutaraldehyde (GA). The HAp/Col composite suspensions, prepared by a simultaneous titration method and aged for 3h, were cross-linked with the reagents for 10min under vigorous stirring. The precipitates obtained were filtrated and compacted by dehydration under a uniaxial pressure. The particle size distribution, 3-point bending strength, contained water amount and swelling ratio of the composites were examined as a function of cross-linkage amount; the biodegradability was estimated by animal tests using rabbits. As regards the cross-linked composites, no long-rage alignment of HAp crystals along collagen molecules was found with a transmission electron microscope, suggesting that the cross-linking reagents suppressed their long-range self-organization mechanism. The 3-point bending strength increased with the GA content and took a maximal value at 1.35 mmol/g(col). The animal tests indicated no toxicity and osteoclastic resorption with good osteoconductivity. The resorption rate was decreased with increasing GA concentration. These results suggest that GA cross-linkage controls mechanical properties and resorption rate without reducing high biocompatibility of the composite. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   Japan Sci & Technol Co, CREST, Kawaguchi, Saitama 3320012, Japan.
   Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Biomed Engn, Div Biosyst,Chiyoda Ku, Tokyo 1010062, Japan.
RP Kikuchi, M (reprint author), Natl Inst Mat Sci, Ctr Biomat, 1-1,Namiki, Tsukuba, Ibaraki 3050044, Japan.
RI Kikuchi, Masanori/B-5993-2008; Matsumoto, Hiroko/B-8335-2011
OI Kikuchi, Masanori/0000-0002-9451-8147; 
CR Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   BACON GE, 1979, J ANAT, V128, P277
   Borsato KS, 1997, J BIOMECH, V30, P955, DOI 10.1016/S0021-9290(97)00044-4
   COLE AA, 1987, J HISTOCHEM CYTOCHEM, V35, P203, DOI 10.1177/35.2.3540104
   Cornell C N, 1991, J Orthop Trauma, V5, P1
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Galbavy S, 1995, Bratisl Lek Listy, V96, P368
   GAUR RK, 1989, ANAL BIOCHEM, V280, P25
   Hasegawa Y, 2002, J BIOMED MATER RES, V63, P679, DOI 10.1002/jbm.10388
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   KAWAHARA J, 1997, ACS SYM SER, P119
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim KM, 1999, AM J PATHOL, V154, P843, DOI 10.1016/S0002-9440(10)65331-X
   KOCIALKOWSKI A, 1990, INJURY, V21, P142, DOI 10.1016/0020-1383(90)90082-6
   MAMMONE JF, 1993, J BIOMECH, V26, P439, DOI 10.1016/0021-9290(93)90007-2
   MAROUF H A, 1990, International Journal of Oral and Maxillofacial Implants, V5, P148
   Martins VCA, 1998, ARTIF ORGANS, V22, P215, DOI 10.1046/j.1525-1594.1998.06004.x
   Martins VCA, 2000, ARTIF ORGANS, V24, P224, DOI 10.1046/j.1525-1594.2000.06517.x
   MEHLISCH DR, 1990, ORAL SURG ORAL MED O, V70, P685, DOI 10.1016/0030-4220(90)90001-9
   Miyamoto Y, 1998, BIOMATERIALS, V19, P707, DOI 10.1016/S0142-9612(97)00186-5
   NEUMAN WF, 1958, CHEM DYNAMICS BONE M
   Ogose A, 2002, J BIOMED MATER RES, V63, P601, DOI 10.1002/jbm.10380
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244
   Sikinami Y, 1999, BIOMATERIALS, V20, P859
   SUH H, 1995, ASAIO J, V41, pM652, DOI 10.1097/00002480-199507000-00091
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   WALSH WR, 1994, BIOMATERIALS, V15, P137, DOI 10.1016/0142-9612(94)90263-1
   Walsh WR, 2000, CLIN ORTHOP RELAT R, P258
   Zhang QQ, 1996, ARTIF CELL BLOOD SUB, V24, P693, DOI 10.3109/10731199609118892
NR 33
TC 115
Z9 125
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2004
VL 25
IS 1
BP 63
EP 69
DI 10.1016/S0142-9612(03)00472-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 745DR
UT WOS:000186674300007
PM 14580909
DA 2018-10-19
ER

PT J
AU Matzelle, MM
   Babensee, JE
AF Matzelle, MM
   Babensee, JE
TI Humoral immune responses to model antigen co-delivered with biomaterials
   used in tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE poly(lactic-co-glycolic acid) microparticles and scaffolds; adjuvant;
   humoral immune response; tissue engineering
ID CTLA4-IG PROLONGS SURVIVAL; DIABETIC NOD MICE; ISLET XENOGRAFTS;
   DENDRITIC CELLS; IN-VITRO; T-CELLS; MICROSPHERES; MECHANISMS;
   DESTRUCTION; EXPRESSION
AB A model shed antigen, ovalbumin (OVA), was co-delivered with polymeric biomaterial carrier vehicles in C57BL6 mice to test whether the presence of the biomaterial acted as an adjuvant in the immune response towards the associated antigen. The biomaterials tested were non-biodegradable polystyrene microparticles and biodegradable 50:50 or 75:25 poly(lactic-co-glycolic acid) (PLGA) microparticles or scaffolds. For each biomaterial carrier vehicle, to assess the resulting time-dependent systemic humoral immune response towards the co-delivered OVA, the OVA-specific IgG concentration and isotypes (IgG2a or IgG1, indicating a predominant Th1 or Th2 response, respectively) were determined using ELISA. OVA co-delivered with biomaterial carrier vehicles supported a moderate humoral immune response that was maintained for the 18-week duration of the experiment. This humoral immune response was primarily Th2 helper T cell-dependent as indicated by the predominant IgG1 isotype. Furthermore, this humoral immune response was not material chemistry-dependent within the material set tested here. With the presence of the biomaterial resulting in an enhancement of the humoral immune response to co-delivered antigen, it appears that the biomaterial acts as an adjuvant in the development of an adaptive immune response to co-delivered antigen. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Georgia Tech, Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Georgia Tech, Emory Ctr Engn Living Tissues, 315 Ferst Dr, Atlanta, GA 30332 USA.
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196
   Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   CHANDLER C, 1993, ARCH SURG-CHICAGO, V128, P279
   Chen NX, 1996, TRANSPLANTATION, V61, P1076, DOI 10.1097/00007890-199604150-00016
   Coombes AGA, 1999, VACCINE, V17, P2410, DOI 10.1016/S0264-410X(99)00025-0
   GALLUCCI S, 1999, NAT MED, V5, P1233
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Igartua M, 1998, J CONTROL RELEASE, V56, P63, DOI 10.1016/S0168-3659(98)00077-7
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142
   Ke Y, 1997, CELL IMMUNOL, V176, P113, DOI 10.1006/cimm.1997.1084
   Loudovaris T, 1996, TRANSPLANTATION, V61, P1678, DOI 10.1097/00007890-199606270-00003
   McKenzie AW, 2001, CELL TRANSPLANT, V10, P183
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Nakaoka R, 1996, VACCINE, V14, P1251, DOI 10.1016/S0264-410X(96)00016-3
   Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019
   Piccotti JR, 1997, TRANSPLANTATION, V63, P619, DOI 10.1097/00007890-199703150-00001
   Platt J L, 1992, ASAIO J, V38, P8, DOI 10.1097/00002480-199201000-00005
   SAYEGH MH, 1994, TRANSPLANTATION, V57, P1295, DOI 10.1097/00007890-199405150-00001
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   WEBER CJ, 1990, TRANSPLANTATION, V49, P396, DOI 10.1097/00007890-199002000-00034
   Weber CJ, 1996, TRANSPLANT P, V28, P821
   Weber CJ, 1997, CELL TRANSPLANT, V6, P505, DOI 10.1016/S0963-6897(97)00045-6
   YOSHIDA M, UNPUB J LAB CLIN MED
   Zhao Z, 1996, J PHARM SCI-US, V85, P1261, DOI 10.1021/js9602812
NR 33
TC 46
Z9 46
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2004
VL 25
IS 2
BP 295
EP 304
DI 10.1016/S0142-9612(03)00531-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 746BZ
UT WOS:000186727700012
PM 14585717
DA 2018-10-19
ER

PT J
AU Knabe, C
   Berger, G
   Gildenhaar, R
   Howlett, CR
   Markovic, B
   Zreiqat, H
AF Knabe, C
   Berger, G
   Gildenhaar, R
   Howlett, CR
   Markovic, B
   Zreiqat, H
TI The functional expression of human bone-derived cells grown on rapidly
   resorbable calcium phosphate ceramics
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate ceramics; human bone-derived cells; cell-biomaterial
   interactions; bone substitutes; in situ hybridization
ID BETA-TRICALCIUM PHOSPHATE; BIOACTIVE GLASS PARTICLES; IN-SITU
   HYBRIDIZATION; FOCAL ADHESION KINASE; OSTEOBLAST-LIKE CELLS; POROUS
   HYDROXYAPATITE; MESSENGER-RNAS; SIGNAL-TRANSDUCTION; INTEGRIN
   EXPRESSION; IMPLANT MATERIALS
AB The use of biodegradable bone substitutes is advantageous for alveolar ridge augmentation, since it avoids second-site surgery for autograft harvesting. This study examines the effect of novel, rapidly resorbable calcium phosphates on the expression of bone-related genes and proteins by human bone-derived cells (HBDC) and compares this behavior to that of tricalciumphosphate (TCP). Test materials were alpha-TCP, and four materials which were created from beta-Rhenanite and its derivatives: R1-beta-Rhenanite (CaNaPO4); R1/M2 composed of CaNaPO4 and MgNaPO4; R1 + SiO2 composed of CaNaPO4 and 9% SiO2 (wt%); and R17-Ca2KNa(PO4)(2). HBDC were grown on the substrata for 3, 5, 7, 14 and 21 days, counted and probed for various mRNAs and proteins (Type I collagen, osteocalcin, osteopontin, osteonectin, alkaline phosphatase and bone sialoprotein). All substrata supported continuous cellular growth for 21 days. At day 21, surfaces of R1 + SiO2 and R17 had the highest number of HBDC. At 14 and 21 days, cells on R1 and on R1 + SiO2 displayed significantly enhanced expression of all osteogenic proteins. Since all novel calcium phosphates supported cellular proliferation together with expression of bone-related proteins at least as much as TCP, these ceramics can be regarded as potential bone substitutes. R1 and R1 + SiO2 had the most effect on osteoblastic differentiation, thus suggesting that these materials may possess a higher potency to enhance osteogenesis than TCP. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Free Univ Berlin, Benjamin Franklin Hosp, Dept Expt Dent, D-14197 Berlin, Germany.
   Univ New S Wales, Sch Safety Sci, Sydney, NSW 2052, Australia.
   Fed Inst Mat Res & Testing, Lab Biomat, D-12200 Berlin, Germany.
   Univ New S Wales, Fac Med, Sch Med Sci, Dept Pathol,Bone Biomat Unit, Sydney, NSW 2052, Australia.
RP Knabe, C (reprint author), Free Univ Berlin, Benjamin Franklin Hosp, Dept Expt Dent, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
CR Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Aubin JE, 2000, BONE ENG, P19
   BATES RC, 1995, CANCER METAST REV, V14, P191, DOI 10.1007/BF00690291
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   BERGER G, 1995, BIOMATERIALS, V16, P1241, DOI 10.1016/0142-9612(95)98131-W
   BERGER G, 1995, BIOCERAMICS, V8, P453
   Bolind P, 1999, CLIN IMPLANT DENT R, V1, P33
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BUSER D, 1994, GUIDED BONE REGENERA, P189
   Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F
   Davies JE, 1996, ANAT REC, V245, P426
   DEBRUIJN JD, 1994, BIOMATERIALS, V15, P543, DOI 10.1016/0142-9612(94)90021-3
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   FAULL RJ, 1995, STEM CELLS, V13, P38, DOI 10.1002/stem.5530130106
   FISHER LW, 1985, CLIN ORTHOP RELAT R, P362
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   GROSS UM, 1991, BONE-BIOMATERIAL INTERFACE, P308
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HOWLETT CR, 2000, BONE ENG, P240
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KAHARI VM, 1987, MED SCI RES-BIOCHEM, V15, P417
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   LEGEROS RZ, 1990, CRC HDB BIOACTIVE CE, V2, P179
   Merten HA, 2001, J CRANIOFAC SURG, V12, P59, DOI 10.1097/00001665-200101000-00010
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MULLERMAI CM, 2000, THESIS FREE U BERLIN
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Neo M, 1996, J BIOMED MATER RES, V30, P485, DOI 10.1002/(SICI)1097-4636(199604)30:4<485::AID-JBM6>3.0.CO;2-L
   Neo M, 1998, J BIOMED MATER RES, V39, P71, DOI 10.1002/(SICI)1097-4636(199801)39:1<71::AID-JBM9>3.0.CO;2-F
   NEO M, 1998, J BIOMED MATER RES, V3, P1
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Ohsawa K, 2000, J BIOMED MATER RES, V52, P460, DOI 10.1002/1097-4636(20001205)52:3<460::AID-JBM3>3.3.CO;2-L
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Reis SA, 1996, CLIN ORAL IMPLAN RES, V7, P253, DOI 10.1034/j.1600-0501.1996.070307.x
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   RICHARDSON A, 1995, BIOESSAYS, V17, P229, DOI 10.1002/bies.950170309
   RODAN GA, 1984, BONE MINERAL RES ANN, V2, P244
   Roeser Kerstin, 2000, Journal of Biomedical Materials Research, V51, P280
   SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L
   SCHNEIDER M, 1994, CRYST RES TECHNOL, V29, P671, DOI 10.1002/crat.2170290516
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615
   SODEK J, 1991, BONE-BIOMATERIAL INTERFACE, P97
   SODEK J, 2000, BONE ENG, P31
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   von Arx T, 2002, INT J ORAL MAX SURG, V31, P190, DOI 10.1054/ijom.2001.0205
   Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 1999, J BIOMAT SCI-POLYM E, V10, P199, DOI 10.1163/156856299X00135
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 73
TC 34
Z9 36
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2004
VL 25
IS 2
BP 335
EP 344
DI 10.1016/S0142-9612(03)00525-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 746BZ
UT WOS:000186727700016
PM 14585721
DA 2018-10-19
ER

PT S
AU Yilmaz, E
AF Yilmaz, E
BE Hasirci, N
   Hasirci, V
TI Chitosan: A versatile biomaterial
SO BIOMATERIALS: FROM MOLECULES TO ENGINEERED TISSUES
SE ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
LA English
DT Article; Proceedings Paper
CT 10th International Symposium on Biomedical Science and Technology
CY OCT 10-12, 2003
CL CYPRUS
ID DELIVERY-SYSTEMS; DRUG-DELIVERY; DERIVATIVES; POLYSACCHARIDE; CHITIN
C1 Eastern Mediterranean Univ, Fac Arts & Sci, Dept Chem, Mersin 10, Turkey.
RP Yilmaz, E (reprint author), Eastern Mediterranean Univ, Fac Arts & Sci, Dept Chem, Mersin 10, Turkey.
RI Yilmaz, Elvan/A-8528-2008
CR ALBAYRAK B, 2000, THESIS MIDDLE E TU
   ANTHONSEN MW, 1993, CARBOHYD POLYM, V22, P193, DOI 10.1016/0144-8617(93)90140-Y
   Bernkop-Schnurch A, 2000, INT J PHARM, V194, P1, DOI 10.1016/S0378-5173(99)00365-8
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Burke A, 2002, J APPL POLYM SCI, V84, P1185, DOI 10.1002/app.10416
   BURKE A, 2002, THESIS E MEDITERRANE
   CANER H, 2002, THESIS SYNTHESIS CHA
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Kato Y, 2000, STP PHARMA SCI, V10, P133
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Liu WG, 2002, J CONTROL RELEASE, V83, P1
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Muzzarelli RA., 2000, CHITOSAN PER OS DIET, P3
   Muzzarelli RAA, 1996, CARBOHYD POLYM, V29, P309, DOI 10.1016/S0144-8617(96)00033-1
   Okuyama K, 2000, CARBOHYD POLYM, V41, P237, DOI 10.1016/S0144-8617(99)00142-3
   Onishi H, 2001, DRUG DEV IND PHARM, V27, P659, DOI 10.1081/DDC-100107322
   SANFORD PA, 1989, CHITIN CHITOSAN SOUR, P51
   Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4
   Senel S, 2000, INT J PHARM, V193, P197, DOI 10.1016/S0378-5173(99)00334-8
   Singh DK, 2000, J MACROMOL SCI R M C, VC40, P69, DOI 10.1081/MC-100100579
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tan SC, 1998, TALANTA, V45, P713, DOI 10.1016/S0039-9140(97)00288-9
   UYLUCKCUOGLU B, 2000, THESIS MIDDLE E TU
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1
   Woodley J, 2001, CLIN PHARMACOKINET, V40, P77, DOI 10.2165/00003088-200140020-00001
NR 29
TC 28
Z9 28
U1 0
U2 6
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0065-2598
BN 0-306-48583-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2004
VL 553
BP 59
EP 68
PG 10
WC Engineering, Biomedical; Medicine, Research & Experimental; Materials
   Science, Biomaterials
SC Engineering; Research & Experimental Medicine; Materials Science
GA BAW84
UT WOS:000223979400005
PM 15503447
DA 2018-10-19
ER

PT S
AU Godek, ML
   Duchsherer, NL
   McElwee, Q
   Grainger, DW
AF Godek, ML
   Duchsherer, NL
   McElwee, Q
   Grainger, DW
GP ISA
TI Morphology and growth of murine cell lines on model biomaterials
SO BIOMEDICAL SCIENCES INSTRUMENTATION, VOL 40
SE TECHNICAL PAPERS OF ISA
LA English
DT Proceedings Paper
CT 41st Annual Rocky Mountain Bioengineering Symposium/41st International
   ISA Biomedical Sciences Instrumentation Symposium
CY APR 23-25, 2004
CL Ft Collins, CO
SP Instrumentat Syst & Automat Soc
DE macrophage; fibroblast; foreign body response; biomaterial;
   biocompatibility; fusion; giant cell
ID MULTINUCLEATED GIANT-CELLS; MACROPHAGES; IMPLANTS; POLYURETHANE;
   INFECTION; SILICONE; ADHESION
AB All biomaterial implants are assaulted by the host "foreign body" immune response. Understanding the complex, dynamic relationship between cells, biomaterials and milieu is an important first step towards controlling this reaction. Material surface chemistry dictates protein adsorption, and thus subsequent cell interactions. The cell-implant is a microenvironment involving 1) proteins that coat the surface and 2) cells that interact with these proteins. Macrophages and fibroblasts are two cell types that interact with proteins on biomaterials surfaces and play different related, but equally important, roles in biomaterials rejection and implant failure.
   Growth characteristics of four murine cell lines on model biomaterials surfaces were examined. Murine monocyte-macrophages (RAW 264.7 and J774A.1), murine macrophage (IC-21) and murine fibroblast (NIH 3T3)) cell lines were tested to determine, proliferation, differentiation, spreading, and si whether differences exist in adhesion, fusion (macrophage lineages only) on these surfaces. Differences were observed in the ability of cells to adhere to and subsequently proliferate on polymer surfaces. (Monocyte-) macrophages grew well on all surfaces tested and growth rates were measured on three representative polymer biomaterials surfaces: tissue culture polystyrene (TCPS), polystyrene, and Teflon(R)-AF.J774A.1 cultures grown on TCPS and treated with exogenous cytokines IL-4 and GM-CSF were observed to contain multinucleate cells with unusual morphologies. Thus, (monocyte-) macrophage cell lines were found to effectively attach to and interrogate each surface presented, with evidence of extensive spreading on Teflon(R)-AF surfaces, particularly in the IC-21 cultures. The J774A.1 line was able to proliferate and/or differentiate to more specialized cell types (multinucleate/dendritic-like cells) in the presence of soluble chemokine cues.
C1 Colorado State Univ, Program Mol & Cell Biol, Ft Collins, CO 80523 USA.
RP Godek, ML (reprint author), Colorado State Univ, Program Mol & Cell Biol, Ft Collins, CO 80523 USA.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   BERKEN A, 1966, J EXP MED, V123, P119, DOI 10.1084/jem.123.1.119
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   DESAI NP, 1992, BIOMATERIALS, V13, P505, DOI 10.1016/0142-9612(92)90101-S
   Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1722, DOI 10.1128/IAI.69.3.1722-1728.2001
   Grainger DW, 2003, J BIOMAT SCI-POLYM E, V14, P973, DOI 10.1163/156856203322381456
   HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664
   KUBY J, 2000, CELL ORGANS IMMUNE S, P27
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378
   STARK GB, 1990, ANN PLAS SURG, V24, P156, DOI 10.1097/00000637-199002000-00009
   UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 22
TC 5
Z9 5
U1 1
U2 3
PU INSTRUMENT SOC AMER
PI RESEARCH TRIANGLE PARK
PA 67 ALEXANDER DR, PO BOX 12277, RESEARCH TRIANGLE PARK, NC 27709 USA
SN 1054-0032
J9 TECH PAPERS ISA
PY 2004
VL 449
BP 7
EP 12
PG 6
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BAE76
UT WOS:000221906600002
DA 2018-10-19
ER

PT S
AU Brooks, AE
   Lewis, RV
AF Brooks, AE
   Lewis, RV
GP ISA
TI Probing the elastic nature of spider silk in pursuit of the next
   designer fiber
SO BIOMEDICAL SCIENCES INSTRUMENTATION, VOL 40
SE TECHNICAL PAPERS OF ISA
LA English
DT Proceedings Paper
CT 41st Annual Rocky Mountain Bioengineering Symposium/41st International
   ISA Biomedical Sciences Instrumentation Symposium
CY APR 23-25, 2004
CL Ft Collins, CO
SP Instrumentat Syst & Automat Soc
DE spider silk; elasticity; mechanical properties
ID DRAGLINE SILK; SEQUENCE; PROTEINS; FIBROIN
AB Spider silk, one of nature's greatest accomplishments, has a combination of strength and elasticity that is unrivaled. Spiders produce up to 7 different silks; each one with a unique combination of tensile strength and elasticity Mat allows the spiders' web to hold prey while being resilient enough not to break upon impact. In an attempt to determine the sequences responsible for these enviable mechanical properties, several different amino acid motifs have been defined. Much of the recent work is now concentrated on correlating amino acid motifs with a specific mechanical property. The current hypothesis is that the strength property of spider silk is conferred by a poly-alanine or alanine rich (A. or G-A.) motif whereas the elastic nature of spider silk is conferred by the amino acid motif GPGXX, where X is Q, S, A, G, or Y. Despite the fact that these different motifs are now known, the combination of strength and elasticity are yet to be duplicated ex vivo.
   In an attempt to verify that the GPGXX motif imparts elasticity to the spider silk, the number of repeats and/or the amino acid composition of the Argiope aurantia "elastic motif" were varied and expressed in various strains of E. coli to change the elastic properties of the resulting film and/or fiber. Concurrent with work on the elasticity motif is ongoing work on the strength module. Understanding these two different motifs will aide efforts to produce a designer biomaterial for medical, commercial, and military applications.
C1 Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.
RP Brooks, AE (reprint author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.
CR Atkins E, 2003, NATURE, V424, P1010, DOI 10.1038/4241010a
   Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   JONES J, COMMUNICATION
   Kaplan D.L., 1991, BIOMATERIALS NOVEL M, P1
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   PETERS HM, 1955, Z NATURFORSCH PT B, V10, P395
NR 12
TC 0
Z9 0
U1 0
U2 1
PU INSTRUMENT SOC AMER
PI RESEARCH TRIANGLE PARK
PA 67 ALEXANDER DR, PO BOX 12277, RESEARCH TRIANGLE PARK, NC 27709 USA
SN 1054-0032
J9 TECH PAPERS ISA
PY 2004
VL 449
BP 232
EP 237
PG 6
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BAE76
UT WOS:000221906600038
DA 2018-10-19
ER

PT J
AU Agnihotri, A
   Siedlecki, CA
AF Agnihotri, A
   Siedlecki, CA
TI Adhesion mapping of fibrinogen over model biomaterial surfaces using
   polyclonal antibody modified probe
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Biophysical Society
CY FEB 14-18, 2004
CL Baltimore, MD
SP Biophys Soc
C1 Penn State Univ, Hershey, PA 17033 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2004
VL 86
IS 1
SU S
BP 154A
EP 154A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 762KQ
UT WOS:000187971200795
DA 2018-10-19
ER

PT J
AU Guilak, F
   Awad, HA
   Fermor, B
   Leddy, HA
   Gimble, JM
AF Guilak, F
   Awad, HA
   Fermor, B
   Leddy, HA
   Gimble, JM
TI Adipose-derived adult stem cells for cartilage tissue engineering
SO BIORHEOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Mechanobiology of Cartilage and
   Chondrocyte
CY MAY 16-17, 2003
CL Brussels, BELGIUM
DE articular cartilage; chondrocyte; pre-adipocyte; stromal cell;
   osteoarthritis; collagen; proteoglycan
ID MESENCHYMAL PROGENITOR CELLS; MARROW STROMAL CELLS; ARTICULAR-CARTILAGE;
   CHONDROGENIC DIFFERENTIATION; BONE-MARROW; IN-VITRO; GENE-EXPRESSION;
   REPAIR PROCEDURES; CHONDRAL DEFECTS; ALGINATE
AB Tissue engineering is a promising therapeutic approach that uses combinations of implanted cells, biomaterial scaffolds, and biologically active molecules to repair or regenerate damaged or diseased tissues. Many diverse and increasingly complex approaches are being developed to repair articular cartilage, with the underlying premise that cells introduced exogenously play a necessary role in the success of engineered tissue replacements. A major consideration that remains in this field is the identification and characterization of appropriate sources of cells for tissue-engineered repair of cartilage. In particular, there has been significant emphasis on the use of undifferentiated progenitor cells, or "stem" cells that can be expanded in culture and differentiated into a variety of different cell types. Recent studies have identified the presence of an abundant source of stem cells in subcutaneous adipose tissue. These cells, termed adipose-derived adult stem (ADAS) cells, show characteristics of multipotent adult stein cells, similar to those of bone marrow derived mesenchymal stem cells (MSCs), and under appropriate culture conditions, synthesize cartilage-specific matrix proteins that are assembled in a cartilaginous extracellular matrix. The growth and chondrogenic differentiation of ADAS cells is strongly influenced by factors in the biochemical as well as biophysical environment of the cells. Furthermore, there is strong evidence that the interaction between the cells, the extracellular biomaterial substrate, and growth factors regulate ADAS cell differentiation and tissue growth. Overall, ADAS cells show significant promise for the development of functional tissue replacements for various tissues of the musculoskeletal system.
C1 Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
   Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Awad, Hani/G-6976-2014
OI Awad, Hani/0000-0003-2197-2610; Guilak, Farshid/0000-0001-7380-0330
FU NIAMS NIH HHS [AR48182, AR50245, AR49294]; NIA NIH HHS [AG15768]; NIGMS
   NIH HHS [GM08555]
CR Adachi N, 2002, J RHEUMATOL, V29, P1920
   Akizuki S, 1997, ARTHROSCOPY, V13, P9, DOI 10.1016/S0749-8063(97)90204-8
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   AWAD HA, 2003, SUMM BIOENG C, P273
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Blevins FT, 1998, ORTHOPEDICS, V21, P761
   Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Ghivizzani S C, 2000, Phys Med Rehabil Clin N Am, V11, P289
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   GUILAK F, 2003, FUNCTIONAL TISSUE EN
   HALE JE, 1993, J BIOMECH, V26, P1319, DOI 10.1016/0021-9290(93)90355-I
   Halvorsen YC, 2000, INT J OBESITY, V24, pS41, DOI 10.1038/sj.ijo.0801503
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Huang JI, 2002, PLAST RECONSTR SURG, V109, P1033, DOI 10.1097/00006534-200203000-00037
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kirschstein R, 2001, STEM CELLS SCI PROGR
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Leddy HA, 2003, ANN BIOMED ENG, V31, P753, DOI 10.1114/1.1581879
   LEDDY HA, 2003, T ORTHOP RES SOC, V28, P289
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085
   LOTT KE, 2004, T ORTHOP RES SOC, V29, P162
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Minas T, 1997, ORTHOPEDICS, V20, P525
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   NAKAHARA H, 1990, BONE, V11, P181, DOI 10.1016/8756-3282(90)90212-H
   NAKASE T, 1993, BIOCHEM BIOPH RES CO, V195, P1422, DOI 10.1006/bbrc.1993.2202
   Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249
   Nishimura K, 1999, ARTHRITIS RHEUM, V42, P2631, DOI 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   O'Driscoll SW, 2001, CLIN ORTHOP RELAT R, pS190
   ODRISCOLL SW, 1994, J BONE JOINT SURG AM, V76A, P1042, DOI 10.2106/00004623-199407000-00013
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 2001, CYTOTHERAPY, V3, P393, DOI 10.1080/146532401753277229
   Prockop DJ, 2002, NAT BIOTECHNOL, V20, P791, DOI 10.1038/nbt0802-791
   Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2
   Solchaga LA, 2001, CLIN ORTHOP RELAT R, pS161
   Sottile V, 2002, BONE, V30, P699, DOI 10.1016/S8756-3282(02)00674-9
   Verfaillie CM, 2002, TRENDS CELL BIOL, V12, P502, DOI 10.1016/S0962-8924(02)02386-3
   Waldman SD, 2003, J BONE JOINT SURG AM, V85A, P101, DOI 10.2106/00004623-200300002-00013
   WANG DW, 2003, T ORTHOP RES SOC, V28, P875
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Young HE, 1999, P SOC EXP BIOL MED, V221, P63, DOI 10.1046/j.1525-1373.1999.d01-55.x
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 75
TC 132
Z9 144
U1 0
U2 16
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0006-355X
J9 BIORHEOLOGY
JI Biorheology
PY 2004
VL 41
IS 3-4
SI SI
BP 389
EP 399
PG 11
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA 871BN
UT WOS:000225104400025
PM 15299271
DA 2018-10-19
ER

PT J
AU Seidel, JO
   Pei, M
   Gray, ML
   Langer, R
   Freed, LE
   Vunjak-Novakovic, G
AF Seidel, JO
   Pei, M
   Gray, ML
   Langer, R
   Freed, LE
   Vunjak-Novakovic, G
TI Long-term culture of tissue engineered cartilage in a perfused chamber
   with mechanical stimulation
SO BIORHEOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Mechanobiology of Cartilage and
   Chondrocyte
CY MAY 16-17, 2003
CL Brussels, BELGIUM
DE chondrogenesis; bioreactor; loading; fluid flow; glycosaminoglycans;
   collagen
ID CHONDROCYTE DIFFERENTIATION; EXTRACELLULAR-MATRIX; DYNAMIC COMPRESSION;
   ARTICULAR-CARTILAGE; POLYMER SCAFFOLDS; AGAROSE CULTURE; II COLLAGEN;
   BIOREACTOR; EXPLANTS; CELLS
AB One approach to functional tissue engineering of cartilage is to utilize bioreactors to provide environmental conditions that stimulate chondrogenesis in cells cultured on biomaterial scaffolds. We report the combined use of a three-dimensional in vitro model and a novel bioreactor with perfusion of culture medium and mechanical stimulation in long-term studies of cartilage development and function. To engineer cartilage, scaffolds made of a non-woven mesh of polyglycolic acid (PGA) were seeded with bovine calf articular chondrocytes, cultured for an initial 30-day period under free swelling conditions, and cultured for an additional 37 day period in one of the three groups: (1) free-swelling, (2) static compression (on 24 h/day, strain control. static offset 10%), and (3) dynamic compression (on 1 h/day; off 23 h/day; strain control, static offset 2%, dynamic strain amplitude 5%; frequency 0.3 Hz). Constructs were sampled at timed intervals and assessed with respect to structure, biochemical composition, and mechanical function. Mechanical simulation had little effect on the compositions, morphologies and on mechanical properties of construct interiors discs, but it resulted in distincly different properties of the peripheral rings and face sides. Contructs cultured with mechanical loading maintained their cylindrical shape with flat and parallel top and bottom surfaces, and retained larger amounts of GAG. The modular bioreactor system with medium perfusion and mechanical loading can be utilized to define the conditions of cultivation for functional tissue engineering of cartilage.
C1 MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Vunjak-Novakovic, G (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, MIT E25-330,45 Carleton St, Cambridge, MA 02139 USA.
EM gordana@mit.edu
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574; Freed,
   Lisa/0000-0002-0720-8432
CR AIGNER T, 1993, J CLIN INVEST, V91, P829, DOI 10.1172/JCI116303
   Allen R G, 1999, Methods Mol Med, V18, P521, DOI 10.1385/0-89603-516-6:521
   ALTMAN GH, 2003, J BIOMECH ENG, V124, P734
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Buschmann MD, 1999, ARCH BIOCHEM BIOPHYS, V366, P1, DOI 10.1006/abbi.1999.1197
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Carver SE, 1999, TISSUE ENG, V5, P1, DOI 10.1089/ten.1999.5.1
   Davisson T, 2002, J ORTHOPAED RES, V20, P842, DOI 10.1016/S0736-0266(01)00160-7
   DAVISSON TH, 2003, 49 ANN M ORTH RES SO
   Demarteau O, 2003, BIORHEOLOGY, V40, P331
   Elder SH, 2001, ANN BIOMED ENG, V29, P476, DOI 10.1114/1.1376696
   Elder SH, 2000, J ORTHOPAED RES, V18, P78, DOI 10.1002/jor.1100180112
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Frank EH, 2000, J BIOMECH, V33, P1523, DOI 10.1016/S0021-9290(00)00100-7
   FRANK EH, 1987, J BIOMECH, V20, P615, DOI 10.1016/0021-9290(87)90282-X
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Guilak F, 2001, Clin Orthop Relat Res, pS295, DOI 10.1097/00003086-200110001-00027
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Jin G, 2000, J ORTHOPAED RES, V18, P899, DOI 10.1002/jor.1100180608
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Lee DA, 1997, J ORTHOP RES, V15, P181, DOI 10.1002/jor.1100150205
   Lee Jennifer H, 2003, Novartis Found Symp, V249, P52
   Levenson M, 1999, MODERNISM-MODERNITY, V6, P1, DOI 10.1353/mod.1999.0032
   LILLIE RD, 1976, HISTOPATHOLOGIC TECH
   Madry H, 2002, HUM GENE THER, V13, P1621, DOI 10.1089/10430340260201716
   Martin I, 1999, ANN BIOMED ENG, V27, P656, DOI 10.1114/1.205
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Pazzano D, 2000, BIOTECHNOL PROGR, V16, P893, DOI 10.1021/bp000082v
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   Stoltz JF, 2002, BIORHEOLOGY, V39, P5
   Tagil M, 1999, J ORTHOPAED RES, V17, P200, DOI 10.1002/jor.1100170208
   Takahashi I, 1998, J CELL SCI, V111, P2067
   Thibault M, 2002, J ORTHOPAED RES, V20, P1265, DOI 10.1016/S0736-0266(02)00070-0
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   VunjakNovakovic G, 1996, AICHE J, V42, P850, DOI 10.1002/aic.690420323
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wu F, 1999, ANN NY ACAD SCI, V875, P405, DOI 10.1111/j.1749-6632.1999.tb08523.x
   Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847
NR 48
TC 75
Z9 82
U1 1
U2 18
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0006-355X
J9 BIORHEOLOGY
JI Biorheology
PY 2004
VL 41
IS 3-4
SI SI
BP 445
EP 458
PG 14
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA 871BN
UT WOS:000225104400030
PM 15299276
DA 2018-10-19
ER

PT J
AU Fearon, P
   Lind, T
   McCaskie, A
   Birch, M
AF Fearon, P
   Lind, T
   McCaskie, A
   Birch, M
TI The use of novel biomolecules as a means of improving osteogenesis on
   biomaterial surfaces
SO BONE
LA English
DT Meeting Abstract
CT Workshop on Frontiers of Skeletal Biology
CY MAR 20-24, 2004
CL Davos, SWITZERLAND
C1 Univ Newcastle Upon Tyne, Sch Surg & Reprod Sci Trauma & Orthopaed, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PY 2004
VL 34
SU 1
BP S2
EP S3
PG 2
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 808HK
UT WOS:000220560000005
DA 2018-10-19
ER

PT J
AU Grimandi, G
   Soueidan, AA
   Faucheux, C
   Josse, S
   Destaing, O
   Jurdic, P
   Laib, S
   Daculsi, G
   Bouler, JM
   Janvier, P
   Bujoli, B
   Guicheux, JJ
AF Grimandi, Gael
   Soueidan, Assem A.
   Faucheux, Corinne
   Josse, Solen
   Destaing, Olivier
   Jurdic, Pierre
   Laib, Samia
   Daculsi, Guy
   Bouler, Jean M.
   Janvier, Pascal
   Bujoli, Bruno
   Guicheux, Jerome J.
TI INNOVATIVE STRATEGY FOR THE LOCAL TREATMENT OF PATHOLOGICAL BONE
   RESORPTION: IN VITRO BIOLOGICAL CHARACTERIZATION OF
   BISPHOSPHONATE-LOADED CALCIUM PHOSPHATE BIOMATERIAL
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Meeting Abstract
C1 [Grimandi, Gael; Soueidan, Assem A.; Faucheux, Corinne; Daculsi, Guy; Bouler, Jean M.; Guicheux, Jerome J.] Sch Dent Surg, INSERM, EM 9903, Nantes, France.
   [Josse, Solen; Laib, Samia; Janvier, Pascal; Bujoli, Bruno] CNRS, UMR 6513, Nantes, France.
   [Destaing, Olivier; Jurdic, Pierre] ENSL, CNRS, UMR 5161, Lyon, France.
RI guicheux, Jerome/F-7767-2013; destaing, olivier/M-3802-2013; Daculsi,
   Guy/P-1320-2014
OI guicheux, Jerome/0000-0003-2754-3024; Daculsi, Guy/0000-0003-1030-3446
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0171-967X
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PY 2004
VL 74
BP S59
EP S59
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 460TI
UT WOS:000267211300146
DA 2018-10-19
ER

PT J
AU Mabilleau, G
   Moreau, M
   Filmon, R
   Basle, MF
   Chappard, D
AF Mabilleau, G.
   Moreau, M.
   Filmon, R.
   Basle, M. F.
   Chappard, D.
TI BIOMATERIAL FOR BONE RECONSTRUCTION STUDY OF THE DEGRADABILITY OF POLY
   (2-HYDROXYETHYL) METHACRYLATE
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Meeting Abstract
C1 [Mabilleau, G.; Moreau, M.; Filmon, R.; Basle, M. F.; Chappard, D.] Fac Med, INSERM, EMI 335, Angers, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0171-967X
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PY 2004
VL 74
BP S119
EP S119
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 460TI
UT WOS:000267211300371
DA 2018-10-19
ER

PT S
AU Leor, J
   Cohen, S
AF Leor, J
   Cohen, S
BE Sideman, S
   Beyar, R
TI Myocardial tissue engineering: Creating a muscle patch for a wounded
   heart
SO CARDIAC ENGINEERING: FROM GENES AND CELLS TO STRUCTURE AND FUNCTION
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 2nd Larry and Horti Fairberg Cardiac Workshop
CY SEP 20-24, 2003
CL Erice, ITALY
SP Technion Israel Inst Technol, Ettore Majorana Fdn & Ctr Sci Culture
DE biomaterial; cell; heart; three-dimensional scaffold
ID CARDIAC-MUSCLE; STEM-CELLS; ALGINATE SCAFFOLDS; FABRICATION;
   TRANSPLANTATION; REGENERATION; ARCHITECTURE; CONSTRUCT; CULTURE; GRAFTS
AB Cardiac tissue engineering promises to revolutionize the treatment of patients with end-stage heart failure and provide new solutions to the serious problem of heart donor shortage. By its broad definition, tissue engineering involves the construction of tissue equivalents from donor cells seeded within three-dimensional polymeric scaffolds, then culturing and implanting of the cell-seeded scaffolds to induce and direct the growth of new, healthy tissue. Here, we present an up-to-date summary of research studies in cardiac tissue engineering, with an emphasis on the critical design principles.
C1 Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
   Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
RP Leor, J (reprint author), Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
EM leorj@post.tau.ac.il
RI COHEN, SMADAR/F-1901-2012; Leor, Jonathan/O-2930-2017
CR Akhyari P, 2002, CIRCULATION, V106, P1137
   Akins RE, 1999, TISSUE ENG, V5, P103, DOI 10.1089/ten.1999.5.103
   Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DAR A, 2000, BIOTECHNOL BIOENG, V80, P305
   Dohmen Pascal M, 2002, Asian Cardiovasc Thorac Ann, V10, P25
   Gepstein L, 2002, CIRC RES, V91, P866, DOI 10.1161/01.RES.0000041435.95082.84
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leor J, 2000, CIRCULATION, V102, P56
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Reffelmann T, 2003, HEART FAIL REV, V8, P201, DOI 10.1023/A:1024796912475
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   VACANTI JP, 1999, LANCET S1, V354, pS132
   Williams R. Sanders, 1998, Cardiology Clinics, V16, P739
   Zandonella C, 2003, NATURE, V421, P884, DOI 10.1038/421884a
   Zimmermann W.H., 2002, CIRCULATION, V106, P1151
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 34
TC 46
Z9 51
U1 1
U2 14
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-480-3
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1015
BP 312
EP 319
DI 10.1196/annals.1302.026
PG 8
WC Biotechnology & Applied Microbiology; Cardiac & Cardiovascular Systems;
   Multidisciplinary Sciences
SC Biotechnology & Applied Microbiology; Cardiovascular System &
   Cardiology; Science & Technology - Other Topics
GA BAN56
UT WOS:000222976600027
PM 15201170
DA 2018-10-19
ER

PT S
AU Weihe, S
   Schiller, C
   Rasche, C
   Hassfeld, S
   Wehmoller, M
   Knoop, H
   Epple, A
   Eufinger, H
AF Weihe, S
   Schiller, C
   Rasche, C
   Hassfeld, S
   Wehmoller, M
   Knoop, H
   Epple, A
   Eufinger, H
BE Lemke, HU
   Inamura, K
   Doi, K
   Vannier, MW
   Farman, AG
   Reiber, JHC
TI CAD/CAM prefabricated individual skull implants: new aspects in robot
   resection and guided bone regeneration
SO CARS 2004: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS
SE INTERNATIONAL CONGRESS SERIES
LA English
DT Proceedings Paper
CT 18th International Congress and Exhibition on Computer Assisted
   Radiology and Surgery (CARS 2004)
CY JUN 23-26, 2004
CL Chicago, IL
DE biomaterial; CAD/CAM; composite; cranioplasty; robot
ID ASSISTED ORTHOPEDIC-SURGERY; RECONSTRUCTION; PROSTHESES; TEMPLATES;
   DEFECTS
AB According to the desire of single-step skull bone resection and reconstruction the acquired CT data were not only used for the design of the individual implant but also for a robot-guided bone resection in an animal cadaver model. The results of three robot skull bone resections during 4 years showed a perspicuously improved precision combined with a dramatically reduced set-up time. As the evaluation of 166 patients with titanium skull implants showed thermal and psychic stress factors, a biodegradable composite material from polyesters, calcium phosphate and calcium carbonate for guided bone regeneration was developed. Skull implants made of this new bone substitution material showed promising results in animal experiments over a follow-up period from 2 to 11 months so far. (C) 2004 Published by Elsevier B.V.
C1 Ruhr Univ Bochum, Dept Oral & Maxillofacial Plast Surg, D-44892 Bochum, Germany.
RP Weihe, S (reprint author), Ruhr Univ Bochum, Dept Oral & Maxillofacial Plast Surg, Schornau 23-25, D-44892 Bochum, Germany.
EM stephan.weihe@ruhr-uni-bochum.de
CR Birnbaum K, 2001, SPINE, V26, P365, DOI 10.1097/00007632-200102150-00012
   Engel D, 2003, INT CONGR SER, V1256, P760, DOI 10.1016/S0531-5131(03)00300-5
   Engel D, 2002, CARS 2002: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS, P212
   ENGEL D, 2003, SENSORGESTUTZTE ROBO
   Eufinger H, 1998, J CRANIO MAXILL SURG, V26, P373, DOI 10.1016/S1010-5182(98)80070-X
   EUFINGER H, 1995, INT J ORAL MAX SURG, V24, P104, DOI 10.1016/S0901-5027(05)80870-7
   EUFINGER H, 1995, J CRANIO MAXILL SURG, V23, P175, DOI 10.1016/S1010-5182(05)80007-1
   Hassfeld S, 1997, Mund Kiefer Gesichtschir, V1, P316
   Radermacher K, 1998, CLIN ORTHOP RELAT R, P28
   Schiller C, 2004, BIOMATERIALS, V25, P1239, DOI 10.1016/j.biomaterials.2003.08.047
   WEHMOLLER M, 1995, INT J ORAL MAX SURG, V24, P90, DOI 10.1016/S0901-5027(05)80868-9
   Wehmoller M, 2001, INT CONGR SER, V1230, P219
   Wehmoller M, 2000, INT CONGR SER, V1214, P869
   Weihe S, 2000, INT J ORAL MAX SURG, V29, P384
   Weihe S, 2002, CARS 2002: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS, P86
NR 15
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0531-5131
BN 0-444-51731-6
J9 INT CONGR SER
JI Int. Congr. Ser.
PY 2004
VL 1268
BP 584
EP 590
DI 10.1016/j.ics.2004.03.170
PG 7
WC Computer Science, Interdisciplinary Applications; Radiology, Nuclear
   Medicine & Medical Imaging; Surgery
SC Computer Science; Radiology, Nuclear Medicine & Medical Imaging; Surgery
GA BAV01
UT WOS:000223659100103
DA 2018-10-19
ER

PT J
AU Ozawa, T
   Mickle, DAG
   Weisel, RD
   Matsubayashi, K
   Fujii, T
   Fedak, PWM
   Koyama, N
   Ikada, Y
   Li, RK
AF Ozawa, T
   Mickle, DAG
   Weisel, RD
   Matsubayashi, K
   Fujii, T
   Fedak, PWM
   Koyama, N
   Ikada, Y
   Li, RK
TI Tissue-engineered grafts matured in the right ventricular outflow tract
SO CELL TRANSPLANTATION
LA English
DT Article
DE congenital heart defects; pediatric cardiac surgery; myocardium; tissue
   engineering; smooth muscle cells; phenotype; biodegradable scaffold;
   biomaterial
ID SMOOTH-MUSCLE CELLS; BIOENGINEERED CARDIAC GRAFTS; HEAVY-CHAIN ISOFORMS;
   IN-VITRO; COLLAGEN; PHENOTYPE; POLYMER; PROLIFERATION; FABRICATION;
   EXPRESSION
AB Autologous smooth muscle cell (SMC)-seeded biodegradable scaffolds could be a suitable material to repair some pediatric right ventricular outflow tract (RVOT) cardiac anomalies. Adult syngenic Lewis rat SMCs (2 x 10(6)) were seeded onto a new biodegradable copolymer sponge made of F-caprolactone-CO-L-lactide reinforced with poly-L-lactide fabric (PCLA). Two weeks after seeding, the patch was used to repair a surgically created RVOT defect in an adult rat. At 8 weeks after implantation the spongy copolymer component was biodegraded, and SM tissue and extracellular matrices containing elastin fibers were present in the scaffolds. By 22 weeks more fibroblasts and collagen were present (p < 0.05). The number of capillaries in the grafts also increased (p < 0.001) between 8 and 22 weeks. The fibrous poly-L-lactide component of the PCLA scaffold remained. The 22-week grafts maintained their thickness and surface area in the RVOT. The SMCs prior to implantation were in a synthetic phenotype and developed in vivo into a more contractile phenotype. By 8 weeks the patches were endothelialized on their endocardial surfaces. Future work to increase the SM tissue and elastin content in the patch will be necessary before implantation into a pediatric large-animal model is tested.
C1 Univ Toronto, Toranomon Gen Hosp, Toronto Gen Res Inst, Dept Surg,Div Cardiovasc Surg, Toronto, ON M5G 2C4, Canada.
   Toho Univ, Sch Med, Tokyo, Japan.
   Suzuka Univ Med Sci, Suzuka, Japan.
RP Li, RK (reprint author), Univ Toronto, Toranomon Gen Hosp, Toronto Gen Res Inst, Dept Surg,Div Cardiovasc Surg, NU-G108,200 Elixabeth St, Toronto, ON M5G 2C4, Canada.
EM renkeli@uhnres.utoronto.ca
OI Li, Ren-Ke/0000-0002-2584-060X; Fedak, Paul/0000-0003-0658-9381
CR Abukawa H, 2003, J ORAL MAXIL SURG, V61, P94, DOI 10.1053/joms.2003.50015
   Aikawa M, 1997, CIRCULATION, V96, P82
   AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Chedrawy EG, 2002, J THORAC CARDIOV SUR, V124, P584, DOI 10.1067/mtc.2002.122544
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Eschenhagen T, 1997, FASEB J, V11, P683
   GABALLA MA, 2002, HEART SURG FORUM, V6, P3
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   KUROO M, 1989, J BIOL CHEM, V264, P18272
   Leor J, 2000, CIRCULATION, V102, P56
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Ozawa T, 2002, J THORAC CARDIOV SUR, V124, P1157, DOI 10.1067/mtc.2002.127449
   Ozawa T., 2002, CIRCULATION S1, V106, P1176
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Rajasubramanian G, 1994, ASAIO J, V40, pM584, DOI 10.1097/00002480-199407000-00066
   RUCKMAN JL, 1994, MATRIX BIOL, V14, P135, DOI 10.1016/0945-053X(94)90003-5
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Thyberg J, 1996, INT REV CYTOL, V169, P183, DOI 10.1016/S0074-7696(08)61987-7
   VANDERHEIJDEN FHWM, 1994, J VASC SURG, V20, P607, DOI 10.1016/0741-5214(94)90285-2
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
   YOUNG B, 2000, WHEATERS FUNCTIONAL, P65
   Zhang JY, 2000, BIOMATERIALS, V21, P1247, DOI 10.1016/S0142-9612(00)00005-3
NR 33
TC 17
Z9 18
U1 0
U2 2
PU COGNIZANT COMMUNICATION CORP
PI ELMSFORD
PA 3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2004
VL 13
IS 2
BP 169
EP 177
DI 10.3727/000000004773301852
PG 9
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 813MD
UT WOS:000220910300009
PM 28853932
OA Bronze
DA 2018-10-19
ER

PT J
AU Itoh, S
   Kikuchi, M
   Koyama, Y
   Takakuda, K
   Shinomiya, K
   Tanaka, J
AF Itoh, S
   Kikuchi, M
   Koyama, Y
   Takakuda, K
   Shinomiya, K
   Tanaka, J
TI Development of a hydroxyapatite/collagen nanocomposite as a medical
   device
SO CELL TRANSPLANTATION
LA English
DT Article; Proceedings Paper
CT 2nd Annual Meeting of the Japanese-Society-for-Regenerative-Medicine
   (JRSM)
CY MAR 11-12, 2003
CL Kobe, JAPAN
SP Japanese Soc Regenerat Med
DE hydroxyapatite/type 1 collagen (HA/Col) composite; bone remodeling unit;
   recombinant human bone morphogenetic protein-2 (rhBMP-2);
   self-organization
ID BONE; BIOMATERIAL; COMPOSITE; BIOCOMPATIBILITY; RHBMP-2; MODEL
AB The effect of cross-linking of a hydroxyapatite/collagen (HA/Col) nanocomposite, in which HA nanocrystals and collagen fibers are aligned like natural bone by a self-organization mechanism between HA and collagen in vitro, on mechanical properties was examined. The influence of degree of cross-linking, as well as rhBMP-2 preadsorption to the composite on the substitution pattern and rate with bone, was examined. In Experiment 1, anterior fusion was carried out at the C3-C4 vertebrae on 10 dogs and they were implanted as follows: without cross-linking and without adsorbed rhBMP-2 (three dogs), with cross-linking and without adsorbed rhBMP-2 (three dogs), without cross-linking and with adsorbed rhBMP-2 (two dogs), and with cross-linking and adsorbed rhBMP-2 (two dogs). Implants were removed from each dog for histology determinations after 12, 16, and 24 weeks in the non-rhBMP-treated groups, and after 16 and 24 weeks in the rhBMP-treated groups. In Experiment 2, the HA/Col composites with cross-linking and both with and without rhBMP-2 pretreatment were implanted into a bone defect of 20 mm made in the central part of tibiae in dogs (N = 3 in each group). As a control, bone defects of 20 mm remained without implantation (N = 3). The dogs were allowed to walk using an Ilizarov extra skeletal fixator. The implants were removed after 12, 16, and 24 weeks from one dog in each group. The cross-linking of the HA/Col composite was effective in controlling both the mechanical strength and bioresorbability. A "self-organization process" on the HA/Col implant surface resulted in the formation of bone remodeling units in and around the implant. Radiographic and histological findings suggest that a combined treatment of cross-linking of the HA/Col composite with preadsorption of rhBMP-2 molecules may be a very suitable replacement of existing ceramic systems in the anterior fusion of the cervical spine, as well as inlay grafting of bone defects in weight-bearing sites.
C1 Tokyo Med & Dent Univ, Dept Orthopaed Surg, Div Mol Tissue Engn, Bunkyo Ku, Tokyo 1138519, Japan.
   Tokyo Med & Dent Univ, Dept Biomech Engn, Bunkyo Ku, Tokyo 1138519, Japan.
   Tokyo Med & Dent Univ, Dept Orthopaed & Spinal Surg, Bunkyo Ku, Tokyo 1138519, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsuchiura, Ibaraki 3050044, Japan.
RP Itoh, S (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Div Mol Tissue Engn, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
EM itoso.gene@cmn.tmd.ac.jp
RI Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
CR BACON GE, 1979, J ANAT, V128, P277
   Hollinger EH, 1996, J SPINAL DISORD, V9, P125
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Kikuchi M, 2000, MATER RES SOC SYMP P, V599, P51
   KIKUCHI M, 1999, BIOCERAMICS, V12, P393
   Kon T, 1997, CALCIFIED TISSUE INT, V60, P291, DOI 10.1007/s002239900231
   Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244
   SHINOMIYA K, 2001, TISSUE ENG THERAP US, V5, P165
   TAKAKUDA K, 2000, TISSUE ENG, P72
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VILLANUEVA AR, 1974, STAIN TECHNOL, V49, P1, DOI 10.3109/10520297409116928
NR 16
TC 36
Z9 40
U1 0
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2004
VL 13
IS 4
BP 451
EP 461
DI 10.3727/000000004783983774
PG 11
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 851SJ
UT WOS:000223705300015
PM 15468687
OA Bronze
DA 2018-10-19
ER

PT J
AU Mitsuishi, M
   Warisawa, S
   Sugita, N
AF Mitsuishi, M
   Warisawa, S
   Sugita, N
TI Determination of the machining characteristics of a biomaterial using a
   machine tool designed for total knee arthroplasty
SO CIRP ANNALS-MANUFACTURING TECHNOLOGY
LA English
DT Article
DE biomedical material cutting; machinability; cutting force analysis
ID FATIGUE DAMAGE; CORTICAL BONE
AB The authors have developed a prototype of a sophisticated 9-axis machine tool for bone cutting to reduce the machining error in cutting bone to accept artificial joint replacements and to improve the postoperative performance of the implants. It is necessary to determine the machining characteristics of the bone to optimize the cutting state. In this paper, model bones with mechanical characteristics similar to those of human bone and pig bone, were endmilled. The relationship between the cutting conditions and the cutting characteristics of cortical bone and cancellous tissue, of which bone is comprised, were evaluated.
C1 Univ Tokyo, Sch Engn, Dept Engn Synth, Tokyo, Japan.
RP Mitsuishi, M (reprint author), Univ Tokyo, Sch Engn, Dept Engn Synth, Tokyo, Japan.
CR BERNARD A, 2002, ANN CIRP, V51, P635
   BRAIDOTTI P, 1995, J BIOMECH, V28, P439, DOI 10.1016/0021-9290(94)00082-F
   Burger EH, 1999, FASEB J, V13, P101
   Burger T, 2001, CIRP ANN-MANUF TECHN, V50, P295, DOI 10.1016/S0007-8506(07)62125-8
   CARTER DR, 1977, J BIOMECH, V10, P325, DOI 10.1016/0021-9290(77)90005-7
   Gu P, 2002, CIRP ANN-MANUF TECHN, V51, P181, DOI 10.1016/S0007-8506(07)61495-4
   ITOH S, 1983, B JSME, V26, P2295
   Jacobs CR, 1997, J BIOMECH, V30, P603, DOI 10.1016/S0021-9290(96)00189-3
   MITSUISHI M, 2003, ANN CIRP, V52, P323
   MITSUISHI M, 1992, ANN CIRP, V41, P505
   Shaffler M, 1995, BONE, V17, P521
   Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8
   Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5
   Yeni YN, 2002, BONE, V30, P509, DOI 10.1016/S8756-3282(01)00696-2
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 15
TC 20
Z9 20
U1 0
U2 11
PU TECHNISCHE RUNDSCHAU EDITION COLIBRI LTD
PI BERN
PA NORDRING 4, CH-3001 BERN, SWITZERLAND
J9 CIRP ANN-MANUF TECHN
JI CIRP Ann-Manuf. Technol.
PY 2004
VL 53
IS 1
BP 107
EP 112
DI 10.1016/S0007-8506(07)60656-8
PG 6
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA 835XV
UT WOS:000222519700026
DA 2018-10-19
ER

PT J
AU Binzen, E
   Lendlein, A
   Kelch, S
   Rickert, D
   Franke, RP
AF Binzen, E
   Lendlein, A
   Kelch, S
   Rickert, D
   Franke, RP
TI Biomaterial-microvasculature interaction on polymers after implantation
   in mice
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article; Proceedings Paper
CT 12th European Conference on Clinicial Hemorheology
CY JUN 22-26, 2003
CL Sofia, BULGARIA
SP European Soc Clin Hemorheol, Bulgarian Soc Biorheol, Minist Educ & Sci Bulgaria, Bulgarian Acad Sci, Union Bulgarian Sci, Prima Soft Ltd, Pharmaceut Co Sopharma Pharmaceut, UCB Pharma, Gedeon Richter AD, Pfizer Inc, Novartis, Boehringer Ingelheim, Slovakofarma & Schering
ID OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; ANGIOGENESIS; NETWORKS; TISSUE
AB Biomaterial research is expected to forward new materials to be used as, e.g., implant materials or as scaffolds for tissue engineering. It is central for such a scaffold material to create the track on which those cells can inhabitate the scaffold needed to rebuild functional tissue substitutes. For the biointegration of the implant with the native cellular tissue this must be able to grow on the material surface. For the elimination of the degradation products and the adeqaute transport of nutrients/gases within the newly formed tissue the angiogenesis of new blood vessels is thought to play an important role.
   In the present study, a new biomaterial, a non-porous polymeric AB-network based on oligo (epsilon-hydroxycaproat) and oligobutylacrylat, was implanted in animals. Male NMRI mice were implanted subcutaneously for one week to nine weeks. Immediately after the explantation, the probes were examined histologically. Already one week after implantation, there was a strong tissue-integration of the polymer. Importantly, blood vessels appeared at the polymer surface. At nine weeks after implantation the tissue integration was stronger than after one week and blood vessels were still observed in the periimplant tissue.
   The mechanism of the early integration of the polymer is not clear. The relationship between the new periimplant vessels and the integration of the polymer has to be studied.
C1 Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89069 Ulm, Germany.
   Univ Ulm, Dept Otolaryngol & Head & Neck Surg, D-89075 Ulm, Germany.
   GKSS Forschungszentrum GmbH, Inst Chem, D-14513 Teltow, Germany.
RP Binzen, E (reprint author), Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, Albert Einstein Allee 47, D-89069 Ulm, Germany.
EM eva.binzen@zibmt.uni-ulm.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Black AF, 1998, FASEB J, V12, P1331
   BRANEMARK P. I., 1965, BIBL ANAT, V7, P9
   Bromer H., 1973, German patent, Patent No. [2,326,100, 2326100]
   CANFIELD AE, 2000, BONE ENG, V2, P143
   CHONEKA J, 1996, J BIOMED MATER RES, V31, P35
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   FLOREY HW, 1962, BRIT J EXP PATHOL, V43, P655
   GREISLER HP, 1986, J VASC SURG, V3, P747, DOI 10.1067/mva.1986.avs0030747
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   ILLIG L, 1961, PATHOLOGIE KLIN EINZ
   JARCHO M, 1977, J BIOENG, V1, P79
   JUNG F, 1992, J VASC RES, V29, P71, DOI 10.1159/000158935
   JUNG F, 1995, ARZNEIMITTEL-FORSCH, V45-2, P1138
   KOKUBO T, 1982, B I CHEM RES KYOTO U, V60, P206
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   Niimi H, 2000, CLIN HEMORHEOL MICRO, V23, P293
   RADDER AM, 1995, BIOMATERIALS, V16, P507, DOI 10.1016/0142-9612(95)91122-F
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   YAN WQ, 1997, J BIOMED MATER RES, V37, P265
NR 27
TC 18
Z9 18
U1 1
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2004
VL 30
IS 3-4
BP 283
EP 288
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 845MV
UT WOS:000223249500021
PM 15258355
DA 2018-10-19
ER

PT J
AU Iwata, NY
   Lee, GH
   Tsunakawa, S
   Tokuoka, Y
   Kawashima, N
AF Iwata, NY
   Lee, GH
   Tsunakawa, S
   Tokuoka, Y
   Kawashima, N
TI Preparation of diopside with apatite-forming ability by sol-gel process
   using metal alkoxide and metal salts
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE diopside; sol-gel process; metal alkoxide; metal salts; apatite-forming
   ability
ID BIOACTIVE GLASS-CERAMICS; BONE BONDING BEHAVIOR; SIMULATED BODY-FLUID;
   P-RICH LAYER; HYDROLYSIS; CRYSTALS; SURFACE; POWDER; SODIUM; FILMS
AB The thermal and biological properties of diopside, CaMgSi2O6 prepared by a sol-gel process using a metal alkoxide and metal salts were investigated for its applicability as a biomaterial. Precursor wet gel was synthesized by hydrolyzing a homogeneous solution consisting of Ca(NO3)(2).4H(2)O, MgCl2.6H(2)O and Si(OC2H5)(4) dissolved in ethanol. The effect of thermal treatment on crystallization of the hydrolyzed product was examined by DTA, XRD and TG-MS measurements. The dried gel powder was X-ray amorphous and crystallized into diopside single phase at 751.4 degreesC. This crystallization temperature was lower than that for the dried gel powder prepared by a sol-gel process using metal alkoxides reported by Nonami et al., which suggests that acidic compounds such as HNO3 and HCl generated in the powder during the heating process promotes the crystallization. Moreover, when the sintered body of diopside was immersed in simulated body fluid, an apatite layer was formed on the surface. Thus, the diopside prepared by the sol-gel process using the metal alkoxide and the metal salts without acidic catalysts addition was found to have an apatite-forming ability. (C) 2003 Elsevier B.V. All rights reserved.
C1 Toin Univ Yokohama, Grad Sch Engn, Dept Mat Sci & Technol, Aoba Ku, Yokohama, Kanagawa 2258502, Japan.
   Dong Eui Univ, Coll Engn, Dept Adv Mat Engn, Pusan 614714, South Korea.
   Toin Univ Yokohama, Fac Engn, Dept Biomed Engn, Aoba Ku, Yokohama, Kanagawa 2258502, Japan.
   Toin Univ Yokohama, Ctr Biomed Engn, Aoba Ku, Yokohama, Kanagawa 2258502, Japan.
RP Iwata, NY (reprint author), Toin Univ Yokohama, Grad Sch Engn, Dept Mat Sci & Technol, Aoba Ku, Kurogane 1614, Yokohama, Kanagawa 2258502, Japan.
EM nyi@cc.toin.ac.jp
RI Iwata, Noriyuki/G-2955-2010
CR ASHIZUKA M, 1989, NIPPON SERAM KYO GAK, V97, P544
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Cho SB, 1996, J CERAM SOC JPN, V104, P399, DOI 10.2109/jcersj.104.399
   HAYASHI K, 1990, J CERAM SOC JPN, V98, P801
   HAYASHI S, 1990, J MATER SCI LETT, V9, P382, DOI 10.1007/BF00721005
   HAYASHI S, 1993, J MATER SCI LETT, V12, P153, DOI 10.1007/BF00819943
   Iwata N, 1999, MATER RES SOC SYMP P, V547, P243
   Iwata NY, 2000, MATER RES SOC SYMP P, V599, P169
   KAMIYA K, 1989, NIPPON SERAM KYO GAK, V97, P229
   KAMIYA K, 1986, J MATER SCI LETT, V5, P402, DOI 10.1007/BF01672341
   KIKUCHI N, 1993, NIPPON SERAM KYO GAK, V101, P824
   KITSUGI T, 1989, J BIOMED MATER RES, V23, P631, DOI 10.1002/jbm.820230607
   KITSUGI T, 1986, J BIOMED MATER RES, V20, P1295, DOI 10.1002/jbm.820200906
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   KOKUBO T, 1995, B CERAM SOC JAPAN, V30, P223
   KON R, 1996, J JPN DENT MAT, V15, P176
   Miake Y, 1995, J DENT RES, V74, P1756, DOI 10.1177/00220345950740110701
   NAKAJIMA S, 1989, Shikwa Gakuho, V89, P1709
   NAKAJIMA S, 1990, Shikwa Gakuho, V90, P525
   NONAMI T, 1992, MATER RES SOC SYMP P, V252, P87
   NONAMI T, 1995, J CERAM SOC JPN, V103, P703, DOI 10.2109/jcersj.103.703
   Nonami T, 1996, J CERAM SOC JPN, V104, P146, DOI 10.2109/jcersj.104.146
   NONAMI T, 1995, J CERAM SOC JPN, V103, P804, DOI 10.2109/jcersj.103.804
   Nonami T, 1996, J CERAM SOC JPN, V104, P201, DOI 10.2109/jcersj.104.201
   Nonami T., 1994, J JPN SOC BIOMATER, V12, P274
   NONAMI T, 1995, J JPN SOC BIOMATER, V13, P261
   NONAMI T, 1990, MATER RES SOC S P, V175, P71
   NONAMI T, 1995, J JPN DENT MAT, V14, P387
   NONAMI T, 1994, J JPN DENT MAT, V13, P568
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   Ohyama M, 1996, J CERAM SOC JPN, V104, P296, DOI 10.2109/jcersj.104.296
   SHIBUYA T, 1996, J SOC INORG MAT JPN, V3, P419
   ZARZYCKI J, 1982, J MATER SCI, V17, P3371, DOI 10.1007/BF01203507
NR 37
TC 43
Z9 44
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2004
VL 33
IS 1
BP 1
EP 6
DI 10.1016/j.colsurfb.2003.07.004
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 768DF
UT WOS:000188512400001
DA 2018-10-19
ER

PT J
AU Zheng, Q
   Milthorpe, BK
   Jones, AS
AF Zheng, Q
   Milthorpe, BK
   Jones, AS
TI Direct neural network application for automated cell recognition
SO CYTOMETRY PART A
LA English
DT Article
DE image analysis; neural networks; direct classification
ID PATTERN-RECOGNITION; IMAGE-ANALYSIS; SYSTEM; CLASSIFICATION; PATHOLOGY;
   DIAGNOSIS
AB Background: Automated cell recognition from histologic images is a very complex task. Traditionally, the image is segmented by some methods chosen to suit the image type, the objects are measured, and then a classifier is used to determine cell type from the object's measurements. Different classifiers have been used with reasonable success, including neural networks working with data from morphometric analysis.
   Methods: Image data of cells were input directly into neural networks to determine the feasibility of direct classification by using pixel intensity information. Several types of neural network and their ability to work with cells in a complex patterned background were assessed for a variety of images and cell types and for the accuracy of classification.
   Results: inflammatory cells from animal biomaterial implants in rabbit paravertebral muscle were imaged in histologic sections. Simple, three-layer, fully connected, back-propagation neural networks and four-layer networks with two layers of a shared-weights neural network were most successful at classifying the cells from the images, with 97% and 98% correct recognition rates, respectively.
   Conclusions: The high accuracy recognition rate shows the potential for direct classification of visual image pixel data by neural networks. (C) 2003 Wiley-Liss, Inc.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   Univ Sydney, Australian Key Ctr Microscopy & Microanal, Sydney, NSW 2006, Australia.
RP Milthorpe, BK (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
EM b.milthorpe@unsw.edu.au
RI Milthorpe, Bruce/A-7014-2008
CR Arica N, 2001, IEEE T SYST MAN CY C, V31, P216, DOI 10.1109/5326.941845
   Berger P, 1999, EUR RESPIR J, V14, P1394, DOI 10.1183/09031936.99.14613949
   Boon ME, 1995, DIAGN CYTOPATHOL, V13, P423, DOI 10.1002/dc.2840130510
   CEDEON TD, 1994, COMP4444 NEURAL NETW
   CSEKE I, 1992, INT C PATT REC HAG N
   Fausett L., 1994, FUNDAMENTALS NEURAL
   Foody GM, 2001, GLOBAL ECOL BIOGEOGR, V10, P379, DOI 10.1046/j.1466-822X.2001.00248.x
   Godavarti M, 1996, CYTOMETRY, V24, P330
   Hurst RE, 1997, CYTOMETRY, V27, P36, DOI 10.1002/(SICI)1097-0320(19970101)27:1<36::AID-CYTO5>3.3.CO;2-4
   Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819
   Kok MR, 2001, CANCER CYTOPATHOL, V93, P173
   Kolles H, 1996, ANAL QUANT CYTOL, V18, P298
   Lo SCB, 1995, NEURAL NETWORKS, V8, P1201, DOI 10.1016/0893-6080(95)00061-5
   MCCLELLAND JL, 1986, EXPLORATIONS PARALLE
   MELLORS RC, 1955, AM J PATHOL, V31, P687
   MELLORS RC, 1955, LAB INVEST, V4, P69
   MELLORS RC, 1955, AM J PATHOL, V32, P455
   REVENU M, 1993, P SOC PHOTO-OPT INS, V2055, P32, DOI 10.1117/12.150150
   Romeo M, 1998, CELL MOL BIOL, V44, P179
   Ruggeri A, 2002, COMPUT METH PROG BIO, V68, P25, DOI 10.1016/S0169-2607(01)00153-5
   Schluter N, 2002, METEOROL Z, V11, P21, DOI 10.1127/0941-2948/2002/0011-0021
   Sjostrom PJ, 1999, CYTOMETRY, V36, P18
   VAAFAADUST M, 1994, THESIS U NEW S WALES
   WALTS AE, 1993, AM J CLIN PATHOL, V99, P570
NR 24
TC 26
Z9 27
U1 1
U2 4
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-4763
J9 CYTOM PART A
JI Cytom. Part A
PD JAN
PY 2004
VL 57A
IS 1
BP 1
EP 9
DI 10.1002/cyto.a.10106
PG 9
WC Biochemical Research Methods; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 765JK
UT WOS:000188263200001
PM 14699600
OA Bronze
DA 2018-10-19
ER

PT J
AU Sever, MJ
   Wilker, JJ
AF Sever, MJ
   Wilker, JJ
TI Visible absorption spectra of metal-catecholate and metal-tironate
   complexes
SO DALTON TRANSACTIONS
LA English
DT Article
ID IRON TRANSPORT COMPOUNDS; PROTOCATECHUATE 3,4-DIOXYGENASE; COORDINATION
   CHEMISTRY; COBALT(II) COMPLEXES; STABILITY-CONSTANTS;
   CRYSTAL-STRUCTURES; MYTILUS-EDULIS; MANGANESE(II); LIGANDS; PYROCATECHOL
AB Interactions between metals and catechol (1,2-dihydroxybenzene) or other ortho-dihydroxy moieties are being found in an increasing number of biological systems with functions ranging from metal ion internalization to biomaterial synthesis. Although metal-catecholate interactions have been studied in the past, we present the first systematic study of an array of these compounds, all prepared under identical conditions. We report the ultraviolet - visible absorption (UV-vis) spectra for catecholate and tironate complexes of the first row transition elements. Generation and identification of these species were accomplished by preparing aqueous solutions with varied ligand : metal ratios and subsequently titrating with base (NaOH). Controlled ligand deprotonation and metal binding resulted in sequential formation of complexes with one, two, and sometimes three catecholate or tironate ligands bound to a metal ion. We prepared the mono-, bis- and tris-catecholates and - tironates of Fe3+, V3+, V4+ and Mn3+, the mono- and biscatecholates and - tironates of Cu2+, Co2+, Ni2+, Zn2+, Cr2+ and Mn2+, and several Ti4+ and Cr3+ species. The UV - vis spectra of each complex are described, some of which have not been reported previously. These data can now be applied to characterization of biological metal - catecholate systems.
C1 Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
RP Wilker, JJ (reprint author), Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA.
CR AVDEEF A, 1978, J AM CHEM SOC, V100, P5362, DOI 10.1021/ja00485a018
   Ball EG, 1933, J BIOL CHEM, V102, P691
   Baruah B, 2002, INORG CHEM, V41, P4502, DOI 10.1021/ic020259d
   Boldt YR, 1997, BIOCHEMISTRY-US, V36, P2147, DOI 10.1021/bi962362i
   BORGIAS BA, 1984, INORG CHEM, V23, P1009, DOI 10.1021/ic00176a005
   Bruckner C, 1998, INORG CHEM, V37, P6759, DOI 10.1021/ic980620p
   BUGG TDH, 2001, CHEM COMMUN, V11, P941
   CARLIN RL, 1965, TRANSITION METAL CHE, V1, P1
   CHIOU YM, 1995, INORG CHEM, V34, P3577, DOI 10.1021/ic00118a001
   COOMBS TL, 1981, AQUAT TOXICOL, V1, P291, DOI 10.1016/0166-445X(81)90023-0
   COOPER SR, 1982, J AM CHEM SOC, V104, P5092, DOI 10.1021/ja00383a016
   COTTON FA, 1999, ADV INORG CHEM, P679
   COTTON FA, 1999, ADV INORG CHEM, P786
   COTTON FA, 1999, ADV INORG CHEM, P761
   CRANS DC, 1998, VANADIUM COMPOUNDS C, V711, P2
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Dhungana S, 2001, INORG CHEM, V40, P7079, DOI 10.1021/ic0104003
   Dilworth JR, 1997, J CHEM SOC DALTON, P2931, DOI 10.1039/a702935g
   Donat John R., 1995, P247
   DUBEY SN, 1986, J INDIAN CHEM SOC, V63, P842
   Eicken C, 1999, CURR OPIN STRUC BIOL, V9, P677, DOI 10.1016/S0959-440X(99)00029-9
   FAZAKERLEY GV, 1979, J CHEM SOC DALTON, P1872, DOI 10.1039/dt9790001872
   Frank BP, 2002, BIOTECHNOL PROGR, V18, P580, DOI 10.1021/bp010140s
   GREENWOOD NN, 1984, CHEM ELEMENTS, P1170
   GREENWOOD NN, 1984, CHEM ELEMENTS, P1231
   GRIESSER R, 1971, INORG CHEM, V10, P2229, DOI 10.1021/ic50104a028
   Grillo VA, 1996, INORG CHEM, V35, P3568, DOI 10.1021/ic950499b
   HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976
   HARTMAN JR, 1984, INORG CHEM, V23, P1381, DOI 10.1021/ic00178a017
   HEISTAND RH, 1982, INORG CHEM, V21, P676, DOI 10.1021/ic00132a041
   HENRY RP, 1971, J CHEM SOC A, P3392, DOI 10.1039/j19710003392
   ISIED SS, 1976, J AM CHEM SOC, V98, P1763, DOI 10.1021/ja00423a021
   ITOH Y, 1971, NIPPON KAGAKU ZASSHI, V92, P227, DOI 10.1246/nikkashi1948.92.227
   Jo DH, 2001, INORG CHEM, V40, P3181, DOI 10.1021/ic001185d
   KISS T, 1983, ACTA CHIM HUNG, V114, P249
   KURIHARA M, 1995, INORG CHEM, V34, P4888, DOI 10.1021/ic00123a025
   KWIK WL, 1974, J AM CHEM SOC, V96, P1638, DOI 10.1021/ja00812a083
   MAGERS KD, 1978, INORG CHEM, V17, P515, DOI 10.1021/ic50181a001
   MARTIN JL, 1975, CAN J CHEM, V53, P572, DOI 10.1139/v75-079
   McMillin D. R., 2000, PHYS METHODS BIOINOR
   NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723
   OHLENDORF DH, 1988, NATURE, V336, P403, DOI 10.1038/336403a0
   PECORARO VL, 1983, J AM CHEM SOC, V105, P4623, DOI 10.1021/ja00352a018
   PFEIFFER VP, 1948, Z ANORG ALLG CHEM, V256, P318
   PIERPONT CG, 1994, PROG INORG CHEM, V41, P331, DOI 10.1002/9780470166420.ch5
   PIERPONT CG, 1982, INORG CHEM, V21, P652, DOI 10.1021/ic00132a037
   Pierpont CG, 2001, COORDIN CHEM REV, V216, P99, DOI 10.1016/S0010-8545(01)00309-5
   POWELL HKJ, 1982, AUST J CHEM, V35, P739, DOI 10.1071/CH9820739
   Rath SP, 1999, INORG CHEM, V38, P4376, DOI 10.1021/ic990551u
   RAYMOND KN, 1984, TOP CURR CHEM, V123, P49
   Reynolds RA, 1996, INORG CHEM, V35, P2721, DOI 10.1021/ic960097j
   ROHRSCHEID F, 1966, INORG CHEM, V5, P1542, DOI 10.1021/ic50043a017
   Rzepecki L.M., 1991, Bioorganic Marine Chemistry, V4, P119
   Rzepecki LM, 1995, MOL MAR BIOL BIOTECH, V4, P313
   Saccni L., 1979, TRANSITION METAL CHE, V4, P199
   SANDHU SS, 1976, J INDIAN CHEM SOC, V53, P114
   SCHARFF JP, 1975, ANAL CHIM ACTA, V78, P201, DOI 10.1016/S0003-2670(01)84766-8
   SHERIFF TS, 1992, J CHEM SOC DALTON, P1051, DOI 10.1039/dt9920001051
   SHONER SC, 1992, INORG CHEM, V31, P1001, DOI 10.1021/ic00032a016
   SOMMER L, 1963, COLLECT CZECH CHEM C, V28, P2102, DOI 10.1135/cccc19632102
   SZPOGANICZ B, 1990, INORG CHEM, V29, P1467, DOI 10.1021/ic00333a006
   Taylor SW, 1997, CHEM REV, V97, P333, DOI 10.1021/cr940467q
   Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s
   TAYLOR SW, 1994, INORG CHEM, V33, P7572
   TIMBERLAKE CF, 1957, J CHEM SOC, P4987, DOI 10.1039/jr9570004987
   TKACHEV VV, 1976, KOORDINATS KHIM, V2, P110
   TYSON CA, 1968, J AM CHEM SOC, V90, P3379, DOI 10.1021/ja01015a015
   Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682
   VALLEE BL, 1968, CHEM BRIT, V4, P397
   Vetting MW, 2000, BIOCHEMISTRY-US, V39, P7943, DOI 10.1021/bi000151e
   Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x
   WAITE JH, 1992, BIOCHEMISTRY-US, V31, P5733, DOI 10.1021/bi00140a007
   WEINLAND VR, 1925, Z ANORG ALLG CHEM, V150, P69
   WICKLUND PA, 1976, INORG CHEM, V15, P396, DOI 10.1021/ic50156a031
   WULFSBERG G, 1991, PRINCIPLES DESCRIPTI, P445
   WULFSBERG G, 1991, PRINCIPLES DESCRIPTI, P21
   WUTHRICH K, 1965, HELV CHIM ACTA, V48, P1012, DOI 10.1002/hlca.19650480504
   ZELINKA J, 1974, COLLECT CZECH CHEM C, V39, P83, DOI 10.1135/cccc19740083
   Zirong D., 1992, INORG CHEM, V31, P870
NR 79
TC 107
Z9 107
U1 4
U2 53
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-9226
J9 DALTON T
JI Dalton Trans.
PY 2004
IS 7
BP 1061
EP 1072
DI 10.1039/b315811j
PG 12
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 805DZ
UT WOS:000220348300013
PM 15252685
DA 2018-10-19
ER

PT S
AU Kim, JS
   Yang, SG
   Kang, JH
   Kang, SB
   Yoon, KS
   Kwon, YS
AF Kim, JS
   Yang, SG
   Kang, JH
   Kang, SB
   Yoon, KS
   Kwon, YS
BE Kang, SG
   Kobayashi, T
TI Porous TiNi biomaterial produced by self-propagating high-temperature
   synthesis: Pore structure, mechanical property and application
SO DESIGNING, PROCESSING AND PROPERTIES OF ADVANCED ENGINEERING MATERIALS,
   PTS 1 AND 2
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Designing, Processing and Properties of
   Advanced Engineering Materials
CY NOV 05-08, 2003
CL Jeju, SOUTH KOREA
SP Mat Res Soc Korea, Japan Soc Promot Sci, Adv Engn Mat Comm
DE porous TiNiSMA; self-propagating high-temperature synthesis; pore
   structure; mechanical property; in vivo test; bone ingrowth
ID SHAPE-MEMORY METAL; TITANIUM; NICKEL; BIOCOMPATIBILITY; IMPLANT; ALLOY;
   CORROSION
AB Porous TiNi shape-memory alloy (TiNi SMA) bodies were produced from the (Ti+Ni) powder mixture by self-propagating high-temperature synthesis (SHS) method. Various processing variables such as ignition temperature and heating schedule were used to control the pore structure. Relationship between pore structure and mechanical property was also investigated. An in vivo test was performed to evaluate bone tissue response and biocompatibility of porous TiNi SMA. It showed no apparent adverse reactions such as inflammation and foreign body reaction. Bone ingrowth was found in the pore space of all implanted blocks.
C1 Univ Ulsan, Sch Mat Sci & Engn, Res Ctr Machine Parts & Mat Proc, ReMM, Ulsan 680749, South Korea.
   Biosmart Co Ltd, Seongnam 463760, South Korea.
   Seoul Natl Univ, Med Univ, Boramae Hosp, Dept Orthoped Surg,Dept Orthoped, Seoul 156707, South Korea.
RP Kim, JS (reprint author), Univ Ulsan, Sch Mat Sci & Engn, Res Ctr Machine Parts & Mat Proc, ReMM, Ulsan 680749, South Korea.
RI Kang, Seung Baik/J-5362-2012
CR ASSAD M, 1994, ANN CHIR, V48, P731
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   BUCHLER WK, 1968, OCEAN ENG, V1, P105
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   DUERIG T, 1999, MAT SCI ENG A-STRUCT, V149, P273, DOI DOI 10.1016/S0921-5093(99)00294-4
   Kim Ji Soon, 2003, [JOURAL OF KOREAN POWER METALLURGY INSTIT, 한국분말야금학회지], V10, P34
   KIM JS, 2000, SMST 2000 CAL US, P77
   MERZHANOV AG, 1997, EXPT HEAT TRANSFER F, P1869
   MOORE JJ, 1995, PROG MATER SCI, V39, P243, DOI 10.1016/0079-6425(94)00011-5
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
NR 14
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-939-3
J9 MATER SCI FORUM
PY 2004
VL 449-4
BP 1097
EP 1100
DI 10.4028/www.scientific.net/MSF.449-452.1097
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BY90Q
UT WOS:000189492000271
DA 2018-10-19
ER

PT S
AU Akahori, T
   Niinomi, M
   Fukui, H
   Suzuki, A
AF Akahori, T
   Niinomi, M
   Fukui, H
   Suzuki, A
BE Kang, SG
   Kobayashi, T
TI Fatigue performance of low rigidity titanium alloy for biomedical
   applications
SO DESIGNING, PROCESSING AND PROPERTIES OF ADVANCED ENGINEERING MATERIALS,
   PTS 1 AND 2
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Designing, Processing and Properties of
   Advanced Engineering Materials
CY NOV 05-08, 2003
CL Jeju, SOUTH KOREA
SP Mat Res Soc Korea, Japan Soc Promot Sci, Adv Engn Mat Comm
DE beta type titanium alloy; metallic biomaterial; mechanical properties
   and fatigue properties
AB Microstructures of Ti-29Nb-13Ta-4.6Zr (TNTZ) aged at temperatures between 573 and 723 K after solution treatment at 1063 K have super fine omega phase, or both super fine alpha and omega phases, respectively in beta phase with an average grain diameter of 20 mum. Plain fatigue strength of TNTZ aged after solution treatment is much greater than that of as-solutionized TNTZ in both low cycle fatigue and high cycle fatigue life regions. This is due to the improvement of the balance of strength and ductility by the precipitation of alpha phase. Fretting fatigue strength of TNTZ conducted with various heat treatments decreases dramatically as compared with their plain fatigue strength in both low cycle fatigue and high cycle fatigue life regions. In this case, the decreasing ratio of fretting fatigue life increases with increasing the small crack propagation area where both the tangential force and frictional force at the contact plane of pad exist. In fretting fatigue in air, the ratio of fretting damage (P-f/F-f), where P-f and F-f stand for plain fatigue limit and fretting fatigue limit, respectively.. increases with increasing elastic modulus. In fretting fatigue in Ringer's solution, the passive film on specimen surface is broken by fretting action in TNTZ, which have excellent corrosion resistance, and, as a result, corrosion pits that lead to decreasing fretting fatigue strength especially in high cycle fatigue life region, are formed on its surface.
C1 Toyohashi Univ Technol, Dept Prod Syst, Toyohashi, Aichi 4418580, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 464, Japan.
   Daido Steel Co Ltd, R&D Lab, Nagoya, Aichi 4578545, Japan.
RP Akahori, T (reprint author), Toyohashi Univ Technol, Dept Prod Syst, 1-1,Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR ENDO K, 1997, DEGRADATION METALLIC, V46, P682
   KURODA D, 2000, TETSU TO HAGANE, V86, P40
   Niinomi M, 2002, TETSU TO HAGANE, V88, P553, DOI 10.2355/tetsutohagane1955.88.9_553
   OKAZAKI Y, 1993, J JPN I MET, V57, P332, DOI 10.2320/jinstmet1952.57.3_332
   Steineman S., 1980, EVALUATION BIOMATERI
NR 5
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-939-3
J9 MATER SCI FORUM
PY 2004
VL 449-4
BP 1265
EP 1268
DI 10.4028/www.scientific.net/MSF.449-452.1265
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BY90Q
UT WOS:000189492000313
DA 2018-10-19
ER

PT S
AU Sakaguchi, N
   Mitsuo, N
   Akahori, T
   Saito, T
   Furuta, T
AF Sakaguchi, N
   Mitsuo, N
   Akahori, T
   Saito, T
   Furuta, T
BE Kang, SG
   Kobayashi, T
TI Effects of alloying elements on elastic modulus of Ti-Nb-Ta-Zr system
   alloy for biomedical applications
SO DESIGNING, PROCESSING AND PROPERTIES OF ADVANCED ENGINEERING MATERIALS,
   PTS 1 AND 2
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Designing, Processing and Properties of
   Advanced Engineering Materials
CY NOV 05-08, 2003
CL Jeju, SOUTH KOREA
SP Mat Res Soc Korea, Japan Soc Promot Sci, Adv Engn Mat Comm
DE titanium alloy; mechanical properties; Young's modulus; microstructure;
   biomaterial and powder metallurgy
ID MECHANICAL-PROPERTIES
AB Effects of alloying elements on elastic moduli (Young's moduli) of Ti-Nb-Ta-Zr system alloys for biomedical applications were investigated. In this case, Ti-30Nb- I 10Ta-5Zr which is the simplified chemical compositional alloy of Ti-29Nb-13Ta-4.6Zr for biomedical applications has been selected as the basic alloy composition. Each alloying element content of Ti-Nb-Ta-Zr quaternary alloys was varied independently. Nb content was varied from 0 through 40 mass % by eight levels. Ta content was varied from 0 through 20 mass % by five levels. Zr content was varied from 0 through 10 mass % by five levels. Every alloy was fabricated by powder metallurgy processing, followed by forging.
   Ti-30Nb-10Ta-5Zr with single beta phase, which is a basic alloy composition, shows the lowest Young's modulus. omega phase precipitation in beta phase has much greater effect on increasing Young's modulus than alpha phase precipitation in Ti-Nb-Ta-Zr quaternary alloys.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Toyota Cent R&D Labs Inc, Div Mat 1, Nagakute, Aichi 4801192, Japan.
RP Sakaguchi, N (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
CR FEDOTOV SG, 1970, P 2 INT C TAIT BOST, P871
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   HANADA S, 1985, METALL TRANS A, V16, P789, DOI 10.1007/BF02814829
   Kuroda D, 2000, TETSU TO HAGANE, V86, P610, DOI 10.2355/tetsutohagane1955.86.9_610
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
NR 5
TC 10
Z9 17
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-939-3
J9 MATER SCI FORUM
PY 2004
VL 449-4
BP 1269
EP 1272
DI 10.4028/www.scientific.net/MSF.449-452.1269
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BY90Q
UT WOS:000189492000314
DA 2018-10-19
ER

PT S
AU Kang, SB
   Yoon, KS
   Nam, TH
   Kim, JS
AF Kang, SB
   Yoon, KS
   Nam, TH
   Kim, JS
BE Kang, SG
   Kobayashi, T
TI Clinical application of TiNi shape memory alloy bone fastener
SO DESIGNING, PROCESSING AND PROPERTIES OF ADVANCED ENGINEERING MATERIALS,
   PTS 1 AND 2
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Designing, Processing and Properties of
   Advanced Engineering Materials
CY NOV 05-08, 2003
CL Jeju, SOUTH KOREA
SP Mat Res Soc Korea, Japan Soc Promot Sci, Adv Engn Mat Comm
DE Titanium-Nickel shape memory alloy; fracture; bone fastener
ID IN-VITRO BIOCOMPATIBILITY; NICKEL-TITANIUM; METAL
AB Titanium-Nickel shape memory alloy (TiNi SMA) has great potential as a biomaterial in orthopaedic applications due to its unique thermal shape memory effects, superelasticity and high damping properties. We designed and manufactured bone fasteners using newly developed TiNi SMA wire (Af, 35+/-2.C. Several types of bone fastener designs were prepared for the application of orthopedic treatment of bone fracture. We applied this fastener to 82 fracture patients. Fracture types according to the anatomic location included distal fibular (21), femur shaft (periprosthetic fracture, 17), distal tibia (15), distal femur (10), metacarpal bone (9), and subtrochanter of femur (5), distal clavicle (5). Serial radiographs, complete blood count (CBC) and urine analysis were performed postoperatively. Radiological union was achieved without complications at due time after operation. There were no abnormal findings on follow-up CBC or urine analysis. On a subjective level, use and application of the TiNi SMA fastener was not as demanding as conventional fixation methods, such as circumferential wiring (cerclage) or the Dall-Miles technique. The efficacy of SMA bone fastener in this study is very excellent as demonstrated in this clinical study. It gives the new armament to orthopedic surgeon.
C1 Seoul Natl Univ, Dept Orthopaed Surg, Coll Med, Seoul 156707, South Korea.
   Seoul Municipal Boramae Hosp, Seoul 156707, South Korea.
   Gyeongsang Natl Univ, Dept Mat Sci & Engn, Chinju 660701, Gyeongnam, South Korea.
   Univ Ulsan, Sch Mat & Met Engn, Ulsan 680749, South Korea.
RP Kang, SB (reprint author), Seoul Natl Univ, Dept Orthopaed Surg, Coll Med, 425 Shindaebangdong, Seoul 156707, South Korea.
RI Kang, Seung Baik/J-5362-2012
CR Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   Banim RH, 2000, J ARTHROPLASTY, V15, P131, DOI 10.1016/S0883-5403(00)91493-1
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   Buehler WJ, 1968, OCEAN ENGNG, V1, P105
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   HIL FJ, 1998, P I MECH ENG, V21, P473
   KANG SB, 2002, MAT T, V5, P1049
   Nam TH, 2002, MATER LETT, V52, P234, DOI 10.1016/S0167-577X(01)00424-4
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
NR 12
TC 5
Z9 5
U1 2
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-939-3
J9 MATER SCI FORUM
PY 2004
VL 449-4
BP 1317
EP 1320
DI 10.4028/www.scientific.net/MSF.449-452.1317
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BY90Q
UT WOS:000189492000326
DA 2018-10-19
ER

PT J
AU Liu, XD
   Ding, XM
   Wang, XZ
   Pan, YK
   Cao, CW
   Liu, DY
AF Liu, XD
   Ding, XM
   Wang, XZ
   Pan, YK
   Cao, CW
   Liu, DY
TI Drying research and development in China
SO DRYING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Drying Symposium
CY 2002
CL BEIJING, PEOPLES R CHINA
DE China; development; dryer manufacture; drying technology; research;
   review
ID FLOW
AB The developments in fundamental research on drying, drying technology, dryer manufacture from 1995 to 2001 in China were reviewed. The progress and current situation in drying fundamental research in China, such as heat and mass transfer in wet porous media, non-Fick and non-Fourier effects on rapid transient heat and mass transfer during drying, numerical simulations of a drying process and so on, were reviewed. The states of manufacturing of various dryers in China were investigated. Some studies on novel drying processes, such as pulse combustion drying, biomaterial drying, electro-dewatering technique etc., were also presented.
C1 China Agr Univ, Coll Engn, Beijing 100083, Peoples R China.
   CAS, Inst Engn Thermophys, Beijing, Peoples R China.
   Tianjin Inst Light Ind, Dept Mech Engn, Tianjin, Peoples R China.
   Dalian Univ Technol, Sch Chem Engn, Dalian, Peoples R China.
RP Liu, XD (reprint author), China Agr Univ, Coll Engn, 17 Qinghua E Rd, Beijing 100083, Peoples R China.
EM xdliu@cau.edu.cn
CR Cao CW, 1999, DRY TECHNOL, V17, P1759, DOI 10.1080/07373939908917650
   CAO CW, 2000, P 12 INT DRYING S TH
   CAO CW, 1998, BOOK DRYING PRINCIPL, P416
   Huai X. L., 2000, J ENG THERMOPHYSICS, V21, P595
   HUAI XL, 1999, CHEM IND ENG PHYS, V10, P42
   Jiang Fang-Ming, 2001, Journal of Applied Sciences, V19, P95
   LI CY, 2002, P 8 CHIN NAT DRYING, P46
   LI CZ, 2001, J NE U, V22, P47
   LI XG, 2002, P 8 CHIN NAT DRYING, P225
   LIU DY, 2000, CHEM IND ENG PROGR, V11, P1
   Liu XD, 2001, DRY TECHNOL, V19, P1939, DOI 10.1081/DRT-100107281
   LIU XD, 1998, P 11 INT DRYING S ID, VB, P732
   MAO ZH, 1998, BOOK DRYING PRINCIPL, P394
   Pan Y., 1997, CHEM ENG, V25, P37
   PAN YK, 1995, FOOD FERMENTATION IN, V1, P32
   PAN YK, 1997, CHEM EQUIPMENT TECHN, V18, P25
   Pan Yongkang, 1998, MODERN DRYING TECHNO
   Shi M., 1994, J SE U S, V24, P1
   SHI MH, 1999, CHEM IND ENG PROGR, V10, P28
   SHI MH, 2000, CHEM IND ENG PROGR, V11, P9
   Tang JX, 1999, DRY TECHNOL, V17, P1747, DOI 10.1080/07373939908917649
   WANG GG, 1994, J WORLD TRADE, V28, P51
   WANG XZ, 2000, SEM DRYING TECHN CHI
   WANG ZH, 1998, SCI CHINA SER E, V28, P225
   WU Y, 1998, CHEM ENG, V26, P14
   WU Y, 2002, P 8 CHIN NAT DRYING, P116
   WU Y, 2001, CHEM IND ENG PROGR, V11, P7
   Wu ZH, 2002, DRY TECHNOL, V20, P1101, DOI 10.1081/DRT-120004042
   XU CH, 1999, CHEM IND ENG PROGR, V10, P37
   XU CH, 2000, VACUUM TECHNOLOGY AP, V4, P16
   XU YK, 1995, J DALIAN U TECHNOLOG, V35, P154
   YAN H, 1999, CHEM IND ENG PROGR, V10, P16
   Yu CY, 1999, DRY TECHNOL, V17, P1893, DOI 10.1080/07373939908917659
   Zhang Z., 2000, ADV MECH, V30, P446
   Zheng YuShan, 2001, World Forestry Research, V14, P8
   Zhou JX, 2001, DRY TECHNOL, V19, P627, DOI 10.1081/DRT-100103939
   ZOU HF, 2000, CHEM IND ENG PROGR, V11, P46
   ZOU HF, 2000, VACUUM CRYOGENICS, V6, P213
NR 38
TC 5
Z9 7
U1 0
U2 4
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0737-3937
J9 DRY TECHNOL
JI Dry. Technol.
PY 2004
VL 22
IS 1-2
BP 123
EP 144
DI 10.1081/DRT-120028223
PG 22
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA 806TP
UT WOS:000220456500010
DA 2018-10-19
ER

PT J
AU Katz, E
   Willner, I
   Wang, J
AF Katz, E
   Willner, I
   Wang, J
TI Electroanalytical and bioelectroanalytical systems based on metal and
   semiconductor nanoparticles
SO ELECTROANALYSIS
LA English
DT Review
DE metal nanoparticles; semiconductor nanoparticles; magnetic particles;
   sensors; biosensors; immunosensors; DNA sensors; enzyme electrodes;
   biomaterial-nanoparticle hybrid system; photoelectrochemistry;
   field-effect transistors; magnetic switches
ID SELF-ASSEMBLED MONOLAYERS; CHEMICALLY MODIFIED ELECTRODES;
   SURFACE-PLASMON RESONANCE; VAPOR-SENSING PROPERTIES; ELECTROCHEMICAL
   STRIPPING DETECTION; DIRECT ELECTRICAL COMMUNICATION; STABILIZED GOLD
   CLUSTERS; DNA-HYBRIDIZATION; GLUCOSE-OXIDASE; AMPEROMETRIC BIOSENSORS
AB Metal, semiconductor and magnetic particles act as functional units for electroanalytical applications. Metal nanoparticles provide three important functions for electroanalysis. These include the roughening of the conductive sensing interface, the catalytic properties of the nanoparticles permiting their enlargement with metals and the amplified electrochemical detection of the metal deposits and the conductivity properties of nanoparticles at nanoscale dimensions that allow the electrical contact of redox-centers in proteins with electrode surfaces. Also, metal and semiconductor nanoparticles provide versatile labels for amplified electroanalysis. Dissolution of the nanoparticle labels and the electrochemical collection of the dissolved ions on the electrode followed by the stripping-off of the deposited metals represents a general electroanalytical procedure. These unique functions of nanoparticles were employed for developing electrochemical gas sensors, electrochemical sensors based on molecular- or polymer-functionalized nanoparticle sensing interfaces, and for the construction of different biosensors including enzyme-based electrodes, immunosensors and DNA sensors. Semiconductor nanoparticles enable the photoelectrochemical detection of analytes. Several studies have revealed the photocurrent generation by enzyme-mediated processes and as a result of DNA hybridization. Magnetic particles act as functional components for the separation of biorecognition complexes and for the amplified electrochemical sensing of DNA or antigen/antibody complexes. Also, electro-catalytic and bioelectrocatalytic processes at electrode surfaces are switched by means of functionalized magnetic particles and in the presence of an external magnet.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
   New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.
RP Katz, E (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
EM ekatz@vms.huji.ac.il; willnea@vms.huji.ac.il; joewang@nmsu.edu
RI Wang, Joseph/C-6175-2011
CR ABRUNA HD, 1988, COORDIN CHEM REV, V86, P135, DOI 10.1016/0010-8545(88)85013-6
   AHUJA R, 1993, ANGEW CHEM INT EDIT, V32, P1033, DOI 10.1002/anie.199310331
   ALBERY WJ, 1981, ANNU REP PROG CHEM C, V78, P377
   Alfonta L, 2001, ANAL CHEM, V73, P91, DOI 10.1021/ac00819v
   Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506
   Alvarez MM, 1997, J PHYS CHEM B, V101, P3706, DOI 10.1021/jp962922n
   Armstrong F.A., 1986, Q REV BIOPHYS, V18, P261
   ARMSTRONG FA, 1988, ACCOUNTS CHEM RES, V21, P407, DOI 10.1021/ar00155a004
   Armstrong FA, 2000, ELECTROCHIM ACTA, V45, P2623, DOI 10.1016/S0013-4686(00)00342-X
   Armstrong FA, 1997, CHEM SOC REV, V26, P169, DOI 10.1039/cs9972600169
   Authier L, 2001, ANAL CHEM, V73, P4450, DOI 10.1021/ac0103221
   BADIA A, 1993, J AM CHEM SOC, V115, P7053, DOI 10.1021/ja00069a001
   Bandyopadhyay K, 1997, LANGMUIR, V13, P5244, DOI 10.1021/la960463b
   Bard A. J., 1980, ELECTROCHEMICAL METH
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BARTLETT P N, 1991, Progress in Reaction Kinetics, V16, P55
   Blonder R, 1998, CHEM COMMUN, P1393, DOI 10.1039/a802727g
   Boal AK, 2000, NATURE, V404, P746
   Bochenkov VE, 2002, COLLOID SURFACE A, V198, P911, DOI 10.1016/S0927-7757(01)01019-6
   BOND AM, 1980, MODERN POLARGRAPHIC
   Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826
   BRUS L, 1991, APPL PHYS A-MATER, V53, P465, DOI 10.1007/BF00331535
   Brust M, 2002, COLLOID SURFACE A, V202, P175, DOI 10.1016/S0927-7757(01)01087-1
   BUCKMANN AF, 1992, BIOTECHNOL APPL BIOC, V15, P303
   Cai H, 2001, J ELECTROANAL CHEM, V510, P78, DOI 10.1016/S0022-0728(01)00548-4
   Cai H, 2002, ANAL CHIM ACTA, V469, P165, DOI 10.1016/S0003-2670(02)00670-0
   Cai H, 2002, ANALYST, V127, P803, DOI 10.1039/b200555g
   Chegel VI, 2002, ADV MATER, V14, P1549, DOI 10.1002/1521-4095(20021104)14:21<1549::AID-ADMA1549>3.0.CO;2-C
   Chen T, 2001, J AM CHEM SOC, V123, P8630, DOI 10.1021/ja0163164
   Cheng WL, 2002, ANAL CHEM, V74, P3599, DOI 10.1021/ac025661o
   Ciebien JF, 1998, NEW J CHEM, V22, P685, DOI 10.1039/a709233d
   Cioffi N, 2002, SENSOR ACTUAT B-CHEM, V84, P49, DOI 10.1016/S0925-4005(01)01073-5
   Cosnier S, 1997, ELECTROANAL, V9, P894, DOI 10.1002/elan.1140091206
   CRUMBLISS AL, 1992, BIOTECHNOL BIOENG, V40, P483, DOI 10.1002/bit.260400406
   Curri ML, 2002, MAT SCI ENG C-BIO S, V22, P449, DOI 10.1016/S0928-4931(02)00191-1
   DEGANI Y, 1988, J AM CHEM SOC, V110, P2615, DOI 10.1021/ja00216a040
   DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001
   DORON A, 1995, LANGMUIR, V11, P1313, DOI 10.1021/la00004a044
   Eichen Y, 1998, ACTA POLYM, V49, P663, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<663::AID-APOL663>3.3.CO;2-W
   EMR SA, 1995, ELECTROANAL, V7, P913, DOI 10.1002/elan.1140071002
   Englebienne P, 2001, ANALYST, V126, P1645, DOI 10.1039/b105252g
   Evans SD, 2000, J MATER CHEM, V10, P183, DOI 10.1039/a903951a
   Fendler JH, 1996, CHEM MATER, V8, P1616, DOI 10.1021/cm960116n
   Foos EE, 2002, CHEM MATER, V14, P2401, DOI 10.1021/cm020007a
   FREW JE, 1988, EUR J BIOCHEM, V172, P261, DOI 10.1111/j.1432-1033.1988.tb13882.x
   Gangopadhyay R, 2000, CHEM MATER, V12, P608, DOI 10.1021/cm990537f
   Gooding JJ, 2002, ELECTROANAL, V14, P1149, DOI 10.1002/1521-4109(200209)14:17<1149::AID-ELAN1149>3.0.CO;2-8
   Grieve K, 2000, CURR OPIN COLLOID IN, V5, P168, DOI 10.1016/S1359-0294(00)00050-9
   Habermuller L, 2000, FRESEN J ANAL CHEM, V366, P560
   Han L, 2001, ANAL CHEM, V73, P4441, DOI 10.1021/ac0104025
   He L, 2000, J AM CHEM SOC, V122, P9071, DOI 10.1021/ja001215b
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   Hernandez-Santos D, 2002, ELECTROANAL, V14, P1225, DOI 10.1002/1521-4109(200210)14:18<1225::AID-ELAN1225>3.0.CO;2-Z
   Herron N, 1998, ADV MATER, V10, P1173, DOI 10.1002/(SICI)1521-4095(199810)10:15<1173::AID-ADMA1173>3.0.CO;2-6
   Hicks JF, 2002, J AM CHEM SOC, V124, P13322, DOI 10.1021/ja027724q
   Hirsch R, 2000, J AM CHEM SOC, V122, P12053, DOI 10.1021/ja005523l
   Hostetler MJ, 1996, J AM CHEM SOC, V118, P4212, DOI 10.1021/ja960198g
   Imahori H, 2001, ADV MATER, V13, P1197, DOI 10.1002/1521-4095(200108)13:15<1197::AID-ADMA1197>3.0.CO;2-4
   Imahori H, 2001, J AM CHEM SOC, V123, P335, DOI 10.1021/ja002838s
   Ingram RS, 1997, J AM CHEM SOC, V119, P9279, DOI 10.1021/ja972319y
   Ingram RS, 1998, LANGMUIR, V14, P4115, DOI 10.1021/la9800452
   Israel LB, 2001, J ELECTROANAL CHEM, V517, P69, DOI 10.1016/S0022-0728(01)00671-4
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   Katz E, 2003, J AM CHEM SOC, V125, P6803, DOI 10.1021/ja034008v
   Katz E, 2002, CHEM-EUR J, V8, P4138, DOI 10.1002/1521-3765(20020916)8:18<4138::AID-CHEM4138>3.0.CO;2-Z
   Katz E, 2002, ANGEW CHEM INT EDIT, V41, P1343, DOI 10.1002/1521-3773(20020415)41:8<1343::AID-ANIE1343>3.0.CO;2-K
   Katz E, 2002, J AM CHEM SOC, V124, P10290, DOI 10.1021/ja0264145
   Katz E, 1999, ANAL CHIM ACTA, V385, P45, DOI 10.1016/S0003-2670(98)00688-6
   Katz E., 2003, NANOSCALE MAT, P5
   KATZ E, 2003, IN PRESS NANOPARTICL
   KATZ E, 2003, ELECTROANAL, V15, P912
   KATZ E, 2003, HDB FUEL CELLS FUNDA, V1, P355
   Kawde AN, 2004, ELECTROANAL, V16, P101, DOI 10.1002/elan.200302924
   Kesavan V, 1999, ANGEW CHEM INT EDIT, V38, P3521, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3521::AID-ANIE3521>3.0.CO;2-S
   Khairutdinov RF, 1997, COLLOID J+, V59, P535
   Kharitonov AB, 1999, ANAL CHEM, V71, P5441, DOI 10.1021/ac990997s
   Kharitonov AB, 1999, REV ANAL CHEM, V18, P255
   Klein DL, 1997, NATURE, V389, P699
   KRASTEVA B, 2003, SENSOR ACTUAT B-CHEM, V92, P137
   Krasteva N, 2002, NANO LETT, V2, P551, DOI 10.1021/nl020242s
   Kubitschko S, 1997, ANAL BIOCHEM, V253, P112, DOI 10.1006/abio.1997.2337
   Lahav M, 1999, J CHEM SOC PERK T 2, P1925, DOI 10.1039/a902763g
   Lahav M, 1999, CHEM COMMUN, P1937, DOI 10.1039/a906310b
   Lahav M, 2000, J ELECTROANAL CHEM, V482, P217, DOI 10.1016/S0022-0728(00)00053-X
   LAVAL JM, 1991, BIOTECHNOL BIOENG, V38, P788, DOI 10.1002/bit.260380713
   Lee TMH, 2003, LANGMUIR, V19, P4338, DOI 10.1021/la0270385
   Lei CX, 2003, TALANTA, V59, P981, DOI 10.1016/S0039-9140(02)00641-0
   LEWIS LN, 1993, CHEM REV, V93, P2693, DOI 10.1021/cr00024a006
   Lue JT, 2001, J PHYS CHEM SOLIDS, V62, P1599, DOI 10.1016/S0022-3697(01)00099-3
   Lyon LA, 1998, ANAL CHEM, V70, P5177, DOI 10.1021/ac9809940
   McConnell WP, 2000, J PHYS CHEM B, V104, P8925, DOI 10.1021/jp000926t
   Mertig M, 2002, NANO LETT, V2, P841, DOI 10.1021/nl025612r
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   MURRAY RW, 1984, ELECTROANAL CHEM, V13, P191
   MURRAY RW, 1980, ACCOUNTS CHEM RES, V13, P135, DOI 10.1021/ar50149a002
   Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Ozsoz M, 2003, ANAL CHEM, V75, P2181, DOI 10.1021/ac026212r
   Palmer RE, 2002, PHYS CHEM CHEM PHYS, V4, P4275, DOI 10.1039/b202462d
   Pardo-Yissar V, 2003, J AM CHEM SOC, V125, P622, DOI 10.1021/ja028922k
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   Patolsky F, 1999, LANGMUIR, V15, P3703, DOI 10.1021/la981682v
   Patolsky F, 2001, J AM CHEM SOC, V123, P5194, DOI 10.1021/ja0036256
   Patolsky F, 2001, ANGEW CHEM INT EDIT, V40, P2261, DOI 10.1002/1521-3773(20010618)40:12<2261::AID-ANIE2261>3.0.CO;2-P
   Patolsky F, 2001, NAT BIOTECHNOL, V19, P253, DOI 10.1038/85704
   Pietron JJ, 1999, J PHYS CHEM B, V103, P4440, DOI 10.1021/jp984588w
   Raitman OA, 2002, J AM CHEM SOC, V124, P6487, DOI 10.1021/ja012680r
   Raitman OA, 2002, CHEM COMMUN, P1936, DOI 10.1039/b205393d
   Raj CR, 2003, J ELECTROANAL CHEM, V543, P127, DOI 10.1016/S0022-0728(02)01481-X
   Riboh JC, 2003, J PHYS CHEM B, V107, P1772, DOI 10.1021/jp022130v
   Richter J, 2000, ADV MATER, V12, P507, DOI 10.1002/(SICI)1521-4095(200004)12:7<507::AID-ADMA507>3.0.CO;2-G
   Richter J, 2003, PHYSICA E, V16, P157, DOI 10.1016/S1386-9477(02)00670-7
   Sarathy KV, 1999, J PHYS CHEM B, V103, P399, DOI 10.1021/jp983836l
   Sato T, 1997, APPL PHYS LETT, V70, P2759, DOI 10.1063/1.118975
   Sato T, 1997, J APPL PHYS, V82, P696, DOI 10.1063/1.365600
   SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048
   SCHUHMANN W, 1995, BIOSENS BIOELECTRON, V10, P181, DOI 10.1016/0956-5663(95)96805-9
   Shen LF, 1999, LANGMUIR, V15, P447, DOI 10.1021/la9807661
   Shipway AN, 2000, ADV MATER, V12, P993, DOI 10.1002/1521-4095(200006)12:13<993::AID-ADMA993>3.0.CO;2-3
   Shipway AN, 2000, CHEMPHYSCHEM, V1, P18, DOI 10.1002/1439-7641(20000804)1:1<18::AID-CPHC18>3.0.CO;2-L
   Shipway AN, 2001, CHEM COMMUN, P2035, DOI 10.1039/b105164b
   Shipway AN, 1999, CHEM MATER, V11, P13, DOI 10.1021/cm981025o
   Stefan RI, 2000, FRESEN J ANAL CHEM, V366, P659, DOI 10.1007/s002160051560
   TANIGUCHI I, 1982, J CHEM SOC CHEM COMM, P1032, DOI 10.1039/c39820001032
   Templeton AC, 1999, J AM CHEM SOC, V121, P7081, DOI 10.1021/ja990513+
   Trau D, 2002, ANAL CHEM, V74, P5480, DOI 10.1021/ac0200522
   Trindade T, 2001, CHEM MATER, V13, P3843, DOI 10.1021/cm000843p
   Urban M, 2003, REV SCI INSTRUM, V74, P1077, DOI 10.1063/1.1533103
   Velev OD, 1999, LANGMUIR, V15, P3693, DOI 10.1021/la981729c
   Vossmeyer T, 2002, ADV MATER, V14, P238, DOI 10.1002/1521-4095(20020205)14:3<238::AID-ADMA238>3.0.CO;2-#
   Wang J, 1999, CHEM-EUR J, V5, P1681, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1681::AID-CHEM1681>3.0.CO;2-U
   Wang J, 1999, J PHARMACEUT BIOMED, V19, P47, DOI 10.1016/S0731-7085(98)00056-9
   Wang J, 2003, ANAL CHIM ACTA, V500, P247, DOI 10.1016/S0003-2670(03)00725-6
   Wang J, 2003, ANAL CHIM ACTA, V482, P149, DOI 10.1016/S0003-2670(03)00206-X
   Wang J, 2003, J AM CHEM SOC, V125, P3214, DOI 10.1021/ja029668z
   Wang J, 2003, LANGMUIR, V19, P989, DOI 10.1021/la026697e
   Wang J, 2003, ELECTROCHEM COMMUN, V5, P83, DOI 10.1016/S1388-2481(02)00542-8
   Wang J, 2002, ELECTROCHEM COMMUN, V4, P722, DOI 10.1016/S1388-2481(02)00434-4
   Wang J, 2002, J AM CHEM SOC, V124, P4208, DOI 10.1021/ja0255709
   Wang J, 2002, ELECTROCHEM COMMUN, V4, P349, DOI 10.1016/S1388-2481(02)00311-9
   Wang J, 2001, ANALYST, V126, P2020, DOI 10.1039/b106343j
   Wang J, 2001, ANAL CHEM, V73, P5576, DOI 10.1021/ac0107148
   Wang J, 2001, LANGMUIR, V17, P5739, DOI 10.1021/la011002f
   Warsinke A, 2000, FRESEN J ANAL CHEM, V366, P622, DOI 10.1007/s002160051557
   Weller H, 1998, ANGEW CHEM INT EDIT, V37, P1658, DOI 10.1002/(SICI)1521-3773(19980703)37:12<1658::AID-ANIE1658>3.0.CO;2-L
   WILLNER I, 1992, BIOELECTROCH BIOENER, V29, P29, DOI 10.1016/0302-4598(92)80051-H
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Willner I, 2003, ACS SYM SER, V844, P88
   WILLNER I, 1992, J AM CHEM SOC, V114, P10965, DOI 10.1021/ja00053a045
   Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1
   Willner I, 2001, ANGEW CHEM INT EDIT, V40, P1861
   Willner I, 1997, ELECTROANAL, V9, P965, DOI 10.1002/elan.1140091302
   Willner I, 2000, BIOSENSORS THEIR APP, P47
   WILLNER I, 2003, IN PRESS ANGEW CHEM
   WILLNER I, 2002, ELECTROANALYTICAL ME, P43
   Willner Itamar, 2002, J Biotechnol, V82, P325, DOI 10.1016/S1389-0352(01)00050-2
   Wohltjen H, 1998, ANAL CHEM, V70, P2856, DOI 10.1021/ac9713464
   WRIGHTON MS, 1986, SCIENCE, V231, P32, DOI 10.1126/science.231.4733.32
   Xiao Y, 2003, SCIENCE, V299, P1877, DOI 10.1126/science.1080664
   Zamborini FP, 2002, J AM CHEM SOC, V124, P8958, DOI 10.1021/ja025965s
   Zayats M, 2002, J AM CHEM SOC, V124, P14724, DOI 10.1021/ja027919y
   ZAYATS M, IN PRESS J AM CHEM S
   Zhao JG, 1996, BIOSENS BIOELECTRON, V11, P493, DOI 10.1016/0956-5663(96)86786-8
   ZHAO JG, 1992, J ELECTROANAL CHEM, V327, P109, DOI 10.1016/0022-0728(92)80140-Y
   Zhu NN, 2003, ANAL CHIM ACTA, V481, P181, DOI 10.1016/S0003-2670(03)00123-5
   Zhu T, 1998, THIN SOLID FILMS, V327, P595, DOI 10.1016/S0040-6090(98)00720-2
   1992, NATO ASI SER B, P294
NR 169
TC 563
Z9 570
U1 23
U2 385
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1040-0397
J9 ELECTROANAL
JI Electroanalysis
PD JAN
PY 2004
VL 16
IS 1-2
BP 19
EP 44
DI 10.1002/elan.200302930
PG 26
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 771ZJ
UT WOS:000188815700003
DA 2018-10-19
ER

PT J
AU Abu Shakra, A
   Li, Y
   Schutte, R
   Reichert, WM
AF Abu Shakra, A
   Li, Y
   Schutte, R
   Reichert, WM
TI Protein array method for assessing in vitro biomaterial-induced cytokine
   expression
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Meeting Abstract
CT 35th Annual Meeting of the Environmental-Mutagen-Society
CY OCT 02-06, 2004
CL Pittsburgh, PA
SP Environm Mutagen Soc
C1 NCCU, Dept Biol, Durham, NC 27707 USA.
   Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0893-6692
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PY 2004
VL 44
IS 3
MA 1
BP 186
EP 186
PG 1
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA 852MF
UT WOS:000223758700002
DA 2018-10-19
ER

PT S
AU Kim, SR
   Jung, SJ
   Lee, YJ
   Song, H
   Kim, YH
AF Kim, SR
   Jung, SJ
   Lee, YJ
   Song, H
   Kim, YH
BE Mandal, H
   Ovecoglu, L
TI Silicon-substituted hydroxyapatite derived from coral
SO EURO CERAMICS VIII, PTS 1-3
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Conference of the European-Ceramic-Society
CY JUN 29-JUL 03, 2003
CL Istanbul, TURKEY
SP Turkish Ceram Soc, European Ceram Soc
DE hydroxyapatite; silicon; substitution; porous block; biomaterial
AB Ion-substituted hydroxyapatite can be used for a potential biological material in the form of porous body. A porous silicon-substituted hydroxyapatite has been prepared using natural coral as a calcium source to obtain a biomaterial having an improved biocompatibility. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon dioxide or other calcium phosphate species. Silicon content was 0.73% by weight. EDS investigation confirmed the presence of silicon in the framework of hydroxyapatite structure.
C1 Korea Inst Ceram Engn & Technol, Seoul, South Korea.
RP Kim, YH (reprint author), Korea Inst Ceram Engn & Technol, Seoul, South Korea.
EM yhkokim@kicet.re.kr
CR CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kasuga T, 2001, J AM CERAM SOC, V84, P450
   Kim S. R., 2002, KEY ENG MATER, V85, P218
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   KOKUBO T., 1994, BIOCERAMICS, V7, P49
   Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4
   Xu Y, 2001, MATER CHARACT, V47, P83, DOI 10.1016/S1044-5803(01)00154-1
NR 9
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-946-6
J9 KEY ENG MAT
PY 2004
VL 264-268
BP 1941
EP 1944
DI 10.4028/www.scientific.net/KEM.264-268.1941
PN 1-3
PG 4
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BAO19
UT WOS:000223059700465
DA 2018-10-19
ER

PT S
AU Celotti, G
   Landi, E
   Sandri, M
   Tampieri, A
AF Celotti, G
   Landi, E
   Sandri, M
   Tampieri, A
BE Mandal, H
   Ovecoglu, L
TI New method to prepare natural-like carbonate apatite for bone
   replacement
SO EURO CERAMICS VIII, PTS 1-3
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Conference of the European-Ceramic-Society
CY JUN 29-JUL 03, 2003
CL Istanbul, TURKEY
SP Turkish Ceram Soc, European Ceram Soc
DE carbonate apatite; biomaterial; biomimetic carbonation; synthesis
AB A new method to synthesize the carbonate substituted hydroxyapatite (CHA) powder has been set up introducing a CO2 flux, as a source of carbonate, in the HA synthesis process based on the neutralization reaction between Ca(OH)(2) and H3PO4; the Ca/P molar ratio of the starting reactants has been fixed at the stoichiometric value of hydroxyapatite (1.67). The reactants are abundant and inexpensive, the yield is good compared to other CHA powder synthesis, the reaction may be performed at low temperature and without pH control and does not produce any by-products that have to be disposed off: these are all things of great interest for an industrialisation of the process.
   The influence of the synthesis parameters (temperature, H3PO4 solution dropping rate, i.e. reaction time, CO2 flux, aging time) has been tested to optimise the process conditions in order to obtain the highest carbonation degree and favour the B-type CHA precipitation in respect to A-type one.
C1 CNR, Inst Sci & Technol Ceram, I-48018 Faenza, RA, Italy.
RP Celotti, G (reprint author), CNR, Inst Sci & Technol Ceram, Via Granarolo,64, I-48018 Faenza, RA, Italy.
OI Landi, Elena/0000-0003-4495-129X
CR BURNELL JM, 1980, CALCIFIED TISSUE INT, V31, P13, DOI 10.1007/BF02407162
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, P1
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   LANDI E, 2002, IN PRESS P INT MAT C
   LeGeros RZ, 1991, MONOGRAPHS ORAL SCI, V15, P82
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
NR 8
TC 2
Z9 2
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-946-6
J9 KEY ENG MAT
PY 2004
VL 264-268
BP 2071
EP 2074
DI 10.4028/www.scientific.net/KEM.264-268.2071
PN 1-3
PG 4
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BAO19
UT WOS:000223059700497
DA 2018-10-19
ER

PT S
AU Choubey, A
   Dorner-Reisel, A
   Basu, B
AF Choubey, A
   Dorner-Reisel, A
   Basu, B
BE Mandal, H
   Ovecoglu, L
TI Friction and wear behaviour of DLC coated biomaterials in simulated body
   fluid solution at fretting contacts
SO EURO CERAMICS VIII, PTS 1-3
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Conference of the European-Ceramic-Society
CY JUN 29-JUL 03, 2003
CL Istanbul, TURKEY
SP Turkish Ceram Soc, European Ceram Soc
DE DLC; CoCrMo; CVD; biomaterial; friction and wear
AB Considering the significance of wear on the materials performance in biomedical applications, the present research is carried out to understand the tribological behavior of CVD-DLC coated CoCrMo alloys under fretting contacts. The fretting experiments were carried out on uncoated and coated CoCrMo alloys against bearing steel under varying load for different test duration on a fretting (low amplitude reciprocatory tangential sliding) wear tester. The wear tests were performed in Hank's balanced salt solution to assess the performance in simulated body fluid (physiological) solution. Based on the microstructural characterization of the worn surfaces, the underlying wear mechanisms of the investigated wear couples are elucidated. The obtained research results clearly indicate the superior tribological performance of DLC coatings as compared to uncoated CoCrMo alloys.
C1 Tech Univ Bergakad Freiberg, Inst Ceram Mat, D-09596 Freiberg, Germany.
   Indian Inst Technol, Ceram Lab, Dept Mat & Met Engn, Kanpur 208016, Uttar Pradesh, India.
RP Choubey, A (reprint author), Tech Univ Bergakad Freiberg, Inst Ceram Mat, Gustav Zeuner Str 3, D-09596 Freiberg, Germany.
RI BASU, BIKRAMJIT/A-9967-2013
CR DORNERREISEL A, 2003, WERKST K LEHRST VERB
   DORNERREISEL A, UNPUB DIAM RELAT MAT
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KUMAR P, 1991, J BIOMED MATER RES, V25, P813, DOI 10.1002/jbm.820250703
NR 4
TC 3
Z9 3
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-946-6
J9 KEY ENG MAT
PY 2004
VL 264-268
BP 2115
EP 2118
DI 10.4028/www.scientific.net/KEM.264-268.2115
PN 1-3
PG 4
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BAO19
UT WOS:000223059700508
DA 2018-10-19
ER

PT J
AU Nagaya, M
   Kubota, S
   Suzuki, N
   Tadokoro, M
   Akashi, K
AF Nagaya, M
   Kubota, S
   Suzuki, N
   Tadokoro, M
   Akashi, K
TI Evaluation of thermoreversible gelation polymer for regeneration of
   focal liver injury
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Article
DE dogs, liver resection; dogs, regeneration of focal liver injury;
   thermoreversible gelation polymer; fibrin glue; liver regeneration;
   focal liver injury; wound-healing process of liver; macrophages;
   stellate cells; organoids
ID HEPATIC STELLATE CELLS; FIBRIN GLUE; RAT-LIVER; EXTRACELLULAR-MATRIX;
   MECHANISMS; COPOLYMER; FIBROSIS; TRAUMA
AB Liver injuries are often associated with complications including infection of the dead space, bleeding, leakage of bile and so on. We have recently developed a thermoreversible gelation polymer ( TGP) which provides a good healing environment for wounds and possibly reduces complications. The purpose of this study was to evaluate whether adequate regeneration occurred with a liver defect by using TGP. The sol-gel transition of TGP is reversibly controlled by temperature; TGP is soluble below a lower critical solution temperature (LCST) of 22 degreesC, and becomes solid above the LCST. Soluble TGP can reach anywhere, and gelation of TGP occurs at the wound surface by body temperature to fill the wound/ cavity. A section of median part of the left lobe comprising 3% ( 2 x 2 cm wide and 1 cm deep) of the liver was resected, and the Beagle dogs were assigned to three groups: 'resection alone group', 'resection + fibrin glue FG) group' and 'resection + TGP group'. The resection alone group and the resection + FG group showed severe fibrosis at week 12, and a scarring was clearly visible. The resection + TGP group showed almost complete healing by week 4, with no adhesion and recession of the wound; the resection site was completely filled with TGP, liver-like capsule organoids emerged to cover the wound and neovascularization was observed within the organoids. Furthermore, the resected liver regenerated completely by week 12, TGP was replaced by hepatocytes, and the presence of hepatic lobules confirmed structural reorganization. The number of RCA-1-positive macrophages accumulating around the wound was significantly reduced in the resection + TGP group compared to the other two groups. In the early stage of liver resection and regeneration, TGP seemed to suppress the accumulation of macrophages and stellate cells. In the late stage, when massive inflammatory cell accumulation had subsided, TGP was degraded, that may contribute to avoid unnecessary inhibition of the liver regeneration process. Collectively, TGP may induce efficient regeneration by reducing the fibrosis and enhancing proliferation, even with a minor liver defect. Because TGP has good biocompatibility, it may become useful as an ideal biomaterial for the treatment of liver injuries. Copyright (C) 2004 S. Karger AG, Basel.
C1 St Marianna Univ, Sch Med, Dept Emergency & Crit Care Med, Miyamae Ku, Kanagawa 2168511, Japan.
   St Marianna Univ, Sch Med, Dept Gen Surg, Kanagawa 2168511, Japan.
   St Marianna Univ, Sch Med, Dept Immunol & Med, Kanagawa 2168511, Japan.
   St Marianna Univ, Sch Med, Dept Pathol, Kanagawa 2168511, Japan.
RP Nagaya, M (reprint author), St Marianna Univ, Sch Med, Dept Emergency & Crit Care Med, Miyamae Ku, 2-16-1 Sugao, Kanagawa 2168511, Japan.
EM m2nagaya@marianna-u.ac.jp
CR BRENNAN M, 1991, BLOOD REV, V5, P240, DOI 10.1016/0268-960X(91)90015-5
   Bruel D., 1993, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V22, P459
   BUCHER NLR, 1964, CANCER RES, V24, P1611
   Chen RJ, 1998, J TRAUMA, V44, P691, DOI 10.1097/00005373-199804000-00024
   DEIMANN W, 1980, LAB INVEST, V43, P172
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   Gagne N, 1999, SEX TRANSM DIS, V26, P177, DOI 10.1097/00007435-199903000-00009
   GRESSNER AM, 1995, HEPATOLOGY, V22, P1507, DOI 10.1002/hep.1840220526
   Holcomb JB, 2000, J TRAUMA, V49, P246, DOI 10.1097/00005373-200008000-00010
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Knittel T, 1999, HISTOCHEM CELL BIOL, V112, P387, DOI 10.1007/s004180050421
   KNITTEL T, 1994, FORUM TRENDS EXP CLI, V4, P236
   KRAM HB, 1988, J TRAUMA, V28, P1195, DOI 10.1097/00005373-198808000-00010
   MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401
   MCDONALD RA, 1962, LAB INVEST, V11, P544
   OGAWA K, 1985, AM J PATHOL, V119, P158
   Shimizu S, 1996, ARTIF ORGANS, V20, P1232
   TAKEZAWA T, 1990, BIO-TECHNOL, V8, P854, DOI 10.1038/nbt0990-854
   Tsukikawa S, 2003, ARTIF ORGANS, V27, P598, DOI 10.1046/j.1525-1594.2003.07131.x
   VANFURTH R, 1972, B WORLD HEALTH ORGAN, V47, P651
   Vernon B, 2000, J BIOMED MATER RES, V51, P69
   Yoshioka H., 1998, Japanese Journal of Artificial Organs, V27, P503
   Yoshioka H, 1998, POLYM ADVAN TECHNOL, V9, P155
   YOSHIOKA H, 1994, J MACROMOL SCI PURE, VA31, P109
   YOSHIOKA H, 1994, J MACROMOL SCI PURE, VA31, P113
NR 25
TC 14
Z9 14
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PY 2004
VL 36
IS 2
BP 95
EP 103
DI 10.1159/000076649
PG 9
WC Surgery
SC Surgery
GA 801GH
UT WOS:000220083900005
PM 15007262
DA 2018-10-19
ER

PT S
AU Salzer, R
   Steiner, G
   Krafft, C
   Zimmerer, C
   Tunc, S
AF Salzer, R
   Steiner, G
   Krafft, C
   Zimmerer, C
   Tunc, S
BE Kundu, T
TI Health monitoring of biomaterials from molecular fingerprints
SO HEALTH MONITORING AND SMART NONDESTRUCTIVE EVALUATION OF STRUCTURAL AND
   BIOLOGICAL SYSTEM III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Health Monitoring and Smart Nondestructive Evaluation of
   Structural and Biological Systems III
CY MAR 15-17, 2004
CL San Diego, CA
SP SPIE
DE infrared; Raman; spectroscopic imaging; biomolecules; biomimetic
   material
ID ATOMIC-FORCE MICROSCOPY; SURFACE-DEPENDENT CONFORMATIONS; FTIR
   SPECTROSCOPY; BINDING-SITE; PROTEIN; FIBRINOGEN; GLYCOPROTEIN;
   ADSORPTION; PEPTIDES; SILICA
AB Structural changes in proteins may result in interactions between proteins themselves or between proteins and other biomolecules, which in turn may introduce deterioration of the health state of the system, might it be biological or biomimetic. The initial structural changes in proteins can not be observed by established methods of material analysis like X-ray diffraction or NMR spectroscopy, because proteins in biological cells have an extremely low abundance and are in the non-crystalline state. An obvious gap exists between sequencing techniques for amino acids and the molecular understanding of the functional properties of a particular protein. Vibrational spectroscopic methods offer the potential of fast and accurate characterization of essential supramolecular properties in the native state of the biomaterial. Imaging techniques recently became available for both FTIR and Raman spectroscopy. Here we report on the utilization of the enormous information content of FTIR and Raman spectra for health monitoring in engineering and medicine.
C1 Tech Univ Dresden, Inst Analyt Chem, D-01062 Dresden, Germany.
RP Salzer, R (reprint author), Tech Univ Dresden, Inst Analyt Chem, D-01062 Dresden, Germany.
RI Krafft, Christoph/A-4595-2009; Tunc, Sibel/C-1651-2016
OI Krafft, Christoph/0000-0003-1049-0560; 
CR Balsera M, 2003, BIOCHEMISTRY-US, V42, P1000, DOI 10.1021/bi0265751
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Campanella R, 1992, J Neurosurg Sci, V36, P11
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V220, P13, DOI 10.1006/jcis.1999.6479
   JORGENSEN L, 2003, INT J PHARM, V18, P7
   Kariakin A, 2002, BIOCHEMISTRY-US, V41, P13514, DOI 10.1021/bi0262505
   Kopecky V, 2003, BIOCHEM BIOPH RES CO, V300, P41, DOI 10.1016/S0006-291X(02)02765-1
   Krafft C, 2003, VIB SPECTROSC, V32, P75, DOI 10.1016/S0924-2031(03)00049-3
   KRAFFT C, 2003, SPIE P, V5141, P230
   Kuznetsov SV, 2003, BIOCHEMISTRY-US, V42, P4321, DOI 10.1021/bi026893k
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu XY, 2003, J BIOMED MATER RES A, V66A, P722, DOI 10.1002/jbm.a.10014
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Rigler P, 2003, CHEMPHYSCHEM, V4, P268, DOI 10.1002/cphc.200390043
   SARVER RW, 1991, ANAL BIOCHEM, V199, P61, DOI 10.1016/0003-2697(91)90269-Y
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Szalontai B, 2003, BIOCHEMISTRY-US, V42, P4292, DOI 10.1021/bi026894c
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TABATA Y, 1998, POLYM MICROELECTRONI
   Tsuboi M, 2003, BIOCHEMISTRY-US, V42, P940, DOI 10.1021/bi020566v
   Vigano C, 2003, CHEM PHYS LIPIDS, V122, P121, DOI 10.1016/S0009-3084(02)00183-4
   Wells TA, 2003, BIOCHEMISTRY-US, V42, P4064, DOI 10.1021/bi026958j
NR 23
TC 1
Z9 1
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5311-0
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5394
BP 255
EP 262
DI 10.1117/12.538374
PG 8
WC Engineering, Biomedical; Engineering, Civil; Materials Science,
   Characterization & Testing
SC Engineering; Materials Science
GA BAS11
UT WOS:000223343600026
DA 2018-10-19
ER

PT S
AU Ngwa, W
   Grill, W
   Kundu, T
AF Ngwa, W
   Grill, W
   Kundu, T
BE Kundu, T
TI Bio-soft matter imaging and micro-metrology by phase-sensitive
   ultrasonic microscopy
SO HEALTH MONITORING AND SMART NONDESTRUCTIVE EVALUATION OF STRUCTURAL AND
   BIOLOGICAL SYSTEM III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Health Monitoring and Smart Nondestructive Evaluation of
   Structural and Biological Systems III
CY MAR 15-17, 2004
CL San Diego, CA
SP SPIE
DE phase-sensitive acoustic microscopy; acoustic microscopy; chitosan;
   bio-soft matter; soft matter; acoustic impedance; P-wave speed;
   carapace; mechanical properties
ID SCANNING ACOUSTIC MICROSCOPY; CHITOSAN; CONTRAST; FILMS
AB Phase-sensitive acoustic microscopy (PSAM) is used for investigating bio-soft matter systems constituting the important biopolymer and biomaterial chitosan. Incipient micro-analytic ways for the determination of mechanical properties from the simultaneously obtained amplitude and phase images, allow the coeval estimation of the depth of structures and acoustic velocities, from which the density, stiffness and other elastic parameters may be derived. Chitosan is an important derivative from chitin the major component of the carapace (also examined here) of living species like Daphnia. The results obtained exemplify the unique power of PSAM for revealing essential features and information in biological soft matter.
C1 Univ Leipzig, Inst Expt Phys 2, D-7010 Leipzig, Germany.
RP Ngwa, W (reprint author), Univ Leipzig, Inst Expt Phys 2, D-7010 Leipzig, Germany.
CR Boal D., 2002, MECH CELL
   CHANNELL PJ, 1990, NONLINEARITY, V3, P1
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Genta I, 1998, DRUG DEV IND PHARM, V24, P779, DOI 10.3109/03639049809082726
   Grill W, 1999, PHYSICA B, V263, P553, DOI 10.1016/S0921-4526(98)01478-1
   GRILL W, 2004, P SPIE, V5394
   GRILL W., 1996, ADV ACOUST MICROS, P167
   HAMMER R, 1982, APPL PHYS LETT, V40, P678, DOI 10.1063/1.93225
   Hanel V, 1998, J APPL PHYS, V84, P668, DOI 10.1063/1.368120
   Hirsekorn S, 1996, APPL PHYS LETT, V69, P2138, DOI 10.1063/1.118156
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   KUBOTA N, 1991, J APPL POLYM SCI, V42, P495, DOI 10.1002/app.1991.070420222
   LAFORSCH C, UNPUB SCIENCE
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   MIYAZAKI S, 1990, ACTA PHARM NORDICA, V2, P401
   Ngwa W, 2003, EUROPHYS LETT, V64, P830, DOI 10.1209/epl/i2003-00633-9
   NGWA W, IN PRESS ULTRASONICS
   RAUM K, 2003, SIMULTANEOUS DETERMI, P321
   Schubert M, 1999, INSTRUM SCI TECHNOL, V27, P227, DOI 10.1080/10739149908085856
   SCHUBERT M, 2003, THESIS U LEIPZIG
   Yu ZL, 1995, REV MOD PHYS, V67, P863, DOI 10.1103/RevModPhys.67.863
NR 21
TC 4
Z9 4
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5311-0
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5394
BP 263
EP 272
DI 10.1117/12.538794
PG 10
WC Engineering, Biomedical; Engineering, Civil; Materials Science,
   Characterization & Testing
SC Engineering; Materials Science
GA BAS11
UT WOS:000223343600027
DA 2018-10-19
ER

PT S
AU Wickramasinghe, NC
   Wainwright, M
   Wickramasinghe, JT
AF Wickramasinghe, NC
   Wainwright, M
   Wickramasinghe, JT
BE Hoover, RB
   Rozanov, AY
TI Panspermia 2003: New horizons
SO INSTRUMENTS, METHODS, AND MISSIONS FOR ASTROBIOLOGY VII
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Instruments, Methods and Missions for Astrobiology VII
CY AUG 03-04, 2003
CL San Diego, CA
SP SPIE
DE Panspermia; interstellar dust; comets; microorganisms
ID INFRARED EXTINCTION; BACTERIAL-SPORES; MAGELLANIC CLOUD; DOMINICAN
   AMBER; SPACE; LIFE; MICROORGANISMS; IDENTIFICATION; GRAINS; EARTH
AB Data acquired from various scientific disciplines in the past five years have converged to elevate the status of panspermia as one of the major contenders in theories of the origins of life on Earth. We review the trends that point towards a vindication of the idea that biomaterial from comets may be distributed widely throughout the universe and might even be reaching us in the present day.
C1 Univ Wales Coll Cardiff, Cardiff Ctr Astrobiol, Cardiff CT10 3DY, S Glam, Wales.
RP Wickramasinghe, NC (reprint author), Univ Wales Coll Cardiff, Cardiff Ctr Astrobiol, 2 North Rd, Cardiff CT10 3DY, S Glam, Wales.
CR Arrhenius S, 1903, UMSCHAU, V7, P481
   BECQUEREL P, 1924, B SOC ASTRON, V38, P393
   BIGG EK, 1983, FUNDAMENTAL STUDIES, P38
   CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699
   CHRISTENSEN EA, 1964, ACTA PATHOL MIC SC, V61, P483, DOI 10.1111/apm.1964.61.3.483
   COLBECK I, 1998, PHYSICAL CHEM PROPER
   Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904
   Greenblatt CL, 1999, MICROBIAL ECOL, V38, P58, DOI 10.1007/s002489900153
   Harris M., 2002, P SPIE C, V4495, P192
   HOOVER RB, 2003, IN PRESS P SPIE, V5163
   HORGAN J, 1996, END SCI, pCH5
   HORNECK G, 1994, ADV SPACE RES, V14, P41, DOI 10.1016/0273-1177(94)90448-0
   HOYLE F, 1976, NATURE, V264, P45, DOI 10.1038/264045a0
   HOYLE F, 1977, NATURE, V270, P323, DOI 10.1038/270323a0
   HOYLE F, 1979, ASTROPHYS SPACE SCI, V66, P77, DOI 10.1007/BF00648361
   HOYLE F, 1982, ASTROPHYS SPACE SCI, V83, P405, DOI 10.1007/BF00648568
   HOYLE F, 1977, NATURE, V268, P610, DOI 10.1038/268610a0
   Hoyle F., 1991, THEORY COSMIC GRAINS
   HOYLE F, 1999, ASTRONOMICAL ORIGINS
   HOYLE F, 1981, COMETS ORIGIN LIFE, P227
   KOORNNEEF J, 1982, ASTRON ASTROPHYS, V107, P247
   Lambert LH, 1998, INT J SYST BACTERIOL, V48, P511, DOI 10.1099/00207713-48-2-511
   LEWIS NF, 1971, J GEN MICROBIOL, V66, P29, DOI 10.1099/00221287-66-1-29
   McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924
   MELOSH HJ, 1993, NATURE, V363, P498, DOI 10.1038/363498a0
   Mileikowsky C, 2000, ICARUS, V145, P391, DOI 10.1006/icar.1999.6317
   Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0
   Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557
   MORGAN DH, 1982, MON NOT R ASTRON SOC, V199, P979, DOI 10.1093/mnras/199.4.979
   Motta V, 2002, ASTROPHYS J, V574, P719, DOI 10.1086/341118
   NANDY K, 1984, MON NOT R ASTRON SOC, V211, P895, DOI 10.1093/mnras/211.4.895
   Narlikar JV, 2003, CURR SCI INDIA, V85, P23
   Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210
   SALPETER EE, 1969, NATURE, V222, P442, DOI 10.1038/222442a0
   SAPAR A, 1978, PUBL TARTU ASTROPHYS, V46, P71
   Taft E.A., 1965, PHYS REV           A, V138A, P197
   Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060
   WAINWRIGHT M, 2003, IN PRESS P SPIE, V5163
   WICKRAMASINGHE NC, 1974, NATURE, V252, P462, DOI 10.1038/252462a0
   Wickramasinghe NC, 2003, ASTROPHYS SPACE SCI, V283, P403, DOI 10.1023/A:1021677122937
   WICKRAMASINGHE NC, 1972, LIGHT SCATTERING FUN
   WICKRAMASINGHE NC, 1967, INSTERSTELLAR GRAINS
NR 42
TC 2
Z9 2
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5036-7
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5163
BP 222
EP 234
DI 10.1117/12.515613
PG 13
WC Astronomy & Astrophysics; Instruments & Instrumentation
SC Astronomy & Astrophysics; Instruments & Instrumentation
GA BY69V
UT WOS:000189441600021
DA 2018-10-19
ER

PT J
AU Cirillo, B
   Morra, M
   Catapano, G
AF Cirillo, B
   Morra, M
   Catapano, G
TI Adhesion and function of rat liver cells adherent to silk
   fibroin/collagen blend films
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE bioartificial; biomaterial; cells; fibroin; liver; silk
ID IN-VITRO EVALUATION; FIBROIN; CULTURE; GROWTH; HEPATOCYTES; SUPPORT;
   MATRIX; OXYGEN; GEL
AB Collagen is often used in bioartificial livers as a biomimetic coating to promote liver cell adhesion and differentiation. Animal proteins are expensive and expose the host to risks of cross-species infection due to contamination with prions. Silk fibroin (SF) is a biocompatible protein produced by Bombyx mori silk worms and possibly an alternative to collagen. We prepared SF-collagen blend films with different SF content adherent to the bottom of standard tissue culture dishes, and characterized their surface morphology by SEM, their wettability and examined them for their capacity to support rat liver cell adhesion and metabolism. Cell metabolism was characterized by estimating the rate at which cells eliminated ammonia and synthesized urea for up to 48h of culture. SF-containing films were smooth, clear and more wettable than collagen. Cells readily adhered, formed junctions and small size aggregates on all films. As many cells adhered on SF as on collagen films. Cell adhesion to high collagen content blend films could not be reliably estimated because cells dwelt in the large cavities in the film. The effect of SF on cell metabolism differed with the investigated metabolic pathway However, cells on SF-containing films eliminated ammonia; and synthesized urea at rates generally comparable to, for urea synthesis at times higher than, that of cells on collagen. These results suggest that silk fibroin is a suitable substratum for liver cell attachment and culture, and a potential alternative to collagen as a biomimetic coating.
C1 Univ Calabria, Dept Chem Engn & Mat, I-87030 Arcavacata Di Rende, CS, Italy.
   NobilBioRicerche, Francavilla dAsti, AT, Italy.
RP Catapano, G (reprint author), Univ Calabria, Dept Chem Engn & Mat, Via P Bucci, I-87030 Arcavacata Di Rende, CS, Italy.
EM catapano@unical.it
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARMATO U, Patent No. 00501
   BADER A, 1995, ARTIF ORGANS, V19, P368, DOI 10.1111/j.1525-1594.1995.tb02343.x
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BISSEL DM, 1987, BIOARTIFICIAL LIVER, P55
   BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Catapano G, 1996, INT J ARTIF ORGANS, V19, P61
   Catapano G, 2002, INT J ARTIF ORGANS, V25, P151
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Flendrig LM, 1997, J HEPATOL, V26, P1379, DOI 10.1016/S0168-8278(97)80475-8
   Gerlach JC, 2001, INT J ARTIF ORGANS, V24, P793
   GUANG Y, 2000, J MEMB SCI, V177, P153
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Khalili TM, 2001, ARTIF ORGANS, V25, P566, DOI 10.1046/j.1525-1594.2001.025007566.x
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Nakazawa K, 2002, INT J ARTIF ORGANS, V25, P51
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SIELAFF TD, 1995, J SURG RES, V59, P179, DOI 10.1006/jsre.1995.1151
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Te Velde Anje, 1995, Journal of Hepatology, V23, P184, DOI 10.1016/0168-8278(95)80333-5
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
NR 24
TC 21
Z9 25
U1 1
U2 10
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JAN
PY 2004
VL 27
IS 1
BP 60
EP 68
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 775AB
UT WOS:000189017600012
PM 14984185
DA 2018-10-19
ER

PT J
AU Nakamura, T
   Yoshitani, M
   Rigby, H
   Fullwood, NJ
   Ito, W
   Inatomi, T
   Sotozono, C
   Nakamura, T
   Shimizu, Y
   Kinoshita, S
AF Nakamura, T
   Yoshitani, M
   Rigby, H
   Fullwood, NJ
   Ito, W
   Inatomi, T
   Sotozono, C
   Nakamura, T
   Shimizu, Y
   Kinoshita, S
TI Sterilized, freeze-dried amniotic membrane: A useful substrate for
   ocular surface reconstruction
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID STEM-CELL TRANSPLANTATION; LIMBAL EPITHELIAL-CELLS; AUTOLOGOUS
   TRANSPLANTATION; FETAL MEMBRANES; CORNEAL; EXPRESSION; DISEASE;
   IMMUNOGENICITY; CONJUNCTIVA; SUPPRESSION
AB PURPOSE. To examine the feasibility of using sterilized, freeze-dried amniotic membrane (FD-AM) as a substrate for cultivating autologous corneal epithelial cells for ocular surface reconstruction.
   METHODS. Human AM deprived of amniotic epithelial cells by incubation with EDTA was freeze dried, vacuum packed, and sterilized With gamma-irradiation. The resultant FD-AM was characterized for its physical, biological, and morphologic properties by stretch stress tests, immunohistochemistry, electron microscopy, and cell culture. In addition, 3 weeks after an ocular surface injury, the conjunctivalized corneal surfaces of eyes in eight rabbits were surgically reconstructed by transplantation of autologous cultivated corneal epithelial cells on FD-AM.
   RESULTS. A stretch stress test revealed no significant differences between sterilized FD-AM and cryopreserved AM. Immunohistochemistry for several extracellular matrix molecules and electron microscopic analysis of FD-AM revealed that the process of drying and irradiation did not affect its biological and morphologic properties. The corneal epithelial cells cultivated on FD-AM had four to five stratified, well-differentiated cell layers. Corneas that were grafted with the cultivated corneal epithelial cells on FD-AM were clear and were all epithelialized at 10 days after surgery.
   CONCLUSIONS. The sterilized, freeze-dried AM retained most of the physical, biological, and morphologic characteristics of cryopreserved AM; consequently, it is a useful biomaterial for ocular surface reconstruction.
C1 Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, Kyoto, Japan.
   Kyoto Univ, Dept Bioartificial Organs, Inst Frontier Med Sci, Kyoto, Japan.
   Univ Lancaster, Inst Environm & Nat Sci, Lancaster, England.
RP Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, 465 Hiroko Ji, Kyoto, Japan.
EM tnakamur@ophth.kpu-m.ac.jp
OI Fullwood, Nigel James/0000-0002-9405-8515
CR ADINOLFI M, 1982, NATURE, V295, P325, DOI 10.1038/295325a0
   AKLE CA, 1981, LANCET, V2, P1003
   DAVIS JW, 1910, J HOPKINS MED J, V15, P307
   de Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522
   DHALL K, 1984, BRIT J OBSTET GYNAEC, V91, P279, DOI 10.1111/j.1471-0528.1984.tb04768.x
   Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   KIM JC, 1995, CORNEA, V14, P473
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013
   Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7
   Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539
   MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6
   Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195
   Nakamura T, 2002, INVEST OPHTH VIS SCI, V43, P1702
   Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549
   RENNEKAMPFF HO, 1994, INVEST SURG, V7, P187
   Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003
   Shimazaki J, 1997, OPHTHALMOLOGY, V104, P2068, DOI 10.1016/S0161-6420(97)30057-8
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   SORSBY A, 1946, BRIT J OPHTHALMOL, V30, P337, DOI 10.1136/bjo.30.6.337
   STERN W, 1931, JAMA-J AM MED ASSOC, V13, P973
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   TROENSEGAARDHANSEN E, 1950, LANCET, V258, P859
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
   Tsubota K, 1999, NEW ENGL J MED, V340, P1697, DOI 10.1056/NEJM199906033402201
   VANHERENDAEL, 1978, AM J OBSTET GYNECOL, V83, P470
   Yamamoto Y., 1997, Japanese Journal of Artificial Organs, V26, P219
NR 32
TC 94
Z9 105
U1 0
U2 7
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JAN
PY 2004
VL 45
IS 1
BP 93
EP 99
DI 10.1167/iovs.03-0752
PG 7
WC Ophthalmology
SC Ophthalmology
GA 761AF
UT WOS:000187875600014
PM 14691159
OA Bronze
DA 2018-10-19
ER

PT B
AU Shrivastava, S
   Sammakia, B
AF Shrivastava, S
   Sammakia, B
BE Ramakrishna, K
   Sammakia, BG
   Culham, JR
   Joshi, YK
   Pang, JHL
   Jonnalagadda, K
   Tonapi, S
   Refai-Ahmed, G
   Lee, TYT
   Copeland, DW
   Ellsworth, MJ
TI Thermal management of biomaterials in a rectangular cavity surrounded by
   a phase change material
SO ITHERM 2004, VOL 1
LA English
DT Proceedings Paper
CT 9th Intersociety Conference on Thermal and Thermomechanical Phenomena in
   Electronic Systems
CY JUN 01-04, 2004
CL Las Vegas, NV
SP IEEE, CPMT, Amer Soc Mech Engineers, 50th ECTC, Int Microelect & Packaging Soc
DE transient natural convection; cooling of biomaterials; Finite Thermal
   Capacity block; Rayleigh Benard Convection; closed enclosure cooling
ID NATURAL-CONVECTION; ONE SIDE; ENCLOSURES; FLOWS
AB The shipping of live biological materials requires very close monitoring and perhaps active control of the temperature of the materials. This paper presents the results of a numerical study of 2-Dimensional transient natural convection inside a rectangular cavity. The cavity is intended to simulate a typical biological shipping container in which the biornaterials are encased in a chamber surrounded by a phase change material. The rectangular cavity is filled with air (Prapproximate to 0.69). Initially the air is at uniform temperature and zero velocity. The top and side walls of the rectangular cavity are fixed at a low temperature and the bottom wall is coupled to the top wall of the heated solid block. The lower solid block, whose side and bottom wall are assumed to be adiabatic and filled with solid biomaterials. The biomaterial is subjected to a step heat input at time zero. Finite volume approach is used to solve the generic transport equations with the boussinesq approximation. The flow inside the rectangular cavity is divided into three transient regimes: (1) Initial Transient stage (2) Quasi Steady stage (3) Late Quasi Steady stage. The results of the parametric study are included for shallow cavities, Ar= 0.5, AT=0.25, Ar=0.125. The transient regimes and fluid flow structure were found to be functions of Rayleigh Number (Ra), Aspect ratio (Ar), Prandtl Number (Pr), Thermal Capacity Parameter (Q*) and non-dimensional time (t*).
C1 SUNY Binghamton, Dept Mech Engn, Binghamton, NY 13902 USA.
RP Shrivastava, S (reprint author), SUNY Binghamton, Dept Mech Engn, POB 6000, Binghamton, NY 13902 USA.
EM sshriva1@binghamton.edu
CR ARMFIELD S, INT J NUM METHODS FL, V40, P1009
   Aydin O, 1999, INT COMMUN HEAT MASS, V26, P135
   BEJAN A, 1981, J FLUID MECH, V103, P465, DOI 10.1017/S0022112081001420
   Bejan A, 1984, CONVECTION HEAT TRAN
   Christon MA, 2002, INT J NUMER METH FL, V40, P953, DOI 10.1002/fld.395
   CHUN SBH, 2002, NUMERICAL HEAT TRA A, V41, P183
   DRUMMOND JE, 1987, J FLUID MECH, V182, P543, DOI 10.1017/S0022112087002453
   GANZAROLLI MM, 1995, INT J HEAT MASS TRAN, V38, P1063, DOI 10.1016/0017-9310(94)00217-J
   GEBHART B, 1988, J HEAT TRANS-T ASME, V110, P1166, DOI 10.1115/1.3250618
   GEBHART B, 1987, BUOYANCY INDUCED FLO
   Guo YH, 2002, INT J NUMER METH FL, V40, P1045, DOI 10.1002/fld.391
   HELLUMS JD, 1961, CHEM ENG PROGR S SER, V57, P75
   NOVEMBER M, 1987, INT J HEAT MASS TRAN, V30, P2433, DOI 10.1016/0017-9310(87)90233-X
   ORTEGA A, 2001, P IPACK JUL 8 13 KAU
   OSTRACH S, 1988, J HEAT TRANS-T ASME, V110, P1175, DOI 10.1115/1.3250619
   Sammakia B., 1978, Numerical Heat Transfer, V1, P529, DOI 10.1080/10407787808913394
   FLUENT 6 0 TUTORIAL
NR 17
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8357-5
PY 2004
BP 108
EP 120
DI 10.1109/ITHERM.2004.1319162
PG 13
WC Thermodynamics; Engineering, Electrical & Electronic; Engineering,
   Mechanical
SC Thermodynamics; Engineering
GA BAI95
UT WOS:000222478500016
DA 2018-10-19
ER

PT J
AU Bren, L
   English, L
   Fogarty, J
   Policoro, R
   Zsidi, A
   Vance, J
   Drelich, J
   Istephanous, N
   Rohly, K
AF Bren, L
   English, L
   Fogarty, J
   Policoro, R
   Zsidi, A
   Vance, J
   Drelich, J
   Istephanous, N
   Rohly, K
TI Hydrophilic/electron-acceptor surface properties of metallic
   biomaterials and their effect on osteoblast cell activity
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE contact angle; osteoblast; stainless steel; surface energy; surface
   tension; titanium alloy
ID CONTACT ANGLES; SOLID-SURFACES; TITANIUM; ADHESION; TENSION; FILMS
AB Mice osteoblast cells were cultured on samples of 316L stainless steel and titanium alloy (Ti-6Al-4V) with different surface treatments. The resulting cell differentiation was correlated with the solid surface tension and electron-acceptor surface tension parameter of the biomaterial samples. Both of these characteristics were determined through contact angle measurements, using the Lifshitz-van der Waals/Lewis acid-base interaction model. Before calculating the surface tension of the biomaterials, the experimental contact angles were corrected for the effect of roughness using the Wenzel equation. For this calculation, the roughness characteristics of the solid surfaces were determined using atomic force microscopy and interferometric profilometry at the nano-scale and micro-scale, respectively. It was found that osteoblast cell differentiation directly related to the implant surface tension and electron-acceptor properties. The alkaline phosphatase activity increased both with increasing surface tension and increasing electron-acceptor surface tension parameter of the implant materials. These results suggest that the formation of surface hydroxyl groups with acidic character gives rise to enhanced attachment of osteoblast cells.
C1 Michigan Technol Univ, Dept Mat Sci & Engn, Houghton, MI 49931 USA.
   Medtron USA Inc, Minneapolis, MN 55432 USA.
RP Drelich, J (reprint author), Michigan Technol Univ, Dept Mat Sci & Engn, Houghton, MI 49931 USA.
EM jwdrelic@mtu.edu
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BREN L, 2003, ANAL SURFACE PROPERT
   Della Volpe C., 2002, ENCY SURFACE COLLOID, P17
   DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9
   Drelich J, 1996, J COLLOID INTERF SCI, V179, P37, DOI 10.1006/jcis.1996.0186
   DUNN D, 1992, SURF COAT TECH, V50, P223, DOI 10.1016/0257-8972(92)90005-U
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Fowkes F.M., 1987, J ADHES SCI TECHNOL, V1, P7, DOI DOI 10.1163/156856187X00049
   Fuerstenau D. W., 1982, PRINCIPLES FLOTATION, P109
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P395
   Giese R. F., 2002, COLLOID SURFACE PROP
   Kosmulski M, 2002, J COLLOID INTERF SCI, V253, P77, DOI 10.1006/jcis.2002.8490
   Olsson COA, 2003, ELECTROCHIM ACTA, V48, P1093, DOI 10.1016/S0013-4686(02)00841-1
   RAIKAR GN, 1995, J VAC SCI TECHNOL A, V13, P2633, DOI 10.1116/1.579462
   Ratner BD, 1996, INTRO MAT MED
   RECUM A, 1998, HDB BIOMATERIALS EVA
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Tamura H, 2001, J COLLOID INTERF SCI, V243, P202, DOI 10.1006/jcis.2001.7864
   Van Oss CJ, 2002, J ADHES SCI TECHNOL, V16, P669, DOI 10.1163/156856102760099870
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
NR 25
TC 13
Z9 13
U1 0
U2 3
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2004
VL 18
IS 15-16
BP 1711
EP 1722
DI 10.1163/1568561042708403
PG 12
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 898QT
UT WOS:000227092000003
DA 2018-10-19
ER

PT J
AU Won, YY
   Dorr, LD
   Bloebaum, R
   Wan, ZN
AF Won, YY
   Dorr, LD
   Bloebaum, R
   Wan, ZN
TI Assessment of bone graft substitutes in autopsy implant retrievals of
   the acetabulum in total hip arthroplasty
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE retrieval study; acetabular reconstruction; bone grafts
ID RECONSTRUCTION; ALLOGRAFTS; COMPONENTS
AB Two autopsy retrievals of acetabular reconstruction with different bone graft Substitutes were analyzed. one patient underwent surgery with hydroxyapatite (HA) granules, and the other with demineralized bone chips. Incorporation occurred with the biomaterial bone-graft substitute HA primarily in the superior part of the acetabulum, where the HA was in contact with host cortical bone. No bony union occurred with the demineralized bone chips because of motion and migration of the acetabular cup. No bone incorporation of either bone-graft substitute was observed in the medial wall defects in both patients. There were two important. findings: (1) the 3- to 8-tunt depth and 70% to 75% surface of union of the HA bone graft substitute to host cortical bone was the same as seen with morselized, fresh-frozen bone graft; and (2) union of graft material to host bone was dependent on secure fixation of the acetabular construct.
C1 Centinela Hosp, Arthrit Inst, Med Ctr, Inglewood, CA 90301 USA.
   Ajou Univ Hosp, Dept Orthoped Surg, Suwon, South Korea.
   VA Med Ctr, Div Res, Salt Lake City, UT USA.
RP Dorr, LD (reprint author), Centinela Hosp, Arthrit Inst, Med Ctr, 501 E Hardy St,Suite 300, Inglewood, CA 90301 USA.
CR Bloebaum RD, 1997, J BONE JOINT SURG AM, V79A, P1013, DOI 10.2106/00004623-199707000-00007
   BUOUNCRISTIANI AM, 1997, J ARTHROPLASTY, V12, P403
   DANTONIO JA, 1989, CLIN ORTHOP RELAT R, P126
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   DORR LD, 1995, CLIN ORTHOP RELAT R, P191
   HEEKIN RD, 1995, CLIN ORTHOP RELAT R, P184
   HOOTEN JP, 1994, J BONE JOINT SURG BR, V76B, P419
   Shinar AA, 1997, J BONE JOINT SURG AM, V79A, P159, DOI 10.2106/00004623-199702000-00001
   Young S K, 1991, J Arthroplasty, V6 Suppl, pS73, DOI 10.1016/S0883-5403(08)80059-9
NR 9
TC 1
Z9 1
U1 0
U2 1
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD JAN
PY 2004
VL 19
IS 1
BP 116
EP 122
DI 10.1016/S0883-5403(03)00452-2
PG 7
WC Orthopedics
SC Orthopedics
GA 765AL
UT WOS:000188244400018
PM 14716659
DA 2018-10-19
ER

PT J
AU Croce, MA
   Silvestri, C
   Guerra, D
   Carnevali, E
   Boraldi, F
   Tiozzo, R
   Parma, B
AF Croce, MA
   Silvestri, C
   Guerra, D
   Carnevali, E
   Boraldi, F
   Tiozzo, R
   Parma, B
TI Adhesion and proliferation of human dermal fibroblasts on collagen
   matrix
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE collagen matrix; dermal fibroblast cultured in vitro; adhesion;
   proliferation
ID PSEUDOXANTHOMA ELASTICUM PXE; INVITRO; SKIN; BIOMATERIAL; SURVIVAL;
   ASSAY
AB The purpose of this study was to evaluate adhesion and growth of human dermal fibroblasts on a 0.150 mm-thick matrix of reconstituted collagen isolated from horse tendon. Collagen was extracted and polymerized according to the standard procedures (Opocrin, Corlo, Modena, Italy). By light microscopy, the bottom surface of the matrix appeared linear and compact, whereas the superficial one was indented and less homogeneous. By scanning electron microscopy, the collagen fibrils had different diameters and the great majority of them was oriented parallel to the surface of the gel. By transmission electron microscopy, collagen fibrils showed the typical banding. Human dermal fibroblasts were seeded on the collagen matrix, previously equilibrated in growth medium. Fibroblast proliferation stopped in the second week and was always significantly lower than that of the same cell strain seeded on plastic and cultured in parallel. By light microscopy, after six days culture, cells formed a confluent multilayer on the surface of the gel. By scanning and transmission electron microscopy, fibroblasts appeared flat and adherent to the matrix. Contacts of cells among themselves and with the collagen fibrils were observed. Fibroblasts never moved into the collagen gel. In conclusion, human dermal fibroblasts can be grown in a three-dimensional matrix made by horse tendon that, on the other hand, seems to condition their proliferation rate.
C1 Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy.
   Opocrin, I-41040 Modena, Italy.
RP Tiozzo, R (reprint author), Univ Modena & Reggio Emilia, Dept Biomed Sci, Via G Campi 287, I-41100 Modena, Italy.
EM tiozzo.roberta@unimo.it
RI Boraldi, Federica/D-1263-2015
OI Boraldi, Federica/0000-0002-0277-9017
CR Bianchini P, 2001, ARZNEIMITTEL-FORSCH, V51, P414
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   COSTA RT, 1988, COLLAGEN REL RES, V8, P49
   COURTNEY JM, 1993, INT J ARTIF ORGANS, V16, P164
   DEJANA E, 1987, J CELL BIOL, V104, P1403, DOI 10.1083/jcb.104.5.1403
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Hillmann G, 1999, J CELL SCI, V112, P2823
   Kawamura A., 1969, FLUORESCENT ANTIBODY
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Lamme EN, 1998, J INVEST DERMATOL, V111, P989, DOI 10.1046/j.1523-1747.1998.00459.x
   Machens HG, 2000, CELLS TISSUES ORGANS, V167, P88, DOI 10.1159/000016772
   Mansbridge J, 1998, TISSUE ENG, V4, P403, DOI 10.1089/ten.1998.4.403
   MIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447, DOI 10.1007/BF00307818
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   Mio T, 1996, IN VITRO CELL DEV-AN, V32, P427
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Quaglino D, 2000, BBA-MOL BASIS DIS, V1501, P51, DOI 10.1016/S0925-4439(00)00007-7
   SCHOR SL, 1980, J CELL SCI, V41, P159
   SEFTON MV, 1998, J CUTAN MED SURG S1, V3
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sorensen J C, 1998, Clin Podiatr Med Surg, V15, P129
   VANDERREST M, 1991, FASEB J, V5, P2814
   Wang FP, 1998, SPE RESERV EVAL ENG, V1, P105, DOI 10.2118/36515-PA
NR 23
TC 17
Z9 17
U1 0
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2004
VL 18
IS 3
BP 209
EP 222
DI 10.1177/0885328204039692
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 769BH
UT WOS:000188606200005
PM 14871046
DA 2018-10-19
ER

PT J
AU Khorasani, MT
   Mirzadeh, H
AF Khorasani, MT
   Mirzadeh, H
TI Laser surface modification of silicone rubber to reduce platelet
   adhesion in vitro
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE PDMS; acrylamide (AAm); platelet; blood compatibility; laser; surface
   modification
ID POLYURETHANE SURFACE; POLYMERS; IMPROVE; ACID; BIOCOMPATIBILITY;
   ACRYLAMIDE; MONOMERS
AB To improve the blood compatibility, the surface of polydimethylsiloxane (PDMS) films were irradiated using a CO2-pulsed laser. Acrylamide (AAm) was grafted onto a pre-irradiated surface. The AAm-grafted and laser-treated films were characterized using different techniques. Platelet adhesion and activation onto the AAm-grafted PDMS, laser-treated (ungrafted) and unmodified PDMS film surfaces were compared. Data from in vitro assays indicated that the platelet adhesion was reduced on the AAm-grafted PDMS and laser treated PDMS films in comparison with the unmodified PDMS. The laser-irradiated sample showed the minimum platelet adhesion. It seems that laser irradiation onto a silicone rubber surface is a versatile technique to produce anti-thrombogenic surface for biomaterial applications.
C1 Iran Polymer & Petrochem Inst, Biomat Dept, Tehran, Iran.
RP Khorasani, MT (reprint author), Iran Polymer & Petrochem Inst, Biomat Dept, POB 14185-0515, Tehran, Iran.
EM m.khorasani@proxy.ipi.ac.ir
CR Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   CHAPIRO A, 1983, EUR POLYM J, V19, P859, DOI 10.1016/0014-3057(83)90038-1
   CHOUVELLEBRET DJ, 1999, BIOMATERIALS, V20, P291
   Cooper S. L., 1982, BIOMATERIALS INTERFA
   DECKER C, 1990, ACS SYM SER, V417, P446
   DEFIFE KM, 1999, BIOMED MAT RES, V21, P30298
   FEREI H, 1985, ANNU REV PHYS CHEM, V36, P491
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   GARBASSI F, 1995, POLYM SURFACES
   HOFFMAN AS, 1977, RADIAT PHYS CHEM, V9, P207, DOI 10.1016/0146-5724(77)90080-2
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ikada Y., 1984, POLYM BIOMATERIALS
   JANSEN B, 1981, RADIAT PHYS CHEM, V18, P1195, DOI 10.1016/0146-5724(81)90310-1
   Khorasani MT, 1999, RADIAT PHYS CHEM, V55, P685, DOI 10.1016/S0969-806X(99)00212-1
   Khorasani MT, 1996, RADIAT PHYS CHEM, V47, P881, DOI 10.1016/0969-806X(95)00166-U
   KUBOTA H, 1993, J APPL POLYM SCI, V48, P1717, DOI 10.1002/app.1993.070481004
   Ma ZW, 2003, J BIOMAT SCI-POLYM E, V14, P13, DOI 10.1163/15685620360511119
   MATHEW J, 1992, BIOMATERIALS, V13, P1051, DOI 10.1016/0142-9612(92)90137-D
   Mirzadeh H., 1994, Clinical Materials, V16, P177, DOI 10.1016/0267-6605(94)90115-5
   NEU TR, 1993, BIOMATERIALS, V14, P459, DOI 10.1016/0142-9612(93)90149-V
   OLAFSEN K, 1992, J APPL POLYM SCI, V46, P1673, DOI 10.1002/app.1992.070460916
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   SILVERMAN J, 1977, RADIAT PHYS CHEM, V9, P1, DOI 10.1016/0146-5724(77)90069-3
   Turner AS, 2002, J BIOMED MATER RES, V63, P37, DOI 10.1002/jbm.10081
   Watkins AW, 2003, J BIOMAT SCI-POLYM E, V14, P267, DOI 10.1163/156856203763572716
   YANG JS, 1995, J APPL POLYM SCI, V55, P296
   ZARE RN, 1987, CHEM PHYS LETT, V136, P593, DOI 10.1016/0009-2614(87)80524-9
NR 30
TC 25
Z9 25
U1 1
U2 14
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 1
BP 59
EP 72
DI 10.1163/156856204322752237
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 809JM
UT WOS:000220633000004
PM 15027843
DA 2018-10-19
ER

PT J
AU Vacheethasanee, K
   Wang, SW
   Qiu, YX
   Marchant, RE
AF Vacheethasanee, K
   Wang, SW
   Qiu, YX
   Marchant, RE
TI Poly(ethylene oxide) surfactant polymers
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE nonionic surfactant polymers; poly(ethylene oxide); poly(vinyl amine);
   surface tension; atomic force microscopy
ID STAPHYLOCOCCUS-EPIDERMIDIS; MAMMALIAN-CELLS; ADHESION; POLYETHYLENE;
   COPOLYMERS; GLYCOL); IMMOBILIZATION; BIOMATERIALS; DERIVATIVES;
   ADSORPTION
AB We report on a series of structurally well-defined surfactant polymers that undergo surface-induced self-assembly on hydrophobic biomaterial surfaces. The surfactant polymers consist of a poly(vinyl amine) backbone with poly(ethylene oxide) and hexanal pendant groups. The poly(vinyl amine) (PVAm) was synthesized by hydrolysis of poly(N-vinyl formamide) following free radical polymerization of N-vinyl formamide. Hexanal and aldehyde-terminated poly(ethylene oxide) (PEO) were simultaneously attached to PVAm via reductive amination. Surfactant polymers with different PEO : hexanal ratios and hydrophilic/hydrophobic balances were prepared, and characterized by FT-IR, (1)H-NMR and XPS spectroscopies. Surface active properties at the air/water interface were determined by surface tension measurements. Surface activity at a solid surface/water interface was demonstrated by atomic force microscopy, showing epitaxially molecular alignment for surfactant polymers adsorbed on highly oriented pyrolytic graphite. The surfactant polymers described in this report can be adapted for simple non-covalent surface modification of biomaterials and hydrophobic surfaces to provide highly hydrated interfaces.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Qiu, YX (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Wickenden Bldg, Cleveland, OH 44106 USA.
EM rxm4@po.cwru.edu
FU NIBIB NIH HHS [EB-002067, R01 EB002067, EB-00279, R01 EB000279]; NHLBI
   NIH HHS [R01 HL047300]
CR ALEXANDRIDIS P, 1994, LANGMUIR, V10, P2604, DOI 10.1021/la00020a019
   Caldwell KD, 1997, ACS SYM SER, V680, P400
   Dexter SJ, 2001, J BIOMED MATER RES, V56, P222, DOI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
   EISA T, 1993, BIOMATERIALS, V14, P755, DOI 10.1016/0142-9612(93)90040-9
   Evans WH, 1989, MEMBRANE STRUCTURE F
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207
   HARRIS JM, 1985, J MACROMOL SCI R M C, VC25, P325, DOI 10.1080/07366578508081960
   HELMUS MN, 1993, CARDIOVASC PATHOL, V2, pS53
   Higashi JM, 1999, HDB BIOMATERIALS EVA, P493
   Holland NB, 1998, NATURE, V392, P799
   Holland NB, 2001, MACROMOLECULES, V34, P6424, DOI 10.1021/ma001215w
   KIM MW, 1993, EUROPHYS LETT, V24, P229, DOI 10.1209/0295-5075/24/3/012
   LASIC DD, 1991, BIOCHIM BIOPHYS ACTA, V1070, P187, DOI 10.1016/0005-2736(91)90162-2
   LLANOS GR, 1991, MACROMOLECULES, V24, P6065, DOI 10.1021/ma00023a003
   MARCHANT RE, 1994, IMPLANTATION BIOL HO
   Park S, 2000, J BIOMED MATER RES, V53, P568, DOI 10.1002/1097-4636(200009)53:5<568::AID-JBM17>3.0.CO;2-8
   Qiu YX, 1998, MACROMOLECULES, V31, P165, DOI 10.1021/ma9707401
   Rippner B, 2002, LANGMUIR, V18, P5213, DOI 10.1021/la0118614
   Ruegsegger MA, 2001, J BIOMED MATER RES, V56, P159, DOI 10.1002/1097-4636(200108)56:2<159::AID-JBM1080>3.0.CO;2-R
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Vieira JB, 2002, J PHYS CHEM B, V106, P5400, DOI 10.1021/jp013286i
   WANG XD, 1993, ANN SURG, V217, P155, DOI 10.1097/00000658-199302000-00010
   WANKA G, 1990, COLLOID POLYM SCI, V268, P101, DOI 10.1007/BF01513189
NR 26
TC 6
Z9 6
U1 6
U2 18
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 1
BP 95
EP 110
DI 10.1163/156856204322752255
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 809JM
UT WOS:000220633000006
PM 15027845
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Patel, ZS
   Mikos, AG
AF Patel, ZS
   Mikos, AG
TI Angiogenesis with biomaterial-based drug- and cell-delivery systems
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE angiogenesis; biomaterials; drug delivery; cell delivery; tissue
   engineering; wound healing
ID ENDOTHELIAL GROWTH-FACTOR; DIABETIC FOOT ULCERS; IN-VITRO;
   CONTROLLED-RELEASE; THERAPEUTIC ANGIOGENESIS; EXTRACELLULAR-MATRIX;
   HYALURONIC-ACID; GENE-THERAPY; FACTOR VEGF; COLLATERAL DEVELOPMENT
AB Angiogenesis, the formation of new blood vessels from existing ones, is an important event in several biological processes, including wound healing. It plays a key role in determining the final functionality and integration of any implanted medical device. In addition, angiogenesis is a required event for organ development and has been accepted as a rate-limiting step in engineering tissue replacements. Besides these regenerative processes, uncontrolled angiogenesis is also involved in a number of pathologies, including tumor growth and metastases. Like angiogenesis, biomaterials also play a role in wound healing after medical device implantation and in tissue engineering. Interactions between the device biomaterials and host tissue will factor into the final device integration. Additionally, tissue-engineering strategies utilize biornaterials to a great extent because the paradigm of tissue engineering involves the use of cells, growth factors and scaffolding matrices in order to regenerate or replace tissue. Since almost all tissues are three-dimensional, the biomaterial scaffold plays an integral role in the paradigm. This review will emphasize the influence of biomaterials on angiogenesis as it applies to medical device implantation, tissue engineering and therapies for pathological angiogenesis.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, POB 1892,MS 142, Houston, TX 77251 USA.
EM mikos@rice.edu
FU NIAMS NIH HHS [R01 AR48756, R01 AR42639]
CR Ahrendt G, 1998, TISSUE ENG, V4, P117, DOI 10.1089/ten.1998.4.117
   Albini A, 2000, AM J PATHOL, V156, P1381, DOI 10.1016/S0002-9440(10)65007-9
   ANDERSON JM, 2000, BONE ENG, P81
   Aoki T, 1995, J BIOMAT SCI-POLYM E, V7, P539, DOI 10.1163/156856295X00463
   Asahara T., 1995, CIRCULATION, V92, P11365
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Bezuidenhout D, 2002, ASAIO J, V48, P465, DOI 10.1097/01.MAT.0000026345.66193.59
   BNZEN E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Bouhadir KH, 2001, J DRUG TARGET, V9, P397, DOI 10.3109/10611860108998775
   Browder T, 2000, CANCER RES, V60, P1878
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carmeliet P, 2001, NAT BIOTECHNOL, V19, P1019, DOI 10.1038/nbt1101-1019
   Carrasquillo KG, 2003, INVEST OPHTH VIS SCI, V44, P290, DOI 10.1167/iovs.01-1156
   Castelli MD, 2003, HOSP MED, V64, P400, DOI 10.12968/hosp.2003.64.7.2276
   Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Contreras MA, 2000, MICROSURG, V20, P15, DOI 10.1002/(SICI)1098-2752(2000)20:1<15::AID-MICR3>3.3.CO;2-G
   Dagtekin G, 2003, BIOMATERIALS, V24, P3395, DOI 10.1016/S0142-9612(03)00201-1
   Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696
   Doi K, 1997, J BIOMED MATER RES, V34, P361, DOI 10.1002/(SICI)1097-4636(19970305)34:3<361::AID-JBM11>3.0.CO;2-J
   Drake Christopher J., 2003, Birth Defects Research, V69, P73, DOI 10.1002/bdrc.10003
   Emanueli C, 2001, BRIT J PHARMACOL, V133, P951, DOI 10.1038/sj.bjp.0704155
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   Eyetech Study Group, 2002, RETINA, V22, P143
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358
   Finkelstein A, 2003, CIRCULATION, V107, P777, DOI 10.1161/01.CIR.0000050367.65079.71
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Foschi D, 2001, EUR SURG RES, V33, P16, DOI 10.1159/000049687
   Fournier N, 1996, BIOMATERIALS, V17, P1659, DOI 10.1016/0142-9612(96)87645-9
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130
   FRESHNEY RI, 1994, CULTURE ANIMAL CELLS
   Ganta SR, 2003, J BIOMED MATER RES A, V64A, P242, DOI 10.1002/jbm.a.10402
   Gerwins P, 2000, CRIT REV ONCOL HEMAT, V34, P185, DOI 10.1016/S1040-8428(00)00062-7
   Goncalves LM, 2001, CARDIOVASC RES, V49, P495, DOI 10.1016/S0008-6363(00)00286-8
   Henry TD, 1999, BRIT MED J, V318, P1536, DOI 10.1136/bmj.318.7197.1536
   Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A
   Hudon V, 2003, BRIT J DERMATOL, V148, P1094, DOI 10.1046/j.1365-2133.2003.05298.x
   Hung WS, 2001, J BIOMED MATER RES, V56, P93, DOI 10.1002/1097-4636(200107)56:1<93::AID-JBM1072>3.0.CO;2-B
   INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8
   Isner Jeffrey M., 1998, Frontiers in Bioscience, V3, pE49
   Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Joki T, 2001, NAT BIOTECHNOL, V19, P35
   Kam L, 2001, J BIOMED MATER RES, V55, P487, DOI 10.1002/1097-4636(20010615)55:4<487::AID-JBM1041>3.0.CO;2-7
   Kawamoto Atsuhiko, 2002, Cardiovasc Radiat Med, V3, P221, DOI 10.1016/S1522-1865(03)00082-9
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   King TW, 2000, J BIOMED MATER RES, V51, P383, DOI 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Knoll A, 1999, MICROVASC RES, V58, P1, DOI 10.1006/mvre.1999.2149
   Kroon Marielle E., 2002, Angiogenesis, V5, P257, DOI 10.1023/A:1024540701634
   Kyriakides TR, 2001, MOL THER, V3, P842, DOI 10.1006/mthe.2001.0336
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   Lakey LA, 2000, BONE ENG, P137
   LANGER R, 1991, J CELL BIOCHEM, V45, P340, DOI 10.1002/jcb.240450406
   Langer R, 1992, EXS, V61, P23
   LANGER R, 1983, APPL BIOCHEM BIOTECH, V8, P9, DOI 10.1007/BF02798344
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   Lee KY, 2003, J CONTROL RELEASE, V87, P49, DOI 10.1016/S0168-3659(02)00349-8
   Li C, 2002, ADV DRUG DELIVER REV, V54, P695, DOI 10.1016/S0169-409X(02)00045-5
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   Liekens S, 2001, BIOCHEM PHARMACOL, V61, P253, DOI 10.1016/S0006-2952(00)00529-3
   Longo R., 2002, Angiogenesis, V5, P237, DOI 10.1023/A:1024532022166
   Mansbridge JN, 1999, DIABETES OBES METAB, V1, P265, DOI 10.1046/j.1463-1326.1999.00032.x
   Margalit E, 2003, ARTIF ORGANS, V27, P963, DOI 10.1046/j.1525-1594.2003.07304.x
   Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   Moldovan NI, 2002, ARCH PATHOL LAB MED, V126, P320
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   MUMPER RJ, 1994, J CONTROL REL, V30
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Naughton G, 1997, ARTIF ORGANS, V21, P1203
   Neufeld G, 1999, FASEB J, V13, P9
   Nicoletti VG, 2003, EXP CLIN ENDOCR DIAB, V111, P209, DOI 10.1055/s-2003-40465
   Nissen NN, 1998, AM J PATHOL, V152, P1445
   Nor JE, 2001, LAB INVEST, V81, P453
   Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4
   Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733
   Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5
   Pandit AS, 1998, J BIOMATER APPL, V12, P222, DOI 10.1177/088532829801200303
   Pandit AS, 1998, GROWTH FACTORS, V15, P113, DOI 10.3109/08977199809117187
   Park HJ, 1999, J UROLOGY, V162, P1106, DOI 10.1016/S0022-5347(01)68084-4
   PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   Pinney E, 2000, J CELL PHYSIOL, V183, P74, DOI 10.1002/(SICI)1097-4652(200004)183:1<74::AID-JCP9>3.0.CO;2-G
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471
   Ribatti D, 2001, MECH DEVELOP, V100, P157, DOI 10.1016/S0925-4773(00)00522-0
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Rubin PAD, 1997, OPHTHALMIC PLAST REC, V13, P8, DOI 10.1097/00002341-199703000-00002
   Ruel M, 2002, J THORAC CARDIOV SUR, V124, P28, DOI 10.1067/mtc.2002.121974
   Sakakibara Y, 2003, EUR J CARDIO-THORAC, V24, P105, DOI 10.1016/S1010-7940(03)00159-3
   Sanders JE, 2002, J BIOMED MATER RES, V60, P36, DOI 10.1002/jbm.1279
   Schratzberger P, 2003, CURR PHARM DESIGN, V9, P1041, DOI 10.2174/1381612033455062
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070
   Streit M, 2002, CANCER RES, V62, P2004
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   WAKE MC, 1995, CELL TRANSPLANT, V4, P275, DOI 10.1177/096368979500400305
   Ware JA, 1997, NAT MED, V3, P158, DOI 10.1038/nm0297-158
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Willis MC, 1998, BIOCONJUGATE CHEM, V9, P573, DOI 10.1021/bc980002x
   WONG C, 2003, THROMB HAEMOSTASIS, V89, P5573
   Xue L, 2002, SURGERY, V132, P259, DOI 10.1067/msy.2002.125720
   Yamamoto M, 2003, ARTIF ORGANS, V27, P181, DOI 10.1046/j.1525-1594.2003.06993.x
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
NR 125
TC 104
Z9 107
U1 2
U2 39
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 6
BP 701
EP 726
DI 10.1163/156856204774196117
PG 26
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 834KN
UT WOS:000222410100001
PM 15255521
DA 2018-10-19
ER

PT J
AU Lee, JW
   Jung, MC
   Park, HD
   Park, KD
   Ryu, GH
AF Lee, JW
   Jung, MC
   Park, HD
   Park, KD
   Ryu, GH
TI Synthesis and characterization of thermosensitive chitosan copolymer as
   a novel biomaterial
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE chitosan; hydrogel; thermally-responsive material; N-isopropyl
   acrylamide (NIPAAm); cell viability
ID DRUG-DELIVERY SYSTEMS; N-ISOPROPYLACRYLAMIDE; GRAFT-POLYMERIZATION;
   ACRYLIC-MONOMERS; BLOCK-COPOLYMERS; IN-VITRO; GELS; HYDROGELS; POLYMERS
AB Novel water-soluble thermosensitive chitosan copolymers were prepared by graft polymerization of N-isopropylacrylamide (NIPAAm) onto chitosan using cerium ammonium nitrate (CAN) as an initiator. The physicochemical properties of the resulting chitosan-g-NIPAAm copolymers were characterized by Fourier transform infrared (FT-IR) spectroscopy, 1 H-nuclear magnetic resonance, X-ray diffraction measurement, thermogravimetric analysis (TGA) and solubility test. Sol-gel transition behavior was investigated by the cloud point measurement of the chitosan-g-NIPAAm aqueous solution. The gelling temperature was examined using the vial inversion method. The percentage of grafting (%) and efficiency of grafting (%) were investigated according to concentrations of monomer and initiator. The maximum grafted chitosan copolymer was obtained with 0.4 M NIPAAm and 6 x 10(-3) M CAN. Water-soluble chitosan-g-NIPAAm copolymers were prepared successfully and they formed thermally reversible hydrogel, which exhibits a lower critical solution temperature (LCST) around 32degreesC in aqueous solutions. A preliminary in vitro cell study showed nontoxic and biocompatible properties. These results suggest that chitosan-g-NIPAAm copolymer could be very useful in biomedical and pharmaceutical applications as an injectable material for cell and drug delivery.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea.
   Korea Inst Sci & Technol Informat, Dept Mat & Component Informat Anal, Seoul 130742, South Korea.
   Korea Food & Drug Adm, Dept Med Devices & Radiat, Seoul 122704, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea.
EM kdp@ajou.ac.kr
RI Park, Hee-Deung/D-2596-2013; Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771; Jung, Myung-Chul/0000-0002-7348-3272
CR Ahn Y., 2001, US patent, Patent No. [US 6103528, 6103528]
   Bae YH, 1997, CONTROLLED DRUG DELI, P147
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   CERRAI P, 1996, MACROMOL CHEM PHYS, V197, P3367
   Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO;2-F
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028
   DONG LC, 1991, J CONTROL RELEASE, V15, P141, DOI 10.1016/0168-3659(91)90072-L
   Ebara M, 2000, MACROMOLECULES, V33, P8312, DOI 10.1021/ma000121j
   Felt O, 1999, INT J PHARM, V180, P185, DOI 10.1016/S0378-5173(99)00003-4
   Ganorkar CR, 1999, J CONTROL RELEASE, V59, P287
   GONI I, 1983, J POLYM SCI POL CHEM, V21, P2573, DOI 10.1002/pol.1983.170210837
   GURRUCHAGA M, 1989, J POLYM SCI POL LETT, V27, P149, DOI 10.1002/pol.1989.140270501
   Han CK, 1998, POLYMER, V39, P2809, DOI 10.1016/S0032-3861(97)00612-5
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Hoffman AS, 1997, CONTROLLED DRUG DELI, P485
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Nonaka T, 1997, J APPL POLYM SCI, V66, P209, DOI 10.1002/(SICI)1097-4628(19971010)66:2<209::AID-APP1>3.3.CO;2-#
   ROBERTS GAF, 1992, CHITIN CHEM, P77
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Topp MDC, 1997, MACROMOLECULES, V30, P8518, DOI 10.1021/ma9710803
   Vernon B, 1999, J BIOMAT SCI-POLYM E, V10, P183, DOI 10.1163/156856299X00126
NR 27
TC 38
Z9 40
U1 4
U2 25
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 8
BP 1065
EP 1079
DI 10.1163/1568562041526496
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 868RR
UT WOS:000224931200008
PM 15461190
DA 2018-10-19
ER

PT J
AU Frank, L
   Lebreton-Decoster, C
   Godeau, G
   Coulomb, B
   Jozefonvicz, J
AF Frank, L
   Lebreton-Decoster, C
   Godeau, G
   Coulomb, B
   Jozefonvicz, J
TI Effect of a dextran derivative associated with TGF-beta 1 or FGF-2 on
   dermal fibroblast behaviour in dermal equivalents
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Conference on Remote Sensing of Clouds and the Atmosphere VIII
CY SEP 09-12, 2003
CL Barcelona, SPAIN
SP SPIE
DE derivatized dextran; TGF-beta 1; FGF-2; human dermal fibroblasts; dermal
   equivalents
ID HEPARIN-LIKE POLYMERS; GROWTH-FACTOR BETA-1; IN-VITRO; RECEPTOR-BINDING;
   CONTRACTION; SULFATE; CELLS
AB Dextran derivatives that mimic the action of heparin have been shown to protect heparin-binding growth factors, such as Transforming Growth Factor-beta1 (TGF-beta1) and Fibroblast Growth Factor-2 (FGF-2). The aim of this study was to investigate the effect of LS21 DMCBSu. a dextran derivative which contains methylcarboxylate, benzylamide and sulfate groups, both by itself and when combined with TGF-beta1 and FGF-2. on the behaviour of fibroblasts. Two systems were assessed: a monolayer culture and three-dimensional collagenous matrices (dermal equivalent). Polymeric biomaterial LS21 DN4CBSu and LS21 DMCBSu associated with either TGF-beta1 or FGF-2, were added to the monolayer culture on day 3. After 7 days of culture the number of cells was determined. Two treatments were carried out on the dermal equivalents: 9 days of treatment from day 0 to day 9 of culture and 9 days of treatment from day 21 to day 30 of culture for the premature and the mature dermal equivalents respectively. In the monolayer culture, the bioactive polymer produced a slight increase in fibroblast growth (10% with 10 mug/ml of LS21 DMCBSu) and promoted the stimulating effect of the a growth factors on cell growth. In the premature dermal equivalents growth was stimulated by 20% when 10 mug/ml LS21 DMCBSu was added. The dextran derivative mixed with TGF-beta1 slightly inhibited the a growth effect of the growth factor in the dermal equivalents. The functionalized dextran with FGF-2 enhanced the stimulatin- effect of the growth factor in the premature dermal equivalent. A significant increase in cell growth was observed with the fibroblasts created with the FGF-2 LS21 DMCBSu mixture and FGF-2 (51% and 40%, respectively). However. none of the described treatments affected the cell growth in the mature dermal equivalent. Furthermore, the dextran derivative had no effect on dermal contraction under these experimental conditions (3D culture).
C1 Univ Paris 13, CNRS FRE 2314, Lab Rech Macromol, F-93430 Villetaneuse, France.
   Hop St Louis, Inst Rech Peau, INSERM U532, Dermatol Lab, F-75475 Paris 10, France.
   Univ Paris 05, Fac Odontol, Lab Physiopathol Tissus Mineral, F-92120 Montrouge, France.
RP Frank, L (reprint author), Univ Paris 13, CNRS FRE 2314, Lab Rech Macromol, F-93430 Villetaneuse, France.
EM laetitia.frank@free.fr
CR AMENTO EP, 1991, CIBA F SYMP, V157, P115
   Bagheri-Yarmand R, 1998, CELL GROWTH DIFFER, V9, P497
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BENAZZOUG Y, 1995, BIOCHEM PHARMACOL, V49, P847, DOI 10.1016/0006-2952(94)00455-U
   BERRADA S, 1994, J BIOMAT SCI-POLYM E, V6, P211, DOI 10.1163/156856294X00329
   Besseau L, 2002, BIOMATERIALS, V23, P27, DOI 10.1016/S0142-9612(01)00075-8
   Bittoun P, 1999, BIOCHEM PHARMACOL, V57, P1399, DOI 10.1016/S0006-2952(99)00051-9
   BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043
   Cordeiro MF, 2000, INVEST OPHTH VIS SCI, V41, P756
   CROMACK DT, 1991, PROG CLIN BIOL RES, V365, P359
   DUBERTRET L, 1991, J INVEST DERMATOL, V79, P793
   Ehrlich H P, 1998, Adv Wound Care, V11, P326
   Genever P G, 1993, Exp Dermatol, V2, P266, DOI 10.1111/j.1600-0625.1993.tb00043.x
   Gentilhomme E, 1999, CELL BIOL TOXICOL, V15, P229, DOI 10.1023/A:1007611712275
   Huynh R, 2001, CARBOHYD RES, V332, P75, DOI 10.1016/S0008-6215(01)00066-0
   KAJIO T, 1992, FEBS LETT, V306, P243, DOI 10.1016/0014-5793(92)81009-B
   Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0
   Ledoux D, 2000, J BIOL CHEM, V275, P29383, DOI 10.1074/jbc.M000837200
   LETOURNEUR D, 1993, J BIOMAT SCI-POLYM E, V4, P431, DOI 10.1163/156856293X00681
   LETOURNEUR D, 1993, IN VITRO CELL DEV-AN, V29A, P67
   LOGEARTAVRAMOGLOU, 1999, J BIOMED MATER RES, V48, P578
   LOGEARTAVRAMOGLOU, 2002, BIOCHEM PHARMACOL, V63, P129
   MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226
   MCGRATH MH, 1990, CLIN PLAST SURG, V17, P421
   Meddahi A, 1996, J BIOMED MATER RES, V31, P293, DOI 10.1002/(SICI)1097-4636(199607)31:3<293::AID-JBM1>3.0.CO;2-H
   Meddahi A, 2002, J BIOMED MATER RES, V60, P497, DOI 10.1002/jbm.1293
   Meddahi A, 2002, J BIOMED MATER RES, V62, P525, DOI 10.1002/jbm.10283
   Mellin T N, 1992, Growth Factors, V7, P1, DOI 10.3109/08977199209023933
   MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894
   Moulin V, 1998, EXP CELL RES, V238, P283, DOI 10.1006/excr.1997.3827
   Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5
   SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831
   Takehara K., 2000, J DERMATOL SCI, V24, P70
   TARDIEU M, 1992, J CELL PHYSIOL, V150, P194, DOI 10.1002/jcp.1041500126
   WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208
NR 35
TC 2
Z9 2
U1 0
U2 1
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 11
BP 1463
EP 1480
DI 10.1163/1568562042368040
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 892JP
UT WOS:000226647000010
PM 15648575
DA 2018-10-19
ER

PT J
AU Meek, MF
   Jansen, K
   Steendam, R
   van Oeveren, W
   van Wachem, PB
   van Luyn, MJA
AF Meek, MF
   Jansen, K
   Steendam, R
   van Oeveren, W
   van Wachem, PB
   van Luyn, MJA
TI In vitro degradation and biocompatibility of
   poly(DL-lactide-epsilon-caprolactone) nerve guides
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE peripheral nerve guide; cytotoxicity; hemocompatibility; in vitro
   degradation; implantation
ID LONG-TERM EVALUATION; PERIPHERAL-NERVE; ALIPHATIC POLYESTERS;
   EPSILON-CAPROLACTONE; L-LACTIDE; REGENERATION; REPAIR; INVIVO; TUBE;
   POLY(EPSILON-CAPROLACTONE)
AB Bridging nerve gaps by means of autologous nerve grafts involves donor nerve graft harvesting. Recent studies have focused on the use of alternative methods, and one of these is the use of biodegradable nerve guides. After serving their function, nerve guides should degrade to avoid a chronic foreign body reaction. The in vitro degradation, in vitro cytotoxicity, hemocompatibility, and short-term in vivo foreign body reaction of poly((65)/(35) ((85)/(L)(15)/(D)) lactide-is an element of-caprolactone) nerve guides was studied. The in vitro degradation characteristics of poly(DLLA-is an element of-CL) nerve guides were monitored at 2-week time intervals during a period of 22 weeks. Weight loss, degree of swelling of the tube wall, mechanical strength, thermal properties, and the intrinsic viscosity of the nerve guides were determined. Cytotoxicity was studied by measuring the cell proliferation inhibition index (CPU) on mouse fibroblasts in vitro. Cell growth was evaluated by cell counting, while morphology was assessed by light microscopy. Hemocompatibility was evaluated using a thrombin generation assay and a complement convertase assay. The foreign body reaction against poly(DLLA-is an element of-CL) nerve guides was investigated by examining toluidine blue stained sections. The in vitro degradation data showed that poly(DLLA-is an element of-CL) nerve guides do not swell, maintain their mechanical strength and flexibility for a period of about 8-10 weeks, and start to lose mass after about 10 weeks. Poly(DLLA-is an element of-CL) nerve guides were classified as noncytotoxic, as cytotoxicity tests demonstrated that cell morphology was not affected (CPII 0%). The thrombin generation assay and complement convertase assay indicated that the material is highly hemocompatible. The foreign body reaction against the biomaterial was mild with a light priming of the immunesystem. The results presented in this study demonstrate that poly((65)/(35) ((65)/(15) (L)/(D)) lactide-is an element of-caprolactone) nerve guides are biocompatible, and show good in vitro degradation characteristics, making these biodegradable nerve guides promising candidates for bridging peripheral nerve defects up to several centimeters. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Groningen Hosp, Dept Plast Surg, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Med Biol, NL-9712 KZ Groningen, Netherlands.
   Polygan BV, NL-9713 GX Groningen, Netherlands.
   Haemoprobe, NL-9713 GX Groningen, Netherlands.
RP Meek, MF (reprint author), Univ Groningen Hosp, Dept Plast Surg, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands.
CR [Anonymous], 1997, 109931 ISO
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   CATALTEPE O, 1993, ACTA NEUROCHIR, V121, P181, DOI 10.1007/BF01809272
   COLIN W, 1984, J DENT RES, V63, P987, DOI 10.1177/00220345840630071601
   CORDEWENER FW, 1996, THESIS GRONINGEN
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   den Dunnen WFA, 2000, J BIOMED MATER RES, V51, P575, DOI 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.3.CO;2-Q
   DENDUNNEN WFA, 1993, J MATER SCI-MATER M, V4, P521, DOI 10.1007/BF00120133
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   DENDUNNEN WFA, 1995, J BIOMED MATER RES, V29, P757, DOI 10.1002/jbm.820290612
   DUCKER TB, 1968, J NEUROSURG, V28, P582, DOI 10.3171/jns.1968.28.6.0582
   GRIJPMA DW, 1991, POLYM BULL, V25, P327, DOI 10.1007/BF00316902
   GRIJPMA DW, 1993, HIGH IMPACT STRENGTH
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   *ISO DIS, 1992, 109935EN309935 ISO D
   LI S-T, 1992, Clinical Materials, V9, P195, DOI 10.1016/0267-6605(92)90100-8
   Liu H M, 1996, J Peripher Nerv Syst, V1, P97
   LONGO FM, 1984, BRAIN RES, V309, P105, DOI 10.1016/0006-8993(84)91014-X
   LUNDBORG G, 1994, J RECONSTR MICROSURG, V10, P345, DOI 10.1055/s-2007-1006604
   Meek M F, 2003, Ned Tijdschr Geneeskd, V147, P717
   Meek M. F., 1996, Cells and Materials, V6, P103
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   MEEK MF, 2001, MUSCLE NERVE, V24, P755
   MEEK MF, 1997, CELLS MAT, V7, P53
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   Mollnes TE, 1997, EXP CLIN IMMUNOGENET, V14, P24
   Nakamura T, 1998, J BIOMED MATER RES, V42, P475, DOI 10.1002/(SICI)1097-4636(19981215)42:4<475::AID-JBM1>3.0.CO;2-B
   Navarro X, 1996, J Peripher Nerv Syst, V1, P53
   NYILAS E, 1983, T AM SOC ART INT ORG, V29, P307
   PITT CG, 1981, BIOMATERIALS, V2, P215
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Tomihata K, 1998, POLYM DEGRAD STABIL, V59, P13, DOI 10.1016/S0141-3910(97)00183-3
   van Oeveren W, 2002, ARTIF ORGANS, V26, P506, DOI 10.1046/j.1525-1594.2002.06872.x
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P944, DOI 10.1097/00006534-198912000-00013
NR 40
TC 39
Z9 41
U1 0
U2 11
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN 1
PY 2004
VL 68A
IS 1
BP 43
EP 51
DI 10.1002/jbm.a.10157
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 758TN
UT WOS:000187666400006
PM 14661248
OA Bronze
DA 2018-10-19
ER

PT J
AU Choe, ES
   Warrier, B
   Chun, JS
   Park, JC
   Lee, CH
AF Choe, ES
   Warrier, B
   Chun, JS
   Park, JC
   Lee, CH
TI EDTA-induced activation of Ca-regulated proteins in the vaginal mucosa
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE EDTA; vaginal mucosa; MAP kinase; Ca2+- regulated proteins;
   phosphorylation
ID NF-KAPPA-B; ELEMENT-BINDING PROTEIN; ELK-1 PHOSPHORYLATION;
   CHELATING-AGENTS; KINASE; CELLS; JUN; ERK; STRIATUM; JNK
AB The effects of EDTA on the expression and topologic localization of mitogen-activated protein (MAP) kinases (ERK, JNK, and p38), along with nitric oxide synthase (NOS), I-KappaB, and p53 were examined to elucidate the host response provoked by the intravaginal application of a female controlled drug delivery system (FcDDS) containing a spermicidal/microbicidal agent and EDTA. Immunohistochemical and immunoblotting studies were conducted to identify and quantitate the EDTA-inducible proteins in vaginal mucosa. The content of nitrite, which is one of the primary stable breakdown products of nitric oxide (NO), was determined to correlate the expression of NOS with NO formation in HeLa cervical carcinoma cell line. The immunohistochemical study demonstrated that the modulation of the calcium gradient by EDTA activated MAP kinases (ERK and JNK) in the rabbit vaginal mucosa. The results of Western immunoblot study demonstrated differential expression of MAP kinases (ERK and JNK) with EDTA treatment, whereas the expression of NOS and NF-KappaB was not affected by EDTA. There was no significant difference in nitrite production in the HeLa cell line upon exposure to EDTA compared with the control, which was consistent with the results of the Western blot study. The results of this work support that the regulation of MAP kinase was affected by calcium, which is controlled by chelation activity of EDTA. The specific tissue responses exerted by the loading components of a biomaterial-based system should be fully taken into consideration for its intravaginal application. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA.
   Pusan Natl Univ, Dept Biol, Pusan 609735, South Korea.
   Kwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea.
   Chosun Univ, Coll Dent, Dept Oral Histol & Proteous Mat, Kwangju 501759, South Korea.
RP Lee, CH (reprint author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, 5005 Rockhill Rd,Katz Bldg 108, Kansas City, MO 64110 USA.
EM Leech@umkc.edu
CR Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7
   Chakravortty D, 2001, INFECT IMMUN, V69, P1315, DOI 10.1128/IAI.69.3.1315-1321.2001
   Chatterjee S, 1996, HISTOCHEM J, V28, P715, DOI 10.1007/BF02409009
   Choe ES, 2000, NEUROSCIENCE, V101, P607, DOI 10.1016/S0306-4522(00)00379-1
   Choe ES, 2001, J NEUROCHEM, V76, P401, DOI 10.1046/j.1471-4159.2001.00051.x
   Choi WS, 2001, BIOCHEM BIOPH RES CO, V287, P656, DOI 10.1006/bbrc.2001.5649
   COBB MH, 1999, PROG BIOPHYSIC MOL B, P71
   Del Rio MJ, 2002, BIOCHEM PHARMACOL, V63, P677, DOI 10.1016/S0006-2952(01)00907-8
   Griess P., 1879, CHEM BER, V12, P426, DOI DOI 10.1002/CBER.187901201117
   Haefner B, 2002, DRUG DISCOV TODAY, V7, P653, DOI 10.1016/S1359-6446(02)02309-7
   Kan H, 1999, AM J PHYSIOL-HEART C, V277, pH1641, DOI 10.1152/ajpheart.1999.277.4.H1641
   Kumar A, 1998, BIOCHEM PHARMACOL, V55, P775, DOI 10.1016/S0006-2952(97)00557-1
   Lee CH, 1997, J CONTROL RELEASE, V43, P283, DOI 10.1016/S0168-3659(96)01498-8
   Lee CH, 1996, J PHARM SCI, V85, P91, DOI 10.1021/js9501876
   Lee CH, 2002, CONTRACEPTION, V65, P435, DOI 10.1016/S0010-7824(02)00300-1
   Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404
   Li HL, 2002, WORLD J GASTROENTERO, V8, P431, DOI 10.3748/wjg.v8.i3.431
   Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1
   MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4
   Park KS, 2002, BRIT J PHARMACOL, V137, P597, DOI 10.1038/sj.bjp.0704909
   Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0
   Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130
   SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0
   Sanna PP, 2002, BRAIN RES, V948, P186, DOI 10.1016/S0006-8993(02)03191-8
   Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200
   SIMPSON JN, 1995, SYNAPSE, V19, P151, DOI 10.1002/syn.890190302
   SINGLA R, 2002, PHARM RES, V19, P1378
   Takahashi A, 2001, J IMMUNOL, V166, P6771, DOI 10.4049/jimmunol.166.11.6771
   Tantini B, 2002, FEBS LETT, V512, P75, DOI 10.1016/S0014-5793(02)02222-6
   Towbin H, 1992, Biotechnology, V24, P145
   Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6
   Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360
NR 32
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN 1
PY 2004
VL 68A
IS 1
BP 159
EP 167
DI 10.1002/jbm.a.20047
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 758TN
UT WOS:000187666400019
OA Bronze
DA 2018-10-19
ER

PT J
AU Massia, SP
   Holecko, MM
   Ehteshami, GR
AF Massia, SP
   Holecko, MM
   Ehteshami, GR
TI In vitro assessment of bioactive coatings for neural implant
   applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biospecific cell adhesion; engineered biomaterials; neural prosthetics;
   surface modification
ID CELL ATTACHMENT; BIOMATERIALS; SURFACES; DEXTRAN; GROWTH;
   POLYSACCHARIDE; PROTEINS; PEPTIDES; ADHESION; TISSUE
AB Recent efforts in our laboratory have focused on developing methods for immobilizing bioactive peptides to low cell-adhesive dextran monolayer coatings and promoting biospecific cell adhesion for biomaterial implant applications. In the current study, this dextran-based bioactive coating technology was developed for silicon, polyimide, and gold, the base materials utilized to fabricate our prototype neural implants. Chemical composition of all modified surfaces was verified by X-ray photoelectron spectroscopy (XPS). We observed that surface-immobilized dextran supported very little cell adhesion in vitro (24-h incubation with serum-supplemented medium) on all base materials. Inactive nonadhesion-promoting Gly-Arg-Ala-Asp-Ser-Pro peptides immobilized on dextran-coated materials promoted adhesion and spreading at low levels not significantly different from dextran-coated substrates. Arg-Gly-Asp (RGD) peptide-grafted surfaces were observed to promote substantial fibroblast and glial cell adhesion with minimal PC12 (neuronal cell) adhesion. In contrast, dextran-coated materials with surface-grafted laminin-based, neurite-promoting Ile-Lys-Val-Ala-Val (IKVAV) peptide promoted substantial neuron cell adhesion and minimal fibroblast and glial cell adhesion. It was concluded that neuron-selective substrates are feasible using dextran-based surface chemistry strategies. The chemical surface modifications could be utilized to establish a stable neural tissue-implant interface for long-term performance of neural prosthetic devices. (C) 2003 Wiley Periodicals, Inc.
C1 Arizona State Univ, Dept Bioengn, Tempe, AZ 85287 USA.
RP Massia, SP (reprint author), Arizona State Univ, Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
RI Zhou, Feng/E-9510-2011
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Frutos AG, 2000, LANGMUIR, V16, P2192, DOI 10.1021/la990718w
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Heiduschka P, 2001, ELECTROCHIM ACTA, V47, P299, DOI 10.1016/S0013-4686(01)00573-4
   Heiduschka P, 1998, PROG NEUROBIOL, V55, P433, DOI 10.1016/S0301-0082(98)00013-6
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Huber M, 1998, J BIOMED MATER RES, V41, P278, DOI 10.1002/(SICI)1097-4636(199808)41:2<278::AID-JBM13>3.0.CO;2-H
   KIMELBERG HK, 1989, SCI AM, V260, P66, DOI 10.1038/scientificamerican0489-66
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MASSIA S, IN PRESS BIOCONJUGAT
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J
   MORGANTIKOSSMAN.MC, 1995, IMMUNE RESPONSES NER, P159
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384
   WILSON MB, 1976, J IMMUNOL METHODS, V12, P171
NR 23
TC 64
Z9 69
U1 1
U2 19
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN 1
PY 2004
VL 68A
IS 1
BP 177
EP 186
DI 10.1002/jbm.a.20009
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 758TN
UT WOS:000187666400021
PM 14661263
OA Bronze
DA 2018-10-19
ER

PT J
AU Bobyn, JD
   Poggie, RA
   Krygier, JJ
   Lewallen, DG
   Hanssen, AD
   Lewis, RJ
   Unger, AS
   O'Keefe, TJ
   Christie, MJ
   Nasser, S
   Wood, JE
   Stulberg, SD
   Tanzer, M
AF Bobyn, JD
   Poggie, RA
   Krygier, JJ
   Lewallen, DG
   Hanssen, AD
   Lewis, RJ
   Unger, AS
   O'Keefe, TJ
   Christie, MJ
   Nasser, S
   Wood, JE
   Stulberg, SD
   Tanzer, M
TI Clinical validation of a structural porous tantalum biomaterial for
   adult reconstruction
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article; Proceedings Paper
CT 71st Annual Meeting of the American-Academy-of-Orthopaedic-Surgeons
CY MAR, 2004
CL San Francisco, CA
SP Amer Acad Orthopaed Surg
ID TOTAL KNEE ARTHROPLASTY; BONE LOSS; INGROWTH; METAL; CUPS
C1 Montreal Gen Hosp, Jo Miller Orthopaed Res Lab, Montreal, PQ H3G 1A4, Canada.
RP Bobyn, JD (reprint author), Montreal Gen Hosp, Jo Miller Orthopaed Res Lab, 1650 Cedar Ave,Room LS1-409, Montreal, PQ H3G 1A4, Canada.
EM john.bobyn@mcgill.ca
CR ALBERIUS P, 1983, ACTA ANAT, V115, P310
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   BOBYN D, 2001, T ORTHOP RES SOC, V26, P637
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOBYN JD, 1999, ANN M AM AC ORTH SUR
   Brown T, 1999, T ORTHOP RES SOC, V24, P747
   CHAN SP, 1999, TIANN M INT RES SOC
   Claassen B, 1987, T SOC BIOMATER, V10, P481
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   FLORIO CS, 2004, T ORTHOP RES SOC, V29, P1530
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   GRUEN T, 2004, ANN M AM AC ORTH SUR
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Heiner A. D., 1998, Journal of Musculoskeletal Research, V2, P267, DOI 10.1142/S0218957798000263
   Heiner AD, 2001, T ORTHOP RES SOC, V26, P480
   HOLT GE, IN PRESS CLIN ORTHOP
   LEWIS R, 2002, ANN M AM AC ORTH SUR
   LITSKY AS, 1999, T SOC BIOMATER, V22, P600
   NASSER S, 2004, ANN M AM AC ORTH SUR
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   POGGIE RA, 1998, T ORTHOP RES SOC, V23, P777
   Pudenz RH, 1943, J AMER MED ASSOC, V121, P478
   Robertson RCL, 1943, SURG CLIN N AM, V23, P1491
   Sculco TP, 2002, J ARTHROPLASTY, V17, P118, DOI 10.1054/arth.2002.32690
   STIEHL JB, 2001, ANN M AM AC ORTH SUR
   Stulberg SD, 2003, J ARTHROPLASTY, V18, P48, DOI 10.1054/arth.2003.50106
   TURNER TM, 1995, T SOC BIOMATER, V18, P125
   Walter WL, 2004, J ARTHROPLASTY, V19, P230, DOI 10.1016/j.arth.2003.10.005
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
NR 31
TC 156
Z9 175
U1 1
U2 12
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0021-9355
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PY 2004
VL 86A
SU 2
BP 123
EP 129
DI 10.2106/00004623-200412002-00017
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 880FO
UT WOS:000225774600017
PM 15691117
DA 2018-10-19
ER

PT J
AU Stavropoulos, A
   Kostopoulos, L
   Nyengaard, JR
   Karring, T
AF Stavropoulos, A
   Kostopoulos, L
   Nyengaard, JR
   Karring, T
TI Fate of bone formed by guided tissue regeneration with or without
   grafting of Bio-Oss (R) or Biogran (R)
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE alloplast; bioactive glass; bioglass; Biogran (R); Bio-Oss (R);
   deproteinized bovine bone; GBR; GTR; guided bone regeneration; guided
   tissue regeneration; xenograft
ID ANORGANIC BOVINE BONE; BIOACTIVE GLASS; OSSEOUS RESPONSE; DEFECTS;
   IMPLANTS; HUMANS; OSTEOPROMOTION; AUGMENTATION; MEMBRANE; SIZE
AB Objectives: The aim of the study was to examine whether bone produced by guided tissue regeneration (GTR) in combination with Bio-Oss(R) or Biogran(R) is stable on a long-term basis.
   Material and Methods: Fifty-four, 3-month-old Wistar rats were divided into three groups and rigid, hemispherical, teflon capsules were placed with their open part facing the lateral surface of the exposed mandibular ramus (one capsule per animal). In the first group, the capsules were loosely packed with a standardized quantity of Bio-Oss(R), in the second group with Biogran(R), and in the last group were left empty. After 1 year of healing, the capsules were removed. Six animals from each of the 3 experimental groups were killed immediately after capsule removal (baseline), or 3 or 6 months after re-entry. The volume of (1) newly formed bone, (2) remaining biomaterial particles, and (3) soft connective tissue in the space originally created by the capsule was estimated by a point-counting technique in three to four histological sections, taken by uniformly random sampling.
   Results: While considerable bone formation had occurred in the empty control capsules, only limited bone formation was observed in the two test groups. The major portion of the space originally created by the capsules in the test groups was occupied by biomaterial particles embedded in connective tissue. At baseline, the mean volume of newly formed bone occupied 23% of the original capsule space in the animals grafted with Bio-Oss(R), 12.6% in those implanted with Biogran(R), and 94.1% in those that received empty control capsules. Six months after capsule removal, the corresponding values were 21.5%, 13.2%, and 91.7%, respectively. No statistically significant differences were observed between baseline, and the 3-, and 6-month observation times in terms of bone volume for any of the three treatment groups (p>0.05).
   Conclusion: Bone produced by GTR with and without implantation of Bio-Oss(R), or Biogran(R), is stable on a long-term basis, but bone formation is obstructed by implantation of these biomaterials.
C1 Aarhus Univ, Fac Hlth Sci, Royal Dent Coll, Dept Periodontol & Oral Gerontol, DK-8000 Aarhus C, Denmark.
   Univ Aarhus, Royal Dent Coll, Dept Oral & Maxillofacial Surg, DK-8000 Aarhus C, Denmark.
   Univ Aarhus, Electron Microscopy & Stereol Res Lab, DK-8000 Aarhus C, Denmark.
RP Stavropoulos, A (reprint author), Aarhus Univ, Fac Hlth Sci, Royal Dent Coll, Dept Periodontol & Oral Gerontol, Vennelyst Blvd 9, DK-8000 Aarhus C, Denmark.
EM stavropoulos@odont.au.dk
CR Al Ruhaimi KA, 2001, INT J ORAL MAX IMPL, V16, P105
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Buser D, 1995, Int J Oral Maxillofac Implants, V10, P666
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Carmagnola D, 2002, J CLIN PERIODONTOL, V29, P377, DOI 10.1034/j.1600-051X.2002.290501.x
   Carpio L, 2000, J PERIODONTOL, V71, P1743, DOI 10.1902/jop.2000.71.11.1743
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   DAHLIN C, 1991, J NEUROSURG, V74, P487, DOI 10.3171/jns.1991.74.3.0487
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Fukuta K, 1992, J Craniofac Surg, V3, P25, DOI 10.1097/00001665-199207000-00010
   Furusawa T, 1998, INT J ORAL MAX IMPL, V13, P672
   GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x
   Hammerle CHF, 1996, CLIN ORAL IMPLAN RES, V7, P38, DOI 10.1034/j.1600-0501.1996.070105.x
   HAMMERLE CHF, 1995, J ORAL MAXIL SURG, V53, P167, DOI 10.1016/0278-2391(95)90396-8
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Hammerle CHF, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P468
   Hurzeler M B, 1996, Int J Oral Maxillofac Implants, V11, P466
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   JOVANOVIC S A, 1992, International Journal of Oral and Maxillofacial Implants, V7, P233
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Leonetti J A, 2000, Implant Dent, V9, P177, DOI 10.1097/00008505-200009020-00012
   Lioubavina N, 1999, CLIN ORAL IMPLAN RES, V10, P477, DOI 10.1034/j.1600-0501.1999.100606.x
   Mayfield LJA, 2001, CLIN ORAL IMPLAN RES, V12, P508
   Paolantonio M, 2001, INT J PERIODONT REST, V21, P505
   SANDBERG E, 1993, J ORAL MAXIL SURG, V51, P1106, DOI 10.1016/S0278-2391(10)80450-1
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Schepers E J, 1993, Implant Dent, V2, P151, DOI 10.1097/00008505-199309000-00002
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Slotte C, 1999, CLIN ORAL IMPLAN RES, V10, P468, DOI 10.1034/j.1600-0501.1999.100605.x
   Stavropoulos A, 2003, J CLIN PERIODONTOL, V30, P454
   Stavropoulos A, 2001, Clin Implant Dent Relat Res, V3, P156, DOI 10.1111/j.1708-8208.2001.tb00136.x
   STAVROPOULOS A, 2001, 3 PH D DAY AARH U
   Tawil G, 2001, INT J ORAL MAX IMPL, V16, P713
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   Wheeler DL, 1998, J BIOMED MATER RES, V41, P527, DOI 10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.3.CO;2-S
   Zitzmann NU, 2001, INT J ORAL MAX IMPL, V16, P355
NR 39
TC 34
Z9 36
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JAN
PY 2004
VL 31
IS 1
BP 30
EP 39
DI 10.1111/j.0303-6979.2004.00434.x
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 755LU
UT WOS:000187405000007
PM 15058372
DA 2018-10-19
ER

PT J
AU Okada, E
   Maruyama, Y
   Hayashi, A
AF Okada, E
   Maruyama, Y
   Hayashi, A
TI Nasal augmentation using calcium phosphate cement
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE calcium phosphate cement; hydroxyapatite; nasal augmentation; biopex
ID HYDROXYAPATITE CEMENT; IN-VIVO; RHINOPLASTY; EXPERIENCE; MONOXIDE;
   DEFECTS
AB This report describes a simple technique for augmentation rhinoplasty using calcium phosphate cement paste for postoperative and posttraumatic nasal deformities. This biomaterial was used to correct traumatic nasal bone deformity in one patient and for augmentation rhinoplasty after removal of the nasal implant in two patients. These patients were followed for a minimum 6 months and a maximum of 26 months. The esthetic results were satisfactory with no complication. Calcium phosphate cement consisting of alpha-tricalcium phosphate, dicalcium phosphate dibasic, and tetracalcium phosphate monoxide has been used for bone replacement and augmentation because of its good biocompatibility and osteoconductivity. This technique is easy and safe. It seems to be a suitable material for augmentation rhinoplasty in the Orient. Its long-term safety and reliability require proof with longer follow-up periods, however.
C1 Toho Univ, Sch Med, Dept Plast & Reconstruct Surg, Ota Ku, Tokyo 1438541, Japan.
RP Okada, E (reprint author), Toho Univ, Sch Med, Dept Plast & Reconstruct Surg, Ota Ku, 6-11-1 Omorinishi, Tokyo 1438541, Japan.
EM prsnet@med.toho-u.ac.jp
CR Brown WE, 1987, CEMENTS RES PROGR 19, P352
   Deva AK, 1998, PLAST RECONSTR SURG, V102, P1230, DOI 10.1097/00006534-199809040-00052
   ENDO T, 1991, PLAST RECONSTR SURG, V87, P54, DOI 10.1097/00006534-199101000-00010
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   KIHWAN H, 1996, PLAST RECONSTR SURG, V97, P436
   KURASHINA K, 1995, J MATER SCI-MATER M, V6, P340, DOI 10.1007/BF00120302
   Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1
   Lew D, 1997, J ORAL MAXIL SURG, V55, P1441, DOI 10.1016/S0278-2391(97)90647-9
   Losee JE, 2003, J CRANIOFAC SURG, V14, P117, DOI 10.1097/00001665-200301000-00022
   Monma H., 1976, YOGYO-KYOKAI-SHI, V84, P209, DOI 10.2109/jcersj1950.84.968_209
   Ohmori K., 1990, PLASTIC SURG, V3, P2415
   SHIRAKABE Y, 1981, BRIT J PLAST SURG, V34, P353, DOI 10.1016/0007-1226(81)90030-8
   Turk J B, 2000, Facial Plast Surg, V16, P7, DOI 10.1055/s-2000-7321
   Verheggen R, 2001, ACTA NEUROCHIR, V143, P919, DOI 10.1007/s007010170022
NR 14
TC 8
Z9 10
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2004
VL 15
IS 1
BP 102
EP 105
DI 10.1097/00001665-200401000-00028
PG 4
WC Surgery
SC Surgery
GA 881FJ
UT WOS:000225848500027
PM 14704574
DA 2018-10-19
ER

PT J
AU Finer, Y
   Santerre, JP
AF Finer, Y
   Santerre, JP
TI Salivary esterase activity and its association with the biodegradation
   of dental composites
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE biodegradation; biomaterial hydrolysis; esterases; serine esterase
   inhibitor; dental resins
ID CHOLESTEROL ESTERASE; PSEUDOCHOLINESTERASE ACTIVITY;
   ENZYMATIC-HYDROLYSIS; ENZYMES; ORIGIN; RESIN; INFLAMMATION; MACROPHAGES;
   MONOMERS; PRODUCTS
AB Pseudocholinesterase (PCE) and cholesterol esterase (CE) can hydrolyze bisphenylglycidyl dimethacrylate (bisGMA) and triethylene glycol dimethacrylate (TEGDMA) monomers. This study will test the hypothesis that enzyme activities showing CE and PCE character are found in human saliva at levels sufficient to hydrolyze ester-containing composites important to restorative denstistry. The study also seeks to ask if the active sites of CE and PCE with respect to composite could be inhibited. Photo-polymerized model composite resin was incubated in PCE and CE solutions, in the presence and absence of a specific esterase inhibitor, phenylmethylsulfonyl fluoride (PMSF). Incubation solutions were analyzed for resin degradation products by high-performance liquid chromatography (HPLC), UV spectroscopy, and mass spectrometry. Saliva was found to contain both hydrolase activities at levels that could degrade composite resins. PMSF inhibited the composite degradation, indicating a material hydrolysis mechanism similar to the enzymes' common function.
C1 Univ Toronto, Fac Dent, Biomat Discipline, Toronto, ON M5G 1G6, Canada.
   Univ Toronto, Fac Dent, Restorat Discipline, Toronto, ON M5G 1G6, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Biomat Discipline, 124 Edward St, Toronto, ON M5G 1G6, Canada.
CR CHAUNCEY HH, 1961, J AM DENT ASSOC, V63, P360, DOI 10.14219/jada.archive.1961.0215
   Feaster SR, 1996, BIOCHEMISTRY-US, V35, P16723, DOI 10.1021/bi961677v
   Finer Y, 2003, J BIOMAT SCI-POLYM E, V14, P837, DOI 10.1163/156856203768366558
   Jaffer F, 2002, BIOMATERIALS, V23, P1707, DOI 10.1016/S0142-9612(01)00298-8
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1983, BIOCHIM BIOPHYS ACTA, V749, P32, DOI 10.1016/0167-4838(83)90147-4
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lappin DF, 1999, J CLIN PERIODONTOL, V26, P183, DOI 10.1034/j.1600-051X.1999.260309.x
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0
   LINDQVIST L, 1977, ENZYME, V22, P166, DOI 10.1159/000458785
   MUNKSGAARD EC, 1990, SCAND J DENT RES, V98, P261
   NAKAMURA M, 1983, J PERIODONTAL RES, V18, P559, DOI 10.1111/j.1600-0765.1983.tb00393.x
   PAYNE WA, 1975, J PERIODONTAL RES, V10, P51, DOI 10.1111/j.1600-0765.1975.tb00008.x
   RYHANEN R, 1983, J DENT RES, V62, P20, DOI 10.1177/00220345830620010501
   RYHANEN RJJ, 1983, GEN PHARMACOL, V14, P459, DOI 10.1016/0306-3623(83)90030-7
   Santerre JP, 1999, J DENT RES, V78, P1459, DOI 10.1177/00220345990780081201
   Santerre JP, 2001, CRIT REV ORAL BIOL M, V12, P136, DOI 10.1177/10454411010120020401
   Shajii L, 1999, BIOMATERIALS, V20, P1897, DOI 10.1016/S0142-9612(99)00087-3
   SUTTON LD, 1986, BIOCHEM BIOPH RES CO, V134, P386, DOI 10.1016/0006-291X(86)90575-9
   SUTTON LD, 1990, BIOCHIM BIOPHYS ACTA, V1041, P79, DOI 10.1016/0167-4838(90)90125-Y
   SUTTON LD, 1991, BIOCHEMISTRY-US, V30, P5888, DOI 10.1021/bi00238a012
   TANAKA K, 1991, J ORAL REHABIL, V18, P353, DOI 10.1111/j.1365-2842.1991.tb00067.x
   TENOVUO J, 1990, J CLIN PERIODONTOL, V17, P525
   WILLIAMS FM, 1985, CLIN PHARMACOKINET, V10, P392, DOI 10.2165/00003088-198510050-00002
   YAMALIK N, 1991, J DENT RES, V70, P988, DOI 10.1177/00220345910700061601
   YAMALIK N, 1990, J DENT RES, V69, P87, DOI 10.1177/00220345900690011501
   Yourtee DM, 2001, J BIOMED MATER RES, V57, P522, DOI 10.1002/1097-4636(20011215)57:4<522::AID-JBM1198>3.0.CO;2-9
NR 28
TC 105
Z9 110
U1 1
U2 20
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD JAN
PY 2004
VL 83
IS 1
BP 22
EP 26
DI 10.1177/154405910408300105
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 760CF
UT WOS:000187792700004
PM 14691108
DA 2018-10-19
ER

PT J
AU Mc Cullagh, SD
   Malcolm, RK
   Woolfson, AD
   Gorman, SP
   Jones, DS
   Cuddy, J
AF Mc Cullagh, SD
   Malcolm, RK
   Woolfson, AD
   Gorman, SP
   Jones, DS
   Cuddy, J
TI Release kinetics of oleyl alcohol from a self-lubricating silicone
   biomaterial
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID LIGHT-SCATTERING DETECTOR; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   EVAPORATIVE ANALYZER; MASS DETECTOR; DELIVERY; SURFACTANTS; DRUGS
AB The development of self-lubricating silicone elastomeric biomaterials, prepared using the novel crosslinking agent tetra( oleyloxy) silane and having very low coefficients of friction, has recently been reported. In this study, the in vitro release characteristics of lubricious oleyl alcohol produced during the silicone curing reaction have been quantitatively evaluated for a range of tetra( propoxy) silane/tetra(oleyloxy) silane crosslinker compositions using a novel evaporative light scattering detection method in combination with high performance liquid chromatography. The mechanism of oleyl alcohol release was seen to deviate from a simple, matrix-controlled diffusion process and instead obeyed an anomalous transport mechanism. An explanation for the observed release behaviour has been proposed based on competitive reaction kinetics between the tetra( oleyloxy) silane and tetra( propoxy) silane substituents of the silicone crosslinking agents.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
RP Woolfson, AD (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM d.woolfson@qub.ac.uk
CR ARKLES B, 1983, CHEMTECH, V13, P542
   BARTLE KD, 1983, FUEL, V62, P1181, DOI 10.1016/0016-2361(83)90061-3
   BEAR GR, 1988, J CHROMATOGR, V459, P91, DOI 10.1016/S0021-9673(01)82019-7
   Cardenas S, 1999, ANAL CHIM ACTA, V402, P1, DOI 10.1016/S0003-2670(99)00712-6
   CHARLESWORTH JM, 1978, ANAL CHEM, V50, P1414, DOI 10.1021/ac50033a011
   CRANK J, 1979, MATH DIFFUSION, P254
   CUDDY JP, 2002, J PHARM PHARMACOL, V54, pS95
   HIERRO MTG, 1992, J CHROMATOGR, V607, P329, DOI 10.1016/0021-9673(92)87092-M
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   HOMBURGER F, 1985, J AM COLL TOXICOL, V4, P1
   KAJIHARA M, 2003, CHEM PHARM BULL, V51, P779
   Lee CH, 1997, J CONTROL RELEASE, V44, P43, DOI 10.1016/S0168-3659(96)01499-X
   Malcolm R. K., 2003, J CONTROL RELEASE, V91, P355
   Malcolm RK, 2002, BIOMATERIALS, V23, P3589, DOI 10.1016/S0142-9612(02)00086-8
   MALCOLM RK, 2001, DRUG DELIV SYS SCI, V1, P117
   Malcolm RK, 2003, J CONTROL RELEASE, V90, P217
   MENGERINK Y, 1991, J CHROMATOGR, V552, P593, DOI 10.1016/S0021-9673(01)95975-8
   MONERAPONS A, 1998, J CHROMATOGR A, V823, P475
   MOUREY TH, 1985, ANAL CHEM, V56, P1342
   Narasimhan B., 1999, ENCY CONTROLLED DRUG, P921
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   SANCHEZ N, 1992, IND ENG CHEM RES, V31, P1985, DOI 10.1021/ie00008a021
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   STOLYHWO A, 1985, ANAL CHEM, V57, P1342, DOI 10.1021/ac00284a038
   TAVERNA M, 1990, J CHROMATOGR, V514, P70, DOI 10.1016/S0021-9673(01)89378-X
   Woolfson AD, 2003, J MATER CHEM, V13, P2465, DOI 10.1039/b306578b
NR 26
TC 5
Z9 5
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2004
VL 14
IS 7
BP 1093
EP 1098
DI 10.1039/b313483k
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 805QJ
UT WOS:000220380500003
DA 2018-10-19
ER

PT J
AU Murugan, R
   Ramakrishna, S
AF Murugan, R
   Ramakrishna, S
TI Modification of demineralized bone matrix by a chemical route
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID POSTERIOR SPINAL-FUSION; CORALLINE HYDROXYAPATITE; GLYCIDYL
   METHACRYLATE; GRAFT-POLYMERIZATION; XENOGENEIC BONE;
   GLYCIDYLMETHACRYLATE; DEFECTS; PARTICLES; INTERFACE; COMPOSITE
AB Demineralized bone matrix (DBM) is a well known osteoinductive biomaterial being used in bone related therapies and recently in biomolecular delivery. To widen its usage in therapeutic delivery, the present study was focused on chemical modification of DBM by a grafting technique using glycidylmethacrylate (GMA) as a monomer and ceric ammonium nitrate (CAN) as an initiating system. The chemical modification of DBM was proved by using Fourier transform infrared (FTIR) spectroscopy to analyze functional groups before and after grafting. The grafting results and grafting mechanism are described in detail. The chemically modified DBM was evaluated for in-vitro therapeutic delivery by coupling the gentamicin through epoxy functional groups introduced by GMA. The loading and release of gentamicin was evaluated in Hank's medium at pH 7.4 and 37 degreesC under physiological conditions and it was found to release the drug for a prolonged period as compared to ungrafted DBM. Based on the experimental results, the chemical modification paves the way to utilization of DBM macromolecules in therapeutic delivery.
C1 Natl Univ Singapore, NUS Nanosci & Nanotechnol Initiat, Div Bioeng, Nanobioengn Lab, Singapore 117576, Singapore.
RP Murugan, R (reprint author), Natl Univ Singapore, NUS Nanosci & Nanotechnol Initiat, Div Bioeng, Nanobioengn Lab, 9 Engn Dr 1, Singapore 117576, Singapore.
EM engmr@nus.edu.sg
RI Ramalingam, Murugan/C-9827-2010
CR BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342
   COOK SD, 1995, SPINE, V20, P877, DOI 10.1097/00007632-199504150-00002
   Eckert AW, 2000, BIOMATERIALS, V21, P441
   Edwards JT, 1998, CLIN ORTHOP RELAT R, P219
   GEPSTEIN R, 1987, J BONE JOINT SURG AM, V69A, P984, DOI 10.2106/00004623-198769070-00005
   GLOWACKI J, 1981, LANCET, V1, P959
   GUIZZARDI S, 1992, SPINE, V17, P701, DOI 10.1097/00007632-199206000-00010
   HAGEN JW, 1992, J BIOMED MATER RES, V26, P897, DOI 10.1002/jbm.820260706
   Helm GA, 1997, J NEUROSURG, V86, P93, DOI 10.3171/jns.1997.86.1.0093
   Martin GJ, 1999, SPINE, V24, P637, DOI 10.1097/00007632-199904010-00005
   Mizuno S, 1996, BIOMATERIALS, V17, P1819, DOI 10.1016/0142-9612(96)00041-5
   Murugan R, 2004, BIOMATERIALS, V25, P3073, DOI 10.1016/j.biomaterials.2003.09.089
   Murugan R, 2003, B MATER SCI, V26, P523, DOI 10.1007/BF02707351
   Murugan R, 2003, MACROMOL RES, V11, P14, DOI 10.1007/BF03218272
   Murugan R, 2003, J BIOMAT SCI-POLYM E, V14, P457, DOI 10.1163/156856203766652066
   Murugan R, 2003, POLYM BULL, V49, P395, DOI 10.1007/s00289-002-0120-1
   Murugan R, 2002, MATER LETT, V57, P429, DOI 10.1016/S0167-577X(02)00805-4
   Murugan R, 2002, TRENDS BIOMATER ARTI, V16, P43
   MURUGAN R, 2004, COLLOID POLYM SCI
   Niederwanger M, 1996, J Oral Implantol, V22, P210
   Rao K.P., 1969, LEATHER SCI, V16, P401
   REDDI AH, 1985, J BIOMED MATER RES, V19, P233, DOI 10.1002/jbm.820190306
   Rong MZ, 2002, EUR POLYM J, V38, P1573, DOI 10.1016/S0014-3057(02)00037-X
   SVEC F, 1981, ANGEW MAKROMOL CHEM, V99, P11, DOI 10.1002/apmc.1981.050990102
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
NR 28
TC 8
Z9 8
U1 0
U2 5
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2004
VL 14
IS 13
BP 2041
EP 2045
DI 10.1039/b315169g
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 833BX
UT WOS:000222312500019
DA 2018-10-19
ER

PT J
AU Pryce, RS
   Hench, LL
AF Pryce, RS
   Hench, LL
TI Tailoring of bioactive glasses for the release of nitric oxide as an
   osteogenic stimulus
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; IN-VIVO EVALUATION; INDUCED BONE LOSS;
   SILICA-GEL; SYNTHASE ISOFORMS; FUNCTIONAL-ROLE; IONIC PRODUCTS; SURFACE;
   EXPRESSION; PROLIFERATION
AB The production of bioactive glasses using the sol - gel process has increased the viability of using such glass-ceramics in the field of biomaterials. The mesoporous nature of the sol - gel structure enables the incorporation of specific stimuli into the glass for subsequent delivery at the local site upon implantation. This incorporation can be achieved by chemically patterning the sol - gel matrix with organosilanes that contain specific functional groups. This paper examines the synthesis and characterisation of a novel sol-gel-derived bioactive glass that can generate nitric oxide in an aqueous environment. Its synthesis is achieved via a two-step process. The first stage involves surface modification of the ternary 58S bioactive gel - glass (60 mol% SiO2, 36 mol% CaO, 4 mol% P2O5) with an organosilane (3-aminopropyltriethoxysilane). The incorporation of an amino-functional group onto the surface of the gel - glass increases the site reactivity and affinity for nitric oxide. After modification with the organosilane, the bioactive gel - glass is subsequently reacted with molecular nitric oxide resulting in the formation of a nitric oxide-releasing biomaterial. Modification of the gel - glass surface does not alter the reaction mechanisms or bioactivity of the gel - glass, maintaining in-vitro behaviour typically associated with bioactive materials that exhibit both osteoconduction and osteoproduction.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, Ctr Tissue Engn, London SW7 2BP, England.
RP Pryce, RS (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Ctr Tissue Engn, Prince Consort Rd, London SW7 2BP, England.
EM russell.pryce@imperial.ac.uk
CR Aguirre J, 2001, AM J PATHOL, V158, P247, DOI 10.1016/S0002-9440(10)63963-6
   ALBERTS B, 2002, MOL BIOL CELL, P831
   ARCHER S, 1993, FASEB J, V7, P349
   Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760
   Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8
   BONNER FT, 1996, METHODS NITRIC OXIDE, P3
   BRANDI ML, 1995, P NATL ACAD SCI USA, V92, P2954, DOI 10.1073/pnas.92.7.2954
   Carre A, 2003, J COLLOID INTERF SCI, V260, P49, DOI 10.1016/S0021-9797(02)00147-9
   De Boer J., 1958, STRUCTURE PROPERTIES, P68
   DRAGO R, 1960, J AM CHEM SOC, V83, P1819
   DRAGO RS, 1960, J AM CHEM SOC, V82, P96, DOI 10.1021/ja01486a021
   Eiserich Jason P., 1998, Molecular Aspects of Medicine, V19, P221, DOI 10.1016/S0098-2997(99)00002-3
   Feelisch M., 1996, METHODS NITRIC OXIDE, P71
   Garin F, 2001, APPL CATAL A-GEN, V222, P183, DOI 10.1016/S0926-860X(01)00827-4
   GREENSPAN DC, 1997, BIOCERAMICS, V10, P391
   Helfrich MH, 1997, J BONE MINER RES, V12, P1108, DOI 10.1359/jbmr.1997.12.7.1108
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Hench LL, 2002, J INORG MATER, V17, P897
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   Hikiji H, 1997, FEBS LETT, V410, P238, DOI 10.1016/S0014-5793(97)00597-8
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   HUGHES F, 1998, NITRIC OXIDE BONE JO, P105
   HUKKANEN M, 1995, ENDOCRINOLOGY, V136, P5445, DOI 10.1210/en.136.12.5445
   ISHIDA H, 1982, J POLYM SCI POL PHYS, V20, P701, DOI 10.1002/pol.1982.180200412
   Jamal SA, 1998, J BONE MINER RES, V13, P1755, DOI 10.1359/jbmr.1998.13.11.1755
   KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KURTH DG, 1995, LANGMUIR, V11, P3061, DOI 10.1021/la00008a035
   MACINTYRE I, 1991, P NATL ACAD SCI USA, V88, P2936, DOI 10.1073/pnas.88.7.2936
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   MORROW BA, 1992, J PHYS CHEM-US, V96, P1395, DOI 10.1021/j100182a068
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Notingher I, 2002, MATER CHARACT, V49, P255, DOI 10.1016/S1044-5803(03)00029-9
   Plueddemann E., 1991, SILANE COUPLING AGEN
   RALSTON SH, 1995, J BONE MINER RES, V10, P1040
   RALSTON SH, 1994, ENDOCRINOLOGY, V135, P330, DOI 10.1210/en.135.1.330
   Ramamurthi A, 1997, CHEM RES TOXICOL, V10, P408, DOI 10.1021/tx960183w
   RIANCHO JA, 1995, J BONE MINER RES, V10, P439
   Saavedra J. E., 2000, NITRIC OXIDE CARDIOV, P431
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   SHAPILOV OD, 1983, J ANAL CHEM-USSR+, V38, P436
   Shimizu I, 1997, VIB SPECTROSC, V14, P113, DOI 10.1016/S0924-2031(97)00002-7
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Socrates G., 2001, INFRARED RAMAN CHARA
   SUDHOLTER EJR, 1985, J COLLOID INTERF SCI, V103, P554, DOI 10.1016/0021-9797(85)90130-4
   TAYLOR I, 1993, ANAL CHIM ACTA, V271, P77, DOI 10.1016/0003-2670(93)80554-X
   VANSANT EF, 1995, CHARACTERIZATION CHE, P193
   VRANCKEN KC, 1995, J COLLOID INTERF SCI, V170, P71, DOI 10.1006/jcis.1995.1073
   VRANCKEN KC, 1995, J COLLOID INTERF SCI, V174, P86, DOI 10.1006/jcis.1995.1367
   White LD, 2000, J COLLOID INTERF SCI, V232, P400, DOI 10.1006/jcis.2000.7224
   Wimalawansa S, 2000, J BONE MINER RES, V15, P1119, DOI 10.1359/jbmr.2000.15.6.1119
   Wimalawansa SJ, 2000, J BONE MINER RES, V15, P2240, DOI 10.1359/jbmr.2000.15.11.2240
   Wimalawansa SJ, 1996, BONE, V18, P301, DOI 10.1016/8756-3282(96)00005-1
   WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 60
TC 28
Z9 28
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2004
VL 14
IS 14
BP 2303
EP 2310
DI 10.1039/b400922c
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 845VH
UT WOS:000223272900031
DA 2018-10-19
ER

PT J
AU Furuzono, T
   Kishida, A
   Tanaka, J
AF Furuzono, T
   Kishida, A
   Tanaka, J
TI Nano-scaled hydroxyapatite/polymer composite I. Coating of sintered
   hydroxyapatite particles on poly(gamma-methacryloxypropyl
   trimethoxysilane)-grafted silk fibroin fibers through chemical bonding
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMPLANT MATERIAL; EMULSION; GROWTH
AB The inorganic-organic composite consisting of a nano-scaled hydroxyapatite (HAp) and silk fibroin (SF) fibers was prepared through convalent linkage to develop a novel biomaterial for a soft-tissue-compatible material. The preparation of the composite was conducted through the three-step procedure consisting of chemical modification using 2-methacryloxyethyl isocyanate (MOI) monomer to introduce vinyl groups on SF, poly(gamma-mehtacryloxypropyl trimethoxysilane) (MPTS) graft-polymerization of SF, and coupling process between the surface of polyMPTS-grafted SF and HAp nano-particles. The amount of the graft-polymerization of polyMPTS through vinyl groups was well controlled by the reaction time. The nano-crystals were subsequently coated on the grafted fibers by heating at 120degreesC for 2 h in a vacuum. The crystalline structure of the SF substrate did not change in the procedure. In the SEM observation of the composite surface, it was found that the bonded nano-crystals were separated and partially aggregated with several crystals attached on the SF fiber surface. The HAp particles adhered more strongly on the SF surface with separation or aggregation of several crystals than on the surface of the original SF after ultrasonic treatment. (C) 2004 Kluwer Academic Publishers.
C1 Natl Cardiovasc Ctr, Res Inst, Dept Bioengn, Osaka 5658565, Japan.
   Natl Inst Mat Sci, Independent Adm Inst, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
RP Furuzono, T (reprint author), Natl Cardiovasc Ctr, Res Inst, Dept Bioengn, 5-7-1 Fujishiro Dai, Osaka 5658565, Japan.
CR Aoki H, 1994, MED APPL HYDROXYAPAT, P90
   FRASER R. D., 1973, CONFORMATION FIBROUS, P293
   Furuzono T, 2003, J BIOMED MATER RES B, V65B, P217, DOI 10.1002/jbm.b.10002
   Furuzono T, 2001, J BIOMED MATER RES, V56, P9, DOI 10.1002/1097-4636(200107)56:1<9::AID-JBM1073>3.0.CO;2-2
   Furuzono T, 2001, J MATER SCI LETT, V20, P111, DOI 10.1023/A:1006725931450
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   Nishizawa K, 1995, CHEM SOC JPN, V1, P63
   PAUL MZ, 1994, ASAIO J, V40, pM896
   Sonoda K, 2002, SOLID STATE IONICS, V151, P321, DOI 10.1016/S0167-2738(02)00730-0
NR 11
TC 54
Z9 55
U1 1
U2 32
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2004
VL 15
IS 1
BP 19
EP 23
DI 10.1023/B:JMSM.0000010093.39298.5a
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 757EF
UT WOS:000187535300004
PM 15338587
DA 2018-10-19
ER

PT J
AU Otto, M
   Franzen, A
   Hansen, T
   Kirkpatrick, CJ
AF Otto, M
   Franzen, A
   Hansen, T
   Kirkpatrick, CJ
TI Modification of human platelet adhesion on biomaterial surfaces by
   protein preadsorption under static and flow conditions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BLOOD-MATERIAL INTERACTIONS; NEUTROPHIL ADHESION; DEPOSITION;
   ANTICOAGULATION; ACTIVATION; CONTACT
AB Biomaterial-induced thrombosis remains one of the main complications of vascular implant devices. Preadsorbed proteins on the biomaterial/blood interface will modify the adhesion and activation of platelets (PTLs) during the initial contact-phase. Our results clearly show that PTL-adherence on biomaterials is influenced not only by protein preadsorption, but also by flow conditions. The covalent coating of TCPS and glass by phosphorylcholine (PC) induces a significant decrease of PTL adhesion but leads to a slight, but nevertheless significant activation of PTL, which was detected by induction of P-selection expression using FACS analysis. Methodologically, the visualization of PTL adhesion have more reliable results for measurement of PTL adhesion than the cell-enzyme immunoassay (EIA) for P-selectin.
   Human citrated plasma caused an inhibition of PTL. It is probable, that the contained sodium citrate may inhibit PTL adhesion by its calcium ion-binding capacity. The flow experiment as dynamic system is in our view absolutely essential for the evaluation of biomaterials for vascular prosthesis, and is in accordance with the international standards. The results of the experiments also suggest that investigation under static and flow conditions are needed to determine the influence of protein adsorption on mixed blood cell populations, for example, on PTL and PMN mixtures/co-cultures in order to achieve a better simulation of the in vivo situation. (C) 2004 Kluwer Academic Publishers.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   WHO Collaborating Ctr Dev Histopathol Classificat, Dept Mol Pathol, Reference Ctr Implant & Biomat Pathol, Inst Pathol Trier, D-54292 Trier, Germany.
   Univ Mainz, Clin Gynaecol & Obstet, D-55101 Mainz, Germany.
RP Otto, M (reprint author), Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
CR [Anonymous], 1992, 10993 ISO 4
   [Anonymous], 1999, 10993 ISO 5
   Bar J, 1996, CLIN LAB HAEMATOL, V18, P281
   Bos JC, 1997, NEPHROL DIAL TRANSPL, V12, P1387, DOI 10.1093/ndt/12.7.1387
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BRASH JL, 1991, MODERN ASPECTS PROTE
   CAMPBELL EJ, 1994, ASAIO J, V40, P853
   CASTNER DG, 1992, REFERENCE MAT EUROPE
   Cenni E, 1997, J BIOMED MATER RES, V36, P289, DOI 10.1002/(SICI)1097-4636(19970905)36:3<289::AID-JBM3>3.0.CO;2-A
   DAMME HSV, 1991, MODERN ASPECTS PROTE
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Ishihara Kazuhiko, 2000, Frontiers of Medical and Biological Engineering, V10, P83, DOI 10.1163/15685570052061946
   *ISO, 1992, 10993 ISO 3
   *ISO, 1997, 10993 ISO 1
   Kuijper PHM, 1997, BLOOD, V89, P166
   Michanetzis GPA, 1996, J MATER SCI-MATER M, V7, P29, DOI 10.1007/BF00121186
   MULLER KM, 1994, PATHOLOGY DEVICES
   Otto M, 2003, J MATER SCI-MATER M, V14, P263, DOI 10.1023/A:1022840909038
   Otto M, 2001, PATHOBIOLOGY, V69, P159, DOI 10.1159/000048771
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   OTTO M, 2002, BIOMATERIALIEN, V3, P133
   OTTO M, 1996, 5 WORLD BIONM C C P, V1, P705
   RHEE BG, 1986, CHEM ENG COMMUN, V47, P147, DOI 10.1080/00986448608911760
   SALZMANN EW, 1994, HEMOSTASIS THROMBOSI
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   SHEPPECK RA, 1991, BLOOD, V78, P673
   Zwaginga JJ, 1999, ARTERIOSCL THROM VAS, V19, P1549, DOI 10.1161/01.ATV.19.6.1549
NR 29
TC 18
Z9 18
U1 0
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2004
VL 15
IS 1
BP 35
EP 42
DI 10.1023/B:JMSM.0000010095.19693.67
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 757EF
UT WOS:000187535300006
PM 15338589
DA 2018-10-19
ER

PT J
AU Musahl, V
   Abramowitch, SD
   Gilbert, TW
   Tsuda, E
   Wang, JHC
   Badylak, SF
   Woo, SLY
AF Musahl, V
   Abramowitch, SD
   Gilbert, TW
   Tsuda, E
   Wang, JHC
   Badylak, SF
   Woo, SLY
TI The use of porcine small intestinal submucosa to enhance the healing of
   the medial collateral ligament - a functional tissue engineering study
   in rabbits
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE small intestinal submucosa; medial collateral ligament; healing;
   mechanical properties; functional tissue engineering
ID ANTERIOR CRUCIATE LIGAMENT; DOG-MODEL; IN-VIVO; COLLAGEN; INJURIES;
   SYSTEM; REPAIR; RECONSTRUCTION; BIOMATERIAL; BEHAVIOR
AB Introduction: Small intestinal submucosa (SIS) from porcine has been successfully used as a collagen scaffold for the repair of various tissues, including those of the human vascular, urogenital, and musculoskeletal systems. The objective of this study was to evaluate whether SIS can be used to enhance the healing process of a medial collateral ligament (MCL) with a gap injury in a rabbit model.
   Methods: A 6 mm wide gap was surgically created in the right MCL of 20 skeletally mature, female New Zealand White rabbits. In 10 rabbits, a strip of SIS was sutured onto the two ends of the MCL, while for the other 10 animals their injured MCL remained untreated and served as a non-treated group. The left MCL of all animals was exposed and undermined serving as the sham-operated side. At 12 weeks post-healing, eight hind limbs from each group were used for mechanical testing. The cross-sectional areas (CSA) of the MCLs were measured. The femur-MCL-tibia complex (FMTC) was tensile tested to failure. The load-elongation curves representing the structural properties of the FMTC and the stress-strain curves representing the mechanical properties of the healing MCL were obtained. The remaining two animals from each group were prepared for histological evaluation.
   Results: The CSA between the SIS-treated and non-treated groups were not significantly different (p > 0.05). Both treatment groups appeared to increase by nearly 40% compared to the sham-operated side, although statistical significance was not found for the non-treated group (p > 0.05). The stiffness of the FMTC from the SIS-treated group was 56% higher than the non-treated group (45.7 +/- 13.3 N/mm vs. 29.2 +/- 9.2 N/mm, respectively, p < 0.05) and the ultimate load also nearly doubled (117.434.5 N vs. 66.4 +/- 31.4 N, respectively, p < 0.05). These values were lower compared to the sham-operated side (89.7 +/- 15.3 N/min and 332.0 +/- 50.8 N, respectively). The tangent modulus of the healing MCL (279.7 +/- 132.1 MPa vs. 149.0 +/- 76.5 MPa, respectively) and stress at failure (15.7 +/- 4.1 MPa vs. 10.2 +/- 3.9 MPa, respectively) both increased by more than 50% with SIS treatment (p < 0.05). Yet, each remained lower compared to the sham-operated side (936.3 +/- 283.6 MPa and 75.6 +/- 14.2 MPa, respectively). Blinded histological comparisons between the SIS-treated MCL and the non-treated control demonstrated qualitatively that the SIS treated group had increased cellularity, greater collagen density, and improved collagen fiber alignment.
   Conclusion: Healing of a gap MCL injury was significantly enhanced with SIS. The improved mechanical properties and histological appearance of the MCL suggest that SIS treatment improves the quality of tissue and renders the possibility for future studies investigating functional tissue engineering of healing ligaments. (C) 2003 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.
C1 Univ Pittsburgh, Dept Orthoped Surg, Musculoskeletal Res Ctr, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
RP Woo, SLY (reprint author), Univ Pittsburgh, Dept Orthoped Surg, Musculoskeletal Res Ctr, E1641 Biomed Sci Tower,210 Lothrop St,POB 71199, Pittsburgh, PA 15213 USA.
EM decenzod@msx.upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
FU NIAMS NIH HHS [AR41820]
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   ARAGONA J, 1983, AM J SPORT MED, V11, P228, DOI 10.1177/036354658301100409
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK S, IN PRESS TISSUE ENG
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   CHIMICH D, 1991, J ORTHOPAED RES, V9, P37, DOI 10.1002/jor.1100090106
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Dunn MG, 1997, J APPL POLYM SCI, V63, P1423, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1423::AID-APP4>3.0.CO;2-O
   Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G
   Evans CH, 1999, CLIN ORTHOP RELAT R, pS410
   FRANK C, 1983, AM J SPORT MED, V11, P379, DOI 10.1177/036354658301100602
   Hildebrand KA, 1998, AM J SPORT MED, V26, P549, DOI 10.1177/03635465980260041401
   HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184
   JOHNSON RJ, 1980, AM J SPORT MED, V8, P106, DOI 10.1177/036354658000800209
   KANNUS P, 1988, CLIN ORTHOP RELAT R, P103
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   LoitzRamage BJ, 1997, CLIN ORTHOP RELAT R, P272
   Miyasaka KC, 1991, AM J KNEE SURG, V4, P3
   Nakamura N, 2000, J ORTHOPAED RES, V18, P517, DOI 10.1002/jor.1100180402
   Niyibizi C, 2000, KNEE SURG SPORT TR A, V8, P281, DOI 10.1007/s001670000134
   OHNO K, 1995, J ORTHOPAED RES, V13, P442, DOI 10.1002/jor.1100130319
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Scheffler SU, 2001, ANN BIOMED ENG, V29, P173, DOI 10.1114/1.1349701
   Smutz WP, 1996, J BIOMECH, V29, P813, DOI 10.1016/0021-9290(95)00131-X
   WEISS JA, 1991, J ORTHOPAED RES, V9, P516, DOI 10.1002/jor.1100090407
   Woo SLY, 1997, ACTA ORTHOP SCAND, V68, P142, DOI 10.3109/17453679709003997
   WOO SLY, 1986, J BIOMECH, V19, P399, DOI 10.1016/0021-9290(86)90016-3
   WOO SLY, 1990, J BIOMECH ENG-T ASME, V112, P426, DOI 10.1115/1.2891206
   Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312
   WOO SLY, 1990, J ORTHOP RES, V8, P712, DOI 10.1002/jor.1100080513
NR 33
TC 97
Z9 107
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
EI 1554-527X
J9 J ORTHOP RES
JI J. Orthop. Res.
PD JAN
PY 2004
VL 22
IS 1
BP 214
EP 220
DI 10.1016/S0736-0266(03)00163-3
PG 7
WC Orthopedics
SC Orthopedics
GA 761DG
UT WOS:000187884300032
PM 14656683
OA Bronze
DA 2018-10-19
ER

PT J
AU Oudadesse, H
   Martin, S
   Derrien, AC
   Lucas-Girot, A
   Cathelineau, G
   Blondiaux, G
AF Oudadesse, H
   Martin, S
   Derrien, AC
   Lucas-Girot, A
   Cathelineau, G
   Blondiaux, G
TI Determination of Ca, P, Sr and Mg in the synthetic biomaterial aragonite
   by NAA
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article
AB In orthopaedic surgery, synthetic biomaterials encountered a great success. In this work, the "in-vivo" behaviour of aragonite synthesized in our laboratory was studied. The in vivo experiments have been carried out on femurs sites of nine ovine. Neutron activation analysis was applied to evaluate the ossification kinetics of synthetic aragonite. The content of several elements (Ca, P, Sr and Mg and phosphorous to calcium ratio) were determined versus time after implantation. Results showed that the biomaterial undergoes a lot of transformations during time. The chemical composition of the aragonite was modified and progress to become close to that of an ovine bone. Biological studies assess its biocompatibility.
C1 Univ Rennes 1, Inst Chim Rennes, Chim Solide & Inorgan Mol Lab, CNRS,UMR Cristallochim & Biomat 6511, F-35042 Rennes, France.
   Univ Rennes 1, UFR Odontol, F-3500 Rennes, France.
   CNRS, CERI, F-45071 Orleans, France.
RP Oudadesse, H (reprint author), Univ Rennes 1, Inst Chim Rennes, Chim Solide & Inorgan Mol Lab, CNRS,UMR Cristallochim & Biomat 6511, CS 74205,Campus Beaulieu,Bat 10B, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR ALBERT P, 1964, ANAL ACTIVATION
   CIROFF RT, 1985, J BIOMED MATER RES, V6, P29
   DESOTE D, 1972, NEUTRON ACTIVATION A
   DZHELEPOV BS, 1961, DECAY SCHEME RADIOAC
   ELSOLH N, 1981, HDB STABLE STRONTIUM, P11
   HEYDORN K, 1980, RISO R
   HEYDORN K, 1984, RESEARCH, V11
   *INT AT EN AG, 1974, HDB NUCL ACT CROSS S, V156
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V174, P93, DOI 10.1007/BF02040337
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V169, P339, DOI 10.1007/BF02042992
   IYENER V, 1999, NAHRES39 IAEA
   Lucas A, 1999, J SOLID STATE CHEM, V146, P73, DOI 10.1006/jssc.1999.8310
   Lucas A, 2001, INT J INORG MATER, V3, P87, DOI 10.1016/S1466-6049(00)00058-1
   LUCASGIROT A, 1996, THESIS U RENNESL
   MARTIN S, 2002, THESIS U RENNES 1
   MAY S, 1973, COLLECTION TECHNIQUE, P2565
   MELKI S, 1986, THESIS CERI CNRS ORL
   OUDADESSE H, 1989, THESIS U B PASCAL CL
NR 18
TC 18
Z9 18
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0236-5731
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PY 2004
VL 262
IS 2
BP 479
EP 483
DI 10.1023/B:JRNC.0000046781.15503.eb
PG 5
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA 867QR
UT WOS:000224857800025
DA 2018-10-19
ER

PT J
AU Kveton, JF
   Coelho, DH
AF Kveton, JF
   Coelho, DH
TI Hydroxyapatite cement in temporal bone surgery: A 10 year experience
SO LARYNGOSCOPE
LA English
DT Article; Proceedings Paper
CT Meeting of the Eastern Section of the American-Triological-Society
CY JAN 24-26, 2003
CL BOSTON, MA
SP Amer Triolog Soc
DE hydroxyapatite; cement; temporal bone; reconstruction; CSF leak
ID RECONSTRUCTION
AB Objectives. To describe the indications for successful use of hydroxyapatite cement (HAC) in temporal bone surgery. Study Design: Retrospective case review. Methods. One hundred nine temporal bone defects related to surgical approaches to the skull base, infection, neoplasms, or congenital defect in 102 adults and children were corrected using HAC over a 10-year period. The results and complications were obtained through retrospective chart review. Results: Ninety-seven percent of temporal bone defects were successfully repaired using HAC, and the reconstruction remained stable over the course of this study. There was one case of postoperative cerebrospinal fluid leak. Wound infection occurred in three patients, which required reoperation and removal of the biomaterial. Conclusions. HAC is a biomaterial that should be used as the primary method to reconstruct temporal bone defects. Proper use of this biomaterial results in restoration of the integrity of the temporal bone and elimination of cerebrospinal. fluid leak as a postoperative complication.
C1 Yale Univ, Sch Med, Otolaryngol Sect, New Haven, CT 06510 USA.
RP Kveton, JF (reprint author), 46 Prince St, Suite 601, New Haven, CT 06519 USA.
CR Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   Burstein FD, 1999, PLAST RECONSTR SURG, V104, P1270, DOI 10.1097/00006534-199910000-00005
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   Friedman C D, 2000, Arch Facial Plast Surg, V2, P124, DOI 10.1001/archfaci.2.2.124
   GOSAIN AK, 1997, J CRANIFAC SURG, V8, P5106
   Havlik J, 2002, PLAST RECONSTR SURG, V110, P1176, DOI 10.1097/01.PRS.0000020998.55126.10
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   KVETON JF, 1995, AM J OTOL, V16, P465
   Matic D, 2002, PLAST RECONSTR SURG, V110, P1, DOI 10.1097/00006534-200207000-00001
NR 9
TC 20
Z9 23
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0023-852X
J9 LARYNGOSCOPE
JI Laryngoscope
PD JAN
PY 2004
VL 114
IS 1
BP 33
EP 37
DI 10.1097/00005537-200401000-00005
PG 5
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA 882CM
UT WOS:000225916200004
PM 14709991
DA 2018-10-19
ER

PT S
AU Liu, Y
   Allen, J
   Kim, YL
   Turzhitsky, V
   Ameer, G
   Backman, V
AF Liu, Y
   Allen, J
   Kim, YL
   Turzhitsky, V
   Ameer, G
   Backman, V
BE Jacques, SL
   Roach, WP
TI Light scattering "fingerprinting" for characterization of smooth muscle
   cell proliferation
SO LASER INTERACTION WITH TISSUE AND CELLS XV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Laser Interaction with Tissue and Cells XV
CY JAN 26-28, 2004
CL San Jose, CA
SP SPIE, USAF Off Sci Res
DE light scattering; smooth muscle cell; proliferation
ID POLARIZED-LIGHT; TISSUE PHANTOMS; SPECTROSCOPY; FLUORESCENCE;
   ATHEROSCLEROSIS; REFLECTANCE; CANCER; SIZE
AB Accelerated proliferation of smooth muscle cells (SMCs) is known to play an integral role in atherosclerotic lesion formation. Thus, there has been significant interest in defining both positive and negative regulators of SMC growth. We have applied a novel optical technique referred to as four-dimensional light scattering fingerprinting (4D-ELF) that enables non-invasive assessment of living cells. 4D-ELF can serve for highly sensitive detection of slight alterations in cellular and subcellular microstructure. Using 4D-ELF, we characterized the proliferation of SMC grown on two different substrates: laminin and fibronectin. Fibronectin-grown SMC have been previously shown to be more proliferative. Our results indicate that light scattering can be used to monitor the changes in the intracellular structure caused by the cell-substrate interaction and differentiate between more and less proliferative SMCs. Thus, light scattering fingerprinting may potentially provide a quick, inexpensive, and accurate means to noninvasively characterize the proliferation of living cells as well as cell-biomaterial interaction.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Liu, Y (reprint author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RI Backman, Vadim/B-6689-2009; Ameer, Guillermo/B-6765-2009
CR *AM HEART ASS, 2001, 2002 HEART STROK STA
   Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325
   Backman V, 2000, NATURE, V406, P35
   Backman V, 2001, IEEE J SEL TOP QUANT, V7, P887, DOI 10.1109/2944.983289
   Bigio IJ, 1997, PHYS MED BIOL, V42, P803, DOI 10.1088/0031-9155/42/5/005
   BORSE GJ, 1991, FORTRAN 77 NUMERICAL
   Demos SG, 1997, APPL OPTICS, V36, P150, DOI 10.1364/AO.36.000150
   Georgakoudi I, 2001, GASTROENTEROLOGY, V120, P1620, DOI 10.1053/gast.2001.24842
   Gurjar RS, 2001, NAT MED, V7, P1245, DOI 10.1038/nm1101-1245
   Hielscher AH, 1997, APPL OPTICS, V36, P125, DOI 10.1364/AO.36.000125
   Jacques SL, 2000, LASER SURG MED, V26, P119, DOI 10.1002/(SICI)1096-9101(2000)26:2<119::AID-LSM3>3.3.CO;2-P
   Jacques SL, 2002, J BIOMED OPT, V7, P329, DOI 10.1117/1.1484498
   Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183
   Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949
   Mourant JR, 1995, LASER SURG MED, V17, P350, DOI 10.1002/lsm.1900170403
   Perelman L.T., 2002, HDB OPTICAL BIOMEDIC, P675
   Perelman LT, 1998, PHYS REV LETT, V80, P627, DOI 10.1103/PhysRevLett.80.627
   Ramanujam N, 1996, LASER SURG MED, V19, P46, DOI 10.1002/(SICI)1096-9101(1996)19:1<46::AID-LSM7>3.3.CO;2-J
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   SANDERS M, 1994, PHARMACOL THERAPEUT, V61, P109, DOI 10.1016/0163-7258(94)90060-4
   Schmitt JM, 1998, APPL OPTICS, V37, P2788, DOI 10.1364/AO.37.002788
   SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427
   Thyberg J, 1997, J HISTOCHEM CYTOCHEM, V45, P837, DOI 10.1177/002215549704500608
   Wax A, 2003, CANCER RES, V63, P3556
   Wax A, 2002, BIOPHYS J, V82, P2256, DOI 10.1016/S0006-3495(02)75571-9
   WILLON WR, 1984, MULTIVARIATE ANAL ME
NR 26
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5227-0
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5319
BP 32
EP 40
DI 10.1117/12.529175
PG 9
WC Biophysics; Engineering, Biomedical; Optics
SC Biophysics; Engineering; Optics
GA BAO13
UT WOS:000223056000005
DA 2018-10-19
ER

PT B
AU Salgado, AJ
   Gomes, ME
   Reis, RL
AF Salgado, AJ
   Gomes, ME
   Reis, RL
BE Reis, RL
   Weiner, S
TI Tissue engineering of mineralized tissues: The essential elements
SO LEARNING FROM NATURE HOW TO DESIGN NEW IMPLANTABLE BIOMATERIALS: FROM
   BIOMINERALIZATION FUNDAMENTALS TO BIOMIMETIC MATERIALS AND PROCESSING
   ROUTES
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Learning from Nature
   How to Design New Implantable Biomaterials
CY OCT 13-24, 2003
CL Alvor, PORTUGAL
ID MESENCHYMAL STEM-CELLS; SYNTHETIC BIODEGRADABLE POLYMERS; ECTOPIC
   BONE-FORMATION; STARCH-BASED POLYMERS; MARROW STROMAL CELLS; 3D
   PERFUSION CULTURE; ROTATING-WALL VESSEL; IN-VITRO; OSTEOGENIC
   DIFFERENTIATION; MECHANICAL-PROPERTIES
AB Tissue Engineering (TE) has been emerging as a valid approach to the current therapies for hard tissue regeneration/substitution. In contrast to classic biomaterial approach, TE is based on the understanding of tissue formation and regeneration, and aims to induce new functional tissues, rather than just to implant new spare parts. The present chapter focuses on aspects that are believed to be essential for hard tissue engineering. Therefore, the use of cell transplantation and culturing on biodegradable scaffolds for the development of hybrid constructs aiming at the regeneration of hard tissues, like bone will be addressed. This review will also focus on the available in vitro systems for the culturing of cells-polymers constructs. Finally it will discussed the biofuctionality testing, and the several animal models that are available for evaluating the developed proofs of concept.
C1 Univ Minho, 3Bs Res Grp Biomat Biodegrabables & Biomimet, P-4710057 Braga, Portugal.
RP Salgado, AJ (reprint author), Univ Minho, 3Bs Res Grp Biomat Biodegrabables & Biomimet, P-4710057 Braga, Portugal.
RI Gomes, Manuela/B-6282-2009; Reis, Rui L./A-8938-2008; Salgado,
   Antonio/J-4129-2013; Group, 3Bs/E-4374-2012
OI Gomes, Manuela/0000-0002-2036-6291; Reis, Rui L./0000-0002-4295-6129;
   Salgado, Antonio/0000-0003-3806-9823; Group, 3Bs/0000-0002-5195-3456
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Allay JA, 1997, HUM GENE THER, V8, P1417, DOI 10.1089/hum.1997.8.12-1417
   AN YH, 1999, ANIMAL MODELS ORTHOP, P241
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Barry F, 2002, BIOCHEM BIOPH RES CO, V290, P1609, DOI 10.1006/bbrc.2002.6381
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bruder SP, 1998, J BONE MINER RES, V13, P655, DOI 10.1359/jbmr.1998.13.4.655
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Bruder SP, 1997, BONE, V21, P225, DOI 10.1016/S8756-3282(97)00127-0
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   Devine SM, 2002, J CELL BIOCHEM, P73, DOI 10.1002/jcb.10046
   DURAY PH, 1997, SCI MED          MAY, P46
   Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   FREED LE, 2000, TISSUE ENG BIOREACTO, P143
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Han B, 2002, J ORTHOPAED RES, V20, P747, DOI 10.1016/S0736-0266(01)00157-7
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kneser U, 2002, MINIM INVASIV THER, V11, P107, DOI 10.1080/136457002320174177
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kruyt MC, 2004, BIOMATERIALS, V25, P1463, DOI 10.1016/S0142-9612(03)00490-3
   Landers R, 2000, MACROMOL MATER ENG, V282, P17, DOI 10.1002/1439-2054(20001001)282:1<17::AID-MAME17>3.0.CO;2-8
   Langer R, 1999, J CONTROL RELEASE, V62, P7, DOI 10.1016/S0168-3659(99)00057-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lind M, 2001, EUR SPINE J, V10, pS102, DOI 10.1007/s005860100269
   Lu LC, 1996, MRS BULL, V21, P28
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MALAFAYA PB, 2003, POROUS BIOACTIVE COM, P39
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mooney DJ, 1999, SCI AM, V280, P38
   Nilsson SK, 1999, J EXP MED, V189, P729, DOI 10.1084/jem.189.4.729
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Park JH, 2000, INT J INORG MATER, V2, P153, DOI 10.1016/S1466-6049(99)00071-9
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qiu Q, 1998, TISSUE ENG, V4, P19, DOI 10.1089/ten.1998.4.19
   Qiu QQ, 2001, IN VITRO CELL DEV-AN, V37, P157
   Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   ROUFOSSE CA, 2004, IN PRESS INT J BIOCH
   Rzeszutek K, 2003, J CRANIOFAC SURG, V14, P301, DOI 10.1097/00001665-200305000-00007
   Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   SALGADO AJ, 2004, IN PRESS J MAT SCI M
   SALGADO AJ, 2004, UNPUB MACROMOLECULAR
   Schantz JT, 2003, TISSUE ENG, V9, pS127, DOI 10.1089/10763270360697030
   Short B, 2003, ARCH MED RES, V34, P565, DOI 10.1016/j.arcmed.2003.09.007
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Thomson R. C., 1995, ADV POLYM SCI, V122, P247
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Ueda H, 2002, BIOMATERIALS, V23, P1003, DOI 10.1016/S0142-9612(01)00211-3
   Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   Vacanti CA, 1999, CLIN ORTHOP RELAT R, pS375
   VACANTI JP, 1997, PRINCIPLES TISSUE EN, P1
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhang JY, 2003, TISSUE ENG, V9, P1143, DOI 10.1089/10763270360728053
NR 105
TC 1
Z9 1
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-2644-7
J9 NATO SCI SER II MATH
PY 2004
VL 171
BP 205
EP 222
PG 18
WC Materials Science, Biomaterials
SC Materials Science
GA BBH09
UT WOS:000225478500013
DA 2018-10-19
ER

PT S
AU Perez, MM
   Perez-Ocon, F
   Yebra, A
   Lucena-Martin, C
   Pulgar, R
AF Perez, MM
   Perez-Ocon, F
   Yebra, A
   Lucena-Martin, C
   Pulgar, R
BE Zissis, G
TI Temporal stability and reproducibility of radiometric properties of high
   power light emitting diode (LED) arrays and halogen light polymerization
   of oral biomaterial
SO LIGHT SOURCES 2004
SE INSTITUTE OF PHYSICS CONFERENCE SERIES
LA English
DT Article; Proceedings Paper
CT 10th International Symposium on the Science and Technology of Light
   Sources
CY JUL 18-22, 2004
CL Toulouse, FRANCE
SP European COST 529 Network, GE, Philips, Heraeus, Osram, SLi, Welch Allyn
ID COMPRESSIVE STRENGTH; HARDNESS
C1 Univ Granada, Fac Ciencias, Dept Opt, E-18071 Granada, Spain.
   Univ Granada, Dept Estomatol, E-18071 Granada, Spain.
RP Perez, MM (reprint author), Univ Granada, Fac Ciencias, Dept Opt, Campus Fuentenueva S-N, E-18071 Granada, Spain.
EM mmperez@ugr.es
OI Perez-Ocon, Francisco/0000-0001-9532-3328; Perez Gomez, Maria Del
   Mar/0000-0003-1528-3659; Yebra Rodriguez, Ana Maria/0000-0003-0524-6336
CR Mills RW, 2002, BIOMATERIALS, V23, P2955, DOI 10.1016/S0142-9612(02)00024-8
   Perez-Ocon F, 1999, COLOR RES APPL, V24, P377, DOI 10.1002/(SICI)1520-6378(199910)24:5<377::AID-COL9>3.0.CO;2-C
   Uhl A, 2002, J BIOMED MATER RES, V63, P729, DOI 10.1002/jbm.10390
   UHL A, 2003, IN PRESS DENT MAT
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0951-3248
BN 0-7503-1007-3
J9 INST PHYS CONF SER
PY 2004
IS 182
BP 351
EP 352
PG 2
WC Optics; Physics, Multidisciplinary
SC Optics; Physics
GA BAU82
UT WOS:000223655300119
DA 2018-10-19
ER

PT J
AU Guillemot, F
   Prima, F
   Bareille, R
   Gordin, D
   Gloriant, T
   Porte-Durrieu, MC
   Ansel, D
   Baquey, C
AF Guillemot, F
   Prima, F
   Bareille, R
   Gordin, D
   Gloriant, T
   Porte-Durrieu, MC
   Ansel, D
   Baquey, C
TI Design of new titanium alloys for orthopaedic applications
SO MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
LA English
DT Article
DE biomaterials; titanium alloys; phase transformations; resistivity
   measurements; cytocompatibility
ID COLORIMETRIC ASSAY; SURFACE SCIENCE; CYTO-TOXICITY; DIFFUSION
AB Parallel to the biofunctionalisation of existing materials, innovation in biomaterials engineering has led to the specific design of titanium alloys for medical applications. Studies of the biological behaviour of metallic elements have shown that the composition and structure of the material should be carefully tailored to minimise adverse body reactions and to enhance implant longevity, respectively. Consequently, interest has focused on a new family of titanium alloys: Ti-6Mo-3Fe-5Ta, Ti-4Mo-2Fe-5Ta and Ti-6Mo-3Fe-5Zr-5Hf alloys. The non-toxicity of the specially designed titanium alloys compared with osteoblastic cells has been ascertained using MTT and RN tests. In addition, phase transformations upon thermal processing have been investigated, with comparison with a well-defined beta titanium alloy. Optimum thermal processing windows (above 550degreesC) have been designed to generate a stable and nanostructured alpha phase from the isothermal omega phase that precipitates in a low temperature range (150-350degreesC). The generation of such nanostructured microstructures should provide a promising opportunity to investigate tissue-biomaterial interactions at the scale of biomolecules such as proteins.
C1 INSERM, Biomat & Tissue Repair Unit, U443, Bordeaux, France.
   ENSCP, Lab Met Struct, Paris, France.
   INSA, Grp Rech Chim & Met, Rennes, France.
RP Guillemot, F (reprint author), INSERM, Biomat & Tissue Repair Unit, U443, Bordeaux, France.
EM fabien.guillemot@bordeaux.inserm.fr
RI Guillemot, Fabien/F-5174-2012; DURRIEU, Marie-Christine/I-4358-2016
OI Guillemot, Fabien/0000-0002-4263-4365; DURRIEU,
   Marie-Christine/0000-0003-0583-9289; Gordin, Doina
   Margareta/0000-0003-2200-9930
CR AHMED T., 1999, U. S. Patent, Patent No. [5,871,595, 5871595]
   Ankem S, 1999, MAT SCI ENG A-STRUCT, V263, P127, DOI 10.1016/S0921-5093(98)01170-8
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   BREME HJ, 1989, MEM ETUD SCI REV MET, P625
   BREME J, 1998, METALS BIOMATERIALS
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Guillemot F, 2002, J MATER SCI LETT, V21, P1537, DOI 10.1023/A:1020056700790
   GUILLEMOT F, 2000, THESIS INSA RENNES
   HADJADJ L, 1988, THESIS ROUEN
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   NIINOMI M, 1999, JOM, P32
   Okazaki Y, 2001, CURR OPIN SOLID ST M, V5, P45, DOI 10.1016/S1359-0286(00)00025-5
   PARISH CR, 1983, J IMMUNOL METHODS, V58, P225, DOI 10.1016/0022-1759(83)90277-6
   PORTEDURRIEU MC, IN PRESS BIOMATERIAL
   Prima F, 2000, MATER T JIM, V41, P1092, DOI 10.2320/matertrans1989.41.1092
   Prima F, 2000, J MATER SCI LETT, V19, P2219, DOI 10.1023/A:1006708420478
   SANCHEZ JM, 1978, ACTA METALL MATER, V26, P1083, DOI 10.1016/0001-6160(78)90136-0
   SERAPHIN L, 1965, MEM ETUD SCI REV MET, V62, P291
   SGOURAS D, 1990, J MAT SCI MAT M, V1
   STEINEMANN SG, 1997, SURFACE PERFORMANCE
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Weiss I, 1998, MAT SCI ENG A-STRUCT, V243, P46, DOI 10.1016/S0921-5093(97)00783-1
   Xiao S., 2001, TITANIUM MED
NR 27
TC 20
Z9 20
U1 0
U2 7
PU PETER PEREGRINUS LTD
PI HERTS
PA MICHAEL FARADAY HOUSE, SIX HILLS WAY, STEVANAGE, HERTS SG1 2AY, ENGLAND
SN 0140-0118
J9 MED BIOL ENG COMPUT
JI Med. Biol. Eng. Comput.
PD JAN
PY 2004
VL 42
IS 1
BP 137
EP 141
DI 10.1007/BF02351023
PG 5
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Mathematical & Computational Biology; Medical Informatics
SC Computer Science; Engineering; Mathematical & Computational Biology;
   Medical Informatics
GA 772MK
UT WOS:000188845700022
PM 14977235
DA 2018-10-19
ER

PT J
AU Obermiller, FJ
   Hodde, JP
   McAlexander, CS
   Kokini, K
   Badylak, SF
AF Obermiller, FJ
   Hodde, JP
   McAlexander, CS
   Kokini, K
   Badylak, SF
TI A comparison of suture retention strengths for three biomaterials
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE polypropylene; pericardium; small intestinal submucosa (SIS); soft
   tissue repair; biomaterial
ID SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL REPAIR; POLYPROPYLENE MESH;
   HERNIAS; DEFECTS; DEVICE; MODEL; DOG
AB Background: The suture holding capacity, suture retention strength, and burst strength of three biomaterials (Marlex(R), SIS, and PeriGuard(R)) were evaluated to compare their performance characteristics in an ex vivo setting representing the immediate postoperative period.
   Material/Methods: A circular defect was created in the fascial tissue of the abdominal aponeurosis collected from normal dogs. Defects were repaired with either Marlex (polypropylene mesh), Periguard (bovine pericardium) or small intestinal submucosa (SIS) using 2-0 prolene and a 1.0-cm suture bite. The force required to induce failure at the repair site was recorded as the suture-holding capacity. Suture retention strength was calculated as the load distribution over the specimen cross-section in contact with the suture at the time of rupture. Burst strength of the raw materials was also measured.
   Results: The suture-holding capacity was 370.9+/-56.2 N for Marlex; 214.3+/-36.1 N for Periguard, and 287.9+/-34.3 N for SIS. The suture retention strengths were: Marlex, 413.4+/-59.7 N/mm(2); Periguard, 97.02+/-0.1 N/mm(2);; and SIS, 106.9+/-12.7 N/mm(2).. The burst strength of Marlex, Periguard and SIS were 476.7+/-50.8 N, 432.12 +/-82.1 N, and 433.6+/-79.5 N respectively.
   Conclusions: All three materials provide adequate strength and suture-holding capacities to be of use in the repair of soft tissue defects.
C1 Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Hodde, JP (reprint author), Cook Biotech Inc, 3055 Kent Ave, W Lafayette, IN 47906 USA.
EM hodde@cookbiotech.com
CR ARNAUD JP, 1977, AM J SURG, V133, P338, DOI 10.1016/0002-9610(77)90542-6
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BLEICHRODT RP, 1993, SURG GYNECOL OBSTET, V176, P18
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   CUMBERLAND V H, 1952, Med J Aust, V1, P143
   Franklin M E Jr, 2002, Hernia, V6, P171
   Franz MG, 2001, SURGERY, V129, P203, DOI 10.1067/msy.2001.110220
   Franz MG, 2001, J SURG RES, V97, P109, DOI 10.1006/jsre.2001.6083
   GILSDORF RB, 1975, AM J SURG, V130, P634, DOI 10.1016/0002-9610(75)90411-0
   HARMAN EA, 1988, MED SCI SPORT EXER, V20, P195, DOI 10.1249/00005768-198820020-00015
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   LEAPER DJ, 1977, BRIT J SURG, V64, P603, DOI 10.1002/bjs.1800640822
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   STONE HH, 1981, ANN SURG, V193, P612, DOI 10.1097/00000658-198105000-00011
   TYRELL J, 1989, SURG GYNECOL OBSTET, V168, P227
   VAVRIK J, 2000, MED SCI MONITOR, V6, P746
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
NR 20
TC 4
Z9 4
U1 2
U2 5
PU INT SCIENTIFIC LITERATURE, INC
PI ALBERTSON
PA 1125 WILLIS AVE, ALBERTSON, NY 11507 USA
SN 1234-1010
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD JAN
PY 2004
VL 10
IS 1
BP PI1
EP PI5
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 865XC
UT WOS:000224736500013
DA 2018-10-19
ER

PT B
AU Klosterhalfen, B
   Klinge, U
   Rosch, R
   Junge, K
AF Klosterhalfen, B
   Klinge, U
   Rosch, R
   Junge, K
BE Schumpelick, V
   Nyhus, LM
TI Long-term inertness of meshes - Biomaterial-related foreign body
   reaction
SO MESHES: BENEFITS AND RISK
LA English
DT Proceedings Paper
CT 3rd Suvretta Meeting
CY JAN 14-18, 2003
CL ST MORITZ, SWITZERLAND
ID ACUTE INFLAMMATORY RESPONSES; ABDOMINAL-WALL; POLYPROPYLENE-MESH; HERNIA
   REPAIR; INCISIONAL HERNIAS; PROSTHETIC REPAIR; MARLEX MESH; IN-VIVO;
   QUESTIONNAIRE; IMPLANTATION
C1 Univ Klinikum Aachen, Inst Pathol, D-52074 Aachen, Germany.
RP Klosterhalfen, B (reprint author), Univ Klinikum Aachen, Inst Pathol, Pauwelsstr, D-52074 Aachen, Germany.
CR Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001
   Beets GL, 1996, EUR J SURG, V162, P823
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   BOYD WC, 1977, SURG GYNECOL OBSTET, V144, P251
   Deysine M, 1998, SURG CLIN N AM, V78, P1105, DOI 10.1016/S0039-6109(05)70372-8
   Haapaniemi S, 2002, EUR J SURG, V168, P22, DOI 10.1080/110241502317307535
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Junge K, 2002, WORLD J SURG, V26, P1472, DOI 10.1007/s00268-002-6444-z
   Junge K, 2002, EUR J SURG, V168, P67, DOI 10.1080/11024150252884269
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   Klinge U, 2000, EUR SURG RES, V32, P43, DOI 10.1159/000008740
   Klinge U, 1998, EUR J SURG, V164, P965
   Klinge U, 1999, BIOMATERIALS, V20, P613, DOI 10.1016/S0142-9612(98)00211-7
   Klinge U, 1998, EUR J SURG, V164, P951
   KLINGE U, 2001, J INVEST SURG, V13, P47
   Klosterhalfen B, 2002, BRIT J SURG, V89, P1043, DOI 10.1046/j.1365-2168.2002.02149.x
   Klosterhalfen B, 2000, CHIRURG, V71, P43
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Morin B, 2001, ANN CHIR, V126, P876, DOI 10.1016/S0003-3944(01)00627-7
   Rosch Raphael, 2002, BMC Med Genet, V3, P2, DOI 10.1186/1471-2350-3-2
   Schachtrupp A, 2003, BRIT J SURG, V90, P114, DOI 10.1002/bjs.4023
   Schumpelick V, 1999, CHIRURG, V70, P422, DOI 10.1007/s001040050666
   Schumpelick V, 1999, CHIRURG, V70, P876, DOI 10.1007/s001040050737
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Vestweber KH, 1997, ZBL CHIR, V122, P885
NR 29
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 3-540-40757-X
PY 2004
BP 170
EP 178
PG 9
WC Surgery
SC Surgery
GA BY28J
UT WOS:000188743300016
DA 2018-10-19
ER

PT J
AU Hussain, MA
   Siedlecki, CA
AF Hussain, MA
   Siedlecki, CA
TI The platelet integrin alpha(Ilb) beta(3) imaged by atomic force
   microscopy on model surfaces
SO MICRON
LA English
DT Review
DE atomic force microscopy; platelet; platelet glycoprotein
   alpha(IIb)beta(3) complex; integrins; biomaterials; protein structure
ID IIB-IIIA COMPLEX; 3-DIMENSIONAL STRUCTURE; PHOSPHOLIPID-VESICLES;
   ELECTRON-MICROSCOPY; AQUEOUS CONDITIONS; STRUCTURAL MODEL; HUMAN
   FIBRINOGEN; PLASMA-PROTEINS; LIGAND-BINDING; OXIDE SURFACES
AB The platelet membrane receptor alpha(IIb)beta(3) binds to adsorbed protein ligands including fibrinogen, von Willebrand factor and fibronectin, and is critically important in mediating platelet adhesion to damaged subendothelium and to synthetic biomaterial surfaces. This receptor is a member of the integrin family, a highly prevalent class of heterodimeric molecules consisting of a single a and P subunit. In an ongoing effort to understand the mechanisms underlying platelet adhesion events, high-resolution atomic force microscopy (AFM) under dynamic conditions was used to obtain images Of alpha(IIb)beta(3) Molecules as well as aggregates of the protein. Images of integrin molecules were obtained by tapping mode AFM under aqueous buffer conditions following adsorption on a series of ultrasmooth model surfaces. On a model hydrophobic surface, detergents stabilizing the protein in solution competed for surface adsorption sites. When this detergent was removed from the system, the protein was predominantly seen as aggregates with head groups pointing outward. A limited number of individual integrin molecules were observed, and were found to have dimensions consistent with those reported previously by electron microscopy studies. Integrin molecules showed weak adhesion to the two hydrophilic surfaces used in the study, although formation of a lipid bilayer around surface-adsorbed molecules improved the resolution. At longer time periods, the integrin molecules embedded in this lipid bilayer exhibited sufficient mobility to form molecular aggregates. The structural measurements described in this study not only reveal three-dimensional features of the molecule, they represent an important step towards dynamic adsorption experiments and visualizing the integrin interacting with surface-adsorbed proteins as in biomaterial-induced thrombogenesis. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Penn State Univ, Coll Med, Dept Surg, Milton S Hershey Med Ctr,Biomed Engn Inst, Hershey, PA 17033 USA.
   Penn State Univ, Milton S Hershey Med Ctr, Dept Bioengn, Inst Biomed Engn, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Coll Med, Dept Surg, Milton S Hershey Med Ctr,Biomed Engn Inst, 500 Univ Dr,H151, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
RI Hussain, Mohammad/K-3524-2012
CR Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199
   Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S095506740200371X
   BAYERL TM, 1990, BIOPHYS J, V58, P357, DOI 10.1016/S0006-3495(90)82382-1
   Boudreaux MK, 2001, VET PATHOL, V38, P249, DOI 10.1354/vp.38-3-249
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1
   Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x
   Chiu CY, 1999, J VIROL, V73, P6759
   COLLER BS, 1995, THROMB HAEMOSTASIS, V74, P302
   Csucs G, 1998, BBA-BIOMEMBRANES, V1369, P61, DOI 10.1016/S0005-2736(97)00209-5
   EPPELL SJ, 1995, BIOPHYS J, V68, P671, DOI 10.1016/S0006-3495(95)80228-6
   Erb EM, 1997, BIOCHEMISTRY-US, V36, P7395, DOI 10.1021/bi9702187
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   FARRELL DH, 1994, J BIOL CHEM, V269, P226
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   FRITZ M, 1993, EXP CELL RES, V205, P187, DOI 10.1006/excr.1993.1074
   GINSBERG MH, 1995, THROMB HAEMOSTASIS, V74, P352
   GINSBERG MH, 1993, THROMB HAEMOSTASIS, V70, P87
   Haas TA, 1997, PROTEIN ENG, V10, P1395, DOI 10.1093/protein/10.12.1395
   Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200
   Hantgan RR, 2001, PROTEIN SCI, V10, P1614, DOI 10.1110/ps.3001
   HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7
   Holland NB, 1999, J BIOMED MATER RES, V45, P167, DOI 10.1002/(SICI)1097-4636(19990605)45:3<167::AID-JBM2>3.0.CO;2-7
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   John SA, 1997, J STRUCT BIOL, V120, P22, DOI 10.1006/jsbi.1997.3893
   JOHNSON SJ, 1991, BIOPHYS J, V59, P289, DOI 10.1016/S0006-3495(91)82222-6
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Lee I, 2000, COLLOID SURFACE B, V19, P357, DOI 10.1016/S0927-7765(00)00144-2
   Lee I, 2001, SURF SCI, V491, P433, DOI 10.1016/S0039-6028(01)01309-7
   Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098
   Marchant RE, 2002, CURR PROTEIN PEPT SC, V3, P249, DOI 10.2174/1389203023380611
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x
   PACKHAM MA, 1994, CAN J PHYSIOL PHARM, V72, P278, DOI 10.1139/y94-043
   PARISE LV, 1985, J BIOL CHEM, V260, P1750
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144
   Shattil SJ, 1998, BLOOD, V91, P2645
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Siedlecki CA, 1996, BLOOD, V88, P2939
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Smith PR, 1997, AM J PHYSIOL-CELL PH, V272, pC1295
   Taatjes DJ, 1997, CELL BIOL INT, V21, P715, DOI 10.1006/cbir.1997.0216
   Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2
   Tomiyama Y, 2000, INT J HEMATOL, V72, P448
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WEISEL JW, 1992, J BIOL CHEM, V267, P16637
   Wilson DL, 1996, J VAC SCI TECHNOL B, V14, P2407, DOI 10.1116/1.588870
   WILSON DL, 1995, LANGMUIR, V11, P265, DOI 10.1021/la00001a045
   Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535
NR 54
TC 15
Z9 16
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PY 2004
VL 35
IS 7
BP 565
EP 573
DI 10.1016/j.micron.2004.02.010
PG 9
WC Microscopy
SC Microscopy
GA 840JD
UT WOS:000222853700005
PM 15219903
DA 2018-10-19
ER

PT S
AU Wright, BE
   Hlady, V
AF Wright, BE
   Hlady, V
BE Periasamy, A
TI Quantification of integrin dynamics on cell membranes with fluorescence
   correlation spectroscopy
SO MULTIPHOTON MICROSCOPY IN THE BIOMEDICAL SCIENCES IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Multiphoton Microscopy in the Biomedical Sciences IV
CY JAN 25-27, 2004
CL San Jose, CA
SP SPIE, Bio-Rad Lab Inc, Carl Zeiss Inc, Chroma Technol Corp, Coherent Inc, Nikon Inc, Omega Opt Inc, Spectra-Phys Inc
DE fluorescence correlation spectroscopy; integrin; cell adhesion; dorsal
   root ganglion; biomaterial
ID NEURITE OUTGROWTH; PERIPHERAL-NERVE; SCHWANN-CELLS; SPINAL-CORD; GROWTH;
   EXPRESSION; BINDING; RGD; RAT
AB Integrins are an important and highly conserved class of extracellular matrix binding membrane bound receptors that provide a functional linkage between cells and their environment. The excellent spatial resolution and short observation time of a modem fluorescence correlation spectroscopy (FCS) instrument is uniquely suited to the study of quantitative differences in integrin behavior on different parts of a single cell. We hypothesize that the application of FCS to the study of these integrin dynamics on the membranes of nerve cell growth cones will give previously unavailable quantitative insight into nerve cell guidance. Accordingly, we have characterized the application of two integrin-binding small peptide-based FCS analytes to primary rat dorsal root ganglion cells. It results that neither the RGD-based nor the SIKVAV-based analyte exhibited specific association with primary rat dorsal root ganglion growth cone membranes in a range that is accessible to FCS observation. However, the techniques and instrumentation developed for these experiments will be useful for evaluating additional integrin ligands.
C1 Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Wright, BE (reprint author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
CR ARAGON SR, 1976, J CHEM PHYS, V64, P1791, DOI 10.1063/1.432357
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514
   Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409
   Condic ML, 1999, J NEUROSCI, V19, P10036
   Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512
   HLADY V, IN PRESS
   Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000
   Kunath K, 2003, J GENE MED, V5, P588, DOI 10.1002/jgm.382
   Li RH, 1998, METHOD CELL BIOL, V57, P167
   MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103
   Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753
   MORRISSEY TK, 1991, J NEUROSCI, V11, P2433
   Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318
   RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Takagi Y, 1996, J BIOL CHEM, V271, P18074, DOI 10.1074/jbc.271.30.18074
   Vogelezang MG, 2001, J NEUROSCI, V21, P6732
   Widengren J, 1998, CELL MOL BIOL, V44, P857
   YANG G, 1992, J NEUROBIOL, V23, P491, DOI 10.1002/neu.480230505
   Zamir E, 2000, NAT CELL BIOL, V2, P191
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5231-9
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5323
BP 168
EP 176
DI 10.1117/12.528048
PG 9
WC Engineering, Biomedical; Microscopy; Optics; Spectroscopy
SC Engineering; Microscopy; Optics; Spectroscopy
GA BAN20
UT WOS:000222940200018
DA 2018-10-19
ER

PT J
AU Kiyonaka, S
   Sada, K
   Yoshimura, I
   Shinkai, S
   Kato, N
   Hamachi, I
AF Kiyonaka, S
   Sada, K
   Yoshimura, I
   Shinkai, S
   Kato, N
   Hamachi, I
TI Semi-wet peptide/protein array using supramolecular hydrogel
SO NATURE MATERIALS
LA English
DT Article
ID ACHROMOBACTER-LYTICUS M497-1; GLYCOSYLATED AMINO-ACID;
   EXTRACELLULAR-MATRIX; MOLECULAR DESIGN; ORGANIC-SOLVENTS; GELATION
   PROCESS; WATER; PEPTIDE; DERIVATIVES; GELATORS
AB The protein microarray is a crucial biomaterial for the rapid and high-throughput assay of many biological events where proteins are involved. In contrast to the DNA microarray, it has not been sufficiently established because of protein instability under the conventional dry conditions. Here we report a novel semi-wet peptide/protein microarray using a supramolecular hydrogel composed of glycosylated amino acetate. The spontaneous gel-formation and amphiphilic properties of this supramolecular hydrogel have been applied to a new type of peptide/protein gel array that is compatible with enzyme assays. Aqueous cavities created in the gel matrix are a suitable semi-wet reaction medium for enzymes, whereas the hydrophobic domains of the fibre are useful as a unique site for monitoring the reaction. This array system overcomes several drawbacks of conventional protein chips, and thus can have potential applications in pharmaceutical research and diagnosis.
C1 Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8128581, Japan.
   Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Fukuoka 8128581, Japan.
   Kyushu Univ, PRESTO, Synth & Control, JST, Fukuoka 8128581, Japan.
RP Hamachi, I (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8128581, Japan.
RI U-ID, Kyushu/C-5291-2016
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   ALTOMARE A, 1993, J APPL CRYSTALLOGR, V26, P343, DOI 10.1107/S0021889892010331
   Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363
   Bhattacharya S, 1999, CHEM MATER, V11, P3504, DOI 10.1021/cm9902265
   Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172
   Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a
   DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720
   Estroff LA, 2000, ANGEW CHEM INT EDIT, V39, P3447, DOI 10.1002/1521-3773(20001002)39:19<3447::AID-ANIE3447>3.0.CO;2-X
   Hamachi I, 2001, TETRAHEDRON LETT, V42, P6141, DOI 10.1016/S0040-4039(01)01013-9
   Hamachi I, 2000, CHEM COMMUN, P1281, DOI 10.1039/b002545n
   Hanabusa K, 1996, ANGEW CHEM INT EDIT, V35, P1949, DOI 10.1002/anie.199619491
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Jung JH, 2001, LANGMUIR, V17, P7229, DOI 10.1021/la0109516
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kiyonaka S, 2003, SUPRAMOL CHEM, V15, P521, DOI 10.1080/10610270310001605115
   Kiyonaka S, 2002, J AM CHEM SOC, V124, P10954, DOI 10.1021/ja027277e
   Kiyonaka S, 2003, CHEM-EUR J, V9, P976, DOI 10.1002/chem.200390120
   Kobayashi H, 2002, ORG LETT, V4, P1423, DOI 10.1021/ol025519+
   KUNITAKE T, 1992, ANGEW CHEM INT EDIT, V31, P709, DOI 10.1002/anie.199207091
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341
   MacBeath G, 2000, SCIENCE, V289, P1760
   Maitra U, 2001, ANGEW CHEM INT EDIT, V40, P2281, DOI 10.1002/1521-3773(20010618)40:12<2281::AID-ANIE2281>3.0.CO;2-L
   Makarevic J, 2001, CHEM-EUR J, V7, P3328, DOI 10.1002/1521-3765(20010803)7:15<3328::AID-CHEM3328>3.0.CO;2-C
   MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P51, DOI 10.1016/0005-2744(81)90107-8
   MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6
   MATAYOSHI ED, 1990, SCIENCE, V247, P954, DOI 10.1126/science.2106161
   Menger FM, 2000, J AM CHEM SOC, V122, P11679, DOI 10.1021/ja0016811
   MURATA K, 1994, J AM CHEM SOC, V116, P6665
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Oda R, 1998, ANGEW CHEM INT EDIT, V37, P2689, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2689::AID-ANIE2689>3.0.CO;2-Z
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Shena M., 1995, SCIENCE, V270, P467
   STRYER LUBERT, 1965, J MOL BIOL, V13, P482
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Zhu H, 2000, NAT GENET, V26, P283
   Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191
   1999, NATURE GENET S, V21, P1
NR 45
TC 445
Z9 450
U1 15
U2 229
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD JAN
PY 2004
VL 3
IS 1
BP 58
EP 64
DI 10.1038/nmat1034
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 759PL
UT WOS:000187746000017
PM 14661016
DA 2018-10-19
ER

PT S
AU Brioude, V
   Saoudi, R
   le Blanc, D
   Reynaud, S
   Lyndin, N
   Molloy, J
AF Brioude, V
   Saoudi, R
   le Blanc, D
   Reynaud, S
   Lyndin, N
   Molloy, J
BE Geyl, R
   Rimmer, D
   Wang, L
TI Resonant grating biosensor platform design and fabrication
SO OPTICAL FABRICATION, TESTING, AND METROLOGY
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Optical Fabrication, Testing, And Metrology
CY SEP 30-OCT 03, 2003
CL St Etienne, FRANCE
DE optical waveguides; biosensors; coupling gratings
ID WAVE-GUIDES
AB Grating coupled evanescent wave slab waveguide biosensors are now well established(1,2) about twenty years after they were demonstrated(3). They usually rely upon mode excitation from the substrate side, providing a means to measure the bioreaction at the waveguide surface through the monitoring of the conditions of mode excitation. A new readout principle will be presented whereby the incident beam undergoes a sharp and high reflection while being trapped into the biomaterial loaded grating waveguide. The high index metal oxide waveguide and the grating are designed so that the evanescent wave sensitivity is maximum(4) and the conditions for resonant reflection are fulfilled 5 for both polarizations close to normal incidence. Under these conditions, the grating corrugation cannot be located on both sides of the waveguide, as usually preferred, since the grating strength of the TM polarization would be too low. The corrugation must therefore be at the analyte side of the metal oxide layer; this calls for a specific grating fabrication technology. The option retained for low cost manufacturing is that of wet etching of Ta2O5. This is quite a challenging problem since there is no wet etchant of high density Ta2O5 which does not dissolve standard photoresist, and since the isotropy of wet etching is likely to smooth out the required short period corrugation by underetching. This paper describes the rationale of the design of the reflection interrogation scheme and brings the experimental evidence of the effect obtained on wet etched sensor platforms.
C1 Lab TSI, St Etienne, France.
RP Brioude, V (reprint author), Lab TSI, St Etienne, France.
EM gratings@univ-st-etienne.fr; Lyndin@ran.gpi.ru; james@jmollo.demon.co.uk
CR Avrutskii I. A., 1986, Soviet Journal of Quantum Electronics, V16, P1063, DOI 10.1070/QE1986v016n08ABEH007239
   AVRUTSKY IA, 1989, J MOD OPTIC, V36, P1303, DOI 10.1080/09500348914551351
   Brioude V, 2000, OPT QUANT ELECTRON, V32, P899, DOI 10.1023/A:1007030931823
   BRIOUDE V, 2000, 20 JOURN NAT OPT GUI
   Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V87, P365, DOI 10.1016/S0925-4005(02)00273-3
   Golubenko G. A., 1985, Soviet Journal of Quantum Electronics, V15, P886, DOI 10.1070/QE1985v015n07ABEH007275
   Lukosz W, 1983, IEE C PUBL LONDON, V227, P152
   TIEN PK, 1977, REV MOD PHYS, V49, P361, DOI 10.1103/RevModPhys.49.361
   TISHCHENKO AV, 2003, 11 INT WORKSH OPT WA
   Wiki M, 1998, BIOSENS BIOELECTRON, V13, P1181, DOI 10.1016/S0956-5663(98)00079-7
   WIRGIN A, 1981, OPT ACTA, V28, P1377, DOI 10.1080/713820448
NR 11
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5136-3
J9 PROC SPIE
PY 2004
VL 5252
BP 209
EP 216
DI 10.1117/12.513695
PG 8
WC Engineering, Manufacturing; Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BY77Q
UT WOS:000189460300024
DA 2018-10-19
ER

PT S
AU Wang, WW
   Knopf, GK
   Bassi, AS
AF Wang, WW
   Knopf, GK
   Bassi, AS
BE Moon, KS
TI Light-addressable bacteriorhodopsin photocell
SO OPTOMECHATRONIC SENSORS, ACTUATORS, AND CONTROL
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optomechantronic Sensors, Actuators and Control
CY OCT 25-26, 2004
CL Philadelphia, PA
SP SPIE, IEICE Commun Soc, IEICE Elect Soc
DE photoelectric transducers; bacteriorodopsin films; ITO electrode;
   photocell; optical hybrids
ID PURPLE-MEMBRANE FILMS; PHOTOCURRENT; MECHANISM; MEMORIES; PROTEIN; PROBE
AB Bacteriorhodopsin (W) thin films have been investigated in recent years as a viable biomaterial for constructing microor nanoscale optical devices. During illumination, the bR molecules in the thin film undergo a photocycle that is followed by a proton transport from the cytoplasmatic side to the extracellular side of the cell membrane. The photoelectric response induced by the charge displacement can be influenced by both the wavelength and intensity of the impinging light sources. A photocell based on the photoelectric properties of a thin bR film is described in this paper. The bR-based photocell is built as a sandwich-structural device with an ITO (Indium Tin Oxide) electrode/bR film/ITO electrode configuration. The photocell is fabricated by depositing the oriented bR film onto the grounded ITO electrode. The cytoplasmic side of the bR membrane is attached to the ITO conductive surface and the extracelluar side is placed in contact with the second ITO electrode that provides the signal input to the instrumentation circuit. A polyester thin film was used as the spacer separating the two ITO electrodes. The size of the active area of the photocell is about 10x10 mm. A HeNe laser coupled with an acoustic-optical scanning system is used as the light source. Experimental results confirm that the photoelectric response generated by the bR-photocell prototype is durable, stable, and highly sensitive to changes in light intensity. The sensitivity of the proposed signal transducer is 10.25mV/mW. The wavelength dependence of the photoelectric responses is similar to the optical absorption spectrum of bR membrane.
C1 Univ Western Ontario, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.
RP Wang, WW (reprint author), Univ Western Ontario, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.
CR BHATTACHARYA P, 2002, OPTICS LETT      MAY, P839
   BIRGE RR, 1992, COMPUTER, V25, P56, DOI 10.1109/2.166417
   DER A, 2001, BIOKHIMIYA, V66, P1527
   GROMA GI, 1992, BIOSYSTEMS, V27, P201, DOI 10.1016/0303-2647(92)90056-5
   Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x
   He JA, 1999, ADV MATER, V11, P435, DOI 10.1002/(SICI)1521-4095(199904)11:6<435::AID-ADMA435>3.3.CO;2-L
   Hong FT, 1999, PROG SURF SCI, V62, P1, DOI 10.1016/S0079-6816(99)00014-3
   Huang YH, 2003, CHINESE PHYS LETT, V20, P959
   KNOPF GK, 2003, HANDBOOK
   KONONENKO AA, 1987, BIOCHIM BIOPHYS ACTA, V892, P56, DOI 10.1016/0005-2728(87)90247-7
   KONONENKO AA, 1986, BIOCHIM BIOPHYS ACTA, V850, P162, DOI 10.1016/0005-2728(86)90021-6
   Min JH, 1998, THIN SOLID FILMS, V327, P698, DOI 10.1016/S0040-6090(98)00744-5
   Shibata A, 2002, COLLOID SURFACE B, V23, P375, DOI 10.1016/S0927-7765(01)00272-7
   VARO G, 1983, BIOPHYS J, V43, P47, DOI 10.1016/S0006-3495(83)84322-7
   WANG WW, 2003, OPTOMECHATRONIC SYST, V4, P194
NR 15
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5555-5
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5602
BP 41
EP 50
DI 10.1117/12.578033
PG 10
WC Automation & Control Systems; Engineering, Mechanical; Instruments &
   Instrumentation; Optics
SC Automation & Control Systems; Engineering; Instruments &
   Instrumentation; Optics
GA BBJ97
UT WOS:000225835100006
DA 2018-10-19
ER

PT B
AU Vacatello, M
   D'Auria, G
   Falcigno, L
   Oliva, R
   Bevilacqua, C
   Dettin, M
   Conconi, MT
   Gambaretto, R
   Di Bello, C
   Paolillo, L
AF Vacatello, Manuela
   D'Auria, Gabriella
   Falcigno, Lucia
   Oliva, Romina
   Bevilacqua, Carmen
   Dettin, Monica
   Conconi, Maria T.
   Gambaretto, Roberta
   Di Bello, Carlo
   Paolillo, Livio
BE Chorev, M
   Sawyer, TK
TI Conformation and bioactive properties of novel osteoblast-adhesive
   peptides for biomaterial design
SO Peptide Revolution: Genomics, Proteomics & Therapeutics
LA English
DT Proceedings Paper
CT 18th American Peptide Symposium
CY JUL 19-23, 2003
CL BOSTON, MA
ID BONE-DERIVED CELLS; SPATIAL-DISTRIBUTION; HEPARIN; VITRONECTIN;
   FIBRONECTIN; ATTACHMENT; DOMAIN; NMR
C1 Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy.
RP Vacatello, M (reprint author), Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy.
RI Falcigno, Lucia/A-6720-2012
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CASE DA, 1999, AMBER 6
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284
   MARGALIT H, 1993, J BIOL CHEM, V268, P19228
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   SUZUKI S, 1984, J BIOL CHEM, V259, P5307
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
NR 13
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
BN 0-9715560-1-6
PY 2004
BP 797
EP 799
PG 3
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA BEQ46
UT WOS:000238911100337
DA 2018-10-19
ER

PT J
AU Gunaydin, S
AF Gunaydin, S
TI Clinical significance of coated extracorporeal circuits: a review of
   novel technologies
SO PERFUSION-UK
LA English
DT Article; Proceedings Paper
CT 3rd International Workshop on Therapeutic Filtration
CY JUL, 2002
CL IMPERIAL COLL, HAMMERSMITH HOSP, LONDON, ENGLAND
HO IMPERIAL COLL, HAMMERSMITH HOSP
ID SURFACE-MODIFYING ADDITIVES; CARDIOPULMONARY BYPASS; BLOOD
   COMPATIBILITY; BIOCOMPATIBILITY; CIRCULATION; HEMOCOMPATIBILITY;
   BIOMATERIALS; OXYGENATOR; IMPROVE; PMEA
AB Coating of extracorporeal circuits may be a solution to prevent adverse effects induced by the contact of blood elements and proteins with foreign surfaces. This paper reviews the recent novel coating technologies and compares their documented in vitro and ex vivo advantages under the clinical setting. Data presented have also been supported by postclinical biomaterial research to verify biocompatibility and hemocompatibility.
C1 Numune Training & Res Hosp, Ankara, Turkey.
RP Gunaydin, S (reprint author), Angora Evleri,E-3 Blok No 23, TR-06530 Ankara, Turkey.
EM sgunaydin@isnet.net.tr
CR Courtney JM, 2003, PERFUSION-UK, V18, P33, DOI 10.1191/0267659103pf633oa
   COURTNEY JM, 1995, ARTIF ORGANS, V19, P852, DOI 10.1111/j.1525-1594.1995.tb02440.x
   De Somer F, 2000, EUR J CARDIO-THORAC, V18, P602, DOI 10.1016/S1010-7940(00)00508-X
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   Ereth MH, 2001, J CARDIOTHOR VASC AN, V15, P545, DOI 10.1053/jcan.2001.26525
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   Gourlay T, 2001, PERFUSION-UK, V16, P381, DOI 10.1177/026765910101600508
   Griffith K E, 1994, J Extra Corpor Technol, V26, P114
   Gu YJ, 1998, ANN THORAC SURG, V65, P1342, DOI 10.1016/S0003-4975(98)00223-9
   Gunaydin S, 2002, ANN THORAC SURG, V74, P819, DOI 10.1016/S0003-4975(02)03796-7
   Harig F, 2001, SHOCK, V16, P33, DOI 10.1097/00024382-200116001-00007
   Janvier G, 1996, ANN THORAC SURG, V62, P1926, DOI 10.1016/S0003-4975(96)00942-3
   Kocakulak M, 2002, J BIOACT COMPAT POL, V17, P343, DOI 10.1106/088391102029554
   Mahoney CB, 1998, PERFUSION-UK, V13, P192, DOI 10.1177/026765919801300307
   Rega FR, 2003, PERFUSION-UK, V18, P13, DOI 10.1191/0267659103pf624oa
   Sinci V, 1999, Ann Thorac Cardiovasc Surg, V5, P156
   Stammers AH, 2001, J CARDIOTHOR VASC AN, V15, P539, DOI 10.1053/jcan.2001.26521
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tevaearai HT, 1999, INT J ARTIF ORGANS, V22, P629
   Vijay V, 2003, PERFUSION-UK, V18, P41, DOI 10.1191/0267659103pf626oa
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
NR 21
TC 19
Z9 20
U1 0
U2 3
PU ARNOLD, HODDER HEADLINE PLC
PI LONDON
PA 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PY 2004
VL 19
SU 1
BP S33
EP S41
DI 10.1191/0267659104pf718oa
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 815EU
UT WOS:000221026400005
PM 15161062
DA 2018-10-19
ER

PT J
AU Rubens, FD
   Mesana, T
AF Rubens, FD
   Mesana, T
TI The inflammatory response to cardiopulmonary bypass: a therapeutic
   overview
SO PERFUSION-UK
LA English
DT Article; Proceedings Paper
CT 3rd International Workshop on Therapeutic Filtration
CY JUL, 2002
CL IMPERIAL COLL, HAMMERSMITH HOSP, LONDON, ENGLAND
HO IMPERIAL COLL, HAMMERSMITH HOSP
ID HIGH-DOSE METHYLPREDNISOLONE; CARDIAC-SURGERY; BLOOD ACTIVATION;
   PLATELET DYSFUNCTION; HEART-SURGERY; HEPARIN; CIRCUITS; INHIBITION;
   SURFACES; CYTOKINE
AB The demographic of cardiac surgery patients continues to evolve to include older, sicker candidates, all the while maintaining an expectation of excellent outcomes. These latter results can only be achieved by the parallel advancement and re-examination of the technology of cardiopulmonary bypass (CPB); the key tool used daily by surgical teams worldwide. In this review, we will provide an overview of integrated therapeutic strategies that can be utilized to minimize the complex and myriad changes related to inflammation after CPB with the understanding that this may abrogate the detrimental end-organ and systemic effects of blood activation. Therapeutic strategies specifically related to the technology can be classified into those targeting biomaterial dependent or independent processes. The former can be addressed by the utilization of currently available biocompatible surfaces such as with heparin-coated circuits, phosphorylcholine-coated circuits ('biomembrane mimicry') and circuits composed of copolymers containing surface-modifying additives. The most important strategies related to biomaterial independent activation include the modification of techniques related to cardiotomy blood management and blood filtration. Finally, all of these strategies must be integrated and tailored with complementary pharmacologic agents such as aprotinin and steroids to optimize anti-inflammatory synergism. Only if we are armed with a comprehensive knowledge of the molecular and cellular basis for these strategies will we be able to continue to evolve our treatment in parallel with our patients to achieve these goals.
C1 Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
RP Rubens, FD (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM frubens@ottawaheart.ca
CR Aldea GS, 1996, ANN THORAC SURG, V62, P410, DOI 10.1016/0003-4975(96)00249-4
   Andersen L W, 1989, J Cardiothorac Anesth, V3, P544, DOI 10.1016/0888-6296(89)90150-6
   ANDERSEN LW, 1993, CRIT CARE MED, V21, P210, DOI 10.1097/00003246-199302000-00011
   Baufreton C, 1997, ANN THORAC SURG, V63, P50
   Brooker RF, 1998, ANN THORAC SURG, V65, P1651, DOI 10.1016/S0003-4975(98)00289-6
   Campbell E J, 1994, ASAIO J, V40, pM853, DOI 10.1097/00002480-199407000-00118
   CHENOWETH DE, 1981, NEW ENGL J MED, V304, P497, DOI 10.1056/NEJM198102263040901
   Chung JH, 1996, CIRCULATION, V93, P2014, DOI 10.1161/01.CIR.93.11.2014
   De Somer F, 2002, J THORAC CARDIOV SUR, V123, P951, DOI 10.1067/mtc.2002.120334
   De Somer F, 2000, EUR J CARDIO-THORAC, V18, P602, DOI 10.1016/S1010-7940(00)00508-X
   Defraigne JO, 2000, ANN THORAC SURG, V70, P2075, DOI 10.1016/S0003-4975(00)01838-5
   DEHAAN J, 1995, ANN THORAC SURG, V59, P901, DOI 10.1016/0003-4975(95)00012-A
   Deppisch R, 1998, SEP PURIF TECHNOL, V14, P241, DOI 10.1016/S1383-5866(98)00079-3
   Deppisch R, 1998, NEPHROL DIAL TRANSPL, V13, P1354, DOI 10.1093/oxfordjournals.ndt.a027892
   Diego RP, 1997, J CARDIOTHOR VASC AN, V11, P29, DOI 10.1016/S1053-0770(97)90248-2
   ELGUE G, 1993, THROMB HAEMOSTASIS, V70, P289
   FEARON DT, 1980, J EXP MED, V152, P20, DOI 10.1084/jem.152.1.20
   Gorman RC, 1996, J THORAC CARDIOV SUR, V111, P1, DOI 10.1016/S0022-5223(96)70395-1
   Heller W, 1989, Adv Exp Med Biol, V247B, P43
   HILL GE, 1994, ANESTH ANALG, V79, P23
   HILL GE, 1995, AM J RESP CRIT CARE, V152, P1791, DOI 10.1164/ajrccm.152.6.8520738
   ICHINOSE A, 1984, FEBS LETT, V175, P412, DOI 10.1016/0014-5793(84)80779-6
   JANSEN NJG, 1991, EUR J CARDIO-THORAC, V5, P211, DOI 10.1016/1010-7940(91)90032-F
   JANSEN NJG, 1991, J THORAC CARDIOV SUR, V102, P515
   KAWAMURA T, 1995, CAN J ANAESTH, V42, P399, DOI 10.1007/BF03015485
   Kawamura T, 1999, CRIT CARE MED, V27, P545, DOI 10.1097/00003246-199903000-00033
   KHURI SF, 1995, ANN THORAC SURG, V60, P1008, DOI 10.1016/0003-4975(95)00668-B
   KIM KU, 1993, IMMUNOLOGY, V80, P134
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   Lewis AL, 2002, J BIOMED MATER RES, V63, P699, DOI 10.1002/jbm.10387
   Mahoney CB, 1998, PERFUSION-UK, V13, P192, DOI 10.1177/026765919801300307
   Mayumi H, 1997, ANN THORAC SURG, V63, P129
   MAYUMI H, 1994, J THORAC CARDIOV SUR, V108, P179
   Mayumi H, 2000, Jpn J Thorac Cardiovasc Surg, V48, P47
   Muriithi EW, 2000, ANN THORAC SURG, V69, P1827, DOI 10.1016/S0003-4975(00)01299-6
   Murphy EF, 1999, LANGMUIR, V15, P1313, DOI 10.1021/la9813580
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   OLSON ST, 1993, BIOCHEMISTRY-US, V32, P12136, DOI 10.1021/bi00096a026
   OudemansvanStraaten HM, 1996, J CARDIOTHOR VASC AN, V10, P187, DOI 10.1016/S1053-0770(96)80235-7
   OVRUM E, 1995, ANN THORAC SURG, V60, P365, DOI 10.1016/0003-4975(95)00366-S
   Ovrum E, 1996, ANN THORAC SURG, V62, P1128, DOI 10.1016/0003-4975(96)00490-0
   Parratt R, 1998, BRIT J HAEMATOL, V101, P40, DOI 10.1046/j.1365-2141.1998.00674.x
   Ranucci M, 1999, ANN THORAC SURG, V67, P994, DOI 10.1016/S0003-4975(99)00062-4
   Rich JB, 1998, ANN THORAC SURG, V66, pS6, DOI 10.1016/S0003-4975(98)00964-3
   RUBENS F, 1992, J BIOMED MATER RES, V26, P1651, DOI 10.1002/jbm.820261209
   Rubens FD, 1999, ANN THORAC SURG, V67, P689, DOI 10.1016/S0003-4975(99)00068-5
   RUBENS FD, 2004, SABISTON SPENCER SUR
   RUCINSKI B, 1979, BLOOD, V53, P47
   SCHONBERGER JPAM, 1995, ANN THORAC SURG, V59, P1549, DOI 10.1016/0003-4975(95)00241-C
   SHEPPECK RA, 1991, BLOOD, V78, P673
   STEINBERG JB, 1993, J THORAC CARDIOV SUR, V106, P1008
   Sugiyama K, 2000, MACROMOL MATER ENG, V282, P5, DOI 10.1002/1439-2054(20001001)282:1<5::AID-MAME5>3.0.CO;2-H
   Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3
   TABUCHI N, 1993, J THORAC CARDIOV SUR, V106, P828
   Tassani P, 1999, J CARDIOTHOR VASC AN, V13, P165, DOI 10.1016/S1053-0770(99)90081-2
   Te Velthuis Henk, 1997, Journal of Thoracic and Cardiovascular Surgery, V114, P117, DOI 10.1016/S0022-5223(97)70124-7
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   TEOH KHT, 1995, CIRCULATION, V92, P347, DOI 10.1161/01.CIR.92.9.347
   VANDEVENTER SJH, 1991, PROG CLIN BIOL RES, V367, P101
   WACHTFOGEL YT, 1993, J THORAC CARDIOV SUR, V106, P1
   Wan S, 1999, J THORAC CARDIOV SUR, V117, P1004, DOI 10.1016/S0022-5223(99)70382-X
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   Yilmaz M, 1999, PERFUSION-UK, V14, P201, DOI 10.1177/026765919901400308
   2000, TRILLIUM AFFINITY NT
NR 64
TC 31
Z9 41
U1 0
U2 0
PU ARNOLD, HODDER HEADLINE PLC
PI LONDON
PA 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PY 2004
VL 19
SU 1
BP S5
EP S12
DI 10.1191/0267659104pf717oa
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 815EU
UT WOS:000221026400002
PM 15161059
DA 2018-10-19
ER

PT S
AU Mwenifumbo, S
   Li, MW
   Soboyejo, W
AF Mwenifumbo, S
   Li, MW
   Soboyejo, W
BE Herman, PR
   Fieret, J
   Pique, A
   Okada, T
   Bachmann, FG
   Hoving, W
   Washio, K
   Xu, X
   Dubowski, JJ
   Geohegan, DB
   Trager, F
TI Cell/surface interactions on laser micro-textured titanium-coated
   silicon surfaces
SO PHOTON PROCESSING IN MICROELECTRONICS AND PHOTONICS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Photon Processing in Microelectronics and Photonics III
CY JAN 26-29, 2004
CL San Jose, CA
SP SPIE
DE silicon; laser ablation; micro-grooves; human osteosarcoma cells; cell
   adhesion
ID HUMAN OSTEOBLAST ADHESION; CELL BEHAVIOR; TOPOGRAPHICAL CONTROL;
   BIOMATERIAL SURFACES; MORPHOLOGIC ASPECTS; CONTACT GUIDANCE; IN-VITRO;
   FIBROBLASTS; RESPONSES; SUBSTRATA
AB This paper presents the results of recent efforts to improve the biocompatibility and integration of implantable bioMEMS devices. Laser micro-grooves and micro-grids were irradiated onto silicon surfaces using ultraviolet lasers. The microtextured surfaces were then coated with nano-scale layers of titanium to promote improved biocompatibility. The microgroove geometries have been shown to promote contact guidance, which leads to reduced scar tissue formation. In contrast, smooth surfaces result in random cell orientations and the increased possibility of scar tissue formation. The nature of the cellular attachment and adhesion to the coated/uncoated micro-textured surfaces was elucidated by the visualization of the cells through scanning electron microscopy. Finally, the implications of the results are discussed for integration of silicon-based microelectronics and sensors into biological systems.
C1 Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA.
RP Mwenifumbo, S (reprint author), Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA.
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Cao X, 2001, BIOMED MICRODEVICES, V3, P109, DOI 10.1023/A:1011494008729
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429
   CLARK P, 1987, DEVELOPMENT, V99, P439
   CULLIS AG, 1985, REP PROG PHYS, V48, P1155, DOI 10.1088/0034-4885/48/8/002
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Hanein Y, 2001, SENSOR ACTUAT B-CHEM, V81, P49, DOI 10.1016/S0925-4005(01)00925-X
   LI M, 2002, P SPIE 4830 OS, P206
   LIEPMANN D, 2001, P 3 KOR MEMS C, P13
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   MILBURN C, IN PRESS J MAT SCI M
   MOSBACHER M, 2002, PARTICLES SURFACES, V7, P275
   MWENIFUMBO S, UNPUB INVESTIGATION
   MWENIFUMBO S, 2003, SURFACE ENG MAT SCI, V2, P141
   MWENIFUMBO S, IN PRESS J MAT SCI M
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ricci J.L., 2000, BONE ENG, P1
   Ricci JL, 2001, KEY ENG MAT, V198-1, P179, DOI 10.4028/www.scientific.net/KEM.198-199.179
   RICCI JL, 1994, P 20 ANN M SOC BIOM, P401
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Soboyejo WO, 2001, KEY ENG MAT, V198-1, P203, DOI 10.4028/www.scientific.net/KEM.198-199.203
   Strong ZA, 2002, BIOMED MICRODEVICES, V4, P97, DOI 10.1023/A:1014627029818
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0
   Wang JHC, 2000, CONNECT TISSUE RES, V41, P29, DOI 10.3109/03008200009005639
   WOOD RF, 1984, SEMICONDUCT SEMIMET, P23
NR 34
TC 1
Z9 1
U1 1
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5247-5
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5339
BP 214
EP 225
DI 10.1117/12.531643
PG 12
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BAR96
UT WOS:000223331300023
DA 2018-10-19
ER

PT J
AU Podbielska, H
   Ulatowska-Jarza, A
   Holowacz, I
AF Podbielska, H
   Ulatowska-Jarza, A
   Holowacz, I
TI Sol-gel applicators for medical light therapy
SO PHYSICA MEDICA
LA English
DT Article; Proceedings Paper
CT International Symposium on Medical Physics
CY NOV 13-15, 2003
CL Ustron, POLAND
SP Univ Silesia, A Chelkowski Inst Phys
DE sol-gel biomaterial; medical light applicator
ID PHOTODYNAMIC THERAPY
AB The fiberoptics applicators for light therapy were constructed from plastic-clad silica fibers with the fiber tip modified by sol-gel coatings. These coatings were produced as sol-gel films placed on the fiber cores. It was demonstrated that the light distribution around the applicator can be modified by using coatings with chosen R ratio, whereas R denotes the number of solvent moles to number of precursor moles. The more light is emitted from the applicator made with higher R ratio.
C1 Wroclaw Tech Univ, Inst Phys, BioOpt Grp, PL-50370 Wroclaw, Poland.
   Tech Univ Berlin, Inst Opt, D-10623 Berlin, Germany.
   Laser & Med Technol Berlin, D-14195 Berlin, Germany.
RP Podbielska, H (reprint author), Wroclaw Tech Univ, Inst Phys, BioOpt Grp, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM info@halinapodbielska.pl
RI Podbielska, Halina/A-7311-2012
OI Podbielska, Halina/0000-0001-7162-8530
CR ABRAMOFF B, 1990, SPIE, V1328, P241
   Bissonnette R, 2002, J INVEST DERMATOL, V119, P77, DOI 10.1046/j.1523-1747.2002.01827.x
   BRINKER CJ, 1990, SOL GEOL SCI
   EBELMEN M, 1845, CR HEBD ACAD SCI, V21, P502
   Faust V, 2002, KEY ENG MAT, V206-2, P1547, DOI 10.4028/www.scientific.net/KEM.206-213.1547
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Ibbotson SH, 2002, BRIT J DERMATOL, V146, P178, DOI 10.1046/j.0007-0963.2001.04689.x
   JORGENSEN CK, 1992, STRUCT BOND, P77
   JORGENSEN CK, 1996, STRUCT BOND, P92
   KLEIN LC, 1994, SOL GEOL OPTICS PROC
   Lechna-Marczynska M, 2001, OPT APPL, V31, P257
   Muller G. J., 1995, LASER INDUCED INTERS
   Rohde E., 2001, MED LASER APPL, V16, P81
   Touma DJ, 2003, SEMIN CUTAN MED SURG, V22, P124, DOI 10.1053/sder.2003.50012
   ULATOWSKAJARZA A, 2001, P SPIE BIOPH INSTR A, V4597, P75
NR 15
TC 1
Z9 1
U1 0
U2 3
PU ISTITUTI EDITORIALI E POLGRAFICI INTERNAZIONALI
PI PISA
PA CASELLA POSTALE N 1, SUCCURSALE N 8, 56123 PISA, ITALY
SN 1120-1797
J9 PHYS MEDICA
JI Phys. Medica
PY 2004
VL 20
SU 1
BP 37
EP 39
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 902CI
UT WOS:000227328500011
DA 2018-10-19
ER

PT J
AU Strehle, MA
   Rosch, P
   Petry, R
   Hauck, A
   Thull, R
   Kiefer, W
   Popp, J
AF Strehle, MA
   Rosch, P
   Petry, R
   Hauck, A
   Thull, R
   Kiefer, W
   Popp, J
TI A Raman spectroscopic study of the adsorption of fibronectin and
   fibrinogen on titanium dioxide nanoparticles
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID BOVINE SERUM-ALBUMIN; PROTEIN SECONDARY STRUCTURE; METAL-OXIDE SURFACES;
   CRYSTAL-STRUCTURE; CELL ATTACHMENT; IMPLANTS; HYDROXYAPATITE;
   BIOMATERIAL; MECHANISM; MOLECULES
AB The adsorption of proteins that contain the amino acid sequence Arg-Gly-Asp (RGD) plays a crucial role for the biocompatibility of implant materials. Detailed knowledge of the adsorption process is of great interest because it is a dominant factor that decides on the integration or rejection of an implant by the organism. We have studied the adsorption process on titanium dioxide nanoparticles via two proteins, namely fibrinogen and fibronectin. Bulk protein spectra are compared to spectra of proteins that were adsorbed on TiO2 nanoparticles (as an enlarged model surface for TiO2 implants). In the Raman spectra of the adsorbed proteins a characteristic band occurs that can be assigned to an interaction between TiO2 nanoparticles and the carboxylate groups of the protein. A moderate shift of the amide I band towards higher wavenumbers observed in the adsorbed fibrinogen spectrum in comparison to the bulk protein spectrum is due to conformational changes during the adsorption process. In the spectra of adsorbed fibrinogen the peak area of the multiplet of CH3 and CH2 deformation modes in relation to the amide I Raman peak area is decreased as compared to the spectra of bulk fibrinogen. These spectral features indicate an increasing content of beta-sheet and a decrease of alpha-helical structure content for fibrinogen while for fibronectin an increase of beta-sheet structure and a decreasing content of random coil structure was found. The adsorption takes place via the protein side-chains.
C1 Univ Jena, Inst Phys Chem, D-07743 Jena, Germany.
   Univ Wurzburg, Abt Funkt Werkstoffe Med & Zahnheilkunde, D-97072 Wurzburg, Germany.
   Univ Wurzburg, Inst Phys Chem, D-97074 Wurzburg, Germany.
RP Popp, J (reprint author), Univ Jena, Inst Phys Chem, Helmholtzweg 4, D-07743 Jena, Germany.
EM juergen.popp@uni-jena.de
RI Popp, Juergen/E-6471-2012
CR BERNARDI G, 1968, BIOCHIM BIOPHYS ACTA, V160, P301, DOI 10.1016/0005-2795(68)90203-1
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Creighton T. E., 1993, PROTEINS
   DOEUFF S, 1987, J NON-CRYST SOLIDS, V89, P206, DOI 10.1016/S0022-3093(87)80333-2
   Dopner S, 2002, BIOMATERIALS, V23, P1337, DOI 10.1016/S0142-9612(01)00252-6
   EFFAH EAB, 1995, J BIOMED MATER RES, V29, P73, DOI 10.1002/jbm.820290111
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Faust V, 2002, KEY ENG MAT, V206-2, P1547, DOI 10.4028/www.scientific.net/KEM.206-213.1547
   Fukuzaki S, 1996, J FERMENT BIOENG, V81, P163, DOI 10.1016/0922-338X(96)87596-9
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   HAY DI, 1979, J DENT RES, V58, P930, DOI 10.1177/00220345790580024701
   HEALY KE, 1991, BIOMATERIALS, V12, P593
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   KONIG L, 1972, J POLYM SCI D, V59, P177
   Leize EM, 1999, ANAL BIOCHEM, V272, P19, DOI 10.1006/abio.1999.4142
   LENK TJ, 1989, J BIOMED MATER RES, V23, P549, DOI 10.1002/jbm.820230603
   LIEDBERG B, 1984, J BIOCHEM BIOPH METH, V9, P233, DOI 10.1016/0165-022X(84)90028-9
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H
   MCQUEEN D, 1982, ADV BIOMATER, V4, P179
   MORENO EC, 1984, CALCIFIED TISSUE INT, V36, P48, DOI 10.1007/BF02405293
   Nakamoto K., 1978, INFRARED RAMAN SPECT
   Overman SA, 1999, BIOCHEMISTRY-US, V38, P4018, DOI 10.1021/bi982901e
   PARKER FS, 1983, APPL INFRARED RAMAN, P101
   Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320
   Petry R, 2003, CHEMPHYSCHEM, V4, P14, DOI 10.1002/cphc.200390004
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sane SU, 1999, ANAL BIOCHEM, V269, P255, DOI 10.1006/abio.1999.4034
   Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   URLAUB R, 1999, THESIS J MAXIMILIANS
   Vasin SL, 1998, J BIOMED MATER RES, V39, P491, DOI 10.1002/(SICI)1097-4636(19980305)39:3<491::AID-JBM21>3.3.CO;2-Z
   Voger E A, 1987, J Biomed Mater Res, V21, P1197
   Vollhardt K. P. C., 2000, ORGANISCHE CHEM
   Wassell DTH, 1996, BIOMATERIALS, V17, P859, DOI 10.1016/0142-9612(96)83280-7
   Yang Z, 2000, P NATL ACAD SCI USA, V97, P3907, DOI 10.1073/pnas.080065697
   Yongoli C, 1999, J COLLOID INTERF SCI, V214, P38, DOI DOI 10.1006/JCIS.1999.6159
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
NR 45
TC 39
Z9 39
U1 0
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2004
VL 6
IS 22
BP 5232
EP 5236
DI 10.1039/b406524g
PG 5
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 870BC
UT WOS:000225028000020
DA 2018-10-19
ER

PT J
AU Yuan, YL
   Zang, XP
   Ai, F
   Zhou, J
   Shen, J
   Lin, SC
AF Yuan, YL
   Zang, XP
   Ai, F
   Zhou, J
   Shen, J
   Lin, SC
TI Grafting sulfobetaine monomer onto silicone surface to improve
   haemocompatibility
SO POLYMER INTERNATIONAL
LA English
DT Article
DE silicone film; DMMSA; ozonization; graft polymerization; platelet
   adhesion; protein adsorption
ID PLATELET-ADHESION; CHEMICAL MODIFICATION; POLYMERS; POLYMERIZATION
AB Silicone rubber has been used as a biomaterial for more than two decades and displays good mechanical and optical properties, but its chemical nature, poor antithrombogenicity, as well as its hydrophobicity, prevents its use in many demanding biomedical applications. In order to provide modified silicone with enhanced haemocompatibility, surface modification techniques were used. Ozonization was used to introduce active peroxide groups onto the silicone film surface and, subsequently, graft polymerization of N,N'-dimethyl-N-methacryloyloxyethyl-N-(3-sulfopropyl) ammonium (DMMSA), a zwitterionic sulfobetaine structure, onto the ozone activated silicone surface was conducted. Surface analysis was accomplished by means of attenuated total reflectance-Fourier-transform infrared (ATR-FTIR), and X-ray photoelectron spectra (XPS), and scanning electron microscopy (SEM) and contact angle measurement. ATR-FTIR and XPS investigation confirmed the graft polymerization. The grafted film possessed a relatively hydrophilic surface as indicated by contact angle measurement. The blood compatibility of the grafted films was evaluated by platelet adhesion in platelet-rich plasma (PRP) and protein adsorption in bovine fibrinogen using silicone film as the reference. No platelet adhesion was observed for the grafted, films incubated in PRP for 120 min. The protein adsorption was reduced on the grafted films after incubated in bovine fibrinogen for 120 min. These results confirmed that the improved blood compatibility was obtained by grafting this new zwitterronic sulfobetaine structure onto silicone film. (C) 2003 Society of Chemical Industry.
C1 Nanjing Univ, Coll Chem & Chem Engn, Nanjing 210093, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Coll Chem & Chem Engn, Nanjing 210093, Peoples R China.
EM chennju@263.net
CR AI F, 2002, ACTA POLYMERICA SINC, V4, P257
   Andrade J. D., 1987, ASAIO J, V33, P75
   ARKLES B, 1983, CHEMTECH, V13, P542
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BRASH JL, 1985, MAKROMOL CHEM S, V9, P69
   Cheo SHY, 2001, J MATER SCI-MATER M, V12, P377, DOI 10.1023/A:1011280416520
   CHUANG HYK, 1978, J LAB CLIN MED, V93, P483
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   FOUGNOT C, 1984, MACROMOLECULAR BIOMA
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HORNING EC, 1955, ORGANIC SYNTHESIS CO, V3, P415
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   Ji LY, 2000, REACT FUNCT POLYM, V46, P145, DOI 10.1016/S1381-5148(00)00048-1
   Kokatnur V. R., 1941, J AM CHEM SOC, V63, P1432
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Lelah M. D., 1986, POLYURETHANES MED
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   LIN SC, 1991, J BIOMED MATER RES, V25, P791, DOI 10.1002/jbm.820250608
   Lin SC, 1998, POLYM B, V1, P1
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   NEILL TO, 1972, J POLYM SCI POL CHEM, V10, P569
   PENN LS, 1994, POLYM ADVAN TECHNOL, V5, P809
   REIM M, 1992, Der Ophthalmologe, V89, P109
   SILVER JH, 1999, BIOMATERIALS, V20, P1522
   THOMPSON AR, 1983, MANUAL HEMOSTASIS TH
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   VISSER SA, 1998, BIOMATERIALS SCI INT, P59
   Volcker N, 2001, J MATER SCI-MATER M, V12, P111, DOI 10.1023/A:1008938525489
   WANG CH, 1997, ACTA POLYM SIN, V1, P114
NR 30
TC 43
Z9 44
U1 2
U2 20
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JAN
PY 2004
VL 53
IS 1
BP 121
EP 126
DI 10.1002/pi.1122
PG 6
WC Polymer Science
SC Polymer Science
GA 760UB
UT WOS:000187852300020
DA 2018-10-19
ER

PT J
AU Kim, JH
   Yoon, WS
   Yeum, JH
   Ji, BC
   Kim, HS
   Jeon, HY
   Lyoo, WS
AF Kim, JH
   Yoon, WS
   Yeum, JH
   Ji, BC
   Kim, HS
   Jeon, HY
   Lyoo, WS
TI A zone drawing method to determine optimum initial concentration of
   poly(vinyl alcohol) to make films with different degrees of
   saponification
SO POLYMERS & POLYMER COMPOSITES
LA English
DT Article
ID POLYMER CONCENTRATION; COMPLEX FILM
AB To prepare poly(vinyl alcohol) (PVA) films for various industrial and biomaterial applications, the effects of polymer concentration and degree of saponification (DS) on the draw ratio and physical properties of PVA films were investigated. Atactic PVA (a-PVA) films were prepared by casting in water with different polymer concentrations of 2.5, 5.0, 7.5, 8.5, and 9.5 g/dl, respectively. The a-PVA films were zone-drawn under various conditions. Using the optimum polymer concentration of the a-PVA/water solutions caused a significant change in the draw ratio of the films. Draw ratios of a-PVA films were maximized at the initial polymer concentrations of 7.5 and 8.5 g/dl, but gradually decreased at higher or lower concentrations. Furthermore, the birefringence, degree of crystal orientation, and tensile properties of a-PVA films having the same draw ratios were the highest at these optimum polymer concentrations. These optimum concentrations were reconfirmed by viscometry. Optimum conditions of the film casting of atactic PVAs with various DSs have been established by the zone drawing method. The agreement between the optimum concentration values obtained by zone drawing and viscometry suggests that the zone drawing method is an appropriate and convenient way to establish the optimum concentration for maximum draw ratio, birefringence, degree of crystal orientation, and tensile properties.
C1 Yeungnam Univ, Sch Text, Adv Res Ctr PVA, Kyongsan 712749, South Korea.
   Kyungpook Natl Univ, Dept Dyeing & Finishing, Taegu 702701, South Korea.
   Chonnam Natl Univ, Fac Appl Chem Engn, Kwangju 500757, South Korea.
RP Lyoo, WS (reprint author), Yeungnam Univ, Sch Text, Adv Res Ctr PVA, Kyongsan 712749, South Korea.
EM wslyoo@yu.ac.kr
CR Han SS, 1997, J APPL POLYM SCI, V66, P1583, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1583::AID-APP20>3.0.CO;2-3
   HAN SS, 1994, J KOREAN FIBER SOC, V31, P1012
   JI BC, 1993, J KOREAN FIBER SOC, V30, P328
   KIM SY, 1994, J KOREAN FIBER SOC, V31, P912
   KULANTHAISAMI S, 1995, EUR POLYM J, V32, P969
   Lyoo WS, 2000, POLYMER, V41, P9055, DOI 10.1016/S0032-3861(00)00154-3
   Lyoo WS, 2001, J APPL POLYM SCI, V81, P1297, DOI 10.1002/app.1553
   Lyoo WS, 2001, MACROMOLECULES, V34, P3982, DOI 10.1021/ma001338g
   Lyoo WS, 2001, J APPL POLYM SCI, V82, P108, DOI 10.1002/app.1829
   Lyoo WS, 2001, POLYM TEST, V20, P503, DOI 10.1016/S0142-9418(00)00065-9
   LYOO WS, 1996, J KOREAN FIBER SOC, V33, P321
   LYOO WS, 1995, J KOREAN FIB SOC, V32, P1023
   Martin F. L., 1985, ENCY POLYM SCI TECHN
   PENNINGS AJ, 1984, J COLLOID POLYM SCI, V26, P712
   QIN J, 1994, J APPL POLYM SCI, V51, P1433, DOI 10.1002/app.1994.070510811
   Sakurada I., 1985, POLYVINYL ALCOHOL FI
   YAMADA K, 1982, J APPL POLYM SCI, V27, P2091, DOI 10.1002/app.1982.070270621
NR 17
TC 0
Z9 0
U1 0
U2 0
PU RAPRA TECHNOLOGY LTD
PI SHREWSBURY
PA SHAWBURY, SHREWSBURY SY4 4NR, SHROPS, ENGLAND
SN 0967-3911
J9 POLYM POLYM COMPOS
JI Polym. Polym. Compos.
PY 2004
VL 12
IS 3
BP 235
EP 242
DI 10.1177/096739110401200308
PG 8
WC Materials Science, Characterization & Testing; Materials Science,
   Composites; Polymer Science
SC Materials Science; Polymer Science
GA 811JU
UT WOS:000220769000008
DA 2018-10-19
ER

PT J
AU Sarma, PA
   Pidaparti, RM
   Meiss, RA
AF Sarma, PA
   Pidaparti, RM
   Meiss, RA
TI Shear stiffness estimation for a smooth muscle tissue
SO POLYMERS & POLYMER COMPOSITES
LA English
DT Article
ID STRIP
AB Smooth muscle tissue is a biomaterial whose stiffness changes not only with shortening strain (axial) but also with the degree of off-axis orientation of its cellular alignment. A simple model that predicts the shear stiffness of tracheal smooth muscle tissue as a function of shortening strain is developed. The model is validated with experimental data obtained for a smooth muscle tissue at off-axis orientation. The model predictions compare reasonably well with the experimental data. The results obtained indicate that the muscle shear stiffness values increase non-linearly with shortening strain and this non-linearity increases with higher off-axis alignment of cells.
C1 IUPUI, Dept Mech Engn, Purdue Sch Engn & Technol, Indianapolis, IN 46202 USA.
   So WV Community & Tech Coll, Dept Nat Sci & Math, Pineville, WV 24874 USA.
   Indiana Univ, Med Ctr, Sch Med, Dept OB GYN, Indianapolis, IN 46202 USA.
RP Pidaparti, RM (reprint author), IUPUI, Dept Mech Engn, Purdue Sch Engn & Technol, 723 W Michigan St, Indianapolis, IN 46202 USA.
CR JAIN MK, 1992, NUMERICAL METHODS SC
   Jones RM., 1975, MECH COMPOSITE MAT
   Meiss RA, 2002, BIOPHYS J, V82, p371A
   Meiss RA, 2003, BIOPHYS J, V84, p104A
   Meiss RA, 1999, J APPL PHYSIOL, V86, P5
   MEISS RA, 2001, J BIOPHYS, V80, pA274
   Pidaparti RMV, 1996, J BIOMECH, V29, P909, DOI 10.1016/0021-9290(95)00147-6
   Sarma PA, 2003, J BIOMED MATER RES A, V65A, P1, DOI 10.1002/jbm.a.10355
   SEOM CY, 1989, AM J PHYSL 1, V256, pC341
NR 9
TC 1
Z9 1
U1 0
U2 0
PU RAPRA TECHNOLOGY LTD
PI SHREWSBURY
PA SHAWBURY, SHREWSBURY SY4 4NR, SHROPS, ENGLAND
SN 0967-3911
J9 POLYM POLYM COMPOS
JI Polym. Polym. Compos.
PY 2004
VL 12
IS 4
BP 289
EP 295
PG 7
WC Materials Science, Characterization & Testing; Materials Science,
   Composites; Polymer Science
SC Materials Science; Polymer Science
GA 827HI
UT WOS:000221889900004
DA 2018-10-19
ER

PT B
AU Wang, BQ
   Fan, CY
   Ju, H
AF Wang, BQ
   Fan, CY
   Ju, H
GP ieee
TI Ultrasound-assisted extraction of biomaterials and the design of
   sono-reactors
SO PROCEEDINGS OF THE 2004 INTERNATIONAL CONFERENCE ON INTELLIGENT
   MECHATRONICS AND AUTOMATION
LA English
DT Proceedings Paper
CT International Conference on Intelligent Mechatronics and Automation
CY AUG 26-31, 2004
CL Univ Elect Sci & Technol China, Chengdu, PEOPLES R CHINA
SP Hong Kong Univ Sci & Technol, Kagawa Univ, Univ Electro Commun, Natl Nat Sci Fdn China, Shanghai Univ, Harbin Engn Univ, Japan Soc Precis Engn, IEEE Robot & Automat Soc, IEEE Syst, Man & Cybernet Soc, IEEE Shikoku Sect, Chinese Inst Elect, Chinese Soc Mech Engn, China Cleaning Engn Technol Cooperat Assoc, Robot Soc Japan, Int Mechatron Forum, JSPE, Tech Comm Intell Mechatron, Minist Educ, China
HO Univ Elect Sci & Technol China
DE power-ultrasound; sono-reactor; sonication; ultrasound-assisted
   extraction
AB Biomaterial extraction with the ultrasound is one of very effective technique procedures in the Chinese traditional medicine manufacture. The yield of the extraction was used to examine the effect of sonication. It was determined by the parameters of ultrasonic field and the characteristics of the medium. A design of a large-scale sono-reactor so called multidimensional reactor is introduced in the paper. The key problems of reactor design are the realizations of high intensity and uniformity of the ultrasonic field in a large-scale. The second upright phase-latch (SUPL), FSK and mix-sound response are utilized in the design of multi-dimensional sono-reactor. An ultrasonic field of high intensity and uniformity is upbuilt in the reactor.
C1 Chengdu Univ Informat & Technol, Dept Elect & Technol, Chengdu 610041, Sichuan Prov, Peoples R China.
RP Wang, BQ (reprint author), Chengdu Univ Informat & Technol, Dept Elect & Technol, Chengdu 610041, Sichuan Prov, Peoples R China.
CR Doche ML, 2003, ULTRASON SONOCHEM, V10, P357, DOI 10.1016/S1350-4177(03)00099-3
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   MAOSN TJ, 1997, CHEM EXTREME NONCLAS, P317
   SEONGNAM, 2003, ULTRASONICS SONOCHEM, V10, P139
   Suslick KS., 1998, ULTRASOUND ITS CHEM
   WANG BQ, 2003, J CHENGDU U INFORM T, V18, P25
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8748-1
PY 2004
BP 763
EP 766
PG 4
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Engineering, Mechanical; Robotics
SC Automation & Control Systems; Computer Science; Engineering; Robotics
GA BBG56
UT WOS:000225452400148
DA 2018-10-19
ER

PT S
AU Abraham, S
   Brahim, S
   Guiseppi-Elie, A
AF Abraham, S
   Brahim, S
   Guiseppi-Elie, A
GP ieee
TI Molecularly engineered hydrogels for implant biocompatibility.
SO PROCEEDINGS OF THE 26TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 26th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 01-05, 2004
CL San Francisco, CA
SP IEEE Engn Med & Biol Soc, Whitaker Fdn, Cyberonics, NIH, NIBIB, NIDOCD, NINDS
DE biosmart polymers; biocompatibility; cell proliferation; hydrogels;
   implantable materials; protein adsorption
ID BEHAVIOR; ADHESION
AB The biocompatibitity of biosmart polymer membranes synthesized from cross-linkable (2-hydroxyethyl methacrylate) (HEMA) and tetraethylene glycol diacrylate and containing different mole-percent polyethylene glycol methacrylate (PEGMA) and methacryloyloxyethyl phosphorylcholine (MPC), a phosphorylcholine-containing co-monomer, was investigated. The cytotoxicity (cell viability and proliferation) and the adhesion of extra cellular matrix proteins to these hydrogel surfaces were separately tested. Cell proliferation assays were conducted by cultivating human skeletal muscle tibroblasts onto the surfaces of these polymeric membranes prepared by in-situ polymerization in chemically derivatized 8-well cell-culture plates. The compositions containing MPC and PEGMA concentrations greater than 1.0 and 0.05 mole% respectively demonstrated good protein adhesion and cell viability (>90%) of human muscle fibroblast cells. Morphological deviances and partial colonization of the hydrogel surface has been noticed and suggests good compatibility of hydrogels for cellular vialibility but restricted proliferation. It is well known that the adsorption of proteins onto biomaterial surfaces modulates the cellular interaction with these surfaces. The extent of adsorption of fluorescein labeled proteins (laminin, collagen, and fibronectin) onto these polymer membrane surfaces was evaluated by measuring the resultant fluorescence intensity using a confocal fluorescence scanner.
C1 Virginia Commonwealth Univ, C3B, Richmond, VA 23284 USA.
RP Abraham, S (reprint author), Virginia Commonwealth Univ, C3B, Richmond, VA 23284 USA.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   DERBALIAN G, 1988, ANAL BIOCHEM, V59, P173
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Ishihara K, 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7
   KABRA BG, 1991, J APPL POLYM SCI, V42, P2409, DOI 10.1002/app.1991.070420906
   Park H, 1996, PHARMACEUT RES, V13, P1770, DOI 10.1023/A:1016012520276
   RATNER BD, 1981, BIOCOMPATIBILITY CLI, V2, pCH7
   ROSE FS, IN PRESS BIOMATERIAL
   TAYLOR S, 2003, NUCL ACIDS RES, V31
   Trudel J, 2002, BIOMATERIALS, V23, P3299, DOI 10.1016/S0142-9612(02)00009-1
NR 13
TC 3
Z9 3
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8439-3
J9 P ANN INT IEEE EMBS
PY 2004
VL 26
BP 5036
EP 5039
PN 1-7
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Engineering, Biomedical; Medicine, Research &
   Experimental; Neurosciences; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Research & Experimental Medicine;
   Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA BBG76
UT WOS:000225461801318
PM 17271448
DA 2018-10-19
ER

PT B
AU Venu, P
   McKenzie, JL
   Webster, TJ
AF Venu, P
   McKenzie, JL
   Webster, TJ
BE Schreiner, S
   Cezeaux, JL
   Muratore, DM
TI Effect of coating techniques on the creation of a calcified zone for
   implant-tendon entheses
SO PROCEEDINGS OF THE IEEE 30TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 30th Annual Northeast Bioengineering Conference
CY APR 17-18, 2004
CL Western New England Coll, Springfield, MA
SP IEEE, EMB, MassMEDIC, BEACON, tyco Healthcare, Reebok, bei, Whitaker Fdn
HO Western New England Coll
AB An attachment or insertion site of tendon, ligament or joint capsule to bone, so called entheses, is either fibrous or fibrocartilaginous. A well characterized fibrocartilaginous entheses is comprised of four zones- pure dense fibrous connective tissue, uncalcified and calcified fibrocartilage, and bone. Increase in hardness from fibrous tissue to bone appears to be a natural way of dealing with mechanical stresses in the entheses region. Calcified zone, which is made up of mineralized extracellular matrix (ECM), acts as a transitional zone between the hard and soft regions of the entheses. Thus, success of long term orthopedic implants depends upon the creation of a bio-mimicked calcified zone on their surface. As tendon/ligament entheses are basically composed collagen based ECM in this in vitro investigation, we made use of collagen based bioscaffolds; specifically, gelatin B and porcine small intestinal submucosa (SIS) were used in the creation of a calcified zone on a model orthopedic biomaterial-titanium sheet, by mixing them with saturated levels of hydroxyapatite (RA). In order to enhance attachment on an implant, we gelatinized these bioscaffolds by heat denaturation in water followed by spin coating or coating by pipette on a titanium (Ti) sheet by taking advantage of the self-assembling properties of collagen. Our scanning electron microscope (SEM) results suggest that the calcification as well as the area covered by their coating on Ti is bitter during a pipette technique as compared to spin coating. Further, gelatin B and SIS behaved differently in terms of coating uniformity, except in the pipette coating where the proportion of surface area covered by gelatin B is similar to SIS. In this manner, a coating technique and method has been developed which is promising for entheses biomaterials.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Venu, P (reprint author), Purdue Univ, Dept Biomed Engn, 500 Cent Dr, W Lafayette, IN 47907 USA.
CR Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1
   SILVER FH, 1992, BIOMEDICAL APPL COMP
NR 2
TC 0
Z9 0
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8285-4
PY 2004
BP 138
EP 139
PG 2
WC Engineering, Biomedical; Instruments & Instrumentation; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Instruments & Instrumentation; Materials Science;
   Radiology, Nuclear Medicine & Medical Imaging
GA BAD44
UT WOS:000221665200069
DA 2018-10-19
ER

PT B
AU Park, GE
   Park, K
   Webster, TJ
AF Park, GE
   Park, K
   Webster, TJ
BE Schreiner, S
   Cezeaux, JL
   Muratore, DM
TI NaOH-treated PLGA scaffolds allow for greater articular chondrocyte
   functions
SO PROCEEDINGS OF THE IEEE 30TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 30th Annual Northeast Bioengineering Conference
CY APR 17-18, 2004
CL Western New England Coll, Springfield, MA
SP IEEE, EMB, MassMEDIC, BEACON, tyco Healthcare, Reebok, bei, Whitaker Fdn
HO Western New England Coll
ID SURFACE-FEATURES; ACID) FOAMS; IN-VITRO; CARTILAGE; ADHESION; POLYMER
AB Previous studies have shown that NaOH-treated two-dimensional PLGA films enhanced chondrocyte functions. In this in vitro study, a three-dimensional PLGA scaffold was fabricated and treated with NaOH. Articular chondrocyte function was then examined. Results show, for the first time, greater cell numbers and enhanced subsequent cellular functions (such as select intracellular protein synthesis) on NaOH-treated scaffolds. Underlying material properties that may have enhanced chondrocyte functions include a more hydrophilic surface (due to hydrolytic degradation of PLGA by NaOH), increased surface area, altered porosity, and a greater degree of nanometer roughness. For these reasons, this study adds a novel tissue-engineering scaffold to the cartilage biomaterial community: NaOH-treated PLGA. Clearly, such surface and chemical modifications of PLGA may ultimately enhance the efficacy of tissue-engineering scaffolds for articular cartilage repair.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Park, GE (reprint author), Purdue Univ, Dept Biomed Engn, 500 Cent Dr, W Lafayette, IN 47907 USA.
CR Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   MA PX, 1998, TISSUE ENG METHODS P, P47
   MATLAGA BF, 1983, J BIOMED MATER RES, V17, P185, DOI 10.1002/jbm.820170115
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   WALSH BJ, 1992, ANAL BIOCHEM, V203, P187, DOI 10.1016/0003-2697(92)90301-M
NR 10
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8285-4
PY 2004
BP 148
EP 149
PG 2
WC Engineering, Biomedical; Instruments & Instrumentation; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Instruments & Instrumentation; Materials Science;
   Radiology, Nuclear Medicine & Medical Imaging
GA BAD44
UT WOS:000221665200074
DA 2018-10-19
ER

PT B
AU Khang, D
   McKenzie, JL
   Webster, TJ
AF Khang, D
   McKenzie, JL
   Webster, TJ
BE Schreiner, S
   Cezeaux, JL
   Muratore, DM
TI Carbon nanofibers: Polycarbonate urethane composites' as a neural
   biomaterial
SO PROCEEDINGS OF THE IEEE 30TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 30th Annual Northeast Bioengineering Conference
CY APR 17-18, 2004
CL Western New England Coll, Springfield, MA
SP IEEE, EMB, MassMEDIC, BEACON, tyco Healthcare, Reebok, bei, Whitaker Fdn
HO Western New England Coll
ID GROWTH; CNS
AB Chronic neural implants are usually made from silicon materials and are subject to scar tissue formation at the tissue/implant interface, which interferes with their functionality. Carbon nanofibers are an example of a material that may improve neural implant interactions with native cell populations since these nanofibers have promising cytocompatibility, mechanical, and electrical properties. Neural implants may achieve better tissue interactions simply by incorporating carbon nanofibers into a polymer matrix. Polycarbonate urethane and carbon nanofiber composites have induced neurite extension during in vitro studies. The objective of the present study was to use an electrical field to align carbon nanofibers in a polycarbonate urethane matrix. Polycarbonate urethane was dissolved in chloroform, and then mixed with carbon nanofibers of high and low surface energies separately. When the solution was viscous, it was pored into a parallel copper plate capacitor chamber. Alignment occurred after exposure to 500 to 700 volts. The aligned nanofiber structure was maintained after the polymer cured. These materials have been prepared to determine if neuron axonal extension will be affected by the carbon nanofiber alignment. These materials have promising tunable properties for neural implants such as electrical, nanoscale structure and organization, and surface energy characteristics.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Khang, D (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
CR Chauhan NB, 1999, INT J DEV NEUROSCI, V17, P255, DOI 10.1016/S0736-5748(99)00003-9
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222
   Kuriger RJ, 2002, COMPOS PART A-APPL S, V33, P53, DOI 10.1016/S1359-835X(01)00070-7
   Little AR, 2001, NEUROTOXICOLOGY, V22, P607, DOI 10.1016/S0161-813X(01)00032-8
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
NR 10
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8285-4
PY 2004
BP 241
EP 242
PG 2
WC Engineering, Biomedical; Instruments & Instrumentation; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Instruments & Instrumentation; Materials Science;
   Radiology, Nuclear Medicine & Medical Imaging
GA BAD44
UT WOS:000221665200120
DA 2018-10-19
ER

PT J
AU Hao, L
   Lawrence, J
AF Hao, L
   Lawrence, J
TI On the role of laser-induced microstructures in influencing the surface
   energy of magnesia partially stabilized zirconia bioceramic
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART B-JOURNAL OF
   ENGINEERING MANUFACTURE
LA English
DT Article
DE CO2 laser; magnesia partially stabilized zirconia (MgO-PSZ); surface
   energy; microstructure; wettability characteristics
ID POWER DIODE-LASERS; WETTABILITY CHARACTERISTICS; ND-YAG;
   CORROSION-RESISTANCE; THIN-FILMS; EXCIMER; HYDROXYAPATITE; ABLATION;
   ENHANCEMENT; GROWTH
AB Surface energy must in some way be connected to surface chemistry and is therefore an important determinant of a biomaterial's functions. This work elucidates the basic phenomena and wetting mechanisms associated for a widely used bioinert ceramic, magnesia partially stabilized zirconia (MgO-PSZ) following CO2 laser treatment. Contact angles for a set of test liquids were used to measure the wettability characteristics and to reduce the surface energy of the MgO-PSZ before and after CO2 laser treatment. CO2 laser treatment of the MgO-PSZ surface was seen to effect an improvement in the material's wettability characteristics. Furthermore, it was found that the extent of wettability modification was closely related to the microstructure induced by CO2 laser radiation on the surface of the MgO-PSZ.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Mat Lab, Mfg Engn Div, Singapore 639798, Singapore.
RP Hao, L (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Mat Lab, Mfg Engn Div, N3-1-B2B-02,50 Nanyang Ave, Singapore 639798, Singapore.
OI Lawrence, Jonathan/0000-0002-1649-9948; Hao, Liang/0000-0003-2071-7044
CR ADAM NK, 1958, J CHEM SOC, V18, P2206
   AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   Alessio L.D., 1999, APPL SURF SCI, V138-139, P527
   ANDREW JE, 1983, APPL PHYS LETT, V43, P717, DOI 10.1063/1.94488
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   CHADWICK GA, 1967, FRACTIONAL SOLIDIFIC, P120
   CHATTORAJ DK, 1984, ADSORPTION GIBBS SUR
   Cheang P, 1996, BIOMATERIALS, V17, P1901, DOI 10.1016/0142-9612(95)00146-8
   Chow T.S., 1998, J PHYS-CONDENS MAT, V10, P445
   D'Alessio L, 2001, APPL SURF SCI, V183, P10, DOI 10.1016/S0169-4332(01)00466-4
   DANN JR, 1970, J COLLOID INTERF SCI, V32, P302, DOI 10.1016/0021-9797(70)90054-8
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   ERTAS D, 1994, PHYS REV E, V49, pR2532, DOI 10.1103/PhysRevE.49.R2532
   Esquivel O., 1980, RAPID SOLIDIFICATION, P150
   FENG A, 1998, MAT SCI ENG A-STRUCT, V1, P50
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   GOOD RJ, 1960, J PHYS CHEM-US, V64, P561, DOI 10.1021/j100834a012
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   HAO L, 2003, J MAT SCI ENG C, V23, P627
   HEITZ J, 1992, APPL PHYS A-MATER, V55, P391, DOI 10.1007/BF00324090
   HENARI F, 1995, APPL OPTICS, V34, P581, DOI 10.1364/AO.34.000581
   HOLMES EL, 1957, CAN J PHYS, V35, P1223, DOI 10.1139/p57-132
   Hontsu S, 1997, THIN SOLID FILMS, V295, P214, DOI 10.1016/S0040-6090(96)09146-8
   Jaycock M., 1981, CHEM INTERFACES
   Kasemo B, 1999, Adv Dent Res, V13, P8
   KINLOCH AJ, 1987, ADHESION ADHESIVES S, P30
   Laurens P, 1998, INT J ADHES ADHES, V18, P19, DOI 10.1016/S0143-7496(97)00063-8
   Laurens P, 2000, APPL SURF SCI, V154, P211, DOI 10.1016/S0169-4332(99)00443-2
   Lawrence J, 2001, MAT SCI ENG A-STRUCT, V303, P142, DOI 10.1016/S0921-5093(00)01851-7
   Lawrence J, 2000, APPL SURF SCI, V154, P664, DOI 10.1016/S0169-4332(99)00416-X
   Lawrence J, 1999, APPL SURF SCI, V138, P388, DOI 10.1016/S0169-4332(98)00431-0
   Lawrence J, 1999, J PHYS D APPL PHYS, V32, P1075, DOI 10.1088/0022-3727/32/10/301
   LAWRENCE J, 2002, P ROYAL SOC A, V2026, P2445
   Lawrence J., 2001, LASER MODIFICATION W
   Lawrence J., 2000, OPT LASER ENG, V32, P353
   Liu Z., 1991, THESIS U LIVERPOOL
   MARSH JA, 1993, PHYS REV LETT, V71, P2433, DOI 10.1103/PhysRevLett.71.2433
   McCallum RW, 1993, IEEE T APPL SUPERCON, V3, P1147, DOI 10.1109/77.233351
   MIRZADEH H, 1995, RADIAT PHYS CHEM, V46, P859, DOI 10.1016/0969-806X(95)00278-6
   MIRZADEHA H, 1995, BIOMATERIALS, V168, P641
   MORVAN D, 1994, INT J HEAT MASS TRAN, V37, P1973, DOI 10.1016/0017-9310(94)90300-X
   Neumann A., 1974, ADV COLLOID INTERFAC, V4, P105, DOI DOI 10.1016/0001-8686(74)85001-3
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   Pei YT, 1996, SURF COAT TECH, V81, P131, DOI 10.1016/0257-8972(95)02483-2
   Rivindram K., 1994, NUMER HEAT TRANSFER, V26, P601
   Serra P, 1998, THIN SOLID FILMS, V335, P43, DOI 10.1016/S0040-6090(98)00874-8
   SHIEH YN, 1994, J MATER SCI, V29, P5285, DOI 10.1007/BF01171537
   SHIH CHS, 1994, J MATER SCI, V29, P1629, DOI 10.1007/BF00368937
   Song CE, 1998, TETRAHEDRON-ASYMMETR, V9, P983, DOI 10.1016/S0957-4166(98)00049-4
   SONG Q, 1998, J ADHES SCI TECHNOL, V9, P957
   UEKI M, 1986, J MATER SCI LETT, V5, P1261, DOI 10.1007/BF01729384
   Villermaux F, 1997, APPL SURF SCI, V109, P62, DOI 10.1016/S0169-4332(96)00619-8
   WATANABE H, 1994, J ADHES SCI TECHNOL, V8, P1425, DOI 10.1163/156856194X00717
   WATANABE H, 1993, SEN-I GAKKAISHI, V49, P616
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Yue TM, 2002, MATER LETT, V52, P206, DOI 10.1016/S0167-577X(01)00395-0
   Yue TM, 2001, SURF COAT TECH, V137, P65, DOI 10.1016/S0257-8972(00)01104-X
   Zhang XM, 1997, MATER LETT, V30, P327, DOI 10.1016/S0167-577X(96)00229-7
   ZHOU XB, 1995, J MATER RES, V10, P1984, DOI 10.1557/JMR.1995.1984
   Zisman W. A., 1964, ADV CHEM SER, V43, P1
   李建国, 1993, Rare Metals, V12, P84
NR 62
TC 7
Z9 7
U1 1
U2 1
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0954-4054
J9 P I MECH ENG B-J ENG
JI Proc. Inst. Mech. Eng. Part B-J. Eng. Manuf.
PD JAN
PY 2004
VL 218
IS 1
BP 59
EP 76
DI 10.1243/095440504772830219
PG 18
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 800OO
UT WOS:000220037800007
DA 2018-10-19
ER

PT B
AU Ding, JD
   Wu, LB
   Zhang, H
   Zhu, W
   Zhang, JC
   Jing, DY
   Duan, SF
   Wang, Z
   Graeter, S
   Yu, L
   Sun, JG
   Huang, JH
   Ji, SC
   Zhang, H
AF Ding, JD
   Wu, LB
   Zhang, H
   Zhu, W
   Zhang, JC
   Jing, DY
   Duan, SF
   Wang, Z
   Graeter, S
   Yu, L
   Sun, JG
   Huang, JH
   Ji, SC
   Zhang, H
GP CSTP
TI Tissue engineering materials: Injectable hydrogel and preshaping porous
   scaffold
SO Proceedings of the World Engineers' Convention 2004, Vol B, Biological
   Engineering and Health Care
LA English
DT Proceedings Paper
CT World Engineers Convention 2004
CY NOV 02-06, 2004
CL Shanghai, PEOPLES R CHINA
SP Shanghai Baosteel Grp Corp, Shanghai Automot Ind Corp, China Natl Petroleum Corp, China Petrochem Corp, State Grid Corp China, Shanghai Huizhong Automat Mfg Co Ltd, China Aerosp Sci & Technol Corp, China Yangtze Three Gorges Project Dev Corp, China Natl Nucl Corp, BMW Grp Beijing, Chun Wo Construct & Engn Co Ltd, Shui On Land Ltd, Air China
DE tissue engineering; polymer; scaffold; hydrogel
AB Biodegradable polymers were employed as tissue engineering materials. Both preshaped porous scaffold and injectable hydrogel have been studied. As the former is concerned, we developed a novel fabrication approach to obtain well-defined internal pore structure and complicated external shape. As the tatter is concerned, we synthesized a novel temperature-sensitive hydrogel with tailorable biodegradation rate. Patterned hydrogels and hydrophobic scaffolds have also been used to investigate cell adhesion mechanism on the surface of biomaterial. Surface modification technique has been examined.
C1 Fudan Univ, Dept Macromol Sci, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Dept Macromol Sci, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
CR WU L, IN PRESS TISSUE ENG
   WU L, IN PRESS POLYM MAT S
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
NR 3
TC 0
Z9 0
U1 1
U2 4
PU CHINA SCIENCE TECHNOLOGY PRESS
PI BEIJING
PA 32 BAISHIQIAOLU, BEIJING 100081, PEOPLES R CHINA
BN 7-5046-3929-X
PY 2004
BP 64
EP 66
PG 3
WC Biophysics; Engineering, Biomedical; Medicine, Research & Experimental
SC Biophysics; Engineering; Research & Experimental Medicine
GA BDM44
UT WOS:000234270900018
DA 2018-10-19
ER

PT B
AU Wang, YF
   Bauer, I
   Li, SP
AF Wang, YF
   Bauer, I
   Li, SP
GP CSTP
TI Hydrolysis of dicalcium phosphate dihydrate to hydroxyapatite whiskers
   under hydrothermal condition
SO Proceedings of the World Engineers' Convention 2004, Vol B, Biological
   Engineering and Health Care
LA English
DT Proceedings Paper
CT World Engineers Convention 2004
CY NOV 02-06, 2004
CL Shanghai, PEOPLES R CHINA
SP Shanghai Baosteel Grp Corp, Shanghai Automot Ind Corp, China Natl Petroleum Corp, China Petrochem Corp, State Grid Corp China, Shanghai Huizhong Automat Mfg Co Ltd, China Aerosp Sci & Technol Corp, China Yangtze Three Gorges Project Dev Corp, China Natl Nucl Corp, BMW Grp Beijing, Chun Wo Construct & Engn Co Ltd, Shui On Land Ltd, Air China
DE hydroxyapatite; whiskers; hydrolysis; biomaterial
AB Hydroxyapatite is a kind of bioactive materials. It coincides with sclerous tissue in nonorganic composition and structure. Its perfect biocompatibility enables it inducing newborn bone growth. Used as implant material, hydroxyapatite performs as biological skeleton for newborn bone. It forms a direct synosteosis with surrounding bone tissue. Single crystals have hardly any defects in their crystal lattice. Their strength is similar to the theoretical strength. Thus hydroxyapatite whisker is one of ideal reinforcements for biomaterials. In this study, dicalcium phosphate dihydrate is used as precursor that hydrolyzes to form hydroxyapatite under hydrothermal condition. Hydroxyapatite single crystals are obtained in needle-like in shape. They are characterized through XRD. and SEM. Hydroxyapatite whiskers prepared by hydrothermal method are uniform in length, which is about 1-2mm. The whiskers with high crystalline could be used to reinforce biomaterials.
C1 Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
RP Wang, YF (reprint author), Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
CR AOKI H, 1972, APPARATUS MAT, V27, P170
   HATTORI T, 1990, J AM CERAM SOC, V73, P1803, DOI 10.1111/j.1151-2916.1990.tb09841.x
   IWASAKI H, 1989, CERAMICS, V40, P295
   KAMIYA K, 1989, J MATER SCI, V24, P827, DOI 10.1007/BF01148764
   Kandori K, 1997, J AM CERAM SOC, V80, P1157
   LI SP, 2000, INTRO BIOMEDICAL MAT, V88
   Ota Y, 1998, J AM CERAM SOC, V81, P1665
   SAIDA Y, 1993, Patent No. 517110
   SHI EW, 1996, J INORGANIC MAT, V11, P193
   Suzuki S, 1998, J MATER SCI LETT, V17, P381, DOI 10.1023/A:1006526915828
   YAMADA F, 1990, FUNTION MAT, V7, P46
NR 11
TC 0
Z9 1
U1 0
U2 1
PU CHINA SCIENCE TECHNOLOGY PRESS
PI BEIJING
PA 32 BAISHIQIAOLU, BEIJING 100081, PEOPLES R CHINA
BN 7-5046-3929-X
PY 2004
BP 86
EP 89
PG 4
WC Biophysics; Engineering, Biomedical; Medicine, Research & Experimental
SC Biophysics; Engineering; Research & Experimental Medicine
GA BDM44
UT WOS:000234270900023
DA 2018-10-19
ER

PT B
AU Katz, E
AF Katz, E
BE Yurish, SY
   Gomes, MTS
TI Electronic biosensors based on biomaterial-nanoparticle hybrid systems
SO Smart Sensors and MEMS
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Smart Sensors and
   MEMS
CY SEP 08-19, 2003
CL Povoa de Varzim, PORTUGAL
SP NATO ASI
DE biosensors; biomaterials; nanomaterials; enzyme; antigent; antibodie;
   nanoparticle; nanorods; DNA
ID ELECTROCHEMICAL STRIPPING DETECTION; COLLOIDAL GOLD NANOPARTICLES;
   QUARTZ-CRYSTAL-MICROBALANCE; SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED
   MONOLAYERS; CARBON-PASTE ELECTRODE; DIRECT ELECTRICAL COMMUNICATION;
   CHEMICALLY MODIFIED ENZYMES; DNA-HYBRIDIZATION; GLUCOSE-OXIDASE
AB Nanomaterials such as metal or semiconductor nanoparticles and nanorods exhibit similar dimensions to those of biomolecules, such as proteins (enzymes, antigens, antibodies) or DNA. The integration of the nanoparticles, exhibiting unique electronic, photonic and catalytic properties, with the biomaterials, revealing unique recognition features or catalytic properties, yields novel hybrid nanobiomaterials of synergetic properties and functions. The present review article describes recent advances in the use of biomolecule-nanoparticle (metallic or semiconductive) assemblies for bioanalytical applications. In these systems the unique electronic, photonic, optical and catalytic properties of the nanoparticles are used to transduce the specific biorecognition and biocatalytic functions of the biomaterial components.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Katz, E (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
CR Alfonta L, 2001, ANAL CHEM, V73, P91, DOI 10.1021/ac00819v
   Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506
   Alvarez MM, 1997, J PHYS CHEM B, V101, P3706, DOI 10.1021/jp962922n
   Armstrong FA, 2000, ELECTROCHIM ACTA, V45, P2623, DOI 10.1016/S0013-4686(00)00342-X
   Armstrong FA, 1997, CHEM SOC REV, V26, P169, DOI 10.1039/cs9972600169
   Authier L, 2001, ANAL CHEM, V73, P4450, DOI 10.1021/ac0103221
   BADIA A, 1993, J AM CHEM SOC, V115, P7053, DOI 10.1021/ja00069a001
   Badia A, 1996, CHEM-EUR J, V2, P359, DOI 10.1002/chem.19960020318
   Barton SC, 2001, J AM CHEM SOC, V123, P5802, DOI 10.1021/ja010408b
   Bharathi S, 2001, ANALYST, V126, P1919, DOI 10.1039/b105318n
   Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   BRUS L, 1991, APPL PHYS A-MATER, V53, P465, DOI 10.1007/BF00331535
   BRUST M, 1995, J CHEM SOC CHEM COMM, P1655, DOI 10.1039/c39950001655
   Brust M, 2002, COLLOID SURFACE A, V202, P175, DOI 10.1016/S0927-7757(01)01087-1
   BUTTRY DA, 1992, CHEM REV, V92, P1355, DOI 10.1021/cr00014a006
   Cai H, 2003, BIOSENS BIOELECTRON, V18, P1311, DOI 10.1016/S0956-5663(03)00084-8
   Cai H, 2001, J ELECTROANAL CHEM, V510, P78, DOI 10.1016/S0022-0728(01)00548-4
   Cai H, 2002, ANALYST, V127, P803, DOI 10.1039/b200555g
   Chen SW, 1999, J PHYS CHEM B, V103, P9996, DOI 10.1021/jp992681u
   Chen SW, 1998, J PHYS CHEM B, V102, P9898, DOI 10.1021/jp982822c
   Chen T, 2001, J AM CHEM SOC, V123, P8630, DOI 10.1021/ja0163164
   Chen W, 2002, J NANOSCI NANOTECHNO, V2, P47, DOI 10.1166/jnn.2002.067
   CRUMBLISS AL, 1992, BIOTECHNOL BIOENG, V40, P483, DOI 10.1002/bit.260400406
   Csaki A, 2002, SINGLE MOL, V3, P275, DOI 10.1002/1438-5171(200211)3:5/6<275::AID-SIMO275>3.0.CO;2-0
   Curri ML, 2002, MAT SCI ENG C-BIO S, V22, P449, DOI 10.1016/S0928-4931(02)00191-1
   DEGANI Y, 1988, J AM CHEM SOC, V110, P2615, DOI 10.1021/ja00216a040
   DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001
   DORON A, 1995, LANGMUIR, V11, P1313, DOI 10.1021/la00004a044
   Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873
   Eichen Y, 1998, ACTA POLYM, V49, P663, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<663::AID-APOL663>3.3.CO;2-W
   EMR SA, 1995, ELECTROANAL, V7, P913, DOI 10.1002/elan.1140071002
   Englebienne P, 2001, ANALYST, V126, P1645, DOI 10.1039/b105252g
   Feldheim DL, 1998, CHEM SOC REV, V27, P1
   Feldheim DL, 1996, J AM CHEM SOC, V118, P7640, DOI 10.1021/ja9612007
   Feldheim DL, 2002, METAL NANOPARTICLES
   Gangopadhyay R, 2000, CHEM MATER, V12, P608, DOI 10.1021/cm990537f
   Grieve K, 2000, CURR OPIN COLLOID IN, V5, P168, DOI 10.1016/S1359-0294(00)00050-9
   Gu HY, 2003, CHEM LETT, V32, P934, DOI 10.1246/cl.2003.934
   Guo LH, 1996, J MATER CHEM, V6, P369, DOI 10.1039/jm9960600369
   Habermuller L, 2000, FRESEN J ANAL CHEM, V366, P560
   Han SB, 2001, CHEM COMMUN, P609, DOI 10.1039/b100371m
   Han XJ, 2002, BBA-BIOENERGETICS, V1556, P273, DOI 10.1016/S0005-2728(02)00372-9
   He L, 2000, J AM CHEM SOC, V122, P9071, DOI 10.1021/ja001215b
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   Hicks JF, 2002, J AM CHEM SOC, V124, P13322, DOI 10.1021/ja027724q
   Hicks JF, 2002, J PHYS CHEM B, V106, P7751, DOI 10.1021/jp025663c
   Hicks JF, 2001, J AM CHEM SOC, V123, P7048, DOI 10.1021/ja0106826
   HUA SQ, 2003, TALANTA, V61, P769
   Hussain N, 2003, INT J PHARM, V254, P27, DOI 10.1016/S0378-5173(02)00672-5
   Katz E, 1999, NEW J CHEM, V23, P481, DOI 10.1039/a808561g
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   Katz E, 1999, ANAL CHIM ACTA, V385, P45, DOI 10.1016/S0003-2670(98)00688-6
   Katz E., 2002, ENCY ELECTROCHEMISTR, V9, P559
   Katz E., 2003, NANOSCALE MAT, P5
   KATZ E., 2003, NANOPARTICLES THEORY, P368
   KATZ E, 2003, HDB FUEL CELLS FUNDA, V1, P355
   Kesavan V, 1999, ANGEW CHEM INT EDIT, V38, P3521, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3521::AID-ANIE3521>3.0.CO;2-S
   Khairutdinov RF, 1997, COLLOID J+, V59, P535
   Kim TW, 2002, APPL PHYS LETT, V80, P2168, DOI 10.1063/1.1458685
   Kubitschko S, 1997, ANAL BIOCHEM, V253, P112, DOI 10.1006/abio.1997.2337
   Lahav M, 1999, J CHEM SOC PERK T 2, P1925, DOI 10.1039/a902763g
   Lee TMH, 2003, LANGMUIR, V19, P4338, DOI 10.1021/la0270385
   Lei CX, 2003, SENSOR ACTUAT B-CHEM, V96, P582, DOI 10.1016/j.snb.2003.06.001
   LEWIS LN, 1993, CHEM REV, V93, P2693, DOI 10.1021/cr00024a006
   Lin L, 2000, BIOCHEM BIOPH RES CO, V274, P817, DOI 10.1006/bbrc.2000.3233
   Liu SQ, 2003, ANALYST, V128, P1420, DOI 10.1039/b310100b
   Liu SQ, 2003, BIOSENS BIOELECTRON, V19, P177, DOI 10.1016/S0956-5663(03)00172-6
   Liu SQ, 2003, ELECTROANAL, V15, P1488, DOI 10.1002/elan.200302722
   Liu T, 2002, LANGMUIR, V18, P5624, DOI 10.1021/la015765e
   Long B, 2003, J AM CHEM SOC, V125, P15490, DOI 10.1021/ja037592g
   Lue JT, 2001, J PHYS CHEM SOLIDS, V62, P1599, DOI 10.1016/S0022-3697(01)00099-3
   Lyon LA, 1998, ANAL CHEM, V70, P5177, DOI 10.1021/ac9809940
   McConnell WP, 2000, J PHYS CHEM B, V104, P8925, DOI 10.1021/jp000926t
   Mertig M, 2002, NANO LETT, V2, P841, DOI 10.1021/nl025612r
   Miyazaki A, 2000, LANGMUIR, V16, P7109, DOI 10.1021/la000185n
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   Niemeyer CM, 2003, ANGEW CHEM INT EDIT, V42, P5796, DOI 10.1002/anie.200301703
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Ozsoz M, 2003, ANAL CHEM, V75, P2181, DOI 10.1021/ac026212r
   Parak WJ, 2003, NANOTECHNOLOGY, V14, pR15, DOI 10.1088/0957-4484/14/7/201
   Pardo-Yissar V, 2003, J AM CHEM SOC, V125, P622, DOI 10.1021/ja028922k
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   Patolsky F, 2000, CHEM COMMUN, P1025, DOI 10.1039/b002221g
   Penn SG, 2003, CURR OPIN CHEM BIOL, V7, P609, DOI 10.1016/j.cbpa.2003.08.013
   Raitman OA, 2002, J AM CHEM SOC, V124, P6487, DOI 10.1021/ja012680r
   Raitman OA, 2002, CHEM COMMUN, P1936, DOI 10.1039/b205393d
   Richter J, 2000, ADV MATER, V12, P507, DOI 10.1002/(SICI)1521-4095(200004)12:7<507::AID-ADMA507>3.0.CO;2-G
   Richter J, 2003, PHYSICA E, V16, P157, DOI 10.1016/S1386-9477(02)00670-7
   SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048
   Schwerdtfeger P, 2003, ANGEW CHEM INT EDIT, V42, P1892, DOI 10.1002/anie.200201610
   Shipway AN, 2000, CHEMPHYSCHEM, V1, P18, DOI 10.1002/1439-7641(20000804)1:1<18::AID-CPHC18>3.0.CO;2-L
   Shipway AN, 2001, CHEM COMMUN, P2035, DOI 10.1039/b105164b
   Templeton AC, 1999, LANGMUIR, V15, P66, DOI 10.1021/la9808420
   Teranishi T, 1998, ADV MATER, V10, P596, DOI 10.1002/(SICI)1521-4095(199805)10:8<596::AID-ADMA596>3.0.CO;2-Y
   Trau D, 2002, ANAL CHEM, V74, P5480, DOI 10.1021/ac0200522
   Trindade T, 2001, CHEM MATER, V13, P3843, DOI 10.1021/cm000843p
   Urban M, 2003, REV SCI INSTRUM, V74, P1077, DOI 10.1063/1.1533103
   Valina-Saba M, 1999, MAT SCI ENG C-BIO S, V8-9, P205, DOI 10.1016/S0928-4931(99)00023-5
   Velev OD, 1999, LANGMUIR, V15, P3693, DOI 10.1021/la981729c
   Wang J, 2003, ELECTROCHEM COMMUN, V5, P1000, DOI 10.1016/j.elecom.2003.09.010
   Wang J, 2003, ANAL CHEM, V75, P6218, DOI 10.1021/ac034730b
   Wang J, 2003, ANAL CHEM, V75, P3941, DOI 10.1021/ac0344079
   Wang J, 2003, J AM CHEM SOC, V125, P3214, DOI 10.1021/ja029668z
   Wang J, 2003, LANGMUIR, V19, P989, DOI 10.1021/la026697e
   Wang J, 2003, ELECTROCHEM COMMUN, V5, P83, DOI 10.1016/S1388-2481(02)00542-8
   Wang J, 2002, ELECTROCHEM COMMUN, V4, P722, DOI 10.1016/S1388-2481(02)00434-4
   Wang J, 2001, ANAL CHEM, V73, P5576, DOI 10.1021/ac0107148
   Wang J, 2001, LANGMUIR, V17, P5739, DOI 10.1021/la011002f
   WANG J, 2004, IN PRESS ELECTROANAL, V16
   Wang J, 1985, STRIPPING ANAL
   Wang MJ, 2004, BIOSENS BIOELECTRON, V19, P575, DOI 10.1016/S0956-5663(03)00252-5
   Wang XY, 2003, CHEM LETT, V32, P1054, DOI 10.1246/cl.2003.1054
   Weizmann Y, 2001, ANALYST, V126, P1502, DOI 10.1039/b106613g
   West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   Willner I, 1998, J CHEM SOC PERK T 2, P1817, DOI 10.1039/a801487f
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Willner I, 1998, BIOELECTROCH BIOENER, V44, P209, DOI 10.1016/S0302-4598(97)00091-3
   WILLNER I, 1992, J AM CHEM SOC, V114, P10965, DOI 10.1021/ja00053a045
   Willner I, 2002, PURE APPL CHEM, V74, P1773, DOI 10.1351/pac200274091773
   Willner I, 2002, TALANTA, V56, P847, DOI 10.1016/S0039-9140(01)00658-0
   Willner I, 2001, ANGEW CHEM INT EDIT, V40, P1861
   Willner I, 2000, BIOSENSORS THEIR APP, P47
   Willner Itamar, 2002, J Biotechnol, V82, P325, DOI 10.1016/S1389-0352(01)00050-2
   Wuelfing WP, 1998, J AM CHEM SOC, V120, P12696, DOI 10.1021/ja983183m
   Xiao Y, 2003, SCIENCE, V299, P1877, DOI 10.1126/science.1080664
   Yao H, 2001, CHEM MATER, V13, P4692, DOI 10.1021/cm0104957
   Zhao JG, 1996, BIOSENS BIOELECTRON, V11, P493, DOI 10.1016/0956-5663(96)86786-8
   ZHAO JG, 1992, J ELECTROANAL CHEM, V327, P109, DOI 10.1016/0022-0728(92)80140-Y
   Zhou XC, 2000, CHEM COMMUN, P953, DOI 10.1039/b001737j
   Zhu NN, 2003, ANAL CHIM ACTA, V481, P181, DOI 10.1016/S0003-2670(03)00123-5
   Zimmermann H, 2000, CHEM-EUR J, V6, P592, DOI 10.1002/(SICI)1521-3765(20000218)6:4<592::AID-CHEM592>3.3.CO;2-Y
NR 134
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-2927-6
J9 NATO SCI SER II MATH
PY 2004
VL 181
BP 447
EP 474
PG 28
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BCI14
UT WOS:000229429700014
DA 2018-10-19
ER

PT B
AU Kim, JS
   Kang, JH
   Yum, YJ
   Kang, SB
   Nam, TH
   Kwon, YS
AF Kim, JS
   Kang, JH
   Yum, YJ
   Kang, SB
   Nam, TH
   Kwon, YS
BE Pelton, AR
   Duerig, T
TI Characteristics of porous tint biomaterial as a medical device:
   Compression testing for biomechanical compatibility
SO SMST-2003: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MEMORY
   AND SUPERELASTIC TECHNOLOGIES
LA English
DT Proceedings Paper
CT International Conference on Shape Memory and Superelastic Technologies
   (SMST-2003)
CY MAY 05-08, 2003
CL Pacific Grove, CA
SP Boston Sci, Ft Wayne Met, Johnson Matthey, Shape Mem Applicat, MeKo, Minitubes, Special Met, TiNi Alloy Co, UTI
DE self-propagating high-temperature synthesis (SHS); porous TiNi
   biomaterial; porous structure; biomechanical compatibility; powder
   metallurgy
AB Porous TiNi biomaterial was produced by Self-propagating High-temperature Synthesis (SHS). The structure and compression properties of porous TiNi biomaterial were investigated. According to the compression results, it was concluded that biomechanical compatibility (strength, elastic modulus, recoverable strain) of SHS'ed porous TiNi biomaterial was superior to other commercial metal implants. In spite of 60% porosity, SHS'ed porous TiNi biomaterial showed up to 10% strain and a superelastic behavior.
C1 Univ Ulsan, Sch Mat Sci & Engn, ReMM, KOSEF,RRC, Ulsan 680749, South Korea.
RP Kim, JS (reprint author), Univ Ulsan, Sch Mat Sci & Engn, ReMM, KOSEF,RRC, Ulsan 680749, South Korea.
CR Kang SB, 2002, MATER TRANS, V43, P1045, DOI 10.2320/matertrans.43.1045
   Kim Ji Soon, 2003, [JOURAL OF KOREAN POWER METALLURGY INSTIT, 한국분말야금학회지], V10, P34
   KIM JS, 2000, SMST 2000 CAL US, P77
   PARK JB, 1995, BIOMATERIALS INTRO, P184
NR 4
TC 0
Z9 0
U1 0
U2 0
PU SMST SOC INC
PI MENLO PARK
PA C/O SRI M/S AA287, 333 RAVENSWOOD AVENUE, MENLO PARK, CA 94025 USA
BN 0-9660508-3-5
PY 2004
BP 73
EP 79
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BCC80
UT WOS:000228663400010
DA 2018-10-19
ER

PT J
AU Ignjatovic, N
   Uskokovic, D
AF Ignjatovic, N
   Uskokovic, D
TI Molecular spectroscopy analysis of the substitution of bone tissue by
   HAp/PLLA composite biomaterial
SO SPECTROSCOPY-AN INTERNATIONAL JOURNAL
LA English
DT Article
ID POLY-L-LACTIDE; HYDROXYAPATITE HA PARTICLES; IN-VIVO DEGRADATION;
   INTERNAL-FIXATION; INFRARED-SPECTROSCOPY; FT-IR; BIODEGRADABLE POLYMERS;
   BIORESORBABLE DEVICES; FORGED COMPOSITES; FRACTURES
AB Due to its pronounced osteoinductive properties, calcium hydroxyapatite (HAp) has been widely used in medicine. Bioresorptive poly-L-lactide (PLLA) as a polymer biomaterial has been also used extensively in medicine for its non-toxicity and biocompatibility. To combine the advantages exhibited by each of these materials, a HAp/PLLA composite biomaterial has been synthesized and used for reconstruction and repair of bone defects. Hydroxyapatite/poly-L-lactide (HAp/PLLA) composite biomaterial with PLLA of 50,000 and 430,000 g/mole molecular weight was studied in vivo. The biocomposite with PLLA of both molecular weights was implanted into mice, then removed from their organisms and analyzed by the Fourier transform infrared (FT-IR) spectroscopy, scanning electron microscopy (SEM) and histopathologic analysis. Characteristic absorption bands, registered and defined by FT-IR spectroscopy, confirm the formation of new functional groups and compounds during the bone repair process using HAp/PLLA biocomposite with PLLA of 50,000 and 430,000 molecular weights. Analysis of the microstructures of the sample surfaces by scanning electron microscopy (SEM) before and after implantation revealed bioresorption of the PLLA polymer phase in the system with PLLA of lower molecular weight and generation of collagen fibers at the sites of implanted bioresorptive PLLA. As the studied synthetic materials behave as the natural bone, i.e., they are phagocytosed and resorpable, they can be considered as biocompatible.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, YU-11000 Belgrade, Yugoslavia.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, K Mihailova 35-4, YU-11000 Belgrade, Yugoslavia.
EM uskok@itn.sanu.ac.yu
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968
CR BELLAMY J, 1975, INFRA RED SPECTRA CO, P247
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   BEVER M, 1986, ENCY MAT SCI ENG, V1, P323
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   Calandrelli L, 2000, POLYMER, V41, P8027, DOI 10.1016/S0032-3861(00)00165-8
   Cehreli MC, 2003, J BIOMATER APPL, V17, P265, DOI 10.1177/088532803032109
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   COLARUSSO BP, 1998, APPL SPECTROSC, V52, P106
   Crupi V, 2002, SPECTROSC-INT J, V16, P245, DOI 10.1155/2002/643587
   ELHARAKE W, 1998, AM J PHYS END METAB, V274, P586
   Fujii T, 1997, APPL SPECTROSC, V51, P1682, DOI 10.1366/0003702971939352
   Furukawa T, 2000, CLIN ORTHOP RELAT R, P247
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   HARIS PI, 1992, TRENDS BIOCHEM SCI, V17, P328, DOI 10.1016/0968-0004(92)90305-S
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hooper KA, 2000, J BIOMED MATER RES, V50, P365, DOI 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X
   Huleihel M, 2001, SPECTROSC-INT J, V15, P57, DOI 10.1155/2001/256362
   HUMMEL DO, 1984, ATLAS POLYM PLASTICS, P373
   IGNAJATOVIC N, 2004, J BIOMEDICAL MAT R B, V71
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2000, ADV ENG MATER, V2, P511, DOI 10.1002/1527-2648(200008)2:8<511::AID-ADEM511>3.0.CO;2-B
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic N, 2001, KEY ENG MATER, V192-195, P737
   LAURENCIN C, 1998, POLYM PREPRINTS, V39, P122
   Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718
   Lindner J, 1977, Clin Plast Surg, V4, P425
   MANTSCH H, 1995, J MOL STRUCT, V347, P187, DOI 10.1016/0022-2860(95)08545-7
   MANTSCH HH, 1990, J MOL STRUCT, V217, P347, DOI 10.1016/0022-2860(90)80374-S
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Najman S, 2004, BIO-MED MATER ENG, V14, P61
   Sarasua JR, 1998, MACROMOLECULES, V31, P3895, DOI 10.1021/ma971545p
   SCHUMACHER HR, 1987, AM J MED, V83, P11, DOI 10.1016/0002-9343(87)90845-X
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   STRYER L, 1981, BIOCHEMISTRY-US, P186
   VANSLIEDREGT A, 1992, BIOMATERIALS, V13, P819, DOI 10.1016/0142-9612(92)90174-M
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
NR 40
TC 8
Z9 9
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0712-4813
J9 SPECTROSC-INT J
JI Spectr.-Int. J.
PY 2004
VL 18
IS 4
BP 553
EP 565
DI 10.1155/2004/917656
PG 13
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 890GT
UT WOS:000226500400006
OA Bronze, Other Gold
DA 2018-10-19
ER

PT S
AU Narayan, RJ
AF Narayan, RJ
BE Corcoran, SG
   Joo, YC
   Moody, NR
   Suo, Z
TI DLC/hydroxyapatite nanocomposites
SO THIN FILMS-STRESSES AND MECHANICAL PROPERTIES X
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Thin Films - Stresses and Mechanical Properties X held at
   the 2003 MRS Fall Meeting
CY DEC 01-05, 2003
CL Boston, MA
SP Mat Res Soc, Adv Micro Devices Inc, Hysitron Inc, MTS Syst Corp
ID HYDROXYAPATITE; COATINGS
AB Studies of orthopaedic implant failures have shown that mechanical failure of an implant almost exclusively occurs at the biomaterial-tissue interface. Hydroxyapatite (HA) mimics the behavior of natural bone, and provides a strong, long-lasting adhesive interface between a bone replacement implant and the surrounding tissue. Currently, thin film HA is not commonly used because it contains defects, porosity, and cracks. Delamination of the hydroxyapatite film and formation of hydroxyapatite particles may lead to implant wear and loosening. Furthermore, the coating also acts only as a temporary barrier to ion release from the bulk biomaterial. One method to improve the tribological properties of a bioactive coating is to strengthen the microstructure of the coating through the placement of a DLC (hydrogen-free diamondlike carbon) interlayer. DLC coatings possess properties close to diamond in terms of hardness, atomic smoothness, and chemical inertness. We have developed a diamondlike carbon/HA bilayer, in which the bilayer surface (HA) is bioactive and the interlayer (diamondlike carbon) is biocompatible, wear resistant, and corrosion resistant. We have successfully deposited nanocrystalline hydroxyapatite and DLC films by ablating a hydroxyapatite target and a graphite target using a KrF laser. A novel target design was adopted to incorporate alloying atoms into the films during pulsed laser deposition. These alloying elements possess unique biological properties. Surface morphology was studied using SEM, interfacial structure was studied using TEM, and HA phase microstructure was studied using XRD. The DLC/nanocrystalline HA bilayer material is potentially useful for several orthopedic implant designs.
C1 Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Narayan, RJ (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RI Narayan, Roger/J-2789-2013
OI Narayan, Roger/0000-0002-4876-9869
CR AHN ES, 1998, ABSTR PAP AM CHEM SO, V216
   Chai CS, 1999, J MATER SCI-MATER M, V10, P465, DOI 10.1023/A:1008992807888
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   HAYASHI K, 1993, J BIOMED MATER RES, V27, P557, DOI 10.1002/jbm.820270502
   Soballe Kjeld, 1993, P107
   VENABLES JD, 1990, STATUS APPL DIAMOND, P14
NR 7
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-733-4
J9 MATER RES SOC SYMP P
PY 2004
VL 795
BP 559
EP 564
PG 6
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Materials Science, Coatings & Films;
   Physics, Condensed Matter
SC Materials Science; Physics
GA BY87L
UT WOS:000189484000089
DA 2018-10-19
ER

PT J
AU Resmi, KR
   Varghese, N
   Krishnan, LK
AF Resmi, KR
   Varghese, N
   Krishnan, LK
TI Procedure for quantification of platelet adhesion to biomaterials by
   radioscintigraphy
SO THROMBOSIS RESEARCH
LA English
DT Article
DE biomaterials; platelet adhesion; blood-material interaction;
   radioscintigraphy; I-125 labeling
ID IN-VITRO; GRAFTS
AB Detection of adhered platelets on biomaterial surface that has blood-contacting application is an important test to assess its thrombogenicity. Usually, for measurement of platelet adhesion, after exposure to platelet-rich plasma (PRP) under standardized conditions the test surface is rinsed to remove non-adherent cells and is analyzed under scanning electron microscopy (SEM) to detect morphology of adhered cell and degree of aggregate formation. However, being a qualitative test it is unlikely to give an accurate estimate of platelets adhered to the surface. On the other hand, use of radiolabels enables quantification of platelets deposited on a material or device. Because of high gamma emission of In-111, it can be used for radioscintigraphy, however, its short half life (2.5 days) is,a major hurdle in using it for quantification of platelet adhesion. I-125 is a relatively strong radiolabel that is easily tagged to most of the proteins and has a relatively long half-life (60 days). The major objectives of this study are to standardize the labeling conditions to get good I-125 activity on platelets, while maintaining normal cell function after they are Labeled. Considering all possible uncertainties, quantity of isotope and platelets to be used and the conditions of iodination reaction are established to get repeatable and reproducible labeling of platelets. Further, it is demonstrated that I-125-platelets can be used to determine total number of cells adhered to titanium surface, which is known to be used as a blood-contacting biomaterial. (C) 2004 Elsevier Ltd. ALL rights reserved.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
RP Krishnan, LK (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
EM lissykk@sctimst.ker.nic.in
CR DIDISHEIM P, 1983, THROMB HAEMOSTASIS, V50, P60
   *ISO, 2002, 109934 ISO, V9, P21
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACINTAIR R, 1998, P I MECH ENG H, V212, P465
   MANNUCCI PM, 1972, PALELET FUNCTION THR, P57
   NACHMAN RL, 1973, J BIOL CHEM, V218, P2928
   REIDY MA, 1992, ARCH PATHOL LAB MED, V116, P1276
   SCHOEN FJ, 1993, CARDIOVASC PATHOL, V2, P2095
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   TANGEN O, 1971, THROMB DIATH HAEMOST, V25, P268
   Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3
   ZACHARIAS RK, 1987, J VASC SURG, V6, P429, DOI 10.1067/mva.1987.avs0060429
NR 12
TC 10
Z9 10
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PY 2004
VL 114
IS 2
BP 121
EP 128
DI 10.1016/j.thromres.2004.05.014
PG 8
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 849XY
UT WOS:000223576200007
PM 15306154
DA 2018-10-19
ER

PT J
AU Mauney, JR
   Blumberg, J
   Pirun, M
   Volloch, V
   Vunjak-Novakovic, G
   Kaplan, DL
AF Mauney, JR
   Blumberg, J
   Pirun, M
   Volloch, V
   Vunjak-Novakovic, G
   Kaplan, DL
TI Osteogenic differentiation of human bone marrow stromal cells on
   partially demineralized bone scaffolds in vitro
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT 28th Annual Meeting of the Society-for-Biomaterials
CY APR 24-27, 2002
CL TAMPA, FLORIDA
SP Soc Biomat
ID MESENCHYMAL STEM-CELLS; MATRIX-INDUCED OSTEOGENESIS; ALLOGENEIC BONE;
   CALVARIAL BONE; CLINICAL-APPLICATIONS; HISTOLOGIC EVALUATION;
   QUANTITATIVE-ANALYSIS; ARTICULAR-CARTILAGE; POLYMER SCAFFOLDS;
   GENE-EXPRESSION
AB Tissue engineering has been used to enhance the utility of biomaterials for clinical bone repair by the incorporation of an osteogenic cell source into a scaffold followed by the in vitro promotion of osteogenic differentiation before host implantation. In this study, three-dimensional, partially demineralized bone scaffolds were investigated for their ability to support osteogenic differentiation of human bone marrow stromal cells (BMSCs) in vitro. Dynamic cell seeding resulted in homogeneous cell attachment and infiltration within the matrix and produced significantly higher seeding efficiencies when compared with a conventional static seeding method. Dynamically seeded scaffolds were cultured for 7 and 14 days in the presence of dexamethasone and evaluated on biochemical, molecular, and morphological levels for osteogenic differentiation. Significant elevation in alkaline phosphatase activity was observed versus controls over the 14-day culture, with a transient peak indicative of early mineralization on day 7. On the basis of RT-PCR, dexamethasone-treated samples showed elevations in alkaline phosphatase and osteocalcin expression levels at 7 and 14 days over nontreated controls, while bone sialoprotein was produced only in the presence of dexamethasone at 14 days. Scanning electron microscopy evaluation of dexamethasone-treated samples at 14 days revealed primarily cuboidal cells indicative of mature osteoblasts, in contrast to nontreated controls displaying a majority of cells with a fibroblastic cell morphology. These results demonstrate that partially demineralized bone can be successfully used with human BMSCs to support osteogenic differentiation in vitro. This osseous biomaterial may offer new potential benefits as a tool for clinical bone replacement.
C1 Tufts Univ, Ctr Biotechnol, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Ctr Biotechnol, Dept Chem & Biol Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574
CR Al-Ajmi N, 1996, Adv Space Res, V17, P189, DOI 10.1016/0273-1177(95)00634-Q
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ALTMAN GH, 2001, FASEB J, V16, P270
   Andrades JA, 2001, INT J DEV BIOL, V45, P689
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aubin J E, 1998, J Cell Biochem Suppl, V30-31, P73
   Aubin JE, 1995, BONE, V17, P77
   Becerra J, 1996, J BONE MINER RES, V11, P1703
   BERESFORD JN, 1992, J CELL SCI, V102, P341
   BERVEN S, 2001, EUR SPINE J, V2, pS169
   Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   BRUDER SP, 1999, CLIN ORTHOP S, V367, P68
   Burg KJL, 2000, J BIOMED MATER RES, V51, P642, DOI 10.1002/1097-4636(20000915)51:4<642::AID-JBM12>3.0.CO;2-L
   CAPLAN AI, 1993, ANTERIOR CRUCIATE LI
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   CHEN J, 1994, HISTOCHEM J, V26, P67
   Chow KMC, 2000, CLEFT PALATE-CRAN J, V37, P385, DOI 10.1597/1545-1569(2000)037<0385:VEGPOE>2.3.CO;2
   Coelho MJ, 2000, BIOMATERIALS, V21, P1087, DOI 10.1016/S0142-9612(99)00284-7
   Cooper LF, 2001, J DENT RES, V80, P314, DOI 10.1177/00220345010800010401
   Costantino PD, 2000, OTOLARYNG HEAD NECK, V123, P409, DOI 10.1067/mhn.2000.107679
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   Delloye C, 1996, ARCH ORTHOP TRAUM SU, V115, P141, DOI 10.1007/BF00434541
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   FRIEDLAENDER GE, 1982, J BONE JOINT SURG AM, V64, P307, DOI 10.2106/00004623-198264020-00031
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   HALLFELDT KKJ, 1994, UNFALLCHIRURG, V97, P518
   Hankemeier S, 2001, J ORTHOP RES, V19, P531, DOI 10.1016/S0736-0266(00)00044-9
   HARAKAS NK, 1984, CLIN ORTHOP RELAT R, P239
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   HOSNY M, 1987, J ORAL MAXIL SURG, V45, P1051, DOI 10.1016/0278-2391(87)90162-5
   INOUE T, 1990, Bulletin of Tokyo Dental College, V31, P295
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   ISHAUG SL, 1995, MOL BIOL BIOTECHNOLO, P86
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874
   KOHLES SS, 2001, J BIOMECH, V9, P1197
   Kubler N, 1995, J CRANIO MAXILL SURG, V23, P337, DOI 10.1016/S1010-5182(05)80128-3
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Lee JH, 2000, ANN PLAS SURG, V44, P195, DOI 10.1097/00000637-200044020-00012
   Lewandrowski KU, 2001, BIO-MED MATER ENG, V11, P209
   Lewandrowski KU, 2001, BIO-MED MATER ENG, V11, P197
   Lewandrowski KU, 1997, J ORTHOPAED RES, V15, P748, DOI 10.1002/jor.1100150518
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118
   MULLIKEN JB, 1981, ANN SURG, V194, P366, DOI 10.1097/00000658-198109000-00015
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rabie ABM, 2000, AM J ORTHOD DENTOFAC, V117, P375, DOI 10.1016/S0889-5406(00)70156-9
   Rosenthal RK, 1999, CLIN ORTHOP RELAT R, P61
   Rougraff BT, 2002, J BONE JOINT SURG AM, V84A, P921, DOI 10.2106/00004623-200206000-00005
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   SATO N, 1994, BLOOD, V83, P1093
   Satomura K, 2000, J CELL BIOCHEM, V78, P391
   Seshi B, 2000, BLOOD CELL MOL DIS, V26, P234, DOI 10.1006/bcmd.2000.0301
   Solheim E, 1998, INT ORTHOP, V22, P335, DOI 10.1007/s002640050273
   STUTZLE H, 1998, ORTHOPADE, V27, P188
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
   Turk J B, 2000, Facial Plast Surg, V16, P7, DOI 10.1055/s-2000-7321
   UPTON J, 1984, J HAND SURG-AM, V9A, P388, DOI 10.1016/S0363-5023(84)80229-4
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P486, DOI 10.1007/s002239900737
   Wang J, 2000, CALCIFIED TISSUE INT, V67, P314, DOI 10.1007/s002230001130
   WHITEMAN D, 1993, J HAND SURG-BRIT EUR, V18B, P487, DOI 10.1016/0266-7681(93)90154-8
   YAZDI M, 1991, CLIN ORTHOP RELAT R, P281
   Yoshikawa T, 1998, J BIOMED MATER RES, V41, P568, DOI 10.1002/(SICI)1097-4636(19980915)41:4<568::AID-JBM8>3.3.CO;2-6
   Yoshikawa T, 2000, J BONE MINER RES, V15, P1147, DOI 10.1359/jbmr.2000.15.6.1147
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 80
TC 89
Z9 100
U1 0
U2 18
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JAN-FEB
PY 2004
VL 10
IS 1-2
BP 81
EP 92
DI 10.1089/107632704322791727
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 775EW
UT WOS:000189028600009
PM 15009933
DA 2018-10-19
ER

PT J
AU Fox, DB
   Cook, JL
   Arnoczky, SP
   Tomlinson, JL
   Kuroki, K
   Kreeger, JM
   Malaviya, P
AF Fox, DB
   Cook, JL
   Arnoczky, SP
   Tomlinson, JL
   Kuroki, K
   Kreeger, JM
   Malaviya, P
TI Fibrochondrogenesis of free Intraarticular small intestinal submucosa
   scaffolds
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-College-of-Veterinary-Surgeons
CY OCT 11-14, 2001
CL CHICAGO, IL
SP Amer Coll Vet Surg
ID MENISCAL REGENERATION; TISSUE; DOGS; NEOCHONDROGENESIS; BIOMATERIAL;
   PERIOSTEAL; DEFECTS; GROWTH; AUTOGRAFTS; CARTILAGE
AB Naturally occurring biomaterials, such as small intestine submucosa (SIS), are attractive as potential scaffolds for engineering various tissue types. The aim of this study was to determine whether acellular SIS scaffolds can support cell attachment and ingrowth in a diarthroadial joint without significant intraarticular hemorrhage. Disks of porcine SIS were arthoscopically implanted freely within a randomized knee joint of 21 dogs and harvested 1, 2, 3, and 6 weeks postoperatively. Harvested disks were assessed for gross and histologic appearance, cellular infiltration, and immunoreactivity of collagenase and collagen types I and II. Knee synovium and synovial fluid were also evaluated. All disks were thickened and opacified at harvest. Eleven disks (52%) had adhered to intraarticular tissues and cellular infiltration into the disks was positively correlated with tissue adherence. Further, tissue adherence was positively correlated with duration of intraarticular implantation. Five disks (24%) contained focal areas of homogeneous extracellular matrix. A trend toward more collagenase immunoreactivity was noted in the 3-week disks. Collagen type I was present in remaining SIS and extracellular matrix associated with infiltrated cells. Placed freely within a joint, acellular SIS disks underwent cellular and extracellular matrix modification resulting in fibrocartilage-like tissue. Utilization of SIS as a scaffold for intraarticular tissue-engineering applications is supported as cytoconductivity, appropriate residence time, and absence of untoward effects of implantation are desirable criteria for a tissue-engineering biomaterial.
C1 Univ Missouri, Comparat Orthoped Lab, Columbia, MO USA.
   Michigan State Univ, Lab Comparat Orthoped Res, E Lansing, MI 48824 USA.
   DePuy Orthoped, Warsaw, IN USA.
RP Fox, DB (reprint author), Univ Missouri, Vet Med Teaching Hosp, 379 E Campus Dr, Columbia, MO 65211 USA.
EM foxdb@missouri.edu
OI Cook, James/0000-0002-0862-995X
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   ARNOCZKY SA, 1988, INJURY REPAIR MUSCUL, P483
   ARNOCZKY SP, 1999, CLIN ORTHOP S, V367, pS244
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   BARRIE HJ, 1978, J PATHOL, V125, P163, DOI 10.1002/path.1711250307
   Cook JL, 2001, TISSUE ENG, V7, P321, DOI 10.1089/10763270152044189
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   DELANEY JP, 1989, CLIN ORTHOPAEDICS, V248, P278
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Ibarra C, 2000, ORTHOP CLIN N AM, V31, P411, DOI 10.1016/S0030-5898(05)70160-7
   King D, 1936, J BONE JOINT SURG, V18, P1069
   Koski JA, 2000, ORTHOP CLIN N AM, V31, P419, DOI 10.1016/S0030-5898(05)70161-9
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   PAULINO C, 1998, 2 SIS S ORL FL
   RUSS JC, 1999, IMAGE PROCESSING HDB, P371
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   STONE KR, 1990, CLIN ORTHOP RELAT R, P129
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   Sweigart MA, 2001, TISSUE ENG, V7, P111, DOI 10.1089/107632701300062697
   VACHON A, 1989, AM J VET RES, V50, P1787
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   ZARNETT R, 1987, CLIN ORTHOP RELAT R, V222, P267
NR 28
TC 19
Z9 25
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JAN-FEB
PY 2004
VL 10
IS 1-2
BP 129
EP 137
DI 10.1089/107632704322791772
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA 775EW
UT WOS:000189028600014
PM 15009938
DA 2018-10-19
ER

PT J
AU Banwell, MN
   Hosgood, G
   Kerwin, SC
   Hedlund, CS
   Metcalf, JB
AF Banwell, MN
   Hosgood, G
   Kerwin, SC
   Hedlund, CS
   Metcalf, JB
TI In vitro evaluation of fluorocarbon leader line for use as a
   fabella-tibial suture
SO VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY
LA English
DT Article
DE fluorocarbon; PVDF; cranial cruciate ligament
ID NONABSORBABLE MONOFILAMENT SUTURES; CRANIAL CRUCIATE LIGAMENT; CANINE
   STIFLE JOINT; CRIMP-CLAMP SYSTEM; POLYVINYLIDENE FLUORIDE;
   EXTRAARTICULAR STABILIZATION; DEFICIENT STIFLE; RUPTURE; REPAIR; DOGS
AB Cranial cruciate ligament rupture is a common injury in dogs, for which a variety of surgical techniques have been described. A commonly performed surgical technique is extracapsular stabilization with a lateral fabella-tibial suture (LFS) using large diameter nylon leader line (NLL). Inherent properties of NLL such as memory, low coefficient of friction, and large diameter may compromise knot security. Fluorocarbon (polyvinylidene fluoride; PVDF) has been investigated as a biomaterial for a variety of implants and is available as a high tensile strength fluorocarbon leader line (FCL). For a given tensile strength FCL is one-half the diameter of NLL. This study evaluated the force at failure, elongation, and stiffness of FCL compared to NLL for use as a LFS. The effects of steam and ethylene oxide sterilization on FCL were also evaluated. The results of this study demonstrate similar force at failure and stiffness for FCL when compared to NLL. In addition, the use of FCL may eliminate the elongation under low load observed with NLL. The mechanical properties of FCL loops were not affected by ethylene oxide sterilization. In contrast, steam sterilization caused significant detrimental effects on the mechanical properties of FCL and is not recommended. The reduced diameter and pliable feel of FCL allow for superior handling, formation of a less bulky and potentially more secure knot, and less foreign material in the region of implantation. FCL appears to be a suitable alternative material to NIL for a lateral fabella-tibial suture.
C1 Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.
   Texas A&M Univ, Coll Vet Med, College Stn, TX USA.
   Louisiana State Univ, Dept Civil Engn, Baton Rouge, LA 70803 USA.
RP Banwell, MN (reprint author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.
EM mbanwell@vetmed.lsu.edu
CR Anderson CC, 1998, VET SURG, V27, P533, DOI 10.1111/j.1532-950X.1998.tb00528.x
   BROSNAHAN RE, 1981, J BIOMED MATER RES, V15, P111, DOI 10.1002/jbm.820150115
   Caporn TM, 1996, VET COMP ORTHOPAED, V9, P126
   Flo GL, 1975, J AM ANIM HOSP ASSOC, V11, P570
   Hong T, 1998, ASAIO J, V44, P776, DOI 10.1097/00002480-199811000-00004
   Huber DJ, 1999, VET SURG, V28, P260, DOI 10.1053/jvet.1999.0260
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   LAROCHE G, 1995, ARTIF ORGANS, V19, P1190, DOI 10.1111/j.1525-1594.1995.tb02282.x
   Lewis DD, 1997, AUST VET J, V75, P890, DOI 10.1111/j.1751-0813.1997.tb11260.x
   Nwadike B. S., 1998, Veterinary and Comparative Orthopaedics and Traumatology, V11, P47
   PEYCKE LE, 2002, VET COMP ORTHOPAED T, V4, P210
   Piermattei DL, 1997, BRINKER PIERMATTEI F, P516
   SHIRES PK, 1984, J AM ANIM HOSP ASSOC, V20, P69
   Sicard GK, 2002, VET SURG, V31, P78, DOI 10.1053/jvet.2002.30539
   SICARD GK, 1999, VET COMP ORTHOPAED T, V44, P138
   SLOCUM B, 1993, VET CLIN N AM-SMALL, V23, P777, DOI 10.1016/S0195-5616(93)50082-7
   SMITH GK, 1985, J AM VET MED ASSOC, V187, P375
   Urban E, 1994, ASAIO J, V40, P145
   VASSEUR PB, 1984, VET SURG, V13, P243, DOI 10.1111/j.1532-950X.1984.tb00801.x
   Wada A, 2001, J HAND SURG-BRIT EUR, V26, P212, DOI 10.1054/jhsb.2000.0508
NR 20
TC 5
Z9 6
U1 0
U2 2
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0932-0814
J9 VET COMP ORTHOPAED
JI Vet. Comp. Orthop. Traumatol.
PY 2004
VL 17
IS 1
BP 35
EP 40
PG 6
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 813FX
UT WOS:000220894100007
DA 2018-10-19
ER

PT B
AU Esau, A
   Petersen, F
AF Esau, A
   Petersen, F
BE Popov, V
   Itoh, H
   Brebbia, CA
   Kungolos, A
TI Biosorption technologies for water treatment
SO WASTE MANAGEMENT AND THE ENVIRONMENT II
LA English
DT Proceedings Paper
CT Conference on Advanced Waste Treatment and Management in Japan held at
   the 2nd International Conference on Waste Management and the Environment
CY SEP 29-OCT 01, 2004
CL Rhodes, GREECE
SP Wessex Inst Technol, Univ Thessaly, EcoTopia Sci Inst, Nagoya Univ
DE biosorption; kinetics; sorption; biomaterials; eklonia maxima; seaweed;
   heavy metal removal
AB Ecological problems due to dispersion of heavy metals in natural environments, the high cost of conventional treatment technologies, as well as restrictive environmental legislations have led to investigations into alternate methods for heavy metal removal. Previous work conducted at the Cape Technikon on available biomaterials for heavy metal removal resulted in the identification of eklonia maxima (brown seaweed) as a possible biomaterial for industrial scale heavy metal removal. Preliminary batch column tests, using a similar configuration to a normal ion exchange column, showed that the biosorption process could effectively be utilised to remove up to 100% of heavy metals such as Pb and Cu with very fast kinetics. A comparative cost analysis of the biosorption process and other heavy metal removal processes, such as ion exchange, showed that the biomaterials used for the sorption process were much more cost effective than the conventional resins used in industry.
CR DAVIS TA, 2000, WATER RES, P34
   Forster CF, 1997, BIOSORBENTS METAL IO
   Matheickal JT, 1997, ENVIRON TECHNOL, V18, P25, DOI 10.1080/09593331808616509
   ORHAN Y, 1993, REMOVAL HEAVY METALS
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   TSEZOS M, HYDROMETALLURGY, V59, P245
   ZUMRIYE A, 1997, BIOSORPTION HEAVY ME
NR 7
TC 0
Z9 0
U1 1
U2 1
PU WIT PRESS
PI SOUTHAMPTON
PA ASHURST LODGE, SOUTHAMPTON SO40 7AA, ASHURST, ENGLAND
BN 1-85312-738-8
PY 2004
BP 587
EP 593
PG 7
WC Engineering, Environmental
SC Engineering
GA BBO12
UT WOS:000226547300058
DA 2018-10-19
ER

PT J
AU Demling, RH
   Niezgoda, JA
   Haraway, GD
   Mostow, EN
AF Demling, RH
   Niezgoda, JA
   Haraway, GD
   Mostow, EN
TI Small intestinal submucosa wound matrix and full-thickness venous
   ulcers: Preliminary results
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Article
ID EXTRACELLULAR-MATRIX; FOOT ULCERS; COLLAGEN; REPAIR
AB Recently developed wound care biomaterials derived from natural tissue sources have been shown to improve wound closure by stimulating granulation tissue deposition and epithelization of dermal wounds. These products may offer significant advantages to other available treatments for the management of venous ulcers. One such biomaterial, derived from porcine small intestinal submucosa (SIS), has shown promise as an effective treatment to manage full-thickness wounds. This is an interim analysis of a prospective, randomized, controlled, clinical trial currently being conducted to examine the effectiveness of SIS wound matrix in treating full-thickness venous leg ulcers. Patients meeting inclusion criteria were randomized to either receive treatment with the SIS wound matrix or a standard of care therapy. Ulcer size was determined at enrollment and weekly throughout treatment. Healing, as defined by full epithelization, was assessed at each visit for a period of up to 12 weeks. Complete wound closure within 12 weeks is the primary outcome measure. In this interim analysis, the authors include results from the first 84 evaluable patients enrolled in the trial. The authors found 71 percent of venous ulcers healing at 12 weeks with SIS compared to 46 percent with standard care, a significant group difference. The authors conclude that, in this subset of patients, the SIS wound matrix showed a higher incidence of wound closure as compared to standard of care treatment.
C1 Brigham & Womens Hosp, Burn & Wound Ctr, Boston, MA 02115 USA.
   St Lukes Hosp, Wound Care Ctr, Milwaukee, WI USA.
   Oklahoma State Univ, Coll Osteopath Med, Tulsa Wound Care Clin, Tulsa, OK USA.
   NE Ohio Univ, Coll Med, Dermatol Sect, Cleveland, OH USA.
   Univ Coll Med, NE Union, Cleveland, OH USA.
   Case Western Reserve Univ, Coll Med, Cleveland, OH 44106 USA.
RP Demling, RH (reprint author), Brigham & Womens Hosp, Burn & Wound Ctr, 75 Francis St,OBC-4, Boston, MA 02115 USA.
EM rhdemling@partners.org
CR Allman R M, 1995, Adv Wound Care, V8, P61
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Brown-Etris M, 1995, Adv Wound Care, V8, P53
   Brown-Etris M, 2002, WOUNDS, V14, P150
   Calvin M, 1998, WOUNDS, V10, P12
   Falanga V, 1999, WOUND REPAIR REGEN, V7, P201, DOI 10.1046/j.1524-475X.1999.00201.x
   GAO ZR, 1992, BURNS, V18, P492, DOI 10.1016/0305-4179(92)90183-U
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, WOUNDS, V13, P195
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   Lindberg K, 2001, BURNS, V27, P254, DOI 10.1016/S0305-4179(00)00113-3
   Lyder Courtney H, 2002, Ostomy Wound Manage, V48, P52
   Margolis DJ, 1999, DIABETES CARE, V22, P692, DOI 10.2337/diacare.22.5.692
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   O'Brien JF, 2003, BRIT J SURG, V90, P794, DOI 10.1002/bjs.4167
   Olin JW, 1999, VASC MED, V4, P1
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382
   Troyer-Caudle J, 1996, Home Care Provid, V1, P119, DOI 10.1016/S1084-628X(96)90019-2
   WINTER GD, 1962, NATURE, V200, P377
NR 22
TC 30
Z9 31
U1 1
U2 2
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD JAN
PY 2004
VL 16
IS 1
BP 18
EP 22
PG 5
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 767PJ
UT WOS:000188459400003
DA 2018-10-19
ER

PT J
AU Zheng, H
   Tan, ZA
   Zhan, YR
   Huang, J
AF Zheng, H
   Tan, ZA
   Zhan, YR
   Huang, J
TI Morphology and properties of soy protein plastics modified with chitin
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE blends; phase separation
ID MECHANICAL-PROPERTIES; WATER-ABSORPTION; TEMPERATURE; PRESSURE
AB A series of bioplastics from isolated soy protein (SPI) and chitin (CH) was prepared with glycerol as a plasticizer by blending and compression molding. Their morphology and properties were investigated by wide-angle X-ray diffraction (WAXD), differential scanning calorimetry (DSC), dynamical mechanical thermal analysis (DMTA), scanning electron microscopy (SEM), and tensile and water-absorption tests. The added CH as a filler cannot strongly interact with SPI molecules and, hence, this results in phase separation in blends. However, the rigid nature of the CH molecules enhanced the tensile strength and Young's modulus, but decreased the breaking elongation of the materials. When the CH content was higher than 10 wt %, the water absorption of the blends were obviously lower than that of the sheets without CH, resulting from the formation of a CH framework in the blends. Both soy protein and CH exhibit good biodegradability, biocompatibility, and bioactivity, and their composites may become a promising biomaterial. (C) 2003 Wiley Periodicals, Inc.
C1 Wuhan Univ Technol, Dept Chem Engn, Wuhan 430070, Peoples R China.
   Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China.
   Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
RP Tan, ZA (reprint author), Wuhan Univ Technol, Dept Chem Engn, Wuhan 430070, Peoples R China.
RI Huang, Jin/E-4537-2011
CR Foulk JA, 2001, IND CROP PROD, V14, P11, DOI 10.1016/S0926-6690(00)00084-4
   Huang H. C., 1994, THESIS IOWA STATE U
   HUANG J, INPRESS J APPL POLYM
   HUANG JL, IN PRESS J APPL POLY
   John J, 1999, POLYM INT, V48, P1165, DOI 10.1002/(SICI)1097-0126(199911)48:11<1165::AID-PI286>3.0.CO;2-L
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Mo XQ, 2001, J AM OIL CHEM SOC, V78, P867, DOI 10.1007/s11746-001-0357-1
   Mo XQ, 1999, J APPL POLYM SCI, V73, P2595, DOI 10.1002/(SICI)1097-4628(19990923)73:13<2595::AID-APP6>3.3.CO;2-9
   MUNGARA PM, 2002, POLYM PREPR PMSE, V86, P364
   Otaigbe JU, 1997, J ENVIRON POLYM DEGR, V5, P75, DOI 10.1007/BF02763590
   Otaigbe JU, 1997, J ENVIRON POLYM DEGR, V5, P199
   PAETAU I, 1994, IND ENG CHEM RES, V33, P1821, DOI 10.1021/ie00031a023
   Paetau I., 1994, Journal of Environmental Polymer Degradation, V2, P211, DOI 10.1007/BF02067447
   Park SK, 1999, J AM OIL CHEM SOC, V76, P1201, DOI 10.1007/s11746-999-0094-3
   Sue HJ, 1997, POLYMER, V38, P5035, DOI 10.1016/S0032-3861(97)00048-7
   Zhang J, 2001, POLYMER, V42, P2569, DOI 10.1016/S0032-3861(00)00624-8
   Zhong ZK, 2001, POLYMER, V42, P6961, DOI 10.1016/S0032-3861(01)00118-5
   Zhong ZK, 2000, J APPL POLYM SCI, V78, P1063, DOI 10.1002/1097-4628(20001031)78:5<1063::AID-APP150>3.0.CO;2-9
   ZHONG ZK, 2001, J APPL POLYM SCI, V81, P16
NR 19
TC 31
Z9 33
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 20
PY 2003
VL 90
IS 13
BP 3676
EP 3682
DI 10.1002/app.12997
PG 7
WC Polymer Science
SC Polymer Science
GA 739YQ
UT WOS:000186374600030
DA 2018-10-19
ER

PT J
AU Yoon, SW
   Chung, DJ
   Kim, JH
AF Yoon, SW
   Chung, DJ
   Kim, JH
TI Preparation and swelling behavior of biodegradable hydrogels based on
   alpha,beta-poly(N-2-hydroxyethyl-DL-aspartamide)
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE hydrogels; biodegradable; swelling; polyamides; biomaterials
ID POLY(ASPARTIC ACID)S; GAMMA-IRRADIATION; COPOLYMERS
AB Biodegradable polymers and the hydrogels have been increasingly applied in a variety of biomedical fields and pharmaceutics. alpha,beta-Poly(N-2-hydroxyethyl-DL-aspartamide), PHEA, one of poly(amino acid)s with hydroxyethyl pendants, are known to be biodegradable and biocompatible, and has been studied as an useful biomaterial, especially for drug delivery, via appropriate structural modification. In this work, hydrogels based on PHEA were prepared by two-step reaction, that is, the crosslinking of polysuccinimide, the precursor polymer, with oligomeric PEG or PEI-diamines and the following nucleophilic ring-opening reaction by ethanolamine. Soft hydrogels possessing varying degrees of gel strength could be prepared easily, depending on the amount of different crosslinking reagents. The swelling degrees, which were in the range of 10-40 g-water/dry gel, increased somewhat at higher temperature, and also at alkaline pH of aqueous solution. A typical hydrogel remained almost unchanged for 1 week, at 37degreesC in phosphate buffer of pH 7.4, and then seemed to degrade slowly as time. A porous scaffold could be fabricated by the freeze drying of water-swollen gel. The PHEA-based hydrogels have potential for useful biomaterial applications including current drug delivery system. (C) 2003 Wiley Periodicals, Inc.
C1 Sungkyunkwan Univ, Dept Chem Engn, Polymer Technol Inst, Suwon 440746, South Korea.
   Sungkyunkwan Univ, Dept Polymer Sci & Engn, Suwon 440746, South Korea.
RP Kim, JH (reprint author), Sungkyunkwan Univ, Dept Chem Engn, Polymer Technol Inst, 300 Chunchun, Suwon 440746, South Korea.
CR Andrade J. D., 1996, ACS S SER, V631
   Caldwell G, 1997, J APPL POLYM SCI, V66, P911, DOI 10.1002/(SICI)1097-4628(19971031)66:5<911::AID-APP11>3.0.CO;2-Q
   Caliceti P, 2001, BBA-GEN SUBJECTS, V1528, P177, DOI 10.1016/S0304-4165(01)00191-X
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   DUMITRIU S, 1994, POLYM BIOMATERIALS
   Giammona G, 2000, POLYM INT, V49, P93, DOI 10.1002/(SICI)1097-0126(200001)49:1<93::AID-PI299>3.0.CO;2-6
   Giammona G., 1994, COLLOID POLYM SCI, V272, P12
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kim JH, 2002, J IND ENG CHEM, V8, P138
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Nakato T, 1998, MACROMOLECULES, V31, P2107, DOI 10.1021/ma971629y
   NERI P, 1973, J MED CHEM, V16, P893, DOI 10.1021/jm00266a006
   Park HD, 1999, POLYM-KOREA, V23, P247
   Pitarresi G, 2001, COLLOID POLYM SCI, V279, P579, DOI 10.1007/s003960000457
   Pitarresi G, 1996, J BIOACT COMPAT POL, V11, P328, DOI 10.1177/088391159601100405
   Tomida M, 1997, POLYMER, V38, P2791, DOI 10.1016/S0032-3861(97)85616-9
   WOLK SK, 1994, MACROMOLECULES, V27, P7613, DOI 10.1021/ma00104a016
NR 18
TC 11
Z9 12
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 20
PY 2003
VL 90
IS 13
BP 3741
EP 3746
DI 10.1002/app.13075
PG 6
WC Polymer Science
SC Polymer Science
GA 739YQ
UT WOS:000186374600039
DA 2018-10-19
ER

PT J
AU Li, YH
   Rao, GB
   Rong, LJ
   Li, YY
   Ke, W
AF Li, YH
   Rao, GB
   Rong, LJ
   Li, YY
   Ke, W
TI Effect of pores on corrosion characteristics of porous NiTi alloy in
   simulated body fluid
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Letter
DE corrosion resistance; polarization; porous; shape memory alloy;
   combustion synthesis
ID NICKEL-TITANIUM; SHAPE-MEMORY; RESISTANCE; TISSUE; HARD
AB Porous NiTi shape memory alloy (SMA) is a novel biomaterial used for human surgical implant. The corrosion characteristics of porous NiTi SMAs prepared from combustion synthesis have been investigated by potentiodynamic polarization tests in physiological and Hank's solutions at 310 K. Meanwhile, solid NiTi SMA has been chosen as a control. The preliminary data indicate that pores have strong effects on corrosion characteristics of porous NiTi SMA. Porous NiTi SMA is less corrosion resistant than solid one. (C) 2003 Elsevier B.V. All rights reserved.
C1 Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Li, YH (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
OI Li, Yong-Hua/0000-0003-0005-3789
CR Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   GJUNTER VE, 2000, DELAY LAW NEW CLASS
   HENCH LL, 1982, BIOMATERIALS INTERFA
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Li BY, 2000, J MATER RES, V15, P10, DOI 10.1557/JMR.2000.0004
   Li BY, 2001, SCRIPTA MATER, V44, P823, DOI 10.1016/S1359-6462(00)00653-9
   Li YH, 2001, J ALLOY COMPD, V325, P259, DOI 10.1016/S0925-8388(01)01382-2
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   Seah KHW, 1998, CORROS SCI, V40, P547, DOI 10.1016/S0010-938X(97)00152-2
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
NR 14
TC 43
Z9 46
U1 0
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD DEC 20
PY 2003
VL 363
IS 1-2
BP 356
EP 359
DI 10.1016/S0921-5093(03)00629-4
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 748FC
UT WOS:000186851000045
DA 2018-10-19
ER

PT J
AU Antunes, WM
   Luna, AS
   Henriques, CA
   da Costa, ACA
AF Antunes, WM
   Luna, AS
   Henriques, CA
   da Costa, ACA
TI An evaluation of copper biosorption by a brown seaweed under optimized
   conditions
SO ELECTRONIC JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE biosorption; copper; equilibrium; kinetics; Sargassum sp.
ID AQUEOUS-SOLUTIONS; HEAVY-METALS; RHIZOPUS-ARRHIZUS; REMOVAL; SORPTION;
   BIOMASS; CU(II); EQUILIBRIUM; CADMIUM; CHITIN
AB A basic investigation into the removal of copper ions from aqueous solutions by Sargassum sp. was conducted in batch conditions. The influence of different experimental parameters such as initial pH, shaking rate, sorption time, temperature, equilibrium conditions and initial concentrations of copper ions on copper uptake was evaluated. Results indicated that for shaking rates higher than 100 rpm no significant changes in copper accumulation were observed, as well as for pH values between 3.0 and 5.0. No marked effect on the biosorption of copper was detected for temperatures between 298 and 328K. The Langmuir model better represented the sorption process, in comparison to the model of Freundlich. The process followed a second-order kinetics and its calculated activation energy was 5.2 kcal/mol. Due to its outstanding copper uptake capacity (1.48 mmol/g biomass) Sargassum sp. proved to be an excellent biomaterial for accumulating and recovering copper from industrial solutions.
C1 Univ Estado Rio de Janeiro, Inst Quim, Dept Tecnol Proc Bioquim, BR-20550013 Rio De Janeiro, Brazil.
   Univ Estado Rio de Janeiro, Inst Quim, Dept Quim Analit, BR-550013 Rio De Janeiro, Brazil.
   Univ Estado Rio de Janeiro, Inst Quim, Dept Quim Analit, BR-20550013 Rio De Janeiro, Brazil.
RP da Costa, ACA (reprint author), Univ Estado Rio de Janeiro, Inst Quim, Dept Tecnol Proc Bioquim, Rua Sao Francisco Xavier 524, BR-20550013 Rio De Janeiro, Brazil.
EM asluna@uerj.br; cah@uerj.br; acosta@uerj.br
RI DA COSTA, ANTONIO CARLOS/G-3460-2012
CR Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Bunke G., 1999, BIOTECHNOLOGY A, V11, P431
   Chang JS, 1997, WATER RES, V31, P1651, DOI 10.1016/S0043-1354(97)00008-0
   COSTA ACA, 2001, ELECT J BIOTECHNOLOG, V4
   Eccles H, 1999, TRENDS BIOTECHNOL, V17, P462, DOI 10.1016/S0167-7799(99)01381-5
   FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001
   GALLAGHER MJ, 1998, P INT C SOL WAST TEC
   Kapoor A, 1999, BIORESOURCE TECHNOL, V70, P95, DOI 10.1016/S0960-8524(98)00192-8
   Leung WC, 2000, WATER SCI TECHNOL, V41, P233
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   Mehta SK, 2001, ECOL ENG, V18, P1, DOI 10.1016/S0925-8574(00)00174-9
   Modak JM, 1995, MINER METALL PROC, V12, P189
   MURALEEDHARAN TR, 1995, APPL ENVIRON MICROB, V61, P3507
   Nuhoglu Y, 2002, BIORESOURCE TECHNOL, V85, P331, DOI 10.1016/S0960-8524(02)00098-6
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   Sag Y, 2002, BIOCHEM ENG J, V12, P143, DOI 10.1016/S1369-703X(02)00068-2
   Say R, 2001, BIORESOURCE TECHNOL, V76, P67, DOI 10.1016/S0960-8524(00)00071-7
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   TIANWEI T, 2000, PROGR BIOTECHNOLOGY, V16, P169
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Volesky Bohumil, 1990, BIOSORPTION HEAVY ME
   Zhou JL, 1998, ENVIRON POLLUT, V101, P67, DOI 10.1016/S0269-7491(98)00034-7
NR 24
TC 70
Z9 77
U1 1
U2 6
PU UNIV CATOLICA DE VALPARAISO
PI VALPARAISO
PA AV BRASIL 2950, PO BOX 4059, VALPARAISO, CHILE
SN 0717-3458
J9 ELECTRON J BIOTECHN
JI Electron. J. Biotechnol.
PD DEC 15
PY 2003
VL 6
IS 3
BP 174
EP 184
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 770VL
UT WOS:000188751400002
DA 2018-10-19
ER

PT J
AU Young, TH
   Hung, CH
AF Young, TH
   Hung, CH
TI Change in electrophoretic mobility of PC12 cells after culturing on PVA
   membranes modified with different diamines
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE electrophoresis; mobility; PC12 cells; poly (vinyl alcohol)
ID CEREBELLAR GRANULE NEURONS; HUMAN-ERYTHROCYTES; EVAL MEMBRANES; SURFACE;
   BEHAVIOR; ADHESION; NERVE; FIBRONECTIN; RELEASE; GROWTH
AB The cell-biomaterial interaction is of extreme importance in regulating the numerous functions necessary for cell adhesion, growth, and differentiation. In the current study, electrophoresis was used to investigate the interactions between cells and biomaterials by measuring the change in electrophoretic mobility of pheochromocytoma (PC12) cells after they were cultured on the poly (vinyl alcohol) membranes modified with different diamines. Variations in cellular activity and electrophoretic mobility of cultured cells were compared. It was found that the intracellular metabolism and the cell surface charge properties were altered after cells contacting biomaterials and the variation of the latter occurred earlier than that of the former. Although the precise mechanism by which the variation of electrophoretic mobility of cultured PC12 cells was unknown, the biomaterials could influence the cell mobility within a short incubation time. It was hypothesized that changes in extracellular matrix components of cell surface may be in part responsible. (C) 2003 Wiley Periodicals, Inc.
C1 Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan.
   Natl Taiwan Univ, Coll Engn, Inst Biomed Engn, Taipei 100, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan.
EM thyoung@ha.mc.ntu.edu.tw
CR AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Hsu JP, 2002, ELECTROPHORESIS, V23, P2001, DOI 10.1002/1522-2683(200207)23:13<2001::AID-ELPS2001>3.0.CO;2-5
   KAWAHATA S, 1990, J COLLOID INTERF SCI, V138, P182, DOI 10.1016/0021-9797(90)90193-R
   KONDOH A, 1993, J APPL POLYM SCI, V47, P1983, DOI 10.1002/app.1993.070471108
   LANGONE F, 1995, BIOMATERIALS, V16, P347, DOI 10.1016/0142-9612(95)93851-4
   LEVINE S, 1983, BIOPHYS J, V42, P127, DOI 10.1016/S0006-3495(83)84378-1
   Makino K, 1995, COLLOID SURFACE B, V5, P221, DOI 10.1016/0927-7765(95)01220-3
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MIRONOV SL, 1985, J MEMBRANE BIOL, V86, P197, DOI 10.1007/BF01870598
   MORITA K, 1991, J COLLOID INTERF SCI, V147, P457, DOI 10.1016/0021-9797(91)90179-C
   Rainaldi G, 2001, J BIOMED MATER RES, V55, P104, DOI 10.1002/1097-4636(200104)55:1<104::AID-JBM140>3.3.CO;2-S
   SCHUGENS C, 1995, J BIOMED MATER RES, V29, P1349, DOI 10.1002/jbm.820291106
   Shieh MJ, 2002, J MEMBRANE SCI, V204, P237, DOI 10.1016/S0376-7388(02)00046-7
   SHOICHET MS, 1994, BIOTECHNOL BIOENG, V43, P563, DOI 10.1002/bit.260430705
   SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820
   TARONE G, 1982, J CELL BIOL, V94, P179, DOI 10.1083/jcb.94.1.179
   Yamato M, 2000, BIOMATERIALS, V21, P981, DOI 10.1016/S0142-9612(99)00239-2
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 2003, BIOMATERIALS, V24, P1477, DOI 10.1016/S0142-9612(02)00527-6
   Young TH, 2001, BIOMATERIALS, V22, P1771, DOI 10.1016/S0142-9612(00)00337-9
NR 24
TC 15
Z9 15
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2003
VL 67A
IS 4
BP 1238
EP 1244
DI 10.1002/jbm.a.20033
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748TT
UT WOS:000186877700020
PM 14624510
DA 2018-10-19
ER

PT J
AU Au, A
   Ha, J
   Polotsky, A
   Krzyminski, K
   Gutowska, A
   Hungerford, DS
   Frondoza, CG
AF Au, A
   Ha, J
   Polotsky, A
   Krzyminski, K
   Gutowska, A
   Hungerford, DS
   Frondoza, CG
TI Thermally reversible polymer gel for chondrocyte culture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polymer; chondrocyte; thermo-reversible tissue; engineering; tissue
   culture
ID IN-VITRO; ALGINATE HYDROGELS; POLYGLYCOLIC ACID; TISSUE; SCAFFOLDS;
   CHITOSAN; CARTILAGE; SURFACE; PROLIFERATION; EXPRESSION
AB We have evaluated a biomaterial to serve as a scaffold for the propagation and amplification of chondrocytes that promotes the original cellular phenotype of these cells. The goal of the present study was to investigate the use of thermally reversible polymer gels poly(NiPAAm-co-AAc), as a biocompatible supporting scaffold for the propagation of chondrocytic cells. The polymer gels at temperatures above its lower critical solution temperature whereas liquefying at temperatures below its lower critical solution temperature of 34.5 degreesC. Hence, the polymer, in its gelled form, has the ability to hold cells in situ, forming a matrix similar to the natural cellular environment or the extracellular matrix that comprises cartilage. We tested the hypothesis that the polymer gel promotes cell viability and function. Human osteoblast-like cells, nasal chondrocytes, and articular chondrocytes (1 x 10(5)/150 muL) were resuspended in enriched Dulbecco's minimal essential media and were plated onto control (without gel) and gel containing 24-well plates. The plates were reincubated at 37 degreesC, 5% CO2 for the time point of interest. Additional media was added to the plates and exchanged as needed. After cell culture, cells were retrieved, enumerated, and cell viability was determined. Other aliquots of the cells were stained for morphological analysis whereas expression of chondrocyte markers including collagen type II and aggrecan were determined using reverse transcriptase-polymerase chain reaction. The polymer gel was not cytotoxic because the cell number retrieved from three-dimensional culture gel was found to be one to two times higher than that retrieved from monolayer culture. Chondrocytes propagated in the thermo-reversible polymers expressed enhanced or maintained expression of collagen type II and aggrecan. Collagen type I expression was decreased or unaltered. The N-isopropylac-rylamide and acrylic acid copolymer gel has potential use as a cell culture substrate and as a cell delivery vehicle. (C) 2003 Wiley Periodicals, Inc.
C1 Johns Hopkins Univ, Dept Orthopaed Surg, Baltimore, MD 21239 USA.
   Pacific NW Natl Lab, Richland, WA 99352 USA.
RP Frondoza, CG (reprint author), Johns Hopkins Univ, Dept Orthopaed Surg, 5601 Loch Raven Blvd, Baltimore, MD 21239 USA.
OI Krzyminski, Karol/0000-0003-4811-961X
CR Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Athanasiou KA, 1998, TISSUE ENG, V4, P53, DOI 10.1089/ten.1998.4.53
   Bouchet BY, 2000, J BIOMED MATER RES, V52, P716, DOI 10.1002/1097-4636(20001215)52:4<716::AID-JBM17>3.0.CO;2-T
   Dauben M., 1996, POLYMER, V37, P2927
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   GUERIN P, 1983, PACE, V6, P449, DOI 10.1111/j.1540-8159.1983.tb04388.x
   GUTOWSKA A, 2001, 27 ANN M T SOC BIOM, P566
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kwon IK, 2001, J BIOMAT SCI-POLYM E, V12, P1147, DOI 10.1163/15685620152691904
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Mankin H, 1994, ORTHOPAEDIC BASIC SC, P3
   MAYNE R, 1989, ARTHRITIS RHEUM, V32, P241, DOI 10.1002/anr.1780320302
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Nehrer S, 1998, TISSUE ENG, V4, P175, DOI 10.1089/ten.1998.4.175
   Peniche C, 1999, BIOMATERIALS, V20, P1869, DOI 10.1016/S0142-9612(99)00048-4
   RODEHEAVER GT, 1981, SURG GYNECOL OBSTET, V153, P835
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Stiles B, 2002, POPTRONICS, V3, P3
   TAKEZAWA T, 1990, BIO-TECHNOL, V8, P854, DOI 10.1038/nbt0990-854
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
NR 31
TC 25
Z9 26
U1 0
U2 7
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2003
VL 67A
IS 4
BP 1310
EP 1319
DI 10.1002/jbm.a.10156
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748TT
UT WOS:000186877700028
PM 14624518
DA 2018-10-19
ER

PT J
AU Pompe, W
   Worch, H
   Epple, M
   Friess, W
   Gelinsky, M
   Greil, P
   Hempel, U
   Scharnweber, D
   Schulte, K
AF Pompe, W
   Worch, H
   Epple, M
   Friess, W
   Gelinsky, M
   Greil, P
   Hempel, U
   Scharnweber, D
   Schulte, K
TI Functionally graded materials for biomedical applications
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE functionally graded materials; biomaterials; bone replacement
ID POROUS HYDROXYAPATITE; CALCIUM-PHOSPHATE; BONE-FORMATION; IMPLANTS;
   CELLS; COLLAGEN; MC3T3-E1; PROTEIN; POLY(ANHYDRIDE-CO-IMIDES);
   BIOCOMPATIBILITY
AB Functional gradation is one characteristic feature of living tissue. Bio-inspired materials open new approaches for manufacturing implants for bone replacement. Different routes for new implant materials are presented using the principle of functional gradation. An artificial biomaterial for kneejoint replacement has been developed by building a graded structure consisting of ultra-high molecular weight polyethylene (UHMWPE) fibre reinforced high-density polyethylene combined with a surface of UHMWPE. The ingrowth behaviour of titanium implants into hard tissue can be improved by depositing a graded biopolymer coating of fibronectin, collagen types I and III with a gradation, derived from the mechanisms occurring during healing in vivo. Functionally graded porous hydroxyapatite (HAP) ceramics can be produced using alternative routes, e.g. sintering of laminated structures of HAP tapes filled with polymer spheres or combining biodegradable polyesters such as polylactide, polylactide-co-glycolide and polyglycolide, with carbonated nanocrystalline hydroxyapatite. HAP-collagen I scaffolds are an appropriate material for in vitro growth of bone. The scaffold has to be functionally graded in order to create an optimised mechanical behaviour as well as the intended improvement of the cell ingrowth. (C) 2003 Elsevier B.V. All rights reserved.
C1 Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   Ruhr Univ Bochum, Fac Chem, Solid State Chem, D-44780 Bochum, Germany.
   Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91508 Erlangen, Germany.
   Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91058 Erlangen, Germany.
   Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany.
   Univ Technol Hamburg, Dept Polymers & Composites, D-21073 Hamburg, Germany.
RP Pompe, W (reprint author), Tech Univ Dresden, Inst Werkstoffwissensch, Gebaude Hallwachsstr 3, D-01069 Dresden, Germany.
EM pompe@tmfs.mpgfk.tu-dresden.de
RI Gelinsky, Michael/A-9680-2012; Scharnweber, Dieter/B-3382-2010; Schulte,
   Karl/C-9550-2013
OI Gelinsky, Michael/0000-0001-9075-5121; Schulte, Karl/0000-0001-6521-0488
CR ARITA IH, 1995, J MATER SCI-MATER M, V6, P19, DOI 10.1007/BF00121241
   Attawia MA, 1996, J ORTHOPAED RES, V14, P445, DOI 10.1002/jor.1100140315
   ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P1233, DOI 10.1002/jbm.820291010
   Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   BIRKEN LMO, 2000, P 6 WORLD BIOM C, P420
   BIRKEN LMO, 2000, P 6 WORLD BIOM C HAW, P856
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   CHENU C, 1994, J CELL BIOL, V127, P1149, DOI 10.1083/jcb.127.4.1149
   Chung CY, 1999, BIOCHEM BIOPH RES CO, V265, P246, DOI 10.1006/bbrc.1999.1639
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z
   Floquet I., 1997, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V98, P47
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HILTUNEN A, 1993, CLIN ORTHOP RELAT R, P23
   HOGAN ME, 1991, J ELECTRON MICR TECH, V18, P106, DOI 10.1002/jemt.1060180203
   ITAKURA Y, 1988, J BIOMED MATER RES, V22, P613, DOI 10.1002/jbm.820220703
   Jacobs O, 2000, WEAR, V244, P20, DOI 10.1016/S0043-1648(00)00419-1
   Kitsugi T, 1996, J BIOMED MATER RES, V32, P149
   Kurdy NMG, 1998, J ORTHOP TRAUMA, V12, P122, DOI 10.1097/00005131-199802000-00010
   Lacroix F, 1999, COMPOS PART A-APPL S, V30, P369, DOI 10.1016/S1359-835X(98)00085-2
   LACROIX F, 1998, POLYMER, V40, P843
   Lampenscherf S., 1999, Materials Science Forum, V308-311, P362
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Liu YK, 1997, FEBS LETT, V420, P112, DOI 10.1016/S0014-5793(97)01498-1
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   Pompe W., 1999, Materials Science Forum, V308-311, P325
   PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447
   Quinones CR, 1997, CLIN ORAL IMPLAN RES, V8, P487, DOI 10.1034/j.1600-0501.1997.080607.x
   REMER P, 1998, SCHWERPUNKTPROGRAMM, P30
   Ripamonti U, 2001, PLAST RECONSTR SURG, V107, P977, DOI 10.1097/00006534-200104010-00012
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   Schiller C, 2001, CERAM TRANS, V114, P97
   SCHLIEPHAKE H, 1991, INT J ORAL MAX SURG, V20, P52, DOI 10.1016/S0901-5027(05)80698-8
   SCHULTE K, 1999, MATER SCI FORUM, V308, pF101
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tampieri A, 2000, MATER CHEM PHYS, V64, P54, DOI 10.1016/S0254-0584(99)00252-7
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   Trentz OA, 1997, UNFALLCHIRURG, V100, P39, DOI 10.1007/s001130050093
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Vaz L, 1999, J MATER SCI-MATER M, V10, P239, DOI 10.1023/A:1008910213166
   Verrier S, 1996, J MATER SCI-MATER M, V7, P46, DOI 10.1007/BF00121189
   WAGNER M, 2000, KERAM Z, V6, P490
   Wang CK, 1998, MATER CHEM PHYS, V53, P138, DOI 10.1016/S0254-0584(97)02074-9
   Wang M, 1999, J MATER SCI-MATER M, V10, P269, DOI 10.1023/A:1008901428552
   Weihe S, 2001, Mund Kiefer Gesichtschir, V5, P299, DOI 10.1007/s100060100324
   WEIHE S, 2001, BIOMEDIZINISCHE T S1, V46, P214
   WEIHE S, 2001, BIOMEDIZINISCHE T S1, V46, P204
   WERNER JP, 1999, P 6 C EUR CER SOC, V2, P509
   WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X
   WIMMER MA, 1999, WEAR POLYETHYLENE CO, P43
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   1984, 52292 DIN
NR 60
TC 226
Z9 238
U1 4
U2 118
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD DEC 5
PY 2003
VL 362
IS 1-2
BP 40
EP 60
DI 10.1016/S0921-5093(03)00580-X
PG 21
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 749HF
UT WOS:000186913300004
DA 2018-10-19
ER

PT J
AU Fini, M
   Aldini, NN
   Torricelli, P
   Glavaresi, G
   Borsari, V
   Lenger, H
   Bernauer, J
   Glardino, R
   Chiesa, R
   Cigada, A
AF Fini, M
   Aldini, NN
   Torricelli, P
   Glavaresi, G
   Borsari, V
   Lenger, H
   Bernauer, J
   Glardino, R
   Chiesa, R
   Cigada, A
TI A new austenitic stainless steel with negligible nickel content: an in
   vitro and in vivo comparative investigation
SO BIOMATERIALS
LA English
DT Article
DE stainless steel; nickel; titanium; osteoblasts; bone
ID OSTEOBLAST-LIKE CELLS; TITANIUM PARTICLES; METAL-IONS; BONE; IMPLANT;
   INTERFACE; MICROHARDNESS; FIXATION; RELEASE; ALLOY
AB New nickel (Ni)-reduced stainless-steel metals have recently been developed to avoid sensitivity to Ni. In the present study, an austenitic Ni-reduced SSt named P558 (P558, Bohler, Milan, Italy) was studied in vitro on primary osteoblasts and in vivo after bone implantation in the sheep tibia, and was compared to ISO 5832-9 SSt (SSt) and Ti6Al4V. Cells were cultured directly on P558 and Ti6Al4V. Cells cultured on polystyrene were used as controls. Osteoblast proliferation, viability and synthetic activity were evaluated at 72 h by assaying WST 1, alkaline phosphatase activity (ALP), nitric oxide, pro-collagen I (PICP), osteocalcin (OC), transforming growth factor-beta1 (TGFbeta-1) and interleukin-6 (IL-6) after 1.25(OH)(2)D-3 stimulation. Under general anaesthesia, four sheep were submitted for bilateral tibial implantation of P558, SSt and Ti6Al4V rods. In vitro results demonstrated that the effect of P558 on osteoblast viability, PICP, TGF beta-1, tumor necrosis factor-alpha production did not significantly differ from that exerted by Ti6Al4V and controls. Furthermore, P558 enhanced osteoblast differentiation, as confirmed by ALP and OC levels, and reduced IL-6 6 production. At 26 weeks, the bone-to-implant contact was higher in P558 than in SSt (28%, p < 0.005) and Ti6Al4V (4%, p < 0.05), and was higher in Ti6Al4V than in SSt (22%, p < 0.005). The tested materials did not affect bone microhardness in pre-existing host bone as evidenced by the measurements taken at 1000 pm from the bone-biomaterial interface (F = 1.89, ns). At the bonebiomaterial interface the lowest HV value was found for SSt, whereas no differences in HV were observed between materials (F = 1.55, ns). The current findings demonstrate P558 biocompatibility both in vitro and in vivo, and osteointegration processes are shown to be significantly improved by P558 as compared to the other materials tested. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, I-40136 Bologna, Italy.
   Politecn Milan, Dept Chem Mat & Chem Engn G Natta, I-20133 Milan, Italy.
   Univ Bologna, Bologna, Italy.
   Bohler Edelsthal Gmbh & Co Kg Kapfenberg, Res Dept, Kapfenberg, Austria.
RP Fini, M (reprint author), Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, Via di Barbiano 1-10, I-40136 Bologna, Italy.
RI Fini, Milena/J-4808-2016; Chiesa, Roberto/N-2605-2013; Borsari,
   Veronica/D-1869-2017; TORRICELLI, PAOLA/J-5298-2016
OI Fini, Milena/0000-0002-3732-3570; Borsari, Veronica/0000-0002-6327-4653;
   TORRICELLI, PAOLA/0000-0001-7494-9970; Giavaresi,
   Gianluca/0000-0001-7843-5969; Cigada, Alberto/0000-0002-0925-5558;
   Chiesa, Roberto/0000-0002-5317-6849
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   ALBREKTSSON T, 1980, J BONE JOINT SURG BR, V62, P403
   Bianco PD, 1996, BIOMATERIALS, V17, P1937, DOI 10.1016/0142-9612(96)00023-3
   BISCHOFF UW, 1994, J BONE JOINT SURG BR, V76B, P713
   Brayda-Bruno M, 2001, INT J ARTIF ORGANS, V24, P41
   CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701
   Christensen FB, 2000, EUR SPINE J, V9, P97, DOI 10.1007/s005860050218
   Disegi J.A., 2000, INJURY, V31, P4
   Fini M, 2002, INT J ORAL MAX IMPL, V17, P28
   Fini M, 2002, J ORTHOP RES, V20, P756, DOI 10.1016/S0736-0266(01)00158-9
   Fritz EA, 2002, J ORTHOPAED RES, V20, P490, DOI 10.1016/S0736-0266(01)00154-1
   Hallab N, 2000, BIOMATERIALS, V21, P1301, DOI 10.1016/S0142-9612(99)00235-5
   Huja SS, 1998, J ORTHOPAED RES, V16, P54, DOI 10.1002/jor.1100160110
   Huja SS, 2000, MECH TESTING BONE BO, P247
   JACOBS JJ, 1998, J BONE JT SURG A, V80, P269
   Kapanen A, 2002, BIOMATERIALS, V23, P3341, DOI 10.1016/S0142-9612(02)00023-6
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LINDER L, 1975, INJURY, V6, P277, DOI 10.1016/0020-1383(75)90174-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LUGOWSKI SJ, 1991, J BIOMED MATER RES, V25, P1443, DOI 10.1002/jbm.820251204
   McDonald DJ, 2002, CLIN ORTHOP RELAT R, P206
   Michel KM, 1999, NEUE RUNDSCH, V110, P61
   MILLAR BG, 1990, BRIT J ORAL MAX SURG, V28, P92, DOI 10.1016/0266-4356(90)90129-9
   Moroni A, 1997, J ORTHOP TRAUMA, V11, P154, DOI 10.1097/00005131-199704000-00003
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   PERREN SM, 1991, INJURY, V22, P1
   PIERINI G, 1999, INT J ARTIF ORGANS, V7, P522
   Pioletti DP, 1999, J BIOMED MATER RES, V46, P399, DOI 10.1002/(SICI)1097-4636(19990905)46:3<399::AID-JBM13>3.3.CO;2-2
   Pohler OEM, 2000, INT J CARE INJURED, V31, pSD7
   Rocca M, 2001, INT J ARTIF ORGANS, V24, P649
   SAVARINO L, 1995, J BIOMED MATER RES, V29, P701, DOI 10.1002/jbm.820290605
   Savarino L, 2000, J BIOMED MATER RES, V50, P21, DOI 10.1002/(SICI)1097-4636(200004)50:1<21::AID-JBM4>3.0.CO;2-R
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Shida J, 2000, CALCIFIED TISSUE INT, V67, P151, DOI 10.1007/s00223001125
   Sott AH, 2002, INT ORTHOP, V26, P287, DOI 10.1007/s00264-002-0367-z
   STEA S, 1995, J BIOMED MATER RES, V29, P695, DOI 10.1002/jbm.820290604
   Sun CT, 1999, CHINESE MED J-PEKING, V112, P456
   SWIONTKOWSKI MF, 2001, J ORTHOP TRAUMA, V2, P86
   Takei H, 2000, J BIOMED MATER RES, V52, P382, DOI 10.1002/1097-4636(200011)52:2<382::AID-JBM19>3.0.CO;2-V
   Wang JY, 1997, CLIN ORTHOP RELAT R, P216
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   WATAHA JC, 1991, J BIOMED MATER RES, V25, P1133, DOI 10.1002/jbm.820250907
   Wataha JC, 1997, J BIOMED MATER RES, V36, P145, DOI 10.1002/(SICI)1097-4636(199708)36:2<145::AID-JBM2>3.0.CO;2-K
   WATAHA JC, 2002, J BIOMED MATER RES B, V58, P537
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 46
TC 76
Z9 84
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2003
VL 24
IS 27
BP 4929
EP 4939
DI 10.1016/S0142-9612(03)00416-2
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 738BV
UT WOS:000186267600005
PM 14559006
DA 2018-10-19
ER

PT J
AU Hoshikawa, A
   Fukui, N
   Fukuda, A
   Sawamura, T
   Hattori, M
   Nakamura, K
   Oda, H
AF Hoshikawa, A
   Fukui, N
   Fukuda, A
   Sawamura, T
   Hattori, M
   Nakamura, K
   Oda, H
TI Quantitative analysis of the resorption and osteoconduction process of a
   calcium phosphate cement and its mechanical effect for screw fixation
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate cement; image analysis; mechanical test; osteoclast;
   osteoconduction; osteoporosis
ID HYDROXYAPATITE CEMENT; IN-VIVO; MONOXIDE CEMENT; BONE; MAGNESIUM;
   FRACTURES; AUGMENTATION; CRANIOPLASTY; COMPRESSION; BIOMATERIAL
AB The clinical application of calcium phosphate cements (CPCs) composed of tetracalcium phosphate and dicalcium phosphate anhydrous has been limited because of its longer setting time, so that we developed the CPC in which the setting time was shortened to approximately 10min. Aiming at clinical application, we evaluated the histological response in the bone quantitatively and the biomechanical effectiveness of this substance. The CPC was implanted in the rabbit femoral condyle up to 52 weeks for histological evaluation. In mechanical testing, small cancellous screws were inserted into the condyle, both with and without augmentation with the CPC, and the pull-out strength was measured. The micro-computed tomography finding demonstrated that the cross-sectional area of the implanted CPC at 24 weeks was approximately two-thirds of the initial area. The amount of newly calcified bone around the CPC was significantly greater than that of the sintered hydroxyapatite. Histologically, the new bone was formed on the surface of the implanted CPC I week after the implantation and resorption of the CPC was evident at 3 weeks. The pull-out strength was enhanced significantly by augmentation with the CPC and the initial strength was maintained for a 6 week period. This CPC showed good osteoconductivity and was resorbed without adverse inflammation. Using the CPC as augmentation may be capable of useful treatment options in fractures with poor bone quality. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan.
   NGK SPARK PLUG Co Ltd, Res Dept, Kamaki, Aichi 4858510, Japan.
RP Hoshikawa, A (reprint author), Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.
CR Bai B, 1999, SPINE, V24, P1521, DOI 10.1097/00007632-199908010-00004
   BIGI A, 1992, CALCIFIED TISSUE INT, V50, P439, DOI 10.1007/BF00296775
   Brown WE, 1986, United States patent, Patent No. [4612053, EP 4612053]
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   Elder S, 2000, J ORTHOP TRAUMA, V14, P386, DOI 10.1097/00005131-200008000-00002
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   ISHIKAWA K, 1995, BIOMATERIALS, V16, P527, DOI 10.1016/0142-9612(95)91125-I
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   KURASHINA K, 1994, BIOMATERIALS, V15, P429, DOI 10.1016/0142-9612(94)90221-6
   Kurashina K, 1998, BIOMATERIALS, V19, P701, DOI 10.1016/S0142-9612(97)00178-6
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   MCQUEEN MM, 1986, J BONE JOINT SURG BR, V68, P232
   Mermelstein LE, 1998, SPINE, V23, P664, DOI 10.1097/00007632-199803150-00004
   Miyamoto Y, 1999, J BIOMED MATER RES, V48, P36, DOI 10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I
   Miyamoto Y, 1997, J BIOMED MATER RES, V37, P457
   MIYAMOTO Y, 1995, BIOMATERIALS, V16, P855, DOI 10.1016/0142-9612(95)94147-D
   SCHMALHOLZ A, 1989, ACTA ORTHOP SCAND, V60, P57, DOI 10.3109/17453678909150093
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   SUGAWARA A, 1990, J ENDODONT, V16, P162, DOI 10.1016/S0099-2399(06)81963-1
   TAKEZAWA Y, 1987, J JPN SOC DENT MAT D, V6, P426
   TSUBOI S, 1994, CALCIFIED TISSUE INT, V54, P34, DOI 10.1007/BF00316287
   Wiesmann HP, 1997, J BONE MINER RES, V12, P380, DOI 10.1359/jbmr.1997.12.3.380
   Yamamoto H, 1998, BIOMATERIALS, V19, P1587, DOI 10.1016/S0142-9612(97)00121-X
NR 27
TC 24
Z9 29
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2003
VL 24
IS 27
BP 4967
EP 4975
DI 10.1016/S0142-9612(03)00422-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 738BV
UT WOS:000186267600009
PM 14559010
DA 2018-10-19
ER

PT J
AU Rodrigues, CVM
   Serricella, P
   Linhares, ABR
   Guerdes, RM
   Borojevic, R
   Rossi, MA
   Duarte, MEL
   Farina, M
AF Rodrigues, CVM
   Serricella, P
   Linhares, ABR
   Guerdes, RM
   Borojevic, R
   Rossi, MA
   Duarte, MEL
   Farina, M
TI Characterization of a bovine collagen-hydroxyapatite composite scaffold
   for bone tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; bovine bone; characterization; bone tissue engineering;
   osteoblast; collagen; biocomposite; biomaterial
ID PARTICLE-SIZE; IN-VITRO; POROUS HYDROXYAPATITE; OSTEOBLAST ADHESION;
   NATURAL BONE; BIOMATERIALS; CERAMICS; CARTILAGE; INVITRO; PROLIFERATION
AB Different biomaterials have been used as scaffolds for bone tissue engineering. Here we characterize a biomaterial composed of sintered (1100degreesC) and powdered hydroxyapatite (HA) and type I collagen (Coll), both of bovine origin, designed for osteoconductive and osteoinductive scaffolds. Coll/HA proportions were 1/2.6 and 1/1 (wet weight), and particles sizes varied from 200 to 400 mum. V-v (volume density) and S-v (surface to volume density) for the HA particles in the composite ranged from 0.48+/-0.06 to 0.55+/-0.02 and 5.090+/-0.545 to 6.366+/-0.289 mum(-1) respectively. Due to the relatively small changes in V-v and S-v, a macroporosity could be characterized for the biocomposite. X-ray diffraction and infrared spectroscopy showed that the sintered bone was composed essentially of HA with minimum additional groups such as surface calcium hydroxide, surface and crystal water, free carbon dioxide and possibly brushite. Mass spectrometry detected carbonates at A and B sites of HA, and weakly bound to the structure. Human osteoblasts adhered and spread on both the HA particle surface and the collagen fibers, which seemed to guide cells between adjacent particles. The biocomposite studied has several characteristics considered as ideal for its use as a scaffold for osteoconduction and osteoinduction. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Dept Histol & Embriol, Inst Ciencias Biomed,CCS, BR-21941590 Rio De Janeiro, Brazil.
   CNPq, CBPF, Rio De Janeiro, Brazil.
   Clin Odontol Dr Olympio Faissol Pinto, Rio De Janeiro, Brazil.
   UFRJ, APABCAM, Hosp Univ Clementino Fraga Filho, BR-21941097 Rio De Janeiro, Brazil.
   UFRJ, COPPE, Programa Engn Met & Mat, BR-21941097 Rio De Janeiro, Brazil.
RP Farina, M (reprint author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Dept Histol & Embriol, Inst Ciencias Biomed,CCS, BR-21941590 Rio De Janeiro, Brazil.
RI Rossi, Maria Isabel/J-4802-2012; Farina, Marcos/I-3744-2014
OI Rossi, Maria Isabel/0000-0003-3432-8453; Borojevic,
   Radovan/0000-0002-2393-7280
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Asashina I, 1997, J MED DENT SCI, V44, P63
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyan BD, 1999, CLIN PLAST SURG, V26, P629
   BRUDER SP, 1999, CLIN ORTHOP S, V367, P68
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   CHOW LC, 1973, J DENT RES, V52, P1158, DOI 10.1177/00220345730520053501
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUNN GA, 1978, EXP CELL RES, V111, P475, DOI 10.1016/0014-4827(78)90196-9
   EVANS EJ, 1991, BIOMATERIALS, V12, P574, DOI 10.1016/0142-9612(91)90054-E
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   Higashi T, 1996, J ENDODONT, V22, P236, DOI 10.1016/S0099-2399(06)80139-1
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Lawson AC, 1998, P I MECH ENG H, V212, P413, DOI 10.1243/0954411981534187
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   Ou-Yang H, 2001, J BONE MINER RES, V16, P893, DOI 10.1359/jbmr.2001.16.5.893
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   SHAPOFF CA, 1980, J PERIODONTOL, V51, P625, DOI 10.1902/jop.1980.51.11.625
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun JS, 1997, BIOMATERIALS, V18, P683, DOI 10.1016/S0142-9612(96)00183-4
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Underwood E. E, 1970, QUANTITATIVE STEREOL, P274
   Vidal B de C, 1996, Tissue Eng, V2, P151, DOI 10.1089/ten.1996.2.151
   VIGNOLES M, 1988, CALCIFIED TISSUE INT, V43, P33, DOI 10.1007/BF02555165
   Villarreal D. R., 1998, J ORAL IMPLANTOL, V24, P67, DOI DOI 10.1563/1548-1336(1998)024<0067:PAAORT>2.3.00;2
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
NR 42
TC 177
Z9 192
U1 5
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2003
VL 24
IS 27
BP 4987
EP 4997
DI 10.1016/S0142-9612(03)00410-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 738BV
UT WOS:000186267600011
PM 14559012
DA 2018-10-19
ER

PT J
AU Hiller, JC
   Thompson, TJU
   Evison, MP
   Chamberlain, AT
   Wess, TJ
AF Hiller, JC
   Thompson, TJU
   Evison, MP
   Chamberlain, AT
   Wess, TJ
TI Bone mineral change during experimental heating: an X-ray scattering
   investigation
SO BIOMATERIALS
LA English
DT Article
DE XRD; microstructure; crystal growth; bone; hydroxyapatite
ID DEPROTEINATED COMPACT-BONE; ARCHAEOLOGICAL BONE; STRUCTURAL FEATURES;
   ULTRASTRUCTURE; DIFFRACTION; CRYSTALS; CREMAINS; SAMPLES; REMAINS
AB The effects of heating and burning on bone mineral have previously been studied using techniques such as X-ray diffraction (XRD) with the aim of discerning a characteristic signature of crystal change. This would enable a better understanding of alteration to bone mineral during heating, which would in turn impact on the preparation and use of natural bone hydroxyapatite as a biomaterial resource. In addition, this knowledge could prove invaluable in the investigation of burned human remains from forensic and archaeological contexts in cremation and funerary practice. Here we describe a complementary method, small-angle X-ray scattering (SAXS), to determine more accurately the changes to bone crystallite size and shape during an experimental heating regimen. Samples were subjected to controlled heating at 500degreesC, 700degreesC, or 900degreesC for 15 or 45 min. Our results show bone crystallites begin to alter in the first 15 min of heating to 500degreesC or above. They then appear to stabilise to a ternperature-specific thickness and shape with prolonged heating. While the samples heated to lower temperatures or for shorter periods produce XRD traces showing little alteration to the apatite, corresponding information obtained from SAXS shows an early, subtle change in crystal parameters. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Wales Coll Cardiff, Dept Optometry & Vis Sci, Biophys Grp, Cardiff CF10 3NB, S Glam, Wales.
   Univ Sheffield, Medicolegal Ctr, Dept Forens Pathol, Sheffield S3 7ES, S Yorkshire, England.
   Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England.
RP Hiller, JC (reprint author), Univ Wales Coll Cardiff, Dept Optometry & Vis Sci, Biophys Grp, Redwood Bldg,Cathays Pk, Cardiff CF10 3NB, S Glam, Wales.
RI Chamberlain, Andrew/F-2118-2018; Evison, Martin/E-7263-2015
OI Evison, Martin/0000-0002-4405-4751; Bardsley,
   Jennifer/0000-0001-8714-942X; Thompson, Tim/0000-0003-3265-524X
CR Bennett JL, 1999, J ARCHAEOL SCI, V26, P1, DOI 10.1006/jasc.1998.0283
   Camacho NP, 1999, BONE, V25, P287, DOI 10.1016/S8756-3282(99)00165-9
   Cattaneo C, 1999, FORENSIC SCI INT, V102, P181, DOI 10.1016/S0379-0738(99)00059-6
   Chandler N. P., 1987, ARCHAEOLOGY TODA AUG, P41
   Fratzl P, 1996, Connect Tissue Res, V34, P247, DOI 10.3109/03008209609005268
   Fratzl P, 1996, CALCIFIED TISSUE INT, V58, P341, DOI 10.1007/BF02509383
   GUIZZARDI S, 1995, BIOMATERIALS, V16, P931, DOI 10.1016/0142-9612(95)93118-W
   HOLDEN JL, 1995, J BONE MINER RES, V10, P1400
   HOLDEN JL, 1995, FORENSIC SCI INT, V74, P29, DOI 10.1016/0379-0738(95)01735-2
   Juang HY, 1996, BIOMATERIALS, V17, P2059, DOI 10.1016/0142-9612(96)88882-X
   Kennedy KAR, 1996, J FORENSIC SCI, V41, P689
   MURRAY KA, 1993, J FORENSIC SCI, V38, P98
   Newesely H., 1988, TRACE ELEMENTS ENV H, P1
   OWSLEY DW, 1993, J FORENSIC SCI, V38, P1372
   PARKER S, 1985, THESIS U SHEFFIELD
   Quatrehomme G, 1998, J FORENSIC SCI, V43, P417
   RASPANTI M, 1994, BIOMATERIALS, V15, P433, DOI 10.1016/0142-9612(94)90222-4
   Ravaglioli A, 1996, BIOMATERIALS, V17, P617, DOI 10.1016/0142-9612(96)88712-6
   Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7
   SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X
   Simesen M.G., 1980, CLIN BIOCH DOMESTIC, P576
   STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024
   THOMPSON TJU, 1999, THESIS U BRADFORD
   WACHTEL E, 1994, J BONE MINER RES, V9, P1651
   Wess T, 2002, CALCIFIED TISSUE INT, V70, P103, DOI 10.1007/s002230020045
   Wess TJ, 2001, ARCHAEOMETRY, V43, P117, DOI 10.1111/1475-4754.00007
NR 26
TC 78
Z9 86
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2003
VL 24
IS 28
BP 5091
EP 5097
DI 10.1016/S0142-9612(03)00427-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 745DN
UT WOS:000186674000003
PM 14568425
DA 2018-10-19
ER

PT J
AU Goo, HC
   Hwang, YS
   Choi, YR
   Cho, HN
   Suh, H
AF Goo, HC
   Hwang, YS
   Choi, YR
   Cho, HN
   Suh, H
TI Development of collagenase-resistant collagen and its interaction with
   adult human dermal fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE EGCG; collagen; collagenase resistance; structural stability;
   free-radical scavenging activity; cell adhesion; actin filament
ID CHEMICAL MODIFICATION; TEA CATECHINS; I COLLAGEN; MATRIX; EXPRESSION;
   CLEAVAGE; ADHESION; RADICALS; TISSUE; OZONE
AB Collagen is regarded as one of the most useful biomaterials. The excellent biocompatibility and safety due to its biological characteristics, such as biodegradability and weak antigenecity, made collagen the primary source in biomedical application. Collagen has been widely used in the crosslinked form to extend the durability of collagen. The chemical treatment influences the structural integrity of collagen molecule resulting in the loss of triple helical characteristic. The structural characteristic of collagen is importantly related to its biological function for the interaction with cell. In this study, structural stability of collagen was enhanced thought EGCG treatment, resulting in high resistance against degradation by bacterial collagenase and MMP-1, which is confirmed by collagen zymography. The triple helical structure of EGCG-treated collagen could be maintained at 37degreesC in comparison with collagen, which confirmed by CD spectra analysis, and EGCG-treated collagen showed high free-radical scavenging activity. Also, with fibroblasts culture on EGCG-treated collagen, the structural stability of EGCG-treated collagen provided a favorable support for cell function in cell adhesion and actin filament expression. These observations underscore the need for native, triple helical collagen conformation as a prerequisite for integrin-mediated cell adhesion and functions. According to this experiment, EGCG-treated collagen assumes to provide a practical benefit to resist the degradation by collagenase retaining its structural characteristic, and can be a suitable biomaterial for biomedical application. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Yonsei Univ, Coll Med, Dept Med Engn, Seodaemun Ku, Seoul, South Korea.
   RegenMed Inc, Seodaemun Ku, Seoul, South Korea.
   KIST, Polymer Mat Lab, Seoul, South Korea.
RP Suh, H (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Seodaemun Ku, 134 Shinchon Dong, Seoul, South Korea.
CR Bann JG, 2000, FEBS LETT, V473, P237, DOI 10.1016/S0014-5793(00)01493-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   CHACE KV, 1991, FREE RADICAL RES COM, V12-3, P591
   CURRAN SF, 1984, FEBS LETT, V176, P155, DOI 10.1016/0014-5793(84)80931-X
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D
   Demeule M, 2000, BBA-PROTEIN STRUCT M, V1478, P51, DOI 10.1016/S0167-4838(00)00009-1
   DIAMOND AM, 1991, MATRIX, V11, P321, DOI 10.1016/S0934-8832(11)80203-9
   DIJKSTRA PJ, 1996, CARDIOVASC PATHOL, V5, P286
   Evans MDM, 1998, J BIOMED MATER RES, V40, P621, DOI 10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I
   FREIJE JMP, 1994, J BIOL CHEM, V269, P16766
   GEKKO K, 1983, J BIOCHEM-TOKYO, V94, P199, DOI 10.1093/oxfordjournals.jbchem.a134330
   Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9
   GREENWALD RA, 2001, ARTHRITIS RHEUM, V20, P219
   HASTY KA, 1990, J BIOL CHEM, V265, P11421
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Jacobson Randye G., 1996, Wound Repair and Regeneration, V4, P311, DOI 10.1046/j.1524-475X.1996.40305.x
   Kim SH, 2000, RAPID COMMUN MASS SP, V14, P2125, DOI 10.1002/1097-0231(20001130)14:22<2125::AID-RCM141>3.0.CO;2-6
   Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544
   Kuhn K, 1994, Trends Cell Biol, V4, P256, DOI 10.1016/0962-8924(94)90124-4
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903
   Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011
   LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227
   Madhan B, 2002, BIOMATERIALS, V23, P2841, DOI 10.1016/S0142-9612(01)00410-0
   MAKIMURA M, 1993, J PERIODONTOL, V64, P630, DOI 10.1902/jop.1993.64.7.630
   MATEOS PS, 1996, SEMIN CANCER BIOL, V7, P99
   MAUCH C, 1988, EXP CELL RES, V178, P1508
   MEADE KR, 1990, BIOMATERIALS, V11, P176, DOI 10.1016/0142-9612(90)90151-F
   MIDDLETON E, 1992, BIOCHEM PHARMACOL, V43, P1167, DOI 10.1016/0006-2952(92)90489-6
   MILLER EJ, 1976, BIOCHEMISTRY-US, V15, P787, DOI 10.1021/bi00649a009
   MUKHOPADHYAY CK, 1994, J BIOL CHEM, V269, P30200
   Noishiki Y, 1998, ARTIF ORGANS, V22, P672, DOI 10.1046/j.1525-1594.1998.06066.x
   NUSGENS B, 1984, COLLAGEN REL RES, V4, P351
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PENKOVA RK, 1999, BIOPHYS CHEM, V83, P185
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   RAO CN, 1983, SCAND J RHEUMATOL, V12, P39, DOI 10.3109/03009748309102002
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Reed MJ, 2001, MECH AGEING DEV, V122, P1203, DOI 10.1016/S0047-6374(01)00260-3
   Rout UK, 2002, FERTIL STERIL, V78, P154, DOI 10.1016/S0015-0282(02)03176-X
   Ruggiero F, 1996, J CELL SCI, V109, P1865
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7
   Suh H, 2000, ARTIF ORGANS, V24, P555, DOI 10.1046/j.1525-1594.2000.06562.x
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   Verge S, 2002, TETRAHEDRON LETT, V43, P2363, DOI 10.1016/S0040-4039(02)00255-1
   WELGUS HG, 1982, J BIOL CHEM, V257, P1534
   Wroblewski K, 2001, EUR J BIOCHEM, V268, P4384, DOI 10.1046/j.1432-1327.2001.02350.x
   YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038
   YOSHIZATO K, 1984, ANN PLAS SURG, V13, P9, DOI 10.1097/00000637-198407000-00002
NR 55
TC 59
Z9 64
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2003
VL 24
IS 28
BP 5099
EP 5113
DI 10.1016/S0142-9612(03)00431
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 745DN
UT WOS:000186674000004
PM 14568426
DA 2018-10-19
ER

PT J
AU Chua, KJ
   Mujumdar, AS
   Chou, SK
AF Chua, KJ
   Mujumdar, AS
   Chou, SK
TI Intermittent drying of bioproducts - an overview
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE drying technologies; product quality; drying kinetics
ID AIR-TEMPERATURE; BED; QUALITY; POTATO; PIECES; GUAVA
AB Unlike the conventional practice of supplying energy for batch drying processes at a constant rate, newly developed intermittent drying processes employ time-varying heat input tailored to match the drying kinetics of the material being dried. The energy required may be supplied by combining different modes of heat transfer (e.g. convection coupled with conduction or radiation or dielectric heating simultaneously or in a pre-selected sequence) in a time-varying fashion so as to provide optimal drying kinetics as well as quality of the bioproduct. This is especially important for drying of heat-sensitive materials (such as foods, pharmaceutical, neutraceutical substances, herbs, spices and herbal medicines). Intermittent heat supply is beneficial only for materials which dry primarily in the falling rate period where internal diffusion of heat and moisture controls the overall drying rate. Periods when little or no heat is supplied for drying allow the tempering period needed for the moisture and heat to diffuse within the material. As the moisture content increases at the surface of the biomaterial during the tempering period, the rate of drying is higher when heat input is resumed. It is possible to control the heat input such that the surface temperature of the product does not exceed a pre-determined value beyond which thermal damage of the material may occur. This process results in reduction in the use of thermal energy as well as the mass of air used in convective drying. Thus, the thermal efficiency of such a process is higher. The quality of the product, as such color and ascorbic acid content, is also typically superior to that obtained with a continuous supply of heat. However, in some cases, there will be a nominal increase in drying time. In the case of microwave-assisted and heat pump drying, for example, the capital cost of the drying system can also be reduced by drying in the intermittent mode.
   This paper provides an overview of the basic process, selected results from experiments and mathematical models for a variety of biomaterials dried in a wide assortment of dryers. It begins with a classification of intermittent drying processes that may be applied e.g. time-varying temperature, air flow rate, operating pressure as well as heat input by different modes and in different temporal variations. The beneficial effects of improving the quality of dried bioproducts by different intermittent processes are also included and discussed. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Chua, KJ (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
RI Chua, Kian Jon Ernest/D-1502-2009
OI Chou, S.K./0000-0001-7989-0955; Chua, Kian Jon/0000-0001-9293-7471
CR Chen GH, 2001, CHEM ENG SCI, V56, P6823, DOI 10.1016/S0009-2509(01)00320-7
   Chou SK, 2000, FOOD BIOPROD PROCESS, V78, P193, DOI 10.1205/09603080051065296
   Chua KJ, 2000, DRY TECHNOL, V18, P907, DOI 10.1080/07373930008917744
   Chua KJ, 2000, FOOD BIOPROD PROCESS, V78, P72, DOI 10.1205/096030800532761
   FAROUK SM, 1967, THESIS TEXAS A M U
   FILHO JB, 1982, DRYING 82, P220
   Gawrzynski Z, 1996, DRY TECHNOL, V14, P1121, DOI 10.1080/07373939608917142
   GIOWACKA M, 1986, DRYING SOLIDS, P77
   Gong ZX, 1998, DRY TECHNOL, V16, P1119, DOI 10.1080/07373939808917457
   Gunasekaran S, 1999, DRY TECHNOL, V17, P395, DOI 10.1080/07373939908917542
   ITAYA Y, 2001, P AS AUSTR DRYING C, P277
   JUMAH RY, 1996, ESAIM-MATH MODEL NUM, P339
   Li YB, 1999, DRY TECHNOL, V17, P1779, DOI 10.1080/07373939908917652
   MUJUMDAR AS, 1999, DEV DRYING FOOD DEHY, V1, P59
   Pan J, 1999, UNIX REV-PERFORM COM, V17, P10
   Pan YK, 1999, DRY TECHNOL, V17, P1795, DOI 10.1080/07373939908917653
   Raghavan GSV, 1999, DRY TECHNOL, V17, P2309, DOI 10.1080/07373939908917685
   RAGHAVAN GSV, 1909, P 1 AS AUSTR DRY C B, P117
   RATTI C, 1993, DRY TECHNOL, V11, P1311, DOI 10.1080/07373939308916901
   Sanga E. C. M., 2001, P AS AUSTR DRYING C, P203
   Tan M, 2001, DRY TECHNOL, V19, P2193, DOI 10.1081/DRT-100107494
   ZHANG DS, 1992, DRY TECHNOL, V10, P421
NR 22
TC 86
Z9 99
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD DEC
PY 2003
VL 90
IS 3
BP 285
EP 295
DI 10.1016/S0960-8524(03)00133-0
PG 11
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 742CP
UT WOS:000186498200007
PM 14575951
DA 2018-10-19
ER

PT J
AU MacLeod, TM
   Williams, G
   Sanders, R
   Green, CJ
AF MacLeod, TM
   Williams, G
   Sanders, R
   Green, CJ
TI Prefabricated skin flaps in a rat model based on a dermal replacement
   matrix Permacol (TM)
SO BRITISH JOURNAL OF PLASTIC SURGERY
LA English
DT Article; Proceedings Paper
CT Summer Meeting of the British-Association-of-Plastic-Surgeons
CY JUL, 1999
CL BELFAST, NORTH IRELAND
SP British Assoc Plast Surgeons
DE prefabrication; Permacol (TM); porcine; diamond CO2 laser; vascularity
ID IMPLANTATION; COLLAGEN
AB The reconstruction of three-dimensional structures is one of the most challenging problems in plastic surgery. While shaped frameworks incorporated within soft tissue envelopes often lose their fine detail, the integration of a blood supply to a stable biomaterial scaffold allows skin graft cover and emphasis of fine detail. The aim of this study was to evaluate whether a porcine derived isocyanate crosslinked collagen tissue matrix (Permacol(TM)) could be vascularised from an isolated vascular pedicle and subsequently sustain an overlying skin graft as a pedicled prefabricated flap. A vascular induction technique was employed using the epigastric pedicles in Sprague-Dawley rats to vascularise 2 x 2 cm(2) pieces of Permacol(TM) of standard 0.75 and 1.5 mm thickness Permacol(TM) and laser treated Permacol(TM) of 0.4 and 0.75 mm thickness. Flaps were able to support overlying skin grafts as early as 2 weeks following vessel implantation and laser treated Permacol(TM) had an increased vascularity compared to standard Permacol(TM) with no evidence of degradation. The study showed that Permacol(TM) could be a useful matrix for use in tissue engineered flaps. (C) 2003 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 Mt Vernon Hosp, Restorat Appearance & Funct Trust, Northwood HA6 2RN, Middx, England.
   Northwick Pk Hosp & Clin Res Ctr, Northwick Pk Inst Med Res, Harrow HA1 3UJ, Middx, England.
RP MacLeod, TM (reprint author), Mt Vernon Hosp, Restorat Appearance & Funct Trust, Northwood HA6 2RN, Middx, England.
CR COSTA H, 1993, BRIT J PLAST SURG, V46, P223, DOI 10.1016/0007-1226(93)90172-8
   Hickey MJ, 1998, PLAST RECONSTR SURG, V101, P1296, DOI 10.1097/00006534-199804050-00021
   Horl H W, 1992, Handchir Mikrochir Plast Chir, V24, P243
   KINOSHITA Y, 1993, BIOMATERIALS, V14, P209, DOI 10.1016/0142-9612(93)90025-W
   Kuriloff DB, 1996, ARCH OTOLARYNGOL, V122, P1385
   Kusumoto K, 1998, BRIT J PLAST SURG, V51, P275, DOI 10.1054/bjps.1998.0008
   Tanaka Y, 2000, BRIT J PLAST SURG, V53, P51, DOI 10.1054/bjps.1999.3186
   Tark KC, 2000, ANN PLAS SURG, V44, P392, DOI 10.1097/00000637-200044040-00007
   Walton R, 1987, PLAST SURG FORUM, V56, P32
   WALTON RL, 1993, ANN PLAS SURG, V30, P105, DOI 10.1097/00000637-199302000-00002
   WALTON RL, 1988, PLAST SURG FORUM, V57, P160
   YAO ST, 1981, PLAST RECONSTR SURG, V68, P404, DOI 10.1097/00006534-198100000-00031
NR 12
TC 19
Z9 23
U1 0
U2 6
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0007-1226
J9 BRIT J PLAST SURG
JI Br. J. Plast. Surg.
PD DEC
PY 2003
VL 56
IS 8
BP 775
EP 783
DI 10.1016/S0007-1226(03)00383-7
PG 9
WC Surgery
SC Surgery
GA 748YD
UT WOS:000186887800008
PM 14615252
DA 2018-10-19
ER

PT J
AU Christian, S
   Doris, M
   Alexis, S
   Georgios, L
   Else, S
   Franz, K
   Karl, D
   Rolf, E
AF Christian, S
   Doris, M
   Alexis, S
   Georgios, L
   Else, S
   Franz, K
   Karl, D
   Rolf, E
TI The fluorohydroxyapatite (FHA) FRIOS (R) Algipore (R) is a suitable
   biornaterial for the reconstruction of severely atrophic human maxillae
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; human; sinus grafting; bone formation; remodeling;
   replacement
ID MARROW STROMAL CELLS; SINUS AUGMENTATION; BONE-FORMATION; ILIAC CREST;
   IN-VIVO; PERICYTES; REPAIR; SITE; HARVEST; SAMPLES
AB Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS(R) Algipore((R)) could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS(R) Algipore((R)) were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (+/-8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS(R) Algipore((R)) is a suitable biomaterial for sinus grafting of severely atrophic maxillae.
C1 Univ Vienna, Sch Med, Univ Hosp Cranio Maxillofacial & Oral Surg, A-1090 Vienna, Austria.
   Univ Vienna, Dept Med Stat, Vienna, Austria.
   Univ Hamburg, Inst Pathol, Dept Oral Pathol, D-2000 Hamburg, Germany.
   GesmbH, Inst Cranio Maxillo Facial & Oral Rehabilitat, Ctr Tele Commun & Navigat Surg, Vienna, Austria.
RP Christian, S (reprint author), Univ Vienna, Sch Med, Univ Hosp Cranio Maxillofacial & Oral Surg, Waehringer Guertel 18, A-1090 Vienna, Austria.
CR Akin FA, 2001, J BIOMED MATER RES, V57, P588, DOI 10.1002/1097-4636(20011215)57:4<588::AID-JBM1206>3.0.CO;2-Y
   AUBIN JE, 1996, PRINCIPLES BONE BIOL, P39
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   BRANEMARK PI, 1999, SINUS BONE GRAFT, pR7
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   BRIGHTON CT, 1992, CLIN ORTHOP RELAT R, P287
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   CANADY JW, 1993, CLEFT PALATE-CRAN J, V30, P579, DOI 10.1597/1545-1569(1993)030<0579:SOTICA>2.3.CO;2
   DAHIR GA, 2000, CLIN ORTHOP RELAT R, V379, P134
   DECKER B, 1995, ANAT REC, V242, P310, DOI 10.1002/ar.1092420304
   DERKX P, 1995, BIOTECH HISTOCHEM, V70, P70, DOI 10.3109/10520299509108320
   DIAZFLORES L, 1991, HISTOL HISTOPATHOL, V6, P269
   Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828
   DONATH K, 1987, Journal of Oral Implantology, V13, P120
   Donath K, 1988, TRENN DUENNSCHLIFF T
   Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215
   Eufinger H, 2000, J CRANIO MAXILL SURG, V28, P31, DOI 10.1054/jcms.2000.0105
   Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Kasperk C, 1986, Z ZAHNARZTL IMPLANTO, V2, P242
   Keith A, 1928, P ROY SOC MED, V21, P301
   Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   MUNDY GR, 1999, BONE REMODELING ITS, P1
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   Reynders P, 1999, J ORTHOP TRAUMA, V13, P121, DOI 10.1097/00005131-199902000-00009
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   Springfield D, 1996, ORTHOP CLIN N AM, V27, P483
   Triffitt JT, 1998, BIOCHEM SOC T, V26, P21, DOI 10.1042/bst0260021
   Vlassis JM, 1999, J PERIODONTOL, V70, P692, DOI 10.1902/jop.1999.70.6.692
   WATZEK G, 1999, SINUS BONE GRAFT, P35
   WATZINGER F, 1999, BRIT J ORAL MAX SURG, V38, P312
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 39
TC 2
Z9 2
U1 0
U2 2
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD DEC
PY 2003
VL 14
IS 6
BP 743
EP 749
DI 10.1046/j..2003.00959.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 751UZ
UT WOS:000187107700011
DA 2018-10-19
ER

PT J
AU Ehring, B
   Biber, K
   Upton, TM
   Plosky, D
   Pykett, M
   Rosenzweig, M
AF Ehring, B
   Biber, K
   Upton, TM
   Plosky, D
   Pykett, M
   Rosenzweig, M
TI Expansion of HPCs from cord blood in a novel 3D matrix
SO CYTOTHERAPY
LA English
DT Article
DE 3-D matrix; CD34 expansion; in vitro; umbilical cord blood
ID HEMATOPOIETIC PROGENITOR CELLS; VERSUS-HOST-DISEASE; EX-VIVO EXPANSION;
   BONE-MARROW TRANSPLANT; HUMAN CD34(+) CELLS; IN-VITRO; PERIPHERAL-BLOOD;
   STEM-CELLS; NEGATIVE REGULATION; GROWTH-FACTORS
AB Background An optimal system for the expansion of pluripotent HPCs would ideally eliminate the use of cytokines and animal-derived serum. We have shown previously that a 3D, tantalum-coated porous biomaterial ( Cytomatrix) supports the maintenance and expansion of human BM HPCs in the absence of cytokines.
   Methods Umbilical cord blood (UCB) derived HPC were cultured in the Cytomatrix in the absence of exogenous cytokines. Phenotype was determined using FACS. Colony-forming units (CFU) activity was evaluated. Engraftment capacity was evaluated by transplanting the expanded cells into non-obese diabetic (NOD)/SCID mice.
   Results We describe the expansion of HPCs from UCB using the Cytomatrix system. When UCB-derived CD34(+) cells were cultured in the Cytomatrix system for 2 weeks we observed an increase in the number of nucleated cells (3-fold) and CFU (2.6-fold). The number of CD45(+) and CD34(+) cells both increased three-fold. Trends demonstrated an increase in the frequency of CD34(+) C38(-) cells, and an increase in both CD34(+) C33(+) cells and CD34(+) C61(+) cells. No expansion of T or B lymphocytes was observed. When expanded UCB cells from the Cytomatrix were injected into sub-lethally irradiated NOD/SCID mice, human cells were detected in the murine peripheral blood and BM 6 weeks post-transplantation.
   Discussion This unique approach to the expansion of UCB cells in a serum-free, cytokine-free environment may provide expansion of HPCs with multi-lineage engraftment capability that could be used clinically.
C1 Cytomatrix, Woburn, MA 01801 USA.
RP Rosenzweig, M (reprint author), Cytomatrix, 50 Cummings Pk, Woburn, MA 01801 USA.
CR Alcorn MJ, 1996, BLOOD REV, V10, P167, DOI 10.1016/S0268-960X(96)90023-5
   Alcorn MJ, 1996, J CLIN ONCOL, V14, P1839, DOI 10.1200/JCO.1996.14.6.1839
   BACKX B, 1992, BLOOD, V80, P1213
   Bagley J, 1999, EXP HEMATOL, V27, P496, DOI 10.1016/S0301-472X(98)00053-8
   Banu N, 2001, CYTOKINE, V13, P349, DOI 10.1006/cyto.2001.0836
   Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023
   Biddle W, 1994, Prog Clin Biol Res, V389, P351
   BRUGGER W, 1995, NEW ENGL J MED, V333, P283, DOI 10.1056/NEJM199508033330503
   Bruno S, 2003, HAEMATOLOGICA, V88, P379
   Bruno S, 2001, J BIOL REG HOMEOS AG, V15, P38
   Burgio GR, 2003, LANCET, V361, P250, DOI 10.1016/S0140-6736(03)12276-3
   Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836
   Denning-Kendall P, 2003, STEM CELLS, V21, P61, DOI 10.1634/stemcells.21-1-61
   Dorrell C, 2000, BLOOD, V95, P102
   GORE SD, 1995, EXP HEMATOL, V23, P413
   Gothot A, 1998, EXP HEMATOL, V26, P562
   Herman P, 1998, LEUKEMIA, V12, P735, DOI 10.1038/sj.leu.2400924
   HIRAYAMA F, 1994, P NATL ACAD SCI USA, V91, P469, DOI 10.1073/pnas.91.2.469
   HIRAYAMA F, 1995, BLOOD, V86, P4527
   JACOBSEN FW, 1995, J IMMUNOL, V154, P3732
   Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290
   Kohler T, 1999, STEM CELLS, V17, P19, DOI 10.1002/stem.170019
   Lange W, 1996, LEUKEMIA, V10, P943
   Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4
   LARDON F, 1994, EXP HEMATOL, V22, P903
   Laughlin MJ, 2001, NEW ENGL J MED, V344, P1815, DOI 10.1056/NEJM200106143442402
   LI CL, 1994, BLOOD, V84, P408
   Matsunaga T, 1998, BLOOD, V92, P901
   MUMCUOGLU M, 1990, BONE MARROW TRANSPL, V5, P153
   NOLTA JA, 1990, HUM GENE THER, V1, P257, DOI 10.1089/hum.1990.1.3-257
   NOLTA JA, 1995, BLOOD, V86, P101
   Paquette RL, 2000, BLOOD, V96, P2385
   Rice AM, 2001, BRIT J HAEMATOL, V114, P433, DOI 10.1046/j.1365-2141.2001.02942.x
   Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501
   Rosu-Myles Michael, 2003, Hematol J, V4, P137, DOI 10.1038/sj.thj.6200233
   Shih CC, 1999, BLOOD, V94, P1623
   Shimizu Y, 1998, BLOOD, V91, P3688
   Shpall EJ, 2002, BIOL BLOOD MARROW TR, V8, P368, DOI 10.1053/bbmt.2002.v8.pm12171483
   Sitnicka E, 2003, BLOOD, V102, P881, DOI 10.1182/blood-2002-06-1694
   Soiffer RJ, 2001, J CLIN ONCOL, V19, P1152, DOI 10.1200/JCO.2001.19.4.1152
   Spence SE, 1998, EXP HEMATOL, V26, P507
   TANAKA R, 1995, BLOOD, V86, P73
   Tisdale JF, 1998, BLOOD, V92, P1131
   Urbano-Ispizua A, 2002, BLOOD, V100, P724, DOI 10.1182/blood-2001-11-0057
   VANBEUSECHEM VW, 1995, GENE THER, V2, P245
   Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782
   Williams SF, 1996, BLOOD, V87, P1687
NR 47
TC 34
Z9 36
U1 0
U2 4
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 1465-3249
J9 CYTOTHERAPY
JI Cytotherapy
PD DEC
PY 2003
VL 5
IS 6
BP 490
EP 499
DI 10.1080/14653240310003585
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA 751EL
UT WOS:000187039800003
PM 14660045
DA 2018-10-19
ER

PT J
AU Hobbiesiefken, J
   Ehlers, ME
   Behrens, P
   Wunsch, L
AF Hobbiesiefken, J
   Ehlers, ME
   Behrens, P
   Wunsch, L
TI Urothelial mesh - A new technique of cell culture on biomaterials
SO EUROPEAN JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
DE urothelium; mesh graft; tissue engineering; mesh culture
AB Introduction: Urogenital malformations, trauma or tumours may demand surgical reconstruction in children. Cell culture is an important technology in biomaterial research and tissue engineering. Tissue-engineering of urothelial organs is of interest in children, because the number of complications and re-operations may be reduced. Actually, monolayer cultures of urothelium are used for tissue engineering and biocompatibility testing. A culture system that more closely mimics the physiologic environment of the urothelium would be of interest. The aim of this study was to determine the biological and mechanical characteristics of urothelial mesh cultured in vitro.
   Methods: Meshes containing urothelium, lamina propria, and submucosal tissue were generated using a skin mesh graft cutter. Meshes were cultured in 6-well plates, on collagen I/III, poly-dioxanone/polylactic acid and silicone matrices. Cell morphology was examined by inversion microscopy, histology, and scanning electron microscopy. It was compared to urothelium cultured by methods reported in the literature. To define the basic mechanical properties, meshes were extended longitudinally by a servohydraulic testing machine and strain diagrams generated.
   Results: Urothelium was reproducibly cultured from meshes. Cell growth could be induced onto fibrillary collagen, polydioxanone-polylactic acid matrices and shaped polyurethane surfaces. Cells formed confluent layers of flat cells, resembling native urothelium. The meshes have unique mechanical properties, allowing for stable fixation, surgical handling and mechanical stimulation.
   Conclusions: Meshes can be used for cell culture on biomaterials. They maintain epithelial-stromal integrity and mechanic stability. The small size of tissue bridges allows in vitro culture for long periods with many potential advantages for tissue engineering and biologic research. Applications are possible both in vitro and in vivo.
C1 Univ Lubeck, Dept Paediat Surg, D-23538 Lubeck, Germany.
   Univ Lubeck, Dept Orthopaed, Lubeck, Germany.
   Univ Lubeck, Inst Anat, Lubeck, Germany.
RP Wunsch, L (reprint author), Univ Lubeck, Dept Paediat Surg, Ratzeburger Allee 160, D-23538 Lubeck, Germany.
EM wuensch@medinf.mu-luebeck.de
CR BASKIN L, 1993, J UROLOGY, V150, P601, DOI 10.1016/S0022-5347(17)35560-X
   Choong SKS, 2000, J ENDOUROL, V14, P19, DOI 10.1089/end.2000.14.19
   FUJIYAMA C, 1995, J UROLOGY, V153, P2060, DOI 10.1016/S0022-5347(01)67402-0
   Kim B. -S., 2000, PRINCIPLES TISSUE EN, P655
   Kratz G, 1998, MICROSC RES TECHNIQ, V42, P345, DOI 10.1002/(SICI)1097-0029(19980901)42:5<345::AID-JEMT5>3.0.CO;2-O
   Ludwikowski B, 1999, BJU INT, V84, P507
   Pariente JL, 1998, J BIOMED MATER RES, V40, P31, DOI 10.1002/(SICI)1097-4636(199804)40:1<31::AID-JBM4>3.0.CO;2-S
   Strehl R, 2002, TISSUE ENG, V8, P37, DOI 10.1089/107632702753503036
NR 8
TC 0
Z9 0
U1 0
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0939-7248
J9 EUR J PEDIATR SURG
JI Eur. J. Pediatr. Surg.
PD DEC
PY 2003
VL 13
IS 6
BP 361
EP 366
PG 6
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 769CE
UT WOS:000188608200001
PM 14743321
DA 2018-10-19
ER

PT J
AU Mattioli-Belmonte, M
   Giavaresi, G
   Biagini, G
   Virgili, L
   Giacomini, M
   Fini, M
   Giantomassi, F
   Natali, D
   Torricelli, P
   Giardino, R
AF Mattioli-Belmonte, M
   Giavaresi, G
   Biagini, G
   Virgili, L
   Giacomini, M
   Fini, M
   Giantomassi, F
   Natali, D
   Torricelli, P
   Giardino, R
TI Tailoring biomaterial compatibility: In vivo tissue response versus in
   vitro cell behavior
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE experimental study; cell culture; electroactive polymers; bioresorbable
   polymers
ID SURFACE-PROPERTIES; L-LACTIDE; BIOCOMPATIBILITY; COPOLYMERS; SYSTEMS;
   POLYMER; 1,5-DIOXEPAN-2-ONE; HYDROPHILICITY; DEGRADATION; FIXATION
AB Biocompatibility relies essentially on surface phenomena, represented by cell-cell, cell-material and material (polymer)-protein interactions. An in vivo and in vitro experimental investigation was carried out on the biomaterials of two different classes with a good potential for in situ utilisation. Non-resorbable (Polypyrrole, Polyaniline, Polyimide) and resorbable (PLLA-PDXO-PLLA) materials for tissue engineering were studied for their overall tissue tolerance and cellular interactions. These non-resorbable polymers conceived for biosensor applications and implantable drug-delivery systems are intrinsically conductive. The PLLA-PDXO-PLLA triblock copolymer showed interesting tensile properties for bone and cartilage tissue engineering due to the presence of 1,5-dioxepan-2-one. In vitro and in vivo parallel studies showed an interesting correspondence: a) the cells in contact with the resorbable material that appeared to be capable of migratory-regenerative aspects in vitro exhibited good compatibility in vivo; whereas b) the non-resorbable materials, which are designed to remain in situ in vivo, were seen to have the potential to represent an adverse factor (inflammation, fibrotic reactions) that correlated with some aspects of cell behaviour in vitro.
C1 Univ Politecn Marche, Fac Med & Chirurg, Ist Morfol Umana Normale, I-60020 Ancona, Italy.
   Rizzoli Orthoped Inst, Res Inst Codivilla Putti, Dept Expt Surg, Bologna, Italy.
   Univ Genoa, Dept Commun Comp & Syst Sci, I-16145 Genoa, Italy.
   Univ Bologna, Fac Med, Chair Surg Pathophysiol, Bologna, Italy.
RP Mattioli-Belmonte, M (reprint author), Univ Politecn Marche, Fac Med & Chirurg, Ist Morfol Umana Normale, Via Tronto 10-A, I-60020 Ancona, Italy.
EM belmonte@med.univpm.it
RI Giacomini, Mauro/D-3194-2013; Fini, Milena/J-4808-2016; TORRICELLI,
   PAOLA/J-5298-2016; Mattioli-Belmonte, Monica/J-5861-2012
OI Giacomini, Mauro/0000-0001-5646-2034; Fini, Milena/0000-0002-3732-3570;
   TORRICELLI, PAOLA/0000-0001-7494-9970; Giavaresi,
   Gianluca/0000-0001-7843-5969
CR BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6
   Brayda-Bruno M, 2001, INT J ARTIF ORGANS, V24, P41
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Fini M, 1995, INT J ARTIF ORGANS, V18, P772
   Fini M, 2003, INT J ARTIF ORGANS, V26, P520
   FINI M, IN PRESS J APPL BIOM
   GENTILE FT, 1995, REACT POLYM, V25, P207, DOI 10.1016/0923-1137(94)00097-O
   Giardino R, 1998, INT J ARTIF ORGANS, V21, P473
   Hutcheon GA, 2001, BIOMATERIALS, V22, P667, DOI 10.1016/S0142-9612(00)00229-5
   Kamalesh S, 2000, J BIOMED MATER RES, V52, P467, DOI 10.1002/1097-4636(20001205)52:3<467::AID-JBM4>3.3.CO;2-Y
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Lee KK, 2004, J MICROMECH MICROENG, V14, P32, DOI 10.1088/0960-1317/14/1/305
   LOFGREN A, 1994, J BIOMAT SCI-POLYM E, V6, P411
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Ma ZW, 2002, J APPL POLYM SCI, V85, P2163, DOI 10.1002/app.10803
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Ryner M, 2002, BIOMACROMOLECULES, V3, P601, DOI 10.1021/bm015658z
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106
   Wan YQ, 2003, BIOMATERIALS, V24, P2195, DOI 10.1016/S0142-9612(03)00107-8
   Wang CH, 1999, SYNTHETIC MET, V102, P1313, DOI 10.1016/S0379-6779(98)01006-6
   Wang ML, 2002, J ARTHROPLASTY, V17, P335, DOI 10.1054/arth.2002.30416
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Zhang Z, 2001, J BIOMED MATER RES, V57, P63, DOI 10.1002/1097-4636(200110)57:1<63::AID-JBM1142>3.0.CO;2-L
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 33
TC 81
Z9 84
U1 3
U2 38
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD DEC
PY 2003
VL 26
IS 12
BP 1077
EP 1085
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 762WA
UT WOS:000188004100005
PM 14738191
DA 2018-10-19
ER

PT J
AU Shchipunov, YA
AF Shchipunov, YA
TI Sol-gel-derived biomaterials of silica and carrageenans
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE sol-gel; nanocomposite; mineralization; biomaterial; silica; carrageenan
ID BLOCK COPOLYPEPTIDES; IN-VITRO; ENCAPSULATION; POLYMERIZATION;
   BIOMOLECULES; ORGANOGELS; BIOSILICA; SILOXANE; HYBRIDS
AB A new precursor, tetrakis(2-hydroxyethyl) orthosilicate (THEOS), introduced by Hoffmann et al. (J. Phys. Chem. B 106 (2002) 15281533), was used to synthesize monolithic hybrid biomaterials on the basis of silica and three main types of carrageenans, kappa-, i-, and lambda-carrageenans. The advantage of THEOS over the currently applied TEOS and TMOS is in its complete solubility in water. This negated the need to add organic solvents, thus excluding a denaturating effect on biopolymers. In their turn, carrageenans introduced into the precursor solution made use of common catalysts unneeded to trigger the sol-gel transition. It was found that they promoted the mineralization, acting as a template for the inorganic component. The kinetics of sol-gel processes, mechanical properties, phase behavior, and structure of novel hybrid biomaterials were studied by dynamic rheology, differential scanning calorimetry, and scanning electron microscopy. The material properties were regulated by both the precursor and carrageenan. The increase of silicate concentration led to a rise in the stiffness and brittleness of the material, whereas the polysaccharide addition made it softer and more elastic. It was shown that the formation and properties of mixed gels were determined by the nature of carrageenan. kappa-Carrageenans brought about shrinkage of hybrid materials that led to water separation, while i- and lambda-carrageenans did not induce the syneresis. This is in line with the difference in polysaccharide properties when they are in aqueous solutions without silicate. Furthermore, kappa- and i-carrageenans experienced a thermoreversible phase transition in the hybrid materials owing to the helix-coil transition. This resulted in a step like change in the mechanical properties of mixed systems in the corresponding temperature range. X-Carrageenan is a nongelling polysaccharide, which is why the rheological parameters of its hybrid gel were unchanged with the temperature. It was found that the polysaccharides modified the structure of silica-based materials. They transformed a three-dimensional network of connected silica particles into that consisting of crossed fibers. (C) 2003 Elsevier Inc. All rights reserved.
C1 Russian Acad Sci, Inst Chem, Far E Dept, Vladivostok 690022, Russia.
RP Shchipunov, YA (reprint author), POB 2230, Vladivostok 690022, Russia.
EM chemi@online.ru
CR Arkles B., 1997, KIRK OTHMER ENCY CHE, V22, P69
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   Coradin T, 2001, CHEM COMMUN, P2496, DOI 10.1039/b108324b
   CORADIN T, 2003, SOL GEL SCI TECHNOL, V26, P1165
   Da Silva J. F., 2001, BIOL CHEM ELEMENTS I
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   Dunn B, 1998, ACTA MATER, V46, P737, DOI 10.1016/S1359-6454(97)00254-1
   FERRY JD, 1980, VISCOELASTIC PROPETI
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Goodwin J. W., 2000, RHEOLOGY CHEM INTRO
   GUENET JMM, 1992, THERMOREVERSIBLE GEL
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129
   Livage J, 2001, J PHYS-CONDENS MAT, V13, pR673, DOI 10.1088/0953-8984/13/33/202
   LZRSON RG, 1999, STRUCTURE RHEOLOGY C
   MEHROTRA RC, 1967, INDIAN J CHEM, V5, P444
   Meyer M, 2002, J PHYS CHEM B, V106, P1528, DOI 10.1021/jp013371q
   MORRIS VJ, 2000, HYDROCOLLOIDS, V1, P99
   PERRY CC, 1992, J CHEM SOC FARADAY T, V88, P2915, DOI 10.1039/ft9928802915
   Piculell Lennart, 1995, V67, P205
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Sakai S, 2002, BIOMATERIALS, V23, P4177, DOI 10.1016/S0142-9612(02)00159-X
   Schramm G, 1994, PRACTICAL APPROACH R
   Schuleit M, 2001, BIOTECHNOL BIOENG, V72, P249, DOI 10.1002/1097-0290(20000120)72:2<249::AID-BIT13>3.0.CO;2-B
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   Stanley N.F., 1990, FOOD GELS, P79
   TENIJENHUIS K, 1997, ADV POLYM SCI, V130, P1
   Therkelsen G. H, 1993, IND GUMS POLYSACCHAR, P145, DOI DOI 10.1016/B978-0-08-092654-4.50011-5
   WATZKE HJ, 1994, ADV COLLOID INTERFAC, V50, P1, DOI 10.1016/0001-8686(94)80021-9
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   WISSBRUN KF, 1998, RHEOLOGICAL MEASUREM, P392
   Wong MS, 2002, NANO LETT, V2, P583, DOI 10.1021/nl020244c
   Yoshinaga I, 1996, J SOL-GEL SCI TECHN, V6, P151, DOI 10.1007/BF00425972
   Zaremba CM, 1996, CURR OPIN SOLID ST M, V1, P425, DOI 10.1016/S1359-0286(96)80035-0
NR 36
TC 91
Z9 92
U1 2
U2 45
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD DEC 1
PY 2003
VL 268
IS 1
BP 68
EP 76
DI 10.1016/S0021-9797(03)00457-0
PG 9
WC Chemistry, Physical
SC Chemistry
GA 744PA
UT WOS:000186639800010
PM 14611774
DA 2018-10-19
ER

PT J
AU Cortizo, MC
   Fernandez, I
   De Mele, M
   Cortizo, AM
AF Cortizo, MC
   Fernandez, I
   De Mele, M
   Cortizo, AM
TI Cytotoxicity of copper ions. Influence of the cell-biomaterial distance.
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
CT 35th Annual Meeting of the Interantional-Association-for-Dental-Research
CY NOV 08-09, 2002
CL Buenos Aires, ARGENTINA
SP Int Assoc Dent Res
C1 Natl Univ La Plata, Fac Cs Exactas, INIFTA, La Plata, Argentina.
   Natl Univ La Plata, Fac Cs Exactas, Catedra Bioquim Patol, La Plata, Argentina.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2003
VL 82
SI C
BP 62
EP 62
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 775UD
UT WOS:000189078300350
DA 2018-10-19
ER

PT J
AU De Munck, J
   Van Meerbeek, B
   Lambrechts, P
   Braem, M
AF De Munck, J
   Van Meerbeek, B
   Lambrechts, P
   Braem, M
TI Micro-rotary fatigue of tooth-biomaterial interfaces.
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
CT 1st Annual Meeting of the International-Association-for-Dental-Research
CY SEP   18, 2002
CL Cardiff, WALES
C1 Katholieke Univ Leuven, Louvain, Belgium.
   Univ Antwerp, B-2020 Antwerp, Belgium.
EM jan.demunck@med.kuleuven.ac.be
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2003
VL 82
SI C
BP 531
EP 531
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 775UD
UT WOS:000189078303221
DA 2018-10-19
ER

PT J
AU Yoshida, K
   Morita, M
   Mishina, H
AF Yoshida, K
   Morita, M
   Mishina, H
TI Cytotoxicity of metal and ceramic particles in different sizes
SO JSME INTERNATIONAL JOURNAL SERIES C-MECHANICAL SYSTEMS MACHINE ELEMENTS
   AND MANUFACTURING
LA English
DT Article
DE artificial joint; particle size; wear particles; inflammation; macro;
   phage; in vitro; biomaterial
ID HIP
AB The wear debris caused by joint prosthesis is well known to induce an inflammation in the peripheral tissue. The authors carried out two kinds of experiments, to clarify the phagocytable size of wear particles and the cytotoxicity of macrophage related to the size and materials. The test materials were Al2O3, SiO2, TiO2 fine particles and Ti-6Al-4V, Co-28Cr-6Mo wear particles. The results showed that the phagocytable particle size was less than 11.9+/-11.2 mum. It appears that the cytotoxicity did not depend on the particle size, even if the particles were phagocytable size. In the relationship between material type and inflammation, damage levels were found to be different between SiO2 and TiO2 particles, even if neither material released metal ions. The cells were damaged more severely by SiO, particles than by Co-28Cr-6Mo for which the eluted ion could not be ignored (damage levels; SiO2>Co-28Cr-6Mo>Ti-6Al-4V>Al2O3 greater than or equal toTiO(2)). For these reasons, it was confirmed that there was a factor in addition to the toxicity of the eluted metal ion (i.e., the implant material's corrosion resistance ability), which influenced the inflammation.
C1 Chiba Univ, Grad Sch Sci & Technol, Dept Artificial Sci & Syst, Inage Ku, Chiba, Chiba 2630022, Japan.
   Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2288555, Japan.
   Chiba Univ, Fac Engn, Dept Elect & Mech Engn, Inage Ku, Chiba, Chiba 2630022, Japan.
RP Yoshida, K (reprint author), Chiba Univ, Grad Sch Sci & Technol, Dept Artificial Sci & Syst, Inage Ku, 1-33 Yayoi Cho, Chiba, Chiba 2630022, Japan.
EM tribos@graduate.chiba-u.jp
CR BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   Charlebois SJ, 2002, J BIOMED MATER RES, V59, P166, DOI 10.1002/jbm.1230
   CHARNLEY J, 1961, LANCET, V1, P1129
   JOHANSON NA, 1987, CLIN ORTHOP RELAT R, P123
   Kubo T, 1999, J BIOMED MATER RES, V45, P363, DOI 10.1002/(SICI)1097-4636(19990615)45:4<363::AID-JBM11>3.0.CO;2-3
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   PAZZAGLIA UE, 1985, ARCH ORTHOP TRAUM SU, V104, P164, DOI 10.1007/BF00454694
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   WILES P, 1958, BRIT J SURG, V45, P488, DOI 10.1002/bjs.18004519315
   WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210
NR 10
TC 3
Z9 3
U1 1
U2 8
PU JAPAN SOC MECHANICAL ENGINEERS
PI TOKYO
PA SHINANOMACHI-RENGAKAN BLDG, SHINANOMACHI 35, SHINJUKU-KU, TOKYO,
   160-0016, JAPAN
SN 1344-7653
J9 JSME INT J C-MECH SY
JI JSME Int. J. Ser. C-Mech. Syst. Mach. Elem. Manuf.
PD DEC
PY 2003
VL 46
IS 4
BP 1284
EP 1289
DI 10.1299/jsmec.46.1284
PG 6
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 769AT
UT WOS:000188604800012
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Kuroda, D
   Takemoto, S
   Hanawa, T
   Asami, K
AF Kuroda, D
   Takemoto, S
   Hanawa, T
   Asami, K
TI Characterization of the surface oxide film on an Fe-Cr-N system alloy in
   environments, simulating the human body
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE nickel-free austenitic stainless steel; nitrogen absorption; simulated
   body environment; surface composition; biomaterial
ID QUASI-BIOLOGICAL ENVIRONMENTS; AUSTENITIC STAINLESS-STEEL; XPS;
   CHROMIUM; TITANIUM; IRON
AB The objective of this study was to characterize the surface oxide film on nickel-free austenitic stainless steel with nitrogen absorption, Fe-24Cr-1N in mass% (Fe-26.4Cr-3.4N in at%), located in various environments, to estimate the reconstruction of the surface oxide film in the human body. The specimens were metal lographically polished in deionized water, autoclaved after polishing, immersed in Hanks' solution for 7 days after polishing and autoclaving, immersed in Eagle's minimum essential medium containing fetal bovine serum for 7 days after polishing and autoclaving, and incubated with L929 fibroblasts for 7 days after polishing and autoclaving. L929 fibroblasts cultured on the specimen were removed with a flow of deionized water before surface analysis. X-ray photoelectron spectroscopy was performed to determine the composition of the surface oxide film and substrate and the thickness of the surface oxide film. The depth profiles of elements in the surface region were, also characterized using Auger electron spectroscopy in combination with argon-ion-sputtering. The surface oxide film on Fe-24Cr-1N polished mechanically in deionized water consists of iron and chromium oxides. Large amounts of carbon, nitrogen, oxygen, and sulfur originating from proteins were detected after immersion in the medium. Sulfur existed as sulfide or sulfite. Calcium phosphate was formed on the surface oxide film after immersion in the Hanks' solution and medium. On the other hand, calcium and sulfur were not detected after being incubated with the cells, indicating that a large amount of protein was absorbed on the top of the surface oxide film.
C1 Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050047, Japan.
   Tokyo Dent Coll, Dept Dent Mat Sci, Chiba 2618502, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Kuroda, D (reprint author), Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050047, Japan.
CR ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Asami K., 1985, P 6 EUR S CORR BEH A, P769
   ASAMI K, 1979, T JIM, V20, P120
   GRUNZE M, 1979, SURF SCI, V81, P603, DOI 10.1016/0039-6028(79)90123-7
   Hanawa T, 2002, MATER TRANS, V43, P3088, DOI 10.2320/matertrans.43.3088
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   Kelly E. J., 1982, MOD ASPECT ELECTROC, P319
   Kuroda D, 2003, MATER TRANS, V44, P414, DOI 10.2320/matertrans.44.414
   Kuroda D, 2002, MATER TRANS, V43, P3093, DOI 10.2320/matertrans.43.3093
   KURODA D, 2003, MAT T, V44, P1
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SHIMIZU R, 1989, JITSUYO OHJE DENSHIB, P222
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   TERAMOTO K, 1978, BOSHOKU GIJUTSU, V27, P57
   Wagner C., 1979, HDB XRAY PHOTOELECTR, P54
NR 20
TC 3
Z9 3
U1 0
U2 3
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2003
VL 44
IS 12
BP 2664
EP 2670
DI 10.2320/matertrans.44.2664
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 764PM
UT WOS:000188215300045
OA Bronze
DA 2018-10-19
ER

PT J
AU Kuroda, D
   Takemoto, S
   Hanawa, T
   Asami, K
AF Kuroda, D
   Takemoto, S
   Hanawa, T
   Asami, K
TI Characterization of the surface oxide film on an Fe-Cr-Mo-N system alloy
   in environments simulating the human body
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE nickel-free austenitic stainless steel; nitrogen absorption; simulated
   body environment; surface composition; biomaterial
ID AUSTENITIC STAINLESS-STEEL; QUASI-BIOLOGICAL ENVIRONMENTS; XPS;
   NITROGEN; NICKEL; MOLYBDENUM; CHROMIUM; TITANIUM; IRON
AB The objective of this study was to characterize the surface oxide film on nickel-free austenitic stainless steel, Fe-24Cr-2Mo-1N in mass% (Fe-26.7Cr-1.1Mo-3.6N in at%), with nitrogen absorption located in various environments, to estimate the reconstruction of the surface oxide film in the human body. The specimens were metallographically polished in deionized water, autoclaved after polishing, immersed in Hanks' solution for 7 days after polishing and autoclaving, immersed in Eagle's minimum essential medium containing fetal bovine serum for 7 days after polishing and autoclaving, and incubated with L929 fibroblasts for 7 days after polishing and autoclaving. L929 fibroblasts cultured on the specimen were removed with a flow of deionized water before surface analysis. X-ray photoelectron spectroscopy was performed to determine the composition of the surface oxide film and substrate and the thickness of the surface oxide film. The depth profiles of elements in the surface region were also characterized using Auger electron spectroscopy in combination with argon-ion-sputtering. The surface oxide film on the nickel-free austenitic stainless steel with nitrogen absorption, Fe-24Cr-2Mo-1N, polished mechanically in deionized water, consisted of iron and chromium oxides containing small amount of molybdenum oxide. A large amount of carbon, nitrogen, oxygen, and sulfur originating from proteins was detected after immersion in the medium and incubation with the cells. Sulfur existed as sulfide or sulfite. Calcium phosphate was formed on the surface oxide film after immersion in the Hanks' solution and medium and incubation with the cells.
C1 Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050047, Japan.
   Tokyo Dent Coll, Dept Dent Mat Sci, Chiba 2618502, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Kuroda, D (reprint author), Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050047, Japan.
CR ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Asami K., 1985, P 6 EUR S CORR BEH A, P769
   ASAMI K, 1979, T JIM, V20, P120
   CHANG LW, 1996, TOXICOLOGY METALS, P827
   GRUNZE M, 1979, SURF SCI, V81, P603, DOI 10.1016/0039-6028(79)90123-7
   Hanawa T, 2002, MATER TRANS, V43, P3088, DOI 10.2320/matertrans.43.3088
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   *IARC WORK GROUP E, 1999, IARC MON EV CARC RIS, V74, P241
   Ishii F., 1982, TETSU TO HAGANE, V68, P1560
   Kelly E. J., 1982, MOD ASPECT ELECTROC, P319
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   Kuroda D, 2003, MATER TRANS, V44, P414, DOI 10.2320/matertrans.44.414
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Kuroda D, 2002, MATER TRANS, V43, P3093, DOI 10.2320/matertrans.43.3093
   KURODA D, 2003, IN PRESS MAT T, V44
   Olefjord I, 1996, CORROS SCI, V38, P1203, DOI 10.1016/0010-938X(96)00018-2
   OLSSON COA, 1995, CORROS SCI, V37, P467, DOI 10.1016/0010-938X(94)00148-Y
   PESSALL N, 1974, CORROSION, V30, P381, DOI 10.5006/0010-9312-30.11.381
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SHIMIZU R, 1989, JITSUYO OHJE DENSHIB, P222
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   TERAMOTO K, 1978, BOSHOKU GIJUTSU, V27, P57
   Wagner C., 1979, HDB XRAY PHOTOELECTR, P54
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   YAMAMOTO A, 2001, J BIOMED MATER RES, V59, P176
   YANO E, 1994, TOXICOLOGY TODAY, P119
NR 31
TC 4
Z9 4
U1 0
U2 3
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2003
VL 44
IS 12
BP 2671
EP 2677
DI 10.2320/matertrans.44.2671
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 764PM
UT WOS:000188215300046
OA Bronze
DA 2018-10-19
ER

PT J
AU Yuan, J
   Mao, C
   Zhou, J
   Shen, J
   Lin, SC
   Zhu, W
   Fang, JL
AF Yuan, J
   Mao, C
   Zhou, J
   Shen, J
   Lin, SC
   Zhu, W
   Fang, JL
TI Chemical grafting of sulfobetaine onto poly(ether urethane) surface for
   improving blood compatibility
SO POLYMER INTERNATIONAL
LA English
DT Article
DE poly(ether urethane); surface modification; sulfobetaine; platelet
   adhesion; non-thrombogenic biomaterials
ID PLATELET-ADHESION; POLYURETHANE SURFACES; COPOLYMERS; MONOMER; FILM;
   POLYMERS
AB Poly(ether urethane)s (PEUs) are widely used as blood-contact biomaterials because of their good biocompatibility and mechanical properties. Nevertheless, their blood compatibility is stiff not adequate for more demanding applications. Surface modification is an effective way to improve blood compatibility and retain bulk properties of biomaterials. The purpose of the present study was to design and synthesis a novel non-thrombogenic biomaterial by modifying the surface of PEU with zwitterionic monomer. In this study, sulfobetaine was grafted onto PEU surface through the following reaction steps: (1) Poly(propylene oxide) (PPO) was reacted at both chain ends with hexamethylene diisocyanate (HDI), and OCN-PPO-NCO was obtained; (2) OCN-PPO-NCO was reacted at one chain end with N,N-dimethylethanolamine (DMEA) and OCN-PPO-N(CH3)(2) was formed; (3) the sulfobetaine was prepared by a ring-opening reaction between OCN-PPO-N(CH3)(2) and 1,3-propanesultone (PSu); (4) the sulfobetaine was grafted onto PEU surface by the reaction between NCO and the N-H bonds of PEU. The surface composition of films and the hydrophilicity on the PEU surface were investigated by X-ray photoelectron spectroscopy analysis and contact angle measurements, respectively. The blood compatibility of PEU was evaluated by platelet-rich plasma contact experiments and the results were observed by scanning electron microscopy. The state of platelet adhesion and shape variation for the attached platelets was described. The modified surface showed excellent blood compatibility, featured by low platelet adhesion. (C) 2003 Society of Chemical Industry.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
   Nanjing Univ, Ctr Mat Anal, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Chen Z, 2000, J APPL POLYM SCI, V76, P382, DOI 10.1002/(SICI)1097-4628(20000418)76:3<382::AID-APP13>3.0.CO;2-A
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   LELAH MD, 1986, POLYURETHANES MED, P57
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   LI YJ, 1997, F BIOMATER APPL, V12, P167
   LIAW DJ, 1985, J APPL POLYM SCI, V30, P4697, DOI 10.1002/app.1985.070301216
   LIAW DJ, 1987, J APPL POLYM SCI, V34, P999, DOI 10.1002/app.1987.070340311
   Liaw DJ, 2000, POLYMER, V41, P6123, DOI 10.1016/S0032-3861(99)00824-1
   Lin JC, 2001, J MATER SCI-MATER M, V12, P827, DOI 10.1023/A:1017937304964
   Lin S. C., 1998, CHIN POLYM B, V1, P1
   MCCORMICK CL, 1992, POLYMER, V33, P4617, DOI 10.1016/0032-3861(92)90422-S
   Monroy V.M., 1984, POLYMER, V25, P121
   MONROYSOTO VM, 1984, POLYMER, V25, P254
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   SALAMONE JC, 1977, POLYMER, V18, P1058, DOI 10.1016/0032-3861(77)90013-1
   Wang DA, 2001, BIOMATERIALS, V22, P1549, DOI 10.1016/S0142-9612(00)00311-2
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   YUAN J, IN PRESS CHINESE F P
   Yuan YL, 2002, J BIOMAT SCI-POLYM E, V13, P1081, DOI 10.1163/156856202320813800
   YUAN YL, IN PRESS POLYM INT
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   Zhou J, 2002, CHEM J CHINESE U, V23, P2393
   ZHU JM, 1998, ACTA POLYM SIN, V5, P632
NR 32
TC 37
Z9 40
U1 1
U2 21
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD DEC
PY 2003
VL 52
IS 12
BP 1869
EP 1875
DI 10.1002/pi.1277
PG 7
WC Polymer Science
SC Polymer Science
GA 745GE
UT WOS:000186680300011
DA 2018-10-19
ER

PT J
AU Hiraoka, Y
   Kimura, Y
   Ueda, H
   Tabata, Y
AF Hiraoka, Y
   Kimura, Y
   Ueda, H
   Tabata, Y
TI Fabrication and biocompatibility of collagen sponge reinforced with
   poly(glycolic acid) fiber
SO TISSUE ENGINEERING
LA English
DT Article
ID POLY(LACTIC ACID-CO-LYSINE); HYBRID SPONGE; TISSUE; BIOMATERIAL;
   REPLACEMENT; CULTURE
AB This article describes an investigation of collagen sponge mechanically reinforced through the incorporation of poly(glycolic acid) (PGA) fiber. A collagen solution with PGA fiber homogeneously dispersed at collagen:PGA weight ratios of 1.5, 0.8, 0.4, and 0.2 was freeze-dried, followed by dehydrothermal cross-linking to obtain collagen sponges incorporating PGA fiber to various extents. By scanning electron microscopy observation, the collagen sponges exhibited isotropic and interconnected pore structures with an average size of 180 mum, irrespective of PGA fiber incorporation. As expected, PGA fiber incorporation enabled the collagen sponges to significantly enhance their compression strength. In vitro cell culture studies revealed that the number of L929 fibroblasts initially attached was significantly greater for any collagen sponge incorporating PGA fiber than for collagen sponge. The shrinkage of sponge after cell seeding was suppressed by fiber incorporation. It is possible that shrinkage suppression results in the superior cell attachment of sponge incorporating PGA fiber. After subcutaneous implantation into the backs of mice, the residual volume of collagen sponge incorporating PGA fiber was significant compared with that of collagen sponge and increased with a decrease in the collagen:PGA ratio. The greater number of cells infiltrated and deeper infiltration were observed for collagen sponge incorporating PGA fiber implanted subcutaneously. We conclude that the incorporation of PGA fiber is a simple and promising way to reinforce collagen sponge without impairing biocompatibility.
C1 Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawara Cho, Kyoto 6068507, Japan.
RI Kimura, Yu/C-3442-2008
CR BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0
   Chen GP, 1999, CHEM LETT, P561, DOI 10.1246/cl.1999.561
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Heimburg D., 2001, PLAST RECONSTR SURG, V108, P411
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   NATSUME T, 1993, J BIOMED MATER RES, V27, P867, DOI 10.1002/jbm.820270705
   RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Tabata Y, 2001, DRUG DISCOV TODAY, V6, P483, DOI 10.1016/S1359-6446(01)01753-6
   TABATA Y, 2001, CONNECT TISSUE, V33, P315
   Teramachi M, 1997, ANN THORAC SURG, V64, P965, DOI 10.1016/S0003-4975(97)00755-8
   VACANTI J, 1999, LANCET S1, V354, P3234
   Yamamoto Y, 1999, ASAIO J, V45, P311, DOI 10.1097/00002480-199907000-00011
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
NR 23
TC 74
Z9 75
U1 3
U2 8
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD DEC
PY 2003
VL 9
IS 6
BP 1101
EP 1112
DI 10.1089/10763270360728017
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 748YP
UT WOS:000186889200004
PM 14670098
DA 2018-10-19
ER

PT J
AU Bursac, N
   Papadaki, M
   White, JA
   Eisenberg, SR
   Vunjak-Novakovic, G
   Freed, LE
AF Bursac, N
   Papadaki, M
   White, JA
   Eisenberg, SR
   Vunjak-Novakovic, G
   Freed, LE
TI Cultivation in rotating bioreactors promotes maintenance of cardiac
   myocyte electrophysiology and molecular properties
SO TISSUE ENGINEERING
LA English
DT Article
ID TRANSIENT OUTWARD CURRENT; RAT VENTRICULAR MYOCYTES; ENGINEERED
   HEART-TISSUE; PRIMARY CULTURE; CARDIOMYOCYTE TRANSPLANTATION;
   CELL-CULTURES; MUSCLE; EXPRESSION; GRAFTS; MODEL
AB We tested the hypothesis that cardiomyocytes maintained their phenotype better if cultured as three-dimensional tissue constructs than if cultured as confluent monolayers. Neonatal rat cardiomyocytes were cultured on biomaterial scaffolds in rotating bioreactors for 1 week, and resulting tissue constructs were compared with confluent monolayers and slices of native ventricular tissue with respect to proteins involved in cell metabolism (creatine kinase isoform MM), contractile function (sarcomeric myosin heavy chain), and intercellular communication (connexin 43), as well as action potential characteristics (e.g., membrane resting potential, maximum depolarization slope, and action potential duration), and macroscopic electrophysiological properties (maximum capture rate). The molecular and electrophysiological properties of cardiomyocytes cultured in tissue constructs, although inferior to those of native neonatal ventricles, were superior to those of the same cells cultured as monolayers. Construct levels of creatine kinase, myosin heavy chain, and connexin 43 were 40-60% as high as ventricle levels, whereas monolayer levels of the same proteins were only 11-20% as high. Construct action potential durations were 1.8-fold higher than those in ventricles, whereas monolayer action potential durations were 2.4-fold higher. Pharmacological studies using 4-aminopyridine showed that prolonged action potential duration and reduced maximum capture rate in tissue constructs as compared with native ventricles could be explained by decreased transient outward potassium current.
C1 MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Freed, LE (reprint author), MIT, Harvard MIT Div Hlth Sci & Technol, E25-330,77 Massachusetts Ave, Cambridge, MA 02139 USA.
OI Bursac, Nenad/0000-0002-5688-6061; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574; Freed, Lisa/0000-0002-0720-8432
FU NINDS NIH HHS [NS34425]
CR Akins RE, 1999, TISSUE ENG, V5, P103, DOI 10.1089/ten.1999.5.103
   ATHIAS P, 1979, PATHOL BIOL, V27, P13
   BENZEEV A, 1991, BIOESSAYS, V13, P207, DOI 10.1002/bies.950130502
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898
   Eschenhagen T, 1997, FASEB J, V11, P683
   FAST VG, 1993, CIRC RES, V73, P914, DOI 10.1161/01.RES.73.5.914
   Fast VG, 1996, CIRC RES, V79, P115, DOI 10.1161/01.RES.79.1.115
   Fink C, 2000, FASEB J, V14, P669
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   GOMEZ JP, 1994, PFLUG ARCH EUR J PHY, V428, P241, DOI 10.1007/BF00724503
   Guo W, 1999, CARDIOVASC RES, V41, P157, DOI 10.1016/S0008-6363(98)00157-6
   Guo WN, 1996, AM J PHYSIOL-CELL PH, V271, pC93
   Guo WN, 1996, CARDIOVASC RES, V32, P524, DOI 10.1016/0008-6363(96)00107-1
   Hershman KM, 1998, AM J PHYSIOL-CELL PH, V275, pC1473, DOI 10.1152/ajpcell.1998.275.6.C1473
   HOFFMAN RM, 1993, STEM CELLS, V11, P105, DOI 10.1002/stem.5530110205
   Joyner RW, 1997, CAN J CARDIOL, V13, P1085
   Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262
   KAMMERMEIER H, 1988, BASIC RES CARDIOL, V83, P343, DOI 10.1007/BF02005819
   Leor J, 2000, CIRCULATION, V102, P56
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   Li RK, 1996, ANN THORAC SURG, V62, P654
   MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109
   Nanasi PP, 1996, ACTA PHYSIOL SCAND, V158, P143, DOI 10.1046/j.1365-201X.1996.541304000.x
   OYAMADA M, 1994, EXP CELL RES, V212, P351, DOI 10.1006/excr.1994.1154
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193
   ROOK MB, 1992, AM J PHYSIOL, V263, pC959
   Rozanski GJ, 1998, AM J PHYSIOL-HEART C, V274, pH259, DOI 10.1152/ajpheart.1998.274.1.H259
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   SCHACKOW TE, 1995, AM J PHYSIOL-CELL PH, V268, pC1002
   SCHACKOW TE, 1995, AM J PHYSIOL-CELL PH, V268, pC993
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787
   Spach MS, 2000, CIRC RES, V86, pE23
   SPACH MS, 1992, AM J PHYSIOL, V263, pH1855
   SPERELAKIS N, 1995, PHYSL PATHOPHYSIOLOG, P669
   UTA CH, 2000, CIRC RES, V84, P964
   Volk T, 1999, J PHYSIOL-LONDON, V519, P841, DOI 10.1111/j.1469-7793.1999.0841n.x
   WAHLER GM, 1992, AM J PHYSIOL, V262, pC1266
   Watanabe E, 1998, CELL TRANSPLANT, V7, P239, DOI 10.1016/S0963-6897(98)00011-6
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
   ZIMMERMANN WH, 2002, CIRCULATION, V106, P151
NR 48
TC 59
Z9 64
U1 1
U2 5
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD DEC
PY 2003
VL 9
IS 6
BP 1243
EP 1253
DI 10.1089/10763270360728152
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 748YP
UT WOS:000186889200018
PM 14670112
DA 2018-10-19
ER

PT J
AU Sanders, JE
   Wang, YN
   Malcolm, SG
   Lamont, SE
AF Sanders, JE
   Wang, YN
   Malcolm, SG
   Lamont, SE
TI Biomaterial mesh seeded with vascular remnants from a quail embryo has a
   significant and fast vascular templating effect on host implant tissue
SO TISSUE ENGINEERING
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; MEMBRANE; ANGIOGENESIS; PROLIFERATION;
   RECOGNITION; ALLOGRAFTS; INHIBITION; COMPONENTS; LAMININ; DERMIS
AB Seeding biomaterial implants with vascular remnants has the potential to facilitate host vessel ingrowth via a vascular templating effect. Vessels from quail embryo were grown into a polyurethane fibroporous mesh and the samples were frozen-thawed and then implanted in rat subcutaneous dorsum. Results show that the process of revascularization, using the quail vessel remnants, occurred over the first 3 days after implantation and resulted in functional vessels. Rat endothelial cells were found in the quail templates on day 1. On day 2 the endothelial cells formed a confluent layer and started producing laminin. By this time approximately 70% of the rat vessel tissue in the implant had grown into quail vascular remnants, indicating that the quail vessels were extensively used as templates for host vessel ingrowth. Laminin production was increased and collagen production started by day 3, at which time the vessels were functional in that rat blood flowed through them. At 2 weeks host vessel density was approximately twice that of control samples; thus the implant substantially enhanced the size of the vascular network. For meshes that additionally received vascular endothelial growth factor (VEGF) seeding before implantation, vessel density at 2 weeks was enhanced over samples with quail embryo alone. However, the quail was found to have the greatest angiogenic effect above any of the implant components-quail, VEGF, and collagen. Tissue engineering of vessel templates may thus be a realistic solution to effective fast vascularization of biomaterials.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, Dept Bioengn, 357962, Seattle, WA 98195 USA.
RI Wang, Yak-Nam/D-4924-2011
FU NICHD NIH HHS [HD-38554, R01 HD038554, R01 HD038554-01]
CR Adeghate E, 1998, ANAT REC, V251, P448, DOI 10.1002/(SICI)1097-0185(199808)251:4<448::AID-AR4>3.0.CO;2-O
   CHOW SP, 1983, BRIT J PLAST SURG, V36, P345
   Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9
   Dermarchez M., 1992, TRANSPLANTATION, V54, P317
   FLAMME I, 1995, DEV BIOL, V171, P399, DOI 10.1006/dbio.1995.1291
   FORM DM, 1986, LAB INVEST, V55, P521
   GOLDMAN MH, 1979, TRANSPLANT P, V11, P1510
   Grant D S, 1997, EXS, V79, P317
   GRANT DS, 1990, ANN NY ACAD SCI, V588, P61, DOI 10.1111/j.1749-6632.1990.tb13197.x
   GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   INGBER DE, 1986, ENDOCRINOLOGY, V119, P1768, DOI 10.1210/endo-119-4-1768
   Kimura I, 2000, INT ANGIOL, V19, P26
   MARAGOUDAKIS ME, 1988, J PHARMACOL EXP THER, V244, P729
   Medalie DA, 1996, ASAIO J, V42, pM455, DOI 10.1097/00002480-199609000-00030
   Pahlig H, 1976, Z Exp Chir, V9, P161
   PRATT MF, 1986, LARYNGOSCOPE, V96, P625
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ribatti D, 2001, J VASC RES, V38, P389, DOI 10.1159/000051070
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Sanders JE, 2002, MICROVASC RES, V64, P174, DOI 10.1006/mvre.2002.2410
   SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5
   TAKESHITA S, 1995, AM J PATHOL, V147, P1649
   YURCHENCO PD, 1990, FASEB J, V4, P1577
NR 25
TC 6
Z9 6
U1 0
U2 3
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD DEC
PY 2003
VL 9
IS 6
BP 1271
EP 1279
DI 10.1089/10763270360728189
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA 748YP
UT WOS:000186889200021
PM 14670115
DA 2018-10-19
ER

PT J
AU von Woedtke, T
   Schlosser, M
   Urban, G
   Hartmann, V
   Julich, WD
   Abel, PU
   Wilhelm, L
AF von Woedtke, T
   Schlosser, M
   Urban, G
   Hartmann, V
   Julich, WD
   Abel, PU
   Wilhelm, L
TI The influence of antimicrobial treatments on the cytocompatibility of
   polyurethane biosensor membranes
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE antimicrobial treatments; polyurethane; biosensors
ID GLUCOSE SENSORS; IN-VIVO; PERFORMANCE; CULTURE; CELLS
AB The cytocompatibility of polyurethane membranes was tested following ultraviolet or gamma irradiation as well as treatment with hydrogen peroxide or glutaraldehyde containing solutions. Despite the fact that all of the methods had been recommended for antimicrobial treatment of glucose biosensors, the treatments investigated significantly influenced cytocompatibility characteristics. Cytotoxicity of membrane eluates was not observed following irradiation treatments. This was also the case when the membranes were repeatedly washed following chemical treatment. Cell growth upon the membranes was stimulated to a different extent after gamma and UV irradiation as well as following hydrogen peroxide treatments. Residues of an urea-based hydrogen peroxide inclusion compound caused a restriction in cell growth upon the membranes as was similarly observed with 2 and 4% glutaraldehyde solutions acting over 2 and 4 h, respectively. It is concluded that cytocompatibility in vitro reflecting the host response against a biomaterial in vivo does not only depend upon the material itself but also upon antimicrobial treatments which could have consequences for its bioperformance characteristics. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany.
   Sensor Res Ctr Greifswald, D-17489 Greifswald, Germany.
   Univ Greifswald, Inst Pathophysiol, D-17487 Greifswald, Germany.
   Univ Greifswald, Dept Surg, D-17487 Greifswald, Germany.
RP von Woedtke, T (reprint author), Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany.
RI URBAN, Gerald/H-7893-2014
CR Abel P. U., 2001, Sensor Review, V21, P297, DOI 10.1108/02602280110406954
   Abel PU, 2002, BIOSENS BIOELECTRON, V17, P1059, DOI 10.1016/S0956-5663(02)00099-4
   Abel PU, 1999, J MOL CATAL B-ENZYM, V7, P93, DOI 10.1016/S1381-1177(99)00024-7
   ADRIAN V, 1998, HYG MED S2, V23, P94
   Black J, 1999, BIOL PERFORMANCE MAT
   CHAMBERLAIN VC, 1998, HDB BIOMATERIALS EVA, P253
   Gerritsen M, 1998, J INVEST SURG, V11, P163, DOI 10.3109/08941939809098031
   Gerritsen M, 2001, J BIOMED MATER RES, V54, P69, DOI 10.1002/1097-4636(200101)54:1<69::AID-JBM8>3.3.CO;2-H
   Julich WD, 1999, PHARMAZIE, V54, P171
   JULICH WD, 1998, HYG MED, V23, P338
   LAWRENCE H, 1998, HDB BIOMATERIALS EVA, P263
   REICHERT WM, 1998, HDB BIOMATERIALS EVA, P439
   Rutala WA, 1999, INFECT CONT HOSP EP, V20, P69, DOI 10.1086/501544
   SCHLOSSER M, 1994, HORM METAB RES, V26, P534, DOI 10.1055/s-2007-1001751
   Schlosser M., 1997, BIOSENSORS BODY CONT, P139
   SCOTT EM, 1991, DISINFECTION STERILI, P596
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   von Woedtke T, 2002, MED BIOL ENG COMPUT, V40, P704, DOI 10.1007/BF02345309
   von Woedtke T, 2002, BIOSENS BIOELECTRON, V17, P373, DOI 10.1016/S0956-5663(01)00310-4
   von Woedtke T, 2001, PHARMAZIE, V56, P561
   WENZL MM, 1998, CYTOCOMPATIBILITY PR, P15
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E
   ZIEGLER M, 1994, BIOMATERIALS, V15, P859, DOI 10.1016/0142-9612(94)90043-4
NR 25
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD NOV 30
PY 2003
VL 19
IS 3
BP 269
EP 276
DI 10.1016/S0956-5663(03)00217-3
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 747NU
UT WOS:000186811500016
PM 14611763
DA 2018-10-19
ER

PT J
AU Olsen, D
   Yang, CL
   Bodo, M
   Chang, R
   Leigh, S
   Baez, J
   Carmichael, D
   Perala, M
   Hamalainen, ER
   Jarvinen, M
   Polarek, J
AF Olsen, D
   Yang, CL
   Bodo, M
   Chang, R
   Leigh, S
   Baez, J
   Carmichael, D
   Perala, M
   Hamalainen, ER
   Jarvinen, M
   Polarek, J
TI Recombinant collagen and gelatin for drug delivery
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE recombinant collagen; recombinant gelatin; yeast; transgenic animals and
   plants; prolyl hydroxylase; hydroxyproline
ID YEAST PICHIA-PASTORIS; BACULOVIRUS EXPRESSION SYSTEM; I COLLAGEN; PROLYL
   4-HYDROXYLASE; SACCHAROMYCES-CEREVISIAE; TRANSGENIC PLANTS;
   TRIPLE-HELIX; III COLLAGEN; REQUIRES COEXPRESSION; THERAPEUTIC PROTEINS
AB The tools of recombinant protein expression are now being used to provide recombinant sources of both collagen and gelatin. The primary focus of this review is to discuss alternatives to bovine collagen for biomedical applications. Several recombinant systems have been developed for production of human sequence collagens. Mammalian and insect cells were initially used, but were thought to be too costly for commercial production. Yeast have been engineered to express high levels of type I homotrimer and heterotrimer and type II and type III collagen. Co-expression of collagen genes and cDNAs encoding the subunits of prolyl hydroxylase has lead to the synthesis of completely hydroxylated, thermostable collagens. Human types I and III collagen homotrimers have been expressed in transgenic tobacco plants, while transgenic mice have been engineered to produce full-length type I procollagen homotrimer as well as a alpha2 (1) homotrimeric mini-collagen. Most recently, a transgenic silkworm system was used to produce a fusion protein containing a collagenous sequence. Each of these transgenic systems holds great promise for the cost-effective large-scale production of recombinant human collagens. As seen in other recombinant expression systems, transgenic silkworms, tobacco, and mice lack sufficient endogenous prolyl hydroxylase activity to produce fully hydroxylated collagen. In mice and tobacco, this was overcome by over-expression of prolyl hydroxylase, analogous to what has been done in yeast and insect cell culture. In addition to recombinant alternatives to bovine collagen, other sources such as fish and sponge collagen are discussed briefly. Recombinant gelatin has been expressed in Pichia pastoris and Hansenula polymorpha in both non-hydroxylated and hydroxylated forms. Pichia was shown to be a highly productive system for gelatin production. The recombinant gelatins produced in yeast are of defined molecular weight and physio-chemical properties and represent a new biomaterial not previously available from animal sources. Genetic engineering has made great progress in the areas of recombinant collagen and gelatin expression, and there are now several alternatives to bovine material that offer an enhanced safety profile, greater reproducibility and quality, and the ability of these materials to be tailored to enhance product performance. (C) 2003 Elsevier B.V. All rights reserved.
C1 FibroGen Inc, San Francisco, CA 94080 USA.
   FibroGen Europe, Medipolis, FIN-90230 Oulu, Finland.
RP Olsen, D (reprint author), FibroGen Inc, 225 Gateway Blvd, San Francisco, CA 94080 USA.
EM dolsen@fibrogen.com
OI Polarek, James/0000-0003-4097-5219
FU NIAMS NIH HHS [R01 AR45879]
CR ASA K, 1989, INT ARCH ALLER A IMM, V29, P990
   ASGHAR A, 1982, ADV FOOD RES, V28, P231
   Asher D M, 1999, Dev Biol Stand, V100, P103
   BALLEISEN L, 1975, KLIN WOCHENSCHR, V53, P903, DOI 10.1007/BF01468982
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P213
   BIRK DE, 1991, CELL BIOL EXTRACELLU, P221
   BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642
   Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200
   CAREY DJ, 1991, ANNU REV PHYSIOL, V53, P161, DOI 10.1146/annurev.physiol.53.1.161
   Chen M, 2002, J BIOL CHEM, V277, P2118, DOI 10.1074/jbc.M108779200
   CHUNG E, 1974, SCIENCE, V183, P1200, DOI 10.1126/science.183.4130.1200
   *COLL AESTH INT, 2002, ZYD COLL IMPL PACK I
   COOPERMAN L, 1984, J AM ACAD DERMATOL, V10, P638, DOI 10.1016/S0190-9622(84)80271-6
   COURTS A, 1954, BIOCHEM J, V58, P74, DOI 10.1042/bj0580074
   Cramer CL, 1999, CURR TOP MICROBIOL, V240, P95
   DATAR RV, 1993, BIO-TECHNOL, V11, P349, DOI 10.1038/nbt0393-349
   de Bruin EC, 2000, ENZYME MICROB TECH, V26, P640, DOI 10.1016/S0141-0229(00)00153-8
   de Bruin Eric C., 2002, FEMS Yeast Research, V1, P291, DOI 10.1016/S1567-1356(01)00042-3
   DEBRUIN EC, 2002, ENZYME MICROB TECHNO, V1, P291
   DEWET W, 1987, J BIOL CHEM, V262, P32
   EXPOSITO JY, 1991, J BIOL CHEM, V266, P21923
   EXPOSITO JY, 1990, P NATL ACAD SCI USA, V87, P6669, DOI 10.1073/pnas.87.17.6669
   Farrugia Claude A., 1998, Pharmacy and Pharmacology Communications, V4, P559
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   Friess W., 1998, EUR J PHARMACOL, V54, P54113
   Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547
   Garrone R., 1978, PHYLOGENESIS CONNECT
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   GELMAN RA, 1979, J BIOL CHEM, V254, P1741
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   HEIN MB, 1991, BIOTECHNOL PROGR, V7, P455, DOI 10.1021/bp00011a011
   Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200
   Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598
   Hori H, 2002, J ALLERGY CLIN IMMUN, V110, P652, DOI 10.1067/mai.2002.127862
   Houdebine LM, 2000, TRANSGENIC RES, V9, P305, DOI 10.1023/A:1008934912555
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   JUNQUA S, 1974, CONNECT TISSUE RES, V2, P193, DOI 10.3109/03008207409152244
   Keizer-Gunnink I, 2000, MATRIX BIOL, V19, P29, DOI 10.1016/S0945-053X(99)00059-1
   Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7
   Lachman L, 1986, THEORY PRACTICE IND
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   LAMPORT DTA, 1969, BIOCHEMISTRY-US, V8, P1155, DOI 10.1021/bi00831a049
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LINDSLEY H, 1971, J EXP MED, V133, P1309, DOI 10.1084/jem.133.6.1309
   MA JKC, 1995, SCIENCE, V268, P716, DOI 10.1126/science.7732380
   Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0
   MAILLARD L, 1999, J AM COLL CARDIOL, V34, P1498
   Mason HS, 2002, TRENDS MOL MED, V8, P324, DOI 10.1016/S1471-4914(02)02360-2
   Merle C, 2002, FEBS LETT, V515, P114, DOI 10.1016/S0014-5793(02)02452-3
   Miele L, 1997, TRENDS BIOTECHNOL, V15, P45, DOI 10.1016/S0167-7799(97)84202-3
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P3
   Mison D, 2000, BIOPHARM-APPL T BIO, V13, P48
   Montagnon B, 1983, Dev Biol Stand, V55, P37
   Moskowitz RW, 2000, SEMIN ARTHRITIS RHEU, V30, P87, DOI 10.1053/sarh.2000.9622
   Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   NAKAGAWA S, 1989, EXP CELL RES, V182, P572, DOI 10.1016/0014-4827(89)90260-7
   Nakayama Y, 2001, J BIOMED MATER RES, V57, P559, DOI 10.1002/1097-4636(20011215)57:4<559::AID-JBM1202>3.0.CO;2-H
   Naughton GK, 2002, ANN NY ACAD SCI, V961, P372, DOI 10.1111/j.1749-6632.2002.tb03127.x
   Nimmi M.E., 1987, J BIOMED MATER RES, V21, P741
   Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200
   Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200
   Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200
   PIEZ KA, 1960, J BIOL CHEM, V235, P995
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0
   PROCKOP DJ, 1997, Patent No. 5593859
   Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   SADDLER JM, 1987, ANAESTHESIA, V42, P998, DOI 10.1111/j.1365-2044.1987.tb05376.x
   Sakaguchi M, 1999, J ALLERGY CLIN IMMUN, V104, P695, DOI 10.1016/S0091-6749(99)70344-1
   Sakaguchi M, 2000, J ALLERGY CLIN IMMUN, V106, P579, DOI 10.1067/mai.2000.108499
   Sakaguchi M, 2000, JPN J INFECT DIS, V53, P189
   Sakai Y, 1998, BIOL PHARM BULL, V21, P330
   SCHOR SL, 1980, J CELL SCI, V41, P159
   Sclafani AP, 2002, ANN PLAS SURG, V49, P181, DOI 10.1097/00000637-200208000-00011
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Shirai T, 1998, MATRIX BIOL, V17, P85, DOI 10.1016/S0945-053X(98)90076-2
   SOPER J C, 1997, US Patent, Patent No. [5603952, 5.603.952]
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   TANAKA M, 1981, J BIOL CHEM, V256, P1397
   TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Tomita M, 1995, BIOCHEM J, V312, P847, DOI 10.1042/bj3120847
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Tomita M, 1997, J BIOCHEM-TOKYO, V121, P1061
   Vaughan PR, 1998, DNA CELL BIOL, V17, P511, DOI 10.1089/dna.1998.17.511
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   Wegner G H, 1990, FEMS Microbiol Rev, V7, P279
   Werten MWT, 1999, YEAST, V15, P1087, DOI 10.1002/(SICI)1097-0061(199908)15:11<1087::AID-YEA436>3.0.CO;2-F
   Werten MWT, 2001, PROTEIN ENG, V14, P447, DOI 10.1093/protein/14.6.447
   WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Yamamoto YT, 2001, IN VITRO CELL DEV-PL, V37, P349
   YANG C, 1999, AAPS ANN M
   YOUNG M, 1998, BIOPHARM, V10, P34
   Yuan JQ, 2001, CHINESE MED J-PEKING, V114, P1043
NR 105
TC 265
Z9 298
U1 8
U2 124
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD NOV 28
PY 2003
VL 55
IS 12
BP 1547
EP 1567
DI 10.1016/j.addr.2003.08.008
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 747PN
UT WOS:000186813500003
PM 14623401
DA 2018-10-19
ER

PT J
AU Ruszczak, Z
   Friess, W
AF Ruszczak, Z
   Friess, W
TI Collagen as a carrier for on-site delivery of antibacterial drugs
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE collagen; collagen sponge; antibiotic; gentamicin; wound healing;
   ophthalmology; periodontology; collagen membrane; collagen/PLGA
   composite
ID ACRYLIC BONE-CEMENT; IN-VITRO RELEASE; LOCAL ANTIBIOTIC DELIVERY;
   SOFT-TISSUE INFECTIONS; EXPERIMENTAL OSTEOMYELITIS; IMMOBILIZED
   TETRACYCLINE; WOUND-INFECTION; PMMA BEADS; GENTAMICIN; SYSTEM
AB Due to its biocompatibility and well-established safety profile, collagen represents a favourable matrix for on-site drug delivery. In this review, we summarize some of the recent developments and applications of collagen as a biomaterial in drug delivery systems for antibiotics, especially gentamicin. The main clinical and experimental applications covered include: treatment and prophylaxis of bone and soft tissue infections, wound healing, as well as ophthalmic and periodontal treatment. Advantages of local drug application and the rationale of use local drug delivery systems for adjuvant (ancillary) therapy are discussed. Recent efforts in the use of collagen and collagen-synthetic polymer composites for controlled drug delivery as well as collagen-based diffusion membranes for prolonged drug release have also been included in this review. (C) 2003 Elsevier B.V. All rights reserved.
C1 Innocoll Inc, Innocoll GmbH, European Res & Dev Ctr, D-93342 Saal Donau, Germany.
   Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA.
   Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, D-80539 Munich, Germany.
RP Ruszczak, Z (reprint author), Innocoll Inc, Innocoll GmbH, European Res & Dev Ctr, Donaustr 24, D-93342 Saal Donau, Germany.
CR ADAM D, 1987, PHARM TOXIKOLOGIE, P580
   ANGELE J, 2003, UNPUB BIOMATERIALS
   Antiszko M, 1996, Polim Med, V26, P21
   AQUAVELLA JV, 1987, OPHTHALMIC SURG LAS, V18, P570
   AQUAVELLA JV, 1988, J CATARACT REFR SURG, V14, P492, DOI 10.1016/S0886-3350(88)80004-X
   Aran JM, 1999, ANN NY ACAD SCI, V884, P60, DOI 10.1111/j.1749-6632.1999.tb08636.x
   Attmanspacher W, 2000, UNFALLCHIRURG, V103, P1048, DOI 10.1007/s001130050668
   Baar S, 2001, INFECTION, V29, P27, DOI 10.1007/s15010-001-0073-6
   Bailey I S, 1987, Eur J Vasc Surg, V1, P143, DOI 10.1016/S0950-821X(87)80013-0
   BAZIUK N, 1992, INT OPHTHALMOL, V16, P101, DOI 10.1007/BF00918940
   BECKER PL, 1994, J ORTHOPAED RES, V12, P737, DOI 10.1002/jor.1100120517
   Bittner B, 1999, J CONTROL RELEASE, V59, P23, DOI 10.1016/S0168-3659(98)00170-9
   BROWM JC, 1995, INT ARCH ALLERGY IMM, V107, P484, DOI 10.1159/000237090
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   BUNETEL L, 1989, CLIN PHARMACOKINET, V17, P291, DOI 10.2165/00003088-198917040-00006
   BUNETEL L, 1994, EUR J DRUG METAB PH, V19, P99, DOI 10.1007/BF03188830
   Chvapil M., 1979, FIBROUS PROTEINS SCI, V1, P247
   Della Valle AG, 2001, ACTA ORTHOP SCAND, V72, P237
   Diez-Pena E, 2002, CHEM PHARM BULL, V50, P1201, DOI 10.1248/cpb.50.1201
   *DIN NORM, 1989, 58940 DIN NORM
   ELSAMALIGY MS, 1983, J PHARM PHARMACOL, V35, P537, DOI 10.1111/j.2042-7158.1983.tb04831.x
   Exposito JY, 2002, ANAT REC, V268, P302, DOI 10.1002/ar.10162
   Fleckenstein P.D.C.D., 1986, DE Patent, Patent No. [3429038 A1, 3429038]
   Friess W, 2002, PHARM DEV TECHNOL, V7, P235, DOI 10.1081/PDT-120003491
   Friess W., 2000, DRUG DELIVERY SYSTEM
   FRIESS W, 2001, Patent No. 19934894
   Friess WF, 2002, J PHARM SCI, V91, P845, DOI 10.1002/jps.10012
   FUJIOKA K, 1995, J CONTROL RELEASE, V33, P307, DOI 10.1016/0168-3659(94)00107-6
   Galandiuk S, 1997, AM SURGEON, V63, P831
   Geiger M, 2002, PHARM TECHNOL EUR, V14, P48
   GERICKE R, 1990, Patent No. 4938257
   GRIMM H, 1989, KOLLAGEN WIRKSTOFFTR, P33
   Gruessner U, 2001, AM J SURG, V182, P502, DOI 10.1016/S0002-9610(01)00762-0
   GUNYA NY, 2003, ELECT ORTHOPEDIC TXB
   HEDSTROM SA, 1980, ACTA ORTHOP SCAND, V51, P863, DOI 10.3109/17453678008990886
   Hendricks KJ, 2001, CLIN ORTHOP RELAT R, P418
   HITZIG C, 1994, J CLIN PERIODONTOL, V21, P146, DOI 10.1111/j.1600-051X.1994.tb00293.x
   HUMPHREY SJ, 1998, CLIN ORTHOP RELAT R, V349, P218
   Iannuccelli V, 1996, INT J PHARM, V143, P187, DOI 10.1016/S0378-5173(96)04711-4
   IPSEN T, 1991, ACTA ORTHOP SCAND, V62, P592, DOI 10.3109/17453679108994503
   Jeffcoat MK, 1998, J PERIODONTOL, V69, P989, DOI 10.1902/jop.1998.69.9.989
   Jorgensen L G, 1991, Eur J Vasc Surg, V5, P87, DOI 10.1016/S0950-821X(05)80933-8
   KATZUNG BG, 2000, BASIC CLIN PHARM, P784
   KAUFMAN H E, 1971, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V75, P361
   Klemm K., 1976, ACCID SURG, V4, P1
   KRAUSE W, 1989, J BIOACTIVE COMPAT P, V4, P345
   Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5
   LEE JE, 2002, YONSEI MED J, V42, P291
   Lesiak-Cyganowska E, 2001, ARCH IMMUNOL THER EX, V49, P247
   Levison M E, 1989, Infect Dis Clin North Am, V3, P415
   LI CL, 2002, ADV DRUG DELIV REV, V54, P963
   LINDSEY RW, 1993, CLIN ORTHOP RELAT R, P303
   LIU SH, 1995, CLIN ORTHOP RELAT R, P265
   Lorentzen H, 1996, ANTIMICROB AGENTS CH, V40, P1785, DOI 10.1128/AAC.40.8.1785
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   Marone P, 1999, OPHTHALMOLOGICA, V213, P12, DOI 10.1159/000027386
   MATOBA AY, 1985, OPHTHALMOLOGY, V92, P97
   Mehta S, 1996, J ORTHOPAED RES, V14, P749, DOI 10.1002/jor.1100140511
   MILANI JK, 1993, AM J OPHTHALMOL, V116, P622, DOI 10.1016/S0002-9394(14)73206-4
   MINABE M, 1989, J PERIODONTOL, V60, P113, DOI 10.1902/jop.1989.60.2.113
   MINABE M, 1989, J CLIN PERIODONTOL, V16, P291, DOI 10.1111/j.1600-051X.1989.tb01657.x
   Nelson CL, 2002, J ORTHOPAED RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4
   NELSON RC, 1978, J BIOMED MATER RES, V12, P473, DOI 10.1002/jbm.820120403
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
   OKACHI R, 1984, BIOTECHNOLOGY IND AN, P329
   PERRY CR, 1991, CLIN ORTHOP RELAT R, P215
   PHIENNEY RB, 1988, ARCH OPHTHALMOL-CHIC, V106, P1599
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Prior S, 2000, INT J PHARM, V196, P115, DOI 10.1016/S0378-5173(99)00448-2
   Ramshaw JAM, 1995, BIOTECHNOL REV, V13, P336
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   RENARD G, 1933, J CATARACT REFR SURG, V19, P48
   ROSENKRANTZ BE, 1980, ANAL PROFILES DRUG S, V9, P295
   Rushton N, 1997, EUR J SURG, V163, P27
   Ruszczak Z, 2000, Patent No. [W0-01/66159, 0166159]
   RUSZCZAK Z, 2000, Patent No. 0166162
   Rutten HJT, 1997, EUR J SURG, V163, P31
   Sandberg Soerensen T, 1990, ACTA ORTHOP SCAND, V61, P353
   SANDE M A, 1990, P1098
   SCHLAPP M, IN PRESS J PHARM SCI
   SCHLAPP M, 2001, THESIS ERLANGEN
   SCHMIDT C, 1995, J CONTROL RELEASE, V37, P83, DOI 10.1016/0168-3659(95)00067-I
   Sendil D, 1999, J CONTROL RELEASE, V59, P207, DOI 10.1016/S0168-3659(98)00195-3
   SILBIGER J, 1992, OPHTHALMOLOGY, V99, P889
   SINGH MP, 1995, PHARMACEUT RES, V12, P1205, DOI 10.1023/A:1016272212833
   SINGH MP, 1996, SURG ADHESIVES SEALA, P121
   Soskolne WA, 1997, J PERIODONTOL, V68, P32, DOI 10.1902/jop.1997.68.1.32
   Stemberger A, 1997, EUR J SURG, V163, P17
   Stemberger A., 1990, COSMETIC PHARM APPL, P263
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
   Taylor EW, 1997, EUR J SURG, V163, P5
   TODHUNTER RJ, 1994, AM J VET RES, V55, P425
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   UNTERMAN SR, 1988, J CATARACT REFR SURG, V14, P500, DOI 10.1016/S0886-3350(88)80006-3
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   WAHLIG H, 1982, J ANTIMICROB CHEMOTH, V10, P463, DOI 10.1093/jac/10.5.463
   Walenkamp GHIM, 1983, THESIS U NIJMEGEN NE
   WHEERLESS CE, 2001, TXB ORTHOPEDICS
   Winkler H, 2000, J ANTIMICROB CHEMOTH, V46, P423, DOI 10.1093/jac/46.3.423
   Woolverton CJ, 1999, INFECTION, V27, P28, DOI 10.1007/BF02565167
   Woolverton CJ, 2001, J ANTIMICROB CHEMOTH, V48, P861, DOI 10.1093/jac/48.6.861
   Yagmurlu MF, 1999, J BIOMED MATER RES, V46, P494
   Yang XF, 2003, ACTA PHARMACOL SIN, V24, P306
   Yenice I, 2002, INT J PHARM, V242, P271, DOI 10.1016/S0378-5173(02)00186-2
NR 107
TC 208
Z9 214
U1 4
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD NOV 28
PY 2003
VL 55
IS 12
BP 1679
EP 1698
DI 10.1016/j.addr.2003.08.007
PG 20
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 747PN
UT WOS:000186813500009
PM 14623407
DA 2018-10-19
ER

PT J
AU Rossetti, FF
   Reviakine, I
   Textor, M
AF Rossetti, FF
   Reviakine, I
   Textor, M
TI Characterization of titanium oxide films prepared by the
   template-stripping method
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY; SURFACES;
   ADSORPTION; ESCA; ACID
AB Titanium is a widely used biomaterial, and there is, therefore, considerable interest in studying the processes occurring at its surface. A suitable in situ investigation technique is atomic force microscopy (AFM), which, however, requires very flat substrates. In the case of gold, the so-called "template-stripping method" has allowed the successful preparation of surfaces that are atomically flat over large areas. The method is based on the evaporation of gold onto atomically flat surfaces of freshly cleaved mica, which is subsequently stripped off. Cacciafesta et al. (Langmuir 2000, 16, 8167-8175) have applied this method for preparing model titanium (oxide) surfaces for AFM investigation. The focus of the present study was the characterization of the chemical and topographical characteristics of the resulting surface. In particular, it was found that mica could not be completely removed from the titanium during the stripping step unless a thin layer of carbon was present between the titanium and the mica. In this study, a layer of amorphous carbon was artificially introduced between the two materials, but it is possible that the carbon naturally present in the micas can play a similar role. Detailed investigation by spectroscopic (angle-resolved X-ray photoelectron spectroscopy, depth profiling, X-ray photoelectron diffraction) and imaging methods (AFM) lead to the conclusion that-on samples without a carbon interface-the mica layer is at most a few unit cells thick and is nearly confluent.
C1 Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Mat, Surface Sci & Technol Lab, CH-8952 Schlieren, Switzerland.
RP Textor, M (reprint author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Mat, Surface Sci & Technol Lab, Wagistr 2, CH-8952 Schlieren, Switzerland.
RI Textor, Marcus/A-6200-2012; Reviakine, Ilya/B-2631-2013
OI Textor, Marcus/0000-0002-0178-1801; Reviakine, Ilya/0000-0002-3448-5072
CR BAILEY SW, 1984, REV MINERAL, V13, P1
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Boyer R., 1994, MAT PROPERTIES HDB
   BROWN GM, 1992, J VAC SCI TECHNOL A, V10, P3001, DOI 10.1116/1.577856
   Burkett SL, 2001, LANGMUIR, V17, P5059, DOI 10.1021/la010156s
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   CACCIAFESTA P, COMMUNICATION
   Carpick RW, 1996, J VAC SCI TECHNOL B, V14, P1289, DOI 10.1116/1.589083
   GRONING P, COMMUNICATION
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   IHARA H, 1973, JPN J APPL PHYS, V12, P1462, DOI 10.1143/JJAP.12.1462
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kim DT, 2002, LANGMUIR, V18, P5841, DOI 10.1021/la0256331
   Kuwahara Y, 1999, PHYS CHEM MINER, V26, P198, DOI 10.1007/s002690050177
   Lausmaa J., 2001, TITANIUM MED, P231
   LIDE D, 1994, CRC HDB CHEM PHYS
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   O'Donoghue M., 1990, AM NATURE GUIDES ROC
   Omori S, 1998, J ELECTRON SPECTROSC, V88, P517, DOI 10.1016/S0368-2048(97)00176-X
   OSTERWALDER J, 1990, ARAB J SCI ENG, V15, P274
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   RAMQVIST L, 1969, J PHYS CHEM SOLIDS, V30, P1835, DOI 10.1016/0022-3697(69)90252-2
   SCHWALLER P, COMMUNICATION
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   SITTIG CE, 1998, THESIS ETH ZURICH
   TENGVALL DM, 2001, TITANIUM MED MAT SCI
   Textor M, 2000, LANGMUIR, V16, P3257, DOI 10.1021/la990941t
   Textor M., 2001, TITANIUM MED, P171
   Textor M., 2001, ENCY MAT SCI TECHNOL, V10, P9374
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   WERFEL F, 1983, PHYS SCRIPTA, V28, P92, DOI 10.1088/0031-8949/28/1/013
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
NR 35
TC 20
Z9 20
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 25
PY 2003
VL 19
IS 24
BP 10116
EP 10123
DI 10.1021/la034280i
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 745NJ
UT WOS:000186694500021
DA 2018-10-19
ER

PT J
AU Koh, WG
   Pishko, M
AF Koh, WG
   Pishko, M
TI Photoreaction injection molding of biomaterial microstructures
SO LANGMUIR
LA English
DT Article
ID MICROFLUIDIC NETWORKS; PATTERNING PROTEINS; SYSTEMS; FABRICATION;
   HYDROGELS; DNA; POLY(DIMETHYLSILOXANE); CHANNELS; DESIGN; CELLS
AB Reaction injection molding using in situ photoinduced polymer macromer gelation in microfluidic channels was applied to the fabrication of poly(ethylene glycol) (PEG) hydrogel microstructures. These hydrogel microstructures were fabricated using poly(dimethylsiloxane) (PDMS) microchannels as mold inserts alone or in combination with photolithography. These microstructures were formed by flowing a gel precursor solution through the microfluidic network, exposing to light, and finally removing the PDMS mold. Microchannels as narrow as 10 mum wide could be used for molding PEG hydrogels, and the resulting three-dimensional hydrogel microstructures did not delaminate from substrates treated with 3-(trichlorosilyl)propyl methacrylate, a gel adhesion promoter. By exploitation of the laminar flow and poor mixing conditions in a microfluidic channel, single microstructures with heterogeneous chemistries were also created, using peptide-modified structures to promote cell adhesion as a model.
C1 Penn State Univ, Dept Chem Engn, Fenske Lab 104, University Pk, PA 16802 USA.
   Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA.
RP Pishko, M (reprint author), Penn State Univ, Dept Chem Engn, Fenske Lab 104, University Pk, PA 16802 USA.
RI KOH, WONGUN/G-8204-2012; KOH, WON GUN/G-8557-2012
CR Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Folch A, 1999, J BIOMECH ENG-T ASME, V121, P28, DOI 10.1115/1.2798038
   Hanemann T, 1997, ADV MATER, V9, P927, DOI 10.1002/adma.19970091117
   Hanemann T, 2002, MICROSYST TECHNOL, V7, P209, DOI 10.1007/s005420100116
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Ismagilov RF, 2001, ANAL CHEM, V73, P5207, DOI 10.1021/ac010502a
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Khandurina J, 2002, CURR OPIN CHEM BIOL, V6, P359, DOI 10.1016/S1367-5931(02)00323-X
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   Kim YD, 2001, BIOTECHNOL BIOENG, V73, P331, DOI 10.1002/bit.1066
   Koh WG, 2002, LANGMUIR, V18, P2459, DOI 10.1021/la0115740
   Krishnan M, 2001, CURR OPIN BIOTECH, V12, P92, DOI 10.1016/S0958-1669(00)00166-X
   Mao HB, 2002, ANAL CHEM, V74, P379, DOI 10.1021/ac010822u
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   McCreedy T, 2000, TRAC-TREND ANAL CHEM, V19, P396, DOI 10.1016/S0165-9936(99)00176-4
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Olsen KG, 2002, ANAL CHEM, V74, P1436, DOI 10.1021/ac0156969
   Papra A, 2001, LANGMUIR, V17, P4090, DOI 10.1021/la0016930
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Sanders GHW, 2000, TRAC-TREND ANAL CHEM, V19, P364, DOI 10.1016/S0165-9936(00)00011-X
   Seong GH, 2002, ANAL CHEM, V74, P3372, DOI 10.1021/ac020069k
   Sirkar K, 1998, ANAL CHEM, V70, P2888, DOI 10.1021/ac971236x
NR 25
TC 25
Z9 25
U1 3
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 25
PY 2003
VL 19
IS 24
BP 10310
EP 10316
DI 10.1021/la034257x
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 745NJ
UT WOS:000186694500049
DA 2018-10-19
ER

PT J
AU Fellows, RJ
   Wang, ZM
   Ainsworth, CC
AF Fellows, RJ
   Wang, ZM
   Ainsworth, CC
TI Europium uptake and partitioning in oat (Avena sativa) roots as studied
   by laser-induced fluorescence spectroscopy and confocal microscopy
   profiling technique
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID DATURA-INNOXIA BIOMATERIAL; METAL-ION-BINDING; WATER HYACINTH;
   LUMINESCENCE; PLANTS; TRANSPORT; PLAQUE; ACIDS; ACCUMULATION; EU(III)
AB The uptake of Eu3+ by elongating oat roots was studied by fluorescence spectroscopy, fluorescence lifetime measurement, and a laser excitation time-resolved confocal fluorescence profiling technique. The results of this work indicated that initial uptake of Eu3+ was highest within the undifferentiated cells of the root tip just behind the root cap, a region of maximal cell growth and differentiation and with incomplete formation of the Casparian strip around the central vascular cylinder. Distribution of assimilated Eu3+ within the root's differentiation and elongation zone was nonuniform. Higher concentrations of Eu3+ were observed within the vascular cylinder, specifically in the phloem and developing xylem parenchyma. Elevated levels of the metal were also observed in the root hairs of the mature root zone. Fluorescence spectroscopic characteristics of the assimilated Eu3+ suggested that the Eu3+ exists as inner-sphere mononuclear complexes inside the root. This work also demonstrated the effectiveness of a time-resolved Eu3+ fluorescence spectroscopy and confocal fluorescence profiling techniques for the in vivo, real-time study of metal [Eu3+] accumulation by a functioning intact plant root. This approach can prove valuable for basic and applied studies in plant nutrition and environmental uptake of actinide radionuclides.
C1 Pacific NW Natl Lab, Richland, WA 99352 USA.
RP Wang, ZM (reprint author), Pacific NW Natl Lab, POB 999,MS K8-96, Richland, WA 99352 USA.
RI Wang, Zheming/E-8244-2010
OI Wang, Zheming/0000-0002-1986-4357
CR Aruguete DM, 1998, SCI TOTAL ENVIRON, V224, P43, DOI 10.1016/S0048-9697(98)00319-2
   BARTHELEMY PP, 1989, INORG CHEM, V28, P3354, DOI 10.1021/ic00316a023
   Batty LC, 2000, ANN BOT-LONDON, V86, P647, DOI 10.1006/anbo.2000.1191
   BLASSE G, 1988, PROG SOLID STATE CH, V18, P79, DOI 10.1016/0079-6786(88)90004-0
   BLASSE G, 1989, EUR J SOL STATE INOR, V26, P367
   BOER AD, 1997, J EXP BIOL, V48, P441
   CARNALL WT, 1968, J CHEM PHYS, V49, P4450, DOI 10.1063/1.1669896
   Cavallini A, 1999, SCI TOTAL ENVIRON, V243, P119, DOI 10.1016/S0048-9697(99)00367-8
   Chen H, 2001, CHEMOSPHERE, V45, P21, DOI 10.1016/S0045-6535(01)00031-5
   CHOPPIN GR, 1989, LANTHANIDE PROBES LI
   Christensen KK, 1998, CAN J BOT, V76, P2158, DOI 10.1139/b98-181
   CROWDER AA, 1993, J PLANT NUTR, V16, P589, DOI 10.1080/01904169309364559
   CROWLEY DE, 1999, FOOD PROD PRESS, P1
   DREW MC, 1990, J EXP BOT, V41, P815, DOI 10.1093/jxb/41.7.815
   Emerson D, 1999, APPL ENVIRON MICROB, V65, P2758
   FORD CW, 1989, J SCI FOOD AGR, V46, P301, DOI 10.1002/jsfa.2740460307
   FOSTER RC, 1983, ULTRASTRUCTURE ROOT
   Fricker MD, 1999, J EXP BOT, V50, P1089, DOI 10.1093/jexbot/50.suppl_1.1089
   Garbisu C, 2001, BIORESOURCE TECHNOL, V77, P229, DOI 10.1016/S0960-8524(00)00108-5
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   Gilroy S, 1997, ANNU REV PLANT PHYS, V48, P165, DOI 10.1146/annurev.arplant.48.1.165
   GREIPSSON S, 1995, J PLANT NUTR, V18, P1659, DOI 10.1080/01904169509365011
   HOLTOM GR, 1990, SPIE, P2
   HORROCKS WD, 1979, J AM CHEM SOC, V101, P334, DOI 10.1021/ja00496a010
   HORROCKS WD, 1984, PROGR INORGANIC CHEM, V31
   JACKSON LJ, 1994, CAN J FISH AQUAT SCI, V51, P1769, DOI 10.1139/f94-178
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1993, ENVIRON SCI TECHNOL, V27, P2466, DOI 10.1021/es00048a024
   KE HYD, 1994, ENVIRON SCI TECHNOL, V28, P586, DOI 10.1021/es00053a009
   Kelley C, 1999, ENVIRON SCI TECHNOL, V33, P1439, DOI 10.1021/es9807789
   Knoblauch M, 1998, PLANT CELL, V10, P35
   LACKOWICZ JR, 1991, TOPICS FLUORESCENCE
   LIU Z, 1988, P INT S NEW RES RES
   Marschner H., 1995, MINERAL NUTR HIGHER
   Moulin C, 1997, J RADIOANAL NUCL CH, V226, P135, DOI 10.1007/BF02063637
   OPARKA KJ, 1994, PLANT J, V6, P759, DOI 10.1046/j.1365-313X.1994.6050759.x
   Oparka KJ, 2000, ANNU REV PLANT PHYS, V51, P323, DOI 10.1146/annurev.arplant.51.1.323
   PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001
   Raskin I, 1997, CURR OPIN BIOTECH, V8, P221, DOI 10.1016/S0958-1669(97)80106-1
   RICHARDSON FS, 1982, CHEM REV, V82, P541, DOI 10.1021/cr00051a004
   Steudle E, 2000, J EXP BOT, V51, P1531, DOI 10.1093/jexbot/51.350.1531
   Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775
   Takahashi Y, 2002, GEOCHIM COSMOCHIM AC, V66, P1, DOI 10.1016/S0016-7037(01)00748-7
   Vesk PA, 1997, AQUAT BOT, V59, P33, DOI 10.1016/S0304-3770(97)00032-6
   VESK PA, 1999, PLANT CELL ENV, V22
   WANG, 2001, J PHYS CHEM A, P942
   Wang Z, 2003, RADIOCHIM ACTA, V91, P329, DOI 10.1524/ract.91.6.329.20028
   WANG Z, 2003, DIGEST SCI TECHNOLOG
   Wang ZM, 1999, INORG CHIM ACTA, V293, P167, DOI 10.1016/S0020-1693(99)00234-0
   WANG ZM, 1993, J CHEM SOC DALTON, P2791, DOI 10.1039/dt9930002791
   WATKINS JW, 1987, INORG CHEM, V26, P1147, DOI 10.1021/ic00254a033
   WOOD RM, 1994, ANN BOT-LONDON, V73, P151, DOI 10.1006/anbo.1994.1018
   Wyttenbach A., 1997, P 4 INT C BIOG TRAC, P299
   Ye ZH, 1997, NEW PHYTOL, V136, P469, DOI 10.1046/j.1469-8137.1997.00759.x
   Zararsiz A, 1997, J RADIOANAL NUCL CH, V222, P257, DOI 10.1007/BF02034282
NR 55
TC 11
Z9 11
U1 2
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD NOV 15
PY 2003
VL 37
IS 22
BP 5247
EP 5253
DI 10.1021/es0343609
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 743YN
UT WOS:000186601300023
PM 14655714
DA 2018-10-19
ER

PT J
AU Rickert, D
   Lendlein, A
   Schmidt, AM
   Kelch, S
   Roehlke, W
   Fuhrmann, R
   Franke, RP
AF Rickert, D
   Lendlein, A
   Schmidt, AM
   Kelch, S
   Roehlke, W
   Fuhrmann, R
   Franke, RP
TI In vitro cytotoxicity testing of AB-polymer networks based on
   oligo(epsilon-caprolactone) segments after different sterilization
   techniques
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biocompatibility; poly-epsilon-caprolactone networks; agarose diffusion
   test; image-analysis system; sterilization techniques
ID ELECTROPHYSIOLOGY CATHETERS; PLASMA STERILIZATION;
   POLY(EPSILON-CAPROLACTONE); SAFETY
AB Recently developed versatile biodegradable polymeric biomaterial offer new therapeutic options in numerous medical fields. Biocompatibility is a crucial requirement for the biomedical application of biomaterials, including the sterilization of these materials with the use of accepted protocols. Ethylene-oxide (EO) and low-temperature plasma (LTP) sterilization are frequently used low-temperature sterilization technologies for heat-sensitive materials. The agarose diffusion assay is a recommended cell-screening test to assess the cytotoxicity of biomaterials in vitro. The sensitivity of the agarose assay can be increased by using a modified computer-based image-analysis system. The influence of EO and LTP sterilization on the cytotoxicity of a versatile polymer system of shape-memory polymer networks based on oligo (c-caprolactone) dimethacrylate and n-butyl acrylate was investigated. Statistically significant differences in the rate of cell lysis after EO and LTP sterilization of the polymer samples were detected by using this modified quantification system. The influence of the different sterilization techniques on the cytotoxicity of the polymeric material, as well as the clinical relevance of the described differences, are discussed. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Ulm, Dept Otolaryngol Head & Neck Surg, D-89075 Ulm, Germany.
   GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, D-14513 Teltow, Germany.
   Univ Dusseldorf, Inst Organ & Makromol Chem 1, D-40225 Dusseldorf, Germany.
   Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
RP Rickert, D (reprint author), Univ Ulm, Dept Otolaryngol Head & Neck Surg, Prittwitzstr 43, D-89075 Ulm, Germany.
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR [Anonymous], 1999, HLTH DEVICES, V28, P430
   *ASTM, 1992, F81383 ASTM, P239
   ATON EA, 1994, AM J CARDIOL, V74, P1173, DOI 10.1016/0002-9149(94)90476-6
   Bathina MN, 1998, J AM COLL CARDIOL, V32, P1384, DOI 10.1016/S0735-1097(98)00401-X
   Chau TT, 1996, BIOMATERIALS, V17, P1273, DOI 10.1016/S0142-9612(96)80003-2
   El Mansouri H, 1999, J APPL POLYM SCI, V71, P371, DOI 10.1002/(SICI)1097-4628(19990118)71:3<371::AID-APP2>3.3.CO;2-D
   FELDMAN LA, 1997, MED DEVICE DIAGN IND, P57
   Ferrell M, 1997, AM J CARDIOL, V80, P1558, DOI 10.1016/S0002-9149(97)00785-6
   Goldman M, 1998, J BIOMED MATER RES, V40, P378, DOI 10.1002/(SICI)1097-4636(19980605)40:3<378::AID-JBM6>3.0.CO;2-C
   GUESS WL, 1965, J PHARM SCI, V54, P1545, DOI 10.1002/jps.2600541036
   Hury S, 1998, LETT APPL MICROBIOL, V26, P417
   KHAMBATTA FB, 1976, J POLYM SCI POL PHYS, V14, P1391, DOI 10.1002/pol.1976.180140805
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lerouge S, 2000, J BIOMED MATER RES, V52, P774
   Malucelli G, 1996, POLYMER, V37, P2565, DOI 10.1016/0032-3861(96)85373-0
   Masson V, 1997, BIOMATERIALS, V18, P327, DOI 10.1016/S0142-9612(96)00144-5
   ROGERS SS, 1957, J PHYS CHEM-US, V61, P985, DOI 10.1021/j150553a033
   SCHMALZ G, 1994, DENT MATER, V10, P304, DOI 10.1016/0109-5641(94)90038-8
   TABRIZIAN M, 1997, P 1 INT S ADV BIOM M
   WALLHAUSER KH, 1995, PRAXIS STERILISATION
   Zange R, 1998, J CONTROL RELEASE, V56, P249, DOI 10.1016/S0168-3659(98)00093-5
   Zhang YZ, 1996, BIOMATERIALS, V17, P2265, DOI 10.1016/0142-9612(96)00055-5
NR 24
TC 51
Z9 52
U1 3
U2 26
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV 15
PY 2003
VL 67B
IS 2
BP 722
EP 731
DI 10.1002/jbm.b.10069
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 739LG
UT WOS:000186347100007
PM 14598399
DA 2018-10-19
ER

PT J
AU Chen, HJH
   Chen, TF
   Huang, SRS
   Gong, J
   Li, JC
   Chen, WC
   Hseu, TH
   Hsu, IC
AF Chen, HJH
   Chen, TF
   Huang, SRS
   Gong, J
   Li, JC
   Chen, WC
   Hseu, TH
   Hsu, IC
TI A novel micro-well array chip for liquid phase biomaterial processing
   and detection
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT Workshop on Transducers and Micro/Nano Technologies
CY JUL 22-24, 2002
CL XIAMEN, PEOPLES R CHINA
DE micro-well array; MEMS; biochips; liquid phase
ID MICROSTRUCTURES; 21ST-CENTURY; MICROARRAYS; SEPARATION
AB This paper presents a novel micro-well array chip fabricated by micromachining and CMOS technology for biomedical application. The chip is designed to provide multi-function for liquid phase DNA or protein sample processing and detection, its function and structure includes heating, cooling, temperature sensing, vibration agitation, control circuits, array of micro-wells, and a transparent cover with liquid seal at each well. The embedded heater shows good linearity and, can heat up to 101 degreesC with similar to20 mA current supply, liquid phase biomaterials such as probes and samples can be processed (hybridization, mixing, separation, washing, and detection) on the chip. (C) 2003 Elsevier B.V. All rights reserved.
C1 Natl Tsing Hua Univ, Inst Elect Engn, CMEMS, Hsinchu, Taiwan.
   Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan.
   Natl Tsing Hua Univ, Dept Atom Sci, Hsinchu, Taiwan.
RP Chen, HJH (reprint author), Natl Tsing Hua Univ, Inst Elect Engn, CMEMS, Hsinchu, Taiwan.
CR Dhiman N, 2001, VACCINE, V20, P22, DOI 10.1016/S0264-410X(01)00319-X
   Eteshola E, 2001, SENSOR ACTUAT B-CHEM, V72, P129, DOI 10.1016/S0925-4005(00)00640-7
   Gottschlich N, 2000, J CHROMATOGR B, V745, P243, DOI 10.1016/S0378-4347(00)00287-5
   HOSOKAWA K, 1997, P INT S MICR HUM SCI, P91
   Kricka LJ, 2001, CLIN CHIM ACTA, V307, P219, DOI 10.1016/S0009-8981(01)00451-X
   Laurell T, 2001, J CHROMATOGR B, V752, P217, DOI 10.1016/S0378-4347(00)00358-3
   Laurell T, 2001, TRAC-TREND ANAL CHEM, V20, P225, DOI 10.1016/S0165-9936(01)00061-9
   LAURELL T, 2001, REV MOL BIOTECHNOL, V82, P161
   Lee GB, 2001, SENSOR ACTUAT B-CHEM, V75, P142, DOI 10.1016/S0925-4005(00)00745-0
   Luginbuhl P, 2000, SENSOR ACTUAT B-CHEM, V63, P167, DOI 10.1016/S0925-4005(00)00354-3
   McCreedy T, 2001, ANAL CHIM ACTA, V427, P39, DOI 10.1016/S0003-2670(00)01174-0
   Nagai H, 2001, BIOSENS BIOELECTRON, V16, P1015, DOI 10.1016/S0956-5663(01)00248-2
   Percin G, 1997, REV SCI INSTRUM, V68, P4561, DOI 10.1063/1.1148431
   PERCIN G, 2001, P IEEE INT ULTR S 7
   Son M, 1996, SENSOR ACTUAT B-CHEM, V34, P422, DOI 10.1016/S0925-4005(97)80015-9
   Zou QB, 2002, SENSOR ACTUAT A-PHYS, V102, P114, DOI 10.1016/S0924-4247(02)00384-9
NR 16
TC 5
Z9 6
U1 0
U2 3
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD NOV 15
PY 2003
VL 108
IS 1-3
BP 193
EP 200
DI 10.1016/S0924-4247(03)00365-0
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 749XP
UT WOS:000186955600034
DA 2018-10-19
ER

PT J
AU Moberg, L
   Olsson, A
   Berne, C
   Felldin, M
   Foss, A
   Kallen, R
   Salmela, K
   Tibell, A
   Tufveson, G
   Nilsson, B
   Korsgren, O
AF Moberg, L
   Olsson, A
   Berne, C
   Felldin, M
   Foss, A
   Kallen, R
   Salmela, K
   Tibell, A
   Tufveson, G
   Nilsson, B
   Korsgren, O
TI Nicotinamide inhibits tissue factor expression in isolated human
   pancreatic islets: Implications for clinical islet transplantation
SO TRANSPLANTATION
LA English
DT Article
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; COMPLEMENT ACTIVATION; FACTOR GENE;
   KAPPA-B; CELLS; BLOOD; BIOMATERIAL; BINDING
AB Background. Islet-produced tissue factor (TF) triggers an adverse clotting reaction, the instant blood-mediated inflammatory reaction (IBMIR), providing a likely explanation for the need of tissue from multiple donors in clinical islet transplantation. In this study, the authors investigated whether compounds previously shown to affect TF and macrophage chemoattractant protein (MCP)-1 expression in monocytes and endothelial cells have the same effect in human islet cells.
   Methods. Islets were cultured in the presence of L-arginine, cyclosporine A, enalapril, or nicotinamide for 48 hr, after which the TF content and MCP-1 expression were assessed. The effect of nicotinamide on IBMIR was evaluated by exposing the treated islets to fresh human ABO-compatible blood in an in vitro loop model.
   Results. Nicotinamide was the only compound that significantly reduced both TF and MCP-1. This reduction was dose-dependent. The level of MCP-1 was strongly correlated with TF expression (r(2)=0.98). In addition, the level of TF was also correlated with the ability of the islets to initiate IBMIR (r(2)=0.94).
   Conclusions. TF and MCP-1 expression in human islets can be decreased by adding nicotinamide to the culture medium. These observations indicate that the adverse effects of IBMIR in clinical islet transplantation could be reduced without endangering the recipient using antithrombotic drugs.
C1 Univ Uppsala Hosp, Rudbeck Lab, Dept Radiol Oncol & Clin Immunol, Div Clin Immunol, S-75185 Uppsala, Sweden.
   Univ Uppsala Hosp, Dept Med Sci, Div Med, Uppsala, Sweden.
   Sahlgrens Univ Hosp, Dept Transplantat Surg, Gothenburg, Sweden.
   Rikshosp, Dept Transplantat Surg, Oslo, Norway.
   Malmo Univ Hosp, Dept Nephrol & Transplantat, Malmo, Sweden.
   Univ Helsinki, Surg Hosp, Div Transplantat, Helsinki, Finland.
   Karolinska Inst, Dept Transplantat Surg, Stockholm, Sweden.
   Univ Uppsala Hosp, Dept Surg Sci, Div Transplantat Surg, Uppsala, Sweden.
RP Moberg, L (reprint author), Univ Uppsala Hosp, Rudbeck Lab, Dept Radiol Oncol & Clin Immunol, Div Clin Immunol, S-75185 Uppsala, Sweden.
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1
   Bretzel RG, 2001, EXP CLIN ENDOCR DIAB, V109, pS384, DOI 10.1055/s-2001-18597
   Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Holschermann H, 1996, BLOOD, V88, P3837
   Lakey JRT, 1999, CELL TRANSPLANT, V8, P285, DOI 10.1177/096368979900800309
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   MACKEY ST, 1995, CHIROPR SPORT MED, V9, P10
   MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Napoleone E, 2000, CIRC RES, V86, P139, DOI 10.1161/01.RES.86.2.139
   Oeth P, 1997, ARTERIOSCL THROM VAS, V17, P365, DOI 10.1161/01.ATV.17.2.365
   Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779
   Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55
   RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413
   Rupprecht HD, 2000, KIDNEY INT, V57, P70, DOI 10.1046/j.1523-1755.2000.00828.x
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   UEDA A, 1994, J IMMUNOL, V153, P2052
   UNGERSTEDT J, IN PRESS J THROMB HA
   Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029
NR 22
TC 85
Z9 90
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD NOV 15
PY 2003
VL 76
IS 9
BP 1285
EP 1288
DI 10.1097/01.TP.0000098905.86445.0F
PG 4
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 744VG
UT WOS:000186653100003
PM 14627904
OA Bronze
DA 2018-10-19
ER

PT J
AU Marxer, SM
   Rothrock, AR
   Nablo, BJ
   Robbins, ME
   Schoenfisch, MH
AF Marxer, SM
   Rothrock, AR
   Nablo, BJ
   Robbins, ME
   Schoenfisch, MH
TI Preparation of nitric oxide (NO)-releasing sol-gels for biomaterial
   applications
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID IN-VIVO EVALUATION; PLATELET-ADHESION; BIOLOGICAL RESPONSES; BIOFILM
   FORMATION; CHEMICAL SENSORS; POLYMERIC FILMS; RELEASE; SURFACES; NO;
   THROMBORESISTANT
AB Nitric oxide (NO)-releasing sol-gel materials are synthesized by combining amine-functionalized alkoxysilanes (aminosilanes) with alkyltrimethoxysilanes (alkylsilanes). Upon hydrolysis and condensation, the amine-functionalized silanes are covalently bound to the alkyltrimethoxysilane backbone and easily converted to diazeniumdiolate NO donors via exposure to high pressures of NO. Immersion of the sol-gel into solution is not required to initiate NO release. The NO-release characteristics of the sol-gels are easily controlled by varying the type and amount of the aminosilane precursor in the sol. The sol-gel coatings release NO for up to 20 d with average fluxes between 8.0 x 10(-12) and 5.6 x 10(-11) mol(.)s(-1.)cm(-2) (coating thickness of 50 mum) over the first 10 h. These materials exhibit reduced platelet and bacterial adhesion. The results indicate that sol-gel chemistry may be an effective strategy for preparing coatings that release NO both controllably and locally for a range of applications including blood- and tissue-based devices.
C1 Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
RP Schoenfisch, MH (reprint author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8
   BRINKER CJ, 1989, SOL GEL SCI
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   CAO WQ, 1994, MATER RES SOC SYMP P, V346, P631
   CAZANAVE JP, 1986, BLOOD SURFACE INTERA, P89
   CAZENAVE J, 1993, ROLE PLATELETS BLOOD, P69
   CHARBOUILLOT Y, 1988, J NON-CRYST SOLIDS, V103, P325, DOI 10.1016/0022-3093(88)90212-8
   Collinson MM, 2002, TRAC-TREND ANAL CHEM, V21, P30
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DRAGO RS, 1961, J AM CHEM SOC, V83, P4337, DOI 10.1021/ja01482a008
   Elferink WJ, 1996, J COLLOID INTERF SCI, V180, P127, DOI 10.1006/jcis.1996.0282
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   Hanson S R, 1995, Adv Pharmacol, V34, P383
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   Keefer LK, 1996, METHOD ENZYMOL, V268, P281
   KELM M, 1996, METHODS NITRIC OXIDE
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   MARLETTA M A, 1990, Biofactors, V2, P219
   MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Nablo BJ, 2001, J AM CHEM SOC, V123, P9712, DOI 10.1021/ja0165077
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   RADOMSKI MW, 1992, J PHARM, V107, P754
   RAGSDALE RO, 1965, INORG CHEM, V4, P420, DOI 10.1021/ic50025a038
   Ramamurthi A, 1999, Biomed Sci Instrum, V35, P333
   Ramamurthi A, 2000, ANN BIOMED ENG, V28, P174, DOI 10.1114/1.242
   Ramamurthi A, 1998, ANN BIOMED ENG, V26, P1036, DOI 10.1114/1.34
   ROUSSEAU F, 1995, CHEM MATER, V7, P828, DOI 10.1021/cm00053a004
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   Shabani Mohammad, 1996, Wound Repair and Regeneration, V4, P353, DOI 10.1046/j.1524-475X.1996.40312.x
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   *US DEP HHS, 1985, 203208 HE US DEP HHS
   *US DEP HHS, 1985, 625985 B US DEP HHS
   Walpoth BH, 1998, CIRCULATION, V98, pII319
   Weerwind PW, 1998, INT J ARTIF ORGANS, V21, P291
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 43
TC 88
Z9 90
U1 1
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD NOV 4
PY 2003
VL 15
IS 22
BP 4193
EP 4199
DI 10.1021/cm034347n
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 738ZD
UT WOS:000186317000008
DA 2018-10-19
ER

PT J
AU Bellezza, F
   Cipiciani, A
   Costantino, U
AF Bellezza, F
   Cipiciani, A
   Costantino, U
TI Esterase activity of biocomposites constituted by lipases adsorbed on
   layered zirconium phosphate and phosphonates: selective adsorption of
   different enzyme isoforms
SO JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
LA English
DT Article
DE lipase; enzyme immobilization; zirconium phosphates; zirconium
   phosphonates; adsorption
ID CANDIDA-RUGOSA LIPASE; KINETIC RESOLUTION; ENANTIOSELECTIVITY;
   IMMOBILIZATION; SUPPORTS; HYDROLYSIS; MEMBRANES; SYSTEMS
AB Aqueous solutions of crude extract of lipase from Candida rugosa (C-CRL) and of a semipurified material obtained by treating C-CRL with propan-2-ol (PT-CRL) were used as a source of biomaterial for its adsorption onto the surface of layered micro-crystals of (alpha-zirconium phosphate Zr(HPO4)(2) and phosphonates such as Zr(C6H5PO3)(2), Zr(HPO4)(C6H5PO3) and Zr(HOOCCH PO3)(HPO4), which possess groups with different hydrophobic character anchored to the inorganic matrix. Several biocomposites have been obtained by changing the temperature and the time of equilibration of the various supports with the C-CPL and PT-CRL solutions. The biocomposites have shown different esterase activities and enantio-selectivities in the hydrolysis of p-nitrophenylacetate (p-NPA), ethyl butyrate and (+/-)-methyl-2-(4-chlorophenoxy) propionate as a function of the nature of the support and of the time and temperature of equilibration. These results have been interpreted on the basis of a selective adsorption of different isoforms of the enzyme. The biocomposites can be stored for more than 1 month at 4degreesC and can be used for several cycles without a significant decrease in catalytic activity. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Perugia, Dipartimento Chim, Chim Organ Lab, I-06123 Perugia, Italy.
   Univ Perugia, Dipartimento Chim, Lab Chim Inorgan, I-06123 Perugia, Italy.
RP Cipiciani, A (reprint author), Univ Perugia, Dipartimento Chim, Chim Organ Lab, Via Elce Sotto 10, I-06123 Perugia, Italy.
RI Cipiciani, Antonio/M-6033-2014
CR ALBERTI G, 1985, REACT POLYM, V4, P1, DOI 10.1016/0167-6989(85)90028-5
   Alberti G, 1996, ADV MATER, V8, P291, DOI 10.1002/adma.19960080405
   Arica MY, 2001, PROCESS BIOCHEM, V36, P847, DOI 10.1016/S0032-9592(00)00289-2
   Bastida A, 1998, BIOTECHNOL BIOENG, V58, P486, DOI 10.1002/(SICI)1097-0290(19980605)58:5<486::AID-BIT4>3.0.CO;2-9
   Bellezza F, 2002, LANGMUIR, V18, P8737, DOI 10.1021/la0262912
   BOSLEY JA, 1994, BIOTECHNOL BIOENG, V43, P934, DOI 10.1002/bit.260431006
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064
   Cipiciani A, 1999, TETRAHEDRON-ASYMMETR, V10, P4599, DOI 10.1016/S0957-4166(99)00500-5
   Cipiciani A, 2001, TETRAHEDRON-ASYMMETR, V12, P2277, DOI 10.1016/S0957-4166(01)00416-5
   Cipiciani A, 1998, TETRAHEDRON, V54, P7883, DOI 10.1016/S0040-4020(98)00422-0
   Clearfield A, 1998, PROG INORG CHEM, V47, P371
   de Fuentes IE, 2001, J MOL CATAL B-ENZYM, V11, P657, DOI 10.1016/S1381-1177(00)00069-2
   Fernandez-Lorente G, 2001, J MOL CATAL B-ENZYM, V11, P649, DOI 10.1016/S1381-1177(00)00080-1
   Fernandez-Lorente G, 2001, ENZYME MICROB TECH, V28, P389, DOI 10.1016/S0141-0229(00)00324-0
   HAMACHI I, 1994, J AM CHEM SOC, V116, P8811, DOI 10.1021/ja00098a052
   IVANOV AE, 1997, J MOL CATAL B-ENZYM, V2, P177
   LOTTI M, 1994, PROTEIN ENG, V7, P531, DOI 10.1093/protein/7.4.531
   Lundell K, 1998, ENZYME MICROB TECH, V22, P86, DOI 10.1016/S0141-0229(97)00104-X
   MOSBACH K, 1988, IMMOBILIZED ENZYMES, V137
   Pregnolato M, 2001, J MOL CATAL B-ENZYM, V11, P757, DOI 10.1016/S1381-1177(00)00168-5
   Sabuquillo P, 1998, BBA-PROTEIN STRUCT M, V1388, P337, DOI 10.1016/S0167-4838(98)00183-6
   SANTANIELLO E, 1992, CHEM REV, V92, P1071, DOI 10.1021/cr00013a016
   Tisher W., 1999, TOP CURR CHEM, V200, P95
   WORTHING CR, 1979, PESTICIDE MANUAL, P329
NR 25
TC 28
Z9 29
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-1177
J9 J MOL CATAL B-ENZYM
JI J. Mol. Catal. B-Enzym.
PD NOV 3
PY 2003
VL 26
IS 1-2
BP 47
EP 56
DI 10.1016/S1381-1177(03)00164-4
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA 738FP
UT WOS:000186276300005
DA 2018-10-19
ER

PT J
AU Zhang, F
   Zhu, C
   Oswald, T
   Lei, MP
   Lineaweaver, WC
AF Zhang, F
   Zhu, C
   Oswald, T
   Lei, MP
   Lineaweaver, WC
TI Porcine small intestinal submucosa as a carrier for skin flap
   prefabrication
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID RECONSTRUCTION; GROWTH; MODEL; DEFECTS; FASCIA; REPAIR
AB The feasibility of porcine small intestinal submucosa (SIS) as a carrier in skin flap prefabrication was examined in this study. Thirty-eight rats were randomly divided into five groups. The saphenous vascular bundle was used as the vascular carrier. In group I (n = 8), an arteriovenous fistula was made by anastomosis of distal saphenous artery and vein. A SIS patch (1.5 X 2 cm(2)) was placed underneath the vascular bundle. In group 2 (n 8), the vascular bundle was isolated and laid over the SIS patch. The distal saphenous vessels were ligated when the flap was raised. In group 3 (n 8), an arteriovenous fistula was made without SIS implant. In group 4 (n = 8) the flap was raised with only the vascular bundle with the distal end ligated. After 2 weeks of maturation, the flap was raised with only the vascular bundle. In group 5 (n = 6), SIS was implanted and the flap including the SIS patch was raised and replaced without the vascular pedicles. The survival of the flaps and histology were evaluated at 5 days after flap replacement. The results showed that the average survival area in group I was 99% +/- 3% and the survival area in group 2 was 86% +/- 16%. The mean survival areas in group 3 and 4 were 60% +/- 9% and 25% +/- 10% respectively. No flap survival was observed in the group 5. These were significantly lower than in groups I and 2 (p < 0.05, p < 0.01). Histology showed that SIS patch was incorporated into the adjacent connective tissue and increased amounts of neovascularization were seen between the collagenous sheets and dermis. In conclusion, this study demonstrated that porcine SIS can incorporate into the adjacent tissue and induce angiogenesis in flap prefabrication. This biomaterial can provide a scaffold for supporting and enhancing the survival of vascular prefabricated skin flap.
C1 Univ Mississippi, Med Ctr, Div Plast Surg, Jackson, MS 39216 USA.
RP Zhang, F (reprint author), Univ Mississippi, Med Ctr, Div Plast Surg, 2500 N State St, Jackson, MS 39216 USA.
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Chen HC, 1999, ANN THORAC SURG, V67, P911, DOI 10.1016/S0003-4975(99)00152-6
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   EROL OO, 1976, PLAST RECONSTR SURG, V58, P470
   Govila A, 1993, Acta Chir Plast, V35, P125
   HIRASE Y, 1987, Microsurgery, V8, P218, DOI 10.1002/micr.1920080410
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   HOMMA K, 1995, J RECONSTR MICROSURG, V11, P221, DOI 10.1055/s-2007-1006536
   Horl H W, 1992, Handchir Mikrochir Plast Chir, V24, P243
   KHOURI RK, 1991, PLAST RECONSTR SURG, V87, P108, DOI 10.1097/00006534-199101000-00017
   Kimura N, 2001, PLAST RECONSTR SURG, V108, P1972, DOI 10.1097/00006534-200112000-00020
   Kropp BP, 2000, J ENDOUROL, V14, P59, DOI 10.1089/end.2000.14.59
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Orringer JS, 1999, PLAST RECONSTR SURG, V104, P793, DOI 10.1097/00006534-199909030-00028
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   SANGER JR, 1992, PLAST RECONSTR SURG, V89, P315, DOI 10.1097/00006534-199202000-00020
   SHINTOMI Y, 1982, PLAST RECONSTR SURG, V70, P725, DOI 10.1097/00006534-198212000-00012
   TAKATO T, 1991, BRIT J PLAST SURG, V44, P593, DOI 10.1016/0007-1226(91)90096-3
   Tark KC, 1996, J RECONSTR MICROSURG, V12, P325, DOI 10.1055/s-2007-1006495
   Tark KC, 1996, ANN PLAS SURG, V37, P298, DOI 10.1097/00000637-199609000-00011
   VALAURI F A, 1988, Journal of Reconstructive Microsurgery, V4, P203, DOI 10.1055/s-2007-1006955
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WALTON RL, 1993, ANN PLAS SURG, V30, P105, DOI 10.1097/00000637-199302000-00002
   Xie H, 2000, ASAIO J, V46, P268, DOI 10.1097/00002480-200005000-00005
   YAO ST, 1982, PLAST RECONSTR SURG, V69, P568, DOI 10.1097/00006534-198203000-00051
   YAO ST, 1981, PLAST RECONSTR SURG, V68, P404, DOI 10.1097/00006534-198100000-00031
   ZHANG L, 1992, MICROSURG, V13, P214, DOI 10.1002/micr.1920130414
NR 29
TC 13
Z9 14
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD NOV
PY 2003
VL 51
IS 5
BP 488
EP 492
DI 10.1097/01.SAP.0000070648.65942.E6
PG 5
WC Surgery
SC Surgery
GA 742LT
UT WOS:000186519600011
PM 14595185
DA 2018-10-19
ER

PT J
AU Martin, DP
   Williams, SF
AF Martin, DP
   Williams, SF
TI Medical applications of poly-4-hydroxybutyrate: a strong flexible
   absorbable biomaterial
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Review
DE poly-4-hydroxybutyrate; biomaterial; fermentation; absorbable; P4HB
ID TRILEAFLET HEART-VALVES; POLYMERS;
   POLY(3-HYDROXYBUTYRATE-CO-4-HYDROXYBUTYRATE); POLYHYDROXYALKANOATES
AB Poly-4-hydroxybutyrate (P4HB) is being developed as a new absorbable material for implantable medical applications. P4HB promises to open up new opportunities for the development of medical applications by offering a new set of properties that are not currently available. The absorbable biomaterial is strong yet flexible, and degrades in vivo at least in part by a surface erosion process. While the chemical structure of P4HB is similar to that of current absorbable polyesters used in implantable medical products, P4HB is produced by a fermentation process rather than through a chemical synthesis. P4HB is a thermoplastic material that can be processed using standard plastics processing techniques, such as solution casting or melt extrusion. The strength of P4HB fibers prepared by melt extrusion compare well with that of traditional suturing materials, however, P4HB is typically more flexible. P4HB should find use in a wide variety of medical fields such as cardiovascular, wound healing, orthopedic, drug delivery, and tissue engineering applications. This paper describes some of the basic properties of P4HB and several of its potential applications in medicine. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Tepha Inc, Cambridge, MA 02142 USA.
RP Martin, DP (reprint author), Tepha Inc, 303 3rd St, Cambridge, MA 02142 USA.
CR American Heart Association, 2002, HEART STROK STAT UPD
   BEHREND D, 1999, MED BIOL ENG COMPUT, V37, P1510
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   DENNIS DE, 2000, Patent No. 6117658
   Doi Y., 1990, MICROBIAL POLYESTERS
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Hazari A, 1999, BRIT J PLAST SURG, V52, P653, DOI 10.1054/bjps.1999.3184
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   HORI Y, 1995, POLYMER, V36, P4703, DOI 10.1016/0032-3861(95)96838-Y
   Huisman GW, 2001, Volume US Patent, Patent No. [6,316,262., 6316262]
   Lee SY, 1999, BIOPR TECHNOL, V24, P113
   Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21
   NELSON T, 1981, J NEUROCHEM, V37, P1345, DOI 10.1111/j.1471-4159.1981.tb04689.x
   Saito Y, 1996, POLYM INT, V39, P169
   SENDELBECK SL, 1985, DRUG METAB DISPOS, V13, P291
   Shell K.D., 1998, U.S. Patent, Patent No. [5,811,272, 5811272]
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Sodian R, 2000, CIRCULATION, V102, P22
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   STOCK UA, 1999, PEDIAT CARD SURG ANN, V2, P51
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   UNVERDORBEN M, 1998, AM J CARD TRANSCATHE
   von Fraunhofer JA, 1997, WOUND CLOSURE BIOMAT, P107
   WILLIAMS SF, 2001, Patent No. 0119422
   Williams SF, 2002, BIOPOLYMERS, P91
NR 29
TC 224
Z9 240
U1 2
U2 70
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1369-703X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD NOV
PY 2003
VL 16
IS 2
BP 97
EP 105
DI 10.1016/S1369-703X(03)00040-8
PG 9
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 733UY
UT WOS:000186020100002
DA 2018-10-19
ER

PT J
AU Ba, CY
   Yang, J
   Hao, QH
   Liu, XY
   Cao, A
AF Ba, CY
   Yang, J
   Hao, QH
   Liu, XY
   Cao, A
TI Syntheses and physical characterization of new aliphatic triblock
   poly(L-lactide-b-butylene succinate-b-L-lactide)s bearing soft and hard
   biodegradable building blocks
SO BIOMACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; ALT-GLYCOLIC ACID); L-LACTIDE;
   EPSILON-CAPROLACTONE; MULTIFUNCTIONAL INITIATOR; POLYCONDENSATION
   REACTION; CRYSTALLIZATION BEHAVIOR; THERMOPLASTIC ELASTOMER;
   POLY(ETHYLENE GLYCOL); THERMAL-STABILITY
AB This study presents chemical syntheses and physical characterization of a new aliphatic poly(L-lactide-b-butylene succinate-b-L-lactide) triblock copolyester with soft and hard biodegradable building blocks. First, poly(butylene succinate) (PBS) prepolymers terminated with hydroxyl functional groups were synthesized through melt polycondensation from succinic acid and 1,4-butanediol. Further, a series of new PLLA-b-PBS-b-PLLA triblock copolyesters bearing various average PLLA block lengths were prepared via ring opening polymerization Of L-lactide with the synthesized hydroxyl capped PBS prepolymer ((M) over bar (n) = 4.9 KDa) and stannous octanoate as the macroinitiator and catalyst, respectively. By means of GPC, NMR, FTIR, DSC, TGA, and wide-angle X-ray diffractometer (WAXD), the macromolecular structures and physical properties were intensively studied for these synthesized PBS prepolymer and PLLA-b-PBS-b-PLLA triblock copolyesters. C-13 NMR and GPC experimental results confirmed the formation of sequential block structures without any detectable transesterification under the present experimental conditions, and the molecular weights of triblock copolyesters could be readily regulated by adjusting the feeding molar ratio of L-lactide monomer to the PBS macroinitiator. DSC measurements showed all single glass transitions, and their glass transition temperatures were found to be between those of PLLA and PBS, depending on the lengths of PLLA blocks. It was noteworthy that the segmental flexibilities of the hard PLLA blocks were found to be remarkably enhanced by the more flexible PBS block partner, and the PBS and PLLA building blocks were well mixed in the amorphous regions. Results of TGA analyses indicated that thermal degradation and stabilities of the PLLA blocks strongly depended on the average PLLA block lengths of triblock copolyesters. In addition, FTIR and WAXD results showed the coexistence of the assemblied PLLA and PBS crystal structures when the average PLLA block length became larger than 7.8. These results may be beneficial for this new biodegradable aliphatic triblock copolyester to be applied as a potential biomaterial.
C1 Chinese Acad Sci, Shanghai Inst Organ Chem, Polymer Mat Lab, Shanghai 200032, Peoples R China.
RP Cao, A (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, Polymer Mat Lab, 354 Fenglin Rd, Shanghai 200032, Peoples R China.
EM acao@mail.sioc.ac.cn
RI Ba, Chaoyi/K-9021-2012
CR AJIOKA M, 1995, B CHEM SOC JPN, V68, P2125, DOI 10.1246/bcsj.68.2125
   Babanalbandi A, 1999, POLYM INT, V48, P980, DOI 10.1002/(SICI)1097-0126(199910)48:10<980::AID-PI257>3.0.CO;2-B
   Cai Q, 2003, BIOMACROMOLECULES, V4, P828, DOI 10.1021/bm034051a
   Cao A, 2002, POLYMER, V43, P671, DOI 10.1016/S0032-3861(01)00658-9
   Choi SW, 1999, J POLYM SCI POL CHEM, V37, P2207, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2207::AID-POLA35>3.0.CO;2-0
   Dong CM, 2001, MACROMOLECULES, V34, P4691, DOI 10.1021/ma010005w
   Dong CM, 2001, POLYMER, V42, P6891, DOI 10.1016/S0032-3861(01)00180-X
   Duda A, 1998, POLYM DEGRAD STABIL, V59, P215, DOI 10.1016/S0141-3910(97)00167-5
   DUDA A, 1990, MACROMOLECULES, V23, P1636, DOI 10.1021/ma00208a012
   DUDA A, 1994, MACROMOLECULES, V27, P576, DOI 10.1021/ma00080a036
   Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6
   Fujimaki T, 1996, SEN-I GAKKAISHI, V52, pP320, DOI 10.2115/fiber.52.8_P320
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Hiki S, 2000, POLYMER, V41, P7369, DOI 10.1016/S0032-3861(00)00086-0
   Hong K, 2002, EUR POLYM J, V38, P305, DOI 10.1016/S0014-3057(01)00110-0
   Hyon SH, 1997, BIOMATERIALS, V18, P1503, DOI 10.1016/S0142-9612(97)00076-8
   In't Veld PJA, 1997, J POLYM SCI POL CHEM, V35, P219, DOI 10.1002/(SICI)1099-0518(19970130)35:2<219::AID-POLA3>3.0.CO;2-N
   Ishii M, 2001, BIOMACROMOLECULES, V2, P1267, DOI 10.1021/bm015576a
   Kawasaki N, 1998, MACROMOL CHEM PHYSIC, V199, P2445, DOI 10.1002/(SICI)1521-3935(19981101)199:11<2445::AID-MACP2445>3.0.CO;2-Q
   Kim JH, 2002, POLYM J, V34, P203, DOI 10.1295/polymj.34.203
   Kim JK, 2001, POLYMER, V42, P7429, DOI 10.1016/S0032-3861(01)00217-8
   Kim KS, 1999, J APPL POLYM SCI, V72, P341, DOI 10.1002/(SICI)1097-4628(19990418)72:3<341::AID-APP4>3.0.CO;2-D
   Kowalski A, 2000, MACROMOLECULES, V33, P689, DOI 10.1021/ma9906940
   Kowalski A, 1998, MACROMOL RAPID COMM, V19, P567, DOI 10.1002/(SICI)1521-3927(19981101)19:11<567::AID-MARC567>3.3.CO;2-K
   Kowalski A, 2000, MACROMOLECULES, V33, P1964, DOI 10.1021/ma991751s
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P702, DOI 10.1021/ma991181w
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   Kricheldorf HR, 2001, CHEMOSPHERE, V43, P49, DOI 10.1016/S0045-6535(00)00323-4
   KRICHELDORF HR, 1994, POLYMER, V35, P4175, DOI 10.1016/0032-3861(94)90593-2
   KRICHELDORF HR, 1995, POLYMER, V36, P2995, DOI 10.1016/0032-3861(95)94350-3
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   KUROKI T, 1998, Patent No. 1998120773
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee SH, 2001, J POLYM SCI POL CHEM, V39, P973, DOI 10.1002/1099-0518(20010401)39:7<973::AID-POLA1073>3.0.CO;2-8
   NIJENHUIS AJ, 1992, MACROMOLECULES, V25, P6419, DOI 10.1021/ma00050a006
   Ovitt TM, 2002, J AM CHEM SOC, V124, P1316, DOI 10.1021/ja012052+
   Qian HT, 2000, POLYM DEGRAD STABIL, V68, P423, DOI 10.1016/S0141-3910(00)00031-8
   Robson F, 2002, MACROMOLECULES, V35, P1504
   Sarasua JR, 1998, MACROMOLECULES, V31, P3895, DOI 10.1021/ma971545p
   Seretoudi G, 2002, POLYMER, V43, P5405, DOI 10.1016/S0032-3861(02)00433-0
   Shirahama H, 2001, J APPL POLYM SCI, V80, P340, DOI 10.1002/1097-4628(20010418)80:3<340::AID-APP1105>3.0.CO;2-F
   SONG CX, 1984, MACROMOLECULES, V17, P2764, DOI 10.1021/ma00142a057
   Stridsberg K, 1999, J POLYM SCI POL CHEM, V37, P3407, DOI 10.1002/(SICI)1099-0518(19990815)37:16<3407::AID-POLA40>3.3.CO;2-O
   Trollsas M, 1998, MACROMOLECULES, V31, P2756, DOI 10.1021/ma971645v
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   Yang J, 2003, POLYM DEGRAD STABIL, V81, P1, DOI 10.1016/S0141-3910(03)00056-9
   Zhang SP, 2003, BIOMACROMOLECULES, V4, P437, DOI 10.1021/bm0201183
   ZHANG XC, 1994, J POLYM SCI POL CHEM, V32, P2965, DOI 10.1002/pola.1994.080321519
   ZHANG XC, 1992, POLYM BULL, V27, P623, DOI 10.1007/BF00297431
   Zhong ZY, 2001, MACROMOLECULES, V34, P3863, DOI 10.1021/ma0019510
NR 52
TC 52
Z9 58
U1 3
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2003
VL 4
IS 6
BP 1827
EP 1834
DI 10.1021/bm034235p
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 746CV
UT WOS:000186729700048
PM 14606915
DA 2018-10-19
ER

PT J
AU Yamamoto, M
   Takahashi, Y
   Tabata, Y
AF Yamamoto, M
   Takahashi, Y
   Tabata, Y
TI Controlled release by biodegradable hydrogyels enhances the ectopic bone
   formation of bone morphogenetic protein
SO BIOMATERIALS
LA English
DT Article
DE bone morphogenetic protein; controlled release; ectopic bone formation;
   biodegradable gelatin hydrogel
ID FIBROBLAST-GROWTH-FACTOR; ABSORBABLE COLLAGEN SPONGES; GELATIN
   HYDROGELS; BIOMATERIAL CARRIERS; PHARMACOKINETICS; REGENERATION; MODEL
AB The objective of this study is to develop a carrier for the controlled release of bone morphogenetic protein-2 (BMP-2) suitable for enhancement of the bone regeneration activity. Hydrogels with different water contents were prepared through glutaraldehyde crosslinking of gelatin with an isoelectric point of 9.0 under varied reaction conditions. Following subcutaneous implantation of the gelatin hydrogels incorporating I-125-labeled BMP-2 into the back of mice, the in vivo retention period of BMP-2 prolonged with a decrease in the water content of hydrogels used, although every time period was much longer than that of BMP-2 solution injection. Ectopic bone formation studies demonstrated that the alkaline phosphatase (ALP) activity and osteocalcin content around the implanted site of BMP-2-incorporated gelatin hydrogels were significantly high compared with those around the injected site of BMP-2 solution. The values became maximum for the gelatin hydrogel incorporating BMP-2 with a middle period of BMP-2 retention, while bone formation was histologically observed around the hydrogel incorporating BMP-2. The ALP activity was significantly higher than that of the collagen sponge incorporating BMP-2. We concluded that the controlled release technology of BMP-2 for a certain time period was essential to induce the potential activity for bone formation. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Sakyo Ku, Kyoto 6068507, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Sakyo Ku, 53 Kawara Cho, Kyoto 6068507, Japan.
CR BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   DRURY RAB, 1980, CARLETONS HISTOLOGIC, P217
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Gittens SA, 2001, J DRUG TARGET, V9, P407, DOI 10.3109/10611860108998776
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   KAPLOW LS, 1963, AM J CLIN PATHOL, V39, P439
   Kobayashi D, 1996, J BIOCHEM, V119, P475
   Laursen M, 1999, EUR SPINE J, V8, P485, DOI 10.1007/s005860050210
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   Muniruzzaman M, 1997, MATER SCI FORUM, V250, P89, DOI 10.4028/www.scientific.net/MSF.250.89
   Ozeki M, 2001, J DRUG TARGET, V9, P461, DOI 10.3109/10611860108998780
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   Uludag H, 1998, CURR OPIN ORTHOP, V9, P31
   ULUDAG H, 2001, J BONE JT SURG A, V83, pS1
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Wozney J M, 1990, J Cell Sci Suppl, V13, P149
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yamamoto M, 1996, Tissue Eng, V2, P315, DOI 10.1089/ten.1996.2.315
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   ZEKORN D, 1969, BIBL HAEMATOL, V33, P30
NR 31
TC 236
Z9 240
U1 3
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2003
VL 24
IS 24
BP 4375
EP 4383
DI 10.1016/S0142-9612(03)00337-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 716PN
UT WOS:000185037700005
PM 12922150
DA 2018-10-19
ER

PT J
AU Weiss, P
   Obadia, L
   Magne, D
   Bourges, X
   Rau, C
   Weitkamp, T
   Khairoun, I
   Bouler, JM
   Chappard, D
   Gauthier, O
   Daculsi, G
AF Weiss, P
   Obadia, L
   Magne, D
   Bourges, X
   Rau, C
   Weitkamp, T
   Khairoun, I
   Bouler, JM
   Chappard, D
   Gauthier, O
   Daculsi, G
TI Synchrotron X-ray microtomography (on a micron scale) provides
   three-dimensional imaging representation of bone ingrowth in calcium
   phosphate biomaterials
SO BIOMATERIALS
LA English
DT Article
DE microtomography; synchrotron radiation; calcium phosphate; bone cement;
   ceramics
ID TRABECULAR BONE; HISTOLOGICAL SECTIONS; CERAMICS; CEMENT; MACROPOROSITY;
   CARBONATE; IMPLANTATION; SUBSTITUTE; INJECTION; INTERFACE
AB This study used synchrotron X-ray microtomography on a micron scale to compare three-dimensional (3D) bone ingrowth after implantation of various calcium phosphate bone substitutes in a rabbit model. The advantage of using this new method for the study of biomaterials was then compared with histomorphometry for analysis of interconnection and bone ingrowth. The study focused on the newly formed bone-biomaterial interface. Macroporous Biphasic Calcium Phosphate (MBCP(TM)) ceramic blocks and two different injectable calcium phosphate biomaterials [an injectable bone substitute (IBS) consisting of a biphasic calcium phosphate granule suspension in hydrosoluble polymer and a calcium phosphate cement material (CPC)] were studied after in vivo implantation.
   Absorption or phase-contrast microtomography was performed with the dedicated set-up at beamline ID22. Experimental spatial resolution was between 1 and 1.4 mum, depending on experimental radiation. All calcium phosphates tested showed osteoconduction. IBS observations after 3D reconstruction showed interconnected bioactive biomaterial with total open macroporosity and complete bone ingrowth as early as 3 weeks after implantation. This experimentation was consistent with two-dimensional histomorphometric analysis, which confirmed its suitability for biomaterials. This 3D study relates the different types of bone substitution to biomaterial architecture. As porosity and interconnection increase, bone ingrowth becomes greater at the expense of the bone substitute: IBS > MBCP > CPC. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Fac Chirurg Dent, INSERM 99 03, Lab Rech Mat Interet Biol, F-44042 Nantes 01, France.
   European Synchrotron Radiat Facil, F-38043 Grenoble, France.
   Fac Med, LHEA Lab Histol Embryol, F-49045 Angers, France.
   Ecole Natl Vet Nantes, Lab Chirurg, F-40706 Nantes 03, France.
RP Weiss, P (reprint author), Fac Chirurg Dent, INSERM 99 03, Lab Rech Mat Interet Biol, 1 Pl Alexis Ricordeau, F-44042 Nantes 01, France.
RI Gauthier, Olivier/A-4639-2015; Weiss, Pierre/P-1372-2014; Daculsi,
   Guy/P-1320-2014; Weitkamp, Timm/A-8975-2012
OI Weiss, Pierre/0000-0002-6159-8590; Daculsi, Guy/0000-0003-1030-3446;
   Weitkamp, Timm/0000-0002-0374-0472; BOULER,
   Jean-Michel/0000-0001-9784-5584
CR ADAMSBAUM C, 1993, SKELETAL RADIOL, V22, P317
   Amouriq Y, 2002, J MATER SCI-MATER M, V13, P149, DOI 10.1023/A:1013873828079
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Chappard D, 1999, MICROSC RES TECHNIQ, V45, P303, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<303::AID-JEMT14>3.0.CO;2-8
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DACULSI G, 1994, Patent No. 9521634
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DELECRIN J, 1994, CELL MATER, V4, P51
   Drissens F., 1994, J MATER SCI, V5, P164
   Filmon R, 2002, J BIOMAT SCI-POLYM E, V13, P1105, DOI 10.1163/156856202320813828
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   GAUTHIER O, 1999, BONE, V25, P71
   GAUTHIER O, IN PRESS J BIOMED MA
   KAEMMERLEN P, 1989, NEW ENGL J MED, V321, P121
   Kak A. C., 1988, PRINCIPLES COMPUTERI
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)00096-3
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   Khairoun I, 1997, J BIOMED MATER RES, V38, P356, DOI 10.1002/(SICI)1097-4636(199724)38:4<356::AID-JBM8>3.0.CO;2-N
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Lemaitre J, 1992, Rev Stomatol Chir Maxillofac, V93, P163
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Pothuaud L, 2002, J BIOMECH, V35, P1091, DOI 10.1016/S0021-9290(02)00060-X
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RAVEN C, 1998, MICROIMAGING TOMOGRA
   Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   Weitkamp T, 1999, P SOC PHOTO-OPT INS, V3772, P311, DOI 10.1117/12.363734
NR 37
TC 119
Z9 122
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2003
VL 24
IS 25
BP 4591
EP 4601
DI 10.1016/S0142-9612(03)00335-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 721NN
UT WOS:000185322600007
PM 12951002
DA 2018-10-19
ER

PT J
AU Wang, YW
   Wu, Q
   Chen, GQ
AF Wang, YW
   Wu, Q
   Chen, GQ
TI Reduced mouse fibroblast cell growth by increased hydrophilicity of
   microbial polyhydroxyalkanoates via hyaluronan coating
SO BIOMATERIALS
LA English
DT Article
DE polyhydroxyalkanoates; L929; hyaluronan; PHB; surface coating
ID POLYHYDROXYBUTYRATE; BIOCOMPATIBILITY; SCAFFOLDS; COMPOSITE; BEHAVIOR;
   FIXATION; PROTEIN; CULTURE
AB The mouse fibroblast cell line L929 was inoculated on 3D scaffolds of microbial polyesters, namely polyhydroxybutyrate (PHB) and poly(hydroxybutyrate-co-hydroxyhexanoate) (PHBHHx) to evaluate their in vitro biocompatibility. It was found that both polyhydroxyalkanoates (PHA) subjected to lipase treatment and hyaluronan (HA) coating decreased the contact angle of water to the material surface approximately 30%, meaning an increased hydrophilicity on the PHA surface. At the same time, both the lipase treatment and the HA coating smoothened the PHA surface. After the lipase treatment or HA coating, the ratio of PHA hydrophilic groups including hydroxyl and carboxyl to carbonyl of PHA was approximately 1:1 or 2:1. Cells grown on scaffolds treated with lipase were approximately 4 x 10(5)/ml, twice in number of the control. However, PHA scaffolds coated with HA were observed with a 40% decrease in cell growth compared with that of the control. HA coating reduced the cell attachment and proliferation on PHA although the materials had increased hydrophilicity. In comparison, lipase treatment promoted the cell growth on PHA although the treatment did not lead to better hydrophilicity compared with HA coating. It appeared that an appropriate combination of hydrophilicity and hydrophobicity was important for the biocompatibility of PHBHHx, especially for the growth of L929 cells on the surface of this material. This may have instructive significance for biomaterial selection and design. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
RP Wu, Q (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
CR ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4
   ABERCROMBIE M, 1958, EXP CELL RES, V15, P332, DOI 10.1016/0014-4827(58)90034-X
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Andrade J D, 1973, Med Instrum, V7, P110
   BARBARA DB, 1996, BIOMATERIALS, V17, P137
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Caplan A.I.B.B., 1994, BONE, V8, P1
   Chanvel-Lesrat D. J., 1999, BIOMATERIALS, V20, P291
   Chen G., 2001, TSINGHUA J SCI TECHN, V6, P193
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   NORDE W, 1992, Clinical Materials, V11, P85, DOI 10.1016/0267-6605(92)90032-O
   QING TW, 1999, CHIN REPARATIVE RECO, V13, P31
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Tomihata K, 1997, J POLYM SCI POL CHEM, V35, P3553, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3553::AID-POLA22>3.0.CO;2-D
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   YANG XS, 2001, TSINGHUA J SCI TECHN, V6, P216
   Zhao JQ, 1999, EUR POLYM J, V35, P2115, DOI 10.1016/S0014-3057(99)00026-9
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 26
TC 112
Z9 119
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2003
VL 24
IS 25
BP 4621
EP 4629
DI 10.1016/S0142-9612(03)00356-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 721NN
UT WOS:000185322600010
PM 12951005
DA 2018-10-19
ER

PT J
AU Chung, TW
   Liu, DZ
   Wang, SY
   Wang, SS
AF Chung, TW
   Liu, DZ
   Wang, SY
   Wang, SS
TI Enhancement of the growth of human endothelial cells by surface
   roughness at nanometer scale
SO BIOMATERIALS
LA English
DT Article
DE surface roughness; nm scale; AFM; HUVECs; GRGD
ID ADHESION; RGD
AB This study investigated whether a nanometer scale of surface roughness could improve the adhesion and growth of human endothelial cells on a biomaterial surface. Different molecular weights or chain lengths of polyethylene glycol (PEG) were mixed and then grafted to a polyurethane (PU) surface, a model smooth surface, to form a nanometer (nm) scale of roughness for PU-PEG surfaces (PU-PEG(mix)) while PEG with a molecular weight of 2000 was also grafted to PU to form PU-PEG(2000) for comparison. In addition, the concept was tested on cell-adhesive peptide Gly-Arg-Gly-Asp (GRGD) that was photochemically grafted to PU-PEG(mix) and PU-PEG(2000) surfaces (e.g., PU-PEG(mix)-GRGD and PU-PEG(2000)-GRGD surfaces, respectively). To prepare GRGD-grafted PU-PEG(mix) and PU-PEG(2000) surface, 0.025M of GRGD-SANPAH (N-Succininlidyl-6-[4'-azido-2'-nitrophenylamino]-hexanoate) solutions was grafted to PU-PEG(mix) and PU-PEG(2000) by surface adsorption of the peptide and subsequent ultraviolet (UV) irradiation for photoreaction. The grafting efficiencies for GRGD to PU-PEG(mix) and PU-PEG(2000) surfaces were about 67% for both surfaces, semi-quantitatively analyzed by an HPLC. The surface roughness, presented with a roughness parameter, R-a, and the topography of the tested surfaces were both measured and imaged by an atomic force microscope (AFM). Among the R-a, values of the films, PU was the smoothest (e.g., R-a = 1.53+/-0.20nm, n = 3) while PU-PEG(mix) was the roughest (e.g., R-a = 39.79+/-10.48 nm, n = 4). Moreover, R-a values for PU-PEG(mix) and PU-PEG(mix)-GRGD surfaces were about 20 nm larger than those for PU-PEG,000 and PU-PEG2000-GRGD, respectively, which were consistent with the topographies of the films. Human umbilical vein endothelial cells (HUVECs) were adhered and grown on the tested surfaces after 36 It of incubation. Among the films, HUVEC's adhesion on the surface of PU-PEG(mix)-GRGD was the densest while that on the surface of PU-PEG(2000) was the sparsest. Also, the adhesion and growth of HUVECs for the roughness surfaces were statistically significantly better than that of smooth surface for both GRGD grafted and un-grafted surfaces, respectively. The viability for the growth of HUVECs on the tested surfaces analyzed by MTT assay also confirmed the efficacy of the increased surface roughness.
   In conclusion, increased surface roughness of biomaterial surfaces even at 10-10(2) nm scale could enhance the adhesion and growth of HUVECs on roughness surfaces that could be useful for applications of tissue engineering. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Natl Yunlin Univ Sci & Technol, Dept Chem Engn, Touliu, Yunlin, Taiwan.
   Taipei Med Univ, Grad Inst Biomed Mat, Taipei, Taiwan.
   Chung Yuan Christian Univ, Dept Biomed Engn, Chungli, Taiwan.
   Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.
RP Chung, TW (reprint author), Natl Yunlin Univ Sci & Technol, Dept Chem Engn, Touliu, Yunlin, Taiwan.
RI Zhou, Feng/E-9510-2011
OI Wang, Shoei-Shen/0000-0003-3201-4143
CR Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   HERRING M, 1978, SURGERY, V84, P498
   HOOGENBOOM LAP, 1997, TOXICOLOGY, V11, P385
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   HUANG LH, 1998, J BIOMED MATER RES, V40, P630
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Wang YH, 2000, J CHIN INST CHEM ENG, V31, P27
   WATKINS MT, 1984, J SURG RES, V36, P588, DOI 10.1016/0022-4804(84)90145-8
NR 20
TC 209
Z9 224
U1 3
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2003
VL 24
IS 25
BP 4655
EP 4661
DI 10.1016/S0142-9612(03)00361-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 721NN
UT WOS:000185322600013
PM 12951008
DA 2018-10-19
ER

PT J
AU Spijker, HT
   Graaff, R
   Boonstra, PW
   Busscher, HJ
   van Oeveren, W
AF Spijker, HT
   Graaff, R
   Boonstra, PW
   Busscher, HJ
   van Oeveren, W
TI On the influence of flow conditions and wettability on blood material
   interactions
SO BIOMATERIALS
LA English
DT Review
DE blood compatibility; blood flow; platelet interaction; shear;
   wettability
ID CORONARY STENT IMPLANTATION; PROSTHETIC HEART-VALVES; VENA-CAVA FILTERS;
   INDUCED PLATELET-AGGREGATION; CARDIAC VALVULAR PROSTHESES; IN-VITRO;
   CARDIOPULMONARY BYPASS; POLYVINYL-CHLORIDE; SHEAR-STRESS;
   POLYTETRAFLUOROETHYLENE GRAFTS
AB In this review, we hypothesise that, next to biocompatibility, optimal blood compatibility depends on a combination of biomaterials wettability and the shear stress prevailing in the device. The wettability is discussed in seven different categories of devices, that differ substantially from each other with regard to shear stress and exposure time. These seven categories are stents, prosthetic heart valves, vascular prostheses, cardiopulmonary bypass, hemodialysis, vena cava filters and blood bags. In high shear applications, in combination with blood activation, platelet deposition and thrombosis appear to be major problems and platelet inhibitors are most effective. Exposure of blood to a large biomaterial surface, with or without antithrombotic coating, results in reduction of platelet function. Material-independent activation aggravates this process. In low shear applications, platelets only seem supportive for coagulation and anticoagulants should be used. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   Univ Groningen, Dept Cardiothorac Surg, NL-9700 AD Groningen, Netherlands.
RP van Oeveren, W (reprint author), Univ Groningen, Dept Biomed Engn, Div Biocompatibil, Ant Deusinglaan 1,POB 196, NL-9713 AV Groningen, Netherlands.
CR Akins CW, 1995, ANN THORAC SURG, V60, P1836, DOI 10.1016/0003-4975(95)00766-0
   AKINS CW, 1991, ANN THORAC SURG, V52, P161, DOI 10.1016/0003-4975(91)91453-3
   ALDENHOFF YBJ, 2000, J BIOMED MATER RES, V54, P224
   AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   ANDERSON GH, 1978, BLOOD CELLS, V4, P499
   Antoniucci D, 2000, AM J CARDIOL, V85, P821, DOI 10.1016/S0002-9149(99)00874-7
   Aswad MA, 1996, J VASC SURG, V24, P809, DOI 10.1016/S0741-5214(96)70017-4
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597
   Black MM, 1995, J MED ENG TECHNOL, V19, P151, DOI 10.3109/03091909509009986
   Bonnefoy A, 2000, BIOPHYS J, V78, P2834, DOI 10.1016/S0006-3495(00)76826-3
   Bonomini M, 1999, ARTIF ORGANS, V23, P23, DOI 10.1046/j.1525-1594.1999.06271.x
   BOONSTRA PW, 1994, J THORAC CARDIOV SUR, V107, P289
   Bouchard D, 2001, CAN J CARDIOL, V17, P427
   Brass LF, 1991, HEMATOLOGY BASIC PRI, P1176
   Burger DHC, 2000, J VASC SURG, V32, P278, DOI 10.1067/mva.2000.106496
   CARO CG, 1971, PROC R SOC SER B-BIO, V177, P109, DOI 10.1098/rspb.1971.0019
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   David W, 1999, AM SURGEON, V65, P341
   De Somer F, 2000, EUR J CARDIO-THORAC, V18, P602, DOI 10.1016/S1010-7940(00)00508-X
   Deppisch R, 1998, SEP PURIF TECHNOL, V14, P241, DOI 10.1016/S1383-5866(98)00079-3
   DEWACHTER DS, 1996, ASAIO J, V42, pM254
   Diamantoglou M, 1999, ARTIF ORGANS, V23, P15
   ElKattan I, 1999, CLIN DIAGN LAB IMMUN, V6, P509
   EVANGELISTA RA, 1986, BIOMATERIALS, V7, P206, DOI 10.1016/0142-9612(86)90104-3
   FISCHER KG, 1999, KIDNEY INT, V56, P50
   FREDRICKSON BJ, 1987, HEMOSTASIS THOMBOSIS, P625
   Fung Y. C., 1977, BIOMECHANICS CIRCULA
   Gawaz M, 1996, HEART, V76, P166, DOI 10.1136/hrt.76.2.166
   Gawaz M, 1996, CIRCULATION, V94, P279, DOI 10.1161/01.CIR.94.3.279
   Gawaz MP, 1999, ARTIF ORGANS, V23, P29, DOI 10.1046/j.1525-1594.1999.06289.x
   GAWAZ MP, 1994, KIDNEY INT, V46, P489, DOI 10.1038/ki.1994.299
   Geckeler KE, 2000, NATURWISSENSCHAFTEN, V87, P351, DOI 10.1007/s001140050738
   Geiser T, 1998, STROKE, V29, P1770, DOI 10.1161/01.STR.29.9.1770
   Greenfield LJ, 2000, ANN VASC SURG, V14, P525, DOI 10.1007/s100169910100
   Grontoft KC, 1998, SCAND J UROL NEPHROL, V32, P276
   Gu YJ, 1998, ANN THORAC SURG, V65, P1342, DOI 10.1016/S0003-4975(98)00223-9
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Herrmann R, 1999, THROMB HAEMOSTASIS, V82, P51
   Hoenich NA, 2000, ASAIO J, V46, P70, DOI 10.1097/00002480-200001000-00019
   Hoenich NA, 2000, BIOMATERIALS, V21, P317, DOI 10.1016/S0142-9612(99)00196-9
   Holmes DR, 2000, AM J CARDIOL, V86, P1073, DOI 10.1016/S0002-9149(00)01162-0
   Inoue T, 2000, AM J CARDIOL, V86, P1057, DOI 10.1016/S0002-9149(00)01159-0
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   KAMIYA A, 1980, AM J PHYSIOL, V239, pH14
   Kaufman JS, 2000, J THROMB THROMBOLYS, V10, P127, DOI 10.1023/A:1018758308979
   Kawahito K, 1999, ANN THORAC SURG, V67, P79, DOI 10.1016/S0003-4975(98)00821-2
   Keller K. H., 1981, INTERACTION BLOOD NA, P119
   KICHEVA YI, 1995, BIOMATERIALS, V16, P575, DOI 10.1016/0142-9612(95)91132-I
   Knight CJ, 1998, EUR HEART J, V19, P1239, DOI 10.1053/euhj.1998.1047
   Kuntze CEE, 1998, ANN THORAC SURG, V66, P101, DOI 10.1016/S0003-4975(98)00313-0
   Kvidal P, 2000, EUR HEART J, V21, P1099, DOI 10.1053/euhj.2000.1862
   Lambert AW, 1999, CARDIOVASC SURG, V7, P491, DOI 10.1016/S0967-2109(99)00012-5
   Langan EM, 1999, J VASC SURG, V30, P484, DOI 10.1016/S0741-5214(99)70075-3
   Leask RL, 2001, J VASC INTERV RADIOL, V12, P613, DOI 10.1016/S1051-0443(07)61486-9
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lee JH, 1999, J BIOMED MATER RES, V48, P328, DOI 10.1002/(SICI)1097-4636(1999)48:3<328::AID-JBM18>3.3.CO;2-C
   Leprince P, 2001, EUR J CARDIO-THORAC, V19, P302, DOI 10.1016/S1010-7940(01)00593-0
   Lowe HC, 2002, J AM COLL CARDIOL, V39, P183, DOI 10.1016/S0735-1097(01)01742-9
   LYSAGHT MJ, 2000, ASAIO J, V46, P521
   Mantero S, 1996, INT J ARTIF ORGANS, V19, P372
   May AE, 1997, EUR HEART J, V18, P1913
   MCDONALD DA, 1974, BLOOD FLOW ARTERIES
   McMillan R, 2001, J BIOMED MATER RES, V54, P272, DOI 10.1002/1097-4636(200102)54:2<272::AID-JBM15>3.0.CO;2-3
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mihaylov D, 1999, ARTIF ORGANS, V23, P1117, DOI 10.1046/j.1525-1594.1999.06307.x
   Mintz GS, 2000, CURR INTERV CARDIOL, V2, P316
   Mizuno O, 2000, AM J CARDIOL, V85, P154, DOI 10.1016/S0002-9149(99)00651-7
   MOAKE JL, 1988, BLOOD, V71, P1366
   MOTOMIYA M, 1984, STROKE, V15, P50, DOI 10.1161/01.STR.15.1.50
   MOZES N, 1987, BIOTECHNOL BIOENG, V30, P439, DOI 10.1002/bit.260300315
   Mudaliar JH, 2001, J VASC SURG, V34, P17, DOI 10.1067/mva.2001.115602
   Muramatsu T, 2001, J Invasive Cardiol, V13, P634
   OBRIEN JR, 1990, LANCET, V335, P711, DOI 10.1016/0140-6736(90)90815-M
   Oh E, 1999, INT J PHARM, V188, P203, DOI 10.1016/S0378-5173(99)00224-0
   Park S, 2000, J BIOMED MATER RES, V53, P568, DOI 10.1002/1097-4636(200009)53:5<568::AID-JBM17>3.0.CO;2-8
   Ratnatunga CP, 1998, ANN THORAC SURG, V66, P1940, DOI 10.1016/S0003-4975(98)01183-7
   Rensing BJ, 2001, EUR HEART J, V22, P2125, DOI 10.1053/euhj.2001.2892
   Roe SD, 1998, NEPHROL DIAL TRANSPL, V13, P3226, DOI 10.1093/ndt/13.12.3226
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Snyder SO, 2000, J VASC SURG, V32, P504
   Spijker HT, 2002, J ADHES SCI TECHNOL, V16, P1703, DOI 10.1163/156856102320396094
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Spijker HT, 2003, THROMB RES, V108, P57
   Stein PD, 1998, CHEST, V114, p602S, DOI 10.1378/chest.114.5_Supplement.602S
   STIEKEMA JCJ, 1986, CLIN NEPHROL, V26, pS3
   STURZENEGGER M, 1995, STROKE, V26, P63, DOI 10.1161/01.STR.26.1.63
   SUN X, 1999, J BIOMED MATER RES, V49, P66
   Suzuki H, 1996, PROG HISTOCHEM CYTOC, V30, P1
   Tandon P, 1997, BIOPHYS J, V73, P2819, DOI 10.1016/S0006-3495(97)78311-5
   Utoh J, 1998, J CARDIOVASC SURG, V39, P179
   VANHOLDER R, 1992, Clinical Materials, V10, P87, DOI 10.1016/0267-6605(92)90090-G
   VEITH FJ, 1986, J VASC SURG, V3, P104
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P794, DOI 10.1016/S0022-5223(99)70301-6
   Vrolix MCM, 2000, AM J CARDIOL, V86, P385, DOI 10.1016/S0002-9149(00)00951-6
   Wagner CT, 1996, BIORHEOLOGY, V33, P209, DOI 10.1016/0006-355X(96)00018-2
   Webb JS, 1999, APPL ENVIRON MICROB, V65, P3575
   Wentzel JJ, 2001, CIRCULATION, V103, P1740, DOI 10.1161/01.CIR.103.13.1740
   Windus DW, 1997, AM J KIDNEY DIS, V29, P560, DOI 10.1016/S0272-6386(97)90338-3
   Wittenberg G, 1998, CARDIOVASC INTER RAD, V21, P225, DOI 10.1007/s002709900249
   Wood EM, 2000, J BIOMED MATER RES, V51, P147, DOI 10.1002/(SICI)1097-4636(200008)51:2<147::AID-JBM1>3.0.CO;2-Y
   Wyers MC, 1999, CARDIOVASC PATHOL, V8, P153, DOI 10.1016/S1054-8807(99)00005-8
   Yang MJ, 1999, J BIOMED MATER RES, V48, P648, DOI 10.1002/(SICI)1097-4636(1999)48:5<648::AID-JBM8>3.0.CO;2-6
   Yoganathan AP, 1995, BIOMEDICAL ENG HDB, P1847
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x
NR 107
TC 60
Z9 63
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2003
VL 24
IS 26
BP 4717
EP 4727
DI 10.1016/S0142-9612(03)00380-6
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 734DK
UT WOS:000186039800001
PM 14530069
DA 2018-10-19
ER

PT J
AU Sandeman, SR
   Lloyd, AW
   Tighe, BJ
   Franklin, V
   Li, J
   Lydon, F
   Liu, CSC
   Mann, DJ
   James, SE
   Martin, R
AF Sandeman, SR
   Lloyd, AW
   Tighe, BJ
   Franklin, V
   Li, J
   Lydon, F
   Liu, CSC
   Mann, DJ
   James, SE
   Martin, R
TI A model for the preliminary biological screening of potential
   keratoprosthetic biomaterials
SO BIOMATERIALS
LA English
DT Article
DE keratoprosthesis; cornea; preliminary screening model; GFP
ID IN-VITRO; COMPLEMENT ACTIVATION; PROTEIN; BIOCOMPATIBILITY; FIBRONECTIN;
   EXPRESSION; SURFACES; ADHESION; CORNEA; CELLS
AB A series of in vitro screening assays for the preliminary selection of biomaterials for use in the fabrication of artificial corneas (keratoprostheses) (KPros) have been investigated. These screening assays assessed the initial binding of inflammatory and cell adhesive proteins, activation of inflammatory proteins, adhesion of keratocytes, epithelial cells and macrophages and the production of inflammatory cytokines by keratocytes contacting biomaterials. Central optic biomaterials were selected on the basis of low-inflammatory and cell adhesion potential. Peripheral skirt materials were selected on the basis of low-inflammatory potential but good cell adhesion to anchor the implant within the host cornea. Green fluorescent protein (GFP) gene transfer was used in a novel context to investigate cell invasion in the absence of external staining techniques. Confocal laser scanning microscopy and scanning electron microscopy were used to investigate GFP positive keratocyte invasion of porous materials. The results of in vitro assays were compared to a corneal organ culture system in which the biomaterials were assessed within a stromal environment. A range of polyurethane-based interpenetrating polymers with a range of water contents were screened. All materials showed low-inflammatory potential. A reduction in biomaterial water content induced an increase in complement C3 and fibronectin binding and in cell adhesion to materials, whilst differences in co-monomer formulation had little impact. The screening methods used in the current study provide a suitable preliminary assessment regime for the in vitro evaluation of potential KPro materials. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
   Aston Univ, Biomat Res Grp, Birmingham B4 7ET, W Midlands, England.
   Sussex Eye Hosp, Brighton, E Sussex, England.
   Queen Victoria Hosp, Blond McIndoe Res Ctr, E Grinstead, England.
RP Lloyd, AW (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR Abraham GA, 2001, BIOMATERIALS, V22, P1971, DOI 10.1016/S0142-9612(00)00381-1
   Bradshaw JJ, 1999, INVEST OPHTH VIS SCI, V40, P230
   BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9
   CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295
   Chirila TV, 2001, BIOMATERIALS, V22, P3311, DOI 10.1016/S0142-9612(01)00168-5
   Cole N, 1999, INFECT IMMUN, V67, P2497
   DEKKER A, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P25
   DING M, 1988, J OCUL PHARMACOL, V4, P75, DOI 10.1089/jop.1988.4.75
   DROPCOVA S, 2000, OPHTHALMIC RES, V21, P33
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Evans MDM, 2002, BIOMATERIALS, V23, P1359, DOI 10.1016/S0142-9612(01)00255-1
   Felts K, 2000, STRATEGIES NEWSLETTE, V13, P85
   Garrett Q, 2000, INVEST OPHTH VIS SCI, V41, P1687
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   GIPSON IK, 1993, INT OPHTHALMOL CLIN, V33, P149
   GIRARD MT, 1991, INVEST OPHTH VIS SCI, V32, P2441
   Hicks CR, 1997, SURV OPHTHALMOL, V42, P175, DOI 10.1016/S0039-6257(97)00024-6
   Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5
   Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Soltys-Robitaille CE, 2001, BIOMATERIALS, V22, P3257, DOI 10.1016/S0142-9612(01)00163-6
   STOTOZONO C, 2000, CORNEA, V19, pS155
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 30
TC 15
Z9 19
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2003
VL 24
IS 26
BP 4729
EP 4739
DI 10.1016/S0142-9612(03)00370-3
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 734DK
UT WOS:000186039800002
PM 14530070
DA 2018-10-19
ER

PT J
AU Matsuda, N
   Horikawa, M
   Yoshida, M
   Watanabe, M
   Nagahata, M
   Teramoto, A
   Abe, K
AF Matsuda, N
   Horikawa, M
   Yoshida, M
   Watanabe, M
   Nagahata, M
   Teramoto, A
   Abe, K
TI Enhanced DNA synthesis accompanied by constitutive phosphorylation of
   the ERK pathway in human fibroblasts cultured on a polyelectrolyte
   complex
SO BIOMATERIALS
LA English
DT Article
DE PEC; DNA synthesis; ERK; FAK; aggregation
ID EPIDERMAL-GROWTH-FACTOR; IN-VITRO; DIFFERENTIAL ACTIVATION;
   SIGNAL-TRANSDUCTION; HPLF FUNCTION; CELLS; CHITOSAN; PROLIFERATION;
   AGGREGATION; KINASES
AB In this study, we examined the cellular and molecular responses of fibroblasts cultured on a polyelectrolyte complex (PEC) derived from sulfated chitin as a polyanion and chitosan as a polycation. On PEC-coated dishes, the fibroblasts aggregated and then developed spheroid-like structures. At earlier stages of culture, DNA synthesis of cells cultured on PEC was stimulated approximately 75% higher than control cells. Among various signaling molecules examined, including mitogen-activated protein kinases, Akt/PKB and p53, an extracellular-signal-regulated kinase (ERK) was selectively and constitutively phosphorylated in cells cultured on PEC. The constitutive phosphorylation of ERK was derived from an activation of the ERK kinase MEK, but not from an inactivation of the ERK phosphatase MKP-1. Furthermore, ERK phosphorylation was almost abolished by a membrane receptor tyrosine kinase inhibitor. The enhanced phosphorylation of focal adhesion kinase, a downstream molecule of integrins, was also observed in cells cultured on PEC. These results suggest that fibroblasts recognize PEC as a continuous mitogenic stimulant which results in the constitutive activation of the MEK-ERK pathway toward mitogenesis. Further, PEC interacts with the cell membrane leading to activation of membrane molecules, including integrins and receptor tyrosine kinases. These responses may account, at least in part, for the potential use of PEC as a biomaterial for tissue regeneration. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Nagasaki Univ, Ctr Frontier Life Sci, Nagasaki 8528523, Japan.
   Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan.
   Shinshu Univ, Fac Text Sci & Technol, Nagano 3868567, Japan.
RP Matsuda, N (reprint author), Nagasaki Univ, Ctr Frontier Life Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
CR ANDEREGG G, 1954, HELV CHIM ACTA, V37, P113, DOI 10.1002/hlca.19540370114
   BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0
   Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001, DOI 10.14670/HH-14.1001
   CHANG L, 2001, SCIENCE, V410, P37
   Faucheux N, 2002, BIOMATERIALS, V23, P2295, DOI 10.1016/S0142-9612(01)00363-5
   Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hamano T, 1998, J MACROMOL SCI PURE, VA35, P439, DOI 10.1080/10601329808001988
   Hamano T, 1998, J BIOMED MATER RES, V41, P270, DOI 10.1002/(SICI)1097-4636(199808)41:2<270::AID-JBM12>3.3.CO;2-B
   Hasegawa M, 2001, JPN J CANCER RES, V92, P459, DOI 10.1111/j.1349-7006.2001.tb01116.x
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Huang RP, 1996, J CELL BIOL, V133, P211, DOI 10.1083/jcb.133.1.211
   Kim HJ, 1999, J BIOMAT SCI-POLYM E, V10, P543, DOI 10.1163/156856299X00478
   Kinoshita N, 2001, CELL TRANSPLANT, V10, P473
   Li HY, 1999, PHYTOMEDICINE, V6, P305, DOI 10.1016/S0944-7113(99)80050-6
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   Matsuda N, 2000, PHOTOCHEM PHOTOBIOL, V72, P334, DOI 10.1562/0031-8655(2000)072<0334:DAOEAJ>2.0.CO;2
   Matsuda N, 1998, ARCH ORAL BIOL, V43, P987, DOI 10.1016/S0003-9969(98)00079-X
   Matsuda N, 1998, BIOCHEM BIOPH RES CO, V249, P350, DOI 10.1006/bbrc.1998.9151
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   SCHWEIGER RG, 1972, CARBOHYD RES, V21, P219, DOI 10.1016/S0008-6215(00)82148-5
   SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2
   TONG JZ, 1994, BIOL CELL, V81, P77, DOI 10.1016/0248-4900(94)90058-2
   WATANABE M, 1992, INT J RADIAT BIOL, V62, P711, DOI 10.1080/09553009214552661
   Xian WJ, 1999, BIOCHEMISTRY-US, V38, P7219, DOI 10.1021/bi982301f
   Yanase H, 2001, PIGM CELL RES, V14, P103, DOI 10.1034/j.1600-0749.2001.140205.x
NR 27
TC 9
Z9 12
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2003
VL 24
IS 26
BP 4771
EP 4776
DI 10.1016/S0142-9612(03)00375-2
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 734DK
UT WOS:000186039800006
PM 14530074
DA 2018-10-19
ER

PT J
AU Orth, RN
   Kameoka, J
   Zipfel, WR
   Ilic, B
   Webb, WW
   Clark, TG
   Craighead, HG
AF Orth, RN
   Kameoka, J
   Zipfel, WR
   Ilic, B
   Webb, WW
   Clark, TG
   Craighead, HG
TI Creating biological membranes on the micron scale: Forming patterned
   lipid bilayers using a polymer lift-off technique
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID FLUORESCENCE PHOTOBLEACHING RECOVERY; LATERAL DIFFUSION;
   PHOSPHOLIPID-BILAYERS; SUPPORTS; BARRIERS; MOBILITY; SYSTEM; FIELD
AB We present a new method for creating patches of fluid lipid bilayers with conjugated biotin and other compounds down to 1 mum resolution using a photolithographically patterned polymer lift-off technique. The patterns are realized as the polymer is mechanically peeled away in one contiguous piece in solution. The functionality of these surfaces is verified with binding of antibodies and avidin on these uniform micron-scale platforms. The biomaterial patches, measuring 1 mum - 76 mum on edge, provide a synthetic biological substrate for biochemical analysis that is; 1003 smaller in width than commercial printing technologies. 100 nm unilamellar lipid vesicles spread to form a supported fluid lipid bilayer on oxidized silicon surface as confirmed by fluorescence photobleaching recovery. Fluorescence photobleaching recovery measurements of DiI (1,1'-dioctadecyl- 3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiIC(18)(3))) stained bilayer patches yielded an average diffusion coefficient of 7.54 +/- 1.25 mum(2) s(-1), equal to or slightly faster than typically found in DiI stained cells. This diffusion rate is similar to3 x faster than previous values for bilayers on glass. This method provides a new means to form functionalized fluid lipid bilayers as micron-scale platforms to immobilize biomaterials, capture antibodies and biotinylated reagents from solution, and form antigenic stimuli for cell stimulation.
C1 Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
   Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.
   Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.
RP Orth, RN (reprint author), 1030 S Highway A1A, Patrick AFB, FL 32925 USA.
RI Webb, Watt/B-5905-2011; Ilic, Rob/N-1359-2014
OI Zipfel, Warren/0000-0003-2640-329X
CR *AV POL LIP, 2001, AV POL LIP CAT
   AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4
   BAYERL TM, 1990, BIOPHYS J, V58, P357, DOI 10.1016/S0006-3495(90)82382-1
   Biebuyck HA, 1997, IBM J RES DEV, V41, P159, DOI 10.1147/rd.411.0159
   BLOOM JA, 1983, BIOPHYS J, V42, DOI UNSP 295305
   Branch DW, 2000, IEEE T BIO-MED ENG, V47, P290, DOI 10.1109/10.827289
   Brown EB, 1999, BIOPHYS J, V77, P2837, DOI 10.1016/S0006-3495(99)77115-8
   Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x
   Cremer PS, 1999, LANGMUIR, V15, P3893, DOI 10.1021/la981240j
   Dontha N, 1997, ANAL CHEM, V69, P2619, DOI 10.1021/ac9702094
   FAHEY PF, 1978, BIOCHEMISTRY-US, V17, P3046, DOI 10.1021/bi00608a016
   Fitzgerald DA, 2002, SCIENTIST, V16, P42
   Fulbright RM, 1997, EXP CELL RES, V233, P128, DOI 10.1006/excr.1997.3553
   Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8
   Groves JT, 1995, BIOPHYS J, V69, P1972, DOI 10.1016/S0006-3495(95)80067-6
   Groves JT, 2002, ACCOUNTS CHEM RES, V35, P149, DOI 10.1021/ar950039m
   Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651
   Hovis JS, 2001, LANGMUIR, V17, P3400, DOI 10.1021/la0017577
   Hovis JS, 2000, LANGMUIR, V16, P894, DOI 10.1021/la991175t
   Ilic B, 2000, BIOMED MICRODEVICES, V2, P317, DOI 10.1023/A:1009911407093
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   JOHNSON SJ, 1991, BIOPHYS J, V59, P289, DOI 10.1016/S0006-3495(91)82222-6
   Kam L, 2001, J BIOMED MATER RES, V55, P487, DOI 10.1002/1097-4636(20010615)55:4<487::AID-JBM1041>3.0.CO;2-7
   Kung LA, 2000, LANGMUIR, V16, P6773, DOI 10.1021/la000653t
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Orth RN, 2003, BIOMED MICRODEVICES, V5, P29, DOI 10.1023/A:1024459215654
   Orth RN, 2003, LANGMUIR, V19, P1599, DOI 10.1021/la026314c
   RICHARDS B, 1959, PROC R SOC LON SER-A, V253, P358, DOI 10.1098/rspa.1959.0200
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Savage D., 1994, AVIDIN BIOTIN CHEM H
   TIEN HT, 1990, BIOTECHNOL APPL BIOC, V12, P478
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244
   ZIPFEL WR, 2001, METHODS CELLULAR IMA, P216
   ZVIMAN M, 1991, BIOSENS BIOELECTRON, V6, P37, DOI 10.1016/0956-5663(91)85006-I
NR 35
TC 70
Z9 70
U1 2
U2 25
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD NOV 1
PY 2003
VL 85
IS 5
BP 3066
EP 3073
DI 10.1016/S0006-3495(03)74725-0
PG 8
WC Biophysics
SC Biophysics
GA 736UA
UT WOS:000186190500026
PM 14581207
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Zisch, AH
   Lutolf, MP
   Hubbell, JA
AF Zisch, AH
   Lutolf, MP
   Hubbell, JA
TI Biopolymeric delivery matrices for angiogenic growth factors
SO CARDIOVASCULAR PATHOLOGY
LA English
DT Review
DE therapeutic angiogenesis; controlled release; growth factor; natural
   biopolymers; synthetic biopolymers; cell-responsive matrix
ID EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS; OXIDIZED REGENERATED CELLULOSE;
   ENDOTHELIAL-CELL PROLIFERATION; CONTROLLED-RELEASE; IN-VITRO; ADHESION
   PREVENTION; FIBRIN GLUE; THERAPEUTIC ANGIOGENESIS; INTRAMUSCULAR
   INJECTION; POSTOPERATIVE ADHESIONS
AB The development of new therapeutic approaches that aim to help the body exert its natural mechanisms for vascularized tissue growth (therapeutic angiogenesis) has become one of the most active areas of tissue engineering. Through basic research, several growth factor families and cytokines that are capable to induce physiological blood vessel formation have been identified. Indeed, preclinical and clinical investigations have indicated that therapeutic administration of angiogenic factors, such as the prototypic vascular endothelial growth factor (VEGF) or basic fibroblast growth factor (bFGF), to sites of ischemia in the heart or the limb can improve regional blood flow. For new and lasting tissue vascularization, prolonged tissue exposure to these factors could be critical. Furthermore, as shown for VEGF, dosage must be tightly controlled, as excess amounts of VEGF can cause severe vascular leakage and hypotension. This review emphasizes natural and synthetic polymer matrices with respect to their development as vehicles for local and controlled delivery of angiogenic proteins, such as VEGF and bFGF, and their clinical applicability. In the dawn of experimental vascular engineering, new biomaterial schemes for clinical growth factor administration that take better account of biological principles of angiogenic growth factor function and the cell biological basis necessary to produce functional vasculature are evolving. Alongside their base function as protective embedment for angiogenic growth factors, these new classes of bioactive polymers are engineered with additional functionalities that better preserve growth factor activity and more closely mimic the in vivo release mechanisms band profiles of angiogenic growth factors from the extracellular matrix (ECM). Consequently, the preparation of both natural or completely synthetic materials with biological characteristics of the ECM has become central to many tissue engineering approaches that aim to deliver growth factors in a therapeutically efficient mode. Another promising venue to improve angiogenic performance is presented by biomaterials that allow sequential delivery of growth factors with complementary roles in blood vessel initiation and stabilization. (C) 2003 Elsevier Inc. All rights reserved.
C1 ETH Zentrum, Swiss Fed Inst Technol, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   ETH Zentrum, Swiss Fed Inst Technol, Dept Mat Sci, CH-8044 Zurich, Switzerland.
   Univ Zurich, CH-8044 Zurich, Switzerland.
RP Zisch, AH (reprint author), ETH Zentrum, Swiss Fed Inst Technol, Inst Biomed Engn, Moussonstr 18, CH-8044 Zurich, Switzerland.
RI Lutolf, Matthias/E-5914-2010; Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR ALBES JM, 1994, ANN THORAC SURG, V57, P444, DOI 10.1016/0003-4975(94)91015-4
   Andree C, 2001, TISSUE ENG, V7, P757, DOI 10.1089/107632701753337708
   Arras M, 1998, NAT BIOTECHNOL, V16, P159, DOI 10.1038/nbt0298-159
   AUGER FA, 1995, IN VITRO CELL DEV-AN, V31, P432
   Bach AD, 2001, TISSUE ENG, V7, P45, DOI 10.1089/107632701300003287
   BANAI S, 1994, CARDIOVASC RES, V28, P1176, DOI 10.1093/cvr/28.8.1176
   BERSCHT PC, 1994, BIOMATERIALS, V15, P593, DOI 10.1016/0142-9612(94)90209-7
   BIKFALVI A, 1991, J CELL PHYSIOL, V149, P50, DOI 10.1002/jcp.1041490108
   Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398
   Chekanov VS, 1996, ASAIO J, V42, pM480, DOI 10.1097/00002480-199609000-00034
   Chowdhury SM, 1996, J SURG RES, V61, P58, DOI 10.1006/jsre.1996.0081
   Cleland JL, 2001, J CONTROL RELEASE, V72, P13, DOI 10.1016/S0168-3659(01)00258-9
   Deutsch M, 1997, J VASC SURG, V25, P757, DOI 10.1016/S0741-5214(97)70307-0
   DOWNS EC, 1992, J CELL PHYSIOL, V152, P422, DOI 10.1002/jcp.1041520225
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Elcin YM, 1996, ARTIF CELL BLOOD SUB, V24, P257, DOI 10.3109/10731199609117438
   ELEIN YM, 2001, ARTIF ORGANS, V25, P558
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   FASOL R, 1994, J THORAC CARDIOV SUR, V107, P1432
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   Gerber HP, 1999, NAT MED, V5, P623
   GREISLER HP, 1992, SURGERY, V112, P244
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hall H, 2001, MICROVASC RES, V62, P315, DOI 10.1006/mvre.2001.2348
   HARADA K, 1994, J CLIN INVEST, V94, P623, DOI 10.1172/JCI117378
   Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226
   Henry TD, 2001, AM HEART J, V142, P872, DOI 10.1067/mhj.2001.118471
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HILLWEST JL, 1994, FERTIL STERIL, V62, P630
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   HillWest JL, 1995, J SURG RES, V59, P759, DOI 10.1006/jsre.1995.1236
   Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7
   Horowitz JR, 1997, ARTERIOSCL THROM VAS, V17, P2793, DOI 10.1161/01.ATV.17.11.2793
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Isner JM, 1996, HUM GENE THER, V7, P959, DOI 10.1089/hum.1996.7.8-959
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jiang WG, 1998, INT J MOL MED, V2, P203
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kim TK, 2002, J PHARM PHARMACOL, V54, P897, DOI 10.1211/002235702760089009
   Kipshidze N, 2000, TEX HEART I J, V27, P196
   KUWABARA K, 1995, P NATL ACAD SCI USA, V92, P4606, DOI 10.1073/pnas.92.10.4606
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   Laham RJ, 1999, CURR INTERV CARDIOL, V1, P228
   LANDEEN L, 2001, ABSTR ENG TISS
   Lazarous DF, 2000, J AM COLL CARDIOL, V36, P1239, DOI 10.1016/S0735-1097(00)00882-2
   Lazarous DF, 1997, CARDIOVASC RES, V36, P78, DOI 10.1016/S0008-6363(97)00142-9
   Lee KY, 2000, NATURE, V408, P998
   Lee RJ, 2000, CIRCULATION, V102, P898
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4
   Matsunaga T, 2000, CIRCULATION, V102, P3098
   Newton D J, 2002, J Foot Ankle Surg, V41, P233
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Pepper MS, 1996, ENZYME PROTEIN, V49, P138, DOI 10.1159/000468622
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Porte HL, 2001, ANN THORAC SURG, V71, P1618, DOI 10.1016/S0003-4975(01)02468-7
   Post MJ, 2001, CARDIOVASC RES, V49, P522, DOI 10.1016/S0008-6363(00)00216-9
   Post MJ, 2002, ANN NY ACAD SCI, V961, P249, DOI 10.1111/j.1749-6632.2002.tb03093.x
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rutanen J, 2001, Curr Cardiol Rep, V3, P29, DOI 10.1007/s11886-001-0007-z
   Sahni A, 1999, J BIOL CHEM, V274, P14936, DOI 10.1074/jbc.274.21.14936
   Sahni A, 2000, THROMB HAEMOSTASIS, V83, P736
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   Scarborough JE, 2002, J SURG RES, V107, P119, DOI 10.1006/jsre.2002.6475
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622
   Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shireman PK, 1999, J VASC SURG, V29, P852, DOI 10.1016/S0741-5214(99)70213-2
   Shireman PK, 1998, J LONG-TERM EFF MED, V8, P117
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   SLVIN M, 2002, J BIOL CHEM, V277, P41046
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   Vajanto I, 2002, J GENE MED, V4, P371, DOI 10.1002/jgm.287
   Wain JC, 2001, ANN THORAC SURG, V71, P1623, DOI 10.1016/S0003-4975(01)02537-1
   Watanabe E, 1998, BASIC RES CARDIOL, V93, P30, DOI 10.1007/s003950050059
   Weatherford DA, 1996, SURGERY, V120, P433, DOI 10.1016/S0039-6060(96)80320-5
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   WEST JL, 1995, BIOMATERIALS, V16, P1153, DOI 10.1016/0142-9612(95)93579-3
   West JL, 1996, J REPROD MED, V41, P149
   Whalen G F, 1989, Growth Factors, V1, P157, DOI 10.3109/08977198909029125
   Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Zarge JI, 1997, AM J SURG, V174, P188, DOI 10.1016/S0002-9610(97)00090-1
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 104
TC 227
Z9 243
U1 2
U2 59
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-8807
J9 CARDIOVASC PATHOL
JI Cardiovasc. Pathol.
PD NOV-DEC
PY 2003
VL 12
IS 6
BP 295
EP 310
DI 10.1016/S1054-8807(03)00089-9
PG 16
WC Cardiac & Cardiovascular Systems; Pathology
SC Cardiovascular System & Cardiology; Pathology
GA 750VG
UT WOS:000187018700001
PM 14630296
DA 2018-10-19
ER

PT J
AU Naumann, A
   Aigner, J
   Staudenmaier, R
   Seemann, M
   Bruening, R
   Englmeier, KH
   Kadegge, G
   Pavesio, A
   Kastenbauer, E
   Berghaus, A
AF Naumann, A
   Aigner, J
   Staudenmaier, R
   Seemann, M
   Bruening, R
   Englmeier, KH
   Kadegge, G
   Pavesio, A
   Kastenbauer, E
   Berghaus, A
TI Clinical aspects and strategy for biomaterial engineering of an auricle
   based on three-dimensional stereolithography
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Article
DE auricle deformity; tissue engineering; computer-aided design;
   stereolithography; bioresorbable preformed biomaterials
ID RIB CARTILAGE GRAFTS; EAR RECONSTRUCTION; PERSONAL-EXPERIENCE; EXTERNAL
   EAR; HUMAN BONE; IN-VITRO; CHONDROCYTES; MICROTIA; REPAIR;
   TRANSPLANTATION
AB At the present time, the partial and/or complete reconstruction of an auricle from autologous rib cartilage is one of most widely published techniques. In the field of tissue engineering, different techniques have been described to generate cartilage tissue using isolated chondrocytes. The basis of these tissue-engineering techniques is bioresorbable or non-bioresorbable biomaterials, which serve as a three-dimensional cell carrier. Tissue engineering of an auricle requires preformed bioresorbable biomaterials designed to fit the form of a patient's auricular defect. Three-dimensional imaging acquired from computed tomography scans or laser surface scanning has become an important tool in modern medicine. This study represents the preoperative procedures for the reconstruction of an auricle through tissue engineering in accordance with the clinical aspects. Hyaff 11, a hyaluronic acid derivative, was used as a three-dimensional cell carrier for isolated human nasoseptal chondrocytes. The chondrocytes were amplified in a conventional monolayer culture before the cells were seeded on a hyaluronic non-woven mesh and cultured in vitro for 4 weeks. The chondrogenic potential of human nasal chondrocytes in Hyaff 11 was investigated by confocal laser scanning microscopy, histology (toluidine blue) and immunohistochemistry (collagen type II). Computer-aided design (CAD) and manufacture of an auricle model with stereolithographical methods were used for the prefabrication of a bioresorbable three-dimensional cell carrier designed in the form of a patient's auricular defect. The cell carrier used was Hyaff 11, a fully benzyl-esterified hyaluronic acid derivative. Confocal laser scanning microscopy has shown good cell attachment, a homogenous distribution of amplified chondrocytes and a viability of more than 90%. After 4 weeks in vitro culture the human nasoseptal chondrocytes synthesized new cartilage with the expression of cartilage-specific collagen type II. In order to shape a patient's designed scaffold the auricle model was fitted exactly and symetrically to the contralateral side. Subsequently, the mirror image patient-specific model was used to prepare an identical scaffold model made of a fully benzyl-esterified hyaluronic acid derivative. The bioresorbable scaffold that was produced gave a satisfactory representation of auricle structure. Bioresorbable preformed biomaterials in the form of a patient's auricle defect represent an important prerequisite for the tissue engineering of autologous auricle grafts. Hyaff 11 seems to be a promising material for tissue engineering of cartilage transplants, and the application of this approach will improve conventional reconstructive surgery in the future.
C1 Univ Munich, Dept Otorhinolaryngol & Head & Neck Surg, D-81377 Munich, Germany.
   Univ Munich, Dept Radiol, Munich, Germany.
   GSF, Inst Med Informat, Neuherberg, Germany.
   KL Tech GmbH, Munich, Germany.
   Univ Tubingen, Dept Radiol, Tubingen, Germany.
   Fidia Adv Biopolymers Srl, Padua, Italy.
RP Naumann, A (reprint author), Univ Munich, Dept Otorhinolaryngol & Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany.
OI Englmeier, Karl-Hans/0000-0001-6028-5392
CR Aigner J, 1997, LARYNGO RHINO OTOL, V76, P248, DOI 10.1055/s-2007-997420
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BERGHAUS A, 1983, LARYNG RHINOL OTOL V, V62, P320, DOI 10.1055/s-2007-1008442
   BILL JS, 1995, INT J ORAL MAX SURG, V24, P98, DOI 10.1016/S0901-5027(05)80869-0
   BREITBART AS, 1998, CURR OPIN OTOLARYNGO, V6, P226
   BRENT B, 1992, PLAST RECONSTR SURG, V90, P355, DOI 10.1097/00006534-199209000-00001
   Brent B, 1999, PLAST RECONSTR SURG, V104, P319, DOI 10.1097/00006534-199908000-00001
   Britt JC, 1998, ARCH OTOLARYNGOL, V124, P671, DOI 10.1001/archotol.124.6.671
   Brix F, 1987, Fortschr Kiefer Gesichtschir, V32, P74
   Brunner F X, 1993, Eur Arch Otorhinolaryngol Suppl, V1, P311
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   CONVERSE J M, 1963, Plast Reconstr Surg, V32, P425, DOI 10.1097/00006534-196310000-00004
   DICKSON WA, 1988, BRIT J PLAST SURG, V41, P408, DOI 10.1016/0007-1226(88)90083-5
   Dounchis JS, 1997, J ORTHOPAED RES, V15, P803, DOI 10.1002/jor.1100150603
   Erickson DM, 1999, J ORAL MAXIL SURG, V57, P1040, DOI 10.1016/S0278-2391(99)90322-1
   Firmin F, 1998, SCAND J PLAST RECONS, V32, P35, DOI 10.1080/02844319850158930
   Hammer C, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P3
   HOLTMANN S, 1993, LARYNGO RHINO OTOL, V72, P43, DOI 10.1055/s-2007-997852
   HUETTENBRINK KB, 1995, LARYN RHINOL OTOL, V69, P327
   HULL C, 1991, CIBA GEIGY KUNSTSTOF, V26, P2
   Kamil SH, 2003, LARYNGOSCOPE, V113, P90, DOI 10.1097/00005537-200301000-00017
   KASTENBAUER ER, 1983, HNO, V31, P371
   Kelley TF, 1998, ARCH OTOLARYNGOL, V124, P335, DOI 10.1001/archotol.124.3.335
   Klein-Nulend J, 1998, J BIOMED MATER RES, V40, P614, DOI 10.1002/(SICI)1097-4636(19980615)40:4<614::AID-JBM13>3.0.CO;2-F
   KUBLER N, 1993, J ORAL MAXIL SURG, V51, P1346
   Mankovich N J, 1990, J Digit Imaging, V3, P200
   MARSH JL, 1983, SURGERY, V94, P759
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   NAGATA S, 1994, PLAST RECONSTR SURG, V93, P231, DOI 10.1097/00006534-199402000-00002
   NAGATA S, 1993, PLAST RECONSTR SURG, V92, P187, DOI 10.1097/00006534-199308000-00001
   Naumann A, 1998, AM J RHINOL, V12, P59, DOI 10.2500/105065898782102972
   Park S S, 1995, Facial Plast Surg, V11, P278, DOI 10.1055/s-2008-1064544
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   Rettinger G, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P127
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   RUECKERT F, 1987, PLAST SURG HEAD NECK, V1, P488
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   TANZER RC, 1978, PLAST RECONSTR SURG, V61, P161, DOI 10.1097/00006534-197802000-00001
   ten Koppel PGJ, 1998, PLAST RECONSTR SURG, V102, P2012, DOI 10.1097/00006534-199811000-00031
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WALD HL, 1993, BIOMATERIALS, V14, P270, DOI 10.1016/0142-9612(93)90117-K
   WILLIAMS DF, 1995, P 21 ANN M SOC BIOM, V28, P180
   WUSTROW TPU, 1991, LARYNGO RHINO OTOL, V70, P387, DOI 10.1055/s-2007-998059
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
NR 50
TC 24
Z9 26
U1 0
U2 16
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0937-4477
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD NOV
PY 2003
VL 260
IS 10
BP 568
EP 575
DI 10.1007/s00405-003-0636-5
PG 8
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 744LT
UT WOS:000186632600010
PM 12827382
DA 2018-10-19
ER

PT J
AU Biran, R
   Noble, MD
   Tresco, PA
AF Biran, R
   Noble, MD
   Tresco, PA
TI Directed nerve outgrowth is enhanced by engineered glial substrates
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE neurite; guidance; astrocyte; oriented; neurite outgrowth; engineer;
   axon; glia; extracellular matrix; biomaterial
ID RAT SPINAL-CORD; NEURITE OUTGROWTH; REACTIVE ASTROCYTES; FUNCTIONAL
   RECOVERY; BASEMENT-MEMBRANE; WHITE-MATTER; IN-VITRO; CEREBRAL-CORTEX;
   SYSTEM NEURONS; SCHWANN-CELLS
AB In the present study, the influence of astrocyte alignment on the direction and length of regenerating neurites was examined in vitro. Astrocytes were experimentally manipulated by different approaches to create longitudinally aligned monolayers. When cultured on the aligned monolayers, dorsal root ganglion neurites grew parallel to the long axis of the aligned astrocytes and were significantly longer than controls. Engineered monolayers expressed linear arrays of fibronectin, laminin, neural cell adhesion molecule, and chondroitin sulfate proteoglycan that were organized parallel to one another, suggesting that a particular spatial arrangement of these molecules on the astrocyte surface may be necessary to direct nerve regeneration in vivo. In contrast, no bias in directional outgrowth was observed for neurites growing on unorganized monolayers. The results suggest that altering the organization of astrocytes and their scar-associated matrix at the lesion site may be used to influence the direction and the length of adjacent regenerating axons in the damaged brain and spinal cord. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
   Univ Rochester, Sch Med, Dept Biomed Genet, Rochester, NY 14642 USA.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, 20S 2030E,Bldg 570,Room 108, Salt Lake City, UT 84112 USA.
EM patrick.tresco@utah.edu
CR Alberts B., 1994, MOL BIOL CELL, P984
   ANDERSON PN, 1986, J ANAT, V147, P73
   Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F
   BARRETT CP, 1981, EXP NEUROL, V73, P365, DOI 10.1016/0014-4886(81)90272-7
   BERNSTEIN JJ, 1985, BRAIN RES, V327, P135, DOI 10.1016/0006-8993(85)91507-0
   Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   BOHN RC, 1982, AM J ANAT, V165, P397, DOI 10.1002/aja.1001650405
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   BROOK GA, 1994, EXP NEUROL, V126, P31, DOI 10.1006/exnr.1994.1040
   Brook GA, 2001, GLIA, V33, P118, DOI 10.1002/1098-1136(200102)33:2<118::AID-GLIA1011>3.0.CO;2-Y
   Broome MC, 1998, AUST J DAIRY TECHNOL, V53, P5
   Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409
   Bungner OV, 1891, BEITR PATHOL ANAT, V10, P321
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   CHIU DTW, 1982, SURGERY, V91, P226
   Clemente CD, 1955, REGENERATION CENTRAL, P147
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   Davies SJA, 1997, NATURE, V390, P680
   Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X
   FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4
   Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   GLASBY MA, 1986, J NEUROCYTOL, V15, P497, DOI 10.1007/BF01611732
   GOMEZ TM, 1994, J NEUROSCI, V14, P5959
   GRIERSON JP, 1990, DEV BRAIN RES, V55, P11, DOI 10.1016/0165-3806(90)90100-D
   Grill R, 1997, J NEUROSCI, V17, P5560
   Grimpe B, 2002, J NEUROSCI, V22, P3144, DOI 10.1523/JNEUROSCI.22-08-03144.2002
   HAMMARBACK JA, 1985, J NEUROSCI RES, V13, P213, DOI 10.1002/jnr.490130115
   Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299
   HORTEGA PD, 1927, B J HOPKINS HOSP, V41, P278
   KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2
   KEYNES RJ, 1984, BRAIN RES, V295, P275, DOI 10.1016/0006-8993(84)90976-4
   Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982
   Li Y, 1998, J NEUROSCI, V18, P10514
   LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x
   LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1
   LIESI P, 1983, J CELL BIOL, V96, P920, DOI 10.1083/jcb.96.3.920
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X
   Meiners S, 1995, J NEUROSCI, V15, P8096
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177
   Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905
   NOBLE M, 1985, NATURE, V316, P725, DOI 10.1038/316725a0
   NOBLE M, 1984, J NEUROSCI, V4, P1892
   Pettigrew DB, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-8
   Pettigrew DB, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-9
   Pettigrew DB, 1999, J NEUROSCI, V19, P8358
   Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945
   Powell EM, 2001, GLIA, V33, P288, DOI 10.1002/1098-1136(20010315)33:4<288::AID-GLIA1027>3.0.CO;2-R
   PRICE J, 1985, J NEUROSCI, V5, P2205
   Reier P J, 1988, Adv Neurol, V47, P87
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   RISLING M, 1993, BRAIN RES BULL, V30, P405, DOI 10.1016/0361-9230(93)90272-D
   RUDGE JS, 1990, J NEUROSCI, V10, P3594
   SCHACHNER M, 1981, DEV BIOL, V83, P328, DOI 10.1016/0012-1606(81)90478-4
   SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5
   STEINDLER DA, 1988, J COMP NEUROL, V267, P357, DOI 10.1002/cne.902670306
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   STENSAAS SS, 1976, ACTA NEUROPATHOL, V35, P187
   SUNG JH, 1981, J NEUROPATH EXP NEUR, V40, P645, DOI 10.1097/00005072-198111000-00006
   Tello F., 1911, TRAB LAB INVEST BIOL, V9, P123
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3
   Tresco PA, 2000, PROG BRAIN RES, V128, P349
   van Kooten TG, 1999, TISSUE ENG, V5, P223
   WEBB A, 1995, J CELL SCI, V108, P2747
   WINN SR, 1989, J BIOMED MATER RES, V23, P31, DOI 10.1002/jbm.820230104
   WOERLY S, 1991, BIOMATERIALS, V12, P197, DOI 10.1016/0142-9612(91)90200-T
   WREDE L, 1909, DEUT MED WOCHENSCHR, V35, P1125
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
NR 79
TC 57
Z9 60
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
J9 EXP NEUROL
JI Exp. Neurol.
PD NOV
PY 2003
VL 184
IS 1
BP 141
EP 152
DI 10.1016/S0014-4886(03)00253-X
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 747KZ
UT WOS:000186804800019
PM 14637087
DA 2018-10-19
ER

PT J
AU Andersson, J
   Sanchez, J
   Ekdahl, KN
   Elgue, G
   Nilsson, B
   Larsson, R
AF Andersson, J
   Sanchez, J
   Ekdahl, KN
   Elgue, G
   Nilsson, B
   Larsson, R
TI Optimal heparin surface concentration and antithrombin binding capacity
   as evaluated with human non-anticoagulated blood in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; blood; coagulation; complement activation; immobilized
   heparin
ID QUARTZ-CRYSTAL MICROBALANCE; CARDIOPULMONARY BYPASS CIRCUITS; TERMINAL
   COMPLEMENT COMPLEX; IMMOBILIZED HEPARIN; FACTOR-H;
   MONOCLONAL-ANTIBODIES; CHROMOGENIC SUBSTRATE; HUMAN-PLASMA; WHOLE-BLOOD;
   FACTOR-XII
AB Contact between blood and a biomaterial surface takes place in many applications and is known to activate the coagulation and complement systems. Heparin surface coatings have been shown to reduce blood activation upon contact with artificial surfaces. To establish the optimal heparin surface concentration, blood was incubated in a tubing loop model at 37degreesC. The tubing was coated with different surface concentrations of heparin and rotated at three different velocities. We demonstrate that the blood compatibility of a surface with regard to coagulation, complement, and platelet activation can be improved by increasing the heparin surface concentration in the 6-12 pmol antithrombin/ cm(2) concentration interval. The binding of factor H is not influenced by the increased heparin surface concentration, suggesting that this factor is not the primary regulator of complement on heparin surfaces. In addition, the heparin coating has no effect on the complement activation that occurs on gas surfaces in extracorporeal circuits. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Uppsala Hosp, Rudbeck Lab, Clin Immunol Sect, Dept Oncol Radiol & Clin Immunnol, SE-75185 Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden.
   Corline Syst AB, SE-75109 Uppsala, Sweden.
RP Andersson, J (reprint author), Univ Uppsala Hosp, Rudbeck Lab, Clin Immunol Sect, Dept Oncol Radiol & Clin Immunnol, SE-75185 Uppsala, Sweden.
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR Blackmore TK, 1996, J IMMUNOL, V157, P5422
   Blackmore TK, 1998, J IMMUNOL, V160, P3342
   Brynda E, 2000, J BIOMED MATER RES, V51, P249, DOI 10.1002/(SICI)1097-4636(200008)51:2<249::AID-JBM14>3.3.CO;2-O
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   Christensen K, 2001, BIOMATERIALS, V22, P349, DOI 10.1016/S0142-9612(00)00190-3
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   EGBERG N, 1983, THROMB RES, V31, P875, DOI 10.1016/0049-3848(83)90118-4
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   ELGUE G, 1993, ARTIF ORGANS, V17, P721
   Gemmell CH, 2000, J BIOMAT SCI-POLYM E, V11, P1197, DOI 10.1163/156856200744273
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   GREELEY WJ, 1991, ANN THORAC SURG, V52, P417, DOI 10.1016/0003-4975(91)90900-B
   HAMMER CH, 1981, J BIOL CHEM, V256, P3995
   HEARN JA, 1993, CIRCULATION, V88, P2086, DOI 10.1161/01.CIR.88.5.2086
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   HSU L-C, 1991, Perfusion (London), V6, P209, DOI 10.1177/026765919100600310
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KIRKLIN JK, 1989, CARDIOPULMONARY BYPA, P3026
   Kocsis JF, 2000, J LONG-TERM EFF MED, V10, P19
   KODAMA K, 1987, THROMB HAEMOSTASIS, V58, P1064
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Larm O., 1989, HEPARIN CHEM BIOL PR, P597
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   Nilsson B, 1998, BLOOD, V92, P1661
   OLSON ST, 1993, METHOD ENZYMOL, V222, P525
   Olsson C, 2000, SCAND CARDIOVASC J, V34, P33
   PANGBURN MK, 1991, J BIOL CHEM, V266, P16847
   PASCHE B, 1991, ARTIF ORGANS, V15, P481
   Prodinger WM, 1998, BIOCHEM J, V331, P41, DOI 10.1042/bj3310041
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   Sanchez J, 1997, J BIOMED MATER RES, V37, P37, DOI 10.1002/(SICI)1097-4636(199710)37:1<37::AID-JBM5>3.3.CO;2-O
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Skroeder NR, 1996, NEPHRON, V72, P523
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   TEIEN AN, 1976, THROMB RES, V8, P413, DOI 10.1016/0049-3848(76)90034-7
   van Der Giessen W. J., 1999, CURR INTERV CARDIOL, V1, P234
   van Teijlingen ME, 2000, KIDNEY INT, V57, P2608, DOI 10.1046/j.1523-1755.2000.00121.x
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   WESTABY S, 1987, INTENS CARE MED, V13, P89
NR 45
TC 62
Z9 62
U1 1
U2 5
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2003
VL 67A
IS 2
BP 458
EP 466
DI 10.1002/jbm.a.10104
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740ZB
UT WOS:000186432200010
PM 14566786
DA 2018-10-19
ER

PT J
AU Itala, A
   Koort, J
   Ylanen, HO
   Hupa, M
   Aro, HT
AF Itala, A
   Koort, J
   Ylanen, HO
   Hupa, M
   Aro, HT
TI Biologic significance of surface microroughing in bone incorporation or
   porous bioactive glass implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bioactive glass; bone ingrowth; microrough surface; porous; rabbit model
ID IN-VITRO; CANCELLOUS DEFECTS; OSSEOINTEGRATION; HYDROXYAPATITE;
   STIMULATION; GRANULES; TISSUE; SIZE
AB A novel chemical etching method was recently developed to create a controlled microrough surface on porous bioactive glass implants. Our earlier in vitro studies showed enhanced attachment of osteoblast-like MG63 cells on a microrough bioactive glass surface. The purpose of our current study was to confirm the in vivo significance of surface microroughening for bone bonding of bioactive glass. Porous bioactive glass cones made of sintered microspheres were surgically implanted in the anterior cortex of rabbit femurs. Peripheral quantitative computed tomography (pQCT), biomechanical push-out testing, histomorphometry, and electron microscopy (BEI-SEM) were used to analyze bone ingrowth and osseointegration at 7, 10, 14, 28, 56, and 84 days after implantation. The results showed that microroughening of the bioactive glass surface significantly enhanced the bone-bonding response of the biomaterial. The positive response was seen in one of the three bioactive glass compositions studied. The affinity index of new bone on the glass surface was significantly (p = 0.02) increased with a trend (p = 0.10) toward improved mechanical incorporation. New bone formation was dependent on the glass composition, and it was found to occur not only through the mechanism of bone ingrowth but also based on in situ osteogenesis within implant interstices. Based on these results, the procedure of microroughening could enhance the osteopromotive properties of certain bioactive glass compositions. (C) 2003 Wiley Periodicals, Inc.
C1 Turku Univ, Dept Surg, Skeletal Res Program, FIN-20520 Turku, Finland.
   Abo Akad Univ, Proc Chem Grp, Turku, Finland.
RP Aro, HT (reprint author), Turku Univ, Dept Surg, Skeletal Res Program, FIN-20520 Turku, Finland.
OI Aro, Hannu/0000-0003-3118-9144
CR BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   Brink M, 1996, BIOCERAMICS, V9, P127
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   GATTI AM, 1994, BIOMATERIALS, V15, P208, DOI 10.1016/0142-9612(94)90069-8
   HEIKKILA JT, 1995, ACTA ORTHOP SCAND, V66, P463, DOI 10.3109/17453679508995588
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Huang ZM, 2001, J BIOL CHEM, V276, P21351, DOI 10.1074/jbc.M010921200
   Itala A, 2002, J BIOMED MATER RES, V62, P404, DOI 10.1002/jbm.10273
   Itala A, 2001, J BIOMED MATER RES, V56, P282, DOI 10.1002/1097-4636(200108)56:2<282::AID-JBM1096>3.0.CO;2-5
   Karlsson KH, 2000, CERAM INT, V26, P897, DOI 10.1016/S0272-8842(00)00033-X
   Karlsson KH, 1998, GLASTECH BER-GLASS, V71, P141
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   LIN FH, 1994, BIOMATERIALS, V15, P1087
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   MULLERMAI C, 1991, BIOMATERIALS, V12, P865, DOI 10.1016/0142-9612(91)90076-M
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   PITKANEN V, 1995, J AEROSOL SCI, V26, P831
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Schmitt JM, 1997, J PERIODONTOL, V68, P1043, DOI 10.1902/jop.1997.68.11.1043
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   Wheeler DL, 1998, J BIOMED MATER RES, V41, P527, DOI 10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.3.CO;2-S
   Wheeler DL, 2000, J ORTHOPAED RES, V18, P140, DOI 10.1002/jor.1100180120
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Ylanen HO, 1999, ANN CHIR GYNAECOL FE, V88, P237
   YLANEN HO, 2000, BIOCERAMICS, V13, P192
NR 29
TC 37
Z9 37
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2003
VL 67A
IS 2
BP 496
EP 503
DI 10.1002/jbm.a.10501
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740ZB
UT WOS:000186432200014
PM 14566790
DA 2018-10-19
ER

PT J
AU Marinucci, L
   Lilli, C
   Guerra, M
   Belcastro, S
   Becchetti, E
   Stabellini, G
   Calvi, EM
   Locci, P
AF Marinucci, L
   Lilli, C
   Guerra, M
   Belcastro, S
   Becchetti, E
   Stabellini, G
   Calvi, EM
   Locci, P
TI Biocompatibility of collagen membranes crosslinked with glutaraldehyde
   or diphenylphosphoryl azide: An in vitro study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen membranes; crosslinking methods; biocompatibility; human dermal
   fibroblasts
ID GROWTH-FACTOR-BETA; CHICK SKIN FIBROBLASTS; EXTRACELLULAR-MATRIX; BONE
   REGENERATION; TGF-ALPHA; CYTOTOXICITY; ACCUMULATION; RELEASE;
   BIOMATERIALS; PERICARDIUM
AB Crosslinking of collagen biomaterials increases their resistance to degradation in vivo. Glutaraldehyde (GA) is normally used to crosslink collagen biomaterial, but is often cytotoxic. Diphenylphosphoryl azide (DPPA) has recently been proposed as reagent, but little is known about its effects on cell behavior. In this study, we determined which collagen membrane was the most biocompatible: Paroguide which is crosslinked with DPPA and contains chondroitin sulfate; Opocrin which is crosslinked with DPPA; Biomed Extend which is crosslinked with GA; and Bio-Gide which is left untreated. Cell proliferation and extracellular matrix macromolecule deposition were evaluated in human fibroblasts cultured on the membranes. The GA-crosslinked Biomed Extend membrane and the not-crosslinked Bio-Gide membrane reduced cell growth and collagen secretion compared with DPPA-crosslinked biomembranes. When Paroguide and Opocrin were compared, better results were obtained with Paroguide. The greatest amount of transforming growth factor beta(1), a growth factor involved in extracellular matrix macromolecule accumulation and in tissue regeneration, was produced by cells cultured on Paroguide, with Opocrin second. Our data suggest that the DPPA method is more biocompatible than the GA for crosslinking collagen biomaterials and that membranes made of collagen plus chondroitin sulfate are better than membranes made of pure collagen. (C) 2003 Wiley Periodicals, Inc.
C1 Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.
   Univ Perugia, Inst Clin Dent, I-06100 Perugia, Italy.
   Univ Milan, Dept Human Anat, Milan, Italy.
RP Locci, P (reprint author), Dept Expt Med & Biochem Sci, Via Giochetto, I-06100 Perugia, Italy.
OI MARINUCCI, Lorella/0000-0003-0997-3426
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   BODO M, 1994, INT J DEV BIOL, V38, P535
   EMONARD H, 1987, J CELL PHYSIOL, V133, P95, DOI 10.1002/jcp.1041330112
   EVANGELISTI R, 1989, CELL BIOL INT REP, V13, P437
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Lilli C, 2002, INT J CANCER, V98, P824, DOI 10.1002/ijc.10306
   LOCCI P, 1993, CELL MOL BIOL, V39, P415
   Locci P, 1996, J PERIODONTOL, V67, P1260, DOI 10.1902/jop.1996.67.12.1260
   Locci P, 1999, INT J DEV BIOL, V43, P157
   LOCCI P, 1995, CELL TISSUE RES, V281, P317
   Locci P, 1997, J PERIODONTOL, V68, P857, DOI 10.1902/jop.1997.68.9.857
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marinucci L, 2001, J PERIODONTOL, V72, P753, DOI 10.1902/jop.2001.72.6.753
   MARTINSGREEN M, 1995, DEV BIOL, V6, P149
   McGinnis M, 1998, INT J ORAL MAX IMPL, V13, P30
   MEAGER A, 1991, J IMMUNOL METHODS, V141, P1, DOI 10.1016/0022-1759(91)90204-S
   PETITE H, 1995, BIOMATERIALS, V16, P1003, DOI 10.1016/0142-9612(95)94908-4
   PETITE H, 1994, J BIOMED MATER RES, V28, P150
   Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017
   Stabellini G, 2001, EUR J HISTOCHEM, V45, P151
   Vaissiere G, 2000, MED BIOL ENG COMPUT, V38, P205, DOI 10.1007/BF02344778
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   WEBSTER DF, 1979, ANAL BIOCHEM, V96, P220, DOI 10.1016/0003-2697(79)90576-1
NR 28
TC 41
Z9 41
U1 0
U2 17
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2003
VL 67A
IS 2
BP 504
EP 509
DI 10.1002/jbm.a.10082
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740ZB
UT WOS:000186432200015
PM 14566791
DA 2018-10-19
ER

PT J
AU Dupont-Gillain, CC
   Fauroux, CMJ
   Gardner, DCJ
   Leggett, GJ
AF Dupont-Gillain, CC
   Fauroux, CMJ
   Gardner, DCJ
   Leggett, GJ
TI Use of AFM to probe the adsorption strength and time-dependent changes
   of albumin on self-assembled monolayers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE protein adsorption; atomic force microscopy; self-assembled monolayers
ID ATOMIC-FORCE MICROSCOPY; HUMAN-PLASMA ALBUMIN; HUMAN-SERUM-ALBUMIN;
   PROTEIN ADSORPTION; SURFACE-CHEMISTRY; BIOMATERIAL SURFACES; ADHESION
   FORCES; SOLID-SURFACES; GOLD SURFACES; CELLS
AB The adsorption kinetics of human serum albumin (HSA) on CH3- and COOH-terminated self-assembled monolayers (SAMs) has been investigated using radioassays and atomic force microscopy (AFM). On both surfaces, the amount of HSA adsorbed reached a plateau after 30 min. The plateau level was higher on the CH3 compared to the COOH surface. The adhesion force (F-adh), measured using Si3N4 AFM tips in water, decreased with time of contact with the HSA solution on the CH3 surface. This time-dependent change in the adhesiveness of the adsorbed protein is best explained by a change in the conformation or orientation. In contrast, F-adh was independent of the time of contact with the HSA solution on the COOH surface, indicating that once adsorbed, the HSA molecules do not undergo further conformation or orientation changes. The perturbation induced by scanning with the AFM in water on the adsorbed HSA layers was greater on CH3 surfaces than on COOH surfaces, suggesting a weaker protein-substratum interaction on the CH3-terminated SAMs. This was further confirmed by a stronger desorption of HSA following sodium dodecyl sulfate (SDS) treatment on the CH3 surface compared to the COOH surface. Taken together, these data suggest that for COOH SAMs, (1) there is a strong interaction between HSA and the substratum; (2) there is an absence of reorientation with time; and (3) there is a smaller amount of adsorbed protein at 24 h, possibly due to increased but rapid spreading/denaturation of the protein. On the CH3 surface, less deformation of HSA occurs and the molecules maintain a higher mobility at short adsorption times. AFM measurements performed after aging of an adsorbed HSA layer in buffer suggests the role played by HSA in solution in determining the time-dependent conformation and/or orientation changes. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Manchester, Inst Sci & Technol, Dept Chem, Manchester M60 1QD, Lancs, England.
   Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England.
RP Leggett, GJ (reprint author), Univ Manchester, Inst Sci & Technol, Dept Chem, POB 88, Manchester M60 1QD, Lancs, England.
OI Leggett, Graham/0000-0002-4315-9076
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Baty AM, 1997, LANGMUIR, V13, P5702, DOI 10.1021/la9610720
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BOS MA, 1995, BIOPHYS J, V68, P2566, DOI 10.1016/S0006-3495(95)80439-X
   Bowen WR, 1998, J COLLOID INTERF SCI, V197, P348, DOI 10.1006/jcis.1997.5247
   Brash J. L., 1995, ACS SYM SER, V602, P1
   BREWER NJ, 2001, THESIS U MANCHESTER
   Burns AR, 1999, PHYS REV LETT, V82, P1181, DOI 10.1103/PhysRevLett.82.1181
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Chen X, 1997, LANGMUIR, V13, P4106, DOI 10.1021/la970172i
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Cooper E, 1997, J MATER CHEM, V7, P435, DOI 10.1039/a607204f
   Cooper E, 2000, J MATER CHEM, V10, P133, DOI 10.1039/a903210j
   CULLEN DC, 1994, J COLLOID INTERF SCI, V166, P102, DOI 10.1006/jcis.1994.1276
   Dewez JL, 1997, J COLLOID INTERF SCI, V191, P1, DOI 10.1006/jcis.1997.4908
   Dufrene YF, 1999, LANGMUIR, V15, P2871, DOI 10.1021/la981066z
   Dupont-Gillain CC, 2001, LANGMUIR, V17, P7261, DOI 10.1021/la010042g
   GOLDBERG ME, 1991, TRENDS BIOCHEM SCI, V16, P358, DOI 10.1016/0968-0004(91)90148-O
   Greenfield NJ, 1999, TRAC-TREND ANAL CHEM, V18, P236, DOI 10.1016/S0165-9936(98)00112-5
   ISRAELACHVILI J, INTERMOLECULAR SURFA, P450
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57
   LEA AS, 1992, LANGMUIR, V8, P68, DOI 10.1021/la00037a015
   Leng YS, 2000, J CHEM PHYS, V113, P8800, DOI 10.1063/1.1318223
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   Lo YS, 1999, LANGMUIR, V15, P6522, DOI 10.1021/la990371x
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023
   Mertig M, 1997, SURF INTERFACE ANAL, V25, P514
   MOROZOV VN, 1981, BIOPOLYMERS, V20, P451, DOI 10.1002/bip.1981.360200304
   Mosier-Boss PA, 1999, APPL SPECTROSC, V53, P862, DOI 10.1366/0003702991947469
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   NORDE W, 1995, CELL MATER, V5, P97
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   Oberdorfer Y, 2000, LANGMUIR, V16, P9955, DOI 10.1021/la0008176
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   Ptak A, 2001, J APPL PHYS, V90, P3095, DOI 10.1063/1.1397287
   QUIST AP, 1995, SURF SCI, V325, P406
   RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068
   Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   SENDEN TJ, 1995, COLLOID SURFACE A, V94, P29, DOI 10.1016/0927-7757(94)02954-Q
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Ta TC, 1998, LANGMUIR, V14, P2435, DOI 10.1021/la9712348
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TILTON RD, 1990, J COLLOID INTERF SCI, V137, P192, DOI 10.1016/0021-9797(90)90056-T
   VANDERSCHEER AT, 1978, J COLLOID INTERF SCI, V66, P136, DOI 10.1016/0021-9797(78)90194-7
   VANDULM P, 1983, J COLLOID INTERF SCI, V91, P248, DOI 10.1016/0021-9797(83)90329-6
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Wadu-Mesthrige K, 2000, SCANNING, V22, P380
   WAGNER P, 1995, LANGMUIR, V11, P3867, DOI 10.1021/la00010a043
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   WEISENHORN AL, 1990, BIOPHYS J, V58, P1251, DOI 10.1016/S0006-3495(90)82465-6
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wink Th., 1997, ANALYST, V122, P43
   ZENHAUSERN F, 1993, J ELECTRON MICROSC, V42, P378
NR 61
TC 40
Z9 43
U1 0
U2 11
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2003
VL 67A
IS 2
BP 548
EP 558
DI 10.1002/jbm.a.10092
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740ZB
UT WOS:000186432200021
PM 14566797
DA 2018-10-19
ER

PT J
AU Chen, JS
   Altman, GH
   Karageorgiou, V
   Horan, R
   Collette, A
   Volloch, V
   Colabro, T
   Kaplan, DL
AF Chen, JS
   Altman, GH
   Karageorgiou, V
   Horan, R
   Collette, A
   Volloch, V
   Colabro, T
   Kaplan, DL
TI Human bone marrow stromal cell and ligament fibroblast responses on
   RGD-modified silk fibers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone marrow stromal cells; ligament tissue engineering; RGD; silk;
   biomaterial
ID ANTERIOR CRUCIATE LIGAMENT; IN-VITRO; FIBRONECTIN; GROWTH; MATRIX;
   ATTACHMENT; RECONSTRUCTION; FRAGMENTS; MOLECULES; PEPTIDES
AB Adhesion, spreading, proliferation, and collagen matrix production of human bone marrow stromal cells (BMSCs) on an RGD-modified silk matrix was studied. Anterior cruciate ligament fibroblasts (ACLFs) were used as a control cell source. Scanning electron microscopy (SEM) and MTT analyses demonstrated that the modified silk matrices support improved BMSC and ACLF attachment and show higher cell density over 14 days in culture when compared with the non-RGD-modified matrices. Collagen type I transcript levels (at day 7) and content (at day 14) was significantly higher on the RGD-modified substrate than on the nonmodified group. The ability of RGD-coupled silk matrices to support BMSC attachment, which leads to higher cell density and collagen matrix production in vitro, combined with mechanical, fatigue, and biocompatibility properties of the silk protein matrix, suggest potential for use of this biomaterial for tissue engineering. (C) 2003 Wiley Periodicals, Inc.
C1 Tufts Univ, Dept Biol & Chem Engn, Ctr Bioengn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biol & Chem Engn, Ctr Bioengn, Medford, MA 02155 USA.
OI Karageorgiou, Vassilis/0000-0002-0892-510X
FU NIAMS NIH HHS [R01 AR46563-01]; NIDCR NIH HHS [R01 DE 13405-01]
CR AHLFELD SK, 1987, AM J SPORT MED, V15, P326, DOI 10.1177/036354658701500406
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ALTMAN GH, 2003, SILK BASED BIOMATERI, V24, P401
   ALTMAN GH, 2001, FASEB J, V16, P270
   BUTLER DL, 1989, J ORTHOP RES, V7, P910, DOI 10.1002/jor.1100070618
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   Fermor B, 1998, CELL BIOL INT, V22, P635, DOI 10.1006/cbir.1998.0302
   FETTO JF, 1980, CLIN ORTHOP RELAT R, P29
   FINBOW ME, 1981, EXP CELL RES, V131, P1, DOI 10.1016/0014-4827(81)90399-2
   GARDNER JM, 1985, CELL, V42, P439, DOI 10.1016/0092-8674(85)90101-1
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   Lo IKY, 1998, J ORTHOPAED RES, V16, P421, DOI 10.1002/jor.1100160405
   Marui T, 1997, J ORTHOPAED RES, V15, P18, DOI 10.1002/jor.1100150104
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MITA K, 1994, J MOL EVOL, V38, P583
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   OToole TE, 1997, MATRIX BIOL, V16, P165, DOI 10.1016/S0945-053X(97)90004-4
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Roy V, 1999, EXP HEMATOL, V27, P302, DOI 10.1016/S0301-472X(98)00031-9
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sottile J, 1998, J CELL SCI, V111, P2933
   Sottile J, 2000, J CELL SCI, V113, P4287
   Stidwill RP, 1998, CELL MOTIL CYTOSKEL, V41, P68, DOI 10.1002/(SICI)1097-0169(1998)41:1<68::AID-CM6>3.0.CO;2-B
   Toyoda T, 1998, CLIN ORTHOP RELAT R, P247
   Vunjak-Novakovic G., 1998, ADV DRUG DELIV REV, V33, P15
   Weitzel PP, 2002, ORTHOP CLIN N AM, V33, P653, DOI 10.1016/S0030-5898(02)00017-2
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
   Yamada KM, 1997, MATRIX BIOL, V16, P137, DOI 10.1016/S0945-053X(97)90001-9
NR 37
TC 235
Z9 247
U1 1
U2 49
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2003
VL 67A
IS 2
BP 559
EP 570
DI 10.1002/jbm.a.10120
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740ZB
UT WOS:000186432200022
PM 14566798
DA 2018-10-19
ER

PT J
AU Vasin, SL
   Titushkin, IA
   Sevastianov, VI
AF Vasin, SL
   Titushkin, IA
   Sevastianov, VI
TI Mathematical model of static platelet adhesion on a solid surface
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE platelet/surface interaction; platelet adhesion mechanism; platelet
   activation; mathematical model; kinetics of cell adhesion
ID BIOMATERIAL SURFACES; BLOOD COMPATIBILITY; PROTEIN ADSORPTION;
   CELL-ADHESION; ACTIVATION; DEPOSITION; SATURATION; MONOLAYER; ORIGIN;
   TIME
AB The scheme of platelet/surface interaction and a kinetic model of platelet adhesion on a solid surface are suggested. The elaborated approach takes into account the platelet activation by the surface and accumulation of free activated cells in the bulk of the liquid phase. This effect has an especially important role in static experimental conditions. The suggested model explains three types of adhesion kinetic curves, obtained in experiments in vitro: sigmoid curves with or without saturation and an exponential curve with saturation. According to the model, the curve shape is determined by material surface properties, platelet functionality, and experimental conditions of the platelet/surface interaction. The data of static platelet adhesion from platelet rich plasma on glass, siliconized glass, hexadecyltrichlorosilane monolayers, and low-density polyethylene are described mathematically with the proposed model. Numerical parameters are calculated from approximation of experimental data by the model. These parameters allow quantitative characterization of platelet interaction with the material surface. (C) 2003 Wiley Periodicals, Inc.
C1 Moscow Transplantol & Artificial Organ Res Inst, Res Ctr Biomat, Moscow 123182, Russia.
RP Sevastianov, VI (reprint author), Moscow Transplantol & Artificial Organ Res Inst, Res Ctr Biomat, 1 Shukinskaya, Moscow 123182, Russia.
RI Sevastianov, Victor/B-6674-2017
OI Sevastianov, Victor/0000-0003-1995-3373
CR ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   BAIER RE, 1977, ANN NY ACAD SCI, V283, P17, DOI 10.1111/j.1749-6632.1977.tb41750.x
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Furukawa K, 1999, J BIOMED MATER RES, V46, P93, DOI 10.1002/(SICI)1097-4636(199907)46:1<93::AID-JBM11>3.0.CO;2-I
   Furukawa KS, 2000, ASAIO J, V46, P696, DOI 10.1097/00002480-200011000-00009
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Gemmell CH, 2000, J BIOMAT SCI-POLYM E, V11, P1197, DOI 10.1163/156856200744273
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   MCINTIRE LV, 1985, NIH PUBLICATION
   MCQUARRIE DA, 1997, PHYSICAL CHEM MOL AP
   NEUMANN AW, 1974, J COLLOID INTERF SCI, V49, P291, DOI 10.1016/0021-9797(74)90365-8
   NEUMANN AW, 1980, J BIOMED MATER RES, V14, P499, DOI 10.1002/jbm.820140416
   NEUMANN AW, 1983, J BIOMED MATER RES, V17, P375, DOI 10.1002/jbm.820170213
   Petrash S, 1997, LANGMUIR, V13, P1881, DOI 10.1021/la9610821
   PREDECKI P, 1980, J BIOMED MATER RES, V14, P417, DOI 10.1002/jbm.820140408
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RUCKENSTEIN E, 1982, J BIOMED MATER RES, V16, P169, DOI 10.1002/jbm.820160209
   RUCKENSTEIN E, 1976, THROMB HAEMOSTASIS, V36, P334
   Skarja GA, 1997, J BIOMED MATER RES, V34, P439, DOI 10.1002/(SICI)1097-4636(19970315)34:4<439::AID-JBM5>3.0.CO;2-L
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   SRINIVASAN R, 1981, J COLLOID INTERF SCI, V79, P390, DOI 10.1016/0021-9797(81)90090-4
   STRONG AB, 1987, J BIOMED MATER RES, V21, P1039, DOI 10.1002/jbm.820210810
   Titushkin IA, 2001, ASAIO J, V47, P11, DOI 10.1097/00002480-200101000-00005
   Waples LM, 1996, J BIOMED MATER RES, V32, P65, DOI 10.1002/(SICI)1097-4636(199609)32:1<65::AID-JBM8>3.0.CO;2-N
   ZAIKOV GE, 1988, NEW CONCEPTS POLYM S, P290
   ZINGG W, 1980, MECH PROPERTIES BIOM, P541
NR 29
TC 5
Z9 5
U1 0
U2 8
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2003
VL 67A
IS 2
BP 582
EP 590
DI 10.1002/jbm.a.10112
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740ZB
UT WOS:000186432200025
PM 14566801
DA 2018-10-19
ER

PT J
AU Hu, YY
   Zhang, C
   Zhang, SM
   Xiong, Z
   Xu, JQ
AF Hu, YY
   Zhang, C
   Zhang, SM
   Xiong, Z
   Xu, JQ
TI Development of a porous poly(L-lactic acid)/hydroxyapatite/collagen
   scaffold as a BMP delivery system and its use in healing canine
   segmental bone defect
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone substitute materials; poly(L-lactic acid); hydroxyapatite;
   collagen; bone morphogenetic protein
ID ACID) FOAMS; MORPHOGENETIC PROTEIN-2; CELLS; BIOCOMPATIBILITY;
   INDUCTION; KINETICS
AB A hydroxyapatite/collagen (HAC) composite was produced to mimic the natural extracellular matrix of bone, with the collagen serving as a template for apatite formation. A three-dimensional highly porous scaffold was developed by mixing HAC with poly(L-lactic acid) (PLA) using a thermally induced phase separation technique. Naturally derived bovine bone morphogenetic protein (bBMP) was incorporated into the porous HAC-PLA scaffolds, and the composite then was implanted in diaphyseal defects (2 cm in radius) of adult beagle dogs. Controls were implanted with scaffolds without BMP. The dogs were sacrificed at 6 months, at which time biocompatibility, biodegradability, and osteoinduction were evaluated by histologic and radiologic examination and by bone mineral density (BMD) measurements. All defects healed after treatment with BMP combined with HAC-PLA, and BMD at the site of the defect was higher than the BMD of the intact radius. Fibrous union developed in the control group animals. Histologic observation indicated that the presence of BMP not only promoted osteogenesis but that it also accelerated degradation of the biomaterials. Optimized design parameters of a three-dimensional porous biomaterial would give full scope to the role of BMP as an osteoinductive growth factor. (C) 2003 Wiley Periodicals, Inc.
C1 Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed & Traumatol, Xian 710032, Peoples R China.
   Tsing Hua Univ, Dept Mat Sci, Beijing 100084, Peoples R China.
   Tsing Hua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.
RP Hu, YY (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed & Traumatol, Xian 710032, Peoples R China.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bansil R, 1997, TRENDS POLYM SCI, V5, P146
   Chapman M.W., 1997, J BONE JOINT SURG AM, V79-A, P143
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GAO TJ, 1993, ANN CHIR GYNAECOL, V82, P77
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Glimcher M J, 1987, Instr Course Lect, V36, P49
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   HIENDERAUER G, 1991, CERAMIC B, V70, P1010
   HOLMES RE, 1994, BIODEGRADABLE POLYM, P317
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Kim HD, 1998, TISSUE ENG, V4, P35, DOI 10.1089/ten.1998.4.35
   Koempel JA, 1998, J BIOMED MATER RES, V41, P359, DOI 10.1002/(SICI)1097-4636(19980905)41:3<359::AID-JBM3>3.0.CO;2-B
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   Lu LC, 1996, MRS BULL, V21, P28
   LUCAS PA, 1990, J BIOMED MATER RES, V24, P901, DOI 10.1002/jbm.820240708
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Ristich Ch., 1996, J SERB CHEM SOC, V61, P311
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   Uludag H, 2001, J BONE JOINT SURG AM, V83, P128
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WANG M, 1996, P 7 EUR C COMP MAT L, P445
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Yoon S N, 1999, J BIOMED MATER RES, V47, P8
   Yoon S.N., 1999, BIOMATERIALS, V20, P1783
NR 30
TC 81
Z9 84
U1 1
U2 11
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2003
VL 67A
IS 2
BP 591
EP 598
DI 10.1002/jbm.a.10070
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740ZB
UT WOS:000186432200026
PM 14566802
DA 2018-10-19
ER

PT J
AU Goldstein, AS
   DiMilla, PA
AF Goldstein, AS
   DiMilla, PA
TI Examination of membrane rupture as a mechanism for mammalian cell
   detachment from fibronectin-coated biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE shear stress; radial-flow chamber; fibronectin; membrane rupture
ID PLATE FLOW CHAMBER; EXTRACELLULAR-MATRIX; RADIAL-FLOW; ADHESION
   STRENGTH; SURFACES; TRANSDUCTION; ATTACHMENT; INTEGRINS; AFFINITY; SHEAR
AB Synthetic biomaterials intended for the reconstruction of tissues and organs must be capable of sustaining adhesive contact with adjacent cells and tissues under mechanical and hydrodynamic stresses. To facilitate this adhesion, extracellular matrix proteins or peptide sequences are frequently immobilized to the biomaterial interface. These ligands enhance cell attachment by raising the number of cell receptor/ligand interactions, but consequently they may alter the mechanism of cell detachment. In particular, as the cell membrane is more strongly immobilized to the substratum, the tendency for cell detachment to involve membrane rupture may increase. To test this hypothesis, cells were fluorescent stained with a membrane dye, allowed to attach to fibronectin-coated model substrates for 30 min, and then subjected to a spatially dependent range of shear stress for 5 min (28-220 dyn/cm(2)) using a radial-flow chamber. Phase-contrast and fluorescent images were analyzed to determine the probability for cell detachment and the area of fluorescent debris left by detaching cells as a function of fibronectin concentration, magnitude of shear stress, and time. It was found at all concentrations of fibronectin that the majority of detaching cells left membrane fragments, the mean size of these fragments was independent of shear stress, and the shape independent of the direction of flow. However, mean fragment area increased with concentration of fibronectin and decreased with duration of shearing flow. We postulate that the area of debris reflects the extent of cell attachment prior to the application of shear and that adhesive complexes can disassemble at the onset of flow. (C) 2003 Wiley Periodicals, Inc.
C1 Carnegie Mellon Univ, Dept Chem Engn, Ctr Light Microscope Imaging & Biotechnol Colloid, Pittsburgh, PA 15213 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, 0211, Blacksburg, VA 24061 USA.
CR BID K, 2001, J BIOMED MATER RES, V57, P224
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   COZEZSROBERTS C, 1990, BIOPHYS J, V59, P841
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DIMILLA PA, 1994, J AM CHEM SOC, V116, P2225, DOI 10.1021/ja00084a105
   Garcia AJ, 1997, TISSUE ENG, V3, P197, DOI 10.1089/ten.1997.3.197
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Goldstein AS, 2002, J BIOMED MATER RES, V59, P665, DOI 10.1002/jbm.1276
   Goldstein AS, 1998, AICHE J, V44, P465, DOI 10.1002/aic.690440222
   Goldstein AS, 1997, BIOTECHNOL BIOENG, V55, P616, DOI 10.1002/(SICI)1097-0290(19970820)55:4<616::AID-BIT4>3.0.CO;2-K
   GOLDSTEIN AS, 2001, J BIOMED MATER RES, V59, P665
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   OLIVIER LA, 1993, BIOTECHNOL BIOENG, V42, P963, DOI 10.1002/bit.260420807
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Schnittler HJ, 2001, PFLUG ARCH EUR J PHY, V442, P675, DOI 10.1007/s004240100589
   Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   WARD MD, 1994, BIOPHYS J, V67, P2522, DOI 10.1016/S0006-3495(94)80742-8
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
   Xu JH, 1996, J CELL BIOL, V132, P239, DOI 10.1083/jcb.132.1.239
NR 27
TC 13
Z9 13
U1 0
U2 5
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2003
VL 67A
IS 2
BP 658
EP 666
DI 10.1002/jbm.a.10125
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740ZB
UT WOS:000186432200034
PM 14566810
DA 2018-10-19
ER

PT J
AU Alsberg, E
   Kong, HJ
   Hirano, Y
   Smith, MK
   Albeiruti, A
   Mooney, DJ
AF Alsberg, E
   Kong, HJ
   Hirano, Y
   Smith, MK
   Albeiruti, A
   Mooney, DJ
TI Regulating bone formation via controlled scaffold degradation
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE alginate; biomaterials; tissue engineering; irradiation; osteoblasts
ID SODIUM ALGINATE; ACID-HYDROLYSIS; HYDROGELS; TRANSPLANTATION;
   CHONDROCYTES; TISSUES; MATRIX; CELLS
AB It is widely assumed that coupling the degradation rate of polymers used as cell transplantation carriers to the growth rate of the developing tissue will improve its quantity or quality. To test this hypothesis, we developed alginate hydrogels with a range of degradation rates by gamma-irradiating high-molecular-weight alginate to yield polymers of various molecular weights and structures. Decreasing the size of the polymer chains increased the degradation rate in vivo, as measured by implant retrieval rates, masses, and elastic moduli. Rapidly and slowly degrading alginates, covalently modified with RGD-containing peptides to control cell behavior, were then used to investigate the effect of biodegradation rate on bone tissue development in vivo. The more rapidly degrading gels led to dramatic increases in the extent and quality of bone formation. These results indicate that biomaterial degradability is a critical design criterion for achieving optimal tissue regeneration with cell transplantation.
C1 Univ Michigan, Sch Dent, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Dent, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Sch Dent, Dept Biomed Engn, Room 5213,1011 N Univ, Ann Arbor, MI 48109 USA.
OI Alsberg, Eben/0000-0002-3487-4625
FU NIDCR NIH HHS [T32-DE07057, R01-DE13033]
CR Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Bouhadir KH, 2000, J PHARM SCI-US, V89, P910, DOI 10.1002/1520-6017(200007)89:7<910::AID-JPS8>3.0.CO;2-#
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Bouhadir KH, 2001, BIOMATERIALS, V22, P2625, DOI 10.1016/S0142-9612(01)00003-5
   Bratthall G, 2001, J CLIN PERIODONTOL, V28, P923, DOI 10.1034/j.1600-051x.2001.028010923.x
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183
   HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   KUME T, 1983, AGR BIOL CHEM TOKYO, V47, P889, DOI 10.1080/00021369.1983.10865740
   Lansdown A B, 1994, J R Coll Surg Edinb, V39, P284
   Nagasawa N, 2000, POLYM DEGRAD STABIL, V69, P279, DOI 10.1016/S0141-3910(00)00070-7
   NAKADA HI, 1967, J BIOL CHEM, V242, P845
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315
   Pollok J M, 1996, Semin Pediatr Surg, V5, P191
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   SCHNEIDER WC, 1957, METHOD ENZYMOL, V3, P680, DOI 10.1016/S0076-6879(57)03442-4
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shimokawa T, 1996, BIOSCI BIOTECH BIOCH, V60, P1532, DOI 10.1271/bbb.60.1532
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   TSUJINO I, 1961, NATURE, V192, P970, DOI 10.1038/192970a0
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 32
TC 199
Z9 202
U1 2
U2 31
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD NOV
PY 2003
VL 82
IS 11
BP 903
EP 908
DI 10.1177/154405910308201111
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 736QV
UT WOS:000186185400012
PM 14578503
DA 2018-10-19
ER

PT J
AU Cerdeira, M
   Puppo, MC
   Martini, S
   Herrera, ML
AF Cerdeira, M
   Puppo, MC
   Martini, S
   Herrera, ML
TI Effects of salts on crystallization kinetics and rheological behavior of
   concentrated alpha,alpha-trehalose solutions
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE trehalose; polarized light microscopy; rheology; crystallization
   kinetics; divalent cations
ID AQUEOUS SUGAR SYSTEMS; BIOMATERIAL STABILIZATION; TREHALOSE;
   VITRIFICATION; ANHYDROBIOSIS; CATIONS
AB The effect of addition of CaCl2 . 2H(2)O and MgCl2 . 6H(2)O on crystallization kinetics and the rheological behavior of a 70% trehalose solution was studied by polarized light microscopy and dynamic oscillatory rheometry. Salts caused a delay on nucleation with induction times for crystallization longer for Mg2+ than for Ca2+. Divalent cations were incorporated into crystals, changing the growth of certain faces preferentially, which resulted in changes in morphology. Addition of CaCl2 . 2H(2)O in a high salt/trehalose molar ratio dramatically increased complex modulus (G*), indicating a stronger viscoelastic behavior. A gel-like structure was formed when Ca2+ was added to trehalose solution. The behavior of Mg2+/trehalose solutions cannot be considered viscoelastic in nature but as a fluid-like system.
C1 Univ Buenos Aires, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
   Natl Univ La Plata, CONICET, CIDCA, RA-1900 La Plata, Argentina.
RP Herrera, ML (reprint author), Univ Buenos Aires, Dept Ind, Intendente Guiraldes S-N, RA-1428 Buenos Aires, DF, Argentina.
EM lidia@di.fcen.uba.ar
RI Martini, Silvana/B-4552-2010
OI Martini, Silvana/0000-0002-5870-9931
CR Braccini I, 1999, CARBOHYD RES, V317, P119, DOI 10.1016/S0008-6215(99)00062-2
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   CROWE JH, 1994, CRYOBIOLOGY, V31, P355, DOI 10.1006/cryo.1994.1043
   Dronnet VM, 1998, CARBOHYD POLYM, V35, P29, DOI 10.1016/S0144-8617(97)00118-5
   Gallo A, 2002, J FOOD SCI, V67, P1331, DOI 10.1111/j.1365-2621.2002.tb10283.x
   GREEN JL, 1989, J PHYS CHEM-US, V93, P2880, DOI 10.1021/j100345a006
   HARTEL RW, 1991, CRIT REV FOOD SCI, V30, P49, DOI 10.1080/10408399109527541
   Howell T, 2001, J FOOD SCI, V66, P979, DOI 10.1111/j.1365-2621.2001.tb08222.x
   JOUPPILA K, 1994, J DAIRY SCI, V77, P2907, DOI 10.3168/jds.S0022-0302(94)77231-3
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Mazzobre MF, 2001, FOOD RES INT, V34, P903, DOI 10.1016/S0963-9969(01)00115-6
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   Sussich F, 2001, CARBOHYD RES, V334, P165, DOI 10.1016/S0008-6215(01)00189-6
NR 16
TC 1
Z9 1
U1 0
U2 7
PU INST FOOD TECHNOLOGISTS
PI CHICAGO
PA 525 WEST VAN BUREN, STE 1000, CHICAGO, IL 60607-3814 USA
SN 0022-1147
J9 J FOOD SCI
JI J. Food Sci.
PD NOV-DEC
PY 2003
VL 68
IS 9
BP 2644
EP 2650
DI 10.1111/j.1365-2621.2003.tb05783.x
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA 754UT
UT WOS:000187350600005
DA 2018-10-19
ER

PT J
AU Geer, DJ
   Andreadis, ST
AF Geer, DJ
   Andreadis, ST
TI A novel role of fibrin in epidermal healing: Plasminogen-mediated
   migration and selective detachment of differentiated keratinocytes
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Article
DE fibrin; fibrongin; biomaterials; wound healing; cell migration; calcium;
   plasmin
ID STEM-CELLS; INTEGRIN FUNCTION; WOUND REPAIR; GROWTH; GLUE; CALCIUM;
   ADHESION; DELIVERY; MATRIX; REGENERATION
AB Recent studies have shown that fibrin promotes epidermal regeneration in vitro and maintains the stem cell population after transplantation of keratinocytes in vivo. As epidermal keratinocytes do not express integrin alphavbeta3, the receptor for fibrin and fibrinogen, the mechanism through which fibrin affects epidermal cells remains elusive. To investigate the role of fibrin in epidermal wound healing, we developed an in vitro model in which fibrin was added to the top of wounded keratinocyte monolayers grown on collagen. With this matrix topology, keratinocytes migrate between the collagen on their basal side and fibrin on their apical side mimicking migration of the epidermis in vivo. Using this model, we found that fibrin promoted keratinocyte migration in low and high calcium concentrations by exposing the cells to plasminogen. The migration rate depended strongly on the concentration of fibrinogen and the rate of plasmin-mediated fibrin degradation. Surprisingly, fibrin and fibrinogen caused significant detachment of keratinocytes which was prevented by the addition of calcium. Further examination using flow cytometry revealed that the detached cells were larger, more granular, and had very low levels of beta1 integrin, which are all signs of differentiated keratinocytes. Our results suggest a novel dual role of fibrin in epidermal healing. First, fibrin promotes keratinocyte migration indirectly by exposing plasminogen to migrating cells, and second, fibrin selectively disrupts adhesion of differentiated keratinocytes. Our data are novel and may have important implications in understanding wound healing and in the use of fibrin as a biomaterial for protein and gene delivery.
C1 SUNY Buffalo, Bioengn Lab, Dept Chem Engn, Buffalo, NY 14260 USA.
RP Andreadis, ST (reprint author), SUNY Buffalo, Bioengn Lab, Dept Chem Engn, 908 Furnas Hall, Buffalo, NY 14260 USA.
CR Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com
   Andree C, 2001, TISSUE ENG, V7, P757, DOI 10.1089/107632701753337708
   Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2
   CHENG H, 1995, EXP BRAIN RES, V104, P199
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   CLARK RAF, 1997, PRINCIPLES TISSUE EN, P737
   Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1
   DVORAK HF, 1987, LAB INVEST, V57, P673
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   GRZESIAK JJ, 1995, J INVEST DERMATOL, V104, P768, DOI 10.1111/1523-1747.ep12606983
   GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644
   Guest JD, 1997, J NEUROSCI RES, V50, P888, DOI 10.1002/(SICI)1097-4547(19971201)50:5<888::AID-JNR24>3.3.CO;2-6
   HERTLE MD, 1991, DEVELOPMENT, V112, P193
   Horch RE, 1998, CELL TRANSPLANT, V7, P309, DOI 10.1016/S0963-6897(98)00005-0
   Iwaya K, 1999, NEUROSURGERY, V44, P589, DOI 10.1097/00006123-199903000-00085
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K
   KRAWCZYK WS, 1971, J CELL BIOL, V49, P247, DOI 10.1083/jcb.49.2.247
   Kubo M, 2001, J INVEST DERMATOL, V117, P1369, DOI 10.1046/j.0022-202x.2001.01551.x
   Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453
   Lounes KC, 2001, ANN NY ACAD SCI, V936, P205
   Mirastschijski U, 2002, J INVEST DERMATOL, V118, P55, DOI 10.1046/j.0022-202x.2001.01652.x
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x
   NJAU SN, 1991, FORENSIC SCI INT, V50, P67, DOI 10.1016/0379-0738(91)90135-6
   ODEKON LE, 1994, J CELL PHYSIOL, V158, P398, DOI 10.1002/jcp.1041580303
   Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303
   Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021
   Ravanti L, 2000, INT J MOL MED, V6, P391
   REINARTZ J, 1995, EXP CELL RES, V220, P274, DOI 10.1006/excr.1995.1316
   Ronfard V, 2001, P NATL ACAD SCI USA, V98, P4504, DOI 10.1073/pnas.071631698
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SHAKESPEARE V, 1991, BRIT J PLAST SURG, V44, P219, DOI 10.1016/0007-1226(91)90131-3
   Shireman PK, 1999, J VASC SURG, V29, P852, DOI 10.1016/S0741-5214(99)70213-2
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Vicanova J, 1998, J INVEST DERMATOL, V111, P97, DOI 10.1046/j.1523-1747.1998.00251.x
   Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399
   Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247
   Weiss E, 1998, J CELL PHYSIOL, V174, P58
NR 41
TC 44
Z9 45
U1 0
U2 6
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD NOV
PY 2003
VL 121
IS 5
BP 1210
EP 1216
DI 10.1046/j.1523-1747.2003.12512.x
PG 7
WC Dermatology
SC Dermatology
GA 739VM
UT WOS:000186367200046
PM 14708628
OA Bronze
DA 2018-10-19
ER

PT J
AU Attiah, DG
   Kopher, RA
   Desai, TA
AF Attiah, DG
   Kopher, RA
   Desai, TA
TI Characterization of PC12 cell proliferation and
   differentiation-stimulated by ECM adhesion proteins and neurotrophic
   factors
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NERVE GROWTH-FACTOR; TO-SUBSTRATUM ADHESION; NEURITE OUTGROWTH;
   EXTRACELLULAR-MATRIX; LAMININ; COLLAGEN; AGGREGATION; MOLECULES;
   SURFACES; CULTURES
AB Among the various elements which influence axonal outgrowth in vivo is the physicochemical interaction of actively outgrowing nerve fibers with the various substrata they encounter during differentiation. Several experiments have explored the role of the extracellular matrix (ECM) in the control of neuronal differentiation. The nature, however, of the interactions between neurons and components of the ECM during regeneration and development are largely a matter of speculation. Although previous studies have already explored the influence of a number of ECM adhesion proteins and neurotrophic factors on neurite outgrowth, none have been carried in a systematic approach that allows for the simultaneous comparison of different surface conditions in relation to different neurotrophic factors. Motivated by the necessity of establishing controlled environments that allow for the rational design of stable neuronal/biomaterial interfaces, the long-term effects of NGF and FGF-2 on the behavior of PC12 cells plated on collagen and laminin modified surfaces were evaluated. A pheochromocytoma cell line derived from transplantable rat adrenal medulla, PC12 cells have been commonly employed as an instructive model for studying the underlying mechanisms of neuronal differentiation.
   Long-term characterization of PC12 proliferation and neuronal differentiation for an experimental duration of 7-22 days was achieved by both qualitatively and quantitatively assaying for cell count, neurite number, neurite mean length, and neurite stability. Neurite stability was determined in terms of resistance to loss after neurotrophic factor (NGF/FGF-2) withdrawal. The present findings demonstrate that ECM adhesion proteins collagen and laminin are equally effective in promoting PC12 proliferation. It was noted as well that NGF supplemented collagen cultures are significantly more efficient in providing long-term support to PC12 differentiation in terms of neurite number, mean length, and stability. (C) 2003 Kluwer Academic Publishers.
C1 Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
   Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
CR ANGELETT.RH, 1971, P NATL ACAD SCI USA, V68, P2417, DOI 10.1073/pnas.68.10.2417
   ANSELME K, 1990, J BIOMED MATER RES, V24, P689, DOI 10.1002/jbm.820240605
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   BLADWIN S, 1996, INT J DEV NEUROSCI, V14, P351
   BRADSHAW RA, 1993, TRENDS BIOCHEM SCI, V18, P48, DOI 10.1016/0968-0004(93)90052-O
   CARBONETTO S, 1987, J PHYSIOL-PARIS, V82, P258
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   FUJII DK, 1982, J NEUROSCI, V2, P1157
   GAGE FH, 1991, CURR TOP MICROBIOL, P71
   GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95
   GOSPODAROWICZ D, 1981, BIOL NORMAL HUMAN GR
   GOSPODAROWICZ D, 1987, J CELL PHYSIOL, V5, P15
   GRABHAM PW, 1992, EXP CELL RES, V202, P337, DOI 10.1016/0014-4827(92)90083-K
   Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Haque NSK, 2000, CELL TRANSPLANT, V9, P623, DOI 10.1177/096368970000900507
   ISAO D, 1997, EXP NEUROL, V147, P10
   JONATHAN D, 1990, J NEUROSCI, V10, P2626
   KESHMIRIAN J, 1989, J NEUROCYTOL, V18, P491, DOI 10.1007/BF01474545
   KREWSON CE, 1994, BIOTECHNOL BIOENG, V43, P555, DOI 10.1002/bit.260430704
   LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183
   LANDER AD, 1987, MOL NEUROBIOL, V1, P213, DOI 10.1007/BF02936609
   LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6
   LETOURNEAU PC, 1975, DEV BIOL, V44, P77, DOI 10.1016/0012-1606(75)90378-4
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   OLSEN BR, 2000, PRINCIPLES TISSUE EN, P57
   ONEIL P, 2001, TRENDS MOL MED, V17, P434
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   PACHENCE JM, 1987, COLLAGEN ITS PLACE M
   ROSS A, 1991, CURR TOP MICROBIOL, P27
   RYDEL RE, 1987, J NEUROSCI, V7, P3639
   TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347
   VANDERREST M, 1990, BIOMATERIALS, V11, P28
NR 33
TC 35
Z9 35
U1 1
U2 14
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2003
VL 14
IS 11
BP 1005
EP 1009
DI 10.1023/A:1026363018805
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 738CT
UT WOS:000186269700012
PM 15348515
DA 2018-10-19
ER

PT J
AU Roosjen, A
   Kaper, HJ
   van der Mei, HC
   Norde, W
   Busscher, HJ
AF Roosjen, A
   Kaper, HJ
   van der Mei, HC
   Norde, W
   Busscher, HJ
TI Inhibition of adhesion of yeasts and bacteria by poly(ethylene
   oxide)-brushes on glass in a parallel plate flow chamber
SO MICROBIOLOGY-SGM
LA English
DT Article
ID MICROBIAL ADHESION; VOICE PROSTHESES; SILICONE-RUBBER; SURFACES;
   BRUSHES; CONTAMINATION; BIOMATERIAL; ADSORPTION; CHEMISTRY; GROWTH
AB Poly(ethylene oxide) (PEO)-brushes are generally recognized as protein- repellent surfaces, and although a role in discouraging microbial adhesion has been established for some strains and species, no study exists on the effects of PEO-brushes on a large variety of bacterial and yeast strains. In this paper, a PEO-brush has been covalently attached to glass and silica by reaction in a polymer melt. Subsequently, the presence of a PEO-brush was demonstrated using contact angle measurements, X-ray photoelectron spectroscopy and ellipsometry. For five bacterial (Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus salivarius, Escherichia coli and Pseudomonas aeruginosa) and two yeast strains (Candida albicans and Candida tropicalis), adhesion to PEO-brushes was compared with adhesion to bare glass in a parallel plate flow chamber. The initial deposition rates of Sta. epidermidis, Sta. aureus and Str. salivarius to glass were relatively high, between 2400 and 2600 cm(-2) s(-1), while E coli and P. aeruginosa deposited much more slowly. The initial deposition rates of the yeasts to glass were 144 and 444 cm(-2) s(-1) for C. albicans GB 1/2 and C. tropicalis GB 9/9, respectively. Coating of the glass surface with a PEO-brush yielded more than 98% reduction in bacterial adhesion, although for the more hydrophobic P. aeruginosa a smaller reduction was observed. For both yeast species adhesion suppression was less effective than for the bacteria and here too the more hydrophobic C. tropicalis showed less reduction than the more hydrophilic C. albicans. The PEO-brush had a thickness of 22 nm in water, as inferred from ellipsometry. Assuming that on bare glass the adhered micro-organisms are positioned only a few nanometers away from the surface and that the brush keeps them at a distance of 22 nm, it is calculated that the brush yields a sevenfold attenuation of the Lifshitz-Van der Waals attraction to the surface between the micro-organisms and the surface. Decreased Lifshitz-van der Waals attraction may be responsible for the suppression of the microbial adhesion observed.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Wageningen & Res Ctr, Lab Phys Chem & Colloid Sci, NL-6703 HB Wageningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
RI Hori, Katsutoshi/K-5289-2012
OI Hori, Katsutoshi/0000-0003-1994-3124
CR Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Busscher HJ, 1997, J BIOMED MATER RES, V34, P201, DOI 10.1002/(SICI)1097-4636(199702)34:2<201::AID-JBM9>3.0.CO;2-U
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1016/0378-1097(87)90062-0
   Busscher HJ, 1995, ADHESION MICROBIAL P, P455
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   Efremova NV, 2001, LANGMUIR, V17, P7628, DOI 10.1021/la010405c
   Everaert EPJM, 1998, J MATER SCI-MATER M, V9, P147, DOI 10.1023/A:1008867619481
   Furness EL, 1998, BIOMATERIALS, V19, P1361, DOI 10.1016/S0142-9612(98)00007-6
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HARRIS JM, 1992, POLYETHYLENEGLYCOL C
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Lee SW, 1998, BIOMATERIALS, V19, P1669, DOI 10.1016/S0142-9612(98)00044-1
   Maas JH, 2003, THIN SOLID FILMS, V426, P135, DOI 10.1016/S0040-6090(03)00033-6
   MAFU AA, 1991, APPL ENVIRON MICROB, V57, P1969
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P5, DOI DOI 10.1016/0927-7765(94)01146-V
   RUTTER PR, 1980, CELL ADHESION MOTILI, P103
   SEAH MP, 1994, SURF INTERFACE ANAL, V21, P336, DOI 10.1002/sia.740210603
   Sheth SR, 2000, J PHYS CHEM B, V104, P7652, DOI 10.1021/jp000298f
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   van der Mei HC, 1998, COLLOID SURFACE B, V11, P213, DOI 10.1016/S0927-7765(98)00037-X
NR 33
TC 100
Z9 102
U1 0
U2 25
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD NOV
PY 2003
VL 149
BP 3239
EP 3246
DI 10.1099/mic.0.26519-0
PN 11
PG 8
WC Microbiology
SC Microbiology
GA 746FW
UT WOS:000186737200022
PM 14600236
OA Bronze
DA 2018-10-19
ER

PT J
AU Yang, JM
   Lin, HT
   Wu, TH
   Chen, CC
AF Yang, JM
   Lin, HT
   Wu, TH
   Chen, CC
TI Wettability and antibacterial assessment of chitosan containing
   radiation-induced graft nonwoven fabric of polypropylene-g-acrylic acid
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE graft copolymers; wettability; nonwoven fabrics; antibacterial activity;
   irradiation
ID SBS-G-VP; PVA/CHITOSAN-BLENDED HYDROGELS; QUATERNARY AMMONIUM CHLORIDE;
   DMAEMA COPOLYMER MEMBRANE; OXYGEN PERMEATION; BIOMATERIAL USAGE;
   UV-IRRADIATION; SURFACE; POLYMERIZATION; POLY(ETHYLENE-TEREPHTHALATE)
AB The grafting of acrylic acid (AA) onto polypropylene (PP) nonwoven fabric was induced by gamma-ray irradiation without degassing to obtain PP-g-AA-modified nonwoven fabric. Chitosan was immobilized onto the PP-g-AA-modified nonwoven fabric with 1-ethyl-3-(3-dimethyamino propyl) carbidiimide to get the chitosan-containing PP-g-AA-modified nonwoven fabric. The PP-g-AA-modified nonwoven fabrics were characterized by IR spectroscopy. In addition to the absorption peaks associated with pure PP nonwoven fabric, absorption peaks at 1700 cm(-1) (C=O) and at about 2950 cm(-1) for the COOH group were also found for the PP-g-AA-modified nonwoven fabric. The chitosan-containing PP-g-AA nonwoven fabric obtained had an absorption peak at about 1475-1580 cm(-1) (CO-NH), in addition to those of the PP-g-AA nonwoven fabric. The effects of acrylic acid grafting content and chitosan on the wettability and antibacterial assessment were investigated. The wicking time of water on the PP-g-AA-modified nonwoven fabric decreased with increasing acrylic acid grafting content and chitosan, whereas the water content on the PP-g-AA-modified nonwoven fabric increased. Because the concentration of Pseudomonas aeruginosa on the PP-g-AA-modified nonwoven fabric decreased with increasing acrylic acid grafting content and chitosan, it means that the antibacterial activity of the PP nonwoven fabric was enhanced by the modification of gamma-ray radiation-induced grafting of acrylic acid and the immobilization of chitosan onto the PP-g-AA-modified nonwoven fabric. (C) 2003 Wiley Periodicals, Inc.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
   Inst Nucl Energy Res, Lungtan 32500, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
CR ALLAN CR, 1979, EXP MYCOL, V3, P285, DOI 10.1016/S0147-5975(79)80054-7
   CHEN CC, 2000, Patent No. 6022330
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P441
   HSIUE GH, 1991, MAKROMOL CHEM, V192, P2687
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859
   KANAZAWA A, 1994, J APPL POLYM SCI, V52, P641, DOI 10.1002/app.1994.070520507
   Kawada K, 1983, J ANTIBACT ANTIFUNG, V11, P515
   KINOSHITA Y, 1993, BIOMATERIALS, V14, P546, DOI 10.1016/0142-9612(93)90244-V
   KNORR D, 1983, J FOOD SCI, V48, P36, DOI 10.1111/j.1365-2621.1983.tb14783.x
   KNORR D, 1982, J FOOD SCI, V47, P593, DOI 10.1111/j.1365-2621.1982.tb10131.x
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Koyano T, 2000, POLYMER, V41, P4461, DOI 10.1016/S0032-3861(99)00675-8
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   Matsuyama H, 1999, J APPL POLYM SCI, V72, P397, DOI 10.1002/(SICI)1097-4628(19990418)72:3<397::AID-APP9>3.0.CO;2-C
   NAKAGAWA Y, 1984, APPL ENVIRON MICROB, V47, P513
   OKADA T, 1993, J BIOMED MATER RES, V27, P1559
   Qu X, 1999, J APPL POLYM SCI, V74, P3193, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3193::AID-APP23>3.0.CO;2-V
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   TOMITA N, 1994, J APPL BIOMATER, V5, P175, DOI 10.1002/jab.770050211
   UCHIDA E, 1990, J APPL POLYM SCI, V41, P677, DOI 10.1002/app.1990.070410317
   UCHIDA E, 1993, J APPL POLYM SCI, V47, P417, DOI 10.1002/app.1993.070470305
   UYAMA Y, 1990, J APPL POLYM SCI, V39, P489, DOI 10.1002/app.1990.070390301
   WALFISH IH, 1979, WATER AIR SOIL POLL, V12, P477, DOI 10.1007/BF01046868
   WALTERS PA, 1973, APPL MICROBIOL, V25, P253
   YANG JM, 1990, ANGEW MAKROMOL CHEM, V179, P99, DOI 10.1002/apmc.1990.051790108
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1995, ANGEW MAKROMOL CHEM, V231, P1, DOI 10.1002/apmc.1995.052310101
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
NR 38
TC 71
Z9 74
U1 2
U2 46
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 31
PY 2003
VL 90
IS 5
BP 1331
EP 1336
DI 10.1002/app.12787
PG 6
WC Polymer Science
SC Polymer Science
GA 717LR
UT WOS:000185091200017
DA 2018-10-19
ER

PT J
AU Kim, SH
   Kim, JH
   Akaike, T
AF Kim, SH
   Kim, JH
   Akaike, T
TI Regulation of cell adhesion signaling by synthetic glycopolymer matrix
   in primary cultured hepatocyte
SO FEBS LETTERS
LA English
DT Article
DE extracellular matrix; cell adhesion; integrin; asialoglycoprotein
   receptor; glycopolymer; hepatocyte
ID RAT HEPATOCYTES; EXTRACELLULAR-MATRIX; ASIALOGLYCOPROTEIN RECEPTOR;
   CYTOSKELETAL ORGANIZATION; KINASE; SURFACES; BINDING; PP125(FAK)
AB Control of cell-matrix interactions is a central principle for the design of biomaterial in tissue engineering. In this study, we evaluated a synthetic glycopolymer, which is recognized by the asialoglycoprotein receptor (ASGPR) expressed on the surface of hepatocytes, as an artificial matrix to regulate integrin-mediated signaling. The phosphorylation of focal adhesion kinase was restricted in hepatocytes cultured on the glycopolymer compared with fibronectin. In addition, there was no reorganization of cytoskeleton-related proteins such as actin filaments, microtubules, and vinculin in hepatocytes cultured on the glycopolymer. DNA synthesis and cyclin D1 expression were suppressed in hepatocytes grown on the glycopolymer as compared with those grown on fibronectin and collagen. The data suggest that the glycopolymer will be a good artificial matrix to regulate integrin-mediated signaling and cell growth through the unique ASGPR-carbohydrate interaction. (C) 2003 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
C1 Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan.
   Korea Adv Inst Sci & Technol, Dept Chem Engn, Taejon 305701, South Korea.
RP Akaike, T (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.
CR Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211
   CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552
   Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7
   Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   HANSEN LK, 1994, MOL BIOL CELL, V5, P967
   Humphries MJ, 1998, TRENDS CELL BIOL, V8, P78, DOI 10.1016/S0962-8924(98)80016-0
   Kim SH, 2001, J BIOL CHEM, V276, P35312, DOI 10.1074/jbc.M009749200
   Kim SH, 2000, BIOTECHNOL LETT, V22, P1049, DOI 10.1023/A:1005641928736
   KIM SH, 2003, IN PRESS BIOMATERIAL
   KIM SH, 2003, IN PRESS BIOMED MAT
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   KOBAYASHI K, 1985, POLYM J, V17, P567, DOI 10.1295/polymj.17.567
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   ODA H, 1995, BIOCHEM BIOPH RES CO, V212, P800, DOI 10.1006/bbrc.1995.2039
   ODENTHAL M, 1992, EXP CELL RES, V203, P289, DOI 10.1016/0014-4827(92)90001-O
   Otsu K, 2001, CELL PHYSIOL BIOCHEM, V11, P33, DOI 10.1159/000047790
   PEARSE BMF, 1981, ANNU REV BIOCHEM, V50, P85, DOI 10.1146/annurev.bi.50.070181.000505
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0
   Sauerbrey G., 1959, Z PHYS, V115, P206
   SAWADA N, 1986, EXP CELL RES, V167, P458, DOI 10.1016/0014-4827(86)90186-2
   SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680
   Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4
   STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X
   STOCKERT RJ, 1995, PHYSIOL REV, V75, P591
   SUDHAKARAN PR, 1986, EXP CELL RES, V167, P505, DOI 10.1016/0014-4827(86)90190-4
   van de Water B, 1999, J BIOL CHEM, V274, P13328, DOI 10.1074/jbc.274.19.13328
   WEIGEL PH, 1980, J CELL BIOL, V87, P855, DOI 10.1083/jcb.87.3.855
   WEISZ OA, 1991, J CELL BIOL, V115, P495, DOI 10.1083/jcb.115.2.495
   Zamir E, 2001, J CELL SCI, V114, P3583
NR 32
TC 42
Z9 42
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD OCT 23
PY 2003
VL 553
IS 3
BP 433
EP 439
DI 10.1016/S0014-5793(03)01047-0
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 735VB
UT WOS:000186134300038
PM 14572665
OA Bronze
DA 2018-10-19
ER

PT J
AU Liang, HF
   Chen, CN
   Chang, Y
   Sung, HW
AF Liang, HF
   Chen, CN
   Chang, Y
   Sung, HW
TI Natural antimicrobial agent (Reuterin) produced by Lactobacillus reuteri
   for sanitization of biological tissues inoculated with Pseudomonas
   aeruginosa
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE reuterin; glutaraldehyde; antimicrobial activity; biological tissue
ID CROSS-LINKING REAGENT; IN-VITRO EVALUATION; CYTOTOXICITY; FORMALDEHYDE;
   FEASIBILITY; RESISTANCE; FIXATION
AB The study was done to evaluate the efficacy of using reuterin produced by Lactobacillus reuteri to sanitize biological tissues. The microorganism tested in the study was Pseudomonas aeruginosa, a common cause of nosocomial biomaterial-related infections. The inhibitory effect of reuterin on P. aeruginosa for an inoculated tissue was investigated at different conditions of concentration, temperature, and pH. Additionally, the cellular compatibility of the reuterin-sanitized tissue was evaluated. Glutaraldehyde was employed as a control. It was noted that the minimum inhibitory concentration (MIC, 33.0 +/- 2.9 ppm) and minimum bactericidal concentration (MBC, 50.0 +/- 0.0 ppm) values of reuterin for P. aeruginosa were significantly lower than their glutaraldehyde counterparts (MIC, 130.0 +/- 8.2 ppm and MBC, 180.0 +/- 18.3 ppm). This indicated that reuterin was more efficient than glutaraldehyde as an antimicrobial agent. The addition of reuterin on the inoculated tissue led to a reduced viability of P. aeruginosa. The reduction in the P. aeruginosa culture was more pronounced with increasing the concentration of reuterin (0-100 ppm). At increasing temperature (25-45degreesC), there was an increasing effect of reuterin on its sanitization activity. However, it should be pointed out that the growth of P. aeruginosa in the nutrient broth was also significantly affected by temperature. The sanitization activity of reuterin was more evident with increasing the pH level (pH 6.5-8.5). The cytotoxicity of reuterin was significantly lower than that of glutaraldehyde. Additionally, the cellular compatibility of the reuterin-sanitized tissue was superior to its glutaraldehyde-sanitized counterpart. (C) 2003 Wiley Periodicals, Inc.
C1 Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   Natl Yang Ming Univ, Div Cardiovasc Surg, Taichung Vet Gen Hosp, Taichung, Taiwan.
   Natl Yang Ming Univ, Coll Med, Taipei 112, Taiwan.
RP Sung, HW (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
EM hwsung@che.nthu.edu.tw
CR AXELSSON L, 1987, FEMS MICROBIOL REV, V46, P65
   Axelsson L. T. C., 1989, MICROB ECOL HEALTH D, V2, P131
   BRUCK SD, 1988, J BIOMED MATER RES-A, V22, P133, DOI 10.1002/jbm.820221306
   Chen CN, 2002, J BIOMED MATER RES, V61, P360, DOI 10.1002/jbm.10153
   CHUNG TC, 1989, MICROB ECOL HEALTH D, V2, P137, DOI DOI 10.3109/08910608909140211
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Dodds MG, 2000, BIOTECHNOL BIOENG, V68, P456, DOI 10.1002/(SICI)1097-0290(20000520)68:4<456::AID-BIT11>3.0.CO;2-Z
   El-Ziney MG, 1998, J FOOD PROTECT, V61, P1275, DOI 10.4315/0362-028X-61.10.1275
   El-Ziney MG, 1999, J FOOD PROTECT, V62, P257, DOI 10.4315/0362-028X-62.3.257
   FURUSAWA T, 1986, J ANTIMICROB CHEMOTH, V17, P755, DOI 10.1093/jac/17.6.755
   HENCH LL, 1982, BIOMATERIALS INTERFA, P149
   Lennette E. H., 1980, MANUAL CLIN MICROBIO, P453
   Lohre J M, 1993, ASAIO J, V39, P106, DOI 10.1097/00002480-199304000-00007
   LOHRE JM, 1992, ARTIF ORGANS, V16, P630
   MATTA MS, 1986, GEN ORGANIC BIOL CHE, P536
   MURAYAMA Y, 1988, T AM SOC ART INT ORG, V34, P546
   Murray B E, 1989, Infect Dis Clin North Am, V3, P423
   NESTER EW, 1995, MICROBIOLOGY, P197
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Preston CAK, 1996, INT J ANTIMICROB AG, V7, P251, DOI 10.1016/S0924-8579(96)00330-5
   RASH M, 2002, INT J FOOD MICROBIOL, V72, P225
   Shearer AEH, 2000, BIOTECHNOL BIOENG, V67, P141
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 2002, BIOMATERIALS, V23, P3203, DOI 10.1016/S0142-9612(02)00072-8
   TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674
   TALARICO TL, 1988, ANTIMICROB AGENTS CH, V32, P1854, DOI 10.1128/AAC.32.12.1854
   TRUJILLO R, 1972, APPL MICROBIOL, V23, P618
   WOODROOF EA, 1978, J BIOENG, V2, P1
NR 30
TC 4
Z9 4
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD OCT 20
PY 2003
VL 84
IS 2
BP 233
EP 239
DI 10.1002/bit.10764
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 723RC
UT WOS:000185444500012
PM 12966580
DA 2018-10-19
ER

PT J
AU Trau, D
   Renneberg, R
AF Trau, D
   Renneberg, R
TI Encapsulation of glucose oxidase microparticles within a nanoscale
   layer-by-layer film: immobilization and biosensor applications
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE encapsulation; layer-by-layer; enzyme; crystal; immobilization
ID MULTILAYER; ADSORPTION; POLYELECTROLYTES; ENZYME; CONSTRUCTION;
   SURFACES; POLYIONS
AB We report on an immobilization strategy utilizing layer-by-layer encapsulated microparticles of enzymes within a nanoscale polyelectrolyte film. Encapsulation of glucose oxidase (GOD) microparticles was achieved by the sequential adsorption of oppositely charged polyelectrolytes onto the GOD biocrystal surface. The polyelectrolyte system polyallylamine/polystyrene sulfonate was used under high salt conditions to preserve the solid state of the highly water soluble GOD biocrystals during the encapsulation process. The resulting polymer multilayer capsule of about 15 nm wall thickness is permeable for small molecules (glucose), but non-permeable for macromolecules thus preventing the enzyme from leakage and at the same time shielding it from the outer environment e.g., from protease or microbial activity. Decrease of the buffer salt concentration leads to the dissolution of the enzyme under formation of mu-bioreactors. The spherical mu-bioreactors are hearing an extremely high loading of biocompound per volume. Encapsulated GOD was subsequently used to construct a biosensor by nanoengineered immobilisation of mu-bioreactor capsules onto an electrode surface. The presented approach demonstrates a general method to encapsulate highly soluble solid biomaterials and an immobilization strategy with the potential to create highly active thin and stable Films of biomaterial. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Hong Kong Univ Sci & Technol, Bioengn Grad Program, Kowloon, Hong Kong, Peoples R China.
   Hong Kong Univ Sci & Technol, Sch Engn, Kowloon, Hong Kong, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China.
   Hong Kong Univ Sci & Technol, Sino German Nano Analyt Lab, Kowloon, Hong Kong, Peoples R China.
RP Trau, D (reprint author), Hong Kong Univ Sci & Technol, Bioengn Grad Program, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.
RI Trau, Dieter/B-1633-2008
OI Trau, Dieter/0000-0001-6706-9123
CR Anzai J, 1998, ANAL CHEM, V70, P811, DOI 10.1021/ac970536b
   Arys X, 2000, SUPRAMOLECULAR POLYMERS, P505
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   Caruso F, 2000, LANGMUIR, V16, P8932, DOI 10.1021/la000401s
   Caruso F, 2000, LANGMUIR, V16, P1485, DOI 10.1021/la991161n
   Chien W., 1992, NOVEL DRUG DELIVERY
   COOPER TG, 1981, BIOCH ARBEITSMETHODE, P348
   Cosnier S, 1999, ANAL CHEM, V71, P3692, DOI 10.1021/ac9901788
   DECHER G, 1991, BER BUNSEN PHYS CHEM, V95, P1430, DOI 10.1002/bbpc.19910951122
   Estrela-Lopis I, 2002, LANGMUIR, V18, P7861, DOI 10.1021/la0258603
   Forzani ES, 2000, ANAL CHEM, V72, P5300, DOI 10.1021/ac0003798
   HECHT HJ, 1993, BIOSENS BIOELECTRON, V8, P197, DOI 10.1016/0956-5663(93)85033-K
   Joanny JF, 1999, EUR PHYS J B, V9, P117, DOI 10.1007/s100510050747
   Keller SW, 1995, J AM CHEM SOC, V117, P12879, DOI 10.1021/ja00156a034
   LIM F, 1985, BIOMEDICAL APPL MICR
   Liz-Marzan LM, 1996, LANGMUIR, V12, P4329, DOI 10.1021/la9601871
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345, DOI 10.1080/09205063.1998.9753060
   Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x
   Narvaez A, 2000, BIOSENS BIOELECTRON, V15, P43, DOI 10.1016/S0956-5663(00)00049-X
   Soper J. C., 2000, United States Patent, Patent No. [6,045,835, 6045835]
   VANLENGERICH, 1998, Patent No. 9818610
   VORLOP KD, 1992, BIOTECHNOL TECH, V6, P483
NR 24
TC 78
Z9 79
U1 1
U2 24
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD OCT 15
PY 2003
VL 18
IS 12
BP 1491
EP 1499
DI 10.1016/S0956-5663(03)00119-2
PG 9
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 723WQ
UT WOS:000185454900009
PM 12941565
DA 2018-10-19
ER

PT J
AU Badylak, SF
   Wu, CC
   Bible, M
   McPherson, E
AF Badylak, SF
   Wu, CC
   Bible, M
   McPherson, E
TI Host protection against deliberate bacterial contamination of an
   extracellular matrix bioscaffold versus Dacron (TM) mesh in a dog model
   of orthopedic soft tissue repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE ECM-extracellular matrix; infection resistance; scaffold; orthopedic
   surgery; biomaterial
ID SMALL-INTESTINAL SUBMUCOSA; ACHILLES-TENDON REPAIR; ANTIBACTERIAL
   PROTEINS; PIG INTESTINE; INFECTION; REGENERATION; PEPTIDES; BIOMATERIAL;
   EXPERIENCE; PROSTHESES
AB The resistance of two biomaterials, one synthetic and one biologic in origin, to deliberate bacterial infection was compared in a dog model of orthopedic soft tissue reconstruction. Twenty-four adult female dogs were randomly divided into two equal groups and a 2.0-cm-round full-thickness defect was created on the lateral surface of the stifle joint, leaving only the synovium and skin intact. The defect was surgically repaired with either Dacron(TM) mesh or a porcine derived extracellular matrix (ECM) scaffold material. The repair site was inoculated with 1 X 108 Staphylococcus aureus at the time of surgery and the dogs were survived for 28 days. Results showed a chronic pyogranulomatous inflammatory response at the Dacron(TM) implant sites versus a constructive tissue-remodeling response without residual inflammation at the ECM implant site. Three dogs in the group receiving the Dacron(TM) mesh were treated with Keflex(TM) (500 mg bid X 7 days) for signs of septicemia. A quantitative bacterial count of the implant sites at the time of sacrifice showed 6.52 x 10(5) +/- 1.2 x 10(6) and 6.5 x 10(2) +/- 1.8 x 10(3) bacteria per gram of tissue for the Dacron(TM) and ECM scaffold sites, respectively (P < .03). The ECM implant material was more resistant than the synthetic implant material to persistent infection following deliberate bacterial contamination and the ECM scaffold supported constructive tissue remodeling. (C) 2003 Wiley Periodicals, Inc.
C1 McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   Purdue Univ, Anim Dis Diagnost Lab, W Lafayette, IN 47907 USA.
   Univ So Calif, Keck Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90089 USA.
RP Badylak, SF (reprint author), McGowan Inst Regenerat Med, Suite 200,100 Technol Dr, Pittsburgh, PA 15219 USA.
EM badylaks@msx.upmc
OI Badylak, Stephen/0000-0003-3555-0689
CR AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x
   ALLAN DM, 1997, ANN ACAD MED SINGAP, V26, P687
   ARNOCZKY SP, 1999, CLIN ORTHOP S, V367, pS244
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   BADYLAK S, IN PRESS TISSUE ENG
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x
   BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.iy.13.040195.000425
   BOMAN HG, 1993, INFECT IMMUN, V61, P2978
   CHANG CC, 1994, J ORTHOPAED RES, V12, P526, DOI 10.1002/jor.1100120409
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   DICK HM, 1994, CLIN ORTHOPAEDICS, V306, P46
   GROGAN TJ, 1986, J BONE JOINT SURG AM, V68A, P226, DOI 10.2106/00004623-198668020-00008
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodde JP, 1997, TISSUE ENG, V3, P27, DOI 10.1089/ten.1997.3.27
   JOHNSON KD, 1986, CLIN ORTHOP RELAT R, P281
   Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545
   MADERAZO EG, 1988, CLIN ORTHOP RELAT R, V229, P131
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MUTT V, 1960, ARK KEMI, V15, P69
   Peel SAF, 1998, TISSUE ENG, V4, P143, DOI 10.1089/ten.1998.4.143
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Russell V, 1996, J INSECT PHYSIOL, V42, P65, DOI 10.1016/0022-1910(95)00083-6
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   SIMISON AJM, 1986, J BONE JOINT SURG BR, V68, P100
   SLAVATI EA, 1988, ORTHOPEDIC INFECT, P133
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   XANTHOPOULOS KG, 1988, EUR J BIOCHEM, V172, P371, DOI 10.1111/j.1432-1033.1988.tb13896.x
NR 39
TC 36
Z9 36
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT 15
PY 2003
VL 67B
IS 1
BP 648
EP 654
DI 10.1002/jbm.b.10062
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 729BD
UT WOS:000185750200010
PM 14528463
DA 2018-10-19
ER

PT J
AU Hallab, N
   Link, HD
   McAfee, PC
AF Hallab, N
   Link, HD
   McAfee, PC
TI Biomaterial optimization in total disc arthroplasty
SO SPINE
LA English
DT Article
DE total disc replacement; biomaterials; spine arthroplasty; cobalt alloy;
   titanium alloy; UHMWPE; spine implant; corrosion; wear; osteolysis;
   metal hypersensitivity
ID TOTAL HIP-ARTHROPLASTY; ORTHOPEDIC IMPLANTS; METAL SENSITIVITY; KNEE
   REPLACEMENT; CORROSION; WEAR; PROSTHESES; CHROMIUM; COBALT; POLYETHYLENE
AB Study. Knowledge gained through the clinical history of total joint replacement materials combined with the current promise of new biomaterials provides improved guidelines for biomaterials selection in total disc arthroplasty.
   Objectives. The following will detail 1) current biomaterials technology; 2) how current designs of total disc arthroplasty seek to optimize implant performance through judicious biomaterials selection; and 3) what technical obstacles and clinical concerns remain.
   Methods. Metals and polymers remain the central material components of state-of-the-art total joint arthroplasties. Polymers provide low friction surfaces for articulating bearings and some degree of shock adsorption. Metals provide appropriate material properties such as high strength, ductility, fracture toughness, hardness, corrosion resistance formability, and biocompatibility necessary for <LF>use in lead bearing roles required total disc replacement. There are three principal metal alloys used in orthopaedics and particularly in total joint replacement 1) titanium based alloys 2) cobalt based alloys; and 3) stainless steel alloys. Alloy specific differences in strength, ductility, and hardness generally determine which of these three alloys is used for a particular application or implant component.
   Results. Current designs. Two examples of current lumbar (Charite and Prodisc) and cervical (Bryan and Prestige) disc replacements are compared. The similarities and differences in the biomaterials used for each demonstrate prevailing consensus and some idea of how to best optimize implant performance though biomaterial selection.
   Conclusion. The primary factors governing total disc arthroplasty biomaterials are similar to those of all total joint arthroplasties generation of wear debris is the primary source of implant degradation, and the subsequent tissue reaction to such debris is the primary factor limiting the longevity of joint replacement prosthesis. Particulate debris generated by wear, fretting, or fragmentation induces the formation of an inflammatory reaction, which at a certain point promotes a foreign-body granulation tissue response that has the ability to invade the bone-implant interface. This commonly results in progressive, local bone lass that threatens the fixation of both cemented and cementless devices alike. All metal alloy implants corrode in vivo. When severe, the degradative process may reduce structural integrity of the implant, and the release of corrosion products is potentially toxic to the host. The corrosion resistance of implant alloys is primarily due to the formation of passive oxide films to prevent significant electrochemical dissolution from taking place. The result of this knowledge is a consensus of opinion as to which materials are best suited for use in current total disc arthroplasty designs, where most total disc replacement designs incorporate cobalt-chromium molybdenum alloy endplates articulating internally on a relatively soft polymeric core and externally coated with titanium or titanium alloy for enhanced bone fixation.
C1 Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA.
   Waldemar Link GmbH & Co, Hamburg, Germany.
   Hop St Joseph, Spine & Scoliosis Ctr, Towson, MD USA.
RP Hallab, N (reprint author), Rush Med Coll, Dept Orthoped Surg, 1653 W Congress Pkwy, Chicago, IL 60612 USA.
OI Jacobs, Joshua/0000-0003-3902-7334
CR BERRY DJ, 2000, EVOLUTION UNCEMENTED
   BERTAGNOLI RKS, 2002, EUR SPINE J, P131
   BLACK J, 1996, PROSTHETIC MAT, P141
   BLACK J, 1992, BIOMATERIALS
   Black J., 1988, ORTHOPAEDIC BIOMATER
   BOGDUK N, 1999, CLIN ANATOMY LUMBAR, P55
   BOSTROM PG, 2000, APPL BONE INDUCTIVE
   BREME J, 2001, HDB BIOMATERIAL PROP, P135
   BUNDY KJ, 1989, BONE MECH, P160
   Buttner-Janz K, 2002, ORTHOPADE, V31, P441, DOI 10.1007/s00132-001-0297-2
   DORR LD, 1990, CLIN ORTHOP RELAT R, P82
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   HA SW, 2002, POLYM MED BIOKOMPATI
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   HALLAB NJ, 2000, BIOMATERIALS ENG DEV
   HAMBY WB, 1959, J NEUROSURG, V16, P311, DOI 10.3171/jns.1959.16.3.0311
   HARMON P H, 1963, Clin Orthop Relat Res, V26, P107
   HELLIER WG, 1992, SPINE, V17, pS86, DOI 10.1097/00007632-199206001-00005
   HJALMAR JMJ, 1964, S A MED J, P881
   Jacobs J, 1999, ORTHOPEDIC BASIC SCI, P402
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   Jacobs JJ, 1999, CLIN ORTHOP RELAT R, P173
   JACOBS JJ, 1995, CLIN ORTHOP RELAT R, P94
   JACOBS JJ, 1995, J BONE JOINT SURG AM, V77A, P444, DOI 10.2106/00004623-199503000-00015
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jacobs JJ, 1996, CLIN ORTHOP RELAT R, pS256
   Jacobs JJ, 1994, ADV OPERATIVE ORTHOP, V2, P279
   JACOBS JJ, 1994, ORTH RES SOC NEW ORL, P838
   Jasty M, 1997, J BONE JOINT SURG AM, V79A, P349, DOI 10.2106/00004623-199703000-00005
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   LEE KY, 1998, ASTM STP
   LIEFEITH K, 2000, 3 INT ESS S WORK GRO
   MATHEWS HH, 2002, DESIGN RATIONALE EAR
   MATHIESEN EB, 1995, J BONE JOINT SURG BR, V77B, P345
   MCAFEE CBS, 2003, CHARITE DISC REPLACE
   McKellop H A, 1992, J Arthroplasty, V7, P291, DOI 10.1016/0883-5403(92)90051-Q
   MCKENZIE AH, 1995, ORTHOPEDICS, P313
   MEARS DC, 1979, MAT ORTHOPAEDIC SURG, P196
   MERRITT K, 1981, INT J DERMATOL, V20, P89, DOI 10.1111/j.1365-4362.1981.tb00408.x
   MICHEL R, 1991, ARCH ORTHOP TRAUM SU, V110, P61, DOI 10.1007/BF00393876
   Park JB, 1984, BIOMATERIALS SCI ENG
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   SCHELLNACK BJK, 1992, DEV ARTIFICIAL DISC
   SCHLIEPHAKE H, 1991, INT J ORAL MAXILLOF, V20, P53
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   SINIBALDI K, 1976, CLIN ORTHOP RELAT R, P257
   SPECTOR MBA, 2000, IMPLANT MAT METALS P, P25
   STULBERG BN, 1994, J APPL BIOMATER, V5, P9, DOI 10.1002/jab.770050103
   STULBERG BN, 1987, T ORTHOP RES SOC, V33, P314
   SUNDERMAN FW, 1989, J ORTHOPAED RES, V7, P307, DOI 10.1002/jor.1100070302
   SUNDERMAN FW, 1989, FUND APPL TOXICOL, V13, P205, DOI 10.1016/0272-0590(89)90257-1
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   Urban RM, 1997, AM SOC TEST MATER, V1301, P33, DOI 10.1520/STP12019S
   WRIGHT TLS, 2000, BIOMATERIALS, P181
   WRIGHT TM, 2001, IMPLANT WEAR, P207
   Zeggel P, 2000, INT MAG ORAL IMPLANT, V1, P52
NR 57
TC 38
Z9 43
U1 2
U2 27
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD OCT 15
PY 2003
VL 28
IS 20
SU S
BP S139
EP S152
DI 10.1097/01.BRS.0000092214.87225.80
PG 14
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 736ZF
UT WOS:000186202600007
PM 14560185
OA Bronze
DA 2018-10-19
ER

PT J
AU Zou, XN
   Xue, QY
   Li, HS
   Bunger, M
   Lind, M
   Bunger, C
AF Zou, XN
   Xue, QY
   Li, HS
   Bunger, M
   Lind, M
   Bunger, C
TI Effect of alendronate on bone ingrowth into porous tantalum and carbon
   fiber interbody devices - An experimental study on spinal fusion in pigs
SO ACTA ORTHOPAEDICA SCANDINAVICA
LA English
DT Article
ID RESORPTION; TISSUE; RATS; BISPHOSPHONATES; MODEL; VITRO; VIVO
AB Recent studies have reported that bisphosphonates reduce the resorption of grafted bone and inhibit bone resorption at a bone-implant interface. However, it is not known whether bisphosphonates affect bone ingrowth into porous biomaterial or spine fusion interbody devices with an autograft. In this study, 18 pigs (9 in each group) underwent anterior intervertebral lumbar arthrodeses at L2-3, L4-5 and L6-7. Each level was randomly allocated to one of the 3 implants: a solid piece of porous tantalum (Hedrocel), a porous tantalum ring or a carbon fiber cage both packed with an autograft. Alendronate was given orally to one of the groups. The radiographic and histological findings in the two groups 3 months after operation were similar in these devices. Histological examination showed that the original graft was entirely replaced by new trabecular bone in both groups. On histomorphometric analysis, the bone volume fraction, both inside the central hole of porous tantalum ring and in the porous tantalum, was larger in the pigs given alendronate than in the controls, but the fraction inside and around the central hole of the carbon fiber cage was not affected by this treatment. Short-term alendronate treatment, in a relatively low dose, does not impair the formation of new bone, but increases bone ingrowth into the central hole of the porous tantalum ring and the pores of the porous tantalum in this porcine model. This may be an effective way to enhance early biologic fixation of porous intervertebral implants.
C1 Aarhus Univ Hosp, Spine Sect, Dept Orthopaed, Orthopaed Res Lab, DK-8000 Aarhus, Denmark.
   Sun Yat Sen Univ, Affiliated Hosp Zhongshan 5, Dept Orthopaed, Guangdong, Peoples R China.
RP Zou, XN (reprint author), Aarhus Univ Hosp, Spine Sect, Dept Orthopaed, Orthopaed Res Lab, DK-8000 Aarhus, Denmark.
CR Astrand J, 1999, ACTA ORTHOP SCAND, V70, P67, DOI 10.3109/17453679909000961
   Astrand J, 2002, ACTA ORTHOP SCAND, V73, P24, DOI 10.1080/000164702317281369
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   FLEISCH H, 1969, SCIENCE, V165, P1262, DOI 10.1126/science.165.3899.1262
   Fleisch H, 1993, OSTEOPOROSIS INT S2, V3, P15
   GAMERO P, 1994, J CLIN ENDOCR METAB, V79, P1693
   Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7
   Hilding M, 2000, ACTA ORTHOP SCAND, V71, P553, DOI 10.1080/000164700317362163
   Li HS, 2002, EUR SPINE J, V11, P476, DOI 10.1007/s00586-002-0455-1
   LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201
   Myoung H, 2001, J PERIODONTAL RES, V36, P244, DOI 10.1034/j.1600-0765.2001.036004244.x
   PILLIAR RM, 1981, CLIN ORTHOP RELAT R, P249
   POGGIE RA, 1998, 44 ORS, P777
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P33
   STEINMANN JC, 1992, CLIN ORTHOP RELAT R, P80
   YAFFE A, 1995, J PERIODONTOL, V66, P999, DOI 10.1902/jop.1995.66.11.999
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   ZDEBLICK TA, 1993, SPINE, V18, P983, DOI 10.1097/00007632-199306150-00006
NR 20
TC 22
Z9 23
U1 1
U2 6
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0001-6470
J9 ACTA ORTHOP SCAND
JI Acta Orthop. Scand.
PD OCT
PY 2003
VL 74
IS 5
BP 596
EP 603
DI 10.1080/00016470310018027
PG 8
WC Orthopedics
SC Orthopedics
GA 734PJ
UT WOS:000186065500015
PM 14620983
OA Bronze
DA 2018-10-19
ER

PT J
AU Daamen, WF
   van Moerkerk, HTB
   Hafmans, T
   Buttafoco, L
   Poot, AA
   Veerkamp, JH
   van Kuppevelt, TH
AF Daamen, WF
   van Moerkerk, HTB
   Hafmans, T
   Buttafoco, L
   Poot, AA
   Veerkamp, JH
   van Kuppevelt, TH
TI Preparation and evaluation of molecularly-defined
   collagen-elastin-glycosaminoglycan scaffolds for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE collagen; elastin; glycosaminoglycans; biomaterial; tissue engineering
ID GROWTH-FACTOR; CHONDROITIN SULFATE; VASCULAR GRAFTS; HEPARAN-SULFATE;
   CROSS-LINKING; MATRICES; RELEASE; BINDING; DESIGN
AB Extracellular matrix components are valuable building blocks for the preparation of biomaterials involved in tissue engineering, especially if their biological, chemical and physical characteristics can be controlled. In this study, isolated type I collagen fibrils, elastin fibres and chondroitin sulphate (CS) were used for the preparation of molecularly-defined collagen-elastin glycosaminoglycan scaffolds. A total of 12 different scaffolds were prepared with four different ratios of collagen and elastin (1:9. 1:1. 9:1 and 1:0), with and without chemical crosslinking, and with and without CS. Collagen was essential to fabricate coherent, porous scaffolds. Electron microscopy showed that collagen and elastin physically interacted with each other and that elastin fibres were enveloped by collagen. By carbodiimide-crosslinking, amine groups were coupled to carboxylic groups and CS could be incorporated. More CS could be bound to collagen scaffolds (10%) than to collagen-elastin scaffolds (2.4-8.5% depending on the ratio). The attachment of CS increased the water-binding capacity to up to 65%. Scaffolds with a higher collagen content had a higher tensile strength whereas addition of elastin increased elasticity. Scaffolds were cytocompatible as was established using human myoblast and fibroblast culture systems. It is concluded that molecularly-defined composite scaffolds can be composed from individual, purified, extracellular matrix components. Data are important in the design and application of tailor-made biomaterials for tissue engineering. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Nijmegen, Med Ctr, Dept Biochem 194, NCMLS, NL-6500 HB Nijmegen, Netherlands.
   Univ Twente, Inst Biomed Technol, Dept Chem Technol, Polymer Chem & Biomat Grp, NL-7500 AE Enschede, Netherlands.
RP van Kuppevelt, TH (reprint author), Univ Nijmegen, Med Ctr, Dept Biochem 194, NCMLS, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM a.vankuppevelt@ncmls.kun.nl
RI Kuppevelt, A.H.M.S.M./L-4463-2015; Daamen, Willeke/D-5854-2015
OI Daamen, Willeke/0000-0003-3155-3030
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   BENDERS AAGM, 1991, EXP CELL RES, V195, P284, DOI 10.1016/0014-4827(91)90375-5
   Bradbury P, 1990, THEORY PRACTICE HIST, P119
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458
   Goissis G, 2000, ARTIF ORGANS, V24, P217, DOI 10.1046/j.1525-1594.2000.06537.x
   Iozzo R. V., 2000, PROTEOGLYCANS STRUCT
   Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   NICHOLS WW, 1998, MCDONALDS BLOOD FLOW
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   RABAUD M, 1991, BIOMATERIALS, V12, P313, DOI 10.1016/0142-9612(91)90040-H
   ROYCE PM, 2002, CONNECTIVE TISSUE IT
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Singla A, 2002, J BIOMED MATER RES, V60, P368, DOI 10.1002/jbm.10077
   VANKUPPEVELT TH, 1995, INT J BIOCHEM CELL B, V27, P775, DOI 10.1016/1357-2725(95)00047-S
   Watanabe H, 1998, J BIOCHEM-TOKYO, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 26
TC 137
Z9 138
U1 5
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2003
VL 24
IS 22
BP 4001
EP 4009
DI 10.1016/S0142-9612(03)00273-4
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 700FD
UT WOS:000184101200015
PM 12834595
DA 2018-10-19
ER

PT J
AU Souto, RM
   Laz, MM
   Reis, RL
AF Souto, RM
   Laz, MM
   Reis, RL
TI Degradation characteristics of hydroxyapatite coatings on orthopaedic
   TiAlV in simulated physiological media investigated by electrochemical
   impedance spectroscopy
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; hydroxyapatite; Ti-6Al-4V; plasma-sprayed coatings;
   corrosion resistance; electrochemical impedance spectroscopy
ID METAL-ION RELEASE; STAINLESS-STEEL; BIOMATERIAL APPLICATIONS;
   TRICALCIUM-PHOSPHATE; PASSIVE TITANIUM; INTERFACE ZONE; OXIDE-FILMS;
   IMPLANTS; BONE; INVIVO
AB This paper concentrates on the degradation characteristics of hydroxyapatite (HA) coatings on orthopaedic Ti-6Al-4V alloy while immersed in Ringer's salt solution, which were investigated by electrochemical impedance spectroscopy. Electrochemical impedance spectroscopy measurements were used to in situ characterize the electrochemical behavior of the passivated alloy covered with HA during aging in Ringer's solution. Comparison of the electrochemical data for the coated material with that for the uncoated metal substrate was also performed. The characteristic feature that describes the electrochemical behavior of the coated material is the coexistence of large areas of the coating itself with pores where the substrate is exposed to the aggressive media. The interpretation of results was thus performed in terms of a two-layer model of the film, in which the precipitation of hydrated oxide or phosphate compounds seals the pores left by the ceramic coating. The blocking effect due to salt precipitation inside the pores produces an enhancement of the resistance values, thus effectively diminishing the metal ion release in the system. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ La Laguna, Dept Phys Chem, E-38071 San Cristobal la Laguna, Tenerife, Spain.
   Univ La Laguna, Dept Edaphol & Geol, E-38071 San Cristobal la Laguna, Tenerife, Spain.
   Univ Minho, Dept Polymer Engn, P-4710057 Braga, Portugal.
RP Souto, RM (reprint author), Univ La Laguna, Dept Phys Chem, Campus Anchieta, E-38071 San Cristobal la Laguna, Tenerife, Spain.
RI Group, 3Bs/E-4374-2012; Souto, Ricardo M./G-4004-2014; Reis, Rui
   L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Souto, Ricardo M./0000-0001-9429-5513;
   Reis, Rui L./0000-0002-4295-6129
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   ASK M, 1989, APPL SURF SCI, V35, P283, DOI 10.1016/0169-4332(89)90013-5
   Baltat-Bazia A, 1992, MATER SCI FORUM, V111-112, P359
   Bard A. J., 2001, ELECTROCHEMICAL METH
   BARDWELL JA, 1991, ELECTROCHIM ACTA, V36, P647, DOI 10.1016/0013-4686(91)85153-X
   BOUKAMP BA, 1986, SOLID STATE IONICS, V18-9, P136, DOI 10.1016/0167-2738(86)90100-1
   BOUKAMP BA, 1989, EQUIVALENT CIRCUIT M
   BROWN SD, 1984, THIN SOLID FILMS, V119, P127, DOI 10.1016/0040-6090(84)90528-5
   BUNDY KJ, 1993, BIOMATERIALS, V14, P529, DOI 10.1016/0142-9612(93)90242-T
   BURSTEIN GT, 1995, ELECTROCHIM ACTA, V40, P1881, DOI 10.1016/0013-4686(95)00126-Y
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   GLUSZEK J, 1993, PROGR UNDERSTANDING, P1289
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1111, DOI 10.1002/jbm.820240813
   HEALY KE, 1992, J COLLOID INTERF SCI, V150, P404, DOI 10.1016/0021-9797(92)90210-D
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   JOHANSSON C, 1989, J BIOMED ENG, V11, P3, DOI 10.1016/0141-5425(89)90158-1
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   MANSFELD F, 1994, P ELECTROCHEM SOC, V9415, P59
   Mansfeld F., 1993, 26 SOL SCHLUMB
   MORONI A, 1994, J MATER SCI-MATER M, V5, P411, DOI 10.1007/BF00058975
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   REIS RL, 1994, BIOCERAMICS, V7, P125
   Solar RJ, 1979, ASTM STP, P259
   Sousa SR, 1996, BIOMATERIALS, V17, P397, DOI 10.1016/0142-9612(96)89655-4
   Souto RM, 1998, MATER SCI FORUM, V289-2, P799, DOI 10.4028/www.scientific.net/MSF.289-292.799
   Souto RM, 1996, J MATER SCI-MATER M, V7, P337
   SRIDHAR TM, 2000, P 7 INT S EL METH CO
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   THOMPSON I, 1994, CORROS SCI, V36, P187, DOI 10.1016/0010-938X(94)90119-8
   TISDEL CL, 1994, J BONE JOINT SURG AM, V76A, P159, DOI 10.2106/00004623-199402000-00001
   TRANQUILLI PL, 1994, J MATER SCI-MATER M, V5, P345, DOI 10.1007/BF00058960
NR 36
TC 117
Z9 119
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2003
VL 24
IS 23
BP 4213
EP 4221
DI 10.1016/S0142-9612(03)00362-4
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 702TH
UT WOS:000184239500013
PM 12853252
DA 2018-10-19
ER

PT J
AU Chang, YS
   Kobayashi, M
   Li, ZL
   Oka, M
   Nakamura, T
AF Chang, YS
   Kobayashi, M
   Li, ZL
   Oka, M
   Nakamura, T
TI Significance of peak value and duration of the interfacial shear load in
   evaluation of the bone-implant interface
SO CLINICAL BIOMECHANICS
LA English
DT Article
DE interfacial shear load; peak value duration; bone; fibrous tissue;
   bone-implant interface
ID BEARING CONDITIONS; ARTHROPLASTY; REPLACEMENT; INGROWTH; FIXATION;
   TISSUE
AB Objective. To determine if there is any merit in measuring peak load duration in studies of bone-implant interface during a pull-out test was performed to record the interfacial shear load.
   Design. Mechanical and histological investigations were performed to determine the bone-implant interfacial strength.
   Background. A common long-term problem following artificial joint replacement is the formation of an intervening fibrous tissue seam at the interface between bone and a prosthesis. To investigate the nature and strength of interfacial attachment between bone and an implanted biomaterial, a detaching method such as pull-out test can be used.
   Methods. Four porous surfaced alumina ceramic implants with or without glass-ceramic containing apatite and wollastonite coating at the surface of the beads and the substrate were implanted into canine the femoral condyles. Peak value and its duration of the interfacial shear load for the different types of implants were analyzed. Tissue formed at the bone-implant interfaces were examined histoloaically.
   Results. The peak value of interfacial shear load of the apatite and wollastonite glass-ceramic-coated implant was significantly greater than that of the non-coated implant at every stage, but the peak value duration in the control at each time period was greater than that of the coated implant. Histologically, more bone tissue ingrowth in the pores of coated implants, whereas a gap was observed at the interface of bone and the non-coated implant.
   Conclusions. The interfacial shear load values, peak and its duration, are significantly influenced by the direct bone bonding or the intervening fibrous tissue which formed at the bone-implant interface.
C1 Kyoto Univ, Inst Frontier Med Sci, Kyoto 606, Japan.
   Texas Hlth Res Inst, Plano, TX 75093 USA.
RP Chang, YS (reprint author), Kyoto Univ, Inst Frontier Med Sci, Kyoto 606, Japan.
CR Berme N, 1979, J Biomed Eng, V1, P268, DOI 10.1016/0141-5425(79)90164-X
   BURSTEIN AH, 1972, J BIOMECH, V5, P35, DOI 10.1016/0021-9290(72)90017-6
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   Chang YS, 1998, J ARTHROPLASTY, V13, P816, DOI 10.1016/S0883-5403(98)90037-7
   Chang YS, 1996, J BIOMED MATER RES, V30, P117, DOI 10.1002/(SICI)1097-4636(199601)30:1<117::AID-JBM15>3.0.CO;2-L
   Dean JC, 1995, J ARTHROPLASTY, V10, P830, DOI 10.1016/S0883-5403(05)80083-X
   GITELIS S, 1982, CLIN ORTHOP RELAT R, P291
   Hadjipavlou AG, 1997, J SPINAL DISORD, V10, P12
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   REILLY DT, 1974, J BONE JOINT SURG AM, VA 56, P1001, DOI 10.2106/00004623-197456050-00012
   SLEDGE CB, 1984, CLIN ORTHOP RELAT R, P127
   Stone JJS, 1996, J ORTHOPAED RES, V14, P834, DOI 10.1002/jor.1100140523
   TAKAGI H, 1989, J BIOMED MATER RES-A, V23, P161
   Unwin PS, 1996, J BONE JOINT SURG BR, V78B, P5
   WALKER PS, 1990, J ORTHOPAED RES, V8, P453, DOI 10.1002/jor.1100080317
   WEINANS H, 1990, J BIOMECH, V23, P991, DOI 10.1016/0021-9290(90)90314-S
   WEINANS H, 1992, J ORTHOPAED RES, V10, P845, DOI 10.1002/jor.1100100614
   WOO SLY, 1983, J BIOMED MATER RES, V17, P427, DOI 10.1002/jbm.820170304
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1, P335
NR 19
TC 8
Z9 9
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-0033
J9 CLIN BIOMECH
JI Clin. Biomech.
PD OCT
PY 2003
VL 18
IS 8
BP 773
EP 779
DI 10.1016/S0268-0033(03)00138-4
PG 7
WC Engineering, Biomedical; Orthopedics; Sport Sciences
SC Engineering; Orthopedics; Sport Sciences
GA 722XF
UT WOS:000185402800012
PM 12957565
DA 2018-10-19
ER

PT J
AU Mann, BK
AF Mann, BK
TI Biologic gels in tissue engineering
SO CLINICS IN PLASTIC SURGERY
LA English
DT Article
ID SMOOTH-MUSCLE CELLS; POLY(ETHYLENE GLYCOL) HYDROGELS; ENHANCES NEURITE
   EXTENSION; 3-DIMENSIONAL FIBRIN GELS; TENDON INJURY REPAIR;
   EXTRACELLULAR-MATRIX; ALGINATE HYDROGELS; GROWTH-FACTOR;
   PHOTOCROSSLINKABLE CHITOSAN; POLY(PROPYLENE FUMARATE)
AB The field of tissue engineering has been gaining attention over the past decade. Hydrogels are one type of biomaterial that are being investigated for various tissue engineering and wound healing applications. Natural and synthetic biologic hydrogels that have been developed are discussed here. Combining these hydrogel scaffolds with cells and appropriate signals for the cells will aid in developing new tissue engineered products.
C1 Keck Grad Inst, Claremont, CA 91711 USA.
RP Mann, BK (reprint author), Keck Grad Inst, 535 Watson Dr, Claremont, CA 91711 USA.
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   An YH, 2001, ANAT REC, V263, P336, DOI 10.1002/ar.1114
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   BELL E, 1995, MOL ENG, V1, P28
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BOTS JGF, 1986, BIOMATERIALS, V7, P393, DOI 10.1016/0142-9612(86)90011-6
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Butler DL, 1999, CLIN ORTHOP RELAT R, pS324
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   de Chalain T, 1999, J BIOMED MATER RES, V44, P280, DOI 10.1002/(SICI)1097-4636(19990305)44:3<280::AID-JBM6>3.0.CO;2-H
   Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0
   Elisseeff JH, 2002, ANN NY ACAD SCI, V961, P118, DOI 10.1111/j.1749-6632.2002.tb03062.x
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Halberstadt C, 2002, TISSUE ENG, V8, P309, DOI 10.1089/107632702753725067
   Hall H, 2001, MICROVASC RES, V62, P315, DOI 10.1006/mvre.2001.2348
   Hallen L, 1999, ACTA OTO-LARYNGOL, V119, P107
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Herbert CB, 1996, J COMP NEUROL, V365, P380, DOI 10.1002/(SICI)1096-9861(19960212)365:3<380::AID-CNE4>3.0.CO;2-0
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114
   Huss FRM, 2001, CELLS TISSUES ORGANS, V169, P361, DOI 10.1159/000047903
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Jockenhoevel S, 2001, THORAC CARDIOV SURG, V49, P287, DOI 10.1055/s-2001-17807
   Knight MM, 2002, BBA-GEN SUBJECTS, V1570, P1, DOI 10.1016/S0304-4165(02)00144-7
   Kobayashi M, 2001, J HAND SURG-BRIT EUR, V26, P436, DOI 10.1054/jhsb.2001.0581
   Kobayashi M, 2001, J BIOMED MATER RES, V58, P344
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   KUPCHIK HZ, 1983, EXP CELL RES, V147, P454, DOI 10.1016/0014-4827(83)90228-8
   Lindsey WH, 1996, ARCH OTOLARYNGOL, V122, P37
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Malette W.G., 1986, CHITIN NATURE TECHNO, P435
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   Masters KS, 2002, P ANN INT IEEE EMBS, P860, DOI 10.1109/IEMBS.2002.1137113
   Meana A, 1998, BURNS, V24, P621, DOI 10.1016/S0305-4179(98)00107-7
   MOGHADDAM MJ, 1991, ASAIO T, V37, P437
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Mosahebi A, 2001, TISSUE ENG, V7, P525, DOI 10.1089/107632701753213156
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Ohya S, 2001, BIOMACROMOLECULES, V2, P856, DOI 10.1021/bm010040a
   Okano T, 1997, ASAIO J, V43, pM749
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   Perka C, 2000, J BIOMED MATER RES, V49, P305, DOI 10.1002/(SICI)1097-4636(20000305)49:3<305::AID-JBM2>3.3.CO;2-0
   PETERSEN EF, 2002, BIOTECHNOL BIOENG, V78, P802
   Ramamurthi A, 2002, P ANN INT IEEE EMBS, P854, DOI 10.1109/IEMBS.2002.1137110
   Risbud M, 2001, J BIOMED MATER RES, V56, P120, DOI 10.1002/1097-4636(200107)56:1<120::AID-JBM1076>3.0.CO;2-W
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saadeh PB, 2001, J CRANIOFAC SURG, V12, P573, DOI 10.1097/00001665-200111000-00015
   Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Saris DBF, 2000, TISSUE ENG, V6, P531, DOI 10.1089/107632700750022170
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Suzuki Y, 1997, ASAIO J, V43, pM854
   SWEENEY TM, 1995, J NEUROSURG, V83, P710, DOI 10.3171/jns.1995.83.4.0710
   Tamura T, 2000, BIOMACROMOLECULES, V1, P552, DOI 10.1021/bm005606u
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Toda S, 2001, ENDOCR J, V48, P407, DOI 10.1507/endocrj.48.407
   Toung JS, 1998, LARYNGOSCOPE, V108, P1654, DOI 10.1097/00005537-199811000-00012
   Urry DW, 1997, ANN NY ACAD SCI, V831, P32
   Watanabe J, 2000, J BIOMAT SCI-POLYM E, V11, P1333, DOI 10.1163/156856200744363
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WEINBERG CB, 1985, J CELL PHYSIOL, V122, P410, DOI 10.1002/jcp.1041220311
   Weiser L, 1999, TISSUE ENG, V5, P533, DOI 10.1089/ten.1999.5.533
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   WEST JL, 1995, BIOMATERIALS, V16, P1153, DOI 10.1016/0142-9612(95)93579-3
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Yamamoto T, 2002, TISSUE ENG, V8, P119, DOI 10.1089/107632702753503117
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Yu XJ, 2001, J NEUROSCI RES, V66, P303, DOI 10.1002/jnr.1225
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   ZIEGLER T, 1995, ANN BIOMED ENG, V23, P216, DOI 10.1007/BF02584424
   ZIEGLER T, 1995, CELL MATER, V5, P115
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 100
TC 24
Z9 26
U1 1
U2 10
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0094-1298
J9 CLIN PLAST SURG
JI Clin. Plast. Surg.
PD OCT
PY 2003
VL 30
IS 4
BP 601
EP +
DI 10.1016/S0094-1298(03)00078-6
PG 10
WC Surgery
SC Surgery
GA 738XP
UT WOS:000186313400013
PM 14621308
DA 2018-10-19
ER

PT J
AU Boontheekul, T
   Mooney, DJ
AF Boontheekul, T
   Mooney, DJ
TI Protein-based signaling systems in tissue engineering
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID FIBROBLAST-GROWTH-FACTOR; BONE MORPHOGENETIC PROTEIN-2; CELL ATTACHMENT;
   IN-VIVO; BIODEGRADABLE POLYMER; SURFACE MODIFICATION;
   CONTROLLED-RELEASE; DRUG-DELIVERY; RGD PEPTIDES; ANGIOGENESIS
AB Tissue engineering aims to replace damaged tissues or organs using either transplanted cells or host cells recruited to the target site. Protein signaling is crucial to regulate cell phenotype and thus engineered tissue structure and function. Biomaterial vehicles are being designed to incorporate and locally deliver various molecules involved in this signaling, including both growth factors and peptides that mimick whole proteins. Controlling the concentration, local duration and spatial distribution of these factors is key to their utility and efficacy. Recent advances have been made in the development of polymeric delivery systems intended to achieve this control.
C1 Univ Michigan, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, 1011 N Univ Ave,5213 Dent Bldg, Ann Arbor, MI 48109 USA.
CR Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Bell E., 2000, PRINCIPLES TISSUE EN, pxxxv
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Bottaro DP, 2002, ANN NY ACAD SCI, V961, P143, DOI 10.1111/j.1749-6632.2002.tb03068.x
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Demers CN, 2002, J BIOMED MATER RES, V59, P403, DOI 10.1002/jbm.1256
   EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513
   Ennett AB, 2002, EXPERT OPIN BIOL TH, V2, P805, DOI 10.1517/14712598.2.8.805
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0
   Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Im SY, 2003, ARCH PHARM RES, V26, P76, DOI 10.1007/BF03179936
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Ishikawa T, 2003, ARTIF ORGANS, V27, P147, DOI 10.1046/j.1525-1594.2003.07009.x
   Isner JM, 2002, NATURE, V415, P234
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Kandziora F, 2002, SPINE, V27, P1710, DOI 10.1097/01.BRS.0000020306.86675.60
   Khurana R, 2003, TRENDS CARDIOVAS MED, V13, P116, DOI 10.1016/S1050-1738(02)00259-1
   Koo LY, 2002, J CELL SCI, V115, P1423
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   Lee KB, 2003, J PHARM SCI, V92, P933, DOI 10.1002/jps.10556
   Lee KY, 2001, ADV MATER, V13, P837, DOI 10.1002/1521-4095(200106)13:11<837::AID-ADMA837>3.0.CO;2-D
   Lu LC, 2001, J BONE JOINT SURG AM, V83A, pS82
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Luttun A, 2002, ANN NY ACAD SCI, V979, P80, DOI 10.1111/j.1749-6632.2002.tb04870.x
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Matsunaga T, 2003, AM J PHYSIOL-HEART C, V285, pH352, DOI 10.1152/ajpheart.00621.2002
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   Nagai MK, 2002, EXPERT OPIN BIOL TH, V2, P211, DOI 10.1517/14712598.2.2.211
   Nakahara T, 2003, TISSUE ENG, V9, P153, DOI 10.1089/107632703762687636
   Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2
   Parker JATC, 2002, TISSUE ENG, V8, P853, DOI 10.1089/10763270260424213
   PETERSEN W, 2003, IN PRESS ARCH ORTHOP
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rowley JA, 2002, ADV MATER, V14, P886, DOI 10.1002/1521-4095(20020618)14:12<886::AID-ADMA886>3.0.CO;2-I
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Sohier J, 2003, J CONTROL RELEASE, V87, P57, DOI 10.1016/S0168-3659(02)00350-4
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 61
TC 127
Z9 134
U1 1
U2 33
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD OCT
PY 2003
VL 14
IS 5
BP 559
EP 565
DI 10.1016/j.copbio.2003.08.004
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 741FN
UT WOS:000186448200018
PM 14580589
DA 2018-10-19
ER

PT J
AU Mehbod, A
   Aunoble, S
   Le Huec, JC
AF Mehbod, A
   Aunoble, S
   Le Huec, JC
TI Vertebroplasty for osteoporotic spine fracture: prevention and treatment
SO EUROPEAN SPINE JOURNAL
LA English
DT Review
DE vertebral compression fracture; osteoporotic compression fracture;
   percutaneous vertebroplasty; vertebroplasty; kyphoplasty
ID VERTEBRAL COMPRESSION FRACTURES; CALCIUM-PHOSPHATE CEMENT;
   QUALITY-OF-LIFE; PERCUTANEOUS POLYMETHYLMETHACRYLATE VERTEBROPLASTY;
   BIOMECHANICAL EVALUATION; INITIAL EXPERIENCE; ACRYLIC CEMENT; PAIN
   RELIEF; BONE-CEMENT; VENOGRAPHY
AB There is a relatively high prevalence of osteoporotic vertebral compression fractures (VCFs) in the elderly population, especially in women aged 50 or older. The result of these VCFs is increased morbidity and mortality in the short and long term. Medical treatment of these fractures includes bed rest, orthotics, analgesic medication and time. Percutaneous vertebroplasty (PVP) consists of percutaneous injection of biomaterial, such as methylmethacrylate, into the VCF to produce stability and pain relief. Biomechanical testing has shown that PVP can restore strength and stiffness of the vertebral body to the pre-fracture levels. Clinical results show immediate and maintained pain relief in 70-95% of the patients. Possible major complications include cement leakage into the spinal canal or into the venous system. Additionally, percutaneous vertebroplasty may alter the normal loading behavior of the adjacent vertebral body, and there is an increased risk of adjacent segment VCR Kyphoplasty is a new technique, which introduces a balloon into the vertebral body transpedicularly to reduce the VCF while creating a cavity for the cement injection. This technique has the benefit of kyphosis reduction as well as less cement leakage. Research continues into the development of injectable biomaterials that are resorbable and allow for new bone formation. Vertebroplasty and kyphoplasty are safe and effective in the treatment of osteoporotic VCFs. They may allow for a faster return to function, and thus avoid the morbidity associated with medical treatment.
C1 Bordeaux Univ Hosp, CHU Pellegrin Tripode, Spine Unit, F-33076 Bordeaux, France.
   Twin Cities Spine Ctr, Minneapolis, MN USA.
RP Le Huec, JC (reprint author), Bordeaux Univ Hosp, CHU Pellegrin Tripode, Spine Unit, F-33076 Bordeaux, France.
CR Adachi JD, 2002, BMC MUSCULOSKELET DI, V3, DOI 10.1186/1471-2474-3-11
   Aebli N, 2002, SPINE, V27, P460, DOI 10.1097/00007632-200203010-00005
   Barr JD, 2000, SPINE, V25, P923, DOI 10.1097/00007632-200004150-00005
   Belkoff SM, 2002, SPINE, V27, P1640, DOI 10.1097/01.BRS.0000018791.65404.1C
   Belkoff SM, 2001, SPINE, V26, P1537, DOI 10.1097/00007632-200107150-00007
   Belkoff SM, 2001, SPINE, V26, P151, DOI 10.1097/00007632-200101150-00008
   Belkoff SM, 2000, SPINE, V25, P1061, DOI 10.1097/00007632-200005010-00004
   Belkoff SM, 2002, AM J NEURORADIOL, V23, P1647
   Berlemann U, 2002, J BONE JOINT SURG BR, V84B, P748, DOI 10.1302/0301-620X.84B5.11841
   Convertino VA, 1997, MED SCI SPORT EXER, V29, P187, DOI 10.1097/00005768-199702000-00004
   COOK DJ, 1993, ARTHRITIS RHEUM, V36, P750, DOI 10.1002/art.1780360603
   COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756
   Cortet B, 1999, J RHEUMATOL, V26, P2222
   Cortet B, 2002, JOINT BONE SPINE, V69, P201, DOI 10.1016/S1297-319X(02)00381-0
   Cyteval C, 1999, AM J ROENTGENOL, V173, P1685, DOI 10.2214/ajr.173.6.10584820
   DENIS F, 1983, SPINE, V8, P817, DOI 10.1097/00007632-198311000-00003
   Deramond H, 1999, BONE S, V25, P17
   Evans AJ, 2003, RADIOLOGY, V226, P366, DOI 10.1148/radiol.2262010906
   GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166
   GARFIN S, 2001, P N AM SPIN SOC SEAT
   Gaughen JR, 2002, AM J NEURORADIOL, V23, P1657
   Gaughen JR, 2002, AM J NEURORADIOL, V23, P594
   Grados F, 2000, RHEUMATOLOGY, V39, P1410, DOI 10.1093/rheumatology/39.12.1410
   Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308
   Hitchon PW, 2001, J NEUROSURG, V95, P215, DOI 10.3171/spi.2001.95.2.0215
   Hiwatashi A, 2003, AM J NEURORADIOL, V24, P185
   Jang Jee Soo, 2002, Spine (Phila Pa 1976), V27, pE416, DOI 10.1097/00007632-200210010-00021
   Jensen ME, 1997, AM J NEURORADIOL, V18, P1897
   Kallmes DF, 2002, AM J NEURORADIOL, V23, P1117
   KARJALAINEN M, 1991, ANN CHIR GYNAECOL FE, V80, P45
   Kaufmann TJ, 2001, AM J NEURORADIOL, V22, P1860
   Keller TS, 2003, SPINE, V28, P455, DOI 10.1097/00007632-200303010-00009
   Kim AK, 2002, RADIOLOGY, V222, P737, DOI 10.1148/radiol.2223010718
   Lane JM, 2000, CLIN ORTHOP RELAT R, P139
   Lee Bong-Jin, 2002, Spine (Phila Pa 1976), V27, pE419, DOI 10.1097/00007632-200210010-00022
   LEHUEC J, 1998, BIOMATERIALS, P733
   LeidigBruckner G, 1997, J BONE MINER RES, V12, P663, DOI 10.1359/jbmr.1997.12.4.663
   Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026
   Liebschner MAK, 2001, SPINE, V26, P1547, DOI 10.1097/00007632-200107150-00009
   Lim TH, 2002, SPINE, V27, P1297, DOI 10.1097/00007632-200206150-00010
   LUKERT BP, 1994, GERIATRICS, V49, P22
   McGraw JK, 2002, J VASC INTERV RADIOL, V13, P149, DOI 10.1016/S1051-0443(07)61931-9
   McGraw JK, 2002, J VASC INTERV RADIOL, V13, P883, DOI 10.1016/S1051-0443(07)61770-9
   McKercher HG, 2000, CAN FAM PHYSICIAN, V46, P2228
   Melton LJ, 1997, J BONE MINER RES, V12, P16, DOI 10.1359/jbmr.1997.12.1.16
   Nakano M, 2002, J NEUROSURG, V97, P287, DOI 10.3171/spi.2002.97.3.0287
   Padovani B, 1999, AM J NEURORADIOL, V20, P375
   Peh WCG, 2002, RADIOLOGY, V223, P121, DOI 10.1148/radiol.2231010234
   Perez-Higueras A, 2002, NEURORADIOLOGY, V44, P950, DOI 10.1007/s00234-002-0856-1
   Phillips FM, 2002, SPINE, V27, P2173, DOI 10.1097/01.BRS.0000025689.39941.26
   RYAN PJ, 1992, ANN RHEUM DIS, V51, P1063, DOI 10.1136/ard.51.9.1063
   Ryu KS, 2002, J NEUROSURG, V96, P56, DOI 10.3171/spi.2002.96.1.0056
   Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063
   Schousboe JT, 2002, J CLIN DENSITOM, V5, P239, DOI 10.1385/JCD:5:3:239
   Scroop R, 2002, AM J NEURORADIOL, V23, P868
   Silverman SL, 1992, BONE S2, V13, P27
   Sinaki M, 1998, AGING CLIN EXP RES, V10, P249, DOI 10.1007/BF03339659
   SZPALSKI M, 2003, VERTEBRAL OSTEOPOROT, P171
   SZPALSKI M, 2003, VERTEBRAL OSTEOPOROT, P151
   Tsou IYY, 2002, ANN ACAD MED SINGAP, V31, P15
   Uppin AA, 2003, RADIOLOGY, V226, P119, DOI 10.1148/radiol.2261011911
   Vasconcelos C, 2002, AM J NEURORADIOL, V23, P913
   Verlaan JJ, 2002, SPINE, V27, P543, DOI 10.1097/00007632-200203010-00021
NR 63
TC 33
Z9 39
U1 0
U2 6
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD OCT
PY 2003
VL 12
SU 2
BP S155
EP S162
DI 10.1007/s00586-003-0607-y
PG 8
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 745UT
UT WOS:000186708700011
PM 14505122
OA Green Published
DA 2018-10-19
ER

PT J
AU Chou, SK
   Chua, KJ
AF Chou, SK
   Chua, KJ
TI On the study of the drying behavior of a heat-sensitive biomaterial
   undergoing stepwise-varying temperature schemes
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID AIR-TEMPERATURE; MOISTURE TRANSFER; KINETICS; PIECES; DRYER
AB A mechanistic model is presented for predicting the moisture and temperature distribution of biomaterials undergoing stepwise temperature drying. Good conformity of up to 7.4% was obtained between the simulated results and experimental data from product moisture and temperature. The calibrated model was used to conduct a parametric study on the stepwise variation of the air temperature and the impact on the internal temperature distribution and quality kinetics. The benefit of employing stepwise temperature profiles includes reversing the direction of heat flow within the product, resulting in appreciable improvement in product quality parameters such as ascorbic acid retention and surface color.
C1 Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Chua, KJ (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
RI Chua, Kian Jon Ernest/D-1502-2009
OI Chou, S.K./0000-0001-7989-0955; Chua, Kian Jon/0000-0001-9293-7471
CR BOMBERG M, 1974, 52 LUND I TECHN DIV
   Chou SK, 1997, DRY TECHNOL, V15, P1353, DOI 10.1080/07373939708917298
   Chua KJ, 2000, FOOD BIOPROD PROCESS, V78, P72, DOI 10.1205/096030800532761
   Chua KJ, 2001, FOOD RES INT, V34, P721, DOI 10.1016/S0963-9969(01)00094-1
   Devahastin S, 1999, T ASAE, V42, P421
   Guggenheim E. A, 1966, APPL STAT MECH
   Gunasekaran S, 1999, DRY TECHNOL, V17, P395, DOI 10.1080/07373939908917542
   HALLSTROM B, 1990, Journal of Food Engineering, V12, P45, DOI 10.1016/0260-8774(90)90018-4
   Hawlader MNA, 2001, INT J ENERG RES, V25, P859, DOI 10.1002/er.725
   Jelen P., 1986, FOOD ENG PROCESS APP, V1
   KAMEOKA T, 1986, FOOD ENG PROCESS APP, V1
   KANADE PB, 1988, J FOOD SCI, V53, P1218, DOI 10.1111/j.1365-2621.1988.tb13566.x
   LEE CY, 1970, NY FOOD LIFE SCI B, P1
   LOZANO JE, 1983, J FOOD SCI, V48, P1497, DOI 10.1111/j.1365-2621.1983.tb03524.x
   MADAMBA PS, 1994, DRY TECHNOL, V12, P669, DOI 10.1080/07373939408959983
   McMinn WAM, 1997, FOOD BIOPROD PROCESS, V75, P223, DOI 10.1205/096030897531621
   Ni H, 1999, DRY TECHNOL, V17, P2069, DOI 10.1080/07373939908917673
   Ni H, 1999, INT J HEAT MASS TRAN, V42, P1501, DOI 10.1016/S0017-9310(98)00123-9
   Pakowski Z., 1995, HDB IND DRYING
   PANG S, 1992, DRYING 92
   Patankar S., 1980, NUMERICAL HEAT TRANS
   PEDERSEN CR, 1992, BUILD ENVIRON, V27, P387, DOI 10.1016/0360-1323(92)90038-Q
   RICHARDS RF, 1992, ASHRAE TRAN, V98, P475
   SARAVACOS GD, 1986, J FOOD SCI, V51, P381, DOI 10.1111/j.1365-2621.1986.tb11135.x
   Singh R.P, 1993, INTRO FOOD ENG
   Sokhansanj S., 1995, HDB IND DRYING
   TOEI R, 1995, ADV DRYING
   ZHANG Q, 1991, DRY TECHNOL, V9, P383, DOI 10.1080/07373939108916672
NR 28
TC 6
Z9 6
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD OCT 1
PY 2003
VL 42
IS 20
BP 4939
EP 4952
DI 10.1021/ie0301536
PG 14
WC Engineering, Chemical
SC Engineering
GA 726TV
UT WOS:000185616700049
DA 2018-10-19
ER

PT J
AU Desai, SD
   Patel, JV
   Sinha, VK
AF Desai, SD
   Patel, JV
   Sinha, VK
TI Polyurethane adhesive system from biomaterial-based polyol for bonding
   wood
SO INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES
LA English
DT Article
DE adhesives for wood; polyurethane; mechanical properties of adhesives;
   renewable resources
AB Polyester polyols for use in the preparation of polyurethane (PU) adhesives were synthesized from potato starch and natural oils by a transesterification reaction. These polyester polyols were combined with an aromatic adduct based on toluene 2,4-diisocyanate to form a PU adhesive. Both the polyols and the PU adhesives were characterized by means of FTIR spectroscopy. The adhesive performance of the PU adhesives in bonding wood was evaluated by lap shear tests. The effect on adhesion of variation of NCO/OH ratio and hydroxyl value were studied. The change in lap shear strength before and after exposure to cold water, hot water, acid, and alkali were evaluated. Development of bond strength to wood was determined by means of tests at regular intervals, and also curing time required for different adhesive formulations were determined. The PU adhesive derived from natural products was found superior to the commercially available adhesive. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Vithalbha Patel & Rajratna PT Patel Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
RP Sinha, VK (reprint author), Vithalbha Patel & Rajratna PT Patel Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
CR COCKS LV, 1976, LAB HDB OIL FAT ANAL
   DESAI DH, 1973, THESIS SARDAR PATEL
   DINWOODIE JM, 1978, J I WOOD SCI, V8, P59
   EBEWELE RO, 1993, ADHES AGE        DEC, P23
   Frank H., 1994, STAT CONCEPTS APPL
   FREEMAN H. G., 1968, FOREST PROD J, V18, P39
   HUI YH, 1996, BAILEYS IND OIL FAT, V3, P224
   JIA D, 1994, POLYM SCI SER B+, V132, P817
   John N., 1998, J APPL POLYM SCI, V168, P1185
   Miller I, 1992, PROBABILITY STAT ENG
   MYRES GE, 1988, ADHES AGE        OCT, P31
   Oertel G, 1985, POLYURETHANE HDB
   OSREKAR U, 1992, INT J ADHES ADHES, V112, P38
   OTTEY FH, 1965, I EC PRODUCT RES DEV, V4, P228
   Packham D. E., 1992, HDB ADHESIVES, V407
   Patel JV, 1999, J SCI IND RES INDIA, V58, P579
   PATEL P, 1990, J APPL POLYM SCI, V40, P1037, DOI 10.1002/app.1990.070400535
   PIZZI A, 1983, WOOD ADHESIVES CHEM, V12
   SCHMELZER HG, 1987, POLYURETHANES WORLD, P614
   Skeist I., 1962, HDB ADHESIVES, V669
   Tronghton G. E., 1968, J I WOOD SCI, V21, P29
   Vallat MF, 2000, J APPL POLYM SCI, V76, P665, DOI 10.1002/(SICI)1097-4628(20000502)76:5<665::AID-APP8>3.0.CO;2-A
   Vick CB, 1998, FOREST PROD J, V48, P71
   WHITE JT, 1981, ADHES AGE        JUL, P19
   WILSON JB, 1981, ADHES AGE        MAY, P41
NR 25
TC 71
Z9 78
U1 4
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-7496
J9 INT J ADHES ADHES
JI Int. J. Adhes. Adhes.
PD OCT
PY 2003
VL 23
IS 5
BP 393
EP 399
DI 10.1016/S0143-7496(03)00070-8
PG 7
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 716XN
UT WOS:000185055100007
DA 2018-10-19
ER

PT J
AU Yuan, J
   Zhang, J
   Zhu, J
   Shen, J
   Lin, SC
   Zhu, W
   Fang, JL
AF Yuan, J
   Zhang, J
   Zhu, J
   Shen, J
   Lin, SC
   Zhu, W
   Fang, JL
TI Reduced platelet adhesion on the surface of polyurethane bearing
   structure of sulfobetaine
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE polyurethane; sulfobetaine; surface modification; platelet adhesion;
   nonthrombogenic biomaterials
ID BLOOD COMPATIBILITY; POLY(ETHER URETHANE); COPOLYMERS; MONOMER; FILM;
   POLYMERS
AB Poly(etherurethane)s are widely used as blood-contacting biomaterials due to their good biocompatibility and mechanical properties. Nevertheless, their blood compatibility is still not adequate for the more demanding applications. Surface modification is an effective way to improve the blood compatibility and retain the bulk properties of biomaterials. The purpose of present study was to design and synthesize a novel nonthrombogenic biomaterial by modifying the surface of poly(etherurethane) with zwitterionic monomer. Films of polyurethane were grafted with sulfobetaine by a three-step procedure. In the first step, the film surfaces were treated with hexamethylene diisocyanate (HDI) in toluene at 50degreesC in the presence of di-n-butyl tin dilaurate (DBTDL) as a catalyst. The extent of the reaction was measured by ATR-IR spectra; a maximum number of free NCO group was obtained after a reaction time of 90 min. In the second step, the hydroxyl group of 4-dimethylamino-1-butanol (DMAB) was allowed to react in toluene with isocyanate groups bound on the surface. In the third step, sulfobetaine was formed on the surface through the ring-opening reaction between tertiary amine of DMAB and 1,3-propane-sultone (PS). It was characterized by ATR-IR, XPS. The data showed that the grafted surfaces were composed of sulfobetaine. The results of the contact angle measurements showed that they were strongly hydrophilic. The state of platelet adhesion and shape variation for the attached platelets was described. The modified surface shows excellent blood compatibility feature by the low platelet adhesion.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
   Nanjing Univ, Ctr Mat Anal, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Chen Z, 2000, J APPL POLYM SCI, V76, P382, DOI 10.1002/(SICI)1097-4628(20000418)76:3<382::AID-APP13>3.0.CO;2-A
   CHRISTINA FL, 1993, J APPL POLYM SCI, V50, P345
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   LELAH MD, 1986, POLYURETHANES MED, P57
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   LIAW DJ, 1985, J APPL POLYM SCI, V30, P4697, DOI 10.1002/app.1985.070301216
   LIAW DJ, 1987, J APPL POLYM SCI, V34, P999, DOI 10.1002/app.1987.070340311
   Liaw DJ, 2000, POLYMER, V41, P6123, DOI 10.1016/S0032-3861(99)00824-1
   Lin JC, 2001, J MATER SCI-MATER M, V12, P827, DOI 10.1023/A:1017937304964
   Lin S. C., 1998, CHIN POLYM B, V1, P1
   MCCORMICK CL, 1992, POLYMER, V33, P4617, DOI 10.1016/0032-3861(92)90422-S
   Monroy V.M., 1984, POLYMER, V25, P121
   MONROYSOTO VM, 1984, POLYMER, V25, P254
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   SALAMONE JC, 1977, POLYMER, V18, P1058, DOI 10.1016/0032-3861(77)90013-1
   Wang DA, 2001, BIOMATERIALS, V22, P1549, DOI 10.1016/S0142-9612(00)00311-2
   Yuan J, 2003, CHINESE J POLYM SCI, V21, P419
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   Yuan J, 2003, COLLOID SURFACE B, V30, P147, DOI 10.1016/S0927-7765(03)00082-1
   YUAN J, 2003, IN PRESS POLYM INT
   Yuan YL, 2002, J BIOMAT SCI-POLYM E, V13, P1081, DOI 10.1163/156856202320813800
   YUAN YL, 2003, IN PRESS POLYM INT
   Zhang J, 2003, BIOMATERIALS, V24, P4223, DOI 10.1016/S0142-9612(03)00365-X
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   Zhou J, 2002, CHEM J CHINESE U, V23, P2393
NR 33
TC 20
Z9 21
U1 2
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 2003
VL 18
IS 2
BP 123
EP 135
DI 10.1177/088532803038100
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736RA
UT WOS:000186185900004
PM 14621338
DA 2018-10-19
ER

PT J
AU Einmahl, S
   Ponsart, S
   Bejjani, RA
   D'Hermies, F
   Savoldelli, M
   Heller, J
   Tabatabay, C
   Gurny, R
   Behar-Cohen, F
AF Einmahl, S
   Ponsart, S
   Bejjani, RA
   D'Hermies, F
   Savoldelli, M
   Heller, J
   Tabatabay, C
   Gurny, R
   Behar-Cohen, F
TI Ocular biocompatibility of a poly(ortho ester) characterized by
   autocatalyzed degradation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; poly(ortho esters); biodegradable polymers; ocular;
   rabbit; drug delivery; biomaterials
ID EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY; MACULAR DEGENERATION;
   CONTROLLED-RELEASE; FILTERING SURGERY; DRUG-DELIVERY/; 5-FLUOROURACIL;
   EROSION; BIOMATERIAL; PREVENTION; POLYMER
AB The biocompatibility of autocatalyzed poly(ortho ester) (POE(70)LA(30)), a viscous, hydrophobic, bioerodible polymer, was investigated. POE(70)LA(30) was synthesized, sterilized by gamma irradiation, and injected in rabbit eyes at adequate volumes through subconjunctival, intracameral, intravitreal, and suprachoroidal routes. Clinical examinations were performed postoperatively at regular time points for 6 mo, and histopathologic analysis was carried out to confirm tissular biocompatibility. After subconjunctival injection, the polymer was well tolerated and persisted in the subconjunctival space for about 5 weeks. In the case of intracameral injections, polymer biocompatibility was good; the POE(70)LA(30) bubble was still present in the anterior chamber for up to 6 mo after injection. No major histopathologic anomalies were detected, with the exception of a localized Descemet membrane thickening. After intravitreal administration, POE(70)LA(30) biocompatibility was excellent, and no inflammatory reaction could be detected during the observation period. The polymer was degraded in approximately 3 mo. Suprachoroidal injections of POE(70)LA(30) were reproducible and well tolerated. POE(70)LA(30) triggered a slight elevation of the retina and choroid upon clinical observation. The polymer was detectable in the suprachoroidal space for about 6 mo. No inflammatory reaction and no major retinal anomalies could be detected by histology. In conclusion, POE(70)LA(30) appears to be a promising biomaterial for intraocular application, potentially providing sustained drug delivery over an extended period of time, with a good tolerance. (C) 2003 Wiley Periodicals, Inc.
C1 Inst Biomed Cordeliers, INSERM, U450, F-75270 Paris 6, France.
   Univ Geneva, Sch Pharm, CH-1211 Geneva, Switzerland.
   Hop Hotel Dieu, F-75004 Paris, France.
   AP Pharma, Redwood City, CA 94063 USA.
RP Behar-Cohen, F (reprint author), Inst Biomed Cordeliers, INSERM, U450, 15 Rue Ecole Med, F-75270 Paris 6, France.
CR ARAIE M, 1990, GRAEF ARCH CLIN EXP, V228, P573, DOI 10.1007/BF00918493
   Asaria RHY, 2001, OPHTHALMOLOGY, V108, P1179, DOI 10.1016/S0161-6420(01)00589-9
   Ciulla TA, 1998, SURV OPHTHALMOL, V43, P134, DOI 10.1016/S0039-6257(98)00014-9
   Danis RP, 2000, RETINA-J RET VIT DIS, V20, P244, DOI 10.1097/00006982-200005000-00003
   Einmahl S, 2002, INVEST OPHTH VIS SCI, V43, P1533
   Einmahl S, 2001, INVEST OPHTH VIS SCI, V42, P695
   Einmahl S, 2001, ADV DRUG DELIVER REV, V53, P45, DOI 10.1016/S0169-409X(01)00220-4
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707
   FOULDS WS, 1988, BRIT J OPHTHALMOL, V72, P278, DOI 10.1136/bjo.72.4.278
   Gopferich A, 1996, EUR J PHARM BIOPHARM, V42, P1
   GUYER DR, 1989, RETINA, P17
   Herrero-Vanrell R, 2001, ADV DRUG DELIVER REV, V52, P5, DOI 10.1016/S0169-409X(01)00200-9
   Hui YN, 1999, GRAEF ARCH CLIN EXP, V237, P601, DOI 10.1007/s004170050284
   Khaw PT, 2001, CURR OPIN OPHTHALMOL, V12, P143, DOI 10.1097/00055735-200104000-00011
   Merkli A, 1998, PROG POLYM SCI, V23, P563, DOI 10.1016/S0079-6700(97)00048-8
   Miyamoto H, 1997, CURR EYE RES, V16, P930, DOI 10.1076/ceyr.16.9.930.5042
   Ng SY, 1997, MACROMOLECULES, V30, P770, DOI 10.1021/ma9610626
   Ogura Y, 2001, ADV DRUG DELIVER REV, V52, P1, DOI 10.1016/S0169-409X(01)00199-5
   PATITSAS CJ, 1992, OPHTHALMOLOGY, V99, P594
   PEYMAN GA, 1987, INT OPHTHALMOL, V10, P133, DOI 10.1007/BF00139338
   Rothen-Weinhold A, 2001, J CONTROL RELEASE, V71, P31, DOI 10.1016/S0168-3659(00)00348-5
   RUBSAMEN PE, 1994, ARCH OPHTHALMOL-CHIC, V112, P407, DOI 10.1001/archopht.1994.01090150137036
   SCHACHAT AP, 1994, ARCH OPHTHALMOL-CHIC, V112, P500
   Schwach-Abdellaoui K, 1999, J BIOMAT SCI-POLYM E, V10, P375, DOI 10.1163/156856299X00432
   Schwach-Abdellaoui K, 1999, MACROMOLECULES, V32, P301, DOI 10.1021/ma981517m
   Schwach-Abdellaoui K, 2001, BIOMATERIALS, V22, P1659, DOI 10.1016/S0142-9612(00)00327-6
   SCHWACHABDELLAO.K, 2002, IN PRESS INT J POLYM
   WONG VG, 1992, Patent No. 5164188
   Yasukawa T, 2001, ADV DRUG DELIVER REV, V52, P25, DOI 10.1016/S0169-409X(01)00192-2
   Zignani M, 1998, J BIOMED MATER RES, V39, P277
NR 31
TC 21
Z9 22
U1 0
U2 5
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2003
VL 67A
IS 1
BP 44
EP 53
DI 10.1002/jbm.a.10597
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 729ER
UT WOS:000185760300006
PM 14517860
DA 2018-10-19
ER

PT J
AU Gilbert, M
   Giachelli, CM
   Stayton, PS
AF Gilbert, M
   Giachelli, CM
   Stayton, PS
TI Biomimetic peptides that engage specific integrindependent signaling
   pathways and bind to calcium phosphate surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
ID FOCAL ADHESION KINASE; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR;
   CYTOPLASMIC DOMAINS; INTEGRIN RECEPTORS; PROTEIN-KINASE; CELL-ADHESION;
   COLLAGEN; HYDROXYAPATITE; OSTEOPONTIN
AB Many important matrix proteins involved in bone remodeling contain separate domains that orient the protein on hydroxyapatite and interact with target cell receptors, respectively. We have designed two synthetic peptides that mimic the dual activities of these large, complex proteins by binding to calcium phosphate minerals and by engaging integrin-dependent signaling pathways in osteoblasts. The addition of either PGRGDS from osteopontin or PDGEA from collagen type I to the HAP-binding domain of statherin (N15 domain) did not alter its alpha-helical structure or diminish its affinity for hydroxyapatite. Immobilized N15-PGRGDS bound MC3T3-E1 osteoblasts predominantly via the alphavbeta3 integrin and induced focal adhesion kinase (FAK) phosphorylation at comparable levels to immobilized osteopontin. Immobilized N15-PDGEA bound MC3T3-E1 osteoblasts predominantly through the alpha2beta1 integrin and induced similar levels of FAK phosphorylation. Although both peptides induced FAK phosphorylation with similar time courses, only the N15-PDGEA peptide induced ERK1/2 phosphorylation, showing that these peptides are also capable of engaging integrin-specific signaling pathways. This peptide system can be used to study adhesion-dependent control of signaling in the context of the relevant biomineral surface and may also be useful in biomaterial and tissue engineering applications. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Stayton, PS (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
FU NIDCR NIH HHS [DE 12554]
CR AKIYAMA SK, 1994, J BIOL CHEM, V269, P15961
   Aplin AE, 1998, PHARMACOL REV, V50, P197
   Asplin JR, 1998, KIDNEY INT, V53, P194, DOI 10.1046/j.1523-1755.1998.00739.x
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F
   DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   Grzesik Wojciech J., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P271
   Jiang XJ, 1998, UROL RES, V26, P389, DOI 10.1007/s002400050074
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Lieske JC, 1996, SEMIN NEPHROL, V16, P458
   Liu YK, 1997, FEBS LETT, V420, P112, DOI 10.1016/S0014-5793(97)01498-1
   Lundstrom A, 1998, BIOCHEM BIOPH RES CO, V250, P735, DOI 10.1006/bbrc.1998.9389
   MORINO N, 1995, J BIOL CHEM, V270, P269, DOI 10.1074/jbc.270.1.269
   Moursi AM, 1997, J CELL SCI, V110, P2187
   PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x
   PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766
   Roberts AI, 1999, IMMUNOLOGY, V97, P679
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702
   Shaw WJ, 2000, J AM CHEM SOC, V122, P1709, DOI 10.1021/ja9842823
   Shaw WJ, 2000, J AM CHEM SOC, V122, P7118, DOI 10.1021/ja000878q
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Wesson JA, 1998, KIDNEY INT, V53, P952, DOI 10.1046/j.1523-1755.1998.00839.x
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144
NR 30
TC 51
Z9 51
U1 0
U2 8
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2003
VL 67A
IS 1
BP 69
EP 77
DI 10.1002/jbm.a.10053
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 729ER
UT WOS:000185760300009
PM 14517863
DA 2018-10-19
ER

PT J
AU Barros, VMR
   Rosa, AL
   Beloti, MM
   Chierice, G
AF Barros, VMR
   Rosa, AL
   Beloti, MM
   Chierice, G
TI In vivo biocompatibility of three different chemical compositions of
   Ricinus communis polyurethane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Ricinus communis polyurethane; osseointegration; osseoconductivity;
   polymer blend; biocompatibility
ID BONE-MARROW; HUMAN OSTEOBLASTS; ATTACHMENT; SURFACE; RESIN
AB Alteration in the chemical composition of a biomaterial may be undertaken to improve its biological properties. The aim of this work was to evaluate the biocompatibility of three chemical compositions of Ricinus communis polyurethane (RCP): RCPp (pure RCP), RCP + CaCO3, and RCP +Ca-3(PO4)(2). RCP cylinders were surgically implanted in rabbit femurs. After 8, 12, and 16 weeks, the femurs were removed, fixed, sectioned, ground, and stained by Stevenel's blue/Alizarin red S for light microscopy and histomorphometry. The osseointegration and osseoconductivity were calculated by means of image analysis and the data were submitted to the Kruskal-Wallis test followed by Dunn's test. Osseointegration was already completed after 8 weeks on RCP + Ca-3(PO4)(2) because similar values were found from week 8 to 16, whereas it showed a time-dependent increase on RCPp and RCP +CaCO3. The osseointegration was greater on RCP + Ca-3(PO4)(2) in all periods when compared with RCPp, and after 8 and 12 weeks when compared with RCP + CaCO3. None of the RCP samples presented osseoconductivity. The present results showed that RCP blended with calcium phosphate improved the biocompatibility by both enhancing and accelerating its osseointegration. Based on the absence of osseoconductivity, RCP was considered to be a bioinert material. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg, BR-14040904 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Chem Inst Sao Carlos, Dept Analyt Chem & Polymer Technol, BR-13560970 Sao Carlos, SP, Brazil.
RP Barros, VMR (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg, Av Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
RI Rosa, Adalberto/A-6314-2008; Chierice, Gilberto Orivaldo/C-7580-2012;
   Beloti, Marcio/E-7473-2012
OI Rosa, Adalberto/0000-0002-6495-2778; Beloti, Marcio/0000-0003-0149-7189
CR Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Beloti MM, 2003, J BIOMED MATER RES A, V64A, P171, DOI 10.1002/jbm.a.10435
   Carvalho TLL, 1997, INT J ORAL MAX SURG, V26, P149, DOI 10.1016/S0901-5027(05)80838-0
   Carvalho TLL, 1997, J BIOMED MATER RES, V37, P449
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   FRANCINO LF, 1998, THESIS FM U FEDERAL
   KHARMANDAYAN P, 1997, THESIS ECOLA PAULIST
   KOJIMA KE, 1995, ACTA ORTOP BRAS, V3, P62
   Lane JM, 1999, CLIN ORTHOP RELAT R, P216
   Maniatopoulos C, 1986, Int J Oral Maxillofac Implants, V1, P31
   NIELSEN FF, 1992, ACTA ORTHOP SCAND, V63, P66, DOI 10.3109/17453679209154853
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Parr G R, 1993, Int J Oral Maxillofac Implants, V8, P534
   POSTNER AS, 1975, ACCOUNTS CHEM RES, V8, P273
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   REDEY AS, 2000, J BIOMED MATER RES, V508, P353
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   ROSA AL, 2002, J MATER SCI-MATER M, V14, P1
   WILLIANS DF, 1987, DEFINITIONS BIOMATER, P4
   WU SC, 1990, BIOMATERIALS, V11, P491, DOI 10.1016/0142-9612(90)90063-V
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 22
TC 22
Z9 23
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2003
VL 67A
IS 1
BP 235
EP 239
DI 10.1002/jbm.a.10105
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 729ER
UT WOS:000185760300027
PM 14517881
DA 2018-10-19
ER

PT J
AU Reyes, CD
   Garcia, AJ
AF Reyes, CD
   Garcia, AJ
TI A centrifugation cell adhesion assay for high-throughput screening of
   biomaterial surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell adhesion; centrifugation; biomaterials; surface engineering;
   adhesion assay
ID FOCAL ADHESIONS; INITIAL BINDING; FLOW CHAMBER; SHEAR-STRESS;
   FIBRONECTIN; DETACHMENT; INTEGRINS
AB A quantitative analysis of cell adhesion is essential in understanding physiological phenomena and designing biomaterials, implant surfaces, and tissue-engineering scaffolds. The most common cell adhesion assays used to evaluate biomaterial surfaces lack sensitivity and reproducibility and/or require specialized equipment and skill-intensive operation. We describe a modified centrifugation cell adhesion assay that uses simple and convenient techniques with standard laboratory equipment and provides reliable, quantitative measurements of cell adhesion. This centrifugation assay applies controlled and uniform detachment forces to a large population of adherent cells, providing robust statistics for quantifying cell adhesion. The applicability of this system to the design and characterization of biomaterial surfaces is shown by evaluating cell adhesion on substrates using different coating proteins, cell types, seeding times, and relative centrifugal forces (RCF). Results verify that this centrifugation cell adhesion assay represents a simple, convenient, and standard method for high-throughput characterization of a variety of biomaterial surfaces and conditions. (C) 2003 Wiley Periodicals, Inc.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
CR Bundy KJ, 2001, CELL BIOL INT, V25, P289, DOI 10.1006/cbir.2000.0648
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3
   DOROSZEWSKI J, 1977, EXP CELL RES, V104, P335, DOI 10.1016/0014-4827(77)90099-4
   EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Giacomello E, 1999, BIOTECHNIQUES, V26, P758, DOI 10.2144/99264pf01
   HERTL W, 1984, IN VITRO CELL DEV B, V20, P796
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   Horbett Thomas A., 1996, P133
   HUBBE MA, 1981, PROG SURF SCI, V11, P65, DOI 10.1016/0079-6816(81)90009-5
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   LAWRENCE MB, 1987, BLOOD, V70, P1284
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   MCCLAY DR, 1981, P NATL ACAD SCI-BIOL, V78, P4975, DOI 10.1073/pnas.78.8.4975
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   Nauman EA, 1999, ANN BIOMED ENG, V27, P194, DOI 10.1114/1.173
   Nugiel D J, 1996, Tissue Eng, V2, P127, DOI 10.1089/ten.1996.2.127
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167
   WEISS LEONARD, 1961, EXPTL CELL RES SUPPL, V8, P141, DOI 10.1016/0014-4827(61)90345-7
NR 25
TC 112
Z9 113
U1 9
U2 43
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2003
VL 67A
IS 1
BP 328
EP 333
DI 10.1002/jbm.a.10122
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 729ER
UT WOS:000185760300038
PM 14517892
DA 2018-10-19
ER

PT J
AU Martin, SM
   Ganapathy, R
   Kim, TK
   Leach-Scampavia, D
   Giachelli, CM
   Ratner, BD
AF Martin, SM
   Ganapathy, R
   Kim, TK
   Leach-Scampavia, D
   Giachelli, CM
   Ratner, BD
TI Characterization and analysis of osteopontin-immobilized
   poly(2-hydroxyethyl methacrylate) surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(HEMA); osteopontin; covalent immobilization; surface analysis; cell
   ahesion
ID IN-VITRO; CELL-MIGRATION; INTEGRIN; HYDROGELS; ADHESION;
   ALPHA(V)BETA(3); INFLAMMATION; ADSORPTION; THROMBIN; PROTEINS
AB A wide array of technologies exist for the characterization and quantification of molecules present at surfaces. We have used several of these experimental and instrumental techniques for the analysis of a novel biomaterial surface. Osteopontin, an extracellular matrix molecule involved in wound-healing processes, has been chosen as a relevant model protein to immobilize onto poly(2-hydroxyethyl methacrylate) [poly(HEMA)]. Electron spectroscopy for chemical analysis and time-of-Right secondary ion mass spectrometry were used to verify the surface chemistry and the presence of protein. Iodination of osteopontin yielded quantitative data supportive of dose-dependent immobilization. Enzyme-linked immunosorbent assay was also used to investigate the presence of osteopontin on poly(HEMA). Finally, the cell adhesive properties of immobilized osteopontin were confirmed by using a bovine aortic endothelial cell adhesion assay. The use of multiple tools to characterize the many facets of a biomaterial surface will undoubtedly improve our understanding of the surface and facilitate the amelioration of in vivo performance. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Natl ESCA, Seattle, WA 98195 USA.
   Univ Washington, Surface Anal Ctr Biomed Problems, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
FU NCRR NIH HHS [RR01296]
CR Beamson G., 1998, HIGH RESOLUTION XPS
   Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980
   DENHARDT DT, 2001, ANN REV PHARM TOXICO, V1, P7223
   Giachelli C.M., 1997, J BONE MINER METAB, V15, P179
   Giachelli CM, 1998, AM J PATHOL, V152, P353
   Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6
   GIACHELLI CM, 1998, CELL ADHESION MOL MA, P203
   HERMANSON G, 1996, BIOCONJUATE TECHNIQU
   HORBATSCH M, 1986, Z PHYS D ATOM MOL CL, V2, P183, DOI 10.1007/BF01429072
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P403, DOI 10.1002/jbm.820150311
   Kang JS, 2001, LANGMUIR, V17, P4352, DOI 10.1021/la001310y
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665
   LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214
   LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   Montdargent B, 2000, INFECT CONT HOSP EP, V21, P404, DOI 10.1086/501782
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   RATNER BD, 1972, J POLYM SCI A1, V10, P2425, DOI 10.1002/pol.1972.150100818
   Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083
   Senger DR, 1996, AM J PATHOL, V149, P293
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108
   Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   vanOss CJ, 1997, CURR OPIN COLLOID IN, V2, P503, DOI 10.1016/S1359-0294(97)80099-4
   VICKERMANN JC, 1998, STAT SIMS LIBRARY
   Wagner C. D., 1979, HDB XRAY PHOTOELECTR
NR 29
TC 31
Z9 31
U1 1
U2 14
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2003
VL 67A
IS 1
BP 334
EP 343
DI 10.1002/jbm.a.10060
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 729ER
UT WOS:000185760300039
PM 14517893
DA 2018-10-19
ER

PT J
AU Delmar-Greenberg, D
   Ali, MA
   Gonsalves, KE
AF Delmar-Greenberg, D
   Ali, MA
   Gonsalves, KE
TI Non cell adhesive photopolymerized cross-linked layers (I): synthesis
   and characterization
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SWELLING BEHAVIOR; COPOLYMERIC HYDROGELS; PENETRANT DIFFUSION; SWELLABLE
   POLYMERS; PEPTIDES; SURFACES; BIOCOMPATIBILITY; FIBROBLAST; SOLUTE;
   FILMS
AB The aim of this study is to design an effective hydrogel, which has good potential for application in the field of tissue regeneration. Ultimately, the polymeric biomaterial will be used as a bottom, non-cell adhering layer of a polymeric scaffold, which will inhibit the adhesion and proliferation of fibroblast cells. A series of terpolymer hydrogels were prepared from MMA/HPOEM/MePOEM monomers based on varying formulations. The gels were polymerized via free radical polymerization under UV and characterized by TGA, DSC and FTIR studies. Furthermore, the double bond conversion, gel content and swelling properties of the polymer were analyzed and correlated to its crosslinking density, which revealed details about the hydrogel's character. Finally, cell culture experiments were used to compare the UV-cured polymer to its thermally derived non-functionalized polymer of the same formulation. Inverted optical microscopy was used to demonstrate cell-resistance of both materials with respect to a control Tissue Culture PolyStyrene plate. (C) 2003 Kluwer Acadamic Publishers.
C1 Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA.
   Univ N Carolina, CC Cameron Appl Res Ctr, Charlotte, NC 28223 USA.
RP Gonsalves, KE (reprint author), Univ N Carolina, Dept Chem, 9201 Univ City Blvd, Charlotte, NC 28223 USA.
OI Ali, Dr Azam/0000-0002-0136-6800
CR Ali MA, 2001, J APPL POLYM SCI, V79, P2156, DOI 10.1002/1097-4628(20010321)79:12<2156::AID-APP1023>3.0.CO;2-K
   De Groot CJ, 2001, BIOMATERIALS, V22, P1197, DOI 10.1016/S0142-9612(00)00266-0
   FRANSON NM, 1983, J APPL POLYM SCI, V28, P1299, DOI 10.1002/app.1983.070280404
   Hyun JH, 2002, LANGMUIR, V18, P2975, DOI 10.1021/la015712x
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   KORSMEYER RW, 1986, J POLYM SCI POL PHYS, V24, P409, DOI 10.1002/polb.1986.090240215
   Lee WF, 2001, J APPL POLYM SCI, V81, P1360, DOI 10.1002/app.1561
   Lee WF, 2000, J APPL POLYM SCI, V77, P1769, DOI 10.1002/1097-4628(20000822)77:8<1769::AID-APP14>3.0.CO;2-7
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   Park H, 1996, PHARMACEUT RES, V13, P1770, DOI 10.1023/A:1016012520276
   Pionteck J, 1998, ACTA POLYM, V49, P192, DOI 10.1002/(SICI)1521-4044(199804)49:4<192::AID-APOL192>3.0.CO;2-5
   PRIOLA A, 1993, PROG ORG COAT, V22, P301, DOI 10.1016/0033-0655(93)80032-6
   RATNER BD, 1981, BIOCOMPATIBILITY CLI, V2, pCH7
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   Sabino MA, 2002, J MATER SCI, V37, P35, DOI 10.1023/A:1013129421038
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   SHIEH LY, 1991, J APPL POLYM SCI, V42, P1579, DOI 10.1002/app.1991.070420611
NR 20
TC 5
Z9 5
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2003
VL 14
IS 10
BP 833
EP 841
DI 10.1023/A:1025670323657
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 719WY
UT WOS:000185229100002
PM 15348519
DA 2018-10-19
ER

PT J
AU Matthews, BD
   Pratt, BL
   Pollinger, HS
   Backus, CL
   Kercher, KW
   Sing, RF
   Heniford, BT
AF Matthews, BD
   Pratt, BL
   Pollinger, HS
   Backus, CL
   Kercher, KW
   Sing, RF
   Heniford, BT
TI Assessment of adhesion formation to intra-abdominal polypropylene mesh
   and polytetrafluoroethylene mesh
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE mini-laparoscopy; adhesions; ePTFE; polypropylene; biomaterial; ventral
   hernia repair; New Zealand white rabbit; laparoscopic surgery; hernia
ID LARGE INCISIONAL HERNIAS; ABDOMINAL-WALL DEFECTS; PERITONEAL ADHESIONS;
   LAPAROSCOPIC REPAIR; PROSTHESIS; PREVENTION; PATHOPHYSIOLOGY; REDUCTION;
   IMPLANT; SURGERY
AB Background. The development of intra-abdominal adhesions, bowel obstruction, and enterocutaneous fistulas are potentially severe complications related to the intraperitoneal placement of prosthetic biomaterials. The purpose of this study was to determine the natural history of adhesion formation to polypropylene mesh and two types of polytetrafluoroethylene (ePTFE) mesh when placed intraperitoneally in a rabbit model that simulates laparoscopic ventral hernia repair.
   Materials and methods. Thirty New Zealand white rabbits were used for this study. A 10-cm midline incision was performed for intra-abdominal access and a 2 cm x 2 cm piece of mesh (n = 60) was sewn to an intact peritoneum on each side of the midline. Two types of ePTFE mesh (Dual Mesh and modified Dual Mesh, W.L. Gore & Assoc., Flagstaff, AZ) and polypropylene mesh were compared. The rate of adhesion formation was evaluated by direct visualization using microlaparoscopy (2-mm endoscope/trocar) at 7 days, 3 weeks, 9 weeks, and 16 weeks after mesh implantation. Adhesions to the prosthetic mesh were scored for extent (%) using the Modified Diamond Scale (0 = 0%, 1 less than or equal to 25%, 2 = 25-50%, 3 > 50%). At necropsy the mesh was excised en bloc with the anterior abdominal wall for histological evaluation of mesothelial layer growth.
   Results. The mean adhesion score for the polypropylene mesh was significantly greater (P < 0.05) than Dual Mesh at 9 weeks and 16 weeks and modified Dual Mesh at 7 days, 9 weeks, and 16 weeks. Fifty-five percent (n = 11) of the polypropylene mesh had adhesions to small intestine or omentum at necropsy compared to 30% (n = 6) of the Dual Mesh and 20% (n = 4) of the modified Dual Mesh. There was a significantly greater percentage (P < 0.003) of ePTFE mesh mesothelialized at explant (modified Dual Mesh 44.2%; Dual Mesh 55.8%) compared to the polypropylene mesh (12.9%).
   Conclusions. Serial microlaparoscopic evaluation of intraperitoneally implanted polypropylene mesh and ePTFE mesh in a rabbit model revealed a progression of adhesions to polypropylene mesh over a 16 week period. The pore size of mesh is critical in the development and maintenance of abdominal adhesions and tissue ingrowth. The macroporous polypropylene mesh promoted adhesion formation, while the microporous nature of the visceral side of the ePTFE served as a barrier to adhesions. (C) 2003 Elsevier Inc. All rights reserved.
C1 Carolinas Med Ctr, Dept Gen Surg, Charlotte, NC 28203 USA.
   Carolinas Med Ctr, James B Cannon Res Ctr, Charlotte, NC 28203 USA.
RP Heniford, BT (reprint author), Carolinas Med Ctr, Dept Gen Surg, 1000 Blythe Blvd,MEB 601, Charlotte, NC 28203 USA.
CR Amid P. K., 2001, ABDOMINAL WALL HERNI, P272
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   BAUER JJ, 1987, ANN SURG, V206, P765, DOI 10.1097/00000658-198712000-00013
   Bellon JM, 1997, J BIOMATER APPL, V12, P121, DOI 10.1177/088532829701200203
   Bellon JM, 1997, WORLD J SURG, V21, P402, DOI 10.1007/PL00012261
   Bellon JM, 2001, WORLD J SURG, V25, P147, DOI 10.1007/s002680020069
   BERLINER SD, 1994, INGUINAL HERNIA ADV, P103
   BRELAND U, 1989, PERITONEUM PERITONEA, P122
   Carbajo MA, 2000, SURG ENDOSC-ULTRAS, V14, P408, DOI 10.1007/s004640000058
   *COMM CAR US LAB A, GUID CAR US LAB AN
   CUMBERLAND V H, 1952, Med J Aust, V1, P143
   DeCherney AH, 1997, SURG CLIN N AM, V77, P671, DOI 10.1016/S0039-6109(05)70574-0
   DiZerega GS, 1992, FEMALE REPROD SURG, P2
   DROLLETTE CM, 1992, J REPROD MED, V37, P107
   ELLIS H, 1982, BRIT J SURG, V69, P241, DOI 10.1002/bjs.1800690502
   Falk K, 2001, BRIT J SURG, V88, P286, DOI 10.1046/j.1365-2168.2001.01647.x
   HANEY AF, 1992, FERTIL STERIL, V57, P202
   Heniford BT, 2000, J AM COLL SURGEONS, V190, P645, DOI 10.1016/S1072-7515(00)00280-5
   HESSELINK VJ, 1993, SURG GYNECOL OBSTET, V176, P228
   Holmdahl L, 1997, Eur J Surg Suppl, P24
   Holzman MD, 1997, SURG ENDOSC-ULTRAS, V11, P32, DOI 10.1007/s004649900290
   Kossovsky N, 2001, ABDOMINAL WALL HERNI, P221
   Kyzer S, 1999, SURG ENDOSC-ULTRAS, V13, P928, DOI 10.1007/s004649901137
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149
   LINSKY CB, 1987, J REPROD MED, V32, P17
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   MENZIES D, 1990, ANN ROY COLL SURG, V72, P60
   MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127
   Myllarniemi H, 1967, Acta Chir Scand Suppl, V377, P13
   Park A, 1996, SURG LAPAROSC ENDOSC, V6, P123, DOI 10.1097/00019509-199604000-00007
   PARK A, 1999, HERNIA, V4, P209
   POSTLETHWAIT RW, 1970, ANN SURG, V171, P892, DOI 10.1097/00000658-197006010-00010
   Ramshaw BJ, 1999, AM SURGEON, V65, P827
   Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0
   RIGNAULT D, 1981, J CHIR-PARIS, V118, P673
   RIVES J, 1977, MINERVA CHIR, V32, P749
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   SMITH RS, 1971, SURG CLIN N AM, V51, P1387
   STOPPA RE, 1989, WORLD J SURG, V13, P545, DOI 10.1007/BF01658869
   Stoppa RE, 1989, HERNIA, P199
   USHER CF, 1964, HERNIA, P752
   VOELLER GR, 2001, ABDOMINAL WALL HERNI, P519
   WEIBEL MA, 1973, AM J SURG, V126, P345, DOI 10.1016/S0002-9610(73)80123-0
   WHITE RA, 1998, ASAIO, V11, P95
NR 45
TC 101
Z9 106
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD OCT
PY 2003
VL 114
IS 2
BP 126
EP 132
DI 10.1016/S0022-4804(03)00158-6
PG 7
WC Surgery
SC Surgery
GA 730LF
UT WOS:000185831700005
PM 14559437
DA 2018-10-19
ER

PT J
AU Weiser, AC
   Franco, I
   Herz, DB
   Silver, RI
   Reda, EF
AF Weiser, AC
   Franco, I
   Herz, DB
   Silver, RI
   Reda, EF
TI Single layered small intestinal submucosa in the repair of severe
   chordee and complicated hypospadias
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT 54th Annual Meeting of the American-Academy-of-Pediatrics
CY OCT 18-21, 2002
CL BOSTON, MASSACHUSETTS
SP Amer Acad Pediat
DE hypospadias; mucosa; intestinal; grafting; penis
ID CORRECTING PENILE CHORDEE; DERMAL GRAFTS; MANAGEMENT; CURVATURE
AB Purpose: Severe ventral chordee often accompanies proximal hypospadias. We describe our experience with single layered small intestinal submucosa (SIS), a commercially available, acellular, collagen based biomaterial, in the repair of severe chordee as part of a multistage approach to the repair of proximal hypospadias.
   Materials and Methods: Between 2001 and 2002, 9 boys with proximal hypospadias (penoscrotal to perineal) and severe ventral chordee (greater than 40 degrees) underwent SIS grafting to correct the curvature. In each case the urethral plate was transected at the point of maximal curvature, the defect in the corporal bodies was measured, and the SIS graft was cut 2 mm wider around the perimeter of the defect and sutured into place. Skin resurfacing of the ventral penis was performed in standard fashion using Byars flaps. Recurrence of chordee was assessed by an artificial penile erection test at the time of stage 2 reconstruction.
   Results: Of the 9 boys 8 underwent a planned 2-stage repair with subsequent urethroplasty 6 to 12 months after the initial stage 1 chordee repair. Median age at stage 1 repair of the 8 boys was 9 months. Native meatus location was penoscrotal in 6 boys, mid scrotal in 1 and perineal in 1. A 14 month-old boy underwent 1-stage chordee correction with SIS and a transverse preputial island tube graft urethroplasty for penoscrotal hypospadias. There were no perioperative medical or surgical complications related to use of SIS for chordee repair. Median age of the 8 boys at stage 2 repair was 18 months. At stage 2 the graft site was supple and smooth without significant scarring. All chordee correction has remained durable with followup ranging from 16 to 21 months. Postoperative complications occurred in 3 cases, including meatal stenosis requiring meatoplasty, subcoronal fistula requiring repair and complete breakdown of the neourethra in the single stage repair case.
   Conclusions: Although this study includes a small population of patients and has limited followup, our favorable experience with single layer SIS suggests that it is a safe and effective, commercially available material for corporal body grafting to correct severe chordee as part of a multistage surgical approach to repair complex hypospadias. A larger series of patients with longer followup is necessary to determine if the chordee correction remains durable. Our experience is insufficient to judge its efficacy in single stage repairs.
C1 Childrens Hosp, Westchester Med Ctr, Div Pediat Urol, Valhalla, NY USA.
   Schneider Childrens Hosp, Div Pediat Urol, New Hyde Pk, NY USA.
   Maimonides Hosp, Div Pediat Urol, Brooklyn, NY 11219 USA.
RP Franco, I (reprint author), 19 Bradhurst Ave,Suite 2575, Hawthorne, NY 10532 USA.
OI Franco, Israel/0000-0002-5675-873X
CR Caesar RE, 2000, J UROLOGY, V164, P1691, DOI 10.1016/S0022-5347(05)67084-X
   Hafez AT, 2001, J UROLOGY, V166, P1429, DOI 10.1016/S0022-5347(05)65802-8
   HORTON CE, 1993, J UROLOGY, V150, P452, DOI 10.1016/S0022-5347(17)35508-8
   Knoll LD, 2001, UROLOGY, V57, P753, DOI 10.1016/S0090-4295(00)01079-7
   KOGAN SJ, 1983, J UROLOGY, V130, P952, DOI 10.1016/S0022-5347(17)51591-8
   Kolligian ME, 2000, J UROLOGY, V164, P994, DOI 10.1016/S0022-5347(05)67235-7
   Kropp BP, 2002, J UROLOGY, V168, P1742, DOI 10.1097/01.ju.0000028154.79247.ca
   Lindgren BW, 1998, J UROLOGY, V160, P1128, DOI 10.1016/S0022-5347(01)62715-0
   PATTERSON RF, 2002, J UROLOGY, V168, P2253
   SOERGEL TM, 2003, J UROL S, V170
   Sugasi S, 2000, J UROLOGY, V164, P951, DOI 10.1016/S0022-5347(05)67224-2
   Vandersteen DR, 1998, J UROLOGY, V160, P1131, DOI 10.1016/S0022-5347(01)62716-2
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 13
TC 32
Z9 35
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 2003
VL 170
IS 4
BP 1593
EP 1595
DI 10.1097/01.ju.0000083863.01634.e1
PN 2
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 722WP
UT WOS:000185401300056
PM 14501669
DA 2018-10-19
ER

PT J
AU Barrere, F
   van der Valk, CM
   Dalmeijer, RAJ
   Meijer, G
   van Blitterswijk, CA
   de Groot, K
   Layrolle, P
AF Barrere, F
   van der Valk, CM
   Dalmeijer, RAJ
   Meijer, G
   van Blitterswijk, CA
   de Groot, K
   Layrolle, P
TI Osteogenecity of octacalcium phosphate coatings applied on porous metal
   implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biornimetic calcium phosphate coatings; octacalcium phosphate (OCP);
   carbonated apatite; porous metallic implants; osteogenecity;
   osteoinduction
ID PLASMA-SPRAYED COATINGS; COATED IMPLANTS; CALCIUM PHOSPHATES; TITANIUM
   IMPLANTS; CARBONATE APATITE; SURFACE-STRUCTURE; DENTAL IMPLANTS;
   CRYSTAL-GROWTH; BONE-FORMATION; IN-VITRO
AB The biomimetic route allows the homogeneous deposition of calcium phosphate (Ca-P) coatings on porous implants by immersion in simulated physiologic solution. In addition, various Ca-P phases, such as octacalcium phosphate (OCP) or bone-like carbonated apatite (BCA), which are stable only at low temperatures, can be deposited. In this pilot study, experiments were designed with a twofold-purpose: (1) to investigate the osteoinduction of OCP-coated and noncoated porous tantalum cylinders and of dense titanium alloy cylinders (5 mm in diameter and 10 mm in length) in the back muscle of goats at 12 and 24 weeks (n = 4); and (2) to compare the osteogenic potentials of BCA-coated, OCP-coated, and bare porous tantalum cylinders in a gap of 1 mm created in the femoral condyle of a goat at 12 weeks (n = 2). In the goat muscle, after 12 weeks the OCP-coated porous cylinder had induced ectopic bone as well as bone within the cavity of the OCP-coated dense titanium cylinder. In the femoral condyle, bone did not fill the gap in any of the porous implants. In contrast with the two other groups, OCP-coated porous cylinders exhibited bone formation in the center of the implant. The nature of the Ca-P coating, via its microstructure, its dissolution rate, and its specific interactions with body fluids, may influence the osteogenecity of the Ca-P biomaterial. (C) 2003 Wiley Periodicals, Inc.
C1 IsoTis NV, NL-3720 AB Bilthoven, Netherlands.
   Univ Twente, IBME, Enschede, Netherlands.
   Acad Hosp Utrecht, Utrecht, Netherlands.
   Leiden Univ, Biomat Res Grp, Leiden, Netherlands.
   Fac Dent Surg, INSERM, EM9903, Math Biol Inst, Nantes, France.
RP Layrolle, P (reprint author), IsoTis NV, Prof Bronkhorstlaan 10POB 98, NL-3720 AB Bilthoven, Netherlands.
RI Layrolle, Pierre/K-9257-2015; Meijer, G.J./H-8073-2014
OI Layrolle, Pierre/0000-0001-9800-5210; van Blitterswijk,
   Clemens/0000-0003-2371-4615
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Barrere F, 2003, J BIOMED MATER RES A, V64A, P378, DOI 10.1002/jbm.a.10291
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   Barrere F., 1999, BIOCERAMICS, V12, P125
   Barros LFM, 2000, SHOCK, V13, P67, DOI 10.1097/00024382-200013010-00012
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   Clemens JAM, 1998, J BIOMED MATER RES, V40, P341, DOI 10.1002/(SICI)1097-4636(19980605)40:3<341::AID-JBM1>3.3.CO;2-V
   COOK S D, 1992, Dental Clinics of North America, V36, P247
   Cook S D, 1991, Semin Arthroplasty, V2, P268
   De Bruijin J. D., 2000, BONE ENG, P421
   DEPORTER DA, 1990, J DENT RES, V69, P1138, DOI 10.1177/00220345900690050401
   DHERT WJA, 1993, J BIOMED MATER RES, V27, P127, DOI 10.1002/jbm.820270116
   Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Leeuwenburgh S, 2001, J BIOMED MATER RES, V56, P208, DOI 10.1002/1097-4636(200108)56:2<208::AID-JBM1085>3.0.CO;2-R
   Magan A, 1996, J CRANIOFAC SURG, V7, P71, DOI 10.1097/00001665-199601000-00016
   Ong JL, 1998, J BIOMED MATER RES, V39, P176, DOI 10.1002/(SICI)1097-4636(199802)39:2<176::AID-JBM2>3.0.CO;2-M
   Overgaard S, 1998, J ARTHROPLASTY, V13, P449, DOI 10.1016/S0883-5403(98)90011-0
   PILLIAR RM, 1991, J DENT RES, V70, P1338, DOI 10.1177/00220345910700100501
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Sakkers RJB, 1997, J BIOMED MATER RES, V36, P265, DOI 10.1002/(SICI)1097-4636(199708)36:2<265::AID-JBM16>3.0.CO;2-F
   Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P300
   Vargervik K., 1992, BONE GRAFTS BONE SUB, P112
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamasaki H., 1990, JPN J ORAL BIOL, V32, P190, DOI DOI 10.2330/JORALBIOSCI1965.32.190
   YUAN H, 2001, THESIS LEIDEN U
   YUAN H, 2000, BIOMATERIALS, V20, P1283
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
NR 44
TC 152
Z9 161
U1 2
U2 15
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2003
VL 66A
IS 4
BP 779
EP 788
DI 10.1002/jbm.a.10454
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717DB
UT WOS:000185069400007
PM 12926029
DA 2018-10-19
ER

PT J
AU Timmer, MD
   Ambrose, CG
   Mikos, AG
AF Timmer, MD
   Ambrose, CG
   Mikos, AG
TI Evaluation of thermal- and photo-crosslinked biodegradable
   poly(propylene fumarate)-based networks
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(propylene fumarate); free radical polymerization; network
   structure; mechanical properties; orthopedic biomaterial
ID BONE-CEMENT; POLYMERIZATION INITIATOR; LINKING CHARACTERISTICS;
   MECHANICAL-PROPERTIES; VIVO DEGRADATION; COMPOSITE; RESIN;
   FUMARATE)-DIACRYLATE; HYDROGELS; PRODUCTS
AB Biodegradable networks of poly(propylene fumarate) (PPF) and the crosslinking reagent poly(propylene fumarate)-diacrylate (PPF-DA) were prepared with thermal- and photo-initiator systems. Thermal-crosslinking was performed with benzoyl peroxide (BP), which is accelerated by N,N-dimethyl-p-toluidine (DMT) and enables injection and in situ polymerization. Photo-crosslinking was accomplished with bis(2,4,6-trimethylbenzoyl) phenylphosphine oxide (BAPO), which is activated by long-wavelength UV light and facilitates material processing with rapid manufacturing techniques, such as stereolithography. Networks were evaluated to assess the effects of the initiators and the PPF/PPF-DA double bond ratio on the mechanical properties. Regardless of the initiator system, the compressive properties of the PPF/PPF-DA networks increased as the double bond ratio decreased from 2 to 0.5. BAPO/UV-initiated networks were significantly stronger than those formed with BP/DMT. The compressive modulus of the photo- and thermal-crosslinked PPF/PPF-DA networks ranged from 310 +/- 25 to 1270 +/- 286 MPa and 75 +/- 8 to 332 +/- 89 MPa, respectively. The corresponding fracture strengths varied from 58 +/- 7 to 129 +/- 17 MPa and 31 +/- 13 to 105 +/- 12 MPa. The mechanical properties were not affected by the initiator concentration. Characterization of the network structures indicated that BAPO was a more efficient initiator for the crosslinking of PPF/PPF-DA, achieving a higher double bond conversion and crosslinking density than its BP counterpart. Estimated average molecular weights between crosslinks (M-c) confirmed the effects of the initiators and PPF/PPF-DA double bond ratio on the mechanical properties. This work demonstrates the capability to control the properties of PPF/PPF-DA networks as well as their versatility to be used as an injectable material or a prefabricated implant. (C) 2003 Wiley Periodicals, Inc.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Univ Texas, Hlth Sci Ctr, Dept Orthopaed Surg, Houston, TX 77030 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, MS-142, Houston, TX 77251 USA.
OI Ambrose, Catherine/0000-0002-3866-0683
FU NIDCR NIH HHS [R01 DE13031]
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Fini M, 1995, INT J ARTIF ORGANS, V18, P772
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Frazier DD, 1997, J BIOMED MATER RES, V35, P383, DOI 10.1002/(SICI)1097-4636(19970605)35:3<383::AID-JBM12>3.0.CO;2-G
   GRESSER JD, 1995, J BIOMED MATER RES, V29, P1241, DOI 10.1002/jbm.820291011
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Jan CM, 2001, J BIOMED MATER RES, V58, P42, DOI 10.1002/1097-4636(2001)58:1<42::AID-JBM60>3.0.CO;2-#
   Jockusch S, 1998, J AM CHEM SOC, V120, P11773, DOI 10.1021/ja982463z
   Kolczak U, 1996, J AM CHEM SOC, V118, P6477, DOI 10.1021/ja9534213
   Moreau MF, 1998, J BIOMED MATER RES, V40, P124, DOI 10.1002/(SICI)1097-4636(199804)40:1<124::AID-JBM14>3.0.CO;2-O
   Peppas NA, 1986, HYDROGELS MED PHARM, V1, P27
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Timmer MD, 2002, MACROMOLECULES, V35, P4373, DOI 10.1021/ma020028q
   Timmer MD, 2003, BIOMATERIALS, V24, P571, DOI 10.1016/S0142-9612(02)00368-X
   Urabe H, 1999, J ORAL REHABIL, V26, P442, DOI 10.1046/j.1365-2842.1999.00380.x
   Yoshida K, 1999, DENT MATER, V15, P332, DOI 10.1016/S0109-5641(99)00053-6
   Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5
   Zhang YL, 1999, J POLYM SCI POL CHEM, V37, P4554, DOI 10.1002/(SICI)1099-0518(19991215)37:24<4554::AID-POLA13>3.0.CO;2-T
NR 23
TC 53
Z9 53
U1 2
U2 20
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2003
VL 66A
IS 4
BP 811
EP 818
DI 10.1002/jbm.a.10011
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717DB
UT WOS:000185069400011
PM 12926033
DA 2018-10-19
ER

PT J
AU Luo, N
   Metters, AT
   Hutchison, JB
   Bowman, CN
   Anseth, KS
AF Luo, N
   Metters, AT
   Hutchison, JB
   Bowman, CN
   Anseth, KS
TI A methacrylated photoiniferter as a chemical basis for microlithography:
   Micropatterning based on photografting polymerization
SO MACROMOLECULES
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; RADICAL POLYMERIZATION; SURFACE-CHEMISTRY;
   COPOLYMERIZATION; INIFERTER; CELLS; N,N-DIETHYLDITHIOCARBAMATE;
   MICROFABRICATION; PROTEINS; DESIGN
AB A polymer patterning technology based on photografting polymerization mediated by photoiniferter chemistry is presented as a simple microlithographic technique that affords flexibility in fabricating and subsequently modifying polymer substrates with various chemistries. In principle, the technique relies upon the design and synthesis of a methacrylated photoiniferter, (methacryloyl ethylenedioxycarbonyl) benzyl N,N-diethyldithiocarbamate (HEMA-E-In). This photoiniferter allows the production of micropatterned polymer substrates with surface or internally grafted chemical modifications. The ability to modify surfaces with covalently bound polymer is demonstrated where the thickness of the layer depends on the exposure time. Furthermore, patterning chemical surface modifications was achieved by combining this process with photomasks to produce micron-sized features (approximately 20 Pro). The method is quite diverse and enables spatially controlled internal modification of polymer networks as demonstrated herein. The developed techniques should be very useful for the facile development of 2-D and 3-D patterned and surface-modified polymers for microfluidic and biomaterial applications.
C1 Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
   Univ Colorado, Hlth Sci Ctr, Sch Dent, Denver, CO 80262 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Metters, AT (reprint author), Clemson Univ, Dept Chem Engn, Clemson, SC 29634 USA.
RI Bowman, Christopher/B-1490-2008
OI Bowman, Christopher/0000-0001-8458-7723
CR Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553, DOI 10.1016/0956-5663(95)96931-N
   Higashi J, 1999, LANGMUIR, V15, P2080, DOI 10.1021/la9810511
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795
   Jung DR, 1998, J VAC SCI TECHNOL A, V16, P1183, DOI 10.1116/1.581256
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Lee HJ, 1999, J BIOMED MATER RES, V47, P564
   Lee HJ, 1999, MACROMOLECULES, V32, P6989, DOI 10.1021/ma990566b
   Luo N, 2002, MACROMOLECULES, V35, P2487, DOI 10.1021/ma011487e
   Luo N, 2002, J POLYM SCI POL CHEM, V40, P1885, DOI 10.1002/pola.10272
   Mrksich M, 1997, ACS SYM SER, V680, P361
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   Nakayama Y, 2002, LANGMUIR, V18, P2601, DOI 10.1021/la011415g
   Nakayama Y, 1999, LANGMUIR, V15, P5560, DOI 10.1021/la981581x
   Nakayama Y, 2000, J BIOMED MATER RES, V53, P584, DOI 10.1002/1097-4636(200009)53:5<584::AID-JBM19>3.0.CO;2-0
   OKAMURA S, 1960, J POLYM SCI, V43, P509, DOI 10.1002/pol.1960.1204314220
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P133
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P127
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Xia YN, 1996, CHEM MATER, V8, P601, DOI 10.1021/cm950464+
NR 27
TC 50
Z9 51
U1 1
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 9
PY 2003
VL 36
IS 18
BP 6739
EP 6745
DI 10.1021/ma0344341
PG 7
WC Polymer Science
SC Polymer Science
GA 719VB
UT WOS:000185224800010
DA 2018-10-19
ER

PT J
AU McNally, AK
   Anderson, JM
AF McNally, AK
   Anderson, JM
TI Foreign body-type multinucleated giant cell formation is potently
   induced by alpha-tocopherol and prevented by the diacylglycerol kinase
   inhibitor R59022
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID BIOMATERIAL SURFACE-CHEMISTRY; MANNOSE RECEPTOR ACTIVITY;
   SMOOTH-MUSCLE-CELL; VITAMIN-E; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC-ACID;
   MACROPHAGE ACTIVATION; HUMAN MONOCYTES; IN-VIVO; POLY(ETHERURETHANE
   UREA)
AB Multinucleated foreign body giant cells (FBGCs) form by monocyte-derived macrophage fusion on implanted biomedical devices and are believed to mediate oxidative damage to biomaterial surfaces. Our in vitro system of human macrophage culture and interleukin (IL)-4-induced FBGC formation was developed to study the macrophage fusion mechanism and the physiological significance of FBGCs on implanted biomaterials and at other sites of chronic inflammation. Here, we demonstrate that the antioxidant vitamin E (90% alpha-tocopherol) moderately induces macrophage fusion and increases IL-4-induced FBGC formation. Moreover, purified a-tocopherol, but not beta-, gamma-, or delta-tocopherol, most remarkably induces macrophage fusion, leading to cultures of confluent FBGCs below normal plasma concentrations. This is not observed with the similar antioxidants; probucol or Trolox, suggesting that the a-tocopherol effects on FBGC formation are independent of its antioxidant activity. Consistent with the reported activation of diacylglycerol kinase by a-tocopherol, the diacylglycerol kinase inhibitor R59022 completely abrogates FBGC formation. R59022 inhibition of IL-4-induced FBGC formation is reversed by alpha-tocopherol, suggesting that FBGC formation involves diacylglycerol kinase activation. This study suggests a novel role for diacylglycerol kinase in the mechanism of macrophage fusion/ FBGC formation at sites of chronic inflammation and reveals that the pleiotropic lipophilic compound, alpha-tocopherol, is a highly potent macrophage fusion factor.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [R01 HL055714, HL 55714]
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1988, ASAIO, V11, P101
   Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0
   Azzi A, 2000, J NUTR, V130, P1649
   Azzi A, 2002, FEBS LETT, V519, P8, DOI 10.1016/S0014-5793(02)02706-0
   Bauldry SA, 1997, BIOCHEM J, V322, P353, DOI 10.1042/bj3220353
   BLITTERSWIJK WJ, 2000, CELL SIGNAL, V12, P595
   Brigelius-Flohe R, 1999, FASEB J, V13, P1145
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chan SS, 2001, FREE RADICAL RES, V35, P843, DOI 10.1080/10715760100301341
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Devaraj S, 1996, J CLIN INVEST, V98, P756, DOI 10.1172/JCI118848
   ENELOW RI, 1992, AM J RESP CELL MOL, V6, P57
   English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2
   ESTERBAUER H, 1991, AM J CLIN NUTR S, V53, P314
   Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650
   Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096
   Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x
   HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789
   Harsh DM, 2001, BIOCHEM BIOPH RES CO, V282, P480, DOI 10.1006/bbrc.2001.4601
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   HEIPLE JM, 1990, CELL MOTIL CYTOSKEL, V15, P260, DOI 10.1002/cm.970150408
   HENSON PM, 1988, INFLAMMATION BASIC P, P363
   Islam KN, 1998, CIRCULATION, V98, P2255, DOI 10.1161/01.CIR.98.21.2255
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0
   Kodelja V, 1998, J IMMUNOL, V160, P1411
   Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002
   LANGHANS T, 1868, VIRCHOWS ARCH, V42, P382
   Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x
   Lee IK, 1999, DIABETES RES CLIN PR, V45, P183, DOI 10.1016/S0168-8227(99)00048-0
   Malefyt RW, 1999, INFLAMMATION BASIC P, P837
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MCNALLY AK, 1996, 5 WORLD BIOM C MAY 2
   MCNALLY AK, 2000, 6 WORLD BIOM C 2000
   MCNALLY AK, 1994, THESIS CASE W RESERV
   Morrissey PA, 1999, P NUTR SOC, V58, P459, DOI 10.1017/S0029665199000609
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807
   Mukherjee AK, 1997, CELL MOL LIFE SCI, V53, P152, DOI 10.1007/PL00000586
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Olorundare OE, 2001, BLOOD, V98, P117, DOI 10.1182/blood.V98.1.117
   Sakai T, 1999, J BIOL CHEM, V274, P15480, DOI 10.1074/jbc.274.22.15480
   Schubert MA, 1996, J BIOMED MATER RES, V32, P493, DOI 10.1002/(SICI)1097-4636(199612)32:4<493::AID-JBM1>3.3.CO;2-H
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   TAKASHIMA T, 1993, J IMMUNOL, V150, P3002
   Tasinato A, 1995, P NATL ACAD SCI USA, V92, P12190, DOI 10.1073/pnas.92.26.12190
   Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447
   Trach CC, 1996, EUR J CELL BIOL, V71, P199
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   Wang XY, 2000, MOL MEMBR BIOL, V17, P143, DOI 10.1080/09687680010000311
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
   ZHOU D, 1995, J BIOL CHEM, V270, P25549, DOI 10.1074/jbc.270.43.25549
NR 67
TC 41
Z9 43
U1 1
U2 1
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD SEP
PY 2003
VL 163
IS 3
BP 1147
EP 1156
DI 10.1016/S0002-9440(10)63474-8
PG 10
WC Pathology
SC Pathology
GA 714DB
UT WOS:000184896100035
PM 12937156
DA 2018-10-19
ER

PT J
AU Thompson, LO
   Loebe, M
   Noon, GP
AF Thompson, LO
   Loebe, M
   Noon, GP
TI What price support? Ventricular assist device induced systemic response
SO ASAIO JOURNAL
LA English
DT Review
ID MECHANICAL CIRCULATORY SUPPORT; NECROSIS-FACTOR-ALPHA; STAGE
   HEART-FAILURE; FAILING HUMAN HEART; COMPLEX CLASS-I; CARDIOPULMONARY
   BYPASS; INFLAMMATORY RESPONSE; IMPLANTABLE LVAD; T-CELLS; NEUROENDOCRINE
   ACTIVATION
AB Use of ventricular support systems has been associated with myriad systemic complications. Engendered by the blood-biomaterial interface of a unique host/device relationship, these complications include diverse humoral dyscrasias that frequently culminate in episodes of bleeding, hemolysis and thrombogenicity, heightened susceptibility to inflammation and infection, and transient immunal compromise. Recent endeavor in biocompatibility research has served to illustrate the critical role played by cellular, humoral, and neurohormonal components in regulating cytokine expression and has provided insight into the complexities involved in such biomechanical juxtapositions. The following is intended as a review of current literature attempting to address the many aspects of this host/device interaction and their consequences for the supported patient.
C1 Baylor Coll Med, Div Transplant Surg & Assist Devices, Dept Surg, Houston, TX 77030 USA.
RP Thompson, LO (reprint author), Scurlock Tower,Suite 1860,6560 Fannin St, Houston, TX 77030 USA.
CR American Heart Association, 2003, HEART DIS STROK STAT
   Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8
   Ankersmit HJ, 2002, J THORAC CARDIOV SUR, V123, P557, DOI 10.1067/mtc.2002.120011
   Argenziano M, 1997, J HEART LUNG TRANSPL, V16, P822
   Arusoglu L, 1999, ANN THORAC SURG, V68, P1875, DOI 10.1016/S0003-4975(99)01036-X
   Baufreton C, 1999, ANN THORAC SURG, V67, P972, DOI 10.1016/S0003-4975(98)01345-9
   Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34
   BERNHARD WF, 1969, SURGERY, V66, P284
   Birks EJ, 2000, CIRCULATION, V102, P352
   Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B
   Boyle EM, 1997, ANN THORAC SURG, V63, P277
   Brinkmann T, 1997, IMMUNOPHARMACOLOGY, V35, P221, DOI 10.1016/S0162-3109(96)00148-8
   Chen JC, 1998, ASAIO J, V44, pM682, DOI 10.1097/00002480-199809000-00076
   Choi L, 1999, J HEART LUNG TRANSPL, V18, P1103, DOI 10.1016/S1053-2498(99)00076-5
   Clubb FJ, 1999, ASAIO J, V45, P281
   Copeland JG, 1996, ANN THORAC SURG, V61, P376, DOI 10.1016/0003-4975(95)00995-7
   Corry DC, 1998, ASAIO J, V44, pM347, DOI 10.1097/00002480-199809000-00005
   Daniel PT, 1999, EXP HEMATOL, V27, P1402, DOI 10.1016/S0301-472X(99)00079-X
   Delgado R, 1998, ASAIO J, V44, P299
   Delgado RM, 1999, TEX HEART I J, V26, P28
   Deng MC, 1999, THORAC CARDIOV SURG, V47, P326, DOI 10.1055/s-2007-1013192
   Deswal A, 2001, CIRCULATION, V103, P2055
   Dibbs Z, 1999, P ASSOC AM PHYSICIAN, V111, P423
   Didisheim P, 2001, ASAIO J, V47, P195, DOI 10.1097/00002480-200105000-00004
   DURANTE W, 1994, BLOOD, V83, P1831
   Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9
   EDMUNDS LH, 2000, J CONGEST HEART FAIL, V1, P141
   Ernofsson M, 1996, THROMB RES, V83, P307, DOI 10.1016/0049-3848(96)00139-9
   Erren M, 2001, TRANSPLANT P, V33, P1965, DOI 10.1016/S0041-1345(00)02756-1
   Fischer SA, 1997, CLIN INFECT DIS, V24, P18, DOI 10.1093/clinids/24.1.18
   Giamarellou H, 2002, J HOSP INFECT, V50, P91, DOI 10.1053/jhin.2001.1144
   GOLDBERG SP, 2000, ASAIO J, V45, pS37
   Goldstein D J, 1995, ASAIO J, V41, P873, DOI 10.1097/00002480-199510000-00010
   Goldstein DJ, 1997, ANN THORAC SURG, V63, P971, DOI 10.1016/S0003-4975(96)01117-4
   Goldstein DJ, 1996, ANN THORAC SURG, V61, P692, DOI 10.1016/0003-4975(95)01041-6
   Gordon SM, 2001, ANN THORAC SURG, V72, P725, DOI 10.1016/S0003-4975(01)02888-0
   Gross DR, 1999, CARDIOVASC RES, V42, P45, DOI 10.1016/S0008-6363(99)00003-6
   Herrmann M, 1997, CIRCULATION, V95, P814
   Heverly D N, 2001, Ann Diagn Pathol, V5, P67, DOI 10.1053/adpa.2001.23019
   Holman WL, 1999, ANN THORAC SURG, V68, P711, DOI 10.1016/S0003-4975(99)00529-9
   Houel R, 1999, ANN THORAC SURG, V68, P717, DOI 10.1016/S0003-4975(99)00527-5
   Ichiyama T, 1999, J NEUROIMMUNOL, V99, P211, DOI 10.1016/S0165-5728(99)00122-8
   Itescu S, 2000, PROG CARDIOVASC DIS, V43, P67, DOI 10.1053/pcad.2000.7191
   JAMES KB, 1995, CIRCULATION, V92, P191, DOI 10.1161/01.CIR.92.9.191
   Janatova J, 2000, ASAIO J, V46, pS53, DOI 10.1097/00002480-200011000-00038
   Jett GK, 1999, ASAIO J, V45, P119
   Kapadia Samir, 1998, Cardiology Clinics, V16, P645, DOI 10.1016/S0733-8651(05)70041-2
   Kaplon RJ, 1999, J HEART LUNG TRANSPL, V18, P346, DOI 10.1016/S1053-2498(98)00066-7
   Kavarana MN, 2002, ANN THORAC SURG, V73, P745, DOI 10.1016/S0003-4975(01)03406-3
   Kawahito K, 1998, ARTIF ORGANS, V22, P348, DOI 10.1046/j.1525-1594.1998.06050.x
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   Kleesiek K, 1999, THROMB HAEMOSTASIS, V82, P1
   Koster A, 2000, ASAIO J, V46, P319, DOI 10.1097/00002480-200005000-00015
   Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718
   LIOTTA D, 1966, T AM SOC ART INT ORG, V12, P129
   Lipton JM, 1998, ANN NY ACAD SCI, V840, P373, DOI 10.1111/j.1749-6632.1998.tb09576.x
   Livingston ER, 1996, CIRCULATION, V94, P227
   Loebe M, 1998, ASAIO J, V44, pM340, DOI 10.1097/00002480-199809000-00004
   Loebe M, 1999, CURR OPIN CARDIOL, V14, P234, DOI 10.1097/00001573-199905000-00008
   Loebe M, 2001, ASAIO J, V47, P272, DOI 10.1097/00002480-200105000-00023
   Mann DL, 1999, LANCET, V353, P1812, DOI 10.1016/S0140-6736(99)90069-7
   Masai T, 2002, ANN THORAC SURG, V73, P549, DOI 10.1016/S0003-4975(01)03510-X
   Massad MG, 1997, ANN THORAC SURG, V64, P1120, DOI 10.1016/S0003-4975(97)00807-2
   McCarthy PM, 1996, ANN THORAC SURG, V61, P359, DOI 10.1016/0003-4975(95)00990-6
   McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4
   McTiernan C F, 2000, Curr Cardiol Rep, V2, P189, DOI 10.1007/s11886-000-0068-4
   Milting H, 1999, THORAC CARDIOV SURG, V47, P48, DOI 10.1055/s-2007-1013108
   Moazami N, 1997, ASAIO J, V43, P177
   Moazami N, 1998, J HEART LUNG TRANSPL, V17, P876
   Myers TJ, 2000, ASAIO J, V46, pS28, DOI 10.1097/00002480-200011000-00034
   Noirhomme P, 1999, EUR J CARDIO-THORAC, V16, P63, DOI 10.1016/S1010-7940(99)00140-2
   Noutsias M, 1999, CIRCULATION, V99, P2124, DOI 10.1161/01.CIR.99.16.2124
   Nurozler F, 2001, ANN THORAC SURG, V71, P614, DOI 10.1016/S0003-4975(00)01444-2
   Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603
   Oosterwegel MA, 1999, J IMMUNOL, V163, P2634
   *ORG PROC TRANSPL, 2003, DON REC US DON TYP
   Pacher R, 1996, J AM COLL CARDIOL, V27, P633, DOI 10.1016/0735-1097(95)00520-X
   Pagani FD, 2001, J HEART LUNG TRANSPL, V20, P646, DOI 10.1016/S1053-2498(01)00232-7
   Pavie A, 1999, ANN THORAC SURG, V68, P705, DOI 10.1016/S0003-4975(99)00628-1
   Piccione W, 2000, J HEART LUNG TRANSPL, V19, pS89, DOI 10.1016/S1053-2498(99)00110-2
   Potapov EV, 2001, ASAIO J, V47, P249, DOI 10.1097/00002480-200105000-00018
   REIS E, 1999, CURR OPIN IMMUNOL, V11, P392
   Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202
   RINDER CS, 1992, BLOOD, V79, P1201
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Rose EA, 1994, CIRCULATION, V90, P1187
   SAENGER S, 1999, ASAIO J, V45, P150
   SCHIRMER WJ, 1988, ARCH SURG-CHICAGO, V123, P316
   Schmid C, 1998, ANN THORAC SURG, V65, P1703, DOI 10.1016/S0003-4975(98)00299-9
   Schumann H, 1997, BIOCHEM BIOPH RES CO, V239, P794, DOI 10.1006/bbrc.1997.7555
   Schuster M, 2001, TRANSPLANT P, V33, P1960, DOI 10.1016/S0041-1345(00)02754-8
   SCOTTBURDEN T, 1998, CIRCULATION, V98, P339
   Serna DL, 1998, ASAIO J, V44, pM352, DOI 10.1097/00002480-199809000-00006
   Singh VK, 1999, IMMUNOL RES, V20, P147, DOI 10.1007/BF02786470
   Sinha P, 2000, CIRCULATION, V102, P194
   Sivaratnam K, 2002, ASAIO J, V48, P2, DOI 10.1097/00002480-200201000-00002
   Skinner JL, 2000, ASAIO J, V46, P587, DOI 10.1097/00002480-200009000-00016
   Skok J, 1999, J IMMUNOL, V163, P4284
   Spanier TB, 1999, J THORAC CARDIOV SUR, V118, P404, DOI 10.1016/S0022-5223(99)70176-5
   SPANIER TB, 1998, J HEART LUNG TRANSPL
   Takahama T, 1990, ASAIO Trans, V36, pM141
   Takeuchi K, 1999, J THORAC CARDIOV SUR, V117, P375, DOI 10.1016/S0022-5223(99)70436-8
   TERMUHLEN DF, 1989, CIRCULATION, V80, P174
   Thompson LO, 2001, J HEART LUNG TRANSPL, V20, P798, DOI 10.1016/S1053-2498(00)00250-3
   Torre-Amione G, 1999, CURR OPIN CARDIOL, V14, P206, DOI 10.1097/00001573-199905000-00003
   Torre-Amione G, 1999, CIRCULATION, V100, P1189, DOI 10.1161/01.CIR.100.11.1189
   TRONO R, 1978, ARTIF ORGANS, V2, P173, DOI 10.1111/j.1525-1594.1978.tb03448.x
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   Wan S, 1997, ANN THORAC SURG, V63, P269
   WANG DL, 1992, THROMB RES, V65, P757, DOI 10.1016/0049-3848(92)90114-P
   WANG IW, 1995, ASAIO J, V41, pM782, DOI 10.1097/00002480-199507000-00120
   Weipert J, 1997, J THORAC CARDIOV SUR, V114, P676, DOI 10.1016/S0022-5223(97)70061-8
   Weyand M, 1997, TRANSPLANT P, V29, P3327, DOI 10.1016/S0041-1345(97)00932-9
   Wickline SA, 2000, ASAIO J, V46, pS80, DOI 10.1097/00002480-200011000-00042
   Wilhelm CR, 1999, STROKE, V30, P2554, DOI 10.1161/01.STR.30.12.2554
   Woiciechowsky C, 1999, BRAIN RES, V816, P563, DOI 10.1016/S0006-8993(98)01238-4
   Wollert KC, 2000, CIRCULATION, V101, P1172, DOI 10.1161/01.CIR.101.10.1172
NR 117
TC 17
Z9 17
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD SEP-OCT
PY 2003
VL 49
IS 5
BP 518
EP 526
DI 10.1097/01.MAT.0000085672.42122.49
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 723NJ
UT WOS:000185438200007
PM 14524557
OA Bronze
DA 2018-10-19
ER

PT J
AU Belu, AM
   Graham, DJ
   Castner, DG
AF Belu, AM
   Graham, DJ
   Castner, DG
TI Time-of-flight secondary ion mass spectrometry: techniques and
   applications for the characterization of biomaterial surfaces
SO BIOMATERIALS
LA English
DT Review
DE TOF-SIMS; biomaterials; surface characterization; imaging; multivariate
   analysis
ID PRINCIPAL COMPONENT ANALYSIS; ADSORBED PROTEIN FILMS; RAY
   PHOTOELECTRON-SPECTROSCOPY; SELF-ASSEMBLED MONOLAYERS; ACTIVATED POLYMER
   SURFACE; PLASMA-DEPOSITED FILMS; TOF-SIMS; POLY(METHYL METHACRYLATE);
   STATIC SIMS; XPS
AB The surface of a biomaterial plays a critical role in the success of an implant. Much effort is currently being focused on controlling the chemistry at biomaterial surfaces to ensure favorable results in vivo. The successful tailoring of the surface chemistry will require a detailed surface characterization to verify that the desired changes have been made. This will include the ability to determine the composition, structure, orientation, and spatial distribution, of the molecules and chemical structures on the surface. TOF-SIMS is a powerful surface characterization technique that is able to address these requirements through both spectral analysis and direct chemical state imaging. The flexibility of the TOF-SIMS technique, and the wealth of data produced have generated much interest in its use for biomaterial characterization. This review discusses the strengths, weaknesses, and challenges of static TOF-SIMS for biomaterial surface characterization. First the basic principles of TOF-SIMS are introduced, giving an overview of the technique. Next, sample type, and other sample considerations are discussed. Then data interpretation is overviewed using examples from both spectral and imaging data. Finally, quantitative SIMS analysis is discussed and an outlook for TOF-SIMS analysis of biomaterials will be given. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem & Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Bioengn, Seattle, WA 98195 USA.
RP Castner, DG (reprint author), Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem & Engn, POB 351750, Seattle, WA 98195 USA.
FU NCRR NIH HHS [RR-01296]
CR BELU A, 2001, SURFACE BIOMATERIALS
   Belu AM, 2000, ANAL CHEM, V72, P5625, DOI 10.1021/ac000450+
   Belu AM, 2001, ANAL CHEM, V73, P143, DOI 10.1021/ac000771l
   BENNINGHOVEN A, 1994, SURF SCI, V299, P246, DOI 10.1016/0039-6028(94)90658-0
   BENNINGHOVEN A, 1973, SURF SCI, V35, P427, DOI 10.1016/0039-6028(73)90232-X
   BENNINGHOVEN A, 1970, Z PHYS, V230, P403, DOI 10.1007/BF01394486
   Beyec Y. L., 1998, INT J MASS SPECTROM, V174, P101
   BHATIA QS, 1990, SURF INTERFACE ANAL, V15, P388, DOI 10.1002/sia.740150608
   BRIGGS D, 1982, SURF INTERFACE ANAL, V4, P109, DOI 10.1002/sia.740040306
   BRIGGS D, 1988, POLYM COMMUN, V29, P6
   BRIGGS D, 1990, SURF INTERFACE ANAL, V15, P62, DOI 10.1002/sia.740150111
   Briggs D, 1996, SURF INTERFACE ANAL, V24, P419, DOI 10.1002/(SICI)1096-9918(199606)24:6<419::AID-SIA132>3.3.CO;2-P
   BRIGGS D, 1987, ORG MASS SPECTROM, V22, P91, DOI 10.1002/oms.1210220208
   BRIGGS D, 1990, PRACTICAL SURFACE AN, V2
   Briggs D., 1989, HDB STATIC SECONDARY
   BRINEN JS, 1991, SURF INTERFACE ANAL, V17, P63, DOI 10.1002/sia.740170202
   BROWN A, 1984, SURF INTERFACE ANAL, V6, P1, DOI 10.1002/sia.740060102
   BRUMMEL CL, 1994, SCIENCE, V264, P399, DOI 10.1126/science.8153627
   BRYAN SR, TOF SIMS ANAL DRUG P
   CHILKOTI A, 1990, J VAC SCI TECHNOL A, V8, P2274, DOI 10.1116/1.576750
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   DAVIES MC, 1988, SURF INTERFACE ANAL, V11, P591, DOI 10.1002/sia.740111202
   DAVIES MC, 1991, MACROMOLECULES, V24, P5508, DOI 10.1021/ma00020a004
   DAVIES N, 2003, APPL SURF SCI, P203
   Eynde XV, 1997, SURF INTERFACE ANAL, V25, P878
   Favia P., 1996, PLASMAS POLYM, V1, P299
   FRISBIE CD, 1995, LANGMUIR, V11, P2563, DOI 10.1021/la00007a040
   Galuska A, 1996, SURF INTERFACE ANAL, V24, P380, DOI 10.1002/(SICI)1096-9918(199606)24:6<380::AID-SIA128>3.0.CO;2-3
   GALUSKA AA, 1994, SURF INTERFACE ANAL, V21, P703, DOI 10.1002/sia.740211005
   GILLEN G, 1994, ANAL CHEM, V66, P2170, DOI 10.1021/ac00085a036
   GOLLEDGE SL, UNPUB
   Graham DJ, 2002, LANGMUIR, V18, P5861, DOI 10.1021/la0113062
   Graham DJ, 2002, LANGMUIR, V18, P1518, DOI 10.1021/la010059z
   GRAHAM DT, UNPUB
   HAGENHOFF B, 1992, J PHYS D APPL PHYS, V25, P818, DOI 10.1088/0022-3727/25/5/012
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   HEARN MJ, 1986, SURF INTERFACE ANAL, V9, P411
   Hyun J, 2001, LANGMUIR, V17, P6358, DOI 10.1021/la010695x
   IBACH H, 1994, SURF SCI, V299, P116, DOI 10.1016/0039-6028(94)90650-5
   JACKSON ST, 1992, J MATER CHEM, V2, P259, DOI 10.1039/jm9920200259
   JOHN CM, 1995, ANAL CHEM, V67, P3871, DOI 10.1021/ac00117a009
   Kotter F, 1998, APPL SURF SCI, V133, P47, DOI 10.1016/S0169-4332(97)00515-1
   Leufgen KM, 1996, LANGMUIR, V12, P1708, DOI 10.1021/la950614v
   LHOEST JB, 1995, MACROMOLECULES, V28, P4631, DOI 10.1021/ma00117a038
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   LINTON RW, 1993, SURF INTERFACE ANAL, V20, P991, DOI 10.1002/sia.740201210
   LUB J, 1989, J POLYM SCI POL PHYS, V27, P2071, DOI 10.1002/polb.1989.090271011
   McLafferty F.W., 1993, INTERPRETATION MASS
   Michel R, 2000, LANGMUIR, V16, P6503, DOI 10.1021/la991436z
   MUDDIMAN DC, 1994, ANAL CHEM, V66, P2362, DOI 10.1021/ac00086a023
   Muddiman DC, 1996, FRESEN J ANAL CHEM, V354, P103, DOI 10.1007/s002169600017
   NEWMAN JC, 1991, STATIC SIMS HDB POLY
   NIEHUIS E, 1987, J VAC SCI TECHNOL A, V5, P1243, DOI 10.1116/1.574781
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   Ratner BD, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P43
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Reed N. M., 1993, SURFACE CHARACTERIZA
   REICH DF, 1998, P 45 INT AVS S BALT
   ROHRER H, 1994, SURF SCI, V299, P956, DOI 10.1016/0039-6028(94)90709-9
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   SCHUELER BW, 1992, MICROSC MICROANAL M, V3, P119, DOI 10.1051/mmm:0199200302-3011900
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Somorjai GA, 1998, MRS BULL, V23, P11
   STIPDONK MJV, 2001, TOF SIMS SURFACE ANA, P309
   Sun F, 1996, J AM CHEM SOC, V118, P1856, DOI 10.1021/ja952225t
   THOMPSON PM, 1991, ANAL CHEM, V63, P2447, DOI 10.1021/ac00021a012
   TYLER BJ, 2001, IM PUBLICATIONS SURF, P475
   VanStipdonk MJ, 1996, RAPID COMMUN MASS SP, V10, P1987
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   Vickerman J. C., 1997, SURFACE ANAL PRINCIP
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   WALKER AV, 2003, APPL SURF SCI, P203
   Weng LT, 1995, SURF INTERFACE ANAL, V23, P879, DOI 10.1002/sia.740231305
   WILLSE A, SIMS, V11, P843
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   WONG SCC, 2003, APPL SURF SCI, P203
   Yang ZP, 2000, LANGMUIR, V16, P7482, DOI 10.1021/la0000623
   Zhuang HZ, 1996, MRS BULL, V21, P43
NR 82
TC 258
Z9 261
U1 14
U2 178
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2003
VL 24
IS 21
BP 3635
EP 3653
DI 10.1016/S0142-9612(03)00159-5
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 698HJ
UT WOS:000183992700001
PM 12818535
DA 2018-10-19
ER

PT J
AU Klee, D
   Ademovic, Z
   Bosserhoff, A
   Hoecker, H
   Maziolis, G
   Erli, HJ
AF Klee, D
   Ademovic, Z
   Bosserhoff, A
   Hoecker, H
   Maziolis, G
   Erli, HJ
TI Surface modification of poly(vinylidenefluoride) to improve the
   osteoblast adhesion
SO BIOMATERIALS
LA English
DT Article
DE PVDF; graft copolymerisation; CVD; osteoblasts
ID POLYVINYLIDENE FLUORIDE; CELL-ADHESION; BIOMATERIALS; INTEGRINS;
   PEPTIDES; PROTEINS; SUTURES
AB Cell adhesion to biomaterials is mediated primarily by the interaction between surface bound proteins and corresponding receptors on the membrane of the cells. The attachment of fibronectin onto poly(vinylidenefluoride) (PVDF) surface and the application of PVDF as biomaterial in bone contact was the subject of our study. PVDF is a biomaterial established for soft tissue applications. Surface modifications of PVDF were performed by plasma induced graft copolymerisation of acrylic acid or CVD polymerisation of 4-amino[2.2]paracyclophane. The provided functionalised PVDF surface was used to immobilise fibronectin using different techniques. All modification steps were verified by means of X-ray photoelectron spectroscopy (XPS), attenuated total reflection infrared spectroscopy (IR-ATR) and contact angle measurements. Surface topology was studied by atomic force measurements (AFM). Protein adsorption was controlled by enzyme linked immunosorbent assay (ELISA). Cell attachment was enhanced if physically adsorbed fibronectin was used, while enhanced attachment and proliferation were induced by covalently binding fibronectin to the surface modified PVDF. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Rhein Westfal TH Aachen, Dept Text Chem & Macromol Chem, D-52062 Aachen, Germany.
   Univ Hosp Aachen, Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany.
   Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany.
   Univ Hosp Aachen, Rhein Westfal TH Aachen, Clin Trauma Surg, D-52074 Aachen, Germany.
RP Klee, D (reprint author), Rhein Westfal TH Aachen, Dept Text Chem & Macromol Chem, Veltmanpl 8, D-52062 Aachen, Germany.
OI Bosserhoff, Anja/0000-0001-8147-394X
CR ALLEY MC, 1988, CANCER RES, V48, P589
   ALLEY MC, 1982, LIFE SCI, P3071
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   DRUMHELLER PD, 1996, BIOPR TECHNOL, V23, P273
   Hoffman A.S., 1996, BIOMATERIALS SCI INT, P124
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUGHES J, 1997, METHODS BONE BIOL, P1
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   KOBAYASHI H, 1991, CURR EYE RES, V10, P899, DOI 10.3109/02713689109020325
   Lahann J, 1999, J MATER SCI-MATER M, V10, P443, DOI 10.1023/A:1008939400812
   Lahann J, 1998, MACROMOL RAPID COMM, V19, P441, DOI 10.1002/(SICI)1521-3927(19980901)19:9<441::AID-MARC441>3.0.CO;2-G
   LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209
   Mary C, 1998, ASAIO J, V44, P199, DOI 10.1097/00002480-199805000-00015
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Steffens GCM, 2002, BIOMATERIALS, V23, P3523, DOI 10.1016/S0142-9612(02)00091-1
   UCHIDA E, 1993, LANGMUIR, V9, P1121, DOI 10.1021/la00028a040
   Urban E, 1994, ASAIO J, V40, P145
   VOELCKER N, 2001, J MATER SCI-MATER M, V12, P111
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
NR 22
TC 82
Z9 87
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2003
VL 24
IS 21
BP 3663
EP 3670
DI 10.1016/S0142-9612(03)00235-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 698HJ
UT WOS:000183992700003
PM 12818537
DA 2018-10-19
ER

PT J
AU Zhao, CS
   Liu, XD
   Nomizu, M
   Nishi, N
AF Zhao, CS
   Liu, XD
   Nomizu, M
   Nishi, N
TI Blood compatible aspects of DNA-modified polysulfone membrane-protein
   adsorption and platelet adhesion
SO BIOMATERIALS
LA English
DT Article
DE DNA; polysulfone membrane; protein adsorption; conformational change;
   platelet adhesion
ID POLY(2-METHOXYETHYLACRYLATE) PMEA; FIBRINOGEN ADSORPTION; SURFACE;
   IMMOBILIZATION; BIOMATERIALS; ACTIVATION; POLYMER; FTIR
AB DNA was used as a biomaterial to modify the polysulfone (PSf) membrane by blending it with PSf. The blood compatibility of the membranes was then investigated. The water contact angle decreased, and the hydrophilicity increased when a single strand DNA was blended with PSf. Because of the hydrophilic surface, the DNA-blended PSf membranes had a lower protein adsorption than the PSf membrane, but it was not significantly decreased due to the interaction between the DNA and proteins. Circular dichroism (CD) spectroscopy was used to examine the changes in the secondary structure of the proteins after adsorption onto the polymer surface and desorption from the polymer surface into the SDS solution. The conformation of the proteins adsorbed onto the PSf membrane and desorbed from the PSf membrane significantly changed, but that of the proteins for the DNA-blended PSf membranes differed only slightly from the native one. The number of platelets that adhered on the surface of the DNA-blended PSf membranes was reduced compared to that on the PSf membrane. This suggested that DNA can be regarded as a biopolymer to modify PSf, and contributes to the hydrophilic and hemocompatible wipers on the surface of the hydrophobic PSf membranes. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
RP Nishi, N (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan.
RI XiangDong, Liu/M-9548-2015
OI XiangDong, Liu/0000-0001-5262-0031
CR AKAIKE T, 1979, KOBUNSHI RONBUNSHU, V36, P217, DOI 10.1295/koron.36.217
   ALKHAMIS TM, 1990, BLOOD, V75, P1568
   ARMSTRONG JK, 1995, THROMB RES, V79, P437, DOI 10.1016/0049-3848(95)00134-D
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Bummer PM, 1996, INT J PHARM, V132, P143, DOI 10.1016/0378-5173(95)04344-6
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   Ehsani N, 1997, J MEMBRANE SCI, V123, P105, DOI 10.1016/S0376-7388(96)00207-4
   Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   Ishida T, 2001, POLYHEDRON, V20, P1545, DOI 10.1016/S0277-5387(01)00652-0
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   NISHIMURA T, 1993, BIOMEDICAL APPL POLY, P191
   PARK K, 1991, J BIOMED MATER RES, V25, P407, DOI 10.1002/jbm.820250311
   RABINOW BE, 1994, J BIOMAT SCI-POLYM E, V6, P91, DOI 10.1163/156856295X00788
   Serrano CV, 1997, J AM COLL CARDIOL, V29, P1276, DOI 10.1016/S0735-1097(97)00070-3
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M, 2002, COLLOID SURFACE A, V203, P195, DOI 10.1016/S0927-7757(01)01100-1
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
   Yamada M., 1999, NUCL ACIDS S SER, V42, P103
   Zhao CS, 2003, J MEMBRANE SCI, V214, P179, DOI 10.1016/S0376-7388(02)00524-0
   Zhao CS, 2001, ARTIF ORGANS, V25, P60
NR 25
TC 80
Z9 85
U1 4
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2003
VL 24
IS 21
BP 3747
EP 3755
DI 10.1016/S0142-9612(03)00250-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 698HJ
UT WOS:000183992700013
PM 12818547
DA 2018-10-19
ER

PT J
AU Gentleman, E
   Lay, AN
   Dickerson, DA
   Nauman, EA
   Livesay, GA
   Dee, KC
AF Gentleman, E
   Lay, AN
   Dickerson, DA
   Nauman, EA
   Livesay, GA
   Dee, KC
TI Mechanical characterization of collagen fibers and scaffolds for tissue
   engineering
SO BIOMATERIALS
LA English
DT Article
DE collagen; mechanical properties; composite; scaffold; ligament
ID MEDIAL COLLATERAL LIGAMENT; RAT-TAIL TENDON; ANTERIOR CRUCIATE LIGAMENT;
   HUMAN PATELLAR TENDON; ACL RECONSTRUCTION; TENSILE FAILURE; MATRIX;
   CELLS; MODEL; IMPLANTATION
AB Engineered tissues must utilize scaffolding biomaterials that support desired cellular functions and possess or can develop appropriate mechanical characteristics. This study assessed properties of collagen as a scaffolding biomaterial for ligament replacements. Mechanical properties of extruded bovine achilles tendon collagen fibers were significantly affected by fiber diameter, with smaller fibers displaying higher tangent moduli and peak stresses. Mechanical properties of 125 mum-diameter extruded fibers (tangent modulus of 359.6+/-28.4MPa; peak stress of 36.0+/-5.4MPa) were similar to properties reported for human ligaments. Scaffolds of extruded fibers did not exhibit viscoelastic creep properties similar to natural ligaments. Collagen fibers from rat tail tendon (a well-studied comparison material) displayed characteristic strain-softening behavior, and scaffolds of rat tail fibers demonstrated a non-intuitive relationship between tangent modulus and specimen length. Composite scaffolds (extruded collagen fibers cast within a gel of Type 1 rat tail tendon collagen) were maintained with and without fibroblasts under standard culture conditions for 25 days; cell-incorporated scaffolds displayed significantly higher tangent moduli and peak stresses than those without cells. Because tissue-engineered products must possess appropriate mechanical as well as biological/chemical properties, data front this study should help enable the development of improved tissue analogues. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Tulane Univ, Lindy Boggs Ctr, Dept Biomed Engn, New Orleans, LA 70118 USA.
RP Dee, KC (reprint author), Tulane Univ, Lindy Boggs Ctr, Dept Biomed Engn, New Orleans, LA 70118 USA.
OI Gentleman, Eileen/0000-0003-0447-5137; Dee, Kay C/0000-0002-9069-4880
CR Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   BUTLER DL, 1986, J BIOMECH, V19, P425, DOI 10.1016/0021-9290(86)90019-9
   BUTLER DL, 1990, J BIOMECH ENG-T ASME, V112, P38, DOI 10.1115/1.2891124
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   DANTO MI, 1993, J ORTHOP RES, V11, P58, DOI 10.1002/jor.1100110108
   DUNN MG, 1995, J BIOMED MATER RES, V29, P1363, DOI 10.1002/jbm.820291107
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   DUNN MG, 1994, J ORTHOPAED RES, V12, P128, DOI 10.1002/jor.1100120116
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   GOULET F, 1997, PRINCIPLES TISSUE EN, P634
   HAUT RC, 1983, J BIOMECH ENG-T ASME, V105, P296, DOI 10.1115/1.3138422
   HAUT RC, 1986, J BIOMECH, V19, P951, DOI 10.1016/0021-9290(86)90190-9
   Hori Y, 2001, ASAIO J, V47, P206, DOI 10.1097/00002480-200105000-00008
   HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184
   Huss FRM, 2001, CELLS TISSUES ORGANS, V169, P361, DOI 10.1159/000047903
   KASTELIC J, 1980, J BIOMECH, V13, P887, DOI 10.1016/0021-9290(80)90177-3
   KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   Knezevic V, 2002, BIOMECH MODEL MECHAN, V1, P59, DOI 10.1007/s10237-002-0005-0
   Koski JA, 2000, ORTHOP CLIN N AM, V31, P437, DOI 10.1016/S0030-5898(05)70162-0
   Langelier E, 1999, ANN BIOMED ENG, V27, P67, DOI 10.1114/1.166
   LAW JK, 1989, J BIOMED MATER RES, V23, P961, DOI 10.1002/jbm.820230902
   Quapp KM, 1998, J BIOMECH ENG-T ASME, V120, P757, DOI 10.1115/1.2834890
   RIGBY BJ, 1959, J GEN PHYSIOL, V43, P265, DOI 10.1085/jgp.43.2.265
   Rothenburger M, 2001, THORAC CARDIOV SURG, V49, P204, DOI 10.1055/s-2001-16108
   SANJEEVI R, 1982, J BIOMECH, V15, P181, DOI 10.1016/0021-9290(82)90250-0
   Silver FH., 1994, BIOMATERIALS MED DEV
   Thornton GM, 2002, J ORTHOPAED RES, V20, P346, DOI 10.1016/S0736-0266(01)00100-0
   Thornton GM, 2002, J ORTHOP RES, V20, P967, DOI 10.1016/S0736-0266(02)00028-1
   VIIDIK A, 1972, BIOL COLLAGEN, P257
   Woo S L, 1983, J Orthop Res, V1, P22, DOI 10.1002/jor.1100010104
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Zaleskas JM, 2001, EXP CELL RES, V270, P21, DOI 10.1006/excr.2001.5325
NR 35
TC 213
Z9 219
U1 3
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2003
VL 24
IS 21
BP 3805
EP 3813
DI 10.1016/S0142-9612(03)00206-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 698HJ
UT WOS:000183992700019
PM 12818553
DA 2018-10-19
ER

PT J
AU Shu, XZ
   Liu, YC
   Palumbo, F
   Prestwich, GD
AF Shu, XZ
   Liu, YC
   Palumbo, F
   Prestwich, GD
TI Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent
   mimic of the extracellular matrix for in vitro cell growth
SO BIOMATERIALS
LA English
DT Article
DE hyaluronic acid; gelatin; disulfide; cell growth; biomaterial
ID DENATURED THIOLATED COLLAGEN; FUNCTIONALIZED DERIVATIVES;
   CHEMICAL-MODIFICATION; DRUG-DELIVERY; ACID; PROTEIN; BIOMATERIALS;
   ADHESIONS; LINKING; ATTACHMENT
AB A new disulfide crosslinking method was developed for the preparation of blended hyaluronan (HA)-gelatin hydrogels to form a synthetic, covalently linked mimic of the extracellular matrix (ECM). The HA and gelatin were chemically modified using 3,3'dithiobis(propionic hydrazide) (DTP). After reduction with dithiothreitol (DTT), the thiol derivatives of HA (HA-DTPH) and gelatin (gelatin-DTPH) were obtained and characterized. To minimize interference with biological function, the degree of substitution of HA-DTPH and gelatin-DTPH was kept below 50%. Solutions of HA-DTPH and gelatin-DTPH in varying blends (20%, 40%. 60%3 80% gelatin) were prepared in 1% w/v NaCl and crossfinked by disulfide bond formation in air. Hydrogel films were dried and further crossfinked with dilute hydrogen peroxide. Disulfide crossfinked HA-DTPH, gelatin-DTPH, and blends thereof, were degradable enzymatically by collagenase and by hyaluronidase (HAse). The rapid digestion of the crosslinked 100% gelatin-DTPH film by collagenase was significantly retarded by the presence of 20% or 40% HA-DTPH. Addition of at least 40% w/v gelatin into the 100% HA-DTPH films significantly improved the attachment and spreading of Balb/c 3T3 murine fibroblasts seeded on the surface of the hydrogel. These results demonstrate that disulfide-crosslinked HA-gelatin hydrogels, a new type of covalent synthetic ECM constitute biocompatible and biodegradable substrata for cell culture in vitro. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA.
   Univ Palermo, Dipartimento Chim & Tecnol Farmaceut, I-90123 Palermo, Italy.
RP Prestwich, GD (reprint author), Univ Utah, Dept Med Chem, 419 Wakara Way,Suite 205, Salt Lake City, UT 84108 USA.
EM gprestwich@pharm.utah.edu
CR Balazs E A, 1986, US patent, Patent No. [4582865, 4,582,865]
   BALAZS EA, 1987, Patent No. 4713448
   Band PA, 1998, WENN GR INT, V72, P33
   BENESCH R, 1958, P NATL ACAD SCI USA, V44, P848, DOI 10.1073/pnas.44.9.848
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   BUTTERWORTH PH, 1967, ARCH BIOCHEM BIOPHYS, V118, P716, DOI 10.1016/0003-9861(67)90409-2
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   CAPOZZI G, 1974, CHEM THIOL GROUP 2, P785
   Cheung WF, 1999, BIOCHEM SOC T, V27, P135, DOI 10.1042/bst0270135
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   COELHO AM, 1974, J CELL PHYSL, V83, P379
   Dowthwaite GP, 1998, J HISTOCHEM CYTOCHEM, V46, P641, DOI 10.1177/002215549804600509
   ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343
   Hu M, 2000, TISSUE ENG, V6, P585, DOI 10.1089/10763270050199532
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   IIO K, 1994, J BIOMED MATER RES, V28, P459, DOI 10.1002/jbm.820280408
   Jackson JK, 2002, PHARM RES-DORDR, V19, P411, DOI 10.1023/A:1015175108183
   Jiang HL, 2001, J APPL POLYM SCI, V80, P1416, DOI 10.1002/app.1231
   KENCHINGTON AW, 1958, BIOCHEM J, V68, P458, DOI 10.1042/bj0680458
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Leach RE, 1998, FERTIL STERIL, V69, P415, DOI 10.1016/S0015-0282(97)00573-6
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Miller JA, 1997, J BIOMED MATER RES, V38, P25, DOI 10.1002/(SICI)1097-4636(199721)38:1<25::AID-JBM4>3.0.CO;2-J
   Moriyama K, 1999, J CONTROL RELEASE, V59, P77, DOI 10.1016/S0168-3659(98)00183-7
   Nicolas FL, 1997, BIOMATERIALS, V18, P807, DOI 10.1016/S0142-9612(97)00002-1
   Nicolas FL, 1997, BIOMATERIALS, V18, P815, DOI 10.1016/S0142-9612(97)00003-3
   Ohya S, 2001, BIOMACROMOLECULES, V2, P856, DOI 10.1021/bm010040a
   PARK JM, 1992, MACROMOLECULES, V25, P290, DOI 10.1021/ma00027a047
   Piacquadio D, 1997, J AM ACAD DERMATOL, V36, P544, DOI 10.1016/S0190-9622(97)70241-X
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   Prestwich GD, 2000, INT CONGR SER, V1196, P181
   Prestwich GD, 2001, BIOMATERIALS CHEM MO
   Preswich GD, 1998, PHARM SCI TECHNOL TO, V1, P42
   Ramamurthi A, 2002, J BIOMED MATER RES, V60, P196
   Sawada T, 1999, HUM REPROD, V14, P1470, DOI 10.1093/humrep/14.6.1470
   Shu XZ, 2001, INT J PHARM, V212, P19, DOI 10.1016/S0378-5173(00)00582-2
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tomihata K, 1997, J POLYM SCI POL CHEM, V35, P3553, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3553::AID-POLA22>3.0.CO;2-D
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Yamauchi K, 2001, BIOMATERIALS, V22, P855, DOI 10.1016/S0142-9612(00)00249-0
   Yoldemir T, 2002, FERTIL STERIL, V78, P335, DOI 10.1016/S0015-0282(02)03224-7
NR 52
TC 210
Z9 212
U1 15
U2 160
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2003
VL 24
IS 21
BP 3825
EP 3834
DI 10.1016/S0142-9612(03)00267-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 698HJ
UT WOS:000183992700021
PM 12818555
DA 2018-10-19
ER

PT J
AU Nakata, M
   Pavcnik, D
   Uchida, BT
   VanAlstine, W
   Timmermans, HA
   Toyota, N
   Terada, M
   Brountzos, E
   Kaufman, JA
   Keller, FS
   Rosch, J
AF Nakata, M
   Pavcnik, D
   Uchida, BT
   VanAlstine, W
   Timmermans, HA
   Toyota, N
   Terada, M
   Brountzos, E
   Kaufman, JA
   Keller, FS
   Rosch, J
TI Comparison of small intestinal submucosa-covered and noncovered nitinol
   stents with PTFE endografts in injured ovine femoral arteries: A pilot
   study
SO CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
LA English
DT Article
DE endovascular stent-grafts; neointima; super-ficial femoral arteries;
   nitinol stent; animal model; neointima biomaterial
ID ILIAC ARTERIES; PALMAZ STENTS; VENOUS VALVE; SQUARE STENT; MODEL; SHEEP;
   DOG; HYPERPLASIA; RESTENOSIS; GRAFT
AB The purpose of this study was to compare performance of small intestinal submucosa (SIS)-covered endografts (SCEs) to polytetra-fluoroethylene (PTFE)-covered endografts (PCEs) and to bare nitinol stents (BSs) in injured sheep femoral artery (FA). Bare Zilver 6 mm x 40 mm nitinol stents (n = 6), Zilver stents covered with SIS (n = 6), and Palmaz stents 6 mm x 37 mm covered with PTFE (n = 6) were implanted in the balloon-injured FAs of nine female sheep. Follow-up arteriograms were obtained before animal sacrifice at 1, 3 and 6 months, with three animals at each time point. The FAs with the implanted device were explanted for histologic studies and morphologic measurements. Stent implantation was technically successful in all sheep. All BS and SCEs were patent at each time point. Five BSs and five SCEs exhibited formation of progressive eccentric intimal hyperplasia (IH) that was more advanced in SCE at 6 months. Cross-sectional area narrowing averaged 60% for BSs and 67% for SCEs. One BS, one SCE and two patent PCEs exhibited mild-to-moderate formation of concentric IH. Four PCS occluded one at 1 month, two at 3 months and one at 6 months. Performance of the devices placed into sheep FAs depended on their relation to the curving peri-articular portion of the FA during extremity flexion. BSs and SCEs placed in this portion exhibited progressive growth of eccentric IH while PCEs placed in this portion occluded.
C1 OHSU, Dotter Intervent Inst, Res Labs, Portland, OR USA.
   Osaka City Univ, Dept Radiol, Osaka 558, Japan.
   Purdue Univ, Anim Dis Diagnost Lab, W Lafayette, IN 47907 USA.
RP Pavcnik, D (reprint author), OHSU, Dotter Intervent Inst, Res Labs, Portland, OR USA.
CR Anderson P G, 1992, Cardiovasc Pathol, V1, P263, DOI 10.1016/1054-8807(92)90037-O
   Andrews RT, 1999, J VASC INTERV RADIOL, V10, P1219, DOI 10.1016/S1051-0443(99)70222-8
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Barth KH, 1996, CIRCULATION, V93, P2161, DOI 10.1161/01.CIR.93.12.2161
   GETTY R, 1975, SISSON GROSSMANS ANA, P994
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Marin ML, 1996, J VASC INTERV RADIOL, V7, P651, DOI 10.1016/S1051-0443(96)70823-0
   Pavcnik D, 2000, MINIM INVASIV THER, V9, P287, DOI 10.1080/13645700009169659
   Pavcnik D, 2000, J VASC INTERV RADIOL, V11, P1227, DOI 10.1016/S1051-0443(07)61369-4
   Pavcnik D, 2002, J VASC SURG, V35, P598, DOI 10.1067/mva.2002.118825
   Pavcnik D, 2001, CARDIOVASC INTER RAD, V24, P207, DOI 10.1007/s00270-001-0041-7
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   Toyota N, 2002, J VASC INTERV RADIOL, V13, P489, DOI 10.1016/S1051-0443(07)61529-2
   Yamada K, 2001, CARDIOVASC INTER RAD, V24, P99, DOI 10.1007/s002700000400
NR 17
TC 12
Z9 12
U1 0
U2 0
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0174-1551
J9 CARDIOVASC INTER RAD
JI Cardiovasc. Interv. Radiol.
PD SEP-OCT
PY 2003
VL 26
IS 5
BP 459
EP 467
PG 9
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 745PT
UT WOS:000186697600008
PM 14753305
DA 2018-10-19
ER

PT J
AU Gingras, M
   Bergeron, J
   Dery, J
   Durham, HD
   Berthod, F
AF Gingras, M
   Bergeron, J
   Dery, J
   Durham, HD
   Berthod, F
TI In vitro development of a tissue-engineered model of peripheral nerve
   regeneration to study neurite growth
SO FASEB JOURNAL
LA English
DT Article
DE axon guidance; biomaterial; peripheral nervous system; keratinocytes;
   NGF
ID SCHWANN-CELL INVASION; LONG-TERM CULTURE; NEUROTROPHIC FACTOR; SENSORY
   NEURONS; COLLAGEN SPONGE; SKIN EQUIVALENT; AXONAL GROWTH; FIBROBLASTS;
   OUTGROWTH; EXPRESSION
AB A unique tissue-engineered model of peripheral nerve regeneration was developed in vitro to study neurite outgrowth. Mouse dorsal root ganglia neurons were seeded on a collagen sponge populated with human endothelial cells and/or human fibroblasts. Addition of nerve growth factor (NGF; 10 ng/ml) was not required for sensory neurons survival but was necessary to promote neurite outgrowth, as assessed by immunostaining of the 150 kDa neurofilament. A vigorous neurite elongation was detected inside the reconstructed tissue after 14 and 31 days of neurons culture, reaching up to 770 mum from day 14. Axons were often observed closely associated with the capillary-like tubes reconstructed in the model, in a similar pattern as in the human dermis. The presence of endothelial cells induced a significant increase of the neurite elongation after 14 days of culture. The addition of human keratinocytes totally avoided the twofold decrease in the amount of neurites observed between 14 and 31 days in controls. Besides the addition of NGF, axonal growth did not necessitate B27 supplement or glial cell coculture to be promoted and stabilized for long-term culture. Thus, this model might be a valuable tool to study the effect of various cells and/or attractive or repulsive molecules on neurite outgrowth in vitro.
C1 Univ Laval, CHA, Hop St Sacrement, Lab Organogenese Expt, Quebec City, PQ G1S 4L8, Canada.
   McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.
RP Berthod, F (reprint author), Univ Laval, CHA, Hop St Sacrement, Lab Organogenese Expt, 1050 Chemin St Foy, Quebec City, PQ G1S 4L8, Canada.
EM berthod@chg.ulaval.ca
CR ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2
   AUGER FA, 1995, IN VITRO CELL DEV-AN, V31, P432
   Backstrom E, 2000, J IMMUNOL, V165, P4895, DOI 10.4049/jimmunol.165.9.4895
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Becq H, 1999, J NEUROSCI RES, V58, P553, DOI 10.1002/(SICI)1097-4547(19991115)58:4<553::AID-JNR8>3.0.CO;2-8
   Berthod F, 1996, J BIOMED MATER RES, V32, P87, DOI 10.1002/(SICI)1097-4636(199609)32:1<87::AID-JBM10>3.0.CO;2-F
   Berthod F, 1997, J INVEST DERMATOL, V108, P737, DOI 10.1111/1523-1747.ep12292122
   BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Berthod F, 1997, SKIN SUBSTITUTE PROD, P23
   Black AF, 1998, FASEB J, V12, P1331
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Byers M R, 1992, Growth Factors, V6, P41, DOI 10.3109/08977199209008870
   Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Cheng B, 2002, MICROSURG, V22, P133, DOI 10.1002/micr.21740
   D'Arcangelo D, 2000, CIRC RES, V86, P312, DOI 10.1161/01.RES.86.3.312
   DANIELSEN N, 1988, J NEUROSCI RES, V20, P320, DOI 10.1002/jnr.490200306
   Doroudchi MM, 1996, J NEUROPATH EXP NEUR, V55, P246, DOI 10.1097/00005072-199602000-00013
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008
   Edoff K, 2002, J NEUROSCI RES, V67, P255, DOI 10.1002/jnr.10092
   GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7
   Gotz ME, 2002, J NEURAL TRANSM, V109, P597, DOI 10.1007/s007020200049
   Hudon V, 2003, BRIT J DERMATOL, V148, P1094, DOI 10.1046/j.1365-2133.2003.05298.x
   Jerregard H, 2001, J NEUROCYTOL, V30, P327, DOI 10.1023/A:1014460413884
   KNOOPS B, 1991, BRAIN RES, V540, P183, DOI 10.1016/0006-8993(91)90506-Q
   Lee YS, 2002, J NEUROTRAUM, V19, P357, DOI 10.1089/089771502753594927
   Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037
   Lillesaar C, 2001, NEUROSCI LETT, V308, P161, DOI 10.1016/S0304-3940(01)01997-8
   Luo FR, 1999, CANCER CHEMOTH PHARM, V44, P29, DOI 10.1007/s002800050941
   Ma Weiya, 2000, Journal of Neurocytology, V29, P249, DOI 10.1023/A:1026519720352
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2
   Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8
   Padilla F, 1999, J NEUROSCI RES, V58, P270
   Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5
   Pincelli C, 1997, J INVEST DERMATOL, V109, P757, DOI 10.1111/1523-1747.ep12340768
   Pinney E, 2000, J CELL PHYSIOL, V183, P74, DOI 10.1002/(SICI)1097-4652(200004)183:1<74::AID-JCP9>3.0.CO;2-G
   Rangappa N, 2000, J BIOMED MATER RES, V51, P625, DOI 10.1002/1097-4636(20000915)51:4<625::AID-JBM10>3.0.CO;2-U
   Ruscheweyh R, 2001, NEUROSCIENCE, V107, P275, DOI 10.1016/S0306-4522(01)00354-2
   Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034
   Snow DM, 2002, J NEUROBIOL, V51, P285, DOI 10.1002/neu.10060
   SODERSTROM S, 1995, TOXICOL LETT, V75, P133, DOI 10.1016/0378-4274(94)03176-8
   Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9
   Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x
   Steinbrech DS, 1999, ANN PLAS SURG, V42, P514, DOI 10.1097/00000637-199905000-00009
   Terman GW, 2001, J NEUROPHYSIOL, V85, P485
   Vikman KS, 2001, J NEUROSCI METH, V105, P175, DOI 10.1016/S0165-0270(00)00360-5
   Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Yu XJ, 2001, J NEUROSCI RES, V66, P303, DOI 10.1002/jnr.1225
NR 53
TC 26
Z9 26
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD SEP
PY 2003
VL 17
IS 12
BP 2124
EP +
DI 10.1096/fj.02-1180fje
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 732DG
UT WOS:000185925100022
PM 12958159
DA 2018-10-19
ER

PT J
AU Kazimoglu, C
   Bolukabsi, S
   Kanatli, U
   Senkoylu, A
   Altun, NS
   Babac, C
   Yavuz, H
   Piskin, E
AF Kazimoglu, C
   Bolukabsi, S
   Kanatli, U
   Senkoylu, A
   Altun, NS
   Babac, C
   Yavuz, H
   Piskin, E
TI A novel biodegradable PCL film for tendon reconstruction: Achilles
   tendon defect model in rats
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE polycaprolactone; tendon prosthesis
ID FUNCTIONAL INDEX; COMPOSITES; LACTIDE; REPAIR
AB This study aims to investigate applicability of poly(E-caprolactone) (PCL) biodegradable films for repair of gaps in Achilles tendons in a rat model, also comparing surgical repair versus no repair approaches. PCL was synthesized with tailor-made properties, then, PCL films were prepared by solvent casting. Seventy-five outbred Sprague-Dawley rats were randomly allocated into five groups: (i) sham operated (skin incision only); (ii) no repair (complete division of the Achilles tendon and plantaris tendon without repair); (iii) Achilles repair (with a modified Kessler type suture); and (iv) plasty of Achilles tendon defects with the biodegradable PCL films, and (v) animals subjected to 1cm, mid-substance defect with no repair. Functional performance was determined from the measurements of hindpaw prints utilizing the Achilles functional index. The animals were killed 8 weeks after surgery and histological and biomechanical evaluations were made. All groups subjected to Achilles tendon division had a significant functional impairment that gradually improved so that by day 28 there were no functional impairments in any group whereas animals with a defect remained impaired. The magnitude of the biomechanical and morphological changes at postoperative 8 weeks were similar for no repair group (conservative), Achilles repair group and tendonplasty group (biodegradable PCL film group). The initial rate of functional recovery was significantly different for primary suture, Achilles repair group and PCL film group (p>0.01). But, at the 28th day, functional recovery was quite similar to the other groups. In summary, our results suggest that the PCl film can be an alternative biomaterial for tendon replacement.
C1 Gazi Univ, Fac Med, Orthoped & Traumatol Dept, TR-06510 Ankara, Turkey.
   Middle E Tech Univ, Med Ctr, TR-06531 Ankara, Turkey.
   Hacettepe Univ, Ctr Excellence, Dept Chem Engn, Ankara, Turkey.
   Hacettepe Univ, Ctr Excellence, Bioengn Div, Ankara, Turkey.
RP Bolukabsi, S (reprint author), Gazi Univ, Fac Med, Orthoped & Traumatol Dept, TR-06510 Ankara, Turkey.
OI Kanatli, Ulunay/0000-0002-9807-9305
CR AMIS AA, 1984, J BONE JOINT SURG BR, V66, P131
   *ASTM, 88297 ASTM D
   BABAC C, 2002, THESIS HACETTEPE U
   BEST TM, 1993, J ORTHOP RES, V11, P897, DOI 10.1002/jor.1100110617
   DEMEDINACELLI L, 1992, EXP NEUROL, V7, P634
   DONALT L, 1999, ANIMAL MODELS ORTHOP, P461
   GIARDINO R, 1995, INT J ARTIF ORGANS, V18, P225
   HOWARD CB, 1985, J BONE JOINT SURG BR, V67, P313
   LOWDON IMR, 1988, J NEUROSCI METH, V24, P279, DOI 10.1016/0165-0270(88)90173-2
   Meek MF, 1997, INT J ARTIF ORGANS, V20, P463
   Murray G A, 1979, J Biomed Eng, V1, P177, DOI 10.1016/0141-5425(79)90040-2
   Murrell G A, 1993, Foot Ankle, V14, P400
   MURRELL GAC, 1992, J ORTHOPAED RES, V10, P398, DOI 10.1002/jor.1100100313
   RODKEY WG, 1985, AM J SPORT MED, V13, P242, DOI 10.1177/036354658501300405
   Sato M, 2000, J Orthop Sci, V5, P256, DOI 10.1007/s007760050161
   Senkoylu A, 2002, INT J ARTIF ORGANS, V25, P1174
   Ural E, 2000, BIOMATERIALS, V21, P2147, DOI 10.1016/S0142-9612(00)00098-3
   Valente M, 2002, INT J ARTIF ORGANS, V25, P777
   WRIGHT PE, 2003, CAMPBELLS OPERATIVE, P3428
   Yavuz H, 2002, POLYM DEGRAD STABIL, V75, P431, DOI 10.1016/S0141-3910(01)00242-7
   YAVUZ H, 2002, IN PRESS J POLYM ENV
NR 21
TC 13
Z9 15
U1 0
U2 7
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2003
VL 26
IS 9
BP 804
EP 812
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 734JN
UT WOS:000186052300003
PM 14655860
DA 2018-10-19
ER

PT J
AU Zhu, Y
   Wang, XH
   Cui, FZ
   Feng, QL
   De Groot, K
AF Zhu, Y
   Wang, XH
   Cui, FZ
   Feng, QL
   De Groot, K
TI In vitro cytocompatibility and osteoinduction of phosphorylated chitosan
   with osteoblasts
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE phosphorylated chitosan (P-chitosan); cytocompatibility; osteoinduction;
   osteoblasts; bone forming
ID PARTIALLY DEACETYLATED CHITIN; CALCIUM-PHOSPHATE CEMENTS; FUNCTIONAL
   POLYMERS; IMPLANT MATERIALS; BONE-CELLS; CULTURE; DERIVATIVES; COLLAGEN;
   INVITRO; ASSAY
AB The cytocompatibility and osteoinduction of water-soluble phosphorylated chitosan (P-chitosan), that was modified by PO32- groups, with neonatal rat osteoblasts in vitro was studied. To identify the biocompatibility of P-chitosan with osteoblasts, the biofunctions of osteoblast cells, in the presence of three different concentrations of P-chitosan solutions as culture media and DMEM with 10% FBS as controls, were determined. The osteoblast differences in the P-chitosan solutions and on chitosan films were also investigated with immunocytochemistry. It was found, based on the ALP activity and mineralization assay that water-soluble P-chitosan has excellent cytocompatibility compared to the chitosan without phosphorylated modification. P-chitosan concentrations as high as 2% had a significant influence on cytocompatibility and osteoinduction; one tissue (or derived product) caused a second undifferentiated tissue to differentiate into bone. Water-soluble P-chitosan could be a promising osteoinductive biomaterial for tissue engineering and orthopedic uses.
C1 Tsinghua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
   Leiden Univ, Biomat Res Grp, NL-3723 MB Bilthoven, Netherlands.
RP Cui, FZ (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
EM cuifz@mail.tsinghua.edu.cn
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   AUFMKOLK B, 1985, CALCIFIED TISSUE INT, V37, P228, DOI 10.1007/BF02554868
   BECKER J, 1986, J HISTOCHEM CYTOCHEM, V34, P1417, DOI 10.1177/34.11.3772076
   BELOWS CG, 1982, J CELL BIOL, V92, P452
   BRONWYN MK, 2000, DEV BRAIN RES, V120, P199
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   COLLIN P, 1992, CALCIFIED TISSUE INT, V50, P175, DOI 10.1007/BF00298797
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   GERSTENFELD LC, 1988, J CELL BIOL, V106, P979, DOI 10.1083/jcb.106.3.979
   LIEBERHERR M, 1973, BIOCHIM BIOPHYS ACTA, V293, P160, DOI 10.1016/0005-2744(73)90387-2
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   MUZZARELLI RAA, 1977, CHITIN
   NISHI N, 1987, INT J BIOL MACROMOL, V9, P109, DOI 10.1016/0141-8130(87)90035-3
   NISHI N, 1986, INT J BIOL MACROMOL, V8, P311, DOI 10.1016/0141-8130(86)90046-2
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Ripamonti U, 1996, MRS BULL, V21, P36
   SAKAGUCHI T, 1981, AGR BIOL CHEM TOKYO, V45, P2191, DOI 10.1080/00021369.1981.10864862
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Siggelkow H, 1998, CLIN CHIM ACTA, V272, P111, DOI 10.1016/S0009-8981(98)00007-2
   SRINGA E, 1996, BONE, V16, P663
   THOMAS JW, 2000, BIOMATERIALS, V21, P1803
   WALSH S, 1994, J BONE MINER RES, V9, P1687
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   WERGEDAL JE, 1984, P SOC EXP BIOL MED, V176, P60
   WIESTNER M, 1981, EXP CELL RES, V133, P115, DOI 10.1016/0014-4827(81)90362-1
   Xu J, 1996, MACROMOLECULES, V29, P3436, DOI 10.1021/ma951638b
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 30
TC 15
Z9 15
U1 2
U2 11
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD SEP
PY 2003
VL 18
IS 5
BP 375
EP 390
DI 10.1177/088391103039020
PG 16
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 744CD
UT WOS:000186609600004
DA 2018-10-19
ER

PT J
AU Meredith, JC
   Sormana, JL
   Keselowsky, BG
   Garcia, AJ
   Tona, A
   Karim, A
   Amis, EJ
AF Meredith, JC
   Sormana, JL
   Keselowsky, BG
   Garcia, AJ
   Tona, A
   Karim, A
   Amis, EJ
TI Combinatorial characterization of cell interactions with polymer
   surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE combinatorial; osteoblasts; polymer; tissue engineering; surface
   interactions
ID OSTEOBLAST-LIKE CELLS; GEOMETRIC CONTROL; MATRIX PRODUCTION; SHAPE;
   ROUGHNESS; DIFFERENTIATION; BEHAVIOR; GROWTH; 1-ALPHA,25-(OH)(2)D-3;
   RESPONSIVENESS
AB We report a novel combinatorial methodology for characterizing the effects of polymer surface features on cell function. Libraries containing hundreds to thousands of distinct chemistries, microstructures, and roughnesses are prepared using composition spread and temperature gradient techniques. The method enables orders of magnitude increases in discovery rate, decreases variance, and allows for the first time high-throughput assays of cell response to physical and chemical surface features. The technique overcomes complex variable spaces that limit development of biomaterial surfaces for control of cell function. This report demonstrates these advantages by investigating the sensitivity of osteoblasts to the chemistry, microstructure, and roughness of poly(D,L-lactide) and poly(epsilon-caprolactone tone) blends. In particular, we use the phenomenon of heat-induced phase separation in these polymer mixtures to generate libraries with diverse surface features, followed by culture of UMR-106 and MC3T3-E1 osteoblasts on the libraries. Surface features produced at a specific composition and process temperature range were discovered to enhance dramatically alkaline phosphatase expression in both cell lines, not previously observed for osteoblasts on polymer blends.
C1 Georgia Inst Technol, Sch Chem Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Georgia Tech, Emory Dept Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Woodrow Sch Mech Engn, Atlanta, GA 30332 USA.
   NIST, Div Biotechnol, Gaithersburg, MD 20899 USA.
   NIST, Div Polymer, Gaithersburg, MD 20899 USA.
RP Meredith, JC (reprint author), Georgia Inst Technol, Sch Chem Engn, 311 Ferst Dr, Atlanta, GA 30332 USA.
RI Keselowsky, Benjamin/A-8000-2009; Meredith, Carson/B-3323-2009
OI Meredith, Carson/0000-0003-2519-5003
CR Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chicurel M, 2001, NATURE, V412, P580, DOI 10.1038/35088146
   Chicurel ME, 1998, NATURE, V392, P730
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Gruber R, 2000, BIOCHEM BIOPH RES CO, V270, P1080, DOI 10.1006/bbrc.2000.2573
   Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   MCGEERUSSELL SM, 1958, J HISTOCHEM CYTOCHEM, V6, P22, DOI 10.1177/6.1.22
   Meredith JC, 2000, MACROMOLECULES, V33, P5760, DOI 10.1021/ma0004662
   Meredith JC, 2000, MACROMOLECULES, V33, P9747, DOI 10.1021/ma001298g
   Meredith JC, 2000, MACROMOL CHEM PHYSIC, V201, P733, DOI 10.1002/(SICI)1521-3935(20000301)201:6<733::AID-MACP733>3.3.CO;2-X
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   Park A, 1996, J BIOMED MATER RES, V31, P117
   PARTRIDGE NC, 1981, ENDOCRINOLOGY, V108, P213, DOI 10.1210/endo-108-1-213
   Ranucci CS, 1999, TISSUE ENG, V5, P407, DOI 10.1089/ten.1999.5.407
   Recum A F, 1996, Tissue Eng, V2, P241, DOI 10.1089/ten.1996.2.241
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SODEK J, 1987, METHOD ENZYMOL, V145, P303
   TAMS J, 1995, BIOMATERIALS, V16, P1409, DOI 10.1016/0142-9612(95)96877-3
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   vanLeeuwen JPTM, 1996, BBA-MOL CELL RES, V1312, P55, DOI 10.1016/0167-4889(96)00016-X
   Wieland M, 2002, J BIOMED MATER RES, V60, P434, DOI 10.1002/jbm.10059
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
NR 33
TC 126
Z9 128
U1 2
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2003
VL 66A
IS 3
BP 483
EP 490
DI 10.1002/jbm.a.10004
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717RV
UT WOS:000185104800007
PM 12918030
DA 2018-10-19
ER

PT J
AU Schmidt, S
   Haase, G
   Csomor, E
   Lutticken, R
   Peltroche-Llacsahuanga, H
AF Schmidt, S
   Haase, G
   Csomor, E
   Lutticken, R
   Peltroche-Llacsahuanga, H
TI Inhibitor of complement, Compstatin, prevents polymer-mediated Mac-1
   up-regulation of human neutrophils independent of biomaterial type
   tested
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; complement; Compstatin; neutrophil; Mac-1 adhesion receptor
ID EXTRACORPOREAL-CIRCULATION; INFLAMMATORY RESPONSE; ARTIFICIAL SURFACES;
   PROTEIN ADSORPTION; OXYGEN RADICALS; IN-VITRO; ACTIVATION; RELEASE; C3;
   HEMODIALYSIS
AB The inflammatory reaction after cell contact with polymer materials is primarily mediated by activated neutrophils and may, in some cases, lead to exhaustion of neutrophil cell function. A direct consequence of this can be impairment of local or even systemic host defense mechanisms, which in turn can result in foreign body infections. Neutrophil activation, as indicated by the up-regulation of the Mac-1 adhesion receptor, is a reliable parameter for estimating the inflammatory risk due to implanted biomaterials. Because at blood contact, biomaterials immediately acquire a material-specific layer of blood proteins on their surface, including fibrinogen, complement, and immunoglobulin G, it is generally believed that after biomaterial contact, neutrophil activation primarily occurs by interaction with this protein layer. In this study, using our recently established polymer bead in vitro assay, we investigated whether complement inhibition alone can reduce biomaterial-mediated neutrophil activation, independent of the type of polymer and, hence, also its surface chemistry. Complement inhibition was achieved by using Compstatin, a recently developed complement inhibitor that binds to the complement component C3 preventing C3 convertase formation. We revealed significantly reduced (pless than or equal to0.025) Mac-I receptor expression levels after 45 min of blood contact with the following polymers (without and with Compstatin): 1. polyurethane, 98.3%, 13.6%; 2. polymethylmetacrylate, 88.5%, 11.0%; and poly-D,L-lactide, 71.8%, 8.4%. Although these three polymer types acquire material-specific protein layers because of their different surface chemistry, complement inhibition by Compstatin alone proved to be sufficient to reduce neutrophil activation after surface contact, thus reducing the risk of biomaterial-mediated inflammatory reaction.
C1 Univ Hosp RWTH, Inst Med Mikrobiol, D-52057 Aachen, Germany.
RP Peltroche-Llacsahuanga, H (reprint author), Univ Hosp RWTH, Inst Med Mikrobiol, Pauwelsstr 30, D-52057 Aachen, Germany.
RI Haase, Gerhard/C-6492-2009
OI Haase, Gerhard/0000-0001-7771-3189
CR ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   Fiane AE, 1999, XENOTRANSPLANTATION, V6, P52, DOI 10.1034/j.1399-3089.1999.00007.x
   Furlong ST, 2000, IMMUNOPHARMACOLOGY, V48, P199, DOI 10.1016/S0162-3109(00)00205-8
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   HAEFFNERCAVAILLON N, 1987, J IMMUNOL, V139, P794
   Higgins PJ, 1997, J IMMUNOL, V158, P2872
   HIMMELFARB J, 1995, J LAB CLIN MED, V126, P392
   HLADY V, 1993, CLIN MATER, V13, P85, DOI 10.1016/0267-6605(93)90094-N
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   INO Y, 1987, INT J IMMUNOPHARMACO, V9, P533, DOI 10.1016/0192-0561(87)90120-2
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   JANATOVA J, 2000, ASAIO J, V46, P53
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   KAM CM, 1992, J IMMUNOL, V149, P163
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Lazar HL, 1999, CIRCULATION, V100, P1438, DOI 10.1161/01.CIR.100.13.1438
   LUNDGREN B, 1992, J CATARACT REFR SURG, V18, P65, DOI 10.1016/S0886-3350(13)80385-9
   Maxfield A, 2000, HEALTH EDUC RES, V15, P463, DOI 10.1093/her/15.4.463
   Nilsson B, 1998, BLOOD, V92, P1661
   Peltroche-Llacsahuanga H, 2001, J IMMUNOL METHODS, V258, P13, DOI 10.1016/S0022-1759(01)00468-9
   Rinder CS, 1999, CIRCULATION, V100, P553, DOI 10.1161/01.CIR.100.5.553
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   SACKS T, 1978, J CLIN INVEST, V61, P1161, DOI 10.1172/JCI109031
   Sahu A, 1996, J IMMUNOL, V157, P884
   Schmidmaier G, 2001, BONE, V28, P341, DOI 10.1016/S8756-3282(00)00456-7
   Sirolli V, 2000, INT J ARTIF ORGANS, V23, P356
   Soulika AM, 2000, CLIN IMMUNOL, V96, P212, DOI 10.1006/clim.2000.4903
   Sundaram S, 1996, BIOMATERIALS, V17, P1041, DOI 10.1016/0142-9612(96)84681-3
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1994, CELL MATER, V4, P429
   Trindade MCD, 1999, J BIOMED MATER RES, V47, P1
   van Eeden SF, 1999, J IMMUNOL METHODS, V232, P23, DOI 10.1016/S0022-1759(99)00148-9
   WARD RA, 1994, NEPHROL DIAL TRANSPL, V9, P46
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 41
TC 16
Z9 16
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2003
VL 66A
IS 3
BP 491
EP 499
DI 10.1002/jbm.a.10031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717RV
UT WOS:000185104800008
PM 12918031
DA 2018-10-19
ER

EF